data_2klb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2klb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 57.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.375 -0.232 . . . . 50.140000000000001 110.375 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.721 HD11 HG23 ' A' ' 142' ' ' VAL . 30.3 mm 69.96 103.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.971 -174.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -90.13 106.58 3.35 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.211 -0.518 . . . . 65.319999999999993 112.969 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.611 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -83.09 116.1 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.53 0.681 . . . . 75.040000000000006 111.705 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.497 ' HB3' HD23 ' A' ' 36' ' ' LEU . 63.0 m-85 -89.98 113.25 24.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.715 -0.675 . . . . 74.439999999999998 110.467 176.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 36.8 p90 -137.84 -178.59 5.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.146 0.498 . . . . 74.25 112.01 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 10' ' ' TYR . 23.8 t -126.87 111.94 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.145 -0.48 . . . . 72.0 111.004 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.851 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 46.6 t -61.9 -26.33 68.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.19 0.811 . . . . 72.329999999999998 113.19 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.38 -64.5 1.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.285 0.564 . . . . 65.349999999999994 112.42 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.4 ' H ' HG12 ' A' ' 7' ' ' VAL . 19.8 t80 -71.6 127.26 31.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.855 -0.611 . . . . 74.340000000000003 112.247 -171.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.91 -161.98 7.44 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 114.994 0.758 . . . . 36.75 114.994 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -87.35 7.22 29.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.04 0.385 . . . . 74.430000000000007 112.04 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.502 ' HB2' ' HE1' ' A' ' 59' ' ' MET . 32.1 t -46.87 -40.85 14.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.115 0.783 . . . . 63.039999999999999 113.115 -171.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.851 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 20.1 p-10 -67.38 -41.63 84.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.143 0.497 . . . . 65.349999999999994 111.526 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -68.19 -36.66 79.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.174 -0.466 . . . . 73.040000000000006 110.819 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.85 -44.79 96.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.313 0.578 . . . . 71.219999999999999 110.375 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.85 87.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.806 -0.634 . . . . 72.140000000000001 111.303 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.96 -44.06 91.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.589 -0.278 . . . . 44.329999999999998 111.083 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -43.17 82.23 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.006 0.432 . . . . 61.109999999999999 111.158 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.41 -58.71 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.152 -0.476 . . . . 63.350000000000001 111.846 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.657 HG13 ' HB ' ' A' ' 31' ' ' VAL . 13.4 tt -60.02 -48.92 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 111.903 0.334 . . . . 74.120000000000005 111.903 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -66.65 -39.26 88.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.542 0.201 . . . . 74.439999999999998 111.542 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.47 95.02 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.891 -0.671 . . . . 72.040000000000006 112.644 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 29' ' ' VAL . 59.9 mt -83.04 -35.71 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.17 0.433 . . . . 61.399999999999999 112.17 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.8 p -69.12 -39.58 78.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.006 -0.434 . . . . 45.43 111.054 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.35 -43.07 78.74 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.097 0.475 . . . . 73.299999999999997 110.094 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.3 m -63.0 -43.01 99.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 111.028 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.54 67.44 0.33 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.222 -0.513 . . . . 63.109999999999999 113.619 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 24' ' ' ILE . 62.5 t -139.37 -68.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 122.525 -0.397 . . . . 70.120000000000005 111.71 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.93 113.14 2.94 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.28 -0.486 . . . . 73.140000000000001 112.814 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.657 ' HB ' HG13 ' A' ' 21' ' ' ILE . 82.2 t -109.65 144.42 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.686 0.279 . . . . 55.219999999999999 111.698 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 18.2 m-20 -93.38 147.47 22.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 64.450000000000003 110.986 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.73 132.28 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 112.431 0.53 . . . . 74.219999999999999 112.431 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 86.9 t -141.49 125.02 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.035 -0.529 . . . . 73.209999999999994 111.026 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.5 m-20 -85.73 99.77 11.55 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.007 -0.433 . . . . 62.030000000000001 111.935 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -69.78 -21.12 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.027 0.442 . . . . 52.5 111.675 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' HD13 ' A' ' 36' ' ' LEU . . . -114.64 23.63 11.86 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.651 -0.785 . . . . 62.340000000000003 113.805 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.87 -72.95 0.11 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.73 0.641 . . . . 73.200000000000003 112.73 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.01 23.47 1.22 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.184 0.809 . . . . 74.540000000000006 113.184 -172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.0 m -57.84 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.645 0.736 . . . . 73.209999999999994 112.25 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.77 171.59 14.94 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.87 -0.605 . . . . 75.040000000000006 110.448 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.27 -36.25 60.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.306 0.242 . . . . 60.450000000000003 111.242 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -57.17 -36.27 70.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.034 0.383 . . . . 55.229999999999997 112.034 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -69.04 -46.28 68.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.394 0.616 . . . . 62.32 110.519 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' O ' HG22 ' A' ' 49' ' ' VAL . 82.2 mt -61.52 -36.81 81.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.768 -0.651 . . . . 73.349999999999994 111.309 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' NH2' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.55 -46.97 85.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 110.288 177.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 7.7 tp10 -66.39 -37.95 86.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.951 0.405 . . . . 65.420000000000002 110.877 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 tp -57.63 -30.48 65.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.178 -0.464 . . . . 74.239999999999995 111.607 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 45' ' ' LEU . 63.7 t -63.25 -53.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.98 0.419 . . . . 64.25 111.478 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.17 -37.36 49.08 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.264 -0.493 . . . . 63.340000000000003 113.697 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -90.24 8.08 34.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.078 0.399 . . . . 73.010000000000005 112.078 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -51.31 -8.77 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.425 1.268 . . . . 72.209999999999994 114.425 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 p -65.09 -18.18 65.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.778 0.659 . . . . 74.310000000000002 112.778 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.64 ' HA3' HD12 ' A' ' 2' ' ' ILE . . . -160.85 137.84 5.17 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.587 -0.816 . . . . 42.299999999999997 113.973 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.76 159.22 36.36 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.866 0.466 . . . . 73.299999999999997 110.824 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 70.7 t -140.66 122.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.429 0.291 . . . . 74.519999999999996 110.824 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 87' ' ' ILE . 4.0 mp -122.22 130.87 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.886 0.374 . . . . 75.230000000000004 111.253 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.23 -128.0 3.22 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.993 -0.622 . . . . 73.420000000000002 112.908 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.502 ' HE1' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -84.5 161.29 20.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.14 0.495 . . . . 64.450000000000003 111.515 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -113.03 90.62 16.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.525 -0.307 . . . . 70.109999999999999 111.505 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.36 137.64 16.95 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.971 2.448 . . . . 75.230000000000004 112.093 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.93 -48.28 51.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.414 0.524 . . . . 72.200000000000003 112.414 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.62 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.311 0.485 . . . . 44.329999999999998 112.311 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m -78.84 -33.85 45.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.745 0.307 . . . . 64.319999999999993 111.493 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 72.25 111.927 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.64 -33.58 76.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.97 0.359 . . . . 63.039999999999999 111.97 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -85.22 -12.59 52.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.033 0.383 . . . . 73.400000000000006 112.033 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mm -87.86 -23.33 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.177 0.436 . . . . 73.329999999999998 112.177 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -48.49 -48.15 38.2 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.769 0.655 . . . . 60.420000000000002 112.769 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 -57.3 7.35 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.14 -0.553 . . . . 75.420000000000002 113.322 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -55.86 -35.91 66.97 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.417 0.525 . . . . 74.530000000000001 112.417 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.53 -41.68 66.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.612 0.365 . . . . 73.430000000000007 111.006 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -58.98 -47.21 85.97 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.781 0.324 . . . . 74.540000000000006 111.537 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.0 -39.09 93.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.839 0.352 . . . . 71.420000000000002 111.275 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 71' ' ' ALA . 65.3 mt -58.37 -47.06 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.358 -0.383 . . . . 71.140000000000001 111.335 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 82.4 mt -55.35 -28.18 52.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.481 -0.327 . . . . 70.239999999999995 111.875 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.68 -32.23 30.85 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.216 -0.516 . . . . 73.420000000000002 113.195 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p -80.78 -58.68 2.99 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.855 0.317 . . . . 72.209999999999994 111.855 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 75' ' ' ILE . 29.8 m -68.79 145.12 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.338 0.59 . . . . 71.409999999999997 112.112 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -161.37 -168.76 2.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.021 -0.536 . . . . 72.329999999999998 111.429 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.72 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 10.5 tp10 64.08 -95.76 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.701 1.0 . . . . 75.109999999999999 113.701 167.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.72 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.2 ptpp? -169.43 30.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.95 0.405 . . . . 73.230000000000004 111.801 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.452 ' OE1' ' HB3' ' A' ' 81' ' ' GLU . 8.0 mp0 -61.33 176.35 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.578 0.704 . . . . 72.439999999999998 112.642 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.685 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.06 139.53 30.53 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.573 0.582 . . . . 75.030000000000001 112.573 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.99 96.15 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.679 0.752 . . . . 74.319999999999993 110.854 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.3 80.68 0.73 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.944 -0.571 . . . . 53.399999999999999 113.285 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.426 HD13 ' HB ' ' A' ' 57' ' ' ILE . 32.5 mm -82.78 113.85 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 122.725 -0.28 . . . . 64.549999999999997 110.576 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.16 133.07 53.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.368 0.604 . . . . 75.230000000000004 112.267 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.79 ' HB3' ' HB1' ' A' ' 116' ' ' ALA . 9.5 tp10 -76.23 137.86 40.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.76 -0.655 . . . . 62.420000000000002 111.335 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.536 ' HG1' ' HG3' ' A' ' 123' ' ' PRO . 10.2 t -156.11 -2.75 0.13 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.97 0.73 . . . . 73.310000000000002 112.97 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.81 109.86 0.39 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.692 -0.766 . . . . 73.129999999999995 113.13 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.24 79.67 0.52 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.527 -0.368 . . . . 53.520000000000003 113.22 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.82 78.39 0.06 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.379 -0.439 . . . . 36.75 112.53 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -98.47 -174.8 2.91 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.239 0.542 . . . . 70.109999999999999 111.966 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -118.67 138.08 52.86 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.919 -0.582 . . . . 62.140000000000001 109.959 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.535 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 32.8 mt-10 -45.34 -48.4 34.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.601 1.334 . . . . 71.040000000000006 114.601 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 86.0 Cg_exo -50.46 -12.21 0.49 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.915 2.41 . . . . 54.219999999999999 115.092 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.89 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 121.903 -0.498 . . . . 71.310000000000002 111.854 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.486 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.1 m-20 -57.18 -51.18 83.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 112.577 0.584 . . . . 74.109999999999999 112.577 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 90.4 Cg_exo -47.78 -40.18 31.49 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.309 2.006 . . . . 74.140000000000001 112.893 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 97' ' ' PRO . 9.7 mp -71.99 -41.57 67.49 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.58 -0.282 . . . . 62.140000000000001 111.205 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.3 mt -58.64 -37.3 75.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 55.530000000000001 111.056 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -58.08 -31.85 67.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.19 -0.459 . . . . 72.310000000000002 110.917 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -68.29 -50.12 55.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.798 0.333 . . . . 73.129999999999995 110.742 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.91 -37.33 76.37 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.16 0.505 . . . . 75.530000000000001 110.777 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -64.74 -60.05 3.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.69 -0.687 . . . . 74.340000000000003 111.207 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.18 -56.08 24.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 112.529 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.17 -23.07 65.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.737 0.273 . . . . 73.219999999999999 111.737 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.4 61.24 5.23 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.291 -0.481 . . . . 72.409999999999997 113.558 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.59 156.55 19.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.625 -0.338 . . . . 74.140000000000001 110.989 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.685 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 27.5 m -70.12 93.1 0.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 51.329999999999998 111.509 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -86.63 159.07 19.33 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.22 0.533 . . . . 45.340000000000003 112.319 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.04 -164.81 1.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.127 -0.488 . . . . 73.409999999999997 111.808 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.25 112.34 5.34 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 112.074 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -90.68 107.4 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.014 2.476 . . . . 74.439999999999998 113.484 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 89' ' ' GLU . . . -89.66 177.38 6.55 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.189 -0.319 . . . . 51.240000000000002 110.634 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.9 tt -132.58 102.52 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.665 0.617 . . . . 74.530000000000001 112.665 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 55.99 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.353 0.871 . . . . 71.310000000000002 113.353 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.552 HG12 ' HG3' ' A' ' 89' ' ' GLU . 46.4 mm -95.35 74.71 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.04 0.447 . . . . 64.200000000000003 110.39 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 51.46 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.807 0.669 . . . . 65.030000000000001 112.807 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 179.09 -42.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.181 0.592 . . . . 42.119999999999997 110.674 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.8 p -96.08 114.62 64.56 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 111.521 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HG3' ' HG1' ' A' ' 90' ' ' THR . 52.6 Cg_exo -53.47 127.76 26.63 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.713 2.276 . . . . 64.340000000000003 113.133 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 33.9 p -107.89 177.09 4.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.569 -0.287 . . . . 73.430000000000007 111.608 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.56 -34.96 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.01 0.433 . . . . 71.310000000000002 111.586 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.416 ' O ' HD12 ' A' ' 130' ' ' LEU . 16.0 m120 -58.05 -41.19 82.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.974 0.416 . . . . 71.430000000000007 110.609 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.7 m -56.82 -44.48 82.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.251 -0.431 . . . . 71.140000000000001 111.377 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -58.85 -46.36 87.93 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.279 0.562 . . . . 73.340000000000003 111.04 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.578 ' HB3' ' HZ1' ' A' ' 129' ' ' LYS . 8.6 mtpm? -61.94 -32.48 72.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.775 -0.648 . . . . 65.409999999999997 111.802 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 126' ' ' ASN . 10.9 mp -77.78 -42.25 34.59 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.303 -0.248 . . . . 73.349999999999994 111.418 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.9 m -58.66 -53.32 59.72 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 111.566 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.1 -54.08 50.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.269 -0.423 . . . . 64.5 111.759 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.81 -54.86 36.44 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.221 -0.445 . . . . 54.439999999999998 111.843 -177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.5 97.27 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.71 0.29 . . . . 75.319999999999993 111.777 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.55 76.04 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.08 -0.581 . . . . 72.420000000000002 112.789 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.8 m -61.2 -42.62 98.91 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 62.299999999999997 111.041 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.33 -42.15 95.06 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.026 -0.534 . . . . 51.439999999999998 111.182 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 84' ' ' ALA . 52.5 tp -62.73 -44.28 96.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.125 0.488 . . . . 73.129999999999995 110.636 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -34.57 75.11 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 116.018 -0.537 . . . . 62.32 112.781 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 136' ' ' THR . 55.5 mt-30 -64.78 -25.68 68.02 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.714 0.292 . . . . 74.239999999999995 111.711 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -72.82 -52.43 14.94 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.068 0.461 . . . . 74.349999999999994 110.166 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.721 HG23 HD11 ' A' ' 2' ' ' ILE . 60.9 t -57.2 -45.16 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.797 -0.638 . . . . 72.329999999999998 112.172 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 9.0 t -61.71 -51.78 66.99 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.997 0.369 . . . . 72.450000000000003 111.997 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 143' ' ' THR . 90.5 mtt-85 -64.26 -41.64 96.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.113 0.482 . . . . 72.540000000000006 111.13 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.15 -49.87 68.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.122 -0.49 . . . . 70.450000000000003 111.725 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.484 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 0.1 OUTLIER -82.7 -11.07 58.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.183 0.438 . . . . 74.340000000000003 112.183 -174.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 143' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.157 0.503 . . . . 43.109999999999999 110.395 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 25.3 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.389 0.137 . . . . 65.430000000000007 111.357 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.0 mp 58.7 97.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.214 0.531 . . . . 53.219999999999999 111.869 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.29 96.11 1.9 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.193 -0.527 . . . . 42.340000000000003 112.98 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -85.56 105.73 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 O-C-N 122.374 -0.486 . . . . 74.200000000000003 111.398 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.21 123.14 38.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.755 0.312 . . . . 75.439999999999998 111.276 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.18 175.0 9.95 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.956 0.407 . . . . 73.530000000000001 111.541 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 7' ' ' VAL . 5.9 p -121.62 95.99 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 64.430000000000007 111.129 176.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -52.6 -34.64 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.595 -0.73 . . . . 75.239999999999995 112.788 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.13 -35.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.64 0.608 . . . . 44.420000000000002 112.64 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -109.05 146.57 33.76 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.243 0.46 . . . . 75.319999999999993 112.243 -170.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.19 -164.18 5.18 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 114.521 0.568 . . . . 73.219999999999999 114.521 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.589 ' HD2' ' HG2' ' A' ' 123' ' ' PRO . 57.4 m-85 -87.45 9.47 20.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.762 0.425 . . . . 74.120000000000005 111.778 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -29.98 -48.97 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.729 1.381 . . . . 72.340000000000003 114.729 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.86 -46.17 90.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.896 0.379 . . . . 75.519999999999996 111.644 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.35 -38.21 89.39 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.928 0.394 . . . . 75.510000000000005 110.858 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.565 HD13 ' HG3' ' A' ' 123' ' ' PRO . 85.8 mt -61.59 -42.59 99.07 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.062 0.458 . . . . 74.120000000000005 110.778 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -58.6 -47.26 84.92 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.135 -0.484 . . . . 62.420000000000002 110.759 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.8 -37.75 60.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.14 0.495 . . . . 64.25 111.095 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.84 -54.37 19.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.289 -0.414 . . . . 55.509999999999998 111.498 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.4 mt -56.72 -46.79 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.234 0.54 . . . . 74.010000000000005 111.909 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.512 HG12 HG22 ' A' ' 31' ' ' VAL . 74.5 mt -60.19 -27.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.899 -0.591 . . . . 74.239999999999995 112.19 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -54.01 -68.59 0.17 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.018 0.377 . . . . 62.340000000000003 112.018 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.16 -36.64 89.57 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.242 -0.504 . . . . 63.539999999999999 113.644 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.05 -47.51 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 122.526 -0.397 . . . . 73.400000000000006 111.796 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.0 p -67.43 -34.66 77.68 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.109 0.411 . . . . 70.420000000000002 112.109 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.09 -23.23 64.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.277 0.56 . . . . 75.109999999999999 110.689 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -80.6 -12.98 59.43 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.225 0.536 . . . . 64.109999999999999 110.544 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.15 27.22 26.35 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.183 -0.532 . . . . 70.0 113.113 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.14 137.28 50.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 122.582 -0.364 . . . . 73.310000000000002 111.463 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 142.59 17.89 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.348 -0.453 . . . . 37.530000000000001 112.747 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG22 HG12 ' A' ' 21' ' ' ILE . 34.4 m -107.97 146.25 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.46 0.541 . . . . 72.219999999999999 112.46 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -108.16 92.7 4.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 110.654 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.62 122.63 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.759 0.314 . . . . 74.519999999999996 111.58 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -127.61 136.76 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.001 0.429 . . . . 74.299999999999997 111.537 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.1 123.75 32.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.925 0.393 . . . . 74.409999999999997 111.196 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.75 -13.46 48.22 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.173 0.434 . . . . 74.319999999999993 112.173 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.65 68.27 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.364 -0.446 . . . . 52.200000000000003 112.993 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.86 14.66 3.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.166 0.432 . . . . 45.100000000000001 112.166 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.07 118.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.333 0.587 . . . . 63.409999999999997 112.217 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.71 99.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.625 0.726 . . . . 62.009999999999998 112.199 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.59 158.15 27.93 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.592 -0.731 . . . . 72.109999999999999 111.724 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.623 HD11 HD13 ' A' ' 45' ' ' LEU . 3.4 mm? -60.37 -37.89 82.18 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.037 0.384 . . . . 72.329999999999998 112.037 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -66.88 -30.11 70.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.089 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.2 -32.88 56.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.093 0.473 . . . . 72.329999999999998 110.597 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 42' ' ' LEU . 85.4 mt -64.75 -32.28 73.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.416 -0.356 . . . . 75.319999999999993 110.825 174.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -58.78 -47.66 83.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.022 0.439 . . . . 75.510000000000005 110.193 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 73.1 mm-40 -58.19 -39.83 79.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.094 175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.38 -34.34 66.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.762 0.315 . . . . 70.030000000000001 111.336 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.07 -52.94 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.844 0.354 . . . . 72.340000000000003 111.21 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.93 -25.14 73.2 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.905 -0.664 . . . . 53.219999999999999 113.47 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -98.87 7.42 46.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.717 0.407 . . . . 74.510000000000005 111.806 178.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.59 5.69 0.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.629 0.974 . . . . 55.32 113.629 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.0 p -79.79 -36.88 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.112 -0.368 . . . . 75.420000000000002 111.876 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.8 137.71 5.33 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.92 -0.657 . . . . 74.400000000000006 113.239 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.69 164.17 39.15 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.865 0.364 . . . . 65.540000000000006 111.597 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -122.36 129.58 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.611 0.364 . . . . 72.409999999999997 110.664 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.8 mp -117.75 136.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.288 0.566 . . . . 64.420000000000002 112.463 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.91 125.55 8.45 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 116.071 -0.513 . . . . 44.130000000000003 112.476 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.461 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 55.5 ttm -56.87 101.86 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.353 0.596 . . . . 71.230000000000004 111.465 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 67.1 m -92.88 132.95 29.88 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 112.196 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.79 169.04 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.51 2.14 . . . . 62.229999999999997 112.756 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.96 -42.83 6.19 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.358 0.874 . . . . 75.010000000000005 113.358 -173.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.72 -62.84 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.983 0.364 . . . . 51.350000000000001 111.983 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 50.3 m -70.76 -22.22 62.42 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.009 0.433 . . . . 52.140000000000001 111.515 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.5 65.15 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 61.219999999999999 111.435 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.31 99.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.94 0.4 . . . . 71.530000000000001 111.356 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -62.24 -44.05 97.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.231 0.538 . . . . 61.5 110.904 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.436 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 61.5 mt -64.32 -45.32 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.044 -0.525 . . . . 53.109999999999999 110.832 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -54.42 -48.97 71.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.912 -0.586 . . . . 75.129999999999995 111.47 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.24 -27.28 72.21 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 73.340000000000003 112.927 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.96 -21.33 29.62 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 72.409999999999997 112.365 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 70.6 mt -51.26 -38.07 50.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.369 0.507 . . . . 72.439999999999998 112.369 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.4 m -54.25 -31.6 53.96 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.089 0.471 . . . . 71.310000000000002 111.535 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 m -94.13 -39.87 10.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 70.400000000000006 111.196 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.0 -54.27 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.262 0.467 . . . . 64.409999999999997 112.262 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.43 -17.53 13.55 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 63.340000000000003 112.723 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.15 -27.85 7.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.149 -0.548 . . . . 54.399999999999999 113.113 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.7 m -84.76 -25.58 28.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.462 0.542 . . . . 74.120000000000005 112.462 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.66 158.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.329 0.585 . . . . 63.109999999999999 112.359 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 27.9 t-20 -92.9 143.79 25.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.03 -0.532 . . . . 74.239999999999995 110.914 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -44.89 -44.62 9.78 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.382 0.882 . . . . 74.140000000000001 113.382 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 24.2 pttm -135.62 41.56 2.72 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.055 0.455 . . . . 71.409999999999997 112.012 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 3.9 pt20 -61.44 167.89 3.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.076 -0.511 . . . . 74.420000000000002 112.255 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HB1' HD11 ' A' ' 138' ' ' LEU . . . -96.12 116.88 29.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.272 -0.422 . . . . 64.219999999999999 111.64 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.34 118.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.432 0.634 . . . . 73.200000000000003 112.121 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 139.27 15.14 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.088 -0.505 . . . . 72.140000000000001 112.781 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.31 138.95 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.896 0.379 . . . . 73.049999999999997 111.751 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -139.87 150.83 45.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 110.466 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -76.3 91.57 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.554 0.692 . . . . 75.540000000000006 112.309 -174.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.471 ' N ' HG12 ' A' ' 119' ' ' ILE . 52.8 m -154.51 134.34 12.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.192 -0.458 . . . . 72.129999999999995 111.243 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 59' ' ' MET . . . 99.35 -133.03 11.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.189 -0.529 . . . . 64.120000000000005 113.132 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.46 -125.69 9.54 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.084 -0.579 . . . . 62.310000000000002 113.297 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.66 -104.1 1.09 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.082 -0.58 . . . . 37.530000000000001 112.89 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.65 109.58 21.82 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.658 -0.319 . . . . 74.049999999999997 110.392 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.26 155.95 39.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.932 0.396 . . . . 63.25 111.543 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.635 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 31.6 mt-10 -106.95 -63.94 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 113.041 0.756 . . . . 75.099999999999994 113.041 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 32.5 Cg_endo -104.1 27.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 123.203 2.602 . . . . 73.049999999999997 116.204 -167.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 12.6 tt -53.26 -49.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.769 0.713 . . . . 63.140000000000001 112.842 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 16.7 m-20 -61.8 -51.59 74.8 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.491 0.552 . . . . 74.310000000000002 112.491 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.6 Cg_exo -48.99 -43.92 34.23 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.117 1.878 . . . . 73.120000000000005 113.063 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 97' ' ' PRO . 10.7 mp -65.48 -48.43 72.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.678 0.251 . . . . 73.109999999999999 111.678 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 95.1 mt -53.4 -47.85 69.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.003 0.43 . . . . 52.530000000000001 111.24 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -64.01 -43.83 94.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.429 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -56.53 -62.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.339 -0.391 . . . . 64.409999999999997 111.313 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -58.73 -30.53 67.54 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.797 0.295 . . . . 75.319999999999993 111.797 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 106' ' ' ARG . 31.5 ttt180 -61.76 -49.87 74.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.966 0.412 . . . . 74.530000000000001 111.256 175.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.47 -8.07 43.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.721 0.637 . . . . 70.510000000000005 112.721 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 mp -98.43 -40.33 8.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.849 0.357 . . . . 74.239999999999995 110.628 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 52.54 3.08 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.202 -0.523 . . . . 54.32 113.873 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 6.5 mp -76.54 151.17 36.44 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.894 0.378 . . . . 74.349999999999994 111.47 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.2 m -68.36 87.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.377 0.608 . . . . 75.140000000000001 110.142 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.9 m -99.53 135.74 40.49 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.733 -0.667 . . . . 72.530000000000001 112.149 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.83 -64.17 0.94 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.854 0.359 . . . . 51.340000000000003 111.889 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -158.23 99.72 1.76 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 120.656 0.265 . . . . 74.510000000000005 111.31 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -90.52 17.37 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.083 2.522 . . . . 75.219999999999999 114.027 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.98 13.07 19.44 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.458 . . . . 64.040000000000006 112.238 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.59 139.43 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.088 0.47 . . . . 73.420000000000002 111.545 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -128.41 127.51 42.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.368 -0.378 . . . . 65.019999999999996 110.375 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.4 mp -106.48 141.06 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.225 0.536 . . . . 64.420000000000002 111.734 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 121' ' ' GLN . 19.5 ptmt -78.63 -40.32 34.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 112.497 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.566 ' HG2' HG22 ' A' ' 122' ' ' THR . 65.1 tt0 -175.36 -70.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.102 0.477 . . . . 73.219999999999999 111.679 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.566 HG22 ' HG2' ' A' ' 121' ' ' GLN . 60.7 p -115.1 153.45 47.22 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.459 -0.337 . . . . 73.510000000000005 111.78 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.589 ' HG2' ' HD2' ' A' ' 12' ' ' TYR . 72.7 Cg_endo -75.37 -175.57 2.49 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.619 2.213 . . . . 75.099999999999994 113.185 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.0 p -111.53 175.54 5.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.92 0.39 . . . . 63.420000000000002 111.322 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.82 -25.33 62.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 74.230000000000004 110.83 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -70.3 -28.33 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.046 0.451 . . . . 74.299999999999997 110.901 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.9 m -54.22 -35.33 62.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.084 -0.507 . . . . 71.209999999999994 111.931 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -58.03 -27.55 63.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.008 0.432 . . . . 63.25 111.687 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -85.65 -39.67 17.02 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.939 0.399 . . . . 75.209999999999994 110.447 177.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.23 -56.17 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.008 -0.542 . . . . 71.400000000000006 111.155 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.4 m -55.06 -38.04 67.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.014 0.376 . . . . 75.120000000000005 112.014 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.12 -46.44 74.16 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.226 0.536 . . . . 72.230000000000004 110.908 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.18 -52.93 61.82 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.981 -0.554 . . . . 61.200000000000003 111.522 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.05 99.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.245 -0.434 . . . . 61.520000000000003 111.566 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -55.81 -38.94 75.62 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.258 -0.496 . . . . 73.040000000000006 112.799 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 88.9 m -65.96 -44.67 84.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.731 0.301 . . . . 71.349999999999994 111.126 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.04 -50.79 72.22 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.987 0.422 . . . . 54.520000000000003 111.695 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.422 HD11 ' HB1' ' A' ' 84' ' ' ALA . 3.9 mm? -70.14 -43.26 71.29 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.865 0.364 . . . . 64.219999999999999 111.165 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.0 -47.83 65.02 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 116.132 -0.486 . . . . 50.240000000000002 113.566 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.654 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 90.5 mt-30 -59.79 -53.12 61.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.668 0.27 . . . . 64.140000000000001 111.35 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 77.4 t90 -51.62 -52.98 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.753 0.311 . . . . 73.439999999999998 111.426 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.4 t -57.08 -43.0 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.52 0.563 . . . . 72.129999999999995 112.52 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 144' ' ' ARG . 8.7 t -78.11 -49.92 13.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.152 0.797 . . . . 75.140000000000001 113.152 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -84.88 -4.73 59.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.155 0.798 . . . . 73.400000000000006 113.155 -172.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.413 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 27.7 t70 -62.09 -18.39 60.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.189 0.44 . . . . 50.420000000000002 112.189 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.593 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 1.7 mpt_? -78.72 -27.57 44.93 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.662 0.615 . . . . 75.439999999999998 112.662 -176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.11 0.481 . . . . 63.32 109.919 -174.567 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.853 0.316 . . . . 74.140000000000001 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 24' ' ' ILE . 46.4 mm -69.77 97.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.992 0.367 . . . . 75.200000000000003 111.992 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.16 1.38 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.084 -0.579 . . . . 55.0 112.529 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 17' ' ' ALA . 6.7 p -91.9 110.25 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.261 0.553 . . . . 71.0 112.11 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.402 ' HB3' HD22 ' A' ' 36' ' ' LEU . 82.5 m-85 -95.07 99.09 11.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 70.230000000000004 110.955 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 14' ' ' ASP . 26.6 p90 -130.13 -179.52 5.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.837 0.351 . . . . 73.109999999999999 111.52 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.647 HG13 ' H ' ' A' ' 10' ' ' TYR . 22.3 t -121.98 107.32 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.921 0.391 . . . . 74.230000000000004 111.842 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 74.1 m -78.23 -21.91 49.25 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 111.354 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -78.24 -32.69 49.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.885 -0.598 . . . . 75.5 112.052 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.647 ' H ' HG13 ' A' ' 7' ' ' VAL . 69.1 t80 -129.13 133.03 47.45 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.92 0.711 . . . . 75.209999999999994 112.92 -170.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.5 -162.49 5.19 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.562 0.985 . . . . 64.209999999999994 115.562 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 2.12 29.11 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.64 0.607 . . . . 72.329999999999998 112.64 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.3 t -49.36 -37.56 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.102 0.477 . . . . 71.239999999999995 111.853 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 17.0 t0 -56.71 -60.18 3.93 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.864 -0.607 . . . . 62.229999999999997 111.255 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 15' ' ' ARG . 20.1 mmt180 -70.97 -28.58 64.56 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.28 0.474 . . . . 72.530000000000001 112.28 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.11 -43.99 87.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 75.340000000000003 110.501 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -75.04 -44.27 48.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.753 -0.658 . . . . 73.239999999999995 111.43 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -53.77 -53.26 54.79 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.387 -0.37 . . . . 74.120000000000005 111.883 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -25.21 61.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.31 0.485 . . . . 75.400000000000006 112.31 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 132' ' ' GLU . 66.1 mt -87.55 -57.4 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.846 0.355 . . . . 75.340000000000003 111.442 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.485 ' HB ' HG12 ' A' ' 31' ' ' VAL . 2.7 pp -59.15 -27.17 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.7 0.286 . . . . 72.329999999999998 111.762 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.431 ' N ' HD12 ' A' ' 21' ' ' ILE . 27.3 t-20 -59.4 -48.88 79.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.515 -0.311 . . . . 70.120000000000005 110.619 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.36 -34.24 87.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.166 -0.54 . . . . 38.130000000000003 112.758 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.622 HG21 HG13 ' A' ' 2' ' ' ILE . 62.4 mt -62.69 -53.12 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 122.49 -0.418 . . . . 75.420000000000002 111.335 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.8 t -68.19 -31.15 70.48 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.909 0.385 . . . . 70.030000000000001 111.001 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -62.34 -34.52 76.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.057 0.456 . . . . 74.430000000000007 111.034 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -71.35 -31.88 67.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.311 -0.404 . . . . 72.299999999999997 111.0 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.81 5.42 4.89 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.165 -0.541 . . . . 55.219999999999999 114.17 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.634 HG23 ' HB ' ' A' ' 143' ' ' THR . 21.8 t -94.34 126.53 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 117.439 0.619 . . . . 71.209999999999994 111.698 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.95 122.6 22.19 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.444 -0.408 . . . . 73.530000000000001 113.689 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG12 ' HB ' ' A' ' 21' ' ' ILE . 61.3 t -104.07 143.56 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.118 0.485 . . . . 64.010000000000005 112.168 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.77 113.68 22.91 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.136 -0.484 . . . . 75.099999999999994 110.422 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.84 124.0 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.269 0.557 . . . . 63.450000000000003 112.11 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.04 108.03 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.85 0.357 . . . . 60.119999999999997 111.497 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.49 111.23 20.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.908 0.385 . . . . 41.450000000000003 111.188 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.438 ' HA ' HG11 ' A' ' 40' ' ' VAL . 4.4 pp -86.8 -8.96 56.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.424 -0.353 . . . . 64.209999999999994 111.1 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -59.72 -45.3 95.95 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.356 -0.449 . . . . 64.409999999999997 112.768 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.58 17.69 3.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.701 0.286 . . . . 62.409999999999997 111.446 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.16 147.22 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.198 0.599 . . . . 54.119999999999997 111.917 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 36' ' ' LEU . 27.1 m -117.43 151.87 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.337 . . . . 72.420000000000002 111.546 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -104.98 169.36 8.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.053 0.454 . . . . 72.209999999999994 111.064 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.81 -18.44 32.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.116 0.413 . . . . 74.420000000000002 112.116 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -57.6 -55.46 34.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.828 0.347 . . . . 73.140000000000001 110.775 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.94 -37.19 78.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.179 0.514 . . . . 63.020000000000003 110.837 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 3.0 tm? -61.32 -38.73 87.92 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.978 -0.555 . . . . 72.319999999999993 111.127 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -70.85 -40.32 72.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.961 -0.462 . . . . 70.329999999999998 110.925 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 18.1 mm-40 -58.41 -28.15 64.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.008 0.432 . . . . 72.340000000000003 111.323 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.608 HD12 HD12 ' A' ' 55' ' ' LEU . 57.7 tp -56.18 -31.11 63.12 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.189 -0.459 . . . . 71.030000000000001 111.448 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.97 -36.39 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.872 0.367 . . . . 65.239999999999995 111.328 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.55 -20.01 55.31 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.081 -0.581 . . . . 54.539999999999999 112.895 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 7.4 mpt_? -94.38 5.11 52.79 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.579 -0.365 . . . . 60.140000000000001 111.934 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -63.56 -16.0 59.61 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.889 0.329 . . . . 75.420000000000002 111.889 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.1 p -66.15 -25.31 66.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.821 0.343 . . . . 72.219999999999999 111.643 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.5 135.93 3.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.374 -0.441 . . . . 38.130000000000003 112.493 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.608 HD12 HD12 ' A' ' 48' ' ' LEU . 2.3 pt? -163.83 170.32 17.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.117 0.484 . . . . 70.5 111.662 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 p -148.76 124.33 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.340000000000003 111.174 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -95.8 135.4 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.13 -0.486 . . . . 71.239999999999995 110.96 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.5 -86.58 0.68 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.229 -0.51 . . . . 70.120000000000005 113.805 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.5 pmm? -151.92 167.96 26.7 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.3 -0.53 . . . . 73.129999999999995 111.855 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.3 p -144.18 49.13 0.99 Allowed Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 112.345 0.498 . . . . 74.209999999999994 112.345 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.13 157.57 61.1 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.414 2.076 . . . . 75.129999999999995 113.599 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.0 -50.48 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.523 0.934 . . . . 74.519999999999996 113.523 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.04 -46.51 65.09 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.601 0.593 . . . . 64.299999999999997 112.601 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -102.11 5.26 40.31 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.507 0.558 . . . . 64.120000000000005 112.507 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.86 -29.88 70.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.776 1.028 . . . . 64.239999999999995 113.776 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -37.47 -70.53 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.905 1.076 . . . . 73.120000000000005 113.905 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.4 m -77.39 -37.77 51.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.823 0.344 . . . . 71.349999999999994 111.79 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.45 -43.99 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.462 0.541 . . . . 63.329999999999998 112.462 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.03 -40.82 95.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.852 0.358 . . . . 72.519999999999996 111.413 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.88 -36.52 90.35 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.016 -0.611 . . . . 38.130000000000003 112.203 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -68.52 -51.14 46.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.826 -0.22 . . . . 74.040000000000006 111.119 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 75' ' ' ILE . 98.3 mt -53.79 -45.71 70.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.925 0.393 . . . . 64.230000000000004 111.678 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -56.75 -28.1 60.58 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.104 -0.498 . . . . 61.200000000000003 111.285 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 m -86.89 -40.19 15.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.259 -0.428 . . . . 75.439999999999998 111.136 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.485 HD12 HD22 ' A' ' 72' ' ' LEU . 73.7 mt -56.13 -40.6 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.394 -0.366 . . . . 73.340000000000003 111.679 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.2 mt -56.37 -26.67 53.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.51 -0.314 . . . . 62.140000000000001 111.651 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.9 31.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.189 -0.529 . . . . 38.130000000000003 113.463 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 75' ' ' ILE . 89.4 p -87.8 -34.27 18.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.247 0.524 . . . . 74.140000000000001 111.882 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.97 135.13 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.974 0.416 . . . . 73.120000000000005 111.59 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 82' ' ' LYS . 24.7 t-20 -89.53 107.01 18.83 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.298 0.481 . . . . 72.329999999999998 112.298 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 36.84 -75.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.89 1.441 . . . . 73.5 114.89 167.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.1 96.51 5.13 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.216 0.531 . . . . 74.299999999999997 112.401 -174.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.683 ' H ' HD23 ' A' ' 110' ' ' LEU . 85.6 mm-40 -133.97 172.72 12.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.433 -0.349 . . . . 74.120000000000005 110.851 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.5 107.81 18.06 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.048 0.452 . . . . 38.130000000000003 111.282 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.485 HG11 HD22 ' A' ' 55' ' ' LEU . 24.4 m -109.67 119.4 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.565 0.698 . . . . 72.129999999999995 112.158 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.39 142.51 25.01 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.177 -0.535 . . . . 74.400000000000006 112.507 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.455 ' H ' ' HB1' ' A' ' 113' ' ' ALA . 7.1 tp -160.86 137.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.655 -0.32 . . . . 73.120000000000005 110.793 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -161.64 161.69 29.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.532 0.333 . . . . 73.430000000000007 110.753 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 1.3 pm0 -81.65 146.28 30.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.495 0.664 . . . . 71.510000000000005 112.095 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.3 m -140.1 100.61 3.96 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.157 -0.474 . . . . 71.150000000000006 111.126 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . 79.01 -170.81 54.91 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.081 -0.58 . . . . 38.130000000000003 113.309 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.23 79.26 0.41 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.127 -0.559 . . . . 72.519999999999996 112.708 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.05 159.34 53.5 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.427 -0.416 . . . . 51.539999999999999 113.856 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -162.69 108.03 1.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.436 -0.579 . . . . 74.200000000000003 109.436 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.18 151.52 50.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.987 0.422 . . . . 70.310000000000002 111.556 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.616 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.2 tm-20 -91.47 -58.05 0.24 Allowed Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 116.384 -0.371 . . . . 55.100000000000001 111.943 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 96' ' ' GLU . 85.0 Cg_endo -84.83 84.95 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.93 1.753 . . . . 74.25 113.224 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.647 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.5 tp -92.08 -66.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 112.005 0.372 . . . . 72.209999999999994 112.005 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.647 ' H ' HG23 ' A' ' 98' ' ' ILE . 4.6 m-20 -59.19 -46.85 99.23 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 113.029 0.751 . . . . 52.229999999999997 113.029 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -42.67 -38.4 6.4 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.935 2.423 . . . . 73.430000000000007 114.289 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.42 -49.38 10.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.686 0.279 . . . . 74.219999999999999 111.053 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 86.1 mt -51.28 -44.06 61.73 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.421 0.526 . . . . 70.319999999999993 112.421 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.3 t -57.24 -42.28 81.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.699 0.285 . . . . 71.129999999999995 111.655 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -59.32 -46.84 87.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 74.519999999999996 111.271 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 110' ' ' LEU . 78.0 m-85 -63.22 -52.21 63.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.123 0.487 . . . . 71.439999999999998 111.135 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -54.62 -45.02 73.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.571 -0.74 . . . . 71.25 112.415 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -74.28 -56.1 5.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 74.519999999999996 112.569 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.37 -40.96 96.22 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.508 0.558 . . . . 64.340000000000003 112.508 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.2 17.54 4.88 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.968 -0.634 . . . . 70.129999999999995 112.774 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 83' ' ' GLN . 59.7 mt -73.31 102.9 3.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.064 0.459 . . . . 72.439999999999998 110.384 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.9 m -63.58 102.74 0.46 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.109 -0.496 . . . . 74.420000000000002 111.971 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -85.7 132.24 34.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.92 -0.582 . . . . 74.310000000000002 111.171 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HB1' ' H ' ' A' ' 87' ' ' ILE . . . -55.66 -76.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.773 0.286 . . . . 74.150000000000006 111.773 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -164.69 88.54 1.05 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.966 0.412 . . . . 74.340000000000003 111.253 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.06 112.03 1.69 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.649 2.233 . . . . 73.329999999999998 113.859 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB2' HH21 ' A' ' 118' ' ' ARG . . . -170.28 -173.17 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.581 -0.281 . . . . 40.520000000000003 111.209 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.71 88.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.233 0.539 . . . . 74.150000000000006 111.525 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.571 HH21 ' HB2' ' A' ' 116' ' ' ALA . 8.4 ptp180 -104.87 -18.63 14.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.759 0.314 . . . . 75.129999999999995 111.658 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.67 111.39 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 71.450000000000003 110.806 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.97 -48.68 80.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.04 -0.527 . . . . 74.010000000000005 112.138 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.463 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 8.7 tt0 -158.81 -49.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.083 0.468 . . . . 71.040000000000006 111.335 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -114.49 117.85 42.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.337 -0.392 . . . . 74.400000000000006 111.662 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.55 126.45 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.376 2.05 . . . . 63.100000000000001 112.423 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.4 p -78.14 172.29 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.571 0.224 . . . . 73.150000000000006 110.924 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.63 -30.8 44.56 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.751 0.278 . . . . 70.439999999999998 111.751 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -52.95 -32.37 45.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.161 0.505 . . . . 70.010000000000005 111.081 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 m -61.19 -48.49 81.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.054 -0.521 . . . . 73.109999999999999 110.908 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -58.81 -51.51 69.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.192 -0.458 . . . . 65.230000000000004 111.248 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -33.76 76.3 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.22 -0.445 . . . . 73.019999999999996 112.097 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.24 -60.04 2.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.043 0.449 . . . . 52.409999999999997 110.914 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.99 -27.86 67.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.262 -0.426 . . . . 73.340000000000003 112.084 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 20' ' ' ILE . 40.0 tt0 -52.43 -50.96 61.53 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.404 -0.362 . . . . 72.519999999999996 111.896 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.8 -46.89 85.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.735 0.303 . . . . 74.019999999999996 111.316 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.42 -48.94 73.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.914 0.388 . . . . 65.040000000000006 111.604 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.83 -38.72 94.62 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.097 -0.573 . . . . 70.0 113.108 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 99.7 m -63.35 -49.15 75.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.733 0.302 . . . . 72.25 111.186 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.12 -37.49 80.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.1 0.476 . . . . 72.439999999999998 110.751 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.42 ' O ' HG21 ' A' ' 142' ' ' VAL . 3.4 tm? -59.16 -51.59 69.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 74.230000000000004 110.237 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.97 -44.2 94.64 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.278 -0.487 . . . . 38.130000000000003 112.762 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.06 -30.84 71.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.230000000000004 111.331 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.49 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 88.5 t90 -71.65 -51.52 22.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.187 0.518 . . . . 74.310000000000002 110.833 176.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 138' ' ' LEU . 77.2 t -54.43 -46.88 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.279 -0.419 . . . . 74.109999999999999 112.005 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.634 ' HB ' HG23 ' A' ' 29' ' ' VAL . 7.4 t -62.41 -37.98 87.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.8 0.667 . . . . 71.510000000000005 112.8 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 141' ' ' TRP . 8.0 ptp180 -75.32 -41.38 56.92 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.076 -0.39 . . . . 71.219999999999999 111.54 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.19 -14.54 35.82 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.952 0.723 . . . . 72.530000000000001 112.952 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.77 -34.65 78.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.42 0.629 . . . . 73.209999999999994 109.673 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.5 tp . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 115.433 -0.803 . . . . 74.299999999999997 109.818 171.087 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.281 0.086 . . . . 64.099999999999994 110.779 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 mm 63.49 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.246 0.545 . . . . 75.010000000000005 110.919 -174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -80.55 108.86 2.86 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.723 -0.751 . . . . 72.129999999999995 112.622 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.17 105.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.732 0.777 . . . . 60.350000000000001 111.203 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.535 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 88.1 m-85 -99.57 98.27 9.17 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.633 -0.712 . . . . 75.519999999999996 111.107 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 9.5 p90 -119.06 157.93 26.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.453 0.644 . . . . 64.420000000000002 112.349 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.644 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 43.6 t -104.66 101.29 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.822 -0.626 . . . . 71.340000000000003 112.066 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 m -63.26 -23.83 67.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.438 0.637 . . . . 62.109999999999999 111.341 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -78.22 -20.59 51.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.783 -0.644 . . . . 64.329999999999998 112.407 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.406 ' HH ' ' HA3' ' A' ' 91' ' ' GLY . 29.4 t80 -137.24 132.67 34.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.11 0.782 . . . . 72.140000000000001 113.11 -169.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.42 ' HA3' HG21 ' A' ' 90' ' ' THR . . . 56.36 -163.62 5.71 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 115.336 0.894 . . . . 74.329999999999998 115.336 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.84 7.52 10.29 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.502 0.556 . . . . 75.120000000000005 112.502 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 53.3 m -35.64 -47.88 0.5 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.987 1.106 . . . . 50.020000000000003 113.987 -172.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -54.66 -52.37 62.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.149 0.499 . . . . 64.299999999999997 111.687 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -77.3 -25.33 51.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 111.931 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.39 -48.14 71.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.356 0.598 . . . . 72.040000000000006 110.087 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -64.79 -43.71 92.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.635 -0.711 . . . . 70.120000000000005 111.268 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -51.26 -40.19 58.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.09 -0.504 . . . . 75.400000000000006 111.484 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.89 89.91 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.95 0.405 . . . . 71.319999999999993 111.343 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.9 -52.34 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.123 0.487 . . . . 72.420000000000002 111.351 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.45 ' HA ' HG23 ' A' ' 31' ' ' VAL . 65.3 mt -55.08 -49.51 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.738 -0.665 . . . . 60.420000000000002 111.544 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.77 -36.41 69.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.341 -0.39 . . . . 43.210000000000001 111.82 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.26 -46.46 42.18 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.088 -0.577 . . . . 52.009999999999998 113.258 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.68 -43.97 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.811 0.338 . . . . 74.530000000000001 111.572 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.8 p -63.53 -38.37 90.87 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 71.340000000000003 111.164 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -64.8 -21.12 66.71 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.304 0.573 . . . . 75.219999999999999 111.285 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.7 m -85.43 -17.84 35.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 111.438 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.26 16.71 10.82 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.302 -0.475 . . . . 54.030000000000001 113.848 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.14 138.39 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 117.212 0.506 . . . . 72.049999999999997 111.443 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.19 139.24 19.57 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.116 -0.564 . . . . 71.219999999999999 112.932 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 21' ' ' ILE . 29.8 t -105.79 141.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.84 0.352 . . . . 75.5 111.582 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.524 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 22.6 m-20 -93.49 106.49 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.113 0.483 . . . . 71.200000000000003 111.134 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -87.6 109.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.349 0.595 . . . . 62.43 112.224 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -118.49 112.5 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.054 0.454 . . . . 64.109999999999999 111.404 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.48 76.46 8.23 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.385 -0.371 . . . . 71.319999999999993 111.234 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.577 HD11 ' N ' ' A' ' 37' ' ' GLY . 2.0 pp -70.31 -23.83 62.92 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.912 -0.493 . . . . 73.109999999999999 111.319 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -87.94 47.79 3.59 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.289 -0.481 . . . . 55.049999999999997 112.291 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.97 -65.95 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.942 0.497 . . . . 54.520000000000003 110.516 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.16 130.1 0.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.254 -0.43 . . . . 75.219999999999999 111.397 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.33 150.7 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 111.641 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.82 165.49 27.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.458 -0.337 . . . . 71.299999999999997 111.238 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.56 -26.27 65.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.147 0.425 . . . . 64.519999999999996 112.147 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -56.41 -50.52 71.4 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.030000000000001 111.917 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -83.3 -33.92 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.567 -0.288 . . . . 71.049999999999997 111.274 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.37 -29.45 68.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.627 0.251 . . . . 73.319999999999993 111.613 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.13 -39.02 89.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.181 0.515 . . . . 74.109999999999999 110.802 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.01 -25.72 62.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.326 -0.397 . . . . 61.520000000000003 111.912 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.0 tp -53.22 -28.91 29.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.907 0.384 . . . . 62.219999999999999 111.255 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.37 -49.67 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.312 -0.404 . . . . 72.209999999999994 111.865 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.68 -20.42 63.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.094 -0.574 . . . . 61.119999999999997 114.309 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -100.71 5.7 43.77 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.244 -0.563 . . . . 73.340000000000003 111.43 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.5 p -64.72 -7.38 10.6 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.648 0.981 . . . . 71.540000000000006 113.648 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 p -60.58 -42.93 97.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.139 0.422 . . . . 75.430000000000007 112.139 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.26 135.35 6.59 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.989 -0.624 . . . . 37.380000000000003 112.34 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.2 mp -133.3 152.38 51.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 74.400000000000006 111.287 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.36 92.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.452 -0.34 . . . . 73.409999999999997 110.175 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.3 mp -99.92 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.513 . . . . 74.349999999999994 111.786 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.82 151.73 17.87 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.33 -0.462 . . . . 43.210000000000001 112.714 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.505 ' SD ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -53.09 142.01 21.28 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.361 0.6 . . . . 71.140000000000001 112.559 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 92.5 p -132.82 124.15 18.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.405 0.521 . . . . 60.030000000000001 112.405 -173.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 166.14 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.27 1.98 . . . . 72.409999999999997 112.149 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -29.36 -62.8 0.12 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.152 1.538 . . . . 74.230000000000004 115.152 -170.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.14 70.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.399 0.518 . . . . 73.219999999999999 112.399 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.8 m -84.14 -39.67 19.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 43.229999999999997 111.215 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.72 68.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.864 0.364 . . . . 74.209999999999994 111.315 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.11 -36.66 70.92 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 50.119999999999997 111.298 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.2 m -63.47 -48.34 78.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.148 0.499 . . . . 74.030000000000001 110.748 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.79 -52.47 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.099 -0.501 . . . . 75.549999999999997 111.611 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.84 -26.7 67.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.396 -0.366 . . . . 75.209999999999994 111.373 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.93 -42.25 38.3 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.027 -0.606 . . . . 73.230000000000004 112.159 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.18 5.78 18.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.927 0.343 . . . . 53.140000000000001 111.927 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 76' ' ' LEU . 2.1 tm? -46.0 -48.4 16.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.115 0.566 . . . . 62.200000000000003 111.457 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -53.72 -37.48 63.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.135 -0.484 . . . . 73.430000000000007 111.939 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -77.72 -44.51 27.62 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.344 -0.389 . . . . 74.310000000000002 111.357 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.16 -58.86 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 112.173 0.434 . . . . 71.239999999999995 112.173 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 72' ' ' LEU . 4.4 mm? -63.15 -23.68 67.55 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.061 0.393 . . . . 64.239999999999995 112.061 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.31 -25.04 52.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.026 -0.606 . . . . 65.510000000000005 112.99 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 m -85.52 -38.0 19.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.146 0.424 . . . . 64.430000000000007 112.146 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.27 125.06 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.253 0.549 . . . . 70.319999999999993 111.89 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -128.63 158.3 38.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.261 0.553 . . . . 74.530000000000001 112.122 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.667 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 44.1 tt0 62.37 -85.64 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.502 0.927 . . . . 74.010000000000005 113.502 168.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.667 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 65.2 pttt -165.04 23.51 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.394 -0.191 . . . . 74.409999999999997 111.48 -173.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.4 ' NE2' ' HB3' ' A' ' 81' ' ' GLU . 14.7 mm-40 -50.79 158.33 0.68 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.137 0.791 . . . . 63.240000000000002 113.137 -169.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.504 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.15 117.64 28.28 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.617 0.599 . . . . 62.119999999999997 112.617 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.14 112.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.532 0.682 . . . . 54.43 111.894 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.12 145.05 17.16 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.111 -0.495 . . . . 37.380000000000003 112.102 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 42.7 mm -129.12 139.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 117.12 0.46 . . . . 73.319999999999993 111.519 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -128.41 150.75 49.99 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 74.200000000000003 110.694 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 36.2 tt0 -127.91 150.91 49.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.002 0.371 . . . . 71.349999999999994 112.002 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.505 HG23 ' SD ' ' A' ' 59' ' ' MET . 11.4 t -136.05 10.83 3.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.755 0.312 . . . . 73.319999999999993 111.481 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.461 ' H ' ' HG2' ' A' ' 89' ' ' GLU . . . -130.24 -85.75 0.39 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.456 -0.402 . . . . 62.140000000000001 112.985 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.1 -12.35 5.55 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.999 -0.62 . . . . 44.509999999999998 114.071 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.66 44.51 0.75 Allowed Glycine 0 N--CA 1.463 0.448 0 C-N-CA 121.153 -0.546 . . . . 64.430000000000007 112.059 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -173.27 3.44 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.599 0.36 . . . . 74.430000000000007 111.596 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' SER . 19.9 t70 74.09 116.99 0.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.578 0.751 . . . . 71.409999999999997 111.938 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -79.21 -47.47 1.6 Allowed Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 113.523 0.935 . . . . 72.200000000000003 113.523 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.05 9.54 2.37 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.181 1.921 . . . . 73.450000000000003 114.705 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.642 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.9 tt -46.82 -64.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.393 0.886 . . . . 72.310000000000002 113.393 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.642 ' H ' HG23 ' A' ' 98' ' ' ILE . 13.5 m-20 -67.92 -49.43 37.0 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.715 -0.616 . . . . 51.109999999999999 112.593 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.8 Cg_exo -44.76 -39.52 13.76 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.444 2.096 . . . . 71.310000000000002 113.651 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.18 -62.37 1.68 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.752 0.279 . . . . 71.519999999999996 111.752 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.2 mt -56.96 -47.85 79.74 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.415 0.524 . . . . 54.240000000000002 112.415 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.7 t -59.37 -32.32 70.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.951 0.405 . . . . 61.350000000000001 111.557 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -78.89 -42.58 26.87 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.406 -0.361 . . . . 72.030000000000001 111.374 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -60.04 -29.01 68.23 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.908 0.336 . . . . 72.329999999999998 111.908 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -55.86 -36.28 67.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.011 0.374 . . . . 74.310000000000002 112.011 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.42 -21.63 61.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.944 0.402 . . . . 71.310000000000002 111.829 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.407 HD11 ' N ' ' A' ' 108' ' ' LEU . 6.8 mp -92.95 -68.77 0.78 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.914 0.388 . . . . 74.129999999999995 110.73 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.16 67.16 0.37 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.218 -0.515 . . . . 71.239999999999995 113.519 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 110' ' ' LEU . 6.4 mp -95.58 144.61 25.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.686 -0.303 . . . . 71.530000000000001 110.775 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.504 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 89.6 m -65.59 109.55 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.028 0.442 . . . . 74.319999999999993 111.524 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.5 m -86.44 135.01 33.65 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.279 -0.418 . . . . 74.219999999999999 111.313 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.78 -92.62 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.453 0.538 . . . . 70.140000000000001 112.453 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -144.71 91.77 6.05 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.323 -0.236 . . . . 75.129999999999995 111.539 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -96.22 9.27 1.53 Allowed 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.979 2.453 . . . . 73.299999999999997 113.884 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.72 32.66 0.96 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.263 0.838 . . . . 74.209999999999994 113.263 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.1 tt -146.39 134.49 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.815 -0.553 . . . . 71.530000000000001 112.248 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.96 155.16 46.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.076 0.465 . . . . 65.030000000000001 111.17 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 121' ' ' GLN . 2.1 mp -95.57 150.13 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 116.2 -0.454 . . . . 60.210000000000001 111.308 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -62.89 -44.91 94.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.097 0.475 . . . . 74.450000000000003 111.93 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.496 ' H ' HG22 ' A' ' 119' ' ' ILE . 58.1 tt0 -178.36 -63.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.832 -0.622 . . . . 74.420000000000002 109.656 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -119.52 115.0 34.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.802 -0.635 . . . . 72.129999999999995 110.559 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HB2' ' OG1' ' A' ' 127' ' ' THR . 96.0 Cg_endo -77.43 -170.78 1.0 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.819 2.346 . . . . 73.219999999999999 113.564 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.1 p -131.22 -169.08 2.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.121 0.486 . . . . 72.109999999999999 111.723 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.06 -26.44 64.61 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.214 -0.448 . . . . 70.420000000000002 111.939 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.52 -35.87 72.94 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.439999999999998 111.685 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 123' ' ' PRO . 30.6 m -60.3 -39.72 87.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.015 0.436 . . . . 62.299999999999997 111.389 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -59.97 -50.81 72.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.177 0.513 . . . . 71.349999999999994 110.895 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -62.6 -36.21 82.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.766 -0.652 . . . . 75.010000000000005 111.289 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.2 tt -61.48 -44.93 96.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.037 -0.529 . . . . 74.129999999999995 110.264 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 89.2 m -59.19 -42.57 91.16 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.134 -0.485 . . . . 60.020000000000003 111.502 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -58.68 -49.33 77.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.055 0.455 . . . . 62.030000000000001 111.226 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -58.77 -49.41 77.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.142 -0.481 . . . . 75.510000000000005 111.385 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.99 -51.92 67.2 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.092 -0.504 . . . . 44.130000000000003 112.006 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.39 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.168 -0.539 . . . . 71.430000000000007 113.145 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 96.3 m -60.31 -44.91 95.0 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.665 0.269 . . . . 74.120000000000005 111.627 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.77 -48.62 80.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.879 0.371 . . . . 72.340000000000003 110.973 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.31 -43.15 92.66 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.337 -0.392 . . . . 71.010000000000005 111.048 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 143' ' ' THR . . . -58.7 -42.42 96.32 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.112 -0.566 . . . . 43.450000000000003 112.918 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -62.3 -35.12 78.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.672 0.272 . . . . 72.0 111.321 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -65.92 -47.51 74.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.849 0.357 . . . . 72.120000000000005 111.343 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.89 -53.07 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.937 0.347 . . . . 54.509999999999998 111.937 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 139' ' ' GLY . 2.9 t -62.06 -34.82 76.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.042 0.449 . . . . 64.430000000000007 111.248 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.97 -37.67 88.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.197 -0.456 . . . . 73.239999999999995 111.476 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -80.04 -44.9 19.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.858 0.361 . . . . 74.230000000000004 111.787 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -76.61 -7.84 56.04 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.318 0.859 . . . . 54.140000000000001 113.318 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.492 -0.558 . . . . 75.400000000000006 109.492 170.462 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 75.5 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 111.25 0.093 . . . . 65.299999999999997 111.25 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 48.1 mm 62.65 108.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.183 0.516 . . . . 62.229999999999997 111.898 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.68 117.01 4.34 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.914 -0.66 . . . . 65.019999999999996 113.04 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.54 115.85 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.411 0.624 . . . . 63.340000000000003 111.979 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 3.1 m-85 -94.69 112.77 24.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.854 -0.612 . . . . 74.200000000000003 111.21 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -135.02 148.92 50.07 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.179 0.514 . . . . 75.349999999999994 112.225 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.596 HG23 HD12 ' A' ' 36' ' ' LEU . 15.1 t -112.86 95.43 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.956 -0.565 . . . . 72.340000000000003 111.096 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 m -56.14 -16.16 4.76 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.033 0.444 . . . . 74.519999999999996 112.038 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.27 -25.13 20.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.535 0.569 . . . . 72.420000000000002 112.535 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.18 123.76 35.1 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.479 0.918 . . . . 74.129999999999995 113.479 -170.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.69 -163.61 4.86 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.626 1.01 . . . . 51.0 115.626 171.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.416 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 93.7 m-85 -75.03 -0.86 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.044 0.757 . . . . 64.340000000000003 113.044 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -59.28 -31.02 68.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.225 0.536 . . . . 73.239999999999995 110.351 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.84 -37.97 72.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.467 -0.788 . . . . 74.010000000000005 111.266 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -85.85 -38.41 18.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.33 -0.395 . . . . 73.430000000000007 111.807 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.9 mt -50.45 -47.25 56.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.529 -0.305 . . . . 71.019999999999996 111.792 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.45 65.99 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.104 0.409 . . . . 65.0 112.104 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.435 -0.348 . . . . 72.439999999999998 111.568 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.46 -41.96 31.2 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.824 0.345 . . . . 73.209999999999994 111.279 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 16' ' ' LEU . 71.9 mt -59.47 -56.06 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.884 0.373 . . . . 75.409999999999997 111.885 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.61 -30.61 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.979 0.419 . . . . 71.120000000000005 111.81 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.82 -53.1 12.38 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.037 0.446 . . . . 72.530000000000001 111.182 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.521 ' HA3' ' HG3' ' A' ' 132' ' ' GLU . . . -63.58 -44.74 96.08 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.188 -0.46 . . . . 73.439999999999998 114.082 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.89 -52.05 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.381 0.511 . . . . 72.140000000000001 112.381 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -59.46 -34.49 72.59 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.031 0.443 . . . . 71.409999999999997 112.01 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.467 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 9.6 mtpm? -84.53 5.76 26.35 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.502 0.556 . . . . 75.099999999999994 112.502 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.25 -47.78 1.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.789 0.328 . . . . 74.439999999999998 111.702 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.85 -89.32 0.75 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.997 -0.62 . . . . 64.310000000000002 113.585 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.86 172.31 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.164 0.431 . . . . 64.099999999999994 112.164 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.03 157.61 53.05 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.397 -0.43 . . . . 61.32 113.652 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 1' ' ' SER . 38.8 t -108.73 148.35 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.527 0.331 . . . . 73.319999999999993 111.867 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.45 128.27 53.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.821 0.343 . . . . 43.409999999999997 110.858 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.68 138.9 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.538 0.569 . . . . 74.530000000000001 112.538 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.53 96.98 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.145 0.497 . . . . 74.109999999999999 111.277 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.64 86.83 6.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.314 -0.403 . . . . 75.329999999999998 110.955 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.596 HD12 HG23 ' A' ' 7' ' ' VAL . 3.5 pp -91.29 -23.87 20.01 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.331 0.493 . . . . 70.120000000000005 112.331 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.568 ' N ' HD11 ' A' ' 36' ' ' LEU . . . -78.99 47.99 3.23 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.027 -0.606 . . . . 61.039999999999999 113.303 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -171.91 -167.27 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.76 0.424 . . . . 74.430000000000007 110.691 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.58 104.28 5.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.854 0.359 . . . . 62.200000000000003 111.028 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.74 175.1 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.503 -0.317 . . . . 71.519999999999996 111.601 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -140.48 160.49 39.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.307 0.575 . . . . 71.340000000000003 112.331 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.5 tm? -55.16 -35.51 64.84 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.805 -0.634 . . . . 60.420000000000002 111.989 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.3 mt-30 -50.78 -43.38 58.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.083 0.468 . . . . 74.319999999999993 111.457 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.15 -24.36 64.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.001 -0.545 . . . . 53.210000000000001 111.445 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.99 -51.17 34.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.338 -0.392 . . . . 74.150000000000006 110.815 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -61.65 -32.64 72.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.83 0.347 . . . . 73.140000000000001 111.034 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 71.4 mm-40 -60.62 -48.87 79.86 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.034 0.445 . . . . 63.509999999999998 110.641 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.02 -39.35 71.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.887 -0.597 . . . . 64.230000000000004 111.812 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.8 -35.09 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.157 0.503 . . . . 72.109999999999999 111.186 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.36 -10.81 76.66 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.225 -0.512 . . . . 52.329999999999998 113.163 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -101.45 4.58 41.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.396 -0.473 . . . . 52.130000000000003 111.569 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.58 1.76 3.8 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.565 0.95 . . . . 74.230000000000004 113.565 -172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.5 p -64.15 -42.09 96.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.208 0.527 . . . . 62.100000000000001 110.838 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.59 136.59 5.35 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.803 -0.635 . . . . 51.439999999999998 112.32 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -160.81 148.41 15.75 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.496 -0.414 . . . . 74.329999999999998 111.657 -177.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -112.26 125.31 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 71.519999999999996 110.974 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 47.5 mt -128.92 136.27 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.064 0.459 . . . . 74.200000000000003 112.191 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.69 -163.88 34.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.146 -0.549 . . . . 62.43 112.401 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtm -98.17 135.26 40.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.018 -0.695 . . . . 72.349999999999994 110.648 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.9 p -79.62 150.8 73.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.199 0.444 . . . . 62.43 112.199 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 64' ' ' SER . 16.5 Cg_endo -90.85 157.59 4.07 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.831 2.354 . . . . 65.530000000000001 111.78 169.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.97 -31.58 29.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.174 0.435 . . . . 70.329999999999998 112.174 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.02 73.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.975 0.361 . . . . 73.450000000000003 111.975 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 38.9 m -95.76 -13.21 24.31 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.685 0.278 . . . . 71.439999999999998 111.679 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.73 -42.4 35.1 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.86 0.689 . . . . 74.030000000000001 112.86 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.96 -47.08 78.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.99 0.424 . . . . 62.530000000000001 111.853 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -67.13 -45.82 75.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.147 0.498 . . . . 72.310000000000002 111.401 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.2 -46.96 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.981 -0.554 . . . . 75.129999999999995 112.155 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -57.82 -35.56 71.03 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.821 0.343 . . . . 75.450000000000003 111.895 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.83 -43.38 28.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.062 -0.59 . . . . 73.310000000000002 113.072 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.35 -26.07 51.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.225 0.454 . . . . 74.239999999999995 112.225 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.449 HD21 HD11 ' A' ' 101' ' ' LEU . 52.1 tp -52.8 -37.38 59.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.066 0.395 . . . . 72.120000000000005 112.066 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -59.12 -43.97 91.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.944 0.402 . . . . 63.109999999999999 111.324 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.9 m -68.63 -36.1 78.17 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.171 0.51 . . . . 72.349999999999994 111.004 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' VAL . 67.7 mt -61.96 -59.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.266 -0.425 . . . . 71.510000000000005 111.009 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.57 -30.16 65.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.251 0.463 . . . . 62.539999999999999 112.251 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.15 -24.04 67.21 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.127 -0.559 . . . . 65.310000000000002 113.439 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 p -97.97 -48.36 5.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.304 0.483 . . . . 74.129999999999995 112.304 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' ILE . 34.8 m -77.88 85.99 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 122.033 0.92 . . . . 75.239999999999995 111.687 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -178.12 4.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.862 -0.608 . . . . 73.230000000000004 112.144 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 65.74 -77.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.249 0.62 . . . . 72.030000000000001 111.981 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -168.35 29.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.9 0.704 . . . . 71.340000000000003 112.9 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.58 160.99 12.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.095 0.474 . . . . 75.329999999999998 111.647 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.61 ' HB3' HD23 ' A' ' 138' ' ' LEU . . . -89.19 95.62 10.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.012 0.745 . . . . 72.109999999999999 113.012 -170.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.67 92.95 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.76 0.791 . . . . 63.340000000000003 111.551 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.55 72.72 2.5 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.029 -0.532 . . . . 75.310000000000002 113.367 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 12.0 tt -96.54 133.67 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 122.639 -0.33 . . . . 73.409999999999997 111.035 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' CZ ' ' SG ' ' A' ' 131' ' ' CYS . 8.0 p90 -146.79 173.42 12.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.152 0.501 . . . . 75.420000000000002 112.206 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.05 96.61 0.15 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.239 0.542 . . . . 70.239999999999995 112.323 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.2 m -131.43 94.02 3.46 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.262 -0.426 . . . . 60.200000000000003 110.512 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.65 168.63 11.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.355 -0.45 . . . . 37.770000000000003 112.629 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA3' ' OE1' ' A' ' 121' ' ' GLN . . . -114.52 -135.12 5.9 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.852 -0.689 . . . . 64.349999999999994 114.022 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.92 77.06 1.8 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.319 -0.467 . . . . 41.409999999999997 113.125 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.3 -179.86 7.25 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.631 -0.335 . . . . 72.340000000000003 110.734 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 70.89 154.82 0.14 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.868 0.692 . . . . 54.130000000000003 112.868 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.45 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.1 mt-10 -104.63 -57.36 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.755 0.65 . . . . 71.349999999999994 112.755 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.506 ' O ' HD12 ' A' ' 101' ' ' LEU . 57.4 Cg_endo -68.51 -1.98 8.4 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.322 2.014 . . . . 65.230000000000004 113.996 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.8 tp -50.99 -45.1 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 112.734 0.642 . . . . 73.400000000000006 112.734 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 5.5 m-20 -58.21 -55.74 42.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 111.997 0.369 . . . . 52.409999999999997 111.997 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 82.6 Cg_exo -50.24 -48.99 17.64 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.328 2.019 . . . . 74.310000000000002 113.358 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 97' ' ' PRO . 11.2 mp -56.74 -51.98 66.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.06 0.393 . . . . 72.299999999999997 112.06 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.44 -52.03 60.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.797 0.332 . . . . 73.109999999999999 111.67 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t -66.93 -34.46 77.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.776 0.322 . . . . 74.319999999999993 111.581 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 1.4 tpmt? -59.86 -60.85 3.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.841 0.353 . . . . 54.329999999999998 111.305 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.58 -30.85 71.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.533 -0.303 . . . . 74.310000000000002 111.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -59.5 -45.83 90.56 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.868 0.366 . . . . 73.439999999999998 110.378 176.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -47.95 62.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.208 -0.451 . . . . 72.549999999999997 110.666 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.74 -48.7 77.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.866 0.365 . . . . 75.430000000000007 111.52 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.53 71.83 0.71 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.654 0.622 . . . . 37.770000000000003 114.654 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 110' ' ' LEU . 6.0 mp -90.93 -177.31 4.91 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.415 -0.461 . . . . 64.340000000000003 110.415 173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.2 m -63.83 101.89 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.123 0.416 . . . . 74.349999999999994 112.123 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 p -105.64 137.39 43.57 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.065 0.459 . . . . 75.109999999999999 111.565 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.41 -58.01 3.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.886 0.375 . . . . 54.039999999999999 111.796 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -167.78 89.83 0.69 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.735 0.302 . . . . 74.230000000000004 110.453 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.01 -33.56 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.62 2.214 . . . . 73.409999999999997 114.368 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.49 118.03 28.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.27 0.47 . . . . 62.32 112.27 -173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.493 HG23 HG12 ' A' ' 119' ' ' ILE . 12.6 tt -137.78 7.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.322 0.582 . . . . 73.510000000000005 111.779 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 67.73 65.56 0.38 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.026 0.53 . . . . 72.510000000000005 112.429 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.648 HD11 ' HA ' ' A' ' 123' ' ' PRO . 50.8 mm -104.62 111.67 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 74.109999999999999 111.115 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -93.53 -23.13 18.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.234 -0.439 . . . . 71.019999999999996 111.683 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.486 ' OE1' ' HA3' ' A' ' 92' ' ' GLY . 6.0 tp-100 -161.48 -65.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.021 0.438 . . . . 64.129999999999995 111.291 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.7 p -104.04 125.67 33.82 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.208 0.448 . . . . 73.409999999999997 112.208 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.648 ' HA ' HD11 ' A' ' 119' ' ' ILE . 52.2 Cg_exo -55.93 150.23 47.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.545 2.163 . . . . 74.450000000000003 112.456 170.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.8 p -118.93 -176.12 3.05 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 -174.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.63 -48.41 19.86 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.104 -0.498 . . . . 64.349999999999994 112.049 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.96 -25.94 65.6 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.036 -0.529 . . . . 75.430000000000007 111.974 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 123' ' ' PRO . 59.2 m -63.87 -36.99 85.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.83 0.348 . . . . 63.310000000000002 110.856 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.39 -47.1 74.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.979 0.419 . . . . 75.340000000000003 110.937 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.72 -41.47 95.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.224 -0.443 . . . . 64.519999999999996 111.072 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.37 -54.43 47.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.466 -0.334 . . . . 74.519999999999996 110.238 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.428 ' SG ' ' CZ ' ' A' ' 88' ' ' PHE . 74.4 m -50.03 -51.58 40.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 111.785 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.521 ' HG3' ' HA3' ' A' ' 23' ' ' GLY . 46.1 tt0 -67.17 -55.02 15.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.381 -0.372 . . . . 73.129999999999995 111.792 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.49 -54.86 42.29 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.942 0.349 . . . . 52.229999999999997 111.942 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.6 76.47 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.4 -0.364 . . . . 54.340000000000003 111.85 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.15 -46.85 93.67 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 63.509999999999998 113.274 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 94.7 m -63.34 -51.2 66.92 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.88 0.371 . . . . 63.340000000000003 111.815 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.06 -42.63 98.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.133 0.492 . . . . 64.25 111.068 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 84' ' ' ALA . 53.7 tp -64.76 -41.24 96.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.053 0.454 . . . . 73.439999999999998 110.757 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.24 -42.72 98.82 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.183 -0.462 . . . . 52.210000000000001 112.68 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.15 -39.18 85.44 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.955 0.407 . . . . 74.140000000000001 110.926 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -59.89 -49.5 77.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.46 -0.336 . . . . 72.420000000000002 111.12 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.38 -47.91 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 112.133 0.419 . . . . 71.239999999999995 112.133 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -71.83 -41.5 68.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.106 0.409 . . . . 64.439999999999998 112.106 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -64.08 -33.16 75.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 111.559 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.6 -26.86 14.7 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.109 -0.496 . . . . 70.239999999999995 111.286 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -97.69 -63.68 1.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.339 -0.391 . . . . 75.219999999999999 112.013 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 147' ' ' LEU . 4.8 tt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 111.861 0.319 . . . . 64.239999999999995 111.861 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.59 -0.152 . . . . 73.450000000000003 110.59 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 46.8 mm 74.55 96.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 121.31 0.576 . . . . 63.32 110.589 -172.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.99 123.24 5.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.056 -0.52 . . . . 54.229999999999997 113.735 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.7 t -95.36 106.4 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 O-C-N 122.608 -0.348 . . . . 65.400000000000006 111.115 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.589 ' HB3' HD22 ' A' ' 36' ' ' LEU . 93.1 m-85 -90.96 105.96 18.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.925 0.393 . . . . 74.540000000000006 111.614 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.603 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 35.9 p90 -146.75 -178.59 6.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.434 -0.348 . . . . 72.420000000000002 110.945 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 10' ' ' TYR . 2.8 p -134.55 104.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.089 0.471 . . . . 75.329999999999998 111.086 176.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -52.48 -25.34 9.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.215 0.82 . . . . 73.319999999999993 113.215 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -74.08 -32.42 63.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.763 0.316 . . . . 73.109999999999999 111.644 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB3' HG12 ' A' ' 7' ' ' VAL . 61.0 t80 -104.31 137.41 42.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.07 0.462 . . . . 74.409999999999997 112.226 -173.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.12 -161.79 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.98 0.752 . . . . 63.009999999999998 114.98 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.63 7.56 17.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.772 0.429 . . . . 73.5 111.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.8 p -30.75 -65.65 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.279 1.214 . . . . 55.509999999999998 114.279 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.46 -35.04 79.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.085 0.402 . . . . 72.409999999999997 112.085 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -60.21 -40.29 89.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.092 0.472 . . . . 72.239999999999995 110.747 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.44 -37.18 68.64 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 71.439999999999998 110.764 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.92 -31.64 67.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.206 -0.452 . . . . 51.329999999999998 111.352 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -52.21 -43.02 64.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.251 -0.431 . . . . 64.299999999999997 110.997 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.76 -47.29 69.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.972 -0.558 . . . . 72.319999999999993 111.609 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.74 -55.4 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 71.530000000000001 111.386 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.03 -46.73 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.212 -0.449 . . . . 75.239999999999995 111.207 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.17 -50.22 74.88 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.414 -0.357 . . . . 71.040000000000006 111.864 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.17 -48.77 84.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.819 -0.705 . . . . 74.310000000000002 113.305 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.408 HG23 HG12 ' A' ' 31' ' ' VAL . 1.8 mp -72.11 -32.3 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 122.521 -0.399 . . . . 74.340000000000003 112.013 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -72.0 -30.2 64.99 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.679 -0.638 . . . . 63.210000000000001 110.628 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.742 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 4.6 mmmp? -64.99 -24.11 67.42 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.137 0.494 . . . . 74.430000000000007 110.692 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 140' ' ' GLN . 60.3 m -79.07 -40.44 31.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.219 0.533 . . . . 74.239999999999995 110.474 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.57 21.63 7.47 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.892 -0.595 . . . . 73.140000000000001 113.492 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.44 -77.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 122.402 -0.47 . . . . 72.0 111.995 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.67 115.48 3.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.306 -0.473 . . . . 72.25 113.133 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 1' ' ' SER . 29.7 m -90.59 157.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.187 0.518 . . . . 65.329999999999998 112.247 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' CG ' ' H1 ' ' A' ' 1' ' ' SER . 9.4 m-20 -96.28 130.62 43.33 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 110.926 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.41 120.19 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.142 -0.348 . . . . 71.329999999999998 111.759 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.79 104.15 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.672 0.273 . . . . 60.229999999999997 111.717 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.603 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 11.4 m-20 -77.05 103.23 6.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.811 0.339 . . . . 74.400000000000006 111.049 173.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -67.96 78.81 0.22 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.968 0.89 . . . . 72.109999999999999 111.864 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.1 -25.62 0.23 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.404 -0.816 . . . . 75.239999999999995 112.397 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.97 157.87 34.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.778 0.323 . . . . 72.329999999999998 111.364 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 70.28 2.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.207 0.527 . . . . 72.420000000000002 111.976 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.63 147.65 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 75.430000000000007 111.527 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.4 166.8 10.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.98 0.419 . . . . 74.340000000000003 111.259 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 45' ' ' LEU . 3.9 mm? -56.22 -24.4 41.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.451 -0.341 . . . . 74.299999999999997 111.201 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.74 -49.6 77.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.218 -0.446 . . . . 65.0 111.033 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.82 -46.41 71.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.879 0.371 . . . . 75.0 111.168 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 42' ' ' LEU . 93.7 mt -57.53 -46.82 83.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.191 -0.459 . . . . 74.239999999999995 111.767 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.4 -44.92 96.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.698 0.285 . . . . 74.349999999999994 111.586 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.57 -42.52 95.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.167 0.508 . . . . 70.209999999999994 110.83 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.73 -42.06 71.1 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.969 -0.56 . . . . 74.540000000000006 111.485 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 45' ' ' LEU . 67.2 t -56.1 -37.61 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.979 0.418 . . . . 74.049999999999997 111.43 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.11 -21.32 79.89 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.964 -0.636 . . . . 54.119999999999997 112.993 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -100.74 5.3 43.59 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.57 -0.371 . . . . 71.310000000000002 111.821 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.1 p -70.83 4.58 2.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.324 0.861 . . . . 75.409999999999997 113.324 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.5 p -58.96 -36.39 74.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 64.510000000000005 110.927 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -154.95 138.82 6.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.624 -0.716 . . . . 37.600000000000001 112.047 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.0 169.76 17.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.256 0.528 . . . . 75.340000000000003 112.196 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 88' ' ' PHE . 7.3 p -131.46 136.24 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.767 0.318 . . . . 74.230000000000004 111.388 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.7 mp -112.69 133.16 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.936 0.398 . . . . 60.0 112.062 -175.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.93 -124.45 5.41 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.263 -0.494 . . . . 50.310000000000002 112.686 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.436 ' SD ' ' HA3' ' A' ' 91' ' ' GLY . 54.9 ttm -155.07 154.7 32.83 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.429 -0.454 . . . . 72.239999999999995 110.892 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 36' ' ' LEU . 67.7 p -114.19 156.95 43.52 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 120.607 0.242 . . . . 72.150000000000006 111.38 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.43 152.14 78.78 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.951 1.767 . . . . 74.230000000000004 111.826 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.34 -41.08 8.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.422 0.897 . . . . 73.129999999999995 113.422 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.48 -48.34 56.21 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.155 0.428 . . . . 72.209999999999994 112.155 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -14.49 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.027 0.38 . . . . 75.129999999999995 112.027 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.517 ' HB3' ' H ' ' A' ' 96' ' ' GLU . . . -54.22 -32.18 55.2 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.225 0.454 . . . . 73.040000000000006 112.225 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.19 -33.21 70.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 75.430000000000007 111.252 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -67.84 -42.13 81.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.176 -0.465 . . . . 75.030000000000001 111.296 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.418 HD11 ' HG ' ' A' ' 60' ' ' SER . 29.7 mt -63.5 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.814 0.34 . . . . 55.020000000000003 110.855 175.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -51.62 -45.4 63.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.208 -0.451 . . . . 71.150000000000006 111.545 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.01 -49.47 16.43 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.047 -0.596 . . . . 64.409999999999997 113.184 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.83 76.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.005 0.372 . . . . 54.530000000000001 112.005 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 tt -48.39 -49.73 33.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.21 0.604 . . . . 74.299999999999997 111.387 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -60.13 -40.09 88.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.105 0.409 . . . . 71.400000000000006 112.105 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.2 m -74.33 -36.87 63.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.876 0.37 . . . . 72.230000000000004 111.395 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 79' ' ' VAL . 74.7 mt -71.63 -67.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.469 -0.332 . . . . 74.200000000000003 111.397 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.435 ' HA ' HG23 ' A' ' 79' ' ' VAL . 68.4 mt -61.65 -22.15 65.03 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.452 0.538 . . . . 75.400000000000006 112.452 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.45 -22.68 64.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.727 -0.749 . . . . 44.299999999999997 113.259 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -101.03 -26.2 13.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.458 0.54 . . . . 71.230000000000004 112.458 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 75' ' ' ILE . 33.7 m -70.51 179.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.381 0.61 . . . . 72.409999999999997 112.417 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.61 161.34 25.97 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.092 -0.504 . . . . 74.099999999999994 111.691 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -46.97 -42.89 18.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 112.814 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -145.92 133.03 20.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.089 0.471 . . . . 71.209999999999994 111.39 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -133.54 177.18 7.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.073 -0.512 . . . . 73.099999999999994 111.806 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 138' ' ' LEU . . . -102.74 112.18 24.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.845 0.355 . . . . 62.350000000000001 111.24 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.75 169.69 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.91 0.386 . . . . 72.239999999999995 111.967 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.12 169.29 32.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.37 -0.443 . . . . 71.040000000000006 112.749 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.428 HG21 ' HB1' ' A' ' 116' ' ' ALA . 43.9 mm -100.42 146.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 74.129999999999995 111.895 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.536 ' HB2' HG21 ' A' ' 56' ' ' VAL . 17.8 t80 -135.28 109.58 8.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.501 -0.318 . . . . 74.409999999999997 110.749 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -64.62 93.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.557 0.577 . . . . 62.329999999999998 112.557 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 t -160.58 77.79 0.61 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.258 0.551 . . . . 73.329999999999998 111.819 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.436 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . 171.31 121.51 0.59 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.091 -0.576 . . . . 37.600000000000001 113.193 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.87 51.09 4.27 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.128 -0.558 . . . . 62.240000000000002 113.407 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.32 56.76 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.281 -0.485 . . . . 62.140000000000001 113.313 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.6 -154.89 0.38 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.67 0.388 . . . . 71.049999999999997 111.404 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 23.3 t70 69.66 154.93 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.321 0.648 . . . . 65.109999999999999 112.593 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' H ' ' HB3' ' A' ' 65' ' ' ALA . 8.3 mm-40 -103.42 -56.33 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.095 -0.502 . . . . 72.140000000000001 112.31 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 88.4 Cg_endo -80.04 16.96 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.122 1.881 . . . . 72.109999999999999 113.759 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.422 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.3 tt -48.0 -56.39 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.705 1.002 . . . . 62.219999999999999 113.705 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.663 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.5 m-20 -61.17 -54.07 57.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.972 -0.455 . . . . 70.510000000000005 111.953 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 51.8 Cg_exo -54.66 -42.2 70.56 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.905 1.737 . . . . 74.340000000000003 112.654 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.61 -59.52 4.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.984 0.421 . . . . 74.409999999999997 111.342 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.51 -35.4 79.26 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.02 0.438 . . . . 44.210000000000001 111.511 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -62.71 -46.28 88.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.394 -0.366 . . . . 73.140000000000001 111.784 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 100' ' ' PRO . 53.2 mtpt -61.08 -45.15 95.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.499 0.19 . . . . 74.129999999999995 111.356 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' HD11 ' A' ' 110' ' ' LEU . 2.3 m-85 -58.59 -40.96 84.66 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 110.991 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.76 -49.66 74.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.715 -0.675 . . . . 74.439999999999998 111.9 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -81.29 -46.85 14.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.864 0.69 . . . . 74.310000000000002 112.864 -174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.5 -15.18 57.14 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.238 0.458 . . . . 75.150000000000006 112.238 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.61 4.98 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 114.398 0.519 . . . . 73.420000000000002 114.398 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 105' ' ' PHE . 7.5 mp -88.88 -175.33 4.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.095 0.448 . . . . 63.43 110.995 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 154.16 26.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.258 0.552 . . . . 61.140000000000001 111.982 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -100.98 -51.94 3.41 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.069 -0.514 . . . . 75.040000000000006 111.757 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.59 42.87 13.44 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.093 0.473 . . . . 72.540000000000006 111.563 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.5 t80 68.23 93.71 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.468 -0.787 . . . . 74.310000000000002 111.706 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.31 96.5 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.432 2.088 . . . . 70.030000000000001 112.276 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -56.57 156.14 6.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.524 0.564 . . . . 71.040000000000006 112.524 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -77.13 139.42 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 110.402 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.643 ' N ' HD12 ' A' ' 117' ' ' ILE . 82.2 mtt180 -56.74 120.72 8.32 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.133 0.492 . . . . 73.319999999999993 111.659 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.475 HD11 ' N ' ' A' ' 119' ' ' ILE . 2.8 mp -70.15 138.15 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.302 0.572 . . . . 71.109999999999999 112.172 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -65.86 -70.94 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.912 -0.586 . . . . 74.230000000000004 110.723 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -155.1 -58.98 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.172 0.511 . . . . 72.420000000000002 110.413 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.3 p -94.69 136.87 22.7 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.123 -0.489 . . . . 54.530000000000001 111.933 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.46 -165.21 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.962 2.442 . . . . 72.129999999999995 112.8 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 55.0 p -133.08 171.89 13.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.939 0.4 . . . . 60.310000000000002 111.542 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.81 -33.41 56.0 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.155 0.503 . . . . 63.43 111.569 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.76 -10.77 30.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.533 0.568 . . . . 71.5 112.533 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.5 m -63.56 -33.11 74.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.012 0.434 . . . . 71.099999999999994 111.13 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.484 ' HA ' ' SG ' ' A' ' 131' ' ' CYS . 82.9 m-85 -65.16 -41.67 94.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.301 0.572 . . . . 74.439999999999998 110.514 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.17 -49.71 76.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 73.510000000000005 111.099 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.17 -58.13 9.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.106 -0.497 . . . . 75.219999999999999 111.218 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 128' ' ' TYR . 27.8 p -58.15 -47.09 84.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.671 0.619 . . . . 75.310000000000002 112.671 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.58 -54.75 27.15 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.154 0.427 . . . . 71.530000000000001 112.154 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.33 -48.6 72.47 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.117 0.414 . . . . 41.420000000000002 112.117 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.31 -42.84 92.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 111.312 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.49 97.48 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.317 -0.468 . . . . 75.299999999999997 112.774 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.466 HG21 ' NE2' ' A' ' 140' ' ' GLN . 46.6 m -62.05 -44.17 97.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.999 0.428 . . . . 63.310000000000002 111.096 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.92 -61.07 2.13 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.441 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.604 HD11 ' HB1' ' A' ' 84' ' ' ALA . 46.9 tp -63.34 -37.86 88.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.83 0.348 . . . . 74.299999999999997 111.722 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -51.14 45.46 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.114 -0.565 . . . . 74.099999999999994 113.165 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.473 ' O ' HG21 ' A' ' 143' ' ' THR . 80.7 mt-30 -73.01 -7.84 53.04 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.353 -0.498 . . . . 74.420000000000002 111.983 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.454 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 62.6 t90 -55.26 -32.3 62.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.137 0.494 . . . . 73.409999999999997 110.191 170.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.62 -47.07 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 111.95 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 140' ' ' GLN . 11.3 t -73.66 -32.06 63.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.143 -0.348 . . . . 55.210000000000001 111.49 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -70.74 -41.83 71.29 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.86 0.362 . . . . 62.149999999999999 111.438 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.53 -61.05 1.76 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.532 0.567 . . . . 60.329999999999998 112.532 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -75.08 -55.08 6.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.902 0.382 . . . . 64.450000000000003 111.838 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.452 ' O ' HD21 ' A' ' 147' ' ' LEU . 10.1 tt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 120.922 0.392 . . . . 71.349999999999994 110.994 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 45.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.143 -0.317 . . . . 55.119999999999997 110.143 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.644 HD12 ' HA3' ' A' ' 54' ' ' GLY . 47.2 mm 59.64 91.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.184 0.516 . . . . 71.519999999999996 111.53 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 104.64 2.3 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.833 -0.698 . . . . 65.439999999999998 112.84 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 m -87.3 107.79 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.427 0.632 . . . . 62.340000000000003 110.881 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.718 ' HB3' HD23 ' A' ' 36' ' ' LEU . 55.3 m-85 -104.22 118.37 36.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.897 -0.592 . . . . 72.219999999999999 111.206 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -152.16 176.51 11.49 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.202 0.445 . . . . 75.400000000000006 112.202 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 13' ' ' SER . 48.4 t -109.08 104.04 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 116.089 -0.505 . . . . 74.140000000000001 110.28 172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.689 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 62.1 p -59.67 -56.74 18.08 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.415 0.895 . . . . 74.099999999999994 113.415 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.23 -43.26 92.35 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.087 0.773 . . . . 65.0 113.087 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -77.26 121.02 23.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.14 0.495 . . . . 64.010000000000005 112.266 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.28 -162.61 6.17 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.844 -0.616 . . . . 44.509999999999998 114.408 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -81.9 7.77 12.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.925 0.343 . . . . 72.519999999999996 111.925 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 20.0 m -44.22 -43.97 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.578 0.955 . . . . 75.450000000000003 113.578 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 19.6 p-10 -73.57 -36.71 65.62 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.922 -0.486 . . . . 60.299999999999997 111.358 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mmt-85 -61.22 -40.62 94.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.519 0.676 . . . . 74.109999999999999 109.713 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.657 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . 79.7 mt -66.67 -41.68 87.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 73.439999999999998 110.838 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.74 83.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 75.109999999999999 111.136 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.48 -27.56 65.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.801 0.334 . . . . 72.329999999999998 110.994 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 22' ' ' ASN . . . -64.27 -37.64 88.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.089 0.471 . . . . 72.5 110.362 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.584 HG23 ' HA3' ' A' ' 135' ' ' GLY . 63.1 mt -63.1 -53.1 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.278 0.561 . . . . 74.510000000000005 110.301 171.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.14 -33.45 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.751 -0.659 . . . . 75.5 111.283 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 39.2 t30 -53.65 -60.14 3.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.356 -0.384 . . . . 53.439999999999998 111.187 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.17 97.93 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.12 -0.562 . . . . 71.549999999999997 113.06 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.676 HG22 ' HB ' ' A' ' 29' ' ' VAL . 55.4 mt -60.75 -50.6 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.235 0.457 . . . . 73.120000000000005 112.235 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -67.97 -38.22 82.47 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.165 -0.335 . . . . 75.329999999999998 111.298 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.8 -32.89 69.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.091 0.472 . . . . 73.019999999999996 111.078 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 140' ' ' GLN . 88.6 m -79.4 -35.27 40.92 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.175 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.91 32.25 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.365 -0.445 . . . . 75.519999999999996 113.279 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.676 ' HB ' HG22 ' A' ' 24' ' ' ILE . 29.5 t -108.91 133.95 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 122.462 -0.434 . . . . 74.209999999999994 111.417 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.09 112.64 3.64 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.111 -0.566 . . . . 70.409999999999997 112.534 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 ' HB ' HG21 ' A' ' 24' ' ' ILE . 7.7 p -99.22 140.85 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 112.48 0.548 . . . . 64.239999999999995 112.48 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -96.48 109.38 21.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.027 0.441 . . . . 71.319999999999993 110.695 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.07 116.91 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 111.872 0.323 . . . . 74.129999999999995 111.872 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.41 119.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.017 0.437 . . . . 54.420000000000002 111.942 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.67 105.27 16.1 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.934 0.397 . . . . 74.219999999999999 111.255 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 5' ' ' PHE . 2.9 pp -77.38 -10.02 59.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.843 0.354 . . . . 73.109999999999999 111.43 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.58 -12.26 66.67 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.206 -0.521 . . . . 37.299999999999997 113.14 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.18 -48.23 0.06 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.867 0.365 . . . . 73.409999999999997 111.77 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.613 0.597 . . . . 74.409999999999997 112.613 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.0 m -117.96 45.79 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.323 0.583 . . . . 73.129999999999995 110.957 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.35 149.39 48.46 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.463 0.542 . . . . 70.420000000000002 112.463 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.3 mm? -58.55 -35.12 71.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 112.175 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -62.94 -40.17 96.86 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.883 0.373 . . . . 62.350000000000001 110.723 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LEU . 17.6 tp10 -70.41 -29.7 66.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.3 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.617 HD12 HG21 ' A' ' 74' ' ' THR . 3.3 tm? -60.9 -46.96 88.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.146 0.498 . . . . 73.540000000000006 109.815 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.403 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.32 -40.0 94.88 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.39 0.614 . . . . 73.400000000000006 110.721 172.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.71 ' HG3' HH11 ' A' ' 51' ' ' ARG . 20.5 tp10 -79.83 -10.63 59.8 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.642 -0.708 . . . . 74.25 111.332 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 51' ' ' ARG . 53.3 tp -59.22 -28.67 66.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.92 0.488 . . . . 73.519999999999996 111.696 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.9 -23.95 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.988 0.423 . . . . 74.129999999999995 111.351 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.15 -34.95 25.19 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.926 -0.654 . . . . 61.439999999999998 112.151 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.71 HH11 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -68.83 -38.28 79.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.839 0.352 . . . . 72.230000000000004 111.273 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.6 p -67.12 -2.84 6.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.868 0.692 . . . . 63.439999999999998 112.868 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -62.88 -22.21 66.55 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.134 0.492 . . . . 61.310000000000002 110.892 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.644 ' HA3' HD12 ' A' ' 2' ' ' ILE . . . -153.58 137.43 5.77 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.99 -0.844 . . . . 70.120000000000005 110.99 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HB2' HG13 ' A' ' 85' ' ' VAL . 95.4 mt -116.58 116.54 27.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.583 0.691 . . . . 64.310000000000002 112.434 -173.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.02 105.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 74.129999999999995 110.266 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 57' ' ' ILE . 3.4 mp -101.93 119.61 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.846 0.355 . . . . 64.409999999999997 111.273 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 59' ' ' MET . . . -80.91 -12.04 83.14 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.028 -0.606 . . . . 54.210000000000001 113.84 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 49.6 ttp 71.3 149.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.301 0.572 . . . . 61.450000000000003 111.723 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 60.0 m -151.22 140.77 13.99 Favored Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 122.182 -0.324 . . . . 75.310000000000002 111.132 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.91 161.68 28.46 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.514 2.143 . . . . 73.450000000000003 112.978 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.38 -39.7 7.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.53 0.567 . . . . 71.340000000000003 112.53 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.68 64.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.092 0.405 . . . . 54.509999999999998 112.092 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.487 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 19.6 m -79.86 -19.27 48.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.443 -0.344 . . . . 73.329999999999998 111.893 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.629 ' HB3' HE22 ' A' ' 69' ' ' GLN . . . -64.88 -11.93 43.14 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.601 0.593 . . . . 71.420000000000002 112.601 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.94 -49.67 68.17 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.884 0.373 . . . . 64.230000000000004 111.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.7 p -65.59 -43.49 89.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.979 0.418 . . . . 44.020000000000003 111.197 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -53.85 -56.08 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.018 -0.537 . . . . 61.43 111.618 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.629 HE22 ' HB3' ' A' ' 65' ' ' ALA . 2.1 mp0 -60.33 -21.65 62.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.18 0.437 . . . . 74.319999999999993 112.18 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.23 -48.3 80.64 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.033 -0.603 . . . . 75.239999999999995 112.661 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -89.67 -19.34 24.97 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.869 0.366 . . . . 71.530000000000001 111.855 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tt -49.74 -34.71 19.86 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.904 0.481 . . . . 72.109999999999999 111.891 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m -47.7 -37.45 13.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.096 -0.502 . . . . 73.150000000000006 112.234 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.617 HG21 HD12 ' A' ' 45' ' ' LEU . 45.5 m -99.47 -35.79 9.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 111.759 0.281 . . . . 63.420000000000002 111.759 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 71' ' ' ALA . 68.3 mt -47.86 -44.4 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.491 0.552 . . . . 64.420000000000002 112.491 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.8 -35.76 64.21 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 71.239999999999995 111.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.06 -29.39 28.5 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.123 -0.561 . . . . 65.420000000000002 113.111 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -69.6 -30.01 67.66 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.025 0.38 . . . . 72.219999999999999 112.025 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.21 164.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.275 0.472 . . . . 52.299999999999997 112.275 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.99 148.33 22.44 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.233 -0.44 . . . . 70.340000000000003 110.28 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.19 -62.12 1.91 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.931 0.715 . . . . 74.209999999999994 112.931 -173.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.548 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 53.2 mttm -100.49 114.45 28.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.343 0.592 . . . . 75.439999999999998 111.799 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.677 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -163.8 -174.53 3.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.883 -0.599 . . . . 73.019999999999996 110.274 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.677 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -110.38 132.57 54.07 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.034 -0.416 . . . . 75.450000000000003 111.336 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 55' ' ' LEU . 29.8 m -119.72 134.64 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.415 0.626 . . . . 72.310000000000002 112.43 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 127.72 8.42 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.84 -0.618 . . . . 73.219999999999999 112.334 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -129.02 145.86 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.687 -0.302 . . . . 74.510000000000005 110.917 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -146.81 135.31 21.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.997 0.427 . . . . 75.230000000000004 110.903 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 117' ' ' ILE . 18.5 pt-20 -78.69 98.47 6.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 112.43 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -115.76 119.28 35.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.149 0.5 . . . . 74.030000000000001 111.756 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.26 -75.36 0.5 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.34 -0.457 . . . . 61.039999999999999 114.115 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.3 -72.98 1.85 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.077 -0.582 . . . . 41.329999999999998 112.263 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.9 -84.65 0.38 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.218 -0.515 . . . . 73.230000000000004 113.678 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.85 128.54 2.04 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.758 0.313 . . . . 75.099999999999994 111.827 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -150.38 158.03 43.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.334 -0.394 . . . . 64.319999999999993 111.024 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mt-10 -101.29 -59.47 0.1 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.709 0.633 . . . . 73.319999999999993 112.709 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 66.2 Cg_endo -81.79 44.94 1.83 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.366 2.044 . . . . 71.450000000000003 113.649 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.58 -39.92 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.213 0.449 . . . . 74.209999999999994 112.213 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.603 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 26.0 m-20 -68.15 -52.25 23.41 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 122.102 -0.374 . . . . 53.32 111.342 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 72.8 Cg_exo -51.41 -35.94 56.5 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.127 1.884 . . . . 74.319999999999993 112.613 172.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.86 -58.26 9.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.41 -0.359 . . . . 73.400000000000006 111.003 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.39 -34.11 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.169 0.509 . . . . 71.209999999999994 111.207 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -60.13 -40.51 90.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.806 -0.633 . . . . 74.120000000000005 111.675 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -60.46 -22.25 63.27 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.09 0.404 . . . . 63.420000000000002 112.09 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -91.15 -70.96 0.66 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.122 0.487 . . . . 74.150000000000006 111.996 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -71.46 -35.15 70.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.287 0.847 . . . . 64.219999999999999 113.287 -169.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.52 -24.97 63.81 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.965 0.412 . . . . 62.229999999999997 111.305 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.82 -55.4 3.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.97 0.414 . . . . 73.510000000000005 110.948 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.548 ' HA3' ' HG2' ' A' ' 82' ' ' LYS . . . 159.09 -5.05 0.11 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.853 -0.689 . . . . 75.209999999999994 113.759 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.59 99.44 5.75 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.52 -0.4 . . . . 73.019999999999996 111.236 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -74.88 129.51 37.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.124 0.488 . . . . 74.129999999999995 111.423 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -80.87 110.59 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.179 -0.464 . . . . 75.040000000000006 111.682 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.67 66.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.225 0.536 . . . . 71.109999999999999 111.692 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -118.39 90.34 38.48 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.459 -0.571 . . . . 75.540000000000006 109.459 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.91 33.22 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.126 2.551 . . . . 63.439999999999998 114.753 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 122.84 4.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.364 0.505 . . . . 53.539999999999999 112.364 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.573 HD11 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.74 123.48 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.296 -0.411 . . . . 75.420000000000002 110.516 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -149.22 28.44 0.82 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.392 0.516 . . . . 72.230000000000004 112.392 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mm -68.8 142.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.067 0.461 . . . . 74.319999999999993 111.332 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -75.16 -51.15 14.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 71.140000000000001 111.577 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -166.29 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.12 0.486 . . . . 71.340000000000003 111.201 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.8 p -114.3 130.37 24.04 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 111.862 0.319 . . . . 72.230000000000004 111.862 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.24 155.8 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.666 2.244 . . . . 53.140000000000001 112.641 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -105.84 170.07 8.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.08 0.467 . . . . 72.219999999999999 111.642 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.37 -24.73 60.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.547 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -84.39 -24.19 29.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.801 0.334 . . . . 71.239999999999995 111.557 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -55.56 -32.17 62.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.052 0.453 . . . . 75.349999999999994 111.253 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.415 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 71.0 m-85 -56.48 -45.77 80.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 111.182 175.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -57.53 -46.24 84.09 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.345 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.34 -47.11 72.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.143 0.496 . . . . 73.25 111.005 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 16' ' ' LEU . 67.7 m -58.04 -48.42 80.13 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.72 -0.673 . . . . 75.239999999999995 111.343 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 52.4 mt-10 -58.54 -49.5 77.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.405 . . . . 65.230000000000004 111.604 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.71 -32.7 71.43 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.476 0.547 . . . . 74.010000000000005 112.476 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.67 -60.49 2.35 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.193 0.442 . . . . 70.430000000000007 112.193 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.584 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -65.34 -43.16 95.52 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.141 -0.552 . . . . 73.510000000000005 113.995 -174.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 73.2 m -60.92 -38.78 86.96 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.448 -0.442 . . . . 74.099999999999994 112.127 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.62 -49.89 73.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.935 0.398 . . . . 73.040000000000006 110.973 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.06 -40.26 92.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.324 -0.398 . . . . 75.420000000000002 110.987 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.473 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -59.32 -45.71 95.01 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.104 -0.57 . . . . 62.420000000000002 112.771 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.583 ' HG2' HG23 ' A' ' 27' ' ' THR . 52.4 mt-30 -64.29 -38.97 92.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.037 0.446 . . . . 75.400000000000006 111.254 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -65.49 -58.0 6.88 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.194 -0.457 . . . . 74.040000000000006 111.87 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.402 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 83.9 t -57.11 -50.88 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.379 0.511 . . . . 64.319999999999993 112.379 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.515 HG22 HG23 ' A' ' 29' ' ' VAL . 15.2 t -62.69 -36.86 84.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 55.439999999999998 112.034 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -81.87 -23.26 36.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.737 0.303 . . . . 73.120000000000005 111.414 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.91 -47.97 15.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.024 0.44 . . . . 75.129999999999995 110.518 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -79.61 6.72 9.86 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.46 -0.336 . . . . 72.219999999999999 111.829 177.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.562 HD11 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 122.926 0.491 . . . . 72.140000000000001 111.739 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.6 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.634 0.254 . . . . 72.519999999999996 111.496 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.66 HD11 ' HA2' ' A' ' 139' ' ' GLY . 46.0 mm 58.8 95.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.155 0.503 . . . . 74.030000000000001 112.181 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.67 96.09 1.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.915 -0.659 . . . . 50.229999999999997 112.473 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.33 114.09 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.655 0.74 . . . . 73.219999999999999 112.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.64 105.05 17.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.753 -0.658 . . . . 72.239999999999995 110.78 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.4 ' HE1' ' HB ' ' A' ' 33' ' ' VAL . 24.7 p90 -116.21 179.99 3.83 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.897 0.38 . . . . 75.409999999999997 111.455 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.14 113.79 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.242 0.544 . . . . 74.530000000000001 111.408 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 24.5 m -75.57 -25.02 56.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.195 0.522 . . . . 64.519999999999996 111.556 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -71.78 -16.37 62.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.751 -0.659 . . . . 75.239999999999995 111.978 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.504 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 70.8 t80 -125.69 106.24 9.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.979 0.419 . . . . 64.430000000000007 112.056 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.65 -162.4 5.44 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.583 0.593 . . . . 55.25 114.583 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -80.41 7.63 9.32 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.456 0.539 . . . . 74.549999999999997 112.456 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.6 m -44.69 -35.92 2.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.843 0.683 . . . . 74.230000000000004 112.843 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 11.7 p-10 -65.67 -43.19 90.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 70.140000000000001 111.328 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -71.09 -38.94 72.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.014 0.435 . . . . 73.319999999999993 110.618 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.92 -43.73 91.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 64.400000000000006 110.968 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.13 75.62 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 111.221 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.23 -34.06 77.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.309 -0.405 . . . . 74.219999999999999 111.144 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.97 92.88 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.042 0.448 . . . . 71.129999999999995 110.736 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.7 mt -63.4 -48.49 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.171 0.51 . . . . 70.150000000000006 110.347 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.585 HG22 HG21 ' A' ' 31' ' ' VAL . 74.6 mt -56.96 -33.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.938 -0.574 . . . . 54.25 111.573 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -58.67 -43.54 89.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.961 0.41 . . . . 70.140000000000001 111.045 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.51 -37.28 62.34 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.05 -0.595 . . . . 73.439999999999998 112.875 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 2' ' ' ILE . 46.5 mm -64.47 -45.21 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.044 0.45 . . . . 74.219999999999999 111.305 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 p -61.83 -42.49 99.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.842 0.353 . . . . 53.310000000000002 111.034 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -57.84 -36.79 72.78 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.827 0.346 . . . . 73.230000000000004 111.439 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.0 m -78.15 -8.6 58.49 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.225 0.536 . . . . 73.519999999999996 111.401 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.19 42.71 23.11 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.163 -0.541 . . . . 40.140000000000001 113.092 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.9 t -127.76 143.94 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 122.595 -0.356 . . . . 72.430000000000007 111.506 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.93 152.25 36.51 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.116 -0.564 . . . . 74.200000000000003 112.732 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.585 HG21 HG22 ' A' ' 21' ' ' ILE . 22.4 t -112.87 147.39 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.465 0.543 . . . . 75.219999999999999 112.465 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -111.26 103.41 11.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.556 0.343 . . . . 73.549999999999997 110.387 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 30.5 m -100.91 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.851 0.685 . . . . 52.43 112.851 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -139.88 127.3 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 116.125 -0.489 . . . . 74.400000000000006 110.931 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -94.22 111.01 22.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.915 0.388 . . . . 74.530000000000001 110.969 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -82.57 11.79 5.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.314 0.487 . . . . 71.150000000000006 112.314 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.39 -9.08 58.18 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.453 -0.403 . . . . 64.319999999999993 112.369 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.41 179.29 5.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.999 0.428 . . . . 45.109999999999999 111.468 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 93.09 0.22 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 65.340000000000003 111.416 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.99 149.75 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.277 0.561 . . . . 74.129999999999995 112.214 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -147.95 170.58 17.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.959 -0.564 . . . . 75.409999999999997 111.176 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.0 mm? -65.18 -22.48 66.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.394 -0.366 . . . . 65.409999999999997 111.686 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -62.45 -42.25 99.33 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.632 0.253 . . . . 63.43 111.361 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.2 -45.19 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.986 0.422 . . . . 55.43 110.813 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.434 ' O ' HD22 ' A' ' 45' ' ' LEU . 5.7 tt -55.79 -38.67 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.074 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -61.39 -21.92 64.51 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.375 0.509 . . . . 73.340000000000003 112.375 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -58.69 -19.7 41.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.991 0.425 . . . . 72.209999999999994 111.355 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -53.18 -34.97 59.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.238 -0.437 . . . . 72.299999999999997 111.436 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.96 -44.11 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.942 0.401 . . . . 74.329999999999998 111.599 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.99 -23.14 50.47 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.984 -0.627 . . . . 51.240000000000002 113.812 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 -1.86 40.69 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.187 -0.596 . . . . 75.230000000000004 111.557 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 53' ' ' THR . 27.9 p -36.79 -58.76 0.73 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.172 1.545 . . . . 71.340000000000003 115.172 -170.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 71.6 p -61.09 -20.54 62.74 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.701 1.0 . . . . 75.420000000000002 113.701 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.34 136.18 4.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.19 -1.005 . . . . 37.729999999999997 113.838 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 57' ' ' ILE . 0.7 OUTLIER -171.08 -179.48 2.74 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.064 0.546 . . . . 54.219999999999999 111.258 -178.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.53 131.07 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.409 . . . . 73.120000000000005 111.46 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.499 HD13 HD12 ' A' ' 55' ' ' LEU . 3.3 mp -117.05 137.01 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.991 0.424 . . . . 72.120000000000005 111.983 -176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.88 140.26 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.481 -0.648 . . . . 74.209999999999994 111.481 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.488 ' SD ' ' CE2' ' A' ' 10' ' ' TYR . 4.2 ppp? -67.49 146.95 53.46 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 117.652 0.726 . . . . 53.409999999999997 111.897 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 95.1 p -99.38 144.56 28.49 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 112.758 0.651 . . . . 61.240000000000002 112.758 -172.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 90.3 Cg_endo -75.39 -176.3 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.807 2.338 . . . . 74.400000000000006 112.526 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.94 -55.16 25.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.813 0.672 . . . . 44.229999999999997 112.813 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.73 73.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.232 0.456 . . . . 75.019999999999996 112.232 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 62.2 m -65.08 -50.07 67.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.681 -0.236 . . . . 71.150000000000006 111.506 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.64 -49.67 67.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.007 0.432 . . . . 64.230000000000004 111.644 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.45 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.188 0.44 . . . . 72.040000000000006 112.188 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -95.65 -29.56 14.24 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.846 0.313 . . . . 73.329999999999998 111.846 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.11 -13.44 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.021 0.378 . . . . 54.43 112.021 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.49 -40.8 5.87 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.2 0.815 . . . . 71.239999999999995 113.2 -175.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.05 -52.3 28.86 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.858 -0.687 . . . . 64.140000000000001 112.614 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.18 -28.25 66.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.734 0.302 . . . . 73.409999999999997 111.767 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.25 -46.13 86.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.82 0.343 . . . . 74.140000000000001 110.899 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -58.04 -45.06 87.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.09 0.471 . . . . 72.040000000000006 110.431 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.3 m -55.97 -47.7 77.17 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.853 -0.612 . . . . 75.099999999999994 111.479 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 79' ' ' VAL . 77.4 mt -61.06 -55.73 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.34 -0.391 . . . . 65.430000000000007 111.204 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.8 -30.92 58.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.228 0.455 . . . . 75.510000000000005 112.228 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.24 -21.24 55.41 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.061 -0.59 . . . . 63.200000000000003 113.656 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 m -100.18 -6.44 26.15 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.088 0.773 . . . . 65.25 113.088 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -75.86 172.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.46 0.541 . . . . 75.200000000000003 112.46 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -99.68 178.32 4.88 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.528 . . . . 70.439999999999998 110.585 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -87.49 -18.05 30.74 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.871 0.693 . . . . 64.040000000000006 112.871 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -148.96 44.98 1.0 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.192 1.182 . . . . 73.510000000000005 114.192 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -94.38 166.78 11.9 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.393 -0.817 . . . . 71.430000000000007 111.425 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.75 115.46 27.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 111.843 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.92 114.76 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.572 0.701 . . . . 72.420000000000002 112.031 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.47 145.36 25.16 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.06 -0.591 . . . . 64.299999999999997 112.416 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -152.83 140.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.071 0.435 . . . . 75.049999999999997 111.192 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -155.85 110.84 2.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.217 0.532 . . . . 74.239999999999995 110.72 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.99 131.31 35.95 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.4 -0.364 . . . . 73.510000000000005 111.506 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 HG23 ' A' ' 127' ' ' THR . 12.2 t -170.89 179.91 3.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.402 -0.363 . . . . 73.450000000000003 111.161 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.31 -17.56 18.08 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.287 -0.483 . . . . 44.439999999999998 113.92 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.82 -119.25 0.75 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.398 -0.43 . . . . 37.729999999999997 112.336 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.55 74.03 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.424 -0.893 . . . . 60.109999999999999 114.155 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -97.89 109.98 22.64 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.609 -0.348 . . . . 75.439999999999998 110.654 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.673 ' HB2' ' HB ' ' A' ' 98' ' ' ILE . 16.2 p-10 -137.98 95.02 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.654 0.74 . . . . 64.329999999999998 112.454 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 39.1 mt-10 -103.76 -48.78 0.15 Allowed Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.189 -0.46 . . . . 75.439999999999998 112.051 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.52 ' O ' HD13 ' A' ' 101' ' ' LEU . 54.8 Cg_endo -91.52 27.46 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.231 1.954 . . . . 71.409999999999997 112.647 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 95' ' ' ASP . 7.1 tt -59.93 -51.49 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.988 0.736 . . . . 74.519999999999996 112.988 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.519 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 12.0 m-20 -62.74 -49.46 82.38 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.403 0.519 . . . . 71.519999999999996 112.403 -175.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.544 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 74.7 Cg_exo -51.45 -50.3 14.39 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.102 1.868 . . . . 74.409999999999997 112.973 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.5 mp -63.05 -47.7 81.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.87 0.322 . . . . 63.340000000000003 111.87 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.1 mt -58.77 -38.79 79.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.008 0.432 . . . . 70.209999999999994 111.044 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -58.17 -42.16 85.41 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.282 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 100' ' ' PRO . 11.3 mmpt? -55.98 -49.51 73.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 74.150000000000006 111.215 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -56.0 -47.49 77.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.233 0.457 . . . . 72.129999999999995 112.233 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -79.61 -35.53 39.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.679 0.622 . . . . 65.019999999999996 112.679 -175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.59 -44.94 63.56 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.07 -0.394 . . . . 72.329999999999998 111.873 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.51 -41.39 63.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.835 0.35 . . . . 63.229999999999997 111.34 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.36 43.43 2.54 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.013 -0.613 . . . . 62.409999999999997 112.612 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 59.3 mt -83.86 136.21 34.2 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.869 0.366 . . . . 61.0 111.553 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 74.0 m -71.68 93.41 1.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.856 0.36 . . . . 65.209999999999994 110.841 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.0 p -88.15 128.91 35.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.286 -0.416 . . . . 70.450000000000003 111.328 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.75 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.777 0.288 . . . . 52.43 111.777 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -164.89 94.44 0.91 Allowed Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.523 0.202 . . . . 70.200000000000003 111.408 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 115.67 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.309 2.006 . . . . 65.200000000000003 111.706 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.0 35.9 3.91 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.067 0.766 . . . . 64.239999999999995 113.067 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 tt -61.09 82.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.293 1.044 . . . . 62.399999999999999 111.427 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -163.63 25.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.011 -0.995 . . . . 70.319999999999993 109.744 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.3 mm -88.59 137.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.795 -0.639 . . . . 72.299999999999997 111.954 -172.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -52.04 -51.8 55.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.689 -0.687 . . . . 72.239999999999995 112.35 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 179.98 -72.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.274 0.559 . . . . 64.019999999999996 110.958 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p -82.56 146.85 54.43 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.024 -0.535 . . . . 70.239999999999995 111.96 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.48 106.0 1.86 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.401 2.067 . . . . 61.439999999999998 112.903 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 52.3 p -85.79 -178.58 6.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.276 -0.42 . . . . 71.109999999999999 111.23 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.4 ' HG2' ' HE2' ' A' ' 129' ' ' LYS . 44.4 tt0 -49.57 -35.61 21.11 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.165 0.431 . . . . 43.509999999999998 112.165 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -55.9 -42.74 76.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 73.239999999999995 111.319 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.43 HG23 HG21 ' A' ' 90' ' ' THR . 46.5 m -63.8 -40.72 97.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.997 0.427 . . . . 74.230000000000004 111.025 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -61.68 -48.84 78.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.222 -0.445 . . . . 72.5 111.619 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.4 ' HE2' ' HG2' ' A' ' 125' ' ' GLU . 67.6 mttm -53.54 -42.06 67.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.885 0.328 . . . . 62.119999999999997 111.885 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.02 -47.47 85.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.869 0.366 . . . . 74.349999999999994 111.056 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.1 m -66.46 -46.4 76.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.188 -0.46 . . . . 70.340000000000003 111.797 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.51 -48.81 77.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.233 -0.439 . . . . 62.310000000000002 111.898 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -78.26 -51.11 10.65 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.545 0.572 . . . . 71.540000000000006 112.545 -172.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.66 -36.07 71.39 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.34 0.496 . . . . 75.319999999999993 112.34 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.96 -45.01 62.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.406 -0.426 . . . . 73.120000000000005 113.399 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 88.5 m -67.8 -55.05 14.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.93 0.344 . . . . 75.409999999999997 111.93 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.82 -54.05 43.85 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.875 0.369 . . . . 53.25 111.635 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.8 -40.23 83.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.653 -0.249 . . . . 74.319999999999993 111.539 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.66 ' HA2' HD11 ' A' ' 2' ' ' ILE . . . -55.93 -47.72 77.69 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.259 -0.496 . . . . 60.32 113.2 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.96 -14.87 62.37 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.186 0.439 . . . . 75.230000000000004 112.186 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -90.62 -53.77 4.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.84 0.352 . . . . 73.530000000000001 110.972 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.9 t -54.43 -40.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 112.16 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 139' ' ' GLY . 6.8 t -69.64 -43.87 71.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.697 0.284 . . . . 64.340000000000003 111.575 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -63.81 -38.99 93.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.144 0.497 . . . . 74.420000000000002 111.011 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.37 -44.95 72.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.605 -0.725 . . . . 73.400000000000006 112.192 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -92.75 -21.97 19.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.308 -0.405 . . . . 65.120000000000005 111.865 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 120.71 0.29 . . . . 75.010000000000005 110.937 179.324 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 28.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 119.999 -0.048 . . . . 75.540000000000006 110.888 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 3' ' ' GLY . 47.8 mm 67.8 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.182 0.515 . . . . 51.009999999999998 111.892 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 2' ' ' ILE . . . -123.58 101.08 0.68 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.204 -0.522 . . . . 36.5 113.077 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 57.4 t -86.23 99.66 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 122.322 -0.516 . . . . 72.5 110.975 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.683 ' HB3' HD22 ' A' ' 36' ' ' LEU . 82.1 m-85 -90.25 126.74 35.94 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.282 0.475 . . . . 73.349999999999994 112.282 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.53 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 6.7 p90 -143.96 163.29 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.272 -0.422 . . . . 73.129999999999995 110.945 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 36' ' ' LEU . 3.9 p -129.02 105.41 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.452 0.644 . . . . 74.439999999999998 112.487 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -61.5 -28.14 69.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.077 0.465 . . . . 73.150000000000006 111.445 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.05 -22.59 62.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.795 0.665 . . . . 70.409999999999997 112.795 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 2.3 t80 -129.06 92.15 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.895 0.702 . . . . 71.239999999999995 112.895 -173.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 -158.58 7.67 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 115.746 1.058 . . . . 41.530000000000001 115.746 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -59.34 7.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.528 1.307 . . . . 74.230000000000004 114.528 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -47.16 -35.79 7.78 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.561 0.619 . . . . 74.519999999999996 112.298 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.89 -39.69 79.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.974 0.416 . . . . 74.409999999999997 110.784 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -58.34 -45.65 87.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.192 0.52 . . . . 60.409999999999997 110.508 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 20' ' ' ILE . 79.6 mt -59.49 -51.33 70.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.894 -0.594 . . . . 73.519999999999996 111.644 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 6' ' ' TYR . . . -55.49 -43.24 75.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.106 0.479 . . . . 54.509999999999998 111.479 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.431 ' HA ' HG23 ' A' ' 21' ' ' ILE . 34.7 tt0 -66.29 -34.49 78.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.078 0.466 . . . . 73.239999999999995 110.845 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.17 -31.61 72.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.175 -0.466 . . . . 52.340000000000003 111.29 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.483 HG22 ' HA3' ' A' ' 135' ' ' GLY . 71.5 mt -67.91 -57.46 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.152 0.501 . . . . 71.230000000000004 111.005 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.431 HG23 ' HA ' ' A' ' 18' ' ' GLN . 14.0 tt -63.2 -25.17 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.088 -0.506 . . . . 75.420000000000002 111.736 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -54.56 -46.8 73.74 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.778 0.323 . . . . 72.219999999999999 111.744 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.19 -37.35 42.77 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.019 -0.61 . . . . 74.239999999999995 112.922 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -62.94 -42.73 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.994 0.426 . . . . 64.439999999999998 111.585 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.422 HG21 HG12 ' A' ' 21' ' ' ILE . 44.6 p -66.64 -39.87 88.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.574 -0.285 . . . . 71.230000000000004 111.574 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -58.54 -41.6 85.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.272 0.558 . . . . 74.510000000000005 109.888 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -64.0 -31.74 73.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.843 -0.617 . . . . 74.120000000000005 110.806 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 39.59 3.41 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.126 -0.488 . . . . 53.439999999999998 113.633 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.08 132.14 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.915 0.388 . . . . 73.549999999999997 111.444 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.33 96.54 2.18 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.314 -0.47 . . . . 74.299999999999997 113.708 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.3 m -102.86 142.48 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.911 0.386 . . . . 75.310000000000002 111.797 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -95.75 144.65 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.974 0.416 . . . . 75.319999999999993 111.78 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.422 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 32.6 m -101.18 151.72 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.913 0.387 . . . . 75.230000000000004 111.512 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -137.16 114.18 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.012 0.434 . . . . 75.019999999999996 111.984 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.69 92.6 3.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.732 0.301 . . . . 74.530000000000001 110.374 171.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -65.81 -23.81 66.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.274 0.472 . . . . 71.400000000000006 112.274 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.467 ' N ' HD11 ' A' ' 36' ' ' LEU . . . -98.08 24.51 31.48 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.12 -0.562 . . . . 41.039999999999999 112.943 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.88 -178.14 3.35 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.038 0.447 . . . . 50.119999999999997 111.837 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.45 44.9 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.307 0.484 . . . . 65.209999999999994 112.307 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.62 128.33 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.115 0.483 . . . . 75.409999999999997 111.765 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.61 166.85 11.31 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.341 -0.391 . . . . 71.450000000000003 111.263 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.75 -25.55 55.25 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.419 -0.355 . . . . 75.099999999999994 111.824 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -59.38 -49.75 76.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.624 0.25 . . . . 71.540000000000006 110.831 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.23 -39.1 75.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.037 0.446 . . . . 71.310000000000002 111.049 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -35.18 71.5 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.031 0.443 . . . . 71.530000000000001 110.626 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -58.3 -29.89 66.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.558 -0.292 . . . . 73.420000000000002 111.673 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -60.37 -29.19 68.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.033 0.444 . . . . 61.420000000000002 110.961 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.2 -21.28 66.11 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.358 -0.383 . . . . 72.310000000000002 111.699 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.15 -55.13 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.893 0.378 . . . . 62.240000000000002 111.243 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.61 -18.43 77.2 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.923 -0.656 . . . . 63.109999999999999 112.76 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -100.63 5.99 43.98 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.209 0.448 . . . . 73.120000000000005 112.209 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -64.92 -9.47 21.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.026 0.38 . . . . 61.25 112.026 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.4 p -58.44 -18.92 32.27 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.136 0.493 . . . . 70.340000000000003 111.355 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.68 137.23 3.65 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 112.59 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 ' N ' HD21 ' A' ' 55' ' ' LEU . 1.7 pt? -148.59 133.52 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 64.109999999999999 110.628 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 4' ' ' VAL . 5.6 p -112.58 117.74 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 75.510000000000005 111.443 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.6 mp -116.49 110.38 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.252 -0.431 . . . . 75.439999999999998 110.653 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.56 41.55 3.06 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.043 -0.599 . . . . 72.530000000000001 113.396 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' A' ' 88' ' ' PHE . 92.1 mmm 61.84 173.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.381 0.61 . . . . 72.439999999999998 112.425 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -158.84 154.25 22.31 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.305 -0.407 . . . . 54.409999999999997 111.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.576 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 60.3 Cg_endo -70.69 157.9 57.27 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.462 2.108 . . . . 64.329999999999998 111.915 173.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.71 62.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.591 0.589 . . . . 73.129999999999995 112.591 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.26 68.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.548 0.573 . . . . 72.230000000000004 112.548 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.2 m -89.07 -49.77 6.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.91 0.386 . . . . 73.239999999999995 111.567 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.45 -23.26 65.73 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.368 -0.378 . . . . 65.409999999999997 111.549 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.8 -34.53 59.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.779 0.324 . . . . 73.120000000000005 111.403 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 t -65.18 -45.15 86.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.236 0.541 . . . . 74.099999999999994 110.455 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.95 -40.55 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.002 -0.544 . . . . 61.329999999999998 110.617 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.92 -34.8 78.22 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.818 -0.628 . . . . 71.109999999999999 111.028 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.38 -42.26 56.95 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.211 -0.518 . . . . 73.209999999999994 112.93 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.85 6.82 33.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.041 0.385 . . . . 64.430000000000007 112.041 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.1 tp -39.58 -61.1 0.86 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.295 0.85 . . . . 72.049999999999997 113.295 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.9 m -57.23 -40.02 76.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.172 0.434 . . . . 75.430000000000007 112.172 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.06 -45.01 94.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.937 0.399 . . . . 74.329999999999998 110.926 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.45 -37.49 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.058 0.456 . . . . 75.239999999999995 111.255 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.16 -15.2 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.289 -0.414 . . . . 62.020000000000003 111.157 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 -39.28 5.75 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.403 -0.427 . . . . 42.100000000000001 112.664 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.6 p -67.56 -40.12 84.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.878 0.325 . . . . 54.130000000000003 111.878 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -69.44 169.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.041 0.448 . . . . 71.540000000000006 111.803 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -133.06 -176.15 4.02 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.288 -0.258 . . . . 62.219999999999999 110.704 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 43.1 tt0 -47.27 -65.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.486 0.55 . . . . 64.040000000000006 112.486 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -152.49 130.03 11.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.256 0.551 . . . . 75.129999999999995 112.036 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.78 -79.47 0.18 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.005 -0.543 . . . . 73.140000000000001 110.896 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.556 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -170.21 117.78 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.902 0.334 . . . . 62.549999999999997 111.902 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.62 99.56 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.648 0.737 . . . . 63.439999999999998 111.529 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -74.84 77.88 1.09 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.125 -0.489 . . . . 65.349999999999994 113.147 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.5 mm -86.63 121.43 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.059 0.392 . . . . 74.120000000000005 112.059 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.422 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 p90 -153.76 -179.03 7.44 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.296 -0.411 . . . . 73.109999999999999 110.41 174.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.478 ' HB2' HG23 ' A' ' 117' ' ' ILE . 11.3 tp10 -106.43 144.25 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.779 0.659 . . . . 75.0 112.779 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -125.51 -23.76 4.03 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.413 -0.358 . . . . 72.299999999999997 111.905 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 119' ' ' ILE . . . -119.75 -98.52 1.75 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.604 -0.332 . . . . 44.119999999999997 113.097 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.95 42.91 0.48 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.532 -0.842 . . . . 63.439999999999998 114.037 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.33 55.1 22.86 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.353 -0.451 . . . . 55.240000000000002 113.459 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.24 -159.96 0.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.883 0.327 . . . . 73.140000000000001 111.883 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD1' ' HD2' ' A' ' 97' ' ' PRO . 32.4 t70 74.05 162.1 0.25 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.267 0.627 . . . . 51.109999999999999 112.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 40.1 mt-10 -103.26 -55.45 0.11 Allowed Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 64.450000000000003 112.744 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 91.8 Cg_endo -76.46 11.19 1.93 Allowed 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.337 2.025 . . . . 62.240000000000002 113.513 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.443 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.3 tt -44.64 -56.31 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.122 0.786 . . . . 63.210000000000001 113.122 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.686 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.6 m-20 -60.83 -54.89 50.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 112.327 0.492 . . . . 73.109999999999999 112.327 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.0 Cg_exo -54.0 -36.17 83.35 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.275 1.983 . . . . 55.119999999999997 113.093 176.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.19 -62.16 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.462 -0.335 . . . . 70.120000000000005 111.68 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.51 -41.02 88.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.16 0.43 . . . . 73.420000000000002 112.16 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t -57.93 -37.31 73.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.826 0.346 . . . . 74.129999999999995 111.57 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -64.3 -45.85 86.17 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.734 0.302 . . . . 74.25 111.522 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -62.37 -29.13 70.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.994 0.426 . . . . 74.430000000000007 111.361 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -71.35 -37.4 71.68 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.944 0.402 . . . . 75.030000000000001 110.579 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.464 HD21 HD13 ' A' ' 108' ' ' LEU . 6.7 t30 -62.58 -46.34 88.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.348 -0.387 . . . . 73.340000000000003 111.528 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 107' ' ' ASN . 9.5 mp -73.52 -41.77 62.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.785 0.326 . . . . 62.420000000000002 111.326 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 72.22 1.26 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.316 -0.468 . . . . 55.229999999999997 113.61 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 mp -102.29 164.41 11.7 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 72.349999999999994 111.112 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 29.4 m -66.2 95.36 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.72 0.295 . . . . 64.349999999999994 111.289 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.2 p -83.68 164.72 19.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.036 0.446 . . . . 75.209999999999994 111.785 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.484 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -94.72 -83.83 0.34 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.617 -0.265 . . . . 71.140000000000001 111.671 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CE2' ' HB1' ' A' ' 116' ' ' ALA . 34.3 t80 -162.38 89.29 1.38 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.948 0.404 . . . . 74.140000000000001 110.907 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.0 27.28 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.625 2.883 . . . . 72.25 114.199 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.409 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -87.69 94.65 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.827 -0.546 . . . . 41.329999999999998 110.991 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 89' ' ' GLU . 31.2 pt -68.61 107.31 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.495 0.664 . . . . 73.319999999999993 112.674 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -103.34 -23.95 13.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.081 -0.509 . . . . 70.450000000000003 111.651 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.2 mp -90.42 145.73 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.556 -0.293 . . . . 70.420000000000002 110.605 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -120.23 5.68 10.75 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.426 0.528 . . . . 74.120000000000005 112.426 -178.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.508 ' H ' HG22 ' A' ' 119' ' ' ILE . 53.1 tt0 -178.76 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.795 0.331 . . . . 71.319999999999993 111.662 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.1 p -117.42 122.56 30.83 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 116.516 -0.311 . . . . 74.519999999999996 111.603 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.507 ' HA ' HG12 ' A' ' 119' ' ' ILE . 32.8 Cg_endo -63.34 141.03 79.99 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.653 2.235 . . . . 74.340000000000003 112.863 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 62.1 p -93.68 173.87 7.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.331 0.586 . . . . 72.120000000000005 112.383 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -53.58 -28.73 33.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.644 -0.707 . . . . 71.430000000000007 112.509 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -66.86 -39.55 87.61 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.322 0.49 . . . . 63.149999999999999 112.322 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 71.9 p -54.62 -40.46 68.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.571 0.582 . . . . 74.109999999999999 112.571 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -55.27 -35.3 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.313 0.486 . . . . 70.420000000000002 112.313 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.42 -50.64 51.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.831 0.348 . . . . 74.230000000000004 111.098 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -61.66 -33.9 74.77 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.931 0.396 . . . . 65.299999999999997 111.036 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -61.75 -45.89 91.99 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.288 -0.414 . . . . 74.109999999999999 111.227 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.22 -52.77 62.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.392 -0.367 . . . . 73.140000000000001 111.166 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.9 -50.18 73.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 111.93 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.13 73.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.872 0.323 . . . . 71.540000000000006 111.872 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.483 ' HA3' HG22 ' A' ' 20' ' ' ILE . . . -68.55 -42.17 81.93 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.016 -0.612 . . . . 63.329999999999998 113.643 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.1 m -70.61 -47.74 58.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.556 -0.379 . . . . 73.310000000000002 111.931 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -55.92 -47.63 77.15 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.152 0.501 . . . . 65.340000000000003 110.989 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -70.08 -39.98 75.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.996 -0.547 . . . . 73.5 110.385 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.49 -40.72 78.78 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.577 -0.344 . . . . 36.5 112.803 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 136' ' ' THR . 96.7 mt-30 -62.35 -38.31 89.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.131 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -61.09 -45.16 95.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.797 0.332 . . . . 73.319999999999993 110.563 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.35 -53.28 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.346 -0.388 . . . . 64.540000000000006 111.791 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.0 t -68.32 -37.54 80.68 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.132 0.419 . . . . 71.430000000000007 112.132 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -71.56 -35.44 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.887 0.375 . . . . 74.439999999999998 111.438 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.18 -25.36 66.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 74.040000000000006 110.353 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 77.0 mtt180 -100.1 8.02 44.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.591 -0.731 . . . . 44.140000000000001 111.848 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 C-N-CA 125.777 1.631 . . . . 62.210000000000001 111.506 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 80.1 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.885 -0.043 . . . . 71.409999999999997 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.9 mp 60.27 110.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.173 0.511 . . . . 62.329999999999998 111.73 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.02 91.82 1.66 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.853 -0.689 . . . . 55.200000000000003 113.326 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.657 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 59.4 t -80.91 123.54 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.027 0.413 . . . . 72.5 111.392 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 84.0 m-85 -116.38 133.69 55.73 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.494 0.553 . . . . 63.310000000000002 112.494 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -149.27 -178.18 6.26 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 110.826 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 p -129.51 83.55 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.482 0.658 . . . . 75.319999999999993 111.799 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -53.77 -29.75 41.48 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.008 0.744 . . . . 72.430000000000007 113.008 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.81 -13.94 62.52 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.345 0.498 . . . . 73.430000000000007 112.345 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.89 135.35 41.55 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.497 0.925 . . . . 71.239999999999995 113.497 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.19 -162.1 4.97 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 116.394 1.318 . . . . 62.140000000000001 116.394 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 73.8 m-85 -76.03 8.57 3.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.383 0.882 . . . . 73.349999999999994 113.383 -174.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -49.04 -35.58 16.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.114 0.413 . . . . 72.209999999999994 112.114 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -66.43 -37.99 86.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 64.340000000000003 110.919 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -69.16 -39.27 78.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.869 -0.605 . . . . 75.430000000000007 110.735 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -41.37 94.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 110.626 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.98 92.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.071 -0.513 . . . . 62.219999999999999 110.858 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -57.48 -46.62 83.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 110.946 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -47.03 80.38 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.174 -0.466 . . . . 62.210000000000001 111.302 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.15 -51.45 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 111.042 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.475 ' O ' HG21 ' A' ' 25' ' ' THR . 75.4 mt -55.79 -57.74 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 111.191 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -58.81 -29.45 66.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.865 0.364 . . . . 75.349999999999994 111.705 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -38.82 34.43 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.102 -0.57 . . . . 43.530000000000001 113.484 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.15 -24.7 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.486 0.55 . . . . 73.299999999999997 112.486 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 21' ' ' ILE . 32.9 p -57.57 -29.3 64.32 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.061 -0.4 . . . . 75.109999999999999 111.777 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.72 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.5 mmpt? -64.63 -17.61 64.18 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.937 0.399 . . . . 54.229999999999997 111.941 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -88.23 -9.79 51.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.085 0.469 . . . . 62.119999999999997 110.825 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.98 37.53 74.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.528 -0.368 . . . . 62.119999999999997 113.363 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.711 HG21 HG22 ' A' ' 143' ' ' THR . 61.8 t -128.84 141.55 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.56 -0.376 . . . . 55.439999999999998 111.564 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.95 4.64 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.46 -0.4 . . . . 43.130000000000003 113.092 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.2 m -94.86 148.45 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.109 0.48 . . . . 71.129999999999995 112.016 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.4 125.07 37.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.217 -0.447 . . . . 75.239999999999995 111.072 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 131.89 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.983 0.42 . . . . 72.329999999999998 111.793 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 62.2 t -141.43 147.21 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.6 0.36 . . . . 64.219999999999999 110.991 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 6.6 m-20 -82.72 118.06 23.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.125 0.417 . . . . 74.340000000000003 112.125 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 37' ' ' GLY . 1.6 pp -77.65 -25.41 49.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.963 0.411 . . . . 73.409999999999997 111.85 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.602 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -87.31 -13.13 66.35 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.072 -0.585 . . . . 75.540000000000006 113.233 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 166.58 20.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.434 0.635 . . . . 63.439999999999998 112.039 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.84 76.83 2.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.954 -0.566 . . . . 63.399999999999999 111.396 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.72 164.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.336 0.495 . . . . 65.230000000000004 112.336 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.54 -163.24 1.32 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.215 0.531 . . . . 53.130000000000003 111.943 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.25 -24.17 67.1 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.151 0.797 . . . . 72.340000000000003 113.151 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.87 -52.53 62.74 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.104 -0.372 . . . . 65.120000000000005 110.844 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.05 -42.51 99.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.886 0.374 . . . . 73.140000000000001 111.1 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.08 -58.28 9.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.127 -0.488 . . . . 50.530000000000001 110.999 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -64.49 -36.38 84.0 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.844 0.312 . . . . 74.150000000000006 111.844 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.68 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.902 0.382 . . . . 71.230000000000004 110.704 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 55' ' ' LEU . 45.0 tp -59.53 -44.23 93.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.382 -0.372 . . . . 73.230000000000004 110.71 172.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.92 -33.25 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.071 0.462 . . . . 63.049999999999997 110.91 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.46 -40.38 94.36 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.02 -0.609 . . . . 74.329999999999998 112.469 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -87.03 6.37 32.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.084 0.402 . . . . 70.299999999999997 112.084 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.4 p -45.35 -26.59 0.55 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.256 1.206 . . . . 64.129999999999995 114.256 -170.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -54.71 -32.51 59.72 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.14 -0.35 . . . . 75.209999999999994 111.569 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.641 ' HA3' HG21 ' A' ' 142' ' ' VAL . . . -160.8 137.64 5.07 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.071 -0.585 . . . . 73.109999999999999 113.375 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' N ' HD21 ' A' ' 55' ' ' LEU . 2.0 pt? -145.2 157.56 44.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.076 0.465 . . . . 65.420000000000002 111.416 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.657 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 75.1 t -114.58 116.59 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.458 -0.337 . . . . 72.310000000000002 110.998 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.533 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.4 mp -98.69 115.18 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.65 0.262 . . . . 65.340000000000003 111.077 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.6 -24.09 61.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.117 -0.563 . . . . 72.25 114.079 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 60' ' ' SER . 16.7 tmm? 68.62 153.92 0.1 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.987 0.423 . . . . 64.049999999999997 111.665 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.513 ' N ' ' SD ' ' A' ' 59' ' ' MET . 40.6 t -162.95 146.46 8.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.031 -0.418 . . . . 74.450000000000003 111.342 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.0 160.52 12.41 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.954 2.436 . . . . 75.239999999999995 113.546 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.565 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . . . -41.43 -37.31 1.02 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.685 0.994 . . . . 64.519999999999996 113.685 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.3 -47.28 47.05 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.168 0.433 . . . . 75.040000000000006 112.168 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.432 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 66.6 m -98.4 -27.08 14.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.681 0.277 . . . . 63.420000000000002 111.409 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.565 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -55.69 -32.67 63.47 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.492 -0.322 . . . . 51.149999999999999 111.824 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.11 89.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.941 0.4 . . . . 73.209999999999994 111.128 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -62.49 -33.61 75.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.203 0.525 . . . . 75.109999999999999 111.01 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 36' ' ' LEU . 57.8 mt -75.04 -40.08 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.969 -0.56 . . . . 54.329999999999998 111.203 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -53.01 -44.73 67.52 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.851 -0.613 . . . . 63.229999999999997 112.573 -172.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.75 -43.71 80.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.032 -0.604 . . . . 63.329999999999998 112.839 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -77.31 -34.77 55.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 110.949 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -56.46 -42.86 78.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.99 0.516 . . . . 72.329999999999998 111.267 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -53.06 -33.91 54.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.26 0.552 . . . . 73.409999999999997 111.105 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -82.89 -41.67 18.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.036 -0.529 . . . . 74.219999999999999 111.257 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 71' ' ' ALA . 78.6 mt -57.62 -43.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.027 0.38 . . . . 72.010000000000005 112.027 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' HB3' ' HE2' ' A' ' 104' ' ' LYS . 67.5 mt -61.69 -19.85 62.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.288 0.477 . . . . 72.239999999999995 112.288 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.63 -15.63 65.49 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.026 -0.607 . . . . 71.310000000000002 112.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.9 m -98.41 -36.85 9.83 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.881 0.326 . . . . 64.349999999999994 111.881 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 75' ' ' ILE . 27.2 m -106.13 123.46 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.233 0.539 . . . . 73.349999999999994 112.096 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.465 ' HA ' HD23 ' A' ' 108' ' ' LEU . 3.3 p-10 -160.9 -172.56 3.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.268 0.556 . . . . 72.439999999999998 111.806 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.7 -86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 73.400000000000006 113.519 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 16.9 ptmt -155.45 6.49 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.658 0.984 . . . . 74.230000000000004 113.658 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 3.1 pt20 -65.16 178.01 0.95 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.972 0.415 . . . . 74.310000000000002 112.051 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.571 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.89 124.53 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.439 0.903 . . . . 74.040000000000006 113.439 -168.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.12 102.53 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.648 0.737 . . . . 73.420000000000002 111.569 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.33 94.6 1.67 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.42 -0.419 . . . . 55.409999999999997 112.771 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.24 139.02 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 122.274 -0.545 . . . . 75.239999999999995 112.144 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -136.83 -179.38 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 110.249 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -112.86 134.4 54.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.363 0.875 . . . . 73.310000000000002 113.363 -173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -154.41 130.67 10.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.796 -0.638 . . . . 51.420000000000002 110.864 169.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 86.84 -59.21 4.57 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.077 -0.582 . . . . 72.340000000000003 113.551 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.78 -98.42 0.18 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.502 -0.38 . . . . 74.409999999999997 113.184 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.51 -128.01 26.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.248 -0.501 . . . . 72.209999999999994 113.882 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -123.09 136.0 54.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.403 -0.469 . . . . 75.099999999999994 111.888 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.51 145.52 3.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.735 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 5.7 mp0 -103.58 -44.32 0.18 Allowed Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 112.566 0.58 . . . . 74.400000000000006 112.566 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 87.7 Cg_exo -50.59 -13.75 0.9 Allowed 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.762 2.308 . . . . 72.219999999999999 114.128 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -51.78 -37.67 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.183 0.438 . . . . 65.209999999999994 112.183 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.71 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.2 m-20 -63.63 -56.38 26.51 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.004 0.372 . . . . 72.519999999999996 112.004 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.5 Cg_exo -55.04 -36.92 93.91 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.008 1.805 . . . . 75.140000000000001 112.64 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.98 -58.3 9.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.406 -0.361 . . . . 63.210000000000001 111.326 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 91.3 mt -57.96 -40.77 81.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.128 0.49 . . . . 54.299999999999997 111.068 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t -56.59 -45.12 81.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.846 -0.615 . . . . 71.510000000000005 111.581 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 53.7 tptt -55.46 -49.22 73.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.302 -0.408 . . . . 74.129999999999995 111.347 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.2 -35.5 81.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.489 -0.323 . . . . 73.519999999999996 111.869 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 102' ' ' LEU . 74.7 mmt-85 -69.0 -55.46 10.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 111.913 0.338 . . . . 75.530000000000001 111.913 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -61.08 -43.77 98.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.104 0.409 . . . . 65.25 112.104 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 80' ' ' ASN . 8.6 mp -73.97 -37.43 64.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.622 0.249 . . . . 73.150000000000006 111.29 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.09 53.12 35.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.318 -0.468 . . . . 72.510000000000005 114.035 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 110' ' ' LEU . 3.4 mp -77.18 173.42 11.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.474 -0.427 . . . . 72.329999999999998 111.024 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.571 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 94.1 m -65.87 93.47 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 74.540000000000006 110.142 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -101.37 132.73 46.78 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.301 0.482 . . . . 74.430000000000007 112.301 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.65 -64.16 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.155 0.428 . . . . 50.119999999999997 112.155 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -147.99 111.97 3.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 120.725 0.298 . . . . 51.420000000000002 110.305 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -89.14 6.57 4.51 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.858 2.372 . . . . 75.329999999999998 114.822 -171.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.71 144.61 45.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.038 0.385 . . . . 64.219999999999999 112.038 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.2 pt -94.16 157.19 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.947 0.721 . . . . 62.409999999999997 112.947 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 118' ' ' ARG . 9.7 mmt85 -152.52 -49.77 0.1 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.386 0.674 . . . . 73.540000000000006 111.645 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.447 HD13 ' N ' ' A' ' 119' ' ' ILE . 1.9 mp -72.7 112.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.232 0.539 . . . . 73.030000000000001 111.669 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -82.83 -22.86 34.0 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.187 -0.46 . . . . 61.539999999999999 111.418 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.6 tt0 -160.13 -67.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.165 0.507 . . . . 73.209999999999994 111.714 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.3 p -91.8 129.35 42.56 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.343 -0.389 . . . . 74.540000000000006 112.03 -174.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 37.3 Cg_exo -61.84 152.69 73.02 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.801 2.334 . . . . 71.099999999999994 112.779 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.8 p -111.16 166.17 11.3 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.906 0.384 . . . . 74.209999999999994 111.85 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.52 -34.76 64.95 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.26 0.552 . . . . 73.049999999999997 111.197 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -73.47 -31.22 63.65 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.865 -0.607 . . . . 72.109999999999999 111.356 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.1 m -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.818 0.342 . . . . 63.140000000000001 111.42 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -57.35 -40.74 78.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.481 -0.327 . . . . 74.099999999999994 111.331 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.666 ' HB3' ' HZ3' ' A' ' 129' ' ' LYS . 8.4 mtpm? -60.89 -28.79 69.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.011 0.434 . . . . 65.430000000000007 111.616 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 91.7 mt -70.75 -48.14 55.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.043 0.449 . . . . 64.439999999999998 110.223 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.54 -33.26 72.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.05 -0.523 . . . . 72.230000000000004 111.364 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -83.4 -75.17 0.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.274 -0.421 . . . . 64.140000000000001 112.046 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.85 -53.68 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.555 0.576 . . . . 70.010000000000005 112.555 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 130' ' ' LEU . . . -65.79 -40.36 91.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.863 0.363 . . . . 71.120000000000005 111.231 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.62 66.46 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 53.340000000000003 113.156 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.533 HG22 ' NE2' ' A' ' 140' ' ' GLN . 61.0 m -60.27 -50.12 74.89 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.702 -0.293 . . . . 74.349999999999994 111.631 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.83 -50.56 72.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.038 0.447 . . . . 72.109999999999999 111.311 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.23 -50.19 65.26 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.653 -0.703 . . . . 72.510000000000005 110.94 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.53 95.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.219 -0.515 . . . . 37.850000000000001 113.186 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.533 ' NE2' HG22 ' A' ' 136' ' ' THR . 45.0 mt-30 -58.33 -51.37 70.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.216 0.45 . . . . 52.229999999999997 112.216 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -56.11 -52.85 62.82 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.977 0.418 . . . . 71.400000000000006 111.655 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.641 HG21 ' HA3' ' A' ' 54' ' ' GLY . 61.9 t -57.91 -51.68 67.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.027 -0.533 . . . . 60.420000000000002 112.4 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.711 HG22 HG21 ' A' ' 29' ' ' VAL . 14.2 t -74.07 -37.34 64.25 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.934 0.346 . . . . 73.239999999999995 111.934 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -76.64 -13.36 60.06 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.144 -0.347 . . . . 74.400000000000006 111.625 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -67.57 -51.31 52.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.388 0.614 . . . . 74.310000000000002 110.074 167.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -62.54 -34.2 76.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.594 -0.73 . . . . 73.219999999999999 110.642 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.545 0.783 0 CA-C-N 115.723 -0.671 . . . . 61.130000000000003 111.244 177.674 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.076 0.028 . . . . 75.530000000000001 111.076 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 2.4 mp 66.83 109.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 121.256 0.55 . . . . 73.239999999999995 111.241 -173.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.04 113.74 4.08 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.22 -0.514 . . . . 50.409999999999997 113.186 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.95 104.86 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.48 -0.423 . . . . 75.030000000000001 111.15 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.748 ' HB3' HD22 ' A' ' 36' ' ' LEU . 98.6 m-85 -96.29 111.63 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.099 0.476 . . . . 61.439999999999998 111.679 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -127.86 178.51 6.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 111.624 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.48 HG12 ' HA3' ' A' ' 37' ' ' GLY . 17.3 t -134.46 114.61 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.335 -0.393 . . . . 71.310000000000002 110.637 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 m -74.45 -8.52 56.58 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.957 0.408 . . . . 71.049999999999997 111.79 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.465 ' H ' HG13 ' A' ' 7' ' ' VAL . 44.6 tt0 -96.25 -50.53 4.76 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.459 0.54 . . . . 73.239999999999995 112.459 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.442 ' H ' HG13 ' A' ' 7' ' ' VAL . 78.2 t80 -103.16 138.87 39.41 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.109 0.48 . . . . 74.349999999999994 112.239 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.87 -164.37 4.7 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.566 -0.743 . . . . 70.120000000000005 114.606 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.498 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 97.5 m-85 -100.37 7.8 44.06 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.889 0.329 . . . . 73.409999999999997 111.889 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.732 ' HB3' HG21 ' A' ' 90' ' ' THR . 89.8 p -41.41 -46.76 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.553 0.575 . . . . 74.109999999999999 112.553 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.66 -43.91 76.72 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.088 0.47 . . . . 75.340000000000003 111.748 175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.23 -35.45 73.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.151 0.501 . . . . 73.120000000000005 110.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.78 -38.68 83.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.95 -0.568 . . . . 62.450000000000003 110.818 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.3 75.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.871 -0.604 . . . . 71.310000000000002 111.069 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -58.92 -42.87 90.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.962 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.523 ' HB2' ' HG ' ' A' ' 131' ' ' CYS . . . -65.3 -39.2 92.19 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.011 0.434 . . . . 73.400000000000006 111.137 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.98 -58.49 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.276 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 tt -59.1 -37.16 66.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.652 0.263 . . . . 63.350000000000001 110.938 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -53.66 -56.77 14.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 70.120000000000005 111.457 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.12 -45.23 88.53 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.116 -0.564 . . . . 38.539999999999999 113.926 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.3 mt -66.19 -45.98 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 112.424 0.527 . . . . 72.209999999999994 112.424 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.6 p -65.2 -42.71 93.28 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.909 -0.495 . . . . 74.040000000000006 110.821 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.42 -32.4 64.82 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.192 -0.458 . . . . 64.549999999999997 110.88 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 m -71.98 -33.15 67.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.375 -0.375 . . . . 73.209999999999994 110.993 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.45 5.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.106 -0.569 . . . . 44.240000000000002 114.165 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.1 t -112.49 130.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 122.2 -0.588 . . . . 72.209999999999994 111.979 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 121.49 6.14 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.462 -0.399 . . . . 62.240000000000002 112.927 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.9 m -99.41 164.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 112.667 0.618 . . . . 73.109999999999999 112.667 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.15 110.34 21.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.801 -0.636 . . . . 73.209999999999994 111.092 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.47 112.71 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.295 0.569 . . . . 71.540000000000006 112.077 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.46 129.22 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.283 -0.417 . . . . 74.409999999999997 111.47 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -94.58 116.62 28.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.005 -0.368 . . . . 70.349999999999994 110.005 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 5' ' ' PHE . 4.4 pp -89.31 -7.48 55.29 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.113 0.412 . . . . 65.200000000000003 112.113 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.48 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -86.55 -26.71 31.94 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.12 -0.562 . . . . 51.149999999999999 112.506 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.31 162.79 18.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.107 0.48 . . . . 61.219999999999999 111.705 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.67 96.36 0.08 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.015 0.435 . . . . 64.230000000000004 111.648 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.11 150.02 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.286 0.565 . . . . 54.420000000000002 112.039 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -107.4 173.05 6.49 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.939 -0.573 . . . . 74.25 110.249 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.81 -20.57 57.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.323 -0.236 . . . . 74.510000000000005 111.114 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -61.98 -52.81 62.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.756 0.312 . . . . 61.399999999999999 111.506 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -40.79 84.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.868 0.366 . . . . 74.310000000000002 110.835 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.8 tm? -65.09 -39.81 93.7 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.264 0.554 . . . . 72.209999999999994 109.964 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -59.42 -40.86 88.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.789 -0.641 . . . . 74.040000000000006 111.274 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.86 -36.09 75.24 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.51 -0.314 . . . . 72.010000000000005 111.053 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.58 -47.05 83.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.869 0.366 . . . . 64.120000000000005 110.224 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 45' ' ' LEU . 82.3 t -55.01 -37.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.08 0.467 . . . . 74.109999999999999 111.479 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.36 -53.13 14.23 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.274 -0.488 . . . . 73.439999999999998 113.131 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.19 6.1 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.52 0.563 . . . . 74.439999999999998 112.52 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -48.39 -24.92 1.39 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.848 1.055 . . . . 71.230000000000004 113.848 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.68 HG22 HH22 ' A' ' 146' ' ' ARG . 77.7 p -67.24 -25.86 66.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.587 0.588 . . . . 71.420000000000002 112.587 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.12 137.02 5.6 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.138 -0.553 . . . . 54.310000000000002 112.69 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 HD12 HG13 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -163.2 172.84 14.2 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.578 -0.366 . . . . 74.310000000000002 111.811 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.08 124.65 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.909 0.385 . . . . 74.030000000000001 111.144 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -117.2 145.32 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.966 0.413 . . . . 74.319999999999993 111.569 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.5 -89.74 0.39 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 73.540000000000006 112.583 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' HG23 ' A' ' 90' ' ' THR . 4.0 ppp? -172.48 158.47 4.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.557 0.343 . . . . 73.129999999999995 110.642 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -117.58 114.42 37.98 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 111.798 0.296 . . . . 64.450000000000003 111.798 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.66 160.32 28.15 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.368 2.045 . . . . 73.530000000000001 112.432 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.13 -31.45 19.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.522 0.564 . . . . 72.219999999999999 112.522 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.6 96.16 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.158 0.504 . . . . 74.129999999999995 111.681 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -90.11 -21.8 22.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 111.541 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.93 -24.56 9.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.2 0.815 . . . . 72.519999999999996 113.2 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.01 -56.04 7.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.408 0.522 . . . . 64.420000000000002 112.408 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -84.6 -33.63 23.31 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.822 0.344 . . . . 54.009999999999998 111.4 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -60.89 -53.21 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.288 0.477 . . . . 75.409999999999997 112.288 -176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.5 -38.65 69.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.848 0.356 . . . . 72.099999999999994 111.346 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.11 87.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.0 -0.619 . . . . 70.400000000000006 112.391 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.98 95.07 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.991 0.424 . . . . 73.430000000000007 111.495 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.79 -35.44 68.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.333 -0.394 . . . . 73.540000000000006 111.353 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.6 m -54.28 -27.02 32.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.998 0.428 . . . . 62.329999999999998 111.427 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.7 m -99.19 -49.53 4.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.312 -0.403 . . . . 72.340000000000003 111.284 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.1 mt -54.57 -48.59 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.818 0.673 . . . . 73.530000000000001 112.818 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.27 -36.68 68.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.031 0.382 . . . . 55.43 112.031 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.49 66.24 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.038 -0.601 . . . . 64.409999999999997 113.13 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -100.29 5.12 44.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.188 0.44 . . . . 51.229999999999997 112.188 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.82 162.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.01 0.433 . . . . 64.420000000000002 111.996 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -117.54 106.84 13.57 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.851 0.358 . . . . 73.140000000000001 111.456 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.608 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 38.3 tt0 50.14 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.978 0.732 . . . . 63.5 112.978 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 62.2 pttt -159.39 48.02 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.261 0.553 . . . . 73.510000000000005 110.972 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.44 172.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.065 0.765 . . . . 72.439999999999998 113.065 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.569 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -88.02 109.65 20.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 74.439999999999998 111.894 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 55' ' ' LEU . 29.7 m -107.41 119.02 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.567 0.699 . . . . 71.140000000000001 111.788 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.06 159.85 21.43 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.997 -0.547 . . . . 42.229999999999997 112.399 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -144.39 131.36 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.398 -0.472 . . . . 74.430000000000007 111.961 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -140.05 93.44 2.64 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.65 0.738 . . . . 74.120000000000005 110.659 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.33 114.48 2.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.834 -0.621 . . . . 64.120000000000005 112.16 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.732 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.0 t -108.65 29.68 7.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 111.973 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . -178.53 -54.41 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.186 -1.007 . . . . 52.299999999999997 114.086 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.85 -14.35 58.8 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.496 -0.859 . . . . 54.539999999999999 113.2 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.05 67.48 3.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.226 -0.511 . . . . 71.120000000000005 112.499 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.48 -179.27 6.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.221 0.534 . . . . 65.409999999999997 112.15 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -75.93 133.65 40.44 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.124 -0.489 . . . . 71.540000000000006 110.818 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.561 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.7 mt-10 -54.46 -37.45 54.54 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 113.744 1.016 . . . . 72.450000000000003 113.744 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 38.0 Cg_endo -66.21 32.18 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.843 1.695 . . . . 65.430000000000007 113.94 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 96' ' ' GLU . 7.6 tp -66.59 -44.1 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.118 -0.364 . . . . 74.400000000000006 111.975 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.419 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 9.6 m-20 -56.09 -47.0 99.7 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 112.429 0.529 . . . . 65.299999999999997 112.429 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 83.1 Cg_exo -45.77 -37.46 16.28 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.717 2.278 . . . . 74.049999999999997 113.436 170.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.5 -42.65 34.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.802 0.334 . . . . 73.239999999999995 110.927 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.35 -32.48 64.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.348 -0.387 . . . . 75.239999999999995 111.197 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -55.58 -46.92 77.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.264 0.554 . . . . 71.019999999999996 110.992 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -66.36 -51.62 55.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.065 -0.516 . . . . 73.299999999999997 111.313 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.595 ' HD1' HD21 ' A' ' 110' ' ' LEU . 24.3 m-85 -59.58 -44.86 93.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.034 0.445 . . . . 74.230000000000004 112.119 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -77.46 -60.76 2.23 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.423 0.527 . . . . 65.109999999999999 112.423 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -62.41 -32.37 73.19 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.542 0.571 . . . . 71.510000000000005 112.542 -170.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -79.06 -20.37 49.02 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.347 175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.61 44.62 6.79 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.28 -0.486 . . . . 54.43 114.166 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.595 HD21 ' HD1' ' A' ' 105' ' ' PHE . 8.7 mp -70.39 133.96 47.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.256 0.528 . . . . 74.129999999999995 111.361 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.569 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 36.7 m -60.8 94.02 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.947 0.403 . . . . 73.299999999999997 111.381 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -103.82 137.03 42.41 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.513 -0.312 . . . . 61.509999999999998 111.64 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HB2' HD23 ' A' ' 138' ' ' LEU . . . -54.69 -64.15 0.93 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.408 -0.36 . . . . 65.409999999999997 111.942 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -162.79 98.49 1.08 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.894 0.378 . . . . 73.150000000000006 110.873 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -85.18 46.6 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.008 2.472 . . . . 74.200000000000003 113.887 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.17 37.75 0.95 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 62.530000000000001 112.024 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.9 pt -105.3 144.0 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 112.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -133.37 108.74 8.89 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.313 -0.403 . . . . 73.120000000000005 110.55 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.42 140.95 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 65.439999999999998 110.697 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 120' ' ' LYS . 0.4 OUTLIER -62.58 153.26 32.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.667 0.27 . . . . 63.340000000000003 111.224 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 21.8 tt0 -51.66 -33.67 34.67 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.682 0.623 . . . . 74.140000000000001 112.682 -171.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p -108.61 99.09 31.87 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 120.606 0.241 . . . . 74.420000000000002 111.078 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.498 ' HD2' ' HD2' ' A' ' 12' ' ' TYR . 85.0 Cg_exo -46.78 128.86 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.492 2.794 . . . . 61.340000000000003 114.301 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.5 p -100.45 -178.1 3.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.068 -0.514 . . . . 64.230000000000004 111.043 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -57.37 -27.22 62.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.977 0.418 . . . . 74.439999999999998 111.404 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -59.33 -41.41 89.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 64.319999999999993 110.851 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 m -63.43 -36.75 84.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.098 -0.501 . . . . 75.239999999999995 111.175 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -62.38 -36.35 82.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.135 0.493 . . . . 71.239999999999995 111.144 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -69.63 -38.99 77.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 110.889 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.29 -54.74 32.41 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.849 -0.614 . . . . 63.399999999999999 110.721 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.523 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 31.0 p -62.27 -38.29 88.77 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.75 0.278 . . . . 75.340000000000003 111.75 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.63 -56.63 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.349 0.595 . . . . 70.439999999999998 111.475 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -64.18 -56.89 11.59 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.735 -0.666 . . . . 71.409999999999997 111.94 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.73 84.41 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.863 0.32 . . . . 63.109999999999999 111.863 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.41 -44.64 66.48 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.348 -0.453 . . . . 72.010000000000005 113.24 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 24' ' ' ILE . 94.8 m -55.83 -41.19 73.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.815 0.34 . . . . 73.030000000000001 111.486 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.36 -45.26 94.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.315 -0.402 . . . . 73.040000000000006 111.739 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 113' ' ' ALA . 4.1 mm? -56.49 -42.12 77.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.942 0.401 . . . . 62.299999999999997 110.936 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.35 82.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.097 -0.573 . . . . 50.109999999999999 112.693 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.25 -46.98 87.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.006 0.431 . . . . 74.140000000000001 111.857 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -56.67 -50.83 70.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.113 -0.494 . . . . 72.420000000000002 111.5 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.84 -44.61 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.324 0.491 . . . . 74.409999999999997 112.324 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.4 t -65.98 -28.45 68.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.978 0.418 . . . . 72.209999999999994 111.712 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.03 -56.63 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.756 0.313 . . . . 74.310000000000002 111.207 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.37 -29.72 69.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.004 0.43 . . . . 73.329999999999998 111.522 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.68 HH22 HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER -75.73 -30.76 59.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.2 -0.312 . . . . 74.120000000000005 111.764 175.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.21 0.529 . . . . 75.209999999999994 109.579 175.21 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.645 0.259 . . . . 75.129999999999995 111.384 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm 64.93 111.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 112.67 0.618 . . . . 74.150000000000006 112.67 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.58 103.42 1.43 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.114 -0.565 . . . . 71.150000000000006 112.578 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.18 93.84 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.889 0.376 . . . . 71.120000000000005 111.558 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.641 ' HD2' HD21 ' A' ' 36' ' ' LEU . 17.5 m-85 -89.09 117.0 27.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.718 0.294 . . . . 75.340000000000003 111.443 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.42 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 35.7 p90 -134.92 151.03 50.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.432 0.634 . . . . 72.519999999999996 112.416 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 10' ' ' TYR . 39.7 t -96.1 97.95 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.788 -0.642 . . . . 63.439999999999998 111.52 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.699 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 20.1 m -70.88 -27.21 63.64 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.234 0.457 . . . . 64.510000000000005 112.234 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.5 -42.25 71.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.662 0.616 . . . . 74.329999999999998 112.662 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.519 ' OH ' ' HG3' ' A' ' 121' ' ' GLN . 69.4 t80 -111.5 106.77 15.75 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.666 0.988 . . . . 74.040000000000006 113.666 -171.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.94 -160.49 5.41 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.829 1.092 . . . . 71.150000000000006 115.829 167.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 56.7 m-85 -63.11 -2.17 1.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.22 0.822 . . . . 74.200000000000003 113.22 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 m -54.11 -31.51 52.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.231 0.538 . . . . 72.109999999999999 111.345 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.699 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 25.1 t70 -65.87 -32.73 74.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.652 -0.704 . . . . 60.229999999999997 111.745 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -94.44 -23.73 17.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.442 0.534 . . . . 74.329999999999998 112.442 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 12' ' ' TYR . 92.7 mt -54.64 -39.92 68.47 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.231 0.538 . . . . 73.25 111.384 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 6' ' ' TYR . . . -70.41 -23.0 62.67 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.07 -0.513 . . . . 74.120000000000005 112.141 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.76 -34.9 76.67 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.912 0.387 . . . . 74.150000000000006 110.945 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 132' ' ' GLU . . . -62.09 -40.77 96.96 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.492 . . . . 73.430000000000007 111.04 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.439 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.5 mt -62.76 -52.95 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.044 -0.525 . . . . 74.450000000000003 110.601 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.487 HG22 HG22 ' A' ' 31' ' ' VAL . 83.5 mt -52.85 -43.94 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.939 -0.573 . . . . 74.109999999999999 111.235 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -56.95 -48.77 77.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.108 -0.496 . . . . 64.209999999999994 111.323 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.46 99.57 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.013 -0.613 . . . . 70.040000000000006 113.091 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -65.55 -48.47 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 72.230000000000004 111.71 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -68.33 -34.94 77.02 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.788 0.328 . . . . 74.519999999999996 111.267 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.12 -31.81 73.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.458 0.647 . . . . 62.43 110.558 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.0 m -75.16 -14.44 60.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.848 -0.615 . . . . 75.0 111.15 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.42 26.65 11.73 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.363 -0.38 . . . . 71.430000000000007 113.779 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.472 HG21 ' HB ' ' A' ' 143' ' ' THR . 42.0 t -118.88 142.31 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.555 -0.379 . . . . 60.520000000000003 111.603 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.68 140.7 24.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.009 -0.615 . . . . 40.399999999999999 112.859 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.487 HG22 HG22 ' A' ' 21' ' ' ILE . 33.1 m -106.4 145.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.985 0.365 . . . . 71.439999999999998 111.985 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -107.09 110.55 22.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.912 0.387 . . . . 70.409999999999997 110.172 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.94 113.8 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.55 0.69 . . . . 75.310000000000002 112.788 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.96 93.42 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.197 0.523 . . . . 74.230000000000004 110.925 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -79.0 70.88 5.41 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.557 0.694 . . . . 64.030000000000001 111.743 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -64.79 -23.79 67.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.231 -0.441 . . . . 75.25 111.636 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' N ' HD11 ' A' ' 36' ' ' LEU . . . -75.17 -0.36 61.02 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.239 -0.505 . . . . 55.219999999999999 112.889 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 17.13 12.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.917 0.389 . . . . 61.420000000000002 110.607 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.99 97.63 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.527 -0.761 . . . . 73.329999999999998 112.166 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 36' ' ' LEU . 24.7 m -83.47 156.13 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.775 0.321 . . . . 74.040000000000006 111.327 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.6 179.61 4.17 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 111.364 -174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 HD11 ' A' ' 45' ' ' LEU . 3.8 mm? -60.67 -20.87 62.03 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.322 0.49 . . . . 75.450000000000003 112.322 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 1.4 mp0 -59.42 -29.88 68.07 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.117 0.414 . . . . 71.109999999999999 112.117 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -86.25 -43.83 12.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.806 0.336 . . . . 72.230000000000004 111.311 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.703 HD11 HD12 ' A' ' 42' ' ' LEU . 80.6 mt -54.09 -28.3 38.36 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.564 0.579 . . . . 63.130000000000003 112.564 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 20.3 ptt180 -61.34 -33.16 73.16 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.696 0.284 . . . . 74.239999999999995 111.231 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.25 3.18 46.18 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.04 0.385 . . . . 75.129999999999995 112.04 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 2.3 tm? -56.52 -34.48 67.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.998 0.428 . . . . 74.299999999999997 110.213 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.62 -23.46 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.222 0.534 . . . . 72.299999999999997 111.785 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.17 -40.89 5.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.394 -0.431 . . . . 52.450000000000003 112.535 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -76.1 -15.42 60.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.242 0.46 . . . . 74.140000000000001 112.242 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -69.37 -7.67 39.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.004 0.372 . . . . 63.009999999999998 112.004 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.0 p -70.54 -26.79 63.72 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.327 0.584 . . . . 74.439999999999998 111.033 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.57 135.56 3.57 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.85 -0.614 . . . . 73.420000000000002 111.8 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 HD22 HG13 ' A' ' 85' ' ' VAL . 2.1 pt? -168.14 169.17 11.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.011 0.405 . . . . 75.040000000000006 111.491 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 8.5 p -134.69 128.14 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.929 0.395 . . . . 64.25 111.454 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.479 HD13 ' N ' ' A' ' 57' ' ' ILE . 3.7 mp -113.75 135.12 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.302 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.03 133.34 10.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.359 -0.448 . . . . 74.040000000000006 112.823 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.48 ' HE1' ' H ' ' A' ' 93' ' ' GLY . 44.1 ttp -65.91 110.5 2.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.638 -0.33 . . . . 64.540000000000006 111.717 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 7' ' ' VAL . 93.4 p -103.49 148.27 35.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 111.982 0.364 . . . . 75.109999999999999 111.982 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.655 ' HA ' ' HB3' ' A' ' 94' ' ' ASP . 28.0 Cg_endo -60.73 159.67 27.74 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.87 2.38 . . . . 61.329999999999998 112.451 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.57 -40.53 52.46 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.868 0.692 . . . . 63.5 112.868 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.79 -53.03 54.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.196 0.443 . . . . 71.120000000000005 112.196 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.1 m -79.34 -32.23 43.26 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.073 0.463 . . . . 73.140000000000001 111.204 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -27.56 65.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.99 -0.55 . . . . 52.409999999999997 111.498 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.71 -29.66 62.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.211 0.449 . . . . 71.230000000000004 112.211 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -82.05 -17.45 46.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.052 0.453 . . . . 74.430000000000007 111.717 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 36' ' ' LEU . 26.1 mt -100.59 -47.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 112.169 -175.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -45.32 -45.48 12.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.288 1.035 . . . . 71.319999999999993 113.435 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.78 -63.94 4.52 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.047 -0.597 . . . . 71.349999999999994 113.196 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.446 ' HB1' HD12 ' A' ' 45' ' ' LEU . . . -62.44 -28.73 70.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.069 0.461 . . . . 63.399999999999999 112.165 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.14 -33.69 63.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.079 -0.509 . . . . 54.5 111.363 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 m -54.66 -39.24 67.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.125 -0.489 . . . . 65.409999999999997 111.563 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -73.66 -38.16 65.05 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.916 0.389 . . . . 74.420000000000002 111.293 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.41 -58.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.849 0.357 . . . . 75.519999999999996 111.85 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.465 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.1 mp -60.91 -12.47 11.25 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.564 0.579 . . . . 74.109999999999999 112.564 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.17 -30.33 7.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 60.020000000000003 112.793 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -79.21 -24.16 43.3 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 111.792 0.293 . . . . 74.409999999999997 111.792 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -64.36 155.57 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.042 0.449 . . . . 74.510000000000005 111.878 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -80.15 160.55 25.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 71.019999999999996 111.612 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.464 ' HA ' HD21 ' A' ' 108' ' ' LEU . 35.9 tt0 -54.87 -36.64 65.31 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.098 0.475 . . . . 60.030000000000001 111.939 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -138.87 122.08 16.96 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.452 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 6.2 tp-100 -163.78 169.93 17.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.778 0.323 . . . . 74.340000000000003 110.983 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -89.45 93.85 9.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.173 0.511 . . . . 72.219999999999999 111.801 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG13 HD22 ' A' ' 55' ' ' LEU . 35.4 m -107.94 148.69 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.137 -0.483 . . . . 72.450000000000003 111.121 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.03 146.24 17.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.327 -0.463 . . . . 74.319999999999993 113.123 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.574 ' H ' ' HB1' ' A' ' 113' ' ' ALA . 39.0 mm -140.93 132.62 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.817 0.447 . . . . 74.430000000000007 110.623 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -152.21 159.38 43.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.956 0.408 . . . . 72.319999999999993 111.258 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.82 138.85 39.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.035 0.445 . . . . 72.540000000000006 111.556 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 t -121.01 4.04 10.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.526 0.679 . . . . 73.530000000000001 110.656 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.45 -93.09 0.45 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.652 -0.704 . . . . 74.510000000000005 112.359 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.57 70.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.195 -0.526 . . . . 63.439999999999998 113.416 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.48 ' H ' ' HE1' ' A' ' 59' ' ' MET . . . 85.24 52.98 3.24 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.502 -0.38 . . . . 64.450000000000003 113.158 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.655 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 11.3 m-20 -96.1 176.97 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.324 0.49 . . . . 74.040000000000006 112.324 -175.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.6 t70 64.41 160.67 0.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.41 0.684 . . . . 62.509999999999998 112.082 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.717 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 41.8 mt-10 -102.01 -53.81 0.14 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 112.254 0.464 . . . . 70.219999999999999 112.254 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 8.2 Cg_exo -75.27 22.97 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.395 2.064 . . . . 74.340000000000003 112.991 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.7 -35.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.336 0.495 . . . . 64.109999999999999 112.336 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.661 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.1 m-20 -66.36 -54.16 26.56 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 122.168 -0.332 . . . . 75.230000000000004 111.768 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.661 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 73.5 Cg_exo -51.0 -45.8 34.45 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.435 2.09 . . . . 73.450000000000003 113.0 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 97' ' ' PRO . 8.5 mp -55.46 -58.12 9.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.46 -0.336 . . . . 73.030000000000001 111.299 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.58 -32.24 71.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.499 -0.319 . . . . 73.319999999999993 111.488 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 t -62.93 -37.62 87.75 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.893 0.377 . . . . 72.430000000000007 111.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 76' ' ' LEU . 27.8 tptp -64.34 -41.76 96.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.729 0.299 . . . . 75.439999999999998 111.018 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -68.15 -44.06 76.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.023 0.44 . . . . 72.310000000000002 110.847 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -64.68 -39.1 93.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.961 -0.563 . . . . 74.030000000000001 111.813 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -62.23 -49.92 73.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.905 0.383 . . . . 74.140000000000001 111.181 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 81' ' ' GLU . 8.2 mp -74.17 -24.22 59.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.098 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.22 43.55 9.53 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.182 -0.532 . . . . 62.25 112.502 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.85 156.63 32.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.19 0.519 . . . . 71.099999999999994 111.905 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.4 m -66.97 106.54 1.96 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.774 0.657 . . . . 65.019999999999996 112.774 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.0 p -84.04 95.04 8.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.742 0.306 . . . . 64.140000000000001 111.12 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.574 ' HB1' ' H ' ' A' ' 87' ' ' ILE . . . -53.71 -70.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.202 0.445 . . . . 73.430000000000007 112.202 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -125.49 90.01 51.45 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 120.853 0.358 . . . . 75.5 111.044 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.14 98.71 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.57 2.18 . . . . 70.319999999999993 112.803 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.08 159.44 20.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.103 0.477 . . . . 52.210000000000001 111.987 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -138.26 34.1 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.892 -0.594 . . . . 73.129999999999995 110.59 175.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.7 mtm180 -96.92 20.2 11.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.493 0.923 . . . . 74.409999999999997 113.493 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.2 mt -100.42 149.49 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.86 -0.422 . . . . 73.200000000000003 109.86 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.04 -65.99 0.58 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.048 -0.408 . . . . 63.109999999999999 111.518 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -177.3 -26.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.987 0.423 . . . . 64.430000000000007 111.453 -177.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p -89.82 117.81 68.43 Favored Pre-proline 0 N--CA 1.47 0.553 0 N-CA-C 111.851 0.315 . . . . 65.239999999999995 111.851 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.68 134.48 44.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.56 2.173 . . . . 75.450000000000003 111.864 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -100.49 168.49 9.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.712 0.768 . . . . 64.409999999999997 112.717 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.59 -29.94 68.31 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.36 -0.836 . . . . 74.140000000000001 111.053 174.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -73.01 -31.92 64.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.888 -0.596 . . . . 73.319999999999993 110.973 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -35.58 67.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.858 0.361 . . . . 52.140000000000001 111.059 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -55.71 -48.27 75.45 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.284 -0.416 . . . . 73.349999999999994 111.591 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 5.3 mptp? -67.19 -32.77 74.07 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.945 0.35 . . . . 72.530000000000001 111.945 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.93 -53.58 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.234 0.54 . . . . 75.129999999999995 110.466 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.43 -34.35 75.84 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.87 -0.604 . . . . 73.099999999999994 111.526 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.9 tt0 -59.15 -66.67 0.47 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.952 0.501 . . . . 73.430000000000007 112.173 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.95 -47.21 86.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.795 0.331 . . . . 72.349999999999994 111.589 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.817 0.342 . . . . 72.099999999999994 111.454 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.439 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -63.02 -37.23 94.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.321 -0.466 . . . . 73.420000000000002 113.362 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 99.2 m -63.0 -58.0 8.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.738 0.304 . . . . 75.430000000000007 111.212 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.15 -41.52 99.29 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.616 -0.266 . . . . 74.239999999999995 111.457 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.63 -43.46 93.81 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 110.18 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 143' ' ' THR . . . -60.1 -45.81 95.32 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.103 -0.57 . . . . 62.009999999999998 112.458 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 136' ' ' THR . 80.3 mt-30 -66.68 -29.22 69.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.216 0.532 . . . . 75.420000000000002 111.166 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -65.1 -54.64 26.9 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.968 -0.56 . . . . 72.239999999999995 110.541 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.27 -46.81 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 112.789 0.663 . . . . 73.030000000000001 112.789 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.558 HG23 ' HD3' ' A' ' 144' ' ' ARG . 4.7 t -53.46 -33.61 54.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.681 0.623 . . . . 74.230000000000004 112.681 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.558 ' HD3' HG23 ' A' ' 143' ' ' THR . 11.0 mpt_? -99.76 -19.06 16.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.94 0.348 . . . . 75.239999999999995 111.94 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.31 -62.17 1.96 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.03 0.381 . . . . 64.430000000000007 112.03 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -60.17 -16.73 35.47 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.242 -0.435 . . . . 72.140000000000001 112.004 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 143' ' ' THR . 3.9 mm? . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.003 0.371 . . . . 71.019999999999996 112.003 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 67.1 p . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.345 0.116 . . . . 73.239999999999995 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm 63.55 89.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.281 0.562 . . . . 61.43 111.638 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.29 100.5 1.66 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.946 -0.57 . . . . 61.350000000000001 112.729 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 100.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.856 0.36 . . . . 64.329999999999998 111.108 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 94.5 m-85 -98.55 120.96 39.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.082 -0.508 . . . . 73.209999999999994 111.711 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.463 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 13.7 p90 -143.91 -179.7 6.64 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.105 0.479 . . . . 74.439999999999998 112.141 -176.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.423 HG12 ' HA3' ' A' ' 37' ' ' GLY . 33.0 t -126.61 90.79 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.189 -0.46 . . . . 61.140000000000001 110.108 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 m -40.87 -54.26 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.318 1.229 . . . . 73.340000000000003 114.318 -170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.65 -25.92 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.594 0.59 . . . . 74.349999999999994 112.594 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.425 ' HE2' ' HA3' ' A' ' 91' ' ' GLY . 91.0 t80 -79.57 101.84 8.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.984 0.364 . . . . 73.299999999999997 111.984 -174.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 13' ' ' SER . . . 55.43 -159.36 6.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.156 -0.545 . . . . 75.200000000000003 114.365 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.06 7.35 0.06 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.806 1.039 . . . . 74.230000000000004 113.806 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 6' ' ' TYR . 11.4 t -46.15 -56.23 5.95 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.037 0.755 . . . . 70.209999999999994 113.037 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -64.02 -31.44 72.63 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.01 0.433 . . . . 74.510000000000005 111.323 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.81 -35.66 77.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.22 0.533 . . . . 71.329999999999998 110.817 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.5 mt -69.36 -44.84 70.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 72.319999999999993 110.661 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.95 -43.99 73.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.115 0.484 . . . . 72.239999999999995 110.935 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -53.31 -42.43 66.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.626 -0.716 . . . . 61.210000000000001 111.897 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.42 43.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.403 0.52 . . . . 75.530000000000001 112.403 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 16' ' ' LEU . 69.2 mt -61.13 -53.17 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.933 0.396 . . . . 74.319999999999993 111.794 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -59.34 -29.36 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.778 0.323 . . . . 74.239999999999995 111.865 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.61 -54.76 43.19 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.786 0.327 . . . . 70.439999999999998 111.757 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.91 -48.59 84.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.264 -0.494 . . . . 37.170000000000002 113.349 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.6 mt -64.8 -38.1 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.963 0.411 . . . . 63.329999999999998 111.481 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.9 m -60.12 -44.97 94.5 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.176 -0.328 . . . . 73.239999999999995 110.847 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.24 -16.11 63.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.743 0.306 . . . . 71.120000000000005 111.624 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -77.51 -20.99 53.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.34 0.591 . . . . 64.450000000000003 110.319 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 27.09 9.12 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.013 -0.54 . . . . 71.010000000000005 113.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 t -120.1 142.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.984 0.392 . . . . 61.149999999999999 111.62 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.93 118.77 4.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.094 -0.574 . . . . 62.5 112.979 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 1' ' ' SER . 35.6 m -91.07 167.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.519 0.563 . . . . 71.099999999999994 112.519 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -121.46 108.56 13.79 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.087 0.47 . . . . 73.219999999999999 111.203 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.85 113.28 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.522 -0.308 . . . . 75.129999999999995 111.41 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 60.9 t -140.12 110.15 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 120.87 0.367 . . . . 75.299999999999997 111.334 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -84.64 106.58 16.3 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.519 0.676 . . . . 73.25 111.931 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.561 ' HA ' HG11 ' A' ' 40' ' ' VAL . 1.3 pp -70.26 -14.25 62.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.095 -0.378 . . . . 74.319999999999993 111.863 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.449 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -60.0 -32.06 74.38 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.351 -0.386 . . . . 61.420000000000002 113.64 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.15 11.04 17.33 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.511 -0.406 . . . . 53.32 111.792 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.38 106.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.187 0.518 . . . . 71.310000000000002 111.566 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 ' HA ' ' A' ' 36' ' ' LEU . 35.3 m -85.21 151.24 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.083 0.468 . . . . 74.439999999999998 111.544 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.47 176.09 6.43 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.167 -0.47 . . . . 64.340000000000003 111.176 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 42' ' ' LEU . 3.2 mm? -56.98 -24.51 53.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.571 -0.286 . . . . 74.540000000000006 111.736 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -63.07 -56.97 12.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 72.420000000000002 111.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.99 -43.06 95.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.061 0.457 . . . . 75.400000000000006 110.73 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.18 -47.33 78.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.935 -0.575 . . . . 72.230000000000004 110.675 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -65.69 -39.03 90.85 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.25 -0.432 . . . . 41.130000000000003 111.578 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.24 -33.91 76.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.931 0.396 . . . . 73.140000000000001 111.257 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 55' ' ' LEU . 52.8 tp -55.54 -34.61 64.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.495 -0.321 . . . . 74.329999999999998 111.148 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.38 -41.57 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.103 0.478 . . . . 72.129999999999995 111.063 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.67 -16.87 80.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.15 -0.548 . . . . 41.450000000000003 113.088 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -100.38 5.73 44.4 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.617 -0.343 . . . . 74.530000000000001 111.494 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.8 p -59.28 -3.73 0.45 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.059 . . . . 75.329999999999998 113.858 -172.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -67.46 -35.33 78.98 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.03 -0.419 . . . . 65.310000000000002 111.275 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.6 138.0 5.13 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.214 -0.517 . . . . 74.129999999999995 113.045 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 48' ' ' LEU . 1.9 pt? -158.72 146.42 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.621 -0.34 . . . . 75.310000000000002 111.26 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 ' HE1' ' A' ' 88' ' ' PHE . 48.8 t -117.98 118.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.362 0.265 . . . . 71.219999999999999 110.806 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -112.06 120.63 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.217 0.451 . . . . 61.240000000000002 112.217 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.86 99.17 2.54 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.412 -0.423 . . . . 74.099999999999994 112.795 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 90' ' ' THR . 14.0 tmm? -56.67 132.54 52.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.901 0.381 . . . . 71.420000000000002 111.558 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -134.99 147.31 62.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 110.921 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.32 168.07 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.644 2.896 . . . . 70.200000000000003 115.045 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -43.73 -41.33 4.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.577 0.955 . . . . 75.030000000000001 113.577 -173.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.79 -45.88 64.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.038 0.447 . . . . 73.230000000000004 111.739 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -87.32 -36.02 18.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.074 0.464 . . . . 53.219999999999999 111.094 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.0 -26.96 67.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.071 -0.513 . . . . 73.209999999999994 112.147 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.75 83.0 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.835 0.35 . . . . 71.420000000000002 111.534 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -65.28 -31.14 72.12 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.826 0.346 . . . . 71.230000000000004 111.34 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.51 -39.48 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.873 0.368 . . . . 73.219999999999999 111.27 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.9 -43.67 66.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.298 -0.41 . . . . 70.340000000000003 112.018 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.52 -31.33 51.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 121.042 -0.599 . . . . 53.299999999999997 113.512 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.0 22.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.281 0.475 . . . . 74.120000000000005 112.281 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.6 tp -54.73 -55.53 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 51.509999999999998 112.582 -173.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -56.79 -38.15 72.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.836 0.35 . . . . 73.310000000000002 111.809 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -65.47 -46.27 80.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.94 0.4 . . . . 72.400000000000006 111.198 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.63 -47.4 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.418 -0.355 . . . . 73.150000000000006 111.208 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.72 -29.72 69.53 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.884 0.373 . . . . 71.150000000000006 111.55 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.27 -19.59 76.55 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 74.340000000000003 112.917 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -90.64 -37.95 13.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.069 0.396 . . . . 71.340000000000003 112.069 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.11 143.26 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.153 0.501 . . . . 74.219999999999999 112.045 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.583 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -161.32 176.3 11.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.238 -0.437 . . . . 73.549999999999997 111.509 -177.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 57.68 -94.69 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.898 0.479 . . . . 63.32 111.886 173.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -179.07 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.043 0.449 . . . . 62.5 111.836 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -56.79 175.62 0.12 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.376 0.608 . . . . 74.019999999999996 112.611 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.44 98.43 11.62 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.755 0.65 . . . . 73.120000000000005 112.755 -170.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.42 105.0 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.596 0.712 . . . . 72.439999999999998 112.061 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 78.86 1.95 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 122.021 -0.424 . . . . 63.310000000000002 113.032 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.61 122.53 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 111.969 0.359 . . . . 54.229999999999997 111.969 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' HE1' HG12 ' A' ' 56' ' ' VAL . 6.5 p90 -153.82 164.37 38.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.256 -0.276 . . . . 73.310000000000002 110.256 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.431 ' HB2' HD11 ' A' ' 119' ' ' ILE . 1.9 mp0 -83.86 133.64 34.73 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.884 -0.51 . . . . 75.299999999999997 111.427 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 59' ' ' MET . 10.4 t -87.04 7.18 28.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.437 0.637 . . . . 63.409999999999997 110.333 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.425 ' HA3' ' HE2' ' A' ' 10' ' ' TYR . . . 172.2 -82.79 0.08 OUTLIER Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.505 -0.771 . . . . 65.030000000000001 112.04 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.72 124.86 2.88 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.909 -0.662 . . . . 74.200000000000003 113.374 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.46 -152.81 6.9 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.933 -0.651 . . . . 52.520000000000003 112.822 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.06 121.59 35.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.903 0.383 . . . . 72.239999999999995 111.677 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.581 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . 3.3 p-10 -147.02 171.87 14.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 64.530000000000001 110.891 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.557 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 mt-10 -102.97 -44.62 0.19 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.453 0.909 . . . . 74.439999999999998 113.453 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 36.6 Cg_endo -62.83 -12.1 27.45 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.246 1.964 . . . . 73.519999999999996 114.703 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.3 tp -53.99 -51.63 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.986 0.736 . . . . 64.5 112.986 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.686 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 6.6 m-20 -61.71 -54.56 50.42 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.134 0.42 . . . . 45.409999999999997 112.134 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.5 Cg_exo -56.88 -35.87 98.62 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.233 1.955 . . . . 72.109999999999999 112.744 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -56.76 13.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.214 -0.448 . . . . 73.219999999999999 111.12 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.81 -45.03 86.7 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 73.109999999999999 111.23 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 27.3 t -55.74 -37.87 69.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.161 -0.472 . . . . 73.439999999999998 111.943 177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.567 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 1.8 tpmt? -68.24 -58.66 4.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.765 0.317 . . . . 71.099999999999994 111.039 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -58.47 -27.38 64.35 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.732 0.271 . . . . 74.409999999999997 111.732 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 103' ' ' SER . 18.9 ttp180 -52.06 -50.16 62.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.964 0.411 . . . . 71.420000000000002 111.596 173.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.85 -40.56 54.47 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.332 -0.394 . . . . 75.439999999999998 111.593 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.709 ' HB3' HD13 ' A' ' 110' ' ' LEU . 10.8 mp -59.46 -40.09 85.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.846 0.355 . . . . 73.340000000000003 111.904 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 32.07 36.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.211 -0.519 . . . . 42.409999999999997 113.807 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.709 HD13 ' HB3' ' A' ' 108' ' ' LEU . 10.9 mp -88.92 165.6 14.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.041 0.448 . . . . 71.299999999999997 111.509 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.2 m -80.28 122.71 27.23 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.271 0.471 . . . . 63.119999999999997 112.271 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.4 p -103.49 112.26 25.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.273 -0.421 . . . . 73.400000000000006 110.599 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.17 -48.75 67.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.909 0.385 . . . . 44.32 111.244 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.05 144.54 49.14 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 116.007 -0.542 . . . . 73.099999999999994 110.233 172.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.11 4.85 2.1 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.88 2.387 . . . . 71.239999999999995 113.57 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 70.12 159.81 0.2 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.811 0.671 . . . . 71.129999999999995 112.811 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.3 pt 42.44 31.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.295 1.22 . . . . 64.340000000000003 114.295 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.07 -7.86 16.0 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 122.001 -0.437 . . . . 75.310000000000002 111.871 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 89' ' ' GLU . 67.9 mt -91.79 144.78 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 120.939 0.399 . . . . 72.010000000000005 111.189 173.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 19.2 pttp -87.5 53.56 2.84 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.737 0.643 . . . . 53.43 112.737 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 5.5 tp-100 74.17 -47.4 0.64 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.69 0.626 . . . . 74.219999999999999 112.69 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.1 p -96.22 116.8 66.38 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 111.986 0.365 . . . . 61.210000000000001 111.986 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.38 140.08 62.29 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.52 2.147 . . . . 51.229999999999997 111.857 172.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 p -111.37 179.04 4.14 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.332 0.587 . . . . 74.239999999999995 112.096 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 -31.33 59.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.906 -0.588 . . . . 65.230000000000004 111.462 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.35 -40.95 81.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 110.779 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -51.94 -35.19 45.03 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.226 -0.443 . . . . 74.400000000000006 111.292 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -56.16 -63.15 1.28 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.506 -0.316 . . . . 72.109999999999999 111.019 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -51.78 -46.03 64.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.801 0.334 . . . . 73.230000000000004 111.655 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.18 -59.8 4.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.489 -0.323 . . . . 71.420000000000002 111.679 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.2 p -60.5 -39.84 89.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.791 0.293 . . . . 65.219999999999999 111.791 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.94 -69.36 0.22 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.44 0.533 . . . . 73.430000000000007 112.44 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.82 -32.32 69.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.619 0.6 . . . . 73.340000000000003 112.619 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.47 65.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.75 0.31 . . . . 64.340000000000003 110.849 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.0 -38.17 95.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.369 -0.443 . . . . 37.170000000000002 112.545 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.599 HG22 HE21 ' A' ' 140' ' ' GLN . 93.9 m -62.09 -49.16 77.02 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.649 -0.324 . . . . 72.120000000000005 111.032 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.21 -38.4 86.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.322 0.582 . . . . 74.540000000000006 110.408 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -58.45 -43.72 88.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.687 -0.688 . . . . 64.310000000000002 110.131 175.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.0 -33.86 65.26 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.034 -0.53 . . . . 37.170000000000002 113.406 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.599 HE21 HG22 ' A' ' 136' ' ' THR . 79.5 mt-30 -57.8 -44.4 86.3 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.829 0.315 . . . . 74.040000000000006 111.552 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -55.82 -50.67 69.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.674 0.273 . . . . 73.209999999999994 110.797 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.62 -46.06 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.42 0.526 . . . . 73.150000000000006 112.42 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.424 ' O ' HD21 ' A' ' 147' ' ' LEU . 13.0 t -74.36 -42.59 59.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.77 -0.372 . . . . 71.040000000000006 111.829 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -64.02 -40.84 97.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.088 0.47 . . . . 74.150000000000006 110.567 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.07 -46.74 84.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.335 -0.848 . . . . 61.509999999999998 110.178 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -61.54 -47.39 85.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.363 -0.835 . . . . 72.109999999999999 112.266 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 143' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.795 0.665 . . . . 74.319999999999993 112.795 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.231 0.086 . . . . 65.409999999999997 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mm 64.0 96.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 121.326 0.584 . . . . 74.219999999999999 112.19 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 108.76 2.98 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.114 -0.494 . . . . 41.350000000000001 113.42 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.02 106.58 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.832 0.349 . . . . 51.43 110.683 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.697 ' HB3' HD22 ' A' ' 36' ' ' LEU . 23.9 m-85 -111.97 117.03 31.59 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.86 0.362 . . . . 72.420000000000002 111.579 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -147.02 173.16 12.7 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.877 0.37 . . . . 72.430000000000007 111.72 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG12 ' H ' ' A' ' 10' ' ' TYR . 19.2 t -99.59 86.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.098 0.475 . . . . 71.340000000000003 110.821 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -51.07 -19.81 1.22 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.627 0.973 . . . . 53.530000000000001 113.627 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -95.15 -50.95 4.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.515 0.561 . . . . 74.219999999999999 112.515 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.479 ' H ' HG12 ' A' ' 7' ' ' VAL . 60.9 t80 -72.33 114.05 10.03 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.002 0.741 . . . . 74.439999999999998 113.002 -174.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.66 -159.46 5.56 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 115.049 0.779 . . . . 51.530000000000001 115.049 171.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.444 ' HB3' ' HH ' ' A' ' 128' ' ' TYR . 83.5 m-85 -65.55 7.28 0.24 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.917 1.08 . . . . 75.510000000000005 113.917 -177.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.477 ' HB2' HG21 ' A' ' 90' ' ' THR . 34.9 t -49.87 -36.04 25.58 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.455 0.571 . . . . 63.539999999999999 112.337 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.89 -40.75 75.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.123 0.487 . . . . 55.009999999999998 110.689 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -62.18 -42.26 99.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 71.519999999999996 110.854 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.0 mt -59.42 -49.28 78.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.164 0.507 . . . . 71.349999999999994 110.614 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.89 79.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.965 -0.561 . . . . 73.120000000000005 111.548 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.15 -38.25 82.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.724 0.297 . . . . 75.299999999999997 111.352 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.72 88.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.879 0.371 . . . . 72.129999999999995 111.418 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.4 mt -70.17 -54.38 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.192 0.52 . . . . 63.210000000000001 111.157 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG23 HG11 ' A' ' 31' ' ' VAL . 72.1 mt -56.96 -35.25 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.117 -0.492 . . . . 61.25 111.609 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -47.24 -51.7 18.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.132 0.491 . . . . 63.219999999999999 111.272 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.98 -49.97 50.22 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.927 -0.654 . . . . 73.329999999999998 113.058 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.63 -42.9 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.818 0.673 . . . . 70.439999999999998 112.818 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 21' ' ' ILE . 12.7 t -67.76 -35.3 78.45 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.062 0.393 . . . . 75.209999999999994 112.062 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -84.67 -31.65 24.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 73.329999999999998 111.828 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.7 m -65.14 -30.25 71.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.052 0.453 . . . . 64.510000000000005 110.823 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 42.24 4.23 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.195 -0.526 . . . . 55.030000000000001 114.029 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.29 -76.35 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.258 -0.554 . . . . 63.32 111.463 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.34 157.23 8.28 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.481 -0.39 . . . . 72.430000000000007 112.255 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG11 HG23 ' A' ' 21' ' ' ILE . 18.2 m -140.66 122.99 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 117.483 0.641 . . . . 75.129999999999995 112.501 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -109.63 104.27 13.26 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.284 -0.416 . . . . 74.540000000000006 110.357 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.48 124.18 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.173 0.435 . . . . 61.240000000000002 112.173 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.92 123.65 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.146 0.498 . . . . 54.240000000000002 110.71 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.91 81.46 7.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.191 -0.459 . . . . 61.32 112.091 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 5' ' ' PHE . 4.3 pp -66.67 -19.67 65.81 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.853 -0.529 . . . . 74.209999999999994 111.526 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 17.88 51.64 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.403 -0.427 . . . . 75.329999999999998 112.924 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.5 -153.19 0.5 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.739 0.416 . . . . 54.520000000000003 110.503 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.18 99.75 10.49 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 122.074 -0.391 . . . . 70.400000000000006 111.89 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.15 165.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.911 0.386 . . . . 71.030000000000001 111.723 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.52 -171.33 3.2 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.924 0.392 . . . . 73.150000000000006 110.811 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 42' ' ' LEU . 3.1 tm? -58.9 -28.52 66.27 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.125 0.417 . . . . 74.230000000000004 112.125 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -54.2 -48.44 71.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.968 0.413 . . . . 72.129999999999995 111.752 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.49 -41.5 80.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.215 0.531 . . . . 75.049999999999997 110.917 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.9 -39.09 88.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.937 -0.574 . . . . 73.230000000000004 110.643 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -56.86 -48.14 78.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.808 -0.633 . . . . 74.420000000000002 111.709 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.15 -28.15 65.12 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.621 0.23 . . . . 75.430000000000007 111.621 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.51 -27.97 63.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.872 0.367 . . . . 74.319999999999993 111.589 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -61.17 -38.06 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.05 0.452 . . . . 62.240000000000002 111.389 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.79 -30.65 14.46 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.127 -0.558 . . . . 71.340000000000003 112.659 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -75.59 0.57 17.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.936 0.495 . . . . 74.349999999999994 112.029 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.27 6.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.272 0.842 . . . . 72.230000000000004 113.272 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -80.83 -28.94 36.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.264 0.468 . . . . 74.140000000000001 112.264 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.0 137.38 4.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.844 -0.693 . . . . 61.25 113.14 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.79 167.63 20.64 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.693 0.627 . . . . 71.209999999999994 112.693 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.62 121.26 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.104 -0.498 . . . . 52.409999999999997 111.026 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 57' ' ' ILE . 3.4 mp -108.45 143.75 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.009 0.433 . . . . 73.400000000000006 111.67 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -131.08 2.6 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.203 -0.523 . . . . 41.030000000000001 112.61 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.461 ' SD ' ' HA3' ' A' ' 93' ' ' GLY . 13.7 tmm? -110.08 127.27 54.77 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.148 -0.619 . . . . 62.240000000000002 110.901 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.2 p -97.32 105.48 25.46 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.629 -0.259 . . . . 43.329999999999998 111.545 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 155.39 67.98 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.313 2.009 . . . . 73.120000000000005 112.234 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.0 -35.07 23.22 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.573 0.582 . . . . 73.450000000000003 112.573 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.1 74.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 112.064 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -89.94 -40.17 12.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.716 0.294 . . . . 73.430000000000007 110.91 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -49.99 -39.46 41.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.483 0.313 . . . . 64.409999999999997 111.789 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.01 72.65 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.16 0.43 . . . . 71.409999999999997 112.16 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.8 p -76.63 -31.88 57.66 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.138 0.494 . . . . 64.319999999999993 110.695 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -63.04 -29.51 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 111.381 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 29.0 mm-40 -52.56 -26.73 14.14 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.864 0.364 . . . . 71.430000000000007 111.856 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.44 -54.64 2.63 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.136 -0.554 . . . . 50.039999999999999 112.916 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -63.72 -30.13 71.27 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.75 0.648 . . . . 44.310000000000002 112.75 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.0 -47.59 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.529 0.332 . . . . 71.400000000000006 111.288 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -57.88 -48.44 79.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.901 0.381 . . . . 63.109999999999999 111.4 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.2 m -57.86 -44.64 86.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.204 -0.453 . . . . 52.310000000000002 111.271 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.475 ' O ' HG12 ' A' ' 79' ' ' VAL . 69.5 mt -63.01 -55.08 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 74.219999999999999 111.248 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.0 tp -55.17 -34.99 64.31 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.71 -0.677 . . . . 44.119999999999997 112.256 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.01 -21.18 71.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.954 -0.641 . . . . 54.32 113.57 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.9 m -98.77 -21.2 16.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.004 0.742 . . . . 71.5 113.004 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -62.93 163.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.844 0.683 . . . . 73.340000000000003 112.844 -178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -79.53 161.82 25.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.868 -0.605 . . . . 64.299999999999997 111.217 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.39 -44.24 65.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.804 0.442 . . . . 74.340000000000003 112.122 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -143.1 143.74 31.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.768 0.318 . . . . 75.230000000000004 111.155 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.422 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -158.21 177.31 11.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.313 0.578 . . . . 71.340000000000003 112.112 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.638 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -93.58 112.14 23.96 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.811 -0.631 . . . . 74.140000000000001 110.937 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 m -114.33 128.74 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.359 0.6 . . . . 62.299999999999997 112.149 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.67 17.73 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.051 -0.522 . . . . 71.129999999999995 112.409 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 57' ' ' ILE . 6.7 tp -148.46 137.83 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.783 0.325 . . . . 74.439999999999998 111.275 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.83 114.55 7.67 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.241 0.543 . . . . 73.109999999999999 111.21 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.441 ' O ' HD11 ' A' ' 119' ' ' ILE . 44.7 mt-10 -60.02 93.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.21 0.529 . . . . 70.030000000000001 111.901 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.477 HG21 ' HB2' ' A' ' 13' ' ' SER . 24.9 m -74.73 77.41 2.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.119 0.485 . . . . 73.019999999999996 111.491 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.22 -169.15 47.5 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.073 -0.584 . . . . 74.319999999999993 113.53 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.07 77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.421 -0.419 . . . . 60.140000000000001 113.412 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . -89.12 -176.51 46.35 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.254 -0.498 . . . . 53.420000000000002 112.863 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -94.48 164.85 12.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.42 -0.459 . . . . 71.420000000000002 110.848 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.13 115.64 20.12 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.205 0.526 . . . . 72.430000000000007 112.368 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.651 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 63.7 mt-10 -103.39 -59.14 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 112.148 0.425 . . . . 72.140000000000001 112.148 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 39.0 Cg_endo -98.27 27.12 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.87 2.38 . . . . 73.140000000000001 113.715 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.54 -51.61 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.728 0.64 . . . . 73.109999999999999 112.728 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.402 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 6.1 m-20 -64.22 -56.58 22.72 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.611 0.597 . . . . 75.420000000000002 112.611 -176.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 25.6 Cg_endo -59.75 -41.63 53.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.064 1.842 . . . . 63.310000000000002 113.078 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.72 -59.58 3.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.883 0.373 . . . . 65.430000000000007 110.997 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.08 -34.54 78.27 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.058 0.392 . . . . 71.340000000000003 112.058 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -60.48 -50.05 75.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.04 0.448 . . . . 62.520000000000003 111.567 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -65.02 -43.33 92.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.548 -0.296 . . . . 73.239999999999995 111.259 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.28 -40.82 87.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.825 0.345 . . . . 75.010000000000005 111.419 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -55.24 -41.84 72.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.953 0.406 . . . . 74.329999999999998 110.919 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -70.14 -29.84 66.86 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.591 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.3 mt -81.47 -22.26 38.19 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.33 -73.5 2.35 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.238 -0.506 . . . . 71.219999999999999 112.66 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 83' ' ' GLN . 61.1 mt 60.36 -179.21 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.614 0.721 . . . . 74.010000000000005 112.732 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.638 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 73.5 m -97.16 103.98 15.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.852 -0.613 . . . . 62.039999999999999 110.167 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -114.01 102.73 10.46 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.183 0.438 . . . . 62.409999999999997 112.183 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.74 84.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.544 0.572 . . . . 70.230000000000004 112.544 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -152.46 132.44 7.24 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.413 -0.179 . . . . 75.230000000000004 110.787 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.62 -69.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.525 2.15 . . . . 53.439999999999998 114.543 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 161.2 38.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.578 0.584 . . . . 64.319999999999993 112.578 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.78 HG12 ' H ' ' A' ' 118' ' ' ARG . 11.1 tt -123.64 -150.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.156 0.582 . . . . 75.340000000000003 109.74 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.78 ' H ' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -147.08 114.02 6.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.141 -0.974 . . . . 74.049999999999997 111.634 175.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 123' ' ' PRO . 73.4 mt -139.06 139.2 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 115.948 -0.569 . . . . 71.510000000000005 110.597 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -81.52 -61.24 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.966 0.358 . . . . 74.299999999999997 111.966 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -141.64 -52.6 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.145 -0.347 . . . . 75.439999999999998 111.61 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.8 p -92.29 130.0 39.22 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 116.788 -0.187 . . . . 71.420000000000002 111.066 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HA ' HD13 ' A' ' 119' ' ' ILE . 12.3 Cg_endo -55.15 127.22 25.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.404 2.07 . . . . 72.209999999999994 112.691 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.8 p -74.48 154.48 38.68 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.22 -0.445 . . . . 55.229999999999997 111.906 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.45 -25.63 68.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.038 0.447 . . . . 74.219999999999999 111.385 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -38.18 75.13 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 109.998 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.422 ' OG1' HD12 ' A' ' 119' ' ' ILE . 33.6 m -55.19 -38.38 68.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.901 -0.591 . . . . 64.030000000000001 111.879 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.446 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 87.1 m-85 -58.36 -60.33 3.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.994 0.426 . . . . 75.209999999999994 111.265 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -58.33 -29.82 66.22 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.085 -0.507 . . . . 63.219999999999999 111.694 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.28 -50.11 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.273 -0.421 . . . . 71.219999999999999 110.368 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 30.5 p -69.24 -22.74 63.83 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.882 0.327 . . . . 53.530000000000001 111.882 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 53.0 mt-10 -60.11 -53.0 62.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.881 0.372 . . . . 64.239999999999995 111.057 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.13 -55.74 8.63 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.08 0.467 . . . . 64.450000000000003 111.022 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.24 -57.55 12.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.944 -0.571 . . . . 72.349999999999994 112.434 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -56.4 -47.27 84.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.461 -0.4 . . . . 51.439999999999998 113.75 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.4 m -64.87 -33.53 76.23 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.558 -0.378 . . . . 64.010000000000005 111.64 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -55.04 -36.5 65.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.197 0.443 . . . . 73.030000000000001 112.197 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.479 HD11 ' HB1' ' A' ' 84' ' ' ALA . 3.3 mm? -56.32 -45.66 80.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.18 0.514 . . . . 70.129999999999995 110.902 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.69 -38.86 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.079 -0.581 . . . . 64.25 112.796 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 136' ' ' THR . 17.5 mm-40 -57.61 -50.05 74.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.847 0.356 . . . . 72.5 111.642 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -54.48 -50.88 66.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 111.533 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.18 -51.92 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.16 -0.473 . . . . 74.209999999999994 112.234 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -69.46 -43.3 73.54 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.403 0.52 . . . . 72.129999999999995 112.403 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.34 -43.1 78.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.106 0.41 . . . . 70.400000000000006 112.106 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.77 -30.59 71.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 111.095 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -75.24 -21.56 58.51 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.988 -0.551 . . . . 75.430000000000007 111.801 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.256 0.465 . . . . 73.230000000000004 112.256 -177.167 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.1 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.421 0.153 . . . . 61.340000000000003 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.6 mm 59.46 102.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.195 0.521 . . . . 54.030000000000001 111.887 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.65 94.43 1.87 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.833 -0.698 . . . . 62.439999999999998 113.061 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HB ' HG13 ' A' ' 33' ' ' VAL . 47.9 t -88.0 104.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.056 0.428 . . . . 75.120000000000005 111.091 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.43 ' HB3' HD22 ' A' ' 36' ' ' LEU . 97.7 m-85 -103.86 119.03 38.08 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.204 0.526 . . . . 65.299999999999997 111.408 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 45.1 p90 -136.6 -178.08 5.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.155 -0.475 . . . . 74.25 111.678 -175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.9 100.93 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.813 0.339 . . . . 74.439999999999998 110.585 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.568 ' HB3' ' HE2' ' A' ' 6' ' ' TYR . 53.4 p -63.86 -18.49 64.21 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.281 0.845 . . . . 74.430000000000007 113.281 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -89.16 -10.94 45.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.067 0.461 . . . . 74.150000000000006 111.534 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.509 ' HH ' ' HA3' ' A' ' 91' ' ' GLY . 69.1 t80 -115.45 119.11 35.13 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.251 -0.281 . . . . 70.420000000000002 111.082 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA3' ' HG1' ' A' ' 90' ' ' THR . . . 56.61 -161.32 7.45 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.253 -0.498 . . . . 54.340000000000003 114.131 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -84.75 8.23 17.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.01 0.744 . . . . 74.450000000000003 113.01 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 42.8 m -32.19 -51.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.578 0.955 . . . . 60.450000000000003 113.578 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.5 -40.95 76.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.692 0.282 . . . . 74.040000000000006 111.724 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -60.3 -39.06 85.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.292 0.567 . . . . 74.120000000000005 110.544 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.59 -53.32 53.52 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.734 -0.666 . . . . 61.329999999999998 110.905 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -39.8 68.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.999 0.428 . . . . 50.420000000000002 111.379 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -55.71 -45.51 77.89 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.683 -0.689 . . . . 74.049999999999997 111.516 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.18 -43.84 69.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.094 -0.503 . . . . 71.510000000000005 111.424 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 24' ' ' ILE . 82.0 mt -57.0 -56.82 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.209 -0.451 . . . . 54.229999999999997 111.664 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -56.98 -35.92 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.806 0.336 . . . . 63.240000000000002 111.354 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.76 -37.4 86.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.015 0.436 . . . . 73.109999999999999 111.206 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.0 24.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.26 -0.495 . . . . 72.129999999999995 113.775 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.628 HG23 HG13 ' A' ' 31' ' ' VAL . 44.8 mm -75.98 -41.59 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 122.407 -0.466 . . . . 71.439999999999998 112.044 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.2 p -61.24 -30.17 70.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 74.329999999999998 111.344 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.41 -12.57 60.07 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 73.430000000000007 111.176 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -90.35 -36.75 14.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.129 -0.487 . . . . 54.219999999999999 111.016 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.64 22.82 2.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.304 -0.474 . . . . 61.009999999999998 113.748 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.406 ' O ' HG22 ' A' ' 24' ' ' ILE . 67.7 t -130.16 140.39 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 117.148 0.474 . . . . 53.229999999999997 111.069 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.44 113.34 4.65 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.089 -0.577 . . . . 52.219999999999999 112.846 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 24' ' ' ILE . 20.5 m -94.15 140.33 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.129 0.49 . . . . 63.340000000000003 112.139 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.451 ' OD2' ' HD3' ' A' ' 51' ' ' ARG . 23.4 m-20 -101.38 113.26 26.19 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.095 -0.502 . . . . 71.519999999999996 111.079 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.562 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 36.0 m -106.11 125.95 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 120.969 0.414 . . . . 71.420000000000002 111.418 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.81 150.69 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.458 0.303 . . . . 73.120000000000005 111.523 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 15.7 m-20 -84.54 120.52 26.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.796 0.295 . . . . 72.049999999999997 111.796 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.439 HD13 ' HE1' ' A' ' 59' ' ' MET . 4.2 pp -86.12 -16.21 38.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.155 0.503 . . . . 73.140000000000001 111.38 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.73 -10.77 78.55 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.208 -0.52 . . . . 65.040000000000006 112.489 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.44 -178.32 5.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.836 0.35 . . . . 75.420000000000002 111.275 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 96.02 3.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.998 0.428 . . . . 72.200000000000003 111.236 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -85.5 132.58 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.259 0.552 . . . . 71.219999999999999 111.56 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -108.64 170.42 8.04 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.375 -0.375 . . . . 74.439999999999998 110.94 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 45' ' ' LEU . 3.3 mm? -55.9 -24.55 38.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.073 0.463 . . . . 63.140000000000001 111.084 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -57.56 -60.26 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.877 -0.601 . . . . 73.0 110.983 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -65.58 -38.08 88.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.08 -0.509 . . . . 73.310000000000002 110.973 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 42' ' ' LEU . 92.9 mt -59.3 -34.79 72.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.451 -0.34 . . . . 74.329999999999998 111.448 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.84 -33.84 60.07 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.224 -0.297 . . . . 75.120000000000005 111.017 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.14 -39.13 77.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.992 0.425 . . . . 73.400000000000006 110.281 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.621 HD21 HG23 ' A' ' 75' ' ' ILE . 67.7 tp -52.61 -46.5 67.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.98 -0.554 . . . . 73.540000000000006 110.852 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.86 -44.23 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.046 0.45 . . . . 73.340000000000003 111.009 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.43 -29.88 72.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.144 -0.551 . . . . 42.240000000000002 113.025 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.451 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -99.61 8.69 44.2 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.069 0.396 . . . . 73.030000000000001 112.069 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.05 -3.41 0.13 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.502 0.927 . . . . 73.510000000000005 113.502 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -84.58 -27.63 27.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.793 0.33 . . . . 71.409999999999997 111.793 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.55 138.32 5.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.469 -0.396 . . . . 44.329999999999998 112.843 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 pp -159.12 162.99 36.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.319 0.488 . . . . 75.439999999999998 112.319 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -131.05 128.76 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.422 -0.353 . . . . 73.420000000000002 111.387 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.5 mp -95.59 139.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.758 0.313 . . . . 74.430000000000007 110.909 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -116.13 0.46 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.211 -0.519 . . . . 55.030000000000001 113.79 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.645 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -82.68 175.9 9.77 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 112.842 0.682 . . . . 72.299999999999997 112.842 -177.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.447 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 87.7 p -144.52 34.51 0.16 Allowed Pre-proline 0 CA--C 1.555 1.165 0 N-CA-C 114.07 1.137 . . . . 73.329999999999998 114.07 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 87.7 Cg_endo -77.53 149.13 26.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.651 1.568 . . . . 73.530000000000001 112.434 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.41 61.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.439 0.533 . . . . 71.310000000000002 112.439 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.4 66.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.105 0.479 . . . . 51.119999999999997 112.102 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -78.36 -29.95 47.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.987 0.422 . . . . 75.230000000000004 111.215 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.61 -29.37 62.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.139 -0.482 . . . . 63.130000000000003 111.904 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.86 80.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.063 0.459 . . . . 74.549999999999997 111.246 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.8 t -73.73 -43.83 58.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.991 0.424 . . . . 61.32 110.958 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.3 -50.37 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.077 -0.51 . . . . 63.420000000000002 111.846 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.64 -43.57 98.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.034 0.383 . . . . 74.040000000000006 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.44 -41.36 72.11 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.037 -0.601 . . . . 70.340000000000003 112.765 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.455 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -81.45 -32.68 32.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.74 0.305 . . . . 54.340000000000003 111.382 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.15 -43.91 74.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.973 0.509 . . . . 72.519999999999996 111.33 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.6 m -55.86 -21.96 22.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.776 0.322 . . . . 71.219999999999999 111.849 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 m -97.61 -29.89 13.17 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.101 0.476 . . . . 73.310000000000002 110.863 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.621 HG23 HD21 ' A' ' 48' ' ' LEU . 69.4 mt -64.07 -39.17 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.033 0.383 . . . . 71.230000000000004 112.033 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -51.1 -49.2 61.18 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.438 0.533 . . . . 73.25 112.438 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.79 -8.01 87.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.044 -0.598 . . . . 52.329999999999998 113.234 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.2 m -94.04 -24.68 17.52 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.929 0.344 . . . . 73.239999999999995 111.929 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 m -87.01 164.18 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.178 0.513 . . . . 64.010000000000005 111.905 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.93 -156.2 0.52 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.159 -0.473 . . . . 52.509999999999998 111.444 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.11 -80.57 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.951 0.723 . . . . 52.229999999999997 112.951 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -117.57 98.6 6.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.594 0.712 . . . . 64.319999999999993 111.874 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.11 166.48 11.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.459 0.647 . . . . 74.109999999999999 112.564 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.428 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -102.77 110.81 22.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.531 -0.759 . . . . 73.510000000000005 109.298 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -121.03 154.03 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.814 0.816 . . . . 72.409999999999997 113.033 -168.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.72 169.97 14.32 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.249 -0.887 . . . . 42.0 112.684 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -153.76 126.63 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.383 0.273 . . . . 72.340000000000003 110.848 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -137.28 92.48 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.717 0.77 . . . . 72.310000000000002 111.99 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.565 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.5 tp10 -66.63 121.31 15.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.653 -0.703 . . . . 70.299999999999997 110.473 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.476 HG21 ' OG ' ' A' ' 13' ' ' SER . 8.0 t -101.53 15.78 27.79 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 64.109999999999999 111.843 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . -158.24 -64.54 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.811 -0.709 . . . . 72.030000000000001 113.631 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.06 47.66 2.02 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.304 -0.474 . . . . 70.329999999999998 111.967 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 61' ' ' PRO . . . -66.49 -63.81 3.7 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.171 0.428 . . . . 51.240000000000002 114.171 -174.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -152.66 -178.56 6.95 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.182 0.491 . . . . 73.239999999999995 111.244 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.3 23.82 1.81 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.675 0.39 . . . . 71.340000000000003 111.49 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 34.0 tt0 -50.81 -47.85 84.94 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.361 0.874 . . . . 63.119999999999997 113.361 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.47 ' O ' HD22 ' A' ' 101' ' ' LEU . 51.7 Cg_endo -87.98 38.5 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.313 2.009 . . . . 74.0 113.701 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.7 tt -66.59 -58.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 113.635 0.976 . . . . 71.129999999999995 113.635 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 98' ' ' ILE . 9.9 m-20 -57.9 -55.73 42.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.935 1.087 . . . . 73.150000000000006 113.935 -172.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 32.4 Cg_endo -61.65 -14.64 37.0 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.315 2.01 . . . . 74.040000000000006 114.742 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 97' ' ' PRO . 4.0 mm? -100.89 -62.03 1.29 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -50.62 -45.15 57.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.508 0.929 . . . . 72.349999999999994 113.508 -170.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.7 t -52.81 -37.68 60.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.488 0.551 . . . . 71.310000000000002 112.488 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 0.5 OUTLIER -66.61 -44.0 83.25 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.831 0.348 . . . . 71.5 111.449 -177.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -63.16 -35.97 82.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.924 0.393 . . . . 64.140000000000001 111.154 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -69.4 -43.79 72.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.144 -0.48 . . . . 74.319999999999993 110.999 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.32 -55.14 38.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.622 . . . . 73.340000000000003 111.792 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 mp -71.69 -26.19 62.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.758 0.313 . . . . 74.030000000000001 111.312 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.68 62.14 3.32 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.172 -0.537 . . . . 55.219999999999999 113.579 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 110' ' ' LEU . 6.9 mp -79.39 142.66 35.78 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.069 0.461 . . . . 64.540000000000006 111.313 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 35.3 m -70.91 97.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.261 -0.427 . . . . 72.5 110.941 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.3 p -86.73 121.66 29.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 112.152 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.31 -58.8 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.435 0.531 . . . . 73.430000000000007 112.435 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -140.92 84.89 12.81 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 120.996 0.427 . . . . 74.140000000000001 111.667 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.39 64.53 4.96 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.824 2.349 . . . . 63.310000000000002 112.989 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.91 42.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.143 0.423 . . . . 71.349999999999994 112.143 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.493 HG23 ' H ' ' A' ' 89' ' ' GLU . 1.7 pp -71.2 73.23 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.847 0.832 . . . . 74.400000000000006 112.892 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -79.46 50.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.929 -0.578 . . . . 73.439999999999998 112.415 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 89' ' ' GLU . 49.0 mm -76.35 147.82 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 120.932 0.396 . . . . 73.209999999999994 111.721 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.96 -61.86 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.113 0.412 . . . . 74.25 112.113 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.514 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 35.2 tt0 -151.28 -48.94 0.12 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.098 0.475 . . . . 41.020000000000003 111.604 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.0 p -129.35 131.75 23.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.412 -0.358 . . . . 53.240000000000002 111.289 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.96 143.76 73.85 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.475 2.117 . . . . 73.519999999999996 112.226 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.8 p -100.73 -177.72 3.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.991 0.424 . . . . 70.209999999999994 111.592 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -59.89 -26.76 66.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.076 0.465 . . . . 61.439999999999998 111.258 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -76.38 -24.38 54.11 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.38 -0.373 . . . . 74.340000000000003 111.902 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.0 m -59.07 -35.26 73.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.936 0.398 . . . . 75.140000000000001 111.466 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.43 -48.43 80.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.024 0.44 . . . . 63.520000000000003 111.346 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -50.13 -50.11 49.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.653 -0.703 . . . . 75.25 112.54 -174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 mp -63.05 -46.39 87.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 72.519999999999996 111.232 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 82.2 m -61.05 -40.05 92.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 111.773 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.18 -52.56 12.1 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.865 0.364 . . . . 71.340000000000003 111.614 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.61 -63.49 1.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.422 -0.354 . . . . 70.409999999999997 110.941 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.21 79.55 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.481 -0.327 . . . . 72.019999999999996 111.405 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.04 94.67 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.282 -0.485 . . . . 38.490000000000002 113.083 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 54.8 m -60.67 -48.61 81.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.827 0.346 . . . . 75.319999999999993 111.151 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.09 -39.64 86.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.904 0.383 . . . . 62.210000000000001 111.304 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.44 -44.5 97.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.023 0.439 . . . . 65.230000000000004 110.662 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.3 -38.72 96.25 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.265 -0.493 . . . . 64.439999999999998 112.75 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.495 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 86.3 mt-30 -61.89 -28.83 69.79 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.998 0.37 . . . . 74.25 111.998 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -50.63 -40.33 52.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.129 0.49 . . . . 70.010000000000005 110.717 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.97 -51.95 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.025 -0.534 . . . . 74.319999999999993 111.755 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 146' ' ' ARG . 10.0 t -69.1 -25.2 64.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.901 0.334 . . . . 74.310000000000002 111.901 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 94.7 mtt180 -65.73 -41.11 92.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.742 0.306 . . . . 75.239999999999995 111.093 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.65 -27.94 31.01 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.432 . . . . 75.540000000000006 110.936 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.657 ' HE ' ' HA ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -59.83 -59.23 5.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.357 -0.383 . . . . 72.219999999999999 111.132 175.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.662 -0.244 . . . . 72.230000000000004 111.514 174.612 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 53.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.009 -0.043 . . . . 72.219999999999999 110.933 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 63.33 122.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 112.726 0.639 . . . . 74.430000000000007 112.726 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.48 105.11 3.24 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.473 -0.394 . . . . 73.299999999999997 112.663 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.2 t -88.39 107.92 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 122.55 -0.383 . . . . 73.540000000000006 110.982 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.62 ' HE2' ' HB2' ' A' ' 55' ' ' LEU . 83.3 m-85 -88.71 142.0 28.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.938 0.718 . . . . 72.109999999999999 112.938 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -146.58 179.74 7.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.775 -0.648 . . . . 74.030000000000001 110.844 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.578 HG11 ' HA3' ' A' ' 37' ' ' GLY . 86.0 t -130.64 103.7 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.748 0.309 . . . . 44.420000000000002 111.721 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.7 m -54.95 -36.41 65.29 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.087 0.403 . . . . 74.049999999999997 112.087 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.7 -54.81 36.95 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.385 0.513 . . . . 74.200000000000003 112.385 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -138.94 -55.29 0.6 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.092 -0.503 . . . . 64.530000000000001 110.898 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.576 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -30.04 97.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.365 0.906 . . . . 71.420000000000002 115.365 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -70.82 5.76 1.81 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.073 0.464 . . . . 75.409999999999997 111.488 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.596 ' HG ' ' HE2' ' A' ' 88' ' ' PHE . 14.9 m -52.89 -14.17 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.029 0.751 . . . . 73.420000000000002 113.029 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.33 -37.01 74.26 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.093 0.473 . . . . 63.439999999999998 110.916 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.542 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 1.5 mtm180 -65.15 -34.41 78.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.056 -0.52 . . . . 55.0 111.127 175.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 20' ' ' ILE . 75.6 mt -66.79 -48.18 69.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.202 -0.454 . . . . 73.519999999999996 110.406 172.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.85 -41.73 71.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.126 -0.488 . . . . 70.129999999999995 112.116 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -63.0 -46.02 89.64 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.906 0.384 . . . . 62.130000000000003 111.321 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.08 93.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.064 0.459 . . . . 63.149999999999999 111.217 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 16' ' ' LEU . 79.1 mt -63.71 -55.19 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.681 . . . . 73.540000000000006 111.814 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.79 -39.69 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 122.312 -0.243 . . . . 74.349999999999994 111.61 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 25' ' ' THR . 46.1 t-20 -55.77 -59.82 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.842 0.354 . . . . 53.32 111.025 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -45.07 96.67 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 120.952 -0.642 . . . . 73.319999999999993 113.42 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.504 HG21 HG11 ' A' ' 31' ' ' VAL . 33.6 mt -72.92 -30.22 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.115 0.783 . . . . 75.150000000000006 113.115 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 22' ' ' ASN . 14.5 t -69.66 -35.18 74.94 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.571 -0.705 . . . . 54.299999999999997 110.743 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -74.62 -43.01 57.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.933 0.397 . . . . 71.5 110.807 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -59.34 -34.09 71.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.128 -0.487 . . . . 71.349999999999994 111.377 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.48 59.13 0.68 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.036 -0.602 . . . . 61.119999999999997 114.101 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' A' ' 24' ' ' ILE . 61.1 t -140.07 -53.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.844 0.354 . . . . 73.329999999999998 111.24 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 24' ' ' ILE . . . 84.65 119.06 0.83 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.326 -0.464 . . . . 75.519999999999996 113.564 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 1' ' ' SER . 30.9 m -116.6 146.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.324 0.49 . . . . 74.349999999999994 112.324 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.28 129.97 55.5 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.289 -0.414 . . . . 75.430000000000007 111.169 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.16 137.15 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.182 0.515 . . . . 60.450000000000003 112.205 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 59.7 t -132.64 140.33 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.507 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 17.4 t70 -107.88 130.34 55.01 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.176 0.512 . . . . 61.020000000000003 111.711 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 11.32 14.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.288 -0.415 . . . . 71.329999999999998 112.078 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' HG11 ' A' ' 7' ' ' VAL . . . -96.17 -35.12 5.63 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.007 -0.616 . . . . 72.310000000000002 113.353 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.0 -38.22 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.984 0.421 . . . . 72.340000000000003 111.816 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . . . -75.54 12.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.499 0.555 . . . . 71.409999999999997 112.499 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.24 114.05 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.227 0.537 . . . . 71.319999999999993 111.969 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.12 170.43 21.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.886 -0.597 . . . . 71.299999999999997 110.628 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.17 -34.8 70.7 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.618 -0.264 . . . . 64.120000000000005 111.447 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.44 -63.11 1.39 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.643 0.258 . . . . 63.43 111.624 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.47 -48.97 65.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.196 0.522 . . . . 65.5 111.637 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.09 -43.67 98.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.154 -0.475 . . . . 75.120000000000005 111.975 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -71.65 -34.73 70.0 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.309 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 34.5 mt-10 -71.99 -28.75 63.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.659 0.266 . . . . 63.340000000000003 111.141 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.56 -40.0 77.96 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.935 0.398 . . . . 73.099999999999994 110.615 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -36.03 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.22 -0.445 . . . . 64.400000000000006 111.014 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.33 -40.29 41.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.169 -0.539 . . . . 72.209999999999994 112.647 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' NH1' ' HB3' ' A' ' 47' ' ' GLU . 7.2 mpt_? -81.61 6.23 15.71 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.102 0.408 . . . . 73.140000000000001 112.102 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.9 p -49.84 -15.54 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.633 0.975 . . . . 74.439999999999998 113.633 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -47.59 -31.63 4.66 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.338 0.496 . . . . 73.420000000000002 112.338 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -179.82 141.56 4.75 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.076 -0.511 . . . . 37.450000000000003 112.095 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.62 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . 1.4 pt? -144.72 134.48 23.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.369 0.584 . . . . 65.150000000000006 112.136 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.459 HG23 ' HE1' ' A' ' 88' ' ' PHE . 11.4 p -118.11 124.99 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 111.077 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.5 mp -113.2 139.64 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.287 0.477 . . . . 72.540000000000006 112.287 -172.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.1 131.23 10.54 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.3 -0.409 . . . . 74.209999999999994 112.579 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.07 120.26 22.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.551 0.575 . . . . 71.319999999999993 112.551 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.661 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 88.4 p -111.75 171.14 4.57 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.153 0.581 . . . . 61.350000000000001 111.051 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 30.9 Cg_endo -63.18 168.08 11.51 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.289 1.992 . . . . 65.420000000000002 113.526 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.746 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . . . -58.22 -21.62 48.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.076 0.769 . . . . 72.030000000000001 113.076 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.19 -61.0 2.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.785 0.326 . . . . 52.350000000000001 111.305 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 -33.01 36.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.625 -0.261 . . . . 71.25 111.701 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.746 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -54.81 -37.59 66.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.179 0.437 . . . . 72.340000000000003 112.179 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.51 75.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.315 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -68.86 -40.85 79.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.28 0.562 . . . . 72.420000000000002 110.691 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.39 -44.5 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.914 -0.585 . . . . 74.329999999999998 111.081 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -57.44 -40.17 77.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.507 -0.315 . . . . 74.109999999999999 111.357 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.11 -49.16 73.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.153 -0.546 . . . . 37.450000000000003 112.887 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.39 67.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.918 0.39 . . . . 75.329999999999998 111.92 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 tm? -52.8 -32.12 42.29 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.228 -0.442 . . . . 70.120000000000005 111.175 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.4 m -46.8 -41.03 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.729 0.412 . . . . 64.439999999999998 111.752 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.1 m -87.68 -45.32 10.49 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.892 0.377 . . . . 74.510000000000005 111.157 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.39 -51.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 112.418 0.525 . . . . 75.040000000000006 112.418 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.4 tp -55.91 -33.95 65.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.823 0.344 . . . . 72.430000000000007 111.889 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.37 -17.44 55.28 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.944 -0.646 . . . . 70.140000000000001 113.244 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.0 p -87.75 -16.35 34.48 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.336 0.495 . . . . 72.439999999999998 112.336 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.57 153.94 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.22 0.533 . . . . 74.109999999999999 112.084 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -87.14 148.64 25.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.082 -0.508 . . . . 75.109999999999999 111.158 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.76 -36.31 64.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.939 0.4 . . . . 71.019999999999996 111.997 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -118.19 87.15 2.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.489 0.661 . . . . 75.439999999999998 110.837 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.511 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 18.2 tp60 -131.38 172.83 11.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.993 -0.549 . . . . 74.5 110.867 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.511 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -107.98 123.72 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 65.530000000000001 111.836 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 112' ' ' THR . 35.3 m -130.03 171.8 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.842 0.353 . . . . 62.109999999999999 111.12 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.457 ' HA3' HG22 ' A' ' 56' ' ' VAL . . . -142.4 144.4 14.03 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.097 -0.573 . . . . 64.439999999999998 112.826 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -125.06 126.66 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.588 -0.36 . . . . 74.230000000000004 111.829 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.674 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 54.6 p90 -148.94 168.14 23.88 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.101 0.477 . . . . 75.209999999999994 111.725 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.58 155.38 21.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.377 0.608 . . . . 73.340000000000003 111.984 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -134.5 2.26 3.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.999 0.428 . . . . 54.229999999999997 111.765 176.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.62 -164.96 29.66 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.242 -0.504 . . . . 74.120000000000005 112.778 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.09 -29.66 62.79 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.039 0.376 . . . . 60.43 114.039 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.33 126.15 1.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.341 -0.457 . . . . 64.439999999999998 112.98 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 27.2 t70 -160.2 109.37 1.74 Allowed 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.444 -0.445 . . . . 75.099999999999994 111.41 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -168.32 156.77 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.569 0.348 . . . . 60.43 110.846 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.729 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 4.6 mp0 -94.15 -61.12 0.18 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 112.19 0.441 . . . . 73.540000000000006 112.19 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 6.1 Cg_exo -80.03 16.29 1.52 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.567 2.178 . . . . 74.209999999999994 113.749 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.533 HG23 ' H ' ' A' ' 99' ' ' ASP . 5.6 tt -47.9 -59.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.86 0.689 . . . . 72.129999999999995 112.86 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.533 ' H ' HG23 ' A' ' 98' ' ' ILE . 6.8 m-20 -63.83 -50.98 68.02 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 111.983 0.364 . . . . 74.230000000000004 111.983 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 94.3 Cg_exo -47.24 -40.8 27.9 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.437 2.091 . . . . 74.340000000000003 113.704 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 97' ' ' PRO . 7.4 mp -63.8 -59.82 4.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.838 0.351 . . . . 74.129999999999995 111.266 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.7 mt -53.93 -35.82 62.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.081 0.467 . . . . 71.439999999999998 111.334 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.3 t -57.78 -46.04 85.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.826 -0.624 . . . . 74.510000000000005 111.432 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -71.07 -41.07 71.19 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.673 0.249 . . . . 72.349999999999994 111.673 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.32 -35.68 76.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.184 0.516 . . . . 75.430000000000007 111.113 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -79.53 -31.37 42.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.008 0.432 . . . . 74.400000000000006 110.591 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -59.67 -38.32 81.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.033 -0.53 . . . . 72.319999999999993 110.534 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.72 -52.82 26.57 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.103 -0.499 . . . . 72.530000000000001 110.789 173.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.39 34.34 0.82 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.123 -0.561 . . . . 64.120000000000005 113.797 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.56 136.12 34.37 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.458 -0.436 . . . . 73.519999999999996 111.111 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.4 t -77.78 125.74 29.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.096 -0.335 . . . . 74.200000000000003 110.096 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.642 ' HA ' HG23 ' A' ' 85' ' ' VAL . 59.3 p -97.38 -8.48 29.43 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.679 0.992 . . . . 60.420000000000002 113.679 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 50.24 78.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.538 0.569 . . . . 73.319999999999993 112.538 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 64.82 106.9 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 112.388 0.514 . . . . 75.400000000000006 112.388 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.63 74.14 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.08 1.853 . . . . 73.409999999999997 111.906 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 88' ' ' PHE . . . -73.76 114.45 12.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.79 0.663 . . . . 60.149999999999999 112.79 -173.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.2 tt -159.04 80.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.949 0.88 . . . . 64.140000000000001 110.6 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -146.81 90.58 1.93 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.772 -0.649 . . . . 73.340000000000003 111.773 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.45 149.34 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.397 0.618 . . . . 71.109999999999999 112.232 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -91.23 -25.2 19.62 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.715 -0.675 . . . . 61.240000000000002 110.886 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 178.71 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.439 -0.8 . . . . 73.340000000000003 109.962 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p -128.62 140.06 37.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.794 -0.639 . . . . 75.299999999999997 110.795 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.21 169.15 14.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.621 2.214 . . . . 55.409999999999997 114.012 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.412 HG21 ' N ' ' A' ' 125' ' ' GLU . 91.1 m -107.43 160.06 15.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.866 -0.606 . . . . 65.349999999999994 110.526 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.412 ' N ' HG21 ' A' ' 124' ' ' THR . 9.4 pt-20 -43.47 -35.53 1.67 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.634 0.975 . . . . 62.420000000000002 113.634 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -62.36 -23.25 66.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.327 0.492 . . . . 73.310000000000002 112.327 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.0 m -57.98 -39.74 78.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.231 0.538 . . . . 71.349999999999994 110.556 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.542 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 11.3 m-85 -60.44 -32.03 70.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.906 -0.588 . . . . 73.040000000000006 111.278 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.7 -36.52 76.03 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.44 -0.345 . . . . 72.5 111.136 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.28 -53.66 34.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 64.340000000000003 110.256 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.7 m -58.79 -32.7 69.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.006 0.431 . . . . 53.43 111.083 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.04 -56.03 26.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.783 -0.644 . . . . 71.439999999999998 112.019 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.43 -34.76 76.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.802 0.334 . . . . 74.200000000000003 111.74 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.56 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.592 -0.276 . . . . 62.310000000000002 111.718 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -54.19 -49.36 60.0 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.546 -0.359 . . . . 72.209999999999994 113.558 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 55.4 m -59.79 -40.93 89.97 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.849 0.357 . . . . 72.0 111.431 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.47 -42.95 99.57 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.923 0.392 . . . . 74.120000000000005 111.365 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.77 0.319 . . . . 75.120000000000005 110.979 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.28 93.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.832 -0.699 . . . . 63.329999999999998 112.509 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 136' ' ' THR . 83.8 mt-30 -67.93 -23.82 65.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.039 0.447 . . . . 74.340000000000003 111.398 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.56 -44.81 77.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.216 0.531 . . . . 74.129999999999995 110.755 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.6 -50.24 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.97 -0.559 . . . . 73.010000000000005 111.857 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 140' ' ' GLN . 8.9 t -61.36 -33.52 73.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.669 0.271 . . . . 75.019999999999996 111.728 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -56.88 -46.75 81.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.078 0.466 . . . . 63.329999999999998 110.972 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.61 -29.83 62.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.125 -0.488 . . . . 72.439999999999998 111.351 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -86.84 -34.22 19.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.237 -0.438 . . . . 63.409999999999997 112.172 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.4 tp . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 112.544 0.572 . . . . 72.329999999999998 112.544 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 65.6 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.497 0.189 . . . . 72.430000000000007 111.288 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 142' ' ' VAL . 48.9 mm 60.26 89.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.113 0.482 . . . . 74.349999999999994 111.862 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.63 90.11 1.61 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.963 -0.637 . . . . 72.329999999999998 112.278 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.0 p -82.06 120.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.481 0.658 . . . . 65.319999999999993 112.154 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -95.13 126.99 40.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.625 -0.716 . . . . 74.109999999999999 111.197 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 5.3 p90 -159.37 -178.91 7.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.831 0.348 . . . . 73.530000000000001 110.968 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.48 106.18 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.266 0.555 . . . . 74.409999999999997 111.761 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.9 m -70.34 -24.27 62.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.052 0.389 . . . . 71.109999999999999 112.052 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.99 -47.38 77.81 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.145 0.498 . . . . 73.129999999999995 111.43 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -102.71 22.3 13.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.586 0.708 . . . . 72.310000000000002 109.274 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -30.33 91.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 117.392 1.717 . . . . 62.310000000000002 117.392 -170.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -104.69 -34.13 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.79 . . . . 65.129999999999995 109.675 156.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.3 m -79.75 -12.98 59.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.033 -0.985 . . . . 75.430000000000007 112.901 -174.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.36 -39.09 92.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.038 0.447 . . . . 53.509999999999998 111.069 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -70.85 -38.34 73.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.215 0.531 . . . . 74.140000000000001 110.806 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -61.63 -44.53 96.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.961 -0.563 . . . . 75.239999999999995 110.959 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.46 87.42 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.054 -0.521 . . . . 71.310000000000002 111.346 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.07 -42.78 86.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.376 -0.374 . . . . 53.009999999999998 111.232 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.42 89.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.459 . . . . 73.299999999999997 111.115 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.96 -51.24 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.073 -0.512 . . . . 73.040000000000006 110.989 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HA ' HG23 ' A' ' 31' ' ' VAL . 76.3 mt -55.21 -43.06 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.264 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.41 -33.1 73.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.104 0.478 . . . . 73.540000000000006 111.603 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.02 23.4 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.34 -0.457 . . . . 75.519999999999996 113.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.33 -50.54 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.42 0.526 . . . . 61.25 112.42 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.5 p -63.5 -37.39 87.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.319 0.488 . . . . 75.230000000000004 112.319 -175.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 6.9 ttpm? -65.05 -24.0 67.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.048 0.452 . . . . 74.140000000000001 111.213 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 m -81.31 -7.69 59.61 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.169 0.509 . . . . 64.329999999999998 111.185 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.93 13.79 35.97 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.124 -0.56 . . . . 63.049999999999997 113.846 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -116.95 128.36 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.449 -0.442 . . . . 64.319999999999993 111.175 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.41 30.48 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.039 -0.601 . . . . 72.030000000000001 113.225 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 1' ' ' SER . 49.0 t -109.56 141.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.794 -0.239 . . . . 54.539999999999999 111.516 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.52 117.98 34.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.087 0.47 . . . . 64.120000000000005 111.305 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 34.3 m -95.18 135.24 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.95 0.405 . . . . 65.549999999999997 111.724 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.38 104.84 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.012 0.434 . . . . 72.049999999999997 111.592 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 2.7 m-20 -78.8 92.53 4.85 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.954 0.407 . . . . 51.210000000000001 111.392 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -68.21 -13.02 61.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.892 0.377 . . . . 73.109999999999999 111.862 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.405 ' N ' HD11 ' A' ' 36' ' ' LEU . . . -84.51 -8.09 83.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.132 -0.556 . . . . 73.129999999999995 113.016 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.42 172.69 6.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.091 0.472 . . . . 50.229999999999997 111.8 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.32 82.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.076 0.465 . . . . 70.299999999999997 111.399 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.26 162.7 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 72.25 112.145 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.69 167.12 22.03 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.317 -0.401 . . . . 71.299999999999997 110.779 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 HD12 HD11 ' A' ' 45' ' ' LEU . 3.9 mm? -59.55 -25.54 64.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.321 -0.237 . . . . 72.209999999999994 111.441 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -55.96 -34.37 65.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.02 0.438 . . . . 71.439999999999998 110.98 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -84.38 -50.08 8.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.389 0.614 . . . . 42.25 110.63 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.508 HD11 HD12 ' A' ' 42' ' ' LEU . 89.8 mt -56.62 -31.6 64.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.835 -0.62 . . . . 74.120000000000005 112.391 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -63.32 -46.41 86.79 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.961 0.41 . . . . 75.209999999999994 110.866 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 60.3 tt0 -63.11 -34.79 78.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.002 0.429 . . . . 74.239999999999995 110.497 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 54.4 tp -52.19 -45.34 65.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.08 -0.509 . . . . 63.539999999999999 111.177 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.29 -38.3 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.108 0.48 . . . . 75.5 111.077 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.84 -29.97 66.54 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.126 -0.559 . . . . 36.149999999999999 112.961 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 3.5 mpt_? -89.13 5.25 45.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.981 0.363 . . . . 62.409999999999997 111.981 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -51.36 -27.85 10.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.888 0.699 . . . . 74.310000000000002 112.888 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.3 p -53.77 -38.6 64.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.122 0.415 . . . . 70.129999999999995 112.122 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.24 134.84 4.71 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.895 -0.669 . . . . 54.43 113.039 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.46 ' HB2' HG13 ' A' ' 85' ' ' VAL . 80.7 mt -137.93 174.75 10.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.878 0.471 . . . . 74.140000000000001 110.712 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 48.5 t -139.76 111.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 110.325 -0.25 . . . . 74.109999999999999 110.325 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.625 HD11 ' HB ' ' A' ' 85' ' ' VAL . 1.7 mp -91.93 128.41 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.643 0.609 . . . . 72.329999999999998 112.643 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.35 139.86 11.3 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 115.636 -0.711 . . . . 63.509999999999998 112.142 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 98' ' ' ILE . 72.7 mtm -82.8 161.5 21.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.037 0.446 . . . . 72.109999999999999 111.777 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -143.6 164.27 31.53 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.1 0.407 . . . . 61.530000000000001 112.1 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 53.0 Cg_exo -55.51 168.23 1.64 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.063 2.509 . . . . 61.32 113.804 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -50.76 47.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.24 0.83 . . . . 72.049999999999997 113.24 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.18 66.51 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.942 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.4 m -58.39 -49.35 77.55 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.058 0.456 . . . . 74.430000000000007 111.236 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HA ' HD13 ' A' ' 68' ' ' ILE . . . -57.97 -35.39 71.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.245 -0.434 . . . . 71.439999999999998 112.0 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.16 96.54 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.019 0.437 . . . . 63.340000000000003 111.14 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -66.08 -42.15 89.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.384 -0.371 . . . . 74.040000000000006 111.096 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 36' ' ' LEU . 67.3 mt -54.8 -54.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.073 0.463 . . . . 71.409999999999997 111.113 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.9 -30.9 69.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.013 -0.539 . . . . 74.010000000000005 111.53 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.12 -41.59 98.38 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.239 -0.505 . . . . 62.32 113.379 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.53 43.37 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.238 0.458 . . . . 52.039999999999999 112.238 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.25 -35.89 65.46 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.597 0.591 . . . . 74.109999999999999 112.597 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -56.97 -20.07 21.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.713 0.634 . . . . 71.340000000000003 112.713 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -100.42 -10.83 20.75 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.102 0.477 . . . . 70.219999999999999 111.714 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.3 mt -92.58 -46.82 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.198 0.444 . . . . 55.5 112.198 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -50.85 -54.99 19.2 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.969 0.729 . . . . 75.239999999999995 112.969 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.06 5.49 1.95 Allowed Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.033 0.773 . . . . 60.219999999999999 115.033 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.9 m -92.47 -12.65 31.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.87 0.835 . . . . 63.240000000000002 112.247 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.444 HG22 HD23 ' A' ' 110' ' ' LEU . 11.3 m -136.46 129.36 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.927 0.714 . . . . 63.420000000000002 112.927 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.526 ' H ' ' NE2' ' A' ' 83' ' ' GLN . 30.8 p-10 -162.02 -174.22 4.03 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.04 -0.527 . . . . 73.439999999999998 111.074 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 60.69 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.907 1.076 . . . . 54.210000000000001 113.907 170.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' A' ' 145' ' ' ASP . 21.3 ptmt -141.02 -5.01 1.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.189 0.811 . . . . 62.439999999999998 113.189 -172.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.526 ' NE2' ' H ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -53.88 127.22 25.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.999 0.428 . . . . 63.509999999999998 111.273 -178.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.507 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.43 140.76 29.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.671 0.619 . . . . 63.32 112.671 -171.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.625 ' HB ' HD11 ' A' ' 57' ' ' ILE . 17.8 m -131.97 109.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.551 0.691 . . . . 74.510000000000005 111.71 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -69.81 146.98 44.24 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.97 -0.559 . . . . 65.129999999999995 112.566 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 115' ' ' PRO . 49.9 mm -125.54 121.89 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 122.67 -0.312 . . . . 64.150000000000006 111.1 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.579 ' HB2' ' SG ' ' A' ' 131' ' ' CYS . 34.7 p90 -120.04 126.48 50.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.419 . . . . 75.030000000000001 110.411 175.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.44 133.28 50.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.103 0.478 . . . . 74.549999999999997 111.96 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -156.28 -22.6 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.097 -0.501 . . . . 72.409999999999997 111.419 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.41 -60.03 3.64 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.005 -0.617 . . . . 53.229999999999997 113.138 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.11 -76.64 1.32 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.208 -0.52 . . . . 62.329999999999998 113.55 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 173.65 -65.61 0.11 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.642 -0.789 . . . . 62.039999999999999 113.439 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.41 111.79 22.75 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.279 0.562 . . . . 62.450000000000003 110.446 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.09 15.07 14.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.695 0.628 . . . . 75.519999999999996 112.695 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -91.04 -50.5 0.33 Allowed Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.35 0.87 . . . . 64.030000000000001 113.35 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.97 -2.39 10.96 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.163 1.909 . . . . 72.299999999999997 113.61 -174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.434 HD11 ' SD ' ' A' ' 59' ' ' MET . 10.9 tt -72.04 -26.07 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.831 0.348 . . . . 75.540000000000006 111.785 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.94 -53.83 56.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 112.852 0.686 . . . . 61.43 112.852 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 -29.4 35.89 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.674 1.583 . . . . 72.349999999999994 112.461 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.89 -48.63 79.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.181 -0.463 . . . . 72.150000000000006 111.279 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.04 -23.33 65.36 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.423 0.527 . . . . 74.25 112.423 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.9 t -100.68 -71.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.096 0.776 . . . . 74.150000000000006 113.096 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.54 -41.49 69.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.557 0.947 . . . . 52.439999999999998 113.557 -166.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.414 ' HD2' HD22 ' A' ' 110' ' ' LEU . 66.8 m-85 -59.39 -26.51 65.19 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.058 0.392 . . . . 72.329999999999998 112.058 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.0 mtm105 -70.7 -34.18 71.69 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.11 0.481 . . . . 75.439999999999998 110.749 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.7 -33.96 73.25 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.11 -0.495 . . . . 72.349999999999994 111.367 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.97 -34.68 78.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.868 0.366 . . . . 62.109999999999999 111.365 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.48 5.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.072 -0.585 . . . . 64.319999999999993 113.983 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 85' ' ' VAL . 8.7 mp -74.65 122.81 23.77 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.217 -0.578 . . . . 65.319999999999993 111.158 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.507 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 34.9 m -74.46 94.13 2.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.897 0.379 . . . . 63.210000000000001 110.717 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.3 p -76.86 149.1 36.16 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.283 0.564 . . . . 61.420000000000002 112.367 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.472 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -76.73 -66.98 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.131 -0.486 . . . . 61.530000000000001 111.208 174.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -170.18 88.92 0.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 120.875 0.369 . . . . 71.420000000000002 111.106 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HA ' HG21 ' A' ' 87' ' ' ILE . 85.7 Cg_endo -90.46 100.57 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.851 2.367 . . . . 72.129999999999995 113.284 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 110.7 5.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.57 -0.286 . . . . 71.329999999999998 111.225 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.67 94.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.61 0.719 . . . . 74.510000000000005 112.75 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -107.12 -14.49 14.91 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.987 -0.551 . . . . 72.540000000000006 111.987 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 122' ' ' THR . 9.3 tp -84.37 156.16 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.49 0.662 . . . . 72.129999999999995 112.536 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -92.91 -39.34 11.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.738 -0.665 . . . . 64.530000000000001 110.158 171.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 177.01 -59.0 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.644 0.777 . . . . 72.430000000000007 110.245 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.462 ' O ' HD13 ' A' ' 119' ' ' ILE . 82.3 p -80.5 118.72 73.74 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 116.447 -0.342 . . . . 74.439999999999998 111.385 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.56 146.62 68.27 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.476 2.117 . . . . 65.129999999999995 113.295 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.3 p -99.16 179.31 4.64 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.891 0.377 . . . . 73.329999999999998 111.592 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.18 -32.73 72.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.047 0.451 . . . . 65.329999999999998 111.14 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -57.42 -35.59 70.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 110.956 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.6 m -62.55 -39.03 92.31 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.496 -0.32 . . . . 71.239999999999995 111.491 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -60.17 -47.47 85.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.04 0.448 . . . . 73.140000000000001 111.04 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -65.96 -38.39 88.43 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.115 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.58 -52.63 64.83 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 72.200000000000003 110.53 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 88' ' ' PHE . 83.0 m -60.62 -41.08 94.11 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.886 0.374 . . . . 64.109999999999999 111.511 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -55.74 -45.02 78.08 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.204 0.526 . . . . 54.219999999999999 111.295 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.25 -41.66 40.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.004 -0.544 . . . . 74.219999999999999 111.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.8 80.25 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.051 0.389 . . . . 73.299999999999997 112.051 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.19 -47.29 91.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.021 -0.609 . . . . 53.310000000000002 112.918 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 94.1 m -60.46 -45.8 92.37 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.849 0.357 . . . . 75.409999999999997 111.403 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.62 -45.07 90.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.284 -0.416 . . . . 75.439999999999998 111.411 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.53 -42.93 91.44 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.815 0.34 . . . . 72.310000000000002 111.29 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.21 -36.27 61.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.261 -0.495 . . . . 72.430000000000007 112.869 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 136' ' ' THR . 77.5 mt-30 -57.86 -45.48 86.24 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 72.120000000000005 111.165 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -62.7 -49.28 75.73 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.409 -0.36 . . . . 74.299999999999997 111.192 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.43 HG21 HD13 ' A' ' 2' ' ' ILE . 63.7 t -53.73 -56.64 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.325 0.491 . . . . 62.310000000000002 112.325 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -65.13 -40.22 94.15 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.218 0.451 . . . . 71.239999999999995 112.218 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -75.01 -35.43 61.99 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.942 0.349 . . . . 72.319999999999993 111.942 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 82' ' ' LYS . 17.6 t70 -74.08 -44.26 54.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 75.239999999999995 110.672 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -58.14 -42.36 85.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.085 -0.507 . . . . 64.120000000000005 111.206 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 CA--C 1.543 0.689 0 CA-C-N 116.091 -0.504 . . . . 72.099999999999994 110.228 176.85 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.548 0.203 . . . . 63.32 111.548 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 44.3 mm 55.82 93.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 112.688 0.625 . . . . 72.540000000000006 112.688 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.09 109.89 3.81 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.563 -0.827 . . . . 70.200000000000003 113.318 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 32' ' ' ASP . 7.1 p -88.66 111.46 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.527 0.679 . . . . 51.409999999999997 111.747 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -89.31 96.66 10.81 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.757 -0.656 . . . . 74.019999999999996 111.117 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 25.6 p90 -122.04 -177.89 3.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.994 -0.548 . . . . 73.329999999999998 110.358 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.17 93.93 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.413 0.625 . . . . 71.230000000000004 111.893 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 18.2 m -57.13 -27.09 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.379 0.609 . . . . 63.229999999999997 110.955 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.28 -23.06 64.71 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.324 -0.853 . . . . 75.140000000000001 112.598 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -142.73 144.8 32.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.488 0.661 . . . . 74.019999999999996 112.662 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.39 -162.8 6.2 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.385 -0.825 . . . . 72.239999999999995 114.894 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.24 6.59 48.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.105 0.409 . . . . 75.25 112.105 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.463 ' HA ' HD12 ' A' ' 16' ' ' LEU . 60.4 p -51.13 -34.07 29.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.244 0.461 . . . . 72.439999999999998 112.244 -173.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 13.5 t70 -58.31 -56.28 24.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.016 0.436 . . . . 65.209999999999994 111.193 174.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -65.69 -27.84 68.64 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.528 -0.305 . . . . 74.409999999999997 111.516 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 13' ' ' SER . 90.3 mt -67.41 -43.41 81.32 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 52.020000000000003 110.382 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.02 85.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.112 -0.495 . . . . 73.200000000000003 110.805 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -57.63 -45.99 84.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.963 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.49 -43.65 89.09 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 62.530000000000001 111.27 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.538 HD11 HG13 ' A' ' 56' ' ' VAL . 67.1 mt -59.0 -57.71 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.93 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.55 -35.29 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 111.609 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -60.08 -53.47 57.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.713 0.292 . . . . 75.129999999999995 111.129 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.38 97.85 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.558 . . . . 74.040000000000006 112.933 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.685 HG21 ' HB ' ' A' ' 29' ' ' VAL . 36.7 mm -61.47 -47.23 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.916 0.388 . . . . 75.519999999999996 111.889 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 p -70.29 -31.73 69.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.741 0.305 . . . . 72.239999999999995 111.426 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.651 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -64.43 -42.17 96.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.854 0.359 . . . . 75.409999999999997 110.8 174.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -69.6 -51.73 32.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.335 -0.393 . . . . 72.239999999999995 111.134 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.82 53.95 0.13 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.443 -0.344 . . . . 70.129999999999995 113.162 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.685 ' HB ' HG21 ' A' ' 24' ' ' ILE . 46.2 t -139.7 157.82 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.419 0.288 . . . . 65.439999999999998 110.643 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.26 150.19 17.26 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 121.275 -0.488 . . . . 71.329999999999998 113.338 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 24' ' ' ILE . 97.1 t -131.07 145.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.625 0.602 . . . . 75.510000000000005 112.625 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' HG13 ' A' ' 4' ' ' VAL . 29.0 m-20 -93.29 142.83 26.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.982 -0.554 . . . . 74.519999999999996 111.126 171.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -110.02 131.08 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.815 0.34 . . . . 70.200000000000003 111.873 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.17 131.44 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 120.702 0.287 . . . . 70.540000000000006 111.465 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.6 m-20 -95.67 105.42 17.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.679 0.276 . . . . 74.540000000000006 111.17 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.47 -14.29 62.8 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.928 0.394 . . . . 75.200000000000003 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.18 30.86 7.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.372 -0.442 . . . . 73.200000000000003 112.93 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.07 174.83 10.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.881 0.372 . . . . 74.040000000000006 111.508 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.04 93.85 0.3 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.518 0.562 . . . . 73.099999999999994 112.518 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.61 174.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.42 -0.355 . . . . 74.340000000000003 111.336 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -145.46 172.2 13.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.001 0.429 . . . . 53.439999999999998 111.386 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.2 tm? -54.48 -29.56 50.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.769 0.427 . . . . 71.420000000000002 110.735 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -52.82 -48.02 67.27 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 111.986 0.365 . . . . 74.299999999999997 111.986 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.93 -38.05 78.08 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.868 0.366 . . . . 62.100000000000001 111.146 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.9 -43.67 82.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.835 0.35 . . . . 60.130000000000003 110.79 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.59 -50.43 73.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.712 0.291 . . . . 73.230000000000004 111.33 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.92 -30.39 71.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.052 0.453 . . . . 74.400000000000006 110.901 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.649 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 53.2 tp -58.92 -29.84 67.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.558 -0.292 . . . . 63.329999999999998 111.587 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.74 -33.42 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.194 0.521 . . . . 74.420000000000002 110.519 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.05 -31.65 11.77 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.003 -0.544 . . . . 74.310000000000002 112.469 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 99.7 mtt180 -73.47 -10.78 60.08 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.516 -0.403 . . . . 73.5 111.974 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -60.99 -10.79 6.37 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.768 0.285 . . . . 74.209999999999994 111.768 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.502 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 67.9 p -71.5 -28.61 64.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.429 . . . . 73.219999999999999 111.586 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -173.11 137.35 4.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.221 -0.445 . . . . 74.200000000000003 112.642 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' HD11 ' A' ' 57' ' ' ILE . 1.6 pt? -157.62 148.61 21.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.154 0.502 . . . . 63.140000000000001 111.806 -177.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.538 HG13 HD11 ' A' ' 20' ' ' ILE . 59.8 t -116.6 113.27 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 122.838 0.455 . . . . 73.239999999999995 111.03 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.564 HD11 ' HG ' ' A' ' 55' ' ' LEU . 3.3 mp -116.42 146.33 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 122.07 -0.394 . . . . 75.150000000000006 111.887 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -134.93 3.56 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.178 -0.534 . . . . 73.430000000000007 112.921 173.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.654 ' HE1' ' HA ' ' A' ' 59' ' ' MET . 4.8 mmt -122.5 156.23 34.54 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.44 -0.447 . . . . 51.109999999999999 111.11 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.8 p -97.9 113.54 63.86 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.327 -0.397 . . . . 64.409999999999997 111.924 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.45 146.05 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.864 2.376 . . . . 73.329999999999998 112.773 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.54 -24.96 2.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.988 0.736 . . . . 54.039999999999999 112.988 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.8 74.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.13 0.418 . . . . 53.439999999999998 112.13 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.0 p -100.0 4.43 44.81 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.788 0.292 . . . . 63.439999999999998 111.788 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.84 -31.01 10.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.497 0.555 . . . . 62.020000000000003 112.497 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.9 72.21 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.089 0.471 . . . . 38.990000000000002 111.695 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.1 t -65.17 -45.43 84.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.078 0.466 . . . . 73.150000000000006 110.874 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 50.4 mm -54.6 -52.95 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.912 -0.585 . . . . 70.230000000000004 111.657 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.14 -38.85 89.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.919 0.34 . . . . 74.409999999999997 111.919 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.82 -40.38 98.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.177 -0.535 . . . . 71.310000000000002 113.207 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -85.32 -44.4 12.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.314 0.487 . . . . 75.230000000000004 112.314 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 1.4 tm? -53.45 -42.99 67.71 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.592 0.357 . . . . 75.319999999999993 111.57 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -51.16 -34.28 30.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.814 0.34 . . . . 63.140000000000001 111.864 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.3 m -89.93 -39.74 12.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.214 0.53 . . . . 63.43 111.21 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 HD21 ' A' ' 48' ' ' LEU . 72.1 mt -54.58 -41.41 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 111.733 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.94 -33.21 62.02 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.296 -0.411 . . . . 75.030000000000001 111.834 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.19 -31.73 33.72 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.137 -0.554 . . . . 71.049999999999997 112.902 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.8 m -72.7 -39.44 67.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.121 0.415 . . . . 73.109999999999999 112.121 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.0 m -87.91 147.34 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.02 0.438 . . . . 73.109999999999999 111.568 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.586 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -160.94 -179.02 7.2 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.136 0.421 . . . . 55.140000000000001 112.136 -178.024 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.689 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 9.4 tp10 72.2 -106.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.886 0.874 . . . . 70.310000000000002 112.71 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.689 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 19.2 ptpt -164.98 24.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.417 0.895 . . . . 64.209999999999994 113.417 -172.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 53' ' ' THR . 1.3 mp0 -62.08 167.85 3.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.754 0.65 . . . . 70.329999999999998 112.754 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.94 123.92 34.81 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.77 -0.65 . . . . 75.519999999999996 112.349 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.74 108.53 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.493 0.663 . . . . 75.219999999999999 111.025 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 81.43 0.33 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.089 -0.505 . . . . 63.299999999999997 112.774 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 49.5 mm -79.53 109.08 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 122.568 -0.372 . . . . 75.329999999999998 111.391 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -105.27 111.63 24.44 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.354 0.597 . . . . 74.299999999999997 110.555 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.791 ' HB2' HD12 ' A' ' 119' ' ' ILE . 7.7 pt-20 -57.9 104.05 0.17 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.488 0.661 . . . . 64.25 112.703 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.6 m -142.34 112.78 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.131 -0.486 . . . . 53.420000000000002 111.534 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.52 -139.77 15.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.192 -0.528 . . . . 64.400000000000006 113.481 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.04 -102.44 2.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.066 -0.587 . . . . 75.430000000000007 113.359 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.22 -96.18 0.54 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.22 -0.514 . . . . 70.200000000000003 112.46 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -106.89 123.65 48.47 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.559 -0.377 . . . . 73.319999999999993 110.282 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.63 159.1 44.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 65.340000000000003 111.211 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 37.9 mt-10 -103.91 -55.93 0.1 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.922 0.712 . . . . 74.310000000000002 112.922 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.517 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 39.3 Cg_endo -64.7 -14.59 45.55 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.287 1.991 . . . . 71.439999999999998 114.014 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.9 tt -49.12 -51.86 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 113.26 0.837 . . . . 74.319999999999993 113.26 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.683 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 4.5 m-20 -61.53 -55.44 42.68 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.189 0.44 . . . . 75.219999999999999 112.189 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.7 Cg_exo -56.25 -33.35 90.69 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.009 1.806 . . . . 74.239999999999995 112.705 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.64 -57.06 7.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.06 -0.518 . . . . 74.310000000000002 111.479 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.33 -37.79 67.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.988 0.423 . . . . 63.210000000000001 110.862 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 100' ' ' PRO . 6.3 t -49.99 -43.33 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.616 . . . . 72.430000000000007 111.727 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.699 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -64.55 -44.21 91.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.646 -0.252 . . . . 74.230000000000004 111.16 -177.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -60.68 -36.89 79.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.87 0.366 . . . . 72.120000000000005 111.223 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -66.85 -60.77 2.37 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.159 -0.473 . . . . 74.319999999999993 111.698 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -60.61 -39.31 87.68 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.302 0.482 . . . . 63.439999999999998 112.302 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.58 -24.43 49.76 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.205 -0.309 . . . . 72.430000000000007 111.569 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.65 52.59 33.27 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.155 -0.545 . . . . 62.100000000000001 113.04 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.32 159.9 20.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.97 0.414 . . . . 73.129999999999995 111.535 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 88.2 m -79.63 110.02 14.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 73.409999999999997 110.77 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -108.52 141.57 40.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.44 0.533 . . . . 72.420000000000002 112.44 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.31 -86.13 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.418 -0.355 . . . . 74.510000000000005 111.131 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -148.63 96.42 3.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 121.104 0.478 . . . . 72.010000000000005 111.507 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.31 13.47 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.854 2.369 . . . . 73.519999999999996 113.193 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.2 78.01 2.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.285 0.564 . . . . 74.129999999999995 111.441 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.401 HG13 HD13 ' A' ' 119' ' ' ILE . 8.8 tt -62.5 112.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 113.175 0.806 . . . . 73.129999999999995 113.175 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -140.44 49.87 1.71 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.132 0.492 . . . . 74.239999999999995 111.259 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.791 HD12 ' HB2' ' A' ' 89' ' ' GLU . 3.3 mp -89.66 116.31 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 110.957 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.96 -41.81 75.28 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.842 0.353 . . . . 72.030000000000001 111.933 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -178.38 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.432 0.634 . . . . 72.340000000000003 109.997 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -127.06 142.52 43.99 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.862 -0.608 . . . . 72.230000000000004 110.679 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.98 148.36 91.63 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.631 2.221 . . . . 63.32 113.097 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.6 p -90.26 -178.68 5.45 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.158 0.504 . . . . 63.310000000000002 112.057 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.23 -42.48 69.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.023 -0.535 . . . . 72.230000000000004 111.718 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -59.99 -39.95 87.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 112.042 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.8 m -51.78 -30.75 24.21 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.983 0.364 . . . . 74.200000000000003 111.983 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -58.24 -41.01 83.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.717 0.294 . . . . 72.209999999999994 111.733 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.643 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 53.3 mttm -82.94 -26.73 31.12 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.978 0.362 . . . . 71.510000000000005 111.978 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 -41.73 91.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.769 0.319 . . . . 75.209999999999994 110.862 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 30.3 p -81.63 -37.15 28.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.629 0.252 . . . . 73.530000000000001 111.105 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.643 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.7 tt0 -51.62 -71.32 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.01 0.524 . . . . 74.5 112.283 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -67.07 -38.61 86.08 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.465 0.542 . . . . 65.219999999999999 112.465 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.31 -54.44 37.03 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.806 0.336 . . . . 71.400000000000006 111.337 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.28 -43.67 97.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.935 -0.65 . . . . 42.030000000000001 112.641 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.446 HG22 HE21 ' A' ' 140' ' ' GLN . 86.7 m -64.66 -42.97 95.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.79 0.293 . . . . 75.310000000000002 111.79 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.83 -44.69 92.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.867 0.365 . . . . 55.399999999999999 110.781 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.13 -39.01 84.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.949 0.404 . . . . 72.099999999999994 110.83 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.67 -43.01 98.13 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.093 -0.575 . . . . 72.209999999999994 112.309 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.446 HE21 HG22 ' A' ' 136' ' ' THR . 78.5 mt-30 -62.89 -34.91 78.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.661 0.267 . . . . 72.019999999999996 111.059 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -63.09 -42.54 99.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.921 0.391 . . . . 72.420000000000002 110.653 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.04 -49.93 77.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.973 0.416 . . . . 62.140000000000001 111.2 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 4.9 t -77.86 -11.44 59.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.576 -0.284 . . . . 74.329999999999998 111.609 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -72.64 -61.54 1.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.076 0.465 . . . . 71.530000000000001 110.577 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.93 -40.02 96.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.824 -0.625 . . . . 63.25 111.704 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -75.66 -38.88 58.43 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.927 0.343 . . . . 73.420000000000002 111.927 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 143' ' ' THR . 3.1 mm? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.648 0.261 . . . . 72.200000000000003 111.248 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.311 0.101 . . . . 74.129999999999995 111.244 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.74 HG13 ' HA2' ' A' ' 139' ' ' GLY . 45.4 mm 67.14 122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 71.239999999999995 112.561 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.92 109.22 3.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.132 -0.556 . . . . 55.100000000000001 112.703 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.23 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.634 -0.333 . . . . 71.340000000000003 111.57 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 97.1 m-85 -86.87 120.64 28.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.898 0.38 . . . . 75.140000000000001 111.233 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 1.3 p90 -150.32 -179.9 7.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.393 -0.367 . . . . 73.519999999999996 110.924 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.7 t -133.49 110.62 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.68 -0.236 . . . . 64.25 110.522 173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 40.8 t -51.95 -33.48 37.73 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.404 0.52 . . . . 71.209999999999994 112.404 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -85.18 -12.6 52.31 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.711 0.634 . . . . 73.420000000000002 112.711 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -98.62 90.85 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.778 -0.576 . . . . 73.200000000000003 112.121 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.88 -162.03 4.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 115.067 0.787 . . . . 45.329999999999998 115.067 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.458 ' HB2' ' HB2' ' A' ' 123' ' ' PRO . 39.4 m-85 -68.15 1.6 2.71 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.813 0.672 . . . . 64.230000000000004 112.813 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -54.63 -33.61 60.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.428 0.632 . . . . 74.25 110.581 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 23.6 t70 -59.66 -37.24 78.21 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.294 -0.866 . . . . 53.240000000000002 111.878 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -85.26 -26.73 26.46 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.182 -0.463 . . . . 73.5 111.904 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -55.62 -46.25 77.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 44.43 111.474 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.28 -54.29 47.16 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.243 0.46 . . . . 74.510000000000005 112.243 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' A' ' 21' ' ' ILE . 35.0 tt0 -67.25 -36.37 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.557 -0.292 . . . . 72.400000000000006 111.578 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.74 86.74 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.784 0.326 . . . . 74.310000000000002 111.689 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.76 -55.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.784 0.326 . . . . 64.0 111.533 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 18' ' ' GLN . 13.4 tt -60.55 -30.05 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.626 0.25 . . . . 74.109999999999999 111.315 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -53.42 -35.3 60.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.213 0.53 . . . . 63.5 111.32 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.35 -33.92 6.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.156 -0.545 . . . . 75.219999999999999 113.437 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.81 -24.46 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.129 0.789 . . . . 72.109999999999999 113.129 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -53.6 -33.37 54.67 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.404 0.52 . . . . 72.200000000000003 112.404 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.82 -18.45 60.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.282 0.475 . . . . 74.439999999999998 112.282 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.0 m -84.28 -15.93 44.94 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.205 0.526 . . . . 64.329999999999998 111.308 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.85 2.99 57.16 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.385 -0.435 . . . . 54.030000000000001 112.928 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -98.67 104.57 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.046 0.45 . . . . 75.549999999999997 111.299 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.23 128.54 9.55 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.133 -0.556 . . . . 74.430000000000007 112.427 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.2 m -90.54 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.1 0.476 . . . . 71.430000000000007 111.911 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.2 104.83 16.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.034 0.445 . . . . 74.5 111.069 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 6' ' ' TYR . 35.8 m -83.2 139.53 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.121 0.486 . . . . 74.409999999999997 112.285 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.4 t -139.09 118.4 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.382 -0.372 . . . . 72.140000000000001 111.401 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.54 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.9 m-20 -76.32 91.65 3.26 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.344 -0.222 . . . . 62.450000000000003 111.067 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 36' ' ' LEU . 2.5 pt? -59.79 -20.69 58.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.887 0.375 . . . . 55.32 111.963 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 12.58 66.94 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.29 -0.481 . . . . 72.040000000000006 113.39 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -161.51 -65.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.921 0.391 . . . . 75.150000000000006 111.916 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.65 77.82 4.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.132 0.491 . . . . 64.120000000000005 112.127 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.6 126.08 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.128 0.49 . . . . 62.210000000000001 111.807 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -163.78 170.9 16.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.134 -0.485 . . . . 55.32 110.172 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.7 tm? -54.73 -37.28 65.7 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.598 0.237 . . . . 73.299999999999997 111.151 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -58.55 -57.31 13.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 75.319999999999993 111.404 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -61.28 -35.52 77.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.293 -0.412 . . . . 73.329999999999998 111.288 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 2.8 tm? -61.09 -42.07 97.83 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.02 0.438 . . . . 73.129999999999995 110.268 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -67.87 -43.29 79.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.875 0.369 . . . . 75.319999999999993 111.046 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.573 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 27.9 mt-10 -62.63 -25.74 68.27 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.749 0.278 . . . . 72.319999999999993 111.749 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 64.3 tp -57.44 -36.85 71.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 70.299999999999997 110.576 173.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.63 -35.93 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.085 0.469 . . . . 64.120000000000005 111.031 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.48 77.39 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.115 -0.564 . . . . 64.530000000000001 112.642 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.573 ' NH1' ' HB3' ' A' ' 47' ' ' GLU . 7.5 mpt_? -100.39 6.83 44.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.431 0.293 . . . . 74.329999999999998 111.581 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -54.4 -19.94 6.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.135 0.791 . . . . 72.209999999999994 113.135 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 p -70.92 -17.99 62.67 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.933 0.345 . . . . 60.32 111.933 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -169.68 137.76 4.68 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.886 -0.673 . . . . 51.439999999999998 113.744 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.87 143.17 20.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.063 0.459 . . . . 74.200000000000003 111.047 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.51 122.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 73.040000000000006 111.299 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -105.27 130.29 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 111.519 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 88' ' ' PHE . . . -80.15 56.72 4.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.019 -0.61 . . . . 71.0 112.709 175.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 90' ' ' THR . 24.8 mmt 65.41 173.04 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.444 0.64 . . . . 74.329999999999998 111.943 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.8 m -141.24 90.29 9.2 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 116.396 -0.365 . . . . 73.0 110.657 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.45 156.33 26.78 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.617 2.211 . . . . 73.430000000000007 113.258 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.98 -55.19 2.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.335 0.865 . . . . 64.510000000000005 113.335 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.97 67.75 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.305 0.483 . . . . 61.039999999999999 112.305 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -72.03 -40.74 68.22 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.774 0.321 . . . . 64.040000000000006 111.296 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.19 34.89 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.822 0.675 . . . . 75.140000000000001 112.822 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -59.58 4.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 65.140000000000001 112.29 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 t -65.11 -36.6 84.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.118 0.485 . . . . 45.43 111.482 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.498 HG22 ' HG ' ' A' ' 72' ' ' LEU . 56.2 mt -59.75 -33.31 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.924 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -53.24 -35.54 60.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.873 0.368 . . . . 62.140000000000001 111.894 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.95 -22.19 70.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.917 -0.658 . . . . 42.200000000000003 113.354 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.08 -31.45 11.06 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.57 0.581 . . . . 74.340000000000003 112.57 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.498 ' HG ' HG22 ' A' ' 68' ' ' ILE . 49.6 mt -49.94 -44.81 50.69 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.167 0.803 . . . . 71.049999999999997 113.167 -174.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 m -52.28 -35.67 50.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.953 0.353 . . . . 71.340000000000003 111.953 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -85.18 -45.26 12.19 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 73.230000000000004 111.286 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.24 -50.2 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.266 -0.424 . . . . 73.409999999999997 111.776 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.57 -22.87 62.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.766 0.317 . . . . 73.319999999999993 111.747 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.36 -15.28 41.6 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.253 -0.499 . . . . 55.030000000000001 112.983 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.8 m -89.29 -27.21 20.7 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.483 -0.422 . . . . 74.200000000000003 111.804 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.0 m -70.76 131.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.345 0.593 . . . . 63.149999999999999 112.073 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -82.74 170.49 15.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 71.519999999999996 110.786 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 44.2 tt0 -48.6 -35.05 12.74 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.75 0.648 . . . . 65.430000000000007 112.75 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -154.21 141.32 19.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.444 0.64 . . . . 73.120000000000005 112.423 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 -179.08 7.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.416 -0.811 . . . . 72.319999999999993 109.852 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 138' ' ' LEU . . . -88.5 91.51 8.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.259 0.552 . . . . 73.439999999999998 111.691 -177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.8 m -103.32 138.0 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.997 0.427 . . . . 74.209999999999994 111.198 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.57 164.63 25.67 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.985 -0.626 . . . . 52.310000000000002 113.177 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -135.44 145.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.72 0.408 . . . . 75.430000000000007 110.51 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.583 ' HB2' ' HA2' ' A' ' 58' ' ' GLY . 36.8 m-85 -99.21 129.18 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.708 0.29 . . . . 75.129999999999995 110.978 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.422 ' HB3' HG22 ' A' ' 117' ' ' ILE . 35.1 mp0 -70.2 80.29 0.52 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.239 0.542 . . . . 73.319999999999993 111.315 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 59' ' ' MET . 9.0 t -146.66 179.03 7.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.27 -0.423 . . . . 75.239999999999995 111.366 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 75.22 -72.12 1.69 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.336 -0.459 . . . . 72.230000000000004 113.736 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.32 -116.25 0.73 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.198 -0.525 . . . . 71.530000000000001 112.978 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.53 36.29 0.51 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.023 -0.608 . . . . 44.32 112.899 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.91 109.88 21.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.669 0.271 . . . . 73.420000000000002 111.391 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.06 157.27 25.86 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.406 -0.361 . . . . 74.310000000000002 111.622 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 2.8 mp0 -103.49 -55.78 0.1 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.227 0.825 . . . . 53.130000000000003 113.227 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 3.8 Cg_exo -77.26 16.92 0.94 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.703 2.269 . . . . 63.219999999999999 114.332 -176.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.524 HG23 ' H ' ' A' ' 99' ' ' ASP . 9.0 tt -44.36 -62.3 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 114.231 1.197 . . . . 75.409999999999997 114.231 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 98' ' ' ILE . 39.7 m-20 -62.72 -50.29 78.56 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.211 0.819 . . . . 72.109999999999999 113.211 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 63.8 Cg_exo -53.67 -43.22 59.7 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.373 2.049 . . . . 54.240000000000002 113.344 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.2 -44.72 68.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.572 0.225 . . . . 72.530000000000001 111.425 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.536 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 60.5 mt -56.05 -44.95 79.34 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.746 0.308 . . . . 54.509999999999998 110.985 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.2 t -56.91 -40.93 77.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.951 0.405 . . . . 74.519999999999996 110.951 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -39.69 78.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.403 -0.362 . . . . 74.230000000000004 111.185 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.635 ' HD1' HD11 ' A' ' 110' ' ' LEU . 29.4 m-85 -61.39 -32.46 72.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.568 0.223 . . . . 75.120000000000005 111.316 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 102' ' ' LEU . 2.1 mpt_? -73.92 -40.68 62.96 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.807 0.337 . . . . 55.399999999999999 111.111 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.63 -43.29 80.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.021 0.439 . . . . 72.349999999999994 111.426 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 81.2 mt -89.72 -41.76 11.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.031 0.443 . . . . 75.540000000000006 111.911 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 57.39 1.38 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.933 -0.467 . . . . 73.099999999999994 111.933 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.635 HD11 ' HD1' ' A' ' 105' ' ' PHE . 83.5 mt -96.32 163.01 13.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 74.420000000000002 112.34 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.418 HG23 HD13 ' A' ' 138' ' ' LEU . 87.4 m -66.15 136.4 55.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.588 -0.733 . . . . 60.43 112.104 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -131.9 96.54 3.95 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.378 -0.374 . . . . 71.329999999999998 111.073 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.33 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.393 0.516 . . . . 64.019999999999996 112.393 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -150.43 89.65 4.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 121.166 0.507 . . . . 74.409999999999997 110.791 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.95 30.62 0.51 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.037 2.492 . . . . 64.409999999999997 114.378 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.19 101.63 0.74 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.94 0.348 . . . . 62.210000000000001 111.94 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.43 HG23 HG12 ' A' ' 119' ' ' ILE . 14.2 tt -153.0 143.53 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.004 0.431 . . . . 64.010000000000005 111.608 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -79.14 94.01 5.29 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.207 0.527 . . . . 74.540000000000006 111.74 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.43 HG12 HG23 ' A' ' 117' ' ' ILE . 49.4 mm -105.2 116.49 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.187 -0.461 . . . . 64.120000000000005 110.482 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -80.29 50.46 1.26 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.01 0.433 . . . . 64.099999999999994 111.498 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.5 tt0 71.57 -60.45 0.52 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.461 0.704 . . . . 72.019999999999996 112.558 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -86.75 120.85 72.0 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 111.816 0.302 . . . . 72.549999999999997 111.816 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 12' ' ' TYR . 71.5 Cg_exo -51.81 137.85 51.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.81 2.34 . . . . 72.299999999999997 113.085 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.9 p -93.83 168.01 11.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.883 0.373 . . . . 72.349999999999994 111.518 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.44 -32.74 71.66 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.219 0.533 . . . . 70.010000000000005 110.807 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -73.24 -31.63 64.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.013 -0.54 . . . . 74.409999999999997 111.02 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.8 m -52.51 -38.38 59.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.27 -0.423 . . . . 60.5 111.809 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -52.47 -41.9 63.75 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.688 0.28 . . . . 72.349999999999994 111.626 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -65.57 -46.36 79.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.977 0.362 . . . . 62.25 111.977 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.93 -51.61 60.9 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.523 -0.308 . . . . 75.310000000000002 111.091 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.9 -29.94 71.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.804 0.298 . . . . 65.109999999999999 111.804 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.46 -58.16 7.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.942 0.401 . . . . 53.549999999999997 110.369 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.19 -12.35 61.6 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.201 0.445 . . . . 73.010000000000005 112.201 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.59 -62.84 1.53 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.897 0.38 . . . . 44.030000000000001 110.863 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.08 -42.35 99.72 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 63.149999999999999 113.51 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -35.85 61.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.287 0.477 . . . . 75.209999999999994 112.287 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.17 -51.64 68.73 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.976 0.417 . . . . 61.119999999999997 110.925 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 138' ' ' LEU . 2.6 mm? -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.915 0.388 . . . . 74.450000000000003 110.919 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.74 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -63.89 -55.06 26.73 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.321 -0.466 . . . . 62.399999999999999 112.746 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -74.61 -14.88 60.83 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.598 -0.354 . . . . 55.43 111.715 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -50.28 -38.33 40.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.18 0.514 . . . . 73.239999999999995 110.546 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.8 t -54.88 -61.05 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.437 -0.802 . . . . 53.240000000000002 111.623 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -70.62 -25.1 62.88 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.466 0.543 . . . . 73.129999999999995 112.466 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -67.93 -38.09 82.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.132 -0.355 . . . . 73.140000000000001 111.44 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.5 -50.33 7.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 120.965 0.412 . . . . 70.129999999999995 111.274 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 11.9 mtp180 -69.93 -19.0 63.4 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.893 0.701 . . . . 74.409999999999997 112.893 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 52.5 tp . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 123.396 0.678 . . . . 74.540000000000006 112.266 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 43.0 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 111.227 0.084 . . . . 74.129999999999995 111.227 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm 67.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 121.17 0.509 . . . . 64.0 111.766 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.95 109.58 3.21 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.2 -0.524 . . . . 73.040000000000006 112.972 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 111.58 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.795 0.331 . . . . 74.239999999999995 110.971 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.448 ' HE2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 m-85 -97.29 139.46 33.22 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.408 0.521 . . . . 72.25 112.408 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 35' ' ' ASP . 44.1 p90 -142.29 162.91 34.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.751 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.464 ' HB ' ' HA3' ' A' ' 11' ' ' GLY . 20.7 t -106.29 115.73 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 122.213 -0.305 . . . . 61.039999999999999 111.591 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.4 ' OG ' ' HB2' ' A' ' 35' ' ' ASP . 15.1 m -60.12 -20.28 57.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.96 0.41 . . . . 74.010000000000005 111.786 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' H ' HG12 ' A' ' 7' ' ' VAL . 43.2 tt0 -70.13 -69.51 0.35 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.127 -0.488 . . . . 71.329999999999998 111.696 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -137.38 -35.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.943 0.349 . . . . 74.439999999999998 111.943 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -28.55 103.37 0.01 OUTLIER Glycine 0 N--CA 1.472 1.091 0 N-CA-C 115.328 0.891 . . . . 53.210000000000001 115.328 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.62 5.47 3.06 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.83 0.452 . . . . 75.209999999999994 112.208 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 m -57.7 -19.73 29.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.653 0.612 . . . . 42.439999999999998 112.653 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -61.73 -34.85 76.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.247 0.546 . . . . 45.340000000000003 111.067 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -69.47 -37.73 77.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.727 -0.669 . . . . 75.510000000000005 111.079 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.632 HD13 ' SG ' ' A' ' 131' ' ' CYS . 64.5 mt -70.3 -39.98 74.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.811 -0.632 . . . . 75.400000000000006 110.706 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.05 74.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.828 -0.624 . . . . 73.430000000000007 111.706 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -61.73 -41.02 97.09 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.122 0.487 . . . . 73.109999999999999 111.032 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.04 87.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.367 -0.379 . . . . 53.130000000000003 111.399 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.85 -56.81 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.043 -0.526 . . . . 74.129999999999995 111.621 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.486 ' O ' HG22 ' A' ' 25' ' ' THR . 12.8 tt -54.77 -41.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.443 0.164 . . . . 52.520000000000003 111.443 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -51.31 -50.49 59.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.721 0.408 . . . . 55.409999999999997 111.832 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.26 -39.07 32.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.066 -0.588 . . . . 72.140000000000001 113.508 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.482 HG23 ' H ' ' A' ' 30' ' ' GLY . 49.6 mm -67.44 -41.61 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 122.268 -0.548 . . . . 72.200000000000003 112.119 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 21' ' ' ILE . 13.3 t -72.1 -31.18 65.81 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.996 -0.44 . . . . 74.200000000000003 110.532 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -59.04 -42.84 91.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.043 0.449 . . . . 75.239999999999995 109.795 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.1 m -67.09 -27.47 67.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.856 -0.611 . . . . 75.430000000000007 111.218 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.17 22.52 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.23 -0.509 . . . . 71.430000000000007 113.509 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -95.67 -52.96 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.459 -0.436 . . . . 71.239999999999995 112.028 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' H ' HG23 ' A' ' 24' ' ' ILE . . . 87.64 134.78 4.49 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 121.124 -0.56 . . . . 62.219999999999999 113.55 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.0 m -108.69 171.74 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.198 0.523 . . . . 71.430000000000007 112.318 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -127.89 107.28 9.73 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.955 -0.566 . . . . 74.120000000000005 110.078 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -92.3 125.92 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.415 0.626 . . . . 75.25 112.334 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.1 t -122.68 126.19 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 111.374 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 5.4 p-10 -94.66 88.06 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.644 0.735 . . . . 65.010000000000005 111.771 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.73 -3.6 16.07 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.729 -0.669 . . . . 75.420000000000002 112.288 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.48 1.37 85.87 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.021 -0.609 . . . . 63.530000000000001 112.504 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.05 177.47 4.85 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.964 0.411 . . . . 75.510000000000005 111.132 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.64 84.33 0.29 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.035 0.445 . . . . 65.310000000000002 111.993 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.33 163.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.107 -0.497 . . . . 62.240000000000002 111.472 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.51 172.7 17.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.862 0.363 . . . . 73.049999999999997 111.89 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.421 ' N ' HD21 ' A' ' 42' ' ' LEU . 3.4 mm? -56.11 -31.28 63.14 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.779 0.659 . . . . 75.439999999999998 112.779 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -61.33 -34.23 74.92 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.263 0.554 . . . . 65.329999999999998 111.171 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.27 -48.93 12.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.775 -0.648 . . . . 71.129999999999995 110.69 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 49' ' ' VAL . 3.3 tm? -53.53 -40.17 65.25 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.057 -0.52 . . . . 73.129999999999995 111.667 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -59.59 -53.02 62.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.098 0.475 . . . . 54.450000000000003 111.366 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.47 -39.04 93.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.133 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.421 HD13 ' HZ ' ' A' ' 5' ' ' PHE . 59.0 tp -55.53 -52.81 62.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.976 -0.556 . . . . 52.240000000000002 111.434 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 45' ' ' LEU . 87.7 t -60.21 -44.23 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.308 -0.406 . . . . 73.239999999999995 111.608 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.73 89.21 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.059 -0.591 . . . . 53.140000000000001 113.457 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.23 8.22 43.94 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.785 0.661 . . . . 73.319999999999993 112.785 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.4 p -55.28 -3.1 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.93 1.085 . . . . 73.230000000000004 113.93 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -44.74 -41.37 6.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.61 0.596 . . . . 73.209999999999994 112.61 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 84' ' ' ALA . . . -149.84 136.86 5.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.354 -0.451 . . . . 72.319999999999993 112.291 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.448 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 83.9 mt -139.27 141.35 37.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.908 0.354 . . . . 73.040000000000006 111.671 -175.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.48 118.12 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.147 0.499 . . . . 71.310000000000002 111.191 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.2 mp -106.81 131.81 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.922 0.391 . . . . 74.430000000000007 111.709 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.77 58.16 0.46 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.35 -0.453 . . . . 72.120000000000005 113.424 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.521 ' HG3' ' HA ' ' A' ' 89' ' ' GLU . 84.2 mtp 67.0 -178.49 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.96 0.726 . . . . 71.140000000000001 112.96 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -141.79 88.84 9.3 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.514 -0.767 . . . . 71.450000000000003 110.649 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.07 143.0 85.23 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 122.931 2.421 . . . . 63.32 113.253 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.8 -64.51 0.39 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.83 1.048 . . . . 75.319999999999993 113.83 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.31 -53.75 53.57 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.209 0.448 . . . . 74.129999999999995 112.209 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 68' ' ' ILE . 39.0 t -64.79 -25.81 68.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.455 0.539 . . . . 71.340000000000003 112.455 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.81 69.47 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.017 0.377 . . . . 74.299999999999997 112.017 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.24 -53.47 50.31 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.909 0.385 . . . . 73.420000000000002 111.735 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 m -71.19 -32.66 69.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.906 0.335 . . . . 72.209999999999994 111.906 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 64' ' ' SER . 76.6 mt -64.9 -47.35 88.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.852 0.316 . . . . 73.209999999999994 111.852 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.92 -42.34 89.44 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.712 0.292 . . . . 61.409999999999997 111.72 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.14 70.51 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.226 -0.511 . . . . 65.120000000000005 113.038 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.42 -43.12 16.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.794 0.331 . . . . 74.310000000000002 111.514 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.6 tp -52.93 -41.08 64.12 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.801 0.44 . . . . 73.219999999999999 111.833 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 t -51.57 -37.47 49.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.123 0.487 . . . . 72.239999999999995 111.582 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.0 m -84.51 -40.79 17.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 111.356 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.8 -46.76 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.01 -0.541 . . . . 61.5 111.889 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.99 -47.08 65.06 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.883 0.373 . . . . 74.209999999999994 111.937 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.07 -26.86 67.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.059 -0.591 . . . . 72.519999999999996 113.373 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -78.05 -40.66 38.01 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.493 0.553 . . . . 71.200000000000003 112.493 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.01 168.97 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.266 0.555 . . . . 74.319999999999993 112.261 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.54 158.4 25.81 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 110.557 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.17 -82.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.317 0.858 . . . . 72.040000000000006 113.317 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.638 ' HZ1' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -94.5 101.0 12.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.705 0.632 . . . . 74.030000000000001 112.705 -173.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.01 -164.99 1.21 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.051 -0.522 . . . . 74.329999999999998 111.151 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -110.33 134.85 51.88 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.861 0.362 . . . . 61.340000000000003 110.771 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' THR . 29.6 m -132.55 170.96 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.422 0.629 . . . . 74.209999999999994 112.508 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 110.96 0.63 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.819 -0.628 . . . . 63.140000000000001 111.982 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -101.04 114.36 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.217 -0.578 . . . . 55.439999999999998 111.202 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.449 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 29.0 p90 -123.0 110.78 15.8 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 74.230000000000004 111.503 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.521 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 41.8 mt-10 -78.77 81.77 5.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.234 0.54 . . . . 64.010000000000005 111.366 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -79.76 -9.57 59.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.067 -0.515 . . . . 72.299999999999997 112.164 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.26 -70.67 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.24 -0.505 . . . . 70.430000000000007 113.073 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.58 21.75 77.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.169 -0.539 . . . . 74.409999999999997 113.15 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.86 -85.28 0.26 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.278 -0.487 . . . . 72.430000000000007 113.944 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -163.52 129.93 3.26 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.42 -0.459 . . . . 75.140000000000001 111.369 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -163.38 152.75 14.82 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.097 0.475 . . . . 73.230000000000004 111.89 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.445 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.6 mp0 -95.23 -43.96 0.27 Allowed Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.858 1.058 . . . . 74.329999999999998 113.858 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 74.2 Cg_endo -71.13 23.28 0.22 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.27 1.98 . . . . 53.329999999999998 114.928 -170.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tt -57.71 -53.43 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 112.648 0.61 . . . . 75.319999999999993 112.648 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.676 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.3 m-20 -61.89 -55.88 37.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.472 0.545 . . . . 64.200000000000003 112.472 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.676 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.8 Cg_exo -54.12 -44.98 44.48 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.333 2.022 . . . . 73.409999999999997 112.81 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -60.48 -54.48 45.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.305 -0.407 . . . . 75.140000000000001 111.269 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.31 -38.69 80.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.518 -0.31 . . . . 70.450000000000003 111.725 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 t -62.46 -37.66 86.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.808 0.337 . . . . 45.520000000000003 111.339 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HE3' HD12 ' A' ' 108' ' ' LEU . 59.6 tptt -58.41 -47.73 82.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.024 0.44 . . . . 75.519999999999996 111.051 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.67 -46.42 75.73 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.327 -0.397 . . . . 74.340000000000003 111.773 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -62.53 -52.68 62.48 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.42 0.526 . . . . 74.019999999999996 112.42 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.27 -35.53 80.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.698 0.629 . . . . 74.349999999999994 112.698 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.524 HD12 ' HE3' ' A' ' 104' ' ' LYS . 80.7 mt -78.23 -15.58 58.66 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.107 -0.371 . . . . 75.140000000000001 111.605 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.04 40.19 51.91 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.06 -0.59 . . . . 38.039999999999999 112.899 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.93 104.03 3.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.828 0.346 . . . . 65.540000000000006 110.707 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -64.71 123.8 20.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.142 0.496 . . . . 64.120000000000005 112.086 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 76.6 p -89.92 136.89 32.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.361 -0.381 . . . . 55.109999999999999 111.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.78 -54.64 44.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.082 0.468 . . . . 74.140000000000001 111.295 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -150.34 131.12 7.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.369 -0.378 . . . . 70.239999999999995 110.284 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.54 103.53 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.412 2.074 . . . . 72.239999999999995 112.688 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 88' ' ' PHE . . . -80.45 -179.47 7.17 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 74.510000000000005 112.714 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.25 145.2 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.92 -0.582 . . . . 71.400000000000006 111.019 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -72.24 150.23 43.84 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.482 0.919 . . . . 74.200000000000003 113.482 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 120' ' ' LYS . 23.4 mm -106.8 167.14 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.115 -0.948 . . . . 72.530000000000001 110.757 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.49 ' N ' HG22 ' A' ' 119' ' ' ILE . 57.6 tptt -64.19 -66.11 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.843 0.354 . . . . 71.230000000000004 111.773 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -151.13 -55.73 0.15 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.257 0.551 . . . . 74.109999999999999 111.027 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -92.82 118.63 67.98 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.956 -0.565 . . . . 75.150000000000006 110.413 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HA ' HG23 ' A' ' 119' ' ' ILE . 32.1 Cg_endo -61.95 141.27 88.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.675 2.25 . . . . 64.349999999999994 113.389 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.4 p -76.16 156.08 34.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.877 -0.601 . . . . 75.120000000000005 111.428 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.76 -30.9 71.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 111.037 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -57.29 -22.69 43.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.3 -0.409 . . . . 71.230000000000004 111.093 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.9 m -65.6 -25.76 67.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.852 0.358 . . . . 72.439999999999998 111.068 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -67.47 -48.16 67.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.913 0.387 . . . . 73.319999999999993 110.395 172.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.68 -31.62 71.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.467 0.651 . . . . 74.329999999999998 110.692 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.02 -63.02 1.44 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.369 -0.832 . . . . 74.340000000000003 111.005 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 16' ' ' LEU . 64.6 m -62.24 -26.21 68.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.387 -0.37 . . . . 73.319999999999993 111.936 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.02 -69.86 0.1 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.189 -0.46 . . . . 61.409999999999997 111.751 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.57 -16.67 44.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.185 0.439 . . . . 51.329999999999998 112.185 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.78 -53.62 44.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 110.716 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.52 95.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.14 -0.552 . . . . 70.510000000000005 112.444 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 59.4 m -60.85 -46.74 89.4 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.918 0.34 . . . . 73.200000000000003 111.918 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.82 -43.62 98.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.771 0.32 . . . . 74.150000000000006 111.278 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.2 tp -57.31 -45.05 84.59 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.263 0.554 . . . . 63.039999999999999 110.008 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' O ' HG21 ' A' ' 143' ' ' THR . . . -61.97 -35.5 91.48 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.807 -0.633 . . . . 70.510000000000005 112.785 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLN . . . . . 0.497 ' HA ' HG21 ' A' ' 143' ' ' THR . 24.6 mt-30 -65.19 -35.56 81.45 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.909 0.354 . . . . 70.319999999999993 111.352 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -62.38 -47.6 83.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.072 0.463 . . . . 74.109999999999999 110.391 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.24 -55.53 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.821 -0.627 . . . . 72.299999999999997 111.684 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 140' ' ' GLN . 8.8 t -63.27 -28.31 69.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.071 0.397 . . . . 64.409999999999997 112.071 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -68.42 -50.47 52.52 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.104 0.478 . . . . 75.430000000000007 111.164 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.89 -29.69 66.95 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.52 . . . . 75.230000000000004 111.669 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -100.58 -31.72 11.12 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.995 1.109 . . . . 63.450000000000003 113.995 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 113.943 1.09 . . . . 70.450000000000003 113.943 -173.114 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 57.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.375 -0.232 . . . . 50.140000000000001 110.375 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.721 HD11 HG23 ' A' ' 142' ' ' VAL . 30.3 mm 69.96 103.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.971 -174.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -90.13 106.58 3.35 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.211 -0.518 . . . . 65.319999999999993 112.969 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.611 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -83.09 116.1 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.53 0.681 . . . . 75.040000000000006 111.705 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.497 ' HB3' HD23 ' A' ' 36' ' ' LEU . 63.0 m-85 -89.98 113.25 24.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.715 -0.675 . . . . 74.439999999999998 110.467 176.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 36.8 p90 -137.84 -178.59 5.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.146 0.498 . . . . 74.25 112.01 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 10' ' ' TYR . 23.8 t -126.87 111.94 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.145 -0.48 . . . . 72.0 111.004 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.851 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 46.6 t -61.9 -26.33 68.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.19 0.811 . . . . 72.329999999999998 113.19 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.38 -64.5 1.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.285 0.564 . . . . 65.349999999999994 112.42 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.4 ' H ' HG12 ' A' ' 7' ' ' VAL . 19.8 t80 -71.6 127.26 31.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.855 -0.611 . . . . 74.340000000000003 112.247 -171.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.91 -161.98 7.44 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 114.994 0.758 . . . . 36.75 114.994 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -87.35 7.22 29.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.04 0.385 . . . . 74.430000000000007 112.04 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.502 ' HB2' ' HE1' ' A' ' 59' ' ' MET . 32.1 t -46.87 -40.85 14.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.115 0.783 . . . . 63.039999999999999 113.115 -171.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.851 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 20.1 p-10 -67.38 -41.63 84.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.143 0.497 . . . . 65.349999999999994 111.526 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -68.19 -36.66 79.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.174 -0.466 . . . . 73.040000000000006 110.819 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.85 -44.79 96.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.313 0.578 . . . . 71.219999999999999 110.375 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.85 87.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.806 -0.634 . . . . 72.140000000000001 111.303 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.96 -44.06 91.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.589 -0.278 . . . . 44.329999999999998 111.083 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -43.17 82.23 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.006 0.432 . . . . 61.109999999999999 111.158 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.41 -58.71 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.152 -0.476 . . . . 63.350000000000001 111.846 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.657 HG13 ' HB ' ' A' ' 31' ' ' VAL . 13.4 tt -60.02 -48.92 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 111.903 0.334 . . . . 74.120000000000005 111.903 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -66.65 -39.26 88.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.542 0.201 . . . . 74.439999999999998 111.542 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.47 95.02 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.891 -0.671 . . . . 72.040000000000006 112.644 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 29' ' ' VAL . 59.9 mt -83.04 -35.71 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.17 0.433 . . . . 61.399999999999999 112.17 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.8 p -69.12 -39.58 78.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.006 -0.434 . . . . 45.43 111.054 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.35 -43.07 78.74 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.097 0.475 . . . . 73.299999999999997 110.094 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.3 m -63.0 -43.01 99.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 111.028 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.54 67.44 0.33 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.222 -0.513 . . . . 63.109999999999999 113.619 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.625 ' HB ' HG23 ' A' ' 24' ' ' ILE . 62.5 t -139.37 -68.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 122.525 -0.397 . . . . 70.120000000000005 111.71 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.93 113.14 2.94 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.28 -0.486 . . . . 73.140000000000001 112.814 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.657 ' HB ' HG13 ' A' ' 21' ' ' ILE . 82.2 t -109.65 144.42 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.686 0.279 . . . . 55.219999999999999 111.698 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 18.2 m-20 -93.38 147.47 22.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 64.450000000000003 110.986 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.73 132.28 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 112.431 0.53 . . . . 74.219999999999999 112.431 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 86.9 t -141.49 125.02 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.035 -0.529 . . . . 73.209999999999994 111.026 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.5 m-20 -85.73 99.77 11.55 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.007 -0.433 . . . . 62.030000000000001 111.935 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -69.78 -21.12 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.027 0.442 . . . . 52.5 111.675 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' HD13 ' A' ' 36' ' ' LEU . . . -114.64 23.63 11.86 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.651 -0.785 . . . . 62.340000000000003 113.805 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.87 -72.95 0.11 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.73 0.641 . . . . 73.200000000000003 112.73 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.01 23.47 1.22 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.184 0.809 . . . . 74.540000000000006 113.184 -172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.0 m -57.84 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.645 0.736 . . . . 73.209999999999994 112.25 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.77 171.59 14.94 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.87 -0.605 . . . . 75.040000000000006 110.448 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.27 -36.25 60.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.306 0.242 . . . . 60.450000000000003 111.242 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -57.17 -36.27 70.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.034 0.383 . . . . 55.229999999999997 112.034 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -69.04 -46.28 68.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.394 0.616 . . . . 62.32 110.519 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' O ' HG22 ' A' ' 49' ' ' VAL . 82.2 mt -61.52 -36.81 81.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.768 -0.651 . . . . 73.349999999999994 111.309 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' NH2' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.55 -46.97 85.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 72.200000000000003 110.288 177.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 7.7 tp10 -66.39 -37.95 86.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.951 0.405 . . . . 65.420000000000002 110.877 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 tp -57.63 -30.48 65.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.178 -0.464 . . . . 74.239999999999995 111.607 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 45' ' ' LEU . 63.7 t -63.25 -53.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.98 0.419 . . . . 64.25 111.478 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.17 -37.36 49.08 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.264 -0.493 . . . . 63.340000000000003 113.697 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -90.24 8.08 34.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.078 0.399 . . . . 73.010000000000005 112.078 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -51.31 -8.77 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.425 1.268 . . . . 72.209999999999994 114.425 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 p -65.09 -18.18 65.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.778 0.659 . . . . 74.310000000000002 112.778 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.64 ' HA3' HD12 ' A' ' 2' ' ' ILE . . . -160.85 137.84 5.17 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.587 -0.816 . . . . 42.299999999999997 113.973 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.7 mp -128.76 159.22 36.36 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.866 0.466 . . . . 73.299999999999997 110.824 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 70.7 t -140.66 122.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.429 0.291 . . . . 74.519999999999996 110.824 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 87' ' ' ILE . 4.0 mp -122.22 130.87 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.886 0.374 . . . . 75.230000000000004 111.253 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.23 -128.0 3.22 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.993 -0.622 . . . . 73.420000000000002 112.908 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.502 ' HE1' ' HB2' ' A' ' 13' ' ' SER . 0.0 OUTLIER -84.5 161.29 20.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.14 0.495 . . . . 64.450000000000003 111.515 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -113.03 90.62 16.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.525 -0.307 . . . . 70.109999999999999 111.505 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.36 137.64 16.95 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.971 2.448 . . . . 75.230000000000004 112.093 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.93 -48.28 51.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.414 0.524 . . . . 72.200000000000003 112.414 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.62 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.311 0.485 . . . . 44.329999999999998 112.311 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m -78.84 -33.85 45.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.745 0.307 . . . . 64.319999999999993 111.493 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 72.25 111.927 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.64 -33.58 76.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.97 0.359 . . . . 63.039999999999999 111.97 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -85.22 -12.59 52.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.033 0.383 . . . . 73.400000000000006 112.033 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mm -87.86 -23.33 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.177 0.436 . . . . 73.329999999999998 112.177 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -48.49 -48.15 38.2 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.769 0.655 . . . . 60.420000000000002 112.769 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 -57.3 7.35 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.14 -0.553 . . . . 75.420000000000002 113.322 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -55.86 -35.91 66.97 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.417 0.525 . . . . 74.530000000000001 112.417 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.53 -41.68 66.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.612 0.365 . . . . 73.430000000000007 111.006 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -58.98 -47.21 85.97 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.781 0.324 . . . . 74.540000000000006 111.537 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.0 -39.09 93.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.839 0.352 . . . . 71.420000000000002 111.275 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 71' ' ' ALA . 65.3 mt -58.37 -47.06 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.358 -0.383 . . . . 71.140000000000001 111.335 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 82.4 mt -55.35 -28.18 52.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.481 -0.327 . . . . 70.239999999999995 111.875 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.68 -32.23 30.85 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.216 -0.516 . . . . 73.420000000000002 113.195 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p -80.78 -58.68 2.99 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.855 0.317 . . . . 72.209999999999994 111.855 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 75' ' ' ILE . 29.8 m -68.79 145.12 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.338 0.59 . . . . 71.409999999999997 112.112 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -161.37 -168.76 2.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.021 -0.536 . . . . 72.329999999999998 111.429 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.72 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 10.5 tp10 64.08 -95.76 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.701 1.0 . . . . 75.109999999999999 113.701 167.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.72 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.2 ptpp? -169.43 30.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.95 0.405 . . . . 73.230000000000004 111.801 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.452 ' OE1' ' HB3' ' A' ' 81' ' ' GLU . 8.0 mp0 -61.33 176.35 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.578 0.704 . . . . 72.439999999999998 112.642 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.685 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.06 139.53 30.53 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.573 0.582 . . . . 75.030000000000001 112.573 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.99 96.15 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.679 0.752 . . . . 74.319999999999993 110.854 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.3 80.68 0.73 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.944 -0.571 . . . . 53.399999999999999 113.285 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.426 HD13 ' HB ' ' A' ' 57' ' ' ILE . 32.5 mm -82.78 113.85 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 122.725 -0.28 . . . . 64.549999999999997 110.576 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.16 133.07 53.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.368 0.604 . . . . 75.230000000000004 112.267 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.79 ' HB3' ' HB1' ' A' ' 116' ' ' ALA . 9.5 tp10 -76.23 137.86 40.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.76 -0.655 . . . . 62.420000000000002 111.335 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.536 ' HG1' ' HG3' ' A' ' 123' ' ' PRO . 10.2 t -156.11 -2.75 0.13 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.97 0.73 . . . . 73.310000000000002 112.97 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.81 109.86 0.39 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.692 -0.766 . . . . 73.129999999999995 113.13 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.24 79.67 0.52 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.527 -0.368 . . . . 53.520000000000003 113.22 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.82 78.39 0.06 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.379 -0.439 . . . . 36.75 112.53 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -98.47 -174.8 2.91 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.239 0.542 . . . . 70.109999999999999 111.966 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -118.67 138.08 52.86 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.919 -0.582 . . . . 62.140000000000001 109.959 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.535 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 32.8 mt-10 -45.34 -48.4 34.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.601 1.334 . . . . 71.040000000000006 114.601 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 86.0 Cg_exo -50.46 -12.21 0.49 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.915 2.41 . . . . 54.219999999999999 115.092 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.89 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 121.903 -0.498 . . . . 71.310000000000002 111.854 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.486 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.1 m-20 -57.18 -51.18 83.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 112.577 0.584 . . . . 74.109999999999999 112.577 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 90.4 Cg_exo -47.78 -40.18 31.49 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.309 2.006 . . . . 74.140000000000001 112.893 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 97' ' ' PRO . 9.7 mp -71.99 -41.57 67.49 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.58 -0.282 . . . . 62.140000000000001 111.205 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.3 mt -58.64 -37.3 75.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 55.530000000000001 111.056 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -58.08 -31.85 67.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.19 -0.459 . . . . 72.310000000000002 110.917 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -68.29 -50.12 55.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.798 0.333 . . . . 73.129999999999995 110.742 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.91 -37.33 76.37 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.16 0.505 . . . . 75.530000000000001 110.777 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -64.74 -60.05 3.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.69 -0.687 . . . . 74.340000000000003 111.207 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.18 -56.08 24.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 112.529 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.17 -23.07 65.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.737 0.273 . . . . 73.219999999999999 111.737 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.4 61.24 5.23 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.291 -0.481 . . . . 72.409999999999997 113.558 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.59 156.55 19.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.625 -0.338 . . . . 74.140000000000001 110.989 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.685 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 27.5 m -70.12 93.1 0.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 51.329999999999998 111.509 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -86.63 159.07 19.33 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.22 0.533 . . . . 45.340000000000003 112.319 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.04 -164.81 1.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.127 -0.488 . . . . 73.409999999999997 111.808 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.25 112.34 5.34 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 112.074 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -90.68 107.4 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.014 2.476 . . . . 74.439999999999998 113.484 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.79 ' HB1' ' HB3' ' A' ' 89' ' ' GLU . . . -89.66 177.38 6.55 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.189 -0.319 . . . . 51.240000000000002 110.634 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.9 tt -132.58 102.52 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.665 0.617 . . . . 74.530000000000001 112.665 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 55.99 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.353 0.871 . . . . 71.310000000000002 113.353 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.552 HG12 ' HG3' ' A' ' 89' ' ' GLU . 46.4 mm -95.35 74.71 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.04 0.447 . . . . 64.200000000000003 110.39 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 51.46 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.807 0.669 . . . . 65.030000000000001 112.807 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 179.09 -42.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.181 0.592 . . . . 42.119999999999997 110.674 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.8 p -96.08 114.62 64.56 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 111.521 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HG3' ' HG1' ' A' ' 90' ' ' THR . 52.6 Cg_exo -53.47 127.76 26.63 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.713 2.276 . . . . 64.340000000000003 113.133 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 33.9 p -107.89 177.09 4.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.569 -0.287 . . . . 73.430000000000007 111.608 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.56 -34.96 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.01 0.433 . . . . 71.310000000000002 111.586 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.416 ' O ' HD12 ' A' ' 130' ' ' LEU . 16.0 m120 -58.05 -41.19 82.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.974 0.416 . . . . 71.430000000000007 110.609 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.7 m -56.82 -44.48 82.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.251 -0.431 . . . . 71.140000000000001 111.377 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -58.85 -46.36 87.93 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.279 0.562 . . . . 73.340000000000003 111.04 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.578 ' HB3' ' HZ1' ' A' ' 129' ' ' LYS . 8.6 mtpm? -61.94 -32.48 72.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.775 -0.648 . . . . 65.409999999999997 111.802 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 126' ' ' ASN . 10.9 mp -77.78 -42.25 34.59 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.303 -0.248 . . . . 73.349999999999994 111.418 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.9 m -58.66 -53.32 59.72 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 111.566 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.1 -54.08 50.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.269 -0.423 . . . . 64.5 111.759 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.81 -54.86 36.44 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.221 -0.445 . . . . 54.439999999999998 111.843 -177.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.5 97.27 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.71 0.29 . . . . 75.319999999999993 111.777 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.55 76.04 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.08 -0.581 . . . . 72.420000000000002 112.789 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.8 m -61.2 -42.62 98.91 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 62.299999999999997 111.041 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.33 -42.15 95.06 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.026 -0.534 . . . . 51.439999999999998 111.182 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 84' ' ' ALA . 52.5 tp -62.73 -44.28 96.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.125 0.488 . . . . 73.129999999999995 110.636 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -34.57 75.11 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 116.018 -0.537 . . . . 62.32 112.781 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 136' ' ' THR . 55.5 mt-30 -64.78 -25.68 68.02 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.714 0.292 . . . . 74.239999999999995 111.711 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -72.82 -52.43 14.94 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.068 0.461 . . . . 74.349999999999994 110.166 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.721 HG23 HD11 ' A' ' 2' ' ' ILE . 60.9 t -57.2 -45.16 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.797 -0.638 . . . . 72.329999999999998 112.172 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.58 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 9.0 t -61.71 -51.78 66.99 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.997 0.369 . . . . 72.450000000000003 111.997 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 143' ' ' THR . 90.5 mtt-85 -64.26 -41.64 96.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.113 0.482 . . . . 72.540000000000006 111.13 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.15 -49.87 68.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.122 -0.49 . . . . 70.450000000000003 111.725 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.484 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 0.1 OUTLIER -82.7 -11.07 58.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.183 0.438 . . . . 74.340000000000003 112.183 -174.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -88.44 11.15 17.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.157 0.503 . . . . 43.109999999999999 110.395 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.813 ' HB3' ' HB2' ' A' ' 151' ' ' HIS . 39.2 tt0 57.72 19.89 5.95 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.325 0.583 . . . . 71.430000000000007 112.455 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.6 t60 64.26 -76.43 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 112.675 0.62 . . . . 75.25 112.675 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -94.13 18.68 10.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.547 0.573 . . . . 74.420000000000002 112.547 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.813 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 56.1 t60 -74.9 -17.06 60.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.055 0.455 . . . . 74.019999999999996 111.195 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -125.66 109.83 13.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.31 -0.405 . . . . 63.450000000000003 111.134 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.21 143.46 57.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 74.319999999999993 111.83 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.84 -0.6 . . . . 75.340000000000003 111.108 177.153 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 25.3 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.389 0.137 . . . . 65.430000000000007 111.357 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.0 mp 58.7 97.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.214 0.531 . . . . 53.219999999999999 111.869 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.29 96.11 1.9 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.193 -0.527 . . . . 42.340000000000003 112.98 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -85.56 105.73 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 O-C-N 122.374 -0.486 . . . . 74.200000000000003 111.398 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.21 123.14 38.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.755 0.312 . . . . 75.439999999999998 111.276 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.18 175.0 9.95 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.956 0.407 . . . . 73.530000000000001 111.541 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 7' ' ' VAL . 5.9 p -121.62 95.99 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 64.430000000000007 111.129 176.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -52.6 -34.64 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.595 -0.73 . . . . 75.239999999999995 112.788 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.13 -35.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.64 0.608 . . . . 44.420000000000002 112.64 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -109.05 146.57 33.76 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.243 0.46 . . . . 75.319999999999993 112.243 -170.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.19 -164.18 5.18 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 114.521 0.568 . . . . 73.219999999999999 114.521 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.589 ' HD2' ' HG2' ' A' ' 123' ' ' PRO . 57.4 m-85 -87.45 9.47 20.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.762 0.425 . . . . 74.120000000000005 111.778 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -29.98 -48.97 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.729 1.381 . . . . 72.340000000000003 114.729 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.86 -46.17 90.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.896 0.379 . . . . 75.519999999999996 111.644 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.35 -38.21 89.39 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.928 0.394 . . . . 75.510000000000005 110.858 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.565 HD13 ' HG3' ' A' ' 123' ' ' PRO . 85.8 mt -61.59 -42.59 99.07 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.062 0.458 . . . . 74.120000000000005 110.778 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -58.6 -47.26 84.92 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.135 -0.484 . . . . 62.420000000000002 110.759 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.8 -37.75 60.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.14 0.495 . . . . 64.25 111.095 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.84 -54.37 19.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.289 -0.414 . . . . 55.509999999999998 111.498 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.4 mt -56.72 -46.79 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.234 0.54 . . . . 74.010000000000005 111.909 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.512 HG12 HG22 ' A' ' 31' ' ' VAL . 74.5 mt -60.19 -27.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.899 -0.591 . . . . 74.239999999999995 112.19 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -54.01 -68.59 0.17 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.018 0.377 . . . . 62.340000000000003 112.018 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.16 -36.64 89.57 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.242 -0.504 . . . . 63.539999999999999 113.644 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.05 -47.51 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 122.526 -0.397 . . . . 73.400000000000006 111.796 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.0 p -67.43 -34.66 77.68 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.109 0.411 . . . . 70.420000000000002 112.109 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.09 -23.23 64.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.277 0.56 . . . . 75.109999999999999 110.689 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.495 HG22 ' HB2' ' A' ' 152' ' ' HIS . 87.8 m -80.6 -12.98 59.43 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.225 0.536 . . . . 64.109999999999999 110.544 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.15 27.22 26.35 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.183 -0.532 . . . . 70.0 113.113 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.14 137.28 50.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 122.582 -0.364 . . . . 73.310000000000002 111.463 -178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 142.59 17.89 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.348 -0.453 . . . . 37.530000000000001 112.747 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG22 HG12 ' A' ' 21' ' ' ILE . 34.4 m -107.97 146.25 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.46 0.541 . . . . 72.219999999999999 112.46 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -108.16 92.7 4.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 110.654 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.62 122.63 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.759 0.314 . . . . 74.519999999999996 111.58 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -127.61 136.76 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.001 0.429 . . . . 74.299999999999997 111.537 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.1 123.75 32.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.925 0.393 . . . . 74.409999999999997 111.196 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.75 -13.46 48.22 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.173 0.434 . . . . 74.319999999999993 112.173 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.65 68.27 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.364 -0.446 . . . . 52.200000000000003 112.993 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.86 14.66 3.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.166 0.432 . . . . 45.100000000000001 112.166 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.07 118.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.333 0.587 . . . . 63.409999999999997 112.217 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.71 99.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.625 0.726 . . . . 62.009999999999998 112.199 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.59 158.15 27.93 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.592 -0.731 . . . . 72.109999999999999 111.724 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD11 HD13 ' A' ' 45' ' ' LEU . 3.4 mm? -60.37 -37.89 82.18 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.037 0.384 . . . . 72.329999999999998 112.037 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -66.88 -30.11 70.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.089 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.2 -32.88 56.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.093 0.473 . . . . 72.329999999999998 110.597 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 42' ' ' LEU . 85.4 mt -64.75 -32.28 73.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.416 -0.356 . . . . 75.319999999999993 110.825 174.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -58.78 -47.66 83.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.022 0.439 . . . . 75.510000000000005 110.193 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 73.1 mm-40 -58.19 -39.83 79.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.094 175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.38 -34.34 66.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.762 0.315 . . . . 70.030000000000001 111.336 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.07 -52.94 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.844 0.354 . . . . 72.340000000000003 111.21 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.93 -25.14 73.2 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.905 -0.664 . . . . 53.219999999999999 113.47 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -98.87 7.42 46.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.717 0.407 . . . . 74.510000000000005 111.806 178.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.59 5.69 0.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.629 0.974 . . . . 55.32 113.629 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.0 p -79.79 -36.88 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.112 -0.368 . . . . 75.420000000000002 111.876 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.8 137.71 5.33 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.92 -0.657 . . . . 74.400000000000006 113.239 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.69 164.17 39.15 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.865 0.364 . . . . 65.540000000000006 111.597 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -122.36 129.58 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.611 0.364 . . . . 72.409999999999997 110.664 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.478 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.8 mp -117.75 136.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.288 0.566 . . . . 64.420000000000002 112.463 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.91 125.55 8.45 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 116.071 -0.513 . . . . 44.130000000000003 112.476 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.461 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 55.5 ttm -56.87 101.86 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.353 0.596 . . . . 71.230000000000004 111.465 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.495 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 67.1 m -92.88 132.95 29.88 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 112.196 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.79 169.04 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.51 2.14 . . . . 62.229999999999997 112.756 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.96 -42.83 6.19 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.358 0.874 . . . . 75.010000000000005 113.358 -173.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.72 -62.84 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.983 0.364 . . . . 51.350000000000001 111.983 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 50.3 m -70.76 -22.22 62.42 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.009 0.433 . . . . 52.140000000000001 111.515 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.5 65.15 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 61.219999999999999 111.435 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.31 99.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.94 0.4 . . . . 71.530000000000001 111.356 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -62.24 -44.05 97.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.231 0.538 . . . . 61.5 110.904 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.436 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 61.5 mt -64.32 -45.32 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.044 -0.525 . . . . 53.109999999999999 110.832 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -54.42 -48.97 71.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.912 -0.586 . . . . 75.129999999999995 111.47 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.24 -27.28 72.21 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 73.340000000000003 112.927 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.96 -21.33 29.62 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 72.409999999999997 112.365 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 70.6 mt -51.26 -38.07 50.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.369 0.507 . . . . 72.439999999999998 112.369 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.4 m -54.25 -31.6 53.96 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.089 0.471 . . . . 71.310000000000002 111.535 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 m -94.13 -39.87 10.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 70.400000000000006 111.196 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.0 -54.27 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.262 0.467 . . . . 64.409999999999997 112.262 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.43 -17.53 13.55 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 63.340000000000003 112.723 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.15 -27.85 7.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.149 -0.548 . . . . 54.399999999999999 113.113 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.7 m -84.76 -25.58 28.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.462 0.542 . . . . 74.120000000000005 112.462 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.66 158.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.329 0.585 . . . . 63.109999999999999 112.359 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 27.9 t-20 -92.9 143.79 25.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.03 -0.532 . . . . 74.239999999999995 110.914 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -44.89 -44.62 9.78 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.382 0.882 . . . . 74.140000000000001 113.382 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 24.2 pttm -135.62 41.56 2.72 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.055 0.455 . . . . 71.409999999999997 112.012 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 3.9 pt20 -61.44 167.89 3.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.076 -0.511 . . . . 74.420000000000002 112.255 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.422 ' HB1' HD11 ' A' ' 138' ' ' LEU . . . -96.12 116.88 29.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.272 -0.422 . . . . 64.219999999999999 111.64 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.34 118.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.432 0.634 . . . . 73.200000000000003 112.121 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 139.27 15.14 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.088 -0.505 . . . . 72.140000000000001 112.781 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.31 138.95 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.896 0.379 . . . . 73.049999999999997 111.751 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -139.87 150.83 45.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.223 -0.444 . . . . 72.329999999999998 110.466 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -76.3 91.57 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.554 0.692 . . . . 75.540000000000006 112.309 -174.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.471 ' N ' HG12 ' A' ' 119' ' ' ILE . 52.8 m -154.51 134.34 12.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.192 -0.458 . . . . 72.129999999999995 111.243 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 59' ' ' MET . . . 99.35 -133.03 11.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.189 -0.529 . . . . 64.120000000000005 113.132 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.46 -125.69 9.54 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.084 -0.579 . . . . 62.310000000000002 113.297 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.66 -104.1 1.09 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.082 -0.58 . . . . 37.530000000000001 112.89 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.65 109.58 21.82 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.658 -0.319 . . . . 74.049999999999997 110.392 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.26 155.95 39.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.932 0.396 . . . . 63.25 111.543 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.635 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 31.6 mt-10 -106.95 -63.94 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 113.041 0.756 . . . . 75.099999999999994 113.041 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 32.5 Cg_endo -104.1 27.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 123.203 2.602 . . . . 73.049999999999997 116.204 -167.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 12.6 tt -53.26 -49.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.769 0.713 . . . . 63.140000000000001 112.842 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.585 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 16.7 m-20 -61.8 -51.59 74.8 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.491 0.552 . . . . 74.310000000000002 112.491 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.6 Cg_exo -48.99 -43.92 34.23 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.117 1.878 . . . . 73.120000000000005 113.063 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.494 HD12 ' O ' ' A' ' 97' ' ' PRO . 10.7 mp -65.48 -48.43 72.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.678 0.251 . . . . 73.109999999999999 111.678 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 95.1 mt -53.4 -47.85 69.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.003 0.43 . . . . 52.530000000000001 111.24 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -64.01 -43.83 94.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.429 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -56.53 -62.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.339 -0.391 . . . . 64.409999999999997 111.313 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -58.73 -30.53 67.54 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.797 0.295 . . . . 75.319999999999993 111.797 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 106' ' ' ARG . 31.5 ttt180 -61.76 -49.87 74.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.966 0.412 . . . . 74.530000000000001 111.256 175.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.47 -8.07 43.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.721 0.637 . . . . 70.510000000000005 112.721 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 mp -98.43 -40.33 8.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.849 0.357 . . . . 74.239999999999995 110.628 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 52.54 3.08 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.202 -0.523 . . . . 54.32 113.873 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 6.5 mp -76.54 151.17 36.44 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.894 0.378 . . . . 74.349999999999994 111.47 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.2 m -68.36 87.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.377 0.608 . . . . 75.140000000000001 110.142 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.9 m -99.53 135.74 40.49 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.733 -0.667 . . . . 72.530000000000001 112.149 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.83 -64.17 0.94 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.854 0.359 . . . . 51.340000000000003 111.889 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -158.23 99.72 1.76 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 120.656 0.265 . . . . 74.510000000000005 111.31 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -90.52 17.37 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.083 2.522 . . . . 75.219999999999999 114.027 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.98 13.07 19.44 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.458 . . . . 64.040000000000006 112.238 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.59 139.43 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.088 0.47 . . . . 73.420000000000002 111.545 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -128.41 127.51 42.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.368 -0.378 . . . . 65.019999999999996 110.375 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.537 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.4 mp -106.48 141.06 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.225 0.536 . . . . 64.420000000000002 111.734 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 121' ' ' GLN . 19.5 ptmt -78.63 -40.32 34.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 112.497 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.566 ' HG2' HG22 ' A' ' 122' ' ' THR . 65.1 tt0 -175.36 -70.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.102 0.477 . . . . 73.219999999999999 111.679 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.566 HG22 ' HG2' ' A' ' 121' ' ' GLN . 60.7 p -115.1 153.45 47.22 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.459 -0.337 . . . . 73.510000000000005 111.78 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.589 ' HG2' ' HD2' ' A' ' 12' ' ' TYR . 72.7 Cg_endo -75.37 -175.57 2.49 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.619 2.213 . . . . 75.099999999999994 113.185 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.0 p -111.53 175.54 5.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.92 0.39 . . . . 63.420000000000002 111.322 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.82 -25.33 62.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 74.230000000000004 110.83 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -70.3 -28.33 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.046 0.451 . . . . 74.299999999999997 110.901 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.9 m -54.22 -35.33 62.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.084 -0.507 . . . . 71.209999999999994 111.931 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -58.03 -27.55 63.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.008 0.432 . . . . 63.25 111.687 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -85.65 -39.67 17.02 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.939 0.399 . . . . 75.209999999999994 110.447 177.024 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.23 -56.17 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.008 -0.542 . . . . 71.400000000000006 111.155 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.4 m -55.06 -38.04 67.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.014 0.376 . . . . 75.120000000000005 112.014 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.12 -46.44 74.16 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.226 0.536 . . . . 72.230000000000004 110.908 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.18 -52.93 61.82 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.981 -0.554 . . . . 61.200000000000003 111.522 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.05 99.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.245 -0.434 . . . . 61.520000000000003 111.566 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -55.81 -38.94 75.62 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.258 -0.496 . . . . 73.040000000000006 112.799 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.432 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 88.9 m -65.96 -44.67 84.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.731 0.301 . . . . 71.349999999999994 111.126 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.04 -50.79 72.22 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.987 0.422 . . . . 54.520000000000003 111.695 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.422 HD11 ' HB1' ' A' ' 84' ' ' ALA . 3.9 mm? -70.14 -43.26 71.29 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.865 0.364 . . . . 64.219999999999999 111.165 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.0 -47.83 65.02 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 116.132 -0.486 . . . . 50.240000000000002 113.566 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.654 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 90.5 mt-30 -59.79 -53.12 61.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.668 0.27 . . . . 64.140000000000001 111.35 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 77.4 t90 -51.62 -52.98 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.753 0.311 . . . . 73.439999999999998 111.426 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 57.4 t -57.08 -43.0 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.52 0.563 . . . . 72.129999999999995 112.52 -177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 144' ' ' ARG . 8.7 t -78.11 -49.92 13.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.152 0.797 . . . . 75.140000000000001 113.152 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -84.88 -4.73 59.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.155 0.798 . . . . 73.400000000000006 113.155 -172.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.413 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 27.7 t70 -62.09 -18.39 60.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.189 0.44 . . . . 50.420000000000002 112.189 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.593 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 1.7 mpt_? -78.72 -27.57 44.93 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.662 0.615 . . . . 75.439999999999998 112.662 -176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.6 tt -173.9 -37.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.11 0.481 . . . . 63.32 109.919 -174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 76.36 98.42 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.072 -0.967 . . . . 73.510000000000005 113.359 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.8 -5.83 47.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.115 -1.069 . . . . 74.530000000000001 108.115 160.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.1 t60 59.88 -81.38 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.277 -1.329 . . . . 75.340000000000003 112.263 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 51.25 81.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.21 0.818 . . . . 71.329999999999998 113.21 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.495 ' HB2' HG22 ' A' ' 27' ' ' THR . 50.8 t-80 -173.69 146.84 1.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.248 0.547 . . . . 72.349999999999994 111.784 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -134.63 156.08 49.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.621 -0.718 . . . . 74.129999999999995 110.038 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.9 m80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.855 -0.593 . . . . 73.439999999999998 111.344 173.486 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.853 0.316 . . . . 74.140000000000001 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 24' ' ' ILE . 46.4 mm -69.77 97.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.992 0.367 . . . . 75.200000000000003 111.992 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.16 1.38 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.084 -0.579 . . . . 55.0 112.529 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 17' ' ' ALA . 6.7 p -91.9 110.25 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.261 0.553 . . . . 71.0 112.11 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.402 ' HB3' HD22 ' A' ' 36' ' ' LEU . 82.5 m-85 -95.07 99.09 11.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 70.230000000000004 110.955 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CD2' ' HA ' ' A' ' 14' ' ' ASP . 26.6 p90 -130.13 -179.52 5.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.837 0.351 . . . . 73.109999999999999 111.52 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.647 HG13 ' H ' ' A' ' 10' ' ' TYR . 22.3 t -121.98 107.32 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.921 0.391 . . . . 74.230000000000004 111.842 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 74.1 m -78.23 -21.91 49.25 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 111.354 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -78.24 -32.69 49.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.885 -0.598 . . . . 75.5 112.052 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.647 ' H ' HG13 ' A' ' 7' ' ' VAL . 69.1 t80 -129.13 133.03 47.45 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.92 0.711 . . . . 75.209999999999994 112.92 -170.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.5 -162.49 5.19 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.562 0.985 . . . . 64.209999999999994 115.562 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 2.12 29.11 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.64 0.607 . . . . 72.329999999999998 112.64 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.3 t -49.36 -37.56 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.102 0.477 . . . . 71.239999999999995 111.853 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 17.0 t0 -56.71 -60.18 3.93 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.864 -0.607 . . . . 62.229999999999997 111.255 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 15' ' ' ARG . 20.1 mmt180 -70.97 -28.58 64.56 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.28 0.474 . . . . 72.530000000000001 112.28 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.11 -43.99 87.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 75.340000000000003 110.501 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 4' ' ' VAL . . . -75.04 -44.27 48.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.753 -0.658 . . . . 73.239999999999995 111.43 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -53.77 -53.26 54.79 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.387 -0.37 . . . . 74.120000000000005 111.883 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -25.21 61.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.31 0.485 . . . . 75.400000000000006 112.31 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 132' ' ' GLU . 66.1 mt -87.55 -57.4 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.846 0.355 . . . . 75.340000000000003 111.442 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.485 ' HB ' HG12 ' A' ' 31' ' ' VAL . 2.7 pp -59.15 -27.17 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.7 0.286 . . . . 72.329999999999998 111.762 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.431 ' N ' HD12 ' A' ' 21' ' ' ILE . 27.3 t-20 -59.4 -48.88 79.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.515 -0.311 . . . . 70.120000000000005 110.619 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.36 -34.24 87.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.166 -0.54 . . . . 38.130000000000003 112.758 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.622 HG21 HG13 ' A' ' 2' ' ' ILE . 62.4 mt -62.69 -53.12 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 122.49 -0.418 . . . . 75.420000000000002 111.335 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.8 t -68.19 -31.15 70.48 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.909 0.385 . . . . 70.030000000000001 111.001 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -62.34 -34.52 76.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.057 0.456 . . . . 74.430000000000007 111.034 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -71.35 -31.88 67.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.311 -0.404 . . . . 72.299999999999997 111.0 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.81 5.42 4.89 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.165 -0.541 . . . . 55.219999999999999 114.17 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.634 HG23 ' HB ' ' A' ' 143' ' ' THR . 21.8 t -94.34 126.53 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 117.439 0.619 . . . . 71.209999999999994 111.698 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.95 122.6 22.19 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.444 -0.408 . . . . 73.530000000000001 113.689 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG12 ' HB ' ' A' ' 21' ' ' ILE . 61.3 t -104.07 143.56 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.118 0.485 . . . . 64.010000000000005 112.168 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.77 113.68 22.91 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.136 -0.484 . . . . 75.099999999999994 110.422 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.84 124.0 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.269 0.557 . . . . 63.450000000000003 112.11 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.04 108.03 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.85 0.357 . . . . 60.119999999999997 111.497 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.49 111.23 20.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.908 0.385 . . . . 41.450000000000003 111.188 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.438 ' HA ' HG11 ' A' ' 40' ' ' VAL . 4.4 pp -86.8 -8.96 56.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.424 -0.353 . . . . 64.209999999999994 111.1 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -59.72 -45.3 95.95 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.356 -0.449 . . . . 64.409999999999997 112.768 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.58 17.69 3.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.701 0.286 . . . . 62.409999999999997 111.446 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.16 147.22 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.198 0.599 . . . . 54.119999999999997 111.917 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 36' ' ' LEU . 27.1 m -117.43 151.87 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.337 . . . . 72.420000000000002 111.546 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -104.98 169.36 8.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.053 0.454 . . . . 72.209999999999994 111.064 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.81 -18.44 32.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.116 0.413 . . . . 74.420000000000002 112.116 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -57.6 -55.46 34.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.828 0.347 . . . . 73.140000000000001 110.775 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.94 -37.19 78.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.179 0.514 . . . . 63.020000000000003 110.837 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 3.0 tm? -61.32 -38.73 87.92 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.978 -0.555 . . . . 72.319999999999993 111.127 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -70.85 -40.32 72.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.961 -0.462 . . . . 70.329999999999998 110.925 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 18.1 mm-40 -58.41 -28.15 64.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.008 0.432 . . . . 72.340000000000003 111.323 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.608 HD12 HD12 ' A' ' 55' ' ' LEU . 57.7 tp -56.18 -31.11 63.12 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.189 -0.459 . . . . 71.030000000000001 111.448 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.97 -36.39 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.872 0.367 . . . . 65.239999999999995 111.328 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.55 -20.01 55.31 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.081 -0.581 . . . . 54.539999999999999 112.895 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 7.4 mpt_? -94.38 5.11 52.79 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.579 -0.365 . . . . 60.140000000000001 111.934 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -63.56 -16.0 59.61 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.889 0.329 . . . . 75.420000000000002 111.889 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.1 p -66.15 -25.31 66.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.821 0.343 . . . . 72.219999999999999 111.643 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.5 135.93 3.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.374 -0.441 . . . . 38.130000000000003 112.493 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.608 HD12 HD12 ' A' ' 48' ' ' LEU . 2.3 pt? -163.83 170.32 17.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.117 0.484 . . . . 70.5 111.662 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 p -148.76 124.33 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.340000000000003 111.174 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.505 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -95.8 135.4 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.13 -0.486 . . . . 71.239999999999995 110.96 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.5 -86.58 0.68 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.229 -0.51 . . . . 70.120000000000005 113.805 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.5 pmm? -151.92 167.96 26.7 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.3 -0.53 . . . . 73.129999999999995 111.855 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.3 p -144.18 49.13 0.99 Allowed Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 112.345 0.498 . . . . 74.209999999999994 112.345 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.13 157.57 61.1 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.414 2.076 . . . . 75.129999999999995 113.599 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.0 -50.48 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.523 0.934 . . . . 74.519999999999996 113.523 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.04 -46.51 65.09 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.601 0.593 . . . . 64.299999999999997 112.601 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -102.11 5.26 40.31 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.507 0.558 . . . . 64.120000000000005 112.507 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.86 -29.88 70.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.776 1.028 . . . . 64.239999999999995 113.776 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -37.47 -70.53 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.905 1.076 . . . . 73.120000000000005 113.905 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.4 m -77.39 -37.77 51.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.823 0.344 . . . . 71.349999999999994 111.79 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.45 -43.99 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.462 0.541 . . . . 63.329999999999998 112.462 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.03 -40.82 95.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.852 0.358 . . . . 72.519999999999996 111.413 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.88 -36.52 90.35 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.016 -0.611 . . . . 38.130000000000003 112.203 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -68.52 -51.14 46.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.826 -0.22 . . . . 74.040000000000006 111.119 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.485 HD22 HD12 ' A' ' 75' ' ' ILE . 98.3 mt -53.79 -45.71 70.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.925 0.393 . . . . 64.230000000000004 111.678 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -56.75 -28.1 60.58 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.104 -0.498 . . . . 61.200000000000003 111.285 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 m -86.89 -40.19 15.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.259 -0.428 . . . . 75.439999999999998 111.136 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.485 HD12 HD22 ' A' ' 72' ' ' LEU . 73.7 mt -56.13 -40.6 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.394 -0.366 . . . . 73.340000000000003 111.679 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.2 mt -56.37 -26.67 53.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.51 -0.314 . . . . 62.140000000000001 111.651 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.9 31.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.189 -0.529 . . . . 38.130000000000003 113.463 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 75' ' ' ILE . 89.4 p -87.8 -34.27 18.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.247 0.524 . . . . 74.140000000000001 111.882 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.97 135.13 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.974 0.416 . . . . 73.120000000000005 111.59 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 82' ' ' LYS . 24.7 t-20 -89.53 107.01 18.83 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.298 0.481 . . . . 72.329999999999998 112.298 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 36.84 -75.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.89 1.441 . . . . 73.5 114.89 167.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.1 96.51 5.13 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.216 0.531 . . . . 74.299999999999997 112.401 -174.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.683 ' H ' HD23 ' A' ' 110' ' ' LEU . 85.6 mm-40 -133.97 172.72 12.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.433 -0.349 . . . . 74.120000000000005 110.851 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.5 107.81 18.06 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.048 0.452 . . . . 38.130000000000003 111.282 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG11 HD22 ' A' ' 55' ' ' LEU . 24.4 m -109.67 119.4 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.565 0.698 . . . . 72.129999999999995 112.158 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.39 142.51 25.01 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.177 -0.535 . . . . 74.400000000000006 112.507 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.455 ' H ' ' HB1' ' A' ' 113' ' ' ALA . 7.1 tp -160.86 137.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.655 -0.32 . . . . 73.120000000000005 110.793 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -161.64 161.69 29.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.532 0.333 . . . . 73.430000000000007 110.753 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 1.3 pm0 -81.65 146.28 30.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.495 0.664 . . . . 71.510000000000005 112.095 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.3 m -140.1 100.61 3.96 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.157 -0.474 . . . . 71.150000000000006 111.126 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . 79.01 -170.81 54.91 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.081 -0.58 . . . . 38.130000000000003 113.309 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.23 79.26 0.41 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.127 -0.559 . . . . 72.519999999999996 112.708 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.05 159.34 53.5 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.427 -0.416 . . . . 51.539999999999999 113.856 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -162.69 108.03 1.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.436 -0.579 . . . . 74.200000000000003 109.436 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.18 151.52 50.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.987 0.422 . . . . 70.310000000000002 111.556 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.616 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.2 tm-20 -91.47 -58.05 0.24 Allowed Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 116.384 -0.371 . . . . 55.100000000000001 111.943 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 96' ' ' GLU . 85.0 Cg_endo -84.83 84.95 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.93 1.753 . . . . 74.25 113.224 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.647 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.5 tp -92.08 -66.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 112.005 0.372 . . . . 72.209999999999994 112.005 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.647 ' H ' HG23 ' A' ' 98' ' ' ILE . 4.6 m-20 -59.19 -46.85 99.23 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 113.029 0.751 . . . . 52.229999999999997 113.029 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -42.67 -38.4 6.4 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.935 2.423 . . . . 73.430000000000007 114.289 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.42 -49.38 10.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.686 0.279 . . . . 74.219999999999999 111.053 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 86.1 mt -51.28 -44.06 61.73 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.421 0.526 . . . . 70.319999999999993 112.421 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.3 t -57.24 -42.28 81.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.699 0.285 . . . . 71.129999999999995 111.655 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -59.32 -46.84 87.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 74.519999999999996 111.271 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 110' ' ' LEU . 78.0 m-85 -63.22 -52.21 63.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.123 0.487 . . . . 71.439999999999998 111.135 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -54.62 -45.02 73.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.571 -0.74 . . . . 71.25 112.415 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -74.28 -56.1 5.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 74.519999999999996 112.569 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.37 -40.96 96.22 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.508 0.558 . . . . 64.340000000000003 112.508 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.2 17.54 4.88 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.968 -0.634 . . . . 70.129999999999995 112.774 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 83' ' ' GLN . 59.7 mt -73.31 102.9 3.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.064 0.459 . . . . 72.439999999999998 110.384 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.9 m -63.58 102.74 0.46 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.109 -0.496 . . . . 74.420000000000002 111.971 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -85.7 132.24 34.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.92 -0.582 . . . . 74.310000000000002 111.171 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HB1' ' H ' ' A' ' 87' ' ' ILE . . . -55.66 -76.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.773 0.286 . . . . 74.150000000000006 111.773 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -164.69 88.54 1.05 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.966 0.412 . . . . 74.340000000000003 111.253 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.06 112.03 1.69 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.649 2.233 . . . . 73.329999999999998 113.859 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB2' HH21 ' A' ' 118' ' ' ARG . . . -170.28 -173.17 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.581 -0.281 . . . . 40.520000000000003 111.209 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.71 88.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.233 0.539 . . . . 74.150000000000006 111.525 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.571 HH21 ' HB2' ' A' ' 116' ' ' ALA . 8.4 ptp180 -104.87 -18.63 14.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.759 0.314 . . . . 75.129999999999995 111.658 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.67 111.39 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 71.450000000000003 110.806 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.97 -48.68 80.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.04 -0.527 . . . . 74.010000000000005 112.138 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.463 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 8.7 tt0 -158.81 -49.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.083 0.468 . . . . 71.040000000000006 111.335 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -114.49 117.85 42.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.337 -0.392 . . . . 74.400000000000006 111.662 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.55 126.45 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.376 2.05 . . . . 63.100000000000001 112.423 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.4 p -78.14 172.29 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.571 0.224 . . . . 73.150000000000006 110.924 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.63 -30.8 44.56 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.751 0.278 . . . . 70.439999999999998 111.751 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -52.95 -32.37 45.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.161 0.505 . . . . 70.010000000000005 111.081 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 m -61.19 -48.49 81.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.054 -0.521 . . . . 73.109999999999999 110.908 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -58.81 -51.51 69.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.192 -0.458 . . . . 65.230000000000004 111.248 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -33.76 76.3 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.22 -0.445 . . . . 73.019999999999996 112.097 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.24 -60.04 2.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.043 0.449 . . . . 52.409999999999997 110.914 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.99 -27.86 67.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.262 -0.426 . . . . 73.340000000000003 112.084 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.44 ' HA ' HG12 ' A' ' 20' ' ' ILE . 40.0 tt0 -52.43 -50.96 61.53 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.404 -0.362 . . . . 72.519999999999996 111.896 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.8 -46.89 85.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.735 0.303 . . . . 74.019999999999996 111.316 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.42 -48.94 73.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.914 0.388 . . . . 65.040000000000006 111.604 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.83 -38.72 94.62 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.097 -0.573 . . . . 70.0 113.108 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 99.7 m -63.35 -49.15 75.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.733 0.302 . . . . 72.25 111.186 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.12 -37.49 80.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.1 0.476 . . . . 72.439999999999998 110.751 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.42 ' O ' HG21 ' A' ' 142' ' ' VAL . 3.4 tm? -59.16 -51.59 69.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 74.230000000000004 110.237 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.97 -44.2 94.64 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.278 -0.487 . . . . 38.130000000000003 112.762 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.06 -30.84 71.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.230000000000004 111.331 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.49 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 88.5 t90 -71.65 -51.52 22.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.187 0.518 . . . . 74.310000000000002 110.833 176.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 138' ' ' LEU . 77.2 t -54.43 -46.88 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.279 -0.419 . . . . 74.109999999999999 112.005 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.634 ' HB ' HG23 ' A' ' 29' ' ' VAL . 7.4 t -62.41 -37.98 87.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.8 0.667 . . . . 71.510000000000005 112.8 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 141' ' ' TRP . 8.0 ptp180 -75.32 -41.38 56.92 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.076 -0.39 . . . . 71.219999999999999 111.54 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.19 -14.54 35.82 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.952 0.723 . . . . 72.530000000000001 112.952 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.77 -34.65 78.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.42 0.629 . . . . 73.209999999999994 109.673 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.5 tp -85.08 -78.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.433 -0.803 . . . . 74.299999999999997 109.818 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.741 ' HA ' ' HB3' ' A' ' 151' ' ' HIS . 33.1 tt0 -178.02 104.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.273 0.558 . . . . 72.329999999999998 112.231 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -114.83 -64.7 1.28 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.254 -0.647 . . . . 75.299999999999997 109.254 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -120.4 25.8 9.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.979 -1.119 . . . . 75.329999999999998 107.979 168.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.741 ' HB3' ' HA ' ' A' ' 148' ' ' GLU . 20.8 t-80 -86.16 77.16 9.64 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.286 -1.325 . . . . 74.109999999999999 112.364 -170.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -88.57 78.3 7.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.422 0.63 . . . . 72.109999999999999 109.9 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 173.95 167.02 0.2 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.232 -0.895 . . . . 74.5 109.222 -173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 . . . . . 0 C--O 1.256 1.429 0 CA-C-O 118.145 -0.931 . . . . 75.209999999999994 110.212 171.525 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.281 0.086 . . . . 64.099999999999994 110.779 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 mm 63.49 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.246 0.545 . . . . 75.010000000000005 110.919 -174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -80.55 108.86 2.86 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.723 -0.751 . . . . 72.129999999999995 112.622 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.2 p -88.17 105.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.732 0.777 . . . . 60.350000000000001 111.203 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.535 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 88.1 m-85 -99.57 98.27 9.17 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.633 -0.712 . . . . 75.519999999999996 111.107 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.5 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 9.5 p90 -119.06 157.93 26.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.453 0.644 . . . . 64.420000000000002 112.349 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.644 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 43.6 t -104.66 101.29 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.822 -0.626 . . . . 71.340000000000003 112.066 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 m -63.26 -23.83 67.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.438 0.637 . . . . 62.109999999999999 111.341 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -78.22 -20.59 51.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.783 -0.644 . . . . 64.329999999999998 112.407 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.406 ' HH ' ' HA3' ' A' ' 91' ' ' GLY . 29.4 t80 -137.24 132.67 34.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.11 0.782 . . . . 72.140000000000001 113.11 -169.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.42 ' HA3' HG21 ' A' ' 90' ' ' THR . . . 56.36 -163.62 5.71 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 115.336 0.894 . . . . 74.329999999999998 115.336 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.84 7.52 10.29 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.502 0.556 . . . . 75.120000000000005 112.502 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 53.3 m -35.64 -47.88 0.5 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.987 1.106 . . . . 50.020000000000003 113.987 -172.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -54.66 -52.37 62.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.149 0.499 . . . . 64.299999999999997 111.687 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -77.3 -25.33 51.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 111.931 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.39 -48.14 71.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.356 0.598 . . . . 72.040000000000006 110.087 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -64.79 -43.71 92.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.635 -0.711 . . . . 70.120000000000005 111.268 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -51.26 -40.19 58.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.09 -0.504 . . . . 75.400000000000006 111.484 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.89 89.91 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.95 0.405 . . . . 71.319999999999993 111.343 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.9 -52.34 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.123 0.487 . . . . 72.420000000000002 111.351 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' HA ' HG23 ' A' ' 31' ' ' VAL . 65.3 mt -55.08 -49.51 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.738 -0.665 . . . . 60.420000000000002 111.544 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.77 -36.41 69.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.341 -0.39 . . . . 43.210000000000001 111.82 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.26 -46.46 42.18 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.088 -0.577 . . . . 52.009999999999998 113.258 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.68 -43.97 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.811 0.338 . . . . 74.530000000000001 111.572 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.8 p -63.53 -38.37 90.87 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 71.340000000000003 111.164 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -64.8 -21.12 66.71 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.304 0.573 . . . . 75.219999999999999 111.285 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.7 m -85.43 -17.84 35.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 111.438 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.26 16.71 10.82 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.302 -0.475 . . . . 54.030000000000001 113.848 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.14 138.39 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 117.212 0.506 . . . . 72.049999999999997 111.443 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.19 139.24 19.57 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.116 -0.564 . . . . 71.219999999999999 112.932 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG23 ' HA ' ' A' ' 21' ' ' ILE . 29.8 t -105.79 141.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.84 0.352 . . . . 75.5 111.582 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.524 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 22.6 m-20 -93.49 106.49 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.113 0.483 . . . . 71.200000000000003 111.134 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -87.6 109.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.349 0.595 . . . . 62.43 112.224 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -118.49 112.5 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.054 0.454 . . . . 64.109999999999999 111.404 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.48 76.46 8.23 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.385 -0.371 . . . . 71.319999999999993 111.234 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.577 HD11 ' N ' ' A' ' 37' ' ' GLY . 2.0 pp -70.31 -23.83 62.92 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.912 -0.493 . . . . 73.109999999999999 111.319 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -87.94 47.79 3.59 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.289 -0.481 . . . . 55.049999999999997 112.291 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.97 -65.95 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.942 0.497 . . . . 54.520000000000003 110.516 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.16 130.1 0.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.254 -0.43 . . . . 75.219999999999999 111.397 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.33 150.7 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 111.641 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.82 165.49 27.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.458 -0.337 . . . . 71.299999999999997 111.238 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -59.56 -26.27 65.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.147 0.425 . . . . 64.519999999999996 112.147 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -56.41 -50.52 71.4 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.030000000000001 111.917 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -83.3 -33.92 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.567 -0.288 . . . . 71.049999999999997 111.274 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 89.1 mt -60.37 -29.45 68.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.627 0.251 . . . . 73.319999999999993 111.613 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.13 -39.02 89.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.181 0.515 . . . . 74.109999999999999 110.802 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.01 -25.72 62.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.326 -0.397 . . . . 61.520000000000003 111.912 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.0 tp -53.22 -28.91 29.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.907 0.384 . . . . 62.219999999999999 111.255 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.37 -49.67 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.312 -0.404 . . . . 72.209999999999994 111.865 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.68 -20.42 63.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.094 -0.574 . . . . 61.119999999999997 114.309 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -100.71 5.7 43.77 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.244 -0.563 . . . . 73.340000000000003 111.43 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.5 p -64.72 -7.38 10.6 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.648 0.981 . . . . 71.540000000000006 113.648 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 p -60.58 -42.93 97.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.139 0.422 . . . . 75.430000000000007 112.139 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.26 135.35 6.59 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.989 -0.624 . . . . 37.380000000000003 112.34 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.2 mp -133.3 152.38 51.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 74.400000000000006 111.287 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.36 92.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.452 -0.34 . . . . 73.409999999999997 110.175 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.3 mp -99.92 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.513 . . . . 74.349999999999994 111.786 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.82 151.73 17.87 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.33 -0.462 . . . . 43.210000000000001 112.714 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.505 ' SD ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -53.09 142.01 21.28 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.361 0.6 . . . . 71.140000000000001 112.559 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 92.5 p -132.82 124.15 18.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.405 0.521 . . . . 60.030000000000001 112.405 -173.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 166.14 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.27 1.98 . . . . 72.409999999999997 112.149 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -29.36 -62.8 0.12 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.152 1.538 . . . . 74.230000000000004 115.152 -170.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.14 70.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.399 0.518 . . . . 73.219999999999999 112.399 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.8 m -84.14 -39.67 19.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 43.229999999999997 111.215 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.72 68.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.864 0.364 . . . . 74.209999999999994 111.315 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.11 -36.66 70.92 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 50.119999999999997 111.298 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.2 m -63.47 -48.34 78.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.148 0.499 . . . . 74.030000000000001 110.748 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.79 -52.47 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.099 -0.501 . . . . 75.549999999999997 111.611 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.84 -26.7 67.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.396 -0.366 . . . . 75.209999999999994 111.373 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.93 -42.25 38.3 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.027 -0.606 . . . . 73.230000000000004 112.159 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.18 5.78 18.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.927 0.343 . . . . 53.140000000000001 111.927 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD13 HD22 ' A' ' 76' ' ' LEU . 2.1 tm? -46.0 -48.4 16.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.115 0.566 . . . . 62.200000000000003 111.457 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -53.72 -37.48 63.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.135 -0.484 . . . . 73.430000000000007 111.939 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -77.72 -44.51 27.62 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.344 -0.389 . . . . 74.310000000000002 111.357 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.16 -58.86 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 112.173 0.434 . . . . 71.239999999999995 112.173 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.419 HD22 HD13 ' A' ' 72' ' ' LEU . 4.4 mm? -63.15 -23.68 67.55 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.061 0.393 . . . . 64.239999999999995 112.061 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.31 -25.04 52.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.026 -0.606 . . . . 65.510000000000005 112.99 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 m -85.52 -38.0 19.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.146 0.424 . . . . 64.430000000000007 112.146 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.27 125.06 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.253 0.549 . . . . 70.319999999999993 111.89 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -128.63 158.3 38.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.261 0.553 . . . . 74.530000000000001 112.122 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.667 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 44.1 tt0 62.37 -85.64 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.502 0.927 . . . . 74.010000000000005 113.502 168.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.667 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 65.2 pttt -165.04 23.51 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.394 -0.191 . . . . 74.409999999999997 111.48 -173.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' NE2' ' HB3' ' A' ' 81' ' ' GLU . 14.7 mm-40 -50.79 158.33 0.68 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.137 0.791 . . . . 63.240000000000002 113.137 -169.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.504 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.15 117.64 28.28 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.617 0.599 . . . . 62.119999999999997 112.617 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.14 112.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.532 0.682 . . . . 54.43 111.894 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.12 145.05 17.16 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.111 -0.495 . . . . 37.380000000000003 112.102 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 42.7 mm -129.12 139.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 117.12 0.46 . . . . 73.319999999999993 111.519 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -128.41 150.75 49.99 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 74.200000000000003 110.694 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 36.2 tt0 -127.91 150.91 49.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.002 0.371 . . . . 71.349999999999994 112.002 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.505 HG23 ' SD ' ' A' ' 59' ' ' MET . 11.4 t -136.05 10.83 3.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.755 0.312 . . . . 73.319999999999993 111.481 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.461 ' H ' ' HG2' ' A' ' 89' ' ' GLU . . . -130.24 -85.75 0.39 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.456 -0.402 . . . . 62.140000000000001 112.985 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.1 -12.35 5.55 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.999 -0.62 . . . . 44.509999999999998 114.071 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.66 44.51 0.75 Allowed Glycine 0 N--CA 1.463 0.448 0 C-N-CA 121.153 -0.546 . . . . 64.430000000000007 112.059 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -173.27 3.44 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.599 0.36 . . . . 74.430000000000007 111.596 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 60' ' ' SER . 19.9 t70 74.09 116.99 0.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.578 0.751 . . . . 71.409999999999997 111.938 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -79.21 -47.47 1.6 Allowed Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 113.523 0.935 . . . . 72.200000000000003 113.523 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.05 9.54 2.37 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.181 1.921 . . . . 73.450000000000003 114.705 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.642 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.9 tt -46.82 -64.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.393 0.886 . . . . 72.310000000000002 113.393 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.642 ' H ' HG23 ' A' ' 98' ' ' ILE . 13.5 m-20 -67.92 -49.43 37.0 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.715 -0.616 . . . . 51.109999999999999 112.593 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.8 Cg_exo -44.76 -39.52 13.76 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.444 2.096 . . . . 71.310000000000002 113.651 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.18 -62.37 1.68 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.752 0.279 . . . . 71.519999999999996 111.752 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.2 mt -56.96 -47.85 79.74 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.415 0.524 . . . . 54.240000000000002 112.415 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.7 t -59.37 -32.32 70.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.951 0.405 . . . . 61.350000000000001 111.557 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -78.89 -42.58 26.87 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.406 -0.361 . . . . 72.030000000000001 111.374 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -60.04 -29.01 68.23 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.908 0.336 . . . . 72.329999999999998 111.908 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -55.86 -36.28 67.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.011 0.374 . . . . 74.310000000000002 112.011 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.42 -21.63 61.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.944 0.402 . . . . 71.310000000000002 111.829 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.407 HD11 ' N ' ' A' ' 108' ' ' LEU . 6.8 mp -92.95 -68.77 0.78 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.914 0.388 . . . . 74.129999999999995 110.73 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.16 67.16 0.37 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.218 -0.515 . . . . 71.239999999999995 113.519 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 110' ' ' LEU . 6.4 mp -95.58 144.61 25.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.686 -0.303 . . . . 71.530000000000001 110.775 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.504 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 89.6 m -65.59 109.55 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.028 0.442 . . . . 74.319999999999993 111.524 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.5 m -86.44 135.01 33.65 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.279 -0.418 . . . . 74.219999999999999 111.313 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.78 -92.62 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.453 0.538 . . . . 70.140000000000001 112.453 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -144.71 91.77 6.05 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.323 -0.236 . . . . 75.129999999999995 111.539 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -96.22 9.27 1.53 Allowed 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.979 2.453 . . . . 73.299999999999997 113.884 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.72 32.66 0.96 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.263 0.838 . . . . 74.209999999999994 113.263 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.1 tt -146.39 134.49 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.815 -0.553 . . . . 71.530000000000001 112.248 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.96 155.16 46.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.076 0.465 . . . . 65.030000000000001 111.17 175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 121' ' ' GLN . 2.1 mp -95.57 150.13 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 116.2 -0.454 . . . . 60.210000000000001 111.308 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -62.89 -44.91 94.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.097 0.475 . . . . 74.450000000000003 111.93 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.496 ' H ' HG22 ' A' ' 119' ' ' ILE . 58.1 tt0 -178.36 -63.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.832 -0.622 . . . . 74.420000000000002 109.656 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -119.52 115.0 34.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.802 -0.635 . . . . 72.129999999999995 110.559 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.438 ' HB2' ' OG1' ' A' ' 127' ' ' THR . 96.0 Cg_endo -77.43 -170.78 1.0 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.819 2.346 . . . . 73.219999999999999 113.564 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.1 p -131.22 -169.08 2.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.121 0.486 . . . . 72.109999999999999 111.723 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.06 -26.44 64.61 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.214 -0.448 . . . . 70.420000000000002 111.939 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.52 -35.87 72.94 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.439999999999998 111.685 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 123' ' ' PRO . 30.6 m -60.3 -39.72 87.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.015 0.436 . . . . 62.299999999999997 111.389 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -59.97 -50.81 72.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.177 0.513 . . . . 71.349999999999994 110.895 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -62.6 -36.21 82.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.766 -0.652 . . . . 75.010000000000005 111.289 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.2 tt -61.48 -44.93 96.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.037 -0.529 . . . . 74.129999999999995 110.264 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 89.2 m -59.19 -42.57 91.16 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.134 -0.485 . . . . 60.020000000000003 111.502 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -58.68 -49.33 77.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.055 0.455 . . . . 62.030000000000001 111.226 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -58.77 -49.41 77.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.142 -0.481 . . . . 75.510000000000005 111.385 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.99 -51.92 67.2 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.092 -0.504 . . . . 44.130000000000003 112.006 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.39 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.168 -0.539 . . . . 71.430000000000007 113.145 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 96.3 m -60.31 -44.91 95.0 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.665 0.269 . . . . 74.120000000000005 111.627 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.77 -48.62 80.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.879 0.371 . . . . 72.340000000000003 110.973 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.31 -43.15 92.66 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.337 -0.392 . . . . 71.010000000000005 111.048 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 143' ' ' THR . . . -58.7 -42.42 96.32 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.112 -0.566 . . . . 43.450000000000003 112.918 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -62.3 -35.12 78.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.672 0.272 . . . . 72.0 111.321 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -65.92 -47.51 74.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.849 0.357 . . . . 72.120000000000005 111.343 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.89 -53.07 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.937 0.347 . . . . 54.509999999999998 111.937 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 139' ' ' GLY . 2.9 t -62.06 -34.82 76.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.042 0.449 . . . . 64.430000000000007 111.248 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.516 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 43.6 ttm180 -63.97 -37.67 88.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.197 -0.456 . . . . 73.239999999999995 111.476 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 149' ' ' HIS . 16.8 t70 -80.04 -44.9 19.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.858 0.361 . . . . 74.230000000000004 111.787 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -76.61 -7.84 56.04 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.318 0.859 . . . . 54.140000000000001 113.318 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt -93.29 -48.72 6.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.492 -0.558 . . . . 75.400000000000006 109.492 170.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -136.68 -74.9 0.43 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.185 -0.462 . . . . 61.0 110.712 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 75.3 t60 174.96 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.659 0.784 . . . . 74.030000000000001 110.097 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -121.77 -6.85 9.08 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.368 -0.378 . . . . 71.340000000000003 111.655 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -123.74 149.04 46.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.759 0.314 . . . . 71.209999999999994 111.77 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.516 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 3.7 p80 -156.78 85.1 0.96 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.44 0.638 . . . . 72.5 110.632 169.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -67.68 -70.49 0.25 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.259 -0.428 . . . . 63.450000000000003 111.447 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 . . . . . 0 C--O 1.254 1.341 0 CA-C-O 119.253 -0.404 . . . . 55.140000000000001 111.731 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.538 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 75.5 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 111.25 0.093 . . . . 65.299999999999997 111.25 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 48.1 mm 62.65 108.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.183 0.516 . . . . 62.229999999999997 111.898 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.68 117.01 4.34 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.914 -0.66 . . . . 65.019999999999996 113.04 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.54 115.85 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.411 0.624 . . . . 63.340000000000003 111.979 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.4 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 3.1 m-85 -94.69 112.77 24.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.854 -0.612 . . . . 74.200000000000003 111.21 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -135.02 148.92 50.07 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.179 0.514 . . . . 75.349999999999994 112.225 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.596 HG23 HD12 ' A' ' 36' ' ' LEU . 15.1 t -112.86 95.43 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.956 -0.565 . . . . 72.340000000000003 111.096 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 m -56.14 -16.16 4.76 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.033 0.444 . . . . 74.519999999999996 112.038 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.27 -25.13 20.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.535 0.569 . . . . 72.420000000000002 112.535 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.18 123.76 35.1 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.479 0.918 . . . . 74.129999999999995 113.479 -170.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.69 -163.61 4.86 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.626 1.01 . . . . 51.0 115.626 171.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.416 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 93.7 m-85 -75.03 -0.86 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.044 0.757 . . . . 64.340000000000003 113.044 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -59.28 -31.02 68.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.225 0.536 . . . . 73.239999999999995 110.351 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.84 -37.97 72.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.467 -0.788 . . . . 74.010000000000005 111.266 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -85.85 -38.41 18.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.33 -0.395 . . . . 73.430000000000007 111.807 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.9 mt -50.45 -47.25 56.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.529 -0.305 . . . . 71.019999999999996 111.792 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.45 65.99 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.104 0.409 . . . . 65.0 112.104 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.435 -0.348 . . . . 72.439999999999998 111.568 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.46 -41.96 31.2 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.824 0.345 . . . . 73.209999999999994 111.279 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 16' ' ' LEU . 71.9 mt -59.47 -56.06 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.884 0.373 . . . . 75.409999999999997 111.885 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.3 tt -58.61 -30.61 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.979 0.419 . . . . 71.120000000000005 111.81 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.82 -53.1 12.38 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.037 0.446 . . . . 72.530000000000001 111.182 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.521 ' HA3' ' HG3' ' A' ' 132' ' ' GLU . . . -63.58 -44.74 96.08 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.188 -0.46 . . . . 73.439999999999998 114.082 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.89 -52.05 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.381 0.511 . . . . 72.140000000000001 112.381 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -59.46 -34.49 72.59 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.031 0.443 . . . . 71.409999999999997 112.01 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.467 ' HB3' ' HZ3' ' A' ' 26' ' ' LYS . 9.6 mtpm? -84.53 5.76 26.35 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.502 0.556 . . . . 75.099999999999994 112.502 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.25 -47.78 1.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.789 0.328 . . . . 74.439999999999998 111.702 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.85 -89.32 0.75 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.997 -0.62 . . . . 64.310000000000002 113.585 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.86 172.31 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.164 0.431 . . . . 64.099999999999994 112.164 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.03 157.61 53.05 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.397 -0.43 . . . . 61.32 113.652 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 1' ' ' SER . 38.8 t -108.73 148.35 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.527 0.331 . . . . 73.319999999999993 111.867 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.45 128.27 53.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.821 0.343 . . . . 43.409999999999997 110.858 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.68 138.9 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.538 0.569 . . . . 74.530000000000001 112.538 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.53 96.98 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.145 0.497 . . . . 74.109999999999999 111.277 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.64 86.83 6.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.314 -0.403 . . . . 75.329999999999998 110.955 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.596 HD12 HG23 ' A' ' 7' ' ' VAL . 3.5 pp -91.29 -23.87 20.01 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.331 0.493 . . . . 70.120000000000005 112.331 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.568 ' N ' HD11 ' A' ' 36' ' ' LEU . . . -78.99 47.99 3.23 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.027 -0.606 . . . . 61.039999999999999 113.303 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -171.91 -167.27 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.76 0.424 . . . . 74.430000000000007 110.691 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.58 104.28 5.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.854 0.359 . . . . 62.200000000000003 111.028 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.74 175.1 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.503 -0.317 . . . . 71.519999999999996 111.601 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -140.48 160.49 39.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.307 0.575 . . . . 71.340000000000003 112.331 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.5 tm? -55.16 -35.51 64.84 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.805 -0.634 . . . . 60.420000000000002 111.989 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.3 mt-30 -50.78 -43.38 58.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.083 0.468 . . . . 74.319999999999993 111.457 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.15 -24.36 64.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.001 -0.545 . . . . 53.210000000000001 111.445 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.99 -51.17 34.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.338 -0.392 . . . . 74.150000000000006 110.815 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -61.65 -32.64 72.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.83 0.347 . . . . 73.140000000000001 111.034 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 71.4 mm-40 -60.62 -48.87 79.86 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.034 0.445 . . . . 63.509999999999998 110.641 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.02 -39.35 71.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.887 -0.597 . . . . 64.230000000000004 111.812 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.8 -35.09 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.157 0.503 . . . . 72.109999999999999 111.186 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.36 -10.81 76.66 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.225 -0.512 . . . . 52.329999999999998 113.163 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -101.45 4.58 41.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.396 -0.473 . . . . 52.130000000000003 111.569 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.58 1.76 3.8 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.565 0.95 . . . . 74.230000000000004 113.565 -172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.5 p -64.15 -42.09 96.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.208 0.527 . . . . 62.100000000000001 110.838 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.59 136.59 5.35 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.803 -0.635 . . . . 51.439999999999998 112.32 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -160.81 148.41 15.75 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.496 -0.414 . . . . 74.329999999999998 111.657 -177.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -112.26 125.31 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 71.519999999999996 110.974 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 47.5 mt -128.92 136.27 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.064 0.459 . . . . 74.200000000000003 112.191 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.69 -163.88 34.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.146 -0.549 . . . . 62.43 112.401 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtm -98.17 135.26 40.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.018 -0.695 . . . . 72.349999999999994 110.648 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.9 p -79.62 150.8 73.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.199 0.444 . . . . 62.43 112.199 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 64' ' ' SER . 16.5 Cg_endo -90.85 157.59 4.07 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.831 2.354 . . . . 65.530000000000001 111.78 169.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.97 -31.58 29.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.174 0.435 . . . . 70.329999999999998 112.174 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.02 73.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.975 0.361 . . . . 73.450000000000003 111.975 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.54 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 38.9 m -95.76 -13.21 24.31 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.685 0.278 . . . . 71.439999999999998 111.679 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.73 -42.4 35.1 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.86 0.689 . . . . 74.030000000000001 112.86 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.96 -47.08 78.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.99 0.424 . . . . 62.530000000000001 111.853 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -67.13 -45.82 75.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.147 0.498 . . . . 72.310000000000002 111.401 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.2 -46.96 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.981 -0.554 . . . . 75.129999999999995 112.155 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -57.82 -35.56 71.03 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.821 0.343 . . . . 75.450000000000003 111.895 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.83 -43.38 28.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.062 -0.59 . . . . 73.310000000000002 113.072 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.35 -26.07 51.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.225 0.454 . . . . 74.239999999999995 112.225 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.449 HD21 HD11 ' A' ' 101' ' ' LEU . 52.1 tp -52.8 -37.38 59.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.066 0.395 . . . . 72.120000000000005 112.066 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -59.12 -43.97 91.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.944 0.402 . . . . 63.109999999999999 111.324 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.9 m -68.63 -36.1 78.17 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.171 0.51 . . . . 72.349999999999994 111.004 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' VAL . 67.7 mt -61.96 -59.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.266 -0.425 . . . . 71.510000000000005 111.009 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.57 -30.16 65.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.251 0.463 . . . . 62.539999999999999 112.251 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.15 -24.04 67.21 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.127 -0.559 . . . . 65.310000000000002 113.439 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 p -97.97 -48.36 5.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.304 0.483 . . . . 74.129999999999995 112.304 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' ILE . 34.8 m -77.88 85.99 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 122.033 0.92 . . . . 75.239999999999995 111.687 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -178.12 4.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.862 -0.608 . . . . 73.230000000000004 112.144 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 65.74 -77.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.249 0.62 . . . . 72.030000000000001 111.981 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -168.35 29.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.9 0.704 . . . . 71.340000000000003 112.9 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.58 160.99 12.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.095 0.474 . . . . 75.329999999999998 111.647 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.61 ' HB3' HD23 ' A' ' 138' ' ' LEU . . . -89.19 95.62 10.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.012 0.745 . . . . 72.109999999999999 113.012 -170.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.67 92.95 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.76 0.791 . . . . 63.340000000000003 111.551 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.55 72.72 2.5 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.029 -0.532 . . . . 75.310000000000002 113.367 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 12.0 tt -96.54 133.67 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 122.639 -0.33 . . . . 73.409999999999997 111.035 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' CZ ' ' SG ' ' A' ' 131' ' ' CYS . 8.0 p90 -146.79 173.42 12.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.152 0.501 . . . . 75.420000000000002 112.206 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.05 96.61 0.15 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.239 0.542 . . . . 70.239999999999995 112.323 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.2 m -131.43 94.02 3.46 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.262 -0.426 . . . . 60.200000000000003 110.512 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.65 168.63 11.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.355 -0.45 . . . . 37.770000000000003 112.629 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA3' ' OE1' ' A' ' 121' ' ' GLN . . . -114.52 -135.12 5.9 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.852 -0.689 . . . . 64.349999999999994 114.022 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.92 77.06 1.8 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.319 -0.467 . . . . 41.409999999999997 113.125 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.3 -179.86 7.25 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.631 -0.335 . . . . 72.340000000000003 110.734 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 70.89 154.82 0.14 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.868 0.692 . . . . 54.130000000000003 112.868 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.45 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.1 mt-10 -104.63 -57.36 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.755 0.65 . . . . 71.349999999999994 112.755 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.506 ' O ' HD12 ' A' ' 101' ' ' LEU . 57.4 Cg_endo -68.51 -1.98 8.4 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.322 2.014 . . . . 65.230000000000004 113.996 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.8 tp -50.99 -45.1 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 112.734 0.642 . . . . 73.400000000000006 112.734 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 5.5 m-20 -58.21 -55.74 42.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 111.997 0.369 . . . . 52.409999999999997 111.997 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.662 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 82.6 Cg_exo -50.24 -48.99 17.64 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.328 2.019 . . . . 74.310000000000002 113.358 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 97' ' ' PRO . 11.2 mp -56.74 -51.98 66.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.06 0.393 . . . . 72.299999999999997 112.06 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.44 -52.03 60.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.797 0.332 . . . . 73.109999999999999 111.67 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t -66.93 -34.46 77.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.776 0.322 . . . . 74.319999999999993 111.581 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 1.4 tpmt? -59.86 -60.85 3.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.841 0.353 . . . . 54.329999999999998 111.305 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.58 -30.85 71.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.533 -0.303 . . . . 74.310000000000002 111.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -59.5 -45.83 90.56 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.868 0.366 . . . . 73.439999999999998 110.378 176.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -47.95 62.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.208 -0.451 . . . . 72.549999999999997 110.666 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.74 -48.7 77.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.866 0.365 . . . . 75.430000000000007 111.52 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.53 71.83 0.71 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.654 0.622 . . . . 37.770000000000003 114.654 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 110' ' ' LEU . 6.0 mp -90.93 -177.31 4.91 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.415 -0.461 . . . . 64.340000000000003 110.415 173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.2 m -63.83 101.89 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.123 0.416 . . . . 74.349999999999994 112.123 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 p -105.64 137.39 43.57 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.065 0.459 . . . . 75.109999999999999 111.565 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.41 -58.01 3.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.886 0.375 . . . . 54.039999999999999 111.796 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -167.78 89.83 0.69 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.735 0.302 . . . . 74.230000000000004 110.453 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.01 -33.56 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.62 2.214 . . . . 73.409999999999997 114.368 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.49 118.03 28.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.27 0.47 . . . . 62.32 112.27 -173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.493 HG23 HG12 ' A' ' 119' ' ' ILE . 12.6 tt -137.78 7.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.322 0.582 . . . . 73.510000000000005 111.779 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 67.73 65.56 0.38 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.026 0.53 . . . . 72.510000000000005 112.429 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.648 HD11 ' HA ' ' A' ' 123' ' ' PRO . 50.8 mm -104.62 111.67 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 74.109999999999999 111.115 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -93.53 -23.13 18.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.234 -0.439 . . . . 71.019999999999996 111.683 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.486 ' OE1' ' HA3' ' A' ' 92' ' ' GLY . 6.0 tp-100 -161.48 -65.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.021 0.438 . . . . 64.129999999999995 111.291 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.7 p -104.04 125.67 33.82 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.208 0.448 . . . . 73.409999999999997 112.208 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.648 ' HA ' HD11 ' A' ' 119' ' ' ILE . 52.2 Cg_exo -55.93 150.23 47.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.545 2.163 . . . . 74.450000000000003 112.456 170.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.8 p -118.93 -176.12 3.05 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 -174.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.63 -48.41 19.86 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.104 -0.498 . . . . 64.349999999999994 112.049 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.96 -25.94 65.6 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.036 -0.529 . . . . 75.430000000000007 111.974 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 123' ' ' PRO . 59.2 m -63.87 -36.99 85.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.83 0.348 . . . . 63.310000000000002 110.856 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.39 -47.1 74.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.979 0.419 . . . . 75.340000000000003 110.937 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.72 -41.47 95.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.224 -0.443 . . . . 64.519999999999996 111.072 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.37 -54.43 47.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.466 -0.334 . . . . 74.519999999999996 110.238 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.428 ' SG ' ' CZ ' ' A' ' 88' ' ' PHE . 74.4 m -50.03 -51.58 40.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 111.785 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.521 ' HG3' ' HA3' ' A' ' 23' ' ' GLY . 46.1 tt0 -67.17 -55.02 15.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.381 -0.372 . . . . 73.129999999999995 111.792 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.49 -54.86 42.29 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.942 0.349 . . . . 52.229999999999997 111.942 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.6 76.47 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.4 -0.364 . . . . 54.340000000000003 111.85 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.15 -46.85 93.67 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 63.509999999999998 113.274 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 94.7 m -63.34 -51.2 66.92 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.88 0.371 . . . . 63.340000000000003 111.815 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.06 -42.63 98.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.133 0.492 . . . . 64.25 111.068 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.61 HD23 ' HB3' ' A' ' 84' ' ' ALA . 53.7 tp -64.76 -41.24 96.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.053 0.454 . . . . 73.439999999999998 110.757 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.24 -42.72 98.82 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.183 -0.462 . . . . 52.210000000000001 112.68 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.15 -39.18 85.44 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.955 0.407 . . . . 74.140000000000001 110.926 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -59.89 -49.5 77.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.46 -0.336 . . . . 72.420000000000002 111.12 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.38 -47.91 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 112.133 0.419 . . . . 71.239999999999995 112.133 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.616 ' HG1' ' HG2' ' A' ' 148' ' ' GLU . 7.7 t -71.83 -41.5 68.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.106 0.409 . . . . 64.439999999999998 112.106 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.63 ' HA ' ' HG3' ' A' ' 148' ' ' GLU . 61.2 ttt180 -64.08 -33.16 75.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 111.559 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.6 -26.86 14.7 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.109 -0.496 . . . . 70.239999999999995 111.286 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -97.69 -63.68 1.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.339 -0.391 . . . . 75.219999999999999 112.013 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 147' ' ' LEU . 4.8 tt -175.64 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 111.861 0.319 . . . . 64.239999999999995 111.861 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.63 ' HG3' ' HA ' ' A' ' 144' ' ' ARG . 46.1 mt-10 74.87 146.95 0.09 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.397 0.679 . . . . 73.319999999999993 112.198 -175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -106.6 -18.11 14.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.165 0.507 . . . . 74.120000000000005 109.783 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -108.5 130.69 55.26 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.879 -0.601 . . . . 74.319999999999993 111.086 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -134.87 99.42 4.3 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.899 0.38 . . . . 72.010000000000005 110.367 171.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.6 m170 67.27 176.25 0.25 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.616 -0.72 . . . . 74.099999999999994 111.709 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -97.33 154.88 17.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.086 0.469 . . . . 75.450000000000003 112.041 -174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.2 p80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.351 -0.833 . . . . 74.329999999999998 110.931 176.105 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.629 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.59 -0.152 . . . . 73.450000000000003 110.59 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 46.8 mm 74.55 96.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 121.31 0.576 . . . . 63.32 110.589 -172.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.99 123.24 5.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.056 -0.52 . . . . 54.229999999999997 113.735 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.7 t -95.36 106.4 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 O-C-N 122.608 -0.348 . . . . 65.400000000000006 111.115 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.589 ' HB3' HD22 ' A' ' 36' ' ' LEU . 93.1 m-85 -90.96 105.96 18.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.925 0.393 . . . . 74.540000000000006 111.614 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.603 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 35.9 p90 -146.75 -178.59 6.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.434 -0.348 . . . . 72.420000000000002 110.945 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 10' ' ' TYR . 2.8 p -134.55 104.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.089 0.471 . . . . 75.329999999999998 111.086 176.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -52.48 -25.34 9.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.215 0.82 . . . . 73.319999999999993 113.215 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -74.08 -32.42 63.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.763 0.316 . . . . 73.109999999999999 111.644 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB3' HG12 ' A' ' 7' ' ' VAL . 61.0 t80 -104.31 137.41 42.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.07 0.462 . . . . 74.409999999999997 112.226 -173.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.12 -161.79 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.98 0.752 . . . . 63.009999999999998 114.98 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.63 7.56 17.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.772 0.429 . . . . 73.5 111.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 84.8 p -30.75 -65.65 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.279 1.214 . . . . 55.509999999999998 114.279 -174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.46 -35.04 79.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.085 0.402 . . . . 72.409999999999997 112.085 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -60.21 -40.29 89.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.092 0.472 . . . . 72.239999999999995 110.747 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.44 -37.18 68.64 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 71.439999999999998 110.764 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.92 -31.64 67.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.206 -0.452 . . . . 51.329999999999998 111.352 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -52.21 -43.02 64.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.251 -0.431 . . . . 64.299999999999997 110.997 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.76 -47.29 69.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.972 -0.558 . . . . 72.319999999999993 111.609 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.74 -55.4 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 71.530000000000001 111.386 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.03 -46.73 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.212 -0.449 . . . . 75.239999999999995 111.207 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.17 -50.22 74.88 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.414 -0.357 . . . . 71.040000000000006 111.864 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.17 -48.77 84.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.819 -0.705 . . . . 74.310000000000002 113.305 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.408 HG23 HG12 ' A' ' 31' ' ' VAL . 1.8 mp -72.11 -32.3 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 122.521 -0.399 . . . . 74.340000000000003 112.013 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -72.0 -30.2 64.99 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.679 -0.638 . . . . 63.210000000000001 110.628 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.742 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 4.6 mmmp? -64.99 -24.11 67.42 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.137 0.494 . . . . 74.430000000000007 110.692 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 140' ' ' GLN . 60.3 m -79.07 -40.44 31.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.219 0.533 . . . . 74.239999999999995 110.474 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.57 21.63 7.47 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.892 -0.595 . . . . 73.140000000000001 113.492 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.44 -77.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 122.402 -0.47 . . . . 72.0 111.995 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.67 115.48 3.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.306 -0.473 . . . . 72.25 113.133 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 1' ' ' SER . 29.7 m -90.59 157.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.187 0.518 . . . . 65.329999999999998 112.247 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' CG ' ' H1 ' ' A' ' 1' ' ' SER . 9.4 m-20 -96.28 130.62 43.33 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 110.926 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.41 120.19 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.142 -0.348 . . . . 71.329999999999998 111.759 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.79 104.15 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.672 0.273 . . . . 60.229999999999997 111.717 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.603 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 11.4 m-20 -77.05 103.23 6.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.811 0.339 . . . . 74.400000000000006 111.049 173.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.589 HD22 ' HB3' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -67.96 78.81 0.22 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.968 0.89 . . . . 72.109999999999999 111.864 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.1 -25.62 0.23 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.404 -0.816 . . . . 75.239999999999995 112.397 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.97 157.87 34.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.778 0.323 . . . . 72.329999999999998 111.364 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 70.28 2.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.207 0.527 . . . . 72.420000000000002 111.976 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.63 147.65 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 75.430000000000007 111.527 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.4 166.8 10.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.98 0.419 . . . . 74.340000000000003 111.259 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.52 HD12 HD11 ' A' ' 45' ' ' LEU . 3.9 mm? -56.22 -24.4 41.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.451 -0.341 . . . . 74.299999999999997 111.201 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.74 -49.6 77.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.218 -0.446 . . . . 65.0 111.033 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.82 -46.41 71.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.879 0.371 . . . . 75.0 111.168 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.52 HD11 HD12 ' A' ' 42' ' ' LEU . 93.7 mt -57.53 -46.82 83.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.191 -0.459 . . . . 74.239999999999995 111.767 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.4 -44.92 96.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.698 0.285 . . . . 74.349999999999994 111.586 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.57 -42.52 95.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.167 0.508 . . . . 70.209999999999994 110.83 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.73 -42.06 71.1 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.969 -0.56 . . . . 74.540000000000006 111.485 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 45' ' ' LEU . 67.2 t -56.1 -37.61 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.979 0.418 . . . . 74.049999999999997 111.43 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.11 -21.32 79.89 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.964 -0.636 . . . . 54.119999999999997 112.993 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -100.74 5.3 43.59 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.57 -0.371 . . . . 71.310000000000002 111.821 -178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.1 p -70.83 4.58 2.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.324 0.861 . . . . 75.409999999999997 113.324 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.5 p -58.96 -36.39 74.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 64.510000000000005 110.927 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.581 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -154.95 138.82 6.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.624 -0.716 . . . . 37.600000000000001 112.047 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.0 169.76 17.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.256 0.528 . . . . 75.340000000000003 112.196 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 88' ' ' PHE . 7.3 p -131.46 136.24 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.767 0.318 . . . . 74.230000000000004 111.388 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.7 mp -112.69 133.16 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.936 0.398 . . . . 60.0 112.062 -175.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.93 -124.45 5.41 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.263 -0.494 . . . . 50.310000000000002 112.686 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.436 ' SD ' ' HA3' ' A' ' 91' ' ' GLY . 54.9 ttm -155.07 154.7 32.83 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.429 -0.454 . . . . 72.239999999999995 110.892 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 36' ' ' LEU . 67.7 p -114.19 156.95 43.52 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 120.607 0.242 . . . . 72.150000000000006 111.38 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.43 152.14 78.78 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.951 1.767 . . . . 74.230000000000004 111.826 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.34 -41.08 8.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.422 0.897 . . . . 73.129999999999995 113.422 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.48 -48.34 56.21 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.155 0.428 . . . . 72.209999999999994 112.155 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -14.49 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.027 0.38 . . . . 75.129999999999995 112.027 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.517 ' HB3' ' H ' ' A' ' 96' ' ' GLU . . . -54.22 -32.18 55.2 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.225 0.454 . . . . 73.040000000000006 112.225 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.19 -33.21 70.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 75.430000000000007 111.252 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -67.84 -42.13 81.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.176 -0.465 . . . . 75.030000000000001 111.296 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.418 HD11 ' HG ' ' A' ' 60' ' ' SER . 29.7 mt -63.5 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.814 0.34 . . . . 55.020000000000003 110.855 175.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -51.62 -45.4 63.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.208 -0.451 . . . . 71.150000000000006 111.545 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.01 -49.47 16.43 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.047 -0.596 . . . . 64.409999999999997 113.184 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.83 76.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.005 0.372 . . . . 54.530000000000001 112.005 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 tt -48.39 -49.73 33.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.21 0.604 . . . . 74.299999999999997 111.387 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -60.13 -40.09 88.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.105 0.409 . . . . 71.400000000000006 112.105 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.2 m -74.33 -36.87 63.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.876 0.37 . . . . 72.230000000000004 111.395 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 79' ' ' VAL . 74.7 mt -71.63 -67.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.469 -0.332 . . . . 74.200000000000003 111.397 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.435 ' HA ' HG23 ' A' ' 79' ' ' VAL . 68.4 mt -61.65 -22.15 65.03 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.452 0.538 . . . . 75.400000000000006 112.452 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.45 -22.68 64.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.727 -0.749 . . . . 44.299999999999997 113.259 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -101.03 -26.2 13.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.458 0.54 . . . . 71.230000000000004 112.458 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 75' ' ' ILE . 33.7 m -70.51 179.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.381 0.61 . . . . 72.409999999999997 112.417 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.61 161.34 25.97 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.092 -0.504 . . . . 74.099999999999994 111.691 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -46.97 -42.89 18.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 112.814 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -145.92 133.03 20.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.089 0.471 . . . . 71.209999999999994 111.39 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -133.54 177.18 7.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.073 -0.512 . . . . 73.099999999999994 111.806 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.604 ' HB1' HD11 ' A' ' 138' ' ' LEU . . . -102.74 112.18 24.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.845 0.355 . . . . 62.350000000000001 111.24 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.75 169.69 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.91 0.386 . . . . 72.239999999999995 111.967 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.12 169.29 32.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.37 -0.443 . . . . 71.040000000000006 112.749 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.428 HG21 ' HB1' ' A' ' 116' ' ' ALA . 43.9 mm -100.42 146.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 74.129999999999995 111.895 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.536 ' HB2' HG21 ' A' ' 56' ' ' VAL . 17.8 t80 -135.28 109.58 8.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.501 -0.318 . . . . 74.409999999999997 110.749 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -64.62 93.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.557 0.577 . . . . 62.329999999999998 112.557 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 t -160.58 77.79 0.61 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.258 0.551 . . . . 73.329999999999998 111.819 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.436 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . 171.31 121.51 0.59 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.091 -0.576 . . . . 37.600000000000001 113.193 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.87 51.09 4.27 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.128 -0.558 . . . . 62.240000000000002 113.407 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.32 56.76 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.281 -0.485 . . . . 62.140000000000001 113.313 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.6 -154.89 0.38 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.67 0.388 . . . . 71.049999999999997 111.404 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 23.3 t70 69.66 154.93 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.321 0.648 . . . . 65.109999999999999 112.593 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' H ' ' HB3' ' A' ' 65' ' ' ALA . 8.3 mm-40 -103.42 -56.33 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.095 -0.502 . . . . 72.140000000000001 112.31 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 88.4 Cg_endo -80.04 16.96 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.122 1.881 . . . . 72.109999999999999 113.759 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.422 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.3 tt -48.0 -56.39 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.705 1.002 . . . . 62.219999999999999 113.705 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.663 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.5 m-20 -61.17 -54.07 57.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.972 -0.455 . . . . 70.510000000000005 111.953 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 51.8 Cg_exo -54.66 -42.2 70.56 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.905 1.737 . . . . 74.340000000000003 112.654 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.61 -59.52 4.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.984 0.421 . . . . 74.409999999999997 111.342 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.51 -35.4 79.26 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.02 0.438 . . . . 44.210000000000001 111.511 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -62.71 -46.28 88.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.394 -0.366 . . . . 73.140000000000001 111.784 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 100' ' ' PRO . 53.2 mtpt -61.08 -45.15 95.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.499 0.19 . . . . 74.129999999999995 111.356 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' HD11 ' A' ' 110' ' ' LEU . 2.3 m-85 -58.59 -40.96 84.66 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 110.991 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.76 -49.66 74.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.715 -0.675 . . . . 74.439999999999998 111.9 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -81.29 -46.85 14.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.864 0.69 . . . . 74.310000000000002 112.864 -174.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.5 -15.18 57.14 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.238 0.458 . . . . 75.150000000000006 112.238 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.61 4.98 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 114.398 0.519 . . . . 73.420000000000002 114.398 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 105' ' ' PHE . 7.5 mp -88.88 -175.33 4.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.095 0.448 . . . . 63.43 110.995 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 154.16 26.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.258 0.552 . . . . 61.140000000000001 111.982 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -100.98 -51.94 3.41 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.069 -0.514 . . . . 75.040000000000006 111.757 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.59 42.87 13.44 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.093 0.473 . . . . 72.540000000000006 111.563 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.5 t80 68.23 93.71 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.468 -0.787 . . . . 74.310000000000002 111.706 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.31 96.5 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.432 2.088 . . . . 70.030000000000001 112.276 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -56.57 156.14 6.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.524 0.564 . . . . 71.040000000000006 112.524 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -77.13 139.42 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 110.402 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.643 ' N ' HD12 ' A' ' 117' ' ' ILE . 82.2 mtt180 -56.74 120.72 8.32 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.133 0.492 . . . . 73.319999999999993 111.659 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.475 HD11 ' N ' ' A' ' 119' ' ' ILE . 2.8 mp -70.15 138.15 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.302 0.572 . . . . 71.109999999999999 112.172 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -65.86 -70.94 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.912 -0.586 . . . . 74.230000000000004 110.723 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -155.1 -58.98 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.172 0.511 . . . . 72.420000000000002 110.413 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.3 p -94.69 136.87 22.7 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.123 -0.489 . . . . 54.530000000000001 111.933 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.46 -165.21 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.962 2.442 . . . . 72.129999999999995 112.8 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 55.0 p -133.08 171.89 13.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.939 0.4 . . . . 60.310000000000002 111.542 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.81 -33.41 56.0 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.155 0.503 . . . . 63.43 111.569 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.76 -10.77 30.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.533 0.568 . . . . 71.5 112.533 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.5 m -63.56 -33.11 74.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.012 0.434 . . . . 71.099999999999994 111.13 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.484 ' HA ' ' SG ' ' A' ' 131' ' ' CYS . 82.9 m-85 -65.16 -41.67 94.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.301 0.572 . . . . 74.439999999999998 110.514 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.17 -49.71 76.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 73.510000000000005 111.099 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.17 -58.13 9.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.106 -0.497 . . . . 75.219999999999999 111.218 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 128' ' ' TYR . 27.8 p -58.15 -47.09 84.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.671 0.619 . . . . 75.310000000000002 112.671 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.58 -54.75 27.15 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.154 0.427 . . . . 71.530000000000001 112.154 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.33 -48.6 72.47 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.117 0.414 . . . . 41.420000000000002 112.117 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.31 -42.84 92.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 111.312 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.49 97.48 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.317 -0.468 . . . . 75.299999999999997 112.774 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.466 HG21 ' NE2' ' A' ' 140' ' ' GLN . 46.6 m -62.05 -44.17 97.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.999 0.428 . . . . 63.310000000000002 111.096 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.92 -61.07 2.13 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.441 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.604 HD11 ' HB1' ' A' ' 84' ' ' ALA . 46.9 tp -63.34 -37.86 88.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.83 0.348 . . . . 74.299999999999997 111.722 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -51.14 45.46 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.114 -0.565 . . . . 74.099999999999994 113.165 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.473 ' O ' HG21 ' A' ' 143' ' ' THR . 80.7 mt-30 -73.01 -7.84 53.04 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.353 -0.498 . . . . 74.420000000000002 111.983 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.454 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 62.6 t90 -55.26 -32.3 62.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.137 0.494 . . . . 73.409999999999997 110.191 170.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.62 -47.07 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 111.95 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 140' ' ' GLN . 11.3 t -73.66 -32.06 63.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.143 -0.348 . . . . 55.210000000000001 111.49 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -70.74 -41.83 71.29 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.86 0.362 . . . . 62.149999999999999 111.438 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.53 -61.05 1.76 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.532 0.567 . . . . 60.329999999999998 112.532 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -75.08 -55.08 6.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.902 0.382 . . . . 64.450000000000003 111.838 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.452 ' O ' HD21 ' A' ' 147' ' ' LEU . 10.1 tt -68.56 -25.31 64.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.922 0.392 . . . . 71.349999999999994 110.994 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 64.68 49.63 2.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.499 0.666 . . . . 72.329999999999998 111.23 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.43 -21.35 50.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.68 -0.691 . . . . 70.099999999999994 111.61 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.7 t60 68.99 -69.36 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.343 0.657 . . . . 72.430000000000007 112.181 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -74.75 115.31 14.19 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.853 0.316 . . . . 74.239999999999995 111.853 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -76.52 147.09 38.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.694 -0.23 . . . . 72.099999999999994 110.427 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -104.89 165.6 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.113 0.482 . . . . 74.319999999999993 111.979 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.913 -0.585 . . . . 72.519999999999996 110.087 171.592 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 45.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.143 -0.317 . . . . 55.119999999999997 110.143 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.644 HD12 ' HA3' ' A' ' 54' ' ' GLY . 47.2 mm 59.64 91.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.184 0.516 . . . . 71.519999999999996 111.53 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 104.64 2.3 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.833 -0.698 . . . . 65.439999999999998 112.84 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 m -87.3 107.79 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.427 0.632 . . . . 62.340000000000003 110.881 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.718 ' HB3' HD23 ' A' ' 36' ' ' LEU . 55.3 m-85 -104.22 118.37 36.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.897 -0.592 . . . . 72.219999999999999 111.206 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -152.16 176.51 11.49 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.202 0.445 . . . . 75.400000000000006 112.202 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 13' ' ' SER . 48.4 t -109.08 104.04 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 116.089 -0.505 . . . . 74.140000000000001 110.28 172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.689 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 62.1 p -59.67 -56.74 18.08 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.415 0.895 . . . . 74.099999999999994 113.415 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.23 -43.26 92.35 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.087 0.773 . . . . 65.0 113.087 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -77.26 121.02 23.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.14 0.495 . . . . 64.010000000000005 112.266 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.28 -162.61 6.17 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.844 -0.616 . . . . 44.509999999999998 114.408 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -81.9 7.77 12.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.925 0.343 . . . . 72.519999999999996 111.925 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 20.0 m -44.22 -43.97 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.578 0.955 . . . . 75.450000000000003 113.578 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.689 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 19.6 p-10 -73.57 -36.71 65.62 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.922 -0.486 . . . . 60.299999999999997 111.358 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mmt-85 -61.22 -40.62 94.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.519 0.676 . . . . 74.109999999999999 109.713 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.657 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . 79.7 mt -66.67 -41.68 87.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 73.439999999999998 110.838 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.74 83.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 75.109999999999999 111.136 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.48 -27.56 65.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.801 0.334 . . . . 72.329999999999998 110.994 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 22' ' ' ASN . . . -64.27 -37.64 88.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.089 0.471 . . . . 72.5 110.362 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.584 HG23 ' HA3' ' A' ' 135' ' ' GLY . 63.1 mt -63.1 -53.1 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.278 0.561 . . . . 74.510000000000005 110.301 171.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.14 -33.45 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.751 -0.659 . . . . 75.5 111.283 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 39.2 t30 -53.65 -60.14 3.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.356 -0.384 . . . . 53.439999999999998 111.187 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.17 97.93 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.12 -0.562 . . . . 71.549999999999997 113.06 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.676 HG22 ' HB ' ' A' ' 29' ' ' VAL . 55.4 mt -60.75 -50.6 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.235 0.457 . . . . 73.120000000000005 112.235 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -67.97 -38.22 82.47 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.165 -0.335 . . . . 75.329999999999998 111.298 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.8 -32.89 69.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.091 0.472 . . . . 73.019999999999996 111.078 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.583 HG23 ' HG2' ' A' ' 140' ' ' GLN . 88.6 m -79.4 -35.27 40.92 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.175 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.91 32.25 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.365 -0.445 . . . . 75.519999999999996 113.279 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.676 ' HB ' HG22 ' A' ' 24' ' ' ILE . 29.5 t -108.91 133.95 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 122.462 -0.434 . . . . 74.209999999999994 111.417 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.09 112.64 3.64 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.111 -0.566 . . . . 70.409999999999997 112.534 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 ' HB ' HG21 ' A' ' 24' ' ' ILE . 7.7 p -99.22 140.85 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 112.48 0.548 . . . . 64.239999999999995 112.48 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -96.48 109.38 21.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.027 0.441 . . . . 71.319999999999993 110.695 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.07 116.91 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 111.872 0.323 . . . . 74.129999999999995 111.872 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.41 119.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.017 0.437 . . . . 54.420000000000002 111.942 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.67 105.27 16.1 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.934 0.397 . . . . 74.219999999999999 111.255 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 5' ' ' PHE . 2.9 pp -77.38 -10.02 59.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.843 0.354 . . . . 73.109999999999999 111.43 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.58 -12.26 66.67 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.206 -0.521 . . . . 37.299999999999997 113.14 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.18 -48.23 0.06 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.867 0.365 . . . . 73.409999999999997 111.77 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.613 0.597 . . . . 74.409999999999997 112.613 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.0 m -117.96 45.79 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.323 0.583 . . . . 73.129999999999995 110.957 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.35 149.39 48.46 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.463 0.542 . . . . 70.420000000000002 112.463 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.3 mm? -58.55 -35.12 71.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 112.175 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -62.94 -40.17 96.86 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.883 0.373 . . . . 62.350000000000001 110.723 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LEU . 17.6 tp10 -70.41 -29.7 66.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.3 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.617 HD12 HG21 ' A' ' 74' ' ' THR . 3.3 tm? -60.9 -46.96 88.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.146 0.498 . . . . 73.540000000000006 109.815 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.32 -40.0 94.88 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.39 0.614 . . . . 73.400000000000006 110.721 172.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.71 ' HG3' HH11 ' A' ' 51' ' ' ARG . 20.5 tp10 -79.83 -10.63 59.8 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.642 -0.708 . . . . 74.25 111.332 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD12 ' HB2' ' A' ' 51' ' ' ARG . 53.3 tp -59.22 -28.67 66.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.92 0.488 . . . . 73.519999999999996 111.696 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 t -58.9 -23.95 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.988 0.423 . . . . 74.129999999999995 111.351 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.15 -34.95 25.19 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.926 -0.654 . . . . 61.439999999999998 112.151 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.71 HH11 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -68.83 -38.28 79.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.839 0.352 . . . . 72.230000000000004 111.273 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.6 p -67.12 -2.84 6.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.868 0.692 . . . . 63.439999999999998 112.868 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -62.88 -22.21 66.55 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.134 0.492 . . . . 61.310000000000002 110.892 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.644 ' HA3' HD12 ' A' ' 2' ' ' ILE . . . -153.58 137.43 5.77 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.99 -0.844 . . . . 70.120000000000005 110.99 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HB2' HG13 ' A' ' 85' ' ' VAL . 95.4 mt -116.58 116.54 27.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.583 0.691 . . . . 64.310000000000002 112.434 -173.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.02 105.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 74.129999999999995 110.266 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 57' ' ' ILE . 3.4 mp -101.93 119.61 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.846 0.355 . . . . 64.409999999999997 111.273 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 59' ' ' MET . . . -80.91 -12.04 83.14 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.028 -0.606 . . . . 54.210000000000001 113.84 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 49.6 ttp 71.3 149.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.301 0.572 . . . . 61.450000000000003 111.723 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 60.0 m -151.22 140.77 13.99 Favored Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 122.182 -0.324 . . . . 75.310000000000002 111.132 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.91 161.68 28.46 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.514 2.143 . . . . 73.450000000000003 112.978 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.38 -39.7 7.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.53 0.567 . . . . 71.340000000000003 112.53 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.68 64.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.092 0.405 . . . . 54.509999999999998 112.092 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.487 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 19.6 m -79.86 -19.27 48.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.443 -0.344 . . . . 73.329999999999998 111.893 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.629 ' HB3' HE22 ' A' ' 69' ' ' GLN . . . -64.88 -11.93 43.14 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.601 0.593 . . . . 71.420000000000002 112.601 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.94 -49.67 68.17 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.884 0.373 . . . . 64.230000000000004 111.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.7 p -65.59 -43.49 89.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.979 0.418 . . . . 44.020000000000003 111.197 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -53.85 -56.08 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.018 -0.537 . . . . 61.43 111.618 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.629 HE22 ' HB3' ' A' ' 65' ' ' ALA . 2.1 mp0 -60.33 -21.65 62.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.18 0.437 . . . . 74.319999999999993 112.18 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.23 -48.3 80.64 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.033 -0.603 . . . . 75.239999999999995 112.661 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -89.67 -19.34 24.97 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.869 0.366 . . . . 71.530000000000001 111.855 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tt -49.74 -34.71 19.86 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.904 0.481 . . . . 72.109999999999999 111.891 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m -47.7 -37.45 13.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.096 -0.502 . . . . 73.150000000000006 112.234 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.617 HG21 HD12 ' A' ' 45' ' ' LEU . 45.5 m -99.47 -35.79 9.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 111.759 0.281 . . . . 63.420000000000002 111.759 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 71' ' ' ALA . 68.3 mt -47.86 -44.4 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.491 0.552 . . . . 64.420000000000002 112.491 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.8 -35.76 64.21 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 71.239999999999995 111.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.06 -29.39 28.5 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.123 -0.561 . . . . 65.420000000000002 113.111 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -69.6 -30.01 67.66 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.025 0.38 . . . . 72.219999999999999 112.025 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.21 164.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.275 0.472 . . . . 52.299999999999997 112.275 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.99 148.33 22.44 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.233 -0.44 . . . . 70.340000000000003 110.28 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.19 -62.12 1.91 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.931 0.715 . . . . 74.209999999999994 112.931 -173.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.548 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 53.2 mttm -100.49 114.45 28.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.343 0.592 . . . . 75.439999999999998 111.799 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.677 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -163.8 -174.53 3.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.883 -0.599 . . . . 73.019999999999996 110.274 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.677 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -110.38 132.57 54.07 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.034 -0.416 . . . . 75.450000000000003 111.336 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 55' ' ' LEU . 29.8 m -119.72 134.64 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.415 0.626 . . . . 72.310000000000002 112.43 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 127.72 8.42 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.84 -0.618 . . . . 73.219999999999999 112.334 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -129.02 145.86 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.687 -0.302 . . . . 74.510000000000005 110.917 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -146.81 135.31 21.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.997 0.427 . . . . 75.230000000000004 110.903 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.502 ' HB3' HG23 ' A' ' 117' ' ' ILE . 18.5 pt-20 -78.69 98.47 6.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 112.43 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -115.76 119.28 35.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.149 0.5 . . . . 74.030000000000001 111.756 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.26 -75.36 0.5 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.34 -0.457 . . . . 61.039999999999999 114.115 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.3 -72.98 1.85 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.077 -0.582 . . . . 41.329999999999998 112.263 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.9 -84.65 0.38 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.218 -0.515 . . . . 73.230000000000004 113.678 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.85 128.54 2.04 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.758 0.313 . . . . 75.099999999999994 111.827 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -150.38 158.03 43.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.334 -0.394 . . . . 64.319999999999993 111.024 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mt-10 -101.29 -59.47 0.1 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.709 0.633 . . . . 73.319999999999993 112.709 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 66.2 Cg_endo -81.79 44.94 1.83 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.366 2.044 . . . . 71.450000000000003 113.649 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.58 -39.92 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.213 0.449 . . . . 74.209999999999994 112.213 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.603 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 26.0 m-20 -68.15 -52.25 23.41 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 122.102 -0.374 . . . . 53.32 111.342 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 72.8 Cg_exo -51.41 -35.94 56.5 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.127 1.884 . . . . 74.319999999999993 112.613 172.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.86 -58.26 9.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.41 -0.359 . . . . 73.400000000000006 111.003 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.39 -34.11 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.169 0.509 . . . . 71.209999999999994 111.207 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -60.13 -40.51 90.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.806 -0.633 . . . . 74.120000000000005 111.675 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -60.46 -22.25 63.27 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.09 0.404 . . . . 63.420000000000002 112.09 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -91.15 -70.96 0.66 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.122 0.487 . . . . 74.150000000000006 111.996 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -71.46 -35.15 70.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.287 0.847 . . . . 64.219999999999999 113.287 -169.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.52 -24.97 63.81 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.965 0.412 . . . . 62.229999999999997 111.305 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.82 -55.4 3.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.97 0.414 . . . . 73.510000000000005 110.948 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.548 ' HA3' ' HG2' ' A' ' 82' ' ' LYS . . . 159.09 -5.05 0.11 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.853 -0.689 . . . . 75.209999999999994 113.759 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.0 mt -77.59 99.44 5.75 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.52 -0.4 . . . . 73.019999999999996 111.236 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -74.88 129.51 37.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.124 0.488 . . . . 74.129999999999995 111.423 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -80.87 110.59 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.179 -0.464 . . . . 75.040000000000006 111.682 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.67 66.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.225 0.536 . . . . 71.109999999999999 111.692 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -118.39 90.34 38.48 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.459 -0.571 . . . . 75.540000000000006 109.459 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.91 33.22 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.126 2.551 . . . . 63.439999999999998 114.753 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 122.84 4.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.364 0.505 . . . . 53.539999999999999 112.364 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.573 HD11 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.74 123.48 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.296 -0.411 . . . . 75.420000000000002 110.516 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -149.22 28.44 0.82 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.392 0.516 . . . . 72.230000000000004 112.392 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mm -68.8 142.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.067 0.461 . . . . 74.319999999999993 111.332 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -75.16 -51.15 14.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 71.140000000000001 111.577 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -166.29 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.12 0.486 . . . . 71.340000000000003 111.201 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.8 p -114.3 130.37 24.04 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 111.862 0.319 . . . . 72.230000000000004 111.862 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.24 155.8 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.666 2.244 . . . . 53.140000000000001 112.641 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -105.84 170.07 8.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.08 0.467 . . . . 72.219999999999999 111.642 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.37 -24.73 60.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 111.547 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -84.39 -24.19 29.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.801 0.334 . . . . 71.239999999999995 111.557 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -55.56 -32.17 62.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.052 0.453 . . . . 75.349999999999994 111.253 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.415 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 71.0 m-85 -56.48 -45.77 80.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 111.182 175.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -57.53 -46.24 84.09 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.345 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.34 -47.11 72.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.143 0.496 . . . . 73.25 111.005 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 16' ' ' LEU . 67.7 m -58.04 -48.42 80.13 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.72 -0.673 . . . . 75.239999999999995 111.343 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 52.4 mt-10 -58.54 -49.5 77.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.405 . . . . 65.230000000000004 111.604 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.71 -32.7 71.43 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.476 0.547 . . . . 74.010000000000005 112.476 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.67 -60.49 2.35 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.193 0.442 . . . . 70.430000000000007 112.193 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.584 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -65.34 -43.16 95.52 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.141 -0.552 . . . . 73.510000000000005 113.995 -174.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 73.2 m -60.92 -38.78 86.96 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.448 -0.442 . . . . 74.099999999999994 112.127 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.62 -49.89 73.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.935 0.398 . . . . 73.040000000000006 110.973 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.06 -40.26 92.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.324 -0.398 . . . . 75.420000000000002 110.987 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.473 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -59.32 -45.71 95.01 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.104 -0.57 . . . . 62.420000000000002 112.771 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.583 ' HG2' HG23 ' A' ' 27' ' ' THR . 52.4 mt-30 -64.29 -38.97 92.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.037 0.446 . . . . 75.400000000000006 111.254 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -65.49 -58.0 6.88 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.194 -0.457 . . . . 74.040000000000006 111.87 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.402 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 83.9 t -57.11 -50.88 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.379 0.511 . . . . 64.319999999999993 112.379 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.515 HG22 HG23 ' A' ' 29' ' ' VAL . 15.2 t -62.69 -36.86 84.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 55.439999999999998 112.034 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -81.87 -23.26 36.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.737 0.303 . . . . 73.120000000000005 111.414 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.91 -47.97 15.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.024 0.44 . . . . 75.129999999999995 110.518 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -79.61 6.72 9.86 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.46 -0.336 . . . . 72.219999999999999 111.829 177.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.562 HD11 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -58.59 -9.84 1.9 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.926 0.491 . . . . 72.140000000000001 111.739 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -36.57 -47.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.169 0.588 . . . . 63.420000000000002 112.027 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -135.74 -52.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.345 -0.389 . . . . 63.140000000000001 110.576 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 62.57 104.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.026 0.441 . . . . 75.209999999999994 112.005 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -106.74 173.56 6.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.9 0.381 . . . . 71.409999999999997 111.307 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -151.75 151.02 30.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.801 0.334 . . . . 73.530000000000001 111.739 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -150.0 -35.18 0.17 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.524 -0.307 . . . . 73.430000000000007 111.167 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.817 -0.611 . . . . 73.200000000000003 111.18 176.805 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.6 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.634 0.254 . . . . 72.519999999999996 111.496 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.66 HD11 ' HA2' ' A' ' 139' ' ' GLY . 46.0 mm 58.8 95.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.155 0.503 . . . . 74.030000000000001 112.181 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.67 96.09 1.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.915 -0.659 . . . . 50.229999999999997 112.473 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.33 114.09 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.655 0.74 . . . . 73.219999999999999 112.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.64 105.05 17.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.753 -0.658 . . . . 72.239999999999995 110.78 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.4 ' HE1' ' HB ' ' A' ' 33' ' ' VAL . 24.7 p90 -116.21 179.99 3.83 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.897 0.38 . . . . 75.409999999999997 111.455 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.14 113.79 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.242 0.544 . . . . 74.530000000000001 111.408 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.438 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 24.5 m -75.57 -25.02 56.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.195 0.522 . . . . 64.519999999999996 111.556 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -71.78 -16.37 62.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.751 -0.659 . . . . 75.239999999999995 111.978 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.504 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 70.8 t80 -125.69 106.24 9.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.979 0.419 . . . . 64.430000000000007 112.056 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.65 -162.4 5.44 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.583 0.593 . . . . 55.25 114.583 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -80.41 7.63 9.32 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.456 0.539 . . . . 74.549999999999997 112.456 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.6 m -44.69 -35.92 2.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.843 0.683 . . . . 74.230000000000004 112.843 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.438 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 11.7 p-10 -65.67 -43.19 90.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 70.140000000000001 111.328 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -71.09 -38.94 72.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.014 0.435 . . . . 73.319999999999993 110.618 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.92 -43.73 91.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 64.400000000000006 110.968 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.13 75.62 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 111.221 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.23 -34.06 77.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.309 -0.405 . . . . 74.219999999999999 111.144 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.97 92.88 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.042 0.448 . . . . 71.129999999999995 110.736 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.7 mt -63.4 -48.49 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.171 0.51 . . . . 70.150000000000006 110.347 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.585 HG22 HG21 ' A' ' 31' ' ' VAL . 74.6 mt -56.96 -33.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.938 -0.574 . . . . 54.25 111.573 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -58.67 -43.54 89.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.961 0.41 . . . . 70.140000000000001 111.045 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.51 -37.28 62.34 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.05 -0.595 . . . . 73.439999999999998 112.875 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 2' ' ' ILE . 46.5 mm -64.47 -45.21 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.044 0.45 . . . . 74.219999999999999 111.305 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 p -61.83 -42.49 99.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.842 0.353 . . . . 53.310000000000002 111.034 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -57.84 -36.79 72.78 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.827 0.346 . . . . 73.230000000000004 111.439 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.0 m -78.15 -8.6 58.49 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.225 0.536 . . . . 73.519999999999996 111.401 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.19 42.71 23.11 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.163 -0.541 . . . . 40.140000000000001 113.092 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.9 t -127.76 143.94 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 122.595 -0.356 . . . . 72.430000000000007 111.506 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.93 152.25 36.51 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.116 -0.564 . . . . 74.200000000000003 112.732 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.585 HG21 HG22 ' A' ' 21' ' ' ILE . 22.4 t -112.87 147.39 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.465 0.543 . . . . 75.219999999999999 112.465 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -111.26 103.41 11.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.556 0.343 . . . . 73.549999999999997 110.387 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 30.5 m -100.91 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.851 0.685 . . . . 52.43 112.851 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -139.88 127.3 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 116.125 -0.489 . . . . 74.400000000000006 110.931 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -94.22 111.01 22.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.915 0.388 . . . . 74.530000000000001 110.969 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -82.57 11.79 5.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.314 0.487 . . . . 71.150000000000006 112.314 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.39 -9.08 58.18 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.453 -0.403 . . . . 64.319999999999993 112.369 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.41 179.29 5.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.999 0.428 . . . . 45.109999999999999 111.468 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 93.09 0.22 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 65.340000000000003 111.416 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.99 149.75 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.277 0.561 . . . . 74.129999999999995 112.214 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -147.95 170.58 17.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.959 -0.564 . . . . 75.409999999999997 111.176 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.0 mm? -65.18 -22.48 66.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.394 -0.366 . . . . 65.409999999999997 111.686 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -62.45 -42.25 99.33 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.632 0.253 . . . . 63.43 111.361 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.2 -45.19 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.986 0.422 . . . . 55.43 110.813 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.434 ' O ' HD22 ' A' ' 45' ' ' LEU . 5.7 tt -55.79 -38.67 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.074 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -61.39 -21.92 64.51 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.375 0.509 . . . . 73.340000000000003 112.375 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -58.69 -19.7 41.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.991 0.425 . . . . 72.209999999999994 111.355 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -53.18 -34.97 59.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.238 -0.437 . . . . 72.299999999999997 111.436 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.96 -44.11 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.942 0.401 . . . . 74.329999999999998 111.599 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.99 -23.14 50.47 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.984 -0.627 . . . . 51.240000000000002 113.812 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 -1.86 40.69 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.187 -0.596 . . . . 75.230000000000004 111.557 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 53' ' ' THR . 27.9 p -36.79 -58.76 0.73 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.172 1.545 . . . . 71.340000000000003 115.172 -170.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 71.6 p -61.09 -20.54 62.74 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.701 1.0 . . . . 75.420000000000002 113.701 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.34 136.18 4.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.19 -1.005 . . . . 37.729999999999997 113.838 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 57' ' ' ILE . 0.7 OUTLIER -171.08 -179.48 2.74 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.064 0.546 . . . . 54.219999999999999 111.258 -178.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.53 131.07 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.409 . . . . 73.120000000000005 111.46 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.499 HD13 HD12 ' A' ' 55' ' ' LEU . 3.3 mp -117.05 137.01 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.991 0.424 . . . . 72.120000000000005 111.983 -176.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.88 140.26 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.481 -0.648 . . . . 74.209999999999994 111.481 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.488 ' SD ' ' CE2' ' A' ' 10' ' ' TYR . 4.2 ppp? -67.49 146.95 53.46 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 117.652 0.726 . . . . 53.409999999999997 111.897 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 95.1 p -99.38 144.56 28.49 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 112.758 0.651 . . . . 61.240000000000002 112.758 -172.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 90.3 Cg_endo -75.39 -176.3 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.807 2.338 . . . . 74.400000000000006 112.526 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.94 -55.16 25.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.813 0.672 . . . . 44.229999999999997 112.813 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.73 73.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.232 0.456 . . . . 75.019999999999996 112.232 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 62.2 m -65.08 -50.07 67.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.681 -0.236 . . . . 71.150000000000006 111.506 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.64 -49.67 67.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.007 0.432 . . . . 64.230000000000004 111.644 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.45 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.188 0.44 . . . . 72.040000000000006 112.188 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -95.65 -29.56 14.24 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.846 0.313 . . . . 73.329999999999998 111.846 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.11 -13.44 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.021 0.378 . . . . 54.43 112.021 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.49 -40.8 5.87 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.2 0.815 . . . . 71.239999999999995 113.2 -175.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.05 -52.3 28.86 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.858 -0.687 . . . . 64.140000000000001 112.614 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.18 -28.25 66.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.734 0.302 . . . . 73.409999999999997 111.767 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.25 -46.13 86.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.82 0.343 . . . . 74.140000000000001 110.899 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -58.04 -45.06 87.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.09 0.471 . . . . 72.040000000000006 110.431 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.3 m -55.97 -47.7 77.17 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.853 -0.612 . . . . 75.099999999999994 111.479 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 79' ' ' VAL . 77.4 mt -61.06 -55.73 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.34 -0.391 . . . . 65.430000000000007 111.204 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.8 -30.92 58.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.228 0.455 . . . . 75.510000000000005 112.228 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.24 -21.24 55.41 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.061 -0.59 . . . . 63.200000000000003 113.656 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 m -100.18 -6.44 26.15 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.088 0.773 . . . . 65.25 113.088 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -75.86 172.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.46 0.541 . . . . 75.200000000000003 112.46 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -99.68 178.32 4.88 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.528 . . . . 70.439999999999998 110.585 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -87.49 -18.05 30.74 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.871 0.693 . . . . 64.040000000000006 112.871 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -148.96 44.98 1.0 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.192 1.182 . . . . 73.510000000000005 114.192 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.9 pm0 -94.38 166.78 11.9 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.393 -0.817 . . . . 71.430000000000007 111.425 175.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.75 115.46 27.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 111.843 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.92 114.76 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.572 0.701 . . . . 72.420000000000002 112.031 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.47 145.36 25.16 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.06 -0.591 . . . . 64.299999999999997 112.416 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -152.83 140.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.071 0.435 . . . . 75.049999999999997 111.192 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -155.85 110.84 2.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.217 0.532 . . . . 74.239999999999995 110.72 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.99 131.31 35.95 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.4 -0.364 . . . . 73.510000000000005 111.506 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 HG23 ' A' ' 127' ' ' THR . 12.2 t -170.89 179.91 3.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.402 -0.363 . . . . 73.450000000000003 111.161 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.31 -17.56 18.08 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.287 -0.483 . . . . 44.439999999999998 113.92 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.82 -119.25 0.75 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.398 -0.43 . . . . 37.729999999999997 112.336 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.55 74.03 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.424 -0.893 . . . . 60.109999999999999 114.155 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -97.89 109.98 22.64 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.609 -0.348 . . . . 75.439999999999998 110.654 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.673 ' HB2' ' HB ' ' A' ' 98' ' ' ILE . 16.2 p-10 -137.98 95.02 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.654 0.74 . . . . 64.329999999999998 112.454 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 39.1 mt-10 -103.76 -48.78 0.15 Allowed Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.189 -0.46 . . . . 75.439999999999998 112.051 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.52 ' O ' HD13 ' A' ' 101' ' ' LEU . 54.8 Cg_endo -91.52 27.46 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.231 1.954 . . . . 71.409999999999997 112.647 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.673 ' HB ' ' HB2' ' A' ' 95' ' ' ASP . 7.1 tt -59.93 -51.49 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.988 0.736 . . . . 74.519999999999996 112.988 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.519 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 12.0 m-20 -62.74 -49.46 82.38 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.403 0.519 . . . . 71.519999999999996 112.403 -175.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.544 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 74.7 Cg_exo -51.45 -50.3 14.39 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.102 1.868 . . . . 74.409999999999997 112.973 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.5 mp -63.05 -47.7 81.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.87 0.322 . . . . 63.340000000000003 111.87 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 62.1 mt -58.77 -38.79 79.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.008 0.432 . . . . 70.209999999999994 111.044 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -58.17 -42.16 85.41 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.282 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 100' ' ' PRO . 11.3 mmpt? -55.98 -49.51 73.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 74.150000000000006 111.215 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -56.0 -47.49 77.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.233 0.457 . . . . 72.129999999999995 112.233 -177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -79.61 -35.53 39.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.679 0.622 . . . . 65.019999999999996 112.679 -175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.59 -44.94 63.56 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.07 -0.394 . . . . 72.329999999999998 111.873 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.51 -41.39 63.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.835 0.35 . . . . 63.229999999999997 111.34 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.36 43.43 2.54 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.013 -0.613 . . . . 62.409999999999997 112.612 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 59.3 mt -83.86 136.21 34.2 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.869 0.366 . . . . 61.0 111.553 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 74.0 m -71.68 93.41 1.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.856 0.36 . . . . 65.209999999999994 110.841 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.0 p -88.15 128.91 35.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.286 -0.416 . . . . 70.450000000000003 111.328 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.75 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.777 0.288 . . . . 52.43 111.777 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -164.89 94.44 0.91 Allowed Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.523 0.202 . . . . 70.200000000000003 111.408 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 115.67 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.309 2.006 . . . . 65.200000000000003 111.706 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.0 35.9 3.91 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.067 0.766 . . . . 64.239999999999995 113.067 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.7 tt -61.09 82.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.293 1.044 . . . . 62.399999999999999 111.427 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -163.63 25.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.011 -0.995 . . . . 70.319999999999993 109.744 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.3 mm -88.59 137.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.795 -0.639 . . . . 72.299999999999997 111.954 -172.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -52.04 -51.8 55.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.689 -0.687 . . . . 72.239999999999995 112.35 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 179.98 -72.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.274 0.559 . . . . 64.019999999999996 110.958 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p -82.56 146.85 54.43 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.024 -0.535 . . . . 70.239999999999995 111.96 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.48 106.0 1.86 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.401 2.067 . . . . 61.439999999999998 112.903 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 52.3 p -85.79 -178.58 6.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.276 -0.42 . . . . 71.109999999999999 111.23 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.4 ' HG2' ' HE2' ' A' ' 129' ' ' LYS . 44.4 tt0 -49.57 -35.61 21.11 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.165 0.431 . . . . 43.509999999999998 112.165 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -55.9 -42.74 76.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 73.239999999999995 111.319 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.43 HG23 HG21 ' A' ' 90' ' ' THR . 46.5 m -63.8 -40.72 97.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.997 0.427 . . . . 74.230000000000004 111.025 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -61.68 -48.84 78.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.222 -0.445 . . . . 72.5 111.619 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.4 ' HE2' ' HG2' ' A' ' 125' ' ' GLU . 67.6 mttm -53.54 -42.06 67.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.885 0.328 . . . . 62.119999999999997 111.885 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.02 -47.47 85.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.869 0.366 . . . . 74.349999999999994 111.056 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.1 m -66.46 -46.4 76.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.188 -0.46 . . . . 70.340000000000003 111.797 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.51 -48.81 77.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.233 -0.439 . . . . 62.310000000000002 111.898 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -78.26 -51.11 10.65 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.545 0.572 . . . . 71.540000000000006 112.545 -172.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.66 -36.07 71.39 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.34 0.496 . . . . 75.319999999999993 112.34 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.96 -45.01 62.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.406 -0.426 . . . . 73.120000000000005 113.399 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 88.5 m -67.8 -55.05 14.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.93 0.344 . . . . 75.409999999999997 111.93 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.82 -54.05 43.85 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.875 0.369 . . . . 53.25 111.635 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.8 -40.23 83.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.653 -0.249 . . . . 74.319999999999993 111.539 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.66 ' HA2' HD11 ' A' ' 2' ' ' ILE . . . -55.93 -47.72 77.69 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.259 -0.496 . . . . 60.32 113.2 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.96 -14.87 62.37 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.186 0.439 . . . . 75.230000000000004 112.186 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -90.62 -53.77 4.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.84 0.352 . . . . 73.530000000000001 110.972 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.9 t -54.43 -40.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 112.16 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 139' ' ' GLY . 6.8 t -69.64 -43.87 71.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.697 0.284 . . . . 64.340000000000003 111.575 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -63.81 -38.99 93.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.144 0.497 . . . . 74.420000000000002 111.011 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.37 -44.95 72.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.605 -0.725 . . . . 73.400000000000006 112.192 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -92.75 -21.97 19.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.308 -0.405 . . . . 65.120000000000005 111.865 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.27 -35.33 80.68 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.71 0.29 . . . . 75.010000000000005 110.937 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -50.08 -72.52 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.062 0.764 . . . . 74.439999999999998 113.062 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -108.77 -37.74 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.517 0.562 . . . . 75.340000000000003 112.517 -171.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -62.71 -37.92 88.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.872 0.323 . . . . 74.230000000000004 111.872 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.9 m80 51.93 66.22 1.27 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.229 0.455 . . . . 73.109999999999999 112.229 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 52.25 -92.24 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.387 0.514 . . . . 72.239999999999995 112.387 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 67.6 m80 48.98 -166.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.501 0.667 . . . . 70.430000000000007 112.725 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.4 m170 . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.528 -0.76 . . . . 62.109999999999999 110.634 169.816 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 28.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 119.999 -0.048 . . . . 75.540000000000006 110.888 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 3' ' ' GLY . 47.8 mm 67.8 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.182 0.515 . . . . 51.009999999999998 111.892 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 2' ' ' ILE . . . -123.58 101.08 0.68 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.204 -0.522 . . . . 36.5 113.077 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.404 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 57.4 t -86.23 99.66 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 122.322 -0.516 . . . . 72.5 110.975 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.683 ' HB3' HD22 ' A' ' 36' ' ' LEU . 82.1 m-85 -90.25 126.74 35.94 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.282 0.475 . . . . 73.349999999999994 112.282 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.53 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 6.7 p90 -143.96 163.29 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.272 -0.422 . . . . 73.129999999999995 110.945 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 36' ' ' LEU . 3.9 p -129.02 105.41 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.452 0.644 . . . . 74.439999999999998 112.487 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -61.5 -28.14 69.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.077 0.465 . . . . 73.150000000000006 111.445 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.05 -22.59 62.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.795 0.665 . . . . 70.409999999999997 112.795 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 2.3 t80 -129.06 92.15 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.895 0.702 . . . . 71.239999999999995 112.895 -173.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 -158.58 7.67 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 115.746 1.058 . . . . 41.530000000000001 115.746 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -59.34 7.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.528 1.307 . . . . 74.230000000000004 114.528 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -47.16 -35.79 7.78 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.561 0.619 . . . . 74.519999999999996 112.298 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.89 -39.69 79.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.974 0.416 . . . . 74.409999999999997 110.784 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -58.34 -45.65 87.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.192 0.52 . . . . 60.409999999999997 110.508 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 20' ' ' ILE . 79.6 mt -59.49 -51.33 70.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.894 -0.594 . . . . 73.519999999999996 111.644 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 6' ' ' TYR . . . -55.49 -43.24 75.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.106 0.479 . . . . 54.509999999999998 111.479 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.431 ' HA ' HG23 ' A' ' 21' ' ' ILE . 34.7 tt0 -66.29 -34.49 78.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.078 0.466 . . . . 73.239999999999995 110.845 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.17 -31.61 72.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.175 -0.466 . . . . 52.340000000000003 111.29 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.483 HG22 ' HA3' ' A' ' 135' ' ' GLY . 71.5 mt -67.91 -57.46 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.152 0.501 . . . . 71.230000000000004 111.005 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.431 HG23 ' HA ' ' A' ' 18' ' ' GLN . 14.0 tt -63.2 -25.17 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.088 -0.506 . . . . 75.420000000000002 111.736 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -54.56 -46.8 73.74 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.778 0.323 . . . . 72.219999999999999 111.744 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.19 -37.35 42.77 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.019 -0.61 . . . . 74.239999999999995 112.922 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -62.94 -42.73 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.994 0.426 . . . . 64.439999999999998 111.585 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.422 HG21 HG12 ' A' ' 21' ' ' ILE . 44.6 p -66.64 -39.87 88.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.574 -0.285 . . . . 71.230000000000004 111.574 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -58.54 -41.6 85.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.272 0.558 . . . . 74.510000000000005 109.888 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -64.0 -31.74 73.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.843 -0.617 . . . . 74.120000000000005 110.806 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 39.59 3.41 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.126 -0.488 . . . . 53.439999999999998 113.633 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.08 132.14 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.915 0.388 . . . . 73.549999999999997 111.444 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.33 96.54 2.18 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.314 -0.47 . . . . 74.299999999999997 113.708 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.3 m -102.86 142.48 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.911 0.386 . . . . 75.310000000000002 111.797 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -95.75 144.65 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.974 0.416 . . . . 75.319999999999993 111.78 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.422 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 32.6 m -101.18 151.72 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.913 0.387 . . . . 75.230000000000004 111.512 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -137.16 114.18 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.012 0.434 . . . . 75.019999999999996 111.984 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.69 92.6 3.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.732 0.301 . . . . 74.530000000000001 110.374 171.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -65.81 -23.81 66.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.274 0.472 . . . . 71.400000000000006 112.274 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' N ' HD11 ' A' ' 36' ' ' LEU . . . -98.08 24.51 31.48 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.12 -0.562 . . . . 41.039999999999999 112.943 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.88 -178.14 3.35 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.038 0.447 . . . . 50.119999999999997 111.837 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.45 44.9 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.307 0.484 . . . . 65.209999999999994 112.307 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.62 128.33 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.115 0.483 . . . . 75.409999999999997 111.765 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.61 166.85 11.31 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.341 -0.391 . . . . 71.450000000000003 111.263 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.75 -25.55 55.25 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.419 -0.355 . . . . 75.099999999999994 111.824 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -59.38 -49.75 76.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.624 0.25 . . . . 71.540000000000006 110.831 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.23 -39.1 75.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.037 0.446 . . . . 71.310000000000002 111.049 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -35.18 71.5 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.031 0.443 . . . . 71.530000000000001 110.626 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -58.3 -29.89 66.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.558 -0.292 . . . . 73.420000000000002 111.673 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -60.37 -29.19 68.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.033 0.444 . . . . 61.420000000000002 110.961 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.2 -21.28 66.11 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.358 -0.383 . . . . 72.310000000000002 111.699 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.15 -55.13 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.893 0.378 . . . . 62.240000000000002 111.243 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.61 -18.43 77.2 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.923 -0.656 . . . . 63.109999999999999 112.76 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -100.63 5.99 43.98 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.209 0.448 . . . . 73.120000000000005 112.209 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -64.92 -9.47 21.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.026 0.38 . . . . 61.25 112.026 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.4 p -58.44 -18.92 32.27 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.136 0.493 . . . . 70.340000000000003 111.355 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.68 137.23 3.65 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 112.59 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 ' N ' HD21 ' A' ' 55' ' ' LEU . 1.7 pt? -148.59 133.52 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 64.109999999999999 110.628 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 4' ' ' VAL . 5.6 p -112.58 117.74 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 75.510000000000005 111.443 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.49 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.6 mp -116.49 110.38 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.252 -0.431 . . . . 75.439999999999998 110.653 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.56 41.55 3.06 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.043 -0.599 . . . . 72.530000000000001 113.396 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.422 ' HG2' ' O ' ' A' ' 88' ' ' PHE . 92.1 mmm 61.84 173.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.381 0.61 . . . . 72.439999999999998 112.425 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -158.84 154.25 22.31 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.305 -0.407 . . . . 54.409999999999997 111.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.576 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 60.3 Cg_endo -70.69 157.9 57.27 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.462 2.108 . . . . 64.329999999999998 111.915 173.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.71 62.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.591 0.589 . . . . 73.129999999999995 112.591 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.26 68.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.548 0.573 . . . . 72.230000000000004 112.548 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.2 m -89.07 -49.77 6.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.91 0.386 . . . . 73.239999999999995 111.567 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.45 -23.26 65.73 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.368 -0.378 . . . . 65.409999999999997 111.549 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.8 -34.53 59.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.779 0.324 . . . . 73.120000000000005 111.403 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 t -65.18 -45.15 86.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.236 0.541 . . . . 74.099999999999994 110.455 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.95 -40.55 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.002 -0.544 . . . . 61.329999999999998 110.617 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.92 -34.8 78.22 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.818 -0.628 . . . . 71.109999999999999 111.028 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.38 -42.26 56.95 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.211 -0.518 . . . . 73.209999999999994 112.93 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.85 6.82 33.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.041 0.385 . . . . 64.430000000000007 112.041 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.1 tp -39.58 -61.1 0.86 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.295 0.85 . . . . 72.049999999999997 113.295 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.9 m -57.23 -40.02 76.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.172 0.434 . . . . 75.430000000000007 112.172 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.06 -45.01 94.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.937 0.399 . . . . 74.329999999999998 110.926 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.45 -37.49 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.058 0.456 . . . . 75.239999999999995 111.255 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.16 -15.2 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.289 -0.414 . . . . 62.020000000000003 111.157 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 -39.28 5.75 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.403 -0.427 . . . . 42.100000000000001 112.664 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.6 p -67.56 -40.12 84.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.878 0.325 . . . . 54.130000000000003 111.878 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -69.44 169.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.041 0.448 . . . . 71.540000000000006 111.803 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -133.06 -176.15 4.02 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.288 -0.258 . . . . 62.219999999999999 110.704 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 43.1 tt0 -47.27 -65.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.486 0.55 . . . . 64.040000000000006 112.486 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.576 ' HD2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -152.49 130.03 11.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.256 0.551 . . . . 75.129999999999995 112.036 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.78 -79.47 0.18 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.005 -0.543 . . . . 73.140000000000001 110.896 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.556 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -170.21 117.78 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.902 0.334 . . . . 62.549999999999997 111.902 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.62 99.56 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.648 0.737 . . . . 63.439999999999998 111.529 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -74.84 77.88 1.09 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.125 -0.489 . . . . 65.349999999999994 113.147 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.5 mm -86.63 121.43 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.059 0.392 . . . . 74.120000000000005 112.059 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.422 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 p90 -153.76 -179.03 7.44 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.296 -0.411 . . . . 73.109999999999999 110.41 174.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.478 ' HB2' HG23 ' A' ' 117' ' ' ILE . 11.3 tp10 -106.43 144.25 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.779 0.659 . . . . 75.0 112.779 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -125.51 -23.76 4.03 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.413 -0.358 . . . . 72.299999999999997 111.905 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.419 ' O ' HG22 ' A' ' 119' ' ' ILE . . . -119.75 -98.52 1.75 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.604 -0.332 . . . . 44.119999999999997 113.097 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.95 42.91 0.48 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.532 -0.842 . . . . 63.439999999999998 114.037 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.33 55.1 22.86 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.353 -0.451 . . . . 55.240000000000002 113.459 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.24 -159.96 0.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.883 0.327 . . . . 73.140000000000001 111.883 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.439 ' OD1' ' HD2' ' A' ' 97' ' ' PRO . 32.4 t70 74.05 162.1 0.25 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.267 0.627 . . . . 51.109999999999999 112.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 40.1 mt-10 -103.26 -55.45 0.11 Allowed Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 64.450000000000003 112.744 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 91.8 Cg_endo -76.46 11.19 1.93 Allowed 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.337 2.025 . . . . 62.240000000000002 113.513 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.443 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.3 tt -44.64 -56.31 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.122 0.786 . . . . 63.210000000000001 113.122 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.686 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.6 m-20 -60.83 -54.89 50.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 112.327 0.492 . . . . 73.109999999999999 112.327 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.0 Cg_exo -54.0 -36.17 83.35 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.275 1.983 . . . . 55.119999999999997 113.093 176.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.19 -62.16 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.462 -0.335 . . . . 70.120000000000005 111.68 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.51 -41.02 88.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.16 0.43 . . . . 73.420000000000002 112.16 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t -57.93 -37.31 73.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.826 0.346 . . . . 74.129999999999995 111.57 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -64.3 -45.85 86.17 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.734 0.302 . . . . 74.25 111.522 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -62.37 -29.13 70.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.994 0.426 . . . . 74.430000000000007 111.361 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -71.35 -37.4 71.68 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.944 0.402 . . . . 75.030000000000001 110.579 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.464 HD21 HD13 ' A' ' 108' ' ' LEU . 6.7 t30 -62.58 -46.34 88.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.348 -0.387 . . . . 73.340000000000003 111.528 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.464 HD13 HD21 ' A' ' 107' ' ' ASN . 9.5 mp -73.52 -41.77 62.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.785 0.326 . . . . 62.420000000000002 111.326 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 72.22 1.26 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.316 -0.468 . . . . 55.229999999999997 113.61 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 mp -102.29 164.41 11.7 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 72.349999999999994 111.112 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 29.4 m -66.2 95.36 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.72 0.295 . . . . 64.349999999999994 111.289 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.2 p -83.68 164.72 19.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.036 0.446 . . . . 75.209999999999994 111.785 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.484 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -94.72 -83.83 0.34 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.617 -0.265 . . . . 71.140000000000001 111.671 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.409 ' CE2' ' HB1' ' A' ' 116' ' ' ALA . 34.3 t80 -162.38 89.29 1.38 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.948 0.404 . . . . 74.140000000000001 110.907 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.0 27.28 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.625 2.883 . . . . 72.25 114.199 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.409 ' HB1' ' CE2' ' A' ' 114' ' ' PHE . . . -87.69 94.65 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.827 -0.546 . . . . 41.329999999999998 110.991 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 89' ' ' GLU . 31.2 pt -68.61 107.31 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.495 0.664 . . . . 73.319999999999993 112.674 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -103.34 -23.95 13.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.081 -0.509 . . . . 70.450000000000003 111.651 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.2 mp -90.42 145.73 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.556 -0.293 . . . . 70.420000000000002 110.605 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -120.23 5.68 10.75 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.426 0.528 . . . . 74.120000000000005 112.426 -178.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.508 ' H ' HG22 ' A' ' 119' ' ' ILE . 53.1 tt0 -178.76 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.795 0.331 . . . . 71.319999999999993 111.662 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.1 p -117.42 122.56 30.83 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 116.516 -0.311 . . . . 74.519999999999996 111.603 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.507 ' HA ' HG12 ' A' ' 119' ' ' ILE . 32.8 Cg_endo -63.34 141.03 79.99 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.653 2.235 . . . . 74.340000000000003 112.863 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 62.1 p -93.68 173.87 7.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.331 0.586 . . . . 72.120000000000005 112.383 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -53.58 -28.73 33.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.644 -0.707 . . . . 71.430000000000007 112.509 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -66.86 -39.55 87.61 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.322 0.49 . . . . 63.149999999999999 112.322 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 71.9 p -54.62 -40.46 68.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.571 0.582 . . . . 74.109999999999999 112.571 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -55.27 -35.3 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.313 0.486 . . . . 70.420000000000002 112.313 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.42 -50.64 51.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.831 0.348 . . . . 74.230000000000004 111.098 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -61.66 -33.9 74.77 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.931 0.396 . . . . 65.299999999999997 111.036 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -61.75 -45.89 91.99 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.288 -0.414 . . . . 74.109999999999999 111.227 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.22 -52.77 62.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.392 -0.367 . . . . 73.140000000000001 111.166 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.9 -50.18 73.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 111.93 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.13 73.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.872 0.323 . . . . 71.540000000000006 111.872 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.483 ' HA3' HG22 ' A' ' 20' ' ' ILE . . . -68.55 -42.17 81.93 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.016 -0.612 . . . . 63.329999999999998 113.643 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.1 m -70.61 -47.74 58.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.556 -0.379 . . . . 73.310000000000002 111.931 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -55.92 -47.63 77.15 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.152 0.501 . . . . 65.340000000000003 110.989 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -70.08 -39.98 75.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.996 -0.547 . . . . 73.5 110.385 177.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.49 -40.72 78.78 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.577 -0.344 . . . . 36.5 112.803 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 136' ' ' THR . 96.7 mt-30 -62.35 -38.31 89.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.131 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -61.09 -45.16 95.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.797 0.332 . . . . 73.319999999999993 110.563 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.35 -53.28 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.346 -0.388 . . . . 64.540000000000006 111.791 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.0 t -68.32 -37.54 80.68 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.132 0.419 . . . . 71.430000000000007 112.132 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.774 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 21.5 ttt180 -71.56 -35.44 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.887 0.375 . . . . 74.439999999999998 111.438 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.18 -25.36 66.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 74.040000000000006 110.353 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 77.0 mtt180 -100.1 8.02 44.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.591 -0.731 . . . . 44.140000000000001 111.848 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER 117.12 -43.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.777 1.631 . . . . 62.210000000000001 111.506 174.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.774 ' HB2' ' HA ' ' A' ' 144' ' ' ARG . 38.4 tt0 72.08 -62.06 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.042 0.537 . . . . 65.109999999999999 112.369 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.6 t60 71.52 -75.71 0.07 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.905 0.482 . . . . 73.329999999999998 110.513 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -144.39 105.58 4.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.828 0.346 . . . . 72.310000000000002 111.597 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -145.82 114.0 6.61 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.229 0.538 . . . . 73.150000000000006 112.154 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -128.67 149.74 50.54 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.096 -0.502 . . . . 73.219999999999999 110.668 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -95.92 -11.36 26.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.477 0.547 . . . . 74.409999999999997 112.477 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.2 t60 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.464 -0.779 . . . . 72.219999999999999 111.219 179.764 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 80.1 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.885 -0.043 . . . . 71.409999999999997 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.9 mp 60.27 110.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.173 0.511 . . . . 62.329999999999998 111.73 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.02 91.82 1.66 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.853 -0.689 . . . . 55.200000000000003 113.326 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.657 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 59.4 t -80.91 123.54 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.027 0.413 . . . . 72.5 111.392 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 84.0 m-85 -116.38 133.69 55.73 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.494 0.553 . . . . 63.310000000000002 112.494 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -149.27 -178.18 6.26 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 110.826 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 p -129.51 83.55 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.482 0.658 . . . . 75.319999999999993 111.799 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -53.77 -29.75 41.48 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.008 0.744 . . . . 72.430000000000007 113.008 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.81 -13.94 62.52 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.345 0.498 . . . . 73.430000000000007 112.345 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.89 135.35 41.55 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.497 0.925 . . . . 71.239999999999995 113.497 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.19 -162.1 4.97 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 116.394 1.318 . . . . 62.140000000000001 116.394 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 73.8 m-85 -76.03 8.57 3.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.383 0.882 . . . . 73.349999999999994 113.383 -174.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -49.04 -35.58 16.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.114 0.413 . . . . 72.209999999999994 112.114 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -66.43 -37.99 86.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 64.340000000000003 110.919 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -69.16 -39.27 78.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.869 -0.605 . . . . 75.430000000000007 110.735 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -41.37 94.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.149 -0.478 . . . . 74.040000000000006 110.626 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.98 92.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.071 -0.513 . . . . 62.219999999999999 110.858 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -57.48 -46.62 83.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.166 -0.47 . . . . 75.129999999999995 110.946 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.57 -47.03 80.38 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.174 -0.466 . . . . 62.210000000000001 111.302 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.15 -51.45 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 111.042 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.475 ' O ' HG21 ' A' ' 25' ' ' THR . 75.4 mt -55.79 -57.74 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 111.191 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -58.81 -29.45 66.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.865 0.364 . . . . 75.349999999999994 111.705 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -38.82 34.43 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.102 -0.57 . . . . 43.530000000000001 113.484 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.15 -24.7 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.486 0.55 . . . . 73.299999999999997 112.486 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 21' ' ' ILE . 32.9 p -57.57 -29.3 64.32 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.061 -0.4 . . . . 75.109999999999999 111.777 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.72 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.5 mmpt? -64.63 -17.61 64.18 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.937 0.399 . . . . 54.229999999999997 111.941 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -88.23 -9.79 51.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.085 0.469 . . . . 62.119999999999997 110.825 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.98 37.53 74.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.528 -0.368 . . . . 62.119999999999997 113.363 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.711 HG21 HG22 ' A' ' 143' ' ' THR . 61.8 t -128.84 141.55 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.56 -0.376 . . . . 55.439999999999998 111.564 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.95 4.64 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.46 -0.4 . . . . 43.130000000000003 113.092 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.2 m -94.86 148.45 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.109 0.48 . . . . 71.129999999999995 112.016 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.4 125.07 37.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.217 -0.447 . . . . 75.239999999999995 111.072 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 131.89 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.983 0.42 . . . . 72.329999999999998 111.793 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 62.2 t -141.43 147.21 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.6 0.36 . . . . 64.219999999999999 110.991 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 6.6 m-20 -82.72 118.06 23.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.125 0.417 . . . . 74.340000000000003 112.125 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 37' ' ' GLY . 1.6 pp -77.65 -25.41 49.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.963 0.411 . . . . 73.409999999999997 111.85 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.602 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -87.31 -13.13 66.35 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.072 -0.585 . . . . 75.540000000000006 113.233 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 166.58 20.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.434 0.635 . . . . 63.439999999999998 112.039 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.84 76.83 2.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.954 -0.566 . . . . 63.399999999999999 111.396 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.72 164.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.336 0.495 . . . . 65.230000000000004 112.336 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.54 -163.24 1.32 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.215 0.531 . . . . 53.130000000000003 111.943 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -62.25 -24.17 67.1 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.151 0.797 . . . . 72.340000000000003 113.151 -173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.87 -52.53 62.74 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.104 -0.372 . . . . 65.120000000000005 110.844 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.05 -42.51 99.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.886 0.374 . . . . 73.140000000000001 111.1 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.08 -58.28 9.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.127 -0.488 . . . . 50.530000000000001 110.999 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -64.49 -36.38 84.0 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.844 0.312 . . . . 74.150000000000006 111.844 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.68 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.902 0.382 . . . . 71.230000000000004 110.704 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 55' ' ' LEU . 45.0 tp -59.53 -44.23 93.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.382 -0.372 . . . . 73.230000000000004 110.71 172.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -56.92 -33.25 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.071 0.462 . . . . 63.049999999999997 110.91 176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.46 -40.38 94.36 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.02 -0.609 . . . . 74.329999999999998 112.469 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -87.03 6.37 32.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.084 0.402 . . . . 70.299999999999997 112.084 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.4 p -45.35 -26.59 0.55 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.256 1.206 . . . . 64.129999999999995 114.256 -170.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -54.71 -32.51 59.72 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.14 -0.35 . . . . 75.209999999999994 111.569 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.641 ' HA3' HG21 ' A' ' 142' ' ' VAL . . . -160.8 137.64 5.07 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.071 -0.585 . . . . 73.109999999999999 113.375 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' N ' HD21 ' A' ' 55' ' ' LEU . 2.0 pt? -145.2 157.56 44.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.076 0.465 . . . . 65.420000000000002 111.416 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.657 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 75.1 t -114.58 116.59 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.458 -0.337 . . . . 72.310000000000002 110.998 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.533 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.4 mp -98.69 115.18 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.65 0.262 . . . . 65.340000000000003 111.077 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.6 -24.09 61.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.117 -0.563 . . . . 72.25 114.079 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 60' ' ' SER . 16.7 tmm? 68.62 153.92 0.1 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.987 0.423 . . . . 64.049999999999997 111.665 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.513 ' N ' ' SD ' ' A' ' 59' ' ' MET . 40.6 t -162.95 146.46 8.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.031 -0.418 . . . . 74.450000000000003 111.342 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.0 160.52 12.41 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.954 2.436 . . . . 75.239999999999995 113.546 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.565 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . . . -41.43 -37.31 1.02 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.685 0.994 . . . . 64.519999999999996 113.685 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.3 -47.28 47.05 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.168 0.433 . . . . 75.040000000000006 112.168 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.432 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 66.6 m -98.4 -27.08 14.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.681 0.277 . . . . 63.420000000000002 111.409 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.565 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -55.69 -32.67 63.47 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.492 -0.322 . . . . 51.149999999999999 111.824 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.11 89.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.941 0.4 . . . . 73.209999999999994 111.128 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -62.49 -33.61 75.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.203 0.525 . . . . 75.109999999999999 111.01 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 36' ' ' LEU . 57.8 mt -75.04 -40.08 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.969 -0.56 . . . . 54.329999999999998 111.203 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -53.01 -44.73 67.52 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.851 -0.613 . . . . 63.229999999999997 112.573 -172.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.75 -43.71 80.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.032 -0.604 . . . . 63.329999999999998 112.839 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -77.31 -34.77 55.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 110.949 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -56.46 -42.86 78.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.99 0.516 . . . . 72.329999999999998 111.267 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -53.06 -33.91 54.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.26 0.552 . . . . 73.409999999999997 111.105 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -82.89 -41.67 18.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.036 -0.529 . . . . 74.219999999999999 111.257 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 71' ' ' ALA . 78.6 mt -57.62 -43.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.027 0.38 . . . . 72.010000000000005 112.027 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' HB3' ' HE2' ' A' ' 104' ' ' LYS . 67.5 mt -61.69 -19.85 62.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.288 0.477 . . . . 72.239999999999995 112.288 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.63 -15.63 65.49 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.026 -0.607 . . . . 71.310000000000002 112.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.9 m -98.41 -36.85 9.83 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.881 0.326 . . . . 64.349999999999994 111.881 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 75' ' ' ILE . 27.2 m -106.13 123.46 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.233 0.539 . . . . 73.349999999999994 112.096 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.465 ' HA ' HD23 ' A' ' 108' ' ' LEU . 3.3 p-10 -160.9 -172.56 3.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.268 0.556 . . . . 72.439999999999998 111.806 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.7 -86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 73.400000000000006 113.519 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 16.9 ptmt -155.45 6.49 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.658 0.984 . . . . 74.230000000000004 113.658 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 3.1 pt20 -65.16 178.01 0.95 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.972 0.415 . . . . 74.310000000000002 112.051 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.571 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.89 124.53 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.439 0.903 . . . . 74.040000000000006 113.439 -168.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.12 102.53 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.648 0.737 . . . . 73.420000000000002 111.569 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.33 94.6 1.67 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.42 -0.419 . . . . 55.409999999999997 112.771 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.24 139.02 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 122.274 -0.545 . . . . 75.239999999999995 112.144 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -136.83 -179.38 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 110.249 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -112.86 134.4 54.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.363 0.875 . . . . 73.310000000000002 113.363 -173.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -154.41 130.67 10.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.796 -0.638 . . . . 51.420000000000002 110.864 169.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 86.84 -59.21 4.57 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.077 -0.582 . . . . 72.340000000000003 113.551 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.78 -98.42 0.18 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.502 -0.38 . . . . 74.409999999999997 113.184 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.51 -128.01 26.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.248 -0.501 . . . . 72.209999999999994 113.882 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -123.09 136.0 54.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.403 -0.469 . . . . 75.099999999999994 111.888 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.51 145.52 3.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.735 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 5.7 mp0 -103.58 -44.32 0.18 Allowed Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 112.566 0.58 . . . . 74.400000000000006 112.566 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 87.7 Cg_exo -50.59 -13.75 0.9 Allowed 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.762 2.308 . . . . 72.219999999999999 114.128 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -51.78 -37.67 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.183 0.438 . . . . 65.209999999999994 112.183 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.71 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.2 m-20 -63.63 -56.38 26.51 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.004 0.372 . . . . 72.519999999999996 112.004 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.5 Cg_exo -55.04 -36.92 93.91 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.008 1.805 . . . . 75.140000000000001 112.64 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.98 -58.3 9.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.406 -0.361 . . . . 63.210000000000001 111.326 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 91.3 mt -57.96 -40.77 81.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.128 0.49 . . . . 54.299999999999997 111.068 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t -56.59 -45.12 81.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.846 -0.615 . . . . 71.510000000000005 111.581 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.507 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 53.7 tptt -55.46 -49.22 73.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.302 -0.408 . . . . 74.129999999999995 111.347 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.2 -35.5 81.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.489 -0.323 . . . . 73.519999999999996 111.869 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 102' ' ' LEU . 74.7 mmt-85 -69.0 -55.46 10.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 111.913 0.338 . . . . 75.530000000000001 111.913 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -61.08 -43.77 98.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.104 0.409 . . . . 65.25 112.104 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 80' ' ' ASN . 8.6 mp -73.97 -37.43 64.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.622 0.249 . . . . 73.150000000000006 111.29 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.09 53.12 35.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.318 -0.468 . . . . 72.510000000000005 114.035 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.56 ' H ' HD12 ' A' ' 110' ' ' LEU . 3.4 mp -77.18 173.42 11.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.474 -0.427 . . . . 72.329999999999998 111.024 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.571 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 94.1 m -65.87 93.47 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 74.540000000000006 110.142 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -101.37 132.73 46.78 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.301 0.482 . . . . 74.430000000000007 112.301 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.65 -64.16 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.155 0.428 . . . . 50.119999999999997 112.155 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -147.99 111.97 3.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 120.725 0.298 . . . . 51.420000000000002 110.305 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -89.14 6.57 4.51 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.858 2.372 . . . . 75.329999999999998 114.822 -171.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.71 144.61 45.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.038 0.385 . . . . 64.219999999999999 112.038 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.2 pt -94.16 157.19 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.947 0.721 . . . . 62.409999999999997 112.947 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 118' ' ' ARG . 9.7 mmt85 -152.52 -49.77 0.1 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.386 0.674 . . . . 73.540000000000006 111.645 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.447 HD13 ' N ' ' A' ' 119' ' ' ILE . 1.9 mp -72.7 112.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.232 0.539 . . . . 73.030000000000001 111.669 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -82.83 -22.86 34.0 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.187 -0.46 . . . . 61.539999999999999 111.418 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.6 tt0 -160.13 -67.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.165 0.507 . . . . 73.209999999999994 111.714 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.3 p -91.8 129.35 42.56 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.343 -0.389 . . . . 74.540000000000006 112.03 -174.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.412 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 37.3 Cg_exo -61.84 152.69 73.02 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.801 2.334 . . . . 71.099999999999994 112.779 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.8 p -111.16 166.17 11.3 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.906 0.384 . . . . 74.209999999999994 111.85 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.52 -34.76 64.95 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.26 0.552 . . . . 73.049999999999997 111.197 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -73.47 -31.22 63.65 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.865 -0.607 . . . . 72.109999999999999 111.356 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.1 m -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.818 0.342 . . . . 63.140000000000001 111.42 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -57.35 -40.74 78.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.481 -0.327 . . . . 74.099999999999994 111.331 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.666 ' HB3' ' HZ3' ' A' ' 129' ' ' LYS . 8.4 mtpm? -60.89 -28.79 69.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.011 0.434 . . . . 65.430000000000007 111.616 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 91.7 mt -70.75 -48.14 55.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.043 0.449 . . . . 64.439999999999998 110.223 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.54 -33.26 72.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.05 -0.523 . . . . 72.230000000000004 111.364 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -83.4 -75.17 0.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.274 -0.421 . . . . 64.140000000000001 112.046 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.85 -53.68 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.555 0.576 . . . . 70.010000000000005 112.555 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 130' ' ' LEU . . . -65.79 -40.36 91.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.863 0.363 . . . . 71.120000000000005 111.231 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.62 66.46 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 53.340000000000003 113.156 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.533 HG22 ' NE2' ' A' ' 140' ' ' GLN . 61.0 m -60.27 -50.12 74.89 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.702 -0.293 . . . . 74.349999999999994 111.631 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.83 -50.56 72.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.038 0.447 . . . . 72.109999999999999 111.311 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.23 -50.19 65.26 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.653 -0.703 . . . . 72.510000000000005 110.94 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.53 95.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.219 -0.515 . . . . 37.850000000000001 113.186 178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.533 ' NE2' HG22 ' A' ' 136' ' ' THR . 45.0 mt-30 -58.33 -51.37 70.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.216 0.45 . . . . 52.229999999999997 112.216 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -56.11 -52.85 62.82 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.977 0.418 . . . . 71.400000000000006 111.655 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.641 HG21 ' HA3' ' A' ' 54' ' ' GLY . 61.9 t -57.91 -51.68 67.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.027 -0.533 . . . . 60.420000000000002 112.4 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.711 HG22 HG21 ' A' ' 29' ' ' VAL . 14.2 t -74.07 -37.34 64.25 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.934 0.346 . . . . 73.239999999999995 111.934 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -76.64 -13.36 60.06 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.144 -0.347 . . . . 74.400000000000006 111.625 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.585 ' HA ' ' HA ' ' A' ' 149' ' ' HIS . 14.2 t70 -67.57 -51.31 52.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.388 0.614 . . . . 74.310000000000002 110.074 167.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -62.54 -34.2 76.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.594 -0.73 . . . . 73.219999999999999 110.642 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.18 -37.93 44.63 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.723 -0.671 . . . . 61.130000000000003 111.244 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -148.4 -80.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.477 -0.329 . . . . 65.0 110.715 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 11.7 t-80 175.88 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.98 -0.748 . . . . 71.109999999999999 108.98 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.6 t60 63.46 149.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.036 1.124 . . . . 70.25 114.036 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -99.32 177.34 5.23 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.095 -0.502 . . . . 62.439999999999998 111.349 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -74.86 140.13 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.103 0.477 . . . . 74.239999999999995 111.526 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -63.25 -42.73 99.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.033 0.753 . . . . 71.400000000000006 113.033 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.331 -0.842 . . . . 73.140000000000001 111.018 -172.225 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.64 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.076 0.028 . . . . 75.530000000000001 111.076 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 2.4 mp 66.83 109.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 121.256 0.55 . . . . 73.239999999999995 111.241 -173.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.04 113.74 4.08 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.22 -0.514 . . . . 50.409999999999997 113.186 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.95 104.86 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.48 -0.423 . . . . 75.030000000000001 111.15 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.748 ' HB3' HD22 ' A' ' 36' ' ' LEU . 98.6 m-85 -96.29 111.63 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.099 0.476 . . . . 61.439999999999998 111.679 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -127.86 178.51 6.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 111.624 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.48 HG12 ' HA3' ' A' ' 37' ' ' GLY . 17.3 t -134.46 114.61 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.335 -0.393 . . . . 71.310000000000002 110.637 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 m -74.45 -8.52 56.58 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.957 0.408 . . . . 71.049999999999997 111.79 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.465 ' H ' HG13 ' A' ' 7' ' ' VAL . 44.6 tt0 -96.25 -50.53 4.76 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.459 0.54 . . . . 73.239999999999995 112.459 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.442 ' H ' HG13 ' A' ' 7' ' ' VAL . 78.2 t80 -103.16 138.87 39.41 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.109 0.48 . . . . 74.349999999999994 112.239 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.87 -164.37 4.7 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.566 -0.743 . . . . 70.120000000000005 114.606 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.498 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 97.5 m-85 -100.37 7.8 44.06 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.889 0.329 . . . . 73.409999999999997 111.889 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.732 ' HB3' HG21 ' A' ' 90' ' ' THR . 89.8 p -41.41 -46.76 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.553 0.575 . . . . 74.109999999999999 112.553 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.66 -43.91 76.72 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.088 0.47 . . . . 75.340000000000003 111.748 175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.23 -35.45 73.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.151 0.501 . . . . 73.120000000000005 110.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.78 -38.68 83.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.95 -0.568 . . . . 62.450000000000003 110.818 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.3 75.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.871 -0.604 . . . . 71.310000000000002 111.069 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -58.92 -42.87 90.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.163 -0.471 . . . . 74.319999999999993 110.962 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.523 ' HB2' ' HG ' ' A' ' 131' ' ' CYS . . . -65.3 -39.2 92.19 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.011 0.434 . . . . 73.400000000000006 111.137 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.98 -58.49 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 111.276 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 tt -59.1 -37.16 66.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.652 0.263 . . . . 63.350000000000001 110.938 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -53.66 -56.77 14.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 70.120000000000005 111.457 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.12 -45.23 88.53 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.116 -0.564 . . . . 38.539999999999999 113.926 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.3 mt -66.19 -45.98 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 112.424 0.527 . . . . 72.209999999999994 112.424 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.6 p -65.2 -42.71 93.28 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.909 -0.495 . . . . 74.040000000000006 110.821 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.42 -32.4 64.82 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.192 -0.458 . . . . 64.549999999999997 110.88 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 m -71.98 -33.15 67.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.375 -0.375 . . . . 73.209999999999994 110.993 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.45 5.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.106 -0.569 . . . . 44.240000000000002 114.165 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.1 t -112.49 130.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 122.2 -0.588 . . . . 72.209999999999994 111.979 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 121.49 6.14 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.462 -0.399 . . . . 62.240000000000002 112.927 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.9 m -99.41 164.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 112.667 0.618 . . . . 73.109999999999999 112.667 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.15 110.34 21.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.801 -0.636 . . . . 73.209999999999994 111.092 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.47 112.71 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.295 0.569 . . . . 71.540000000000006 112.077 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.46 129.22 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.283 -0.417 . . . . 74.409999999999997 111.47 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -94.58 116.62 28.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.005 -0.368 . . . . 70.349999999999994 110.005 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.748 HD22 ' HB3' ' A' ' 5' ' ' PHE . 4.4 pp -89.31 -7.48 55.29 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.113 0.412 . . . . 65.200000000000003 112.113 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.48 ' HA3' HG12 ' A' ' 7' ' ' VAL . . . -86.55 -26.71 31.94 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.12 -0.562 . . . . 51.149999999999999 112.506 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.31 162.79 18.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.107 0.48 . . . . 61.219999999999999 111.705 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.67 96.36 0.08 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.015 0.435 . . . . 64.230000000000004 111.648 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.11 150.02 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.286 0.565 . . . . 54.420000000000002 112.039 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -107.4 173.05 6.49 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.939 -0.573 . . . . 74.25 110.249 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.81 -20.57 57.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.323 -0.236 . . . . 74.510000000000005 111.114 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -61.98 -52.81 62.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.756 0.312 . . . . 61.399999999999999 111.506 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -40.79 84.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.868 0.366 . . . . 74.310000000000002 110.835 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.8 tm? -65.09 -39.81 93.7 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.264 0.554 . . . . 72.209999999999994 109.964 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -59.42 -40.86 88.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.789 -0.641 . . . . 74.040000000000006 111.274 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.86 -36.09 75.24 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.51 -0.314 . . . . 72.010000000000005 111.053 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.58 -47.05 83.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.869 0.366 . . . . 64.120000000000005 110.224 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 45' ' ' LEU . 82.3 t -55.01 -37.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.08 0.467 . . . . 74.109999999999999 111.479 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.36 -53.13 14.23 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.274 -0.488 . . . . 73.439999999999998 113.131 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.19 6.1 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.52 0.563 . . . . 74.439999999999998 112.52 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -48.39 -24.92 1.39 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.848 1.055 . . . . 71.230000000000004 113.848 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.68 HG22 HH22 ' A' ' 146' ' ' ARG . 77.7 p -67.24 -25.86 66.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.587 0.588 . . . . 71.420000000000002 112.587 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.12 137.02 5.6 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.138 -0.553 . . . . 54.310000000000002 112.69 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 HD12 HG13 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -163.2 172.84 14.2 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.578 -0.366 . . . . 74.310000000000002 111.811 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.08 124.65 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.909 0.385 . . . . 74.030000000000001 111.144 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.463 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -117.2 145.32 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.966 0.413 . . . . 74.319999999999993 111.569 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.5 -89.74 0.39 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 73.540000000000006 112.583 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.47 ' HG3' HG23 ' A' ' 90' ' ' THR . 4.0 ppp? -172.48 158.47 4.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.557 0.343 . . . . 73.129999999999995 110.642 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -117.58 114.42 37.98 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 111.798 0.296 . . . . 64.450000000000003 111.798 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.66 160.32 28.15 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.368 2.045 . . . . 73.530000000000001 112.432 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.13 -31.45 19.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.522 0.564 . . . . 72.219999999999999 112.522 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.6 96.16 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.158 0.504 . . . . 74.129999999999995 111.681 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -90.11 -21.8 22.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 111.541 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.93 -24.56 9.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.2 0.815 . . . . 72.519999999999996 113.2 -176.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.01 -56.04 7.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.408 0.522 . . . . 64.420000000000002 112.408 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -84.6 -33.63 23.31 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.822 0.344 . . . . 54.009999999999998 111.4 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.7 mm -60.89 -53.21 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.288 0.477 . . . . 75.409999999999997 112.288 -176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.5 -38.65 69.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.848 0.356 . . . . 72.099999999999994 111.346 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.11 87.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.0 -0.619 . . . . 70.400000000000006 112.391 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.98 95.07 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.991 0.424 . . . . 73.430000000000007 111.495 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.79 -35.44 68.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.333 -0.394 . . . . 73.540000000000006 111.353 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.6 m -54.28 -27.02 32.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.998 0.428 . . . . 62.329999999999998 111.427 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.7 m -99.19 -49.53 4.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.312 -0.403 . . . . 72.340000000000003 111.284 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.1 mt -54.57 -48.59 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.818 0.673 . . . . 73.530000000000001 112.818 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.27 -36.68 68.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.031 0.382 . . . . 55.43 112.031 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.49 66.24 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.038 -0.601 . . . . 64.409999999999997 113.13 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -100.29 5.12 44.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.188 0.44 . . . . 51.229999999999997 112.188 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.82 162.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.01 0.433 . . . . 64.420000000000002 111.996 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -117.54 106.84 13.57 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.851 0.358 . . . . 73.140000000000001 111.456 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.608 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 38.3 tt0 50.14 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.978 0.732 . . . . 63.5 112.978 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 62.2 pttt -159.39 48.02 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.261 0.553 . . . . 73.510000000000005 110.972 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.44 172.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.065 0.765 . . . . 72.439999999999998 113.065 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.569 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -88.02 109.65 20.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 74.439999999999998 111.894 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG13 HD12 ' A' ' 55' ' ' LEU . 29.7 m -107.41 119.02 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.567 0.699 . . . . 71.140000000000001 111.788 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.06 159.85 21.43 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.997 -0.547 . . . . 42.229999999999997 112.399 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -144.39 131.36 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.398 -0.472 . . . . 74.430000000000007 111.961 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -140.05 93.44 2.64 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.65 0.738 . . . . 74.120000000000005 110.659 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.33 114.48 2.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.834 -0.621 . . . . 64.120000000000005 112.16 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.732 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.0 t -108.65 29.68 7.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 111.973 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . -178.53 -54.41 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.186 -1.007 . . . . 52.299999999999997 114.086 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.85 -14.35 58.8 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.496 -0.859 . . . . 54.539999999999999 113.2 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.05 67.48 3.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.226 -0.511 . . . . 71.120000000000005 112.499 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.48 -179.27 6.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.221 0.534 . . . . 65.409999999999997 112.15 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -75.93 133.65 40.44 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.124 -0.489 . . . . 71.540000000000006 110.818 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.561 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.7 mt-10 -54.46 -37.45 54.54 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 113.744 1.016 . . . . 72.450000000000003 113.744 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 38.0 Cg_endo -66.21 32.18 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.843 1.695 . . . . 65.430000000000007 113.94 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.45 ' H ' ' C ' ' A' ' 96' ' ' GLU . 7.6 tp -66.59 -44.1 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.118 -0.364 . . . . 74.400000000000006 111.975 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 9.6 m-20 -56.09 -47.0 99.7 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 112.429 0.529 . . . . 65.299999999999997 112.429 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 83.1 Cg_exo -45.77 -37.46 16.28 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.717 2.278 . . . . 74.049999999999997 113.436 170.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.5 -42.65 34.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.802 0.334 . . . . 73.239999999999995 110.927 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.35 -32.48 64.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.348 -0.387 . . . . 75.239999999999995 111.197 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -55.58 -46.92 77.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.264 0.554 . . . . 71.019999999999996 110.992 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -66.36 -51.62 55.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.065 -0.516 . . . . 73.299999999999997 111.313 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.595 ' HD1' HD21 ' A' ' 110' ' ' LEU . 24.3 m-85 -59.58 -44.86 93.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.034 0.445 . . . . 74.230000000000004 112.119 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -77.46 -60.76 2.23 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.423 0.527 . . . . 65.109999999999999 112.423 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -62.41 -32.37 73.19 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.542 0.571 . . . . 71.510000000000005 112.542 -170.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 mp -79.06 -20.37 49.02 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.347 175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.61 44.62 6.79 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.28 -0.486 . . . . 54.43 114.166 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.595 HD21 ' HD1' ' A' ' 105' ' ' PHE . 8.7 mp -70.39 133.96 47.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.256 0.528 . . . . 74.129999999999995 111.361 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.569 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 36.7 m -60.8 94.02 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.947 0.403 . . . . 73.299999999999997 111.381 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -103.82 137.03 42.41 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.513 -0.312 . . . . 61.509999999999998 111.64 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.455 ' HB2' HD23 ' A' ' 138' ' ' LEU . . . -54.69 -64.15 0.93 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.408 -0.36 . . . . 65.409999999999997 111.942 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -162.79 98.49 1.08 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.894 0.378 . . . . 73.150000000000006 110.873 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -85.18 46.6 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.008 2.472 . . . . 74.200000000000003 113.887 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.17 37.75 0.95 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 62.530000000000001 112.024 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.9 pt -105.3 144.0 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 112.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -133.37 108.74 8.89 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.313 -0.403 . . . . 73.120000000000005 110.55 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.42 140.95 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 65.439999999999998 110.697 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 120' ' ' LYS . 0.4 OUTLIER -62.58 153.26 32.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.667 0.27 . . . . 63.340000000000003 111.224 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 21.8 tt0 -51.66 -33.67 34.67 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.682 0.623 . . . . 74.140000000000001 112.682 -171.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p -108.61 99.09 31.87 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 120.606 0.241 . . . . 74.420000000000002 111.078 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.498 ' HD2' ' HD2' ' A' ' 12' ' ' TYR . 85.0 Cg_exo -46.78 128.86 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.492 2.794 . . . . 61.340000000000003 114.301 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.5 p -100.45 -178.1 3.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.068 -0.514 . . . . 64.230000000000004 111.043 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -57.37 -27.22 62.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.977 0.418 . . . . 74.439999999999998 111.404 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -59.33 -41.41 89.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 64.319999999999993 110.851 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 m -63.43 -36.75 84.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.098 -0.501 . . . . 75.239999999999995 111.175 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -62.38 -36.35 82.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.135 0.493 . . . . 71.239999999999995 111.144 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -69.63 -38.99 77.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 110.889 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.29 -54.74 32.41 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.849 -0.614 . . . . 63.399999999999999 110.721 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.523 ' HG ' ' HB2' ' A' ' 19' ' ' ALA . 31.0 p -62.27 -38.29 88.77 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.75 0.278 . . . . 75.340000000000003 111.75 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.63 -56.63 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.349 0.595 . . . . 70.439999999999998 111.475 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -64.18 -56.89 11.59 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.735 -0.666 . . . . 71.409999999999997 111.94 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.73 84.41 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.863 0.32 . . . . 63.109999999999999 111.863 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.41 -44.64 66.48 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.348 -0.453 . . . . 72.010000000000005 113.24 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 24' ' ' ILE . 94.8 m -55.83 -41.19 73.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.815 0.34 . . . . 73.030000000000001 111.486 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.36 -45.26 94.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.315 -0.402 . . . . 73.040000000000006 111.739 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 113' ' ' ALA . 4.1 mm? -56.49 -42.12 77.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.942 0.401 . . . . 62.299999999999997 110.936 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.35 82.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.097 -0.573 . . . . 50.109999999999999 112.693 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.25 -46.98 87.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.006 0.431 . . . . 74.140000000000001 111.857 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -56.67 -50.83 70.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.113 -0.494 . . . . 72.420000000000002 111.5 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.84 -44.61 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.324 0.491 . . . . 74.409999999999997 112.324 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.4 t -65.98 -28.45 68.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.978 0.418 . . . . 72.209999999999994 111.712 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.03 -56.63 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.756 0.313 . . . . 74.310000000000002 111.207 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.37 -29.72 69.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.004 0.43 . . . . 73.329999999999998 111.522 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.68 HH22 HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER -75.73 -30.76 59.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.2 -0.312 . . . . 74.120000000000005 111.764 175.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.58 -44.09 87.75 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.21 0.529 . . . . 75.209999999999994 109.579 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.582 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 17.7 mm-40 -69.37 -41.05 77.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.179 -0.464 . . . . 73.510000000000005 110.414 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 74.27 -57.96 0.6 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.035 0.934 . . . . 63.109999999999999 112.859 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -111.65 28.72 8.48 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.25 -0.281 . . . . 71.409999999999997 111.231 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 51.6 m80 57.84 84.99 0.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.404 0.621 . . . . 73.099999999999994 110.841 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.582 ' H ' ' HB3' ' A' ' 148' ' ' GLU . 86.4 t60 -76.77 115.71 16.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.681 -0.69 . . . . 71.239999999999995 111.405 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.66 -178.21 6.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.125 -0.489 . . . . 64.329999999999998 111.189 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.489 -0.767 . . . . 74.109999999999999 111.199 179.532 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.645 0.259 . . . . 75.129999999999995 111.384 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm 64.93 111.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 112.67 0.618 . . . . 74.150000000000006 112.67 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.58 103.42 1.43 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.114 -0.565 . . . . 71.150000000000006 112.578 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.18 93.84 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.889 0.376 . . . . 71.120000000000005 111.558 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.641 ' HD2' HD21 ' A' ' 36' ' ' LEU . 17.5 m-85 -89.09 117.0 27.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.718 0.294 . . . . 75.340000000000003 111.443 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.42 ' HB3' ' HB1' ' A' ' 17' ' ' ALA . 35.7 p90 -134.92 151.03 50.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.432 0.634 . . . . 72.519999999999996 112.416 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 10' ' ' TYR . 39.7 t -96.1 97.95 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.788 -0.642 . . . . 63.439999999999998 111.52 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.699 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 20.1 m -70.88 -27.21 63.64 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.234 0.457 . . . . 64.510000000000005 112.234 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -70.5 -42.25 71.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.662 0.616 . . . . 74.329999999999998 112.662 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.519 ' OH ' ' HG3' ' A' ' 121' ' ' GLN . 69.4 t80 -111.5 106.77 15.75 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.666 0.988 . . . . 74.040000000000006 113.666 -171.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.94 -160.49 5.41 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.829 1.092 . . . . 71.150000000000006 115.829 167.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 56.7 m-85 -63.11 -2.17 1.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.22 0.822 . . . . 74.200000000000003 113.22 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 m -54.11 -31.51 52.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.231 0.538 . . . . 72.109999999999999 111.345 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.699 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 25.1 t70 -65.87 -32.73 74.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.652 -0.704 . . . . 60.229999999999997 111.745 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -94.44 -23.73 17.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.442 0.534 . . . . 74.329999999999998 112.442 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 12' ' ' TYR . 92.7 mt -54.64 -39.92 68.47 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.231 0.538 . . . . 73.25 111.384 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 6' ' ' TYR . . . -70.41 -23.0 62.67 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.07 -0.513 . . . . 74.120000000000005 112.141 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.76 -34.9 76.67 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.912 0.387 . . . . 74.150000000000006 110.945 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HB1' ' HB2' ' A' ' 132' ' ' GLU . . . -62.09 -40.77 96.96 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.492 . . . . 73.430000000000007 111.04 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.439 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.5 mt -62.76 -52.95 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.044 -0.525 . . . . 74.450000000000003 110.601 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.487 HG22 HG22 ' A' ' 31' ' ' VAL . 83.5 mt -52.85 -43.94 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.939 -0.573 . . . . 74.109999999999999 111.235 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -56.95 -48.77 77.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.108 -0.496 . . . . 64.209999999999994 111.323 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.46 99.57 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.013 -0.613 . . . . 70.040000000000006 113.091 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -65.55 -48.47 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 72.230000000000004 111.71 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -68.33 -34.94 77.02 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.788 0.328 . . . . 74.519999999999996 111.267 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.12 -31.81 73.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.458 0.647 . . . . 62.43 110.558 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.0 m -75.16 -14.44 60.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.848 -0.615 . . . . 75.0 111.15 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.42 26.65 11.73 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.363 -0.38 . . . . 71.430000000000007 113.779 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.472 HG21 ' HB ' ' A' ' 143' ' ' THR . 42.0 t -118.88 142.31 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.555 -0.379 . . . . 60.520000000000003 111.603 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.68 140.7 24.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.009 -0.615 . . . . 40.399999999999999 112.859 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.487 HG22 HG22 ' A' ' 21' ' ' ILE . 33.1 m -106.4 145.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.985 0.365 . . . . 71.439999999999998 111.985 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -107.09 110.55 22.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.912 0.387 . . . . 70.409999999999997 110.172 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.94 113.8 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.55 0.69 . . . . 75.310000000000002 112.788 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.96 93.42 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.197 0.523 . . . . 74.230000000000004 110.925 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -79.0 70.88 5.41 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.557 0.694 . . . . 64.030000000000001 111.743 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -64.79 -23.79 67.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.231 -0.441 . . . . 75.25 111.636 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' N ' HD11 ' A' ' 36' ' ' LEU . . . -75.17 -0.36 61.02 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.239 -0.505 . . . . 55.219999999999999 112.889 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 17.13 12.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.917 0.389 . . . . 61.420000000000002 110.607 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.99 97.63 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.527 -0.761 . . . . 73.329999999999998 112.166 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 36' ' ' LEU . 24.7 m -83.47 156.13 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.775 0.321 . . . . 74.040000000000006 111.327 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.6 179.61 4.17 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 111.364 -174.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 HD11 ' A' ' 45' ' ' LEU . 3.8 mm? -60.67 -20.87 62.03 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.322 0.49 . . . . 75.450000000000003 112.322 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 1.4 mp0 -59.42 -29.88 68.07 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.117 0.414 . . . . 71.109999999999999 112.117 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -86.25 -43.83 12.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.806 0.336 . . . . 72.230000000000004 111.311 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.703 HD11 HD12 ' A' ' 42' ' ' LEU . 80.6 mt -54.09 -28.3 38.36 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.564 0.579 . . . . 63.130000000000003 112.564 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 20.3 ptt180 -61.34 -33.16 73.16 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.696 0.284 . . . . 74.239999999999995 111.231 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.25 3.18 46.18 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.04 0.385 . . . . 75.129999999999995 112.04 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 2.3 tm? -56.52 -34.48 67.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.998 0.428 . . . . 74.299999999999997 110.213 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.62 -23.46 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.222 0.534 . . . . 72.299999999999997 111.785 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.17 -40.89 5.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.394 -0.431 . . . . 52.450000000000003 112.535 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -76.1 -15.42 60.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.242 0.46 . . . . 74.140000000000001 112.242 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -69.37 -7.67 39.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.004 0.372 . . . . 63.009999999999998 112.004 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.0 p -70.54 -26.79 63.72 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.327 0.584 . . . . 74.439999999999998 111.033 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.57 135.56 3.57 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.85 -0.614 . . . . 73.420000000000002 111.8 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 HD22 HG13 ' A' ' 85' ' ' VAL . 2.1 pt? -168.14 169.17 11.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.011 0.405 . . . . 75.040000000000006 111.491 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 8.5 p -134.69 128.14 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.929 0.395 . . . . 64.25 111.454 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.479 HD13 ' N ' ' A' ' 57' ' ' ILE . 3.7 mp -113.75 135.12 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.302 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.03 133.34 10.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.359 -0.448 . . . . 74.040000000000006 112.823 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.48 ' HE1' ' H ' ' A' ' 93' ' ' GLY . 44.1 ttp -65.91 110.5 2.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.638 -0.33 . . . . 64.540000000000006 111.717 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 7' ' ' VAL . 93.4 p -103.49 148.27 35.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 111.982 0.364 . . . . 75.109999999999999 111.982 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.655 ' HA ' ' HB3' ' A' ' 94' ' ' ASP . 28.0 Cg_endo -60.73 159.67 27.74 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.87 2.38 . . . . 61.329999999999998 112.451 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.57 -40.53 52.46 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.868 0.692 . . . . 63.5 112.868 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.79 -53.03 54.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.196 0.443 . . . . 71.120000000000005 112.196 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.1 m -79.34 -32.23 43.26 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.073 0.463 . . . . 73.140000000000001 111.204 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -27.56 65.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.99 -0.55 . . . . 52.409999999999997 111.498 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.71 -29.66 62.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.211 0.449 . . . . 71.230000000000004 112.211 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -82.05 -17.45 46.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.052 0.453 . . . . 74.430000000000007 111.717 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 36' ' ' LEU . 26.1 mt -100.59 -47.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 112.169 -175.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -45.32 -45.48 12.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.288 1.035 . . . . 71.319999999999993 113.435 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.78 -63.94 4.52 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.047 -0.597 . . . . 71.349999999999994 113.196 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.446 ' HB1' HD12 ' A' ' 45' ' ' LEU . . . -62.44 -28.73 70.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.069 0.461 . . . . 63.399999999999999 112.165 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.14 -33.69 63.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.079 -0.509 . . . . 54.5 111.363 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 m -54.66 -39.24 67.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.125 -0.489 . . . . 65.409999999999997 111.563 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -73.66 -38.16 65.05 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.916 0.389 . . . . 74.420000000000002 111.293 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.41 -58.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.849 0.357 . . . . 75.519999999999996 111.85 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.465 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.1 mp -60.91 -12.47 11.25 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.564 0.579 . . . . 74.109999999999999 112.564 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.17 -30.33 7.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 60.020000000000003 112.793 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -79.21 -24.16 43.3 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 111.792 0.293 . . . . 74.409999999999997 111.792 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -64.36 155.57 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.042 0.449 . . . . 74.510000000000005 111.878 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -80.15 160.55 25.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 71.019999999999996 111.612 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.464 ' HA ' HD21 ' A' ' 108' ' ' LEU . 35.9 tt0 -54.87 -36.64 65.31 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.098 0.475 . . . . 60.030000000000001 111.939 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -138.87 122.08 16.96 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.452 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.404 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 6.2 tp-100 -163.78 169.93 17.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.778 0.323 . . . . 74.340000000000003 110.983 -176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -89.45 93.85 9.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.173 0.511 . . . . 72.219999999999999 111.801 -178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG13 HD22 ' A' ' 55' ' ' LEU . 35.4 m -107.94 148.69 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.137 -0.483 . . . . 72.450000000000003 111.121 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.03 146.24 17.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.327 -0.463 . . . . 74.319999999999993 113.123 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.574 ' H ' ' HB1' ' A' ' 113' ' ' ALA . 39.0 mm -140.93 132.62 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.817 0.447 . . . . 74.430000000000007 110.623 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -152.21 159.38 43.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.956 0.408 . . . . 72.319999999999993 111.258 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.82 138.85 39.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.035 0.445 . . . . 72.540000000000006 111.556 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 t -121.01 4.04 10.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.526 0.679 . . . . 73.530000000000001 110.656 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.45 -93.09 0.45 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.652 -0.704 . . . . 74.510000000000005 112.359 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.57 70.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.195 -0.526 . . . . 63.439999999999998 113.416 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.48 ' H ' ' HE1' ' A' ' 59' ' ' MET . . . 85.24 52.98 3.24 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.502 -0.38 . . . . 64.450000000000003 113.158 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.655 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 11.3 m-20 -96.1 176.97 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.324 0.49 . . . . 74.040000000000006 112.324 -175.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.6 t70 64.41 160.67 0.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.41 0.684 . . . . 62.509999999999998 112.082 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.717 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 41.8 mt-10 -102.01 -53.81 0.14 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 112.254 0.464 . . . . 70.219999999999999 112.254 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 8.2 Cg_exo -75.27 22.97 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.395 2.064 . . . . 74.340000000000003 112.991 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.7 -35.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.336 0.495 . . . . 64.109999999999999 112.336 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.661 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.1 m-20 -66.36 -54.16 26.56 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 122.168 -0.332 . . . . 75.230000000000004 111.768 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.661 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 73.5 Cg_exo -51.0 -45.8 34.45 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.435 2.09 . . . . 73.450000000000003 113.0 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 97' ' ' PRO . 8.5 mp -55.46 -58.12 9.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.46 -0.336 . . . . 73.030000000000001 111.299 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.58 -32.24 71.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.499 -0.319 . . . . 73.319999999999993 111.488 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 t -62.93 -37.62 87.75 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.893 0.377 . . . . 72.430000000000007 111.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 76' ' ' LEU . 27.8 tptp -64.34 -41.76 96.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.729 0.299 . . . . 75.439999999999998 111.018 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -68.15 -44.06 76.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.023 0.44 . . . . 72.310000000000002 110.847 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -64.68 -39.1 93.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.961 -0.563 . . . . 74.030000000000001 111.813 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -62.23 -49.92 73.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.905 0.383 . . . . 74.140000000000001 111.181 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 81' ' ' GLU . 8.2 mp -74.17 -24.22 59.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.098 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.22 43.55 9.53 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.182 -0.532 . . . . 62.25 112.502 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.85 156.63 32.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.19 0.519 . . . . 71.099999999999994 111.905 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.4 m -66.97 106.54 1.96 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.774 0.657 . . . . 65.019999999999996 112.774 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.0 p -84.04 95.04 8.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.742 0.306 . . . . 64.140000000000001 111.12 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.574 ' HB1' ' H ' ' A' ' 87' ' ' ILE . . . -53.71 -70.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.202 0.445 . . . . 73.430000000000007 112.202 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -125.49 90.01 51.45 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 120.853 0.358 . . . . 75.5 111.044 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.14 98.71 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.57 2.18 . . . . 70.319999999999993 112.803 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.08 159.44 20.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.103 0.477 . . . . 52.210000000000001 111.987 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -138.26 34.1 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.892 -0.594 . . . . 73.129999999999995 110.59 175.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.7 mtm180 -96.92 20.2 11.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.493 0.923 . . . . 74.409999999999997 113.493 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.2 mt -100.42 149.49 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.86 -0.422 . . . . 73.200000000000003 109.86 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.04 -65.99 0.58 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.048 -0.408 . . . . 63.109999999999999 111.518 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -177.3 -26.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.987 0.423 . . . . 64.430000000000007 111.453 -177.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p -89.82 117.81 68.43 Favored Pre-proline 0 N--CA 1.47 0.553 0 N-CA-C 111.851 0.315 . . . . 65.239999999999995 111.851 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.68 134.48 44.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.56 2.173 . . . . 75.450000000000003 111.864 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -100.49 168.49 9.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.712 0.768 . . . . 64.409999999999997 112.717 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.59 -29.94 68.31 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.36 -0.836 . . . . 74.140000000000001 111.053 174.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -73.01 -31.92 64.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.888 -0.596 . . . . 73.319999999999993 110.973 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -35.58 67.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.858 0.361 . . . . 52.140000000000001 111.059 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -55.71 -48.27 75.45 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.284 -0.416 . . . . 73.349999999999994 111.591 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 5.3 mptp? -67.19 -32.77 74.07 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.945 0.35 . . . . 72.530000000000001 111.945 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.93 -53.58 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.234 0.54 . . . . 75.129999999999995 110.466 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.43 -34.35 75.84 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.87 -0.604 . . . . 73.099999999999994 111.526 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.9 tt0 -59.15 -66.67 0.47 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.952 0.501 . . . . 73.430000000000007 112.173 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.95 -47.21 86.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.795 0.331 . . . . 72.349999999999994 111.589 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.817 0.342 . . . . 72.099999999999994 111.454 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.439 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -63.02 -37.23 94.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.321 -0.466 . . . . 73.420000000000002 113.362 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.487 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 99.2 m -63.0 -58.0 8.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.738 0.304 . . . . 75.430000000000007 111.212 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.15 -41.52 99.29 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.616 -0.266 . . . . 74.239999999999995 111.457 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.63 -43.46 93.81 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 110.18 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.432 ' O ' HG21 ' A' ' 143' ' ' THR . . . -60.1 -45.81 95.32 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.103 -0.57 . . . . 62.009999999999998 112.458 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 136' ' ' THR . 80.3 mt-30 -66.68 -29.22 69.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.216 0.532 . . . . 75.420000000000002 111.166 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -65.1 -54.64 26.9 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.968 -0.56 . . . . 72.239999999999995 110.541 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.27 -46.81 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 112.789 0.663 . . . . 73.030000000000001 112.789 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.558 HG23 ' HD3' ' A' ' 144' ' ' ARG . 4.7 t -53.46 -33.61 54.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.681 0.623 . . . . 74.230000000000004 112.681 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.558 ' HD3' HG23 ' A' ' 143' ' ' THR . 11.0 mpt_? -99.76 -19.06 16.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.94 0.348 . . . . 75.239999999999995 111.94 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.701 ' HA ' ' HB2' ' A' ' 149' ' ' HIS . 30.3 t70 -57.31 -62.17 1.96 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.03 0.381 . . . . 64.430000000000007 112.03 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -60.17 -16.73 35.47 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.242 -0.435 . . . . 72.140000000000001 112.004 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 143' ' ' THR . 3.9 mm? -89.78 -49.25 6.74 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.003 0.371 . . . . 71.019999999999996 112.003 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -170.21 -39.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 111.867 0.321 . . . . 72.209999999999994 111.867 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.701 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . 42.5 t-80 73.68 51.48 0.12 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.636 0.976 . . . . 74.430000000000007 113.636 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -113.97 132.89 55.8 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.805 -0.559 . . . . 71.219999999999999 112.034 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.8 m170 62.11 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.396 0.887 . . . . 72.340000000000003 113.396 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.457 ' O ' ' CG ' ' A' ' 152' ' ' HIS . 0.9 OUTLIER 56.4 96.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.649 0.738 . . . . 74.439999999999998 109.642 -166.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.4 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 85.7 t60 68.19 130.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.371 -0.831 . . . . 72.019999999999996 110.998 -168.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 57.6 t60 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.204 -0.903 . . . . 64.019999999999996 111.749 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 67.1 p . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.345 0.116 . . . . 73.239999999999995 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm 63.55 89.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.281 0.562 . . . . 61.43 111.638 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.29 100.5 1.66 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.946 -0.57 . . . . 61.350000000000001 112.729 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 100.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.856 0.36 . . . . 64.329999999999998 111.108 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 94.5 m-85 -98.55 120.96 39.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.082 -0.508 . . . . 73.209999999999994 111.711 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.463 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 13.7 p90 -143.91 -179.7 6.64 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.105 0.479 . . . . 74.439999999999998 112.141 -176.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.423 HG12 ' HA3' ' A' ' 37' ' ' GLY . 33.0 t -126.61 90.79 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.189 -0.46 . . . . 61.140000000000001 110.108 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.2 m -40.87 -54.26 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.318 1.229 . . . . 73.340000000000003 114.318 -170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.65 -25.92 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.594 0.59 . . . . 74.349999999999994 112.594 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.425 ' HE2' ' HA3' ' A' ' 91' ' ' GLY . 91.0 t80 -79.57 101.84 8.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.984 0.364 . . . . 73.299999999999997 111.984 -174.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 13' ' ' SER . . . 55.43 -159.36 6.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.156 -0.545 . . . . 75.200000000000003 114.365 176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.06 7.35 0.06 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.806 1.039 . . . . 74.230000000000004 113.806 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 6' ' ' TYR . 11.4 t -46.15 -56.23 5.95 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.037 0.755 . . . . 70.209999999999994 113.037 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -64.02 -31.44 72.63 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.01 0.433 . . . . 74.510000000000005 111.323 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.81 -35.66 77.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.22 0.533 . . . . 71.329999999999998 110.817 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.5 mt -69.36 -44.84 70.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 72.319999999999993 110.661 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.95 -43.99 73.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.115 0.484 . . . . 72.239999999999995 110.935 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -53.31 -42.43 66.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.626 -0.716 . . . . 61.210000000000001 111.897 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.42 43.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.403 0.52 . . . . 75.530000000000001 112.403 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 16' ' ' LEU . 69.2 mt -61.13 -53.17 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.933 0.396 . . . . 74.319999999999993 111.794 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -59.34 -29.36 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.778 0.323 . . . . 74.239999999999995 111.865 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.61 -54.76 43.19 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.786 0.327 . . . . 70.439999999999998 111.757 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.91 -48.59 84.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.264 -0.494 . . . . 37.170000000000002 113.349 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.402 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.6 mt -64.8 -38.1 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.963 0.411 . . . . 63.329999999999998 111.481 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.9 m -60.12 -44.97 94.5 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.176 -0.328 . . . . 73.239999999999995 110.847 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.24 -16.11 63.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.743 0.306 . . . . 71.120000000000005 111.624 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -77.51 -20.99 53.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.34 0.591 . . . . 64.450000000000003 110.319 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 27.09 9.12 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.013 -0.54 . . . . 71.010000000000005 113.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 t -120.1 142.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.984 0.392 . . . . 61.149999999999999 111.62 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.93 118.77 4.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.094 -0.574 . . . . 62.5 112.979 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 1' ' ' SER . 35.6 m -91.07 167.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.519 0.563 . . . . 71.099999999999994 112.519 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -121.46 108.56 13.79 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.087 0.47 . . . . 73.219999999999999 111.203 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.85 113.28 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.522 -0.308 . . . . 75.129999999999995 111.41 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 60.9 t -140.12 110.15 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 120.87 0.367 . . . . 75.299999999999997 111.334 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -84.64 106.58 16.3 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.519 0.676 . . . . 73.25 111.931 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.561 ' HA ' HG11 ' A' ' 40' ' ' VAL . 1.3 pp -70.26 -14.25 62.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.095 -0.378 . . . . 74.319999999999993 111.863 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -60.0 -32.06 74.38 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.351 -0.386 . . . . 61.420000000000002 113.64 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.15 11.04 17.33 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.511 -0.406 . . . . 53.32 111.792 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.38 106.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.187 0.518 . . . . 71.310000000000002 111.566 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG11 ' HA ' ' A' ' 36' ' ' LEU . 35.3 m -85.21 151.24 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.083 0.468 . . . . 74.439999999999998 111.544 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.47 176.09 6.43 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.167 -0.47 . . . . 64.340000000000003 111.176 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 42' ' ' LEU . 3.2 mm? -56.98 -24.51 53.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.571 -0.286 . . . . 74.540000000000006 111.736 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -63.07 -56.97 12.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 72.420000000000002 111.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.99 -43.06 95.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.061 0.457 . . . . 75.400000000000006 110.73 176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.18 -47.33 78.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.935 -0.575 . . . . 72.230000000000004 110.675 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -65.69 -39.03 90.85 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.25 -0.432 . . . . 41.130000000000003 111.578 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.24 -33.91 76.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.931 0.396 . . . . 73.140000000000001 111.257 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 55' ' ' LEU . 52.8 tp -55.54 -34.61 64.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.495 -0.321 . . . . 74.329999999999998 111.148 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.38 -41.57 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.103 0.478 . . . . 72.129999999999995 111.063 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.67 -16.87 80.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.15 -0.548 . . . . 41.450000000000003 113.088 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -100.38 5.73 44.4 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.617 -0.343 . . . . 74.530000000000001 111.494 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.8 p -59.28 -3.73 0.45 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.059 . . . . 75.329999999999998 113.858 -172.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -67.46 -35.33 78.98 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.03 -0.419 . . . . 65.310000000000002 111.275 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.6 138.0 5.13 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.214 -0.517 . . . . 74.129999999999995 113.045 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 48' ' ' LEU . 1.9 pt? -158.72 146.42 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.621 -0.34 . . . . 75.310000000000002 111.26 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.416 HG12 ' HE1' ' A' ' 88' ' ' PHE . 48.8 t -117.98 118.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.362 0.265 . . . . 71.219999999999999 110.806 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -112.06 120.63 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.217 0.451 . . . . 61.240000000000002 112.217 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.86 99.17 2.54 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.412 -0.423 . . . . 74.099999999999994 112.795 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.457 ' O ' HG23 ' A' ' 90' ' ' THR . 14.0 tmm? -56.67 132.54 52.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.901 0.381 . . . . 71.420000000000002 111.558 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -134.99 147.31 62.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 110.921 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.32 168.07 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.644 2.896 . . . . 70.200000000000003 115.045 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -43.73 -41.33 4.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.577 0.955 . . . . 75.030000000000001 113.577 -173.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.79 -45.88 64.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.038 0.447 . . . . 73.230000000000004 111.739 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -87.32 -36.02 18.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.074 0.464 . . . . 53.219999999999999 111.094 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.0 -26.96 67.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.071 -0.513 . . . . 73.209999999999994 112.147 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.75 83.0 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.835 0.35 . . . . 71.420000000000002 111.534 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -65.28 -31.14 72.12 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.826 0.346 . . . . 71.230000000000004 111.34 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.51 -39.48 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.873 0.368 . . . . 73.219999999999999 111.27 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.9 -43.67 66.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.298 -0.41 . . . . 70.340000000000003 112.018 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.52 -31.33 51.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 121.042 -0.599 . . . . 53.299999999999997 113.512 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.0 22.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.281 0.475 . . . . 74.120000000000005 112.281 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.6 tp -54.73 -55.53 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 51.509999999999998 112.582 -173.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -56.79 -38.15 72.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.836 0.35 . . . . 73.310000000000002 111.809 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -65.47 -46.27 80.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.94 0.4 . . . . 72.400000000000006 111.198 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.63 -47.4 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.418 -0.355 . . . . 73.150000000000006 111.208 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.72 -29.72 69.53 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.884 0.373 . . . . 71.150000000000006 111.55 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.27 -19.59 76.55 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 74.340000000000003 112.917 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -90.64 -37.95 13.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.069 0.396 . . . . 71.340000000000003 112.069 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.11 143.26 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.153 0.501 . . . . 74.219999999999999 112.045 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.583 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -161.32 176.3 11.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.238 -0.437 . . . . 73.549999999999997 111.509 -177.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 57.68 -94.69 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.898 0.479 . . . . 63.32 111.886 173.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' H ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -179.07 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.043 0.449 . . . . 62.5 111.836 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -56.79 175.62 0.12 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.376 0.608 . . . . 74.019999999999996 112.611 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.44 98.43 11.62 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.755 0.65 . . . . 73.120000000000005 112.755 -170.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.42 105.0 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.596 0.712 . . . . 72.439999999999998 112.061 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 78.86 1.95 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 122.021 -0.424 . . . . 63.310000000000002 113.032 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.61 122.53 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 111.969 0.359 . . . . 54.229999999999997 111.969 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' HE1' HG12 ' A' ' 56' ' ' VAL . 6.5 p90 -153.82 164.37 38.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.256 -0.276 . . . . 73.310000000000002 110.256 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' HB2' HD11 ' A' ' 119' ' ' ILE . 1.9 mp0 -83.86 133.64 34.73 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.884 -0.51 . . . . 75.299999999999997 111.427 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 59' ' ' MET . 10.4 t -87.04 7.18 28.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.437 0.637 . . . . 63.409999999999997 110.333 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.425 ' HA3' ' HE2' ' A' ' 10' ' ' TYR . . . 172.2 -82.79 0.08 OUTLIER Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.505 -0.771 . . . . 65.030000000000001 112.04 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.72 124.86 2.88 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.909 -0.662 . . . . 74.200000000000003 113.374 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.46 -152.81 6.9 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.933 -0.651 . . . . 52.520000000000003 112.822 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.06 121.59 35.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.903 0.383 . . . . 72.239999999999995 111.677 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.581 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . 3.3 p-10 -147.02 171.87 14.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 64.530000000000001 110.891 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.557 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 mt-10 -102.97 -44.62 0.19 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.453 0.909 . . . . 74.439999999999998 113.453 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.557 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 36.6 Cg_endo -62.83 -12.1 27.45 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.246 1.964 . . . . 73.519999999999996 114.703 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.3 tp -53.99 -51.63 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.986 0.736 . . . . 64.5 112.986 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.686 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 6.6 m-20 -61.71 -54.56 50.42 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.134 0.42 . . . . 45.409999999999997 112.134 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.5 Cg_exo -56.88 -35.87 98.62 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.233 1.955 . . . . 72.109999999999999 112.744 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -56.76 13.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.214 -0.448 . . . . 73.219999999999999 111.12 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.81 -45.03 86.7 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 73.109999999999999 111.23 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 27.3 t -55.74 -37.87 69.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.161 -0.472 . . . . 73.439999999999998 111.943 177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.567 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 1.8 tpmt? -68.24 -58.66 4.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.765 0.317 . . . . 71.099999999999994 111.039 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -58.47 -27.38 64.35 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.732 0.271 . . . . 74.409999999999997 111.732 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 103' ' ' SER . 18.9 ttp180 -52.06 -50.16 62.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.964 0.411 . . . . 71.420000000000002 111.596 173.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.85 -40.56 54.47 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.332 -0.394 . . . . 75.439999999999998 111.593 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.709 ' HB3' HD13 ' A' ' 110' ' ' LEU . 10.8 mp -59.46 -40.09 85.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.846 0.355 . . . . 73.340000000000003 111.904 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 32.07 36.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.211 -0.519 . . . . 42.409999999999997 113.807 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.709 HD13 ' HB3' ' A' ' 108' ' ' LEU . 10.9 mp -88.92 165.6 14.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.041 0.448 . . . . 71.299999999999997 111.509 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.2 m -80.28 122.71 27.23 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.271 0.471 . . . . 63.119999999999997 112.271 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.4 p -103.49 112.26 25.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.273 -0.421 . . . . 73.400000000000006 110.599 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.17 -48.75 67.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.909 0.385 . . . . 44.32 111.244 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.05 144.54 49.14 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 116.007 -0.542 . . . . 73.099999999999994 110.233 172.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.11 4.85 2.1 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.88 2.387 . . . . 71.239999999999995 113.57 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 70.12 159.81 0.2 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.811 0.671 . . . . 71.129999999999995 112.811 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.3 pt 42.44 31.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.295 1.22 . . . . 64.340000000000003 114.295 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.07 -7.86 16.0 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 122.001 -0.437 . . . . 75.310000000000002 111.871 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.431 HD11 ' HB2' ' A' ' 89' ' ' GLU . 67.9 mt -91.79 144.78 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 120.939 0.399 . . . . 72.010000000000005 111.189 173.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 19.2 pttp -87.5 53.56 2.84 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.737 0.643 . . . . 53.43 112.737 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 5.5 tp-100 74.17 -47.4 0.64 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.69 0.626 . . . . 74.219999999999999 112.69 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.1 p -96.22 116.8 66.38 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 111.986 0.365 . . . . 61.210000000000001 111.986 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.38 140.08 62.29 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.52 2.147 . . . . 51.229999999999997 111.857 172.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 p -111.37 179.04 4.14 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.332 0.587 . . . . 74.239999999999995 112.096 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 -31.33 59.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.906 -0.588 . . . . 65.230000000000004 111.462 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.35 -40.95 81.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 110.779 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -51.94 -35.19 45.03 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.226 -0.443 . . . . 74.400000000000006 111.292 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -56.16 -63.15 1.28 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.506 -0.316 . . . . 72.109999999999999 111.019 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -51.78 -46.03 64.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.801 0.334 . . . . 73.230000000000004 111.655 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.18 -59.8 4.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.489 -0.323 . . . . 71.420000000000002 111.679 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.2 p -60.5 -39.84 89.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.791 0.293 . . . . 65.219999999999999 111.791 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.94 -69.36 0.22 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.44 0.533 . . . . 73.430000000000007 112.44 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.82 -32.32 69.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.619 0.6 . . . . 73.340000000000003 112.619 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.47 65.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.75 0.31 . . . . 64.340000000000003 110.849 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.0 -38.17 95.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.369 -0.443 . . . . 37.170000000000002 112.545 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.599 HG22 HE21 ' A' ' 140' ' ' GLN . 93.9 m -62.09 -49.16 77.02 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.649 -0.324 . . . . 72.120000000000005 111.032 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.21 -38.4 86.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.322 0.582 . . . . 74.540000000000006 110.408 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -58.45 -43.72 88.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.687 -0.688 . . . . 64.310000000000002 110.131 175.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.0 -33.86 65.26 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.034 -0.53 . . . . 37.170000000000002 113.406 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.599 HE21 HG22 ' A' ' 136' ' ' THR . 79.5 mt-30 -57.8 -44.4 86.3 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.829 0.315 . . . . 74.040000000000006 111.552 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -55.82 -50.67 69.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.674 0.273 . . . . 73.209999999999994 110.797 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.62 -46.06 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.42 0.526 . . . . 73.150000000000006 112.42 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.424 ' O ' HD21 ' A' ' 147' ' ' LEU . 13.0 t -74.36 -42.59 59.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.77 -0.372 . . . . 71.040000000000006 111.829 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -64.02 -40.84 97.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.088 0.47 . . . . 74.150000000000006 110.567 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.07 -46.74 84.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.335 -0.848 . . . . 61.509999999999998 110.178 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -61.54 -47.39 85.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.363 -0.835 . . . . 72.109999999999999 112.266 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 143' ' ' THR . 4.3 mm? -62.99 -46.4 87.87 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.795 0.665 . . . . 74.319999999999993 112.795 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.26 -17.4 37.07 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.997 -0.44 . . . . 61.420000000000002 111.977 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 73.69 -37.24 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.487 0.715 . . . . 75.409999999999997 112.171 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -82.17 135.02 35.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 110.047 -0.353 . . . . 74.310000000000002 110.047 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -73.04 -31.12 64.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.209 0.818 . . . . 72.129999999999995 113.209 -171.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 61.47 175.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.519 0.676 . . . . 74.239999999999995 112.67 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -174.16 108.12 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.577 -0.738 . . . . 74.319999999999993 110.782 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 71.2 m80 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.565 -0.731 . . . . 73.439999999999998 111.157 178.191 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.231 0.086 . . . . 65.409999999999997 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mm 64.0 96.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 121.326 0.584 . . . . 74.219999999999999 112.19 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 108.76 2.98 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.114 -0.494 . . . . 41.350000000000001 113.42 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.02 106.58 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.832 0.349 . . . . 51.43 110.683 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.697 ' HB3' HD22 ' A' ' 36' ' ' LEU . 23.9 m-85 -111.97 117.03 31.59 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.86 0.362 . . . . 72.420000000000002 111.579 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -147.02 173.16 12.7 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.877 0.37 . . . . 72.430000000000007 111.72 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG12 ' H ' ' A' ' 10' ' ' TYR . 19.2 t -99.59 86.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.098 0.475 . . . . 71.340000000000003 110.821 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -51.07 -19.81 1.22 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.627 0.973 . . . . 53.530000000000001 113.627 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -95.15 -50.95 4.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.515 0.561 . . . . 74.219999999999999 112.515 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.479 ' H ' HG12 ' A' ' 7' ' ' VAL . 60.9 t80 -72.33 114.05 10.03 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.002 0.741 . . . . 74.439999999999998 113.002 -174.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.66 -159.46 5.56 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 115.049 0.779 . . . . 51.530000000000001 115.049 171.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.444 ' HB3' ' HH ' ' A' ' 128' ' ' TYR . 83.5 m-85 -65.55 7.28 0.24 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.917 1.08 . . . . 75.510000000000005 113.917 -177.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.477 ' HB2' HG21 ' A' ' 90' ' ' THR . 34.9 t -49.87 -36.04 25.58 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.455 0.571 . . . . 63.539999999999999 112.337 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.89 -40.75 75.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.123 0.487 . . . . 55.009999999999998 110.689 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -62.18 -42.26 99.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 71.519999999999996 110.854 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.0 mt -59.42 -49.28 78.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.164 0.507 . . . . 71.349999999999994 110.614 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.89 79.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.965 -0.561 . . . . 73.120000000000005 111.548 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.15 -38.25 82.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.724 0.297 . . . . 75.299999999999997 111.352 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.72 88.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.879 0.371 . . . . 72.129999999999995 111.418 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.4 mt -70.17 -54.38 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.192 0.52 . . . . 63.210000000000001 111.157 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.492 HG23 HG11 ' A' ' 31' ' ' VAL . 72.1 mt -56.96 -35.25 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.117 -0.492 . . . . 61.25 111.609 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -47.24 -51.7 18.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.132 0.491 . . . . 63.219999999999999 111.272 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.98 -49.97 50.22 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.927 -0.654 . . . . 73.329999999999998 113.058 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.63 -42.9 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.818 0.673 . . . . 70.439999999999998 112.818 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 21' ' ' ILE . 12.7 t -67.76 -35.3 78.45 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.062 0.393 . . . . 75.209999999999994 112.062 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -84.67 -31.65 24.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 73.329999999999998 111.828 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.7 m -65.14 -30.25 71.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.052 0.453 . . . . 64.510000000000005 110.823 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 42.24 4.23 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.195 -0.526 . . . . 55.030000000000001 114.029 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.29 -76.35 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.258 -0.554 . . . . 63.32 111.463 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.34 157.23 8.28 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.481 -0.39 . . . . 72.430000000000007 112.255 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG11 HG23 ' A' ' 21' ' ' ILE . 18.2 m -140.66 122.99 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 117.483 0.641 . . . . 75.129999999999995 112.501 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -109.63 104.27 13.26 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.284 -0.416 . . . . 74.540000000000006 110.357 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.48 124.18 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.173 0.435 . . . . 61.240000000000002 112.173 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.92 123.65 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.146 0.498 . . . . 54.240000000000002 110.71 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.91 81.46 7.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.191 -0.459 . . . . 61.32 112.091 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.697 HD22 ' HB3' ' A' ' 5' ' ' PHE . 4.3 pp -66.67 -19.67 65.81 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.853 -0.529 . . . . 74.209999999999994 111.526 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 17.88 51.64 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.403 -0.427 . . . . 75.329999999999998 112.924 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.5 -153.19 0.5 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.739 0.416 . . . . 54.520000000000003 110.503 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.18 99.75 10.49 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 122.074 -0.391 . . . . 70.400000000000006 111.89 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.15 165.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.911 0.386 . . . . 71.030000000000001 111.723 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.52 -171.33 3.2 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.924 0.392 . . . . 73.150000000000006 110.811 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 42' ' ' LEU . 3.1 tm? -58.9 -28.52 66.27 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.125 0.417 . . . . 74.230000000000004 112.125 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -54.2 -48.44 71.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.968 0.413 . . . . 72.129999999999995 111.752 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.49 -41.5 80.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.215 0.531 . . . . 75.049999999999997 110.917 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.9 -39.09 88.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.937 -0.574 . . . . 73.230000000000004 110.643 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -56.86 -48.14 78.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.808 -0.633 . . . . 74.420000000000002 111.709 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.15 -28.15 65.12 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.621 0.23 . . . . 75.430000000000007 111.621 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.4 tp -57.51 -27.97 63.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.872 0.367 . . . . 74.319999999999993 111.589 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -61.17 -38.06 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.05 0.452 . . . . 62.240000000000002 111.389 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.79 -30.65 14.46 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.127 -0.558 . . . . 71.340000000000003 112.659 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -75.59 0.57 17.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.936 0.495 . . . . 74.349999999999994 112.029 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.27 6.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.272 0.842 . . . . 72.230000000000004 113.272 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -80.83 -28.94 36.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.264 0.468 . . . . 74.140000000000001 112.264 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.0 137.38 4.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.844 -0.693 . . . . 61.25 113.14 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.79 167.63 20.64 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.693 0.627 . . . . 71.209999999999994 112.693 -176.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.62 121.26 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.104 -0.498 . . . . 52.409999999999997 111.026 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.497 HD13 ' N ' ' A' ' 57' ' ' ILE . 3.4 mp -108.45 143.75 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.009 0.433 . . . . 73.400000000000006 111.67 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -131.08 2.6 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.203 -0.523 . . . . 41.030000000000001 112.61 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.461 ' SD ' ' HA3' ' A' ' 93' ' ' GLY . 13.7 tmm? -110.08 127.27 54.77 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.148 -0.619 . . . . 62.240000000000002 110.901 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.2 p -97.32 105.48 25.46 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.629 -0.259 . . . . 43.329999999999998 111.545 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 155.39 67.98 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.313 2.009 . . . . 73.120000000000005 112.234 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.0 -35.07 23.22 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.573 0.582 . . . . 73.450000000000003 112.573 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.1 74.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 112.064 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -89.94 -40.17 12.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.716 0.294 . . . . 73.430000000000007 110.91 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -49.99 -39.46 41.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.483 0.313 . . . . 64.409999999999997 111.789 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.01 72.65 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.16 0.43 . . . . 71.409999999999997 112.16 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.8 p -76.63 -31.88 57.66 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.138 0.494 . . . . 64.319999999999993 110.695 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -63.04 -29.51 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 111.381 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 29.0 mm-40 -52.56 -26.73 14.14 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.864 0.364 . . . . 71.430000000000007 111.856 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.44 -54.64 2.63 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.136 -0.554 . . . . 50.039999999999999 112.916 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -63.72 -30.13 71.27 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.75 0.648 . . . . 44.310000000000002 112.75 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.0 -47.59 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.529 0.332 . . . . 71.400000000000006 111.288 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -57.88 -48.44 79.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.901 0.381 . . . . 63.109999999999999 111.4 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.2 m -57.86 -44.64 86.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.204 -0.453 . . . . 52.310000000000002 111.271 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.475 ' O ' HG12 ' A' ' 79' ' ' VAL . 69.5 mt -63.01 -55.08 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 74.219999999999999 111.248 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.0 tp -55.17 -34.99 64.31 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.71 -0.677 . . . . 44.119999999999997 112.256 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.01 -21.18 71.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.954 -0.641 . . . . 54.32 113.57 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.9 m -98.77 -21.2 16.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.004 0.742 . . . . 71.5 113.004 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -62.93 163.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.844 0.683 . . . . 73.340000000000003 112.844 -178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -79.53 161.82 25.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.868 -0.605 . . . . 64.299999999999997 111.217 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.39 -44.24 65.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.804 0.442 . . . . 74.340000000000003 112.122 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -143.1 143.74 31.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.768 0.318 . . . . 75.230000000000004 111.155 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.422 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -158.21 177.31 11.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.313 0.578 . . . . 71.340000000000003 112.112 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.638 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -93.58 112.14 23.96 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.811 -0.631 . . . . 74.140000000000001 110.937 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 31.6 m -114.33 128.74 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.359 0.6 . . . . 62.299999999999997 112.149 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.67 17.73 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.051 -0.522 . . . . 71.129999999999995 112.409 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 57' ' ' ILE . 6.7 tp -148.46 137.83 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.783 0.325 . . . . 74.439999999999998 111.275 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.83 114.55 7.67 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.241 0.543 . . . . 73.109999999999999 111.21 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' O ' HD11 ' A' ' 119' ' ' ILE . 44.7 mt-10 -60.02 93.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.21 0.529 . . . . 70.030000000000001 111.901 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.477 HG21 ' HB2' ' A' ' 13' ' ' SER . 24.9 m -74.73 77.41 2.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.119 0.485 . . . . 73.019999999999996 111.491 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.22 -169.15 47.5 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.073 -0.584 . . . . 74.319999999999993 113.53 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.07 77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.421 -0.419 . . . . 60.140000000000001 113.412 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.461 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . -89.12 -176.51 46.35 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.254 -0.498 . . . . 53.420000000000002 112.863 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -94.48 164.85 12.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.42 -0.459 . . . . 71.420000000000002 110.848 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.13 115.64 20.12 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.205 0.526 . . . . 72.430000000000007 112.368 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.651 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 63.7 mt-10 -103.39 -59.14 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 112.148 0.425 . . . . 72.140000000000001 112.148 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.651 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 39.0 Cg_endo -98.27 27.12 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.87 2.38 . . . . 73.140000000000001 113.715 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.54 -51.61 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.728 0.64 . . . . 73.109999999999999 112.728 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.402 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 6.1 m-20 -64.22 -56.58 22.72 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.611 0.597 . . . . 75.420000000000002 112.611 -176.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 25.6 Cg_endo -59.75 -41.63 53.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.064 1.842 . . . . 63.310000000000002 113.078 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.72 -59.58 3.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.883 0.373 . . . . 65.430000000000007 110.997 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.08 -34.54 78.27 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.058 0.392 . . . . 71.340000000000003 112.058 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -60.48 -50.05 75.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.04 0.448 . . . . 62.520000000000003 111.567 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -65.02 -43.33 92.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.548 -0.296 . . . . 73.239999999999995 111.259 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.28 -40.82 87.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.825 0.345 . . . . 75.010000000000005 111.419 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -55.24 -41.84 72.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.953 0.406 . . . . 74.329999999999998 110.919 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -70.14 -29.84 66.86 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.591 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.3 mt -81.47 -22.26 38.19 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.33 -73.5 2.35 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.238 -0.506 . . . . 71.219999999999999 112.66 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 83' ' ' GLN . 61.1 mt 60.36 -179.21 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.614 0.721 . . . . 74.010000000000005 112.732 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.638 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 73.5 m -97.16 103.98 15.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.852 -0.613 . . . . 62.039999999999999 110.167 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -114.01 102.73 10.46 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.183 0.438 . . . . 62.409999999999997 112.183 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.74 84.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.544 0.572 . . . . 70.230000000000004 112.544 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -152.46 132.44 7.24 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.413 -0.179 . . . . 75.230000000000004 110.787 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.62 -69.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.525 2.15 . . . . 53.439999999999998 114.543 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 161.2 38.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.578 0.584 . . . . 64.319999999999993 112.578 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.78 HG12 ' H ' ' A' ' 118' ' ' ARG . 11.1 tt -123.64 -150.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.156 0.582 . . . . 75.340000000000003 109.74 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.78 ' H ' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -147.08 114.02 6.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.141 -0.974 . . . . 74.049999999999997 111.634 175.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 123' ' ' PRO . 73.4 mt -139.06 139.2 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 115.948 -0.569 . . . . 71.510000000000005 110.597 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -81.52 -61.24 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.966 0.358 . . . . 74.299999999999997 111.966 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -141.64 -52.6 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.145 -0.347 . . . . 75.439999999999998 111.61 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.8 p -92.29 130.0 39.22 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 116.788 -0.187 . . . . 71.420000000000002 111.066 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HA ' HD13 ' A' ' 119' ' ' ILE . 12.3 Cg_endo -55.15 127.22 25.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.404 2.07 . . . . 72.209999999999994 112.691 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.8 p -74.48 154.48 38.68 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.22 -0.445 . . . . 55.229999999999997 111.906 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.45 -25.63 68.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.038 0.447 . . . . 74.219999999999999 111.385 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -38.18 75.13 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 109.998 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.422 ' OG1' HD12 ' A' ' 119' ' ' ILE . 33.6 m -55.19 -38.38 68.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.901 -0.591 . . . . 64.030000000000001 111.879 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.446 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 87.1 m-85 -58.36 -60.33 3.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.994 0.426 . . . . 75.209999999999994 111.265 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -58.33 -29.82 66.22 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.085 -0.507 . . . . 63.219999999999999 111.694 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.28 -50.11 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.273 -0.421 . . . . 71.219999999999999 110.368 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 30.5 p -69.24 -22.74 63.83 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.882 0.327 . . . . 53.530000000000001 111.882 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 53.0 mt-10 -60.11 -53.0 62.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.881 0.372 . . . . 64.239999999999995 111.057 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.13 -55.74 8.63 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.08 0.467 . . . . 64.450000000000003 111.022 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.24 -57.55 12.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.944 -0.571 . . . . 72.349999999999994 112.434 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -56.4 -47.27 84.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.461 -0.4 . . . . 51.439999999999998 113.75 -176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.4 m -64.87 -33.53 76.23 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.558 -0.378 . . . . 64.010000000000005 111.64 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -55.04 -36.5 65.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.197 0.443 . . . . 73.030000000000001 112.197 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.479 HD11 ' HB1' ' A' ' 84' ' ' ALA . 3.3 mm? -56.32 -45.66 80.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.18 0.514 . . . . 70.129999999999995 110.902 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.69 -38.86 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.079 -0.581 . . . . 64.25 112.796 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 136' ' ' THR . 17.5 mm-40 -57.61 -50.05 74.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.847 0.356 . . . . 72.5 111.642 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -54.48 -50.88 66.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 111.533 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.18 -51.92 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.16 -0.473 . . . . 74.209999999999994 112.234 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -69.46 -43.3 73.54 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.403 0.52 . . . . 72.129999999999995 112.403 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.34 -43.1 78.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.106 0.41 . . . . 70.400000000000006 112.106 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.77 -30.59 71.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 111.095 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -75.24 -21.56 58.51 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.988 -0.551 . . . . 75.430000000000007 111.801 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 92.7 mt -113.69 -56.36 2.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.256 0.465 . . . . 73.230000000000004 112.256 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 43.4 mm-40 71.25 107.49 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.442 0.697 . . . . 75.049999999999997 112.479 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -143.75 -62.71 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.07 -0.514 . . . . 70.230000000000004 111.412 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -134.1 118.01 17.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.679 0.622 . . . . 75.310000000000002 112.679 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -97.28 144.52 26.99 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.296 -0.631 . . . . 64.040000000000006 109.296 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 64.21 99.95 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.606 -0.516 . . . . 75.099999999999994 109.606 -168.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -127.27 179.05 5.65 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.574 0.583 . . . . 71.120000000000005 112.574 -167.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.567 -0.73 . . . . 75.349999999999994 110.835 173.271 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.6 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.1 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.421 0.153 . . . . 61.340000000000003 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.6 mm 59.46 102.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.195 0.521 . . . . 54.030000000000001 111.887 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.65 94.43 1.87 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.833 -0.698 . . . . 62.439999999999998 113.061 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' HB ' HG13 ' A' ' 33' ' ' VAL . 47.9 t -88.0 104.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.056 0.428 . . . . 75.120000000000005 111.091 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.43 ' HB3' HD22 ' A' ' 36' ' ' LEU . 97.7 m-85 -103.86 119.03 38.08 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.204 0.526 . . . . 65.299999999999997 111.408 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.572 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 45.1 p90 -136.6 -178.08 5.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.155 -0.475 . . . . 74.25 111.678 -175.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.9 100.93 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.813 0.339 . . . . 74.439999999999998 110.585 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.568 ' HB3' ' HE2' ' A' ' 6' ' ' TYR . 53.4 p -63.86 -18.49 64.21 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.281 0.845 . . . . 74.430000000000007 113.281 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -89.16 -10.94 45.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.067 0.461 . . . . 74.150000000000006 111.534 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.509 ' HH ' ' HA3' ' A' ' 91' ' ' GLY . 69.1 t80 -115.45 119.11 35.13 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.251 -0.281 . . . . 70.420000000000002 111.082 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.455 ' HA3' ' HG1' ' A' ' 90' ' ' THR . . . 56.61 -161.32 7.45 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.253 -0.498 . . . . 54.340000000000003 114.131 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -84.75 8.23 17.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.01 0.744 . . . . 74.450000000000003 113.01 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 42.8 m -32.19 -51.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.578 0.955 . . . . 60.450000000000003 113.578 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.5 -40.95 76.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.692 0.282 . . . . 74.040000000000006 111.724 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -60.3 -39.06 85.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.292 0.567 . . . . 74.120000000000005 110.544 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.59 -53.32 53.52 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.734 -0.666 . . . . 61.329999999999998 110.905 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -39.8 68.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.999 0.428 . . . . 50.420000000000002 111.379 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -55.71 -45.51 77.89 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.683 -0.689 . . . . 74.049999999999997 111.516 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.18 -43.84 69.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.094 -0.503 . . . . 71.510000000000005 111.424 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' O ' HG12 ' A' ' 24' ' ' ILE . 82.0 mt -57.0 -56.82 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.209 -0.451 . . . . 54.229999999999997 111.664 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -56.98 -35.92 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.806 0.336 . . . . 63.240000000000002 111.354 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.76 -37.4 86.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.015 0.436 . . . . 73.109999999999999 111.206 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.0 24.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.26 -0.495 . . . . 72.129999999999995 113.775 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.628 HG23 HG13 ' A' ' 31' ' ' VAL . 44.8 mm -75.98 -41.59 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 122.407 -0.466 . . . . 71.439999999999998 112.044 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.2 p -61.24 -30.17 70.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 74.329999999999998 111.344 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.41 -12.57 60.07 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 73.430000000000007 111.176 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -90.35 -36.75 14.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.129 -0.487 . . . . 54.219999999999999 111.016 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.64 22.82 2.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.304 -0.474 . . . . 61.009999999999998 113.748 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.406 ' O ' HG22 ' A' ' 24' ' ' ILE . 67.7 t -130.16 140.39 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 117.148 0.474 . . . . 53.229999999999997 111.069 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.44 113.34 4.65 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.089 -0.577 . . . . 52.219999999999999 112.846 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 24' ' ' ILE . 20.5 m -94.15 140.33 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.129 0.49 . . . . 63.340000000000003 112.139 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.451 ' OD2' ' HD3' ' A' ' 51' ' ' ARG . 23.4 m-20 -101.38 113.26 26.19 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.095 -0.502 . . . . 71.519999999999996 111.079 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.562 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 36.0 m -106.11 125.95 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 120.969 0.414 . . . . 71.420000000000002 111.418 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.81 150.69 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.458 0.303 . . . . 73.120000000000005 111.523 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.494 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 15.7 m-20 -84.54 120.52 26.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.796 0.295 . . . . 72.049999999999997 111.796 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.439 HD13 ' HE1' ' A' ' 59' ' ' MET . 4.2 pp -86.12 -16.21 38.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.155 0.503 . . . . 73.140000000000001 111.38 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.73 -10.77 78.55 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.208 -0.52 . . . . 65.040000000000006 112.489 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.44 -178.32 5.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.836 0.35 . . . . 75.420000000000002 111.275 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 96.02 3.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.998 0.428 . . . . 72.200000000000003 111.236 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -85.5 132.58 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.259 0.552 . . . . 71.219999999999999 111.56 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -108.64 170.42 8.04 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.375 -0.375 . . . . 74.439999999999998 110.94 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 45' ' ' LEU . 3.3 mm? -55.9 -24.55 38.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.073 0.463 . . . . 63.140000000000001 111.084 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -57.56 -60.26 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.877 -0.601 . . . . 73.0 110.983 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -65.58 -38.08 88.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.08 -0.509 . . . . 73.310000000000002 110.973 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.547 HD12 HD12 ' A' ' 42' ' ' LEU . 92.9 mt -59.3 -34.79 72.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.451 -0.34 . . . . 74.329999999999998 111.448 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.84 -33.84 60.07 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.224 -0.297 . . . . 75.120000000000005 111.017 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.14 -39.13 77.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.992 0.425 . . . . 73.400000000000006 110.281 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.621 HD21 HG23 ' A' ' 75' ' ' ILE . 67.7 tp -52.61 -46.5 67.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.98 -0.554 . . . . 73.540000000000006 110.852 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.86 -44.23 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.046 0.45 . . . . 73.340000000000003 111.009 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.43 -29.88 72.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.144 -0.551 . . . . 42.240000000000002 113.025 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.451 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -99.61 8.69 44.2 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.069 0.396 . . . . 73.030000000000001 112.069 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.05 -3.41 0.13 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.502 0.927 . . . . 73.510000000000005 113.502 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -84.58 -27.63 27.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.793 0.33 . . . . 71.409999999999997 111.793 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.55 138.32 5.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.469 -0.396 . . . . 44.329999999999998 112.843 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 pp -159.12 162.99 36.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.319 0.488 . . . . 75.439999999999998 112.319 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -131.05 128.76 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.422 -0.353 . . . . 73.420000000000002 111.387 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.5 mp -95.59 139.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.758 0.313 . . . . 74.430000000000007 110.909 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -116.13 0.46 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.211 -0.519 . . . . 55.030000000000001 113.79 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.645 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -82.68 175.9 9.77 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 112.842 0.682 . . . . 72.299999999999997 112.842 -177.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.447 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 87.7 p -144.52 34.51 0.16 Allowed Pre-proline 0 CA--C 1.555 1.165 0 N-CA-C 114.07 1.137 . . . . 73.329999999999998 114.07 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 87.7 Cg_endo -77.53 149.13 26.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.651 1.568 . . . . 73.530000000000001 112.434 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.41 61.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.439 0.533 . . . . 71.310000000000002 112.439 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.4 66.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.105 0.479 . . . . 51.119999999999997 112.102 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -78.36 -29.95 47.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.987 0.422 . . . . 75.230000000000004 111.215 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.61 -29.37 62.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.139 -0.482 . . . . 63.130000000000003 111.904 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.86 80.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.063 0.459 . . . . 74.549999999999997 111.246 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.8 t -73.73 -43.83 58.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.991 0.424 . . . . 61.32 110.958 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.3 -50.37 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.077 -0.51 . . . . 63.420000000000002 111.846 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.64 -43.57 98.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.034 0.383 . . . . 74.040000000000006 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.44 -41.36 72.11 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.037 -0.601 . . . . 70.340000000000003 112.765 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.455 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -81.45 -32.68 32.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.74 0.305 . . . . 54.340000000000003 111.382 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.15 -43.91 74.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.973 0.509 . . . . 72.519999999999996 111.33 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.6 m -55.86 -21.96 22.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.776 0.322 . . . . 71.219999999999999 111.849 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 m -97.61 -29.89 13.17 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.101 0.476 . . . . 73.310000000000002 110.863 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.621 HG23 HD21 ' A' ' 48' ' ' LEU . 69.4 mt -64.07 -39.17 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.033 0.383 . . . . 71.230000000000004 112.033 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -51.1 -49.2 61.18 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.438 0.533 . . . . 73.25 112.438 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.79 -8.01 87.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.044 -0.598 . . . . 52.329999999999998 113.234 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.2 m -94.04 -24.68 17.52 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.929 0.344 . . . . 73.239999999999995 111.929 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 m -87.01 164.18 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.178 0.513 . . . . 64.010000000000005 111.905 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.93 -156.2 0.52 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.159 -0.473 . . . . 52.509999999999998 111.444 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.11 -80.57 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.951 0.723 . . . . 52.229999999999997 112.951 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -117.57 98.6 6.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.594 0.712 . . . . 64.319999999999993 111.874 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.11 166.48 11.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.459 0.647 . . . . 74.109999999999999 112.564 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.428 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -102.77 110.81 22.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.531 -0.759 . . . . 73.510000000000005 109.298 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -121.03 154.03 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.814 0.816 . . . . 72.409999999999997 113.033 -168.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.72 169.97 14.32 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.249 -0.887 . . . . 42.0 112.684 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -153.76 126.63 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.383 0.273 . . . . 72.340000000000003 110.848 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -137.28 92.48 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.717 0.77 . . . . 72.310000000000002 111.99 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.565 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.5 tp10 -66.63 121.31 15.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.653 -0.703 . . . . 70.299999999999997 110.473 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.476 HG21 ' OG ' ' A' ' 13' ' ' SER . 8.0 t -101.53 15.78 27.79 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 64.109999999999999 111.843 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . -158.24 -64.54 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.811 -0.709 . . . . 72.030000000000001 113.631 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.06 47.66 2.02 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.304 -0.474 . . . . 70.329999999999998 111.967 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 61' ' ' PRO . . . -66.49 -63.81 3.7 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.171 0.428 . . . . 51.240000000000002 114.171 -174.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -152.66 -178.56 6.95 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.182 0.491 . . . . 73.239999999999995 111.244 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.3 23.82 1.81 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.675 0.39 . . . . 71.340000000000003 111.49 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 34.0 tt0 -50.81 -47.85 84.94 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.361 0.874 . . . . 63.119999999999997 113.361 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.47 ' O ' HD22 ' A' ' 101' ' ' LEU . 51.7 Cg_endo -87.98 38.5 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.313 2.009 . . . . 74.0 113.701 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.7 tt -66.59 -58.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 113.635 0.976 . . . . 71.129999999999995 113.635 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.442 ' N ' HG23 ' A' ' 98' ' ' ILE . 9.9 m-20 -57.9 -55.73 42.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.935 1.087 . . . . 73.150000000000006 113.935 -172.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 32.4 Cg_endo -61.65 -14.64 37.0 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.315 2.01 . . . . 74.040000000000006 114.742 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.47 HD22 ' O ' ' A' ' 97' ' ' PRO . 4.0 mm? -100.89 -62.03 1.29 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -50.62 -45.15 57.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.508 0.929 . . . . 72.349999999999994 113.508 -170.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.7 t -52.81 -37.68 60.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.488 0.551 . . . . 71.310000000000002 112.488 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 0.5 OUTLIER -66.61 -44.0 83.25 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.831 0.348 . . . . 71.5 111.449 -177.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -63.16 -35.97 82.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.924 0.393 . . . . 64.140000000000001 111.154 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -69.4 -43.79 72.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.144 -0.48 . . . . 74.319999999999993 110.999 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.32 -55.14 38.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.622 . . . . 73.340000000000003 111.792 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 mp -71.69 -26.19 62.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.758 0.313 . . . . 74.030000000000001 111.312 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.68 62.14 3.32 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.172 -0.537 . . . . 55.219999999999999 113.579 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 110' ' ' LEU . 6.9 mp -79.39 142.66 35.78 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.069 0.461 . . . . 64.540000000000006 111.313 177.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.428 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 35.3 m -70.91 97.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.261 -0.427 . . . . 72.5 110.941 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.3 p -86.73 121.66 29.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 112.152 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.31 -58.8 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.435 0.531 . . . . 73.430000000000007 112.435 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -140.92 84.89 12.81 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 120.996 0.427 . . . . 74.140000000000001 111.667 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.39 64.53 4.96 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.824 2.349 . . . . 63.310000000000002 112.989 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.91 42.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.143 0.423 . . . . 71.349999999999994 112.143 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.493 HG23 ' H ' ' A' ' 89' ' ' GLU . 1.7 pp -71.2 73.23 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.847 0.832 . . . . 74.400000000000006 112.892 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -79.46 50.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.929 -0.578 . . . . 73.439999999999998 112.415 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 89' ' ' GLU . 49.0 mm -76.35 147.82 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 120.932 0.396 . . . . 73.209999999999994 111.721 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.96 -61.86 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.113 0.412 . . . . 74.25 112.113 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.514 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 35.2 tt0 -151.28 -48.94 0.12 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.098 0.475 . . . . 41.020000000000003 111.604 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.0 p -129.35 131.75 23.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.412 -0.358 . . . . 53.240000000000002 111.289 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.96 143.76 73.85 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.475 2.117 . . . . 73.519999999999996 112.226 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.8 p -100.73 -177.72 3.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.991 0.424 . . . . 70.209999999999994 111.592 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -59.89 -26.76 66.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.076 0.465 . . . . 61.439999999999998 111.258 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -76.38 -24.38 54.11 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.38 -0.373 . . . . 74.340000000000003 111.902 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.0 m -59.07 -35.26 73.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.936 0.398 . . . . 75.140000000000001 111.466 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.43 -48.43 80.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.024 0.44 . . . . 63.520000000000003 111.346 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -50.13 -50.11 49.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.653 -0.703 . . . . 75.25 112.54 -174.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 mp -63.05 -46.39 87.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 72.519999999999996 111.232 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 82.2 m -61.05 -40.05 92.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 111.773 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.18 -52.56 12.1 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.865 0.364 . . . . 71.340000000000003 111.614 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.61 -63.49 1.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.422 -0.354 . . . . 70.409999999999997 110.941 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.21 79.55 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.481 -0.327 . . . . 72.019999999999996 111.405 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.04 94.67 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.282 -0.485 . . . . 38.490000000000002 113.083 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 54.8 m -60.67 -48.61 81.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.827 0.346 . . . . 75.319999999999993 111.151 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.09 -39.64 86.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.904 0.383 . . . . 62.210000000000001 111.304 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.44 -44.5 97.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.023 0.439 . . . . 65.230000000000004 110.662 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.3 -38.72 96.25 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.265 -0.493 . . . . 64.439999999999998 112.75 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.495 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 86.3 mt-30 -61.89 -28.83 69.79 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.998 0.37 . . . . 74.25 111.998 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -50.63 -40.33 52.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.129 0.49 . . . . 70.010000000000005 110.717 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.97 -51.95 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.025 -0.534 . . . . 74.319999999999993 111.755 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 146' ' ' ARG . 10.0 t -69.1 -25.2 64.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.901 0.334 . . . . 74.310000000000002 111.901 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.495 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 94.7 mtt180 -65.73 -41.11 92.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.742 0.306 . . . . 75.239999999999995 111.093 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.65 -27.94 31.01 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.432 . . . . 75.540000000000006 110.936 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.657 ' HE ' ' HA ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -59.83 -59.23 5.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.357 -0.383 . . . . 72.219999999999999 111.132 175.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.3 tp -175.57 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.662 -0.244 . . . . 72.230000000000004 111.514 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -150.75 109.74 3.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 72.019999999999996 111.409 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -159.54 22.36 0.18 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.522 0.677 . . . . 72.329999999999998 109.984 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -90.65 55.58 3.02 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.573 0.583 . . . . 74.310000000000002 112.573 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -87.07 -32.91 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.867 -0.52 . . . . 73.299999999999997 110.882 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -66.58 97.06 0.41 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.348 -0.387 . . . . 74.530000000000001 111.898 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -87.02 76.98 9.27 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.345 -0.222 . . . . 64.109999999999999 111.458 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.9 m80 . . . . . 0 C--O 1.251 1.171 0 N-CA-C 112.223 0.453 . . . . 63.399999999999999 112.223 -177.53 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 53.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.009 -0.043 . . . . 72.219999999999999 110.933 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 63.33 122.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 112.726 0.639 . . . . 74.430000000000007 112.726 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.48 105.11 3.24 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.473 -0.394 . . . . 73.299999999999997 112.663 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.2 t -88.39 107.92 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 122.55 -0.383 . . . . 73.540000000000006 110.982 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.62 ' HE2' ' HB2' ' A' ' 55' ' ' LEU . 83.3 m-85 -88.71 142.0 28.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.938 0.718 . . . . 72.109999999999999 112.938 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -146.58 179.74 7.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.775 -0.648 . . . . 74.030000000000001 110.844 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.578 HG11 ' HA3' ' A' ' 37' ' ' GLY . 86.0 t -130.64 103.7 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.748 0.309 . . . . 44.420000000000002 111.721 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.7 m -54.95 -36.41 65.29 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.087 0.403 . . . . 74.049999999999997 112.087 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.7 -54.81 36.95 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.385 0.513 . . . . 74.200000000000003 112.385 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -138.94 -55.29 0.6 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.092 -0.503 . . . . 64.530000000000001 110.898 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.576 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -30.04 97.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.365 0.906 . . . . 71.420000000000002 115.365 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -70.82 5.76 1.81 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.073 0.464 . . . . 75.409999999999997 111.488 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.596 ' HG ' ' HE2' ' A' ' 88' ' ' PHE . 14.9 m -52.89 -14.17 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.029 0.751 . . . . 73.420000000000002 113.029 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.33 -37.01 74.26 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.093 0.473 . . . . 63.439999999999998 110.916 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.542 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 1.5 mtm180 -65.15 -34.41 78.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.056 -0.52 . . . . 55.0 111.127 175.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 20' ' ' ILE . 75.6 mt -66.79 -48.18 69.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.202 -0.454 . . . . 73.519999999999996 110.406 172.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.85 -41.73 71.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.126 -0.488 . . . . 70.129999999999995 112.116 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -63.0 -46.02 89.64 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.906 0.384 . . . . 62.130000000000003 111.321 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.08 93.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.064 0.459 . . . . 63.149999999999999 111.217 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 16' ' ' LEU . 79.1 mt -63.71 -55.19 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.681 . . . . 73.540000000000006 111.814 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.79 -39.69 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 122.312 -0.243 . . . . 74.349999999999994 111.61 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 25' ' ' THR . 46.1 t-20 -55.77 -59.82 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.842 0.354 . . . . 53.32 111.025 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -45.07 96.67 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 120.952 -0.642 . . . . 73.319999999999993 113.42 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.504 HG21 HG11 ' A' ' 31' ' ' VAL . 33.6 mt -72.92 -30.22 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.115 0.783 . . . . 75.150000000000006 113.115 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 22' ' ' ASN . 14.5 t -69.66 -35.18 74.94 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.571 -0.705 . . . . 54.299999999999997 110.743 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -74.62 -43.01 57.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.933 0.397 . . . . 71.5 110.807 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -59.34 -34.09 71.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.128 -0.487 . . . . 71.349999999999994 111.377 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' HA3' ' CD2' ' A' ' 150' ' ' HIS . . . 104.48 59.13 0.68 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.036 -0.602 . . . . 61.119999999999997 114.101 175.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' A' ' 24' ' ' ILE . 61.1 t -140.07 -53.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.844 0.354 . . . . 73.329999999999998 111.24 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' H ' HG23 ' A' ' 24' ' ' ILE . . . 84.65 119.06 0.83 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.326 -0.464 . . . . 75.519999999999996 113.564 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 1' ' ' SER . 30.9 m -116.6 146.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.324 0.49 . . . . 74.349999999999994 112.324 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.28 129.97 55.5 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.289 -0.414 . . . . 75.430000000000007 111.169 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.16 137.15 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.182 0.515 . . . . 60.450000000000003 112.205 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 59.7 t -132.64 140.33 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.507 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 17.4 t70 -107.88 130.34 55.01 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.176 0.512 . . . . 61.020000000000003 111.711 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 11.32 14.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.288 -0.415 . . . . 71.329999999999998 112.078 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.578 ' HA3' HG11 ' A' ' 7' ' ' VAL . . . -96.17 -35.12 5.63 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.007 -0.616 . . . . 72.310000000000002 113.353 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.0 -38.22 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.984 0.421 . . . . 72.340000000000003 111.816 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 35' ' ' ASP . . . -75.54 12.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.499 0.555 . . . . 71.409999999999997 112.499 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.24 114.05 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.227 0.537 . . . . 71.319999999999993 111.969 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.12 170.43 21.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.886 -0.597 . . . . 71.299999999999997 110.628 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.17 -34.8 70.7 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.618 -0.264 . . . . 64.120000000000005 111.447 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.44 -63.11 1.39 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.643 0.258 . . . . 63.43 111.624 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.47 -48.97 65.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.196 0.522 . . . . 65.5 111.637 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.09 -43.67 98.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.154 -0.475 . . . . 75.120000000000005 111.975 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -71.65 -34.73 70.0 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.309 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 34.5 mt-10 -71.99 -28.75 63.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.659 0.266 . . . . 63.340000000000003 111.141 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.56 -40.0 77.96 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.935 0.398 . . . . 73.099999999999994 110.615 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -36.03 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.22 -0.445 . . . . 64.400000000000006 111.014 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.33 -40.29 41.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.169 -0.539 . . . . 72.209999999999994 112.647 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' NH1' ' HB3' ' A' ' 47' ' ' GLU . 7.2 mpt_? -81.61 6.23 15.71 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.102 0.408 . . . . 73.140000000000001 112.102 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.9 p -49.84 -15.54 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.633 0.975 . . . . 74.439999999999998 113.633 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -47.59 -31.63 4.66 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.338 0.496 . . . . 73.420000000000002 112.338 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -179.82 141.56 4.75 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.076 -0.511 . . . . 37.450000000000003 112.095 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.62 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . 1.4 pt? -144.72 134.48 23.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.369 0.584 . . . . 65.150000000000006 112.136 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.459 HG23 ' HE1' ' A' ' 88' ' ' PHE . 11.4 p -118.11 124.99 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 111.077 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.5 mp -113.2 139.64 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.287 0.477 . . . . 72.540000000000006 112.287 -172.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.1 131.23 10.54 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.3 -0.409 . . . . 74.209999999999994 112.579 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.07 120.26 22.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.551 0.575 . . . . 71.319999999999993 112.551 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.661 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 88.4 p -111.75 171.14 4.57 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.153 0.581 . . . . 61.350000000000001 111.051 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.661 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 30.9 Cg_endo -63.18 168.08 11.51 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.289 1.992 . . . . 65.420000000000002 113.526 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.746 ' HA ' ' HB1' ' A' ' 65' ' ' ALA . . . -58.22 -21.62 48.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.076 0.769 . . . . 72.030000000000001 113.076 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.19 -61.0 2.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.785 0.326 . . . . 52.350000000000001 111.305 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 -33.01 36.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.625 -0.261 . . . . 71.25 111.701 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.746 ' HB1' ' HA ' ' A' ' 62' ' ' ALA . . . -54.81 -37.59 66.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.179 0.437 . . . . 72.340000000000003 112.179 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.51 75.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.315 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -68.86 -40.85 79.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.28 0.562 . . . . 72.420000000000002 110.691 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.39 -44.5 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.914 -0.585 . . . . 74.329999999999998 111.081 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -57.44 -40.17 77.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.507 -0.315 . . . . 74.109999999999999 111.357 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.11 -49.16 73.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.153 -0.546 . . . . 37.450000000000003 112.887 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.39 67.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.918 0.39 . . . . 75.329999999999998 111.92 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 72' ' ' LEU . 3.2 tm? -52.8 -32.12 42.29 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.228 -0.442 . . . . 70.120000000000005 111.175 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.4 m -46.8 -41.03 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.729 0.412 . . . . 64.439999999999998 111.752 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.1 m -87.68 -45.32 10.49 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.892 0.377 . . . . 74.510000000000005 111.157 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.39 -51.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 112.418 0.525 . . . . 75.040000000000006 112.418 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.4 tp -55.91 -33.95 65.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.823 0.344 . . . . 72.430000000000007 111.889 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.37 -17.44 55.28 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.944 -0.646 . . . . 70.140000000000001 113.244 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.0 p -87.75 -16.35 34.48 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.336 0.495 . . . . 72.439999999999998 112.336 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.57 153.94 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.22 0.533 . . . . 74.109999999999999 112.084 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -87.14 148.64 25.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.082 -0.508 . . . . 75.109999999999999 111.158 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.76 -36.31 64.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.939 0.4 . . . . 71.019999999999996 111.997 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -118.19 87.15 2.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.489 0.661 . . . . 75.439999999999998 110.837 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.511 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 18.2 tp60 -131.38 172.83 11.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.993 -0.549 . . . . 74.5 110.867 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.511 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -107.98 123.72 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 65.530000000000001 111.836 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' A' ' 112' ' ' THR . 35.3 m -130.03 171.8 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.842 0.353 . . . . 62.109999999999999 111.12 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' HA3' HG22 ' A' ' 56' ' ' VAL . . . -142.4 144.4 14.03 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.097 -0.573 . . . . 64.439999999999998 112.826 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -125.06 126.66 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.588 -0.36 . . . . 74.230000000000004 111.829 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.674 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 54.6 p90 -148.94 168.14 23.88 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.101 0.477 . . . . 75.209999999999994 111.725 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.58 155.38 21.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.377 0.608 . . . . 73.340000000000003 111.984 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -134.5 2.26 3.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.999 0.428 . . . . 54.229999999999997 111.765 176.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.62 -164.96 29.66 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.242 -0.504 . . . . 74.120000000000005 112.778 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.09 -29.66 62.79 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.039 0.376 . . . . 60.43 114.039 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.33 126.15 1.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.341 -0.457 . . . . 64.439999999999998 112.98 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 27.2 t70 -160.2 109.37 1.74 Allowed 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.444 -0.445 . . . . 75.099999999999994 111.41 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -168.32 156.77 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.569 0.348 . . . . 60.43 110.846 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.729 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 4.6 mp0 -94.15 -61.12 0.18 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 112.19 0.441 . . . . 73.540000000000006 112.19 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 6.1 Cg_exo -80.03 16.29 1.52 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.567 2.178 . . . . 74.209999999999994 113.749 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.533 HG23 ' H ' ' A' ' 99' ' ' ASP . 5.6 tt -47.9 -59.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.86 0.689 . . . . 72.129999999999995 112.86 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.533 ' H ' HG23 ' A' ' 98' ' ' ILE . 6.8 m-20 -63.83 -50.98 68.02 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 111.983 0.364 . . . . 74.230000000000004 111.983 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 94.3 Cg_exo -47.24 -40.8 27.9 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.437 2.091 . . . . 74.340000000000003 113.704 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 97' ' ' PRO . 7.4 mp -63.8 -59.82 4.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.838 0.351 . . . . 74.129999999999995 111.266 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.7 mt -53.93 -35.82 62.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.081 0.467 . . . . 71.439999999999998 111.334 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.3 t -57.78 -46.04 85.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.826 -0.624 . . . . 74.510000000000005 111.432 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -71.07 -41.07 71.19 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.673 0.249 . . . . 72.349999999999994 111.673 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.32 -35.68 76.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.184 0.516 . . . . 75.430000000000007 111.113 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -79.53 -31.37 42.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.008 0.432 . . . . 74.400000000000006 110.591 177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -59.67 -38.32 81.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.033 -0.53 . . . . 72.319999999999993 110.534 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.72 -52.82 26.57 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.103 -0.499 . . . . 72.530000000000001 110.789 173.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.39 34.34 0.82 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.123 -0.561 . . . . 64.120000000000005 113.797 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.1 mp -83.56 136.12 34.37 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.458 -0.436 . . . . 73.519999999999996 111.111 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.4 t -77.78 125.74 29.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.096 -0.335 . . . . 74.200000000000003 110.096 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.642 ' HA ' HG23 ' A' ' 85' ' ' VAL . 59.3 p -97.38 -8.48 29.43 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.679 0.992 . . . . 60.420000000000002 113.679 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 50.24 78.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.538 0.569 . . . . 73.319999999999993 112.538 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 64.82 106.9 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 112.388 0.514 . . . . 75.400000000000006 112.388 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.63 74.14 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.08 1.853 . . . . 73.409999999999997 111.906 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 88' ' ' PHE . . . -73.76 114.45 12.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.79 0.663 . . . . 60.149999999999999 112.79 -173.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.2 tt -159.04 80.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.949 0.88 . . . . 64.140000000000001 110.6 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -146.81 90.58 1.93 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.772 -0.649 . . . . 73.340000000000003 111.773 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.45 149.34 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.397 0.618 . . . . 71.109999999999999 112.232 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -91.23 -25.2 19.62 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.715 -0.675 . . . . 61.240000000000002 110.886 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 178.71 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.439 -0.8 . . . . 73.340000000000003 109.962 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p -128.62 140.06 37.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.794 -0.639 . . . . 75.299999999999997 110.795 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.21 169.15 14.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.621 2.214 . . . . 55.409999999999997 114.012 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.412 HG21 ' N ' ' A' ' 125' ' ' GLU . 91.1 m -107.43 160.06 15.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.866 -0.606 . . . . 65.349999999999994 110.526 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.412 ' N ' HG21 ' A' ' 124' ' ' THR . 9.4 pt-20 -43.47 -35.53 1.67 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.634 0.975 . . . . 62.420000000000002 113.634 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -62.36 -23.25 66.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.327 0.492 . . . . 73.310000000000002 112.327 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.0 m -57.98 -39.74 78.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.231 0.538 . . . . 71.349999999999994 110.556 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.542 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 11.3 m-85 -60.44 -32.03 70.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.906 -0.588 . . . . 73.040000000000006 111.278 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.7 -36.52 76.03 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.44 -0.345 . . . . 72.5 111.136 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.28 -53.66 34.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 64.340000000000003 110.256 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.7 m -58.79 -32.7 69.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.006 0.431 . . . . 53.43 111.083 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.04 -56.03 26.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.783 -0.644 . . . . 71.439999999999998 112.019 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.43 -34.76 76.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.802 0.334 . . . . 74.200000000000003 111.74 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.56 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.592 -0.276 . . . . 62.310000000000002 111.718 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -54.19 -49.36 60.0 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.546 -0.359 . . . . 72.209999999999994 113.558 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 55.4 m -59.79 -40.93 89.97 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.849 0.357 . . . . 72.0 111.431 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.47 -42.95 99.57 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.923 0.392 . . . . 74.120000000000005 111.365 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.77 0.319 . . . . 75.120000000000005 110.979 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.28 93.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.832 -0.699 . . . . 63.329999999999998 112.509 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 136' ' ' THR . 83.8 mt-30 -67.93 -23.82 65.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.039 0.447 . . . . 74.340000000000003 111.398 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.56 -44.81 77.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.216 0.531 . . . . 74.129999999999995 110.755 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.6 -50.24 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.97 -0.559 . . . . 73.010000000000005 111.857 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.459 HG21 ' HA ' ' A' ' 140' ' ' GLN . 8.9 t -61.36 -33.52 73.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.669 0.271 . . . . 75.019999999999996 111.728 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -56.88 -46.75 81.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.078 0.466 . . . . 63.329999999999998 110.972 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.61 -29.83 62.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.125 -0.488 . . . . 72.439999999999998 111.351 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -86.84 -34.22 19.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.237 -0.438 . . . . 63.409999999999997 112.172 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.4 tp -151.39 -86.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.544 0.572 . . . . 72.329999999999998 112.544 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.23 -70.64 0.36 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.391 0.615 . . . . 75.439999999999998 111.375 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 6.2 t60 -157.82 -51.2 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.863 -0.608 . . . . 71.099999999999994 110.074 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 149' ' ' HIS . 44.8 t-80 175.85 84.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.748 -0.66 . . . . 74.549999999999997 109.847 175.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -72.73 83.42 1.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.166 0.508 . . . . 72.129999999999995 112.166 -173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -159.05 158.36 32.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.548 0.739 . . . . 73.209999999999994 110.107 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.16 149.09 38.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.182 0.515 . . . . 72.109999999999999 112.218 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 . . . . . 0 C--O 1.254 1.332 0 CA-C-O 118.577 -0.725 . . . . 63.210000000000001 109.705 169.704 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 65.6 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.497 0.189 . . . . 72.430000000000007 111.288 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 142' ' ' VAL . 48.9 mm 60.26 89.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.113 0.482 . . . . 74.349999999999994 111.862 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.63 90.11 1.61 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.963 -0.637 . . . . 72.329999999999998 112.278 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.0 p -82.06 120.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.481 0.658 . . . . 65.319999999999993 112.154 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -95.13 126.99 40.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.625 -0.716 . . . . 74.109999999999999 111.197 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 5.3 p90 -159.37 -178.91 7.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.831 0.348 . . . . 73.530000000000001 110.968 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.48 106.18 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.266 0.555 . . . . 74.409999999999997 111.761 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.9 m -70.34 -24.27 62.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.052 0.389 . . . . 71.109999999999999 112.052 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.99 -47.38 77.81 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.145 0.498 . . . . 73.129999999999995 111.43 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -102.71 22.3 13.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.586 0.708 . . . . 72.310000000000002 109.274 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -30.33 91.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 117.392 1.717 . . . . 62.310000000000002 117.392 -170.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -104.69 -34.13 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.79 . . . . 65.129999999999995 109.675 156.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.3 m -79.75 -12.98 59.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.033 -0.985 . . . . 75.430000000000007 112.901 -174.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.36 -39.09 92.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.038 0.447 . . . . 53.509999999999998 111.069 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -70.85 -38.34 73.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.215 0.531 . . . . 74.140000000000001 110.806 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -61.63 -44.53 96.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.961 -0.563 . . . . 75.239999999999995 110.959 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.46 87.42 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.054 -0.521 . . . . 71.310000000000002 111.346 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.07 -42.78 86.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.376 -0.374 . . . . 53.009999999999998 111.232 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.42 89.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.459 . . . . 73.299999999999997 111.115 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.96 -51.24 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.073 -0.512 . . . . 73.040000000000006 110.989 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HA ' HG23 ' A' ' 31' ' ' VAL . 76.3 mt -55.21 -43.06 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.264 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.41 -33.1 73.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.104 0.478 . . . . 73.540000000000006 111.603 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.02 23.4 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.34 -0.457 . . . . 75.519999999999996 113.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.33 -50.54 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.42 0.526 . . . . 61.25 112.42 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.5 p -63.5 -37.39 87.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.319 0.488 . . . . 75.230000000000004 112.319 -175.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.553 ' HZ1' ' HB3' ' A' ' 26' ' ' LYS . 6.9 ttpm? -65.05 -24.0 67.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.048 0.452 . . . . 74.140000000000001 111.213 177.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 m -81.31 -7.69 59.61 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.169 0.509 . . . . 64.329999999999998 111.185 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.93 13.79 35.97 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.124 -0.56 . . . . 63.049999999999997 113.846 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -116.95 128.36 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.449 -0.442 . . . . 64.319999999999993 111.175 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.41 30.48 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.039 -0.601 . . . . 72.030000000000001 113.225 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 1' ' ' SER . 49.0 t -109.56 141.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.794 -0.239 . . . . 54.539999999999999 111.516 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.52 117.98 34.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.087 0.47 . . . . 64.120000000000005 111.305 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 34.3 m -95.18 135.24 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.95 0.405 . . . . 65.549999999999997 111.724 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.38 104.84 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.012 0.434 . . . . 72.049999999999997 111.592 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 2.7 m-20 -78.8 92.53 4.85 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.954 0.407 . . . . 51.210000000000001 111.392 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.583 HD13 HD11 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -68.21 -13.02 61.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.892 0.377 . . . . 73.109999999999999 111.862 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.405 ' N ' HD11 ' A' ' 36' ' ' LEU . . . -84.51 -8.09 83.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.132 -0.556 . . . . 73.129999999999995 113.016 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.42 172.69 6.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.091 0.472 . . . . 50.229999999999997 111.8 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.32 82.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.076 0.465 . . . . 70.299999999999997 111.399 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.26 162.7 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 72.25 112.145 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.69 167.12 22.03 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.317 -0.401 . . . . 71.299999999999997 110.779 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 HD12 HD11 ' A' ' 45' ' ' LEU . 3.9 mm? -59.55 -25.54 64.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.321 -0.237 . . . . 72.209999999999994 111.441 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -55.96 -34.37 65.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.02 0.438 . . . . 71.439999999999998 110.98 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -84.38 -50.08 8.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.389 0.614 . . . . 42.25 110.63 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.508 HD11 HD12 ' A' ' 42' ' ' LEU . 89.8 mt -56.62 -31.6 64.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.835 -0.62 . . . . 74.120000000000005 112.391 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -63.32 -46.41 86.79 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.961 0.41 . . . . 75.209999999999994 110.866 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 60.3 tt0 -63.11 -34.79 78.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.002 0.429 . . . . 74.239999999999995 110.497 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 54.4 tp -52.19 -45.34 65.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.08 -0.509 . . . . 63.539999999999999 111.177 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.29 -38.3 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.108 0.48 . . . . 75.5 111.077 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.84 -29.97 66.54 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.126 -0.559 . . . . 36.149999999999999 112.961 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.466 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 3.5 mpt_? -89.13 5.25 45.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.981 0.363 . . . . 62.409999999999997 111.981 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -51.36 -27.85 10.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.888 0.699 . . . . 74.310000000000002 112.888 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.3 p -53.77 -38.6 64.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.122 0.415 . . . . 70.129999999999995 112.122 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.24 134.84 4.71 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.895 -0.669 . . . . 54.43 113.039 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.46 ' HB2' HG13 ' A' ' 85' ' ' VAL . 80.7 mt -137.93 174.75 10.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.878 0.471 . . . . 74.140000000000001 110.712 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 48.5 t -139.76 111.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 110.325 -0.25 . . . . 74.109999999999999 110.325 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.625 HD11 ' HB ' ' A' ' 85' ' ' VAL . 1.7 mp -91.93 128.41 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.643 0.609 . . . . 72.329999999999998 112.643 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.35 139.86 11.3 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 115.636 -0.711 . . . . 63.509999999999998 112.142 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 98' ' ' ILE . 72.7 mtm -82.8 161.5 21.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.037 0.446 . . . . 72.109999999999999 111.777 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -143.6 164.27 31.53 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.1 0.407 . . . . 61.530000000000001 112.1 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.644 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 53.0 Cg_exo -55.51 168.23 1.64 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.063 2.509 . . . . 61.32 113.804 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -50.76 47.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.24 0.83 . . . . 72.049999999999997 113.24 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.18 66.51 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.942 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.4 m -58.39 -49.35 77.55 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.058 0.456 . . . . 74.430000000000007 111.236 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HA ' HD13 ' A' ' 68' ' ' ILE . . . -57.97 -35.39 71.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.245 -0.434 . . . . 71.439999999999998 112.0 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.16 96.54 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.019 0.437 . . . . 63.340000000000003 111.14 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -66.08 -42.15 89.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.384 -0.371 . . . . 74.040000000000006 111.096 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.583 HD11 HD13 ' A' ' 36' ' ' LEU . 67.3 mt -54.8 -54.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.073 0.463 . . . . 71.409999999999997 111.113 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.9 -30.9 69.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.013 -0.539 . . . . 74.010000000000005 111.53 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.12 -41.59 98.38 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.239 -0.505 . . . . 62.32 113.379 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.53 43.37 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.238 0.458 . . . . 52.039999999999999 112.238 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.25 -35.89 65.46 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.597 0.591 . . . . 74.109999999999999 112.597 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -56.97 -20.07 21.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.713 0.634 . . . . 71.340000000000003 112.713 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -100.42 -10.83 20.75 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.102 0.477 . . . . 70.219999999999999 111.714 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.3 mt -92.58 -46.82 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.198 0.444 . . . . 55.5 112.198 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -50.85 -54.99 19.2 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.969 0.729 . . . . 75.239999999999995 112.969 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.06 5.49 1.95 Allowed Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.033 0.773 . . . . 60.219999999999999 115.033 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.9 m -92.47 -12.65 31.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.87 0.835 . . . . 63.240000000000002 112.247 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.444 HG22 HD23 ' A' ' 110' ' ' LEU . 11.3 m -136.46 129.36 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.927 0.714 . . . . 63.420000000000002 112.927 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.526 ' H ' ' NE2' ' A' ' 83' ' ' GLN . 30.8 p-10 -162.02 -174.22 4.03 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.04 -0.527 . . . . 73.439999999999998 111.074 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 60.69 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.907 1.076 . . . . 54.210000000000001 113.907 170.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' A' ' 145' ' ' ASP . 21.3 ptmt -141.02 -5.01 1.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.189 0.811 . . . . 62.439999999999998 113.189 -172.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.526 ' NE2' ' H ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -53.88 127.22 25.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.999 0.428 . . . . 63.509999999999998 111.273 -178.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.507 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.43 140.76 29.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.671 0.619 . . . . 63.32 112.671 -171.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.625 ' HB ' HD11 ' A' ' 57' ' ' ILE . 17.8 m -131.97 109.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.551 0.691 . . . . 74.510000000000005 111.71 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -69.81 146.98 44.24 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.97 -0.559 . . . . 65.129999999999995 112.566 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 115' ' ' PRO . 49.9 mm -125.54 121.89 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 122.67 -0.312 . . . . 64.150000000000006 111.1 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.579 ' HB2' ' SG ' ' A' ' 131' ' ' CYS . 34.7 p90 -120.04 126.48 50.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.419 . . . . 75.030000000000001 110.411 175.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.44 133.28 50.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.103 0.478 . . . . 74.549999999999997 111.96 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -156.28 -22.6 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.097 -0.501 . . . . 72.409999999999997 111.419 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.41 -60.03 3.64 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.005 -0.617 . . . . 53.229999999999997 113.138 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.11 -76.64 1.32 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.208 -0.52 . . . . 62.329999999999998 113.55 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 173.65 -65.61 0.11 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.642 -0.789 . . . . 62.039999999999999 113.439 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.41 111.79 22.75 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.279 0.562 . . . . 62.450000000000003 110.446 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.09 15.07 14.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.695 0.628 . . . . 75.519999999999996 112.695 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -91.04 -50.5 0.33 Allowed Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.35 0.87 . . . . 64.030000000000001 113.35 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.97 -2.39 10.96 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.163 1.909 . . . . 72.299999999999997 113.61 -174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.434 HD11 ' SD ' ' A' ' 59' ' ' MET . 10.9 tt -72.04 -26.07 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.831 0.348 . . . . 75.540000000000006 111.785 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.94 -53.83 56.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 112.852 0.686 . . . . 61.43 112.852 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 -29.4 35.89 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.674 1.583 . . . . 72.349999999999994 112.461 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.89 -48.63 79.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.181 -0.463 . . . . 72.150000000000006 111.279 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.04 -23.33 65.36 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.423 0.527 . . . . 74.25 112.423 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.9 t -100.68 -71.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.096 0.776 . . . . 74.150000000000006 113.096 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.54 -41.49 69.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.557 0.947 . . . . 52.439999999999998 113.557 -166.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.414 ' HD2' HD22 ' A' ' 110' ' ' LEU . 66.8 m-85 -59.39 -26.51 65.19 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.058 0.392 . . . . 72.329999999999998 112.058 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.0 mtm105 -70.7 -34.18 71.69 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.11 0.481 . . . . 75.439999999999998 110.749 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.7 -33.96 73.25 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.11 -0.495 . . . . 72.349999999999994 111.367 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.97 -34.68 78.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.868 0.366 . . . . 62.109999999999999 111.365 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.48 5.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.072 -0.585 . . . . 64.319999999999993 113.983 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 85' ' ' VAL . 8.7 mp -74.65 122.81 23.77 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.217 -0.578 . . . . 65.319999999999993 111.158 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.507 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 34.9 m -74.46 94.13 2.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.897 0.379 . . . . 63.210000000000001 110.717 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.3 p -76.86 149.1 36.16 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.283 0.564 . . . . 61.420000000000002 112.367 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.472 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -76.73 -66.98 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.131 -0.486 . . . . 61.530000000000001 111.208 174.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -170.18 88.92 0.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 120.875 0.369 . . . . 71.420000000000002 111.106 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.498 ' HA ' HG21 ' A' ' 87' ' ' ILE . 85.7 Cg_endo -90.46 100.57 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.851 2.367 . . . . 72.129999999999995 113.284 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 110.7 5.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.57 -0.286 . . . . 71.329999999999998 111.225 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.67 94.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.61 0.719 . . . . 74.510000000000005 112.75 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -107.12 -14.49 14.91 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.987 -0.551 . . . . 72.540000000000006 111.987 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 122' ' ' THR . 9.3 tp -84.37 156.16 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.49 0.662 . . . . 72.129999999999995 112.536 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.687 ' HD2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -92.91 -39.34 11.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.738 -0.665 . . . . 64.530000000000001 110.158 171.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 177.01 -59.0 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.644 0.777 . . . . 72.430000000000007 110.245 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.462 ' O ' HD13 ' A' ' 119' ' ' ILE . 82.3 p -80.5 118.72 73.74 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 116.447 -0.342 . . . . 74.439999999999998 111.385 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.56 146.62 68.27 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.476 2.117 . . . . 65.129999999999995 113.295 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.3 p -99.16 179.31 4.64 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.891 0.377 . . . . 73.329999999999998 111.592 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.18 -32.73 72.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.047 0.451 . . . . 65.329999999999998 111.14 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -57.42 -35.59 70.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 110.956 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.6 m -62.55 -39.03 92.31 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.496 -0.32 . . . . 71.239999999999995 111.491 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -60.17 -47.47 85.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.04 0.448 . . . . 73.140000000000001 111.04 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -65.96 -38.39 88.43 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.115 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.58 -52.63 64.83 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 72.200000000000003 110.53 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 88' ' ' PHE . 83.0 m -60.62 -41.08 94.11 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.886 0.374 . . . . 64.109999999999999 111.511 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -55.74 -45.02 78.08 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.204 0.526 . . . . 54.219999999999999 111.295 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.25 -41.66 40.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.004 -0.544 . . . . 74.219999999999999 111.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.8 80.25 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.051 0.389 . . . . 73.299999999999997 112.051 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.19 -47.29 91.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.021 -0.609 . . . . 53.310000000000002 112.918 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 94.1 m -60.46 -45.8 92.37 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.849 0.357 . . . . 75.409999999999997 111.403 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.62 -45.07 90.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.284 -0.416 . . . . 75.439999999999998 111.411 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.53 -42.93 91.44 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.815 0.34 . . . . 72.310000000000002 111.29 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.21 -36.27 61.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.261 -0.495 . . . . 72.430000000000007 112.869 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 136' ' ' THR . 77.5 mt-30 -57.86 -45.48 86.24 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 72.120000000000005 111.165 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -62.7 -49.28 75.73 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.409 -0.36 . . . . 74.299999999999997 111.192 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.43 HG21 HD13 ' A' ' 2' ' ' ILE . 63.7 t -53.73 -56.64 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.325 0.491 . . . . 62.310000000000002 112.325 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -65.13 -40.22 94.15 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.218 0.451 . . . . 71.239999999999995 112.218 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -75.01 -35.43 61.99 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.942 0.349 . . . . 72.319999999999993 111.942 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 82' ' ' LYS . 17.6 t70 -74.08 -44.26 54.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 75.239999999999995 110.672 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -58.14 -42.36 85.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.085 -0.507 . . . . 64.120000000000005 111.206 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -77.74 -60.13 2.5 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.091 -0.504 . . . . 72.099999999999994 110.228 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.55 91.33 0.07 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.448 0.699 . . . . 71.340000000000003 111.581 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -112.62 9.77 19.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.519 0.676 . . . . 73.040000000000006 110.808 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -169.82 107.9 0.38 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.638 -0.71 . . . . 64.219999999999999 109.747 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -69.36 -66.82 0.53 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.395 -0.366 . . . . 75.310000000000002 111.88 -172.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 60.73 -178.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.282 0.475 . . . . 72.400000000000006 112.282 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 78.1 t60 69.73 -59.18 0.51 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.294 0.638 . . . . 72.430000000000007 111.617 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.913 -0.565 . . . . 63.420000000000002 111.081 175.357 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.548 0.203 . . . . 63.32 111.548 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 44.3 mm 55.82 93.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 112.688 0.625 . . . . 72.540000000000006 112.688 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.09 109.89 3.81 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.563 -0.827 . . . . 70.200000000000003 113.318 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 32' ' ' ASP . 7.1 p -88.66 111.46 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.527 0.679 . . . . 51.409999999999997 111.747 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -89.31 96.66 10.81 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.757 -0.656 . . . . 74.019999999999996 111.117 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 25.6 p90 -122.04 -177.89 3.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.994 -0.548 . . . . 73.329999999999998 110.358 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.17 93.93 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.413 0.625 . . . . 71.230000000000004 111.893 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 18.2 m -57.13 -27.09 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.379 0.609 . . . . 63.229999999999997 110.955 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.28 -23.06 64.71 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.324 -0.853 . . . . 75.140000000000001 112.598 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -142.73 144.8 32.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.488 0.661 . . . . 74.019999999999996 112.662 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.39 -162.8 6.2 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.385 -0.825 . . . . 72.239999999999995 114.894 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -94.24 6.59 48.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.105 0.409 . . . . 75.25 112.105 -175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.463 ' HA ' HD12 ' A' ' 16' ' ' LEU . 60.4 p -51.13 -34.07 29.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.244 0.461 . . . . 72.439999999999998 112.244 -173.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 13.5 t70 -58.31 -56.28 24.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.016 0.436 . . . . 65.209999999999994 111.193 174.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -65.69 -27.84 68.64 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.528 -0.305 . . . . 74.409999999999997 111.516 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 13' ' ' SER . 90.3 mt -67.41 -43.41 81.32 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 52.020000000000003 110.382 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.02 85.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.112 -0.495 . . . . 73.200000000000003 110.805 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -57.63 -45.99 84.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.963 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.49 -43.65 89.09 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 62.530000000000001 111.27 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.538 HD11 HG13 ' A' ' 56' ' ' VAL . 67.1 mt -59.0 -57.71 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.93 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.55 -35.29 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 111.609 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -60.08 -53.47 57.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.713 0.292 . . . . 75.129999999999995 111.129 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.38 97.85 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.558 . . . . 74.040000000000006 112.933 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.685 HG21 ' HB ' ' A' ' 29' ' ' VAL . 36.7 mm -61.47 -47.23 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.916 0.388 . . . . 75.519999999999996 111.889 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 p -70.29 -31.73 69.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.741 0.305 . . . . 72.239999999999995 111.426 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.651 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -64.43 -42.17 96.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.854 0.359 . . . . 75.409999999999997 110.8 174.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -69.6 -51.73 32.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.335 -0.393 . . . . 72.239999999999995 111.134 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.82 53.95 0.13 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.443 -0.344 . . . . 70.129999999999995 113.162 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.685 ' HB ' HG21 ' A' ' 24' ' ' ILE . 46.2 t -139.7 157.82 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.419 0.288 . . . . 65.439999999999998 110.643 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.26 150.19 17.26 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 121.275 -0.488 . . . . 71.329999999999998 113.338 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 24' ' ' ILE . 97.1 t -131.07 145.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.625 0.602 . . . . 75.510000000000005 112.625 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' HG13 ' A' ' 4' ' ' VAL . 29.0 m-20 -93.29 142.83 26.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.982 -0.554 . . . . 74.519999999999996 111.126 171.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -110.02 131.08 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.815 0.34 . . . . 70.200000000000003 111.873 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.17 131.44 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 120.702 0.287 . . . . 70.540000000000006 111.465 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.6 m-20 -95.67 105.42 17.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.679 0.276 . . . . 74.540000000000006 111.17 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.47 -14.29 62.8 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.928 0.394 . . . . 75.200000000000003 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.18 30.86 7.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.372 -0.442 . . . . 73.200000000000003 112.93 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.07 174.83 10.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.881 0.372 . . . . 74.040000000000006 111.508 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.04 93.85 0.3 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.518 0.562 . . . . 73.099999999999994 112.518 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.61 174.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.42 -0.355 . . . . 74.340000000000003 111.336 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -145.46 172.2 13.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.001 0.429 . . . . 53.439999999999998 111.386 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.2 tm? -54.48 -29.56 50.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.769 0.427 . . . . 71.420000000000002 110.735 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -52.82 -48.02 67.27 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 111.986 0.365 . . . . 74.299999999999997 111.986 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.93 -38.05 78.08 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.868 0.366 . . . . 62.100000000000001 111.146 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.9 -43.67 82.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.835 0.35 . . . . 60.130000000000003 110.79 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.59 -50.43 73.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.712 0.291 . . . . 73.230000000000004 111.33 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.92 -30.39 71.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.052 0.453 . . . . 74.400000000000006 110.901 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.649 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 53.2 tp -58.92 -29.84 67.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.558 -0.292 . . . . 63.329999999999998 111.587 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.74 -33.42 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.194 0.521 . . . . 74.420000000000002 110.519 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.05 -31.65 11.77 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.003 -0.544 . . . . 74.310000000000002 112.469 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.649 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 99.7 mtt180 -73.47 -10.78 60.08 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.516 -0.403 . . . . 73.5 111.974 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -60.99 -10.79 6.37 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.768 0.285 . . . . 74.209999999999994 111.768 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.502 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 67.9 p -71.5 -28.61 64.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.429 . . . . 73.219999999999999 111.586 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -173.11 137.35 4.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.221 -0.445 . . . . 74.200000000000003 112.642 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' HD11 ' A' ' 57' ' ' ILE . 1.6 pt? -157.62 148.61 21.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.154 0.502 . . . . 63.140000000000001 111.806 -177.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.538 HG13 HD11 ' A' ' 20' ' ' ILE . 59.8 t -116.6 113.27 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 122.838 0.455 . . . . 73.239999999999995 111.03 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.564 HD11 ' HG ' ' A' ' 55' ' ' LEU . 3.3 mp -116.42 146.33 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 122.07 -0.394 . . . . 75.150000000000006 111.887 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -134.93 3.56 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.178 -0.534 . . . . 73.430000000000007 112.921 173.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.654 ' HE1' ' HA ' ' A' ' 59' ' ' MET . 4.8 mmt -122.5 156.23 34.54 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.44 -0.447 . . . . 51.109999999999999 111.11 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.8 p -97.9 113.54 63.86 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.327 -0.397 . . . . 64.409999999999997 111.924 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.45 146.05 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.864 2.376 . . . . 73.329999999999998 112.773 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.54 -24.96 2.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.988 0.736 . . . . 54.039999999999999 112.988 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.8 74.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.13 0.418 . . . . 53.439999999999998 112.13 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.0 p -100.0 4.43 44.81 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.788 0.292 . . . . 63.439999999999998 111.788 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.84 -31.01 10.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.497 0.555 . . . . 62.020000000000003 112.497 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.9 72.21 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.089 0.471 . . . . 38.990000000000002 111.695 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.1 t -65.17 -45.43 84.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.078 0.466 . . . . 73.150000000000006 110.874 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 50.4 mm -54.6 -52.95 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.912 -0.585 . . . . 70.230000000000004 111.657 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.14 -38.85 89.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.919 0.34 . . . . 74.409999999999997 111.919 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.82 -40.38 98.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.177 -0.535 . . . . 71.310000000000002 113.207 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -85.32 -44.4 12.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.314 0.487 . . . . 75.230000000000004 112.314 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 68' ' ' ILE . 1.4 tm? -53.45 -42.99 67.71 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.592 0.357 . . . . 75.319999999999993 111.57 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -51.16 -34.28 30.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.814 0.34 . . . . 63.140000000000001 111.864 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.3 m -89.93 -39.74 12.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.214 0.53 . . . . 63.43 111.21 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 HD21 ' A' ' 48' ' ' LEU . 72.1 mt -54.58 -41.41 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 111.733 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.94 -33.21 62.02 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.296 -0.411 . . . . 75.030000000000001 111.834 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.19 -31.73 33.72 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.137 -0.554 . . . . 71.049999999999997 112.902 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.8 m -72.7 -39.44 67.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.121 0.415 . . . . 73.109999999999999 112.121 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.0 m -87.91 147.34 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.02 0.438 . . . . 73.109999999999999 111.568 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.586 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -160.94 -179.02 7.2 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.136 0.421 . . . . 55.140000000000001 112.136 -178.024 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.689 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 9.4 tp10 72.2 -106.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.886 0.874 . . . . 70.310000000000002 112.71 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.689 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 19.2 ptpt -164.98 24.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.417 0.895 . . . . 64.209999999999994 113.417 -172.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 53' ' ' THR . 1.3 mp0 -62.08 167.85 3.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.754 0.65 . . . . 70.329999999999998 112.754 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.94 123.92 34.81 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.77 -0.65 . . . . 75.519999999999996 112.349 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.74 108.53 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.493 0.663 . . . . 75.219999999999999 111.025 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 81.43 0.33 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.089 -0.505 . . . . 63.299999999999997 112.774 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 49.5 mm -79.53 109.08 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 122.568 -0.372 . . . . 75.329999999999998 111.391 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -105.27 111.63 24.44 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.354 0.597 . . . . 74.299999999999997 110.555 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.791 ' HB2' HD12 ' A' ' 119' ' ' ILE . 7.7 pt-20 -57.9 104.05 0.17 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.488 0.661 . . . . 64.25 112.703 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 90.6 m -142.34 112.78 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.131 -0.486 . . . . 53.420000000000002 111.534 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.52 -139.77 15.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.192 -0.528 . . . . 64.400000000000006 113.481 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.04 -102.44 2.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.066 -0.587 . . . . 75.430000000000007 113.359 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.22 -96.18 0.54 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.22 -0.514 . . . . 70.200000000000003 112.46 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -106.89 123.65 48.47 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.559 -0.377 . . . . 73.319999999999993 110.282 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.63 159.1 44.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 65.340000000000003 111.211 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 37.9 mt-10 -103.91 -55.93 0.1 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.922 0.712 . . . . 74.310000000000002 112.922 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.517 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 39.3 Cg_endo -64.7 -14.59 45.55 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.287 1.991 . . . . 71.439999999999998 114.014 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.9 tt -49.12 -51.86 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 113.26 0.837 . . . . 74.319999999999993 113.26 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.683 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 4.5 m-20 -61.53 -55.44 42.68 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.189 0.44 . . . . 75.219999999999999 112.189 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.7 Cg_exo -56.25 -33.35 90.69 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.009 1.806 . . . . 74.239999999999995 112.705 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.64 -57.06 7.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.06 -0.518 . . . . 74.310000000000002 111.479 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.33 -37.79 67.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.988 0.423 . . . . 63.210000000000001 110.862 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 100' ' ' PRO . 6.3 t -49.99 -43.33 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.616 . . . . 72.430000000000007 111.727 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.699 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -64.55 -44.21 91.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.646 -0.252 . . . . 74.230000000000004 111.16 -177.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -60.68 -36.89 79.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.87 0.366 . . . . 72.120000000000005 111.223 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -66.85 -60.77 2.37 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.159 -0.473 . . . . 74.319999999999993 111.698 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -60.61 -39.31 87.68 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.302 0.482 . . . . 63.439999999999998 112.302 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.58 -24.43 49.76 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.205 -0.309 . . . . 72.430000000000007 111.569 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.65 52.59 33.27 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.155 -0.545 . . . . 62.100000000000001 113.04 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.32 159.9 20.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.97 0.414 . . . . 73.129999999999995 111.535 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 88.2 m -79.63 110.02 14.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 73.409999999999997 110.77 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -108.52 141.57 40.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.44 0.533 . . . . 72.420000000000002 112.44 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.31 -86.13 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.418 -0.355 . . . . 74.510000000000005 111.131 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -148.63 96.42 3.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 121.104 0.478 . . . . 72.010000000000005 111.507 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.31 13.47 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.854 2.369 . . . . 73.519999999999996 113.193 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.2 78.01 2.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.285 0.564 . . . . 74.129999999999995 111.441 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.401 HG13 HD13 ' A' ' 119' ' ' ILE . 8.8 tt -62.5 112.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 113.175 0.806 . . . . 73.129999999999995 113.175 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -140.44 49.87 1.71 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.132 0.492 . . . . 74.239999999999995 111.259 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.791 HD12 ' HB2' ' A' ' 89' ' ' GLU . 3.3 mp -89.66 116.31 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 110.957 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.96 -41.81 75.28 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.842 0.353 . . . . 72.030000000000001 111.933 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -178.38 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.432 0.634 . . . . 72.340000000000003 109.997 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -127.06 142.52 43.99 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.862 -0.608 . . . . 72.230000000000004 110.679 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.98 148.36 91.63 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.631 2.221 . . . . 63.32 113.097 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.6 p -90.26 -178.68 5.45 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.158 0.504 . . . . 63.310000000000002 112.057 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.23 -42.48 69.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.023 -0.535 . . . . 72.230000000000004 111.718 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -59.99 -39.95 87.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 112.042 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.8 m -51.78 -30.75 24.21 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.983 0.364 . . . . 74.200000000000003 111.983 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -58.24 -41.01 83.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.717 0.294 . . . . 72.209999999999994 111.733 176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.643 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 53.3 mttm -82.94 -26.73 31.12 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.978 0.362 . . . . 71.510000000000005 111.978 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 -41.73 91.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.769 0.319 . . . . 75.209999999999994 110.862 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 30.3 p -81.63 -37.15 28.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.629 0.252 . . . . 73.530000000000001 111.105 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.643 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.7 tt0 -51.62 -71.32 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.01 0.524 . . . . 74.5 112.283 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -67.07 -38.61 86.08 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.465 0.542 . . . . 65.219999999999999 112.465 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.31 -54.44 37.03 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.806 0.336 . . . . 71.400000000000006 111.337 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.28 -43.67 97.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.935 -0.65 . . . . 42.030000000000001 112.641 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.446 HG22 HE21 ' A' ' 140' ' ' GLN . 86.7 m -64.66 -42.97 95.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.79 0.293 . . . . 75.310000000000002 111.79 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.83 -44.69 92.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.867 0.365 . . . . 55.399999999999999 110.781 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.13 -39.01 84.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.949 0.404 . . . . 72.099999999999994 110.83 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.67 -43.01 98.13 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.093 -0.575 . . . . 72.209999999999994 112.309 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.446 HE21 HG22 ' A' ' 136' ' ' THR . 78.5 mt-30 -62.89 -34.91 78.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.661 0.267 . . . . 72.019999999999996 111.059 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -63.09 -42.54 99.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.921 0.391 . . . . 72.420000000000002 110.653 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.04 -49.93 77.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.973 0.416 . . . . 62.140000000000001 111.2 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 149' ' ' HIS . 4.9 t -77.86 -11.44 59.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.576 -0.284 . . . . 74.329999999999998 111.609 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -72.64 -61.54 1.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.076 0.465 . . . . 71.530000000000001 110.577 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.93 -40.02 96.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.824 -0.625 . . . . 63.25 111.704 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -75.66 -38.88 58.43 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.927 0.343 . . . . 73.420000000000002 111.927 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 3.1 mm? -113.0 -89.0 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.648 0.261 . . . . 72.200000000000003 111.248 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 13.3 mt-10 -156.84 -59.71 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.233 0.613 . . . . 73.349999999999994 110.239 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.46 ' O ' HG23 ' A' ' 143' ' ' THR . 17.7 t-80 -153.1 -48.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.056 -0.52 . . . . 73.319999999999993 110.479 169.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -177.49 93.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 111.286 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 77.5 t60 66.76 151.41 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.319 0.581 . . . . 75.310000000000002 112.344 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -75.4 134.65 40.88 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.318 0.58 . . . . 73.109999999999999 112.395 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -155.44 -101.59 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.727 -0.669 . . . . 75.530000000000001 110.054 174.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 20.7 p80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 119.311 -0.376 . . . . 73.310000000000002 110.611 164.837 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.576 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.311 0.101 . . . . 74.129999999999995 111.244 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.74 HG13 ' HA2' ' A' ' 139' ' ' GLY . 45.4 mm 67.14 122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 71.239999999999995 112.561 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.92 109.22 3.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.132 -0.556 . . . . 55.100000000000001 112.703 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.23 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.634 -0.333 . . . . 71.340000000000003 111.57 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 97.1 m-85 -86.87 120.64 28.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.898 0.38 . . . . 75.140000000000001 111.233 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 1.3 p90 -150.32 -179.9 7.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.393 -0.367 . . . . 73.519999999999996 110.924 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.7 t -133.49 110.62 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.68 -0.236 . . . . 64.25 110.522 173.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.55 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 40.8 t -51.95 -33.48 37.73 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.404 0.52 . . . . 71.209999999999994 112.404 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -85.18 -12.6 52.31 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.711 0.634 . . . . 73.420000000000002 112.711 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -98.62 90.85 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.778 -0.576 . . . . 73.200000000000003 112.121 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.88 -162.03 4.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 115.067 0.787 . . . . 45.329999999999998 115.067 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.458 ' HB2' ' HB2' ' A' ' 123' ' ' PRO . 39.4 m-85 -68.15 1.6 2.71 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.813 0.672 . . . . 64.230000000000004 112.813 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -54.63 -33.61 60.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.428 0.632 . . . . 74.25 110.581 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 23.6 t70 -59.66 -37.24 78.21 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.294 -0.866 . . . . 53.240000000000002 111.878 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -85.26 -26.73 26.46 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.182 -0.463 . . . . 73.5 111.904 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -55.62 -46.25 77.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 44.43 111.474 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.28 -54.29 47.16 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.243 0.46 . . . . 74.510000000000005 112.243 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.437 ' HA ' HG23 ' A' ' 21' ' ' ILE . 35.0 tt0 -67.25 -36.37 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.557 -0.292 . . . . 72.400000000000006 111.578 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.74 86.74 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.784 0.326 . . . . 74.310000000000002 111.689 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.76 -55.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.784 0.326 . . . . 64.0 111.533 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 18' ' ' GLN . 13.4 tt -60.55 -30.05 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.626 0.25 . . . . 74.109999999999999 111.315 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -53.42 -35.3 60.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.213 0.53 . . . . 63.5 111.32 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.35 -33.92 6.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.156 -0.545 . . . . 75.219999999999999 113.437 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.81 -24.46 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.129 0.789 . . . . 72.109999999999999 113.129 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -53.6 -33.37 54.67 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.404 0.52 . . . . 72.200000000000003 112.404 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.82 -18.45 60.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.282 0.475 . . . . 74.439999999999998 112.282 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.0 m -84.28 -15.93 44.94 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.205 0.526 . . . . 64.329999999999998 111.308 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.85 2.99 57.16 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.385 -0.435 . . . . 54.030000000000001 112.928 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -98.67 104.57 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.046 0.45 . . . . 75.549999999999997 111.299 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.23 128.54 9.55 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.133 -0.556 . . . . 74.430000000000007 112.427 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.2 m -90.54 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.1 0.476 . . . . 71.430000000000007 111.911 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.2 104.83 16.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.034 0.445 . . . . 74.5 111.069 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.51 ' HB ' ' CE1' ' A' ' 6' ' ' TYR . 35.8 m -83.2 139.53 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.121 0.486 . . . . 74.409999999999997 112.285 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.4 t -139.09 118.4 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.382 -0.372 . . . . 72.140000000000001 111.401 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.54 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.9 m-20 -76.32 91.65 3.26 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.344 -0.222 . . . . 62.450000000000003 111.067 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 36' ' ' LEU . 2.5 pt? -59.79 -20.69 58.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.887 0.375 . . . . 55.32 111.963 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 12.58 66.94 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.29 -0.481 . . . . 72.040000000000006 113.39 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -161.51 -65.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.921 0.391 . . . . 75.150000000000006 111.916 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.65 77.82 4.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.132 0.491 . . . . 64.120000000000005 112.127 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.6 126.08 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.128 0.49 . . . . 62.210000000000001 111.807 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -163.78 170.9 16.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.134 -0.485 . . . . 55.32 110.172 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 42' ' ' LEU . 2.7 tm? -54.73 -37.28 65.7 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.598 0.237 . . . . 73.299999999999997 111.151 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -58.55 -57.31 13.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 75.319999999999993 111.404 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -61.28 -35.52 77.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.293 -0.412 . . . . 73.329999999999998 111.288 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.438 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 2.8 tm? -61.09 -42.07 97.83 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.02 0.438 . . . . 73.129999999999995 110.268 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -67.87 -43.29 79.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.875 0.369 . . . . 75.319999999999993 111.046 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.573 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 27.9 mt-10 -62.63 -25.74 68.27 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.749 0.278 . . . . 72.319999999999993 111.749 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 64.3 tp -57.44 -36.85 71.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 70.299999999999997 110.576 173.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.63 -35.93 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.085 0.469 . . . . 64.120000000000005 111.031 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.48 77.39 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.115 -0.564 . . . . 64.530000000000001 112.642 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.573 ' NH1' ' HB3' ' A' ' 47' ' ' GLU . 7.5 mpt_? -100.39 6.83 44.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.431 0.293 . . . . 74.329999999999998 111.581 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -54.4 -19.94 6.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.135 0.791 . . . . 72.209999999999994 113.135 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 p -70.92 -17.99 62.67 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.933 0.345 . . . . 60.32 111.933 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -169.68 137.76 4.68 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.886 -0.673 . . . . 51.439999999999998 113.744 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.87 143.17 20.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.063 0.459 . . . . 74.200000000000003 111.047 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.51 122.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 73.040000000000006 111.299 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -105.27 130.29 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.23 -0.441 . . . . 75.439999999999998 111.519 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 88' ' ' PHE . . . -80.15 56.72 4.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.019 -0.61 . . . . 71.0 112.709 175.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 90' ' ' THR . 24.8 mmt 65.41 173.04 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.444 0.64 . . . . 74.329999999999998 111.943 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.8 m -141.24 90.29 9.2 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 116.396 -0.365 . . . . 73.0 110.657 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.45 156.33 26.78 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.617 2.211 . . . . 73.430000000000007 113.258 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.98 -55.19 2.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.335 0.865 . . . . 64.510000000000005 113.335 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.97 67.75 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.305 0.483 . . . . 61.039999999999999 112.305 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -72.03 -40.74 68.22 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.774 0.321 . . . . 64.040000000000006 111.296 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.19 34.89 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.822 0.675 . . . . 75.140000000000001 112.822 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -59.58 4.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 65.140000000000001 112.29 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 t -65.11 -36.6 84.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.118 0.485 . . . . 45.43 111.482 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.498 HG22 ' HG ' ' A' ' 72' ' ' LEU . 56.2 mt -59.75 -33.31 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.924 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -53.24 -35.54 60.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.873 0.368 . . . . 62.140000000000001 111.894 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.95 -22.19 70.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.917 -0.658 . . . . 42.200000000000003 113.354 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.08 -31.45 11.06 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.57 0.581 . . . . 74.340000000000003 112.57 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.498 ' HG ' HG22 ' A' ' 68' ' ' ILE . 49.6 mt -49.94 -44.81 50.69 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.167 0.803 . . . . 71.049999999999997 113.167 -174.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 m -52.28 -35.67 50.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.953 0.353 . . . . 71.340000000000003 111.953 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -85.18 -45.26 12.19 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 73.230000000000004 111.286 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.24 -50.2 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.266 -0.424 . . . . 73.409999999999997 111.776 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.57 -22.87 62.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.766 0.317 . . . . 73.319999999999993 111.747 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.36 -15.28 41.6 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.253 -0.499 . . . . 55.030000000000001 112.983 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.8 m -89.29 -27.21 20.7 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.483 -0.422 . . . . 74.200000000000003 111.804 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.0 m -70.76 131.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.345 0.593 . . . . 63.149999999999999 112.073 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -82.74 170.49 15.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 71.519999999999996 110.786 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 44.2 tt0 -48.6 -35.05 12.74 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.75 0.648 . . . . 65.430000000000007 112.75 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -154.21 141.32 19.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.444 0.64 . . . . 73.120000000000005 112.423 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 -179.08 7.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.416 -0.811 . . . . 72.319999999999993 109.852 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' HB2' HD12 ' A' ' 138' ' ' LEU . . . -88.5 91.51 8.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.259 0.552 . . . . 73.439999999999998 111.691 -177.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.8 m -103.32 138.0 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.997 0.427 . . . . 74.209999999999994 111.198 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.57 164.63 25.67 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.985 -0.626 . . . . 52.310000000000002 113.177 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -135.44 145.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.72 0.408 . . . . 75.430000000000007 110.51 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.583 ' HB2' ' HA2' ' A' ' 58' ' ' GLY . 36.8 m-85 -99.21 129.18 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.708 0.29 . . . . 75.129999999999995 110.978 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' HB3' HG22 ' A' ' 117' ' ' ILE . 35.1 mp0 -70.2 80.29 0.52 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.239 0.542 . . . . 73.319999999999993 111.315 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.438 ' O ' ' HG3' ' A' ' 59' ' ' MET . 9.0 t -146.66 179.03 7.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.27 -0.423 . . . . 75.239999999999995 111.366 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 75.22 -72.12 1.69 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.336 -0.459 . . . . 72.230000000000004 113.736 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.32 -116.25 0.73 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.198 -0.525 . . . . 71.530000000000001 112.978 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.53 36.29 0.51 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.023 -0.608 . . . . 44.32 112.899 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.91 109.88 21.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.669 0.271 . . . . 73.420000000000002 111.391 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.06 157.27 25.86 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.406 -0.361 . . . . 74.310000000000002 111.622 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 2.8 mp0 -103.49 -55.78 0.1 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.227 0.825 . . . . 53.130000000000003 113.227 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 3.8 Cg_exo -77.26 16.92 0.94 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.703 2.269 . . . . 63.219999999999999 114.332 -176.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.524 HG23 ' H ' ' A' ' 99' ' ' ASP . 9.0 tt -44.36 -62.3 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 114.231 1.197 . . . . 75.409999999999997 114.231 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.524 ' H ' HG23 ' A' ' 98' ' ' ILE . 39.7 m-20 -62.72 -50.29 78.56 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.211 0.819 . . . . 72.109999999999999 113.211 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 63.8 Cg_exo -53.67 -43.22 59.7 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.373 2.049 . . . . 54.240000000000002 113.344 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.2 -44.72 68.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.572 0.225 . . . . 72.530000000000001 111.425 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.536 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 60.5 mt -56.05 -44.95 79.34 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.746 0.308 . . . . 54.509999999999998 110.985 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.2 t -56.91 -40.93 77.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.951 0.405 . . . . 74.519999999999996 110.951 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -39.69 78.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.403 -0.362 . . . . 74.230000000000004 111.185 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.635 ' HD1' HD11 ' A' ' 110' ' ' LEU . 29.4 m-85 -61.39 -32.46 72.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.568 0.223 . . . . 75.120000000000005 111.316 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 102' ' ' LEU . 2.1 mpt_? -73.92 -40.68 62.96 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.807 0.337 . . . . 55.399999999999999 111.111 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.63 -43.29 80.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.021 0.439 . . . . 72.349999999999994 111.426 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 81.2 mt -89.72 -41.76 11.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.031 0.443 . . . . 75.540000000000006 111.911 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 57.39 1.38 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.933 -0.467 . . . . 73.099999999999994 111.933 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.635 HD11 ' HD1' ' A' ' 105' ' ' PHE . 83.5 mt -96.32 163.01 13.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 74.420000000000002 112.34 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.418 HG23 HD13 ' A' ' 138' ' ' LEU . 87.4 m -66.15 136.4 55.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.588 -0.733 . . . . 60.43 112.104 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -131.9 96.54 3.95 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.378 -0.374 . . . . 71.329999999999998 111.073 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.33 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.393 0.516 . . . . 64.019999999999996 112.393 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -150.43 89.65 4.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 121.166 0.507 . . . . 74.409999999999997 110.791 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.95 30.62 0.51 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.037 2.492 . . . . 64.409999999999997 114.378 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.19 101.63 0.74 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.94 0.348 . . . . 62.210000000000001 111.94 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.43 HG23 HG12 ' A' ' 119' ' ' ILE . 14.2 tt -153.0 143.53 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.004 0.431 . . . . 64.010000000000005 111.608 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -79.14 94.01 5.29 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.207 0.527 . . . . 74.540000000000006 111.74 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.43 HG12 HG23 ' A' ' 117' ' ' ILE . 49.4 mm -105.2 116.49 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.187 -0.461 . . . . 64.120000000000005 110.482 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 45.8 tptt -80.29 50.46 1.26 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.01 0.433 . . . . 64.099999999999994 111.498 -177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.5 tt0 71.57 -60.45 0.52 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.461 0.704 . . . . 72.019999999999996 112.558 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -86.75 120.85 72.0 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 111.816 0.302 . . . . 72.549999999999997 111.816 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 12' ' ' TYR . 71.5 Cg_exo -51.81 137.85 51.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.81 2.34 . . . . 72.299999999999997 113.085 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.9 p -93.83 168.01 11.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.883 0.373 . . . . 72.349999999999994 111.518 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.44 -32.74 71.66 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.219 0.533 . . . . 70.010000000000005 110.807 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -73.24 -31.63 64.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.013 -0.54 . . . . 74.409999999999997 111.02 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.8 m -52.51 -38.38 59.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.27 -0.423 . . . . 60.5 111.809 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -52.47 -41.9 63.75 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.688 0.28 . . . . 72.349999999999994 111.626 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -65.57 -46.36 79.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.977 0.362 . . . . 62.25 111.977 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.93 -51.61 60.9 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.523 -0.308 . . . . 75.310000000000002 111.091 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.9 -29.94 71.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.804 0.298 . . . . 65.109999999999999 111.804 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.46 -58.16 7.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.942 0.401 . . . . 53.549999999999997 110.369 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.19 -12.35 61.6 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.201 0.445 . . . . 73.010000000000005 112.201 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.59 -62.84 1.53 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.897 0.38 . . . . 44.030000000000001 110.863 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.08 -42.35 99.72 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 63.149999999999999 113.51 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -35.85 61.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.287 0.477 . . . . 75.209999999999994 112.287 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.17 -51.64 68.73 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.976 0.417 . . . . 61.119999999999997 110.925 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 138' ' ' LEU . 2.6 mm? -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.915 0.388 . . . . 74.450000000000003 110.919 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.74 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -63.89 -55.06 26.73 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.321 -0.466 . . . . 62.399999999999999 112.746 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -74.61 -14.88 60.83 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.598 -0.354 . . . . 55.43 111.715 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -50.28 -38.33 40.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.18 0.514 . . . . 73.239999999999995 110.546 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 58.8 t -54.88 -61.05 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.437 -0.802 . . . . 53.240000000000002 111.623 176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.415 ' HG1' ' HB2' ' A' ' 148' ' ' GLU . 7.7 t -70.62 -25.1 62.88 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.466 0.543 . . . . 73.129999999999995 112.466 -177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -67.93 -38.09 82.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.132 -0.355 . . . . 73.140000000000001 111.44 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.5 -50.33 7.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 120.965 0.412 . . . . 70.129999999999995 111.274 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 11.9 mtp180 -69.93 -19.0 63.4 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.893 0.701 . . . . 74.409999999999997 112.893 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.42 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 52.5 tp 77.88 -49.59 0.5 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.396 0.678 . . . . 74.540000000000006 112.266 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' HB2' ' HG1' ' A' ' 143' ' ' THR . 0.5 OUTLIER 55.92 17.93 2.8 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.996 0.427 . . . . 61.549999999999997 112.054 -178.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 57.04 21.27 6.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.989 -0.55 . . . . 71.230000000000004 111.71 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.3 m80 60.37 91.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.206 0.526 . . . . 71.519999999999996 111.064 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -82.97 66.04 8.39 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.599 0.592 . . . . 73.329999999999998 112.599 -170.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.8 m80 62.12 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 70.200000000000003 113.339 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 67.25 96.31 0.06 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.927 0.491 . . . . 75.420000000000002 112.167 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.743 -0.646 . . . . 73.329999999999998 111.58 178.161 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 43.0 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 111.227 0.084 . . . . 74.129999999999995 111.227 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm 67.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 121.17 0.509 . . . . 64.0 111.766 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.95 109.58 3.21 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.2 -0.524 . . . . 73.040000000000006 112.972 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 111.58 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.795 0.331 . . . . 74.239999999999995 110.971 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.448 ' HE2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 m-85 -97.29 139.46 33.22 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.408 0.521 . . . . 72.25 112.408 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 35' ' ' ASP . 44.1 p90 -142.29 162.91 34.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.751 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.464 ' HB ' ' HA3' ' A' ' 11' ' ' GLY . 20.7 t -106.29 115.73 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 122.213 -0.305 . . . . 61.039999999999999 111.591 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.4 ' OG ' ' HB2' ' A' ' 35' ' ' ASP . 15.1 m -60.12 -20.28 57.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.96 0.41 . . . . 74.010000000000005 111.786 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' H ' HG12 ' A' ' 7' ' ' VAL . 43.2 tt0 -70.13 -69.51 0.35 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.127 -0.488 . . . . 71.329999999999998 111.696 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -137.38 -35.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.943 0.349 . . . . 74.439999999999998 111.943 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -28.55 103.37 0.01 OUTLIER Glycine 0 N--CA 1.472 1.091 0 N-CA-C 115.328 0.891 . . . . 53.210000000000001 115.328 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.62 5.47 3.06 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.83 0.452 . . . . 75.209999999999994 112.208 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 m -57.7 -19.73 29.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.653 0.612 . . . . 42.439999999999998 112.653 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -61.73 -34.85 76.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.247 0.546 . . . . 45.340000000000003 111.067 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -69.47 -37.73 77.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.727 -0.669 . . . . 75.510000000000005 111.079 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.632 HD13 ' SG ' ' A' ' 131' ' ' CYS . 64.5 mt -70.3 -39.98 74.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.811 -0.632 . . . . 75.400000000000006 110.706 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.05 74.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.828 -0.624 . . . . 73.430000000000007 111.706 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -61.73 -41.02 97.09 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.122 0.487 . . . . 73.109999999999999 111.032 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.04 87.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.367 -0.379 . . . . 53.130000000000003 111.399 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.85 -56.81 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.043 -0.526 . . . . 74.129999999999995 111.621 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.486 ' O ' HG22 ' A' ' 25' ' ' THR . 12.8 tt -54.77 -41.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.443 0.164 . . . . 52.520000000000003 111.443 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -51.31 -50.49 59.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.721 0.408 . . . . 55.409999999999997 111.832 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.26 -39.07 32.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.066 -0.588 . . . . 72.140000000000001 113.508 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.482 HG23 ' H ' ' A' ' 30' ' ' GLY . 49.6 mm -67.44 -41.61 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 122.268 -0.548 . . . . 72.200000000000003 112.119 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 21' ' ' ILE . 13.3 t -72.1 -31.18 65.81 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.996 -0.44 . . . . 74.200000000000003 110.532 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -59.04 -42.84 91.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.043 0.449 . . . . 75.239999999999995 109.795 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.1 m -67.09 -27.47 67.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.856 -0.611 . . . . 75.430000000000007 111.218 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.17 22.52 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.23 -0.509 . . . . 71.430000000000007 113.509 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -95.67 -52.96 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.459 -0.436 . . . . 71.239999999999995 112.028 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' H ' HG23 ' A' ' 24' ' ' ILE . . . 87.64 134.78 4.49 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 121.124 -0.56 . . . . 62.219999999999999 113.55 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.0 m -108.69 171.74 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.198 0.523 . . . . 71.430000000000007 112.318 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -127.89 107.28 9.73 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.955 -0.566 . . . . 74.120000000000005 110.078 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -92.3 125.92 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.415 0.626 . . . . 75.25 112.334 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.1 t -122.68 126.19 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 111.374 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 5.4 p-10 -94.66 88.06 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.644 0.735 . . . . 65.010000000000005 111.771 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pp -69.73 -3.6 16.07 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.729 -0.669 . . . . 75.420000000000002 112.288 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.48 1.37 85.87 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.021 -0.609 . . . . 63.530000000000001 112.504 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.05 177.47 4.85 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.964 0.411 . . . . 75.510000000000005 111.132 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.64 84.33 0.29 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.035 0.445 . . . . 65.310000000000002 111.993 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.33 163.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.107 -0.497 . . . . 62.240000000000002 111.472 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.51 172.7 17.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.862 0.363 . . . . 73.049999999999997 111.89 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.421 ' N ' HD21 ' A' ' 42' ' ' LEU . 3.4 mm? -56.11 -31.28 63.14 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.779 0.659 . . . . 75.439999999999998 112.779 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -61.33 -34.23 74.92 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.263 0.554 . . . . 65.329999999999998 111.171 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.27 -48.93 12.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.775 -0.648 . . . . 71.129999999999995 110.69 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 49' ' ' VAL . 3.3 tm? -53.53 -40.17 65.25 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.057 -0.52 . . . . 73.129999999999995 111.667 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -59.59 -53.02 62.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.098 0.475 . . . . 54.450000000000003 111.366 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.47 -39.04 93.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.133 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.421 HD13 ' HZ ' ' A' ' 5' ' ' PHE . 59.0 tp -55.53 -52.81 62.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.976 -0.556 . . . . 52.240000000000002 111.434 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 45' ' ' LEU . 87.7 t -60.21 -44.23 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.308 -0.406 . . . . 73.239999999999995 111.608 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.73 89.21 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.059 -0.591 . . . . 53.140000000000001 113.457 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.23 8.22 43.94 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.785 0.661 . . . . 73.319999999999993 112.785 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.4 p -55.28 -3.1 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.93 1.085 . . . . 73.230000000000004 113.93 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -44.74 -41.37 6.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.61 0.596 . . . . 73.209999999999994 112.61 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 84' ' ' ALA . . . -149.84 136.86 5.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.354 -0.451 . . . . 72.319999999999993 112.291 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.448 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 83.9 mt -139.27 141.35 37.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.908 0.354 . . . . 73.040000000000006 111.671 -175.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.48 118.12 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.147 0.499 . . . . 71.310000000000002 111.191 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.2 mp -106.81 131.81 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.922 0.391 . . . . 74.430000000000007 111.709 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.77 58.16 0.46 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.35 -0.453 . . . . 72.120000000000005 113.424 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.521 ' HG3' ' HA ' ' A' ' 89' ' ' GLU . 84.2 mtp 67.0 -178.49 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.96 0.726 . . . . 71.140000000000001 112.96 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -141.79 88.84 9.3 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.514 -0.767 . . . . 71.450000000000003 110.649 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.07 143.0 85.23 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 122.931 2.421 . . . . 63.32 113.253 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.8 -64.51 0.39 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.83 1.048 . . . . 75.319999999999993 113.83 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.31 -53.75 53.57 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.209 0.448 . . . . 74.129999999999995 112.209 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 68' ' ' ILE . 39.0 t -64.79 -25.81 68.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.455 0.539 . . . . 71.340000000000003 112.455 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.81 69.47 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.017 0.377 . . . . 74.299999999999997 112.017 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.24 -53.47 50.31 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.909 0.385 . . . . 73.420000000000002 111.735 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 m -71.19 -32.66 69.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.906 0.335 . . . . 72.209999999999994 111.906 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 64' ' ' SER . 76.6 mt -64.9 -47.35 88.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.852 0.316 . . . . 73.209999999999994 111.852 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.92 -42.34 89.44 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.712 0.292 . . . . 61.409999999999997 111.72 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.14 70.51 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.226 -0.511 . . . . 65.120000000000005 113.038 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.42 -43.12 16.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.794 0.331 . . . . 74.310000000000002 111.514 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.6 tp -52.93 -41.08 64.12 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.801 0.44 . . . . 73.219999999999999 111.833 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 t -51.57 -37.47 49.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.123 0.487 . . . . 72.239999999999995 111.582 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.0 m -84.51 -40.79 17.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 111.356 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -54.8 -46.76 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.01 -0.541 . . . . 61.5 111.889 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.99 -47.08 65.06 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.883 0.373 . . . . 74.209999999999994 111.937 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.07 -26.86 67.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.059 -0.591 . . . . 72.519999999999996 113.373 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -78.05 -40.66 38.01 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.493 0.553 . . . . 71.200000000000003 112.493 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.01 168.97 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.266 0.555 . . . . 74.319999999999993 112.261 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.54 158.4 25.81 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 110.557 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.17 -82.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.317 0.858 . . . . 72.040000000000006 113.317 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.638 ' HZ1' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -94.5 101.0 12.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.705 0.632 . . . . 74.030000000000001 112.705 -173.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.01 -164.99 1.21 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.051 -0.522 . . . . 74.329999999999998 111.151 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -110.33 134.85 51.88 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.861 0.362 . . . . 61.340000000000003 110.771 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 112' ' ' THR . 29.6 m -132.55 170.96 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.422 0.629 . . . . 74.209999999999994 112.508 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 110.96 0.63 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.819 -0.628 . . . . 63.140000000000001 111.982 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -101.04 114.36 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.217 -0.578 . . . . 55.439999999999998 111.202 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.449 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 29.0 p90 -123.0 110.78 15.8 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 74.230000000000004 111.503 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.521 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 41.8 mt-10 -78.77 81.77 5.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.234 0.54 . . . . 64.010000000000005 111.366 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -79.76 -9.57 59.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.067 -0.515 . . . . 72.299999999999997 112.164 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.26 -70.67 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.24 -0.505 . . . . 70.430000000000007 113.073 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.58 21.75 77.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.169 -0.539 . . . . 74.409999999999997 113.15 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.86 -85.28 0.26 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.278 -0.487 . . . . 72.430000000000007 113.944 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -163.52 129.93 3.26 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.42 -0.459 . . . . 75.140000000000001 111.369 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -163.38 152.75 14.82 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.097 0.475 . . . . 73.230000000000004 111.89 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.445 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.6 mp0 -95.23 -43.96 0.27 Allowed Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.858 1.058 . . . . 74.329999999999998 113.858 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 74.2 Cg_endo -71.13 23.28 0.22 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.27 1.98 . . . . 53.329999999999998 114.928 -170.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tt -57.71 -53.43 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 112.648 0.61 . . . . 75.319999999999993 112.648 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.676 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.3 m-20 -61.89 -55.88 37.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.472 0.545 . . . . 64.200000000000003 112.472 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.676 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.8 Cg_exo -54.12 -44.98 44.48 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.333 2.022 . . . . 73.409999999999997 112.81 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -60.48 -54.48 45.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.305 -0.407 . . . . 75.140000000000001 111.269 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.31 -38.69 80.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.518 -0.31 . . . . 70.450000000000003 111.725 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 t -62.46 -37.66 86.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.808 0.337 . . . . 45.520000000000003 111.339 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HE3' HD12 ' A' ' 108' ' ' LEU . 59.6 tptt -58.41 -47.73 82.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.024 0.44 . . . . 75.519999999999996 111.051 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.67 -46.42 75.73 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.327 -0.397 . . . . 74.340000000000003 111.773 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -62.53 -52.68 62.48 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.42 0.526 . . . . 74.019999999999996 112.42 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.27 -35.53 80.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.698 0.629 . . . . 74.349999999999994 112.698 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.524 HD12 ' HE3' ' A' ' 104' ' ' LYS . 80.7 mt -78.23 -15.58 58.66 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.107 -0.371 . . . . 75.140000000000001 111.605 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.04 40.19 51.91 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.06 -0.59 . . . . 38.039999999999999 112.899 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.93 104.03 3.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.828 0.346 . . . . 65.540000000000006 110.707 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -64.71 123.8 20.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.142 0.496 . . . . 64.120000000000005 112.086 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 76.6 p -89.92 136.89 32.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.361 -0.381 . . . . 55.109999999999999 111.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.78 -54.64 44.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.082 0.468 . . . . 74.140000000000001 111.295 176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -150.34 131.12 7.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.369 -0.378 . . . . 70.239999999999995 110.284 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.54 103.53 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.412 2.074 . . . . 72.239999999999995 112.688 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 88' ' ' PHE . . . -80.45 -179.47 7.17 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 74.510000000000005 112.714 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.25 145.2 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.92 -0.582 . . . . 71.400000000000006 111.019 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -72.24 150.23 43.84 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.482 0.919 . . . . 74.200000000000003 113.482 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 120' ' ' LYS . 23.4 mm -106.8 167.14 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.115 -0.948 . . . . 72.530000000000001 110.757 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.49 ' N ' HG22 ' A' ' 119' ' ' ILE . 57.6 tptt -64.19 -66.11 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.843 0.354 . . . . 71.230000000000004 111.773 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -151.13 -55.73 0.15 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.257 0.551 . . . . 74.109999999999999 111.027 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -92.82 118.63 67.98 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.956 -0.565 . . . . 75.150000000000006 110.413 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.433 ' HA ' HG23 ' A' ' 119' ' ' ILE . 32.1 Cg_endo -61.95 141.27 88.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.675 2.25 . . . . 64.349999999999994 113.389 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.4 p -76.16 156.08 34.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.877 -0.601 . . . . 75.120000000000005 111.428 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.76 -30.9 71.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 111.037 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -57.29 -22.69 43.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.3 -0.409 . . . . 71.230000000000004 111.093 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.9 m -65.6 -25.76 67.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.852 0.358 . . . . 72.439999999999998 111.068 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -67.47 -48.16 67.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.913 0.387 . . . . 73.319999999999993 110.395 172.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.68 -31.62 71.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.467 0.651 . . . . 74.329999999999998 110.692 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.02 -63.02 1.44 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.369 -0.832 . . . . 74.340000000000003 111.005 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.632 ' SG ' HD13 ' A' ' 16' ' ' LEU . 64.6 m -62.24 -26.21 68.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.387 -0.37 . . . . 73.319999999999993 111.936 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.02 -69.86 0.1 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.189 -0.46 . . . . 61.409999999999997 111.751 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.57 -16.67 44.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.185 0.439 . . . . 51.329999999999998 112.185 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.78 -53.62 44.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 110.716 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.52 95.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.14 -0.552 . . . . 70.510000000000005 112.444 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 59.4 m -60.85 -46.74 89.4 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.918 0.34 . . . . 73.200000000000003 111.918 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.82 -43.62 98.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.771 0.32 . . . . 74.150000000000006 111.278 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 44.2 tp -57.31 -45.05 84.59 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.263 0.554 . . . . 63.039999999999999 110.008 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' O ' HG21 ' A' ' 143' ' ' THR . . . -61.97 -35.5 91.48 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.807 -0.633 . . . . 70.510000000000005 112.785 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLN . . . . . 0.497 ' HA ' HG21 ' A' ' 143' ' ' THR . 24.6 mt-30 -65.19 -35.56 81.45 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.909 0.354 . . . . 70.319999999999993 111.352 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -62.38 -47.6 83.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.072 0.463 . . . . 74.109999999999999 110.391 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.24 -55.53 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.821 -0.627 . . . . 72.299999999999997 111.684 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 140' ' ' GLN . 8.8 t -63.27 -28.31 69.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.071 0.397 . . . . 64.409999999999997 112.071 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.495 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 37.7 ttt180 -68.42 -50.47 52.52 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.104 0.478 . . . . 75.430000000000007 111.164 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.89 -29.69 66.95 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.52 . . . . 75.230000000000004 111.669 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -100.58 -31.72 11.12 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.995 1.109 . . . . 63.450000000000003 113.995 -172.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.1 tp -151.54 -94.47 0.06 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.943 1.09 . . . . 70.450000000000003 113.943 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.495 ' CG ' ' HA ' ' A' ' 144' ' ' ARG . 7.4 mm-40 58.46 97.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.093 0.557 . . . . 71.239999999999995 112.32 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -115.93 -43.09 3.01 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.212 -0.305 . . . . 73.140000000000001 111.583 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.97 31.81 0.4 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.898 0.38 . . . . 73.219999999999999 111.624 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.419 ' HE1' ' HG2' ' A' ' 140' ' ' GLN . 39.2 t-80 -85.1 134.09 34.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.344 -0.389 . . . . 73.049999999999997 111.314 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -138.57 141.91 39.24 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.13 0.49 . . . . 73.510000000000005 112.051 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -115.6 122.47 45.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 65.230000000000004 110.391 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.248 -0.406 . . . . 74.430000000000007 111.642 178.212 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 57.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.375 -0.232 . . . . 50.14 110.375 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.724 HD11 HG21 ' A' ' 142' ' ' VAL . 30.3 mm 69.96 103.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.963 0.411 . . . . 74.01 110.971 -174.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -90.13 106.58 3.35 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.211 -0.518 . . . . 65.32 112.969 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.626 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -83.09 116.1 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.53 0.681 . . . . 75.04 111.705 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 36' ' ' LEU . 63.0 m-85 -89.98 113.25 24.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.715 -0.675 . . . . 74.44 110.467 176.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 36.8 p90 -137.84 -178.59 5.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.146 0.498 . . . . 73.3 112.01 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 10' ' ' TYR . 23.8 t -126.87 111.94 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.145 -0.48 . . . . 72.0 111.004 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.88 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 46.6 t -61.9 -26.33 68.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.19 0.811 . . . . 52.05 113.19 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.38 -64.5 1.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.285 0.564 . . . . 65.35 112.42 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.442 ' H ' HG12 ' A' ' 7' ' ' VAL . 19.8 t80 -71.6 127.26 31.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.855 -0.611 . . . . 74.34 112.247 -171.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.91 -161.98 7.44 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 114.994 0.758 . . . . 12.54 114.994 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -87.35 7.22 29.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.04 0.385 . . . . 74.43 112.04 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -46.87 -40.85 14.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.115 0.783 . . . . 63.04 113.115 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.88 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 20.1 p-10 -67.38 -41.63 84.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.143 0.497 . . . . 65.35 111.526 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -68.19 -36.66 79.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.174 -0.466 . . . . 73.04 110.819 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.85 -44.79 96.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.313 0.578 . . . . 62.41 110.375 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 21' ' ' ILE . . . -60.0 -39.85 87.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.806 -0.634 . . . . 72.14 111.303 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.96 -44.06 91.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.589 -0.278 . . . . 44.33 111.083 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -43.17 82.23 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.006 0.432 . . . . 61.11 111.158 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.41 -58.71 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.152 -0.476 . . . . 63.35 111.846 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.678 HG13 ' HB ' ' A' ' 31' ' ' VAL . 13.4 tt -60.02 -48.92 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 111.903 0.334 . . . . 74.12 111.903 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.405 ' N ' HG23 ' A' ' 21' ' ' ILE . 10.7 t30 -66.65 -39.26 88.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.542 0.201 . . . . 74.44 111.542 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.47 95.02 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.891 -0.671 . . . . 72.04 112.644 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.64 HG22 ' HB ' ' A' ' 29' ' ' VAL . 59.9 mt -83.04 -35.71 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.17 0.433 . . . . 61.4 112.17 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 21' ' ' ILE . 70.8 p -69.12 -39.58 78.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.006 -0.434 . . . . 41.23 111.054 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.35 -43.07 78.74 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.097 0.475 . . . . 73.3 110.094 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.3 m -63.0 -43.01 99.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.028 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.54 67.44 0.33 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.222 -0.513 . . . . 63.11 113.619 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.64 ' HB ' HG22 ' A' ' 24' ' ' ILE . 62.5 t -139.37 -68.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 122.525 -0.397 . . . . 70.12 111.71 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.93 113.14 2.94 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.28 -0.486 . . . . 73.14 112.814 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 21' ' ' ILE . 82.2 t -109.65 144.42 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.686 0.279 . . . . 55.22 111.698 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.494 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 18.2 m-20 -93.38 147.47 22.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 64.45 110.986 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.73 132.28 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 112.431 0.53 . . . . 72.1 112.431 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 86.9 t -141.49 125.02 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.035 -0.529 . . . . 73.21 111.026 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.5 m-20 -85.73 99.77 11.55 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.007 -0.433 . . . . 62.03 111.935 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.529 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -69.78 -21.12 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.027 0.442 . . . . 51.32 111.675 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.418 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -114.64 23.63 11.86 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.651 -0.785 . . . . 62.34 113.805 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.87 -72.95 0.11 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.73 0.641 . . . . 73.2 112.73 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.01 23.47 1.22 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.184 0.809 . . . . 74.54 113.184 -172.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.0 m -57.84 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.645 0.736 . . . . 73.21 112.25 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.77 171.59 14.94 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.87 -0.605 . . . . 75.04 110.448 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.27 -36.25 60.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.306 0.242 . . . . 60.45 111.242 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -57.17 -36.27 70.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.034 0.383 . . . . 55.23 112.034 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -69.04 -46.28 68.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.394 0.616 . . . . 62.32 110.519 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 49' ' ' VAL . 82.2 mt -61.52 -36.81 81.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.768 -0.651 . . . . 73.35 111.309 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' NH2' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.55 -46.97 85.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 62.32 110.288 177.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 7.7 tp10 -66.39 -37.95 86.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.951 0.405 . . . . 65.42 110.877 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 55' ' ' LEU . 59.4 tp -57.63 -30.48 65.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.178 -0.464 . . . . 74.24 111.607 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 45' ' ' LEU . 63.7 t -63.25 -53.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.98 0.419 . . . . 64.25 111.478 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.17 -37.36 49.08 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.264 -0.493 . . . . 63.34 113.697 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -90.24 8.08 34.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.078 0.399 . . . . 73.01 112.078 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -51.31 -8.77 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.425 1.268 . . . . 62.31 114.425 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 p -65.09 -18.18 65.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.778 0.659 . . . . 74.31 112.778 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.664 ' HA3' HD13 ' A' ' 2' ' ' ILE . . . -160.85 137.84 5.17 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.587 -0.816 . . . . 42.3 113.973 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 48' ' ' LEU . 4.7 mp -128.76 159.22 36.36 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.866 0.466 . . . . 55.32 110.824 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 70.7 t -140.66 122.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.429 0.291 . . . . 74.24 110.824 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -122.22 130.87 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.886 0.374 . . . . 74.52 111.253 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.23 -128.0 3.22 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.993 -0.622 . . . . 73.42 112.908 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -84.5 161.29 20.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.14 0.495 . . . . 64.45 111.515 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -113.03 90.62 16.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.525 -0.307 . . . . 70.11 111.505 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.36 137.64 16.95 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.971 2.448 . . . . 75.23 112.093 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.93 -48.28 51.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.414 0.524 . . . . 72.2 112.414 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.62 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.311 0.485 . . . . 43.43 112.311 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m -78.84 -33.85 45.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.745 0.307 . . . . 64.32 111.493 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 72.25 111.927 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.64 -33.58 76.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.97 0.359 . . . . 63.04 111.97 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -85.22 -12.59 52.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.033 0.383 . . . . 73.4 112.033 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mm -87.86 -23.33 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.177 0.436 . . . . 73.33 112.177 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -48.49 -48.15 38.2 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.769 0.655 . . . . 54.52 112.769 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 -57.3 7.35 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.14 -0.553 . . . . 75.42 113.322 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -55.86 -35.91 66.97 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.417 0.525 . . . . 74.53 112.417 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.53 -41.68 66.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.612 0.365 . . . . 70.1 111.006 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -58.98 -47.21 85.97 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.781 0.324 . . . . 74.54 111.537 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.0 -39.09 93.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.839 0.352 . . . . 71.42 111.275 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.469 ' O ' HG22 ' A' ' 79' ' ' VAL . 65.3 mt -58.37 -47.06 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.358 -0.383 . . . . 64.14 111.335 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 82.4 mt -55.35 -28.18 52.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.481 -0.327 . . . . 70.24 111.875 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.68 -32.23 30.85 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.216 -0.516 . . . . 73.42 113.195 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p -80.78 -58.68 2.99 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.855 0.317 . . . . 72.21 111.855 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 75' ' ' ILE . 29.8 m -68.79 145.12 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.338 0.59 . . . . 71.41 112.112 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -161.37 -168.76 2.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.021 -0.536 . . . . 72.33 111.429 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.743 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 10.5 tp10 64.08 -95.76 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.701 1.0 . . . . 75.11 113.701 167.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.743 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.2 ptpp? -169.43 30.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.95 0.405 . . . . 73.23 111.801 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.458 ' OE1' ' HB3' ' A' ' 81' ' ' GLU . 8.0 mp0 -61.33 176.35 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.578 0.704 . . . . 72.44 112.642 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.688 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.06 139.53 30.53 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.573 0.582 . . . . 75.03 112.573 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.99 96.15 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.679 0.752 . . . . 63.52 110.854 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.3 80.68 0.73 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.944 -0.571 . . . . 53.4 113.285 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.44 HD13 ' HB ' ' A' ' 57' ' ' ILE . 32.5 mm -82.78 113.85 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 122.725 -0.28 . . . . 64.55 110.576 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.16 133.07 53.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.368 0.604 . . . . 75.23 112.267 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 9.5 tp10 -76.23 137.86 40.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.76 -0.655 . . . . 62.42 111.335 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -156.11 -2.75 0.13 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.97 0.73 . . . . 71.32 112.97 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.81 109.86 0.39 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.692 -0.766 . . . . 73.13 113.13 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.24 79.67 0.52 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.527 -0.368 . . . . 53.52 113.22 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.82 78.39 0.06 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.379 -0.439 . . . . 31.01 112.53 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -98.47 -174.8 2.91 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.239 0.542 . . . . 70.11 111.966 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -118.67 138.08 52.86 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.919 -0.582 . . . . 62.14 109.959 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.545 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 32.8 mt-10 -45.34 -48.4 34.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.601 1.334 . . . . 71.03 114.601 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 86.0 Cg_exo -50.46 -12.21 0.49 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.915 2.41 . . . . 45.45 115.092 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.89 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 121.903 -0.498 . . . . 45.35 111.854 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.1 m-20 -57.18 -51.18 83.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 112.577 0.584 . . . . 74.11 112.577 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 90.4 Cg_exo -47.78 -40.18 31.49 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.309 2.006 . . . . 74.14 112.893 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 97' ' ' PRO . 9.7 mp -71.99 -41.57 67.49 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.58 -0.282 . . . . 62.14 111.205 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.3 mt -58.64 -37.3 75.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 55.53 111.056 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -58.08 -31.85 67.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.19 -0.459 . . . . 54.34 110.917 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -68.29 -50.12 55.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.798 0.333 . . . . 73.13 110.742 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.91 -37.33 76.37 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.16 0.505 . . . . 75.53 110.777 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -64.74 -60.05 3.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.69 -0.687 . . . . 74.34 111.207 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.18 -56.08 24.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.911 -0.586 . . . . 74.23 112.529 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.17 -23.07 65.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.737 0.273 . . . . 73.22 111.737 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.4 61.24 5.23 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.291 -0.481 . . . . 72.41 113.558 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.59 156.55 19.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.625 -0.338 . . . . 74.14 110.989 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 27.5 m -70.12 93.1 0.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 50.14 111.509 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -86.63 159.07 19.33 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.22 0.533 . . . . 45.34 112.319 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.04 -164.81 1.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.808 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.25 112.34 5.34 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.171 -0.468 . . . . 72.24 112.074 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -90.68 107.4 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.014 2.476 . . . . 74.44 113.484 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.796 ' HB3' ' HB3' ' A' ' 89' ' ' GLU . . . -89.66 177.38 6.55 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.189 -0.319 . . . . 51.24 110.634 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.9 tt -132.58 102.52 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.665 0.617 . . . . 74.53 112.665 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 55.99 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.353 0.871 . . . . 71.31 113.353 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.589 HG12 ' HG3' ' A' ' 89' ' ' GLU . 46.4 mm -95.35 74.71 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.04 0.447 . . . . 64.2 110.39 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 51.46 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.807 0.669 . . . . 60.43 112.807 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 179.09 -42.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.181 0.592 . . . . 42.12 110.674 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.8 p -96.08 114.62 64.56 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.197 -0.456 . . . . 73.3 111.521 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.47 127.76 26.63 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.713 2.276 . . . . 50.1 113.133 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 33.9 p -107.89 177.09 4.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.569 -0.287 . . . . 73.43 111.608 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.56 -34.96 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.01 0.433 . . . . 71.31 111.586 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.422 ' O ' HD13 ' A' ' 130' ' ' LEU . 83.3 m-20 -58.05 -41.19 82.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.974 0.416 . . . . 71.43 110.609 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.7 m -56.82 -44.48 82.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.251 -0.431 . . . . 71.14 111.377 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -58.85 -46.36 87.93 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.279 0.562 . . . . 73.34 111.04 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.94 -32.48 72.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.775 -0.648 . . . . 65.41 111.802 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 126' ' ' ASN . 10.9 mp -77.78 -42.25 34.59 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.303 -0.248 . . . . 73.35 111.418 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.9 m -58.66 -53.32 59.72 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.853 0.359 . . . . 75.11 111.566 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.1 -54.08 50.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.269 -0.423 . . . . 64.5 111.759 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.81 -54.86 36.44 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.221 -0.445 . . . . 54.44 111.843 -177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.5 97.27 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.71 0.29 . . . . 75.32 111.777 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.55 76.04 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.08 -0.581 . . . . 72.42 112.789 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.8 m -61.2 -42.62 98.91 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 62.3 111.041 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.33 -42.15 95.06 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.026 -0.534 . . . . 51.44 111.182 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.479 HD11 ' HB1' ' A' ' 84' ' ' ALA . 52.5 tp -62.73 -44.28 96.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.125 0.488 . . . . 73.13 110.636 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -34.57 75.11 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 116.018 -0.537 . . . . 62.32 112.781 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 136' ' ' THR . 55.5 mt-30 -64.78 -25.68 68.02 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.714 0.292 . . . . 74.24 111.711 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -72.82 -52.43 14.94 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.068 0.461 . . . . 74.35 110.166 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.724 HG21 HD11 ' A' ' 2' ' ' ILE . 60.9 t -57.2 -45.16 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.797 -0.638 . . . . 72.33 112.172 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 9.0 t -61.71 -51.78 66.99 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.997 0.369 . . . . 51.32 111.997 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 143' ' ' THR . 90.5 mtt-85 -64.26 -41.64 96.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.113 0.482 . . . . 72.54 111.13 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.15 -49.87 68.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.122 -0.49 . . . . 70.45 111.725 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.484 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 0.1 OUTLIER -82.7 -11.07 58.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.183 0.438 . . . . 72.14 112.183 -174.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 143' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.157 0.503 . . . . 43.11 110.395 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 25.3 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.389 0.137 . . . . 65.43 111.357 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.0 mp 58.7 97.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.214 0.531 . . . . 53.22 111.869 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.29 96.11 1.9 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.193 -0.527 . . . . 42.34 112.98 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -85.56 105.73 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 O-C-N 122.374 -0.486 . . . . 74.2 111.398 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.21 123.14 38.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.755 0.312 . . . . 75.44 111.276 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.18 175.0 9.95 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.956 0.407 . . . . 73.53 111.541 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 7' ' ' VAL . 5.9 p -121.62 95.99 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 64.43 111.129 176.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -52.6 -34.64 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.595 -0.73 . . . . 75.24 112.788 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.13 -35.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.64 0.608 . . . . 44.42 112.64 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -109.05 146.57 33.76 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.243 0.46 . . . . 75.32 112.243 -170.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.19 -164.18 5.18 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 114.521 0.568 . . . . 73.22 114.521 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.607 ' HD2' ' HG2' ' A' ' 123' ' ' PRO . 57.4 m-85 -87.45 9.47 20.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.762 0.425 . . . . 64.42 111.778 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -29.98 -48.97 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.729 1.381 . . . . 72.34 114.729 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.86 -46.17 90.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.896 0.379 . . . . 75.52 111.644 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.35 -38.21 89.39 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.928 0.394 . . . . 75.51 110.858 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.597 HD11 ' HG3' ' A' ' 123' ' ' PRO . 85.8 mt -61.59 -42.59 99.07 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.062 0.458 . . . . 74.12 110.778 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -58.6 -47.26 84.92 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.135 -0.484 . . . . 62.42 110.759 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.8 -37.75 60.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.14 0.495 . . . . 54.42 111.095 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.84 -54.37 19.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.289 -0.414 . . . . 55.51 111.498 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.4 mt -56.72 -46.79 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.234 0.54 . . . . 74.01 111.909 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.512 HG12 HG21 ' A' ' 31' ' ' VAL . 74.5 mt -60.19 -27.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.899 -0.591 . . . . 74.24 112.19 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -54.01 -68.59 0.17 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.018 0.377 . . . . 62.34 112.018 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.16 -36.64 89.57 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.242 -0.504 . . . . 63.54 113.644 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.05 -47.51 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 122.526 -0.397 . . . . 73.4 111.796 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.0 p -67.43 -34.66 77.68 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.109 0.411 . . . . 64.52 112.109 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.09 -23.23 64.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.277 0.56 . . . . 75.11 110.689 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -80.6 -12.98 59.43 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.225 0.536 . . . . 45.33 110.544 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.15 27.22 26.35 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.183 -0.532 . . . . 70.0 113.113 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 143' ' ' THR . 45.2 t -116.14 137.28 50.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 122.582 -0.364 . . . . 73.31 111.463 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 142.59 17.89 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.348 -0.453 . . . . 35.41 112.747 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG21 HG12 ' A' ' 21' ' ' ILE . 34.4 m -107.97 146.25 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.46 0.541 . . . . 72.22 112.46 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -108.16 92.7 4.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.336 -0.393 . . . . 73.51 110.654 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.62 122.63 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.759 0.314 . . . . 74.52 111.58 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -127.61 136.76 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.001 0.429 . . . . 73.21 111.537 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.1 123.75 32.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.925 0.393 . . . . 74.41 111.196 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.75 -13.46 48.22 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.173 0.434 . . . . 63.54 112.173 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.65 68.27 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.364 -0.446 . . . . 52.2 112.993 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.86 14.66 3.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.166 0.432 . . . . 45.1 112.166 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.07 118.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.333 0.587 . . . . 63.41 112.217 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.71 99.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.625 0.726 . . . . 62.01 112.199 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.59 158.15 27.93 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.592 -0.731 . . . . 72.11 111.724 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.637 HD13 HD12 ' A' ' 45' ' ' LEU . 3.4 mm? -60.37 -37.89 82.18 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.037 0.384 . . . . 72.33 112.037 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -66.88 -30.11 70.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.932 0.396 . . . . 75.34 111.089 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.2 -32.88 56.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.093 0.473 . . . . 72.33 110.597 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.637 HD12 HD13 ' A' ' 42' ' ' LEU . 85.4 mt -64.75 -32.28 73.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.416 -0.356 . . . . 72.41 110.825 174.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -58.78 -47.66 83.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.022 0.439 . . . . 75.51 110.193 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 73.1 mm-40 -58.19 -39.83 79.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.245 -0.434 . . . . 72.21 111.094 175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.38 -34.34 66.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.762 0.315 . . . . 70.03 111.336 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.07 -52.94 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.844 0.354 . . . . 72.34 111.21 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.93 -25.14 73.2 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.905 -0.664 . . . . 53.22 113.47 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -98.87 7.42 46.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.717 0.407 . . . . 74.51 111.806 178.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.59 5.69 0.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.629 0.974 . . . . 55.32 113.629 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.0 p -79.79 -36.88 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.112 -0.368 . . . . 75.42 111.876 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.8 137.71 5.33 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.92 -0.657 . . . . 74.4 113.239 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.69 164.17 39.15 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.865 0.364 . . . . 65.54 111.597 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -122.36 129.58 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.611 0.364 . . . . 72.41 110.664 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -117.75 136.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.288 0.566 . . . . 64.42 112.463 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.91 125.55 8.45 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 116.071 -0.513 . . . . 44.13 112.476 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.467 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 55.5 ttm -56.87 101.86 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.353 0.596 . . . . 71.23 111.465 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 67.1 m -92.88 132.95 29.88 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 72.12 112.196 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.79 169.04 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.51 2.14 . . . . 62.23 112.756 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.96 -42.83 6.19 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.358 0.874 . . . . 75.01 113.358 -173.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.72 -62.84 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.983 0.364 . . . . 51.35 111.983 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 50.3 m -70.76 -22.22 62.42 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.009 0.433 . . . . 52.14 111.515 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.5 65.15 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 61.22 111.435 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.31 99.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.94 0.4 . . . . 71.53 111.356 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -62.24 -44.05 97.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.231 0.538 . . . . 61.5 110.904 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 61.5 mt -64.32 -45.32 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.044 -0.525 . . . . 51.43 110.832 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -54.42 -48.97 71.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.912 -0.586 . . . . 75.13 111.47 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.24 -27.28 72.21 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 73.34 112.927 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.96 -21.33 29.62 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 72.41 112.365 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 70.6 mt -51.26 -38.07 50.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.369 0.507 . . . . 72.44 112.369 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.4 m -54.25 -31.6 53.96 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.089 0.471 . . . . 71.31 111.535 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 m -94.13 -39.87 10.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 65.11 111.196 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.0 -54.27 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.262 0.467 . . . . 54.23 112.262 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.43 -17.53 13.55 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 63.34 112.723 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.15 -27.85 7.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.149 -0.548 . . . . 54.4 113.113 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.7 m -84.76 -25.58 28.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.462 0.542 . . . . 74.12 112.462 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.66 158.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.329 0.585 . . . . 63.11 112.359 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 27.9 t-20 -92.9 143.79 25.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.03 -0.532 . . . . 74.24 110.914 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -44.89 -44.62 9.78 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.382 0.882 . . . . 74.14 113.382 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 24.2 pttm -135.62 41.56 2.72 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.055 0.455 . . . . 71.41 112.012 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 11.8 pt20 -61.44 167.89 3.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.076 -0.511 . . . . 74.42 112.255 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -96.12 116.88 29.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.272 -0.422 . . . . 64.22 111.64 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.34 118.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.432 0.634 . . . . 73.2 112.121 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 139.27 15.14 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.088 -0.505 . . . . 72.14 112.781 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.31 138.95 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.896 0.379 . . . . 73.05 111.751 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -139.87 150.83 45.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.223 -0.444 . . . . 64.32 110.466 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -76.3 91.57 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.554 0.692 . . . . 75.54 112.309 -174.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 119' ' ' ILE . 52.8 m -154.51 134.34 12.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.192 -0.458 . . . . 53.33 111.243 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 59' ' ' MET . . . 99.35 -133.03 11.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.189 -0.529 . . . . 64.12 113.132 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.46 -125.69 9.54 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.084 -0.579 . . . . 62.31 113.297 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.66 -104.1 1.09 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.082 -0.58 . . . . 31.21 112.89 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.65 109.58 21.82 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.658 -0.319 . . . . 74.05 110.392 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.26 155.95 39.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.932 0.396 . . . . 63.25 111.543 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.632 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 31.6 mt-10 -106.95 -63.94 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 113.041 0.756 . . . . 75.1 113.041 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 32.5 Cg_endo -104.1 27.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 123.203 2.602 . . . . 73.05 116.204 -167.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 99' ' ' ASP . 12.6 tt -53.26 -49.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.769 0.713 . . . . 63.14 112.842 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.61 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 16.7 m-20 -61.8 -51.59 74.8 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.491 0.552 . . . . 74.31 112.491 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.6 Cg_exo -48.99 -43.92 34.23 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.117 1.878 . . . . 73.12 113.063 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.7 mp -65.48 -48.43 72.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.678 0.251 . . . . 63.14 111.678 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 95.1 mt -53.4 -47.85 69.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.003 0.43 . . . . 52.53 111.24 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -64.01 -43.83 94.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.429 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -56.53 -62.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.339 -0.391 . . . . 64.41 111.313 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -58.73 -30.53 67.54 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.797 0.295 . . . . 75.32 111.797 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 106' ' ' ARG . 31.5 ttt180 -61.76 -49.87 74.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.966 0.412 . . . . 74.53 111.256 175.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.47 -8.07 43.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.721 0.637 . . . . 70.51 112.721 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 mp -98.43 -40.33 8.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.849 0.357 . . . . 74.24 110.628 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 52.54 3.08 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.202 -0.523 . . . . 54.32 113.873 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 6.5 mp -76.54 151.17 36.44 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.894 0.378 . . . . 74.35 111.47 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 80.2 m -68.36 87.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.377 0.608 . . . . 75.14 110.142 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.9 m -99.53 135.74 40.49 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.733 -0.667 . . . . 52.42 112.149 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.83 -64.17 0.94 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.854 0.359 . . . . 51.34 111.889 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -158.23 99.72 1.76 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 120.656 0.265 . . . . 51.31 111.31 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -90.52 17.37 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.083 2.522 . . . . 75.22 114.027 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.98 13.07 19.44 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.458 . . . . 61.22 112.238 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.59 139.43 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.088 0.47 . . . . 73.42 111.545 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -128.41 127.51 42.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.368 -0.378 . . . . 65.02 110.375 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' ILE . 3.4 mp -106.48 141.06 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.225 0.536 . . . . 64.42 111.734 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 121' ' ' GLN . 19.5 ptmt -78.63 -40.32 34.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.961 -0.563 . . . . 75.22 112.497 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HG2' HG23 ' A' ' 122' ' ' THR . 65.1 tt0 -175.36 -70.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.102 0.477 . . . . 73.22 111.679 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.58 HG23 ' HG2' ' A' ' 121' ' ' GLN . 60.7 p -115.1 153.45 47.22 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.459 -0.337 . . . . 51.04 111.78 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.607 ' HG2' ' HD2' ' A' ' 12' ' ' TYR . 72.7 Cg_endo -75.37 -175.57 2.49 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.619 2.213 . . . . 75.1 113.185 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.0 p -111.53 175.54 5.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.92 0.39 . . . . 42.14 111.322 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.82 -25.33 62.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 74.23 110.83 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -70.3 -28.33 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.046 0.451 . . . . 74.3 110.901 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.9 m -54.22 -35.33 62.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.084 -0.507 . . . . 70.12 111.931 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -58.03 -27.55 63.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.008 0.432 . . . . 63.25 111.687 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -85.65 -39.67 17.02 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.939 0.399 . . . . 75.21 110.447 177.024 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.23 -56.17 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.008 -0.542 . . . . 71.4 111.155 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.4 m -55.06 -38.04 67.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.014 0.376 . . . . 75.12 112.014 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.12 -46.44 74.16 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.226 0.536 . . . . 72.23 110.908 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.18 -52.93 61.82 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.981 -0.554 . . . . 61.2 111.522 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.05 99.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.245 -0.434 . . . . 61.52 111.566 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -55.81 -38.94 75.62 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.258 -0.496 . . . . 73.04 112.799 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 88.9 m -65.96 -44.67 84.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.731 0.301 . . . . 71.35 111.126 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.04 -50.79 72.22 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.987 0.422 . . . . 54.52 111.695 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.454 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.9 mm? -70.14 -43.26 71.29 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.865 0.364 . . . . 61.42 111.165 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.0 -47.83 65.02 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 116.132 -0.486 . . . . 50.24 113.566 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 90.5 mt-30 -59.79 -53.12 61.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.668 0.27 . . . . 64.14 111.35 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 77.4 t90 -51.62 -52.98 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.753 0.311 . . . . 71.51 111.426 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 138' ' ' LEU . 57.4 t -57.08 -43.0 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.52 0.563 . . . . 72.13 112.52 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.429 HG21 HG21 ' A' ' 29' ' ' VAL . 8.7 t -78.11 -49.92 13.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.152 0.797 . . . . 75.14 113.152 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -84.88 -4.73 59.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.155 0.798 . . . . 73.4 113.155 -172.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.41 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 27.7 t70 -62.09 -18.39 60.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.189 0.44 . . . . 33.21 112.189 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.599 ' HD2' ' N ' ' A' ' 146' ' ' ARG . 1.7 mpt_? -78.72 -27.57 44.93 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.662 0.615 . . . . 75.44 112.662 -176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 147' ' ' LEU . 8.6 tt . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.11 0.481 . . . . 62.42 109.919 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.853 0.316 . . . . 74.14 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.639 HG13 HG21 ' A' ' 24' ' ' ILE . 46.4 mm -69.77 97.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.992 0.367 . . . . 75.2 111.992 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.16 1.38 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.084 -0.579 . . . . 55.0 112.529 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.453 HG21 ' HB1' ' A' ' 17' ' ' ALA . 6.7 p -91.9 110.25 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.261 0.553 . . . . 71.0 112.11 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HB3' HD23 ' A' ' 36' ' ' LEU . 82.5 m-85 -95.07 99.09 11.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 65.43 110.955 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 14' ' ' ASP . 26.6 p90 -130.13 -179.52 5.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.837 0.351 . . . . 73.11 111.52 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 10' ' ' TYR . 22.3 t -121.98 107.32 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.921 0.391 . . . . 74.23 111.842 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 74.1 m -78.23 -21.91 49.25 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.089 0.471 . . . . 74.41 111.354 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -78.24 -32.69 49.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.885 -0.598 . . . . 75.5 112.052 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.689 ' H ' HG12 ' A' ' 7' ' ' VAL . 69.1 t80 -129.13 133.03 47.45 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.92 0.711 . . . . 75.21 112.92 -170.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.5 -162.49 5.19 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.562 0.985 . . . . 64.21 115.562 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 2.12 29.11 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.64 0.607 . . . . 72.33 112.64 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.3 t -49.36 -37.56 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.102 0.477 . . . . 71.24 111.853 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 17.0 t0 -56.71 -60.18 3.93 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.864 -0.607 . . . . 44.43 111.255 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 15' ' ' ARG . 20.1 mmt180 -70.97 -28.58 64.56 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.28 0.474 . . . . 72.53 112.28 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.11 -43.99 87.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 75.22 110.501 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -75.04 -44.27 48.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.753 -0.658 . . . . 73.24 111.43 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -53.77 -53.26 54.79 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.387 -0.37 . . . . 74.12 111.883 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -25.21 61.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.31 0.485 . . . . 75.4 112.31 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 132' ' ' GLU . 66.1 mt -87.55 -57.4 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.846 0.355 . . . . 75.34 111.442 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.468 ' HB ' HG11 ' A' ' 31' ' ' VAL . 2.7 pp -59.15 -27.17 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.7 0.286 . . . . 72.33 111.762 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.442 ' N ' HD12 ' A' ' 21' ' ' ILE . 27.3 t-20 -59.4 -48.88 79.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.515 -0.311 . . . . 62.41 110.619 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.36 -34.24 87.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.166 -0.54 . . . . 31.43 112.758 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.639 HG21 HG13 ' A' ' 2' ' ' ILE . 62.4 mt -62.69 -53.12 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 122.49 -0.418 . . . . 75.42 111.335 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.8 t -68.19 -31.15 70.48 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.909 0.385 . . . . 70.03 111.001 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -62.34 -34.52 76.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.057 0.456 . . . . 74.43 111.034 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -71.35 -31.88 67.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.311 -0.404 . . . . 72.3 111.0 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.81 5.42 4.89 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.165 -0.541 . . . . 55.22 114.17 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.649 HG22 ' HB ' ' A' ' 143' ' ' THR . 21.8 t -94.34 126.53 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 117.439 0.619 . . . . 71.21 111.698 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.95 122.6 22.19 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.444 -0.408 . . . . 73.53 113.689 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.468 HG11 ' HB ' ' A' ' 21' ' ' ILE . 61.3 t -104.07 143.56 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.118 0.485 . . . . 64.01 112.168 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.77 113.68 22.91 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.136 -0.484 . . . . 75.1 110.422 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.84 124.0 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.269 0.557 . . . . 63.45 112.11 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.04 108.03 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.85 0.357 . . . . 60.12 111.497 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.49 111.23 20.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.908 0.385 . . . . 41.45 111.188 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.445 ' HA ' HG13 ' A' ' 40' ' ' VAL . 4.4 pp -86.8 -8.96 56.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.424 -0.353 . . . . 64.21 111.1 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -59.72 -45.3 95.95 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.356 -0.449 . . . . 64.41 112.768 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.58 17.69 3.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.701 0.286 . . . . 62.41 111.446 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.16 147.22 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.198 0.599 . . . . 52.43 111.917 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 36' ' ' LEU . 27.1 m -117.43 151.87 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.337 . . . . 72.42 111.546 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -104.98 169.36 8.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.053 0.454 . . . . 72.21 111.064 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.7 mm? -58.81 -18.44 32.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.116 0.413 . . . . 74.42 112.116 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -57.6 -55.46 34.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.828 0.347 . . . . 73.14 110.775 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.94 -37.19 78.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.179 0.514 . . . . 63.02 110.837 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 3.0 tm? -61.32 -38.73 87.92 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.978 -0.555 . . . . 72.32 111.127 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -70.85 -40.32 72.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.961 -0.462 . . . . 70.33 110.925 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 18.1 mm-40 -58.41 -28.15 64.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.008 0.432 . . . . 71.52 111.323 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.611 HD11 HD13 ' A' ' 55' ' ' LEU . 57.7 tp -56.18 -31.11 63.12 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.189 -0.459 . . . . 71.03 111.448 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.97 -36.39 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.872 0.367 . . . . 65.24 111.328 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.55 -20.01 55.31 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.081 -0.581 . . . . 54.54 112.895 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 7.4 mpt_? -94.38 5.11 52.79 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.579 -0.365 . . . . 60.14 111.934 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -63.56 -16.0 59.61 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.889 0.329 . . . . 75.42 111.889 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.1 p -66.15 -25.31 66.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.821 0.343 . . . . 72.22 111.643 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.5 135.93 3.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.374 -0.441 . . . . 32.21 112.493 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.611 HD13 HD11 ' A' ' 48' ' ' LEU . 2.3 pt? -163.83 170.32 17.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.117 0.484 . . . . 70.5 111.662 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 p -148.76 124.33 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.34 111.174 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -95.8 135.4 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.13 -0.486 . . . . 71.24 110.96 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.5 -86.58 0.68 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.229 -0.51 . . . . 70.12 113.805 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.5 pmm? -151.92 167.96 26.7 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.3 -0.53 . . . . 73.13 111.855 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.3 p -144.18 49.13 0.99 Allowed Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 112.345 0.498 . . . . 72.01 112.345 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.13 157.57 61.1 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.414 2.076 . . . . 75.13 113.599 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.0 -50.48 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.523 0.934 . . . . 74.52 113.523 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.04 -46.51 65.09 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.601 0.593 . . . . 64.3 112.601 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -102.11 5.26 40.31 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.507 0.558 . . . . 64.12 112.507 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.86 -29.88 70.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.776 1.028 . . . . 53.33 113.776 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -37.47 -70.53 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.905 1.076 . . . . 73.12 113.905 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.4 m -77.39 -37.77 51.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.823 0.344 . . . . 71.35 111.79 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.45 -43.99 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.462 0.541 . . . . 63.33 112.462 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.03 -40.82 95.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.852 0.358 . . . . 71.22 111.413 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.88 -36.52 90.35 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.016 -0.611 . . . . 24.24 112.203 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.456 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -68.52 -51.14 46.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.826 -0.22 . . . . 74.04 111.119 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 75' ' ' ILE . 98.3 mt -53.79 -45.71 70.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.925 0.393 . . . . 64.23 111.678 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -56.75 -28.1 60.58 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.104 -0.498 . . . . 61.2 111.285 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 m -86.89 -40.19 15.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.259 -0.428 . . . . 75.44 111.136 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.503 HD12 HD23 ' A' ' 72' ' ' LEU . 73.7 mt -56.13 -40.6 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.394 -0.366 . . . . 73.34 111.679 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.2 mt -56.37 -26.67 53.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.51 -0.314 . . . . 62.14 111.651 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.9 31.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.189 -0.529 . . . . 32.44 113.463 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 75' ' ' ILE . 89.4 p -87.8 -34.27 18.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.247 0.524 . . . . 74.14 111.882 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.97 135.13 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.974 0.416 . . . . 73.12 111.59 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 82' ' ' LYS . 24.7 t-20 -89.53 107.01 18.83 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.298 0.481 . . . . 62.33 112.298 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 36.84 -75.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.89 1.441 . . . . 73.5 114.89 167.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.1 96.51 5.13 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.216 0.531 . . . . 74.3 112.401 -174.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.719 ' H ' HD23 ' A' ' 110' ' ' LEU . 85.6 mm-40 -133.97 172.72 12.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.433 -0.349 . . . . 74.12 110.851 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.5 107.81 18.06 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.048 0.452 . . . . 35.41 111.282 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 HD21 ' A' ' 55' ' ' LEU . 24.4 m -109.67 119.4 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.565 0.698 . . . . 72.13 112.158 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.39 142.51 25.01 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.177 -0.535 . . . . 74.4 112.507 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.54 ' H ' ' HB3' ' A' ' 113' ' ' ALA . 7.1 tp -160.86 137.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.655 -0.32 . . . . 73.12 110.793 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -161.64 161.69 29.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.532 0.333 . . . . 63.45 110.753 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 1.3 pm0 -81.65 146.28 30.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.495 0.664 . . . . 61.32 112.095 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.3 m -140.1 100.61 3.96 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.157 -0.474 . . . . 71.15 111.126 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . 79.01 -170.81 54.91 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.081 -0.58 . . . . 31.0 113.309 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.23 79.26 0.41 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.127 -0.559 . . . . 72.52 112.708 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.05 159.34 53.5 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.427 -0.416 . . . . 51.54 113.856 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -162.69 108.03 1.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.436 -0.579 . . . . 74.2 109.436 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.18 151.52 50.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.987 0.422 . . . . 70.31 111.556 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.633 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.2 tm-20 -91.47 -58.05 0.24 Allowed Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 116.384 -0.371 . . . . 55.1 111.943 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 96' ' ' GLU . 85.0 Cg_endo -84.83 84.95 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.93 1.753 . . . . 74.25 113.224 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.648 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.5 tp -92.08 -66.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 112.005 0.372 . . . . 72.21 112.005 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.648 ' H ' HG23 ' A' ' 98' ' ' ILE . 4.6 m-20 -59.19 -46.85 99.23 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 113.029 0.751 . . . . 52.23 113.029 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.1 Cg_exo -42.67 -38.4 6.4 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.935 2.423 . . . . 73.43 114.289 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.42 -49.38 10.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.686 0.279 . . . . 74.22 111.053 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 86.1 mt -51.28 -44.06 61.73 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.421 0.526 . . . . 52.51 112.421 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.3 t -57.24 -42.28 81.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.699 0.285 . . . . 71.13 111.655 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -59.32 -46.84 87.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 74.52 111.271 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 110' ' ' LEU . 78.0 m-85 -63.22 -52.21 63.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.123 0.487 . . . . 71.44 111.135 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -54.62 -45.02 73.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.571 -0.74 . . . . 71.25 112.415 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -74.28 -56.1 5.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 73.3 112.569 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.37 -40.96 96.22 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.508 0.558 . . . . 64.34 112.508 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.2 17.54 4.88 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.968 -0.634 . . . . 70.13 112.774 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 83' ' ' GLN . 59.7 mt -73.31 102.9 3.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.064 0.459 . . . . 72.44 110.384 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.9 m -63.58 102.74 0.46 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.109 -0.496 . . . . 74.42 111.971 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -85.7 132.24 34.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.92 -0.582 . . . . 74.31 111.171 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.54 ' HB3' ' H ' ' A' ' 87' ' ' ILE . . . -55.66 -76.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.773 0.286 . . . . 71.2 111.773 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -164.69 88.54 1.05 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.966 0.412 . . . . 53.54 111.253 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.06 112.03 1.69 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.649 2.233 . . . . 73.33 113.859 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.603 ' HB3' HH21 ' A' ' 118' ' ' ARG . . . -170.28 -173.17 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.581 -0.281 . . . . 33.2 111.209 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.71 88.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.233 0.539 . . . . 74.15 111.525 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.603 HH21 ' HB3' ' A' ' 116' ' ' ALA . 8.4 ptp180 -104.87 -18.63 14.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.759 0.314 . . . . 75.13 111.658 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.67 111.39 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 71.45 110.806 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.97 -48.68 80.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.04 -0.527 . . . . 74.01 112.138 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.48 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 53.0 tt0 -158.81 -49.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.083 0.468 . . . . 65.31 111.335 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -114.49 117.85 42.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.337 -0.392 . . . . 74.4 111.662 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.55 126.45 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.376 2.05 . . . . 63.1 112.423 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.4 p -78.14 172.29 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.571 0.224 . . . . 62.44 110.924 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.63 -30.8 44.56 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.751 0.278 . . . . 70.44 111.751 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -52.95 -32.37 45.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.161 0.505 . . . . 70.01 111.081 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 m -61.19 -48.49 81.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.054 -0.521 . . . . 73.11 110.908 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -58.81 -51.51 69.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.192 -0.458 . . . . 65.23 111.248 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -33.76 76.3 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.22 -0.445 . . . . 73.02 112.097 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.24 -60.04 2.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.043 0.449 . . . . 52.41 110.914 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.99 -27.86 67.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.262 -0.426 . . . . 73.34 112.084 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.456 ' HA ' HG12 ' A' ' 20' ' ' ILE . 40.0 tt0 -52.43 -50.96 61.53 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.404 -0.362 . . . . 72.52 111.896 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.8 -46.89 85.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.735 0.303 . . . . 74.02 111.316 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.42 -48.94 73.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.914 0.388 . . . . 65.04 111.604 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.83 -38.72 94.62 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.097 -0.573 . . . . 70.0 113.108 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 99.7 m -63.35 -49.15 75.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.733 0.302 . . . . 72.25 111.186 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.12 -37.49 80.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.1 0.476 . . . . 72.44 110.751 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 142' ' ' VAL . 3.4 tm? -59.16 -51.59 69.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 74.23 110.237 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.97 -44.2 94.64 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.278 -0.487 . . . . 34.41 112.762 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.06 -30.84 71.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.23 111.331 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 88.5 t90 -71.65 -51.52 22.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.187 0.518 . . . . 74.31 110.833 176.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 138' ' ' LEU . 77.2 t -54.43 -46.88 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.279 -0.419 . . . . 62.33 112.005 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' ' 29' ' ' VAL . 7.4 t -62.41 -37.98 87.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.8 0.667 . . . . 71.51 112.8 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 141' ' ' TRP . 8.0 ptp180 -75.32 -41.38 56.92 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.076 -0.39 . . . . 71.22 111.54 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.19 -14.54 35.82 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.952 0.723 . . . . 72.53 112.952 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.77 -34.65 78.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.42 0.629 . . . . 64.22 109.673 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.5 tp . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 115.433 -0.803 . . . . 74.3 109.818 171.087 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.281 0.086 . . . . 64.1 110.779 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 mm 63.49 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.246 0.545 . . . . 75.01 110.919 -174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -80.55 108.86 2.86 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.723 -0.751 . . . . 72.13 112.622 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.2 p -88.17 105.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.732 0.777 . . . . 52.24 111.203 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 88.1 m-85 -99.57 98.27 9.17 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.633 -0.712 . . . . 75.52 111.107 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 9.5 p90 -119.06 157.93 26.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.453 0.644 . . . . 64.42 112.349 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 43.6 t -104.66 101.29 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.822 -0.626 . . . . 71.34 112.066 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 m -63.26 -23.83 67.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.438 0.637 . . . . 62.11 111.341 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -78.22 -20.59 51.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.783 -0.644 . . . . 64.33 112.407 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -137.24 132.67 34.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.11 0.782 . . . . 60.22 113.11 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 90' ' ' THR . . . 56.36 -163.62 5.71 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 115.336 0.894 . . . . 74.33 115.336 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.84 7.52 10.29 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.502 0.556 . . . . 75.12 112.502 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 53.3 m -35.64 -47.88 0.5 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.987 1.106 . . . . 50.02 113.987 -172.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -54.66 -52.37 62.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.149 0.499 . . . . 64.3 111.687 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -77.3 -25.33 51.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.11 -0.496 . . . . 72.43 111.931 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.39 -48.14 71.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.356 0.598 . . . . 72.04 110.087 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -64.79 -43.71 92.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.635 -0.711 . . . . 70.12 111.268 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -51.26 -40.19 58.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.09 -0.504 . . . . 75.4 111.484 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.89 89.91 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.95 0.405 . . . . 71.32 111.343 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.9 -52.34 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.123 0.487 . . . . 72.42 111.351 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 31' ' ' VAL . 65.3 mt -55.08 -49.51 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.738 -0.665 . . . . 60.42 111.544 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.77 -36.41 69.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.341 -0.39 . . . . 43.21 111.82 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.26 -46.46 42.18 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.088 -0.577 . . . . 52.01 113.258 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.68 -43.97 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.811 0.338 . . . . 74.53 111.572 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.8 p -63.53 -38.37 90.87 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 71.34 111.164 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -64.8 -21.12 66.71 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.304 0.573 . . . . 75.22 111.285 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.7 m -85.43 -17.84 35.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.156 -0.475 . . . . 72.14 111.438 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.26 16.71 10.82 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.302 -0.475 . . . . 54.03 113.848 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.14 138.39 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 117.212 0.506 . . . . 71.14 111.443 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.19 139.24 19.57 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.116 -0.564 . . . . 71.22 112.932 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 21' ' ' ILE . 29.8 t -105.79 141.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.84 0.352 . . . . 75.5 111.582 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 22.6 m-20 -93.49 106.49 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.113 0.483 . . . . 71.2 111.134 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -87.6 109.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.349 0.595 . . . . 62.43 112.224 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -118.49 112.5 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.054 0.454 . . . . 64.11 111.404 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.48 76.46 8.23 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.385 -0.371 . . . . 71.32 111.234 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 37' ' ' GLY . 2.0 pp -70.31 -23.83 62.92 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.912 -0.493 . . . . 73.11 111.319 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -87.94 47.79 3.59 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.289 -0.481 . . . . 55.05 112.291 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.97 -65.95 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.942 0.497 . . . . 54.52 110.516 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.16 130.1 0.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.254 -0.43 . . . . 75.22 111.397 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.33 150.7 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.852 0.358 . . . . 75.11 111.641 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.82 165.49 27.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.458 -0.337 . . . . 71.3 111.238 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.5 mm? -59.56 -26.27 65.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.147 0.425 . . . . 64.52 112.147 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -56.41 -50.52 71.4 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.03 111.917 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -83.3 -33.92 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.567 -0.288 . . . . 71.05 111.274 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 89.1 mt -60.37 -29.45 68.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.627 0.251 . . . . 61.23 111.613 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.13 -39.02 89.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.181 0.515 . . . . 74.11 110.802 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.01 -25.72 62.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.326 -0.397 . . . . 61.52 111.912 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.0 tp -53.22 -28.91 29.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.907 0.384 . . . . 62.22 111.255 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.37 -49.67 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.312 -0.404 . . . . 72.21 111.865 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.68 -20.42 63.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.094 -0.574 . . . . 61.12 114.309 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -100.71 5.7 43.77 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.244 -0.563 . . . . 73.34 111.43 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.5 p -64.72 -7.38 10.6 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.648 0.981 . . . . 71.54 113.648 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 p -60.58 -42.93 97.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.139 0.422 . . . . 75.43 112.139 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.26 135.35 6.59 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.989 -0.624 . . . . 33.12 112.34 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 55' ' ' LEU . 3.2 mp -133.3 152.38 51.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 74.4 111.287 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.36 92.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.452 -0.34 . . . . 73.41 110.175 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.3 mp -99.92 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.513 . . . . 63.42 111.786 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.82 151.73 17.87 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.33 -0.462 . . . . 43.21 112.714 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.499 ' SD ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -53.09 142.01 21.28 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.361 0.6 . . . . 71.14 112.559 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 92.5 p -132.82 124.15 18.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.405 0.521 . . . . 60.03 112.405 -173.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 166.14 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.27 1.98 . . . . 72.41 112.149 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -29.36 -62.8 0.12 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.152 1.538 . . . . 74.23 115.152 -170.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.14 70.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.399 0.518 . . . . 73.22 112.399 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.8 m -84.14 -39.67 19.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 43.23 111.215 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.72 68.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.864 0.364 . . . . 74.21 111.315 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.11 -36.66 70.92 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 50.12 111.298 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.2 m -63.47 -48.34 78.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.148 0.499 . . . . 74.03 110.748 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.79 -52.47 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.099 -0.501 . . . . 75.55 111.611 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.84 -26.7 67.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.396 -0.366 . . . . 75.21 111.373 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.93 -42.25 38.3 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.027 -0.606 . . . . 73.23 112.159 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.18 5.78 18.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.927 0.343 . . . . 53.14 111.927 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -46.0 -48.4 16.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.115 0.566 . . . . 62.2 111.457 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -53.72 -37.48 63.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.135 -0.484 . . . . 73.14 111.939 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -77.72 -44.51 27.62 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.344 -0.389 . . . . 74.31 111.357 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.16 -58.86 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 112.173 0.434 . . . . 71.24 112.173 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.15 -23.68 67.55 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.061 0.393 . . . . 64.24 112.061 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.31 -25.04 52.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.026 -0.606 . . . . 65.51 112.99 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 m -85.52 -38.0 19.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.146 0.424 . . . . 64.43 112.146 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.27 125.06 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.253 0.549 . . . . 70.32 111.89 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -128.63 158.3 38.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.261 0.553 . . . . 74.53 112.122 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.659 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 44.1 tt0 62.37 -85.64 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.502 0.927 . . . . 74.01 113.502 168.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.659 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 65.2 pttt -165.04 23.51 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.394 -0.191 . . . . 74.41 111.48 -173.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.518 HE21 ' H ' ' A' ' 82' ' ' LYS . 14.7 mm-40 -50.79 158.33 0.68 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.137 0.791 . . . . 63.24 113.137 -169.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.15 117.64 28.28 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.617 0.599 . . . . 62.12 112.617 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.14 112.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.532 0.682 . . . . 54.43 111.894 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.12 145.05 17.16 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.111 -0.495 . . . . 34.53 112.102 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 42.7 mm -129.12 139.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 117.12 0.46 . . . . 73.32 111.519 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -128.41 150.75 49.99 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 74.2 110.694 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 36.2 tt0 -127.91 150.91 49.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.002 0.371 . . . . 71.35 112.002 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.499 HG22 ' SD ' ' A' ' 59' ' ' MET . 11.4 t -136.05 10.83 3.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.755 0.312 . . . . 73.32 111.481 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.504 ' H ' ' HG2' ' A' ' 89' ' ' GLU . . . -130.24 -85.75 0.39 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.456 -0.402 . . . . 62.14 112.985 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.1 -12.35 5.55 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.999 -0.62 . . . . 44.51 114.071 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.66 44.51 0.75 Allowed Glycine 0 N--CA 1.463 0.448 0 C-N-CA 121.153 -0.546 . . . . 64.43 112.059 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -173.27 3.44 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.599 0.36 . . . . 74.42 111.596 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' SER . 19.9 t70 74.09 116.99 0.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.578 0.751 . . . . 71.41 111.938 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -79.21 -47.47 1.6 Allowed Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 113.523 0.935 . . . . 72.2 113.523 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.05 9.54 2.37 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.181 1.921 . . . . 73.45 114.705 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.9 tt -46.82 -64.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.393 0.886 . . . . 72.31 113.393 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.641 ' H ' HG23 ' A' ' 98' ' ' ILE . 13.5 m-20 -67.92 -49.43 37.0 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.715 -0.616 . . . . 51.11 112.593 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.8 Cg_exo -44.76 -39.52 13.76 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.444 2.096 . . . . 71.31 113.651 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.18 -62.37 1.68 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.752 0.279 . . . . 71.52 111.752 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.2 mt -56.96 -47.85 79.74 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.415 0.524 . . . . 54.24 112.415 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.7 t -59.37 -32.32 70.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.951 0.405 . . . . 43.13 111.557 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -78.89 -42.58 26.87 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.406 -0.361 . . . . 72.03 111.374 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -60.04 -29.01 68.23 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.908 0.336 . . . . 72.03 111.908 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -55.86 -36.28 67.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.011 0.374 . . . . 74.31 112.011 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.42 -21.63 61.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.944 0.402 . . . . 71.31 111.829 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 108' ' ' LEU . 6.8 mp -92.95 -68.77 0.78 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.914 0.388 . . . . 74.13 110.73 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.16 67.16 0.37 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.218 -0.515 . . . . 71.24 113.519 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 110' ' ' LEU . 6.4 mp -95.58 144.61 25.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.686 -0.303 . . . . 71.53 110.775 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 89.6 m -65.59 109.55 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.028 0.442 . . . . 64.41 111.524 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.5 m -86.44 135.01 33.65 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.279 -0.418 . . . . 62.3 111.313 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.78 -92.62 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.453 0.538 . . . . 70.14 112.453 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -144.71 91.77 6.05 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.323 -0.236 . . . . 74.3 111.539 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -96.22 9.27 1.53 Allowed 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.979 2.453 . . . . 73.3 113.884 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.72 32.66 0.96 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.263 0.838 . . . . 74.21 113.263 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.4 ' C ' ' HD3' ' A' ' 118' ' ' ARG . 13.1 tt -146.39 134.49 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.815 -0.553 . . . . 71.53 112.248 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -129.96 155.16 46.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.076 0.465 . . . . 65.03 111.17 175.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 121' ' ' GLN . 2.1 mp -95.57 150.13 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 116.2 -0.454 . . . . 54.13 111.308 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -62.89 -44.91 94.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.097 0.475 . . . . 74.45 111.93 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.504 ' H ' HG22 ' A' ' 119' ' ' ILE . 58.1 tt0 -178.36 -63.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.832 -0.622 . . . . 74.42 109.656 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -119.52 115.0 34.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.802 -0.635 . . . . 72.13 110.559 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.461 ' HB2' ' OG1' ' A' ' 127' ' ' THR . 96.0 Cg_endo -77.43 -170.78 1.0 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.819 2.346 . . . . 73.22 113.564 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.1 p -131.22 -169.08 2.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.121 0.486 . . . . 72.11 111.723 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 5.0 mp0 -59.06 -26.44 64.61 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.214 -0.448 . . . . 70.42 111.939 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.52 -35.87 72.94 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.44 111.685 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 123' ' ' PRO . 30.6 m -60.3 -39.72 87.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.015 0.436 . . . . 62.3 111.389 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -59.97 -50.81 72.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.177 0.513 . . . . 71.35 110.895 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -62.6 -36.21 82.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.766 -0.652 . . . . 75.01 111.289 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.2 tt -61.48 -44.93 96.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.037 -0.529 . . . . 74.13 110.264 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 89.2 m -59.19 -42.57 91.16 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.134 -0.485 . . . . 55.51 111.502 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -58.68 -49.33 77.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.055 0.455 . . . . 62.03 111.226 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -58.77 -49.41 77.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.142 -0.481 . . . . 75.51 111.385 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.99 -51.92 67.2 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.092 -0.504 . . . . 44.13 112.006 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.39 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.168 -0.539 . . . . 71.43 113.145 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 96.3 m -60.31 -44.91 95.0 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.665 0.269 . . . . 74.12 111.627 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.77 -48.62 80.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.879 0.371 . . . . 65.41 110.973 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.31 -43.15 92.66 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.337 -0.392 . . . . 60.31 111.048 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 143' ' ' THR . . . -58.7 -42.42 96.32 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.112 -0.566 . . . . 43.45 112.918 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -62.3 -35.12 78.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.672 0.272 . . . . 72.0 111.321 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -65.92 -47.51 74.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.849 0.357 . . . . 72.12 111.343 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.89 -53.07 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.937 0.347 . . . . 42.42 111.937 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 139' ' ' GLY . 2.9 t -62.06 -34.82 76.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.042 0.449 . . . . 64.43 111.248 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.97 -37.67 88.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.476 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -80.04 -44.9 19.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.858 0.361 . . . . 74.23 111.787 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -76.61 -7.84 56.04 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.318 0.859 . . . . 54.14 113.318 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.492 -0.558 . . . . 73.44 109.492 170.462 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 75.5 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 111.25 0.093 . . . . 65.3 111.25 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 48.1 mm 62.65 108.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.183 0.516 . . . . 62.23 111.898 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.68 117.01 4.34 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.914 -0.66 . . . . 65.02 113.04 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.54 115.85 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.411 0.624 . . . . 63.34 111.979 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 3.1 m-85 -94.69 112.77 24.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.854 -0.612 . . . . 71.12 111.21 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -135.02 148.92 50.07 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.179 0.514 . . . . 75.35 112.225 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.615 HG22 HD11 ' A' ' 36' ' ' LEU . 15.1 t -112.86 95.43 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.956 -0.565 . . . . 72.34 111.096 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 m -56.14 -16.16 4.76 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.033 0.444 . . . . 62.24 112.038 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.27 -25.13 20.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.535 0.569 . . . . 72.42 112.535 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.18 123.76 35.1 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.479 0.918 . . . . 74.13 113.479 -170.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.69 -163.61 4.86 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.626 1.01 . . . . 51.0 115.626 171.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 93.7 m-85 -75.03 -0.86 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.044 0.757 . . . . 55.15 113.044 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -59.28 -31.02 68.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.225 0.536 . . . . 73.24 110.351 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.84 -37.97 72.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.467 -0.788 . . . . 74.01 111.266 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 15' ' ' ARG . 5.1 mmp_? -85.85 -38.41 18.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.33 -0.395 . . . . 73.43 111.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.9 mt -50.45 -47.25 56.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.529 -0.305 . . . . 71.02 111.792 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.45 65.99 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.104 0.409 . . . . 53.34 112.104 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.435 -0.348 . . . . 72.44 111.568 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.46 -41.96 31.2 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.824 0.345 . . . . 73.21 111.279 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 16' ' ' LEU . 71.9 mt -59.47 -56.06 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.884 0.373 . . . . 75.41 111.885 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.3 tt -58.61 -30.61 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.979 0.419 . . . . 71.12 111.81 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.82 -53.1 12.38 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.037 0.446 . . . . 72.53 111.182 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' HA3' ' HG3' ' A' ' 132' ' ' GLU . . . -63.58 -44.74 96.08 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.188 -0.46 . . . . 73.44 114.082 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.89 -52.05 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.381 0.511 . . . . 72.14 112.381 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -59.46 -34.49 72.59 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.031 0.443 . . . . 51.14 112.01 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -84.53 5.76 26.35 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.502 0.556 . . . . 75.1 112.502 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.25 -47.78 1.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.789 0.328 . . . . 73.41 111.702 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.85 -89.32 0.75 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.997 -0.62 . . . . 64.31 113.585 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.86 172.31 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.164 0.431 . . . . 64.1 112.164 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.03 157.61 53.05 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.397 -0.43 . . . . 61.32 113.652 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 1' ' ' SER . 38.8 t -108.73 148.35 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.527 0.331 . . . . 73.32 111.867 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.45 128.27 53.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.821 0.343 . . . . 43.41 110.858 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.68 138.9 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.538 0.569 . . . . 64.04 112.538 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.53 96.98 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.145 0.497 . . . . 74.11 111.277 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.64 86.83 6.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.314 -0.403 . . . . 75.33 110.955 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 7' ' ' VAL . 3.5 pp -91.29 -23.87 20.01 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.331 0.493 . . . . 70.12 112.331 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -78.99 47.99 3.23 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.027 -0.606 . . . . 61.04 113.303 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -171.91 -167.27 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.76 0.424 . . . . 74.43 110.691 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.58 104.28 5.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.854 0.359 . . . . 62.2 111.028 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.74 175.1 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.503 -0.317 . . . . 71.52 111.601 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -140.48 160.49 39.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.307 0.575 . . . . 71.34 112.331 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.5 tm? -55.16 -35.51 64.84 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.805 -0.634 . . . . 60.42 111.989 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.3 mt-30 -50.78 -43.38 58.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.083 0.468 . . . . 74.32 111.457 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.15 -24.36 64.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.001 -0.545 . . . . 53.21 111.445 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.99 -51.17 34.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.338 -0.392 . . . . 74.15 110.815 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -61.65 -32.64 72.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.83 0.347 . . . . 73.14 111.034 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 71.4 mm-40 -60.62 -48.87 79.86 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.034 0.445 . . . . 63.51 110.641 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.02 -39.35 71.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.887 -0.597 . . . . 64.23 111.812 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.8 -35.09 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.157 0.503 . . . . 72.11 111.186 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.36 -10.81 76.66 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.225 -0.512 . . . . 52.33 113.163 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -101.45 4.58 41.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.396 -0.473 . . . . 52.13 111.569 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.58 1.76 3.8 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.565 0.95 . . . . 74.23 113.565 -172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.5 p -64.15 -42.09 96.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.208 0.527 . . . . 62.1 110.838 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.59 136.59 5.35 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.803 -0.635 . . . . 51.44 112.32 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -160.81 148.41 15.75 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.496 -0.414 . . . . 74.33 111.657 -177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -112.26 125.31 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 71.52 110.974 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 47.5 mt -128.92 136.27 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.064 0.459 . . . . 74.2 112.191 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.69 -163.88 34.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.146 -0.549 . . . . 62.43 112.401 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtm -98.17 135.26 40.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.018 -0.695 . . . . 72.35 110.648 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.9 p -79.62 150.8 73.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.199 0.444 . . . . 62.43 112.199 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 64' ' ' SER . 16.5 Cg_endo -90.85 157.59 4.07 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.831 2.354 . . . . 65.53 111.78 169.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.97 -31.58 29.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.174 0.435 . . . . 70.33 112.174 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.02 73.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.975 0.361 . . . . 54.33 111.975 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.536 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 38.9 m -95.76 -13.21 24.31 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.685 0.278 . . . . 71.44 111.679 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.73 -42.4 35.1 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.86 0.689 . . . . 74.03 112.86 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.96 -47.08 78.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.99 0.424 . . . . 62.53 111.853 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -67.13 -45.82 75.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.147 0.498 . . . . 64.44 111.401 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.2 -46.96 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.981 -0.554 . . . . 75.13 112.155 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -57.82 -35.56 71.03 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.821 0.343 . . . . 75.45 111.895 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.83 -43.38 28.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.062 -0.59 . . . . 73.31 113.072 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.35 -26.07 51.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.225 0.454 . . . . 60.34 112.225 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 101' ' ' LEU . 52.1 tp -52.8 -37.38 59.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.066 0.395 . . . . 64.15 112.066 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -59.12 -43.97 91.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.944 0.402 . . . . 63.11 111.324 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.9 m -68.63 -36.1 78.17 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.171 0.51 . . . . 72.35 111.004 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 79' ' ' VAL . 67.7 mt -61.96 -59.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.266 -0.425 . . . . 71.51 111.009 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.57 -30.16 65.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.251 0.463 . . . . 62.54 112.251 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.15 -24.04 67.21 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.127 -0.559 . . . . 65.31 113.439 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 p -97.97 -48.36 5.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.304 0.483 . . . . 74.13 112.304 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.8 m -77.88 85.99 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 122.033 0.92 . . . . 75.24 111.687 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -133.24 -178.12 4.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.862 -0.608 . . . . 73.23 112.144 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 65.74 -77.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.249 0.62 . . . . 45.4 111.981 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -168.35 29.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.9 0.704 . . . . 71.34 112.9 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.58 160.99 12.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.095 0.474 . . . . 75.33 111.647 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 138' ' ' LEU . . . -89.19 95.62 10.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.012 0.745 . . . . 72.11 113.012 -170.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 85' ' ' VAL . 18.4 m -102.67 92.95 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.76 0.791 . . . . 63.34 111.551 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.55 72.72 2.5 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.029 -0.532 . . . . 75.31 113.367 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 12.0 tt -96.54 133.67 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 122.639 -0.33 . . . . 73.41 111.035 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' CZ ' ' SG ' ' A' ' 131' ' ' CYS . 8.0 p90 -146.79 173.42 12.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.152 0.501 . . . . 75.42 112.206 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.05 96.61 0.15 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.239 0.542 . . . . 70.24 112.323 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.2 m -131.43 94.02 3.46 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.262 -0.426 . . . . 60.2 110.512 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.65 168.63 11.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.355 -0.45 . . . . 31.42 112.629 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.496 ' HA3' ' OE1' ' A' ' 121' ' ' GLN . . . -114.52 -135.12 5.9 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.852 -0.689 . . . . 64.35 114.022 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.92 77.06 1.8 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.319 -0.467 . . . . 41.41 113.125 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.3 -179.86 7.25 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.631 -0.335 . . . . 72.34 110.734 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 70.89 154.82 0.14 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.868 0.692 . . . . 54.13 112.868 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.525 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.1 mt-10 -104.63 -57.36 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.755 0.65 . . . . 71.35 112.755 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 57.4 Cg_endo -68.51 -1.98 8.4 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.322 2.014 . . . . 65.23 113.996 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.8 tp -50.99 -45.1 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 112.734 0.642 . . . . 73.4 112.734 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.704 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 5.5 m-20 -58.21 -55.74 42.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 111.997 0.369 . . . . 52.41 111.997 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 82.6 Cg_exo -50.24 -48.99 17.64 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.328 2.019 . . . . 74.31 113.358 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' PRO . 11.2 mp -56.74 -51.98 66.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.06 0.393 . . . . 54.41 112.06 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 92.6 mt -53.44 -52.03 60.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.797 0.332 . . . . 73.11 111.67 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t -66.93 -34.46 77.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.776 0.322 . . . . 74.32 111.581 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 1.4 tpmt? -59.86 -60.85 3.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.841 0.353 . . . . 54.33 111.305 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.58 -30.85 71.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.533 -0.303 . . . . 64.42 111.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -59.5 -45.83 90.56 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.868 0.366 . . . . 64.12 110.378 176.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -69.52 -47.95 62.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.208 -0.451 . . . . 72.55 110.666 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.74 -48.7 77.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.866 0.365 . . . . 75.43 111.52 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.53 71.83 0.71 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.654 0.622 . . . . 35.24 114.654 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 110' ' ' LEU . 6.0 mp -90.93 -177.31 4.91 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.415 -0.461 . . . . 64.34 110.415 173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.2 m -63.83 101.89 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.123 0.416 . . . . 74.35 112.123 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 p -105.64 137.39 43.57 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.065 0.459 . . . . 70.14 111.565 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.41 -58.01 3.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.886 0.375 . . . . 50.24 111.796 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -167.78 89.83 0.69 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.735 0.302 . . . . 74.23 110.453 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.01 -33.56 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.62 2.214 . . . . 73.41 114.368 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.49 118.03 28.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.27 0.47 . . . . 62.32 112.27 -173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.507 HG23 HG12 ' A' ' 119' ' ' ILE . 12.6 tt -137.78 7.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.322 0.582 . . . . 73.51 111.779 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 67.73 65.56 0.38 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.026 0.53 . . . . 72.51 112.429 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 123' ' ' PRO . 50.8 mm -104.62 111.67 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 74.11 111.115 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -93.53 -23.13 18.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.234 -0.439 . . . . 71.02 111.683 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.496 ' OE1' ' HA3' ' A' ' 92' ' ' GLY . 6.0 tp-100 -161.48 -65.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.021 0.438 . . . . 64.13 111.291 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.7 p -104.04 125.67 33.82 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.208 0.448 . . . . 73.41 112.208 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HA ' HD12 ' A' ' 119' ' ' ILE . 52.2 Cg_exo -55.93 150.23 47.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.545 2.163 . . . . 74.45 112.456 170.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.8 p -118.93 -176.12 3.05 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.19 0.441 . . . . 73.11 112.19 -174.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.63 -48.41 19.86 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.104 -0.498 . . . . 64.35 112.049 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.96 -25.94 65.6 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.036 -0.529 . . . . 75.43 111.974 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 123' ' ' PRO . 59.2 m -63.87 -36.99 85.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.83 0.348 . . . . 63.31 110.856 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.39 -47.1 74.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.979 0.419 . . . . 75.34 110.937 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.72 -41.47 95.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.224 -0.443 . . . . 64.52 111.072 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.37 -54.43 47.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.466 -0.334 . . . . 74.52 110.238 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 20' ' ' ILE . 74.4 m -50.03 -51.58 40.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.785 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.537 ' HG3' ' HA3' ' A' ' 23' ' ' GLY . 46.1 tt0 -67.17 -55.02 15.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.381 -0.372 . . . . 73.13 111.792 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.49 -54.86 42.29 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.942 0.349 . . . . 52.23 111.942 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.6 76.47 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.4 -0.364 . . . . 54.34 111.85 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.15 -46.85 93.67 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 63.51 113.274 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 94.7 m -63.34 -51.2 66.92 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.88 0.371 . . . . 63.34 111.815 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.06 -42.63 98.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.133 0.492 . . . . 64.25 111.068 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 84' ' ' ALA . 53.7 tp -64.76 -41.24 96.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.053 0.454 . . . . 73.44 110.757 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.24 -42.72 98.82 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.183 -0.462 . . . . 52.21 112.68 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.15 -39.18 85.44 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.955 0.407 . . . . 74.14 110.926 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -59.89 -49.5 77.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.46 -0.336 . . . . 72.42 111.12 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.38 -47.91 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 112.133 0.419 . . . . 71.24 112.133 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -71.83 -41.5 68.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.106 0.409 . . . . 64.44 112.106 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -64.08 -33.16 75.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.919 0.39 . . . . 74.35 111.559 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.6 -26.86 14.7 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.109 -0.496 . . . . 70.24 111.286 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -97.69 -63.68 1.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.339 -0.391 . . . . 75.22 112.013 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 147' ' ' LEU . 4.8 tt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 111.861 0.319 . . . . 64.24 111.861 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.59 -0.152 . . . . 73.45 110.59 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 46.8 mm 74.55 96.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 121.31 0.576 . . . . 63.32 110.589 -172.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -81.99 123.24 5.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.056 -0.52 . . . . 54.23 113.735 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.7 t -95.36 106.4 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 O-C-N 122.608 -0.348 . . . . 65.4 111.115 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.613 ' HB3' HD23 ' A' ' 36' ' ' LEU . 93.1 m-85 -90.96 105.96 18.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.925 0.393 . . . . 71.13 111.614 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 35.9 p90 -146.75 -178.59 6.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.434 -0.348 . . . . 72.42 110.945 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.566 HG13 ' HB3' ' A' ' 10' ' ' TYR . 2.8 p -134.55 104.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.089 0.471 . . . . 75.33 111.086 176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -52.48 -25.34 9.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.215 0.82 . . . . 73.32 113.215 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -74.08 -32.42 63.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.763 0.316 . . . . 54.41 111.644 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.566 ' HB3' HG13 ' A' ' 7' ' ' VAL . 61.0 t80 -104.31 137.41 42.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.07 0.462 . . . . 74.13 112.226 -173.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.12 -161.79 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.98 0.752 . . . . 63.01 114.98 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.63 7.56 17.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.772 0.429 . . . . 73.5 111.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 84.8 p -30.75 -65.65 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.279 1.214 . . . . 55.51 114.279 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.46 -35.04 79.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.085 0.402 . . . . 72.41 112.085 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -60.21 -40.29 89.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.092 0.472 . . . . 70.43 110.747 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.44 -37.18 68.64 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 71.44 110.764 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.92 -31.64 67.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.206 -0.452 . . . . 51.33 111.352 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -52.21 -43.02 64.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.251 -0.431 . . . . 64.3 110.997 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . . . -67.76 -47.29 69.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.972 -0.558 . . . . 61.41 111.609 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.74 -55.4 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 62.12 111.386 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.03 -46.73 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.212 -0.449 . . . . 75.24 111.207 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.17 -50.22 74.88 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.414 -0.357 . . . . 71.04 111.864 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.17 -48.77 84.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.819 -0.705 . . . . 74.31 113.305 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 30' ' ' GLY . 1.8 mp -72.11 -32.3 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 122.521 -0.399 . . . . 74.34 112.013 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -72.0 -30.2 64.99 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.679 -0.638 . . . . 63.21 110.628 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 4.6 mmmp? -64.99 -24.11 67.42 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.137 0.494 . . . . 74.43 110.692 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.449 HG21 ' HG2' ' A' ' 140' ' ' GLN . 60.3 m -79.07 -40.44 31.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.219 0.533 . . . . 74.24 110.474 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.57 21.63 7.47 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.892 -0.595 . . . . 73.14 113.492 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.44 -77.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 122.402 -0.47 . . . . 72.0 111.995 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 114.67 115.48 3.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.306 -0.473 . . . . 72.25 113.133 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' SER . 29.7 m -90.59 157.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.187 0.518 . . . . 65.33 112.247 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' CG ' ' H2 ' ' A' ' 1' ' ' SER . 9.4 m-20 -96.28 130.62 43.33 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.926 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.41 120.19 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.142 -0.348 . . . . 71.33 111.759 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.79 104.15 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.672 0.273 . . . . 60.23 111.717 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 11.4 m-20 -77.05 103.23 6.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.811 0.339 . . . . 74.4 111.049 173.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.613 HD23 ' HB3' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -67.96 78.81 0.22 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.968 0.89 . . . . 72.11 111.864 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.1 -25.62 0.23 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.404 -0.816 . . . . 75.24 112.397 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.97 157.87 34.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.778 0.323 . . . . 43.2 111.364 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 70.28 2.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.207 0.527 . . . . 72.42 111.976 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.63 147.65 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 75.43 111.527 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.4 166.8 10.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.98 0.419 . . . . 74.34 111.259 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD13 HD12 ' A' ' 45' ' ' LEU . 3.9 mm? -56.22 -24.4 41.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.451 -0.341 . . . . 74.3 111.201 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.74 -49.6 77.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.218 -0.446 . . . . 65.0 111.033 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.82 -46.41 71.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.879 0.371 . . . . 74.12 111.168 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 42' ' ' LEU . 93.7 mt -57.53 -46.82 83.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.191 -0.459 . . . . 74.24 111.767 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.4 -44.92 96.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.698 0.285 . . . . 74.35 111.586 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 9.5 tp10 -64.57 -42.52 95.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.167 0.508 . . . . 70.21 110.83 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.73 -42.06 71.1 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.969 -0.56 . . . . 74.54 111.485 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 45' ' ' LEU . 67.2 t -56.1 -37.61 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.979 0.418 . . . . 74.05 111.43 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.11 -21.32 79.89 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.964 -0.636 . . . . 54.12 112.993 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 12.5 mmt180 -100.74 5.3 43.59 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.57 -0.371 . . . . 71.31 111.821 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.1 p -70.83 4.58 2.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.324 0.861 . . . . 75.41 113.324 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.5 p -58.96 -36.39 74.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 52.52 110.927 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -154.95 138.82 6.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.624 -0.716 . . . . 14.01 112.047 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.0 169.76 17.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.256 0.528 . . . . 75.34 112.196 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 88' ' ' PHE . 7.3 p -131.46 136.24 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.767 0.318 . . . . 74.23 111.388 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.7 mp -112.69 133.16 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.936 0.398 . . . . 60.0 112.062 -175.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.93 -124.45 5.41 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.263 -0.494 . . . . 50.31 112.686 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.442 ' SD ' ' HA3' ' A' ' 91' ' ' GLY . 54.9 ttm -155.07 154.7 32.83 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.429 -0.454 . . . . 72.24 110.892 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.546 ' HB3' HD13 ' A' ' 36' ' ' LEU . 67.7 p -114.19 156.95 43.52 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 120.607 0.242 . . . . 72.15 111.38 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.43 152.14 78.78 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.951 1.767 . . . . 74.23 111.826 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.34 -41.08 8.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.422 0.897 . . . . 73.13 113.422 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.48 -48.34 56.21 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.155 0.428 . . . . 72.21 112.155 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -14.49 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.027 0.38 . . . . 75.13 112.027 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -54.22 -32.18 55.2 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.225 0.454 . . . . 73.04 112.225 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.19 -33.21 70.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 75.43 111.252 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -67.84 -42.13 81.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.176 -0.465 . . . . 63.53 111.296 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.5 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.814 0.34 . . . . 51.51 110.855 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -51.62 -45.4 63.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.208 -0.451 . . . . 71.15 111.545 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.01 -49.47 16.43 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.047 -0.596 . . . . 64.41 113.184 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.83 76.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.005 0.372 . . . . 54.53 112.005 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 tt -48.39 -49.73 33.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.21 0.604 . . . . 74.3 111.387 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -60.13 -40.09 88.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.105 0.409 . . . . 71.4 112.105 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.2 m -74.33 -36.87 63.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.876 0.37 . . . . 72.23 111.395 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 79' ' ' VAL . 74.7 mt -71.63 -67.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.469 -0.332 . . . . 74.2 111.397 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.482 ' HA ' HG22 ' A' ' 79' ' ' VAL . 68.4 mt -61.65 -22.15 65.03 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.452 0.538 . . . . 75.4 112.452 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.45 -22.68 64.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.727 -0.749 . . . . 44.3 113.259 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -101.03 -26.2 13.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.458 0.54 . . . . 71.23 112.458 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 75' ' ' ILE . 33.7 m -70.51 179.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.381 0.61 . . . . 72.41 112.417 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.61 161.34 25.97 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.092 -0.504 . . . . 74.1 111.691 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -46.97 -42.89 18.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.699 0.8 . . . . 62.41 112.814 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -145.92 133.03 20.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.089 0.471 . . . . 71.21 111.39 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -133.54 177.18 7.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.073 -0.512 . . . . 73.1 111.806 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.632 ' HB1' HD11 ' A' ' 138' ' ' LEU . . . -102.74 112.18 24.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.845 0.355 . . . . 62.35 111.24 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.75 169.69 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.91 0.386 . . . . 72.24 111.967 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.12 169.29 32.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.37 -0.443 . . . . 71.04 112.749 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.482 HG21 ' HB3' ' A' ' 116' ' ' ALA . 43.9 mm -100.42 146.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 74.13 111.895 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.543 ' HB2' HG22 ' A' ' 56' ' ' VAL . 17.8 t80 -135.28 109.58 8.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.501 -0.318 . . . . 60.32 110.749 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -64.62 93.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.557 0.577 . . . . 62.33 112.557 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 t -160.58 77.79 0.61 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.258 0.551 . . . . 73.33 111.819 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.442 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . 171.31 121.51 0.59 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.091 -0.576 . . . . 35.33 113.193 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.87 51.09 4.27 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.128 -0.558 . . . . 62.24 113.407 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.32 56.76 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.281 -0.485 . . . . 62.14 113.313 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.6 -154.89 0.38 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.67 0.388 . . . . 71.05 111.404 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 23.3 t70 69.66 154.93 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.321 0.648 . . . . 53.33 112.593 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 8.3 mm-40 -103.42 -56.33 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.095 -0.502 . . . . 72.14 112.31 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 88.4 Cg_endo -80.04 16.96 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.122 1.881 . . . . 72.11 113.759 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.3 tt -48.0 -56.39 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.705 1.002 . . . . 62.22 113.705 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.689 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.5 m-20 -61.17 -54.07 57.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.972 -0.455 . . . . 70.51 111.953 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 51.8 Cg_exo -54.66 -42.2 70.56 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.905 1.737 . . . . 74.34 112.654 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.61 -59.52 4.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.984 0.421 . . . . 74.41 111.342 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.51 -35.4 79.26 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.02 0.438 . . . . 44.21 111.511 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -62.71 -46.28 88.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.394 -0.366 . . . . 73.14 111.784 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 100' ' ' PRO . 53.2 mtpt -61.08 -45.15 95.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.499 0.19 . . . . 74.13 111.356 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.439 ' HA ' HD13 ' A' ' 110' ' ' LEU . 2.3 m-85 -58.59 -40.96 84.66 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.026 0.441 . . . . 73.31 110.991 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.76 -49.66 74.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.715 -0.675 . . . . 74.44 111.9 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -81.29 -46.85 14.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.864 0.69 . . . . 73.03 112.864 -174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.5 -15.18 57.14 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.238 0.458 . . . . 54.15 112.238 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.61 4.98 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 114.398 0.519 . . . . 73.42 114.398 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 105' ' ' PHE . 7.5 mp -88.88 -175.33 4.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.095 0.448 . . . . 44.33 110.995 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 154.16 26.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.258 0.552 . . . . 61.14 111.982 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -100.98 -51.94 3.41 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.069 -0.514 . . . . 75.04 111.757 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.59 42.87 13.44 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.093 0.473 . . . . 72.54 111.563 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.5 t80 68.23 93.71 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.468 -0.787 . . . . 70.55 111.706 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.31 96.5 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.432 2.088 . . . . 70.03 112.276 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HB3' HG21 ' A' ' 87' ' ' ILE . . . -56.57 156.14 6.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.524 0.564 . . . . 71.04 112.524 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.667 HD13 ' N ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -77.13 139.42 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.13 -0.486 . . . . 74.24 110.402 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.667 ' N ' HD13 ' A' ' 117' ' ' ILE . 82.2 mtt180 -56.74 120.72 8.32 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.133 0.492 . . . . 73.32 111.659 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.8 mp -70.15 138.15 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.302 0.572 . . . . 71.11 112.172 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -65.86 -70.94 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.912 -0.586 . . . . 74.23 110.723 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -155.1 -58.98 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.172 0.511 . . . . 72.42 110.413 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.3 p -94.69 136.87 22.7 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.123 -0.489 . . . . 51.33 111.933 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.46 -165.21 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.962 2.442 . . . . 72.13 112.8 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 55.0 p -133.08 171.89 13.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.939 0.4 . . . . 60.31 111.542 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.81 -33.41 56.0 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.155 0.503 . . . . 63.43 111.569 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.76 -10.77 30.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.533 0.568 . . . . 71.5 112.533 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.5 m -63.56 -33.11 74.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.012 0.434 . . . . 62.13 111.13 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.552 ' HA ' ' HG ' ' A' ' 131' ' ' CYS . 82.9 m-85 -65.16 -41.67 94.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.301 0.572 . . . . 74.44 110.514 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.17 -49.71 76.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 73.51 111.099 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.17 -58.13 9.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.106 -0.497 . . . . 75.22 111.218 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.552 ' HG ' ' HA ' ' A' ' 128' ' ' TYR . 27.8 p -58.15 -47.09 84.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.671 0.619 . . . . 75.31 112.671 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.58 -54.75 27.15 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.154 0.427 . . . . 71.53 112.154 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.33 -48.6 72.47 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.117 0.414 . . . . 34.31 112.117 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.31 -42.84 92.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.896 0.379 . . . . 71.22 111.312 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.49 97.48 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.317 -0.468 . . . . 75.3 112.774 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 46.6 m -62.05 -44.17 97.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.999 0.428 . . . . 63.31 111.096 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.92 -61.07 2.13 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.82 0.343 . . . . 73.44 111.441 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.632 HD11 ' HB1' ' A' ' 84' ' ' ALA . 46.9 tp -63.34 -37.86 88.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.83 0.348 . . . . 74.3 111.722 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -51.14 45.46 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.114 -0.565 . . . . 74.1 113.165 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 143' ' ' THR . 28.2 mt-30 -73.01 -7.84 53.04 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.353 -0.498 . . . . 74.42 111.983 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.471 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 62.6 t90 -55.26 -32.3 62.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.137 0.494 . . . . 73.21 110.191 170.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.62 -47.07 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.95 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 140' ' ' GLN . 11.3 t -73.66 -32.06 63.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.143 -0.348 . . . . 55.21 111.49 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -70.74 -41.83 71.29 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.86 0.362 . . . . 62.15 111.438 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.53 -61.05 1.76 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.532 0.567 . . . . 51.43 112.532 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -75.08 -55.08 6.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.902 0.382 . . . . 64.45 111.838 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 147' ' ' LEU . 10.1 tt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 120.922 0.392 . . . . 71.35 110.994 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 45.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.143 -0.317 . . . . 55.12 110.143 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 54' ' ' GLY . 47.2 mm 59.64 91.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.184 0.516 . . . . 71.52 111.53 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 104.64 2.3 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.833 -0.698 . . . . 65.44 112.84 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 m -87.3 107.79 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.427 0.632 . . . . 44.42 110.881 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.758 ' HB3' HD23 ' A' ' 36' ' ' LEU . 55.3 m-85 -104.22 118.37 36.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.897 -0.592 . . . . 60.13 111.206 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -152.16 176.51 11.49 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.202 0.445 . . . . 72.5 112.202 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' SER . 48.4 t -109.08 104.04 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 116.089 -0.505 . . . . 74.14 110.28 172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 62.1 p -59.67 -56.74 18.08 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.415 0.895 . . . . 74.1 113.415 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.23 -43.26 92.35 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.087 0.773 . . . . 65.0 113.087 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -77.26 121.02 23.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.14 0.495 . . . . 63.13 112.266 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.28 -162.61 6.17 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.844 -0.616 . . . . 44.51 114.408 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -81.9 7.77 12.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.925 0.343 . . . . 55.41 111.925 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 20.0 m -44.22 -43.97 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.578 0.955 . . . . 75.45 113.578 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.688 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 19.6 p-10 -73.57 -36.71 65.62 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.922 -0.486 . . . . 60.3 111.358 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mmt-85 -61.22 -40.62 94.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.519 0.676 . . . . 74.11 109.713 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.665 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . 79.7 mt -66.67 -41.68 87.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 73.44 110.838 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.74 83.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 75.11 111.136 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.48 -27.56 65.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.801 0.334 . . . . 72.33 110.994 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 22' ' ' ASN . . . -64.27 -37.64 88.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.089 0.471 . . . . 72.5 110.362 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.57 HG23 ' HA3' ' A' ' 135' ' ' GLY . 63.1 mt -63.1 -53.1 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.278 0.561 . . . . 74.51 110.301 171.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.14 -33.45 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.751 -0.659 . . . . 75.5 111.283 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 39.2 t30 -53.65 -60.14 3.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.356 -0.384 . . . . 53.44 111.187 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.17 97.93 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.12 -0.562 . . . . 71.55 113.06 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 29' ' ' VAL . 55.4 mt -60.75 -50.6 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.235 0.457 . . . . 73.12 112.235 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -67.97 -38.22 82.47 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.165 -0.335 . . . . 75.33 111.298 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.8 -32.89 69.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.091 0.472 . . . . 73.02 111.078 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.605 HG21 ' HG2' ' A' ' 140' ' ' GLN . 88.6 m -79.4 -35.27 40.92 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.95 0.405 . . . . 74.11 111.175 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.91 32.25 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.365 -0.445 . . . . 75.52 113.279 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HB ' HG23 ' A' ' 24' ' ' ILE . 29.5 t -108.91 133.95 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 122.462 -0.434 . . . . 74.21 111.417 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.09 112.64 3.64 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.111 -0.566 . . . . 70.41 112.534 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 24' ' ' ILE . 7.7 p -99.22 140.85 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 112.48 0.548 . . . . 64.24 112.48 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -96.48 109.38 21.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.027 0.441 . . . . 71.32 110.695 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.07 116.91 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 111.872 0.323 . . . . 74.13 111.872 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.41 119.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.017 0.437 . . . . 54.42 111.942 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.67 105.27 16.1 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.934 0.397 . . . . 74.22 111.255 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 5' ' ' PHE . 2.9 pp -77.38 -10.02 59.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.843 0.354 . . . . 73.11 111.43 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.58 -12.26 66.67 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.206 -0.521 . . . . 34.53 113.14 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.18 -48.23 0.06 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.867 0.365 . . . . 73.41 111.77 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.613 0.597 . . . . 74.41 112.613 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.0 m -117.96 45.79 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.323 0.583 . . . . 73.13 110.957 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.35 149.39 48.46 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.463 0.542 . . . . 70.42 112.463 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.411 ' H ' HD22 ' A' ' 42' ' ' LEU . 3.3 mm? -58.55 -35.12 71.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.135 -0.484 . . . . 73.33 112.175 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -62.94 -40.17 96.86 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.883 0.373 . . . . 62.35 110.723 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LEU . 17.6 tp10 -70.41 -29.7 66.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.3 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 74' ' ' THR . 3.3 tm? -60.9 -46.96 88.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.146 0.498 . . . . 64.31 109.815 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.32 -40.0 94.88 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.39 0.614 . . . . 73.4 110.721 172.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.728 ' HG3' HH11 ' A' ' 51' ' ' ARG . 20.5 tp10 -79.83 -10.63 59.8 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.642 -0.708 . . . . 74.25 111.332 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 51' ' ' ARG . 53.3 tp -59.22 -28.67 66.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.92 0.488 . . . . 71.04 111.696 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.403 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 35.8 t -58.9 -23.95 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.988 0.423 . . . . 74.13 111.351 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.15 -34.95 25.19 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.926 -0.654 . . . . 61.44 112.151 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.728 HH11 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -68.83 -38.28 79.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.839 0.352 . . . . 72.23 111.273 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 p -67.12 -2.84 6.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.868 0.692 . . . . 63.44 112.868 -174.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -62.88 -22.21 66.55 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.134 0.492 . . . . 61.31 110.892 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 2' ' ' ILE . . . -153.58 137.43 5.77 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.99 -0.844 . . . . 70.12 110.99 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HB2' HG12 ' A' ' 85' ' ' VAL . 95.4 mt -116.58 116.54 27.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.583 0.691 . . . . 64.31 112.434 -173.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.02 105.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 74.13 110.266 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -101.93 119.61 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.846 0.355 . . . . 64.41 111.273 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 59' ' ' MET . . . -80.91 -12.04 83.14 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.028 -0.606 . . . . 54.21 113.84 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 49.6 ttp 71.3 149.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.301 0.572 . . . . 61.45 111.723 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 60.0 m -151.22 140.77 13.99 Favored Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 122.182 -0.324 . . . . 75.31 111.132 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.91 161.68 28.46 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.514 2.143 . . . . 73.45 112.978 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.38 -39.7 7.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.53 0.567 . . . . 71.34 112.53 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.68 64.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.092 0.405 . . . . 54.51 112.092 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 19.6 m -79.86 -19.27 48.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.443 -0.344 . . . . 73.33 111.893 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.88 -11.93 43.14 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.601 0.593 . . . . 52.23 112.601 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.94 -49.67 68.17 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.884 0.373 . . . . 52.42 111.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.7 p -65.59 -43.49 89.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.979 0.418 . . . . 35.33 111.197 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -53.85 -56.08 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.018 -0.537 . . . . 61.43 111.618 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.33 -21.65 62.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.18 0.437 . . . . 74.32 112.18 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.23 -48.3 80.64 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.033 -0.603 . . . . 75.24 112.661 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -89.67 -19.34 24.97 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.869 0.366 . . . . 71.53 111.855 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tt -49.74 -34.71 19.86 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.904 0.481 . . . . 72.11 111.891 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m -47.7 -37.45 13.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.096 -0.502 . . . . 73.15 112.234 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.645 HG21 HD11 ' A' ' 45' ' ' LEU . 45.5 m -99.47 -35.79 9.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 111.759 0.281 . . . . 61.54 111.759 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 71' ' ' ALA . 68.3 mt -47.86 -44.4 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.491 0.552 . . . . 64.42 112.491 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.8 -35.76 64.21 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 71.24 111.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.06 -29.39 28.5 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.123 -0.561 . . . . 65.42 113.111 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -69.6 -30.01 67.66 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.025 0.38 . . . . 72.22 112.025 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.21 164.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.275 0.472 . . . . 51.21 112.275 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.99 148.33 22.44 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.233 -0.44 . . . . 70.34 110.28 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.19 -62.12 1.91 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.931 0.715 . . . . 74.21 112.931 -173.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 53.2 mttm -100.49 114.45 28.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.343 0.592 . . . . 75.44 111.799 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.666 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 5.6 tp60 -163.8 -174.53 3.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.883 -0.599 . . . . 73.02 110.274 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.666 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -110.38 132.57 54.07 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.034 -0.416 . . . . 75.45 111.336 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.589 HG12 ' HB2' ' A' ' 55' ' ' LEU . 29.8 m -119.72 134.64 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.415 0.626 . . . . 72.31 112.43 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 127.72 8.42 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.84 -0.618 . . . . 73.22 112.334 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -129.02 145.86 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.687 -0.302 . . . . 74.51 110.917 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -146.81 135.31 21.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.997 0.427 . . . . 75.23 110.903 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.508 ' HB3' HG22 ' A' ' 117' ' ' ILE . 18.5 pt-20 -78.69 98.47 6.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.328 0.585 . . . . 71.23 112.43 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -115.76 119.28 35.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.149 0.5 . . . . 72.14 111.756 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.26 -75.36 0.5 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.34 -0.457 . . . . 61.04 114.115 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.3 -72.98 1.85 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.077 -0.582 . . . . 41.33 112.263 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.9 -84.65 0.38 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.218 -0.515 . . . . 73.23 113.678 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.85 128.54 2.04 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.758 0.313 . . . . 75.1 111.827 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -150.38 158.03 43.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.334 -0.394 . . . . 64.32 111.024 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.653 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mt-10 -101.29 -59.47 0.1 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.709 0.633 . . . . 73.32 112.709 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 66.2 Cg_endo -81.79 44.94 1.83 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.366 2.044 . . . . 71.45 113.649 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.58 -39.92 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.213 0.449 . . . . 74.21 112.213 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.624 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 26.0 m-20 -68.15 -52.25 23.41 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 122.102 -0.374 . . . . 53.32 111.342 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 72.8 Cg_exo -51.41 -35.94 56.5 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.127 1.884 . . . . 63.12 112.613 172.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.86 -58.26 9.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.41 -0.359 . . . . 72.43 111.003 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.39 -34.11 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.169 0.509 . . . . 71.21 111.207 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -60.13 -40.51 90.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.806 -0.633 . . . . 74.12 111.675 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -60.46 -22.25 63.27 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.09 0.404 . . . . 63.42 112.09 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -91.15 -70.96 0.66 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.122 0.487 . . . . 74.15 111.996 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -71.46 -35.15 70.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.287 0.847 . . . . 64.22 113.287 -169.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.52 -24.97 63.81 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.965 0.412 . . . . 62.23 111.305 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.82 -55.4 3.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.97 0.414 . . . . 73.51 110.948 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HG2' ' A' ' 82' ' ' LYS . . . 159.09 -5.05 0.11 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.853 -0.689 . . . . 75.21 113.759 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 81.0 mt -77.59 99.44 5.75 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.52 -0.4 . . . . 73.02 111.236 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -74.88 129.51 37.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.124 0.488 . . . . 72.53 111.423 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -80.87 110.59 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.179 -0.464 . . . . 75.04 111.682 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.67 66.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.225 0.536 . . . . 45.25 111.692 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -118.39 90.34 38.48 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.459 -0.571 . . . . 75.02 109.459 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.91 33.22 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.126 2.551 . . . . 63.44 114.753 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 122.84 4.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.364 0.505 . . . . 53.54 112.364 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.74 123.48 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.296 -0.411 . . . . 65.12 110.516 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -149.22 28.44 0.82 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.392 0.516 . . . . 72.23 112.392 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mm -68.8 142.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.067 0.461 . . . . 74.32 111.332 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -75.16 -51.15 14.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 71.14 111.577 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -166.29 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.12 0.486 . . . . 71.34 111.201 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.8 p -114.3 130.37 24.04 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 111.862 0.319 . . . . 71.21 111.862 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.24 155.8 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.666 2.244 . . . . 53.14 112.641 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -105.84 170.07 8.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.08 0.467 . . . . 72.22 111.642 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.37 -24.73 60.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.184 -0.462 . . . . 65.43 111.547 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -84.39 -24.19 29.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.801 0.334 . . . . 71.24 111.557 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -55.56 -32.17 62.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.052 0.453 . . . . 75.35 111.253 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 71.0 m-85 -56.48 -45.77 80.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.153 -0.476 . . . . 75.31 111.182 175.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -57.53 -46.24 84.09 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.218 -0.446 . . . . 73.21 111.345 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.34 -47.11 72.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.143 0.496 . . . . 53.4 111.005 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 16' ' ' LEU . 67.7 m -58.04 -48.42 80.13 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.72 -0.673 . . . . 75.24 111.343 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 52.4 mt-10 -58.54 -49.5 77.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.405 . . . . 64.54 111.604 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.71 -32.7 71.43 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.476 0.547 . . . . 74.01 112.476 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.67 -60.49 2.35 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.193 0.442 . . . . 70.43 112.193 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.57 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -65.34 -43.16 95.52 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.141 -0.552 . . . . 73.51 113.995 -174.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 73.2 m -60.92 -38.78 86.96 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.448 -0.442 . . . . 74.1 112.127 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.62 -49.89 73.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.935 0.398 . . . . 73.04 110.973 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.06 -40.26 92.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.324 -0.398 . . . . 75.42 110.987 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.491 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -59.32 -45.71 95.01 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.104 -0.57 . . . . 62.42 112.771 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.605 ' HG2' HG21 ' A' ' 27' ' ' THR . 52.4 mt-30 -64.29 -38.97 92.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.037 0.446 . . . . 75.4 111.254 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -65.49 -58.0 6.88 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.194 -0.457 . . . . 73.15 111.87 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 83.9 t -57.11 -50.88 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.379 0.511 . . . . 64.32 112.379 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.519 HG21 HG22 ' A' ' 29' ' ' VAL . 15.2 t -62.69 -36.86 84.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 34.35 112.034 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -81.87 -23.26 36.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.737 0.303 . . . . 73.12 111.414 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.91 -47.97 15.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.024 0.44 . . . . 75.13 110.518 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -79.61 6.72 9.86 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.46 -0.336 . . . . 72.22 111.829 177.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 122.926 0.491 . . . . 62.02 111.739 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.6 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.634 0.254 . . . . 54.25 111.496 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.683 HD11 ' HA2' ' A' ' 139' ' ' GLY . 46.0 mm 58.8 95.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.155 0.503 . . . . 74.03 112.181 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.67 96.09 1.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.915 -0.659 . . . . 50.23 112.473 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.33 114.09 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.655 0.74 . . . . 72.14 112.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.64 105.05 17.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.753 -0.658 . . . . 72.24 110.78 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HE1' ' HB ' ' A' ' 33' ' ' VAL . 24.7 p90 -116.21 179.99 3.83 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.897 0.38 . . . . 75.41 111.455 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.14 113.79 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.242 0.544 . . . . 71.44 111.408 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 24.5 m -75.57 -25.02 56.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.195 0.522 . . . . 64.52 111.556 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -71.78 -16.37 62.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.751 -0.659 . . . . 75.24 111.978 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 70.8 t80 -125.69 106.24 9.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.979 0.419 . . . . 64.43 112.056 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.65 -162.4 5.44 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.583 0.593 . . . . 55.25 114.583 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -80.41 7.63 9.32 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.456 0.539 . . . . 74.55 112.456 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.6 m -44.69 -35.92 2.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.843 0.683 . . . . 74.23 112.843 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 11.7 p-10 -65.67 -43.19 90.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 70.14 111.328 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -71.09 -38.94 72.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.014 0.435 . . . . 71.05 110.618 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.92 -43.73 91.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 64.4 110.968 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.13 75.62 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.196 -0.456 . . . . 71.21 111.221 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.23 -34.06 77.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.309 -0.405 . . . . 74.22 111.144 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.97 92.88 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.042 0.448 . . . . 71.13 110.736 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.417 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.7 mt -63.4 -48.49 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.171 0.51 . . . . 70.15 110.347 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 31' ' ' VAL . 74.6 mt -56.96 -33.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.938 -0.574 . . . . 54.25 111.573 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -58.67 -43.54 89.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.961 0.41 . . . . 70.14 111.045 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.51 -37.28 62.34 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.05 -0.595 . . . . 73.44 112.875 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.433 HD12 HG13 ' A' ' 2' ' ' ILE . 46.5 mm -64.47 -45.21 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.044 0.45 . . . . 74.22 111.305 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 p -61.83 -42.49 99.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.842 0.353 . . . . 51.34 111.034 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -57.84 -36.79 72.78 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.827 0.346 . . . . 73.23 111.439 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.0 m -78.15 -8.6 58.49 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.225 0.536 . . . . 73.52 111.401 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.19 42.71 23.11 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.163 -0.541 . . . . 40.14 113.092 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.9 t -127.76 143.94 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 122.595 -0.356 . . . . 72.43 111.506 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.93 152.25 36.51 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.116 -0.564 . . . . 74.2 112.732 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 21' ' ' ILE . 22.4 t -112.87 147.39 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.465 0.543 . . . . 75.22 112.465 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -111.26 103.41 11.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.556 0.343 . . . . 73.55 110.387 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 30.5 m -100.91 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.851 0.685 . . . . 52.43 112.851 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -139.88 127.3 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 116.125 -0.489 . . . . 62.21 110.931 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -94.22 111.01 22.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.915 0.388 . . . . 74.53 110.969 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -82.57 11.79 5.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.314 0.487 . . . . 71.15 112.314 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.39 -9.08 58.18 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.453 -0.403 . . . . 64.32 112.369 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.41 179.29 5.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.999 0.428 . . . . 45.11 111.468 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 93.09 0.22 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 51.24 111.416 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.99 149.75 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.277 0.561 . . . . 73.12 112.214 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -147.95 170.58 17.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.959 -0.564 . . . . 75.41 111.176 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.0 mm? -65.18 -22.48 66.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.394 -0.366 . . . . 65.41 111.686 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -62.45 -42.25 99.33 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.632 0.253 . . . . 63.24 111.361 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.2 -45.19 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.986 0.422 . . . . 55.43 110.813 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 45' ' ' LEU . 5.7 tt -55.79 -38.67 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.278 -0.419 . . . . 74.34 111.074 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -61.39 -21.92 64.51 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.375 0.509 . . . . 73.34 112.375 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -58.69 -19.7 41.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.991 0.425 . . . . 72.21 111.355 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -53.18 -34.97 59.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.238 -0.437 . . . . 65.41 111.436 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.96 -44.11 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.942 0.401 . . . . 74.33 111.599 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.99 -23.14 50.47 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.984 -0.627 . . . . 51.24 113.812 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 -1.86 40.69 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.187 -0.596 . . . . 75.23 111.557 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 53' ' ' THR . 27.9 p -36.79 -58.76 0.73 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.172 1.545 . . . . 54.32 115.172 -170.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 71.6 p -61.09 -20.54 62.74 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.701 1.0 . . . . 75.42 113.701 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.34 136.18 4.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.19 -1.005 . . . . 30.33 113.838 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 57' ' ' ILE . 0.7 OUTLIER -171.08 -179.48 2.74 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.064 0.546 . . . . 54.22 111.258 -178.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.53 131.07 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.409 . . . . 61.44 111.46 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.514 HD11 HD13 ' A' ' 55' ' ' LEU . 3.3 mp -117.05 137.01 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.991 0.424 . . . . 72.12 111.983 -176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.88 140.26 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.481 -0.648 . . . . 74.21 111.481 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.488 ' SD ' ' CE2' ' A' ' 10' ' ' TYR . 4.2 ppp? -67.49 146.95 53.46 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 117.652 0.726 . . . . 53.41 111.897 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 95.1 p -99.38 144.56 28.49 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 112.758 0.651 . . . . 61.24 112.758 -172.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 90.3 Cg_endo -75.39 -176.3 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.807 2.338 . . . . 74.4 112.526 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.94 -55.16 25.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.813 0.672 . . . . 44.23 112.813 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.73 73.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.232 0.456 . . . . 75.02 112.232 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 62.2 m -65.08 -50.07 67.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.681 -0.236 . . . . 71.15 111.506 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.64 -49.67 67.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.007 0.432 . . . . 64.23 111.644 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.45 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.188 0.44 . . . . 72.04 112.188 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -95.65 -29.56 14.24 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.846 0.313 . . . . 73.33 111.846 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.11 -13.44 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.021 0.378 . . . . 50.33 112.021 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.49 -40.8 5.87 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.2 0.815 . . . . 71.24 113.2 -175.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.05 -52.3 28.86 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.858 -0.687 . . . . 64.14 112.614 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.18 -28.25 66.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.734 0.302 . . . . 73.41 111.767 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.25 -46.13 86.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.82 0.343 . . . . 74.14 110.899 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -58.04 -45.06 87.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.09 0.471 . . . . 72.04 110.431 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.3 m -55.97 -47.7 77.17 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.853 -0.612 . . . . 75.1 111.479 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.488 ' O ' HG13 ' A' ' 79' ' ' VAL . 77.4 mt -61.06 -55.73 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.34 -0.391 . . . . 65.43 111.204 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.8 -30.92 58.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.228 0.455 . . . . 75.51 112.228 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.24 -21.24 55.41 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.061 -0.59 . . . . 63.2 113.656 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 m -100.18 -6.44 26.15 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.088 0.773 . . . . 65.25 113.088 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -75.86 172.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.46 0.541 . . . . 75.2 112.46 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -99.68 178.32 4.88 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.528 . . . . 70.44 110.585 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -87.49 -18.05 30.74 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.871 0.693 . . . . 64.04 112.871 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -148.96 44.98 1.0 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.192 1.182 . . . . 73.51 114.192 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' NE2' HD22 ' A' ' 110' ' ' LEU . 5.9 pm0 -94.38 166.78 11.9 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.393 -0.817 . . . . 71.43 111.425 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.75 115.46 27.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 74.01 111.843 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.92 114.76 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.572 0.701 . . . . 72.42 112.031 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.47 145.36 25.16 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.06 -0.591 . . . . 64.3 112.416 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -152.83 140.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.071 0.435 . . . . 75.05 111.192 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -155.85 110.84 2.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.217 0.532 . . . . 74.24 110.72 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.99 131.31 35.95 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.4 -0.364 . . . . 73.42 111.506 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 HG21 ' A' ' 127' ' ' THR . 12.2 t -170.89 179.91 3.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.402 -0.363 . . . . 72.35 111.161 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.31 -17.56 18.08 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.287 -0.483 . . . . 44.44 113.92 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.82 -119.25 0.75 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.398 -0.43 . . . . 35.23 112.336 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.55 74.03 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.424 -0.893 . . . . 60.11 114.155 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -97.89 109.98 22.64 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.609 -0.348 . . . . 71.34 110.654 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.696 ' HB2' ' HB ' ' A' ' 98' ' ' ILE . 16.2 p-10 -137.98 95.02 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.654 0.74 . . . . 64.33 112.454 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 39.1 mt-10 -103.76 -48.78 0.15 Allowed Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.189 -0.46 . . . . 75.44 112.051 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.531 ' O ' HD13 ' A' ' 101' ' ' LEU . 54.8 Cg_endo -91.52 27.46 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.231 1.954 . . . . 71.41 112.647 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 95' ' ' ASP . 7.1 tt -59.93 -51.49 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.988 0.736 . . . . 74.52 112.988 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 12.0 m-20 -62.74 -49.46 82.38 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.403 0.519 . . . . 71.52 112.403 -175.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 74.7 Cg_exo -51.45 -50.3 14.39 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.102 1.868 . . . . 74.41 112.973 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.5 mp -63.05 -47.7 81.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.87 0.322 . . . . 63.34 111.87 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 105' ' ' PHE . 62.1 mt -58.77 -38.79 79.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.008 0.432 . . . . 70.21 111.044 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -58.17 -42.16 85.41 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.282 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 100' ' ' PRO . 11.3 mmpt? -55.98 -49.51 73.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 74.15 111.215 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.409 ' HD2' ' HA ' ' A' ' 102' ' ' LEU . 38.9 m-85 -56.0 -47.49 77.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.233 0.457 . . . . 72.13 112.233 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -79.61 -35.53 39.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.679 0.622 . . . . 65.02 112.679 -175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.59 -44.94 63.56 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.07 -0.394 . . . . 72.33 111.873 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.51 -41.39 63.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.835 0.35 . . . . 63.23 111.34 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.36 43.43 2.54 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.013 -0.613 . . . . 62.41 112.612 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.418 HD22 ' NE2' ' A' ' 83' ' ' GLN . 59.3 mt -83.86 136.21 34.2 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.869 0.366 . . . . 61.0 111.553 -176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 74.0 m -71.68 93.41 1.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.856 0.36 . . . . 65.21 110.841 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.0 p -88.15 128.91 35.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.286 -0.416 . . . . 54.22 111.328 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.75 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.777 0.288 . . . . 52.43 111.777 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -164.89 94.44 0.91 Allowed Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.523 0.202 . . . . 70.2 111.408 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 115.67 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.309 2.006 . . . . 64.05 111.706 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.0 35.9 3.91 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.067 0.766 . . . . 64.24 113.067 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 117' ' ' ILE . 13.7 tt -61.09 82.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.293 1.044 . . . . 62.4 111.427 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -163.63 25.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.011 -0.995 . . . . 70.32 109.744 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.3 mm -88.59 137.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.795 -0.639 . . . . 72.3 111.954 -172.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -52.04 -51.8 55.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.689 -0.687 . . . . 72.24 112.35 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 179.98 -72.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.274 0.559 . . . . 62.43 110.958 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p -82.56 146.85 54.43 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.024 -0.535 . . . . 64.25 111.96 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.48 106.0 1.86 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.401 2.067 . . . . 61.44 112.903 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 52.3 p -85.79 -178.58 6.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.276 -0.42 . . . . 64.3 111.23 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -49.57 -35.61 21.11 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.165 0.431 . . . . 43.51 112.165 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -55.9 -42.74 76.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 73.24 111.319 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.43 HG21 HG21 ' A' ' 90' ' ' THR . 46.5 m -63.8 -40.72 97.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.997 0.427 . . . . 73.54 111.025 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -61.68 -48.84 78.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.222 -0.445 . . . . 72.5 111.619 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -53.54 -42.06 67.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.885 0.328 . . . . 62.12 111.885 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.02 -47.47 85.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.869 0.366 . . . . 63.12 111.056 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.1 m -66.46 -46.4 76.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.188 -0.46 . . . . 65.34 111.797 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.51 -48.81 77.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.233 -0.439 . . . . 62.31 111.898 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -78.26 -51.11 10.65 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.545 0.572 . . . . 71.54 112.545 -172.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.66 -36.07 71.39 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.34 0.496 . . . . 75.32 112.34 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.96 -45.01 62.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.406 -0.426 . . . . 73.12 113.399 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 88.5 m -67.8 -55.05 14.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.93 0.344 . . . . 73.43 111.93 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.82 -54.05 43.85 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.875 0.369 . . . . 53.25 111.635 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.8 -40.23 83.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.653 -0.249 . . . . 74.32 111.539 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.683 ' HA2' HD11 ' A' ' 2' ' ' ILE . . . -55.93 -47.72 77.69 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.259 -0.496 . . . . 60.32 113.2 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.96 -14.87 62.37 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.186 0.439 . . . . 75.23 112.186 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -90.62 -53.77 4.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.84 0.352 . . . . 73.53 110.972 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.9 t -54.43 -40.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 64.12 112.16 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 139' ' ' GLY . 6.8 t -69.64 -43.87 71.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.697 0.284 . . . . 64.34 111.575 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -63.81 -38.99 93.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.144 0.497 . . . . 74.42 111.011 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.37 -44.95 72.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.605 -0.725 . . . . 73.4 112.192 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -92.75 -21.97 19.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.308 -0.405 . . . . 65.12 111.865 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 120.71 0.29 . . . . 74.24 110.937 179.324 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 28.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 119.999 -0.048 . . . . 75.54 110.888 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 3' ' ' GLY . 47.8 mm 67.8 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.182 0.515 . . . . 51.01 111.892 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 2' ' ' ILE . . . -123.58 101.08 0.68 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.204 -0.522 . . . . 24.31 113.077 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 57.4 t -86.23 99.66 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 122.322 -0.516 . . . . 72.5 110.975 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.698 ' HB3' HD23 ' A' ' 36' ' ' LEU . 82.1 m-85 -90.25 126.74 35.94 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.282 0.475 . . . . 73.35 112.282 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 6.7 p90 -143.96 163.29 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.272 -0.422 . . . . 72.41 110.945 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.518 ' HB ' HD11 ' A' ' 36' ' ' LEU . 3.9 p -129.02 105.41 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.452 0.644 . . . . 74.44 112.487 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -61.5 -28.14 69.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.077 0.465 . . . . 63.55 111.445 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.05 -22.59 62.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.795 0.665 . . . . 70.41 112.795 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 2.3 t80 -129.06 92.15 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.895 0.702 . . . . 71.24 112.895 -173.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 -158.58 7.67 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 115.746 1.058 . . . . 41.53 115.746 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -59.34 7.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.528 1.307 . . . . 74.23 114.528 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -47.16 -35.79 7.78 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.561 0.619 . . . . 74.52 112.298 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.89 -39.69 79.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.974 0.416 . . . . 74.41 110.784 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -58.34 -45.65 87.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.192 0.52 . . . . 60.22 110.508 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 20' ' ' ILE . 79.6 mt -59.49 -51.33 70.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.894 -0.594 . . . . 72.41 111.644 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . . . -55.49 -43.24 75.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.106 0.479 . . . . 54.51 111.479 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 21' ' ' ILE . 34.7 tt0 -66.29 -34.49 78.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.078 0.466 . . . . 73.24 110.845 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.17 -31.61 72.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.175 -0.466 . . . . 52.34 111.29 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.515 HG23 ' HA3' ' A' ' 135' ' ' GLY . 71.5 mt -67.91 -57.46 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.152 0.501 . . . . 71.23 111.005 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 18' ' ' GLN . 14.0 tt -63.2 -25.17 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.088 -0.506 . . . . 75.42 111.736 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -54.56 -46.8 73.74 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.778 0.323 . . . . 54.32 111.744 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.19 -37.35 42.77 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.019 -0.61 . . . . 74.24 112.922 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -62.94 -42.73 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.994 0.426 . . . . 64.44 111.585 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.439 HG23 HG12 ' A' ' 21' ' ' ILE . 44.6 p -66.64 -39.87 88.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.574 -0.285 . . . . 71.23 111.574 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -58.54 -41.6 85.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.272 0.558 . . . . 74.51 109.888 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -64.0 -31.74 73.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.843 -0.617 . . . . 74.12 110.806 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 39.59 3.41 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.126 -0.488 . . . . 53.44 113.633 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.08 132.14 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.915 0.388 . . . . 73.55 111.444 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.33 96.54 2.18 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.314 -0.47 . . . . 74.3 113.708 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.3 m -102.86 142.48 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.911 0.386 . . . . 71.12 111.797 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -95.75 144.65 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.974 0.416 . . . . 75.32 111.78 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 32.6 m -101.18 151.72 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.913 0.387 . . . . 75.23 111.512 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -137.16 114.18 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.012 0.434 . . . . 75.02 111.984 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.69 92.6 3.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.732 0.301 . . . . 74.53 110.374 171.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -65.81 -23.81 66.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.274 0.472 . . . . 71.4 112.274 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -98.08 24.51 31.48 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.12 -0.562 . . . . 41.04 112.943 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.88 -178.14 3.35 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.038 0.447 . . . . 50.12 111.837 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.45 44.9 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.307 0.484 . . . . 65.21 112.307 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.62 128.33 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.115 0.483 . . . . 75.41 111.765 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.61 166.85 11.31 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.341 -0.391 . . . . 71.45 111.263 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.75 -25.55 55.25 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.419 -0.355 . . . . 75.1 111.824 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -59.38 -49.75 76.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.624 0.25 . . . . 71.54 110.831 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.23 -39.1 75.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.037 0.446 . . . . 71.31 111.049 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -35.18 71.5 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.031 0.443 . . . . 71.53 110.626 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -58.3 -29.89 66.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.558 -0.292 . . . . 73.42 111.673 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -60.37 -29.19 68.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.033 0.444 . . . . 61.42 110.961 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.2 -21.28 66.11 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.358 -0.383 . . . . 72.31 111.699 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.15 -55.13 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.893 0.378 . . . . 62.24 111.243 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.61 -18.43 77.2 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.923 -0.656 . . . . 63.11 112.76 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -100.63 5.99 43.98 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.209 0.448 . . . . 73.12 112.209 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -64.92 -9.47 21.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.026 0.38 . . . . 61.25 112.026 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.4 p -58.44 -18.92 32.27 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.136 0.493 . . . . 70.34 111.355 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.68 137.23 3.65 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.121 -0.491 . . . . 64.24 112.59 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -148.59 133.52 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 64.11 110.628 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 4' ' ' VAL . 5.6 p -112.58 117.74 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 50.55 111.443 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -116.49 110.38 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.653 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.56 41.55 3.06 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.043 -0.599 . . . . 72.53 113.396 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 88' ' ' PHE . 92.1 mmm 61.84 173.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.381 0.61 . . . . 72.44 112.425 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -158.84 154.25 22.31 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.305 -0.407 . . . . 54.41 111.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 60.3 Cg_endo -70.69 157.9 57.27 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.462 2.108 . . . . 64.33 111.915 173.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.71 62.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.591 0.589 . . . . 73.13 112.591 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.26 68.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.548 0.573 . . . . 72.23 112.548 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.2 m -89.07 -49.77 6.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.91 0.386 . . . . 73.24 111.567 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.45 -23.26 65.73 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.368 -0.378 . . . . 65.41 111.549 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.8 -34.53 59.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.779 0.324 . . . . 73.12 111.403 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 t -65.18 -45.15 86.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.236 0.541 . . . . 74.1 110.455 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.401 HD11 HD22 ' A' ' 36' ' ' LEU . 71.5 mt -59.95 -40.55 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.002 -0.544 . . . . 61.33 110.617 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.92 -34.8 78.22 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.818 -0.628 . . . . 71.11 111.028 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.38 -42.26 56.95 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.211 -0.518 . . . . 73.21 112.93 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.85 6.82 33.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.041 0.385 . . . . 55.22 112.041 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.1 tp -39.58 -61.1 0.86 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.295 0.85 . . . . 72.05 113.295 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.9 m -57.23 -40.02 76.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.172 0.434 . . . . 54.15 112.172 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.06 -45.01 94.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.937 0.399 . . . . 74.33 110.926 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.45 -37.49 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.058 0.456 . . . . 75.24 111.255 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.16 -15.2 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.289 -0.414 . . . . 62.02 111.157 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 -39.28 5.75 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.403 -0.427 . . . . 42.1 112.664 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.6 p -67.56 -40.12 84.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.878 0.325 . . . . 54.13 111.878 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -69.44 169.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.041 0.448 . . . . 71.54 111.803 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -133.06 -176.15 4.02 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.288 -0.258 . . . . 62.22 110.704 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 43.1 tt0 -47.27 -65.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.486 0.55 . . . . 64.04 112.486 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -152.49 130.03 11.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.256 0.551 . . . . 75.13 112.036 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.78 -79.47 0.18 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.005 -0.543 . . . . 73.14 110.896 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.558 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -170.21 117.78 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.902 0.334 . . . . 62.55 111.902 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 85' ' ' VAL . 15.9 m -124.62 99.56 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.648 0.737 . . . . 61.52 111.529 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -74.84 77.88 1.09 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.125 -0.489 . . . . 65.35 113.147 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.5 mm -86.63 121.43 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.059 0.392 . . . . 74.12 112.059 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 p90 -153.76 -179.03 7.44 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.296 -0.411 . . . . 73.11 110.41 174.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.497 ' HB2' HG22 ' A' ' 117' ' ' ILE . 11.3 tp10 -106.43 144.25 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.779 0.659 . . . . 75.0 112.779 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -125.51 -23.76 4.03 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.413 -0.358 . . . . 72.3 111.905 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 119' ' ' ILE . . . -119.75 -98.52 1.75 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.604 -0.332 . . . . 44.12 113.097 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.95 42.91 0.48 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.532 -0.842 . . . . 63.44 114.037 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.33 55.1 22.86 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.353 -0.451 . . . . 55.24 113.459 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.24 -159.96 0.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.883 0.327 . . . . 73.14 111.883 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' HD2' ' A' ' 97' ' ' PRO . 32.4 t70 74.05 162.1 0.25 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.267 0.627 . . . . 51.11 112.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 40.1 mt-10 -103.26 -55.45 0.11 Allowed Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 64.45 112.744 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 91.8 Cg_endo -76.46 11.19 1.93 Allowed 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.337 2.025 . . . . 62.24 113.513 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.3 tt -44.64 -56.31 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.122 0.786 . . . . 63.21 113.122 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.697 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.6 m-20 -60.83 -54.89 50.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 112.327 0.492 . . . . 73.11 112.327 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.0 Cg_exo -54.0 -36.17 83.35 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.275 1.983 . . . . 55.12 113.093 176.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.19 -62.16 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.462 -0.335 . . . . 53.21 111.68 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.51 -41.02 88.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t -57.93 -37.31 73.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.826 0.346 . . . . 53.22 111.57 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -64.3 -45.85 86.17 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.734 0.302 . . . . 74.25 111.522 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -62.37 -29.13 70.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.994 0.426 . . . . 74.43 111.361 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -71.35 -37.4 71.68 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.944 0.402 . . . . 73.34 110.579 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -62.58 -46.34 88.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.348 -0.387 . . . . 73.34 111.528 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 mp -73.52 -41.77 62.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.785 0.326 . . . . 52.41 111.326 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 72.22 1.26 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.316 -0.468 . . . . 55.23 113.61 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 mp -102.29 164.41 11.7 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 72.35 111.112 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.558 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 29.4 m -66.2 95.36 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.72 0.295 . . . . 51.25 111.289 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.2 p -83.68 164.72 19.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.036 0.446 . . . . 75.21 111.785 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -94.72 -83.83 0.34 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.617 -0.265 . . . . 71.14 111.671 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 116' ' ' ALA . 34.3 t80 -162.38 89.29 1.38 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.948 0.404 . . . . 73.41 110.907 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.0 27.28 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.625 2.883 . . . . 72.25 114.199 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB3' ' CE2' ' A' ' 114' ' ' PHE . . . -87.69 94.65 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.827 -0.546 . . . . 41.33 110.991 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.497 HG22 ' HB2' ' A' ' 89' ' ' GLU . 31.2 pt -68.61 107.31 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.495 0.664 . . . . 64.21 112.674 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -103.34 -23.95 13.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.081 -0.509 . . . . 70.45 111.651 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 119' ' ' ILE . 3.2 mp -90.42 145.73 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.556 -0.293 . . . . 70.42 110.605 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -120.23 5.68 10.75 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.426 0.528 . . . . 74.12 112.426 -178.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.504 ' H ' HG22 ' A' ' 119' ' ' ILE . 53.1 tt0 -178.76 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.795 0.331 . . . . 71.32 111.662 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.1 p -117.42 122.56 30.83 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 116.516 -0.311 . . . . 74.52 111.603 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 119' ' ' ILE . 32.8 Cg_endo -63.34 141.03 79.99 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.653 2.235 . . . . 74.34 112.863 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 62.1 p -93.68 173.87 7.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.331 0.586 . . . . 60.45 112.383 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -53.58 -28.73 33.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.644 -0.707 . . . . 71.43 112.509 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -66.86 -39.55 87.61 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.322 0.49 . . . . 63.15 112.322 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 71.9 p -54.62 -40.46 68.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.571 0.582 . . . . 70.33 112.571 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -55.27 -35.3 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.313 0.486 . . . . 70.42 112.313 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.42 -50.64 51.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.831 0.348 . . . . 74.23 111.098 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' N ' HD22 ' A' ' 130' ' ' LEU . 3.2 mm? -61.66 -33.9 74.77 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.931 0.396 . . . . 65.3 111.036 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -61.75 -45.89 91.99 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.288 -0.414 . . . . 74.11 111.227 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.22 -52.77 62.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.392 -0.367 . . . . 73.14 111.166 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.9 -50.18 73.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.176 -0.466 . . . . 72.23 111.93 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.13 73.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.872 0.323 . . . . 71.54 111.872 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.515 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -68.55 -42.17 81.93 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.016 -0.612 . . . . 63.33 113.643 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.1 m -70.61 -47.74 58.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.556 -0.379 . . . . 73.11 111.931 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -55.92 -47.63 77.15 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.152 0.501 . . . . 65.34 110.989 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 138' ' ' LEU . 2.5 tm? -70.08 -39.98 75.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.996 -0.547 . . . . 73.5 110.385 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.49 -40.72 78.78 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.577 -0.344 . . . . 24.25 112.803 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 136' ' ' THR . 96.7 mt-30 -62.35 -38.31 89.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.799 0.333 . . . . 64.24 111.131 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -61.09 -45.16 95.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.797 0.332 . . . . 73.32 110.563 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.35 -53.28 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.346 -0.388 . . . . 43.25 111.791 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.0 t -68.32 -37.54 80.68 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.132 0.419 . . . . 71.43 112.132 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -71.56 -35.44 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.887 0.375 . . . . 74.44 111.438 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.18 -25.36 66.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 74.04 110.353 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 77.0 mtt180 -100.1 8.02 44.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.591 -0.731 . . . . 44.14 111.848 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 C-N-CA 125.777 1.631 . . . . 62.21 111.506 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 80.1 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.885 -0.043 . . . . 71.41 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.9 mp 60.27 110.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.173 0.511 . . . . 62.33 111.73 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.02 91.82 1.66 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.853 -0.689 . . . . 55.2 113.326 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 59.4 t -80.91 123.54 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.027 0.413 . . . . 63.43 111.392 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 84.0 m-85 -116.38 133.69 55.73 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.494 0.553 . . . . 63.23 112.494 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -149.27 -178.18 6.26 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.166 -0.47 . . . . 71.44 110.826 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.5 p -129.51 83.55 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.482 0.658 . . . . 50.22 111.799 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -53.77 -29.75 41.48 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.008 0.744 . . . . 72.43 113.008 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.81 -13.94 62.52 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.345 0.498 . . . . 63.32 112.345 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.89 135.35 41.55 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.497 0.925 . . . . 71.24 113.497 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.19 -162.1 4.97 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 116.394 1.318 . . . . 62.14 116.394 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.415 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 73.8 m-85 -76.03 8.57 3.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.383 0.882 . . . . 72.4 113.383 -174.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -49.04 -35.58 16.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.114 0.413 . . . . 64.21 112.114 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -66.43 -37.99 86.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 64.34 110.919 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -69.16 -39.27 78.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.869 -0.605 . . . . 75.43 110.735 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -41.37 94.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.149 -0.478 . . . . 52.35 110.626 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.98 92.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.071 -0.513 . . . . 62.22 110.858 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -57.48 -46.62 83.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.946 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 132' ' ' GLU . . . -56.57 -47.03 80.38 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.174 -0.466 . . . . 62.21 111.302 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.15 -51.45 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.042 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 25' ' ' THR . 75.4 mt -55.79 -57.74 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.204 -0.453 . . . . 50.12 111.191 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -58.81 -29.45 66.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.865 0.364 . . . . 75.35 111.705 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -38.82 34.43 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.102 -0.57 . . . . 43.53 113.484 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.15 -24.7 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.486 0.55 . . . . 73.3 112.486 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 21' ' ' ILE . 32.9 p -57.57 -29.3 64.32 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.061 -0.4 . . . . 75.11 111.777 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.728 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.5 mmpt? -64.63 -17.61 64.18 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.937 0.399 . . . . 54.23 111.941 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -88.23 -9.79 51.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.085 0.469 . . . . 62.12 110.825 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.98 37.53 74.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.528 -0.368 . . . . 62.12 113.363 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 143' ' ' THR . 61.8 t -128.84 141.55 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.56 -0.376 . . . . 55.44 111.564 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.95 4.64 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.46 -0.4 . . . . 43.13 113.092 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.2 m -94.86 148.45 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.109 0.48 . . . . 71.13 112.016 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.4 125.07 37.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.217 -0.447 . . . . 75.24 111.072 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 131.89 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.983 0.42 . . . . 72.33 111.793 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 62.2 t -141.43 147.21 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.6 0.36 . . . . 64.22 110.991 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 6.6 m-20 -82.72 118.06 23.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.125 0.417 . . . . 74.34 112.125 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 37' ' ' GLY . 1.6 pp -77.65 -25.41 49.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.963 0.411 . . . . 73.41 111.85 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.645 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -87.31 -13.13 66.35 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.072 -0.585 . . . . 75.54 113.233 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 166.58 20.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.434 0.635 . . . . 63.44 112.039 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.84 76.83 2.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.954 -0.566 . . . . 63.4 111.396 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.72 164.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.336 0.495 . . . . 65.23 112.336 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.54 -163.24 1.32 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.215 0.531 . . . . 53.13 111.943 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.5 mm? -62.25 -24.17 67.1 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.151 0.797 . . . . 64.41 113.151 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.87 -52.53 62.74 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.104 -0.372 . . . . 65.12 110.844 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.05 -42.51 99.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.886 0.374 . . . . 73.14 111.1 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -58.08 -58.28 9.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.127 -0.488 . . . . 50.53 110.999 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -64.49 -36.38 84.0 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.844 0.312 . . . . 74.15 111.844 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.68 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.902 0.382 . . . . 71.23 110.704 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.503 HD11 HD13 ' A' ' 55' ' ' LEU . 45.0 tp -59.53 -44.23 93.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.382 -0.372 . . . . 72.12 110.71 172.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' LEU . 57.4 t -56.92 -33.25 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.071 0.462 . . . . 63.05 110.91 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.46 -40.38 94.36 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.02 -0.609 . . . . 74.33 112.469 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -87.03 6.37 32.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.084 0.402 . . . . 70.3 112.084 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.4 p -45.35 -26.59 0.55 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.256 1.206 . . . . 64.13 114.256 -170.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -54.71 -32.51 59.72 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.14 -0.35 . . . . 75.21 111.569 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.661 ' HA3' HG21 ' A' ' 142' ' ' VAL . . . -160.8 137.64 5.07 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.071 -0.585 . . . . 73.11 113.375 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD13 HD11 ' A' ' 48' ' ' LEU . 2.0 pt? -145.2 157.56 44.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.076 0.465 . . . . 65.42 111.416 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 75.1 t -114.58 116.59 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.458 -0.337 . . . . 44.35 110.998 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -98.69 115.18 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.65 0.262 . . . . 65.34 111.077 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 90' ' ' THR . . . -79.6 -24.09 61.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.117 -0.563 . . . . 72.25 114.079 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 60' ' ' SER . 16.7 tmm? 68.62 153.92 0.1 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.987 0.423 . . . . 64.05 111.665 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.513 ' N ' ' SD ' ' A' ' 59' ' ' MET . 40.6 t -162.95 146.46 8.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.031 -0.418 . . . . 74.45 111.342 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.0 160.52 12.41 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.954 2.436 . . . . 75.24 113.546 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -41.43 -37.31 1.02 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.685 0.994 . . . . 64.52 113.685 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.3 -47.28 47.05 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.168 0.433 . . . . 72.1 112.168 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.44 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 66.6 m -98.4 -27.08 14.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.681 0.277 . . . . 63.42 111.409 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -55.69 -32.67 63.47 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.492 -0.322 . . . . 42.21 111.824 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.11 89.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.941 0.4 . . . . 72.13 111.128 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -62.49 -33.61 75.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.203 0.525 . . . . 75.11 111.01 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.526 HD11 HD13 ' A' ' 36' ' ' LEU . 57.8 mt -75.04 -40.08 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.969 -0.56 . . . . 54.33 111.203 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -53.01 -44.73 67.52 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.851 -0.613 . . . . 63.23 112.573 -172.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.75 -43.71 80.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.032 -0.604 . . . . 63.33 112.839 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -77.31 -34.77 55.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 74.4 110.949 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -56.46 -42.86 78.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.99 0.516 . . . . 65.24 111.267 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -53.06 -33.91 54.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.26 0.552 . . . . 73.41 111.105 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -82.89 -41.67 18.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.036 -0.529 . . . . 74.22 111.257 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 71' ' ' ALA . 78.6 mt -57.62 -43.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.027 0.38 . . . . 72.01 112.027 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HE2' ' A' ' 104' ' ' LYS . 67.5 mt -61.69 -19.85 62.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.288 0.477 . . . . 72.24 112.288 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.63 -15.63 65.49 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.026 -0.607 . . . . 71.31 112.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.9 m -98.41 -36.85 9.83 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.881 0.326 . . . . 64.35 111.881 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 75' ' ' ILE . 27.2 m -106.13 123.46 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.233 0.539 . . . . 73.35 112.096 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HA ' HD23 ' A' ' 108' ' ' LEU . 7.6 p30 -160.9 -172.56 3.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.268 0.556 . . . . 72.44 111.806 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.7 -86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 64.13 113.519 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 16.9 ptmt -155.45 6.49 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.658 0.984 . . . . 74.23 113.658 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 3.1 pt20 -65.16 178.01 0.95 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.972 0.415 . . . . 64.33 112.051 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.89 124.53 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.439 0.903 . . . . 74.04 113.439 -168.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.12 102.53 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.648 0.737 . . . . 73.42 111.569 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.33 94.6 1.67 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.42 -0.419 . . . . 55.41 112.771 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.24 139.02 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 122.274 -0.545 . . . . 75.24 112.144 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -136.83 -179.38 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.221 -0.445 . . . . 71.31 110.249 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -112.86 134.4 54.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.363 0.875 . . . . 73.31 113.363 -173.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 58' ' ' GLY . 6.4 t -154.41 130.67 10.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.796 -0.638 . . . . 51.01 110.864 169.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 86.84 -59.21 4.57 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.077 -0.582 . . . . 72.34 113.551 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.78 -98.42 0.18 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.502 -0.38 . . . . 74.41 113.184 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.51 -128.01 26.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.248 -0.501 . . . . 72.21 113.882 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -123.09 136.0 54.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.403 -0.469 . . . . 75.1 111.888 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.51 145.52 3.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.173 -0.467 . . . . 64.22 110.735 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 5.7 mp0 -103.58 -44.32 0.18 Allowed Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 112.566 0.58 . . . . 74.4 112.566 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 87.7 Cg_exo -50.59 -13.75 0.9 Allowed 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.762 2.308 . . . . 70.44 114.128 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -51.78 -37.67 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.183 0.438 . . . . 65.21 112.183 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.735 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.2 m-20 -63.63 -56.38 26.51 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.004 0.372 . . . . 72.52 112.004 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.5 Cg_exo -55.04 -36.92 93.91 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.008 1.805 . . . . 53.34 112.64 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.98 -58.3 9.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.406 -0.361 . . . . 63.21 111.326 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 91.3 mt -57.96 -40.77 81.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.128 0.49 . . . . 54.3 111.068 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t -56.59 -45.12 81.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.846 -0.615 . . . . 71.51 111.581 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 53.7 tptt -55.46 -49.22 73.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.302 -0.408 . . . . 74.13 111.347 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.2 -35.5 81.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.489 -0.323 . . . . 71.2 111.869 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 102' ' ' LEU . 74.7 mmt-85 -69.0 -55.46 10.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 111.913 0.338 . . . . 75.53 111.913 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -61.08 -43.77 98.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.104 0.409 . . . . 65.25 112.104 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 80' ' ' ASN . 8.6 mp -73.97 -37.43 64.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.622 0.249 . . . . 73.15 111.29 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.09 53.12 35.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.318 -0.468 . . . . 72.51 114.035 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 110' ' ' LEU . 3.4 mp -77.18 173.42 11.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.474 -0.427 . . . . 72.33 111.024 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 94.1 m -65.87 93.47 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 74.54 110.142 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -101.37 132.73 46.78 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.301 0.482 . . . . 74.43 112.301 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.65 -64.16 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.155 0.428 . . . . 50.12 112.155 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -147.99 111.97 3.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 120.725 0.298 . . . . 51.42 110.305 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -89.14 6.57 4.51 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.858 2.372 . . . . 70.22 114.822 -171.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.71 144.61 45.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.038 0.385 . . . . 64.22 112.038 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.2 pt -94.16 157.19 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.947 0.721 . . . . 62.41 112.947 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 118' ' ' ARG . 9.7 mmt85 -152.52 -49.77 0.1 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.386 0.674 . . . . 73.54 111.645 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 119' ' ' ILE . 1.9 mp -72.7 112.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.232 0.539 . . . . 62.33 111.669 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -82.83 -22.86 34.0 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.187 -0.46 . . . . 61.54 111.418 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 35.9 tt0 -160.13 -67.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.165 0.507 . . . . 73.21 111.714 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.3 p -91.8 129.35 42.56 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.343 -0.389 . . . . 74.54 112.03 -174.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 37.3 Cg_exo -61.84 152.69 73.02 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.801 2.334 . . . . 71.1 112.779 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.8 p -111.16 166.17 11.3 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.906 0.384 . . . . 74.21 111.85 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.52 -34.76 64.95 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.26 0.552 . . . . 73.05 111.197 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -73.47 -31.22 63.65 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.865 -0.607 . . . . 72.11 111.356 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.1 m -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.818 0.342 . . . . 63.14 111.42 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -57.35 -40.74 78.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.481 -0.327 . . . . 70.14 111.331 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.526 ' NZ ' ' HB3' ' A' ' 129' ' ' LYS . 8.4 mtpm? -60.89 -28.79 69.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.011 0.434 . . . . 65.43 111.616 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 91.7 mt -70.75 -48.14 55.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.043 0.449 . . . . 64.44 110.223 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.54 -33.26 72.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.05 -0.523 . . . . 72.23 111.364 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' A' ' 19' ' ' ALA . 45.9 mt-10 -83.4 -75.17 0.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.274 -0.421 . . . . 64.14 112.046 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.85 -53.68 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.555 0.576 . . . . 70.01 112.555 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -65.79 -40.36 91.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.863 0.363 . . . . 71.12 111.231 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.62 66.46 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 53.34 113.156 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 61.0 m -60.27 -50.12 74.89 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.702 -0.293 . . . . 64.2 111.631 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.83 -50.56 72.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.038 0.447 . . . . 72.11 111.311 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.23 -50.19 65.26 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.653 -0.703 . . . . 72.51 110.94 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 143' ' ' THR . . . -64.95 -43.53 95.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.219 -0.515 . . . . 23.44 113.186 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 136' ' ' THR . 54.6 mt-30 -58.33 -51.37 70.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.216 0.45 . . . . 52.23 112.216 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -56.11 -52.85 62.82 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.977 0.418 . . . . 71.4 111.655 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.661 HG21 ' HA3' ' A' ' 54' ' ' GLY . 61.9 t -57.91 -51.68 67.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.027 -0.533 . . . . 54.41 112.4 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 29' ' ' VAL . 14.2 t -74.07 -37.34 64.25 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.934 0.346 . . . . 73.24 111.934 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -76.64 -13.36 60.06 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.144 -0.347 . . . . 74.4 111.625 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -67.57 -51.31 52.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.388 0.614 . . . . 74.31 110.074 167.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -62.54 -34.2 76.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.594 -0.73 . . . . 73.22 110.642 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.545 0.783 0 CA-C-N 115.723 -0.671 . . . . 61.13 111.244 177.674 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.076 0.028 . . . . 75.53 111.076 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 2.4 mp 66.83 109.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 121.256 0.55 . . . . 73.24 111.241 -173.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.04 113.74 4.08 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.22 -0.514 . . . . 50.41 113.186 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.95 104.86 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.48 -0.423 . . . . 75.03 111.15 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.776 ' HB3' HD23 ' A' ' 36' ' ' LEU . 98.6 m-85 -96.29 111.63 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.099 0.476 . . . . 53.04 111.679 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -127.86 178.51 6.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.168 -0.469 . . . . 71.45 111.624 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 9' ' ' GLU . 17.3 t -134.46 114.61 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.335 -0.393 . . . . 71.31 110.637 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 m -74.45 -8.52 56.58 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.957 0.408 . . . . 71.05 111.79 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.563 ' H ' HG12 ' A' ' 7' ' ' VAL . 44.6 tt0 -96.25 -50.53 4.76 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.459 0.54 . . . . 73.24 112.459 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.419 ' H ' HG12 ' A' ' 7' ' ' VAL . 78.2 t80 -103.16 138.87 39.41 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.109 0.48 . . . . 74.35 112.239 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.87 -164.37 4.7 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.566 -0.743 . . . . 70.12 114.606 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.48 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 97.5 m-85 -100.37 7.8 44.06 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.889 0.329 . . . . 73.41 111.889 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.754 ' HB3' HG21 ' A' ' 90' ' ' THR . 89.8 p -41.41 -46.76 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.553 0.575 . . . . 71.1 112.553 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.66 -43.91 76.72 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.088 0.47 . . . . 75.34 111.748 175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.23 -35.45 73.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.151 0.501 . . . . 73.12 110.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.78 -38.68 83.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.95 -0.568 . . . . 62.45 110.818 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.3 75.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.871 -0.604 . . . . 71.31 111.069 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -58.92 -42.87 90.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.163 -0.471 . . . . 72.14 110.962 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . . . -65.3 -39.2 92.19 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.011 0.434 . . . . 73.13 111.137 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.98 -58.49 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.199 -0.455 . . . . 60.14 111.276 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 tt -59.1 -37.16 66.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.652 0.263 . . . . 63.35 110.938 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -53.66 -56.77 14.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 70.12 111.457 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.12 -45.23 88.53 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.116 -0.564 . . . . 31.31 113.926 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.3 mt -66.19 -45.98 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 112.424 0.527 . . . . 72.21 112.424 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.6 p -65.2 -42.71 93.28 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.909 -0.495 . . . . 63.54 110.821 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.42 -32.4 64.82 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.192 -0.458 . . . . 64.55 110.88 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 m -71.98 -33.15 67.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.375 -0.375 . . . . 62.43 110.993 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.45 5.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.106 -0.569 . . . . 44.24 114.165 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.1 t -112.49 130.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 122.2 -0.588 . . . . 72.21 111.979 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 121.49 6.14 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.462 -0.399 . . . . 62.24 112.927 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.9 m -99.41 164.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 112.667 0.618 . . . . 73.11 112.667 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.15 110.34 21.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.801 -0.636 . . . . 73.21 111.092 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.47 112.71 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.295 0.569 . . . . 71.54 112.077 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.46 129.22 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.283 -0.417 . . . . 74.41 111.47 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -94.58 116.62 28.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.005 -0.368 . . . . 70.35 110.005 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.4 pp -89.31 -7.48 55.29 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.113 0.412 . . . . 65.2 112.113 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -86.55 -26.71 31.94 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.12 -0.562 . . . . 51.15 112.506 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.31 162.79 18.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.107 0.48 . . . . 61.22 111.705 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.67 96.36 0.08 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.015 0.435 . . . . 64.23 111.648 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.11 150.02 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.286 0.565 . . . . 54.42 112.039 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -107.4 173.05 6.49 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.939 -0.573 . . . . 73.03 110.249 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.6 mm? -59.81 -20.57 57.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.323 -0.236 . . . . 74.51 111.114 176.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -61.98 -52.81 62.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.756 0.312 . . . . 61.4 111.506 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -40.79 84.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.868 0.366 . . . . 74.31 110.835 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 49' ' ' VAL . 1.8 tm? -65.09 -39.81 93.7 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.264 0.554 . . . . 72.21 109.964 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -59.42 -40.86 88.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.789 -0.641 . . . . 73.33 111.274 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.86 -36.09 75.24 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.51 -0.314 . . . . 72.01 111.053 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.58 -47.05 83.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.869 0.366 . . . . 64.12 110.224 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 45' ' ' LEU . 82.3 t -55.01 -37.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.08 0.467 . . . . 74.11 111.479 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.36 -53.13 14.23 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.274 -0.488 . . . . 73.44 113.131 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.19 6.1 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.52 0.563 . . . . 72.35 112.52 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -48.39 -24.92 1.39 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.848 1.055 . . . . 55.01 113.848 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.733 HG21 HH22 ' A' ' 146' ' ' ARG . 77.7 p -67.24 -25.86 66.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.587 0.588 . . . . 71.13 112.587 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.12 137.02 5.6 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.138 -0.553 . . . . 54.31 112.69 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -163.2 172.84 14.2 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.578 -0.366 . . . . 74.31 111.811 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.08 124.65 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.909 0.385 . . . . 74.03 111.144 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -117.2 145.32 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.966 0.413 . . . . 74.32 111.569 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.5 -89.74 0.39 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 73.54 112.583 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.488 ' HG3' HG22 ' A' ' 90' ' ' THR . 4.0 ppp? -172.48 158.47 4.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.557 0.343 . . . . 73.13 110.642 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -117.58 114.42 37.98 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 111.798 0.296 . . . . 61.11 111.798 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.66 160.32 28.15 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.368 2.045 . . . . 73.53 112.432 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.13 -31.45 19.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.522 0.564 . . . . 72.22 112.522 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.6 96.16 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.158 0.504 . . . . 74.13 111.681 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -90.11 -21.8 22.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.249 -0.432 . . . . 74.53 111.541 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.426 ' HA ' ' HB ' ' A' ' 68' ' ' ILE . . . -52.93 -24.56 9.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.2 0.815 . . . . 72.52 113.2 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.01 -56.04 7.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.408 0.522 . . . . 64.42 112.408 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -84.6 -33.63 23.31 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.822 0.344 . . . . 54.01 111.4 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 65' ' ' ALA . 50.7 mm -60.89 -53.21 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.288 0.477 . . . . 75.41 112.288 -176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.5 -38.65 69.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.848 0.356 . . . . 72.1 111.346 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.11 87.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.0 -0.619 . . . . 70.4 112.391 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.98 95.07 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.991 0.424 . . . . 52.14 111.495 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.79 -35.44 68.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.333 -0.394 . . . . 73.54 111.353 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.6 m -54.28 -27.02 32.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.998 0.428 . . . . 55.41 111.427 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.7 m -99.19 -49.53 4.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.312 -0.403 . . . . 72.34 111.284 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.1 mt -54.57 -48.59 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.818 0.673 . . . . 73.53 112.818 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.27 -36.68 68.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.031 0.382 . . . . 55.43 112.031 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.49 66.24 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.038 -0.601 . . . . 64.41 113.13 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -100.29 5.12 44.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.188 0.44 . . . . 50.2 112.188 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.82 162.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.01 0.433 . . . . 64.42 111.996 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -117.54 106.84 13.57 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.851 0.358 . . . . 73.14 111.456 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.613 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 38.3 tt0 50.14 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.978 0.732 . . . . 63.5 112.978 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.613 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 62.2 pttt -159.39 48.02 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.261 0.553 . . . . 73.51 110.972 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.44 172.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.065 0.765 . . . . 72.44 113.065 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.579 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -88.02 109.65 20.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 74.44 111.894 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG12 HD11 ' A' ' 55' ' ' LEU . 29.7 m -107.41 119.02 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.567 0.699 . . . . 60.24 111.788 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.06 159.85 21.43 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.997 -0.547 . . . . 42.23 112.399 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -144.39 131.36 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.398 -0.472 . . . . 74.43 111.961 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -140.05 93.44 2.64 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.65 0.738 . . . . 74.12 110.659 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.33 114.48 2.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.834 -0.621 . . . . 64.12 112.16 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.754 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.0 t -108.65 29.68 7.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.856 -0.611 . . . . 72.12 111.973 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . -178.53 -54.41 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.186 -1.007 . . . . 52.3 114.086 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.85 -14.35 58.8 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.496 -0.859 . . . . 54.54 113.2 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.05 67.48 3.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.226 -0.511 . . . . 71.12 112.499 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.48 -179.27 6.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.221 0.534 . . . . 61.0 112.15 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -75.93 133.65 40.44 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.124 -0.489 . . . . 71.54 110.818 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.7 mt-10 -54.46 -37.45 54.54 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 113.744 1.016 . . . . 71.43 113.744 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 38.0 Cg_endo -66.21 32.18 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.843 1.695 . . . . 65.43 113.94 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.423 ' H ' ' C ' ' A' ' 96' ' ' GLU . 7.6 tp -66.59 -44.1 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.118 -0.364 . . . . 74.4 111.975 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.452 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 9.6 m-20 -56.09 -47.0 99.7 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 112.429 0.529 . . . . 65.3 112.429 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 83.1 Cg_exo -45.77 -37.46 16.28 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.717 2.278 . . . . 54.11 113.436 170.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.5 -42.65 34.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.802 0.334 . . . . 73.24 110.927 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.35 -32.48 64.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.348 -0.387 . . . . 75.24 111.197 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -55.58 -46.92 77.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.264 0.554 . . . . 71.02 110.992 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' HA ' HD13 ' A' ' 108' ' ' LEU . 32.0 mmtp -66.36 -51.62 55.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.065 -0.516 . . . . 73.3 111.313 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.601 ' HD1' HD22 ' A' ' 110' ' ' LEU . 24.3 m-85 -59.58 -44.86 93.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.034 0.445 . . . . 73.35 112.119 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -77.46 -60.76 2.23 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.423 0.527 . . . . 65.11 112.423 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -62.41 -32.37 73.19 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.542 0.571 . . . . 71.51 112.542 -170.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 104' ' ' LYS . 9.0 mp -79.06 -20.37 49.02 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.825 0.345 . . . . 72.23 111.347 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.61 44.62 6.79 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.28 -0.486 . . . . 54.43 114.166 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.601 HD22 ' HD1' ' A' ' 105' ' ' PHE . 8.7 mp -70.39 133.96 47.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.256 0.528 . . . . 74.13 111.361 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.579 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 36.7 m -60.8 94.02 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.947 0.403 . . . . 64.51 111.381 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -103.82 137.03 42.41 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.513 -0.312 . . . . 61.51 111.64 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' A' ' 138' ' ' LEU . . . -54.69 -64.15 0.93 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.408 -0.36 . . . . 65.41 111.942 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -162.79 98.49 1.08 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.894 0.378 . . . . 73.15 110.873 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -85.18 46.6 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.008 2.472 . . . . 74.2 113.887 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.17 37.75 0.95 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 62.53 112.024 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.9 pt -105.3 144.0 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.035 0.445 . . . . 73.32 112.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -133.37 108.74 8.89 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.313 -0.403 . . . . 73.12 110.55 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.42 140.95 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 64.12 110.697 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.58 153.26 32.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.667 0.27 . . . . 63.34 111.224 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 21.8 tt0 -51.66 -33.67 34.67 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.682 0.623 . . . . 74.14 112.682 -171.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p -108.61 99.09 31.87 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 120.606 0.241 . . . . 74.12 111.078 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HD2' ' HD2' ' A' ' 12' ' ' TYR . 85.0 Cg_exo -46.78 128.86 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.492 2.794 . . . . 61.34 114.301 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.5 p -100.45 -178.1 3.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.068 -0.514 . . . . 64.23 111.043 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 7.0 mp0 -57.37 -27.22 62.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.977 0.418 . . . . 74.44 111.404 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -59.33 -41.41 89.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 64.32 110.851 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 m -63.43 -36.75 84.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.098 -0.501 . . . . 71.43 111.175 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -62.38 -36.35 82.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.135 0.493 . . . . 71.24 111.144 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -69.63 -38.99 77.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.105 -0.498 . . . . 74.33 110.889 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.29 -54.74 32.41 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.849 -0.614 . . . . 63.4 110.721 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 19' ' ' ALA . 31.0 p -62.27 -38.29 88.77 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.75 0.278 . . . . 72.12 111.75 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.63 -56.63 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.349 0.595 . . . . 70.44 111.475 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -64.18 -56.89 11.59 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.735 -0.666 . . . . 71.41 111.94 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.73 84.41 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.863 0.32 . . . . 63.11 111.863 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.41 -44.64 66.48 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.348 -0.453 . . . . 72.01 113.24 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.47 ' HA ' HG12 ' A' ' 24' ' ' ILE . 94.8 m -55.83 -41.19 73.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.815 0.34 . . . . 73.03 111.486 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.36 -45.26 94.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.315 -0.402 . . . . 73.04 111.739 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 113' ' ' ALA . 4.1 mm? -56.49 -42.12 77.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.942 0.401 . . . . 62.3 110.936 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.35 82.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.097 -0.573 . . . . 50.11 112.693 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.25 -46.98 87.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.006 0.431 . . . . 51.41 111.857 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -56.67 -50.83 70.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.113 -0.494 . . . . 72.42 111.5 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 2' ' ' ILE . 58.2 t -69.84 -44.61 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.324 0.491 . . . . 74.41 112.324 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.4 t -65.98 -28.45 68.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.978 0.418 . . . . 62.02 111.712 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.03 -56.63 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.756 0.313 . . . . 74.31 111.207 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.37 -29.72 69.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.004 0.43 . . . . 71.24 111.522 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.733 HH22 HG21 ' A' ' 53' ' ' THR . 0.6 OUTLIER -75.73 -30.76 59.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.2 -0.312 . . . . 74.12 111.764 175.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.21 0.529 . . . . 72.45 109.579 175.21 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.645 0.259 . . . . 75.13 111.384 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm 64.93 111.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 112.67 0.618 . . . . 74.15 112.67 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.58 103.42 1.43 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.114 -0.565 . . . . 71.15 112.578 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.18 93.84 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.889 0.376 . . . . 71.12 111.558 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.656 ' HD2' HD23 ' A' ' 36' ' ' LEU . 17.5 m-85 -89.09 117.0 27.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.718 0.294 . . . . 72.03 111.443 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -134.92 151.03 50.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.432 0.634 . . . . 72.52 112.416 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 10' ' ' TYR . 39.7 t -96.1 97.95 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.788 -0.642 . . . . 63.44 111.52 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.712 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 20.1 m -70.88 -27.21 63.64 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.234 0.457 . . . . 61.2 112.234 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 33.7 tt0 -70.5 -42.25 71.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.662 0.616 . . . . 74.33 112.662 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' H ' HG12 ' A' ' 7' ' ' VAL . 69.4 t80 -111.5 106.77 15.75 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.666 0.988 . . . . 72.14 113.666 -171.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.94 -160.49 5.41 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.829 1.092 . . . . 71.15 115.829 167.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.415 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 56.7 m-85 -63.11 -2.17 1.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.22 0.822 . . . . 72.55 113.22 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 m -54.11 -31.51 52.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.231 0.538 . . . . 72.11 111.345 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 25.1 t70 -65.87 -32.73 74.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.652 -0.704 . . . . 60.23 111.745 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -94.44 -23.73 17.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.442 0.534 . . . . 74.33 112.442 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 12' ' ' TYR . 92.7 mt -54.64 -39.92 68.47 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.231 0.538 . . . . 71.45 111.384 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.41 -23.0 62.67 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.07 -0.513 . . . . 74.12 112.141 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.76 -34.9 76.67 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.912 0.387 . . . . 62.41 110.945 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 132' ' ' GLU . . . -62.09 -40.77 96.96 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.492 . . . . 73.43 111.04 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.467 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.5 mt -62.76 -52.95 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.044 -0.525 . . . . 74.45 110.601 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.521 HG23 HG21 ' A' ' 31' ' ' VAL . 83.5 mt -52.85 -43.94 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.939 -0.573 . . . . 74.11 111.235 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -56.95 -48.77 77.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.108 -0.496 . . . . 64.21 111.323 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.46 99.57 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.013 -0.613 . . . . 70.04 113.091 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -65.55 -48.47 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 72.23 111.71 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -68.33 -34.94 77.02 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.788 0.328 . . . . 74.52 111.267 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.12 -31.81 73.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.458 0.647 . . . . 62.43 110.558 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.0 m -75.16 -14.44 60.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.848 -0.615 . . . . 75.0 111.15 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.42 26.65 11.73 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.363 -0.38 . . . . 71.43 113.779 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 143' ' ' THR . 42.0 t -118.88 142.31 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.555 -0.379 . . . . 60.52 111.603 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.68 140.7 24.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.009 -0.615 . . . . 40.4 112.859 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 21' ' ' ILE . 33.1 m -106.4 145.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.985 0.365 . . . . 71.44 111.985 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -107.09 110.55 22.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.912 0.387 . . . . 70.41 110.172 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.94 113.8 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.55 0.69 . . . . 75.31 112.788 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.96 93.42 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.197 0.523 . . . . 74.23 110.925 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -79.0 70.88 5.41 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.557 0.694 . . . . 64.03 111.743 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.656 HD23 ' HD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -64.79 -23.79 67.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.231 -0.441 . . . . 53.1 111.636 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.614 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -75.17 -0.36 61.02 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.239 -0.505 . . . . 55.22 112.889 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 17.13 12.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.917 0.389 . . . . 61.42 110.607 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.99 97.63 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.527 -0.761 . . . . 73.33 112.166 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 36' ' ' LEU . 24.7 m -83.47 156.13 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.775 0.321 . . . . 74.04 111.327 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.6 179.61 4.17 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.085 0.469 . . . . 74.12 111.364 -174.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.708 HD13 HD12 ' A' ' 45' ' ' LEU . 3.8 mm? -60.67 -20.87 62.03 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.322 0.49 . . . . 75.45 112.322 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 1.4 mp0 -59.42 -29.88 68.07 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.117 0.414 . . . . 71.11 112.117 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -86.25 -43.83 12.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.806 0.336 . . . . 72.23 111.311 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.708 HD12 HD13 ' A' ' 42' ' ' LEU . 80.6 mt -54.09 -28.3 38.36 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.564 0.579 . . . . 53.44 112.564 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 20.3 ptt180 -61.34 -33.16 73.16 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.696 0.284 . . . . 62.23 111.231 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.25 3.18 46.18 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.04 0.385 . . . . 75.13 112.04 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 2.3 tm? -56.52 -34.48 67.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.998 0.428 . . . . 74.3 110.213 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.62 -23.46 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.222 0.534 . . . . 72.3 111.785 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.17 -40.89 5.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.394 -0.431 . . . . 52.45 112.535 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -76.1 -15.42 60.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.242 0.46 . . . . 74.14 112.242 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -69.37 -7.67 39.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.004 0.372 . . . . 63.01 112.004 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.0 p -70.54 -26.79 63.72 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.327 0.584 . . . . 73.42 111.033 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.57 135.56 3.57 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.85 -0.614 . . . . 73.42 111.8 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.462 HD21 HG12 ' A' ' 85' ' ' VAL . 2.1 pt? -168.14 169.17 11.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.011 0.405 . . . . 73.11 111.491 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 8.5 p -134.69 128.14 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.929 0.395 . . . . 63.42 111.454 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.7 mp -113.75 135.12 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.026 0.441 . . . . 73.31 111.302 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.03 133.34 10.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.359 -0.448 . . . . 74.04 112.823 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.526 ' HE1' ' H ' ' A' ' 93' ' ' GLY . 44.1 ttp -65.91 110.5 2.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.638 -0.33 . . . . 64.54 111.717 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 7' ' ' VAL . 93.4 p -103.49 148.27 35.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 111.982 0.364 . . . . 75.11 111.982 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HA ' ' HB3' ' A' ' 94' ' ' ASP . 28.0 Cg_endo -60.73 159.67 27.74 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.87 2.38 . . . . 61.33 112.451 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.57 -40.53 52.46 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.868 0.692 . . . . 63.5 112.868 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.79 -53.03 54.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.196 0.443 . . . . 71.12 112.196 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.1 m -79.34 -32.23 43.26 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.073 0.463 . . . . 73.14 111.204 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -27.56 65.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.99 -0.55 . . . . 52.41 111.498 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.71 -29.66 62.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.211 0.449 . . . . 71.23 112.211 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -82.05 -17.45 46.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.052 0.453 . . . . 74.43 111.717 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.643 HG12 ' HB2' ' A' ' 36' ' ' LEU . 26.1 mt -100.59 -47.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.149 -0.478 . . . . 74.44 112.169 -175.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -45.32 -45.48 12.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.288 1.035 . . . . 71.32 113.435 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.78 -63.94 4.52 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.047 -0.597 . . . . 71.35 113.196 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 45' ' ' LEU . . . -62.44 -28.73 70.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.069 0.461 . . . . 63.4 112.165 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.14 -33.69 63.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.079 -0.509 . . . . 54.5 111.363 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 m -54.66 -39.24 67.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.125 -0.489 . . . . 65.41 111.563 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -73.66 -38.16 65.05 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.916 0.389 . . . . 64.33 111.293 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.41 -58.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.849 0.357 . . . . 73.32 111.85 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.494 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.1 mp -60.91 -12.47 11.25 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.564 0.579 . . . . 72.22 112.564 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.17 -30.33 7.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 60.02 112.793 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -79.21 -24.16 43.3 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 111.792 0.293 . . . . 74.41 111.792 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -64.36 155.57 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.042 0.449 . . . . 74.51 111.878 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -80.15 160.55 25.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 71.02 111.612 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HA ' HD23 ' A' ' 108' ' ' LEU . 35.9 tt0 -54.87 -36.64 65.31 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.098 0.475 . . . . 60.03 111.939 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -138.87 122.08 16.96 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.452 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -163.78 169.93 17.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.778 0.323 . . . . 74.34 110.983 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.45 93.85 9.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.173 0.511 . . . . 72.22 111.801 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 55' ' ' LEU . 35.4 m -107.94 148.69 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.137 -0.483 . . . . 63.55 111.121 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.03 146.24 17.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.327 -0.463 . . . . 74.32 113.123 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.692 ' H ' ' HB3' ' A' ' 113' ' ' ALA . 39.0 mm -140.93 132.62 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.817 0.447 . . . . 74.43 110.623 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -152.21 159.38 43.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.956 0.408 . . . . 72.32 111.258 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.82 138.85 39.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.035 0.445 . . . . 72.54 111.556 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 t -121.01 4.04 10.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.526 0.679 . . . . 73.53 110.656 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.45 -93.09 0.45 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.652 -0.704 . . . . 74.51 112.359 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.57 70.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.195 -0.526 . . . . 63.44 113.416 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.526 ' H ' ' HE1' ' A' ' 59' ' ' MET . . . 85.24 52.98 3.24 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.502 -0.38 . . . . 64.45 113.158 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.67 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 11.3 m-20 -96.1 176.97 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.324 0.49 . . . . 74.04 112.324 -175.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.6 t70 64.41 160.67 0.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.41 0.684 . . . . 54.53 112.082 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.71 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 41.8 mt-10 -102.01 -53.81 0.14 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 112.254 0.464 . . . . 70.22 112.254 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 8.2 Cg_exo -75.27 22.97 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.395 2.064 . . . . 74.34 112.991 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.7 -35.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.336 0.495 . . . . 64.11 112.336 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.683 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.1 m-20 -66.36 -54.16 26.56 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 122.168 -0.332 . . . . 75.23 111.768 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 73.5 Cg_exo -51.0 -45.8 34.45 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.435 2.09 . . . . 73.45 113.0 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 97' ' ' PRO . 8.5 mp -55.46 -58.12 9.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.46 -0.336 . . . . 73.03 111.299 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.58 -32.24 71.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.499 -0.319 . . . . 73.32 111.488 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 t -62.93 -37.62 87.75 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.893 0.377 . . . . 72.43 111.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HG2' ' HB3' ' A' ' 76' ' ' LEU . 27.8 tptp -64.34 -41.76 96.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.729 0.299 . . . . 75.44 111.018 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -68.15 -44.06 76.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.023 0.44 . . . . 72.31 110.847 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -64.68 -39.1 93.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.961 -0.563 . . . . 74.03 111.813 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -62.23 -49.92 73.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.905 0.383 . . . . 74.14 111.181 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 81' ' ' GLU . 8.2 mp -74.17 -24.22 59.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.98 0.419 . . . . 73.31 111.098 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.22 43.55 9.53 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.182 -0.532 . . . . 62.25 112.502 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.85 156.63 32.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.19 0.519 . . . . 71.1 111.905 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.4 m -66.97 106.54 1.96 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.774 0.657 . . . . 65.02 112.774 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.0 p -84.04 95.04 8.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.742 0.306 . . . . 64.14 111.12 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.692 ' HB3' ' H ' ' A' ' 87' ' ' ILE . . . -53.71 -70.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.202 0.445 . . . . 73.43 112.202 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -125.49 90.01 51.45 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 120.853 0.358 . . . . 75.5 111.044 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.14 98.71 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.57 2.18 . . . . 70.32 112.803 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.08 159.44 20.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.103 0.477 . . . . 52.21 111.987 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -138.26 34.1 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.892 -0.594 . . . . 73.13 110.59 175.204 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.7 mtm180 -96.92 20.2 11.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.493 0.923 . . . . 74.41 113.493 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.2 mt -100.42 149.49 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.86 -0.422 . . . . 72.14 109.86 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.04 -65.99 0.58 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.048 -0.408 . . . . 63.11 111.518 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HG3' ' OH ' ' A' ' 10' ' ' TYR . 8.0 tp60 -177.3 -26.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.987 0.423 . . . . 64.43 111.453 -177.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p -89.82 117.81 68.43 Favored Pre-proline 0 N--CA 1.47 0.553 0 N-CA-C 111.851 0.315 . . . . 65.24 111.851 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.68 134.48 44.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.56 2.173 . . . . 75.45 111.864 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -100.49 168.49 9.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.712 0.768 . . . . 64.41 112.717 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.59 -29.94 68.31 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.36 -0.836 . . . . 74.14 111.053 174.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -73.01 -31.92 64.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.888 -0.596 . . . . 73.32 110.973 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -35.58 67.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.858 0.361 . . . . 52.14 111.059 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -55.71 -48.27 75.45 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.284 -0.416 . . . . 73.35 111.591 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 5.3 mptp? -67.19 -32.77 74.07 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.945 0.35 . . . . 72.53 111.945 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.93 -53.58 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.234 0.54 . . . . 75.13 110.466 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.43 -34.35 75.84 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.87 -0.604 . . . . 73.1 111.526 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.9 tt0 -59.15 -66.67 0.47 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.952 0.501 . . . . 73.43 112.173 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.95 -47.21 86.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.795 0.331 . . . . 72.35 111.589 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.817 0.342 . . . . 72.1 111.454 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -63.02 -37.23 94.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.321 -0.466 . . . . 73.42 113.362 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 99.2 m -63.0 -58.0 8.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.738 0.304 . . . . 75.43 111.212 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.15 -41.52 99.29 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.616 -0.266 . . . . 74.24 111.457 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.63 -43.46 93.81 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.098 0.475 . . . . 72.31 110.18 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 143' ' ' THR . . . -60.1 -45.81 95.32 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.103 -0.57 . . . . 62.01 112.458 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 136' ' ' THR . 80.3 mt-30 -66.68 -29.22 69.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.216 0.532 . . . . 75.42 111.166 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -65.1 -54.64 26.9 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.968 -0.56 . . . . 70.12 110.541 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.27 -46.81 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 112.789 0.663 . . . . 72.21 112.789 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.6 HG23 ' HD3' ' A' ' 144' ' ' ARG . 4.7 t -53.46 -33.61 54.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.681 0.623 . . . . 70.42 112.681 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.6 ' HD3' HG23 ' A' ' 143' ' ' THR . 11.0 mpt_? -99.76 -19.06 16.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.94 0.348 . . . . 75.24 111.94 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.31 -62.17 1.96 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.03 0.381 . . . . 64.43 112.03 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -60.17 -16.73 35.47 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.242 -0.435 . . . . 72.14 112.004 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 143' ' ' THR . 3.9 mm? . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.003 0.371 . . . . 71.02 112.003 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 67.1 p . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.345 0.116 . . . . 53.02 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm 63.55 89.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.281 0.562 . . . . 61.43 111.638 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.29 100.5 1.66 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.946 -0.57 . . . . 61.35 112.729 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 100.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.856 0.36 . . . . 64.33 111.108 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 94.5 m-85 -98.55 120.96 39.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.082 -0.508 . . . . 73.21 111.711 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.47 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 13.7 p90 -143.91 -179.7 6.64 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.105 0.479 . . . . 74.44 112.141 -176.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.448 HG13 ' HA3' ' A' ' 37' ' ' GLY . 33.0 t -126.61 90.79 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.189 -0.46 . . . . 32.1 110.108 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.46 ' HG ' ' HE2' ' A' ' 6' ' ' TYR . 23.2 m -40.87 -54.26 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.318 1.229 . . . . 65.11 114.318 -170.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.65 -25.92 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.594 0.59 . . . . 74.35 112.594 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' HE2' ' HA3' ' A' ' 91' ' ' GLY . 91.0 t80 -79.57 101.84 8.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.984 0.364 . . . . 73.3 111.984 -174.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.43 -159.36 6.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.156 -0.545 . . . . 75.2 114.365 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.06 7.35 0.06 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.806 1.039 . . . . 74.23 113.806 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 6' ' ' TYR . 11.4 t -46.15 -56.23 5.95 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.037 0.755 . . . . 55.55 113.037 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -64.02 -31.44 72.63 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.01 0.433 . . . . 74.51 111.323 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.81 -35.66 77.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.22 0.533 . . . . 71.33 110.817 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.5 mt -69.36 -44.84 70.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 71.42 110.661 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.95 -43.99 73.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.115 0.484 . . . . 51.43 110.935 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -53.31 -42.43 66.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.626 -0.716 . . . . 61.21 111.897 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.42 43.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.403 0.52 . . . . 75.53 112.403 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 16' ' ' LEU . 69.2 mt -61.13 -53.17 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.933 0.396 . . . . 74.32 111.794 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -59.34 -29.36 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.778 0.323 . . . . 74.24 111.865 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.61 -54.76 43.19 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.786 0.327 . . . . 70.44 111.757 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.91 -48.59 84.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.264 -0.494 . . . . 35.13 113.349 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.6 mt -64.8 -38.1 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.963 0.411 . . . . 63.33 111.481 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.9 m -60.12 -44.97 94.5 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.176 -0.328 . . . . 73.24 110.847 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.24 -16.11 63.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.743 0.306 . . . . 71.12 111.624 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -77.51 -20.99 53.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.34 0.591 . . . . 64.45 110.319 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 27.09 9.12 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.013 -0.54 . . . . 71.01 113.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 t -120.1 142.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.984 0.392 . . . . 61.15 111.62 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.93 118.77 4.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.094 -0.574 . . . . 62.5 112.979 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 1' ' ' SER . 35.6 m -91.07 167.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.519 0.563 . . . . 71.1 112.519 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -121.46 108.56 13.79 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.087 0.47 . . . . 73.22 111.203 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.85 113.28 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.522 -0.308 . . . . 75.13 111.41 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 60.9 t -140.12 110.15 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 120.87 0.367 . . . . 74.51 111.334 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -84.64 106.58 16.3 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.519 0.676 . . . . 73.25 111.931 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.575 ' HA ' HG13 ' A' ' 40' ' ' VAL . 1.3 pp -70.26 -14.25 62.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.095 -0.378 . . . . 74.32 111.863 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -60.0 -32.06 74.38 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.351 -0.386 . . . . 61.42 113.64 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.15 11.04 17.33 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.511 -0.406 . . . . 53.32 111.792 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.38 106.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.187 0.518 . . . . 71.31 111.566 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 36' ' ' LEU . 35.3 m -85.21 151.24 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.083 0.468 . . . . 74.44 111.544 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.47 176.09 6.43 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.167 -0.47 . . . . 64.34 111.176 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 42' ' ' LEU . 3.2 mm? -56.98 -24.51 53.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.571 -0.286 . . . . 74.54 111.736 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -63.07 -56.97 12.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 72.42 111.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 mp0 -59.99 -43.06 95.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.061 0.457 . . . . 75.4 110.73 176.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.18 -47.33 78.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.935 -0.575 . . . . 72.23 110.675 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -65.69 -39.03 90.85 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.25 -0.432 . . . . 41.13 111.578 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.24 -33.91 76.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.931 0.396 . . . . 70.21 111.257 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.656 HD11 HD13 ' A' ' 55' ' ' LEU . 52.8 tp -55.54 -34.61 64.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.495 -0.321 . . . . 74.33 111.148 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.38 -41.57 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.103 0.478 . . . . 72.13 111.063 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.67 -16.87 80.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.15 -0.548 . . . . 41.45 113.088 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -100.38 5.73 44.4 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.617 -0.343 . . . . 73.32 111.494 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.8 p -59.28 -3.73 0.45 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.059 . . . . 75.33 113.858 -172.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -67.46 -35.33 78.98 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.03 -0.419 . . . . 65.31 111.275 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.6 138.0 5.13 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.214 -0.517 . . . . 74.13 113.045 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.656 HD13 HD11 ' A' ' 48' ' ' LEU . 1.9 pt? -158.72 146.42 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.621 -0.34 . . . . 75.31 111.26 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.418 HG12 ' HE1' ' A' ' 88' ' ' PHE . 48.8 t -117.98 118.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.362 0.265 . . . . 32.24 110.806 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -112.06 120.63 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.217 0.451 . . . . 61.24 112.217 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.86 99.17 2.54 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.412 -0.423 . . . . 74.1 112.795 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.458 ' O ' HG22 ' A' ' 90' ' ' THR . 14.0 tmm? -56.67 132.54 52.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.901 0.381 . . . . 71.42 111.558 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -134.99 147.31 62.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.921 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.32 168.07 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.644 2.896 . . . . 70.2 115.045 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -43.73 -41.33 4.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.577 0.955 . . . . 73.43 113.577 -173.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.79 -45.88 64.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.038 0.447 . . . . 73.23 111.739 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -87.32 -36.02 18.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.074 0.464 . . . . 52.52 111.094 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -61.0 -26.96 67.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.071 -0.513 . . . . 73.21 112.147 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.75 83.0 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.835 0.35 . . . . 71.42 111.534 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -65.28 -31.14 72.12 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.826 0.346 . . . . 71.23 111.34 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.51 -39.48 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.873 0.368 . . . . 73.22 111.27 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.9 -43.67 66.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.298 -0.41 . . . . 70.34 112.018 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.52 -31.33 51.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 121.042 -0.599 . . . . 53.3 113.512 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.0 22.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.281 0.475 . . . . 74.12 112.281 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.6 tp -54.73 -55.53 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 51.51 112.582 -173.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -56.79 -38.15 72.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.836 0.35 . . . . 73.31 111.809 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -65.47 -46.27 80.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.94 0.4 . . . . 72.4 111.198 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.63 -47.4 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.418 -0.355 . . . . 73.15 111.208 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.72 -29.72 69.53 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.884 0.373 . . . . 71.15 111.55 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.27 -19.59 76.55 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 74.34 112.917 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -90.64 -37.95 13.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.069 0.396 . . . . 71.34 112.069 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.11 143.26 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.153 0.501 . . . . 74.22 112.045 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -161.32 176.3 11.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.238 -0.437 . . . . 73.55 111.509 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 57.68 -94.69 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.898 0.479 . . . . 63.32 111.886 173.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -179.07 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.043 0.449 . . . . 62.5 111.836 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -56.79 175.62 0.12 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.376 0.608 . . . . 74.02 112.611 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.44 98.43 11.62 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.755 0.65 . . . . 73.12 112.755 -170.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.42 105.0 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.596 0.712 . . . . 62.12 112.061 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 78.86 1.95 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 122.021 -0.424 . . . . 63.31 113.032 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.61 122.53 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 111.969 0.359 . . . . 43.24 111.969 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HE1' HG12 ' A' ' 56' ' ' VAL . 6.5 p90 -153.82 164.37 38.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.256 -0.276 . . . . 73.31 110.256 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' HB2' HD12 ' A' ' 119' ' ' ILE . 1.9 mp0 -83.86 133.64 34.73 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.884 -0.51 . . . . 75.3 111.427 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 59' ' ' MET . 10.4 t -87.04 7.18 28.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.437 0.637 . . . . 53.22 110.333 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.427 ' HA3' ' HE2' ' A' ' 10' ' ' TYR . . . 172.2 -82.79 0.08 OUTLIER Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.505 -0.771 . . . . 65.03 112.04 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.72 124.86 2.88 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.909 -0.662 . . . . 74.2 113.374 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.46 -152.81 6.9 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.933 -0.651 . . . . 52.52 112.822 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.06 121.59 35.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.903 0.383 . . . . 72.24 111.677 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . 3.3 p-10 -147.02 171.87 14.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 64.42 110.891 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.619 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 mt-10 -102.97 -44.62 0.19 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.453 0.909 . . . . 74.44 113.453 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.619 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 36.6 Cg_endo -62.83 -12.1 27.45 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.246 1.964 . . . . 73.52 114.703 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 99' ' ' ASP . 7.3 tp -53.99 -51.63 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.986 0.736 . . . . 64.5 112.986 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.709 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 6.6 m-20 -61.71 -54.56 50.42 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.134 0.42 . . . . 45.41 112.134 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.5 Cg_exo -56.88 -35.87 98.62 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.233 1.955 . . . . 72.11 112.744 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -56.76 13.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.214 -0.448 . . . . 73.22 111.12 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.81 -45.03 86.7 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 73.11 111.23 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 27.3 t -55.74 -37.87 69.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.161 -0.472 . . . . 73.44 111.943 177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 1.8 tpmt? -68.24 -58.66 4.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.765 0.317 . . . . 71.1 111.039 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -58.47 -27.38 64.35 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.732 0.271 . . . . 73.32 111.732 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' SER . 18.9 ttp180 -52.06 -50.16 62.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.964 0.411 . . . . 55.1 111.596 173.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.85 -40.56 54.47 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.332 -0.394 . . . . 75.44 111.593 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.723 ' HB3' HD13 ' A' ' 110' ' ' LEU . 10.8 mp -59.46 -40.09 85.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.846 0.355 . . . . 73.34 111.904 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 32.07 36.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.211 -0.519 . . . . 42.41 113.807 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 108' ' ' LEU . 10.9 mp -88.92 165.6 14.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.041 0.448 . . . . 71.3 111.509 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.2 m -80.28 122.71 27.23 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.271 0.471 . . . . 63.12 112.271 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.4 p -103.49 112.26 25.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.273 -0.421 . . . . 73.4 110.599 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.17 -48.75 67.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.909 0.385 . . . . 44.32 111.244 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.411 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -126.05 144.54 49.14 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 116.007 -0.542 . . . . 73.1 110.233 172.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.11 4.85 2.1 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.88 2.387 . . . . 71.24 113.57 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 70.12 159.81 0.2 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.811 0.671 . . . . 71.13 112.811 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.3 pt 42.44 31.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.295 1.22 . . . . 64.34 114.295 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.07 -7.86 16.0 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 122.001 -0.437 . . . . 75.31 111.871 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 89' ' ' GLU . 67.9 mt -91.79 144.78 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 120.939 0.399 . . . . 72.01 111.189 173.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 19.2 pttp -87.5 53.56 2.84 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.737 0.643 . . . . 53.43 112.737 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 45.2 tp60 74.17 -47.4 0.64 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.69 0.626 . . . . 74.22 112.69 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.1 p -96.22 116.8 66.38 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 111.986 0.365 . . . . 61.21 111.986 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.38 140.08 62.29 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.52 2.147 . . . . 51.23 111.857 172.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 p -111.37 179.04 4.14 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.332 0.587 . . . . 74.24 112.096 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 -31.33 59.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.906 -0.588 . . . . 65.23 111.462 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.35 -40.95 81.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.246 -0.434 . . . . 74.21 110.779 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -51.94 -35.19 45.03 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.226 -0.443 . . . . 74.4 111.292 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -56.16 -63.15 1.28 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.506 -0.316 . . . . 71.04 111.019 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -51.78 -46.03 64.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.801 0.334 . . . . 73.23 111.655 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.18 -59.8 4.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.489 -0.323 . . . . 71.42 111.679 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.2 p -60.5 -39.84 89.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.791 0.293 . . . . 65.22 111.791 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.94 -69.36 0.22 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.44 0.533 . . . . 73.43 112.44 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.82 -32.32 69.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.619 0.6 . . . . 73.34 112.619 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.47 65.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.75 0.31 . . . . 62.13 110.849 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.0 -38.17 95.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.369 -0.443 . . . . 21.32 112.545 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.49 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 93.9 m -62.09 -49.16 77.02 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.649 -0.324 . . . . 34.24 111.032 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.21 -38.4 86.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.322 0.582 . . . . 74.54 110.408 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -58.45 -43.72 88.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.687 -0.688 . . . . 64.31 110.131 175.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.0 -33.86 65.26 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.034 -0.53 . . . . 32.23 113.406 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 136' ' ' THR . 27.9 mt-30 -57.8 -44.4 86.3 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.829 0.315 . . . . 73.51 111.552 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -55.82 -50.67 69.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.674 0.273 . . . . 73.21 110.797 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.62 -46.06 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.42 0.526 . . . . 73.15 112.42 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' HD23 ' A' ' 147' ' ' LEU . 13.0 t -74.36 -42.59 59.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.77 -0.372 . . . . 71.04 111.829 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -64.02 -40.84 97.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.088 0.47 . . . . 74.15 110.567 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.07 -46.74 84.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.335 -0.848 . . . . 42.23 110.178 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -61.54 -47.39 85.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.363 -0.835 . . . . 72.11 112.266 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 143' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.795 0.665 . . . . 74.32 112.795 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.231 0.086 . . . . 65.41 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mm 64.0 96.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 121.326 0.584 . . . . 61.14 112.19 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 108.76 2.98 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.114 -0.494 . . . . 41.35 113.42 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.02 106.58 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.832 0.349 . . . . 41.13 110.683 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.734 ' HB3' HD23 ' A' ' 36' ' ' LEU . 23.9 m-85 -111.97 117.03 31.59 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.86 0.362 . . . . 71.2 111.579 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -147.02 173.16 12.7 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.877 0.37 . . . . 71.42 111.72 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 10' ' ' TYR . 19.2 t -99.59 86.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.098 0.475 . . . . 71.34 110.821 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -51.07 -19.81 1.22 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.627 0.973 . . . . 53.53 113.627 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -95.15 -50.95 4.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.515 0.561 . . . . 74.22 112.515 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.539 ' H ' HG12 ' A' ' 7' ' ' VAL . 60.9 t80 -72.33 114.05 10.03 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.002 0.741 . . . . 74.44 113.002 -174.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.66 -159.46 5.56 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 115.049 0.779 . . . . 51.53 115.049 171.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -65.55 7.28 0.24 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.917 1.08 . . . . 73.11 113.917 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.465 ' HB2' HG21 ' A' ' 90' ' ' THR . 34.9 t -49.87 -36.04 25.58 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.455 0.571 . . . . 63.54 112.337 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.89 -40.75 75.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.123 0.487 . . . . 55.01 110.689 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -62.18 -42.26 99.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 71.52 110.854 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.0 mt -59.42 -49.28 78.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.164 0.507 . . . . 71.35 110.614 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.89 79.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.965 -0.561 . . . . 73.12 111.548 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.15 -38.25 82.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.724 0.297 . . . . 75.3 111.352 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.72 88.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.879 0.371 . . . . 72.13 111.418 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.4 mt -70.17 -54.38 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.192 0.52 . . . . 63.21 111.157 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.509 HG23 HG11 ' A' ' 31' ' ' VAL . 72.1 mt -56.96 -35.25 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.117 -0.492 . . . . 61.25 111.609 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -47.24 -51.7 18.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.132 0.491 . . . . 63.22 111.272 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.98 -49.97 50.22 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.927 -0.654 . . . . 73.33 113.058 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.63 -42.9 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.818 0.673 . . . . 70.44 112.818 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 21' ' ' ILE . 12.7 t -67.76 -35.3 78.45 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.062 0.393 . . . . 75.21 112.062 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -84.67 -31.65 24.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 73.33 111.828 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.7 m -65.14 -30.25 71.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.052 0.453 . . . . 52.0 110.823 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 42.24 4.23 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.195 -0.526 . . . . 55.03 114.029 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.29 -76.35 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.258 -0.554 . . . . 63.32 111.463 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.34 157.23 8.28 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.481 -0.39 . . . . 72.43 112.255 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 21' ' ' ILE . 18.2 m -140.66 122.99 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 117.483 0.641 . . . . 75.13 112.501 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -109.63 104.27 13.26 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.284 -0.416 . . . . 74.54 110.357 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.48 124.18 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.173 0.435 . . . . 61.24 112.173 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.92 123.65 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.146 0.498 . . . . 54.24 110.71 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.91 81.46 7.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.191 -0.459 . . . . 61.32 112.091 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.3 pp -66.67 -19.67 65.81 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.853 -0.529 . . . . 74.21 111.526 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 17.88 51.64 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.403 -0.427 . . . . 75.33 112.924 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.5 -153.19 0.5 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.739 0.416 . . . . 54.52 110.503 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.18 99.75 10.49 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 122.074 -0.391 . . . . 70.4 111.89 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.15 165.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.911 0.386 . . . . 71.03 111.723 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.52 -171.33 3.2 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.924 0.392 . . . . 73.15 110.811 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.1 tm? -58.9 -28.52 66.27 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.125 0.417 . . . . 74.23 112.125 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.5 mp0 -54.2 -48.44 71.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.968 0.413 . . . . 72.13 111.752 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.49 -41.5 80.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.215 0.531 . . . . 74.21 110.917 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -60.9 -39.09 88.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.937 -0.574 . . . . 61.31 110.643 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -56.86 -48.14 78.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.808 -0.633 . . . . 74.42 111.709 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.15 -28.15 65.12 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.621 0.23 . . . . 75.43 111.621 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 39.4 tp -57.51 -27.97 63.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.872 0.367 . . . . 74.32 111.589 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -61.17 -38.06 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.05 0.452 . . . . 62.24 111.389 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.79 -30.65 14.46 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.127 -0.558 . . . . 71.34 112.659 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 89.2 mtt180 -75.59 0.57 17.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.936 0.495 . . . . 74.35 112.029 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.27 6.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.272 0.842 . . . . 72.23 113.272 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -80.83 -28.94 36.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.264 0.468 . . . . 74.14 112.264 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.0 137.38 4.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.844 -0.693 . . . . 61.25 113.14 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -163.79 167.63 20.64 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.693 0.627 . . . . 71.21 112.693 -176.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.62 121.26 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.104 -0.498 . . . . 52.41 111.026 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -108.45 143.75 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.009 0.433 . . . . 73.4 111.67 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -131.08 2.6 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.203 -0.523 . . . . 41.03 112.61 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.472 ' HB2' ' H ' ' A' ' 90' ' ' THR . 13.7 tmm? -110.08 127.27 54.77 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.148 -0.619 . . . . 62.24 110.901 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.2 p -97.32 105.48 25.46 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.629 -0.259 . . . . 43.33 111.545 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 155.39 67.98 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.313 2.009 . . . . 73.12 112.234 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.0 -35.07 23.22 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.573 0.582 . . . . 73.45 112.573 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.1 74.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.0 0.428 . . . . 74.41 112.064 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -89.94 -40.17 12.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.716 0.294 . . . . 73.43 110.91 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -49.99 -39.46 41.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.483 0.313 . . . . 40.23 111.789 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.01 72.65 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.16 0.43 . . . . 71.41 112.16 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.8 p -76.63 -31.88 57.66 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.138 0.494 . . . . 64.32 110.695 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -63.04 -29.51 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.106 -0.497 . . . . 72.44 111.381 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 13.2 mm100 -52.56 -26.73 14.14 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.864 0.364 . . . . 71.43 111.856 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.44 -54.64 2.63 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.136 -0.554 . . . . 50.04 112.916 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -63.72 -30.13 71.27 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.75 0.648 . . . . 34.24 112.75 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.0 -47.59 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.529 0.332 . . . . 71.4 111.288 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -57.88 -48.44 79.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.901 0.381 . . . . 63.11 111.4 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.2 m -57.86 -44.64 86.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.204 -0.453 . . . . 52.31 111.271 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 79' ' ' VAL . 69.5 mt -63.01 -55.08 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 74.22 111.248 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.42 HD21 ' HD2' ' A' ' 104' ' ' LYS . 49.0 tp -55.17 -34.99 64.31 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.71 -0.677 . . . . 44.12 112.256 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.01 -21.18 71.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.954 -0.641 . . . . 54.32 113.57 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.9 m -98.77 -21.2 16.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.004 0.742 . . . . 60.05 113.004 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -62.93 163.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.844 0.683 . . . . 73.34 112.844 -178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -79.53 161.82 25.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.868 -0.605 . . . . 64.3 111.217 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.39 -44.24 65.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.804 0.442 . . . . 74.34 112.122 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -143.1 143.74 31.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.768 0.318 . . . . 75.23 111.155 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.457 ' H ' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -158.21 177.31 11.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.313 0.578 . . . . 71.34 112.112 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.642 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -93.58 112.14 23.96 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.811 -0.631 . . . . 74.14 110.937 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG12 HD11 ' A' ' 55' ' ' LEU . 31.6 m -114.33 128.74 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.359 0.6 . . . . 55.15 112.149 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.67 17.73 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.051 -0.522 . . . . 71.13 112.409 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 57' ' ' ILE . 6.7 tp -148.46 137.83 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.783 0.325 . . . . 74.44 111.275 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.83 114.55 7.67 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.241 0.543 . . . . 71.11 111.21 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' HD12 ' A' ' 119' ' ' ILE . 44.7 mt-10 -60.02 93.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.21 0.529 . . . . 62.52 111.901 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.472 ' H ' ' HB2' ' A' ' 59' ' ' MET . 24.9 m -74.73 77.41 2.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.119 0.485 . . . . 64.52 111.491 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.22 -169.15 47.5 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.073 -0.584 . . . . 74.32 113.53 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.07 77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.421 -0.419 . . . . 60.14 113.412 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.469 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . -89.12 -176.51 46.35 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.254 -0.498 . . . . 53.42 112.863 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -94.48 164.85 12.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.42 -0.459 . . . . 71.42 110.848 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.13 115.64 20.12 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.205 0.526 . . . . 72.43 112.368 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.659 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 63.7 mt-10 -103.39 -59.14 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 112.148 0.425 . . . . 72.14 112.148 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 39.0 Cg_endo -98.27 27.12 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.87 2.38 . . . . 73.14 113.715 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.54 -51.61 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.728 0.64 . . . . 73.11 112.728 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.415 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 6.1 m-20 -64.22 -56.58 22.72 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.611 0.597 . . . . 75.42 112.611 -176.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 25.6 Cg_endo -59.75 -41.63 53.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.064 1.842 . . . . 63.31 113.078 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.72 -59.58 3.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.883 0.373 . . . . 65.43 110.997 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.08 -34.54 78.27 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.058 0.392 . . . . 71.34 112.058 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -60.48 -50.05 75.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.04 0.448 . . . . 62.52 111.567 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD2' HD21 ' A' ' 76' ' ' LEU . 32.8 ttmt -65.02 -43.33 92.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.548 -0.296 . . . . 73.24 111.259 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.28 -40.82 87.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.825 0.345 . . . . 74.23 111.419 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -55.24 -41.84 72.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.953 0.406 . . . . 74.33 110.919 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -70.14 -29.84 66.86 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.107 -0.497 . . . . 74.34 111.591 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.3 mt -81.47 -22.26 38.19 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.087 0.403 . . . . 73.21 112.087 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.33 -73.5 2.35 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.238 -0.506 . . . . 71.22 112.66 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 83' ' ' GLN . 61.1 mt 60.36 -179.21 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.614 0.721 . . . . 74.01 112.732 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.642 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 73.5 m -97.16 103.98 15.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.852 -0.613 . . . . 62.04 110.167 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -114.01 102.73 10.46 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.183 0.438 . . . . 62.41 112.183 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.74 84.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.544 0.572 . . . . 70.23 112.544 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -152.46 132.44 7.24 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.413 -0.179 . . . . 75.23 110.787 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.62 -69.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.525 2.15 . . . . 53.44 114.543 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 161.2 38.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.578 0.584 . . . . 64.32 112.578 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.796 HG12 ' H ' ' A' ' 118' ' ' ARG . 11.1 tt -123.64 -150.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.156 0.582 . . . . 73.31 109.74 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.796 ' H ' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -147.08 114.02 6.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.141 -0.974 . . . . 74.05 111.634 175.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' HA ' ' A' ' 123' ' ' PRO . 73.4 mt -139.06 139.2 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 115.948 -0.569 . . . . 71.51 110.597 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -81.52 -61.24 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.966 0.358 . . . . 74.3 111.966 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -141.64 -52.6 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.145 -0.347 . . . . 75.44 111.61 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.8 p -92.29 130.0 39.22 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 116.788 -0.187 . . . . 71.42 111.066 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.653 ' HA ' HD13 ' A' ' 119' ' ' ILE . 12.3 Cg_endo -55.15 127.22 25.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.404 2.07 . . . . 72.21 112.691 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.8 p -74.48 154.48 38.68 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.22 -0.445 . . . . 55.23 111.906 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.45 -25.63 68.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.038 0.447 . . . . 74.22 111.385 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -38.18 75.13 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.131 -0.486 . . . . 73.42 109.998 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.452 ' OG1' HD11 ' A' ' 119' ' ' ILE . 33.6 m -55.19 -38.38 68.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.901 -0.591 . . . . 63.35 111.879 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 87.1 m-85 -58.36 -60.33 3.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.994 0.426 . . . . 75.21 111.265 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -58.33 -29.82 66.22 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.085 -0.507 . . . . 63.22 111.694 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.28 -50.11 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.273 -0.421 . . . . 71.22 110.368 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 128' ' ' TYR . 30.5 p -69.24 -22.74 63.83 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.882 0.327 . . . . 53.53 111.882 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 53.0 mt-10 -60.11 -53.0 62.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.881 0.372 . . . . 64.24 111.057 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.13 -55.74 8.63 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.08 0.467 . . . . 64.45 111.022 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.24 -57.55 12.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.944 -0.571 . . . . 72.35 112.434 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -56.4 -47.27 84.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.461 -0.4 . . . . 51.44 113.75 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.4 m -64.87 -33.53 76.23 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.558 -0.378 . . . . 63.34 111.64 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -55.04 -36.5 65.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.197 0.443 . . . . 73.03 112.197 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.3 mm? -56.32 -45.66 80.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.18 0.514 . . . . 70.13 110.902 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.69 -38.86 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.079 -0.581 . . . . 64.25 112.796 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 136' ' ' THR . 17.5 mm-40 -57.61 -50.05 74.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.847 0.356 . . . . 71.4 111.642 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -54.48 -50.88 66.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.111 -0.495 . . . . 73.12 111.533 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.18 -51.92 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.16 -0.473 . . . . 74.12 112.234 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -69.46 -43.3 73.54 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.403 0.52 . . . . 61.12 112.403 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.34 -43.1 78.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.106 0.41 . . . . 70.4 112.106 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.77 -30.59 71.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 73.34 111.095 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -75.24 -21.56 58.51 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.988 -0.551 . . . . 75.43 111.801 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.256 0.465 . . . . 51.44 112.256 -177.167 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.1 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.421 0.153 . . . . 54.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.6 mm 59.46 102.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.195 0.521 . . . . 54.03 111.887 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.65 94.43 1.87 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.833 -0.698 . . . . 62.44 113.061 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 33' ' ' VAL . 47.9 t -88.0 104.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.056 0.428 . . . . 75.12 111.091 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HB3' HD23 ' A' ' 36' ' ' LEU . 97.7 m-85 -103.86 119.03 38.08 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.204 0.526 . . . . 61.54 111.408 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.584 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 45.1 p90 -136.6 -178.08 5.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.155 -0.475 . . . . 74.25 111.678 -175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.9 100.93 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.813 0.339 . . . . 74.44 110.585 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.575 ' HB3' ' HE2' ' A' ' 6' ' ' TYR . 53.4 p -63.86 -18.49 64.21 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.281 0.845 . . . . 74.43 113.281 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -89.16 -10.94 45.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.067 0.461 . . . . 74.15 111.534 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -115.45 119.11 35.13 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.251 -0.281 . . . . 63.13 111.082 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.61 -161.32 7.45 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.253 -0.498 . . . . 54.34 114.131 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -84.75 8.23 17.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.01 0.744 . . . . 71.52 113.01 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 42.8 m -32.19 -51.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.578 0.955 . . . . 52.41 113.578 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.5 -40.95 76.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.692 0.282 . . . . 74.04 111.724 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -60.3 -39.06 85.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.292 0.567 . . . . 74.11 110.544 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.59 -53.32 53.52 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.734 -0.666 . . . . 51.25 110.905 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -39.8 68.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.999 0.428 . . . . 50.42 111.379 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -55.71 -45.51 77.89 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.683 -0.689 . . . . 74.05 111.516 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.18 -43.84 69.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.094 -0.503 . . . . 71.51 111.424 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' HG12 ' A' ' 24' ' ' ILE . 82.0 mt -57.0 -56.82 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.209 -0.451 . . . . 54.23 111.664 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -56.98 -35.92 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.806 0.336 . . . . 63.24 111.354 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.76 -37.4 86.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.015 0.436 . . . . 73.11 111.206 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.0 24.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.26 -0.495 . . . . 72.13 113.775 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 31' ' ' VAL . 44.8 mm -75.98 -41.59 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 122.407 -0.466 . . . . 71.44 112.044 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.2 p -61.24 -30.17 70.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 74.33 111.344 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.41 -12.57 60.07 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 71.25 111.176 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -90.35 -36.75 14.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.129 -0.487 . . . . 54.22 111.016 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.64 22.82 2.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.304 -0.474 . . . . 61.01 113.748 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 24' ' ' ILE . 67.7 t -130.16 140.39 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 117.148 0.474 . . . . 53.23 111.069 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.44 113.34 4.65 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.089 -0.577 . . . . 52.22 112.846 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.635 HG13 HG21 ' A' ' 24' ' ' ILE . 20.5 m -94.15 140.33 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.129 0.49 . . . . 63.34 112.139 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 51' ' ' ARG . 23.4 m-20 -101.38 113.26 26.19 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.095 -0.502 . . . . 71.52 111.079 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.573 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 36.0 m -106.11 125.95 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 120.969 0.414 . . . . 71.42 111.418 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.81 150.69 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.458 0.303 . . . . 45.53 111.523 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 15.7 m-20 -84.54 120.52 26.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.796 0.295 . . . . 72.05 111.796 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.496 HD11 ' HE1' ' A' ' 59' ' ' MET . 4.2 pp -86.12 -16.21 38.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.155 0.503 . . . . 73.14 111.38 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.73 -10.77 78.55 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.208 -0.52 . . . . 65.04 112.489 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.44 -178.32 5.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.836 0.35 . . . . 75.42 111.275 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 96.02 3.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.998 0.428 . . . . 72.2 111.236 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -85.5 132.58 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.259 0.552 . . . . 71.22 111.56 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -108.64 170.42 8.04 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.375 -0.375 . . . . 74.44 110.94 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 45' ' ' LEU . 3.3 mm? -55.9 -24.55 38.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.073 0.463 . . . . 63.14 111.084 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -57.56 -60.26 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.877 -0.601 . . . . 73.0 110.983 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -65.58 -38.08 88.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.08 -0.509 . . . . 73.31 110.973 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.575 HD12 HD13 ' A' ' 42' ' ' LEU . 92.9 mt -59.3 -34.79 72.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.451 -0.34 . . . . 74.33 111.448 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.84 -33.84 60.07 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.224 -0.297 . . . . 75.12 111.017 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.14 -39.13 77.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.992 0.425 . . . . 73.4 110.281 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD21 HG23 ' A' ' 75' ' ' ILE . 67.7 tp -52.61 -46.5 67.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.98 -0.554 . . . . 73.54 110.852 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.86 -44.23 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.046 0.45 . . . . 73.34 111.009 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.43 -29.88 72.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.144 -0.551 . . . . 42.24 113.025 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -99.61 8.69 44.2 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.069 0.396 . . . . 73.03 112.069 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.05 -3.41 0.13 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.502 0.927 . . . . 73.31 113.502 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -84.58 -27.63 27.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.793 0.33 . . . . 71.41 111.793 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.55 138.32 5.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.469 -0.396 . . . . 44.33 112.843 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 pp -159.12 162.99 36.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.319 0.488 . . . . 75.44 112.319 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -131.05 128.76 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.422 -0.353 . . . . 73.42 111.387 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.5 mp -95.59 139.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.758 0.313 . . . . 74.43 110.909 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -116.13 0.46 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.211 -0.519 . . . . 55.03 113.79 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -82.68 175.9 9.77 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 112.842 0.682 . . . . 72.3 112.842 -177.077 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.447 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 87.7 p -144.52 34.51 0.16 Allowed Pre-proline 0 CA--C 1.555 1.165 0 N-CA-C 114.07 1.137 . . . . 73.33 114.07 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 87.7 Cg_endo -77.53 149.13 26.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.651 1.568 . . . . 73.53 112.434 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.41 61.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.439 0.533 . . . . 63.24 112.439 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.4 66.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.105 0.479 . . . . 51.12 112.102 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -78.36 -29.95 47.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.987 0.422 . . . . 75.23 111.215 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.61 -29.37 62.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.139 -0.482 . . . . 63.13 111.904 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.86 80.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.063 0.459 . . . . 74.55 111.246 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.8 t -73.73 -43.83 58.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.991 0.424 . . . . 61.32 110.958 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.3 -50.37 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.077 -0.51 . . . . 61.22 111.846 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.64 -43.57 98.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.034 0.383 . . . . 74.04 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.44 -41.36 72.11 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.037 -0.601 . . . . 70.34 112.765 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -81.45 -32.68 32.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.74 0.305 . . . . 44.13 111.382 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.15 -43.91 74.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.973 0.509 . . . . 72.52 111.33 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.6 m -55.86 -21.96 22.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.776 0.322 . . . . 52.42 111.849 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 m -97.61 -29.89 13.17 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.101 0.476 . . . . 64.42 110.863 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.646 HG23 HD21 ' A' ' 48' ' ' LEU . 69.4 mt -64.07 -39.17 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.033 0.383 . . . . 71.23 112.033 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -51.1 -49.2 61.18 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.438 0.533 . . . . 73.11 112.438 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.79 -8.01 87.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.044 -0.598 . . . . 52.33 113.234 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.2 m -94.04 -24.68 17.52 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.929 0.344 . . . . 73.24 111.929 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 m -87.01 164.18 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.178 0.513 . . . . 64.01 111.905 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.93 -156.2 0.52 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.159 -0.473 . . . . 52.51 111.444 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.11 -80.57 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.951 0.723 . . . . 52.23 112.951 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -117.57 98.6 6.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.594 0.712 . . . . 64.22 111.874 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.11 166.48 11.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.459 0.647 . . . . 74.11 112.564 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -102.77 110.81 22.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.531 -0.759 . . . . 62.15 109.298 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -121.03 154.03 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.814 0.816 . . . . 72.41 113.033 -168.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.72 169.97 14.32 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.249 -0.887 . . . . 42.0 112.684 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -153.76 126.63 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.383 0.273 . . . . 72.34 110.848 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -137.28 92.48 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.717 0.77 . . . . 72.31 111.99 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.58 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.5 tp10 -66.63 121.31 15.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.653 -0.703 . . . . 70.3 110.473 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.492 HG21 ' OG ' ' A' ' 13' ' ' SER . 8.0 t -101.53 15.78 27.79 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 64.11 111.843 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . -158.24 -64.54 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.811 -0.709 . . . . 72.03 113.631 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.06 47.66 2.02 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.304 -0.474 . . . . 70.33 111.967 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 61' ' ' PRO . . . -66.49 -63.81 3.7 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.171 0.428 . . . . 51.24 114.171 -174.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -152.66 -178.56 6.95 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.182 0.491 . . . . 73.24 111.244 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.3 23.82 1.81 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.675 0.39 . . . . 71.34 111.49 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 34.0 tt0 -50.81 -47.85 84.94 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.361 0.874 . . . . 63.12 113.361 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.481 ' O ' HD23 ' A' ' 101' ' ' LEU . 51.7 Cg_endo -87.98 38.5 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.313 2.009 . . . . 74.0 113.701 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.7 tt -66.59 -58.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 113.635 0.976 . . . . 71.13 113.635 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 98' ' ' ILE . 9.9 m-20 -57.9 -55.73 42.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.935 1.087 . . . . 73.15 113.935 -172.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 32.4 Cg_endo -61.65 -14.64 37.0 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.315 2.01 . . . . 74.04 114.742 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 97' ' ' PRO . 4.0 mm? -100.89 -62.03 1.29 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -50.62 -45.15 57.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.508 0.929 . . . . 72.35 113.508 -170.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.7 t -52.81 -37.68 60.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.488 0.551 . . . . 71.31 112.488 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 0.5 OUTLIER -66.61 -44.0 83.25 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.831 0.348 . . . . 71.5 111.449 -177.188 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -63.16 -35.97 82.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.924 0.393 . . . . 64.14 111.154 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -69.4 -43.79 72.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.144 -0.48 . . . . 74.32 110.999 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.32 -55.14 38.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.622 . . . . 73.34 111.792 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 mp -71.69 -26.19 62.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.758 0.313 . . . . 72.43 111.312 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.68 62.14 3.32 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.172 -0.537 . . . . 55.22 113.579 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.39 142.66 35.78 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.069 0.461 . . . . 64.54 111.313 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 35.3 m -70.91 97.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.261 -0.427 . . . . 72.5 110.941 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.3 p -86.73 121.66 29.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.126 -0.488 . . . . 73.12 112.152 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.31 -58.8 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.435 0.531 . . . . 73.43 112.435 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -140.92 84.89 12.81 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 120.996 0.427 . . . . 74.14 111.667 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.39 64.53 4.96 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.824 2.349 . . . . 63.31 112.989 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.91 42.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.143 0.423 . . . . 71.35 112.143 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.518 HG21 ' H ' ' A' ' 89' ' ' GLU . 1.7 pp -71.2 73.23 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.847 0.832 . . . . 74.4 112.892 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -79.46 50.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.929 -0.578 . . . . 73.44 112.415 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 89' ' ' GLU . 49.0 mm -76.35 147.82 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 120.932 0.396 . . . . 73.21 111.721 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.96 -61.86 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.113 0.412 . . . . 70.14 112.113 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.525 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 35.2 tt0 -151.28 -48.94 0.12 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.098 0.475 . . . . 41.02 111.604 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.0 p -129.35 131.75 23.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.412 -0.358 . . . . 53.24 111.289 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 90' ' ' THR . 37.6 Cg_endo -65.96 143.76 73.85 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.475 2.117 . . . . 72.22 112.226 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.8 p -100.73 -177.72 3.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.991 0.424 . . . . 70.21 111.592 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -59.89 -26.76 66.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.076 0.465 . . . . 61.44 111.258 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -76.38 -24.38 54.11 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.38 -0.373 . . . . 74.34 111.902 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.0 m -59.07 -35.26 73.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.936 0.398 . . . . 75.14 111.466 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.43 -48.43 80.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.024 0.44 . . . . 63.52 111.346 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -50.13 -50.11 49.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.653 -0.703 . . . . 75.25 112.54 -174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 130' ' ' LEU . 7.2 mp -63.05 -46.39 87.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 72.4 111.232 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 82.2 m -61.05 -40.05 92.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.236 -0.438 . . . . 71.41 111.773 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.18 -52.56 12.1 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.865 0.364 . . . . 71.34 111.614 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.61 -63.49 1.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.422 -0.354 . . . . 70.41 110.941 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.21 79.55 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.481 -0.327 . . . . 72.02 111.405 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.04 94.67 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.282 -0.485 . . . . 34.44 113.083 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 54.8 m -60.67 -48.61 81.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.827 0.346 . . . . 63.33 111.151 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.09 -39.64 86.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.904 0.383 . . . . 62.21 111.304 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.44 -44.5 97.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.023 0.439 . . . . 65.23 110.662 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.3 -38.72 96.25 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.265 -0.493 . . . . 64.44 112.75 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 86.3 mt-30 -61.89 -28.83 69.79 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.998 0.37 . . . . 61.42 111.998 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -50.63 -40.33 52.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.129 0.49 . . . . 70.01 110.717 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.97 -51.95 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.025 -0.534 . . . . 74.32 111.755 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.564 ' HA ' ' HB2' ' A' ' 146' ' ' ARG . 10.0 t -69.1 -25.2 64.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.901 0.334 . . . . 73.22 111.901 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 94.7 mtt180 -65.73 -41.11 92.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.742 0.306 . . . . 75.24 111.093 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.65 -27.94 31.01 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.432 . . . . 75.54 110.936 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.68 ' HA ' ' HE ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -59.83 -59.23 5.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.357 -0.383 . . . . 72.22 111.132 175.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.662 -0.244 . . . . 72.23 111.514 174.612 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.679 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 53.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.009 -0.043 . . . . 72.22 110.933 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 63.33 122.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 112.726 0.639 . . . . 74.43 112.726 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.48 105.11 3.24 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.473 -0.394 . . . . 73.3 112.663 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.2 t -88.39 107.92 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 122.55 -0.383 . . . . 64.4 110.982 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.633 ' HE2' ' HB2' ' A' ' 55' ' ' LEU . 83.3 m-85 -88.71 142.0 28.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.938 0.718 . . . . 72.11 112.938 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -146.58 179.74 7.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.775 -0.648 . . . . 74.03 110.844 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.606 HG13 ' HA3' ' A' ' 37' ' ' GLY . 86.0 t -130.64 103.7 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.748 0.309 . . . . 44.42 111.721 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.7 m -54.95 -36.41 65.29 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.087 0.403 . . . . 74.05 112.087 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.7 -54.81 36.95 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.385 0.513 . . . . 74.2 112.385 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.423 ' H ' HG12 ' A' ' 7' ' ' VAL . 73.9 t80 -138.94 -55.29 0.6 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.092 -0.503 . . . . 62.24 110.898 -174.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.581 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -30.04 97.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.365 0.906 . . . . 71.42 115.365 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -70.82 5.76 1.81 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.073 0.464 . . . . 75.41 111.488 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -52.89 -14.17 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.029 0.751 . . . . 73.42 113.029 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.33 -37.01 74.26 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.093 0.473 . . . . 63.44 110.916 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.561 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 1.5 mtm180 -65.15 -34.41 78.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.056 -0.52 . . . . 55.0 111.127 175.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' HG13 ' A' ' 20' ' ' ILE . 75.6 mt -66.79 -48.18 69.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.202 -0.454 . . . . 64.14 110.406 172.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.85 -41.73 71.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.126 -0.488 . . . . 70.13 112.116 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -63.0 -46.02 89.64 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.906 0.384 . . . . 62.13 111.321 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.08 93.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.064 0.459 . . . . 63.15 111.217 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 16' ' ' LEU . 79.1 mt -63.71 -55.19 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.681 . . . . 73.54 111.814 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.79 -39.69 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 122.312 -0.243 . . . . 74.35 111.61 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 25' ' ' THR . 46.1 t-20 -55.77 -59.82 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.842 0.354 . . . . 53.32 111.025 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -45.07 96.67 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 120.952 -0.642 . . . . 73.32 113.42 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 30' ' ' GLY . 33.6 mt -72.92 -30.22 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.115 0.783 . . . . 75.15 113.115 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 22' ' ' ASN . 14.5 t -69.66 -35.18 74.94 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.571 -0.705 . . . . 54.3 110.743 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -74.62 -43.01 57.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.933 0.397 . . . . 70.31 110.807 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -59.34 -34.09 71.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.128 -0.487 . . . . 63.01 111.377 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.48 59.13 0.68 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.036 -0.602 . . . . 61.12 114.101 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 24' ' ' ILE . 61.1 t -140.07 -53.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.844 0.354 . . . . 63.25 111.24 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 84.65 119.06 0.83 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.326 -0.464 . . . . 75.52 113.564 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 1' ' ' SER . 30.9 m -116.6 146.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.324 0.49 . . . . 52.1 112.324 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.28 129.97 55.5 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.289 -0.414 . . . . 75.43 111.169 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.16 137.15 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.182 0.515 . . . . 52.42 112.205 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 59.7 t -132.64 140.33 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.507 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 17.4 t70 -107.88 130.34 55.01 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.176 0.512 . . . . 61.02 111.711 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -116.75 11.32 14.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.288 -0.415 . . . . 71.33 112.078 178.342 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.606 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -96.17 -35.12 5.63 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.007 -0.616 . . . . 72.31 113.353 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.0 -38.22 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.984 0.421 . . . . 42.1 111.816 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . . . -75.54 12.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.499 0.555 . . . . 71.41 112.499 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.24 114.05 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.227 0.537 . . . . 65.3 111.969 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.12 170.43 21.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.886 -0.597 . . . . 71.3 110.628 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.17 -34.8 70.7 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.618 -0.264 . . . . 64.12 111.447 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.44 -63.11 1.39 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.643 0.258 . . . . 63.43 111.624 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.47 -48.97 65.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.196 0.522 . . . . 65.5 111.637 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.09 -43.67 98.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.154 -0.475 . . . . 75.12 111.975 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -71.65 -34.73 70.0 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.877 0.37 . . . . 74.54 111.309 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HB3' HH11 ' A' ' 51' ' ' ARG . 34.5 mt-10 -71.99 -28.75 63.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.659 0.266 . . . . 63.34 111.141 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.56 -40.0 77.96 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.935 0.398 . . . . 73.1 110.615 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -36.03 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.22 -0.445 . . . . 64.4 111.014 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.33 -40.29 41.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.169 -0.539 . . . . 72.21 112.647 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 47' ' ' GLU . 7.2 mpt_? -81.61 6.23 15.71 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.102 0.408 . . . . 73.14 112.102 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.9 p -49.84 -15.54 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.633 0.975 . . . . 74.44 113.633 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -47.59 -31.63 4.66 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.338 0.496 . . . . 73.42 112.338 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -179.82 141.56 4.75 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.076 -0.511 . . . . 33.2 112.095 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.633 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . 1.4 pt? -144.72 134.48 23.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.369 0.584 . . . . 65.15 112.136 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG22 ' HE1' ' A' ' 88' ' ' PHE . 11.4 p -118.11 124.99 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.076 0.465 . . . . 71.25 111.077 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.51 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.5 mp -113.2 139.64 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.287 0.477 . . . . 61.2 112.287 -172.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.1 131.23 10.54 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.3 -0.409 . . . . 74.21 112.579 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.07 120.26 22.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.551 0.575 . . . . 71.32 112.551 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.668 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 88.4 p -111.75 171.14 4.57 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.153 0.581 . . . . 61.35 111.051 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.668 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 30.9 Cg_endo -63.18 168.08 11.51 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.289 1.992 . . . . 65.42 113.526 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.831 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -58.22 -21.62 48.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.076 0.769 . . . . 72.03 113.076 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.19 -61.0 2.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.785 0.326 . . . . 52.35 111.305 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 -33.01 36.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.625 -0.261 . . . . 71.25 111.701 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -54.81 -37.59 66.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.179 0.437 . . . . 72.34 112.179 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.51 75.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.073 0.463 . . . . 75.32 111.315 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -68.86 -40.85 79.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.28 0.562 . . . . 72.42 110.691 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.39 -44.5 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.914 -0.585 . . . . 74.33 111.081 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -57.44 -40.17 77.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.507 -0.315 . . . . 74.11 111.357 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.11 -49.16 73.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.153 -0.546 . . . . 33.32 112.887 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.39 67.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.918 0.39 . . . . 75.33 111.92 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 72' ' ' LEU . 3.2 tm? -52.8 -32.12 42.29 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.228 -0.442 . . . . 61.04 111.175 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.4 m -46.8 -41.03 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.729 0.412 . . . . 63.42 111.752 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.1 m -87.68 -45.32 10.49 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.892 0.377 . . . . 74.51 111.157 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.39 -51.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 112.418 0.525 . . . . 74.04 112.418 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.4 tp -55.91 -33.95 65.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.823 0.344 . . . . 72.43 111.889 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.37 -17.44 55.28 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.944 -0.646 . . . . 70.14 113.244 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.0 p -87.75 -16.35 34.48 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.336 0.495 . . . . 72.44 112.336 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.57 153.94 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.22 0.533 . . . . 73.2 112.084 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -87.14 148.64 25.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.082 -0.508 . . . . 75.11 111.158 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.76 -36.31 64.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.939 0.4 . . . . 71.02 111.997 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -118.19 87.15 2.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.489 0.661 . . . . 62.04 110.837 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.482 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 18.2 tp60 -131.38 172.83 11.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.993 -0.549 . . . . 74.5 110.867 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.482 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -107.98 123.72 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 64.54 111.836 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 112' ' ' THR . 35.3 m -130.03 171.8 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.842 0.353 . . . . 62.11 111.12 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.445 ' HA3' HG23 ' A' ' 56' ' ' VAL . . . -142.4 144.4 14.03 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.097 -0.573 . . . . 64.44 112.826 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -125.06 126.66 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.588 -0.36 . . . . 73.52 111.829 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 54.6 p90 -148.94 168.14 23.88 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.101 0.477 . . . . 75.21 111.725 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.58 155.38 21.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.377 0.608 . . . . 73.34 111.984 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -134.5 2.26 3.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.999 0.428 . . . . 54.23 111.765 176.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.62 -164.96 29.66 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.242 -0.504 . . . . 74.12 112.778 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.09 -29.66 62.79 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.039 0.376 . . . . 60.43 114.039 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.33 126.15 1.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.341 -0.457 . . . . 64.44 112.98 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 27.2 t70 -160.2 109.37 1.74 Allowed 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.444 -0.445 . . . . 75.1 111.41 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -168.32 156.77 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.569 0.348 . . . . 60.43 110.846 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.725 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 4.6 mp0 -94.15 -61.12 0.18 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 112.19 0.441 . . . . 64.43 112.19 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 6.1 Cg_exo -80.03 16.29 1.52 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.567 2.178 . . . . 61.23 113.749 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.544 HG23 ' H ' ' A' ' 99' ' ' ASP . 5.6 tt -47.9 -59.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.86 0.689 . . . . 72.13 112.86 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' H ' HG23 ' A' ' 98' ' ' ILE . 6.8 m-20 -63.83 -50.98 68.02 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 111.983 0.364 . . . . 74.23 111.983 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 94.3 Cg_exo -47.24 -40.8 27.9 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.437 2.091 . . . . 74.34 113.704 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 97' ' ' PRO . 7.4 mp -63.8 -59.82 4.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.838 0.351 . . . . 74.13 111.266 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.7 mt -53.93 -35.82 62.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.081 0.467 . . . . 71.44 111.334 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.3 t -57.78 -46.04 85.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.826 -0.624 . . . . 74.51 111.432 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -71.07 -41.07 71.19 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.673 0.249 . . . . 72.35 111.673 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.32 -35.68 76.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.184 0.516 . . . . 75.43 111.113 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 106' ' ' ARG . 15.0 tpt180 -79.53 -31.37 42.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.008 0.432 . . . . 74.4 110.591 177.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -59.67 -38.32 81.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.033 -0.53 . . . . 72.32 110.534 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.72 -52.82 26.57 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.103 -0.499 . . . . 72.53 110.789 173.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.39 34.34 0.82 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.123 -0.561 . . . . 64.12 113.797 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 110' ' ' LEU . 7.1 mp -83.56 136.12 34.37 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.458 -0.436 . . . . 73.52 111.111 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.4 t -77.78 125.74 29.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.096 -0.335 . . . . 74.2 110.096 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 85' ' ' VAL . 59.3 p -97.38 -8.48 29.43 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.679 0.992 . . . . 60.42 113.679 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 50.24 78.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.538 0.569 . . . . 73.32 112.538 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 64.82 106.9 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 112.388 0.514 . . . . 72.23 112.388 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.63 74.14 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.08 1.853 . . . . 73.41 111.906 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . . . -73.76 114.45 12.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.79 0.663 . . . . 60.15 112.79 -173.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.2 tt -159.04 80.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.949 0.88 . . . . 64.14 110.6 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -146.81 90.58 1.93 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.772 -0.649 . . . . 73.1 111.773 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.45 149.34 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.397 0.618 . . . . 71.11 112.232 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -91.23 -25.2 19.62 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.715 -0.675 . . . . 61.24 110.886 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 178.71 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.439 -0.8 . . . . 73.34 109.962 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p -128.62 140.06 37.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.794 -0.639 . . . . 74.32 110.795 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.21 169.15 14.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.621 2.214 . . . . 55.41 114.012 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 125' ' ' GLU . 91.1 m -107.43 160.06 15.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.866 -0.606 . . . . 53.52 110.526 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 124' ' ' THR . 9.4 pt-20 -43.47 -35.53 1.67 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.634 0.975 . . . . 62.42 113.634 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -62.36 -23.25 66.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.327 0.492 . . . . 62.3 112.327 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.0 m -57.98 -39.74 78.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.231 0.538 . . . . 71.35 110.556 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.561 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 11.3 m-85 -60.44 -32.03 70.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.906 -0.588 . . . . 73.04 111.278 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.7 -36.52 76.03 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.44 -0.345 . . . . 72.5 111.136 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.28 -53.66 34.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 64.34 110.256 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.7 m -58.79 -32.7 69.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.006 0.431 . . . . 53.43 111.083 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.04 -56.03 26.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.783 -0.644 . . . . 71.44 112.019 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.43 -34.76 76.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.802 0.334 . . . . 74.2 111.74 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.56 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.592 -0.276 . . . . 62.31 111.718 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -54.19 -49.36 60.0 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.546 -0.359 . . . . 72.21 113.558 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 55.4 m -59.79 -40.93 89.97 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.849 0.357 . . . . 72.0 111.431 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.47 -42.95 99.57 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.923 0.392 . . . . 74.12 111.365 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.77 0.319 . . . . 75.12 110.979 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.28 93.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.832 -0.699 . . . . 63.33 112.509 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 136' ' ' THR . 19.8 mt-30 -67.93 -23.82 65.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.039 0.447 . . . . 74.34 111.398 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.56 -44.81 77.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.216 0.531 . . . . 74.13 110.755 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.6 -50.24 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.97 -0.559 . . . . 73.01 111.857 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 140' ' ' GLN . 8.9 t -61.36 -33.52 73.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.669 0.271 . . . . 75.02 111.728 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -56.88 -46.75 81.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.078 0.466 . . . . 63.33 110.972 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.61 -29.83 62.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.125 -0.488 . . . . 72.44 111.351 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -86.84 -34.22 19.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.237 -0.438 . . . . 63.41 112.172 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.4 tp . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 112.544 0.572 . . . . 72.33 112.544 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 65.6 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.497 0.189 . . . . 72.43 111.288 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 142' ' ' VAL . 48.9 mm 60.26 89.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.113 0.482 . . . . 74.35 111.862 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.63 90.11 1.61 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.963 -0.637 . . . . 72.33 112.278 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.0 p -82.06 120.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.481 0.658 . . . . 65.32 112.154 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -95.13 126.99 40.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.625 -0.716 . . . . 74.11 111.197 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 5.3 p90 -159.37 -178.91 7.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.831 0.348 . . . . 73.51 110.968 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.48 106.18 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.266 0.555 . . . . 62.42 111.761 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.9 m -70.34 -24.27 62.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.052 0.389 . . . . 71.11 112.052 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.99 -47.38 77.81 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.145 0.498 . . . . 73.13 111.43 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -102.71 22.3 13.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.586 0.708 . . . . 64.41 109.274 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -30.33 91.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 117.392 1.717 . . . . 62.31 117.392 -170.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -104.69 -34.13 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.79 . . . . 65.11 109.675 156.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 16.3 m -79.75 -12.98 59.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.033 -0.985 . . . . 75.43 112.901 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.36 -39.09 92.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.038 0.447 . . . . 53.41 111.069 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -70.85 -38.34 73.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.215 0.531 . . . . 74.14 110.806 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -61.63 -44.53 96.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.961 -0.563 . . . . 71.23 110.959 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.46 87.42 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.054 -0.521 . . . . 71.31 111.346 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.07 -42.78 86.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.376 -0.374 . . . . 53.01 111.232 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.42 89.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.459 . . . . 73.3 111.115 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.96 -51.24 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.073 -0.512 . . . . 73.04 110.989 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.48 ' HA ' HG21 ' A' ' 31' ' ' VAL . 76.3 mt -55.21 -43.06 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.264 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.41 -33.1 73.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.104 0.478 . . . . 73.54 111.603 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.02 23.4 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.34 -0.457 . . . . 75.52 113.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.33 -50.54 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.42 0.526 . . . . 60.41 112.42 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 81.5 p -63.5 -37.39 87.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.319 0.488 . . . . 71.23 112.319 -175.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.05 -24.0 67.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.048 0.452 . . . . 71.12 111.213 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 m -81.31 -7.69 59.61 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.169 0.509 . . . . 64.33 111.185 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.93 13.79 35.97 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.124 -0.56 . . . . 63.05 113.846 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' THR . 58.4 t -116.95 128.36 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.449 -0.442 . . . . 64.32 111.175 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.41 30.48 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.039 -0.601 . . . . 72.03 113.225 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 1' ' ' SER . 49.0 t -109.56 141.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.794 -0.239 . . . . 54.54 111.516 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.52 117.98 34.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.087 0.47 . . . . 64.12 111.305 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 34.3 m -95.18 135.24 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.95 0.405 . . . . 65.55 111.724 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.38 104.84 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.012 0.434 . . . . 54.44 111.592 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 2.7 m-20 -78.8 92.53 4.85 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.954 0.407 . . . . 51.21 111.392 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -68.21 -13.02 61.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.892 0.377 . . . . 73.11 111.862 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -84.51 -8.09 83.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.132 -0.556 . . . . 73.13 113.016 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.42 172.69 6.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.091 0.472 . . . . 50.23 111.8 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.32 82.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.076 0.465 . . . . 70.3 111.399 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.26 162.7 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 72.25 112.145 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.69 167.12 22.03 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.317 -0.401 . . . . 71.3 110.779 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.502 HD13 HD12 ' A' ' 45' ' ' LEU . 3.9 mm? -59.55 -25.54 64.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.321 -0.237 . . . . 72.21 111.441 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.96 -34.37 65.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.02 0.438 . . . . 62.03 110.98 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -84.38 -50.08 8.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.389 0.614 . . . . 42.25 110.63 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.502 HD12 HD13 ' A' ' 42' ' ' LEU . 89.8 mt -56.62 -31.6 64.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.835 -0.62 . . . . 74.12 112.391 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -63.32 -46.41 86.79 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.961 0.41 . . . . 75.21 110.866 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 60.3 tt0 -63.11 -34.79 78.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.002 0.429 . . . . 74.24 110.497 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 54.4 tp -52.19 -45.34 65.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.08 -0.509 . . . . 53.3 111.177 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.29 -38.3 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.108 0.48 . . . . 72.04 111.077 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.84 -29.97 66.54 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.126 -0.559 . . . . 24.12 112.961 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 3.5 mpt_? -89.13 5.25 45.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.981 0.363 . . . . 51.34 111.981 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -51.36 -27.85 10.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.888 0.699 . . . . 61.14 112.888 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.3 p -53.77 -38.6 64.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.122 0.415 . . . . 52.11 112.122 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.24 134.84 4.71 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.895 -0.669 . . . . 54.43 113.039 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HB2' HG12 ' A' ' 85' ' ' VAL . 80.7 mt -137.93 174.75 10.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.878 0.471 . . . . 74.14 110.712 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 48.5 t -139.76 111.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 110.325 -0.25 . . . . 74.11 110.325 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.642 HD13 ' HB ' ' A' ' 85' ' ' VAL . 1.7 mp -91.93 128.41 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.643 0.609 . . . . 72.33 112.643 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.35 139.86 11.3 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 115.636 -0.711 . . . . 63.51 112.142 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.453 ' SD ' HD12 ' A' ' 98' ' ' ILE . 72.7 mtm -82.8 161.5 21.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.037 0.446 . . . . 72.11 111.777 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -143.6 164.27 31.53 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.1 0.407 . . . . 55.54 112.1 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 53.0 Cg_exo -55.51 168.23 1.64 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.063 2.509 . . . . 61.32 113.804 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -50.76 47.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.24 0.83 . . . . 61.31 113.24 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.18 66.51 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.877 0.37 . . . . 74.54 111.942 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.4 m -58.39 -49.35 77.55 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.058 0.456 . . . . 74.43 111.236 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.504 ' HA ' HD12 ' A' ' 68' ' ' ILE . . . -57.97 -35.39 71.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.245 -0.434 . . . . 71.44 112.0 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.16 96.54 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.019 0.437 . . . . 63.34 111.14 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -66.08 -42.15 89.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.384 -0.371 . . . . 62.13 111.096 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 36' ' ' LEU . 67.3 mt -54.8 -54.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.073 0.463 . . . . 71.41 111.113 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.9 -30.9 69.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.013 -0.539 . . . . 74.01 111.53 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.12 -41.59 98.38 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.239 -0.505 . . . . 62.32 113.379 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.53 43.37 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.238 0.458 . . . . 51.1 112.238 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.25 -35.89 65.46 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.597 0.591 . . . . 74.11 112.597 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -56.97 -20.07 21.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.713 0.634 . . . . 71.34 112.713 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -100.42 -10.83 20.75 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.102 0.477 . . . . 70.22 111.714 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.3 mt -92.58 -46.82 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.198 0.444 . . . . 55.5 112.198 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -50.85 -54.99 19.2 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.969 0.729 . . . . 75.24 112.969 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.06 5.49 1.95 Allowed Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.033 0.773 . . . . 60.22 115.033 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.9 m -92.47 -12.65 31.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.87 0.835 . . . . 52.43 112.247 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 110' ' ' LEU . 11.3 m -136.46 129.36 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.927 0.714 . . . . 63.42 112.927 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -162.02 -174.22 4.03 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.04 -0.527 . . . . 73.44 111.074 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 60.69 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.907 1.076 . . . . 54.21 113.907 170.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -141.02 -5.01 1.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.189 0.811 . . . . 45.45 113.189 -172.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.88 127.22 25.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.999 0.428 . . . . 63.45 111.273 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.43 140.76 29.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.671 0.619 . . . . 63.32 112.671 -171.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.642 ' HB ' HD13 ' A' ' 57' ' ' ILE . 17.8 m -131.97 109.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.551 0.691 . . . . 74.51 111.71 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -69.81 146.98 44.24 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.97 -0.559 . . . . 65.13 112.566 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 115' ' ' PRO . 49.9 mm -125.54 121.89 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 122.67 -0.312 . . . . 64.15 111.1 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.593 ' HB2' ' SG ' ' A' ' 131' ' ' CYS . 34.7 p90 -120.04 126.48 50.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.419 . . . . 75.03 110.411 175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.44 133.28 50.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.103 0.478 . . . . 74.55 111.96 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -156.28 -22.6 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.097 -0.501 . . . . 63.45 111.419 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.41 -60.03 3.64 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.005 -0.617 . . . . 53.23 113.138 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.11 -76.64 1.32 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.208 -0.52 . . . . 62.33 113.55 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 173.65 -65.61 0.11 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.642 -0.789 . . . . 62.04 113.439 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.41 111.79 22.75 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.279 0.562 . . . . 62.45 110.446 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.09 15.07 14.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.695 0.628 . . . . 75.52 112.695 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.403 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 45.4 tt0 -91.04 -50.5 0.33 Allowed Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.35 0.87 . . . . 64.03 113.35 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 71.7 Cg_endo -70.97 -2.39 10.96 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.163 1.909 . . . . 62.31 113.61 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.453 HD12 ' SD ' ' A' ' 59' ' ' MET . 10.9 tt -72.04 -26.07 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.831 0.348 . . . . 71.24 111.785 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.94 -53.83 56.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 112.852 0.686 . . . . 61.43 112.852 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 -29.4 35.89 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.674 1.583 . . . . 72.35 112.461 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.89 -48.63 79.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.181 -0.463 . . . . 72.15 111.279 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.04 -23.33 65.36 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.423 0.527 . . . . 74.25 112.423 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.9 t -100.68 -71.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.096 0.776 . . . . 74.15 113.096 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.54 -41.49 69.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.557 0.947 . . . . 52.44 113.557 -166.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.415 ' HD2' HD22 ' A' ' 110' ' ' LEU . 66.8 m-85 -59.39 -26.51 65.19 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.058 0.392 . . . . 72.33 112.058 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 106' ' ' ARG . 50.0 mtm105 -70.7 -34.18 71.69 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.11 0.481 . . . . 75.44 110.749 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.7 -33.96 73.25 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.11 -0.495 . . . . 72.35 111.367 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.97 -34.68 78.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.868 0.366 . . . . 62.11 111.365 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.48 5.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.072 -0.585 . . . . 64.32 113.983 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 85' ' ' VAL . 8.7 mp -74.65 122.81 23.77 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.217 -0.578 . . . . 64.35 111.158 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 34.9 m -74.46 94.13 2.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.897 0.379 . . . . 55.53 110.717 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.3 p -76.86 149.1 36.16 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.283 0.564 . . . . 32.13 112.367 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.458 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -76.73 -66.98 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.131 -0.486 . . . . 61.53 111.208 174.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -170.18 88.92 0.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 120.875 0.369 . . . . 71.42 111.106 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HA ' HG21 ' A' ' 87' ' ' ILE . 85.7 Cg_endo -90.46 100.57 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.851 2.367 . . . . 72.13 113.284 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 110.7 5.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.57 -0.286 . . . . 71.33 111.225 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.67 94.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.61 0.719 . . . . 74.45 112.75 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -107.12 -14.49 14.91 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.987 -0.551 . . . . 72.54 111.987 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 122' ' ' THR . 9.3 tp -84.37 156.16 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.49 0.662 . . . . 72.13 112.536 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.772 ' H ' ' HD2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -92.91 -39.34 11.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.738 -0.665 . . . . 50.01 110.158 171.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 177.01 -59.0 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.644 0.777 . . . . 63.4 110.245 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.476 ' O ' HD11 ' A' ' 119' ' ' ILE . 82.3 p -80.5 118.72 73.74 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 116.447 -0.342 . . . . 74.44 111.385 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.56 146.62 68.27 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.476 2.117 . . . . 65.13 113.295 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.3 p -99.16 179.31 4.64 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.891 0.377 . . . . 73.33 111.592 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.18 -32.73 72.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.047 0.451 . . . . 65.33 111.14 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -57.42 -35.59 70.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.214 -0.448 . . . . 72.42 110.956 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.6 m -62.55 -39.03 92.31 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.496 -0.32 . . . . 71.24 111.491 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -60.17 -47.47 85.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.04 0.448 . . . . 65.23 111.04 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -65.96 -38.39 88.43 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.115 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.58 -52.63 64.83 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 72.2 110.53 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 88' ' ' PHE . 83.0 m -60.62 -41.08 94.11 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.886 0.374 . . . . 64.11 111.511 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -55.74 -45.02 78.08 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.204 0.526 . . . . 54.22 111.295 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.25 -41.66 40.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.004 -0.544 . . . . 74.22 111.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.8 80.25 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.051 0.389 . . . . 73.3 112.051 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.19 -47.29 91.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.021 -0.609 . . . . 53.31 112.918 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 94.1 m -60.46 -45.8 92.37 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.849 0.357 . . . . 75.41 111.403 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.62 -45.07 90.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.284 -0.416 . . . . 74.13 111.411 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.53 -42.93 91.44 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.815 0.34 . . . . 72.31 111.29 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.21 -36.27 61.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.261 -0.495 . . . . 72.43 112.869 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 136' ' ' THR . 77.5 mt-30 -57.86 -45.48 86.24 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 65.1 111.165 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -62.7 -49.28 75.73 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.409 -0.36 . . . . 74.3 111.192 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.423 HG21 HD11 ' A' ' 2' ' ' ILE . 63.7 t -53.73 -56.64 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.325 0.491 . . . . 62.31 112.325 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -65.13 -40.22 94.15 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.218 0.451 . . . . 71.1 112.218 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -75.01 -35.43 61.99 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.942 0.349 . . . . 72.32 111.942 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.08 -44.26 54.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 75.24 110.672 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -58.14 -42.36 85.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.085 -0.507 . . . . 64.12 111.206 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 CA--C 1.543 0.689 0 CA-C-N 116.091 -0.504 . . . . 72.1 110.228 176.85 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.548 0.203 . . . . 63.32 111.548 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 44.3 mm 55.82 93.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 112.688 0.625 . . . . 72.32 112.688 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.09 109.89 3.81 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.563 -0.827 . . . . 70.2 113.318 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.1 p -88.66 111.46 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.527 0.679 . . . . 51.02 111.747 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -89.31 96.66 10.81 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.757 -0.656 . . . . 74.02 111.117 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 25.6 p90 -122.04 -177.89 3.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.994 -0.548 . . . . 73.33 110.358 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.17 93.93 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.413 0.625 . . . . 71.23 111.893 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.427 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 18.2 m -57.13 -27.09 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.379 0.609 . . . . 60.02 110.955 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.28 -23.06 64.71 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.324 -0.853 . . . . 75.14 112.598 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -142.73 144.8 32.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.488 0.661 . . . . 74.02 112.662 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.39 -162.8 6.2 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.385 -0.825 . . . . 72.24 114.894 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 38.2 m-85 -94.24 6.59 48.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.105 0.409 . . . . 75.25 112.105 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 16' ' ' LEU . 60.4 p -51.13 -34.07 29.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.244 0.461 . . . . 72.44 112.244 -173.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 13.5 t70 -58.31 -56.28 24.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.016 0.436 . . . . 65.21 111.193 174.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 18.7 mmt180 -65.69 -27.84 68.64 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.528 -0.305 . . . . 74.41 111.516 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 13' ' ' SER . 90.3 mt -67.41 -43.41 81.32 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 52.02 110.382 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.02 85.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.112 -0.495 . . . . 73.2 110.805 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -57.63 -45.99 84.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.963 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.49 -43.65 89.09 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 62.53 111.27 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.551 HD13 HG11 ' A' ' 56' ' ' VAL . 67.1 mt -59.0 -57.71 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 63.21 110.93 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.55 -35.29 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.118 -0.492 . . . . 73.24 111.609 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -60.08 -53.47 57.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.713 0.292 . . . . 75.13 111.129 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.38 97.85 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.558 . . . . 74.04 112.933 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.685 HG23 ' HB ' ' A' ' 29' ' ' VAL . 36.7 mm -61.47 -47.23 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.916 0.388 . . . . 75.52 111.889 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 p -70.29 -31.73 69.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.741 0.305 . . . . 72.24 111.426 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.675 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -64.43 -42.17 96.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.854 0.359 . . . . 75.41 110.8 174.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -69.6 -51.73 32.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.335 -0.393 . . . . 72.24 111.134 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.82 53.95 0.13 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.443 -0.344 . . . . 70.13 113.162 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.685 ' HB ' HG23 ' A' ' 24' ' ' ILE . 46.2 t -139.7 157.82 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.419 0.288 . . . . 53.41 110.643 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.26 150.19 17.26 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 121.275 -0.488 . . . . 71.33 113.338 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 24' ' ' ILE . 97.1 t -131.07 145.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.625 0.602 . . . . 75.51 112.625 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 4' ' ' VAL . 29.0 m-20 -93.29 142.83 26.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.982 -0.554 . . . . 74.13 111.126 171.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -110.02 131.08 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.815 0.34 . . . . 70.2 111.873 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.17 131.44 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 120.702 0.287 . . . . 70.54 111.465 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.6 m-20 -95.67 105.42 17.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.679 0.276 . . . . 74.54 111.17 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.47 -14.29 62.8 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.928 0.394 . . . . 75.2 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.18 30.86 7.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.372 -0.442 . . . . 73.2 112.93 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.07 174.83 10.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.881 0.372 . . . . 74.04 111.508 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.04 93.85 0.3 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.518 0.562 . . . . 62.22 112.518 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.61 174.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.42 -0.355 . . . . 74.34 111.336 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -145.46 172.2 13.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.001 0.429 . . . . 53.44 111.386 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.2 tm? -54.48 -29.56 50.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.769 0.427 . . . . 71.42 110.735 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -52.82 -48.02 67.27 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 111.986 0.365 . . . . 74.3 111.986 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.93 -38.05 78.08 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.868 0.366 . . . . 62.1 111.146 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.9 -43.67 82.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.835 0.35 . . . . 43.32 110.79 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.59 -50.43 73.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.712 0.291 . . . . 73.23 111.33 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.92 -30.39 71.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.052 0.453 . . . . 70.12 110.901 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 53.2 tp -58.92 -29.84 67.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.558 -0.292 . . . . 63.33 111.587 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.74 -33.42 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.194 0.521 . . . . 74.42 110.519 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.05 -31.65 11.77 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.003 -0.544 . . . . 74.31 112.469 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.657 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 99.7 mtt180 -73.47 -10.78 60.08 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.516 -0.403 . . . . 73.5 111.974 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -60.99 -10.79 6.37 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.768 0.285 . . . . 74.21 111.768 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.535 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 67.9 p -71.5 -28.61 64.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.429 . . . . 73.22 111.586 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -173.11 137.35 4.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.221 -0.445 . . . . 74.2 112.642 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.576 ' HG ' HD11 ' A' ' 57' ' ' ILE . 1.6 pt? -157.62 148.61 21.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.154 0.502 . . . . 63.14 111.806 -177.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.551 HG11 HD13 ' A' ' 20' ' ' ILE . 59.8 t -116.6 113.27 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 122.838 0.455 . . . . 73.24 111.03 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.576 HD11 ' HG ' ' A' ' 55' ' ' LEU . 3.3 mp -116.42 146.33 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 122.07 -0.394 . . . . 75.15 111.887 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -134.93 3.56 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.178 -0.534 . . . . 73.43 112.921 173.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mmt -122.5 156.23 34.54 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.44 -0.447 . . . . 51.11 111.11 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.8 p -97.9 113.54 63.86 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.327 -0.397 . . . . 64.41 111.924 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.45 146.05 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.864 2.376 . . . . 73.33 112.773 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.54 -24.96 2.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.988 0.736 . . . . 54.04 112.988 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.8 74.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.13 0.418 . . . . 53.44 112.13 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.0 p -100.0 4.43 44.81 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.788 0.292 . . . . 62.13 111.788 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.84 -31.01 10.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.497 0.555 . . . . 62.02 112.497 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.9 72.21 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.089 0.471 . . . . 33.54 111.695 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.1 t -65.17 -45.43 84.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.078 0.466 . . . . 73.15 110.874 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 50.4 mm -54.6 -52.95 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.912 -0.585 . . . . 70.23 111.657 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.14 -38.85 89.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.919 0.34 . . . . 74.41 111.919 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.82 -40.38 98.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.177 -0.535 . . . . 71.31 113.207 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -85.32 -44.4 12.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.314 0.487 . . . . 75.23 112.314 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 72' ' ' LEU . 1.4 tm? -53.45 -42.99 67.71 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.592 0.357 . . . . 75.32 111.57 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -51.16 -34.28 30.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.814 0.34 . . . . 63.14 111.864 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.3 m -89.93 -39.74 12.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.214 0.53 . . . . 63.43 111.21 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.575 HG23 HD21 ' A' ' 48' ' ' LEU . 72.1 mt -54.58 -41.41 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.163 -0.471 . . . . 74.04 111.733 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.94 -33.21 62.02 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.296 -0.411 . . . . 52.22 111.834 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.19 -31.73 33.72 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.137 -0.554 . . . . 71.05 112.902 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.8 m -72.7 -39.44 67.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.121 0.415 . . . . 61.31 112.121 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.0 m -87.91 147.34 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.02 0.438 . . . . 73.11 111.568 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -160.94 -179.02 7.2 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.136 0.421 . . . . 55.14 112.136 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.715 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 9.4 tp10 72.2 -106.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.886 0.874 . . . . 70.31 112.71 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.715 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 19.2 ptpt -164.98 24.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.417 0.895 . . . . 50.35 113.417 -172.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HG2' ' HA ' ' A' ' 53' ' ' THR . 1.3 mp0 -62.08 167.85 3.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.754 0.65 . . . . 70.33 112.754 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.94 123.92 34.81 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.77 -0.65 . . . . 75.52 112.349 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.74 108.53 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.493 0.663 . . . . 75.22 111.025 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 81.43 0.33 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.089 -0.505 . . . . 63.3 112.774 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 49.5 mm -79.53 109.08 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 122.568 -0.372 . . . . 75.33 111.391 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' HD2' ' HG1' ' A' ' 90' ' ' THR . 40.1 p90 -105.27 111.63 24.44 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.354 0.597 . . . . 74.01 110.555 173.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.819 ' HB2' HD11 ' A' ' 119' ' ' ILE . 7.7 pt-20 -57.9 104.05 0.17 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.488 0.661 . . . . 64.25 112.703 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.409 ' HG1' ' HD2' ' A' ' 88' ' ' PHE . 90.6 m -142.34 112.78 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.131 -0.486 . . . . 53.42 111.534 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.52 -139.77 15.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.192 -0.528 . . . . 64.4 113.481 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.04 -102.44 2.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.066 -0.587 . . . . 75.43 113.359 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.22 -96.18 0.54 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.22 -0.514 . . . . 70.2 112.46 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -106.89 123.65 48.47 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.559 -0.377 . . . . 65.43 110.282 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.63 159.1 44.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 64.41 111.211 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.583 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 37.9 mt-10 -103.91 -55.93 0.1 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.922 0.712 . . . . 74.31 112.922 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.583 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 39.3 Cg_endo -64.7 -14.59 45.55 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.287 1.991 . . . . 71.44 114.014 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 99' ' ' ASP . 9.9 tt -49.12 -51.86 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 113.26 0.837 . . . . 74.32 113.26 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.71 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 4.5 m-20 -61.53 -55.44 42.68 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.189 0.44 . . . . 75.22 112.189 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.7 Cg_exo -56.25 -33.35 90.69 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.009 1.806 . . . . 52.41 112.705 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.64 -57.06 7.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.06 -0.518 . . . . 74.31 111.479 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.33 -37.79 67.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.988 0.423 . . . . 63.21 110.862 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 100' ' ' PRO . 6.3 t -49.99 -43.33 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.616 . . . . 72.43 111.727 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.702 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -64.55 -44.21 91.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.646 -0.252 . . . . 74.23 111.16 -177.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -60.68 -36.89 79.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.87 0.366 . . . . 72.12 111.223 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -66.85 -60.77 2.37 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.159 -0.473 . . . . 74.32 111.698 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -60.61 -39.31 87.68 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.302 0.482 . . . . 63.44 112.302 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.58 -24.43 49.76 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.205 -0.309 . . . . 63.01 111.569 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.65 52.59 33.27 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.155 -0.545 . . . . 62.1 113.04 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.32 159.9 20.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.97 0.414 . . . . 73.13 111.535 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 88.2 m -79.63 110.02 14.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 40.5 110.77 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -108.52 141.57 40.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.44 0.533 . . . . 72.42 112.44 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.31 -86.13 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.418 -0.355 . . . . 74.51 111.131 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -148.63 96.42 3.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 121.104 0.478 . . . . 72.01 111.507 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.31 13.47 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.854 2.369 . . . . 73.52 113.193 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.2 78.01 2.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.285 0.564 . . . . 74.13 111.441 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.405 HG13 HD13 ' A' ' 119' ' ' ILE . 8.8 tt -62.5 112.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 113.175 0.806 . . . . 73.13 113.175 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -140.44 49.87 1.71 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.132 0.492 . . . . 74.24 111.259 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 89' ' ' GLU . 3.3 mp -89.66 116.31 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.793 0.33 . . . . 64.42 110.957 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.96 -41.81 75.28 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.842 0.353 . . . . 72.03 111.933 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -178.38 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.432 0.634 . . . . 72.34 109.997 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -127.06 142.52 43.99 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.862 -0.608 . . . . 55.12 110.679 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 35.7 Cg_endo -63.98 148.36 91.63 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.631 2.221 . . . . 63.32 113.097 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.6 p -90.26 -178.68 5.45 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.158 0.504 . . . . 63.31 112.057 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.23 -42.48 69.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.023 -0.535 . . . . 72.23 111.718 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -59.99 -39.95 87.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.146 -0.479 . . . . 74.22 112.042 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.8 m -51.78 -30.75 24.21 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.983 0.364 . . . . 74.2 111.983 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.416 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 69.9 m-85 -58.24 -41.01 83.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.717 0.294 . . . . 71.23 111.733 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 53.3 mttm -82.94 -26.73 31.12 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.978 0.362 . . . . 71.51 111.978 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 -41.73 91.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.769 0.319 . . . . 75.21 110.862 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 30.3 p -81.63 -37.15 28.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.629 0.252 . . . . 73.53 111.105 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.67 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.7 tt0 -51.62 -71.32 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.01 0.524 . . . . 74.5 112.283 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -67.07 -38.61 86.08 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.465 0.542 . . . . 65.22 112.465 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.31 -54.44 37.03 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.806 0.336 . . . . 71.4 111.337 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.28 -43.67 97.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.935 -0.65 . . . . 42.03 112.641 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 86.7 m -64.66 -42.97 95.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.79 0.293 . . . . 75.31 111.79 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.83 -44.69 92.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.867 0.365 . . . . 55.4 110.781 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.13 -39.01 84.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.949 0.404 . . . . 72.1 110.83 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.67 -43.01 98.13 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.093 -0.575 . . . . 72.21 112.309 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -62.89 -34.91 78.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.661 0.267 . . . . 72.02 111.059 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -63.09 -42.54 99.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.921 0.391 . . . . 72.21 110.653 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.04 -49.93 77.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.973 0.416 . . . . 62.14 111.2 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 4.9 t -77.86 -11.44 59.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.576 -0.284 . . . . 74.33 111.609 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -72.64 -61.54 1.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.076 0.465 . . . . 71.53 110.577 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.93 -40.02 96.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.824 -0.625 . . . . 63.25 111.704 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -75.66 -38.88 58.43 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.927 0.343 . . . . 73.42 111.927 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 143' ' ' THR . 3.1 mm? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.648 0.261 . . . . 72.2 111.248 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.311 0.101 . . . . 54.31 111.244 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.759 HG13 ' HA2' ' A' ' 139' ' ' GLY . 45.4 mm 67.14 122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 71.24 112.561 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.92 109.22 3.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.132 -0.556 . . . . 55.1 112.703 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.23 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.634 -0.333 . . . . 65.31 111.57 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 97.1 m-85 -86.87 120.64 28.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.898 0.38 . . . . 74.44 111.233 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 1.3 p90 -150.32 -179.9 7.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.393 -0.367 . . . . 64.34 110.924 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.7 t -133.49 110.62 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.68 -0.236 . . . . 64.25 110.522 173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 40.8 t -51.95 -33.48 37.73 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.404 0.52 . . . . 71.21 112.404 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -85.18 -12.6 52.31 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.711 0.634 . . . . 73.42 112.711 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -98.62 90.85 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.778 -0.576 . . . . 73.2 112.121 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.88 -162.03 4.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 115.067 0.787 . . . . 45.33 115.067 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' PRO . 39.4 m-85 -68.15 1.6 2.71 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.813 0.672 . . . . 64.23 112.813 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -54.63 -33.61 60.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.428 0.632 . . . . 74.25 110.581 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 23.6 t70 -59.66 -37.24 78.21 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.294 -0.866 . . . . 53.24 111.878 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -85.26 -26.73 26.46 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.182 -0.463 . . . . 73.5 111.904 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -55.62 -46.25 77.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 44.43 111.474 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.28 -54.29 47.16 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.243 0.46 . . . . 74.51 112.243 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.464 ' HA ' HG22 ' A' ' 21' ' ' ILE . 35.0 tt0 -67.25 -36.37 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.557 -0.292 . . . . 72.4 111.578 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.74 86.74 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.784 0.326 . . . . 74.31 111.689 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.76 -55.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.784 0.326 . . . . 64.0 111.533 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 18' ' ' GLN . 13.4 tt -60.55 -30.05 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.626 0.25 . . . . 74.11 111.315 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -53.42 -35.3 60.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.213 0.53 . . . . 63.5 111.32 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.35 -33.92 6.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.156 -0.545 . . . . 75.22 113.437 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.81 -24.46 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.129 0.789 . . . . 72.11 113.129 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -53.6 -33.37 54.67 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.404 0.52 . . . . 72.2 112.404 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.82 -18.45 60.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.282 0.475 . . . . 74.44 112.282 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.0 m -84.28 -15.93 44.94 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.205 0.526 . . . . 64.33 111.308 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.85 2.99 57.16 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.385 -0.435 . . . . 54.03 112.928 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -98.67 104.57 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.046 0.45 . . . . 63.53 111.299 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.23 128.54 9.55 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.133 -0.556 . . . . 74.43 112.427 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.2 m -90.54 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.1 0.476 . . . . 71.43 111.911 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.2 104.83 16.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.034 0.445 . . . . 74.5 111.069 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 6' ' ' TYR . 35.8 m -83.2 139.53 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.121 0.486 . . . . 74.41 112.285 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.4 t -139.09 118.4 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.382 -0.372 . . . . 72.14 111.401 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.9 m-20 -76.32 91.65 3.26 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.344 -0.222 . . . . 62.45 111.067 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 36' ' ' LEU . 2.5 pt? -59.79 -20.69 58.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.887 0.375 . . . . 55.32 111.963 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 12.58 66.94 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.29 -0.481 . . . . 72.04 113.39 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -161.51 -65.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.921 0.391 . . . . 75.15 111.916 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.65 77.82 4.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.132 0.491 . . . . 64.12 112.127 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.6 126.08 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.128 0.49 . . . . 62.21 111.807 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -163.78 170.9 16.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.134 -0.485 . . . . 55.32 110.172 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.7 tm? -54.73 -37.28 65.7 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.598 0.237 . . . . 73.3 111.151 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -58.55 -57.31 13.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 75.32 111.404 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -61.28 -35.52 77.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.293 -0.412 . . . . 73.33 111.288 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 2.8 tm? -61.09 -42.07 97.83 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.02 0.438 . . . . 73.13 110.268 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -67.87 -43.29 79.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.875 0.369 . . . . 75.32 111.046 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 27.9 mt-10 -62.63 -25.74 68.27 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.749 0.278 . . . . 72.32 111.749 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 64.3 tp -57.44 -36.85 71.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 70.3 110.576 173.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.63 -35.93 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.085 0.469 . . . . 43.11 111.031 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.48 77.39 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.115 -0.564 . . . . 64.53 112.642 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.571 ' NH1' ' HB3' ' A' ' 47' ' ' GLU . 7.5 mpt_? -100.39 6.83 44.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.431 0.293 . . . . 74.33 111.581 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -54.4 -19.94 6.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.135 0.791 . . . . 72.21 113.135 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 p -70.92 -17.99 62.67 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.933 0.345 . . . . 52.51 111.933 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -169.68 137.76 4.68 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.886 -0.673 . . . . 51.44 113.744 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.87 143.17 20.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.063 0.459 . . . . 74.2 111.047 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.51 122.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 73.04 111.299 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -105.27 130.29 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.23 -0.441 . . . . 73.03 111.519 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.597 ' HA2' ' HB2' ' A' ' 88' ' ' PHE . . . -80.15 56.72 4.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.019 -0.61 . . . . 71.0 112.709 175.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 90' ' ' THR . 24.8 mmt 65.41 173.04 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.444 0.64 . . . . 74.33 111.943 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.8 m -141.24 90.29 9.2 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 116.396 -0.365 . . . . 73.0 110.657 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.45 156.33 26.78 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.617 2.211 . . . . 41.4 113.258 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.98 -55.19 2.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.335 0.865 . . . . 64.51 113.335 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.97 67.75 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.305 0.483 . . . . 61.04 112.305 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -72.03 -40.74 68.22 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.774 0.321 . . . . 64.04 111.296 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.19 34.89 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.822 0.675 . . . . 74.54 112.822 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -59.58 4.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 65.14 112.29 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 t -65.11 -36.6 84.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.118 0.485 . . . . 45.43 111.482 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.495 HG22 ' HG ' ' A' ' 72' ' ' LEU . 56.2 mt -59.75 -33.31 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.924 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -53.24 -35.54 60.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.873 0.368 . . . . 62.14 111.894 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.95 -22.19 70.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.917 -0.658 . . . . 42.2 113.354 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.08 -31.45 11.06 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.57 0.581 . . . . 74.34 112.57 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HG ' HG22 ' A' ' 68' ' ' ILE . 49.6 mt -49.94 -44.81 50.69 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.167 0.803 . . . . 71.05 113.167 -174.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 m -52.28 -35.67 50.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.953 0.353 . . . . 71.34 111.953 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -85.18 -45.26 12.19 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 71.42 111.286 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.24 -50.2 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.266 -0.424 . . . . 55.01 111.776 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.57 -22.87 62.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.766 0.317 . . . . 73.32 111.747 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.36 -15.28 41.6 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.253 -0.499 . . . . 55.03 112.983 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.8 m -89.29 -27.21 20.7 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.483 -0.422 . . . . 74.2 111.804 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.0 m -70.76 131.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.345 0.593 . . . . 63.15 112.073 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -82.74 170.49 15.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 71.52 110.786 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 44.2 tt0 -48.6 -35.05 12.74 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.75 0.648 . . . . 65.43 112.75 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -154.21 141.32 19.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.444 0.64 . . . . 73.12 112.423 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 -179.08 7.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.416 -0.811 . . . . 72.32 109.852 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -88.5 91.51 8.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.259 0.552 . . . . 73.44 111.691 -177.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.8 m -103.32 138.0 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.997 0.427 . . . . 74.21 111.198 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.57 164.63 25.67 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.985 -0.626 . . . . 52.31 113.177 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -135.44 145.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.72 0.408 . . . . 75.43 110.51 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' HB2' ' HA2' ' A' ' 58' ' ' GLY . 36.8 m-85 -99.21 129.18 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.708 0.29 . . . . 74.24 110.978 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 117' ' ' ILE . 35.1 mp0 -70.2 80.29 0.52 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.239 0.542 . . . . 72.3 111.315 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 59' ' ' MET . 9.0 t -146.66 179.03 7.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.27 -0.423 . . . . 75.24 111.366 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 75.22 -72.12 1.69 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.336 -0.459 . . . . 72.23 113.736 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.32 -116.25 0.73 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.198 -0.525 . . . . 71.53 112.978 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.53 36.29 0.51 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.023 -0.608 . . . . 44.32 112.899 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.91 109.88 21.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.669 0.271 . . . . 73.42 111.391 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.06 157.27 25.86 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.406 -0.361 . . . . 74.31 111.622 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 2.8 mp0 -103.49 -55.78 0.1 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.227 0.825 . . . . 53.13 113.227 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 3.8 Cg_exo -77.26 16.92 0.94 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.703 2.269 . . . . 63.22 114.332 -176.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 99' ' ' ASP . 9.0 tt -44.36 -62.3 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 114.231 1.197 . . . . 75.41 114.231 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.515 ' H ' HG23 ' A' ' 98' ' ' ILE . 39.7 m-20 -62.72 -50.29 78.56 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.211 0.819 . . . . 72.11 113.211 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 63.8 Cg_exo -53.67 -43.22 59.7 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.373 2.049 . . . . 54.24 113.344 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.2 -44.72 68.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.572 0.225 . . . . 72.53 111.425 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.555 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 60.5 mt -56.05 -44.95 79.34 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.746 0.308 . . . . 54.5 110.985 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.2 t -56.91 -40.93 77.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.951 0.405 . . . . 74.52 110.951 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -39.69 78.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.403 -0.362 . . . . 74.23 111.185 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.646 ' HD1' HD12 ' A' ' 110' ' ' LEU . 29.4 m-85 -61.39 -32.46 72.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.568 0.223 . . . . 75.12 111.316 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 102' ' ' LEU . 2.1 mpt_? -73.92 -40.68 62.96 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.807 0.337 . . . . 55.4 111.111 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.63 -43.29 80.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.021 0.439 . . . . 63.44 111.426 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.496 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 81.2 mt -89.72 -41.76 11.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.031 0.443 . . . . 75.54 111.911 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 57.39 1.38 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.933 -0.467 . . . . 73.1 111.933 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.646 HD12 ' HD1' ' A' ' 105' ' ' PHE . 83.5 mt -96.32 163.01 13.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 74.42 112.34 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.438 HG21 HD11 ' A' ' 138' ' ' LEU . 87.4 m -66.15 136.4 55.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.588 -0.733 . . . . 60.43 112.104 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -131.9 96.54 3.95 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.378 -0.374 . . . . 55.33 111.073 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.33 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.393 0.516 . . . . 61.45 112.393 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -150.43 89.65 4.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 121.166 0.507 . . . . 74.4 110.791 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.95 30.62 0.51 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.037 2.492 . . . . 64.41 114.378 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.19 101.63 0.74 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.94 0.348 . . . . 62.21 111.94 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 89' ' ' GLU . 14.2 tt -153.0 143.53 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.004 0.431 . . . . 64.01 111.608 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -79.14 94.01 5.29 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.207 0.527 . . . . 74.54 111.74 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.436 HG12 HG23 ' A' ' 117' ' ' ILE . 49.4 mm -105.2 116.49 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.187 -0.461 . . . . 62.11 110.482 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 45.8 tptt -80.29 50.46 1.26 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.01 0.433 . . . . 61.44 111.498 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.5 tt0 71.57 -60.45 0.52 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.461 0.704 . . . . 72.02 112.558 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -86.75 120.85 72.0 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 111.816 0.302 . . . . 60.22 111.816 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' A' ' 12' ' ' TYR . 71.5 Cg_exo -51.81 137.85 51.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.81 2.34 . . . . 72.3 113.085 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.9 p -93.83 168.01 11.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.883 0.373 . . . . 72.35 111.518 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.44 -32.74 71.66 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.219 0.533 . . . . 70.01 110.807 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -73.24 -31.63 64.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.013 -0.54 . . . . 74.41 111.02 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.8 m -52.51 -38.38 59.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.27 -0.423 . . . . 60.5 111.809 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -52.47 -41.9 63.75 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.688 0.28 . . . . 64.23 111.626 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -65.57 -46.36 79.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.977 0.362 . . . . 62.25 111.977 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.93 -51.61 60.9 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.523 -0.308 . . . . 75.31 111.091 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.9 -29.94 71.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.804 0.298 . . . . 65.11 111.804 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.46 -58.16 7.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.942 0.401 . . . . 53.55 110.369 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.19 -12.35 61.6 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.201 0.445 . . . . 73.01 112.201 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.59 -62.84 1.53 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.897 0.38 . . . . 44.03 110.863 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.08 -42.35 99.72 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 63.15 113.51 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -35.85 61.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.287 0.477 . . . . 75.21 112.287 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 141' ' ' TRP . 29.4 t70 -60.17 -51.64 68.73 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.976 0.417 . . . . 61.12 110.925 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 138' ' ' LEU . 2.6 mm? -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.915 0.388 . . . . 74.45 110.919 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.759 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -63.89 -55.06 26.73 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.321 -0.466 . . . . 62.4 112.746 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -74.61 -14.88 60.83 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.598 -0.354 . . . . 55.43 111.715 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 62.2 t90 -50.28 -38.33 40.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.18 0.514 . . . . 73.11 110.546 176.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 146' ' ' ARG . 58.8 t -54.88 -61.05 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.437 -0.802 . . . . 51.24 111.623 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -70.62 -25.1 62.88 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.466 0.543 . . . . 71.03 112.466 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -67.93 -38.09 82.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.132 -0.355 . . . . 73.14 111.44 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.5 -50.33 7.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 120.965 0.412 . . . . 70.13 111.274 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 11.9 mtp180 -69.93 -19.0 63.4 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.893 0.701 . . . . 74.41 112.893 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 52.5 tp . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 123.396 0.678 . . . . 74.54 112.266 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 43.0 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 111.227 0.084 . . . . 74.13 111.227 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm 67.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 121.17 0.509 . . . . 61.43 111.766 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.95 109.58 3.21 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.2 -0.524 . . . . 73.04 112.972 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 111.58 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.795 0.331 . . . . 54.25 110.971 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.453 ' HE2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 m-85 -97.29 139.46 33.22 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.408 0.521 . . . . 71.03 112.408 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 35' ' ' ASP . 44.1 p90 -142.29 162.91 34.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.972 0.415 . . . . 72.12 110.751 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 9' ' ' GLU . 20.7 t -106.29 115.73 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 122.213 -0.305 . . . . 61.04 111.591 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 35' ' ' ASP . 15.1 m -60.12 -20.28 57.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.96 0.41 . . . . 74.01 111.786 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.54 ' H ' HG12 ' A' ' 7' ' ' VAL . 43.2 tt0 -70.13 -69.51 0.35 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.127 -0.488 . . . . 71.33 111.696 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -137.38 -35.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.943 0.349 . . . . 72.21 111.943 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -28.55 103.37 0.01 OUTLIER Glycine 0 N--CA 1.472 1.091 0 N-CA-C 115.328 0.891 . . . . 53.21 115.328 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.62 5.47 3.06 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.83 0.452 . . . . 75.21 112.208 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 m -57.7 -19.73 29.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.653 0.612 . . . . 42.44 112.653 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -61.73 -34.85 76.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.247 0.546 . . . . 45.34 111.067 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -69.47 -37.73 77.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.727 -0.669 . . . . 75.51 111.079 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.641 HD13 ' SG ' ' A' ' 131' ' ' CYS . 64.5 mt -70.3 -39.98 74.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.811 -0.632 . . . . 75.4 110.706 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.05 74.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.828 -0.624 . . . . 73.43 111.706 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.73 -41.02 97.09 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.122 0.487 . . . . 73.11 111.032 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.04 87.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.367 -0.379 . . . . 53.13 111.399 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.85 -56.81 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.043 -0.526 . . . . 74.13 111.621 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 25' ' ' THR . 12.8 tt -54.77 -41.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.443 0.164 . . . . 52.52 111.443 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -51.31 -50.49 59.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.721 0.408 . . . . 55.41 111.832 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.26 -39.07 32.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.066 -0.588 . . . . 72.14 113.508 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 30' ' ' GLY . 49.6 mm -67.44 -41.61 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 122.268 -0.548 . . . . 70.25 112.119 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 21' ' ' ILE . 13.3 t -72.1 -31.18 65.81 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.996 -0.44 . . . . 74.2 110.532 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -59.04 -42.84 91.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.043 0.449 . . . . 75.24 109.795 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.1 m -67.09 -27.47 67.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.856 -0.611 . . . . 75.43 111.218 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.17 22.52 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.23 -0.509 . . . . 71.43 113.509 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -95.67 -52.96 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.459 -0.436 . . . . 71.24 112.028 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.54 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 87.64 134.78 4.49 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 121.124 -0.56 . . . . 62.22 113.55 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.0 m -108.69 171.74 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.198 0.523 . . . . 53.13 112.318 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -127.89 107.28 9.73 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.955 -0.566 . . . . 74.12 110.078 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -92.3 125.92 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.415 0.626 . . . . 75.25 112.334 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.1 t -122.68 126.19 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.99 0.424 . . . . 73.34 111.374 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 5.4 p-10 -94.66 88.06 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.644 0.735 . . . . 65.01 111.771 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 36' ' ' LEU . 1.2 pp -69.73 -3.6 16.07 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.729 -0.669 . . . . 75.42 112.288 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.48 1.37 85.87 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.021 -0.609 . . . . 63.53 112.504 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.05 177.47 4.85 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.964 0.411 . . . . 71.35 111.132 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.64 84.33 0.29 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.035 0.445 . . . . 65.31 111.993 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.33 163.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.107 -0.497 . . . . 62.24 111.472 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.51 172.7 17.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.862 0.363 . . . . 73.05 111.89 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.4 mm? -56.11 -31.28 63.14 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.779 0.659 . . . . 75.44 112.779 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -61.33 -34.23 74.92 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.263 0.554 . . . . 65.33 111.171 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.27 -48.93 12.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.775 -0.648 . . . . 71.13 110.69 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.44 HD23 HG12 ' A' ' 75' ' ' ILE . 3.3 tm? -53.53 -40.17 65.25 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.057 -0.52 . . . . 73.13 111.667 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -59.59 -53.02 62.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.098 0.475 . . . . 54.45 111.366 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.47 -39.04 93.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.193 -0.458 . . . . 72.33 111.133 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.428 HD11 ' HZ ' ' A' ' 5' ' ' PHE . 59.0 tp -55.53 -52.81 62.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.976 -0.556 . . . . 52.24 111.434 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 45' ' ' LEU . 87.7 t -60.21 -44.23 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.308 -0.406 . . . . 61.21 111.608 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.73 89.21 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.059 -0.591 . . . . 53.14 113.457 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.23 8.22 43.94 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.785 0.661 . . . . 72.3 112.785 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.4 p -55.28 -3.1 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.93 1.085 . . . . 73.23 113.93 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -44.74 -41.37 6.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.61 0.596 . . . . 73.21 112.61 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 84' ' ' ALA . . . -149.84 136.86 5.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.354 -0.451 . . . . 72.32 112.291 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.453 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 83.9 mt -139.27 141.35 37.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.908 0.354 . . . . 73.04 111.671 -175.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.48 118.12 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.147 0.499 . . . . 71.31 111.191 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.2 mp -106.81 131.81 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.922 0.391 . . . . 74.43 111.709 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.77 58.16 0.46 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.35 -0.453 . . . . 72.12 113.424 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 89' ' ' GLU . 84.2 mtp 67.0 -178.49 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.96 0.726 . . . . 70.02 112.96 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -141.79 88.84 9.3 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.514 -0.767 . . . . 71.45 110.649 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.07 143.0 85.23 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 122.931 2.421 . . . . 63.32 113.253 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.8 -64.51 0.39 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.83 1.048 . . . . 75.32 113.83 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.31 -53.75 53.57 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.209 0.448 . . . . 74.13 112.209 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 68' ' ' ILE . 39.0 t -64.79 -25.81 68.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.455 0.539 . . . . 71.34 112.455 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.81 69.47 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.017 0.377 . . . . 74.3 112.017 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.24 -53.47 50.31 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.909 0.385 . . . . 73.42 111.735 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 m -71.19 -32.66 69.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.906 0.335 . . . . 72.21 111.906 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 64' ' ' SER . 76.6 mt -64.9 -47.35 88.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.852 0.316 . . . . 73.21 111.852 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.92 -42.34 89.44 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.712 0.292 . . . . 61.41 111.72 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.14 70.51 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.226 -0.511 . . . . 65.12 113.038 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.42 -43.12 16.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.794 0.331 . . . . 74.31 111.514 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.6 tp -52.93 -41.08 64.12 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.801 0.44 . . . . 73.22 111.833 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 t -51.57 -37.47 49.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.123 0.487 . . . . 72.24 111.582 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.0 m -84.51 -40.79 17.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.034 0.445 . . . . 73.32 111.356 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.44 HG12 HD23 ' A' ' 45' ' ' LEU . 72.4 mt -54.8 -46.76 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.01 -0.541 . . . . 61.5 111.889 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.99 -47.08 65.06 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.883 0.373 . . . . 74.21 111.937 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.07 -26.86 67.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.059 -0.591 . . . . 72.52 113.373 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -78.05 -40.66 38.01 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.493 0.553 . . . . 71.2 112.493 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.01 168.97 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.266 0.555 . . . . 74.32 112.261 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.54 158.4 25.81 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.142 -0.481 . . . . 74.24 110.557 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.17 -82.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.317 0.858 . . . . 71.04 113.317 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -94.5 101.0 12.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.705 0.632 . . . . 70.22 112.705 -173.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -122.01 -164.99 1.21 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.051 -0.522 . . . . 74.33 111.151 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -110.33 134.85 51.88 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.861 0.362 . . . . 61.34 110.771 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 112' ' ' THR . 29.6 m -132.55 170.96 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.422 0.629 . . . . 72.41 112.508 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 110.96 0.63 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.819 -0.628 . . . . 63.14 111.982 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -101.04 114.36 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.217 -0.578 . . . . 55.44 111.202 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 29.0 p90 -123.0 110.78 15.8 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 74.23 111.503 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 41.8 mt-10 -78.77 81.77 5.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.234 0.54 . . . . 64.01 111.366 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -79.76 -9.57 59.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.067 -0.515 . . . . 72.3 112.164 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.26 -70.67 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.24 -0.505 . . . . 70.43 113.073 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.58 21.75 77.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.169 -0.539 . . . . 74.41 113.15 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.86 -85.28 0.26 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.278 -0.487 . . . . 72.43 113.944 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -163.52 129.93 3.26 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.42 -0.459 . . . . 75.14 111.369 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -163.38 152.75 14.82 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.097 0.475 . . . . 73.23 111.89 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.6 mp0 -95.23 -43.96 0.27 Allowed Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.858 1.058 . . . . 74.33 113.858 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 74.2 Cg_endo -71.13 23.28 0.22 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.27 1.98 . . . . 53.33 114.928 -170.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 99' ' ' ASP . 10.8 tt -57.71 -53.43 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 112.648 0.61 . . . . 75.32 112.648 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.679 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.3 m-20 -61.89 -55.88 37.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.472 0.545 . . . . 64.2 112.472 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.8 Cg_exo -54.12 -44.98 44.48 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.333 2.022 . . . . 73.41 112.81 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -60.48 -54.48 45.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.305 -0.407 . . . . 53.14 111.269 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.31 -38.69 80.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.518 -0.31 . . . . 70.45 111.725 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 t -62.46 -37.66 86.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.808 0.337 . . . . 45.52 111.339 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HE3' HD11 ' A' ' 108' ' ' LEU . 59.6 tptt -58.41 -47.73 82.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.024 0.44 . . . . 75.52 111.051 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.67 -46.42 75.73 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.327 -0.397 . . . . 74.34 111.773 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -62.53 -52.68 62.48 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.42 0.526 . . . . 74.02 112.42 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.27 -35.53 80.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.698 0.629 . . . . 74.35 112.698 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 ' HE3' ' A' ' 104' ' ' LYS . 80.7 mt -78.23 -15.58 58.66 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.107 -0.371 . . . . 75.14 111.605 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.04 40.19 51.91 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.06 -0.59 . . . . 20.44 112.899 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.93 104.03 3.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.828 0.346 . . . . 51.1 110.707 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -64.71 123.8 20.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.142 0.496 . . . . 64.12 112.086 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 76.6 p -89.92 136.89 32.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.361 -0.381 . . . . 42.22 111.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 138' ' ' LEU . . . -56.78 -54.64 44.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.082 0.468 . . . . 74.14 111.295 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -150.34 131.12 7.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.369 -0.378 . . . . 70.24 110.284 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.54 103.53 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.412 2.074 . . . . 72.24 112.688 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . . . -80.45 -179.47 7.17 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 44.32 112.714 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.25 145.2 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.92 -0.582 . . . . 71.4 111.019 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -72.24 150.23 43.84 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.482 0.919 . . . . 74.2 113.482 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 123' ' ' PRO . 23.4 mm -106.8 167.14 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.115 -0.948 . . . . 71.52 110.757 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.481 ' N ' HG22 ' A' ' 119' ' ' ILE . 57.6 tptt -64.19 -66.11 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.843 0.354 . . . . 71.23 111.773 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -151.13 -55.73 0.15 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.257 0.551 . . . . 74.11 111.027 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -92.82 118.63 67.98 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.956 -0.565 . . . . 75.15 110.413 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 119' ' ' ILE . 32.1 Cg_endo -61.95 141.27 88.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.675 2.25 . . . . 64.35 113.389 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.4 p -76.16 156.08 34.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.877 -0.601 . . . . 75.12 111.428 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.76 -30.9 71.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.165 0.507 . . . . 74.34 111.037 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -57.29 -22.69 43.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.3 -0.409 . . . . 71.23 111.093 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.9 m -65.6 -25.76 67.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.852 0.358 . . . . 72.44 111.068 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -67.47 -48.16 67.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.913 0.387 . . . . 73.32 110.395 172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.68 -31.62 71.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.467 0.651 . . . . 74.33 110.692 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.02 -63.02 1.44 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.369 -0.832 . . . . 74.34 111.005 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.641 ' SG ' HD13 ' A' ' 16' ' ' LEU . 64.6 m -62.24 -26.21 68.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.387 -0.37 . . . . 42.12 111.936 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.02 -69.86 0.1 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.189 -0.46 . . . . 61.41 111.751 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.57 -16.67 44.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.185 0.439 . . . . 42.41 112.185 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.78 -53.62 44.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.812 0.339 . . . . 74.43 110.716 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.52 95.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.14 -0.552 . . . . 70.51 112.444 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 59.4 m -60.85 -46.74 89.4 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.918 0.34 . . . . 71.44 111.918 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.82 -43.62 98.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.771 0.32 . . . . 74.15 111.278 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 44.2 tp -57.31 -45.05 84.59 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.263 0.554 . . . . 51.1 110.008 173.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 143' ' ' THR . . . -61.97 -35.5 91.48 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.807 -0.633 . . . . 70.51 112.785 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLN . . . . . 0.511 ' HA ' HG22 ' A' ' 143' ' ' THR . 24.6 mt-30 -65.19 -35.56 81.45 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.909 0.354 . . . . 70.32 111.352 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -62.38 -47.6 83.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.072 0.463 . . . . 74.11 110.391 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.24 -55.53 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.821 -0.627 . . . . 55.44 111.684 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 140' ' ' GLN . 8.8 t -63.27 -28.31 69.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.071 0.397 . . . . 63.45 112.071 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -68.42 -50.47 52.52 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.104 0.478 . . . . 51.21 111.164 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.89 -29.69 66.95 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.52 . . . . 75.23 111.669 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 146' ' ' ARG . 23.8 ttt180 -100.58 -31.72 11.12 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.995 1.109 . . . . 63.45 113.995 -172.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 113.943 1.09 . . . . 70.45 113.943 -173.114 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 57.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.375 -0.232 . . . . 50.14 110.375 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.724 HD11 HG21 ' A' ' 142' ' ' VAL . 30.3 mm 69.96 103.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.963 0.411 . . . . 74.01 110.971 -174.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -90.13 106.58 3.35 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.211 -0.518 . . . . 65.32 112.969 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.626 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -83.09 116.1 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.53 0.681 . . . . 75.04 111.705 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 36' ' ' LEU . 63.0 m-85 -89.98 113.25 24.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.715 -0.675 . . . . 74.44 110.467 176.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 36.8 p90 -137.84 -178.59 5.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.146 0.498 . . . . 73.3 112.01 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 10' ' ' TYR . 23.8 t -126.87 111.94 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.145 -0.48 . . . . 72.0 111.004 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.88 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 46.6 t -61.9 -26.33 68.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.19 0.811 . . . . 52.05 113.19 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.38 -64.5 1.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.285 0.564 . . . . 65.35 112.42 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.442 ' H ' HG12 ' A' ' 7' ' ' VAL . 19.8 t80 -71.6 127.26 31.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.855 -0.611 . . . . 74.34 112.247 -171.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.91 -161.98 7.44 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 114.994 0.758 . . . . 12.54 114.994 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -87.35 7.22 29.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.04 0.385 . . . . 74.43 112.04 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -46.87 -40.85 14.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.115 0.783 . . . . 63.04 113.115 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.88 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 20.1 p-10 -67.38 -41.63 84.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.143 0.497 . . . . 65.35 111.526 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -68.19 -36.66 79.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.174 -0.466 . . . . 73.04 110.819 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.85 -44.79 96.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.313 0.578 . . . . 62.41 110.375 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 21' ' ' ILE . . . -60.0 -39.85 87.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.806 -0.634 . . . . 72.14 111.303 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.96 -44.06 91.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.589 -0.278 . . . . 44.33 111.083 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -43.17 82.23 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.006 0.432 . . . . 61.11 111.158 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.41 -58.71 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.152 -0.476 . . . . 63.35 111.846 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.678 HG13 ' HB ' ' A' ' 31' ' ' VAL . 13.4 tt -60.02 -48.92 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 111.903 0.334 . . . . 74.12 111.903 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.405 ' N ' HG23 ' A' ' 21' ' ' ILE . 10.7 t30 -66.65 -39.26 88.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.542 0.201 . . . . 74.44 111.542 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.47 95.02 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.891 -0.671 . . . . 72.04 112.644 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.64 HG22 ' HB ' ' A' ' 29' ' ' VAL . 59.9 mt -83.04 -35.71 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.17 0.433 . . . . 61.4 112.17 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 21' ' ' ILE . 70.8 p -69.12 -39.58 78.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.006 -0.434 . . . . 41.23 111.054 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.35 -43.07 78.74 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.097 0.475 . . . . 73.3 110.094 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.3 m -63.0 -43.01 99.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.028 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.54 67.44 0.33 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.222 -0.513 . . . . 63.11 113.619 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.64 ' HB ' HG22 ' A' ' 24' ' ' ILE . 62.5 t -139.37 -68.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 122.525 -0.397 . . . . 70.12 111.71 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.93 113.14 2.94 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.28 -0.486 . . . . 73.14 112.814 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 21' ' ' ILE . 82.2 t -109.65 144.42 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.686 0.279 . . . . 55.22 111.698 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.494 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 18.2 m-20 -93.38 147.47 22.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 64.45 110.986 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.73 132.28 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 112.431 0.53 . . . . 72.1 112.431 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 86.9 t -141.49 125.02 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.035 -0.529 . . . . 73.21 111.026 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.5 m-20 -85.73 99.77 11.55 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.007 -0.433 . . . . 62.03 111.935 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.529 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -69.78 -21.12 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.027 0.442 . . . . 51.32 111.675 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.418 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -114.64 23.63 11.86 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.651 -0.785 . . . . 62.34 113.805 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.87 -72.95 0.11 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.73 0.641 . . . . 73.2 112.73 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.01 23.47 1.22 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.184 0.809 . . . . 74.54 113.184 -172.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.0 m -57.84 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.645 0.736 . . . . 73.21 112.25 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.77 171.59 14.94 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.87 -0.605 . . . . 75.04 110.448 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.27 -36.25 60.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.306 0.242 . . . . 60.45 111.242 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -57.17 -36.27 70.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.034 0.383 . . . . 55.23 112.034 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -69.04 -46.28 68.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.394 0.616 . . . . 62.32 110.519 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 49' ' ' VAL . 82.2 mt -61.52 -36.81 81.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.768 -0.651 . . . . 73.35 111.309 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' NH2' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.55 -46.97 85.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 62.32 110.288 177.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 7.7 tp10 -66.39 -37.95 86.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.951 0.405 . . . . 65.42 110.877 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 55' ' ' LEU . 59.4 tp -57.63 -30.48 65.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.178 -0.464 . . . . 74.24 111.607 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 45' ' ' LEU . 63.7 t -63.25 -53.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.98 0.419 . . . . 64.25 111.478 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.17 -37.36 49.08 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.264 -0.493 . . . . 63.34 113.697 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -90.24 8.08 34.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.078 0.399 . . . . 73.01 112.078 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -51.31 -8.77 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.425 1.268 . . . . 62.31 114.425 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 p -65.09 -18.18 65.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.778 0.659 . . . . 74.31 112.778 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.664 ' HA3' HD13 ' A' ' 2' ' ' ILE . . . -160.85 137.84 5.17 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.587 -0.816 . . . . 42.3 113.973 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 48' ' ' LEU . 4.7 mp -128.76 159.22 36.36 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.866 0.466 . . . . 55.32 110.824 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 70.7 t -140.66 122.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.429 0.291 . . . . 74.24 110.824 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -122.22 130.87 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.886 0.374 . . . . 74.52 111.253 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.23 -128.0 3.22 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.993 -0.622 . . . . 73.42 112.908 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -84.5 161.29 20.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.14 0.495 . . . . 64.45 111.515 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -113.03 90.62 16.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.525 -0.307 . . . . 70.11 111.505 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.36 137.64 16.95 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.971 2.448 . . . . 75.23 112.093 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.93 -48.28 51.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.414 0.524 . . . . 72.2 112.414 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.62 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.311 0.485 . . . . 43.43 112.311 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m -78.84 -33.85 45.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.745 0.307 . . . . 64.32 111.493 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 72.25 111.927 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.64 -33.58 76.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.97 0.359 . . . . 63.04 111.97 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -85.22 -12.59 52.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.033 0.383 . . . . 73.4 112.033 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mm -87.86 -23.33 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.177 0.436 . . . . 73.33 112.177 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -48.49 -48.15 38.2 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.769 0.655 . . . . 54.52 112.769 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 -57.3 7.35 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.14 -0.553 . . . . 75.42 113.322 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -55.86 -35.91 66.97 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.417 0.525 . . . . 74.53 112.417 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.53 -41.68 66.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.612 0.365 . . . . 70.1 111.006 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -58.98 -47.21 85.97 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.781 0.324 . . . . 74.54 111.537 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.0 -39.09 93.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.839 0.352 . . . . 71.42 111.275 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.469 ' O ' HG22 ' A' ' 79' ' ' VAL . 65.3 mt -58.37 -47.06 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.358 -0.383 . . . . 64.14 111.335 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 82.4 mt -55.35 -28.18 52.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.481 -0.327 . . . . 70.24 111.875 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.68 -32.23 30.85 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.216 -0.516 . . . . 73.42 113.195 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p -80.78 -58.68 2.99 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.855 0.317 . . . . 72.21 111.855 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 75' ' ' ILE . 29.8 m -68.79 145.12 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.338 0.59 . . . . 71.41 112.112 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -161.37 -168.76 2.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.021 -0.536 . . . . 72.33 111.429 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.743 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 10.5 tp10 64.08 -95.76 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.701 1.0 . . . . 75.11 113.701 167.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.743 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.2 ptpp? -169.43 30.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.95 0.405 . . . . 73.23 111.801 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.458 ' OE1' ' HB3' ' A' ' 81' ' ' GLU . 8.0 mp0 -61.33 176.35 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.578 0.704 . . . . 72.44 112.642 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.688 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.06 139.53 30.53 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.573 0.582 . . . . 75.03 112.573 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.99 96.15 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.679 0.752 . . . . 63.52 110.854 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.3 80.68 0.73 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.944 -0.571 . . . . 53.4 113.285 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.44 HD13 ' HB ' ' A' ' 57' ' ' ILE . 32.5 mm -82.78 113.85 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 122.725 -0.28 . . . . 64.55 110.576 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.16 133.07 53.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.368 0.604 . . . . 75.23 112.267 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 9.5 tp10 -76.23 137.86 40.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.76 -0.655 . . . . 62.42 111.335 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -156.11 -2.75 0.13 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.97 0.73 . . . . 71.32 112.97 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.81 109.86 0.39 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.692 -0.766 . . . . 73.13 113.13 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.24 79.67 0.52 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.527 -0.368 . . . . 53.52 113.22 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.82 78.39 0.06 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.379 -0.439 . . . . 31.01 112.53 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -98.47 -174.8 2.91 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.239 0.542 . . . . 70.11 111.966 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -118.67 138.08 52.86 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.919 -0.582 . . . . 62.14 109.959 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.545 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 32.8 mt-10 -45.34 -48.4 34.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.601 1.334 . . . . 71.03 114.601 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 86.0 Cg_exo -50.46 -12.21 0.49 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.915 2.41 . . . . 45.45 115.092 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.89 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 121.903 -0.498 . . . . 45.35 111.854 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.1 m-20 -57.18 -51.18 83.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 112.577 0.584 . . . . 74.11 112.577 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 90.4 Cg_exo -47.78 -40.18 31.49 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.309 2.006 . . . . 74.14 112.893 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 97' ' ' PRO . 9.7 mp -71.99 -41.57 67.49 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.58 -0.282 . . . . 62.14 111.205 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.3 mt -58.64 -37.3 75.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 55.53 111.056 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -58.08 -31.85 67.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.19 -0.459 . . . . 54.34 110.917 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -68.29 -50.12 55.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.798 0.333 . . . . 73.13 110.742 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.91 -37.33 76.37 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.16 0.505 . . . . 75.53 110.777 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -64.74 -60.05 3.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.69 -0.687 . . . . 74.34 111.207 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.18 -56.08 24.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.911 -0.586 . . . . 74.23 112.529 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.17 -23.07 65.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.737 0.273 . . . . 73.22 111.737 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.4 61.24 5.23 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.291 -0.481 . . . . 72.41 113.558 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.59 156.55 19.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.625 -0.338 . . . . 74.14 110.989 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 27.5 m -70.12 93.1 0.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 50.14 111.509 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -86.63 159.07 19.33 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.22 0.533 . . . . 45.34 112.319 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.04 -164.81 1.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.808 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.25 112.34 5.34 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.171 -0.468 . . . . 72.24 112.074 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -90.68 107.4 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.014 2.476 . . . . 74.44 113.484 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.796 ' HB3' ' HB3' ' A' ' 89' ' ' GLU . . . -89.66 177.38 6.55 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.189 -0.319 . . . . 51.24 110.634 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.9 tt -132.58 102.52 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.665 0.617 . . . . 74.53 112.665 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 55.99 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.353 0.871 . . . . 71.31 113.353 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.589 HG12 ' HG3' ' A' ' 89' ' ' GLU . 46.4 mm -95.35 74.71 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.04 0.447 . . . . 64.2 110.39 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 51.46 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.807 0.669 . . . . 60.43 112.807 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 179.09 -42.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.181 0.592 . . . . 42.12 110.674 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.8 p -96.08 114.62 64.56 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.197 -0.456 . . . . 73.3 111.521 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.47 127.76 26.63 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.713 2.276 . . . . 50.1 113.133 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 33.9 p -107.89 177.09 4.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.569 -0.287 . . . . 73.43 111.608 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.56 -34.96 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.01 0.433 . . . . 71.31 111.586 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.422 ' O ' HD13 ' A' ' 130' ' ' LEU . 83.3 m-20 -58.05 -41.19 82.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.974 0.416 . . . . 71.43 110.609 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.7 m -56.82 -44.48 82.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.251 -0.431 . . . . 71.14 111.377 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -58.85 -46.36 87.93 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.279 0.562 . . . . 73.34 111.04 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.94 -32.48 72.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.775 -0.648 . . . . 65.41 111.802 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 126' ' ' ASN . 10.9 mp -77.78 -42.25 34.59 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.303 -0.248 . . . . 73.35 111.418 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.9 m -58.66 -53.32 59.72 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.853 0.359 . . . . 75.11 111.566 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.1 -54.08 50.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.269 -0.423 . . . . 64.5 111.759 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.81 -54.86 36.44 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.221 -0.445 . . . . 54.44 111.843 -177.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.5 97.27 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.71 0.29 . . . . 75.32 111.777 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.55 76.04 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.08 -0.581 . . . . 72.42 112.789 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.8 m -61.2 -42.62 98.91 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 62.3 111.041 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.33 -42.15 95.06 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.026 -0.534 . . . . 51.44 111.182 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.479 HD11 ' HB1' ' A' ' 84' ' ' ALA . 52.5 tp -62.73 -44.28 96.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.125 0.488 . . . . 73.13 110.636 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -34.57 75.11 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 116.018 -0.537 . . . . 62.32 112.781 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 136' ' ' THR . 55.5 mt-30 -64.78 -25.68 68.02 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.714 0.292 . . . . 74.24 111.711 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -72.82 -52.43 14.94 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.068 0.461 . . . . 74.35 110.166 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.724 HG21 HD11 ' A' ' 2' ' ' ILE . 60.9 t -57.2 -45.16 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.797 -0.638 . . . . 72.33 112.172 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 9.0 t -61.71 -51.78 66.99 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.997 0.369 . . . . 51.32 111.997 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 143' ' ' THR . 90.5 mtt-85 -64.26 -41.64 96.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.113 0.482 . . . . 72.54 111.13 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.15 -49.87 68.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.122 -0.49 . . . . 70.45 111.725 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.484 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 0.1 OUTLIER -82.7 -11.07 58.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.183 0.438 . . . . 72.14 112.183 -174.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -88.44 11.15 17.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.157 0.503 . . . . 43.11 110.395 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.838 ' HB3' ' HB2' ' A' ' 151' ' ' HIS . 39.2 tt0 57.72 19.89 5.95 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.325 0.583 . . . . 71.43 112.455 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 64.26 -76.43 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 112.675 0.62 . . . . 75.25 112.675 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -94.13 18.68 10.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.547 0.573 . . . . 74.42 112.547 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.838 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 56.1 t60 -74.9 -17.06 60.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.055 0.455 . . . . 63.13 111.195 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -125.66 109.83 13.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.31 -0.405 . . . . 63.45 111.134 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.21 143.46 57.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 74.32 111.83 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.84 -0.6 . . . . 75.34 111.108 177.153 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 25.3 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.389 0.137 . . . . 65.43 111.357 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.0 mp 58.7 97.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.214 0.531 . . . . 53.22 111.869 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.29 96.11 1.9 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.193 -0.527 . . . . 42.34 112.98 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -85.56 105.73 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 O-C-N 122.374 -0.486 . . . . 74.2 111.398 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.21 123.14 38.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.755 0.312 . . . . 75.44 111.276 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.18 175.0 9.95 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.956 0.407 . . . . 73.53 111.541 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 7' ' ' VAL . 5.9 p -121.62 95.99 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 64.43 111.129 176.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -52.6 -34.64 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.595 -0.73 . . . . 75.24 112.788 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.13 -35.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.64 0.608 . . . . 44.42 112.64 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -109.05 146.57 33.76 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.243 0.46 . . . . 75.32 112.243 -170.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.19 -164.18 5.18 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 114.521 0.568 . . . . 73.22 114.521 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.607 ' HD2' ' HG2' ' A' ' 123' ' ' PRO . 57.4 m-85 -87.45 9.47 20.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.762 0.425 . . . . 64.42 111.778 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -29.98 -48.97 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.729 1.381 . . . . 72.34 114.729 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.86 -46.17 90.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.896 0.379 . . . . 75.52 111.644 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.35 -38.21 89.39 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.928 0.394 . . . . 75.51 110.858 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.597 HD11 ' HG3' ' A' ' 123' ' ' PRO . 85.8 mt -61.59 -42.59 99.07 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.062 0.458 . . . . 74.12 110.778 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -58.6 -47.26 84.92 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.135 -0.484 . . . . 62.42 110.759 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.8 -37.75 60.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.14 0.495 . . . . 54.42 111.095 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.84 -54.37 19.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.289 -0.414 . . . . 55.51 111.498 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.4 mt -56.72 -46.79 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.234 0.54 . . . . 74.01 111.909 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.512 HG12 HG21 ' A' ' 31' ' ' VAL . 74.5 mt -60.19 -27.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.899 -0.591 . . . . 74.24 112.19 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -54.01 -68.59 0.17 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.018 0.377 . . . . 62.34 112.018 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.16 -36.64 89.57 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.242 -0.504 . . . . 63.54 113.644 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.05 -47.51 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 122.526 -0.397 . . . . 73.4 111.796 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.0 p -67.43 -34.66 77.68 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.109 0.411 . . . . 64.52 112.109 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.09 -23.23 64.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.277 0.56 . . . . 75.11 110.689 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 152' ' ' HIS . 87.8 m -80.6 -12.98 59.43 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.225 0.536 . . . . 45.33 110.544 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.15 27.22 26.35 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.183 -0.532 . . . . 70.0 113.113 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 143' ' ' THR . 45.2 t -116.14 137.28 50.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 122.582 -0.364 . . . . 73.31 111.463 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 142.59 17.89 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.348 -0.453 . . . . 35.41 112.747 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG21 HG12 ' A' ' 21' ' ' ILE . 34.4 m -107.97 146.25 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.46 0.541 . . . . 72.22 112.46 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -108.16 92.7 4.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.336 -0.393 . . . . 73.51 110.654 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.62 122.63 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.759 0.314 . . . . 74.52 111.58 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -127.61 136.76 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.001 0.429 . . . . 73.21 111.537 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.1 123.75 32.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.925 0.393 . . . . 74.41 111.196 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.75 -13.46 48.22 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.173 0.434 . . . . 63.54 112.173 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.65 68.27 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.364 -0.446 . . . . 52.2 112.993 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.86 14.66 3.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.166 0.432 . . . . 45.1 112.166 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.07 118.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.333 0.587 . . . . 63.41 112.217 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.71 99.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.625 0.726 . . . . 62.01 112.199 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.59 158.15 27.93 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.592 -0.731 . . . . 72.11 111.724 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.637 HD13 HD12 ' A' ' 45' ' ' LEU . 3.4 mm? -60.37 -37.89 82.18 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.037 0.384 . . . . 72.33 112.037 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -66.88 -30.11 70.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.932 0.396 . . . . 75.34 111.089 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.2 -32.88 56.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.093 0.473 . . . . 72.33 110.597 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.637 HD12 HD13 ' A' ' 42' ' ' LEU . 85.4 mt -64.75 -32.28 73.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.416 -0.356 . . . . 72.41 110.825 174.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -58.78 -47.66 83.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.022 0.439 . . . . 75.51 110.193 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 73.1 mm-40 -58.19 -39.83 79.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.245 -0.434 . . . . 72.21 111.094 175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.38 -34.34 66.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.762 0.315 . . . . 70.03 111.336 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.07 -52.94 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.844 0.354 . . . . 72.34 111.21 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.93 -25.14 73.2 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.905 -0.664 . . . . 53.22 113.47 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -98.87 7.42 46.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.717 0.407 . . . . 74.51 111.806 178.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.59 5.69 0.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.629 0.974 . . . . 55.32 113.629 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.0 p -79.79 -36.88 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.112 -0.368 . . . . 75.42 111.876 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.8 137.71 5.33 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.92 -0.657 . . . . 74.4 113.239 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.69 164.17 39.15 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.865 0.364 . . . . 65.54 111.597 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -122.36 129.58 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.611 0.364 . . . . 72.41 110.664 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -117.75 136.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.288 0.566 . . . . 64.42 112.463 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.91 125.55 8.45 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 116.071 -0.513 . . . . 44.13 112.476 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.467 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 55.5 ttm -56.87 101.86 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.353 0.596 . . . . 71.23 111.465 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 67.1 m -92.88 132.95 29.88 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 72.12 112.196 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.79 169.04 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.51 2.14 . . . . 62.23 112.756 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.96 -42.83 6.19 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.358 0.874 . . . . 75.01 113.358 -173.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.72 -62.84 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.983 0.364 . . . . 51.35 111.983 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 50.3 m -70.76 -22.22 62.42 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.009 0.433 . . . . 52.14 111.515 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.5 65.15 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 61.22 111.435 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.31 99.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.94 0.4 . . . . 71.53 111.356 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -62.24 -44.05 97.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.231 0.538 . . . . 61.5 110.904 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 61.5 mt -64.32 -45.32 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.044 -0.525 . . . . 51.43 110.832 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -54.42 -48.97 71.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.912 -0.586 . . . . 75.13 111.47 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.24 -27.28 72.21 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 73.34 112.927 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.96 -21.33 29.62 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 72.41 112.365 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 70.6 mt -51.26 -38.07 50.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.369 0.507 . . . . 72.44 112.369 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.4 m -54.25 -31.6 53.96 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.089 0.471 . . . . 71.31 111.535 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 m -94.13 -39.87 10.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 65.11 111.196 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.0 -54.27 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.262 0.467 . . . . 54.23 112.262 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.43 -17.53 13.55 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 63.34 112.723 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.15 -27.85 7.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.149 -0.548 . . . . 54.4 113.113 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.7 m -84.76 -25.58 28.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.462 0.542 . . . . 74.12 112.462 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.66 158.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.329 0.585 . . . . 63.11 112.359 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 27.9 t-20 -92.9 143.79 25.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.03 -0.532 . . . . 74.24 110.914 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -44.89 -44.62 9.78 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.382 0.882 . . . . 74.14 113.382 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 24.2 pttm -135.62 41.56 2.72 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.055 0.455 . . . . 71.41 112.012 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 11.8 pt20 -61.44 167.89 3.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.076 -0.511 . . . . 74.42 112.255 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -96.12 116.88 29.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.272 -0.422 . . . . 64.22 111.64 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.34 118.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.432 0.634 . . . . 73.2 112.121 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 139.27 15.14 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.088 -0.505 . . . . 72.14 112.781 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.31 138.95 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.896 0.379 . . . . 73.05 111.751 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -139.87 150.83 45.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.223 -0.444 . . . . 64.32 110.466 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -76.3 91.57 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.554 0.692 . . . . 75.54 112.309 -174.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 119' ' ' ILE . 52.8 m -154.51 134.34 12.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.192 -0.458 . . . . 53.33 111.243 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 59' ' ' MET . . . 99.35 -133.03 11.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.189 -0.529 . . . . 64.12 113.132 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.46 -125.69 9.54 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.084 -0.579 . . . . 62.31 113.297 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.66 -104.1 1.09 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.082 -0.58 . . . . 31.21 112.89 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.65 109.58 21.82 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.658 -0.319 . . . . 74.05 110.392 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.26 155.95 39.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.932 0.396 . . . . 63.25 111.543 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.632 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 31.6 mt-10 -106.95 -63.94 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 113.041 0.756 . . . . 75.1 113.041 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 32.5 Cg_endo -104.1 27.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 123.203 2.602 . . . . 73.05 116.204 -167.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 99' ' ' ASP . 12.6 tt -53.26 -49.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.769 0.713 . . . . 63.14 112.842 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.61 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 16.7 m-20 -61.8 -51.59 74.8 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.491 0.552 . . . . 74.31 112.491 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.6 Cg_exo -48.99 -43.92 34.23 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.117 1.878 . . . . 73.12 113.063 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.7 mp -65.48 -48.43 72.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.678 0.251 . . . . 63.14 111.678 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 95.1 mt -53.4 -47.85 69.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.003 0.43 . . . . 52.53 111.24 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -64.01 -43.83 94.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.429 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -56.53 -62.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.339 -0.391 . . . . 64.41 111.313 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -58.73 -30.53 67.54 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.797 0.295 . . . . 75.32 111.797 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 106' ' ' ARG . 31.5 ttt180 -61.76 -49.87 74.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.966 0.412 . . . . 74.53 111.256 175.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.47 -8.07 43.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.721 0.637 . . . . 70.51 112.721 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 mp -98.43 -40.33 8.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.849 0.357 . . . . 74.24 110.628 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 52.54 3.08 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.202 -0.523 . . . . 54.32 113.873 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 6.5 mp -76.54 151.17 36.44 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.894 0.378 . . . . 74.35 111.47 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 80.2 m -68.36 87.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.377 0.608 . . . . 75.14 110.142 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.9 m -99.53 135.74 40.49 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.733 -0.667 . . . . 52.42 112.149 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.83 -64.17 0.94 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.854 0.359 . . . . 51.34 111.889 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -158.23 99.72 1.76 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 120.656 0.265 . . . . 51.31 111.31 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -90.52 17.37 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.083 2.522 . . . . 75.22 114.027 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.98 13.07 19.44 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.458 . . . . 61.22 112.238 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.59 139.43 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.088 0.47 . . . . 73.42 111.545 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -128.41 127.51 42.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.368 -0.378 . . . . 65.02 110.375 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 119' ' ' ILE . 3.4 mp -106.48 141.06 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.225 0.536 . . . . 64.42 111.734 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 121' ' ' GLN . 19.5 ptmt -78.63 -40.32 34.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.961 -0.563 . . . . 75.22 112.497 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HG2' HG23 ' A' ' 122' ' ' THR . 65.1 tt0 -175.36 -70.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.102 0.477 . . . . 73.22 111.679 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.58 HG23 ' HG2' ' A' ' 121' ' ' GLN . 60.7 p -115.1 153.45 47.22 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.459 -0.337 . . . . 51.04 111.78 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.607 ' HG2' ' HD2' ' A' ' 12' ' ' TYR . 72.7 Cg_endo -75.37 -175.57 2.49 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.619 2.213 . . . . 75.1 113.185 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.0 p -111.53 175.54 5.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.92 0.39 . . . . 42.14 111.322 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.82 -25.33 62.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 74.23 110.83 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -70.3 -28.33 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.046 0.451 . . . . 74.3 110.901 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.9 m -54.22 -35.33 62.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.084 -0.507 . . . . 70.12 111.931 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -58.03 -27.55 63.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.008 0.432 . . . . 63.25 111.687 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.511 ' HD2' ' N ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -85.65 -39.67 17.02 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.939 0.399 . . . . 75.21 110.447 177.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.23 -56.17 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.008 -0.542 . . . . 71.4 111.155 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.4 m -55.06 -38.04 67.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.014 0.376 . . . . 75.12 112.014 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.12 -46.44 74.16 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.226 0.536 . . . . 72.23 110.908 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.18 -52.93 61.82 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.981 -0.554 . . . . 61.2 111.522 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.05 99.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.245 -0.434 . . . . 61.52 111.566 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -55.81 -38.94 75.62 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.258 -0.496 . . . . 73.04 112.799 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 88.9 m -65.96 -44.67 84.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.731 0.301 . . . . 71.35 111.126 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.04 -50.79 72.22 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.987 0.422 . . . . 54.52 111.695 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.454 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.9 mm? -70.14 -43.26 71.29 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.865 0.364 . . . . 61.42 111.165 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.0 -47.83 65.02 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 116.132 -0.486 . . . . 50.24 113.566 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 90.5 mt-30 -59.79 -53.12 61.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.668 0.27 . . . . 64.14 111.35 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 77.4 t90 -51.62 -52.98 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.753 0.311 . . . . 71.51 111.426 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 138' ' ' LEU . 57.4 t -57.08 -43.0 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.52 0.563 . . . . 72.13 112.52 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.429 HG21 HG21 ' A' ' 29' ' ' VAL . 8.7 t -78.11 -49.92 13.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.152 0.797 . . . . 75.14 113.152 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -84.88 -4.73 59.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.155 0.798 . . . . 73.4 113.155 -172.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.41 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 27.7 t70 -62.09 -18.39 60.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.189 0.44 . . . . 33.21 112.189 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.599 ' HD2' ' N ' ' A' ' 146' ' ' ARG . 1.7 mpt_? -78.72 -27.57 44.93 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.662 0.615 . . . . 75.44 112.662 -176.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.403 ' O ' HD23 ' A' ' 147' ' ' LEU . 8.6 tt -173.9 -37.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.11 0.481 . . . . 62.42 109.919 -174.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 76.36 98.42 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.072 -0.967 . . . . 73.51 113.359 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.8 -5.83 47.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.115 -1.069 . . . . 74.53 108.115 160.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.1 t60 59.88 -81.38 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.277 -1.329 . . . . 75.31 112.263 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 51.25 81.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.21 0.818 . . . . 71.33 113.21 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.513 ' HB2' HG23 ' A' ' 27' ' ' THR . 50.8 t-80 -173.69 146.84 1.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.248 0.547 . . . . 64.03 111.784 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -134.63 156.08 49.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.621 -0.718 . . . . 74.13 110.038 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.9 m80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.855 -0.593 . . . . 73.44 111.344 173.486 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.853 0.316 . . . . 74.14 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.639 HG13 HG21 ' A' ' 24' ' ' ILE . 46.4 mm -69.77 97.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.992 0.367 . . . . 75.2 111.992 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.16 1.38 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.084 -0.579 . . . . 55.0 112.529 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.453 HG21 ' HB1' ' A' ' 17' ' ' ALA . 6.7 p -91.9 110.25 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.261 0.553 . . . . 71.0 112.11 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HB3' HD23 ' A' ' 36' ' ' LEU . 82.5 m-85 -95.07 99.09 11.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 65.43 110.955 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 14' ' ' ASP . 26.6 p90 -130.13 -179.52 5.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.837 0.351 . . . . 73.11 111.52 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 10' ' ' TYR . 22.3 t -121.98 107.32 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.921 0.391 . . . . 74.23 111.842 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 74.1 m -78.23 -21.91 49.25 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.089 0.471 . . . . 74.41 111.354 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -78.24 -32.69 49.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.885 -0.598 . . . . 75.5 112.052 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.689 ' H ' HG12 ' A' ' 7' ' ' VAL . 69.1 t80 -129.13 133.03 47.45 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.92 0.711 . . . . 75.21 112.92 -170.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.5 -162.49 5.19 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.562 0.985 . . . . 64.21 115.562 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 2.12 29.11 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.64 0.607 . . . . 72.33 112.64 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.3 t -49.36 -37.56 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.102 0.477 . . . . 71.24 111.853 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 17.0 t0 -56.71 -60.18 3.93 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.864 -0.607 . . . . 44.43 111.255 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 15' ' ' ARG . 20.1 mmt180 -70.97 -28.58 64.56 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.28 0.474 . . . . 72.53 112.28 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.11 -43.99 87.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 75.22 110.501 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -75.04 -44.27 48.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.753 -0.658 . . . . 73.24 111.43 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -53.77 -53.26 54.79 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.387 -0.37 . . . . 74.12 111.883 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -25.21 61.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.31 0.485 . . . . 75.4 112.31 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 132' ' ' GLU . 66.1 mt -87.55 -57.4 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.846 0.355 . . . . 75.34 111.442 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.468 ' HB ' HG11 ' A' ' 31' ' ' VAL . 2.7 pp -59.15 -27.17 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.7 0.286 . . . . 72.33 111.762 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' N ' HD12 ' A' ' 21' ' ' ILE . 27.3 t-20 -59.4 -48.88 79.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.515 -0.311 . . . . 62.41 110.619 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.36 -34.24 87.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.166 -0.54 . . . . 31.43 112.758 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.639 HG21 HG13 ' A' ' 2' ' ' ILE . 62.4 mt -62.69 -53.12 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 122.49 -0.418 . . . . 75.42 111.335 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.8 t -68.19 -31.15 70.48 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.909 0.385 . . . . 70.03 111.001 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -62.34 -34.52 76.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.057 0.456 . . . . 74.43 111.034 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -71.35 -31.88 67.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.311 -0.404 . . . . 72.3 111.0 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.81 5.42 4.89 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.165 -0.541 . . . . 55.22 114.17 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.649 HG22 ' HB ' ' A' ' 143' ' ' THR . 21.8 t -94.34 126.53 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 117.439 0.619 . . . . 71.21 111.698 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.95 122.6 22.19 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.444 -0.408 . . . . 73.53 113.689 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG11 ' HB ' ' A' ' 21' ' ' ILE . 61.3 t -104.07 143.56 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.118 0.485 . . . . 64.01 112.168 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.77 113.68 22.91 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.136 -0.484 . . . . 75.1 110.422 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.84 124.0 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.269 0.557 . . . . 63.45 112.11 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.04 108.03 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.85 0.357 . . . . 60.12 111.497 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.49 111.23 20.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.908 0.385 . . . . 41.45 111.188 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.445 ' HA ' HG13 ' A' ' 40' ' ' VAL . 4.4 pp -86.8 -8.96 56.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.424 -0.353 . . . . 64.21 111.1 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -59.72 -45.3 95.95 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.356 -0.449 . . . . 64.41 112.768 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.58 17.69 3.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.701 0.286 . . . . 62.41 111.446 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.16 147.22 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.198 0.599 . . . . 52.43 111.917 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 36' ' ' LEU . 27.1 m -117.43 151.87 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.337 . . . . 72.42 111.546 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -104.98 169.36 8.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.053 0.454 . . . . 72.21 111.064 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.7 mm? -58.81 -18.44 32.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.116 0.413 . . . . 74.42 112.116 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -57.6 -55.46 34.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.828 0.347 . . . . 73.14 110.775 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.94 -37.19 78.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.179 0.514 . . . . 63.02 110.837 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 3.0 tm? -61.32 -38.73 87.92 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.978 -0.555 . . . . 72.32 111.127 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -70.85 -40.32 72.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.961 -0.462 . . . . 70.33 110.925 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 18.1 mm-40 -58.41 -28.15 64.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.008 0.432 . . . . 71.52 111.323 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.611 HD11 HD13 ' A' ' 55' ' ' LEU . 57.7 tp -56.18 -31.11 63.12 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.189 -0.459 . . . . 71.03 111.448 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.97 -36.39 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.872 0.367 . . . . 65.24 111.328 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.55 -20.01 55.31 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.081 -0.581 . . . . 54.54 112.895 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 7.4 mpt_? -94.38 5.11 52.79 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.579 -0.365 . . . . 60.14 111.934 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -63.56 -16.0 59.61 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.889 0.329 . . . . 75.42 111.889 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.1 p -66.15 -25.31 66.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.821 0.343 . . . . 72.22 111.643 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.5 135.93 3.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.374 -0.441 . . . . 32.21 112.493 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.611 HD13 HD11 ' A' ' 48' ' ' LEU . 2.3 pt? -163.83 170.32 17.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.117 0.484 . . . . 70.5 111.662 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 p -148.76 124.33 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.34 111.174 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -95.8 135.4 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.13 -0.486 . . . . 71.24 110.96 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.5 -86.58 0.68 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.229 -0.51 . . . . 70.12 113.805 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.5 pmm? -151.92 167.96 26.7 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.3 -0.53 . . . . 73.13 111.855 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.3 p -144.18 49.13 0.99 Allowed Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 112.345 0.498 . . . . 72.01 112.345 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.13 157.57 61.1 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.414 2.076 . . . . 75.13 113.599 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.0 -50.48 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.523 0.934 . . . . 74.52 113.523 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.04 -46.51 65.09 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.601 0.593 . . . . 64.3 112.601 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -102.11 5.26 40.31 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.507 0.558 . . . . 64.12 112.507 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.86 -29.88 70.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.776 1.028 . . . . 53.33 113.776 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -37.47 -70.53 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.905 1.076 . . . . 73.12 113.905 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.4 m -77.39 -37.77 51.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.823 0.344 . . . . 71.35 111.79 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.45 -43.99 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.462 0.541 . . . . 63.33 112.462 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.03 -40.82 95.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.852 0.358 . . . . 71.22 111.413 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.88 -36.52 90.35 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.016 -0.611 . . . . 24.24 112.203 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.456 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -68.52 -51.14 46.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.826 -0.22 . . . . 74.04 111.119 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 75' ' ' ILE . 98.3 mt -53.79 -45.71 70.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.925 0.393 . . . . 64.23 111.678 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -56.75 -28.1 60.58 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.104 -0.498 . . . . 61.2 111.285 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 m -86.89 -40.19 15.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.259 -0.428 . . . . 75.44 111.136 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.503 HD12 HD23 ' A' ' 72' ' ' LEU . 73.7 mt -56.13 -40.6 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.394 -0.366 . . . . 73.34 111.679 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.2 mt -56.37 -26.67 53.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.51 -0.314 . . . . 62.14 111.651 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.9 31.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.189 -0.529 . . . . 32.44 113.463 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 75' ' ' ILE . 89.4 p -87.8 -34.27 18.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.247 0.524 . . . . 74.14 111.882 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.97 135.13 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.974 0.416 . . . . 73.12 111.59 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 82' ' ' LYS . 24.7 t-20 -89.53 107.01 18.83 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.298 0.481 . . . . 62.33 112.298 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 36.84 -75.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.89 1.441 . . . . 73.5 114.89 167.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.1 96.51 5.13 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.216 0.531 . . . . 74.3 112.401 -174.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.719 ' H ' HD23 ' A' ' 110' ' ' LEU . 85.6 mm-40 -133.97 172.72 12.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.433 -0.349 . . . . 74.12 110.851 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.5 107.81 18.06 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.048 0.452 . . . . 35.41 111.282 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 HD21 ' A' ' 55' ' ' LEU . 24.4 m -109.67 119.4 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.565 0.698 . . . . 72.13 112.158 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.39 142.51 25.01 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.177 -0.535 . . . . 74.4 112.507 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.54 ' H ' ' HB3' ' A' ' 113' ' ' ALA . 7.1 tp -160.86 137.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.655 -0.32 . . . . 73.12 110.793 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -161.64 161.69 29.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.532 0.333 . . . . 63.45 110.753 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 1.3 pm0 -81.65 146.28 30.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.495 0.664 . . . . 61.32 112.095 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.3 m -140.1 100.61 3.96 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.157 -0.474 . . . . 71.15 111.126 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . 79.01 -170.81 54.91 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.081 -0.58 . . . . 31.0 113.309 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.23 79.26 0.41 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.127 -0.559 . . . . 72.52 112.708 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.05 159.34 53.5 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.427 -0.416 . . . . 51.54 113.856 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -162.69 108.03 1.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.436 -0.579 . . . . 74.2 109.436 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.18 151.52 50.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.987 0.422 . . . . 70.31 111.556 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.633 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.2 tm-20 -91.47 -58.05 0.24 Allowed Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 116.384 -0.371 . . . . 55.1 111.943 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 96' ' ' GLU . 85.0 Cg_endo -84.83 84.95 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.93 1.753 . . . . 74.25 113.224 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.648 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.5 tp -92.08 -66.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 112.005 0.372 . . . . 72.21 112.005 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.648 ' H ' HG23 ' A' ' 98' ' ' ILE . 4.6 m-20 -59.19 -46.85 99.23 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 113.029 0.751 . . . . 52.23 113.029 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.1 Cg_exo -42.67 -38.4 6.4 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.935 2.423 . . . . 73.43 114.289 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.42 -49.38 10.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.686 0.279 . . . . 74.22 111.053 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 86.1 mt -51.28 -44.06 61.73 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.421 0.526 . . . . 52.51 112.421 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.3 t -57.24 -42.28 81.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.699 0.285 . . . . 71.13 111.655 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -59.32 -46.84 87.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 74.52 111.271 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 110' ' ' LEU . 78.0 m-85 -63.22 -52.21 63.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.123 0.487 . . . . 71.44 111.135 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -54.62 -45.02 73.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.571 -0.74 . . . . 71.25 112.415 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -74.28 -56.1 5.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 73.3 112.569 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.37 -40.96 96.22 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.508 0.558 . . . . 64.34 112.508 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.2 17.54 4.88 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.968 -0.634 . . . . 70.13 112.774 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 83' ' ' GLN . 59.7 mt -73.31 102.9 3.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.064 0.459 . . . . 72.44 110.384 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.9 m -63.58 102.74 0.46 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.109 -0.496 . . . . 74.42 111.971 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -85.7 132.24 34.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.92 -0.582 . . . . 74.31 111.171 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.54 ' HB3' ' H ' ' A' ' 87' ' ' ILE . . . -55.66 -76.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.773 0.286 . . . . 71.2 111.773 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -164.69 88.54 1.05 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.966 0.412 . . . . 53.54 111.253 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.06 112.03 1.69 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.649 2.233 . . . . 73.33 113.859 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.603 ' HB3' HH21 ' A' ' 118' ' ' ARG . . . -170.28 -173.17 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.581 -0.281 . . . . 33.2 111.209 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.71 88.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.233 0.539 . . . . 74.15 111.525 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.603 HH21 ' HB3' ' A' ' 116' ' ' ALA . 8.4 ptp180 -104.87 -18.63 14.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.759 0.314 . . . . 75.13 111.658 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.67 111.39 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 71.45 110.806 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.97 -48.68 80.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.04 -0.527 . . . . 74.01 112.138 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.48 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 53.0 tt0 -158.81 -49.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.083 0.468 . . . . 65.31 111.335 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -114.49 117.85 42.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.337 -0.392 . . . . 74.4 111.662 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.55 126.45 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.376 2.05 . . . . 63.1 112.423 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.4 p -78.14 172.29 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.571 0.224 . . . . 62.44 110.924 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.63 -30.8 44.56 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.751 0.278 . . . . 70.44 111.751 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -52.95 -32.37 45.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.161 0.505 . . . . 70.01 111.081 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 m -61.19 -48.49 81.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.054 -0.521 . . . . 73.11 110.908 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -58.81 -51.51 69.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.192 -0.458 . . . . 65.23 111.248 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -33.76 76.3 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.22 -0.445 . . . . 73.02 112.097 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.24 -60.04 2.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.043 0.449 . . . . 52.41 110.914 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.99 -27.86 67.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.262 -0.426 . . . . 73.34 112.084 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.456 ' HA ' HG12 ' A' ' 20' ' ' ILE . 40.0 tt0 -52.43 -50.96 61.53 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.404 -0.362 . . . . 72.52 111.896 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.8 -46.89 85.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.735 0.303 . . . . 74.02 111.316 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.42 -48.94 73.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.914 0.388 . . . . 65.04 111.604 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.83 -38.72 94.62 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.097 -0.573 . . . . 70.0 113.108 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 99.7 m -63.35 -49.15 75.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.733 0.302 . . . . 72.25 111.186 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.12 -37.49 80.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.1 0.476 . . . . 72.44 110.751 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 142' ' ' VAL . 3.4 tm? -59.16 -51.59 69.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 74.23 110.237 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.97 -44.2 94.64 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.278 -0.487 . . . . 34.41 112.762 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.06 -30.84 71.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.23 111.331 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 88.5 t90 -71.65 -51.52 22.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.187 0.518 . . . . 74.31 110.833 176.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 138' ' ' LEU . 77.2 t -54.43 -46.88 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.279 -0.419 . . . . 62.33 112.005 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' ' 29' ' ' VAL . 7.4 t -62.41 -37.98 87.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.8 0.667 . . . . 71.51 112.8 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 141' ' ' TRP . 8.0 ptp180 -75.32 -41.38 56.92 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.076 -0.39 . . . . 71.22 111.54 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.19 -14.54 35.82 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.952 0.723 . . . . 72.53 112.952 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.77 -34.65 78.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.42 0.629 . . . . 64.22 109.673 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.5 tp -85.08 -78.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.433 -0.803 . . . . 74.3 109.818 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.756 ' HA ' ' HB3' ' A' ' 151' ' ' HIS . 33.1 tt0 -178.02 104.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.273 0.558 . . . . 72.33 112.231 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -114.83 -64.7 1.28 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.254 -0.647 . . . . 75.3 109.254 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -120.4 25.8 9.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.979 -1.119 . . . . 75.33 107.979 168.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.756 ' HB3' ' HA ' ' A' ' 148' ' ' GLU . 20.8 t-80 -86.16 77.16 9.64 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.286 -1.325 . . . . 73.04 112.364 -170.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -88.57 78.3 7.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.422 0.63 . . . . 72.11 109.9 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 173.95 167.02 0.2 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.232 -0.895 . . . . 74.5 109.222 -173.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 . . . . . 0 C--O 1.256 1.429 0 CA-C-O 118.145 -0.931 . . . . 75.21 110.212 171.525 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.281 0.086 . . . . 64.1 110.779 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 mm 63.49 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.246 0.545 . . . . 75.01 110.919 -174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -80.55 108.86 2.86 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.723 -0.751 . . . . 72.13 112.622 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.2 p -88.17 105.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.732 0.777 . . . . 52.24 111.203 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 88.1 m-85 -99.57 98.27 9.17 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.633 -0.712 . . . . 75.52 111.107 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 9.5 p90 -119.06 157.93 26.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.453 0.644 . . . . 64.42 112.349 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 43.6 t -104.66 101.29 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.822 -0.626 . . . . 71.34 112.066 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 m -63.26 -23.83 67.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.438 0.637 . . . . 62.11 111.341 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -78.22 -20.59 51.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.783 -0.644 . . . . 64.33 112.407 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -137.24 132.67 34.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.11 0.782 . . . . 60.22 113.11 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 90' ' ' THR . . . 56.36 -163.62 5.71 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 115.336 0.894 . . . . 74.33 115.336 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.84 7.52 10.29 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.502 0.556 . . . . 75.12 112.502 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 53.3 m -35.64 -47.88 0.5 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.987 1.106 . . . . 50.02 113.987 -172.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -54.66 -52.37 62.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.149 0.499 . . . . 64.3 111.687 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -77.3 -25.33 51.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.11 -0.496 . . . . 72.43 111.931 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.39 -48.14 71.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.356 0.598 . . . . 72.04 110.087 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -64.79 -43.71 92.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.635 -0.711 . . . . 70.12 111.268 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -51.26 -40.19 58.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.09 -0.504 . . . . 75.4 111.484 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.89 89.91 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.95 0.405 . . . . 71.32 111.343 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.9 -52.34 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.123 0.487 . . . . 72.42 111.351 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 31' ' ' VAL . 65.3 mt -55.08 -49.51 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.738 -0.665 . . . . 60.42 111.544 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.77 -36.41 69.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.341 -0.39 . . . . 43.21 111.82 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.26 -46.46 42.18 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.088 -0.577 . . . . 52.01 113.258 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.68 -43.97 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.811 0.338 . . . . 74.53 111.572 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.8 p -63.53 -38.37 90.87 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 71.34 111.164 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -64.8 -21.12 66.71 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.304 0.573 . . . . 75.22 111.285 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.7 m -85.43 -17.84 35.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.156 -0.475 . . . . 72.14 111.438 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.26 16.71 10.82 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.302 -0.475 . . . . 54.03 113.848 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.14 138.39 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 117.212 0.506 . . . . 71.14 111.443 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.19 139.24 19.57 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.116 -0.564 . . . . 71.22 112.932 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 21' ' ' ILE . 29.8 t -105.79 141.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.84 0.352 . . . . 75.5 111.582 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 22.6 m-20 -93.49 106.49 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.113 0.483 . . . . 71.2 111.134 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -87.6 109.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.349 0.595 . . . . 62.43 112.224 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -118.49 112.5 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.054 0.454 . . . . 64.11 111.404 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.48 76.46 8.23 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.385 -0.371 . . . . 71.32 111.234 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 37' ' ' GLY . 2.0 pp -70.31 -23.83 62.92 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.912 -0.493 . . . . 73.11 111.319 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -87.94 47.79 3.59 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.289 -0.481 . . . . 55.05 112.291 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.97 -65.95 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.942 0.497 . . . . 54.52 110.516 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.16 130.1 0.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.254 -0.43 . . . . 75.22 111.397 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.33 150.7 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.852 0.358 . . . . 75.11 111.641 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.82 165.49 27.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.458 -0.337 . . . . 71.3 111.238 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.5 mm? -59.56 -26.27 65.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.147 0.425 . . . . 64.52 112.147 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -56.41 -50.52 71.4 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.03 111.917 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -83.3 -33.92 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.567 -0.288 . . . . 71.05 111.274 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 89.1 mt -60.37 -29.45 68.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.627 0.251 . . . . 61.23 111.613 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.13 -39.02 89.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.181 0.515 . . . . 74.11 110.802 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.01 -25.72 62.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.326 -0.397 . . . . 61.52 111.912 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.0 tp -53.22 -28.91 29.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.907 0.384 . . . . 62.22 111.255 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.37 -49.67 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.312 -0.404 . . . . 72.21 111.865 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.68 -20.42 63.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.094 -0.574 . . . . 61.12 114.309 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -100.71 5.7 43.77 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.244 -0.563 . . . . 73.34 111.43 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.5 p -64.72 -7.38 10.6 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.648 0.981 . . . . 71.54 113.648 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 p -60.58 -42.93 97.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.139 0.422 . . . . 75.43 112.139 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.26 135.35 6.59 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.989 -0.624 . . . . 33.12 112.34 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 55' ' ' LEU . 3.2 mp -133.3 152.38 51.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 74.4 111.287 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.36 92.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.452 -0.34 . . . . 73.41 110.175 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.3 mp -99.92 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.513 . . . . 63.42 111.786 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.82 151.73 17.87 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.33 -0.462 . . . . 43.21 112.714 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.499 ' SD ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -53.09 142.01 21.28 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.361 0.6 . . . . 71.14 112.559 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 92.5 p -132.82 124.15 18.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.405 0.521 . . . . 60.03 112.405 -173.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 166.14 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.27 1.98 . . . . 72.41 112.149 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -29.36 -62.8 0.12 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.152 1.538 . . . . 74.23 115.152 -170.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.14 70.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.399 0.518 . . . . 73.22 112.399 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.8 m -84.14 -39.67 19.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 43.23 111.215 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.72 68.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.864 0.364 . . . . 74.21 111.315 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.11 -36.66 70.92 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 50.12 111.298 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.2 m -63.47 -48.34 78.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.148 0.499 . . . . 74.03 110.748 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.79 -52.47 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.099 -0.501 . . . . 75.55 111.611 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.84 -26.7 67.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.396 -0.366 . . . . 75.21 111.373 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.93 -42.25 38.3 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.027 -0.606 . . . . 73.23 112.159 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.18 5.78 18.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.927 0.343 . . . . 53.14 111.927 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -46.0 -48.4 16.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.115 0.566 . . . . 62.2 111.457 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -53.72 -37.48 63.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.135 -0.484 . . . . 73.14 111.939 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -77.72 -44.51 27.62 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.344 -0.389 . . . . 74.31 111.357 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.16 -58.86 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 112.173 0.434 . . . . 71.24 112.173 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.15 -23.68 67.55 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.061 0.393 . . . . 64.24 112.061 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.31 -25.04 52.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.026 -0.606 . . . . 65.51 112.99 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 m -85.52 -38.0 19.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.146 0.424 . . . . 64.43 112.146 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.27 125.06 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.253 0.549 . . . . 70.32 111.89 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -128.63 158.3 38.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.261 0.553 . . . . 74.53 112.122 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.659 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 44.1 tt0 62.37 -85.64 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.502 0.927 . . . . 74.01 113.502 168.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.659 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 65.2 pttt -165.04 23.51 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.394 -0.191 . . . . 74.41 111.48 -173.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.518 HE21 ' H ' ' A' ' 82' ' ' LYS . 14.7 mm-40 -50.79 158.33 0.68 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.137 0.791 . . . . 63.24 113.137 -169.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.15 117.64 28.28 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.617 0.599 . . . . 62.12 112.617 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.14 112.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.532 0.682 . . . . 54.43 111.894 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.12 145.05 17.16 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.111 -0.495 . . . . 34.53 112.102 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 42.7 mm -129.12 139.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 117.12 0.46 . . . . 73.32 111.519 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -128.41 150.75 49.99 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 74.2 110.694 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 36.2 tt0 -127.91 150.91 49.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.002 0.371 . . . . 71.35 112.002 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.499 HG22 ' SD ' ' A' ' 59' ' ' MET . 11.4 t -136.05 10.83 3.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.755 0.312 . . . . 73.32 111.481 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.504 ' H ' ' HG2' ' A' ' 89' ' ' GLU . . . -130.24 -85.75 0.39 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.456 -0.402 . . . . 62.14 112.985 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.1 -12.35 5.55 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.999 -0.62 . . . . 44.51 114.071 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.66 44.51 0.75 Allowed Glycine 0 N--CA 1.463 0.448 0 C-N-CA 121.153 -0.546 . . . . 64.43 112.059 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -173.27 3.44 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.599 0.36 . . . . 74.42 111.596 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' SER . 19.9 t70 74.09 116.99 0.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.578 0.751 . . . . 71.41 111.938 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -79.21 -47.47 1.6 Allowed Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 113.523 0.935 . . . . 72.2 113.523 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.05 9.54 2.37 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.181 1.921 . . . . 73.45 114.705 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.9 tt -46.82 -64.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.393 0.886 . . . . 72.31 113.393 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.641 ' H ' HG23 ' A' ' 98' ' ' ILE . 13.5 m-20 -67.92 -49.43 37.0 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.715 -0.616 . . . . 51.11 112.593 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.8 Cg_exo -44.76 -39.52 13.76 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.444 2.096 . . . . 71.31 113.651 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.18 -62.37 1.68 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.752 0.279 . . . . 71.52 111.752 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.2 mt -56.96 -47.85 79.74 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.415 0.524 . . . . 54.24 112.415 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.7 t -59.37 -32.32 70.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.951 0.405 . . . . 43.13 111.557 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -78.89 -42.58 26.87 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.406 -0.361 . . . . 72.03 111.374 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -60.04 -29.01 68.23 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.908 0.336 . . . . 72.03 111.908 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -55.86 -36.28 67.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.011 0.374 . . . . 74.31 112.011 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.42 -21.63 61.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.944 0.402 . . . . 71.31 111.829 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 108' ' ' LEU . 6.8 mp -92.95 -68.77 0.78 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.914 0.388 . . . . 74.13 110.73 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.16 67.16 0.37 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.218 -0.515 . . . . 71.24 113.519 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.442 HD12 ' N ' ' A' ' 110' ' ' LEU . 6.4 mp -95.58 144.61 25.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.686 -0.303 . . . . 71.53 110.775 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 89.6 m -65.59 109.55 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.028 0.442 . . . . 64.41 111.524 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.5 m -86.44 135.01 33.65 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.279 -0.418 . . . . 62.3 111.313 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.78 -92.62 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.453 0.538 . . . . 70.14 112.453 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -144.71 91.77 6.05 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.323 -0.236 . . . . 74.3 111.539 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -96.22 9.27 1.53 Allowed 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.979 2.453 . . . . 73.3 113.884 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.72 32.66 0.96 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.263 0.838 . . . . 74.21 113.263 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.4 ' C ' ' HD3' ' A' ' 118' ' ' ARG . 13.1 tt -146.39 134.49 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.815 -0.553 . . . . 71.53 112.248 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -129.96 155.16 46.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.076 0.465 . . . . 65.03 111.17 175.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 121' ' ' GLN . 2.1 mp -95.57 150.13 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 116.2 -0.454 . . . . 54.13 111.308 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -62.89 -44.91 94.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.097 0.475 . . . . 74.45 111.93 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.504 ' H ' HG22 ' A' ' 119' ' ' ILE . 58.1 tt0 -178.36 -63.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.832 -0.622 . . . . 74.42 109.656 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -119.52 115.0 34.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.802 -0.635 . . . . 72.13 110.559 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.461 ' HB2' ' OG1' ' A' ' 127' ' ' THR . 96.0 Cg_endo -77.43 -170.78 1.0 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.819 2.346 . . . . 73.22 113.564 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.1 p -131.22 -169.08 2.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.121 0.486 . . . . 72.11 111.723 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 5.0 mp0 -59.06 -26.44 64.61 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.214 -0.448 . . . . 70.42 111.939 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.52 -35.87 72.94 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.44 111.685 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 123' ' ' PRO . 30.6 m -60.3 -39.72 87.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.015 0.436 . . . . 62.3 111.389 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -59.97 -50.81 72.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.177 0.513 . . . . 71.35 110.895 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -62.6 -36.21 82.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.766 -0.652 . . . . 75.01 111.289 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.2 tt -61.48 -44.93 96.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.037 -0.529 . . . . 74.13 110.264 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 89.2 m -59.19 -42.57 91.16 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.134 -0.485 . . . . 55.51 111.502 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -58.68 -49.33 77.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.055 0.455 . . . . 62.03 111.226 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -58.77 -49.41 77.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.142 -0.481 . . . . 75.51 111.385 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.99 -51.92 67.2 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.092 -0.504 . . . . 44.13 112.006 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.39 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.168 -0.539 . . . . 71.43 113.145 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 96.3 m -60.31 -44.91 95.0 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.665 0.269 . . . . 74.12 111.627 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.77 -48.62 80.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.879 0.371 . . . . 65.41 110.973 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.31 -43.15 92.66 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.337 -0.392 . . . . 60.31 111.048 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 143' ' ' THR . . . -58.7 -42.42 96.32 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.112 -0.566 . . . . 43.45 112.918 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -62.3 -35.12 78.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.672 0.272 . . . . 72.0 111.321 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -65.92 -47.51 74.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.849 0.357 . . . . 72.12 111.343 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.89 -53.07 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.937 0.347 . . . . 42.42 111.937 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 139' ' ' GLY . 2.9 t -62.06 -34.82 76.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.042 0.449 . . . . 64.43 111.248 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 43.6 ttm180 -63.97 -37.67 88.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.197 -0.456 . . . . 73.24 111.476 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 149' ' ' HIS . 16.8 t70 -80.04 -44.9 19.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.858 0.361 . . . . 74.23 111.787 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -76.61 -7.84 56.04 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.318 0.859 . . . . 54.14 113.318 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt -93.29 -48.72 6.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.492 -0.558 . . . . 73.44 109.492 170.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -136.68 -74.9 0.43 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.185 -0.462 . . . . 61.0 110.712 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 75.3 t60 174.96 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.659 0.784 . . . . 74.03 110.097 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -121.77 -6.85 9.08 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.368 -0.378 . . . . 71.34 111.655 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -123.74 149.04 46.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.759 0.314 . . . . 71.21 111.77 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 3.7 p80 -156.78 85.1 0.96 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.44 0.638 . . . . 72.5 110.632 169.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -67.68 -70.49 0.25 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.259 -0.428 . . . . 62.22 111.447 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 . . . . . 0 C--O 1.254 1.341 0 CA-C-O 119.253 -0.404 . . . . 55.14 111.731 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 75.5 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 111.25 0.093 . . . . 65.3 111.25 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 48.1 mm 62.65 108.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.183 0.516 . . . . 62.23 111.898 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.68 117.01 4.34 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.914 -0.66 . . . . 65.02 113.04 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.54 115.85 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.411 0.624 . . . . 63.34 111.979 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 3.1 m-85 -94.69 112.77 24.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.854 -0.612 . . . . 71.12 111.21 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -135.02 148.92 50.07 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.179 0.514 . . . . 75.35 112.225 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.615 HG22 HD11 ' A' ' 36' ' ' LEU . 15.1 t -112.86 95.43 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.956 -0.565 . . . . 72.34 111.096 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 m -56.14 -16.16 4.76 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.033 0.444 . . . . 62.24 112.038 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.27 -25.13 20.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.535 0.569 . . . . 72.42 112.535 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.18 123.76 35.1 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.479 0.918 . . . . 74.13 113.479 -170.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.69 -163.61 4.86 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.626 1.01 . . . . 51.0 115.626 171.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 93.7 m-85 -75.03 -0.86 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.044 0.757 . . . . 55.15 113.044 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -59.28 -31.02 68.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.225 0.536 . . . . 73.24 110.351 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.84 -37.97 72.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.467 -0.788 . . . . 74.01 111.266 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 15' ' ' ARG . 5.1 mmp_? -85.85 -38.41 18.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.33 -0.395 . . . . 73.43 111.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.9 mt -50.45 -47.25 56.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.529 -0.305 . . . . 71.02 111.792 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.45 65.99 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.104 0.409 . . . . 53.34 112.104 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.435 -0.348 . . . . 72.44 111.568 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.46 -41.96 31.2 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.824 0.345 . . . . 73.21 111.279 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 16' ' ' LEU . 71.9 mt -59.47 -56.06 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.884 0.373 . . . . 75.41 111.885 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.3 tt -58.61 -30.61 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.979 0.419 . . . . 71.12 111.81 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.82 -53.1 12.38 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.037 0.446 . . . . 72.53 111.182 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' HA3' ' HG3' ' A' ' 132' ' ' GLU . . . -63.58 -44.74 96.08 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.188 -0.46 . . . . 73.44 114.082 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.89 -52.05 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.381 0.511 . . . . 72.14 112.381 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -59.46 -34.49 72.59 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.031 0.443 . . . . 51.14 112.01 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -84.53 5.76 26.35 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.502 0.556 . . . . 75.1 112.502 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.491 ' HA ' ' HE2' ' A' ' 153' ' ' HIS . 32.4 m -126.25 -47.78 1.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.789 0.328 . . . . 73.41 111.702 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.85 -89.32 0.75 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.997 -0.62 . . . . 64.31 113.585 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.86 172.31 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.164 0.431 . . . . 64.1 112.164 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.03 157.61 53.05 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.397 -0.43 . . . . 61.32 113.652 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 1' ' ' SER . 38.8 t -108.73 148.35 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.527 0.331 . . . . 73.32 111.867 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.45 128.27 53.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.821 0.343 . . . . 43.41 110.858 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.68 138.9 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.538 0.569 . . . . 64.04 112.538 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.53 96.98 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.145 0.497 . . . . 74.11 111.277 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.64 86.83 6.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.314 -0.403 . . . . 75.33 110.955 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 7' ' ' VAL . 3.5 pp -91.29 -23.87 20.01 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.331 0.493 . . . . 70.12 112.331 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -78.99 47.99 3.23 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.027 -0.606 . . . . 61.04 113.303 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -171.91 -167.27 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.76 0.424 . . . . 74.43 110.691 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.58 104.28 5.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.854 0.359 . . . . 62.2 111.028 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.74 175.1 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.503 -0.317 . . . . 71.52 111.601 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -140.48 160.49 39.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.307 0.575 . . . . 71.34 112.331 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.5 tm? -55.16 -35.51 64.84 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.805 -0.634 . . . . 60.42 111.989 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.3 mt-30 -50.78 -43.38 58.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.083 0.468 . . . . 74.32 111.457 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.15 -24.36 64.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.001 -0.545 . . . . 53.21 111.445 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.99 -51.17 34.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.338 -0.392 . . . . 74.15 110.815 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -61.65 -32.64 72.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.83 0.347 . . . . 73.14 111.034 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 71.4 mm-40 -60.62 -48.87 79.86 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.034 0.445 . . . . 63.51 110.641 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.02 -39.35 71.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.887 -0.597 . . . . 64.23 111.812 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.8 -35.09 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.157 0.503 . . . . 72.11 111.186 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.36 -10.81 76.66 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.225 -0.512 . . . . 52.33 113.163 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -101.45 4.58 41.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.396 -0.473 . . . . 52.13 111.569 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.58 1.76 3.8 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.565 0.95 . . . . 74.23 113.565 -172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.5 p -64.15 -42.09 96.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.208 0.527 . . . . 62.1 110.838 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.59 136.59 5.35 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.803 -0.635 . . . . 51.44 112.32 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -160.81 148.41 15.75 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.496 -0.414 . . . . 74.33 111.657 -177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -112.26 125.31 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 71.52 110.974 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 47.5 mt -128.92 136.27 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.064 0.459 . . . . 74.2 112.191 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.69 -163.88 34.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.146 -0.549 . . . . 62.43 112.401 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtm -98.17 135.26 40.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.018 -0.695 . . . . 72.35 110.648 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.9 p -79.62 150.8 73.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.199 0.444 . . . . 62.43 112.199 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 64' ' ' SER . 16.5 Cg_endo -90.85 157.59 4.07 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.831 2.354 . . . . 65.53 111.78 169.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.97 -31.58 29.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.174 0.435 . . . . 70.33 112.174 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.02 73.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.975 0.361 . . . . 54.33 111.975 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.536 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 38.9 m -95.76 -13.21 24.31 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.685 0.278 . . . . 71.44 111.679 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.73 -42.4 35.1 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.86 0.689 . . . . 74.03 112.86 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.96 -47.08 78.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.99 0.424 . . . . 62.53 111.853 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -67.13 -45.82 75.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.147 0.498 . . . . 64.44 111.401 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.2 -46.96 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.981 -0.554 . . . . 75.13 112.155 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -57.82 -35.56 71.03 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.821 0.343 . . . . 75.45 111.895 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.83 -43.38 28.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.062 -0.59 . . . . 73.31 113.072 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.35 -26.07 51.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.225 0.454 . . . . 60.34 112.225 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 101' ' ' LEU . 52.1 tp -52.8 -37.38 59.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.066 0.395 . . . . 64.15 112.066 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -59.12 -43.97 91.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.944 0.402 . . . . 63.11 111.324 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.9 m -68.63 -36.1 78.17 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.171 0.51 . . . . 72.35 111.004 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 79' ' ' VAL . 67.7 mt -61.96 -59.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.266 -0.425 . . . . 71.51 111.009 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.57 -30.16 65.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.251 0.463 . . . . 62.54 112.251 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.15 -24.04 67.21 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.127 -0.559 . . . . 65.31 113.439 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 p -97.97 -48.36 5.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.304 0.483 . . . . 74.13 112.304 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.8 m -77.88 85.99 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 122.033 0.92 . . . . 75.24 111.687 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -133.24 -178.12 4.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.862 -0.608 . . . . 73.23 112.144 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 65.74 -77.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.249 0.62 . . . . 45.4 111.981 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -168.35 29.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.9 0.704 . . . . 71.34 112.9 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.58 160.99 12.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.095 0.474 . . . . 75.33 111.647 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 138' ' ' LEU . . . -89.19 95.62 10.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.012 0.745 . . . . 72.11 113.012 -170.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 85' ' ' VAL . 18.4 m -102.67 92.95 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.76 0.791 . . . . 63.34 111.551 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.55 72.72 2.5 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.029 -0.532 . . . . 75.31 113.367 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 12.0 tt -96.54 133.67 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 122.639 -0.33 . . . . 73.41 111.035 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' CZ ' ' SG ' ' A' ' 131' ' ' CYS . 8.0 p90 -146.79 173.42 12.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.152 0.501 . . . . 75.42 112.206 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.05 96.61 0.15 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.239 0.542 . . . . 70.24 112.323 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.2 m -131.43 94.02 3.46 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.262 -0.426 . . . . 60.2 110.512 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.65 168.63 11.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.355 -0.45 . . . . 31.42 112.629 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.496 ' HA3' ' OE1' ' A' ' 121' ' ' GLN . . . -114.52 -135.12 5.9 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.852 -0.689 . . . . 64.35 114.022 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.92 77.06 1.8 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.319 -0.467 . . . . 41.41 113.125 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.3 -179.86 7.25 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.631 -0.335 . . . . 72.34 110.734 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 70.89 154.82 0.14 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.868 0.692 . . . . 54.13 112.868 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.1 mt-10 -104.63 -57.36 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.755 0.65 . . . . 71.35 112.755 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 57.4 Cg_endo -68.51 -1.98 8.4 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.322 2.014 . . . . 65.23 113.996 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.8 tp -50.99 -45.1 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 112.734 0.642 . . . . 73.4 112.734 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.704 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 5.5 m-20 -58.21 -55.74 42.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 111.997 0.369 . . . . 52.41 111.997 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 82.6 Cg_exo -50.24 -48.99 17.64 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.328 2.019 . . . . 74.31 113.358 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' PRO . 11.2 mp -56.74 -51.98 66.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.06 0.393 . . . . 54.41 112.06 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 92.6 mt -53.44 -52.03 60.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.797 0.332 . . . . 73.11 111.67 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t -66.93 -34.46 77.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.776 0.322 . . . . 74.32 111.581 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 1.4 tpmt? -59.86 -60.85 3.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.841 0.353 . . . . 54.33 111.305 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.58 -30.85 71.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.533 -0.303 . . . . 64.42 111.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -59.5 -45.83 90.56 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.868 0.366 . . . . 64.12 110.378 176.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -69.52 -47.95 62.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.208 -0.451 . . . . 72.55 110.666 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.74 -48.7 77.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.866 0.365 . . . . 75.43 111.52 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.53 71.83 0.71 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.654 0.622 . . . . 35.24 114.654 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 110' ' ' LEU . 6.0 mp -90.93 -177.31 4.91 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.415 -0.461 . . . . 64.34 110.415 173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.2 m -63.83 101.89 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.123 0.416 . . . . 74.35 112.123 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 p -105.64 137.39 43.57 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.065 0.459 . . . . 70.14 111.565 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.41 -58.01 3.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.886 0.375 . . . . 50.24 111.796 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -167.78 89.83 0.69 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.735 0.302 . . . . 74.23 110.453 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.01 -33.56 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.62 2.214 . . . . 73.41 114.368 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.49 118.03 28.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.27 0.47 . . . . 62.32 112.27 -173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.507 HG23 HG12 ' A' ' 119' ' ' ILE . 12.6 tt -137.78 7.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.322 0.582 . . . . 73.51 111.779 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 67.73 65.56 0.38 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.026 0.53 . . . . 72.51 112.429 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 123' ' ' PRO . 50.8 mm -104.62 111.67 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 74.11 111.115 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -93.53 -23.13 18.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.234 -0.439 . . . . 71.02 111.683 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.496 ' OE1' ' HA3' ' A' ' 92' ' ' GLY . 6.0 tp-100 -161.48 -65.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.021 0.438 . . . . 64.13 111.291 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.7 p -104.04 125.67 33.82 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.208 0.448 . . . . 73.41 112.208 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HA ' HD12 ' A' ' 119' ' ' ILE . 52.2 Cg_exo -55.93 150.23 47.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.545 2.163 . . . . 74.45 112.456 170.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.8 p -118.93 -176.12 3.05 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.19 0.441 . . . . 73.11 112.19 -174.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.63 -48.41 19.86 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.104 -0.498 . . . . 64.35 112.049 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.96 -25.94 65.6 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.036 -0.529 . . . . 75.43 111.974 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 123' ' ' PRO . 59.2 m -63.87 -36.99 85.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.83 0.348 . . . . 63.31 110.856 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.39 -47.1 74.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.979 0.419 . . . . 75.34 110.937 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.72 -41.47 95.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.224 -0.443 . . . . 64.52 111.072 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.37 -54.43 47.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.466 -0.334 . . . . 74.52 110.238 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 20' ' ' ILE . 74.4 m -50.03 -51.58 40.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.785 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.537 ' HG3' ' HA3' ' A' ' 23' ' ' GLY . 46.1 tt0 -67.17 -55.02 15.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.381 -0.372 . . . . 73.13 111.792 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.49 -54.86 42.29 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.942 0.349 . . . . 52.23 111.942 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.6 76.47 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.4 -0.364 . . . . 54.34 111.85 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.15 -46.85 93.67 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 63.51 113.274 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 94.7 m -63.34 -51.2 66.92 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.88 0.371 . . . . 63.34 111.815 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.06 -42.63 98.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.133 0.492 . . . . 64.25 111.068 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 84' ' ' ALA . 53.7 tp -64.76 -41.24 96.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.053 0.454 . . . . 73.44 110.757 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.24 -42.72 98.82 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.183 -0.462 . . . . 52.21 112.68 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.15 -39.18 85.44 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.955 0.407 . . . . 74.14 110.926 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -59.89 -49.5 77.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.46 -0.336 . . . . 72.42 111.12 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.38 -47.91 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 112.133 0.419 . . . . 71.24 112.133 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -71.83 -41.5 68.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.106 0.409 . . . . 64.44 112.106 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.64 ' HA ' ' HG3' ' A' ' 148' ' ' GLU . 61.2 ttt180 -64.08 -33.16 75.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.919 0.39 . . . . 74.35 111.559 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.6 -26.86 14.7 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.109 -0.496 . . . . 70.24 111.286 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -97.69 -63.68 1.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.339 -0.391 . . . . 75.22 112.013 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.472 ' O ' HD23 ' A' ' 147' ' ' LEU . 4.8 tt -175.64 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 111.861 0.319 . . . . 64.24 111.861 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.64 ' HG3' ' HA ' ' A' ' 144' ' ' ARG . 46.1 mt-10 74.87 146.95 0.09 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.397 0.679 . . . . 73.32 112.198 -175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -106.6 -18.11 14.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.165 0.507 . . . . 72.24 109.783 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -108.5 130.69 55.26 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.879 -0.601 . . . . 74.32 111.086 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -134.87 99.42 4.3 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.899 0.38 . . . . 64.2 110.367 171.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.6 m170 67.27 176.25 0.25 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.616 -0.72 . . . . 64.11 111.709 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 27' ' ' THR . 56.9 m80 -97.33 154.88 17.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.086 0.469 . . . . 75.45 112.041 -174.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.2 p80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.351 -0.833 . . . . 73.22 110.931 176.105 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.59 -0.152 . . . . 73.45 110.59 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 46.8 mm 74.55 96.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 121.31 0.576 . . . . 63.32 110.589 -172.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -81.99 123.24 5.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.056 -0.52 . . . . 54.23 113.735 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.7 t -95.36 106.4 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 O-C-N 122.608 -0.348 . . . . 65.4 111.115 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.613 ' HB3' HD23 ' A' ' 36' ' ' LEU . 93.1 m-85 -90.96 105.96 18.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.925 0.393 . . . . 71.13 111.614 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 35.9 p90 -146.75 -178.59 6.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.434 -0.348 . . . . 72.42 110.945 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.566 HG13 ' HB3' ' A' ' 10' ' ' TYR . 2.8 p -134.55 104.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.089 0.471 . . . . 75.33 111.086 176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -52.48 -25.34 9.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.215 0.82 . . . . 73.32 113.215 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -74.08 -32.42 63.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.763 0.316 . . . . 54.41 111.644 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' HB3' HG13 ' A' ' 7' ' ' VAL . 61.0 t80 -104.31 137.41 42.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.07 0.462 . . . . 74.13 112.226 -173.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.12 -161.79 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.98 0.752 . . . . 63.01 114.98 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.63 7.56 17.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.772 0.429 . . . . 73.5 111.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 84.8 p -30.75 -65.65 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.279 1.214 . . . . 55.51 114.279 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.46 -35.04 79.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.085 0.402 . . . . 72.41 112.085 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -60.21 -40.29 89.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.092 0.472 . . . . 70.43 110.747 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.44 -37.18 68.64 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 71.44 110.764 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.92 -31.64 67.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.206 -0.452 . . . . 51.33 111.352 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -52.21 -43.02 64.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.251 -0.431 . . . . 64.3 110.997 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . . . -67.76 -47.29 69.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.972 -0.558 . . . . 61.41 111.609 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.74 -55.4 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 62.12 111.386 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.03 -46.73 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.212 -0.449 . . . . 75.24 111.207 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.17 -50.22 74.88 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.414 -0.357 . . . . 71.04 111.864 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.17 -48.77 84.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.819 -0.705 . . . . 74.31 113.305 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 30' ' ' GLY . 1.8 mp -72.11 -32.3 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 122.521 -0.399 . . . . 74.34 112.013 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -72.0 -30.2 64.99 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.679 -0.638 . . . . 63.21 110.628 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' NZ ' ' HB3' ' A' ' 26' ' ' LYS . 4.6 mmmp? -64.99 -24.11 67.42 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.137 0.494 . . . . 74.43 110.692 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.449 HG21 ' HG2' ' A' ' 140' ' ' GLN . 60.3 m -79.07 -40.44 31.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.219 0.533 . . . . 74.24 110.474 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.57 21.63 7.47 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.892 -0.595 . . . . 73.14 113.492 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.44 -77.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 122.402 -0.47 . . . . 72.0 111.995 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 114.67 115.48 3.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.306 -0.473 . . . . 72.25 113.133 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' SER . 29.7 m -90.59 157.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.187 0.518 . . . . 65.33 112.247 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' CG ' ' H2 ' ' A' ' 1' ' ' SER . 9.4 m-20 -96.28 130.62 43.33 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.211 -0.449 . . . . 75.11 110.926 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.41 120.19 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.142 -0.348 . . . . 71.33 111.759 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.79 104.15 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.672 0.273 . . . . 60.23 111.717 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 11.4 m-20 -77.05 103.23 6.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.811 0.339 . . . . 74.4 111.049 173.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.613 HD23 ' HB3' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -67.96 78.81 0.22 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.968 0.89 . . . . 72.11 111.864 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.1 -25.62 0.23 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.404 -0.816 . . . . 75.24 112.397 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.97 157.87 34.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.778 0.323 . . . . 43.2 111.364 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 70.28 2.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.207 0.527 . . . . 72.42 111.976 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.63 147.65 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 75.43 111.527 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.4 166.8 10.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.98 0.419 . . . . 74.34 111.259 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD13 HD12 ' A' ' 45' ' ' LEU . 3.9 mm? -56.22 -24.4 41.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.451 -0.341 . . . . 74.3 111.201 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.74 -49.6 77.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.218 -0.446 . . . . 65.0 111.033 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.82 -46.41 71.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.879 0.371 . . . . 74.12 111.168 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 42' ' ' LEU . 93.7 mt -57.53 -46.82 83.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.191 -0.459 . . . . 74.24 111.767 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.4 -44.92 96.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.698 0.285 . . . . 74.35 111.586 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 9.5 tp10 -64.57 -42.52 95.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.167 0.508 . . . . 70.21 110.83 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.73 -42.06 71.1 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.969 -0.56 . . . . 74.54 111.485 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 45' ' ' LEU . 67.2 t -56.1 -37.61 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.979 0.418 . . . . 74.05 111.43 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.11 -21.32 79.89 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.964 -0.636 . . . . 54.12 112.993 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 12.5 mmt180 -100.74 5.3 43.59 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.57 -0.371 . . . . 71.31 111.821 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.1 p -70.83 4.58 2.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.324 0.861 . . . . 75.41 113.324 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.5 p -58.96 -36.39 74.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 52.52 110.927 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -154.95 138.82 6.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.624 -0.716 . . . . 14.01 112.047 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.0 169.76 17.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.256 0.528 . . . . 75.34 112.196 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 88' ' ' PHE . 7.3 p -131.46 136.24 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.767 0.318 . . . . 74.23 111.388 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.7 mp -112.69 133.16 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.936 0.398 . . . . 60.0 112.062 -175.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.93 -124.45 5.41 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.263 -0.494 . . . . 50.31 112.686 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.442 ' SD ' ' HA3' ' A' ' 91' ' ' GLY . 54.9 ttm -155.07 154.7 32.83 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.429 -0.454 . . . . 72.24 110.892 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.546 ' HB3' HD13 ' A' ' 36' ' ' LEU . 67.7 p -114.19 156.95 43.52 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 120.607 0.242 . . . . 72.15 111.38 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.43 152.14 78.78 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.951 1.767 . . . . 74.23 111.826 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.34 -41.08 8.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.422 0.897 . . . . 73.13 113.422 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.48 -48.34 56.21 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.155 0.428 . . . . 72.21 112.155 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -14.49 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.027 0.38 . . . . 75.13 112.027 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -54.22 -32.18 55.2 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.225 0.454 . . . . 73.04 112.225 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.19 -33.21 70.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 75.43 111.252 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -67.84 -42.13 81.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.176 -0.465 . . . . 63.53 111.296 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.5 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.814 0.34 . . . . 51.51 110.855 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -51.62 -45.4 63.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.208 -0.451 . . . . 71.15 111.545 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.01 -49.47 16.43 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.047 -0.596 . . . . 64.41 113.184 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.83 76.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.005 0.372 . . . . 54.53 112.005 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 tt -48.39 -49.73 33.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.21 0.604 . . . . 74.3 111.387 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -60.13 -40.09 88.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.105 0.409 . . . . 71.4 112.105 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.2 m -74.33 -36.87 63.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.876 0.37 . . . . 72.23 111.395 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 79' ' ' VAL . 74.7 mt -71.63 -67.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.469 -0.332 . . . . 74.2 111.397 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.482 ' HA ' HG22 ' A' ' 79' ' ' VAL . 68.4 mt -61.65 -22.15 65.03 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.452 0.538 . . . . 75.4 112.452 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.45 -22.68 64.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.727 -0.749 . . . . 44.3 113.259 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -101.03 -26.2 13.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.458 0.54 . . . . 71.23 112.458 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 75' ' ' ILE . 33.7 m -70.51 179.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.381 0.61 . . . . 72.41 112.417 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.61 161.34 25.97 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.092 -0.504 . . . . 74.1 111.691 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -46.97 -42.89 18.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.699 0.8 . . . . 62.41 112.814 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -145.92 133.03 20.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.089 0.471 . . . . 71.21 111.39 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -133.54 177.18 7.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.073 -0.512 . . . . 73.1 111.806 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.632 ' HB1' HD11 ' A' ' 138' ' ' LEU . . . -102.74 112.18 24.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.845 0.355 . . . . 62.35 111.24 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.75 169.69 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.91 0.386 . . . . 72.24 111.967 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.12 169.29 32.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.37 -0.443 . . . . 71.04 112.749 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.482 HG21 ' HB3' ' A' ' 116' ' ' ALA . 43.9 mm -100.42 146.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 74.13 111.895 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.543 ' HB2' HG22 ' A' ' 56' ' ' VAL . 17.8 t80 -135.28 109.58 8.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.501 -0.318 . . . . 60.32 110.749 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -64.62 93.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.557 0.577 . . . . 62.33 112.557 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 t -160.58 77.79 0.61 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.258 0.551 . . . . 73.33 111.819 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.442 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . 171.31 121.51 0.59 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.091 -0.576 . . . . 35.33 113.193 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.87 51.09 4.27 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.128 -0.558 . . . . 62.24 113.407 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.32 56.76 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.281 -0.485 . . . . 62.14 113.313 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.6 -154.89 0.38 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.67 0.388 . . . . 71.05 111.404 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 23.3 t70 69.66 154.93 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.321 0.648 . . . . 53.33 112.593 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 8.3 mm-40 -103.42 -56.33 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.095 -0.502 . . . . 72.14 112.31 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 88.4 Cg_endo -80.04 16.96 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.122 1.881 . . . . 72.11 113.759 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.3 tt -48.0 -56.39 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.705 1.002 . . . . 62.22 113.705 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.689 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.5 m-20 -61.17 -54.07 57.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.972 -0.455 . . . . 70.51 111.953 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 51.8 Cg_exo -54.66 -42.2 70.56 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.905 1.737 . . . . 74.34 112.654 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.61 -59.52 4.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.984 0.421 . . . . 74.41 111.342 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.51 -35.4 79.26 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.02 0.438 . . . . 44.21 111.511 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -62.71 -46.28 88.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.394 -0.366 . . . . 73.14 111.784 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 100' ' ' PRO . 53.2 mtpt -61.08 -45.15 95.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.499 0.19 . . . . 74.13 111.356 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.439 ' HA ' HD13 ' A' ' 110' ' ' LEU . 2.3 m-85 -58.59 -40.96 84.66 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.026 0.441 . . . . 73.31 110.991 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.76 -49.66 74.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.715 -0.675 . . . . 74.44 111.9 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -81.29 -46.85 14.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.864 0.69 . . . . 73.03 112.864 -174.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.5 -15.18 57.14 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.238 0.458 . . . . 54.15 112.238 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.61 4.98 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 114.398 0.519 . . . . 73.42 114.398 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 105' ' ' PHE . 7.5 mp -88.88 -175.33 4.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.095 0.448 . . . . 44.33 110.995 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 154.16 26.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.258 0.552 . . . . 61.14 111.982 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -100.98 -51.94 3.41 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.069 -0.514 . . . . 75.04 111.757 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.59 42.87 13.44 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.093 0.473 . . . . 72.54 111.563 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.5 t80 68.23 93.71 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.468 -0.787 . . . . 70.55 111.706 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.31 96.5 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.432 2.088 . . . . 70.03 112.276 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HB3' HG21 ' A' ' 87' ' ' ILE . . . -56.57 156.14 6.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.524 0.564 . . . . 71.04 112.524 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.667 HD13 ' N ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -77.13 139.42 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.13 -0.486 . . . . 74.24 110.402 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.667 ' N ' HD13 ' A' ' 117' ' ' ILE . 82.2 mtt180 -56.74 120.72 8.32 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.133 0.492 . . . . 73.32 111.659 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.8 mp -70.15 138.15 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.302 0.572 . . . . 71.11 112.172 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -65.86 -70.94 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.912 -0.586 . . . . 74.23 110.723 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -155.1 -58.98 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.172 0.511 . . . . 72.42 110.413 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.3 p -94.69 136.87 22.7 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.123 -0.489 . . . . 51.33 111.933 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.46 -165.21 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.962 2.442 . . . . 72.13 112.8 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 55.0 p -133.08 171.89 13.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.939 0.4 . . . . 60.31 111.542 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.81 -33.41 56.0 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.155 0.503 . . . . 63.43 111.569 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.76 -10.77 30.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.533 0.568 . . . . 71.5 112.533 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.5 m -63.56 -33.11 74.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.012 0.434 . . . . 62.13 111.13 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.552 ' HA ' ' HG ' ' A' ' 131' ' ' CYS . 82.9 m-85 -65.16 -41.67 94.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.301 0.572 . . . . 74.44 110.514 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.17 -49.71 76.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 73.51 111.099 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.17 -58.13 9.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.106 -0.497 . . . . 75.22 111.218 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.552 ' HG ' ' HA ' ' A' ' 128' ' ' TYR . 27.8 p -58.15 -47.09 84.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.671 0.619 . . . . 75.31 112.671 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.58 -54.75 27.15 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.154 0.427 . . . . 71.53 112.154 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.33 -48.6 72.47 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.117 0.414 . . . . 34.31 112.117 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.31 -42.84 92.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.896 0.379 . . . . 71.22 111.312 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.49 97.48 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.317 -0.468 . . . . 75.3 112.774 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 46.6 m -62.05 -44.17 97.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.999 0.428 . . . . 63.31 111.096 175.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.92 -61.07 2.13 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.82 0.343 . . . . 73.44 111.441 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.632 HD11 ' HB1' ' A' ' 84' ' ' ALA . 46.9 tp -63.34 -37.86 88.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.83 0.348 . . . . 74.3 111.722 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -51.14 45.46 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.114 -0.565 . . . . 74.1 113.165 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 143' ' ' THR . 28.2 mt-30 -73.01 -7.84 53.04 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.353 -0.498 . . . . 74.42 111.983 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.471 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 62.6 t90 -55.26 -32.3 62.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.137 0.494 . . . . 73.21 110.191 170.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.62 -47.07 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.206 -0.452 . . . . 73.34 111.95 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 140' ' ' GLN . 11.3 t -73.66 -32.06 63.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.143 -0.348 . . . . 55.21 111.49 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -70.74 -41.83 71.29 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.86 0.362 . . . . 62.15 111.438 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.53 -61.05 1.76 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.532 0.567 . . . . 51.43 112.532 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -75.08 -55.08 6.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.902 0.382 . . . . 64.45 111.838 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.461 ' O ' HD23 ' A' ' 147' ' ' LEU . 10.1 tt -68.56 -25.31 64.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.922 0.392 . . . . 71.35 110.994 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 64.68 49.63 2.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.499 0.666 . . . . 72.15 111.23 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.43 -21.35 50.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.68 -0.691 . . . . 70.1 111.61 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.7 t60 68.99 -69.36 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.343 0.657 . . . . 72.43 112.181 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -74.75 115.31 14.19 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.853 0.316 . . . . 71.21 111.853 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -76.52 147.09 38.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.694 -0.23 . . . . 72.1 110.427 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.416 ' NE2' ' NE2' ' A' ' 140' ' ' GLN . 30.1 p80 -104.89 165.6 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.113 0.482 . . . . 74.32 111.979 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.913 -0.585 . . . . 72.52 110.087 171.592 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 45.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.143 -0.317 . . . . 55.12 110.143 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 54' ' ' GLY . 47.2 mm 59.64 91.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.184 0.516 . . . . 71.52 111.53 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 104.64 2.3 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.833 -0.698 . . . . 65.44 112.84 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 m -87.3 107.79 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.427 0.632 . . . . 44.42 110.881 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.758 ' HB3' HD23 ' A' ' 36' ' ' LEU . 55.3 m-85 -104.22 118.37 36.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.897 -0.592 . . . . 60.13 111.206 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -152.16 176.51 11.49 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.202 0.445 . . . . 72.5 112.202 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' SER . 48.4 t -109.08 104.04 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 116.089 -0.505 . . . . 74.14 110.28 172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 62.1 p -59.67 -56.74 18.08 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.415 0.895 . . . . 74.1 113.415 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.23 -43.26 92.35 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.087 0.773 . . . . 65.0 113.087 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -77.26 121.02 23.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.14 0.495 . . . . 63.13 112.266 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.28 -162.61 6.17 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.844 -0.616 . . . . 44.51 114.408 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -81.9 7.77 12.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.925 0.343 . . . . 55.41 111.925 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 20.0 m -44.22 -43.97 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.578 0.955 . . . . 75.45 113.578 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.688 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 19.6 p-10 -73.57 -36.71 65.62 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.922 -0.486 . . . . 60.3 111.358 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mmt-85 -61.22 -40.62 94.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.519 0.676 . . . . 74.11 109.713 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.665 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . 79.7 mt -66.67 -41.68 87.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 73.44 110.838 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.74 83.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 75.11 111.136 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.48 -27.56 65.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.801 0.334 . . . . 72.33 110.994 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 22' ' ' ASN . . . -64.27 -37.64 88.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.089 0.471 . . . . 72.5 110.362 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.57 HG23 ' HA3' ' A' ' 135' ' ' GLY . 63.1 mt -63.1 -53.1 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.278 0.561 . . . . 74.51 110.301 171.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.14 -33.45 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.751 -0.659 . . . . 75.5 111.283 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 39.2 t30 -53.65 -60.14 3.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.356 -0.384 . . . . 53.44 111.187 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.17 97.93 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.12 -0.562 . . . . 71.55 113.06 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 29' ' ' VAL . 55.4 mt -60.75 -50.6 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.235 0.457 . . . . 73.12 112.235 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -67.97 -38.22 82.47 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.165 -0.335 . . . . 75.33 111.298 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.8 -32.89 69.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.091 0.472 . . . . 73.02 111.078 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.605 HG21 ' HG2' ' A' ' 140' ' ' GLN . 88.6 m -79.4 -35.27 40.92 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.95 0.405 . . . . 74.11 111.175 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.91 32.25 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.365 -0.445 . . . . 75.52 113.279 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HB ' HG23 ' A' ' 24' ' ' ILE . 29.5 t -108.91 133.95 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 122.462 -0.434 . . . . 74.21 111.417 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.09 112.64 3.64 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.111 -0.566 . . . . 70.41 112.534 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 24' ' ' ILE . 7.7 p -99.22 140.85 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 112.48 0.548 . . . . 64.24 112.48 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -96.48 109.38 21.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.027 0.441 . . . . 71.32 110.695 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.07 116.91 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 111.872 0.323 . . . . 74.13 111.872 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.41 119.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.017 0.437 . . . . 54.42 111.942 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.67 105.27 16.1 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.934 0.397 . . . . 74.22 111.255 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 5' ' ' PHE . 2.9 pp -77.38 -10.02 59.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.843 0.354 . . . . 73.11 111.43 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.58 -12.26 66.67 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.206 -0.521 . . . . 34.53 113.14 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.18 -48.23 0.06 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.867 0.365 . . . . 73.41 111.77 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.613 0.597 . . . . 74.41 112.613 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.0 m -117.96 45.79 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.323 0.583 . . . . 73.13 110.957 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.35 149.39 48.46 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.463 0.542 . . . . 70.42 112.463 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' H ' HD22 ' A' ' 42' ' ' LEU . 3.3 mm? -58.55 -35.12 71.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.135 -0.484 . . . . 73.33 112.175 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -62.94 -40.17 96.86 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.883 0.373 . . . . 62.35 110.723 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LEU . 17.6 tp10 -70.41 -29.7 66.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.3 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 74' ' ' THR . 3.3 tm? -60.9 -46.96 88.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.146 0.498 . . . . 64.31 109.815 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.32 -40.0 94.88 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.39 0.614 . . . . 73.4 110.721 172.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.728 ' HG3' HH11 ' A' ' 51' ' ' ARG . 20.5 tp10 -79.83 -10.63 59.8 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.642 -0.708 . . . . 74.25 111.332 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 51' ' ' ARG . 53.3 tp -59.22 -28.67 66.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.92 0.488 . . . . 71.04 111.696 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.403 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 35.8 t -58.9 -23.95 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.988 0.423 . . . . 74.13 111.351 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.15 -34.95 25.19 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.926 -0.654 . . . . 61.44 112.151 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.728 HH11 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -68.83 -38.28 79.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.839 0.352 . . . . 72.23 111.273 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 p -67.12 -2.84 6.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.868 0.692 . . . . 63.44 112.868 -174.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -62.88 -22.21 66.55 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.134 0.492 . . . . 61.31 110.892 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 2' ' ' ILE . . . -153.58 137.43 5.77 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.99 -0.844 . . . . 70.12 110.99 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HB2' HG12 ' A' ' 85' ' ' VAL . 95.4 mt -116.58 116.54 27.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.583 0.691 . . . . 64.31 112.434 -173.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.02 105.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 74.13 110.266 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -101.93 119.61 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.846 0.355 . . . . 64.41 111.273 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 59' ' ' MET . . . -80.91 -12.04 83.14 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.028 -0.606 . . . . 54.21 113.84 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 49.6 ttp 71.3 149.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.301 0.572 . . . . 61.45 111.723 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 60.0 m -151.22 140.77 13.99 Favored Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 122.182 -0.324 . . . . 75.31 111.132 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.91 161.68 28.46 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.514 2.143 . . . . 73.45 112.978 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.38 -39.7 7.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.53 0.567 . . . . 71.34 112.53 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.68 64.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.092 0.405 . . . . 54.51 112.092 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 19.6 m -79.86 -19.27 48.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.443 -0.344 . . . . 73.33 111.893 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.88 -11.93 43.14 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.601 0.593 . . . . 52.23 112.601 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.94 -49.67 68.17 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.884 0.373 . . . . 52.42 111.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.7 p -65.59 -43.49 89.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.979 0.418 . . . . 35.33 111.197 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -53.85 -56.08 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.018 -0.537 . . . . 61.43 111.618 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -60.33 -21.65 62.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.18 0.437 . . . . 74.32 112.18 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.23 -48.3 80.64 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.033 -0.603 . . . . 75.24 112.661 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -89.67 -19.34 24.97 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.869 0.366 . . . . 71.53 111.855 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tt -49.74 -34.71 19.86 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.904 0.481 . . . . 72.11 111.891 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m -47.7 -37.45 13.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.096 -0.502 . . . . 73.15 112.234 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.645 HG21 HD11 ' A' ' 45' ' ' LEU . 45.5 m -99.47 -35.79 9.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 111.759 0.281 . . . . 61.54 111.759 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 71' ' ' ALA . 68.3 mt -47.86 -44.4 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.491 0.552 . . . . 64.42 112.491 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.8 -35.76 64.21 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 71.24 111.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.06 -29.39 28.5 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.123 -0.561 . . . . 65.42 113.111 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -69.6 -30.01 67.66 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.025 0.38 . . . . 72.22 112.025 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.21 164.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.275 0.472 . . . . 51.21 112.275 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.99 148.33 22.44 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.233 -0.44 . . . . 70.34 110.28 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.19 -62.12 1.91 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.931 0.715 . . . . 74.21 112.931 -173.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 53.2 mttm -100.49 114.45 28.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.343 0.592 . . . . 75.44 111.799 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.666 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 5.6 tp60 -163.8 -174.53 3.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.883 -0.599 . . . . 73.02 110.274 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.666 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -110.38 132.57 54.07 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.034 -0.416 . . . . 75.45 111.336 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.589 HG12 ' HB2' ' A' ' 55' ' ' LEU . 29.8 m -119.72 134.64 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.415 0.626 . . . . 72.31 112.43 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 127.72 8.42 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.84 -0.618 . . . . 73.22 112.334 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -129.02 145.86 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.687 -0.302 . . . . 74.51 110.917 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -146.81 135.31 21.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.997 0.427 . . . . 75.23 110.903 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.508 ' HB3' HG22 ' A' ' 117' ' ' ILE . 18.5 pt-20 -78.69 98.47 6.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.328 0.585 . . . . 71.23 112.43 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -115.76 119.28 35.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.149 0.5 . . . . 72.14 111.756 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.26 -75.36 0.5 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.34 -0.457 . . . . 61.04 114.115 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.3 -72.98 1.85 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.077 -0.582 . . . . 41.33 112.263 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.9 -84.65 0.38 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.218 -0.515 . . . . 73.23 113.678 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.85 128.54 2.04 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.758 0.313 . . . . 75.1 111.827 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -150.38 158.03 43.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.334 -0.394 . . . . 64.32 111.024 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.653 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mt-10 -101.29 -59.47 0.1 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.709 0.633 . . . . 73.32 112.709 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 66.2 Cg_endo -81.79 44.94 1.83 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.366 2.044 . . . . 71.45 113.649 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.58 -39.92 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.213 0.449 . . . . 74.21 112.213 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.624 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 26.0 m-20 -68.15 -52.25 23.41 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 122.102 -0.374 . . . . 53.32 111.342 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 72.8 Cg_exo -51.41 -35.94 56.5 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.127 1.884 . . . . 63.12 112.613 172.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.86 -58.26 9.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.41 -0.359 . . . . 72.43 111.003 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.39 -34.11 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.169 0.509 . . . . 71.21 111.207 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -60.13 -40.51 90.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.806 -0.633 . . . . 74.12 111.675 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -60.46 -22.25 63.27 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.09 0.404 . . . . 63.42 112.09 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -91.15 -70.96 0.66 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.122 0.487 . . . . 74.15 111.996 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -71.46 -35.15 70.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.287 0.847 . . . . 64.22 113.287 -169.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.52 -24.97 63.81 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.965 0.412 . . . . 62.23 111.305 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.82 -55.4 3.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.97 0.414 . . . . 73.51 110.948 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HG2' ' A' ' 82' ' ' LYS . . . 159.09 -5.05 0.11 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.853 -0.689 . . . . 75.21 113.759 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 81.0 mt -77.59 99.44 5.75 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.52 -0.4 . . . . 73.02 111.236 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -74.88 129.51 37.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.124 0.488 . . . . 72.53 111.423 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -80.87 110.59 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.179 -0.464 . . . . 75.04 111.682 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.67 66.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.225 0.536 . . . . 45.25 111.692 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -118.39 90.34 38.48 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.459 -0.571 . . . . 75.02 109.459 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.91 33.22 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.126 2.551 . . . . 63.44 114.753 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 122.84 4.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.364 0.505 . . . . 53.54 112.364 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.74 123.48 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.296 -0.411 . . . . 65.12 110.516 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -149.22 28.44 0.82 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.392 0.516 . . . . 72.23 112.392 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mm -68.8 142.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.067 0.461 . . . . 74.32 111.332 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -75.16 -51.15 14.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 71.14 111.577 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -166.29 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.12 0.486 . . . . 71.34 111.201 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.8 p -114.3 130.37 24.04 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 111.862 0.319 . . . . 71.21 111.862 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.24 155.8 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.666 2.244 . . . . 53.14 112.641 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -105.84 170.07 8.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.08 0.467 . . . . 72.22 111.642 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.37 -24.73 60.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.184 -0.462 . . . . 65.43 111.547 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -84.39 -24.19 29.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.801 0.334 . . . . 71.24 111.557 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -55.56 -32.17 62.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.052 0.453 . . . . 75.35 111.253 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 71.0 m-85 -56.48 -45.77 80.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.153 -0.476 . . . . 75.31 111.182 175.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -57.53 -46.24 84.09 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.218 -0.446 . . . . 73.21 111.345 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.34 -47.11 72.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.143 0.496 . . . . 53.4 111.005 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 16' ' ' LEU . 67.7 m -58.04 -48.42 80.13 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.72 -0.673 . . . . 75.24 111.343 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 52.4 mt-10 -58.54 -49.5 77.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.405 . . . . 64.54 111.604 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.71 -32.7 71.43 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.476 0.547 . . . . 74.01 112.476 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.67 -60.49 2.35 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.193 0.442 . . . . 70.43 112.193 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.57 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -65.34 -43.16 95.52 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.141 -0.552 . . . . 73.51 113.995 -174.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 73.2 m -60.92 -38.78 86.96 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.448 -0.442 . . . . 74.1 112.127 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.62 -49.89 73.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.935 0.398 . . . . 73.04 110.973 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.06 -40.26 92.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.324 -0.398 . . . . 75.42 110.987 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.491 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -59.32 -45.71 95.01 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.104 -0.57 . . . . 62.42 112.771 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.605 ' HG2' HG21 ' A' ' 27' ' ' THR . 52.4 mt-30 -64.29 -38.97 92.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.037 0.446 . . . . 75.4 111.254 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -65.49 -58.0 6.88 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.194 -0.457 . . . . 73.15 111.87 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 83.9 t -57.11 -50.88 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.379 0.511 . . . . 64.32 112.379 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.519 HG21 HG22 ' A' ' 29' ' ' VAL . 15.2 t -62.69 -36.86 84.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 34.35 112.034 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -81.87 -23.26 36.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.737 0.303 . . . . 73.12 111.414 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.91 -47.97 15.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.024 0.44 . . . . 75.13 110.518 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -79.61 6.72 9.86 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.46 -0.336 . . . . 72.22 111.829 177.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 147' ' ' LEU . 0.9 OUTLIER -58.59 -9.84 1.9 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.926 0.491 . . . . 62.02 111.739 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -36.57 -47.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.169 0.588 . . . . 63.42 112.027 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -135.74 -52.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.345 -0.389 . . . . 63.14 110.576 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 62.57 104.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.026 0.441 . . . . 75.21 112.005 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -106.74 173.56 6.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.9 0.381 . . . . 71.35 111.307 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -151.75 151.02 30.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.801 0.334 . . . . 73.53 111.739 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -150.0 -35.18 0.17 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.524 -0.307 . . . . 73.43 111.167 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.817 -0.611 . . . . 73.2 111.18 176.805 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.6 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.634 0.254 . . . . 54.25 111.496 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.683 HD11 ' HA2' ' A' ' 139' ' ' GLY . 46.0 mm 58.8 95.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.155 0.503 . . . . 74.03 112.181 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.67 96.09 1.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.915 -0.659 . . . . 50.23 112.473 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.33 114.09 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.655 0.74 . . . . 72.14 112.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.64 105.05 17.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.753 -0.658 . . . . 72.24 110.78 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HE1' ' HB ' ' A' ' 33' ' ' VAL . 24.7 p90 -116.21 179.99 3.83 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.897 0.38 . . . . 75.41 111.455 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.14 113.79 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.242 0.544 . . . . 71.44 111.408 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 24.5 m -75.57 -25.02 56.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.195 0.522 . . . . 64.52 111.556 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -71.78 -16.37 62.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.751 -0.659 . . . . 75.24 111.978 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 70.8 t80 -125.69 106.24 9.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.979 0.419 . . . . 64.43 112.056 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.65 -162.4 5.44 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.583 0.593 . . . . 55.25 114.583 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -80.41 7.63 9.32 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.456 0.539 . . . . 74.55 112.456 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.6 m -44.69 -35.92 2.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.843 0.683 . . . . 74.23 112.843 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 11.7 p-10 -65.67 -43.19 90.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 70.14 111.328 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -71.09 -38.94 72.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.014 0.435 . . . . 71.05 110.618 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.92 -43.73 91.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 64.4 110.968 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.13 75.62 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.196 -0.456 . . . . 71.21 111.221 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.23 -34.06 77.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.309 -0.405 . . . . 74.22 111.144 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.97 92.88 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.042 0.448 . . . . 71.13 110.736 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.417 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.7 mt -63.4 -48.49 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.171 0.51 . . . . 70.15 110.347 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 31' ' ' VAL . 74.6 mt -56.96 -33.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.938 -0.574 . . . . 54.25 111.573 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -58.67 -43.54 89.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.961 0.41 . . . . 70.14 111.045 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.51 -37.28 62.34 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.05 -0.595 . . . . 73.44 112.875 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.433 HD12 HG13 ' A' ' 2' ' ' ILE . 46.5 mm -64.47 -45.21 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.044 0.45 . . . . 74.22 111.305 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 p -61.83 -42.49 99.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.842 0.353 . . . . 51.34 111.034 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -57.84 -36.79 72.78 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.827 0.346 . . . . 73.23 111.439 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.0 m -78.15 -8.6 58.49 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.225 0.536 . . . . 73.52 111.401 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.19 42.71 23.11 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.163 -0.541 . . . . 40.14 113.092 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.9 t -127.76 143.94 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 122.595 -0.356 . . . . 72.43 111.506 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.93 152.25 36.51 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.116 -0.564 . . . . 74.2 112.732 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 21' ' ' ILE . 22.4 t -112.87 147.39 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.465 0.543 . . . . 75.22 112.465 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -111.26 103.41 11.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.556 0.343 . . . . 73.55 110.387 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 30.5 m -100.91 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.851 0.685 . . . . 52.43 112.851 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -139.88 127.3 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 116.125 -0.489 . . . . 62.21 110.931 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -94.22 111.01 22.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.915 0.388 . . . . 74.53 110.969 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -82.57 11.79 5.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.314 0.487 . . . . 71.15 112.314 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.39 -9.08 58.18 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.453 -0.403 . . . . 64.32 112.369 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.41 179.29 5.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.999 0.428 . . . . 45.11 111.468 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 93.09 0.22 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 51.24 111.416 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.99 149.75 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.277 0.561 . . . . 73.12 112.214 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -147.95 170.58 17.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.959 -0.564 . . . . 75.41 111.176 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.0 mm? -65.18 -22.48 66.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.394 -0.366 . . . . 65.41 111.686 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -62.45 -42.25 99.33 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.632 0.253 . . . . 63.24 111.361 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.2 -45.19 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.986 0.422 . . . . 55.43 110.813 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.448 ' O ' HD23 ' A' ' 45' ' ' LEU . 5.7 tt -55.79 -38.67 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.278 -0.419 . . . . 74.34 111.074 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -61.39 -21.92 64.51 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.375 0.509 . . . . 73.34 112.375 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -58.69 -19.7 41.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.991 0.425 . . . . 72.21 111.355 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -53.18 -34.97 59.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.238 -0.437 . . . . 65.41 111.436 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.96 -44.11 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.942 0.401 . . . . 74.33 111.599 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.99 -23.14 50.47 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.984 -0.627 . . . . 51.24 113.812 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 -1.86 40.69 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.187 -0.596 . . . . 75.23 111.557 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 53' ' ' THR . 27.9 p -36.79 -58.76 0.73 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.172 1.545 . . . . 54.32 115.172 -170.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 71.6 p -61.09 -20.54 62.74 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.701 1.0 . . . . 75.42 113.701 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.34 136.18 4.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.19 -1.005 . . . . 30.33 113.838 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 57' ' ' ILE . 0.7 OUTLIER -171.08 -179.48 2.74 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.064 0.546 . . . . 54.22 111.258 -178.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.53 131.07 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.409 . . . . 61.44 111.46 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.514 HD11 HD13 ' A' ' 55' ' ' LEU . 3.3 mp -117.05 137.01 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.991 0.424 . . . . 72.12 111.983 -176.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.88 140.26 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.481 -0.648 . . . . 74.21 111.481 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.488 ' SD ' ' CE2' ' A' ' 10' ' ' TYR . 4.2 ppp? -67.49 146.95 53.46 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 117.652 0.726 . . . . 53.41 111.897 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 95.1 p -99.38 144.56 28.49 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 112.758 0.651 . . . . 61.24 112.758 -172.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 90.3 Cg_endo -75.39 -176.3 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.807 2.338 . . . . 74.4 112.526 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.94 -55.16 25.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.813 0.672 . . . . 44.23 112.813 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.73 73.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.232 0.456 . . . . 75.02 112.232 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 62.2 m -65.08 -50.07 67.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.681 -0.236 . . . . 71.15 111.506 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.64 -49.67 67.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.007 0.432 . . . . 64.23 111.644 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.45 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.188 0.44 . . . . 72.04 112.188 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -95.65 -29.56 14.24 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.846 0.313 . . . . 73.33 111.846 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.11 -13.44 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.021 0.378 . . . . 50.33 112.021 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.49 -40.8 5.87 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.2 0.815 . . . . 71.24 113.2 -175.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.05 -52.3 28.86 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.858 -0.687 . . . . 64.14 112.614 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.18 -28.25 66.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.734 0.302 . . . . 73.41 111.767 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.25 -46.13 86.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.82 0.343 . . . . 74.14 110.899 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -58.04 -45.06 87.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.09 0.471 . . . . 72.04 110.431 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.3 m -55.97 -47.7 77.17 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.853 -0.612 . . . . 75.1 111.479 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.488 ' O ' HG13 ' A' ' 79' ' ' VAL . 77.4 mt -61.06 -55.73 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.34 -0.391 . . . . 65.43 111.204 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.8 -30.92 58.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.228 0.455 . . . . 75.51 112.228 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.24 -21.24 55.41 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.061 -0.59 . . . . 63.2 113.656 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 m -100.18 -6.44 26.15 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.088 0.773 . . . . 65.25 113.088 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -75.86 172.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.46 0.541 . . . . 75.2 112.46 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -99.68 178.32 4.88 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.528 . . . . 70.44 110.585 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -87.49 -18.05 30.74 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.871 0.693 . . . . 64.04 112.871 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -148.96 44.98 1.0 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.192 1.182 . . . . 73.51 114.192 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' NE2' HD22 ' A' ' 110' ' ' LEU . 5.9 pm0 -94.38 166.78 11.9 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.393 -0.817 . . . . 71.43 111.425 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.75 115.46 27.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 74.01 111.843 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.92 114.76 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.572 0.701 . . . . 72.42 112.031 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.47 145.36 25.16 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.06 -0.591 . . . . 64.3 112.416 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -152.83 140.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.071 0.435 . . . . 75.05 111.192 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -155.85 110.84 2.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.217 0.532 . . . . 74.24 110.72 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.99 131.31 35.95 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.4 -0.364 . . . . 73.42 111.506 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 HG21 ' A' ' 127' ' ' THR . 12.2 t -170.89 179.91 3.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.402 -0.363 . . . . 72.35 111.161 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.31 -17.56 18.08 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.287 -0.483 . . . . 44.44 113.92 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.82 -119.25 0.75 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.398 -0.43 . . . . 35.23 112.336 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.55 74.03 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.424 -0.893 . . . . 60.11 114.155 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -97.89 109.98 22.64 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.609 -0.348 . . . . 71.34 110.654 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.696 ' HB2' ' HB ' ' A' ' 98' ' ' ILE . 16.2 p-10 -137.98 95.02 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.654 0.74 . . . . 64.33 112.454 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 39.1 mt-10 -103.76 -48.78 0.15 Allowed Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.189 -0.46 . . . . 75.44 112.051 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.531 ' O ' HD13 ' A' ' 101' ' ' LEU . 54.8 Cg_endo -91.52 27.46 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.231 1.954 . . . . 71.41 112.647 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 95' ' ' ASP . 7.1 tt -59.93 -51.49 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.988 0.736 . . . . 74.52 112.988 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.535 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 12.0 m-20 -62.74 -49.46 82.38 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.403 0.519 . . . . 71.52 112.403 -175.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 74.7 Cg_exo -51.45 -50.3 14.39 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.102 1.868 . . . . 74.41 112.973 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.5 mp -63.05 -47.7 81.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.87 0.322 . . . . 63.34 111.87 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 105' ' ' PHE . 62.1 mt -58.77 -38.79 79.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.008 0.432 . . . . 70.21 111.044 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -58.17 -42.16 85.41 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.282 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 100' ' ' PRO . 11.3 mmpt? -55.98 -49.51 73.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 74.15 111.215 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.409 ' HD2' ' HA ' ' A' ' 102' ' ' LEU . 38.9 m-85 -56.0 -47.49 77.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.233 0.457 . . . . 72.13 112.233 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -79.61 -35.53 39.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.679 0.622 . . . . 65.02 112.679 -175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.59 -44.94 63.56 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.07 -0.394 . . . . 72.33 111.873 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.51 -41.39 63.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.835 0.35 . . . . 63.23 111.34 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.36 43.43 2.54 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.013 -0.613 . . . . 62.41 112.612 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.418 HD22 ' NE2' ' A' ' 83' ' ' GLN . 59.3 mt -83.86 136.21 34.2 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.869 0.366 . . . . 61.0 111.553 -176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 74.0 m -71.68 93.41 1.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.856 0.36 . . . . 65.21 110.841 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.0 p -88.15 128.91 35.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.286 -0.416 . . . . 54.22 111.328 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.75 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.777 0.288 . . . . 52.43 111.777 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -164.89 94.44 0.91 Allowed Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.523 0.202 . . . . 70.2 111.408 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 115.67 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.309 2.006 . . . . 64.05 111.706 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.0 35.9 3.91 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.067 0.766 . . . . 64.24 113.067 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 117' ' ' ILE . 13.7 tt -61.09 82.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.293 1.044 . . . . 62.4 111.427 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -163.63 25.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.011 -0.995 . . . . 70.32 109.744 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.3 mm -88.59 137.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.795 -0.639 . . . . 72.3 111.954 -172.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -52.04 -51.8 55.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.689 -0.687 . . . . 72.24 112.35 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 179.98 -72.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.274 0.559 . . . . 62.43 110.958 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p -82.56 146.85 54.43 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.024 -0.535 . . . . 64.25 111.96 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.48 106.0 1.86 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.401 2.067 . . . . 61.44 112.903 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 52.3 p -85.79 -178.58 6.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.276 -0.42 . . . . 64.3 111.23 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -49.57 -35.61 21.11 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.165 0.431 . . . . 43.51 112.165 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -55.9 -42.74 76.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 73.24 111.319 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.43 HG21 HG21 ' A' ' 90' ' ' THR . 46.5 m -63.8 -40.72 97.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.997 0.427 . . . . 73.54 111.025 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -61.68 -48.84 78.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.222 -0.445 . . . . 72.5 111.619 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -53.54 -42.06 67.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.885 0.328 . . . . 62.12 111.885 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.02 -47.47 85.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.869 0.366 . . . . 63.12 111.056 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.1 m -66.46 -46.4 76.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.188 -0.46 . . . . 65.34 111.797 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.51 -48.81 77.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.233 -0.439 . . . . 62.31 111.898 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -78.26 -51.11 10.65 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.545 0.572 . . . . 71.54 112.545 -172.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.66 -36.07 71.39 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.34 0.496 . . . . 75.32 112.34 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.96 -45.01 62.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.406 -0.426 . . . . 73.12 113.399 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 88.5 m -67.8 -55.05 14.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.93 0.344 . . . . 73.43 111.93 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.82 -54.05 43.85 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.875 0.369 . . . . 53.25 111.635 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.8 -40.23 83.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.653 -0.249 . . . . 74.32 111.539 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.683 ' HA2' HD11 ' A' ' 2' ' ' ILE . . . -55.93 -47.72 77.69 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.259 -0.496 . . . . 60.32 113.2 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.96 -14.87 62.37 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.186 0.439 . . . . 75.23 112.186 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -90.62 -53.77 4.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.84 0.352 . . . . 73.53 110.972 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.9 t -54.43 -40.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 64.12 112.16 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 139' ' ' GLY . 6.8 t -69.64 -43.87 71.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.697 0.284 . . . . 64.34 111.575 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -63.81 -38.99 93.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.144 0.497 . . . . 74.42 111.011 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.37 -44.95 72.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.605 -0.725 . . . . 73.4 112.192 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -92.75 -21.97 19.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.308 -0.405 . . . . 65.12 111.865 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.27 -35.33 80.68 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.71 0.29 . . . . 74.24 110.937 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -50.08 -72.52 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.062 0.764 . . . . 74.44 113.062 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -108.77 -37.74 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.517 0.562 . . . . 74.13 112.517 -171.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -62.71 -37.92 88.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.872 0.323 . . . . 74.23 111.872 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.9 m80 51.93 66.22 1.27 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.229 0.455 . . . . 73.11 112.229 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 52.25 -92.24 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.387 0.514 . . . . 72.24 112.387 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 67.6 m80 48.98 -166.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.501 0.667 . . . . 62.54 112.725 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.4 m170 . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.528 -0.76 . . . . 60.23 110.634 169.816 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 28.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 119.999 -0.048 . . . . 75.54 110.888 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 3' ' ' GLY . 47.8 mm 67.8 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.182 0.515 . . . . 51.01 111.892 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 2' ' ' ILE . . . -123.58 101.08 0.68 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.204 -0.522 . . . . 24.31 113.077 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 57.4 t -86.23 99.66 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 122.322 -0.516 . . . . 72.5 110.975 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.698 ' HB3' HD23 ' A' ' 36' ' ' LEU . 82.1 m-85 -90.25 126.74 35.94 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.282 0.475 . . . . 73.35 112.282 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 6.7 p90 -143.96 163.29 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.272 -0.422 . . . . 72.41 110.945 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.518 ' HB ' HD11 ' A' ' 36' ' ' LEU . 3.9 p -129.02 105.41 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.452 0.644 . . . . 74.44 112.487 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -61.5 -28.14 69.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.077 0.465 . . . . 63.55 111.445 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.05 -22.59 62.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.795 0.665 . . . . 70.41 112.795 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 2.3 t80 -129.06 92.15 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.895 0.702 . . . . 71.24 112.895 -173.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 -158.58 7.67 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 115.746 1.058 . . . . 41.53 115.746 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -59.34 7.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.528 1.307 . . . . 74.23 114.528 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -47.16 -35.79 7.78 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.561 0.619 . . . . 74.52 112.298 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.89 -39.69 79.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.974 0.416 . . . . 74.41 110.784 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -58.34 -45.65 87.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.192 0.52 . . . . 60.22 110.508 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 20' ' ' ILE . 79.6 mt -59.49 -51.33 70.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.894 -0.594 . . . . 72.41 111.644 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . . . -55.49 -43.24 75.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.106 0.479 . . . . 54.51 111.479 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 21' ' ' ILE . 34.7 tt0 -66.29 -34.49 78.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.078 0.466 . . . . 73.24 110.845 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.17 -31.61 72.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.175 -0.466 . . . . 52.34 111.29 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.515 HG23 ' HA3' ' A' ' 135' ' ' GLY . 71.5 mt -67.91 -57.46 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.152 0.501 . . . . 71.23 111.005 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 18' ' ' GLN . 14.0 tt -63.2 -25.17 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.088 -0.506 . . . . 75.42 111.736 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -54.56 -46.8 73.74 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.778 0.323 . . . . 54.32 111.744 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.19 -37.35 42.77 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.019 -0.61 . . . . 74.24 112.922 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -62.94 -42.73 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.994 0.426 . . . . 64.44 111.585 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.439 HG23 HG12 ' A' ' 21' ' ' ILE . 44.6 p -66.64 -39.87 88.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.574 -0.285 . . . . 71.23 111.574 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -58.54 -41.6 85.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.272 0.558 . . . . 74.51 109.888 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -64.0 -31.74 73.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.843 -0.617 . . . . 74.12 110.806 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 39.59 3.41 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.126 -0.488 . . . . 53.44 113.633 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.08 132.14 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.915 0.388 . . . . 73.55 111.444 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.33 96.54 2.18 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.314 -0.47 . . . . 74.3 113.708 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.3 m -102.86 142.48 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.911 0.386 . . . . 71.12 111.797 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -95.75 144.65 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.974 0.416 . . . . 75.32 111.78 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 32.6 m -101.18 151.72 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.913 0.387 . . . . 75.23 111.512 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -137.16 114.18 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.012 0.434 . . . . 75.02 111.984 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.69 92.6 3.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.732 0.301 . . . . 74.53 110.374 171.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -65.81 -23.81 66.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.274 0.472 . . . . 71.4 112.274 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -98.08 24.51 31.48 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.12 -0.562 . . . . 41.04 112.943 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.88 -178.14 3.35 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.038 0.447 . . . . 50.12 111.837 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.45 44.9 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.307 0.484 . . . . 65.21 112.307 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.62 128.33 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.115 0.483 . . . . 75.41 111.765 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.61 166.85 11.31 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.341 -0.391 . . . . 71.45 111.263 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.75 -25.55 55.25 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.419 -0.355 . . . . 75.1 111.824 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -59.38 -49.75 76.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.624 0.25 . . . . 71.54 110.831 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.23 -39.1 75.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.037 0.446 . . . . 71.31 111.049 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -35.18 71.5 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.031 0.443 . . . . 71.53 110.626 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -58.3 -29.89 66.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.558 -0.292 . . . . 73.42 111.673 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -60.37 -29.19 68.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.033 0.444 . . . . 61.42 110.961 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.2 -21.28 66.11 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.358 -0.383 . . . . 72.31 111.699 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.15 -55.13 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.893 0.378 . . . . 62.24 111.243 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.61 -18.43 77.2 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.923 -0.656 . . . . 63.11 112.76 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -100.63 5.99 43.98 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.209 0.448 . . . . 73.12 112.209 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -64.92 -9.47 21.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.026 0.38 . . . . 61.25 112.026 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.4 p -58.44 -18.92 32.27 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.136 0.493 . . . . 70.34 111.355 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.68 137.23 3.65 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.121 -0.491 . . . . 64.24 112.59 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -148.59 133.52 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 64.11 110.628 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 4' ' ' VAL . 5.6 p -112.58 117.74 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 50.55 111.443 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -116.49 110.38 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.252 -0.431 . . . . 74.41 110.653 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.56 41.55 3.06 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.043 -0.599 . . . . 72.53 113.396 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 88' ' ' PHE . 92.1 mmm 61.84 173.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.381 0.61 . . . . 72.44 112.425 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -158.84 154.25 22.31 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.305 -0.407 . . . . 54.41 111.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 60.3 Cg_endo -70.69 157.9 57.27 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.462 2.108 . . . . 64.33 111.915 173.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.71 62.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.591 0.589 . . . . 73.13 112.591 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.26 68.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.548 0.573 . . . . 72.23 112.548 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.2 m -89.07 -49.77 6.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.91 0.386 . . . . 73.24 111.567 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.45 -23.26 65.73 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.368 -0.378 . . . . 65.41 111.549 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.8 -34.53 59.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.779 0.324 . . . . 73.12 111.403 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 t -65.18 -45.15 86.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.236 0.541 . . . . 74.1 110.455 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.401 HD11 HD22 ' A' ' 36' ' ' LEU . 71.5 mt -59.95 -40.55 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.002 -0.544 . . . . 61.33 110.617 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.92 -34.8 78.22 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.818 -0.628 . . . . 71.11 111.028 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.38 -42.26 56.95 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.211 -0.518 . . . . 73.21 112.93 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.85 6.82 33.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.041 0.385 . . . . 55.22 112.041 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.1 tp -39.58 -61.1 0.86 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.295 0.85 . . . . 72.05 113.295 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.9 m -57.23 -40.02 76.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.172 0.434 . . . . 54.15 112.172 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.06 -45.01 94.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.937 0.399 . . . . 74.33 110.926 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.45 -37.49 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.058 0.456 . . . . 75.24 111.255 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.16 -15.2 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.289 -0.414 . . . . 62.02 111.157 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 -39.28 5.75 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.403 -0.427 . . . . 42.1 112.664 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.6 p -67.56 -40.12 84.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.878 0.325 . . . . 54.13 111.878 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -69.44 169.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.041 0.448 . . . . 71.54 111.803 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -133.06 -176.15 4.02 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.288 -0.258 . . . . 62.22 110.704 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 43.1 tt0 -47.27 -65.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.486 0.55 . . . . 64.04 112.486 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -152.49 130.03 11.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.256 0.551 . . . . 75.13 112.036 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.78 -79.47 0.18 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.005 -0.543 . . . . 73.14 110.896 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.558 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -170.21 117.78 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.902 0.334 . . . . 62.55 111.902 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 85' ' ' VAL . 15.9 m -124.62 99.56 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.648 0.737 . . . . 61.52 111.529 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -74.84 77.88 1.09 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.125 -0.489 . . . . 65.35 113.147 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.5 mm -86.63 121.43 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.059 0.392 . . . . 74.12 112.059 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 p90 -153.76 -179.03 7.44 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.296 -0.411 . . . . 73.11 110.41 174.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.497 ' HB2' HG22 ' A' ' 117' ' ' ILE . 11.3 tp10 -106.43 144.25 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.779 0.659 . . . . 75.0 112.779 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -125.51 -23.76 4.03 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.413 -0.358 . . . . 72.3 111.905 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 119' ' ' ILE . . . -119.75 -98.52 1.75 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.604 -0.332 . . . . 44.12 113.097 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.95 42.91 0.48 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.532 -0.842 . . . . 63.44 114.037 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.33 55.1 22.86 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.353 -0.451 . . . . 55.24 113.459 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.24 -159.96 0.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.883 0.327 . . . . 73.14 111.883 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' HD2' ' A' ' 97' ' ' PRO . 32.4 t70 74.05 162.1 0.25 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.267 0.627 . . . . 51.11 112.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 40.1 mt-10 -103.26 -55.45 0.11 Allowed Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 64.45 112.744 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 91.8 Cg_endo -76.46 11.19 1.93 Allowed 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.337 2.025 . . . . 62.24 113.513 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.3 tt -44.64 -56.31 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.122 0.786 . . . . 63.21 113.122 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.697 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.6 m-20 -60.83 -54.89 50.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 112.327 0.492 . . . . 73.11 112.327 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.0 Cg_exo -54.0 -36.17 83.35 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.275 1.983 . . . . 55.12 113.093 176.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.19 -62.16 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.462 -0.335 . . . . 53.21 111.68 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.51 -41.02 88.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t -57.93 -37.31 73.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.826 0.346 . . . . 53.22 111.57 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -64.3 -45.85 86.17 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.734 0.302 . . . . 74.25 111.522 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -62.37 -29.13 70.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.994 0.426 . . . . 74.43 111.361 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -71.35 -37.4 71.68 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.944 0.402 . . . . 73.34 110.579 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -62.58 -46.34 88.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.348 -0.387 . . . . 73.34 111.528 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.5 mp -73.52 -41.77 62.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.785 0.326 . . . . 52.41 111.326 177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 72.22 1.26 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.316 -0.468 . . . . 55.23 113.61 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 mp -102.29 164.41 11.7 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 72.35 111.112 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.558 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 29.4 m -66.2 95.36 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.72 0.295 . . . . 51.25 111.289 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.2 p -83.68 164.72 19.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.036 0.446 . . . . 75.21 111.785 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -94.72 -83.83 0.34 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.617 -0.265 . . . . 71.14 111.671 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 116' ' ' ALA . 34.3 t80 -162.38 89.29 1.38 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.948 0.404 . . . . 73.41 110.907 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.0 27.28 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.625 2.883 . . . . 72.25 114.199 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB3' ' CE2' ' A' ' 114' ' ' PHE . . . -87.69 94.65 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.827 -0.546 . . . . 41.33 110.991 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.497 HG22 ' HB2' ' A' ' 89' ' ' GLU . 31.2 pt -68.61 107.31 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.495 0.664 . . . . 64.21 112.674 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -103.34 -23.95 13.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.081 -0.509 . . . . 70.45 111.651 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 119' ' ' ILE . 3.2 mp -90.42 145.73 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.556 -0.293 . . . . 70.42 110.605 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -120.23 5.68 10.75 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.426 0.528 . . . . 74.12 112.426 -178.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.504 ' H ' HG22 ' A' ' 119' ' ' ILE . 53.1 tt0 -178.76 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.795 0.331 . . . . 71.32 111.662 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.1 p -117.42 122.56 30.83 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 116.516 -0.311 . . . . 74.52 111.603 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 119' ' ' ILE . 32.8 Cg_endo -63.34 141.03 79.99 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.653 2.235 . . . . 74.34 112.863 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 62.1 p -93.68 173.87 7.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.331 0.586 . . . . 60.45 112.383 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -53.58 -28.73 33.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.644 -0.707 . . . . 71.43 112.509 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -66.86 -39.55 87.61 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.322 0.49 . . . . 63.15 112.322 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 71.9 p -54.62 -40.46 68.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.571 0.582 . . . . 70.33 112.571 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -55.27 -35.3 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.313 0.486 . . . . 70.42 112.313 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.42 -50.64 51.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.831 0.348 . . . . 74.23 111.098 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' N ' HD22 ' A' ' 130' ' ' LEU . 3.2 mm? -61.66 -33.9 74.77 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.931 0.396 . . . . 65.3 111.036 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -61.75 -45.89 91.99 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.288 -0.414 . . . . 74.11 111.227 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.22 -52.77 62.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.392 -0.367 . . . . 73.14 111.166 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.9 -50.18 73.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.176 -0.466 . . . . 72.23 111.93 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.13 73.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.872 0.323 . . . . 71.54 111.872 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.515 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -68.55 -42.17 81.93 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.016 -0.612 . . . . 63.33 113.643 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.1 m -70.61 -47.74 58.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.556 -0.379 . . . . 73.11 111.931 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -55.92 -47.63 77.15 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.152 0.501 . . . . 65.34 110.989 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 138' ' ' LEU . 2.5 tm? -70.08 -39.98 75.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.996 -0.547 . . . . 73.5 110.385 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.49 -40.72 78.78 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.577 -0.344 . . . . 24.25 112.803 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 136' ' ' THR . 96.7 mt-30 -62.35 -38.31 89.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.799 0.333 . . . . 64.24 111.131 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -61.09 -45.16 95.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.797 0.332 . . . . 73.32 110.563 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.35 -53.28 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.346 -0.388 . . . . 43.25 111.791 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.0 t -68.32 -37.54 80.68 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.132 0.419 . . . . 71.43 112.132 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.792 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 21.5 ttt180 -71.56 -35.44 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.887 0.375 . . . . 74.44 111.438 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.18 -25.36 66.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 74.04 110.353 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 77.0 mtt180 -100.1 8.02 44.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.591 -0.731 . . . . 44.14 111.848 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER 117.12 -43.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.777 1.631 . . . . 62.21 111.506 174.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.792 ' HB2' ' HA ' ' A' ' 144' ' ' ARG . 38.4 tt0 72.08 -62.06 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.042 0.537 . . . . 65.11 112.369 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 71.52 -75.71 0.07 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.905 0.482 . . . . 73.33 110.513 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -144.39 105.58 4.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.828 0.346 . . . . 62.35 111.597 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -145.82 114.0 6.61 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.229 0.538 . . . . 73.15 112.154 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -128.67 149.74 50.54 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.096 -0.502 . . . . 63.11 110.668 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -95.92 -11.36 26.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.477 0.547 . . . . 74.41 112.477 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.2 t60 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.464 -0.779 . . . . 72.22 111.219 179.764 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 80.1 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.885 -0.043 . . . . 71.41 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.9 mp 60.27 110.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.173 0.511 . . . . 62.33 111.73 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.02 91.82 1.66 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.853 -0.689 . . . . 55.2 113.326 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 59.4 t -80.91 123.54 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.027 0.413 . . . . 63.43 111.392 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 84.0 m-85 -116.38 133.69 55.73 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.494 0.553 . . . . 63.23 112.494 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -149.27 -178.18 6.26 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.166 -0.47 . . . . 71.44 110.826 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.5 p -129.51 83.55 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.482 0.658 . . . . 50.22 111.799 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -53.77 -29.75 41.48 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.008 0.744 . . . . 72.43 113.008 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.81 -13.94 62.52 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.345 0.498 . . . . 63.32 112.345 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.89 135.35 41.55 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.497 0.925 . . . . 71.24 113.497 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.19 -162.1 4.97 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 116.394 1.318 . . . . 62.14 116.394 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.415 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 73.8 m-85 -76.03 8.57 3.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.383 0.882 . . . . 72.4 113.383 -174.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -49.04 -35.58 16.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.114 0.413 . . . . 64.21 112.114 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -66.43 -37.99 86.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 64.34 110.919 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -69.16 -39.27 78.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.869 -0.605 . . . . 75.43 110.735 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -41.37 94.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.149 -0.478 . . . . 52.35 110.626 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.98 92.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.071 -0.513 . . . . 62.22 110.858 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -57.48 -46.62 83.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.946 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 132' ' ' GLU . . . -56.57 -47.03 80.38 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.174 -0.466 . . . . 62.21 111.302 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.15 -51.45 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.16 -0.473 . . . . 74.43 111.042 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 25' ' ' THR . 75.4 mt -55.79 -57.74 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.204 -0.453 . . . . 50.12 111.191 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -58.81 -29.45 66.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.865 0.364 . . . . 75.35 111.705 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -38.82 34.43 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.102 -0.57 . . . . 43.53 113.484 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.15 -24.7 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.486 0.55 . . . . 73.3 112.486 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 21' ' ' ILE . 32.9 p -57.57 -29.3 64.32 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.061 -0.4 . . . . 75.11 111.777 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.728 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.5 mmpt? -64.63 -17.61 64.18 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.937 0.399 . . . . 54.23 111.941 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -88.23 -9.79 51.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.085 0.469 . . . . 62.12 110.825 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.98 37.53 74.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.528 -0.368 . . . . 62.12 113.363 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 143' ' ' THR . 61.8 t -128.84 141.55 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.56 -0.376 . . . . 55.44 111.564 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.95 4.64 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.46 -0.4 . . . . 43.13 113.092 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.2 m -94.86 148.45 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.109 0.48 . . . . 71.13 112.016 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.4 125.07 37.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.217 -0.447 . . . . 75.24 111.072 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 131.89 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.983 0.42 . . . . 72.33 111.793 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 62.2 t -141.43 147.21 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.6 0.36 . . . . 64.22 110.991 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 6.6 m-20 -82.72 118.06 23.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.125 0.417 . . . . 74.34 112.125 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 37' ' ' GLY . 1.6 pp -77.65 -25.41 49.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.963 0.411 . . . . 73.41 111.85 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.645 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -87.31 -13.13 66.35 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.072 -0.585 . . . . 75.54 113.233 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 166.58 20.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.434 0.635 . . . . 63.44 112.039 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.84 76.83 2.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.954 -0.566 . . . . 63.4 111.396 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.72 164.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.336 0.495 . . . . 65.23 112.336 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.54 -163.24 1.32 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.215 0.531 . . . . 53.13 111.943 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.5 mm? -62.25 -24.17 67.1 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.151 0.797 . . . . 64.41 113.151 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.87 -52.53 62.74 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.104 -0.372 . . . . 65.12 110.844 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.05 -42.51 99.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.886 0.374 . . . . 73.14 111.1 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -58.08 -58.28 9.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.127 -0.488 . . . . 50.53 110.999 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -64.49 -36.38 84.0 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.844 0.312 . . . . 74.15 111.844 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.68 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.902 0.382 . . . . 71.23 110.704 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.503 HD11 HD13 ' A' ' 55' ' ' LEU . 45.0 tp -59.53 -44.23 93.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.382 -0.372 . . . . 72.12 110.71 172.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' LEU . 57.4 t -56.92 -33.25 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.071 0.462 . . . . 63.05 110.91 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.46 -40.38 94.36 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.02 -0.609 . . . . 74.33 112.469 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -87.03 6.37 32.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.084 0.402 . . . . 70.3 112.084 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.4 p -45.35 -26.59 0.55 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.256 1.206 . . . . 64.13 114.256 -170.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -54.71 -32.51 59.72 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.14 -0.35 . . . . 75.21 111.569 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.661 ' HA3' HG21 ' A' ' 142' ' ' VAL . . . -160.8 137.64 5.07 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.071 -0.585 . . . . 73.11 113.375 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD13 HD11 ' A' ' 48' ' ' LEU . 2.0 pt? -145.2 157.56 44.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.076 0.465 . . . . 65.42 111.416 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 75.1 t -114.58 116.59 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.458 -0.337 . . . . 44.35 110.998 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -98.69 115.18 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.65 0.262 . . . . 65.34 111.077 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 90' ' ' THR . . . -79.6 -24.09 61.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.117 -0.563 . . . . 72.25 114.079 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 60' ' ' SER . 16.7 tmm? 68.62 153.92 0.1 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.987 0.423 . . . . 64.05 111.665 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.513 ' N ' ' SD ' ' A' ' 59' ' ' MET . 40.6 t -162.95 146.46 8.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.031 -0.418 . . . . 74.45 111.342 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.0 160.52 12.41 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.954 2.436 . . . . 75.24 113.546 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -41.43 -37.31 1.02 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.685 0.994 . . . . 64.52 113.685 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.3 -47.28 47.05 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.168 0.433 . . . . 72.1 112.168 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.44 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 66.6 m -98.4 -27.08 14.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.681 0.277 . . . . 63.42 111.409 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -55.69 -32.67 63.47 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.492 -0.322 . . . . 42.21 111.824 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.11 89.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.941 0.4 . . . . 72.13 111.128 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -62.49 -33.61 75.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.203 0.525 . . . . 75.11 111.01 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.526 HD11 HD13 ' A' ' 36' ' ' LEU . 57.8 mt -75.04 -40.08 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.969 -0.56 . . . . 54.33 111.203 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -53.01 -44.73 67.52 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.851 -0.613 . . . . 63.23 112.573 -172.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.75 -43.71 80.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.032 -0.604 . . . . 63.33 112.839 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -77.31 -34.77 55.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 74.4 110.949 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -56.46 -42.86 78.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.99 0.516 . . . . 65.24 111.267 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -53.06 -33.91 54.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.26 0.552 . . . . 73.41 111.105 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -82.89 -41.67 18.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.036 -0.529 . . . . 74.22 111.257 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 71' ' ' ALA . 78.6 mt -57.62 -43.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.027 0.38 . . . . 72.01 112.027 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HE2' ' A' ' 104' ' ' LYS . 67.5 mt -61.69 -19.85 62.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.288 0.477 . . . . 72.24 112.288 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.63 -15.63 65.49 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.026 -0.607 . . . . 71.31 112.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.9 m -98.41 -36.85 9.83 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.881 0.326 . . . . 64.35 111.881 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 75' ' ' ILE . 27.2 m -106.13 123.46 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.233 0.539 . . . . 73.35 112.096 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HA ' HD23 ' A' ' 108' ' ' LEU . 7.6 p30 -160.9 -172.56 3.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.268 0.556 . . . . 72.44 111.806 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.7 -86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 64.13 113.519 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 16.9 ptmt -155.45 6.49 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.658 0.984 . . . . 74.23 113.658 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 3.1 pt20 -65.16 178.01 0.95 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.972 0.415 . . . . 64.33 112.051 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.89 124.53 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.439 0.903 . . . . 74.04 113.439 -168.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.12 102.53 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.648 0.737 . . . . 73.42 111.569 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.33 94.6 1.67 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.42 -0.419 . . . . 55.41 112.771 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.24 139.02 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 122.274 -0.545 . . . . 75.24 112.144 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -136.83 -179.38 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.221 -0.445 . . . . 71.31 110.249 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -112.86 134.4 54.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.363 0.875 . . . . 73.31 113.363 -173.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 58' ' ' GLY . 6.4 t -154.41 130.67 10.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.796 -0.638 . . . . 51.01 110.864 169.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 86.84 -59.21 4.57 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.077 -0.582 . . . . 72.34 113.551 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.78 -98.42 0.18 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.502 -0.38 . . . . 74.41 113.184 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.51 -128.01 26.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.248 -0.501 . . . . 72.21 113.882 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -123.09 136.0 54.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.403 -0.469 . . . . 75.1 111.888 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.51 145.52 3.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.173 -0.467 . . . . 64.22 110.735 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 5.7 mp0 -103.58 -44.32 0.18 Allowed Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 112.566 0.58 . . . . 74.4 112.566 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 87.7 Cg_exo -50.59 -13.75 0.9 Allowed 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.762 2.308 . . . . 70.44 114.128 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -51.78 -37.67 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.183 0.438 . . . . 65.21 112.183 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.735 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.2 m-20 -63.63 -56.38 26.51 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.004 0.372 . . . . 72.52 112.004 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.5 Cg_exo -55.04 -36.92 93.91 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.008 1.805 . . . . 53.34 112.64 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.98 -58.3 9.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.406 -0.361 . . . . 63.21 111.326 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 91.3 mt -57.96 -40.77 81.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.128 0.49 . . . . 54.3 111.068 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t -56.59 -45.12 81.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.846 -0.615 . . . . 71.51 111.581 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 53.7 tptt -55.46 -49.22 73.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.302 -0.408 . . . . 74.13 111.347 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.2 -35.5 81.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.489 -0.323 . . . . 71.2 111.869 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 102' ' ' LEU . 74.7 mmt-85 -69.0 -55.46 10.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 111.913 0.338 . . . . 75.53 111.913 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -61.08 -43.77 98.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.104 0.409 . . . . 65.25 112.104 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 80' ' ' ASN . 8.6 mp -73.97 -37.43 64.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.622 0.249 . . . . 73.15 111.29 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.09 53.12 35.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.318 -0.468 . . . . 72.51 114.035 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 110' ' ' LEU . 3.4 mp -77.18 173.42 11.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.474 -0.427 . . . . 72.33 111.024 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 94.1 m -65.87 93.47 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 74.54 110.142 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -101.37 132.73 46.78 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.301 0.482 . . . . 74.43 112.301 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.65 -64.16 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.155 0.428 . . . . 50.12 112.155 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -147.99 111.97 3.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 120.725 0.298 . . . . 51.42 110.305 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -89.14 6.57 4.51 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.858 2.372 . . . . 70.22 114.822 -171.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.71 144.61 45.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.038 0.385 . . . . 64.22 112.038 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.2 pt -94.16 157.19 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.947 0.721 . . . . 62.41 112.947 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 118' ' ' ARG . 9.7 mmt85 -152.52 -49.77 0.1 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.386 0.674 . . . . 73.54 111.645 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 119' ' ' ILE . 1.9 mp -72.7 112.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.232 0.539 . . . . 62.33 111.669 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -82.83 -22.86 34.0 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.187 -0.46 . . . . 61.54 111.418 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 35.9 tt0 -160.13 -67.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.165 0.507 . . . . 73.21 111.714 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.3 p -91.8 129.35 42.56 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.343 -0.389 . . . . 74.54 112.03 -174.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 37.3 Cg_exo -61.84 152.69 73.02 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.801 2.334 . . . . 71.1 112.779 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.8 p -111.16 166.17 11.3 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.906 0.384 . . . . 74.21 111.85 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.52 -34.76 64.95 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.26 0.552 . . . . 73.05 111.197 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -73.47 -31.22 63.65 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.865 -0.607 . . . . 72.11 111.356 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.1 m -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.818 0.342 . . . . 63.14 111.42 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -57.35 -40.74 78.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.481 -0.327 . . . . 70.14 111.331 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.526 ' NZ ' ' HB3' ' A' ' 129' ' ' LYS . 8.4 mtpm? -60.89 -28.79 69.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.011 0.434 . . . . 65.43 111.616 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 91.7 mt -70.75 -48.14 55.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.043 0.449 . . . . 64.44 110.223 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.54 -33.26 72.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.05 -0.523 . . . . 72.23 111.364 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' A' ' 19' ' ' ALA . 45.9 mt-10 -83.4 -75.17 0.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.274 -0.421 . . . . 64.14 112.046 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.85 -53.68 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.555 0.576 . . . . 70.01 112.555 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -65.79 -40.36 91.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.863 0.363 . . . . 71.12 111.231 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.62 66.46 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 53.34 113.156 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.467 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 61.0 m -60.27 -50.12 74.89 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.702 -0.293 . . . . 64.2 111.631 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.83 -50.56 72.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.038 0.447 . . . . 72.11 111.311 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.23 -50.19 65.26 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.653 -0.703 . . . . 72.51 110.94 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 143' ' ' THR . . . -64.95 -43.53 95.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.219 -0.515 . . . . 23.44 113.186 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 136' ' ' THR . 54.6 mt-30 -58.33 -51.37 70.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.216 0.45 . . . . 52.23 112.216 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -56.11 -52.85 62.82 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.977 0.418 . . . . 71.4 111.655 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.661 HG21 ' HA3' ' A' ' 54' ' ' GLY . 61.9 t -57.91 -51.68 67.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.027 -0.533 . . . . 54.41 112.4 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 29' ' ' VAL . 14.2 t -74.07 -37.34 64.25 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.934 0.346 . . . . 73.24 111.934 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -76.64 -13.36 60.06 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.144 -0.347 . . . . 74.4 111.625 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 149' ' ' HIS . 14.2 t70 -67.57 -51.31 52.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.388 0.614 . . . . 74.31 110.074 167.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -62.54 -34.2 76.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.594 -0.73 . . . . 73.22 110.642 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.18 -37.93 44.63 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.723 -0.671 . . . . 61.13 111.244 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 3.4 tm-20 -148.4 -80.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.477 -0.329 . . . . 65.0 110.715 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 11.7 t-80 175.88 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.98 -0.748 . . . . 71.11 108.98 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 63.46 149.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.036 1.124 . . . . 70.25 114.036 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -99.32 177.34 5.23 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.095 -0.502 . . . . 62.44 111.349 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -74.86 140.13 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.103 0.477 . . . . 65.45 111.526 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -63.25 -42.73 99.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.033 0.753 . . . . 71.22 113.033 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.331 -0.842 . . . . 73.14 111.018 -172.225 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.076 0.028 . . . . 75.53 111.076 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 2.4 mp 66.83 109.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 121.256 0.55 . . . . 73.24 111.241 -173.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.04 113.74 4.08 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.22 -0.514 . . . . 50.41 113.186 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.95 104.86 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.48 -0.423 . . . . 75.03 111.15 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.776 ' HB3' HD23 ' A' ' 36' ' ' LEU . 98.6 m-85 -96.29 111.63 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.099 0.476 . . . . 53.04 111.679 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -127.86 178.51 6.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.168 -0.469 . . . . 71.45 111.624 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 9' ' ' GLU . 17.3 t -134.46 114.61 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.335 -0.393 . . . . 71.31 110.637 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 m -74.45 -8.52 56.58 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.957 0.408 . . . . 71.05 111.79 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.563 ' H ' HG12 ' A' ' 7' ' ' VAL . 44.6 tt0 -96.25 -50.53 4.76 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.459 0.54 . . . . 73.24 112.459 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' H ' HG12 ' A' ' 7' ' ' VAL . 78.2 t80 -103.16 138.87 39.41 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.109 0.48 . . . . 74.35 112.239 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.87 -164.37 4.7 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.566 -0.743 . . . . 70.12 114.606 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.48 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 97.5 m-85 -100.37 7.8 44.06 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.889 0.329 . . . . 73.41 111.889 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.754 ' HB3' HG21 ' A' ' 90' ' ' THR . 89.8 p -41.41 -46.76 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.553 0.575 . . . . 71.1 112.553 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.66 -43.91 76.72 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.088 0.47 . . . . 75.34 111.748 175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.23 -35.45 73.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.151 0.501 . . . . 73.12 110.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.78 -38.68 83.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.95 -0.568 . . . . 62.45 110.818 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.3 75.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.871 -0.604 . . . . 71.31 111.069 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -58.92 -42.87 90.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.163 -0.471 . . . . 72.14 110.962 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . . . -65.3 -39.2 92.19 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.011 0.434 . . . . 73.13 111.137 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.98 -58.49 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.199 -0.455 . . . . 60.14 111.276 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 tt -59.1 -37.16 66.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.652 0.263 . . . . 63.35 110.938 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -53.66 -56.77 14.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 70.12 111.457 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.12 -45.23 88.53 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.116 -0.564 . . . . 31.31 113.926 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.3 mt -66.19 -45.98 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 112.424 0.527 . . . . 72.21 112.424 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.6 p -65.2 -42.71 93.28 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.909 -0.495 . . . . 63.54 110.821 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.42 -32.4 64.82 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.192 -0.458 . . . . 64.55 110.88 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 m -71.98 -33.15 67.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.375 -0.375 . . . . 62.43 110.993 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.45 5.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.106 -0.569 . . . . 44.24 114.165 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.1 t -112.49 130.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 122.2 -0.588 . . . . 72.21 111.979 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 121.49 6.14 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.462 -0.399 . . . . 62.24 112.927 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.9 m -99.41 164.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 112.667 0.618 . . . . 73.11 112.667 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.15 110.34 21.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.801 -0.636 . . . . 73.21 111.092 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.47 112.71 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.295 0.569 . . . . 71.54 112.077 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.46 129.22 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.283 -0.417 . . . . 74.41 111.47 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -94.58 116.62 28.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.005 -0.368 . . . . 70.35 110.005 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.4 pp -89.31 -7.48 55.29 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.113 0.412 . . . . 65.2 112.113 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -86.55 -26.71 31.94 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.12 -0.562 . . . . 51.15 112.506 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.31 162.79 18.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.107 0.48 . . . . 61.22 111.705 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.67 96.36 0.08 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.015 0.435 . . . . 64.23 111.648 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.11 150.02 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.286 0.565 . . . . 54.42 112.039 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -107.4 173.05 6.49 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.939 -0.573 . . . . 73.03 110.249 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 42' ' ' LEU . 3.6 mm? -59.81 -20.57 57.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.323 -0.236 . . . . 74.51 111.114 176.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -61.98 -52.81 62.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.756 0.312 . . . . 61.4 111.506 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -40.79 84.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.868 0.366 . . . . 74.31 110.835 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 49' ' ' VAL . 1.8 tm? -65.09 -39.81 93.7 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.264 0.554 . . . . 72.21 109.964 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -59.42 -40.86 88.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.789 -0.641 . . . . 73.33 111.274 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.86 -36.09 75.24 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.51 -0.314 . . . . 72.01 111.053 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.58 -47.05 83.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.869 0.366 . . . . 64.12 110.224 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 45' ' ' LEU . 82.3 t -55.01 -37.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.08 0.467 . . . . 74.11 111.479 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.36 -53.13 14.23 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.274 -0.488 . . . . 73.44 113.131 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.19 6.1 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.52 0.563 . . . . 72.35 112.52 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -48.39 -24.92 1.39 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.848 1.055 . . . . 55.01 113.848 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.733 HG21 HH22 ' A' ' 146' ' ' ARG . 77.7 p -67.24 -25.86 66.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.587 0.588 . . . . 71.13 112.587 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.12 137.02 5.6 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.138 -0.553 . . . . 54.31 112.69 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -163.2 172.84 14.2 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.578 -0.366 . . . . 74.31 111.811 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.08 124.65 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.909 0.385 . . . . 74.03 111.144 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -117.2 145.32 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.966 0.413 . . . . 74.32 111.569 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.5 -89.74 0.39 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 73.54 112.583 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.488 ' HG3' HG22 ' A' ' 90' ' ' THR . 4.0 ppp? -172.48 158.47 4.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.557 0.343 . . . . 73.13 110.642 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -117.58 114.42 37.98 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 111.798 0.296 . . . . 61.11 111.798 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.66 160.32 28.15 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.368 2.045 . . . . 73.53 112.432 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.13 -31.45 19.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.522 0.564 . . . . 72.22 112.522 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.6 96.16 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.158 0.504 . . . . 74.13 111.681 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -90.11 -21.8 22.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.249 -0.432 . . . . 74.53 111.541 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.426 ' HA ' ' HB ' ' A' ' 68' ' ' ILE . . . -52.93 -24.56 9.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.2 0.815 . . . . 72.52 113.2 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.01 -56.04 7.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.408 0.522 . . . . 64.42 112.408 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -84.6 -33.63 23.31 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.822 0.344 . . . . 54.01 111.4 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 65' ' ' ALA . 50.7 mm -60.89 -53.21 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.288 0.477 . . . . 75.41 112.288 -176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.5 -38.65 69.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.848 0.356 . . . . 72.1 111.346 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.11 87.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.0 -0.619 . . . . 70.4 112.391 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.98 95.07 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.991 0.424 . . . . 52.14 111.495 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.79 -35.44 68.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.333 -0.394 . . . . 73.54 111.353 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.6 m -54.28 -27.02 32.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.998 0.428 . . . . 55.41 111.427 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.7 m -99.19 -49.53 4.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.312 -0.403 . . . . 72.34 111.284 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.1 mt -54.57 -48.59 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.818 0.673 . . . . 73.53 112.818 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.27 -36.68 68.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.031 0.382 . . . . 55.43 112.031 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.49 66.24 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.038 -0.601 . . . . 64.41 113.13 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -100.29 5.12 44.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.188 0.44 . . . . 50.2 112.188 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.82 162.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.01 0.433 . . . . 64.42 111.996 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -117.54 106.84 13.57 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.851 0.358 . . . . 73.14 111.456 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.613 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 38.3 tt0 50.14 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.978 0.732 . . . . 63.5 112.978 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.613 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 62.2 pttt -159.39 48.02 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.261 0.553 . . . . 73.51 110.972 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.44 172.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.065 0.765 . . . . 72.44 113.065 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.579 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -88.02 109.65 20.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 74.44 111.894 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG12 HD11 ' A' ' 55' ' ' LEU . 29.7 m -107.41 119.02 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.567 0.699 . . . . 60.24 111.788 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.06 159.85 21.43 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.997 -0.547 . . . . 42.23 112.399 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -144.39 131.36 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.398 -0.472 . . . . 74.43 111.961 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -140.05 93.44 2.64 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.65 0.738 . . . . 74.12 110.659 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.33 114.48 2.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.834 -0.621 . . . . 64.12 112.16 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.754 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.0 t -108.65 29.68 7.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.856 -0.611 . . . . 72.12 111.973 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . -178.53 -54.41 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.186 -1.007 . . . . 52.3 114.086 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.85 -14.35 58.8 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.496 -0.859 . . . . 54.54 113.2 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.05 67.48 3.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.226 -0.511 . . . . 71.12 112.499 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.48 -179.27 6.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.221 0.534 . . . . 61.0 112.15 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -75.93 133.65 40.44 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.124 -0.489 . . . . 71.54 110.818 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.7 mt-10 -54.46 -37.45 54.54 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 113.744 1.016 . . . . 71.43 113.744 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 38.0 Cg_endo -66.21 32.18 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.843 1.695 . . . . 65.43 113.94 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.423 ' H ' ' C ' ' A' ' 96' ' ' GLU . 7.6 tp -66.59 -44.1 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.118 -0.364 . . . . 74.4 111.975 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.452 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 9.6 m-20 -56.09 -47.0 99.7 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 112.429 0.529 . . . . 65.3 112.429 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 83.1 Cg_exo -45.77 -37.46 16.28 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.717 2.278 . . . . 54.11 113.436 170.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.5 -42.65 34.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.802 0.334 . . . . 73.24 110.927 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.35 -32.48 64.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.348 -0.387 . . . . 75.24 111.197 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -55.58 -46.92 77.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.264 0.554 . . . . 71.02 110.992 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' HA ' HD13 ' A' ' 108' ' ' LEU . 32.0 mmtp -66.36 -51.62 55.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.065 -0.516 . . . . 73.3 111.313 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.601 ' HD1' HD22 ' A' ' 110' ' ' LEU . 24.3 m-85 -59.58 -44.86 93.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.034 0.445 . . . . 73.35 112.119 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -77.46 -60.76 2.23 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.423 0.527 . . . . 65.11 112.423 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -62.41 -32.37 73.19 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.542 0.571 . . . . 71.51 112.542 -170.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 104' ' ' LYS . 9.0 mp -79.06 -20.37 49.02 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.825 0.345 . . . . 72.23 111.347 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.61 44.62 6.79 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.28 -0.486 . . . . 54.43 114.166 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.601 HD22 ' HD1' ' A' ' 105' ' ' PHE . 8.7 mp -70.39 133.96 47.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.256 0.528 . . . . 74.13 111.361 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.579 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 36.7 m -60.8 94.02 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.947 0.403 . . . . 64.51 111.381 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -103.82 137.03 42.41 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.513 -0.312 . . . . 61.51 111.64 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' A' ' 138' ' ' LEU . . . -54.69 -64.15 0.93 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.408 -0.36 . . . . 65.41 111.942 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -162.79 98.49 1.08 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.894 0.378 . . . . 73.15 110.873 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -85.18 46.6 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.008 2.472 . . . . 74.2 113.887 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.17 37.75 0.95 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 62.53 112.024 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.9 pt -105.3 144.0 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.035 0.445 . . . . 73.32 112.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -133.37 108.74 8.89 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.313 -0.403 . . . . 73.12 110.55 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.42 140.95 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 64.12 110.697 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.58 153.26 32.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.667 0.27 . . . . 63.34 111.224 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 21.8 tt0 -51.66 -33.67 34.67 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.682 0.623 . . . . 74.14 112.682 -171.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p -108.61 99.09 31.87 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 120.606 0.241 . . . . 74.12 111.078 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HD2' ' HD2' ' A' ' 12' ' ' TYR . 85.0 Cg_exo -46.78 128.86 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.492 2.794 . . . . 61.34 114.301 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.5 p -100.45 -178.1 3.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.068 -0.514 . . . . 64.23 111.043 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 125' ' ' GLU . 7.0 mp0 -57.37 -27.22 62.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.977 0.418 . . . . 74.44 111.404 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -59.33 -41.41 89.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 64.32 110.851 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 m -63.43 -36.75 84.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.098 -0.501 . . . . 71.43 111.175 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -62.38 -36.35 82.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.135 0.493 . . . . 71.24 111.144 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -69.63 -38.99 77.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.105 -0.498 . . . . 74.33 110.889 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.29 -54.74 32.41 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.849 -0.614 . . . . 63.4 110.721 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 19' ' ' ALA . 31.0 p -62.27 -38.29 88.77 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.75 0.278 . . . . 72.12 111.75 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.63 -56.63 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.349 0.595 . . . . 70.44 111.475 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -64.18 -56.89 11.59 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.735 -0.666 . . . . 71.41 111.94 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.73 84.41 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.863 0.32 . . . . 63.11 111.863 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.41 -44.64 66.48 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.348 -0.453 . . . . 72.01 113.24 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.47 ' HA ' HG12 ' A' ' 24' ' ' ILE . 94.8 m -55.83 -41.19 73.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.815 0.34 . . . . 73.03 111.486 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.36 -45.26 94.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.315 -0.402 . . . . 73.04 111.739 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 113' ' ' ALA . 4.1 mm? -56.49 -42.12 77.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.942 0.401 . . . . 62.3 110.936 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.35 82.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.097 -0.573 . . . . 50.11 112.693 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.25 -46.98 87.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.006 0.431 . . . . 51.41 111.857 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -56.67 -50.83 70.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.113 -0.494 . . . . 72.42 111.5 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 2' ' ' ILE . 58.2 t -69.84 -44.61 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.324 0.491 . . . . 74.41 112.324 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.4 t -65.98 -28.45 68.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.978 0.418 . . . . 62.02 111.712 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.03 -56.63 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.756 0.313 . . . . 74.31 111.207 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.37 -29.72 69.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.004 0.43 . . . . 71.24 111.522 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.733 HH22 HG21 ' A' ' 53' ' ' THR . 0.6 OUTLIER -75.73 -30.76 59.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.2 -0.312 . . . . 74.12 111.764 175.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.58 -44.09 87.75 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.21 0.529 . . . . 72.45 109.579 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.65 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 17.7 mm-40 -69.37 -41.05 77.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.179 -0.464 . . . . 73.51 110.414 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 74.27 -57.96 0.6 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.035 0.934 . . . . 63.11 112.859 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -111.65 28.72 8.48 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.25 -0.281 . . . . 71.41 111.231 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 51.6 m80 57.84 84.99 0.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.404 0.621 . . . . 72.34 110.841 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.65 ' H ' ' HB3' ' A' ' 148' ' ' GLU . 86.4 t60 -76.77 115.71 16.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.681 -0.69 . . . . 71.24 111.405 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.66 -178.21 6.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.125 -0.489 . . . . 64.33 111.189 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.489 -0.767 . . . . 74.01 111.199 179.532 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.645 0.259 . . . . 75.13 111.384 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm 64.93 111.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 112.67 0.618 . . . . 74.15 112.67 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.58 103.42 1.43 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.114 -0.565 . . . . 71.15 112.578 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.18 93.84 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.889 0.376 . . . . 71.12 111.558 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.656 ' HD2' HD23 ' A' ' 36' ' ' LEU . 17.5 m-85 -89.09 117.0 27.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.718 0.294 . . . . 72.03 111.443 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -134.92 151.03 50.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.432 0.634 . . . . 72.52 112.416 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 10' ' ' TYR . 39.7 t -96.1 97.95 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.788 -0.642 . . . . 63.44 111.52 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.712 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 20.1 m -70.88 -27.21 63.64 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.234 0.457 . . . . 61.2 112.234 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 33.7 tt0 -70.5 -42.25 71.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.662 0.616 . . . . 74.33 112.662 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' H ' HG12 ' A' ' 7' ' ' VAL . 69.4 t80 -111.5 106.77 15.75 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.666 0.988 . . . . 72.14 113.666 -171.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.94 -160.49 5.41 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.829 1.092 . . . . 71.15 115.829 167.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.415 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 56.7 m-85 -63.11 -2.17 1.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.22 0.822 . . . . 72.55 113.22 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 m -54.11 -31.51 52.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.231 0.538 . . . . 72.11 111.345 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 25.1 t70 -65.87 -32.73 74.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.652 -0.704 . . . . 60.23 111.745 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -94.44 -23.73 17.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.442 0.534 . . . . 74.33 112.442 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 12' ' ' TYR . 92.7 mt -54.64 -39.92 68.47 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.231 0.538 . . . . 71.45 111.384 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.41 -23.0 62.67 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.07 -0.513 . . . . 74.12 112.141 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.76 -34.9 76.67 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.912 0.387 . . . . 62.41 110.945 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 132' ' ' GLU . . . -62.09 -40.77 96.96 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.492 . . . . 73.43 111.04 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.467 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.5 mt -62.76 -52.95 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.044 -0.525 . . . . 74.45 110.601 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.521 HG23 HG21 ' A' ' 31' ' ' VAL . 83.5 mt -52.85 -43.94 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.939 -0.573 . . . . 74.11 111.235 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -56.95 -48.77 77.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.108 -0.496 . . . . 64.21 111.323 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.46 99.57 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.013 -0.613 . . . . 70.04 113.091 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -65.55 -48.47 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 72.23 111.71 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -68.33 -34.94 77.02 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.788 0.328 . . . . 74.52 111.267 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.12 -31.81 73.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.458 0.647 . . . . 62.43 110.558 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.0 m -75.16 -14.44 60.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.848 -0.615 . . . . 75.0 111.15 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.42 26.65 11.73 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.363 -0.38 . . . . 71.43 113.779 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 143' ' ' THR . 42.0 t -118.88 142.31 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.555 -0.379 . . . . 60.52 111.603 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.68 140.7 24.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.009 -0.615 . . . . 40.4 112.859 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 21' ' ' ILE . 33.1 m -106.4 145.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.985 0.365 . . . . 71.44 111.985 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -107.09 110.55 22.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.912 0.387 . . . . 70.41 110.172 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.94 113.8 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.55 0.69 . . . . 75.31 112.788 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.96 93.42 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.197 0.523 . . . . 74.23 110.925 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -79.0 70.88 5.41 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.557 0.694 . . . . 64.03 111.743 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.656 HD23 ' HD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -64.79 -23.79 67.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.231 -0.441 . . . . 53.1 111.636 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.614 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -75.17 -0.36 61.02 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.239 -0.505 . . . . 55.22 112.889 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 17.13 12.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.917 0.389 . . . . 61.42 110.607 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.99 97.63 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.527 -0.761 . . . . 73.33 112.166 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 36' ' ' LEU . 24.7 m -83.47 156.13 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.775 0.321 . . . . 74.04 111.327 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.6 179.61 4.17 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.085 0.469 . . . . 74.12 111.364 -174.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.708 HD13 HD12 ' A' ' 45' ' ' LEU . 3.8 mm? -60.67 -20.87 62.03 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.322 0.49 . . . . 75.45 112.322 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 1.4 mp0 -59.42 -29.88 68.07 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.117 0.414 . . . . 71.11 112.117 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -86.25 -43.83 12.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.806 0.336 . . . . 72.23 111.311 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.708 HD12 HD13 ' A' ' 42' ' ' LEU . 80.6 mt -54.09 -28.3 38.36 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.564 0.579 . . . . 53.44 112.564 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 20.3 ptt180 -61.34 -33.16 73.16 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.696 0.284 . . . . 62.23 111.231 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.25 3.18 46.18 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.04 0.385 . . . . 75.13 112.04 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 2.3 tm? -56.52 -34.48 67.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.998 0.428 . . . . 74.3 110.213 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.62 -23.46 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.222 0.534 . . . . 72.3 111.785 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.17 -40.89 5.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.394 -0.431 . . . . 52.45 112.535 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -76.1 -15.42 60.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.242 0.46 . . . . 74.14 112.242 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -69.37 -7.67 39.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.004 0.372 . . . . 63.01 112.004 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.0 p -70.54 -26.79 63.72 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.327 0.584 . . . . 73.42 111.033 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.57 135.56 3.57 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.85 -0.614 . . . . 73.42 111.8 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.462 HD21 HG12 ' A' ' 85' ' ' VAL . 2.1 pt? -168.14 169.17 11.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.011 0.405 . . . . 73.11 111.491 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 8.5 p -134.69 128.14 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.929 0.395 . . . . 63.42 111.454 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.7 mp -113.75 135.12 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.026 0.441 . . . . 73.31 111.302 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.03 133.34 10.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.359 -0.448 . . . . 74.04 112.823 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.526 ' HE1' ' H ' ' A' ' 93' ' ' GLY . 44.1 ttp -65.91 110.5 2.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.638 -0.33 . . . . 64.54 111.717 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 7' ' ' VAL . 93.4 p -103.49 148.27 35.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 111.982 0.364 . . . . 75.11 111.982 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HA ' ' HB3' ' A' ' 94' ' ' ASP . 28.0 Cg_endo -60.73 159.67 27.74 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.87 2.38 . . . . 61.33 112.451 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.57 -40.53 52.46 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.868 0.692 . . . . 63.5 112.868 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.79 -53.03 54.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.196 0.443 . . . . 71.12 112.196 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.1 m -79.34 -32.23 43.26 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.073 0.463 . . . . 73.14 111.204 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -27.56 65.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.99 -0.55 . . . . 52.41 111.498 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.71 -29.66 62.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.211 0.449 . . . . 71.23 112.211 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -82.05 -17.45 46.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.052 0.453 . . . . 74.43 111.717 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.643 HG12 ' HB2' ' A' ' 36' ' ' LEU . 26.1 mt -100.59 -47.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.149 -0.478 . . . . 74.44 112.169 -175.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -45.32 -45.48 12.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.288 1.035 . . . . 71.32 113.435 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.78 -63.94 4.52 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.047 -0.597 . . . . 71.35 113.196 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 45' ' ' LEU . . . -62.44 -28.73 70.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.069 0.461 . . . . 63.4 112.165 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.14 -33.69 63.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.079 -0.509 . . . . 54.5 111.363 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 m -54.66 -39.24 67.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.125 -0.489 . . . . 65.41 111.563 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -73.66 -38.16 65.05 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.916 0.389 . . . . 64.33 111.293 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.41 -58.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.849 0.357 . . . . 73.32 111.85 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.494 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.1 mp -60.91 -12.47 11.25 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.564 0.579 . . . . 72.22 112.564 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.17 -30.33 7.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 60.02 112.793 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -79.21 -24.16 43.3 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 111.792 0.293 . . . . 74.41 111.792 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -64.36 155.57 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.042 0.449 . . . . 74.51 111.878 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -80.15 160.55 25.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 71.02 111.612 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HA ' HD23 ' A' ' 108' ' ' LEU . 35.9 tt0 -54.87 -36.64 65.31 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.098 0.475 . . . . 60.03 111.939 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -138.87 122.08 16.96 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.452 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -163.78 169.93 17.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.778 0.323 . . . . 74.34 110.983 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.45 93.85 9.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.173 0.511 . . . . 72.22 111.801 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 55' ' ' LEU . 35.4 m -107.94 148.69 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.137 -0.483 . . . . 63.55 111.121 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.03 146.24 17.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.327 -0.463 . . . . 74.32 113.123 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.692 ' H ' ' HB3' ' A' ' 113' ' ' ALA . 39.0 mm -140.93 132.62 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.817 0.447 . . . . 74.43 110.623 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -152.21 159.38 43.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.956 0.408 . . . . 72.32 111.258 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.82 138.85 39.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.035 0.445 . . . . 72.54 111.556 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 t -121.01 4.04 10.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.526 0.679 . . . . 73.53 110.656 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.45 -93.09 0.45 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.652 -0.704 . . . . 74.51 112.359 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.57 70.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.195 -0.526 . . . . 63.44 113.416 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.526 ' H ' ' HE1' ' A' ' 59' ' ' MET . . . 85.24 52.98 3.24 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.502 -0.38 . . . . 64.45 113.158 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.67 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 11.3 m-20 -96.1 176.97 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.324 0.49 . . . . 74.04 112.324 -175.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.6 t70 64.41 160.67 0.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.41 0.684 . . . . 54.53 112.082 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.71 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 41.8 mt-10 -102.01 -53.81 0.14 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 112.254 0.464 . . . . 70.22 112.254 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 8.2 Cg_exo -75.27 22.97 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.395 2.064 . . . . 74.34 112.991 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.7 -35.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.336 0.495 . . . . 64.11 112.336 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.683 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.1 m-20 -66.36 -54.16 26.56 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 122.168 -0.332 . . . . 75.23 111.768 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 73.5 Cg_exo -51.0 -45.8 34.45 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.435 2.09 . . . . 73.45 113.0 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 97' ' ' PRO . 8.5 mp -55.46 -58.12 9.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.46 -0.336 . . . . 73.03 111.299 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.58 -32.24 71.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.499 -0.319 . . . . 73.32 111.488 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 t -62.93 -37.62 87.75 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.893 0.377 . . . . 72.43 111.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HG2' ' HB3' ' A' ' 76' ' ' LEU . 27.8 tptp -64.34 -41.76 96.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.729 0.299 . . . . 75.44 111.018 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -68.15 -44.06 76.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.023 0.44 . . . . 72.31 110.847 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -64.68 -39.1 93.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.961 -0.563 . . . . 74.03 111.813 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -62.23 -49.92 73.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.905 0.383 . . . . 74.14 111.181 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 81' ' ' GLU . 8.2 mp -74.17 -24.22 59.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.98 0.419 . . . . 73.31 111.098 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.22 43.55 9.53 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.182 -0.532 . . . . 62.25 112.502 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.85 156.63 32.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.19 0.519 . . . . 71.1 111.905 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.4 m -66.97 106.54 1.96 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.774 0.657 . . . . 65.02 112.774 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.0 p -84.04 95.04 8.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.742 0.306 . . . . 64.14 111.12 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.692 ' HB3' ' H ' ' A' ' 87' ' ' ILE . . . -53.71 -70.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.202 0.445 . . . . 73.43 112.202 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -125.49 90.01 51.45 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 120.853 0.358 . . . . 75.5 111.044 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.14 98.71 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.57 2.18 . . . . 70.32 112.803 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.08 159.44 20.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.103 0.477 . . . . 52.21 111.987 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -138.26 34.1 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.892 -0.594 . . . . 73.13 110.59 175.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.7 mtm180 -96.92 20.2 11.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.493 0.923 . . . . 74.41 113.493 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.2 mt -100.42 149.49 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.86 -0.422 . . . . 72.14 109.86 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.04 -65.99 0.58 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.048 -0.408 . . . . 63.11 111.518 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.532 ' HG3' ' OH ' ' A' ' 10' ' ' TYR . 8.0 tp60 -177.3 -26.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.987 0.423 . . . . 64.43 111.453 -177.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p -89.82 117.81 68.43 Favored Pre-proline 0 N--CA 1.47 0.553 0 N-CA-C 111.851 0.315 . . . . 65.24 111.851 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.68 134.48 44.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.56 2.173 . . . . 75.45 111.864 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -100.49 168.49 9.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.712 0.768 . . . . 64.41 112.717 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.59 -29.94 68.31 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.36 -0.836 . . . . 74.14 111.053 174.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -73.01 -31.92 64.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.888 -0.596 . . . . 73.32 110.973 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -35.58 67.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.858 0.361 . . . . 52.14 111.059 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -55.71 -48.27 75.45 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.284 -0.416 . . . . 73.35 111.591 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 5.3 mptp? -67.19 -32.77 74.07 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.945 0.35 . . . . 72.53 111.945 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.93 -53.58 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.234 0.54 . . . . 75.13 110.466 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.43 -34.35 75.84 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.87 -0.604 . . . . 73.1 111.526 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.9 tt0 -59.15 -66.67 0.47 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.952 0.501 . . . . 73.43 112.173 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.95 -47.21 86.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.795 0.331 . . . . 72.35 111.589 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.817 0.342 . . . . 72.1 111.454 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -63.02 -37.23 94.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.321 -0.466 . . . . 73.42 113.362 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 99.2 m -63.0 -58.0 8.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.738 0.304 . . . . 75.43 111.212 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.15 -41.52 99.29 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.616 -0.266 . . . . 74.24 111.457 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.63 -43.46 93.81 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.098 0.475 . . . . 72.31 110.18 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 143' ' ' THR . . . -60.1 -45.81 95.32 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.103 -0.57 . . . . 62.01 112.458 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 136' ' ' THR . 80.3 mt-30 -66.68 -29.22 69.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.216 0.532 . . . . 75.42 111.166 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -65.1 -54.64 26.9 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.968 -0.56 . . . . 70.12 110.541 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.27 -46.81 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 112.789 0.663 . . . . 72.21 112.789 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.6 HG23 ' HD3' ' A' ' 144' ' ' ARG . 4.7 t -53.46 -33.61 54.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.681 0.623 . . . . 70.42 112.681 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.6 ' HD3' HG23 ' A' ' 143' ' ' THR . 11.0 mpt_? -99.76 -19.06 16.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.94 0.348 . . . . 75.24 111.94 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.71 ' HA ' ' HB2' ' A' ' 149' ' ' HIS . 30.3 t70 -57.31 -62.17 1.96 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.03 0.381 . . . . 64.43 112.03 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -60.17 -16.73 35.47 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.242 -0.435 . . . . 72.14 112.004 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 143' ' ' THR . 3.9 mm? -89.78 -49.25 6.74 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.003 0.371 . . . . 71.02 112.003 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -170.21 -39.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 111.867 0.321 . . . . 65.43 111.867 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . 42.5 t-80 73.68 51.48 0.12 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.636 0.976 . . . . 74.43 113.636 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -113.97 132.89 55.8 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.805 -0.559 . . . . 71.22 112.034 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.8 m170 62.11 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.396 0.887 . . . . 72.34 113.396 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 152' ' ' HIS . 0.9 OUTLIER 56.4 96.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.649 0.738 . . . . 74.44 109.642 -166.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 85.7 t60 68.19 130.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.371 -0.831 . . . . 72.02 110.998 -168.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 57.6 t60 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.204 -0.903 . . . . 64.02 111.749 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 67.1 p . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.345 0.116 . . . . 53.02 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm 63.55 89.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.281 0.562 . . . . 61.43 111.638 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.29 100.5 1.66 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.946 -0.57 . . . . 61.35 112.729 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 100.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.856 0.36 . . . . 64.33 111.108 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 94.5 m-85 -98.55 120.96 39.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.082 -0.508 . . . . 73.21 111.711 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 13.7 p90 -143.91 -179.7 6.64 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.105 0.479 . . . . 74.44 112.141 -176.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.448 HG13 ' HA3' ' A' ' 37' ' ' GLY . 33.0 t -126.61 90.79 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.189 -0.46 . . . . 32.1 110.108 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.46 ' HG ' ' HE2' ' A' ' 6' ' ' TYR . 23.2 m -40.87 -54.26 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.318 1.229 . . . . 65.11 114.318 -170.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.65 -25.92 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.594 0.59 . . . . 74.35 112.594 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' HE2' ' HA3' ' A' ' 91' ' ' GLY . 91.0 t80 -79.57 101.84 8.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.984 0.364 . . . . 73.3 111.984 -174.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.43 -159.36 6.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.156 -0.545 . . . . 75.2 114.365 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.06 7.35 0.06 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.806 1.039 . . . . 74.23 113.806 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 6' ' ' TYR . 11.4 t -46.15 -56.23 5.95 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.037 0.755 . . . . 55.55 113.037 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -64.02 -31.44 72.63 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.01 0.433 . . . . 74.51 111.323 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.81 -35.66 77.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.22 0.533 . . . . 71.33 110.817 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.5 mt -69.36 -44.84 70.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 71.42 110.661 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.95 -43.99 73.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.115 0.484 . . . . 51.43 110.935 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -53.31 -42.43 66.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.626 -0.716 . . . . 61.21 111.897 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.42 43.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.403 0.52 . . . . 75.53 112.403 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 16' ' ' LEU . 69.2 mt -61.13 -53.17 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.933 0.396 . . . . 74.32 111.794 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -59.34 -29.36 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.778 0.323 . . . . 74.24 111.865 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.61 -54.76 43.19 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.786 0.327 . . . . 70.44 111.757 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.91 -48.59 84.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.264 -0.494 . . . . 35.13 113.349 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.6 mt -64.8 -38.1 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.963 0.411 . . . . 63.33 111.481 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.9 m -60.12 -44.97 94.5 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.176 -0.328 . . . . 73.24 110.847 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.24 -16.11 63.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.743 0.306 . . . . 71.12 111.624 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -77.51 -20.99 53.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.34 0.591 . . . . 64.45 110.319 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 27.09 9.12 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.013 -0.54 . . . . 71.01 113.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 t -120.1 142.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.984 0.392 . . . . 61.15 111.62 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.93 118.77 4.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.094 -0.574 . . . . 62.5 112.979 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 1' ' ' SER . 35.6 m -91.07 167.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.519 0.563 . . . . 71.1 112.519 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -121.46 108.56 13.79 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.087 0.47 . . . . 73.22 111.203 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.85 113.28 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.522 -0.308 . . . . 75.13 111.41 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 60.9 t -140.12 110.15 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 120.87 0.367 . . . . 74.51 111.334 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -84.64 106.58 16.3 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.519 0.676 . . . . 73.25 111.931 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.575 ' HA ' HG13 ' A' ' 40' ' ' VAL . 1.3 pp -70.26 -14.25 62.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.095 -0.378 . . . . 74.32 111.863 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -60.0 -32.06 74.38 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.351 -0.386 . . . . 61.42 113.64 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.15 11.04 17.33 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.511 -0.406 . . . . 53.32 111.792 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.38 106.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.187 0.518 . . . . 71.31 111.566 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 36' ' ' LEU . 35.3 m -85.21 151.24 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.083 0.468 . . . . 74.44 111.544 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.47 176.09 6.43 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.167 -0.47 . . . . 64.34 111.176 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 42' ' ' LEU . 3.2 mm? -56.98 -24.51 53.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.571 -0.286 . . . . 74.54 111.736 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -63.07 -56.97 12.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 72.42 111.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 mp0 -59.99 -43.06 95.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.061 0.457 . . . . 75.4 110.73 176.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.18 -47.33 78.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.935 -0.575 . . . . 72.23 110.675 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -65.69 -39.03 90.85 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.25 -0.432 . . . . 41.13 111.578 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.24 -33.91 76.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.931 0.396 . . . . 70.21 111.257 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.656 HD11 HD13 ' A' ' 55' ' ' LEU . 52.8 tp -55.54 -34.61 64.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.495 -0.321 . . . . 74.33 111.148 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.38 -41.57 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.103 0.478 . . . . 72.13 111.063 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.67 -16.87 80.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.15 -0.548 . . . . 41.45 113.088 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -100.38 5.73 44.4 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.617 -0.343 . . . . 73.32 111.494 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.8 p -59.28 -3.73 0.45 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.059 . . . . 75.33 113.858 -172.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -67.46 -35.33 78.98 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.03 -0.419 . . . . 65.31 111.275 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.6 138.0 5.13 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.214 -0.517 . . . . 74.13 113.045 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.656 HD13 HD11 ' A' ' 48' ' ' LEU . 1.9 pt? -158.72 146.42 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.621 -0.34 . . . . 75.31 111.26 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.418 HG12 ' HE1' ' A' ' 88' ' ' PHE . 48.8 t -117.98 118.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.362 0.265 . . . . 32.24 110.806 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -112.06 120.63 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.217 0.451 . . . . 61.24 112.217 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.86 99.17 2.54 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.412 -0.423 . . . . 74.1 112.795 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.458 ' O ' HG22 ' A' ' 90' ' ' THR . 14.0 tmm? -56.67 132.54 52.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.901 0.381 . . . . 71.42 111.558 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -134.99 147.31 62.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.186 -0.461 . . . . 74.21 110.921 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.32 168.07 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.644 2.896 . . . . 70.2 115.045 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -43.73 -41.33 4.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.577 0.955 . . . . 73.43 113.577 -173.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.79 -45.88 64.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.038 0.447 . . . . 73.23 111.739 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -87.32 -36.02 18.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.074 0.464 . . . . 52.52 111.094 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -61.0 -26.96 67.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.071 -0.513 . . . . 73.21 112.147 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.75 83.0 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.835 0.35 . . . . 71.42 111.534 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -65.28 -31.14 72.12 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.826 0.346 . . . . 71.23 111.34 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.51 -39.48 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.873 0.368 . . . . 73.22 111.27 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.9 -43.67 66.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.298 -0.41 . . . . 70.34 112.018 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.52 -31.33 51.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 121.042 -0.599 . . . . 53.3 113.512 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.0 22.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.281 0.475 . . . . 74.12 112.281 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.6 tp -54.73 -55.53 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 51.51 112.582 -173.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -56.79 -38.15 72.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.836 0.35 . . . . 73.31 111.809 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -65.47 -46.27 80.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.94 0.4 . . . . 72.4 111.198 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.63 -47.4 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.418 -0.355 . . . . 73.15 111.208 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.72 -29.72 69.53 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.884 0.373 . . . . 71.15 111.55 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.27 -19.59 76.55 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 74.34 112.917 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -90.64 -37.95 13.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.069 0.396 . . . . 71.34 112.069 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.11 143.26 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.153 0.501 . . . . 74.22 112.045 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -161.32 176.3 11.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.238 -0.437 . . . . 73.55 111.509 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 57.68 -94.69 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.898 0.479 . . . . 63.32 111.886 173.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -179.07 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.043 0.449 . . . . 62.5 111.836 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -56.79 175.62 0.12 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.376 0.608 . . . . 74.02 112.611 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.44 98.43 11.62 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.755 0.65 . . . . 73.12 112.755 -170.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.42 105.0 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.596 0.712 . . . . 62.12 112.061 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 78.86 1.95 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 122.021 -0.424 . . . . 63.31 113.032 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.61 122.53 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 111.969 0.359 . . . . 43.24 111.969 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HE1' HG12 ' A' ' 56' ' ' VAL . 6.5 p90 -153.82 164.37 38.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.256 -0.276 . . . . 73.31 110.256 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' HB2' HD12 ' A' ' 119' ' ' ILE . 1.9 mp0 -83.86 133.64 34.73 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.884 -0.51 . . . . 75.3 111.427 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 59' ' ' MET . 10.4 t -87.04 7.18 28.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.437 0.637 . . . . 53.22 110.333 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.427 ' HA3' ' HE2' ' A' ' 10' ' ' TYR . . . 172.2 -82.79 0.08 OUTLIER Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.505 -0.771 . . . . 65.03 112.04 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.72 124.86 2.88 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.909 -0.662 . . . . 74.2 113.374 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.46 -152.81 6.9 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.933 -0.651 . . . . 52.52 112.822 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.06 121.59 35.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.903 0.383 . . . . 72.24 111.677 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . 3.3 p-10 -147.02 171.87 14.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 64.42 110.891 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.619 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 mt-10 -102.97 -44.62 0.19 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.453 0.909 . . . . 74.44 113.453 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.619 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 36.6 Cg_endo -62.83 -12.1 27.45 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.246 1.964 . . . . 73.52 114.703 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 99' ' ' ASP . 7.3 tp -53.99 -51.63 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.986 0.736 . . . . 64.5 112.986 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.709 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 6.6 m-20 -61.71 -54.56 50.42 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.134 0.42 . . . . 45.41 112.134 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.5 Cg_exo -56.88 -35.87 98.62 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.233 1.955 . . . . 72.11 112.744 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -56.76 13.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.214 -0.448 . . . . 73.22 111.12 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.81 -45.03 86.7 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 73.11 111.23 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 27.3 t -55.74 -37.87 69.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.161 -0.472 . . . . 73.44 111.943 177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 1.8 tpmt? -68.24 -58.66 4.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.765 0.317 . . . . 71.1 111.039 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -58.47 -27.38 64.35 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.732 0.271 . . . . 73.32 111.732 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' SER . 18.9 ttp180 -52.06 -50.16 62.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.964 0.411 . . . . 55.1 111.596 173.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.85 -40.56 54.47 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.332 -0.394 . . . . 75.44 111.593 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.723 ' HB3' HD13 ' A' ' 110' ' ' LEU . 10.8 mp -59.46 -40.09 85.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.846 0.355 . . . . 73.34 111.904 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 32.07 36.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.211 -0.519 . . . . 42.41 113.807 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 108' ' ' LEU . 10.9 mp -88.92 165.6 14.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.041 0.448 . . . . 71.3 111.509 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.2 m -80.28 122.71 27.23 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.271 0.471 . . . . 63.12 112.271 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.4 p -103.49 112.26 25.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.273 -0.421 . . . . 73.4 110.599 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.17 -48.75 67.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.909 0.385 . . . . 44.32 111.244 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.411 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -126.05 144.54 49.14 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 116.007 -0.542 . . . . 73.1 110.233 172.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.11 4.85 2.1 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.88 2.387 . . . . 71.24 113.57 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 70.12 159.81 0.2 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.811 0.671 . . . . 71.13 112.811 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.3 pt 42.44 31.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.295 1.22 . . . . 64.34 114.295 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.07 -7.86 16.0 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 122.001 -0.437 . . . . 75.31 111.871 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 89' ' ' GLU . 67.9 mt -91.79 144.78 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 120.939 0.399 . . . . 72.01 111.189 173.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 19.2 pttp -87.5 53.56 2.84 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.737 0.643 . . . . 53.43 112.737 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 45.2 tp60 74.17 -47.4 0.64 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.69 0.626 . . . . 74.22 112.69 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.1 p -96.22 116.8 66.38 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 111.986 0.365 . . . . 61.21 111.986 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.38 140.08 62.29 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.52 2.147 . . . . 51.23 111.857 172.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 p -111.37 179.04 4.14 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.332 0.587 . . . . 74.24 112.096 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 -31.33 59.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.906 -0.588 . . . . 65.23 111.462 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.35 -40.95 81.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.246 -0.434 . . . . 74.21 110.779 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -51.94 -35.19 45.03 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.226 -0.443 . . . . 74.4 111.292 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -56.16 -63.15 1.28 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.506 -0.316 . . . . 71.04 111.019 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -51.78 -46.03 64.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.801 0.334 . . . . 73.23 111.655 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.18 -59.8 4.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.489 -0.323 . . . . 71.42 111.679 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.2 p -60.5 -39.84 89.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.791 0.293 . . . . 65.22 111.791 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.94 -69.36 0.22 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.44 0.533 . . . . 73.43 112.44 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.82 -32.32 69.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.619 0.6 . . . . 73.34 112.619 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.47 65.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.75 0.31 . . . . 62.13 110.849 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.0 -38.17 95.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.369 -0.443 . . . . 21.32 112.545 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.49 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 93.9 m -62.09 -49.16 77.02 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.649 -0.324 . . . . 34.24 111.032 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.21 -38.4 86.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.322 0.582 . . . . 74.54 110.408 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -58.45 -43.72 88.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.687 -0.688 . . . . 64.31 110.131 175.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.0 -33.86 65.26 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.034 -0.53 . . . . 32.23 113.406 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 136' ' ' THR . 27.9 mt-30 -57.8 -44.4 86.3 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.829 0.315 . . . . 73.51 111.552 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -55.82 -50.67 69.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.674 0.273 . . . . 73.21 110.797 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.62 -46.06 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.42 0.526 . . . . 73.15 112.42 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' HD23 ' A' ' 147' ' ' LEU . 13.0 t -74.36 -42.59 59.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.77 -0.372 . . . . 71.04 111.829 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -64.02 -40.84 97.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.088 0.47 . . . . 74.15 110.567 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.07 -46.74 84.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.335 -0.848 . . . . 42.23 110.178 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -61.54 -47.39 85.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.363 -0.835 . . . . 72.11 112.266 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 143' ' ' THR . 4.3 mm? -62.99 -46.4 87.87 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.795 0.665 . . . . 74.32 112.795 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.26 -17.4 37.07 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.997 -0.44 . . . . 61.42 111.977 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 73.69 -37.24 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.487 0.715 . . . . 75.41 112.171 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -82.17 135.02 35.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 110.047 -0.353 . . . . 70.12 110.047 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -73.04 -31.12 64.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.209 0.818 . . . . 72.13 113.209 -171.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 61.47 175.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.519 0.676 . . . . 73.5 112.67 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -174.16 108.12 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.577 -0.738 . . . . 74.32 110.782 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 71.2 m80 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.565 -0.731 . . . . 73.44 111.157 178.191 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.231 0.086 . . . . 65.41 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mm 64.0 96.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 121.326 0.584 . . . . 61.14 112.19 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 108.76 2.98 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.114 -0.494 . . . . 41.35 113.42 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.02 106.58 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.832 0.349 . . . . 41.13 110.683 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.734 ' HB3' HD23 ' A' ' 36' ' ' LEU . 23.9 m-85 -111.97 117.03 31.59 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.86 0.362 . . . . 71.2 111.579 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -147.02 173.16 12.7 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.877 0.37 . . . . 71.42 111.72 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 10' ' ' TYR . 19.2 t -99.59 86.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.098 0.475 . . . . 71.34 110.821 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -51.07 -19.81 1.22 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.627 0.973 . . . . 53.53 113.627 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -95.15 -50.95 4.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.515 0.561 . . . . 74.22 112.515 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' H ' HG12 ' A' ' 7' ' ' VAL . 60.9 t80 -72.33 114.05 10.03 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.002 0.741 . . . . 74.44 113.002 -174.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.66 -159.46 5.56 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 115.049 0.779 . . . . 51.53 115.049 171.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -65.55 7.28 0.24 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.917 1.08 . . . . 73.11 113.917 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.465 ' HB2' HG21 ' A' ' 90' ' ' THR . 34.9 t -49.87 -36.04 25.58 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.455 0.571 . . . . 63.54 112.337 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.89 -40.75 75.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.123 0.487 . . . . 55.01 110.689 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -62.18 -42.26 99.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 71.52 110.854 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.0 mt -59.42 -49.28 78.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.164 0.507 . . . . 71.35 110.614 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.89 79.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.965 -0.561 . . . . 73.12 111.548 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.15 -38.25 82.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.724 0.297 . . . . 75.3 111.352 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.72 88.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.879 0.371 . . . . 72.13 111.418 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.4 mt -70.17 -54.38 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.192 0.52 . . . . 63.21 111.157 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.509 HG23 HG11 ' A' ' 31' ' ' VAL . 72.1 mt -56.96 -35.25 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.117 -0.492 . . . . 61.25 111.609 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -47.24 -51.7 18.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.132 0.491 . . . . 63.22 111.272 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.98 -49.97 50.22 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.927 -0.654 . . . . 73.33 113.058 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.63 -42.9 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.818 0.673 . . . . 70.44 112.818 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 21' ' ' ILE . 12.7 t -67.76 -35.3 78.45 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.062 0.393 . . . . 75.21 112.062 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -84.67 -31.65 24.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 73.33 111.828 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.7 m -65.14 -30.25 71.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.052 0.453 . . . . 52.0 110.823 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 42.24 4.23 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.195 -0.526 . . . . 55.03 114.029 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.29 -76.35 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.258 -0.554 . . . . 63.32 111.463 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.34 157.23 8.28 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.481 -0.39 . . . . 72.43 112.255 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 21' ' ' ILE . 18.2 m -140.66 122.99 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 117.483 0.641 . . . . 75.13 112.501 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -109.63 104.27 13.26 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.284 -0.416 . . . . 74.54 110.357 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.48 124.18 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.173 0.435 . . . . 61.24 112.173 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.92 123.65 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.146 0.498 . . . . 54.24 110.71 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.91 81.46 7.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.191 -0.459 . . . . 61.32 112.091 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.3 pp -66.67 -19.67 65.81 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.853 -0.529 . . . . 74.21 111.526 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 17.88 51.64 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.403 -0.427 . . . . 75.33 112.924 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.5 -153.19 0.5 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.739 0.416 . . . . 54.52 110.503 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.18 99.75 10.49 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 122.074 -0.391 . . . . 70.4 111.89 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.15 165.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.911 0.386 . . . . 71.03 111.723 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.52 -171.33 3.2 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.924 0.392 . . . . 73.15 110.811 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.1 tm? -58.9 -28.52 66.27 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.125 0.417 . . . . 74.23 112.125 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.5 mp0 -54.2 -48.44 71.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.968 0.413 . . . . 72.13 111.752 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.49 -41.5 80.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.215 0.531 . . . . 74.21 110.917 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.408 ' O ' HD13 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -60.9 -39.09 88.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.937 -0.574 . . . . 61.31 110.643 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -56.86 -48.14 78.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.808 -0.633 . . . . 74.42 111.709 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.15 -28.15 65.12 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.621 0.23 . . . . 75.43 111.621 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 39.4 tp -57.51 -27.97 63.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.872 0.367 . . . . 74.32 111.589 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -61.17 -38.06 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.05 0.452 . . . . 62.24 111.389 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.79 -30.65 14.46 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.127 -0.558 . . . . 71.34 112.659 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 89.2 mtt180 -75.59 0.57 17.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.936 0.495 . . . . 74.35 112.029 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.27 6.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.272 0.842 . . . . 72.23 113.272 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -80.83 -28.94 36.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.264 0.468 . . . . 74.14 112.264 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.0 137.38 4.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.844 -0.693 . . . . 61.25 113.14 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -163.79 167.63 20.64 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.693 0.627 . . . . 71.21 112.693 -176.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.62 121.26 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.104 -0.498 . . . . 52.41 111.026 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -108.45 143.75 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.009 0.433 . . . . 73.4 111.67 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -131.08 2.6 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.203 -0.523 . . . . 41.03 112.61 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.472 ' HB2' ' H ' ' A' ' 90' ' ' THR . 13.7 tmm? -110.08 127.27 54.77 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.148 -0.619 . . . . 62.24 110.901 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.2 p -97.32 105.48 25.46 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.629 -0.259 . . . . 43.33 111.545 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 155.39 67.98 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.313 2.009 . . . . 73.12 112.234 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.0 -35.07 23.22 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.573 0.582 . . . . 73.45 112.573 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.1 74.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.0 0.428 . . . . 74.41 112.064 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -89.94 -40.17 12.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.716 0.294 . . . . 73.43 110.91 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -49.99 -39.46 41.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.483 0.313 . . . . 40.23 111.789 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.01 72.65 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.16 0.43 . . . . 71.41 112.16 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.8 p -76.63 -31.88 57.66 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.138 0.494 . . . . 64.32 110.695 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -63.04 -29.51 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.106 -0.497 . . . . 72.44 111.381 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 13.2 mm100 -52.56 -26.73 14.14 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.864 0.364 . . . . 71.43 111.856 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.44 -54.64 2.63 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.136 -0.554 . . . . 50.04 112.916 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -63.72 -30.13 71.27 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.75 0.648 . . . . 34.24 112.75 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.0 -47.59 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.529 0.332 . . . . 71.4 111.288 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -57.88 -48.44 79.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.901 0.381 . . . . 63.11 111.4 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.2 m -57.86 -44.64 86.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.204 -0.453 . . . . 52.31 111.271 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 79' ' ' VAL . 69.5 mt -63.01 -55.08 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 74.22 111.248 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.42 HD21 ' HD2' ' A' ' 104' ' ' LYS . 49.0 tp -55.17 -34.99 64.31 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.71 -0.677 . . . . 44.12 112.256 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.01 -21.18 71.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.954 -0.641 . . . . 54.32 113.57 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.9 m -98.77 -21.2 16.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.004 0.742 . . . . 60.05 113.004 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -62.93 163.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.844 0.683 . . . . 73.34 112.844 -178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -79.53 161.82 25.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.868 -0.605 . . . . 64.3 111.217 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.39 -44.24 65.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.804 0.442 . . . . 74.34 112.122 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -143.1 143.74 31.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.768 0.318 . . . . 75.23 111.155 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.457 ' H ' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -158.21 177.31 11.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.313 0.578 . . . . 71.34 112.112 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.642 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -93.58 112.14 23.96 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.811 -0.631 . . . . 74.14 110.937 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG12 HD11 ' A' ' 55' ' ' LEU . 31.6 m -114.33 128.74 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.359 0.6 . . . . 55.15 112.149 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.67 17.73 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.051 -0.522 . . . . 71.13 112.409 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 57' ' ' ILE . 6.7 tp -148.46 137.83 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.783 0.325 . . . . 74.44 111.275 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.83 114.55 7.67 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.241 0.543 . . . . 71.11 111.21 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' HD12 ' A' ' 119' ' ' ILE . 44.7 mt-10 -60.02 93.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.21 0.529 . . . . 62.52 111.901 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.472 ' H ' ' HB2' ' A' ' 59' ' ' MET . 24.9 m -74.73 77.41 2.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.119 0.485 . . . . 64.52 111.491 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.22 -169.15 47.5 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.073 -0.584 . . . . 74.32 113.53 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.07 77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.421 -0.419 . . . . 60.14 113.412 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . -89.12 -176.51 46.35 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.254 -0.498 . . . . 53.42 112.863 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -94.48 164.85 12.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.42 -0.459 . . . . 71.42 110.848 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.13 115.64 20.12 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.205 0.526 . . . . 72.43 112.368 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.659 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 63.7 mt-10 -103.39 -59.14 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 112.148 0.425 . . . . 72.14 112.148 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 39.0 Cg_endo -98.27 27.12 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.87 2.38 . . . . 73.14 113.715 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.54 -51.61 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.728 0.64 . . . . 73.11 112.728 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 6.1 m-20 -64.22 -56.58 22.72 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.611 0.597 . . . . 75.42 112.611 -176.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 25.6 Cg_endo -59.75 -41.63 53.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.064 1.842 . . . . 63.31 113.078 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.72 -59.58 3.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.883 0.373 . . . . 65.43 110.997 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.08 -34.54 78.27 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.058 0.392 . . . . 71.34 112.058 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -60.48 -50.05 75.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.04 0.448 . . . . 62.52 111.567 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD2' HD21 ' A' ' 76' ' ' LEU . 32.8 ttmt -65.02 -43.33 92.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.548 -0.296 . . . . 73.24 111.259 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.28 -40.82 87.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.825 0.345 . . . . 74.23 111.419 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -55.24 -41.84 72.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.953 0.406 . . . . 74.33 110.919 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -70.14 -29.84 66.86 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.107 -0.497 . . . . 74.34 111.591 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.3 mt -81.47 -22.26 38.19 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.087 0.403 . . . . 73.21 112.087 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.33 -73.5 2.35 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.238 -0.506 . . . . 71.22 112.66 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 83' ' ' GLN . 61.1 mt 60.36 -179.21 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.614 0.721 . . . . 74.01 112.732 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.642 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 73.5 m -97.16 103.98 15.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.852 -0.613 . . . . 62.04 110.167 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -114.01 102.73 10.46 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.183 0.438 . . . . 62.41 112.183 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.74 84.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.544 0.572 . . . . 70.23 112.544 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -152.46 132.44 7.24 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.413 -0.179 . . . . 75.23 110.787 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.62 -69.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.525 2.15 . . . . 53.44 114.543 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 161.2 38.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.578 0.584 . . . . 64.32 112.578 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.796 HG12 ' H ' ' A' ' 118' ' ' ARG . 11.1 tt -123.64 -150.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.156 0.582 . . . . 73.31 109.74 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.796 ' H ' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -147.08 114.02 6.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.141 -0.974 . . . . 74.05 111.634 175.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' HA ' ' A' ' 123' ' ' PRO . 73.4 mt -139.06 139.2 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 115.948 -0.569 . . . . 71.51 110.597 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -81.52 -61.24 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.966 0.358 . . . . 74.3 111.966 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -141.64 -52.6 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.145 -0.347 . . . . 75.44 111.61 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.8 p -92.29 130.0 39.22 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 116.788 -0.187 . . . . 71.42 111.066 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.653 ' HA ' HD13 ' A' ' 119' ' ' ILE . 12.3 Cg_endo -55.15 127.22 25.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.404 2.07 . . . . 72.21 112.691 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.8 p -74.48 154.48 38.68 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.22 -0.445 . . . . 55.23 111.906 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.45 -25.63 68.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.038 0.447 . . . . 74.22 111.385 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -38.18 75.13 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.131 -0.486 . . . . 73.42 109.998 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.452 ' OG1' HD11 ' A' ' 119' ' ' ILE . 33.6 m -55.19 -38.38 68.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.901 -0.591 . . . . 63.35 111.879 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 87.1 m-85 -58.36 -60.33 3.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.994 0.426 . . . . 75.21 111.265 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -58.33 -29.82 66.22 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.085 -0.507 . . . . 63.22 111.694 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.28 -50.11 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.273 -0.421 . . . . 71.22 110.368 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 128' ' ' TYR . 30.5 p -69.24 -22.74 63.83 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.882 0.327 . . . . 53.53 111.882 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 53.0 mt-10 -60.11 -53.0 62.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.881 0.372 . . . . 64.24 111.057 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.13 -55.74 8.63 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.08 0.467 . . . . 64.45 111.022 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.24 -57.55 12.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.944 -0.571 . . . . 72.35 112.434 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -56.4 -47.27 84.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.461 -0.4 . . . . 51.44 113.75 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.4 m -64.87 -33.53 76.23 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.558 -0.378 . . . . 63.34 111.64 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -55.04 -36.5 65.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.197 0.443 . . . . 73.03 112.197 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.3 mm? -56.32 -45.66 80.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.18 0.514 . . . . 70.13 110.902 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.69 -38.86 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.079 -0.581 . . . . 64.25 112.796 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 136' ' ' THR . 17.5 mm-40 -57.61 -50.05 74.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.847 0.356 . . . . 71.4 111.642 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -54.48 -50.88 66.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.111 -0.495 . . . . 73.12 111.533 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.18 -51.92 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.16 -0.473 . . . . 74.12 112.234 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -69.46 -43.3 73.54 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.403 0.52 . . . . 61.12 112.403 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.34 -43.1 78.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.106 0.41 . . . . 70.4 112.106 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.77 -30.59 71.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 73.34 111.095 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -75.24 -21.56 58.51 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.988 -0.551 . . . . 75.43 111.801 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 92.7 mt -113.69 -56.36 2.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.256 0.465 . . . . 51.44 112.256 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 43.4 mm-40 71.25 107.49 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.442 0.697 . . . . 75.05 112.479 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -143.75 -62.71 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.07 -0.514 . . . . 70.23 111.412 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -134.1 118.01 17.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.679 0.622 . . . . 63.52 112.679 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -97.28 144.52 26.99 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.296 -0.631 . . . . 64.04 109.296 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 64.21 99.95 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.606 -0.516 . . . . 74.12 109.606 -168.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -127.27 179.05 5.65 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.574 0.583 . . . . 54.13 112.574 -167.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.567 -0.73 . . . . 73.25 110.835 173.271 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.1 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.421 0.153 . . . . 54.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.6 mm 59.46 102.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.195 0.521 . . . . 54.03 111.887 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.65 94.43 1.87 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.833 -0.698 . . . . 62.44 113.061 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 33' ' ' VAL . 47.9 t -88.0 104.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.056 0.428 . . . . 75.12 111.091 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HB3' HD23 ' A' ' 36' ' ' LEU . 97.7 m-85 -103.86 119.03 38.08 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.204 0.526 . . . . 61.54 111.408 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.584 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 45.1 p90 -136.6 -178.08 5.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.155 -0.475 . . . . 74.25 111.678 -175.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.9 100.93 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.813 0.339 . . . . 74.44 110.585 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.575 ' HB3' ' HE2' ' A' ' 6' ' ' TYR . 53.4 p -63.86 -18.49 64.21 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.281 0.845 . . . . 74.43 113.281 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -89.16 -10.94 45.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.067 0.461 . . . . 74.15 111.534 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -115.45 119.11 35.13 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.251 -0.281 . . . . 63.13 111.082 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.61 -161.32 7.45 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.253 -0.498 . . . . 54.34 114.131 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -84.75 8.23 17.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.01 0.744 . . . . 71.52 113.01 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 42.8 m -32.19 -51.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.578 0.955 . . . . 52.41 113.578 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.5 -40.95 76.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.692 0.282 . . . . 74.04 111.724 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -60.3 -39.06 85.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.292 0.567 . . . . 74.11 110.544 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.59 -53.32 53.52 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.734 -0.666 . . . . 51.25 110.905 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -39.8 68.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.999 0.428 . . . . 50.42 111.379 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -55.71 -45.51 77.89 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.683 -0.689 . . . . 74.05 111.516 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.18 -43.84 69.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.094 -0.503 . . . . 71.51 111.424 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' HG12 ' A' ' 24' ' ' ILE . 82.0 mt -57.0 -56.82 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.209 -0.451 . . . . 54.23 111.664 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -56.98 -35.92 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.806 0.336 . . . . 63.24 111.354 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.76 -37.4 86.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.015 0.436 . . . . 73.11 111.206 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.0 24.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.26 -0.495 . . . . 72.13 113.775 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 31' ' ' VAL . 44.8 mm -75.98 -41.59 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 122.407 -0.466 . . . . 71.44 112.044 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.2 p -61.24 -30.17 70.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 74.33 111.344 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.41 -12.57 60.07 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 71.25 111.176 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -90.35 -36.75 14.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.129 -0.487 . . . . 54.22 111.016 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.64 22.82 2.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.304 -0.474 . . . . 61.01 113.748 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 24' ' ' ILE . 67.7 t -130.16 140.39 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 117.148 0.474 . . . . 53.23 111.069 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.44 113.34 4.65 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.089 -0.577 . . . . 52.22 112.846 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.635 HG13 HG21 ' A' ' 24' ' ' ILE . 20.5 m -94.15 140.33 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.129 0.49 . . . . 63.34 112.139 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 51' ' ' ARG . 23.4 m-20 -101.38 113.26 26.19 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.095 -0.502 . . . . 71.52 111.079 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.573 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 36.0 m -106.11 125.95 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 120.969 0.414 . . . . 71.42 111.418 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.81 150.69 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.458 0.303 . . . . 45.53 111.523 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 15.7 m-20 -84.54 120.52 26.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.796 0.295 . . . . 72.05 111.796 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.496 HD11 ' HE1' ' A' ' 59' ' ' MET . 4.2 pp -86.12 -16.21 38.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.155 0.503 . . . . 73.14 111.38 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.73 -10.77 78.55 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.208 -0.52 . . . . 65.04 112.489 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.44 -178.32 5.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.836 0.35 . . . . 75.42 111.275 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 96.02 3.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.998 0.428 . . . . 72.2 111.236 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -85.5 132.58 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.259 0.552 . . . . 71.22 111.56 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -108.64 170.42 8.04 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.375 -0.375 . . . . 74.44 110.94 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 45' ' ' LEU . 3.3 mm? -55.9 -24.55 38.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.073 0.463 . . . . 63.14 111.084 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -57.56 -60.26 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.877 -0.601 . . . . 73.0 110.983 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -65.58 -38.08 88.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.08 -0.509 . . . . 73.31 110.973 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.575 HD12 HD13 ' A' ' 42' ' ' LEU . 92.9 mt -59.3 -34.79 72.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.451 -0.34 . . . . 74.33 111.448 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.84 -33.84 60.07 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.224 -0.297 . . . . 75.12 111.017 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.14 -39.13 77.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.992 0.425 . . . . 73.4 110.281 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD21 HG23 ' A' ' 75' ' ' ILE . 67.7 tp -52.61 -46.5 67.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.98 -0.554 . . . . 73.54 110.852 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.86 -44.23 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.046 0.45 . . . . 73.34 111.009 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.43 -29.88 72.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.144 -0.551 . . . . 42.24 113.025 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -99.61 8.69 44.2 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.069 0.396 . . . . 73.03 112.069 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.05 -3.41 0.13 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.502 0.927 . . . . 73.31 113.502 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -84.58 -27.63 27.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.793 0.33 . . . . 71.41 111.793 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.55 138.32 5.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.469 -0.396 . . . . 44.33 112.843 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 pp -159.12 162.99 36.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.319 0.488 . . . . 75.44 112.319 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -131.05 128.76 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.422 -0.353 . . . . 73.42 111.387 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.5 mp -95.59 139.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.758 0.313 . . . . 74.43 110.909 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -116.13 0.46 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.211 -0.519 . . . . 55.03 113.79 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -82.68 175.9 9.77 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 112.842 0.682 . . . . 72.3 112.842 -177.077 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.447 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 87.7 p -144.52 34.51 0.16 Allowed Pre-proline 0 CA--C 1.555 1.165 0 N-CA-C 114.07 1.137 . . . . 73.33 114.07 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 87.7 Cg_endo -77.53 149.13 26.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.651 1.568 . . . . 73.53 112.434 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.41 61.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.439 0.533 . . . . 63.24 112.439 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.4 66.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.105 0.479 . . . . 51.12 112.102 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -78.36 -29.95 47.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.987 0.422 . . . . 75.23 111.215 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.61 -29.37 62.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.139 -0.482 . . . . 63.13 111.904 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.86 80.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.063 0.459 . . . . 74.55 111.246 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.8 t -73.73 -43.83 58.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.991 0.424 . . . . 61.32 110.958 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.3 -50.37 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.077 -0.51 . . . . 61.22 111.846 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.64 -43.57 98.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.034 0.383 . . . . 74.04 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.44 -41.36 72.11 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.037 -0.601 . . . . 70.34 112.765 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -81.45 -32.68 32.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.74 0.305 . . . . 44.13 111.382 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.15 -43.91 74.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.973 0.509 . . . . 72.52 111.33 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.6 m -55.86 -21.96 22.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.776 0.322 . . . . 52.42 111.849 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 m -97.61 -29.89 13.17 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.101 0.476 . . . . 64.42 110.863 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.646 HG23 HD21 ' A' ' 48' ' ' LEU . 69.4 mt -64.07 -39.17 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.033 0.383 . . . . 71.23 112.033 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -51.1 -49.2 61.18 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.438 0.533 . . . . 73.11 112.438 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.79 -8.01 87.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.044 -0.598 . . . . 52.33 113.234 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.2 m -94.04 -24.68 17.52 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.929 0.344 . . . . 73.24 111.929 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 m -87.01 164.18 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.178 0.513 . . . . 64.01 111.905 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.93 -156.2 0.52 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.159 -0.473 . . . . 52.51 111.444 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.11 -80.57 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.951 0.723 . . . . 52.23 112.951 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -117.57 98.6 6.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.594 0.712 . . . . 64.22 111.874 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.11 166.48 11.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.459 0.647 . . . . 74.11 112.564 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -102.77 110.81 22.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.531 -0.759 . . . . 62.15 109.298 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -121.03 154.03 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.814 0.816 . . . . 72.41 113.033 -168.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.72 169.97 14.32 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.249 -0.887 . . . . 42.0 112.684 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -153.76 126.63 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.383 0.273 . . . . 72.34 110.848 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -137.28 92.48 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.717 0.77 . . . . 72.31 111.99 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.58 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.5 tp10 -66.63 121.31 15.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.653 -0.703 . . . . 70.3 110.473 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.492 HG21 ' OG ' ' A' ' 13' ' ' SER . 8.0 t -101.53 15.78 27.79 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 64.11 111.843 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . -158.24 -64.54 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.811 -0.709 . . . . 72.03 113.631 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.06 47.66 2.02 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.304 -0.474 . . . . 70.33 111.967 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 61' ' ' PRO . . . -66.49 -63.81 3.7 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.171 0.428 . . . . 51.24 114.171 -174.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -152.66 -178.56 6.95 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.182 0.491 . . . . 73.24 111.244 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.3 23.82 1.81 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.675 0.39 . . . . 71.34 111.49 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 34.0 tt0 -50.81 -47.85 84.94 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.361 0.874 . . . . 63.12 113.361 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.481 ' O ' HD23 ' A' ' 101' ' ' LEU . 51.7 Cg_endo -87.98 38.5 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.313 2.009 . . . . 74.0 113.701 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.7 tt -66.59 -58.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 113.635 0.976 . . . . 71.13 113.635 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 98' ' ' ILE . 9.9 m-20 -57.9 -55.73 42.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.935 1.087 . . . . 73.15 113.935 -172.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 32.4 Cg_endo -61.65 -14.64 37.0 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.315 2.01 . . . . 74.04 114.742 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 97' ' ' PRO . 4.0 mm? -100.89 -62.03 1.29 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -50.62 -45.15 57.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.508 0.929 . . . . 72.35 113.508 -170.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.7 t -52.81 -37.68 60.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.488 0.551 . . . . 71.31 112.488 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 0.5 OUTLIER -66.61 -44.0 83.25 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.831 0.348 . . . . 71.5 111.449 -177.188 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -63.16 -35.97 82.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.924 0.393 . . . . 64.14 111.154 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -69.4 -43.79 72.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.144 -0.48 . . . . 74.32 110.999 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.32 -55.14 38.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.622 . . . . 73.34 111.792 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 mp -71.69 -26.19 62.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.758 0.313 . . . . 72.43 111.312 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.68 62.14 3.32 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.172 -0.537 . . . . 55.22 113.579 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.39 142.66 35.78 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.069 0.461 . . . . 64.54 111.313 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 35.3 m -70.91 97.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.261 -0.427 . . . . 72.5 110.941 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.3 p -86.73 121.66 29.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.126 -0.488 . . . . 73.12 112.152 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.31 -58.8 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.435 0.531 . . . . 73.43 112.435 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -140.92 84.89 12.81 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 120.996 0.427 . . . . 74.14 111.667 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.39 64.53 4.96 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.824 2.349 . . . . 63.31 112.989 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.91 42.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.143 0.423 . . . . 71.35 112.143 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.518 HG21 ' H ' ' A' ' 89' ' ' GLU . 1.7 pp -71.2 73.23 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.847 0.832 . . . . 74.4 112.892 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -79.46 50.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.929 -0.578 . . . . 73.44 112.415 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 89' ' ' GLU . 49.0 mm -76.35 147.82 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 120.932 0.396 . . . . 73.21 111.721 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.96 -61.86 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.113 0.412 . . . . 70.14 112.113 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.525 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 35.2 tt0 -151.28 -48.94 0.12 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.098 0.475 . . . . 41.02 111.604 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.0 p -129.35 131.75 23.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.412 -0.358 . . . . 53.24 111.289 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 90' ' ' THR . 37.6 Cg_endo -65.96 143.76 73.85 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.475 2.117 . . . . 72.22 112.226 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.8 p -100.73 -177.72 3.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.991 0.424 . . . . 70.21 111.592 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -59.89 -26.76 66.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.076 0.465 . . . . 61.44 111.258 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -76.38 -24.38 54.11 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.38 -0.373 . . . . 74.34 111.902 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.0 m -59.07 -35.26 73.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.936 0.398 . . . . 75.14 111.466 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.43 -48.43 80.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.024 0.44 . . . . 63.52 111.346 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -50.13 -50.11 49.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.653 -0.703 . . . . 75.25 112.54 -174.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 130' ' ' LEU . 7.2 mp -63.05 -46.39 87.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 72.4 111.232 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 82.2 m -61.05 -40.05 92.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.236 -0.438 . . . . 71.41 111.773 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.18 -52.56 12.1 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.865 0.364 . . . . 71.34 111.614 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.61 -63.49 1.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.422 -0.354 . . . . 70.41 110.941 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.21 79.55 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.481 -0.327 . . . . 72.02 111.405 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.04 94.67 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.282 -0.485 . . . . 34.44 113.083 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 54.8 m -60.67 -48.61 81.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.827 0.346 . . . . 63.33 111.151 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.09 -39.64 86.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.904 0.383 . . . . 62.21 111.304 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.44 -44.5 97.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.023 0.439 . . . . 65.23 110.662 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.3 -38.72 96.25 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.265 -0.493 . . . . 64.44 112.75 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 86.3 mt-30 -61.89 -28.83 69.79 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.998 0.37 . . . . 61.42 111.998 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -50.63 -40.33 52.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.129 0.49 . . . . 70.01 110.717 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.97 -51.95 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.025 -0.534 . . . . 74.32 111.755 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.564 ' HA ' ' HB2' ' A' ' 146' ' ' ARG . 10.0 t -69.1 -25.2 64.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.901 0.334 . . . . 73.22 111.901 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 94.7 mtt180 -65.73 -41.11 92.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.742 0.306 . . . . 75.24 111.093 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.65 -27.94 31.01 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.432 . . . . 75.54 110.936 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.68 ' HA ' ' HE ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -59.83 -59.23 5.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.357 -0.383 . . . . 72.22 111.132 175.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.3 tp -175.57 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.662 -0.244 . . . . 72.23 111.514 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -150.75 109.74 3.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 72.02 111.409 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -159.54 22.36 0.18 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.522 0.677 . . . . 63.52 109.984 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -90.65 55.58 3.02 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.573 0.583 . . . . 74.31 112.573 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -87.07 -32.91 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.867 -0.52 . . . . 73.25 110.882 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -66.58 97.06 0.41 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.348 -0.387 . . . . 74.32 111.898 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -87.02 76.98 9.27 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.345 -0.222 . . . . 64.11 111.458 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.9 m80 . . . . . 0 C--O 1.251 1.171 0 N-CA-C 112.223 0.453 . . . . 63.4 112.223 -177.53 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.679 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 53.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.009 -0.043 . . . . 72.22 110.933 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 63.33 122.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 112.726 0.639 . . . . 74.43 112.726 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.48 105.11 3.24 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.473 -0.394 . . . . 73.3 112.663 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.2 t -88.39 107.92 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 122.55 -0.383 . . . . 64.4 110.982 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.633 ' HE2' ' HB2' ' A' ' 55' ' ' LEU . 83.3 m-85 -88.71 142.0 28.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.938 0.718 . . . . 72.11 112.938 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -146.58 179.74 7.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.775 -0.648 . . . . 74.03 110.844 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.606 HG13 ' HA3' ' A' ' 37' ' ' GLY . 86.0 t -130.64 103.7 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.748 0.309 . . . . 44.42 111.721 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.7 m -54.95 -36.41 65.29 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.087 0.403 . . . . 74.05 112.087 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.7 -54.81 36.95 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.385 0.513 . . . . 74.2 112.385 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.423 ' H ' HG12 ' A' ' 7' ' ' VAL . 73.9 t80 -138.94 -55.29 0.6 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.092 -0.503 . . . . 62.24 110.898 -174.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.581 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -30.04 97.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.365 0.906 . . . . 71.42 115.365 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -70.82 5.76 1.81 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.073 0.464 . . . . 75.41 111.488 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -52.89 -14.17 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.029 0.751 . . . . 73.42 113.029 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.33 -37.01 74.26 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.093 0.473 . . . . 63.44 110.916 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.561 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 1.5 mtm180 -65.15 -34.41 78.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.056 -0.52 . . . . 55.0 111.127 175.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' HG13 ' A' ' 20' ' ' ILE . 75.6 mt -66.79 -48.18 69.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.202 -0.454 . . . . 64.14 110.406 172.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.85 -41.73 71.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.126 -0.488 . . . . 70.13 112.116 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -63.0 -46.02 89.64 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.906 0.384 . . . . 62.13 111.321 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.08 93.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.064 0.459 . . . . 63.15 111.217 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 16' ' ' LEU . 79.1 mt -63.71 -55.19 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.681 . . . . 73.54 111.814 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.79 -39.69 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 122.312 -0.243 . . . . 74.35 111.61 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 25' ' ' THR . 46.1 t-20 -55.77 -59.82 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.842 0.354 . . . . 53.32 111.025 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -45.07 96.67 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 120.952 -0.642 . . . . 73.32 113.42 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 30' ' ' GLY . 33.6 mt -72.92 -30.22 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.115 0.783 . . . . 75.15 113.115 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 22' ' ' ASN . 14.5 t -69.66 -35.18 74.94 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.571 -0.705 . . . . 54.3 110.743 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -74.62 -43.01 57.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.933 0.397 . . . . 70.31 110.807 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.9 m -59.34 -34.09 71.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.128 -0.487 . . . . 63.01 111.377 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.48 59.13 0.68 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.036 -0.602 . . . . 61.12 114.101 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 24' ' ' ILE . 61.1 t -140.07 -53.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.844 0.354 . . . . 63.25 111.24 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 84.65 119.06 0.83 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.326 -0.464 . . . . 75.52 113.564 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 1' ' ' SER . 30.9 m -116.6 146.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.324 0.49 . . . . 52.1 112.324 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.28 129.97 55.5 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.289 -0.414 . . . . 75.43 111.169 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.16 137.15 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.182 0.515 . . . . 52.42 112.205 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 59.7 t -132.64 140.33 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.507 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 17.4 t70 -107.88 130.34 55.01 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.176 0.512 . . . . 61.02 111.711 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -116.75 11.32 14.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.288 -0.415 . . . . 71.33 112.078 178.342 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.606 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -96.17 -35.12 5.63 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.007 -0.616 . . . . 72.31 113.353 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.0 -38.22 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.984 0.421 . . . . 42.1 111.816 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . . . -75.54 12.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.499 0.555 . . . . 71.41 112.499 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.24 114.05 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.227 0.537 . . . . 65.3 111.969 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.12 170.43 21.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.886 -0.597 . . . . 71.3 110.628 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.17 -34.8 70.7 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.618 -0.264 . . . . 64.12 111.447 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.44 -63.11 1.39 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.643 0.258 . . . . 63.43 111.624 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.47 -48.97 65.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.196 0.522 . . . . 65.5 111.637 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.09 -43.67 98.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.154 -0.475 . . . . 75.12 111.975 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -71.65 -34.73 70.0 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.877 0.37 . . . . 74.54 111.309 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HB3' HH11 ' A' ' 51' ' ' ARG . 34.5 mt-10 -71.99 -28.75 63.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.659 0.266 . . . . 63.34 111.141 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.56 -40.0 77.96 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.935 0.398 . . . . 73.1 110.615 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -36.03 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.22 -0.445 . . . . 64.4 111.014 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.33 -40.29 41.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.169 -0.539 . . . . 72.21 112.647 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 47' ' ' GLU . 7.2 mpt_? -81.61 6.23 15.71 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.102 0.408 . . . . 73.14 112.102 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.9 p -49.84 -15.54 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.633 0.975 . . . . 74.44 113.633 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -47.59 -31.63 4.66 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.338 0.496 . . . . 73.42 112.338 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -179.82 141.56 4.75 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.076 -0.511 . . . . 33.2 112.095 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.633 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . 1.4 pt? -144.72 134.48 23.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.369 0.584 . . . . 65.15 112.136 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG22 ' HE1' ' A' ' 88' ' ' PHE . 11.4 p -118.11 124.99 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.076 0.465 . . . . 71.25 111.077 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.51 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.5 mp -113.2 139.64 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.287 0.477 . . . . 61.2 112.287 -172.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.1 131.23 10.54 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.3 -0.409 . . . . 74.21 112.579 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.07 120.26 22.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.551 0.575 . . . . 71.32 112.551 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.668 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 88.4 p -111.75 171.14 4.57 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.153 0.581 . . . . 61.35 111.051 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.668 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 30.9 Cg_endo -63.18 168.08 11.51 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.289 1.992 . . . . 65.42 113.526 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.831 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -58.22 -21.62 48.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.076 0.769 . . . . 72.03 113.076 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.19 -61.0 2.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.785 0.326 . . . . 52.35 111.305 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 -33.01 36.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.625 -0.261 . . . . 71.25 111.701 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -54.81 -37.59 66.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.179 0.437 . . . . 72.34 112.179 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.51 75.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.073 0.463 . . . . 75.32 111.315 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -68.86 -40.85 79.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.28 0.562 . . . . 72.42 110.691 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.39 -44.5 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.914 -0.585 . . . . 74.33 111.081 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -57.44 -40.17 77.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.507 -0.315 . . . . 74.11 111.357 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.11 -49.16 73.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.153 -0.546 . . . . 33.32 112.887 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.39 67.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.918 0.39 . . . . 75.33 111.92 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 72' ' ' LEU . 3.2 tm? -52.8 -32.12 42.29 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.228 -0.442 . . . . 61.04 111.175 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.4 m -46.8 -41.03 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.729 0.412 . . . . 63.42 111.752 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.1 m -87.68 -45.32 10.49 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.892 0.377 . . . . 74.51 111.157 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.39 -51.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 112.418 0.525 . . . . 74.04 112.418 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.4 tp -55.91 -33.95 65.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.823 0.344 . . . . 72.43 111.889 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.37 -17.44 55.28 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.944 -0.646 . . . . 70.14 113.244 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.0 p -87.75 -16.35 34.48 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.336 0.495 . . . . 72.44 112.336 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.57 153.94 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.22 0.533 . . . . 73.2 112.084 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -87.14 148.64 25.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.082 -0.508 . . . . 75.11 111.158 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.76 -36.31 64.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.939 0.4 . . . . 71.02 111.997 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -118.19 87.15 2.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.489 0.661 . . . . 62.04 110.837 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.482 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 18.2 tp60 -131.38 172.83 11.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.993 -0.549 . . . . 74.5 110.867 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.482 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -107.98 123.72 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 64.54 111.836 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 112' ' ' THR . 35.3 m -130.03 171.8 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.842 0.353 . . . . 62.11 111.12 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' HA3' HG23 ' A' ' 56' ' ' VAL . . . -142.4 144.4 14.03 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.097 -0.573 . . . . 64.44 112.826 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -125.06 126.66 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.588 -0.36 . . . . 73.52 111.829 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 54.6 p90 -148.94 168.14 23.88 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.101 0.477 . . . . 75.21 111.725 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.58 155.38 21.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.377 0.608 . . . . 73.34 111.984 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -134.5 2.26 3.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.999 0.428 . . . . 54.23 111.765 176.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.62 -164.96 29.66 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.242 -0.504 . . . . 74.12 112.778 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.09 -29.66 62.79 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.039 0.376 . . . . 60.43 114.039 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.33 126.15 1.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.341 -0.457 . . . . 64.44 112.98 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 27.2 t70 -160.2 109.37 1.74 Allowed 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.444 -0.445 . . . . 75.1 111.41 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -168.32 156.77 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.569 0.348 . . . . 60.43 110.846 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.725 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 4.6 mp0 -94.15 -61.12 0.18 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 112.19 0.441 . . . . 64.43 112.19 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 6.1 Cg_exo -80.03 16.29 1.52 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.567 2.178 . . . . 61.23 113.749 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.544 HG23 ' H ' ' A' ' 99' ' ' ASP . 5.6 tt -47.9 -59.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.86 0.689 . . . . 72.13 112.86 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' H ' HG23 ' A' ' 98' ' ' ILE . 6.8 m-20 -63.83 -50.98 68.02 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 111.983 0.364 . . . . 74.23 111.983 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 94.3 Cg_exo -47.24 -40.8 27.9 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.437 2.091 . . . . 74.34 113.704 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 97' ' ' PRO . 7.4 mp -63.8 -59.82 4.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.838 0.351 . . . . 74.13 111.266 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.7 mt -53.93 -35.82 62.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.081 0.467 . . . . 71.44 111.334 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.3 t -57.78 -46.04 85.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.826 -0.624 . . . . 74.51 111.432 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -71.07 -41.07 71.19 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.673 0.249 . . . . 72.35 111.673 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.32 -35.68 76.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.184 0.516 . . . . 75.43 111.113 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 106' ' ' ARG . 15.0 tpt180 -79.53 -31.37 42.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.008 0.432 . . . . 74.4 110.591 177.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -59.67 -38.32 81.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.033 -0.53 . . . . 72.32 110.534 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.72 -52.82 26.57 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.103 -0.499 . . . . 72.53 110.789 173.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.39 34.34 0.82 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.123 -0.561 . . . . 64.12 113.797 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 110' ' ' LEU . 7.1 mp -83.56 136.12 34.37 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.458 -0.436 . . . . 73.52 111.111 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.4 t -77.78 125.74 29.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.096 -0.335 . . . . 74.2 110.096 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 85' ' ' VAL . 59.3 p -97.38 -8.48 29.43 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.679 0.992 . . . . 60.42 113.679 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 50.24 78.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.538 0.569 . . . . 73.32 112.538 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 64.82 106.9 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 112.388 0.514 . . . . 72.23 112.388 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.63 74.14 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.08 1.853 . . . . 73.41 111.906 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . . . -73.76 114.45 12.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.79 0.663 . . . . 60.15 112.79 -173.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.2 tt -159.04 80.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.949 0.88 . . . . 64.14 110.6 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -146.81 90.58 1.93 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.772 -0.649 . . . . 73.1 111.773 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.45 149.34 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.397 0.618 . . . . 71.11 112.232 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -91.23 -25.2 19.62 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.715 -0.675 . . . . 61.24 110.886 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 178.71 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.439 -0.8 . . . . 73.34 109.962 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p -128.62 140.06 37.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.794 -0.639 . . . . 74.32 110.795 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.21 169.15 14.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.621 2.214 . . . . 55.41 114.012 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 125' ' ' GLU . 91.1 m -107.43 160.06 15.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.866 -0.606 . . . . 53.52 110.526 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 124' ' ' THR . 9.4 pt-20 -43.47 -35.53 1.67 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.634 0.975 . . . . 62.42 113.634 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -62.36 -23.25 66.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.327 0.492 . . . . 62.3 112.327 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.0 m -57.98 -39.74 78.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.231 0.538 . . . . 71.35 110.556 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.561 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 11.3 m-85 -60.44 -32.03 70.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.906 -0.588 . . . . 73.04 111.278 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.7 -36.52 76.03 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.44 -0.345 . . . . 72.5 111.136 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.28 -53.66 34.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 64.34 110.256 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.7 m -58.79 -32.7 69.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.006 0.431 . . . . 53.43 111.083 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.04 -56.03 26.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.783 -0.644 . . . . 71.44 112.019 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.43 -34.76 76.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.802 0.334 . . . . 74.2 111.74 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.56 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.592 -0.276 . . . . 62.31 111.718 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -54.19 -49.36 60.0 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.546 -0.359 . . . . 72.21 113.558 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 55.4 m -59.79 -40.93 89.97 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.849 0.357 . . . . 72.0 111.431 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.47 -42.95 99.57 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.923 0.392 . . . . 74.12 111.365 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.77 0.319 . . . . 75.12 110.979 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.28 93.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.832 -0.699 . . . . 63.33 112.509 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 136' ' ' THR . 19.8 mt-30 -67.93 -23.82 65.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.039 0.447 . . . . 74.34 111.398 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.56 -44.81 77.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.216 0.531 . . . . 74.13 110.755 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.6 -50.24 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.97 -0.559 . . . . 73.01 111.857 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 140' ' ' GLN . 8.9 t -61.36 -33.52 73.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.669 0.271 . . . . 75.02 111.728 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -56.88 -46.75 81.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.078 0.466 . . . . 63.33 110.972 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.61 -29.83 62.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.125 -0.488 . . . . 72.44 111.351 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -86.84 -34.22 19.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.237 -0.438 . . . . 63.41 112.172 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.4 tp -151.39 -86.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.544 0.572 . . . . 72.33 112.544 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.23 -70.64 0.36 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.391 0.615 . . . . 75.44 111.375 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 6.2 t60 -157.82 -51.2 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.863 -0.608 . . . . 71.1 110.074 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 149' ' ' HIS . 82.9 t60 175.85 84.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.748 -0.66 . . . . 62.12 109.847 175.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -72.73 83.42 1.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.166 0.508 . . . . 72.13 112.166 -173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -159.05 158.36 32.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.548 0.739 . . . . 63.35 110.107 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.16 149.09 38.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.182 0.515 . . . . 72.11 112.218 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 . . . . . 0 C--O 1.254 1.332 0 CA-C-O 118.577 -0.725 . . . . 63.21 109.705 169.704 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 65.6 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.497 0.189 . . . . 72.43 111.288 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 142' ' ' VAL . 48.9 mm 60.26 89.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.113 0.482 . . . . 74.35 111.862 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.63 90.11 1.61 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.963 -0.637 . . . . 72.33 112.278 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.0 p -82.06 120.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.481 0.658 . . . . 65.32 112.154 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -95.13 126.99 40.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.625 -0.716 . . . . 74.11 111.197 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 5.3 p90 -159.37 -178.91 7.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.831 0.348 . . . . 73.51 110.968 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.48 106.18 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.266 0.555 . . . . 62.42 111.761 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.9 m -70.34 -24.27 62.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.052 0.389 . . . . 71.11 112.052 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.99 -47.38 77.81 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.145 0.498 . . . . 73.13 111.43 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -102.71 22.3 13.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.586 0.708 . . . . 64.41 109.274 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -30.33 91.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 117.392 1.717 . . . . 62.31 117.392 -170.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -104.69 -34.13 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.79 . . . . 65.11 109.675 156.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 16.3 m -79.75 -12.98 59.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.033 -0.985 . . . . 75.43 112.901 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.36 -39.09 92.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.038 0.447 . . . . 53.41 111.069 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -70.85 -38.34 73.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.215 0.531 . . . . 74.14 110.806 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -61.63 -44.53 96.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.961 -0.563 . . . . 71.23 110.959 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.46 87.42 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.054 -0.521 . . . . 71.31 111.346 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.07 -42.78 86.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.376 -0.374 . . . . 53.01 111.232 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.42 89.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.459 . . . . 73.3 111.115 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.96 -51.24 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.073 -0.512 . . . . 73.04 110.989 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.48 ' HA ' HG21 ' A' ' 31' ' ' VAL . 76.3 mt -55.21 -43.06 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.264 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.41 -33.1 73.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.104 0.478 . . . . 73.54 111.603 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.02 23.4 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.34 -0.457 . . . . 75.52 113.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.33 -50.54 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.42 0.526 . . . . 60.41 112.42 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 81.5 p -63.5 -37.39 87.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.319 0.488 . . . . 71.23 112.319 -175.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.05 -24.0 67.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.048 0.452 . . . . 71.12 111.213 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 m -81.31 -7.69 59.61 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.169 0.509 . . . . 64.33 111.185 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.93 13.79 35.97 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.124 -0.56 . . . . 63.05 113.846 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' THR . 58.4 t -116.95 128.36 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.449 -0.442 . . . . 64.32 111.175 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.41 30.48 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.039 -0.601 . . . . 72.03 113.225 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 1' ' ' SER . 49.0 t -109.56 141.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.794 -0.239 . . . . 54.54 111.516 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.52 117.98 34.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.087 0.47 . . . . 64.12 111.305 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 34.3 m -95.18 135.24 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.95 0.405 . . . . 65.55 111.724 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.38 104.84 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.012 0.434 . . . . 54.44 111.592 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 2.7 m-20 -78.8 92.53 4.85 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.954 0.407 . . . . 51.21 111.392 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -68.21 -13.02 61.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.892 0.377 . . . . 73.11 111.862 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -84.51 -8.09 83.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.132 -0.556 . . . . 73.13 113.016 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.42 172.69 6.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.091 0.472 . . . . 50.23 111.8 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.32 82.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.076 0.465 . . . . 70.3 111.399 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.26 162.7 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 72.25 112.145 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.69 167.12 22.03 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.317 -0.401 . . . . 71.3 110.779 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.502 HD13 HD12 ' A' ' 45' ' ' LEU . 3.9 mm? -59.55 -25.54 64.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.321 -0.237 . . . . 72.21 111.441 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -55.96 -34.37 65.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.02 0.438 . . . . 62.03 110.98 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -84.38 -50.08 8.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.389 0.614 . . . . 42.25 110.63 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.502 HD12 HD13 ' A' ' 42' ' ' LEU . 89.8 mt -56.62 -31.6 64.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.835 -0.62 . . . . 74.12 112.391 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -63.32 -46.41 86.79 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.961 0.41 . . . . 75.21 110.866 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 60.3 tt0 -63.11 -34.79 78.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.002 0.429 . . . . 74.24 110.497 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 54.4 tp -52.19 -45.34 65.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.08 -0.509 . . . . 53.3 111.177 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.29 -38.3 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.108 0.48 . . . . 72.04 111.077 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.84 -29.97 66.54 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.126 -0.559 . . . . 24.12 112.961 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 3.5 mpt_? -89.13 5.25 45.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.981 0.363 . . . . 51.34 111.981 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -51.36 -27.85 10.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.888 0.699 . . . . 61.14 112.888 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.3 p -53.77 -38.6 64.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.122 0.415 . . . . 52.11 112.122 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.24 134.84 4.71 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.895 -0.669 . . . . 54.43 113.039 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HB2' HG12 ' A' ' 85' ' ' VAL . 80.7 mt -137.93 174.75 10.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.878 0.471 . . . . 74.14 110.712 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 48.5 t -139.76 111.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 110.325 -0.25 . . . . 74.11 110.325 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.642 HD13 ' HB ' ' A' ' 85' ' ' VAL . 1.7 mp -91.93 128.41 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.643 0.609 . . . . 72.33 112.643 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.35 139.86 11.3 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 115.636 -0.711 . . . . 63.51 112.142 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.453 ' SD ' HD12 ' A' ' 98' ' ' ILE . 72.7 mtm -82.8 161.5 21.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.037 0.446 . . . . 72.11 111.777 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -143.6 164.27 31.53 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.1 0.407 . . . . 55.54 112.1 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 53.0 Cg_exo -55.51 168.23 1.64 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.063 2.509 . . . . 61.32 113.804 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -50.76 47.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.24 0.83 . . . . 61.31 113.24 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.18 66.51 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.877 0.37 . . . . 74.54 111.942 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.4 m -58.39 -49.35 77.55 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.058 0.456 . . . . 74.43 111.236 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.504 ' HA ' HD12 ' A' ' 68' ' ' ILE . . . -57.97 -35.39 71.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.245 -0.434 . . . . 71.44 112.0 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.16 96.54 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.019 0.437 . . . . 63.34 111.14 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -66.08 -42.15 89.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.384 -0.371 . . . . 62.13 111.096 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 36' ' ' LEU . 67.3 mt -54.8 -54.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.073 0.463 . . . . 71.41 111.113 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.9 -30.9 69.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.013 -0.539 . . . . 74.01 111.53 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.12 -41.59 98.38 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.239 -0.505 . . . . 62.32 113.379 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.53 43.37 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.238 0.458 . . . . 51.1 112.238 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.25 -35.89 65.46 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.597 0.591 . . . . 74.11 112.597 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -56.97 -20.07 21.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.713 0.634 . . . . 71.34 112.713 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -100.42 -10.83 20.75 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.102 0.477 . . . . 70.22 111.714 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.3 mt -92.58 -46.82 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.198 0.444 . . . . 55.5 112.198 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -50.85 -54.99 19.2 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.969 0.729 . . . . 75.24 112.969 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.06 5.49 1.95 Allowed Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.033 0.773 . . . . 60.22 115.033 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.9 m -92.47 -12.65 31.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.87 0.835 . . . . 52.43 112.247 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 110' ' ' LEU . 11.3 m -136.46 129.36 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.927 0.714 . . . . 63.42 112.927 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -162.02 -174.22 4.03 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.04 -0.527 . . . . 73.44 111.074 176.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 60.69 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.907 1.076 . . . . 54.21 113.907 170.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -141.02 -5.01 1.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.189 0.811 . . . . 45.45 113.189 -172.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.88 127.22 25.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.999 0.428 . . . . 63.45 111.273 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.43 140.76 29.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.671 0.619 . . . . 63.32 112.671 -171.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.642 ' HB ' HD13 ' A' ' 57' ' ' ILE . 17.8 m -131.97 109.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.551 0.691 . . . . 74.51 111.71 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -69.81 146.98 44.24 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.97 -0.559 . . . . 65.13 112.566 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 115' ' ' PRO . 49.9 mm -125.54 121.89 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 122.67 -0.312 . . . . 64.15 111.1 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.593 ' HB2' ' SG ' ' A' ' 131' ' ' CYS . 34.7 p90 -120.04 126.48 50.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.419 . . . . 75.03 110.411 175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.44 133.28 50.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.103 0.478 . . . . 74.55 111.96 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -156.28 -22.6 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.097 -0.501 . . . . 63.45 111.419 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.41 -60.03 3.64 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.005 -0.617 . . . . 53.23 113.138 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.11 -76.64 1.32 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.208 -0.52 . . . . 62.33 113.55 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 173.65 -65.61 0.11 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.642 -0.789 . . . . 62.04 113.439 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.41 111.79 22.75 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.279 0.562 . . . . 62.45 110.446 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.09 15.07 14.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.695 0.628 . . . . 75.52 112.695 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.403 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 45.4 tt0 -91.04 -50.5 0.33 Allowed Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.35 0.87 . . . . 64.03 113.35 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 71.7 Cg_endo -70.97 -2.39 10.96 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.163 1.909 . . . . 62.31 113.61 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.453 HD12 ' SD ' ' A' ' 59' ' ' MET . 10.9 tt -72.04 -26.07 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.831 0.348 . . . . 71.24 111.785 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.94 -53.83 56.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 112.852 0.686 . . . . 61.43 112.852 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 -29.4 35.89 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.674 1.583 . . . . 72.35 112.461 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.89 -48.63 79.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.181 -0.463 . . . . 72.15 111.279 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.04 -23.33 65.36 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.423 0.527 . . . . 74.25 112.423 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.9 t -100.68 -71.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.096 0.776 . . . . 74.15 113.096 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.54 -41.49 69.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.557 0.947 . . . . 52.44 113.557 -166.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.415 ' HD2' HD22 ' A' ' 110' ' ' LEU . 66.8 m-85 -59.39 -26.51 65.19 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.058 0.392 . . . . 72.33 112.058 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 106' ' ' ARG . 50.0 mtm105 -70.7 -34.18 71.69 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.11 0.481 . . . . 75.44 110.749 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.7 -33.96 73.25 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.11 -0.495 . . . . 72.35 111.367 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.97 -34.68 78.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.868 0.366 . . . . 62.11 111.365 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.48 5.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.072 -0.585 . . . . 64.32 113.983 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 85' ' ' VAL . 8.7 mp -74.65 122.81 23.77 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.217 -0.578 . . . . 64.35 111.158 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 34.9 m -74.46 94.13 2.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.897 0.379 . . . . 55.53 110.717 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.3 p -76.86 149.1 36.16 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.283 0.564 . . . . 32.13 112.367 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.458 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -76.73 -66.98 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.131 -0.486 . . . . 61.53 111.208 174.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -170.18 88.92 0.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 120.875 0.369 . . . . 71.42 111.106 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HA ' HG21 ' A' ' 87' ' ' ILE . 85.7 Cg_endo -90.46 100.57 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.851 2.367 . . . . 72.13 113.284 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 110.7 5.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.57 -0.286 . . . . 71.33 111.225 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.67 94.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.61 0.719 . . . . 74.45 112.75 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -107.12 -14.49 14.91 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.987 -0.551 . . . . 72.54 111.987 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 122' ' ' THR . 9.3 tp -84.37 156.16 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.49 0.662 . . . . 72.13 112.536 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.772 ' H ' ' HD2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -92.91 -39.34 11.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.738 -0.665 . . . . 50.01 110.158 171.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 177.01 -59.0 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.644 0.777 . . . . 63.4 110.245 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.476 ' O ' HD11 ' A' ' 119' ' ' ILE . 82.3 p -80.5 118.72 73.74 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 116.447 -0.342 . . . . 74.44 111.385 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.56 146.62 68.27 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.476 2.117 . . . . 65.13 113.295 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.3 p -99.16 179.31 4.64 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.891 0.377 . . . . 73.33 111.592 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.18 -32.73 72.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.047 0.451 . . . . 65.33 111.14 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -57.42 -35.59 70.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.214 -0.448 . . . . 72.42 110.956 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.6 m -62.55 -39.03 92.31 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.496 -0.32 . . . . 71.24 111.491 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -60.17 -47.47 85.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.04 0.448 . . . . 65.23 111.04 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -65.96 -38.39 88.43 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.115 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.58 -52.63 64.83 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 72.2 110.53 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 88' ' ' PHE . 83.0 m -60.62 -41.08 94.11 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.886 0.374 . . . . 64.11 111.511 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -55.74 -45.02 78.08 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.204 0.526 . . . . 54.22 111.295 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.25 -41.66 40.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.004 -0.544 . . . . 74.22 111.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.8 80.25 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.051 0.389 . . . . 73.3 112.051 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.19 -47.29 91.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.021 -0.609 . . . . 53.31 112.918 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 94.1 m -60.46 -45.8 92.37 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.849 0.357 . . . . 75.41 111.403 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.62 -45.07 90.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.284 -0.416 . . . . 74.13 111.411 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.53 -42.93 91.44 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.815 0.34 . . . . 72.31 111.29 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.21 -36.27 61.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.261 -0.495 . . . . 72.43 112.869 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 136' ' ' THR . 77.5 mt-30 -57.86 -45.48 86.24 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 65.1 111.165 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -62.7 -49.28 75.73 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.409 -0.36 . . . . 74.3 111.192 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.423 HG21 HD11 ' A' ' 2' ' ' ILE . 63.7 t -53.73 -56.64 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.325 0.491 . . . . 62.31 112.325 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -65.13 -40.22 94.15 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.218 0.451 . . . . 71.1 112.218 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -75.01 -35.43 61.99 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.942 0.349 . . . . 72.32 111.942 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.08 -44.26 54.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 75.24 110.672 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -58.14 -42.36 85.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.085 -0.507 . . . . 64.12 111.206 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -77.74 -60.13 2.5 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.091 -0.504 . . . . 72.1 110.228 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.55 91.33 0.07 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.448 0.699 . . . . 71.34 111.581 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -112.62 9.77 19.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.519 0.676 . . . . 73.04 110.808 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -169.82 107.9 0.38 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.638 -0.71 . . . . 64.22 109.747 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -69.36 -66.82 0.53 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.395 -0.366 . . . . 75.31 111.88 -172.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 69.6 m80 60.73 -178.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.282 0.475 . . . . 72.4 112.282 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 78.1 t60 69.73 -59.18 0.51 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.294 0.638 . . . . 72.43 111.617 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.913 -0.565 . . . . 61.11 111.081 175.357 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.548 0.203 . . . . 63.32 111.548 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 44.3 mm 55.82 93.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 112.688 0.625 . . . . 72.32 112.688 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.09 109.89 3.81 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.563 -0.827 . . . . 70.2 113.318 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.1 p -88.66 111.46 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.527 0.679 . . . . 51.02 111.747 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -89.31 96.66 10.81 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.757 -0.656 . . . . 74.02 111.117 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 25.6 p90 -122.04 -177.89 3.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.994 -0.548 . . . . 73.33 110.358 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.17 93.93 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.413 0.625 . . . . 71.23 111.893 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.427 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 18.2 m -57.13 -27.09 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.379 0.609 . . . . 60.02 110.955 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.28 -23.06 64.71 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.324 -0.853 . . . . 75.14 112.598 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -142.73 144.8 32.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.488 0.661 . . . . 74.02 112.662 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.39 -162.8 6.2 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.385 -0.825 . . . . 72.24 114.894 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 38.2 m-85 -94.24 6.59 48.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.105 0.409 . . . . 75.25 112.105 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 16' ' ' LEU . 60.4 p -51.13 -34.07 29.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.244 0.461 . . . . 72.44 112.244 -173.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 13.5 t70 -58.31 -56.28 24.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.016 0.436 . . . . 65.21 111.193 174.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 18.7 mmt180 -65.69 -27.84 68.64 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.528 -0.305 . . . . 74.41 111.516 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 13' ' ' SER . 90.3 mt -67.41 -43.41 81.32 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 52.02 110.382 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.02 85.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.112 -0.495 . . . . 73.2 110.805 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -57.63 -45.99 84.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.963 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.49 -43.65 89.09 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 62.53 111.27 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.551 HD13 HG11 ' A' ' 56' ' ' VAL . 67.1 mt -59.0 -57.71 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 63.21 110.93 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.55 -35.29 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.118 -0.492 . . . . 73.24 111.609 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -60.08 -53.47 57.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.713 0.292 . . . . 75.13 111.129 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.38 97.85 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.558 . . . . 74.04 112.933 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.685 HG23 ' HB ' ' A' ' 29' ' ' VAL . 36.7 mm -61.47 -47.23 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.916 0.388 . . . . 75.52 111.889 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 p -70.29 -31.73 69.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.741 0.305 . . . . 72.24 111.426 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.675 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -64.43 -42.17 96.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.854 0.359 . . . . 75.41 110.8 174.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -69.6 -51.73 32.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.335 -0.393 . . . . 72.24 111.134 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.82 53.95 0.13 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.443 -0.344 . . . . 70.13 113.162 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.685 ' HB ' HG23 ' A' ' 24' ' ' ILE . 46.2 t -139.7 157.82 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.419 0.288 . . . . 53.41 110.643 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.26 150.19 17.26 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 121.275 -0.488 . . . . 71.33 113.338 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 24' ' ' ILE . 97.1 t -131.07 145.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.625 0.602 . . . . 75.51 112.625 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 4' ' ' VAL . 29.0 m-20 -93.29 142.83 26.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.982 -0.554 . . . . 74.13 111.126 171.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -110.02 131.08 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.815 0.34 . . . . 70.2 111.873 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.17 131.44 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 120.702 0.287 . . . . 70.54 111.465 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.6 m-20 -95.67 105.42 17.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.679 0.276 . . . . 74.54 111.17 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.47 -14.29 62.8 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.928 0.394 . . . . 75.2 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.18 30.86 7.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.372 -0.442 . . . . 73.2 112.93 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.07 174.83 10.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.881 0.372 . . . . 74.04 111.508 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.04 93.85 0.3 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.518 0.562 . . . . 62.22 112.518 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.61 174.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.42 -0.355 . . . . 74.34 111.336 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -145.46 172.2 13.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.001 0.429 . . . . 53.44 111.386 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.2 tm? -54.48 -29.56 50.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.769 0.427 . . . . 71.42 110.735 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -52.82 -48.02 67.27 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 111.986 0.365 . . . . 74.3 111.986 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.93 -38.05 78.08 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.868 0.366 . . . . 62.1 111.146 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.9 -43.67 82.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.835 0.35 . . . . 43.32 110.79 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.59 -50.43 73.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.712 0.291 . . . . 73.23 111.33 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.92 -30.39 71.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.052 0.453 . . . . 70.12 110.901 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 53.2 tp -58.92 -29.84 67.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.558 -0.292 . . . . 63.33 111.587 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.74 -33.42 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.194 0.521 . . . . 74.42 110.519 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.05 -31.65 11.77 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.003 -0.544 . . . . 74.31 112.469 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.657 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 99.7 mtt180 -73.47 -10.78 60.08 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.516 -0.403 . . . . 73.5 111.974 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -60.99 -10.79 6.37 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.768 0.285 . . . . 74.21 111.768 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.535 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 67.9 p -71.5 -28.61 64.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.429 . . . . 73.22 111.586 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -173.11 137.35 4.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.221 -0.445 . . . . 74.2 112.642 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' HG ' HD11 ' A' ' 57' ' ' ILE . 1.6 pt? -157.62 148.61 21.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.154 0.502 . . . . 63.14 111.806 -177.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.551 HG11 HD13 ' A' ' 20' ' ' ILE . 59.8 t -116.6 113.27 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 122.838 0.455 . . . . 73.24 111.03 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.576 HD11 ' HG ' ' A' ' 55' ' ' LEU . 3.3 mp -116.42 146.33 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 122.07 -0.394 . . . . 75.15 111.887 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -134.93 3.56 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.178 -0.534 . . . . 73.43 112.921 173.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mmt -122.5 156.23 34.54 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.44 -0.447 . . . . 51.11 111.11 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.8 p -97.9 113.54 63.86 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.327 -0.397 . . . . 64.41 111.924 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.45 146.05 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.864 2.376 . . . . 73.33 112.773 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.54 -24.96 2.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.988 0.736 . . . . 54.04 112.988 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.8 74.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.13 0.418 . . . . 53.44 112.13 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.0 p -100.0 4.43 44.81 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.788 0.292 . . . . 62.13 111.788 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.84 -31.01 10.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.497 0.555 . . . . 62.02 112.497 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.9 72.21 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.089 0.471 . . . . 33.54 111.695 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.1 t -65.17 -45.43 84.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.078 0.466 . . . . 73.15 110.874 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 50.4 mm -54.6 -52.95 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.912 -0.585 . . . . 70.23 111.657 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.14 -38.85 89.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.919 0.34 . . . . 74.41 111.919 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.82 -40.38 98.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.177 -0.535 . . . . 71.31 113.207 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -85.32 -44.4 12.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.314 0.487 . . . . 75.23 112.314 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 72' ' ' LEU . 1.4 tm? -53.45 -42.99 67.71 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.592 0.357 . . . . 75.32 111.57 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -51.16 -34.28 30.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.814 0.34 . . . . 63.14 111.864 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.3 m -89.93 -39.74 12.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.214 0.53 . . . . 63.43 111.21 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.575 HG23 HD21 ' A' ' 48' ' ' LEU . 72.1 mt -54.58 -41.41 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.163 -0.471 . . . . 74.04 111.733 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.94 -33.21 62.02 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.296 -0.411 . . . . 52.22 111.834 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.19 -31.73 33.72 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.137 -0.554 . . . . 71.05 112.902 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.8 m -72.7 -39.44 67.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.121 0.415 . . . . 61.31 112.121 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.0 m -87.91 147.34 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.02 0.438 . . . . 73.11 111.568 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -160.94 -179.02 7.2 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.136 0.421 . . . . 55.14 112.136 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.715 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 9.4 tp10 72.2 -106.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.886 0.874 . . . . 70.31 112.71 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.715 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 19.2 ptpt -164.98 24.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.417 0.895 . . . . 50.35 113.417 -172.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HG2' ' HA ' ' A' ' 53' ' ' THR . 1.3 mp0 -62.08 167.85 3.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.754 0.65 . . . . 70.33 112.754 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.94 123.92 34.81 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.77 -0.65 . . . . 75.52 112.349 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.74 108.53 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.493 0.663 . . . . 75.22 111.025 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 81.43 0.33 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.089 -0.505 . . . . 63.3 112.774 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 49.5 mm -79.53 109.08 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 122.568 -0.372 . . . . 75.33 111.391 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' HD2' ' HG1' ' A' ' 90' ' ' THR . 40.1 p90 -105.27 111.63 24.44 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.354 0.597 . . . . 74.01 110.555 173.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.819 ' HB2' HD11 ' A' ' 119' ' ' ILE . 7.7 pt-20 -57.9 104.05 0.17 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.488 0.661 . . . . 64.25 112.703 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.409 ' HG1' ' HD2' ' A' ' 88' ' ' PHE . 90.6 m -142.34 112.78 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.131 -0.486 . . . . 53.42 111.534 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.52 -139.77 15.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.192 -0.528 . . . . 64.4 113.481 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.04 -102.44 2.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.066 -0.587 . . . . 75.43 113.359 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.22 -96.18 0.54 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.22 -0.514 . . . . 70.2 112.46 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -106.89 123.65 48.47 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.559 -0.377 . . . . 65.43 110.282 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.63 159.1 44.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 64.41 111.211 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.583 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 37.9 mt-10 -103.91 -55.93 0.1 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.922 0.712 . . . . 74.31 112.922 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.583 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 39.3 Cg_endo -64.7 -14.59 45.55 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.287 1.991 . . . . 71.44 114.014 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 99' ' ' ASP . 9.9 tt -49.12 -51.86 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 113.26 0.837 . . . . 74.32 113.26 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.71 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 4.5 m-20 -61.53 -55.44 42.68 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.189 0.44 . . . . 75.22 112.189 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.7 Cg_exo -56.25 -33.35 90.69 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.009 1.806 . . . . 52.41 112.705 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.64 -57.06 7.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.06 -0.518 . . . . 74.31 111.479 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.33 -37.79 67.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.988 0.423 . . . . 63.21 110.862 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 100' ' ' PRO . 6.3 t -49.99 -43.33 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.616 . . . . 72.43 111.727 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.702 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -64.55 -44.21 91.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.646 -0.252 . . . . 74.23 111.16 -177.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -60.68 -36.89 79.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.87 0.366 . . . . 72.12 111.223 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -66.85 -60.77 2.37 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.159 -0.473 . . . . 74.32 111.698 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -60.61 -39.31 87.68 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.302 0.482 . . . . 63.44 112.302 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.58 -24.43 49.76 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.205 -0.309 . . . . 63.01 111.569 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.65 52.59 33.27 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.155 -0.545 . . . . 62.1 113.04 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.32 159.9 20.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.97 0.414 . . . . 73.13 111.535 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 88.2 m -79.63 110.02 14.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 40.5 110.77 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -108.52 141.57 40.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.44 0.533 . . . . 72.42 112.44 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.31 -86.13 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.418 -0.355 . . . . 74.51 111.131 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -148.63 96.42 3.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 121.104 0.478 . . . . 72.01 111.507 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.31 13.47 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.854 2.369 . . . . 73.52 113.193 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.2 78.01 2.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.285 0.564 . . . . 74.13 111.441 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.405 HG13 HD13 ' A' ' 119' ' ' ILE . 8.8 tt -62.5 112.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 113.175 0.806 . . . . 73.13 113.175 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -140.44 49.87 1.71 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.132 0.492 . . . . 74.24 111.259 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 89' ' ' GLU . 3.3 mp -89.66 116.31 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.793 0.33 . . . . 64.42 110.957 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.96 -41.81 75.28 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.842 0.353 . . . . 72.03 111.933 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -178.38 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.432 0.634 . . . . 72.34 109.997 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -127.06 142.52 43.99 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.862 -0.608 . . . . 55.12 110.679 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 35.7 Cg_endo -63.98 148.36 91.63 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.631 2.221 . . . . 63.32 113.097 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.6 p -90.26 -178.68 5.45 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.158 0.504 . . . . 63.31 112.057 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.23 -42.48 69.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.023 -0.535 . . . . 72.23 111.718 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -59.99 -39.95 87.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.146 -0.479 . . . . 74.22 112.042 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.8 m -51.78 -30.75 24.21 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.983 0.364 . . . . 74.2 111.983 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.416 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 69.9 m-85 -58.24 -41.01 83.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.717 0.294 . . . . 71.23 111.733 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 53.3 mttm -82.94 -26.73 31.12 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.978 0.362 . . . . 71.51 111.978 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 -41.73 91.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.769 0.319 . . . . 75.21 110.862 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 30.3 p -81.63 -37.15 28.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.629 0.252 . . . . 73.53 111.105 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.67 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.7 tt0 -51.62 -71.32 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.01 0.524 . . . . 74.5 112.283 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -67.07 -38.61 86.08 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.465 0.542 . . . . 65.22 112.465 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.31 -54.44 37.03 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.806 0.336 . . . . 71.4 111.337 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.28 -43.67 97.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.935 -0.65 . . . . 42.03 112.641 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 86.7 m -64.66 -42.97 95.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.79 0.293 . . . . 75.31 111.79 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.83 -44.69 92.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.867 0.365 . . . . 55.4 110.781 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.13 -39.01 84.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.949 0.404 . . . . 72.1 110.83 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.67 -43.01 98.13 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.093 -0.575 . . . . 72.21 112.309 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -62.89 -34.91 78.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.661 0.267 . . . . 72.02 111.059 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -63.09 -42.54 99.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.921 0.391 . . . . 72.21 110.653 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.04 -49.93 77.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.973 0.416 . . . . 62.14 111.2 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 149' ' ' HIS . 4.9 t -77.86 -11.44 59.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.576 -0.284 . . . . 74.33 111.609 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -72.64 -61.54 1.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.076 0.465 . . . . 71.53 110.577 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.93 -40.02 96.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.824 -0.625 . . . . 63.25 111.704 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -75.66 -38.88 58.43 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.927 0.343 . . . . 73.42 111.927 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 3.1 mm? -113.0 -89.0 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.648 0.261 . . . . 72.2 111.248 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 13.3 mt-10 -156.84 -59.71 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.233 0.613 . . . . 73.35 110.239 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.484 ' O ' HG23 ' A' ' 143' ' ' THR . 17.7 t-80 -153.1 -48.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.056 -0.52 . . . . 73.32 110.479 169.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -177.49 93.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.245 -0.434 . . . . 73.31 111.286 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 77.5 t60 66.76 151.41 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.319 0.581 . . . . 75.31 112.344 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -75.4 134.65 40.88 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.318 0.58 . . . . 73.11 112.395 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -155.44 -101.59 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.727 -0.669 . . . . 75.53 110.054 174.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 20.7 p80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 119.311 -0.376 . . . . 73.31 110.611 164.837 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.311 0.101 . . . . 54.31 111.244 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.759 HG13 ' HA2' ' A' ' 139' ' ' GLY . 45.4 mm 67.14 122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 71.24 112.561 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.92 109.22 3.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.132 -0.556 . . . . 55.1 112.703 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.23 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.634 -0.333 . . . . 65.31 111.57 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 97.1 m-85 -86.87 120.64 28.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.898 0.38 . . . . 74.44 111.233 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 1.3 p90 -150.32 -179.9 7.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.393 -0.367 . . . . 64.34 110.924 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.7 t -133.49 110.62 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.68 -0.236 . . . . 64.25 110.522 173.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 40.8 t -51.95 -33.48 37.73 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.404 0.52 . . . . 71.21 112.404 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -85.18 -12.6 52.31 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.711 0.634 . . . . 73.42 112.711 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -98.62 90.85 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.778 -0.576 . . . . 73.2 112.121 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.88 -162.03 4.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 115.067 0.787 . . . . 45.33 115.067 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' PRO . 39.4 m-85 -68.15 1.6 2.71 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.813 0.672 . . . . 64.23 112.813 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -54.63 -33.61 60.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.428 0.632 . . . . 74.25 110.581 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 23.6 t70 -59.66 -37.24 78.21 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.294 -0.866 . . . . 53.24 111.878 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -85.26 -26.73 26.46 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.182 -0.463 . . . . 73.5 111.904 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -55.62 -46.25 77.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 44.43 111.474 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.28 -54.29 47.16 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.243 0.46 . . . . 74.51 112.243 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.464 ' HA ' HG22 ' A' ' 21' ' ' ILE . 35.0 tt0 -67.25 -36.37 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.557 -0.292 . . . . 72.4 111.578 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.74 86.74 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.784 0.326 . . . . 74.31 111.689 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.76 -55.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.784 0.326 . . . . 64.0 111.533 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 18' ' ' GLN . 13.4 tt -60.55 -30.05 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.626 0.25 . . . . 74.11 111.315 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -53.42 -35.3 60.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.213 0.53 . . . . 63.5 111.32 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.35 -33.92 6.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.156 -0.545 . . . . 75.22 113.437 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.81 -24.46 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.129 0.789 . . . . 72.11 113.129 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -53.6 -33.37 54.67 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.404 0.52 . . . . 72.2 112.404 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.82 -18.45 60.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.282 0.475 . . . . 74.44 112.282 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.0 m -84.28 -15.93 44.94 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.205 0.526 . . . . 64.33 111.308 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.85 2.99 57.16 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.385 -0.435 . . . . 54.03 112.928 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -98.67 104.57 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.046 0.45 . . . . 63.53 111.299 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.23 128.54 9.55 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.133 -0.556 . . . . 74.43 112.427 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.2 m -90.54 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.1 0.476 . . . . 71.43 111.911 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.2 104.83 16.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.034 0.445 . . . . 74.5 111.069 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 6' ' ' TYR . 35.8 m -83.2 139.53 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.121 0.486 . . . . 74.41 112.285 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.4 t -139.09 118.4 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.382 -0.372 . . . . 72.14 111.401 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.9 m-20 -76.32 91.65 3.26 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.344 -0.222 . . . . 62.45 111.067 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 36' ' ' LEU . 2.5 pt? -59.79 -20.69 58.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.887 0.375 . . . . 55.32 111.963 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 12.58 66.94 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.29 -0.481 . . . . 72.04 113.39 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -161.51 -65.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.921 0.391 . . . . 75.15 111.916 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.65 77.82 4.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.132 0.491 . . . . 64.12 112.127 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.6 126.08 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.128 0.49 . . . . 62.21 111.807 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -163.78 170.9 16.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.134 -0.485 . . . . 55.32 110.172 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.7 tm? -54.73 -37.28 65.7 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.598 0.237 . . . . 73.3 111.151 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -58.55 -57.31 13.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 75.32 111.404 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -61.28 -35.52 77.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.293 -0.412 . . . . 73.33 111.288 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 2.8 tm? -61.09 -42.07 97.83 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.02 0.438 . . . . 73.13 110.268 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -67.87 -43.29 79.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.875 0.369 . . . . 75.32 111.046 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 27.9 mt-10 -62.63 -25.74 68.27 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.749 0.278 . . . . 72.32 111.749 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 64.3 tp -57.44 -36.85 71.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 70.3 110.576 173.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.63 -35.93 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.085 0.469 . . . . 43.11 111.031 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.48 77.39 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.115 -0.564 . . . . 64.53 112.642 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.571 ' NH1' ' HB3' ' A' ' 47' ' ' GLU . 7.5 mpt_? -100.39 6.83 44.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.431 0.293 . . . . 74.33 111.581 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -54.4 -19.94 6.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.135 0.791 . . . . 72.21 113.135 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 p -70.92 -17.99 62.67 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.933 0.345 . . . . 52.51 111.933 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -169.68 137.76 4.68 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.886 -0.673 . . . . 51.44 113.744 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.87 143.17 20.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.063 0.459 . . . . 74.2 111.047 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.51 122.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 73.04 111.299 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -105.27 130.29 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.23 -0.441 . . . . 73.03 111.519 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.597 ' HA2' ' HB2' ' A' ' 88' ' ' PHE . . . -80.15 56.72 4.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.019 -0.61 . . . . 71.0 112.709 175.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 90' ' ' THR . 24.8 mmt 65.41 173.04 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.444 0.64 . . . . 74.33 111.943 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.8 m -141.24 90.29 9.2 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 116.396 -0.365 . . . . 73.0 110.657 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.45 156.33 26.78 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.617 2.211 . . . . 41.4 113.258 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.98 -55.19 2.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.335 0.865 . . . . 64.51 113.335 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.97 67.75 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.305 0.483 . . . . 61.04 112.305 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -72.03 -40.74 68.22 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.774 0.321 . . . . 64.04 111.296 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.19 34.89 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.822 0.675 . . . . 74.54 112.822 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -59.58 4.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 65.14 112.29 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 t -65.11 -36.6 84.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.118 0.485 . . . . 45.43 111.482 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.495 HG22 ' HG ' ' A' ' 72' ' ' LEU . 56.2 mt -59.75 -33.31 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.924 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -53.24 -35.54 60.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.873 0.368 . . . . 62.14 111.894 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.95 -22.19 70.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.917 -0.658 . . . . 42.2 113.354 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.08 -31.45 11.06 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.57 0.581 . . . . 74.34 112.57 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HG ' HG22 ' A' ' 68' ' ' ILE . 49.6 mt -49.94 -44.81 50.69 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.167 0.803 . . . . 71.05 113.167 -174.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 m -52.28 -35.67 50.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.953 0.353 . . . . 71.34 111.953 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -85.18 -45.26 12.19 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 71.42 111.286 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.24 -50.2 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.266 -0.424 . . . . 55.01 111.776 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.57 -22.87 62.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.766 0.317 . . . . 73.32 111.747 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.36 -15.28 41.6 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.253 -0.499 . . . . 55.03 112.983 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.8 m -89.29 -27.21 20.7 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.483 -0.422 . . . . 74.2 111.804 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.0 m -70.76 131.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.345 0.593 . . . . 63.15 112.073 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -82.74 170.49 15.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 71.52 110.786 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 44.2 tt0 -48.6 -35.05 12.74 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.75 0.648 . . . . 65.43 112.75 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -154.21 141.32 19.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.444 0.64 . . . . 73.12 112.423 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 -179.08 7.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.416 -0.811 . . . . 72.32 109.852 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -88.5 91.51 8.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.259 0.552 . . . . 73.44 111.691 -177.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.8 m -103.32 138.0 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.997 0.427 . . . . 74.21 111.198 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.57 164.63 25.67 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.985 -0.626 . . . . 52.31 113.177 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -135.44 145.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.72 0.408 . . . . 75.43 110.51 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' HB2' ' HA2' ' A' ' 58' ' ' GLY . 36.8 m-85 -99.21 129.18 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.708 0.29 . . . . 74.24 110.978 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 117' ' ' ILE . 35.1 mp0 -70.2 80.29 0.52 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.239 0.542 . . . . 72.3 111.315 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 59' ' ' MET . 9.0 t -146.66 179.03 7.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.27 -0.423 . . . . 75.24 111.366 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 75.22 -72.12 1.69 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.336 -0.459 . . . . 72.23 113.736 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.32 -116.25 0.73 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.198 -0.525 . . . . 71.53 112.978 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.53 36.29 0.51 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.023 -0.608 . . . . 44.32 112.899 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.91 109.88 21.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.669 0.271 . . . . 73.42 111.391 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.06 157.27 25.86 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.406 -0.361 . . . . 74.31 111.622 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 2.8 mp0 -103.49 -55.78 0.1 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.227 0.825 . . . . 53.13 113.227 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 3.8 Cg_exo -77.26 16.92 0.94 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.703 2.269 . . . . 63.22 114.332 -176.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 99' ' ' ASP . 9.0 tt -44.36 -62.3 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 114.231 1.197 . . . . 75.41 114.231 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.515 ' H ' HG23 ' A' ' 98' ' ' ILE . 39.7 m-20 -62.72 -50.29 78.56 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.211 0.819 . . . . 72.11 113.211 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 63.8 Cg_exo -53.67 -43.22 59.7 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.373 2.049 . . . . 54.24 113.344 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.2 -44.72 68.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.572 0.225 . . . . 72.53 111.425 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.555 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 60.5 mt -56.05 -44.95 79.34 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.746 0.308 . . . . 54.5 110.985 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.2 t -56.91 -40.93 77.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.951 0.405 . . . . 74.52 110.951 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -39.69 78.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.403 -0.362 . . . . 74.23 111.185 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.646 ' HD1' HD12 ' A' ' 110' ' ' LEU . 29.4 m-85 -61.39 -32.46 72.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.568 0.223 . . . . 75.12 111.316 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 102' ' ' LEU . 2.1 mpt_? -73.92 -40.68 62.96 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.807 0.337 . . . . 55.4 111.111 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.63 -43.29 80.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.021 0.439 . . . . 63.44 111.426 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.496 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 81.2 mt -89.72 -41.76 11.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.031 0.443 . . . . 75.54 111.911 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 57.39 1.38 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.933 -0.467 . . . . 73.1 111.933 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.646 HD12 ' HD1' ' A' ' 105' ' ' PHE . 83.5 mt -96.32 163.01 13.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 74.42 112.34 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.438 HG21 HD11 ' A' ' 138' ' ' LEU . 87.4 m -66.15 136.4 55.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.588 -0.733 . . . . 60.43 112.104 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -131.9 96.54 3.95 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.378 -0.374 . . . . 55.33 111.073 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.33 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.393 0.516 . . . . 61.45 112.393 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -150.43 89.65 4.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 121.166 0.507 . . . . 74.4 110.791 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.95 30.62 0.51 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.037 2.492 . . . . 64.41 114.378 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.19 101.63 0.74 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.94 0.348 . . . . 62.21 111.94 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 89' ' ' GLU . 14.2 tt -153.0 143.53 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.004 0.431 . . . . 64.01 111.608 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -79.14 94.01 5.29 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.207 0.527 . . . . 74.54 111.74 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.436 HG12 HG23 ' A' ' 117' ' ' ILE . 49.4 mm -105.2 116.49 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.187 -0.461 . . . . 62.11 110.482 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 45.8 tptt -80.29 50.46 1.26 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.01 0.433 . . . . 61.44 111.498 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.5 tt0 71.57 -60.45 0.52 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.461 0.704 . . . . 72.02 112.558 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -86.75 120.85 72.0 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 111.816 0.302 . . . . 60.22 111.816 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' A' ' 12' ' ' TYR . 71.5 Cg_exo -51.81 137.85 51.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.81 2.34 . . . . 72.3 113.085 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.9 p -93.83 168.01 11.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.883 0.373 . . . . 72.35 111.518 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.44 -32.74 71.66 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.219 0.533 . . . . 70.01 110.807 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -73.24 -31.63 64.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.013 -0.54 . . . . 74.41 111.02 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.8 m -52.51 -38.38 59.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.27 -0.423 . . . . 60.5 111.809 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -52.47 -41.9 63.75 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.688 0.28 . . . . 64.23 111.626 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -65.57 -46.36 79.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.977 0.362 . . . . 62.25 111.977 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.93 -51.61 60.9 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.523 -0.308 . . . . 75.31 111.091 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.9 -29.94 71.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.804 0.298 . . . . 65.11 111.804 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.46 -58.16 7.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.942 0.401 . . . . 53.55 110.369 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.19 -12.35 61.6 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.201 0.445 . . . . 73.01 112.201 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.59 -62.84 1.53 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.897 0.38 . . . . 44.03 110.863 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.08 -42.35 99.72 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 63.15 113.51 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -35.85 61.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.287 0.477 . . . . 75.21 112.287 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 141' ' ' TRP . 29.4 t70 -60.17 -51.64 68.73 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.976 0.417 . . . . 61.12 110.925 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 138' ' ' LEU . 2.6 mm? -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.915 0.388 . . . . 74.45 110.919 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.759 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -63.89 -55.06 26.73 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.321 -0.466 . . . . 62.4 112.746 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -74.61 -14.88 60.83 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.598 -0.354 . . . . 55.43 111.715 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 62.2 t90 -50.28 -38.33 40.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.18 0.514 . . . . 73.11 110.546 176.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 146' ' ' ARG . 58.8 t -54.88 -61.05 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.437 -0.802 . . . . 51.24 111.623 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -70.62 -25.1 62.88 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.466 0.543 . . . . 71.03 112.466 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -67.93 -38.09 82.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.132 -0.355 . . . . 73.14 111.44 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.5 -50.33 7.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 120.965 0.412 . . . . 70.13 111.274 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 11.9 mtp180 -69.93 -19.0 63.4 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.893 0.701 . . . . 74.41 112.893 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 52.5 tp 77.88 -49.59 0.5 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.396 0.678 . . . . 74.54 112.266 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.92 17.93 2.8 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.996 0.427 . . . . 61.55 112.054 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 57.04 21.27 6.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.989 -0.55 . . . . 71.23 111.71 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.3 m80 60.37 91.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.206 0.526 . . . . 71.52 111.064 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -82.97 66.04 8.39 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.599 0.592 . . . . 73.33 112.599 -170.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.8 m80 62.12 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 70.2 113.339 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 37.5 t60 67.25 96.31 0.06 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.927 0.491 . . . . 75.42 112.167 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.743 -0.646 . . . . 73.33 111.58 178.161 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 43.0 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 111.227 0.084 . . . . 74.13 111.227 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm 67.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 121.17 0.509 . . . . 61.43 111.766 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.95 109.58 3.21 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.2 -0.524 . . . . 73.04 112.972 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 111.58 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.795 0.331 . . . . 54.25 110.971 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.453 ' HE2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 m-85 -97.29 139.46 33.22 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.408 0.521 . . . . 71.03 112.408 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 35' ' ' ASP . 44.1 p90 -142.29 162.91 34.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.972 0.415 . . . . 72.12 110.751 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 9' ' ' GLU . 20.7 t -106.29 115.73 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 122.213 -0.305 . . . . 61.04 111.591 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 35' ' ' ASP . 15.1 m -60.12 -20.28 57.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.96 0.41 . . . . 74.01 111.786 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.54 ' H ' HG12 ' A' ' 7' ' ' VAL . 43.2 tt0 -70.13 -69.51 0.35 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.127 -0.488 . . . . 71.33 111.696 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -137.38 -35.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.943 0.349 . . . . 72.21 111.943 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -28.55 103.37 0.01 OUTLIER Glycine 0 N--CA 1.472 1.091 0 N-CA-C 115.328 0.891 . . . . 53.21 115.328 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.62 5.47 3.06 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.83 0.452 . . . . 75.21 112.208 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 m -57.7 -19.73 29.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.653 0.612 . . . . 42.44 112.653 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -61.73 -34.85 76.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.247 0.546 . . . . 45.34 111.067 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -69.47 -37.73 77.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.727 -0.669 . . . . 75.51 111.079 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.641 HD13 ' SG ' ' A' ' 131' ' ' CYS . 64.5 mt -70.3 -39.98 74.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.811 -0.632 . . . . 75.4 110.706 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.05 74.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.828 -0.624 . . . . 73.43 111.706 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -61.73 -41.02 97.09 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.122 0.487 . . . . 73.11 111.032 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.04 87.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.367 -0.379 . . . . 53.13 111.399 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.85 -56.81 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.043 -0.526 . . . . 74.13 111.621 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 25' ' ' THR . 12.8 tt -54.77 -41.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.443 0.164 . . . . 52.52 111.443 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -51.31 -50.49 59.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.721 0.408 . . . . 55.41 111.832 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.26 -39.07 32.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.066 -0.588 . . . . 72.14 113.508 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 30' ' ' GLY . 49.6 mm -67.44 -41.61 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 122.268 -0.548 . . . . 70.25 112.119 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 21' ' ' ILE . 13.3 t -72.1 -31.18 65.81 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.996 -0.44 . . . . 74.2 110.532 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -59.04 -42.84 91.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.043 0.449 . . . . 75.24 109.795 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.1 m -67.09 -27.47 67.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.856 -0.611 . . . . 75.43 111.218 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.17 22.52 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.23 -0.509 . . . . 71.43 113.509 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -95.67 -52.96 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.459 -0.436 . . . . 71.24 112.028 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.54 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 87.64 134.78 4.49 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 121.124 -0.56 . . . . 62.22 113.55 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.0 m -108.69 171.74 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.198 0.523 . . . . 53.13 112.318 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -127.89 107.28 9.73 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.955 -0.566 . . . . 74.12 110.078 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -92.3 125.92 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.415 0.626 . . . . 75.25 112.334 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.1 t -122.68 126.19 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.99 0.424 . . . . 73.34 111.374 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 5.4 p-10 -94.66 88.06 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.644 0.735 . . . . 65.01 111.771 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 36' ' ' LEU . 1.2 pp -69.73 -3.6 16.07 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.729 -0.669 . . . . 75.42 112.288 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.48 1.37 85.87 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.021 -0.609 . . . . 63.53 112.504 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.05 177.47 4.85 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.964 0.411 . . . . 71.35 111.132 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.64 84.33 0.29 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.035 0.445 . . . . 65.31 111.993 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.33 163.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.107 -0.497 . . . . 62.24 111.472 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.51 172.7 17.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.862 0.363 . . . . 73.05 111.89 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.4 mm? -56.11 -31.28 63.14 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.779 0.659 . . . . 75.44 112.779 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -61.33 -34.23 74.92 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.263 0.554 . . . . 65.33 111.171 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.27 -48.93 12.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.775 -0.648 . . . . 71.13 110.69 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.44 HD23 HG12 ' A' ' 75' ' ' ILE . 3.3 tm? -53.53 -40.17 65.25 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.057 -0.52 . . . . 73.13 111.667 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -59.59 -53.02 62.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.098 0.475 . . . . 54.45 111.366 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.47 -39.04 93.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.193 -0.458 . . . . 72.33 111.133 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.428 HD11 ' HZ ' ' A' ' 5' ' ' PHE . 59.0 tp -55.53 -52.81 62.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.976 -0.556 . . . . 52.24 111.434 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 45' ' ' LEU . 87.7 t -60.21 -44.23 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.308 -0.406 . . . . 61.21 111.608 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.73 89.21 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.059 -0.591 . . . . 53.14 113.457 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.23 8.22 43.94 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.785 0.661 . . . . 72.3 112.785 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.4 p -55.28 -3.1 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.93 1.085 . . . . 73.23 113.93 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -44.74 -41.37 6.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.61 0.596 . . . . 73.21 112.61 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 84' ' ' ALA . . . -149.84 136.86 5.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.354 -0.451 . . . . 72.32 112.291 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.453 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 83.9 mt -139.27 141.35 37.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.908 0.354 . . . . 73.04 111.671 -175.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.48 118.12 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.147 0.499 . . . . 71.31 111.191 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.2 mp -106.81 131.81 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.922 0.391 . . . . 74.43 111.709 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.77 58.16 0.46 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.35 -0.453 . . . . 72.12 113.424 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 89' ' ' GLU . 84.2 mtp 67.0 -178.49 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.96 0.726 . . . . 70.02 112.96 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -141.79 88.84 9.3 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.514 -0.767 . . . . 71.45 110.649 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.07 143.0 85.23 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 122.931 2.421 . . . . 63.32 113.253 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.8 -64.51 0.39 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.83 1.048 . . . . 75.32 113.83 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.31 -53.75 53.57 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.209 0.448 . . . . 74.13 112.209 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 68' ' ' ILE . 39.0 t -64.79 -25.81 68.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.455 0.539 . . . . 71.34 112.455 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.81 69.47 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.017 0.377 . . . . 74.3 112.017 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.24 -53.47 50.31 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.909 0.385 . . . . 73.42 111.735 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 m -71.19 -32.66 69.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.906 0.335 . . . . 72.21 111.906 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 64' ' ' SER . 76.6 mt -64.9 -47.35 88.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.852 0.316 . . . . 73.21 111.852 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.92 -42.34 89.44 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.712 0.292 . . . . 61.41 111.72 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.14 70.51 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.226 -0.511 . . . . 65.12 113.038 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.42 -43.12 16.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.794 0.331 . . . . 74.31 111.514 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.6 tp -52.93 -41.08 64.12 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.801 0.44 . . . . 73.22 111.833 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 t -51.57 -37.47 49.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.123 0.487 . . . . 72.24 111.582 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.0 m -84.51 -40.79 17.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.034 0.445 . . . . 73.32 111.356 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.44 HG12 HD23 ' A' ' 45' ' ' LEU . 72.4 mt -54.8 -46.76 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.01 -0.541 . . . . 61.5 111.889 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.99 -47.08 65.06 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.883 0.373 . . . . 74.21 111.937 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.07 -26.86 67.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.059 -0.591 . . . . 72.52 113.373 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -78.05 -40.66 38.01 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.493 0.553 . . . . 71.2 112.493 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.01 168.97 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.266 0.555 . . . . 74.32 112.261 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.54 158.4 25.81 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.142 -0.481 . . . . 74.24 110.557 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.17 -82.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.317 0.858 . . . . 71.04 113.317 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -94.5 101.0 12.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.705 0.632 . . . . 70.22 112.705 -173.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -122.01 -164.99 1.21 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.051 -0.522 . . . . 74.33 111.151 176.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -110.33 134.85 51.88 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.861 0.362 . . . . 61.34 110.771 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 112' ' ' THR . 29.6 m -132.55 170.96 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.422 0.629 . . . . 72.41 112.508 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 110.96 0.63 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.819 -0.628 . . . . 63.14 111.982 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -101.04 114.36 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.217 -0.578 . . . . 55.44 111.202 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 29.0 p90 -123.0 110.78 15.8 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 74.23 111.503 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 41.8 mt-10 -78.77 81.77 5.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.234 0.54 . . . . 64.01 111.366 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -79.76 -9.57 59.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.067 -0.515 . . . . 72.3 112.164 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.26 -70.67 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.24 -0.505 . . . . 70.43 113.073 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.58 21.75 77.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.169 -0.539 . . . . 74.41 113.15 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.86 -85.28 0.26 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.278 -0.487 . . . . 72.43 113.944 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -163.52 129.93 3.26 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.42 -0.459 . . . . 75.14 111.369 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -163.38 152.75 14.82 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.097 0.475 . . . . 73.23 111.89 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.6 mp0 -95.23 -43.96 0.27 Allowed Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.858 1.058 . . . . 74.33 113.858 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 74.2 Cg_endo -71.13 23.28 0.22 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.27 1.98 . . . . 53.33 114.928 -170.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 99' ' ' ASP . 10.8 tt -57.71 -53.43 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 112.648 0.61 . . . . 75.32 112.648 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.679 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.3 m-20 -61.89 -55.88 37.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.472 0.545 . . . . 64.2 112.472 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.8 Cg_exo -54.12 -44.98 44.48 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.333 2.022 . . . . 73.41 112.81 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -60.48 -54.48 45.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.305 -0.407 . . . . 53.14 111.269 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.31 -38.69 80.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.518 -0.31 . . . . 70.45 111.725 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 t -62.46 -37.66 86.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.808 0.337 . . . . 45.52 111.339 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HE3' HD11 ' A' ' 108' ' ' LEU . 59.6 tptt -58.41 -47.73 82.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.024 0.44 . . . . 75.52 111.051 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.67 -46.42 75.73 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.327 -0.397 . . . . 74.34 111.773 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -62.53 -52.68 62.48 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.42 0.526 . . . . 74.02 112.42 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.27 -35.53 80.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.698 0.629 . . . . 74.35 112.698 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 ' HE3' ' A' ' 104' ' ' LYS . 80.7 mt -78.23 -15.58 58.66 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.107 -0.371 . . . . 75.14 111.605 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.04 40.19 51.91 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.06 -0.59 . . . . 20.44 112.899 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.93 104.03 3.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.828 0.346 . . . . 51.1 110.707 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -64.71 123.8 20.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.142 0.496 . . . . 64.12 112.086 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 76.6 p -89.92 136.89 32.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.361 -0.381 . . . . 42.22 111.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 138' ' ' LEU . . . -56.78 -54.64 44.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.082 0.468 . . . . 74.14 111.295 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -150.34 131.12 7.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.369 -0.378 . . . . 70.24 110.284 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.54 103.53 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.412 2.074 . . . . 72.24 112.688 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . . . -80.45 -179.47 7.17 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 44.32 112.714 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.25 145.2 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.92 -0.582 . . . . 71.4 111.019 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -72.24 150.23 43.84 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.482 0.919 . . . . 74.2 113.482 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 123' ' ' PRO . 23.4 mm -106.8 167.14 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.115 -0.948 . . . . 71.52 110.757 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.481 ' N ' HG22 ' A' ' 119' ' ' ILE . 57.6 tptt -64.19 -66.11 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.843 0.354 . . . . 71.23 111.773 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -151.13 -55.73 0.15 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.257 0.551 . . . . 74.11 111.027 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -92.82 118.63 67.98 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.956 -0.565 . . . . 75.15 110.413 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 119' ' ' ILE . 32.1 Cg_endo -61.95 141.27 88.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.675 2.25 . . . . 64.35 113.389 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.4 p -76.16 156.08 34.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.877 -0.601 . . . . 75.12 111.428 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.76 -30.9 71.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.165 0.507 . . . . 74.34 111.037 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -57.29 -22.69 43.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.3 -0.409 . . . . 71.23 111.093 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.9 m -65.6 -25.76 67.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.852 0.358 . . . . 72.44 111.068 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -67.47 -48.16 67.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.913 0.387 . . . . 73.32 110.395 172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.68 -31.62 71.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.467 0.651 . . . . 74.33 110.692 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.02 -63.02 1.44 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.369 -0.832 . . . . 74.34 111.005 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.641 ' SG ' HD13 ' A' ' 16' ' ' LEU . 64.6 m -62.24 -26.21 68.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.387 -0.37 . . . . 42.12 111.936 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.02 -69.86 0.1 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.189 -0.46 . . . . 61.41 111.751 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.57 -16.67 44.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.185 0.439 . . . . 42.41 112.185 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.78 -53.62 44.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.812 0.339 . . . . 74.43 110.716 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.52 95.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.14 -0.552 . . . . 70.51 112.444 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 59.4 m -60.85 -46.74 89.4 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.918 0.34 . . . . 71.44 111.918 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.82 -43.62 98.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.771 0.32 . . . . 74.15 111.278 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 44.2 tp -57.31 -45.05 84.59 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.263 0.554 . . . . 51.1 110.008 173.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 143' ' ' THR . . . -61.97 -35.5 91.48 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.807 -0.633 . . . . 70.51 112.785 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLN . . . . . 0.511 ' HA ' HG22 ' A' ' 143' ' ' THR . 24.6 mt-30 -65.19 -35.56 81.45 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.909 0.354 . . . . 70.32 111.352 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -62.38 -47.6 83.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.072 0.463 . . . . 74.11 110.391 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.24 -55.53 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.821 -0.627 . . . . 55.44 111.684 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 140' ' ' GLN . 8.8 t -63.27 -28.31 69.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.071 0.397 . . . . 63.45 112.071 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.509 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 37.7 ttt180 -68.42 -50.47 52.52 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.104 0.478 . . . . 51.21 111.164 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.89 -29.69 66.95 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.52 . . . . 75.23 111.669 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 146' ' ' ARG . 23.8 ttt180 -100.58 -31.72 11.12 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.995 1.109 . . . . 63.45 113.995 -172.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.1 tp -151.54 -94.47 0.06 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.943 1.09 . . . . 70.45 113.943 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' CG ' ' HA ' ' A' ' 144' ' ' ARG . 7.4 mm-40 58.46 97.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.093 0.557 . . . . 71.24 112.32 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -115.93 -43.09 3.01 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.212 -0.305 . . . . 73.14 111.583 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.97 31.81 0.4 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.898 0.38 . . . . 73.22 111.624 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -85.1 134.09 34.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.344 -0.389 . . . . 73.05 111.314 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -138.57 141.91 39.24 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.13 0.49 . . . . 71.33 112.051 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -115.6 122.47 45.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 65.15 110.391 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.248 -0.406 . . . . 73.43 111.642 178.212 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 57.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.375 -0.232 . . . . 50.140000000000001 110.375 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.724 HD11 HG21 ' A' ' 142' ' ' VAL . 30.3 mm 69.96 103.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.971 -174.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -90.13 106.58 3.35 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.211 -0.518 . . . . 65.319999999999993 112.969 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.626 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -83.09 116.1 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.53 0.681 . . . . 75.040000000000006 111.705 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 36' ' ' LEU . 63.0 m-85 -89.98 113.25 24.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.715 -0.675 . . . . 74.439999999999998 110.467 176.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 36.8 p90 -137.84 -178.59 5.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.146 0.498 . . . . 73.299999999999997 112.01 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 10' ' ' TYR . 23.8 t -126.87 111.94 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.145 -0.48 . . . . 72.0 111.004 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.88 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 46.6 t -61.9 -26.33 68.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.19 0.811 . . . . 52.049999999999997 113.19 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.38 -64.5 1.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.285 0.564 . . . . 65.349999999999994 112.42 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.442 ' H ' HG12 ' A' ' 7' ' ' VAL . 19.8 t80 -71.6 127.26 31.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.855 -0.611 . . . . 74.340000000000003 112.247 -171.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.91 -161.98 7.44 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 114.994 0.758 . . . . 12.539999999999999 114.994 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -87.35 7.22 29.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.04 0.385 . . . . 74.430000000000007 112.04 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -46.87 -40.85 14.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.115 0.783 . . . . 63.039999999999999 113.115 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.88 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 20.1 p-10 -67.38 -41.63 84.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.143 0.497 . . . . 65.349999999999994 111.526 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -68.19 -36.66 79.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.174 -0.466 . . . . 73.040000000000006 110.819 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.85 -44.79 96.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.313 0.578 . . . . 62.409999999999997 110.375 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 21' ' ' ILE . . . -60.0 -39.85 87.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.806 -0.634 . . . . 72.140000000000001 111.303 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.96 -44.06 91.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.589 -0.278 . . . . 44.329999999999998 111.083 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -43.17 82.23 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.006 0.432 . . . . 61.109999999999999 111.158 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.41 -58.71 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.152 -0.476 . . . . 63.350000000000001 111.846 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.678 HG13 ' HB ' ' A' ' 31' ' ' VAL . 13.4 tt -60.02 -48.92 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 111.903 0.334 . . . . 74.120000000000005 111.903 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.405 ' N ' HG23 ' A' ' 21' ' ' ILE . 10.7 t30 -66.65 -39.26 88.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.542 0.201 . . . . 74.439999999999998 111.542 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.47 95.02 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.891 -0.671 . . . . 72.040000000000006 112.644 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.64 HG22 ' HB ' ' A' ' 29' ' ' VAL . 59.9 mt -83.04 -35.71 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.17 0.433 . . . . 61.399999999999999 112.17 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 21' ' ' ILE . 70.8 p -69.12 -39.58 78.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.006 -0.434 . . . . 41.229999999999997 111.054 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.35 -43.07 78.74 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.097 0.475 . . . . 73.299999999999997 110.094 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.3 m -63.0 -43.01 99.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 111.028 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.54 67.44 0.33 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.222 -0.513 . . . . 63.109999999999999 113.619 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.64 ' HB ' HG22 ' A' ' 24' ' ' ILE . 62.5 t -139.37 -68.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 122.525 -0.397 . . . . 70.120000000000005 111.71 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.93 113.14 2.94 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.28 -0.486 . . . . 73.140000000000001 112.814 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 21' ' ' ILE . 82.2 t -109.65 144.42 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.686 0.279 . . . . 55.219999999999999 111.698 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.494 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 18.2 m-20 -93.38 147.47 22.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 64.450000000000003 110.986 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.73 132.28 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 112.431 0.53 . . . . 72.099999999999994 112.431 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 86.9 t -141.49 125.02 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.035 -0.529 . . . . 73.209999999999994 111.026 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.5 m-20 -85.73 99.77 11.55 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.007 -0.433 . . . . 62.030000000000001 111.935 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.529 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -69.78 -21.12 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.027 0.442 . . . . 51.32 111.675 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.418 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -114.64 23.63 11.86 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.651 -0.785 . . . . 62.340000000000003 113.805 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.87 -72.95 0.11 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.73 0.641 . . . . 73.200000000000003 112.73 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.01 23.47 1.22 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.184 0.809 . . . . 74.540000000000006 113.184 -172.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.0 m -57.84 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.645 0.736 . . . . 73.209999999999994 112.25 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.77 171.59 14.94 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.87 -0.605 . . . . 75.040000000000006 110.448 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.27 -36.25 60.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.306 0.242 . . . . 60.450000000000003 111.242 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -57.17 -36.27 70.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.034 0.383 . . . . 55.229999999999997 112.034 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -69.04 -46.28 68.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.394 0.616 . . . . 62.32 110.519 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 49' ' ' VAL . 82.2 mt -61.52 -36.81 81.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.768 -0.651 . . . . 73.349999999999994 111.309 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' NH2' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.55 -46.97 85.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 62.32 110.288 177.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 7.7 tp10 -66.39 -37.95 86.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.951 0.405 . . . . 65.420000000000002 110.877 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 55' ' ' LEU . 59.4 tp -57.63 -30.48 65.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.178 -0.464 . . . . 74.239999999999995 111.607 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 45' ' ' LEU . 63.7 t -63.25 -53.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.98 0.419 . . . . 64.25 111.478 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.17 -37.36 49.08 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.264 -0.493 . . . . 63.340000000000003 113.697 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -90.24 8.08 34.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.078 0.399 . . . . 73.010000000000005 112.078 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -51.31 -8.77 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.425 1.268 . . . . 62.310000000000002 114.425 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 p -65.09 -18.18 65.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.778 0.659 . . . . 74.310000000000002 112.778 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.664 ' HA3' HD13 ' A' ' 2' ' ' ILE . . . -160.85 137.84 5.17 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.587 -0.816 . . . . 42.299999999999997 113.973 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 48' ' ' LEU . 4.7 mp -128.76 159.22 36.36 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.866 0.466 . . . . 55.32 110.824 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 70.7 t -140.66 122.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.429 0.291 . . . . 74.239999999999995 110.824 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -122.22 130.87 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.886 0.374 . . . . 74.519999999999996 111.253 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.23 -128.0 3.22 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.993 -0.622 . . . . 73.420000000000002 112.908 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -84.5 161.29 20.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.14 0.495 . . . . 64.450000000000003 111.515 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -113.03 90.62 16.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.525 -0.307 . . . . 70.109999999999999 111.505 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.36 137.64 16.95 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.971 2.448 . . . . 75.230000000000004 112.093 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.93 -48.28 51.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.414 0.524 . . . . 72.200000000000003 112.414 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.62 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.311 0.485 . . . . 43.43 112.311 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m -78.84 -33.85 45.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.745 0.307 . . . . 64.319999999999993 111.493 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 72.25 111.927 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.64 -33.58 76.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.97 0.359 . . . . 63.039999999999999 111.97 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -85.22 -12.59 52.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.033 0.383 . . . . 73.400000000000006 112.033 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mm -87.86 -23.33 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.177 0.436 . . . . 73.329999999999998 112.177 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -48.49 -48.15 38.2 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.769 0.655 . . . . 54.520000000000003 112.769 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 -57.3 7.35 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.14 -0.553 . . . . 75.420000000000002 113.322 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -55.86 -35.91 66.97 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.417 0.525 . . . . 74.530000000000001 112.417 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.53 -41.68 66.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.612 0.365 . . . . 70.099999999999994 111.006 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -58.98 -47.21 85.97 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.781 0.324 . . . . 74.540000000000006 111.537 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.0 -39.09 93.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.839 0.352 . . . . 71.420000000000002 111.275 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.469 ' O ' HG22 ' A' ' 79' ' ' VAL . 65.3 mt -58.37 -47.06 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.358 -0.383 . . . . 64.140000000000001 111.335 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 82.4 mt -55.35 -28.18 52.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.481 -0.327 . . . . 70.239999999999995 111.875 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.68 -32.23 30.85 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.216 -0.516 . . . . 73.420000000000002 113.195 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p -80.78 -58.68 2.99 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.855 0.317 . . . . 72.209999999999994 111.855 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 75' ' ' ILE . 29.8 m -68.79 145.12 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.338 0.59 . . . . 71.409999999999997 112.112 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -161.37 -168.76 2.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.021 -0.536 . . . . 72.329999999999998 111.429 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.743 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 10.5 tp10 64.08 -95.76 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.701 1.0 . . . . 75.109999999999999 113.701 167.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.743 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.2 ptpp? -169.43 30.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.95 0.405 . . . . 73.230000000000004 111.801 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.458 ' OE1' ' HB3' ' A' ' 81' ' ' GLU . 8.0 mp0 -61.33 176.35 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.578 0.704 . . . . 72.439999999999998 112.642 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.688 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.06 139.53 30.53 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.573 0.582 . . . . 75.030000000000001 112.573 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.99 96.15 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.679 0.752 . . . . 63.520000000000003 110.854 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.3 80.68 0.73 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.944 -0.571 . . . . 53.399999999999999 113.285 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.44 HD13 ' HB ' ' A' ' 57' ' ' ILE . 32.5 mm -82.78 113.85 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 122.725 -0.28 . . . . 64.549999999999997 110.576 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.16 133.07 53.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.368 0.604 . . . . 75.230000000000004 112.267 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 9.5 tp10 -76.23 137.86 40.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.76 -0.655 . . . . 62.420000000000002 111.335 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -156.11 -2.75 0.13 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.97 0.73 . . . . 71.319999999999993 112.97 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.81 109.86 0.39 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.692 -0.766 . . . . 73.129999999999995 113.13 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.24 79.67 0.52 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.527 -0.368 . . . . 53.520000000000003 113.22 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.82 78.39 0.06 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.379 -0.439 . . . . 31.010000000000002 112.53 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -98.47 -174.8 2.91 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.239 0.542 . . . . 70.109999999999999 111.966 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -118.67 138.08 52.86 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.919 -0.582 . . . . 62.140000000000001 109.959 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.545 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 32.8 mt-10 -45.34 -48.4 34.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.601 1.334 . . . . 71.030000000000001 114.601 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 86.0 Cg_exo -50.46 -12.21 0.49 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.915 2.41 . . . . 45.450000000000003 115.092 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.89 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 121.903 -0.498 . . . . 45.350000000000001 111.854 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.1 m-20 -57.18 -51.18 83.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 112.577 0.584 . . . . 74.109999999999999 112.577 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 90.4 Cg_exo -47.78 -40.18 31.49 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.309 2.006 . . . . 74.140000000000001 112.893 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 97' ' ' PRO . 9.7 mp -71.99 -41.57 67.49 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.58 -0.282 . . . . 62.140000000000001 111.205 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.3 mt -58.64 -37.3 75.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 55.530000000000001 111.056 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -58.08 -31.85 67.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.19 -0.459 . . . . 54.340000000000003 110.917 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -68.29 -50.12 55.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.798 0.333 . . . . 73.129999999999995 110.742 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.91 -37.33 76.37 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.16 0.505 . . . . 75.530000000000001 110.777 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -64.74 -60.05 3.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.69 -0.687 . . . . 74.340000000000003 111.207 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.18 -56.08 24.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 112.529 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.17 -23.07 65.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.737 0.273 . . . . 73.219999999999999 111.737 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.4 61.24 5.23 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.291 -0.481 . . . . 72.409999999999997 113.558 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.59 156.55 19.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.625 -0.338 . . . . 74.140000000000001 110.989 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 27.5 m -70.12 93.1 0.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 50.140000000000001 111.509 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -86.63 159.07 19.33 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.22 0.533 . . . . 45.340000000000003 112.319 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.04 -164.81 1.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.127 -0.488 . . . . 73.409999999999997 111.808 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.25 112.34 5.34 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 112.074 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -90.68 107.4 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.014 2.476 . . . . 74.439999999999998 113.484 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.796 ' HB3' ' HB3' ' A' ' 89' ' ' GLU . . . -89.66 177.38 6.55 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.189 -0.319 . . . . 51.240000000000002 110.634 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.9 tt -132.58 102.52 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.665 0.617 . . . . 74.530000000000001 112.665 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 55.99 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.353 0.871 . . . . 71.310000000000002 113.353 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.589 HG12 ' HG3' ' A' ' 89' ' ' GLU . 46.4 mm -95.35 74.71 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.04 0.447 . . . . 64.200000000000003 110.39 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 51.46 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.807 0.669 . . . . 60.43 112.807 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 179.09 -42.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.181 0.592 . . . . 42.119999999999997 110.674 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.8 p -96.08 114.62 64.56 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 111.521 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.47 127.76 26.63 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.713 2.276 . . . . 50.100000000000001 113.133 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 33.9 p -107.89 177.09 4.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.569 -0.287 . . . . 73.430000000000007 111.608 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.56 -34.96 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.01 0.433 . . . . 71.310000000000002 111.586 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.422 ' O ' HD13 ' A' ' 130' ' ' LEU . 16.0 m120 -58.05 -41.19 82.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.974 0.416 . . . . 71.430000000000007 110.609 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.7 m -56.82 -44.48 82.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.251 -0.431 . . . . 71.140000000000001 111.377 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -58.85 -46.36 87.93 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.279 0.562 . . . . 73.340000000000003 111.04 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.94 -32.48 72.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.775 -0.648 . . . . 65.409999999999997 111.802 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 126' ' ' ASN . 10.9 mp -77.78 -42.25 34.59 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.303 -0.248 . . . . 73.349999999999994 111.418 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.9 m -58.66 -53.32 59.72 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 111.566 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.1 -54.08 50.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.269 -0.423 . . . . 64.5 111.759 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.81 -54.86 36.44 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.221 -0.445 . . . . 54.439999999999998 111.843 -177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.5 97.27 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.71 0.29 . . . . 75.319999999999993 111.777 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.55 76.04 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.08 -0.581 . . . . 72.420000000000002 112.789 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.8 m -61.2 -42.62 98.91 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 62.299999999999997 111.041 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.33 -42.15 95.06 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.026 -0.534 . . . . 51.439999999999998 111.182 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.479 HD11 ' HB1' ' A' ' 84' ' ' ALA . 52.5 tp -62.73 -44.28 96.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.125 0.488 . . . . 73.129999999999995 110.636 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -34.57 75.11 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 116.018 -0.537 . . . . 62.32 112.781 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 136' ' ' THR . 55.5 mt-30 -64.78 -25.68 68.02 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.714 0.292 . . . . 74.239999999999995 111.711 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -72.82 -52.43 14.94 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.068 0.461 . . . . 74.349999999999994 110.166 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.724 HG21 HD11 ' A' ' 2' ' ' ILE . 60.9 t -57.2 -45.16 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.797 -0.638 . . . . 72.329999999999998 112.172 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 9.0 t -61.71 -51.78 66.99 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.997 0.369 . . . . 51.32 111.997 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 143' ' ' THR . 90.5 mtt-85 -64.26 -41.64 96.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.113 0.482 . . . . 72.540000000000006 111.13 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.15 -49.87 68.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.122 -0.49 . . . . 70.450000000000003 111.725 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.484 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 0.1 OUTLIER -82.7 -11.07 58.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.183 0.438 . . . . 72.140000000000001 112.183 -174.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 143' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.157 0.503 . . . . 43.109999999999999 110.395 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 25.3 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.389 0.137 . . . . 65.430000000000007 111.357 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.0 mp 58.7 97.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.214 0.531 . . . . 53.219999999999999 111.869 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.29 96.11 1.9 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.193 -0.527 . . . . 42.340000000000003 112.98 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -85.56 105.73 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 O-C-N 122.374 -0.486 . . . . 74.200000000000003 111.398 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.21 123.14 38.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.755 0.312 . . . . 75.439999999999998 111.276 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.18 175.0 9.95 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.956 0.407 . . . . 73.530000000000001 111.541 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 7' ' ' VAL . 5.9 p -121.62 95.99 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 64.430000000000007 111.129 176.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -52.6 -34.64 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.595 -0.73 . . . . 75.239999999999995 112.788 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.13 -35.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.64 0.608 . . . . 44.420000000000002 112.64 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -109.05 146.57 33.76 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.243 0.46 . . . . 75.319999999999993 112.243 -170.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.19 -164.18 5.18 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 114.521 0.568 . . . . 73.219999999999999 114.521 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.607 ' HD2' ' HG2' ' A' ' 123' ' ' PRO . 57.4 m-85 -87.45 9.47 20.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.762 0.425 . . . . 64.420000000000002 111.778 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -29.98 -48.97 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.729 1.381 . . . . 72.340000000000003 114.729 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.86 -46.17 90.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.896 0.379 . . . . 75.519999999999996 111.644 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.35 -38.21 89.39 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.928 0.394 . . . . 75.510000000000005 110.858 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.597 HD11 ' HG3' ' A' ' 123' ' ' PRO . 85.8 mt -61.59 -42.59 99.07 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.062 0.458 . . . . 74.120000000000005 110.778 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -58.6 -47.26 84.92 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.135 -0.484 . . . . 62.420000000000002 110.759 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.8 -37.75 60.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.14 0.495 . . . . 54.420000000000002 111.095 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.84 -54.37 19.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.289 -0.414 . . . . 55.509999999999998 111.498 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.4 mt -56.72 -46.79 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.234 0.54 . . . . 74.010000000000005 111.909 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.512 HG12 HG21 ' A' ' 31' ' ' VAL . 74.5 mt -60.19 -27.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.899 -0.591 . . . . 74.239999999999995 112.19 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -54.01 -68.59 0.17 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.018 0.377 . . . . 62.340000000000003 112.018 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.16 -36.64 89.57 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.242 -0.504 . . . . 63.539999999999999 113.644 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.05 -47.51 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 122.526 -0.397 . . . . 73.400000000000006 111.796 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.0 p -67.43 -34.66 77.68 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.109 0.411 . . . . 64.519999999999996 112.109 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.09 -23.23 64.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.277 0.56 . . . . 75.109999999999999 110.689 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -80.6 -12.98 59.43 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.225 0.536 . . . . 45.329999999999998 110.544 173.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.15 27.22 26.35 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.183 -0.532 . . . . 70.0 113.113 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 143' ' ' THR . 45.2 t -116.14 137.28 50.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 122.582 -0.364 . . . . 73.310000000000002 111.463 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 142.59 17.89 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.348 -0.453 . . . . 35.409999999999997 112.747 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG21 HG12 ' A' ' 21' ' ' ILE . 34.4 m -107.97 146.25 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.46 0.541 . . . . 72.219999999999999 112.46 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -108.16 92.7 4.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 110.654 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.62 122.63 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.759 0.314 . . . . 74.519999999999996 111.58 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -127.61 136.76 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.001 0.429 . . . . 73.209999999999994 111.537 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.1 123.75 32.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.925 0.393 . . . . 74.409999999999997 111.196 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.75 -13.46 48.22 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.173 0.434 . . . . 63.539999999999999 112.173 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.65 68.27 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.364 -0.446 . . . . 52.200000000000003 112.993 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.86 14.66 3.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.166 0.432 . . . . 45.100000000000001 112.166 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.07 118.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.333 0.587 . . . . 63.409999999999997 112.217 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.71 99.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.625 0.726 . . . . 62.009999999999998 112.199 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.59 158.15 27.93 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.592 -0.731 . . . . 72.109999999999999 111.724 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.637 HD13 HD12 ' A' ' 45' ' ' LEU . 3.4 mm? -60.37 -37.89 82.18 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.037 0.384 . . . . 72.329999999999998 112.037 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -66.88 -30.11 70.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.089 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.2 -32.88 56.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.093 0.473 . . . . 72.329999999999998 110.597 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.637 HD12 HD13 ' A' ' 42' ' ' LEU . 85.4 mt -64.75 -32.28 73.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.416 -0.356 . . . . 72.409999999999997 110.825 174.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -58.78 -47.66 83.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.022 0.439 . . . . 75.510000000000005 110.193 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 73.1 mm-40 -58.19 -39.83 79.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.094 175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.38 -34.34 66.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.762 0.315 . . . . 70.030000000000001 111.336 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.07 -52.94 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.844 0.354 . . . . 72.340000000000003 111.21 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.93 -25.14 73.2 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.905 -0.664 . . . . 53.219999999999999 113.47 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -98.87 7.42 46.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.717 0.407 . . . . 74.510000000000005 111.806 178.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.59 5.69 0.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.629 0.974 . . . . 55.32 113.629 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.0 p -79.79 -36.88 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.112 -0.368 . . . . 75.420000000000002 111.876 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.8 137.71 5.33 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.92 -0.657 . . . . 74.400000000000006 113.239 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.69 164.17 39.15 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.865 0.364 . . . . 65.540000000000006 111.597 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -122.36 129.58 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.611 0.364 . . . . 72.409999999999997 110.664 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -117.75 136.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.288 0.566 . . . . 64.420000000000002 112.463 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.91 125.55 8.45 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 116.071 -0.513 . . . . 44.130000000000003 112.476 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.467 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 55.5 ttm -56.87 101.86 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.353 0.596 . . . . 71.230000000000004 111.465 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 67.1 m -92.88 132.95 29.88 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 72.120000000000005 112.196 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.79 169.04 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.51 2.14 . . . . 62.229999999999997 112.756 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.96 -42.83 6.19 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.358 0.874 . . . . 75.010000000000005 113.358 -173.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.72 -62.84 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.983 0.364 . . . . 51.350000000000001 111.983 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 50.3 m -70.76 -22.22 62.42 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.009 0.433 . . . . 52.140000000000001 111.515 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.5 65.15 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 61.219999999999999 111.435 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.31 99.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.94 0.4 . . . . 71.530000000000001 111.356 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -62.24 -44.05 97.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.231 0.538 . . . . 61.5 110.904 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 61.5 mt -64.32 -45.32 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.044 -0.525 . . . . 51.43 110.832 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -54.42 -48.97 71.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.912 -0.586 . . . . 75.129999999999995 111.47 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.24 -27.28 72.21 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 73.340000000000003 112.927 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.96 -21.33 29.62 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 72.409999999999997 112.365 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 70.6 mt -51.26 -38.07 50.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.369 0.507 . . . . 72.439999999999998 112.369 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.4 m -54.25 -31.6 53.96 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.089 0.471 . . . . 71.310000000000002 111.535 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 m -94.13 -39.87 10.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 65.109999999999999 111.196 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.0 -54.27 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.262 0.467 . . . . 54.229999999999997 112.262 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.43 -17.53 13.55 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 63.340000000000003 112.723 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.15 -27.85 7.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.149 -0.548 . . . . 54.399999999999999 113.113 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.7 m -84.76 -25.58 28.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.462 0.542 . . . . 74.120000000000005 112.462 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.66 158.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.329 0.585 . . . . 63.109999999999999 112.359 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 27.9 t-20 -92.9 143.79 25.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.03 -0.532 . . . . 74.239999999999995 110.914 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -44.89 -44.62 9.78 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.382 0.882 . . . . 74.140000000000001 113.382 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 24.2 pttm -135.62 41.56 2.72 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.055 0.455 . . . . 71.409999999999997 112.012 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 3.9 pt20 -61.44 167.89 3.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.076 -0.511 . . . . 74.420000000000002 112.255 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -96.12 116.88 29.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.272 -0.422 . . . . 64.219999999999999 111.64 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.34 118.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.432 0.634 . . . . 73.200000000000003 112.121 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 139.27 15.14 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.088 -0.505 . . . . 72.140000000000001 112.781 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.31 138.95 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.896 0.379 . . . . 73.049999999999997 111.751 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -139.87 150.83 45.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.223 -0.444 . . . . 64.319999999999993 110.466 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -76.3 91.57 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.554 0.692 . . . . 75.540000000000006 112.309 -174.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 119' ' ' ILE . 52.8 m -154.51 134.34 12.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.192 -0.458 . . . . 53.329999999999998 111.243 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 59' ' ' MET . . . 99.35 -133.03 11.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.189 -0.529 . . . . 64.120000000000005 113.132 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.46 -125.69 9.54 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.084 -0.579 . . . . 62.310000000000002 113.297 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.66 -104.1 1.09 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.082 -0.58 . . . . 31.210000000000001 112.89 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.65 109.58 21.82 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.658 -0.319 . . . . 74.049999999999997 110.392 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.26 155.95 39.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.932 0.396 . . . . 63.25 111.543 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.632 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 31.6 mt-10 -106.95 -63.94 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 113.041 0.756 . . . . 75.099999999999994 113.041 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 32.5 Cg_endo -104.1 27.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 123.203 2.602 . . . . 73.049999999999997 116.204 -167.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 99' ' ' ASP . 12.6 tt -53.26 -49.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.769 0.713 . . . . 63.140000000000001 112.842 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.61 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 16.7 m-20 -61.8 -51.59 74.8 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.491 0.552 . . . . 74.310000000000002 112.491 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.6 Cg_exo -48.99 -43.92 34.23 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.117 1.878 . . . . 73.120000000000005 113.063 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.7 mp -65.48 -48.43 72.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.678 0.251 . . . . 63.140000000000001 111.678 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 95.1 mt -53.4 -47.85 69.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.003 0.43 . . . . 52.530000000000001 111.24 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -64.01 -43.83 94.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.429 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -56.53 -62.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.339 -0.391 . . . . 64.409999999999997 111.313 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -58.73 -30.53 67.54 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.797 0.295 . . . . 75.319999999999993 111.797 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 106' ' ' ARG . 31.5 ttt180 -61.76 -49.87 74.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.966 0.412 . . . . 74.530000000000001 111.256 175.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.47 -8.07 43.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.721 0.637 . . . . 70.510000000000005 112.721 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 mp -98.43 -40.33 8.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.849 0.357 . . . . 74.239999999999995 110.628 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 52.54 3.08 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.202 -0.523 . . . . 54.32 113.873 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 6.5 mp -76.54 151.17 36.44 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.894 0.378 . . . . 74.349999999999994 111.47 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 80.2 m -68.36 87.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.377 0.608 . . . . 75.140000000000001 110.142 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.9 m -99.53 135.74 40.49 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.733 -0.667 . . . . 52.420000000000002 112.149 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.83 -64.17 0.94 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.854 0.359 . . . . 51.340000000000003 111.889 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -158.23 99.72 1.76 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 120.656 0.265 . . . . 51.310000000000002 111.31 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -90.52 17.37 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.083 2.522 . . . . 75.219999999999999 114.027 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.98 13.07 19.44 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.458 . . . . 61.219999999999999 112.238 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.59 139.43 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.088 0.47 . . . . 73.420000000000002 111.545 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -128.41 127.51 42.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.368 -0.378 . . . . 65.019999999999996 110.375 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.4 mp -106.48 141.06 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.225 0.536 . . . . 64.420000000000002 111.734 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 121' ' ' GLN . 19.5 ptmt -78.63 -40.32 34.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 112.497 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HG2' HG23 ' A' ' 122' ' ' THR . 65.1 tt0 -175.36 -70.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.102 0.477 . . . . 73.219999999999999 111.679 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.58 HG23 ' HG2' ' A' ' 121' ' ' GLN . 60.7 p -115.1 153.45 47.22 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.459 -0.337 . . . . 51.039999999999999 111.78 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.607 ' HG2' ' HD2' ' A' ' 12' ' ' TYR . 72.7 Cg_endo -75.37 -175.57 2.49 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.619 2.213 . . . . 75.099999999999994 113.185 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.0 p -111.53 175.54 5.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.92 0.39 . . . . 42.140000000000001 111.322 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.82 -25.33 62.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 74.230000000000004 110.83 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -70.3 -28.33 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.046 0.451 . . . . 74.299999999999997 110.901 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.9 m -54.22 -35.33 62.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.084 -0.507 . . . . 70.120000000000005 111.931 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -58.03 -27.55 63.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.008 0.432 . . . . 63.25 111.687 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -85.65 -39.67 17.02 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.939 0.399 . . . . 75.209999999999994 110.447 177.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.23 -56.17 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.008 -0.542 . . . . 71.400000000000006 111.155 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.4 m -55.06 -38.04 67.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.014 0.376 . . . . 75.120000000000005 112.014 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.12 -46.44 74.16 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.226 0.536 . . . . 72.230000000000004 110.908 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.18 -52.93 61.82 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.981 -0.554 . . . . 61.200000000000003 111.522 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.05 99.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.245 -0.434 . . . . 61.520000000000003 111.566 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -55.81 -38.94 75.62 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.258 -0.496 . . . . 73.040000000000006 112.799 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 88.9 m -65.96 -44.67 84.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.731 0.301 . . . . 71.349999999999994 111.126 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.04 -50.79 72.22 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.987 0.422 . . . . 54.520000000000003 111.695 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.454 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.9 mm? -70.14 -43.26 71.29 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.865 0.364 . . . . 61.420000000000002 111.165 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.0 -47.83 65.02 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 116.132 -0.486 . . . . 50.240000000000002 113.566 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 90.5 mt-30 -59.79 -53.12 61.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.668 0.27 . . . . 64.140000000000001 111.35 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 77.4 t90 -51.62 -52.98 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.753 0.311 . . . . 71.510000000000005 111.426 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 138' ' ' LEU . 57.4 t -57.08 -43.0 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.52 0.563 . . . . 72.129999999999995 112.52 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.429 HG21 HG21 ' A' ' 29' ' ' VAL . 8.7 t -78.11 -49.92 13.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.152 0.797 . . . . 75.140000000000001 113.152 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -84.88 -4.73 59.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.155 0.798 . . . . 73.400000000000006 113.155 -172.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.41 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 27.7 t70 -62.09 -18.39 60.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.189 0.44 . . . . 33.210000000000001 112.189 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.599 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 1.7 mpt_? -78.72 -27.57 44.93 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.662 0.615 . . . . 75.439999999999998 112.662 -176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 147' ' ' LEU . 8.6 tt . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.11 0.481 . . . . 62.420000000000002 109.919 -174.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.853 0.316 . . . . 74.140000000000001 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.639 HG13 HG21 ' A' ' 24' ' ' ILE . 46.4 mm -69.77 97.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.992 0.367 . . . . 75.200000000000003 111.992 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.16 1.38 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.084 -0.579 . . . . 55.0 112.529 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.453 HG21 ' HB1' ' A' ' 17' ' ' ALA . 6.7 p -91.9 110.25 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.261 0.553 . . . . 71.0 112.11 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HB3' HD23 ' A' ' 36' ' ' LEU . 82.5 m-85 -95.07 99.09 11.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 65.430000000000007 110.955 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 14' ' ' ASP . 26.6 p90 -130.13 -179.52 5.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.837 0.351 . . . . 73.109999999999999 111.52 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 10' ' ' TYR . 22.3 t -121.98 107.32 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.921 0.391 . . . . 74.230000000000004 111.842 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 74.1 m -78.23 -21.91 49.25 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 111.354 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -78.24 -32.69 49.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.885 -0.598 . . . . 75.5 112.052 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.689 ' H ' HG12 ' A' ' 7' ' ' VAL . 69.1 t80 -129.13 133.03 47.45 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.92 0.711 . . . . 75.209999999999994 112.92 -170.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.5 -162.49 5.19 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.562 0.985 . . . . 64.209999999999994 115.562 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 2.12 29.11 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.64 0.607 . . . . 72.329999999999998 112.64 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.3 t -49.36 -37.56 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.102 0.477 . . . . 71.239999999999995 111.853 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 17.0 t0 -56.71 -60.18 3.93 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.864 -0.607 . . . . 44.43 111.255 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 15' ' ' ARG . 20.1 mmt180 -70.97 -28.58 64.56 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.28 0.474 . . . . 72.530000000000001 112.28 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.11 -43.99 87.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 75.219999999999999 110.501 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -75.04 -44.27 48.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.753 -0.658 . . . . 73.239999999999995 111.43 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -53.77 -53.26 54.79 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.387 -0.37 . . . . 74.120000000000005 111.883 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -25.21 61.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.31 0.485 . . . . 75.400000000000006 112.31 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 132' ' ' GLU . 66.1 mt -87.55 -57.4 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.846 0.355 . . . . 75.340000000000003 111.442 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.468 ' HB ' HG11 ' A' ' 31' ' ' VAL . 2.7 pp -59.15 -27.17 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.7 0.286 . . . . 72.329999999999998 111.762 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.442 ' N ' HD12 ' A' ' 21' ' ' ILE . 27.3 t-20 -59.4 -48.88 79.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.515 -0.311 . . . . 62.409999999999997 110.619 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.36 -34.24 87.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.166 -0.54 . . . . 31.43 112.758 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.639 HG21 HG13 ' A' ' 2' ' ' ILE . 62.4 mt -62.69 -53.12 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 122.49 -0.418 . . . . 75.420000000000002 111.335 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.8 t -68.19 -31.15 70.48 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.909 0.385 . . . . 70.030000000000001 111.001 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -62.34 -34.52 76.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.057 0.456 . . . . 74.430000000000007 111.034 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -71.35 -31.88 67.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.311 -0.404 . . . . 72.299999999999997 111.0 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.81 5.42 4.89 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.165 -0.541 . . . . 55.219999999999999 114.17 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.649 HG22 ' HB ' ' A' ' 143' ' ' THR . 21.8 t -94.34 126.53 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 117.439 0.619 . . . . 71.209999999999994 111.698 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.95 122.6 22.19 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.444 -0.408 . . . . 73.530000000000001 113.689 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.468 HG11 ' HB ' ' A' ' 21' ' ' ILE . 61.3 t -104.07 143.56 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.118 0.485 . . . . 64.010000000000005 112.168 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.77 113.68 22.91 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.136 -0.484 . . . . 75.099999999999994 110.422 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.84 124.0 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.269 0.557 . . . . 63.450000000000003 112.11 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.04 108.03 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.85 0.357 . . . . 60.119999999999997 111.497 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.49 111.23 20.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.908 0.385 . . . . 41.450000000000003 111.188 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.445 ' HA ' HG13 ' A' ' 40' ' ' VAL . 4.4 pp -86.8 -8.96 56.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.424 -0.353 . . . . 64.209999999999994 111.1 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -59.72 -45.3 95.95 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.356 -0.449 . . . . 64.409999999999997 112.768 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.58 17.69 3.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.701 0.286 . . . . 62.409999999999997 111.446 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.16 147.22 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.198 0.599 . . . . 52.43 111.917 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 36' ' ' LEU . 27.1 m -117.43 151.87 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.337 . . . . 72.420000000000002 111.546 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -104.98 169.36 8.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.053 0.454 . . . . 72.209999999999994 111.064 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.7 mm? -58.81 -18.44 32.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.116 0.413 . . . . 74.420000000000002 112.116 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -57.6 -55.46 34.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.828 0.347 . . . . 73.140000000000001 110.775 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.94 -37.19 78.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.179 0.514 . . . . 63.020000000000003 110.837 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 3.0 tm? -61.32 -38.73 87.92 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.978 -0.555 . . . . 72.319999999999993 111.127 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -70.85 -40.32 72.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.961 -0.462 . . . . 70.329999999999998 110.925 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 18.1 mm-40 -58.41 -28.15 64.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.008 0.432 . . . . 71.519999999999996 111.323 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.611 HD11 HD13 ' A' ' 55' ' ' LEU . 57.7 tp -56.18 -31.11 63.12 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.189 -0.459 . . . . 71.030000000000001 111.448 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.97 -36.39 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.872 0.367 . . . . 65.239999999999995 111.328 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.55 -20.01 55.31 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.081 -0.581 . . . . 54.539999999999999 112.895 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 7.4 mpt_? -94.38 5.11 52.79 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.579 -0.365 . . . . 60.140000000000001 111.934 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -63.56 -16.0 59.61 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.889 0.329 . . . . 75.420000000000002 111.889 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.1 p -66.15 -25.31 66.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.821 0.343 . . . . 72.219999999999999 111.643 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.5 135.93 3.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.374 -0.441 . . . . 32.210000000000001 112.493 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.611 HD13 HD11 ' A' ' 48' ' ' LEU . 2.3 pt? -163.83 170.32 17.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.117 0.484 . . . . 70.5 111.662 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 p -148.76 124.33 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.340000000000003 111.174 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -95.8 135.4 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.13 -0.486 . . . . 71.239999999999995 110.96 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.5 -86.58 0.68 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.229 -0.51 . . . . 70.120000000000005 113.805 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.5 pmm? -151.92 167.96 26.7 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.3 -0.53 . . . . 73.129999999999995 111.855 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.3 p -144.18 49.13 0.99 Allowed Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 112.345 0.498 . . . . 72.010000000000005 112.345 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.13 157.57 61.1 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.414 2.076 . . . . 75.129999999999995 113.599 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.0 -50.48 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.523 0.934 . . . . 74.519999999999996 113.523 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.04 -46.51 65.09 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.601 0.593 . . . . 64.299999999999997 112.601 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -102.11 5.26 40.31 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.507 0.558 . . . . 64.120000000000005 112.507 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.86 -29.88 70.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.776 1.028 . . . . 53.329999999999998 113.776 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -37.47 -70.53 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.905 1.076 . . . . 73.120000000000005 113.905 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.4 m -77.39 -37.77 51.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.823 0.344 . . . . 71.349999999999994 111.79 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.45 -43.99 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.462 0.541 . . . . 63.329999999999998 112.462 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.03 -40.82 95.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.852 0.358 . . . . 71.219999999999999 111.413 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.88 -36.52 90.35 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.016 -0.611 . . . . 24.239999999999998 112.203 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.456 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -68.52 -51.14 46.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.826 -0.22 . . . . 74.040000000000006 111.119 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 75' ' ' ILE . 98.3 mt -53.79 -45.71 70.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.925 0.393 . . . . 64.230000000000004 111.678 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -56.75 -28.1 60.58 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.104 -0.498 . . . . 61.200000000000003 111.285 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 m -86.89 -40.19 15.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.259 -0.428 . . . . 75.439999999999998 111.136 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.503 HD12 HD23 ' A' ' 72' ' ' LEU . 73.7 mt -56.13 -40.6 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.394 -0.366 . . . . 73.340000000000003 111.679 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.2 mt -56.37 -26.67 53.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.51 -0.314 . . . . 62.140000000000001 111.651 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.9 31.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.189 -0.529 . . . . 32.439999999999998 113.463 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 75' ' ' ILE . 89.4 p -87.8 -34.27 18.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.247 0.524 . . . . 74.140000000000001 111.882 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.97 135.13 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.974 0.416 . . . . 73.120000000000005 111.59 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 82' ' ' LYS . 24.7 t-20 -89.53 107.01 18.83 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.298 0.481 . . . . 62.329999999999998 112.298 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 36.84 -75.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.89 1.441 . . . . 73.5 114.89 167.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.1 96.51 5.13 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.216 0.531 . . . . 74.299999999999997 112.401 -174.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.719 ' H ' HD23 ' A' ' 110' ' ' LEU . 85.6 mm-40 -133.97 172.72 12.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.433 -0.349 . . . . 74.120000000000005 110.851 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.5 107.81 18.06 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.048 0.452 . . . . 35.409999999999997 111.282 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 HD21 ' A' ' 55' ' ' LEU . 24.4 m -109.67 119.4 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.565 0.698 . . . . 72.129999999999995 112.158 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.39 142.51 25.01 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.177 -0.535 . . . . 74.400000000000006 112.507 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.54 ' H ' ' HB3' ' A' ' 113' ' ' ALA . 7.1 tp -160.86 137.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.655 -0.32 . . . . 73.120000000000005 110.793 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -161.64 161.69 29.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.532 0.333 . . . . 63.450000000000003 110.753 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 1.3 pm0 -81.65 146.28 30.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.495 0.664 . . . . 61.32 112.095 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.3 m -140.1 100.61 3.96 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.157 -0.474 . . . . 71.150000000000006 111.126 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . 79.01 -170.81 54.91 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.081 -0.58 . . . . 31.0 113.309 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.23 79.26 0.41 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.127 -0.559 . . . . 72.519999999999996 112.708 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.05 159.34 53.5 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.427 -0.416 . . . . 51.539999999999999 113.856 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -162.69 108.03 1.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.436 -0.579 . . . . 74.200000000000003 109.436 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.18 151.52 50.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.987 0.422 . . . . 70.310000000000002 111.556 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.633 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.2 tm-20 -91.47 -58.05 0.24 Allowed Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 116.384 -0.371 . . . . 55.100000000000001 111.943 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 96' ' ' GLU . 85.0 Cg_endo -84.83 84.95 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.93 1.753 . . . . 74.25 113.224 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.648 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.5 tp -92.08 -66.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 112.005 0.372 . . . . 72.209999999999994 112.005 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.648 ' H ' HG23 ' A' ' 98' ' ' ILE . 4.6 m-20 -59.19 -46.85 99.23 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 113.029 0.751 . . . . 52.229999999999997 113.029 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.1 Cg_exo -42.67 -38.4 6.4 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.935 2.423 . . . . 73.430000000000007 114.289 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.42 -49.38 10.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.686 0.279 . . . . 74.219999999999999 111.053 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 86.1 mt -51.28 -44.06 61.73 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.421 0.526 . . . . 52.509999999999998 112.421 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.3 t -57.24 -42.28 81.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.699 0.285 . . . . 71.129999999999995 111.655 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -59.32 -46.84 87.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 74.519999999999996 111.271 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 110' ' ' LEU . 78.0 m-85 -63.22 -52.21 63.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.123 0.487 . . . . 71.439999999999998 111.135 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -54.62 -45.02 73.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.571 -0.74 . . . . 71.25 112.415 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -74.28 -56.1 5.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 73.299999999999997 112.569 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.37 -40.96 96.22 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.508 0.558 . . . . 64.340000000000003 112.508 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.2 17.54 4.88 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.968 -0.634 . . . . 70.129999999999995 112.774 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 83' ' ' GLN . 59.7 mt -73.31 102.9 3.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.064 0.459 . . . . 72.439999999999998 110.384 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.9 m -63.58 102.74 0.46 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.109 -0.496 . . . . 74.420000000000002 111.971 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -85.7 132.24 34.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.92 -0.582 . . . . 74.310000000000002 111.171 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.54 ' HB3' ' H ' ' A' ' 87' ' ' ILE . . . -55.66 -76.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.773 0.286 . . . . 71.200000000000003 111.773 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -164.69 88.54 1.05 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.966 0.412 . . . . 53.539999999999999 111.253 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.06 112.03 1.69 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.649 2.233 . . . . 73.329999999999998 113.859 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.603 ' HB3' HH21 ' A' ' 118' ' ' ARG . . . -170.28 -173.17 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.581 -0.281 . . . . 33.200000000000003 111.209 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.71 88.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.233 0.539 . . . . 74.150000000000006 111.525 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.603 HH21 ' HB3' ' A' ' 116' ' ' ALA . 8.4 ptp180 -104.87 -18.63 14.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.759 0.314 . . . . 75.129999999999995 111.658 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.67 111.39 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 71.450000000000003 110.806 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.97 -48.68 80.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.04 -0.527 . . . . 74.010000000000005 112.138 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.48 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 8.7 tt0 -158.81 -49.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.083 0.468 . . . . 65.310000000000002 111.335 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -114.49 117.85 42.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.337 -0.392 . . . . 74.400000000000006 111.662 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.55 126.45 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.376 2.05 . . . . 63.100000000000001 112.423 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.4 p -78.14 172.29 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.571 0.224 . . . . 62.439999999999998 110.924 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.63 -30.8 44.56 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.751 0.278 . . . . 70.439999999999998 111.751 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -52.95 -32.37 45.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.161 0.505 . . . . 70.010000000000005 111.081 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 m -61.19 -48.49 81.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.054 -0.521 . . . . 73.109999999999999 110.908 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -58.81 -51.51 69.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.192 -0.458 . . . . 65.230000000000004 111.248 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -33.76 76.3 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.22 -0.445 . . . . 73.019999999999996 112.097 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.24 -60.04 2.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.043 0.449 . . . . 52.409999999999997 110.914 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.99 -27.86 67.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.262 -0.426 . . . . 73.340000000000003 112.084 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.456 ' HA ' HG12 ' A' ' 20' ' ' ILE . 40.0 tt0 -52.43 -50.96 61.53 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.404 -0.362 . . . . 72.519999999999996 111.896 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.8 -46.89 85.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.735 0.303 . . . . 74.019999999999996 111.316 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.42 -48.94 73.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.914 0.388 . . . . 65.040000000000006 111.604 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.83 -38.72 94.62 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.097 -0.573 . . . . 70.0 113.108 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 99.7 m -63.35 -49.15 75.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.733 0.302 . . . . 72.25 111.186 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.12 -37.49 80.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.1 0.476 . . . . 72.439999999999998 110.751 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 142' ' ' VAL . 3.4 tm? -59.16 -51.59 69.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 74.230000000000004 110.237 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.97 -44.2 94.64 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.278 -0.487 . . . . 34.409999999999997 112.762 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.06 -30.84 71.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.230000000000004 111.331 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 88.5 t90 -71.65 -51.52 22.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.187 0.518 . . . . 74.310000000000002 110.833 176.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 138' ' ' LEU . 77.2 t -54.43 -46.88 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.279 -0.419 . . . . 62.329999999999998 112.005 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' ' 29' ' ' VAL . 7.4 t -62.41 -37.98 87.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.8 0.667 . . . . 71.510000000000005 112.8 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 141' ' ' TRP . 8.0 ptp180 -75.32 -41.38 56.92 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.076 -0.39 . . . . 71.219999999999999 111.54 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.19 -14.54 35.82 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.952 0.723 . . . . 72.530000000000001 112.952 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.77 -34.65 78.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.42 0.629 . . . . 64.219999999999999 109.673 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.5 tp . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 115.433 -0.803 . . . . 74.299999999999997 109.818 171.087 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.281 0.086 . . . . 64.099999999999994 110.779 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 mm 63.49 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.246 0.545 . . . . 75.010000000000005 110.919 -174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -80.55 108.86 2.86 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.723 -0.751 . . . . 72.129999999999995 112.622 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.2 p -88.17 105.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.732 0.777 . . . . 52.240000000000002 111.203 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 88.1 m-85 -99.57 98.27 9.17 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.633 -0.712 . . . . 75.519999999999996 111.107 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 9.5 p90 -119.06 157.93 26.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.453 0.644 . . . . 64.420000000000002 112.349 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 43.6 t -104.66 101.29 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.822 -0.626 . . . . 71.340000000000003 112.066 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 m -63.26 -23.83 67.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.438 0.637 . . . . 62.109999999999999 111.341 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -78.22 -20.59 51.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.783 -0.644 . . . . 64.329999999999998 112.407 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -137.24 132.67 34.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.11 0.782 . . . . 60.219999999999999 113.11 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 90' ' ' THR . . . 56.36 -163.62 5.71 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 115.336 0.894 . . . . 74.329999999999998 115.336 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.84 7.52 10.29 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.502 0.556 . . . . 75.120000000000005 112.502 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 53.3 m -35.64 -47.88 0.5 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.987 1.106 . . . . 50.020000000000003 113.987 -172.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -54.66 -52.37 62.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.149 0.499 . . . . 64.299999999999997 111.687 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -77.3 -25.33 51.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 111.931 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.39 -48.14 71.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.356 0.598 . . . . 72.040000000000006 110.087 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -64.79 -43.71 92.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.635 -0.711 . . . . 70.120000000000005 111.268 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -51.26 -40.19 58.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.09 -0.504 . . . . 75.400000000000006 111.484 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.89 89.91 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.95 0.405 . . . . 71.319999999999993 111.343 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.9 -52.34 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.123 0.487 . . . . 72.420000000000002 111.351 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 31' ' ' VAL . 65.3 mt -55.08 -49.51 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.738 -0.665 . . . . 60.420000000000002 111.544 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.77 -36.41 69.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.341 -0.39 . . . . 43.210000000000001 111.82 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.26 -46.46 42.18 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.088 -0.577 . . . . 52.009999999999998 113.258 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.68 -43.97 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.811 0.338 . . . . 74.530000000000001 111.572 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.8 p -63.53 -38.37 90.87 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 71.340000000000003 111.164 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -64.8 -21.12 66.71 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.304 0.573 . . . . 75.219999999999999 111.285 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.7 m -85.43 -17.84 35.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 111.438 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.26 16.71 10.82 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.302 -0.475 . . . . 54.030000000000001 113.848 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.14 138.39 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 117.212 0.506 . . . . 71.140000000000001 111.443 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.19 139.24 19.57 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.116 -0.564 . . . . 71.219999999999999 112.932 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 21' ' ' ILE . 29.8 t -105.79 141.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.84 0.352 . . . . 75.5 111.582 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 22.6 m-20 -93.49 106.49 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.113 0.483 . . . . 71.200000000000003 111.134 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -87.6 109.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.349 0.595 . . . . 62.43 112.224 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -118.49 112.5 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.054 0.454 . . . . 64.109999999999999 111.404 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.48 76.46 8.23 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.385 -0.371 . . . . 71.319999999999993 111.234 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 37' ' ' GLY . 2.0 pp -70.31 -23.83 62.92 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.912 -0.493 . . . . 73.109999999999999 111.319 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -87.94 47.79 3.59 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.289 -0.481 . . . . 55.049999999999997 112.291 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.97 -65.95 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.942 0.497 . . . . 54.520000000000003 110.516 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.16 130.1 0.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.254 -0.43 . . . . 75.219999999999999 111.397 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.33 150.7 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 111.641 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.82 165.49 27.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.458 -0.337 . . . . 71.299999999999997 111.238 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.5 mm? -59.56 -26.27 65.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.147 0.425 . . . . 64.519999999999996 112.147 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -56.41 -50.52 71.4 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.030000000000001 111.917 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -83.3 -33.92 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.567 -0.288 . . . . 71.049999999999997 111.274 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 89.1 mt -60.37 -29.45 68.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.627 0.251 . . . . 61.229999999999997 111.613 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.13 -39.02 89.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.181 0.515 . . . . 74.109999999999999 110.802 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.01 -25.72 62.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.326 -0.397 . . . . 61.520000000000003 111.912 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.0 tp -53.22 -28.91 29.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.907 0.384 . . . . 62.219999999999999 111.255 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.37 -49.67 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.312 -0.404 . . . . 72.209999999999994 111.865 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.68 -20.42 63.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.094 -0.574 . . . . 61.119999999999997 114.309 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -100.71 5.7 43.77 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.244 -0.563 . . . . 73.340000000000003 111.43 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.5 p -64.72 -7.38 10.6 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.648 0.981 . . . . 71.540000000000006 113.648 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 p -60.58 -42.93 97.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.139 0.422 . . . . 75.430000000000007 112.139 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.26 135.35 6.59 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.989 -0.624 . . . . 33.119999999999997 112.34 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.2 mp -133.3 152.38 51.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 74.400000000000006 111.287 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.36 92.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.452 -0.34 . . . . 73.409999999999997 110.175 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.3 mp -99.92 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.513 . . . . 63.420000000000002 111.786 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.82 151.73 17.87 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.33 -0.462 . . . . 43.210000000000001 112.714 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.499 ' SD ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -53.09 142.01 21.28 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.361 0.6 . . . . 71.140000000000001 112.559 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 92.5 p -132.82 124.15 18.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.405 0.521 . . . . 60.030000000000001 112.405 -173.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 166.14 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.27 1.98 . . . . 72.409999999999997 112.149 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -29.36 -62.8 0.12 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.152 1.538 . . . . 74.230000000000004 115.152 -170.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.14 70.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.399 0.518 . . . . 73.219999999999999 112.399 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.8 m -84.14 -39.67 19.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 43.229999999999997 111.215 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.72 68.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.864 0.364 . . . . 74.209999999999994 111.315 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.11 -36.66 70.92 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 50.119999999999997 111.298 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.2 m -63.47 -48.34 78.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.148 0.499 . . . . 74.030000000000001 110.748 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.79 -52.47 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.099 -0.501 . . . . 75.549999999999997 111.611 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.84 -26.7 67.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.396 -0.366 . . . . 75.209999999999994 111.373 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.93 -42.25 38.3 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.027 -0.606 . . . . 73.230000000000004 112.159 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.18 5.78 18.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.927 0.343 . . . . 53.140000000000001 111.927 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -46.0 -48.4 16.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.115 0.566 . . . . 62.200000000000003 111.457 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -53.72 -37.48 63.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.135 -0.484 . . . . 73.140000000000001 111.939 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -77.72 -44.51 27.62 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.344 -0.389 . . . . 74.310000000000002 111.357 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.16 -58.86 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 112.173 0.434 . . . . 71.239999999999995 112.173 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.15 -23.68 67.55 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.061 0.393 . . . . 64.239999999999995 112.061 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.31 -25.04 52.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.026 -0.606 . . . . 65.510000000000005 112.99 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 m -85.52 -38.0 19.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.146 0.424 . . . . 64.430000000000007 112.146 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.27 125.06 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.253 0.549 . . . . 70.319999999999993 111.89 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -128.63 158.3 38.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.261 0.553 . . . . 74.530000000000001 112.122 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.659 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 44.1 tt0 62.37 -85.64 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.502 0.927 . . . . 74.010000000000005 113.502 168.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.659 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 65.2 pttt -165.04 23.51 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.394 -0.191 . . . . 74.409999999999997 111.48 -173.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.518 HE21 ' H ' ' A' ' 82' ' ' LYS . 14.7 mm-40 -50.79 158.33 0.68 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.137 0.791 . . . . 63.240000000000002 113.137 -169.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.15 117.64 28.28 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.617 0.599 . . . . 62.119999999999997 112.617 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.14 112.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.532 0.682 . . . . 54.43 111.894 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.12 145.05 17.16 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.111 -0.495 . . . . 34.530000000000001 112.102 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 42.7 mm -129.12 139.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 117.12 0.46 . . . . 73.319999999999993 111.519 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -128.41 150.75 49.99 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 74.200000000000003 110.694 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 36.2 tt0 -127.91 150.91 49.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.002 0.371 . . . . 71.349999999999994 112.002 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.499 HG22 ' SD ' ' A' ' 59' ' ' MET . 11.4 t -136.05 10.83 3.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.755 0.312 . . . . 73.319999999999993 111.481 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.504 ' H ' ' HG2' ' A' ' 89' ' ' GLU . . . -130.24 -85.75 0.39 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.456 -0.402 . . . . 62.140000000000001 112.985 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.1 -12.35 5.55 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.999 -0.62 . . . . 44.509999999999998 114.071 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.66 44.51 0.75 Allowed Glycine 0 N--CA 1.463 0.448 0 C-N-CA 121.153 -0.546 . . . . 64.430000000000007 112.059 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -173.27 3.44 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.599 0.36 . . . . 74.420000000000002 111.596 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' SER . 19.9 t70 74.09 116.99 0.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.578 0.751 . . . . 71.409999999999997 111.938 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -79.21 -47.47 1.6 Allowed Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 113.523 0.935 . . . . 72.200000000000003 113.523 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.05 9.54 2.37 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.181 1.921 . . . . 73.450000000000003 114.705 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.9 tt -46.82 -64.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.393 0.886 . . . . 72.310000000000002 113.393 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.641 ' H ' HG23 ' A' ' 98' ' ' ILE . 13.5 m-20 -67.92 -49.43 37.0 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.715 -0.616 . . . . 51.109999999999999 112.593 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.8 Cg_exo -44.76 -39.52 13.76 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.444 2.096 . . . . 71.310000000000002 113.651 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.18 -62.37 1.68 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.752 0.279 . . . . 71.519999999999996 111.752 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.2 mt -56.96 -47.85 79.74 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.415 0.524 . . . . 54.240000000000002 112.415 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.7 t -59.37 -32.32 70.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.951 0.405 . . . . 43.130000000000003 111.557 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -78.89 -42.58 26.87 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.406 -0.361 . . . . 72.030000000000001 111.374 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -60.04 -29.01 68.23 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.908 0.336 . . . . 72.030000000000001 111.908 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -55.86 -36.28 67.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.011 0.374 . . . . 74.310000000000002 112.011 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.42 -21.63 61.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.944 0.402 . . . . 71.310000000000002 111.829 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 108' ' ' LEU . 6.8 mp -92.95 -68.77 0.78 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.914 0.388 . . . . 74.129999999999995 110.73 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.16 67.16 0.37 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.218 -0.515 . . . . 71.239999999999995 113.519 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 110' ' ' LEU . 6.4 mp -95.58 144.61 25.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.686 -0.303 . . . . 71.530000000000001 110.775 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 89.6 m -65.59 109.55 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.028 0.442 . . . . 64.409999999999997 111.524 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.5 m -86.44 135.01 33.65 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.279 -0.418 . . . . 62.299999999999997 111.313 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.78 -92.62 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.453 0.538 . . . . 70.140000000000001 112.453 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -144.71 91.77 6.05 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.323 -0.236 . . . . 74.299999999999997 111.539 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -96.22 9.27 1.53 Allowed 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.979 2.453 . . . . 73.299999999999997 113.884 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.72 32.66 0.96 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.263 0.838 . . . . 74.209999999999994 113.263 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.4 ' C ' ' HD3' ' A' ' 118' ' ' ARG . 13.1 tt -146.39 134.49 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.815 -0.553 . . . . 71.530000000000001 112.248 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -129.96 155.16 46.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.076 0.465 . . . . 65.030000000000001 111.17 175.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 121' ' ' GLN . 2.1 mp -95.57 150.13 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 116.2 -0.454 . . . . 54.130000000000003 111.308 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -62.89 -44.91 94.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.097 0.475 . . . . 74.450000000000003 111.93 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.504 ' H ' HG22 ' A' ' 119' ' ' ILE . 58.1 tt0 -178.36 -63.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.832 -0.622 . . . . 74.420000000000002 109.656 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -119.52 115.0 34.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.802 -0.635 . . . . 72.129999999999995 110.559 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.461 ' HB2' ' OG1' ' A' ' 127' ' ' THR . 96.0 Cg_endo -77.43 -170.78 1.0 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.819 2.346 . . . . 73.219999999999999 113.564 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.1 p -131.22 -169.08 2.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.121 0.486 . . . . 72.109999999999999 111.723 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 5.0 mp0 -59.06 -26.44 64.61 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.214 -0.448 . . . . 70.420000000000002 111.939 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.52 -35.87 72.94 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.439999999999998 111.685 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 123' ' ' PRO . 30.6 m -60.3 -39.72 87.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.015 0.436 . . . . 62.299999999999997 111.389 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -59.97 -50.81 72.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.177 0.513 . . . . 71.349999999999994 110.895 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -62.6 -36.21 82.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.766 -0.652 . . . . 75.010000000000005 111.289 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.2 tt -61.48 -44.93 96.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.037 -0.529 . . . . 74.129999999999995 110.264 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 89.2 m -59.19 -42.57 91.16 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.134 -0.485 . . . . 55.509999999999998 111.502 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -58.68 -49.33 77.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.055 0.455 . . . . 62.030000000000001 111.226 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -58.77 -49.41 77.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.142 -0.481 . . . . 75.510000000000005 111.385 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.99 -51.92 67.2 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.092 -0.504 . . . . 44.130000000000003 112.006 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.39 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.168 -0.539 . . . . 71.430000000000007 113.145 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 96.3 m -60.31 -44.91 95.0 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.665 0.269 . . . . 74.120000000000005 111.627 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.77 -48.62 80.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.879 0.371 . . . . 65.409999999999997 110.973 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.31 -43.15 92.66 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.337 -0.392 . . . . 60.310000000000002 111.048 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 143' ' ' THR . . . -58.7 -42.42 96.32 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.112 -0.566 . . . . 43.450000000000003 112.918 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -62.3 -35.12 78.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.672 0.272 . . . . 72.0 111.321 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -65.92 -47.51 74.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.849 0.357 . . . . 72.120000000000005 111.343 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.89 -53.07 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.937 0.347 . . . . 42.420000000000002 111.937 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 139' ' ' GLY . 2.9 t -62.06 -34.82 76.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.042 0.449 . . . . 64.430000000000007 111.248 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -63.97 -37.67 88.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.197 -0.456 . . . . 73.239999999999995 111.476 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -80.04 -44.9 19.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.858 0.361 . . . . 74.230000000000004 111.787 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -76.61 -7.84 56.04 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.318 0.859 . . . . 54.140000000000001 113.318 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.492 -0.558 . . . . 73.439999999999998 109.492 170.462 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 75.5 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 111.25 0.093 . . . . 65.299999999999997 111.25 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 48.1 mm 62.65 108.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.183 0.516 . . . . 62.229999999999997 111.898 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.68 117.01 4.34 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.914 -0.66 . . . . 65.019999999999996 113.04 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.54 115.85 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.411 0.624 . . . . 63.340000000000003 111.979 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 3.1 m-85 -94.69 112.77 24.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.854 -0.612 . . . . 71.120000000000005 111.21 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -135.02 148.92 50.07 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.179 0.514 . . . . 75.349999999999994 112.225 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.615 HG22 HD11 ' A' ' 36' ' ' LEU . 15.1 t -112.86 95.43 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.956 -0.565 . . . . 72.340000000000003 111.096 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 m -56.14 -16.16 4.76 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.033 0.444 . . . . 62.240000000000002 112.038 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.27 -25.13 20.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.535 0.569 . . . . 72.420000000000002 112.535 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.18 123.76 35.1 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.479 0.918 . . . . 74.129999999999995 113.479 -170.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.69 -163.61 4.86 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.626 1.01 . . . . 51.0 115.626 171.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 93.7 m-85 -75.03 -0.86 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.044 0.757 . . . . 55.149999999999999 113.044 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -59.28 -31.02 68.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.225 0.536 . . . . 73.239999999999995 110.351 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.84 -37.97 72.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.467 -0.788 . . . . 74.010000000000005 111.266 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 15' ' ' ARG . 5.1 mmp_? -85.85 -38.41 18.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.33 -0.395 . . . . 73.430000000000007 111.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.9 mt -50.45 -47.25 56.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.529 -0.305 . . . . 71.019999999999996 111.792 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.45 65.99 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.104 0.409 . . . . 53.340000000000003 112.104 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.435 -0.348 . . . . 72.439999999999998 111.568 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.46 -41.96 31.2 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.824 0.345 . . . . 73.209999999999994 111.279 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 16' ' ' LEU . 71.9 mt -59.47 -56.06 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.884 0.373 . . . . 75.409999999999997 111.885 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.3 tt -58.61 -30.61 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.979 0.419 . . . . 71.120000000000005 111.81 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.82 -53.1 12.38 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.037 0.446 . . . . 72.530000000000001 111.182 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.537 ' HA3' ' HG3' ' A' ' 132' ' ' GLU . . . -63.58 -44.74 96.08 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.188 -0.46 . . . . 73.439999999999998 114.082 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.89 -52.05 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.381 0.511 . . . . 72.140000000000001 112.381 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -59.46 -34.49 72.59 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.031 0.443 . . . . 51.140000000000001 112.01 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -84.53 5.76 26.35 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.502 0.556 . . . . 75.099999999999994 112.502 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 m -126.25 -47.78 1.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.789 0.328 . . . . 73.409999999999997 111.702 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.85 -89.32 0.75 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.997 -0.62 . . . . 64.310000000000002 113.585 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.86 172.31 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.164 0.431 . . . . 64.099999999999994 112.164 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.03 157.61 53.05 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.397 -0.43 . . . . 61.32 113.652 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 1' ' ' SER . 38.8 t -108.73 148.35 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.527 0.331 . . . . 73.319999999999993 111.867 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.45 128.27 53.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.821 0.343 . . . . 43.409999999999997 110.858 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.68 138.9 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.538 0.569 . . . . 64.040000000000006 112.538 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.53 96.98 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.145 0.497 . . . . 74.109999999999999 111.277 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.64 86.83 6.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.314 -0.403 . . . . 75.329999999999998 110.955 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 7' ' ' VAL . 3.5 pp -91.29 -23.87 20.01 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.331 0.493 . . . . 70.120000000000005 112.331 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -78.99 47.99 3.23 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.027 -0.606 . . . . 61.039999999999999 113.303 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -171.91 -167.27 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.76 0.424 . . . . 74.430000000000007 110.691 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.58 104.28 5.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.854 0.359 . . . . 62.200000000000003 111.028 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.74 175.1 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.503 -0.317 . . . . 71.519999999999996 111.601 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -140.48 160.49 39.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.307 0.575 . . . . 71.340000000000003 112.331 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.5 tm? -55.16 -35.51 64.84 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.805 -0.634 . . . . 60.420000000000002 111.989 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.3 mt-30 -50.78 -43.38 58.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.083 0.468 . . . . 74.319999999999993 111.457 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.15 -24.36 64.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.001 -0.545 . . . . 53.210000000000001 111.445 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.99 -51.17 34.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.338 -0.392 . . . . 74.150000000000006 110.815 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -61.65 -32.64 72.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.83 0.347 . . . . 73.140000000000001 111.034 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 71.4 mm-40 -60.62 -48.87 79.86 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.034 0.445 . . . . 63.509999999999998 110.641 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.02 -39.35 71.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.887 -0.597 . . . . 64.230000000000004 111.812 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.8 -35.09 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.157 0.503 . . . . 72.109999999999999 111.186 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.36 -10.81 76.66 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.225 -0.512 . . . . 52.329999999999998 113.163 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -101.45 4.58 41.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.396 -0.473 . . . . 52.130000000000003 111.569 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.58 1.76 3.8 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.565 0.95 . . . . 74.230000000000004 113.565 -172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.5 p -64.15 -42.09 96.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.208 0.527 . . . . 62.100000000000001 110.838 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.59 136.59 5.35 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.803 -0.635 . . . . 51.439999999999998 112.32 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -160.81 148.41 15.75 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.496 -0.414 . . . . 74.329999999999998 111.657 -177.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -112.26 125.31 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 71.519999999999996 110.974 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 47.5 mt -128.92 136.27 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.064 0.459 . . . . 74.200000000000003 112.191 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.69 -163.88 34.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.146 -0.549 . . . . 62.43 112.401 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtm -98.17 135.26 40.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.018 -0.695 . . . . 72.349999999999994 110.648 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.9 p -79.62 150.8 73.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.199 0.444 . . . . 62.43 112.199 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 64' ' ' SER . 16.5 Cg_endo -90.85 157.59 4.07 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.831 2.354 . . . . 65.530000000000001 111.78 169.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.97 -31.58 29.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.174 0.435 . . . . 70.329999999999998 112.174 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.02 73.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.975 0.361 . . . . 54.329999999999998 111.975 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.536 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 38.9 m -95.76 -13.21 24.31 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.685 0.278 . . . . 71.439999999999998 111.679 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.73 -42.4 35.1 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.86 0.689 . . . . 74.030000000000001 112.86 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.96 -47.08 78.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.99 0.424 . . . . 62.530000000000001 111.853 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -67.13 -45.82 75.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.147 0.498 . . . . 64.439999999999998 111.401 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.2 -46.96 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.981 -0.554 . . . . 75.129999999999995 112.155 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -57.82 -35.56 71.03 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.821 0.343 . . . . 75.450000000000003 111.895 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.83 -43.38 28.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.062 -0.59 . . . . 73.310000000000002 113.072 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.35 -26.07 51.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.225 0.454 . . . . 60.340000000000003 112.225 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 101' ' ' LEU . 52.1 tp -52.8 -37.38 59.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.066 0.395 . . . . 64.150000000000006 112.066 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -59.12 -43.97 91.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.944 0.402 . . . . 63.109999999999999 111.324 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.9 m -68.63 -36.1 78.17 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.171 0.51 . . . . 72.349999999999994 111.004 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 79' ' ' VAL . 67.7 mt -61.96 -59.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.266 -0.425 . . . . 71.510000000000005 111.009 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.57 -30.16 65.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.251 0.463 . . . . 62.539999999999999 112.251 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.15 -24.04 67.21 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.127 -0.559 . . . . 65.310000000000002 113.439 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 p -97.97 -48.36 5.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.304 0.483 . . . . 74.129999999999995 112.304 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.8 m -77.88 85.99 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 122.033 0.92 . . . . 75.239999999999995 111.687 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -178.12 4.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.862 -0.608 . . . . 73.230000000000004 112.144 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 65.74 -77.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.249 0.62 . . . . 45.399999999999999 111.981 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -168.35 29.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.9 0.704 . . . . 71.340000000000003 112.9 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.58 160.99 12.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.095 0.474 . . . . 75.329999999999998 111.647 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 138' ' ' LEU . . . -89.19 95.62 10.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.012 0.745 . . . . 72.109999999999999 113.012 -170.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 85' ' ' VAL . 18.4 m -102.67 92.95 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.76 0.791 . . . . 63.340000000000003 111.551 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.55 72.72 2.5 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.029 -0.532 . . . . 75.310000000000002 113.367 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 12.0 tt -96.54 133.67 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 122.639 -0.33 . . . . 73.409999999999997 111.035 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' CZ ' ' SG ' ' A' ' 131' ' ' CYS . 8.0 p90 -146.79 173.42 12.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.152 0.501 . . . . 75.420000000000002 112.206 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.05 96.61 0.15 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.239 0.542 . . . . 70.239999999999995 112.323 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.2 m -131.43 94.02 3.46 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.262 -0.426 . . . . 60.200000000000003 110.512 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.65 168.63 11.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.355 -0.45 . . . . 31.420000000000002 112.629 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.496 ' HA3' ' OE1' ' A' ' 121' ' ' GLN . . . -114.52 -135.12 5.9 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.852 -0.689 . . . . 64.349999999999994 114.022 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.92 77.06 1.8 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.319 -0.467 . . . . 41.409999999999997 113.125 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.3 -179.86 7.25 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.631 -0.335 . . . . 72.340000000000003 110.734 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 70.89 154.82 0.14 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.868 0.692 . . . . 54.130000000000003 112.868 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.525 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.1 mt-10 -104.63 -57.36 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.755 0.65 . . . . 71.349999999999994 112.755 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 57.4 Cg_endo -68.51 -1.98 8.4 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.322 2.014 . . . . 65.230000000000004 113.996 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.8 tp -50.99 -45.1 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 112.734 0.642 . . . . 73.400000000000006 112.734 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.704 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 5.5 m-20 -58.21 -55.74 42.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 111.997 0.369 . . . . 52.409999999999997 111.997 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 82.6 Cg_exo -50.24 -48.99 17.64 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.328 2.019 . . . . 74.310000000000002 113.358 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' PRO . 11.2 mp -56.74 -51.98 66.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.06 0.393 . . . . 54.409999999999997 112.06 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 92.6 mt -53.44 -52.03 60.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.797 0.332 . . . . 73.109999999999999 111.67 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t -66.93 -34.46 77.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.776 0.322 . . . . 74.319999999999993 111.581 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.573 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 1.4 tpmt? -59.86 -60.85 3.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.841 0.353 . . . . 54.329999999999998 111.305 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.58 -30.85 71.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.533 -0.303 . . . . 64.420000000000002 111.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -59.5 -45.83 90.56 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.868 0.366 . . . . 64.120000000000005 110.378 176.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -47.95 62.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.208 -0.451 . . . . 72.549999999999997 110.666 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.74 -48.7 77.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.866 0.365 . . . . 75.430000000000007 111.52 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.53 71.83 0.71 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.654 0.622 . . . . 35.240000000000002 114.654 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 110' ' ' LEU . 6.0 mp -90.93 -177.31 4.91 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.415 -0.461 . . . . 64.340000000000003 110.415 173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.2 m -63.83 101.89 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.123 0.416 . . . . 74.349999999999994 112.123 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 p -105.64 137.39 43.57 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.065 0.459 . . . . 70.140000000000001 111.565 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.41 -58.01 3.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.886 0.375 . . . . 50.240000000000002 111.796 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -167.78 89.83 0.69 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.735 0.302 . . . . 74.230000000000004 110.453 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.01 -33.56 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.62 2.214 . . . . 73.409999999999997 114.368 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.49 118.03 28.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.27 0.47 . . . . 62.32 112.27 -173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.507 HG23 HG12 ' A' ' 119' ' ' ILE . 12.6 tt -137.78 7.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.322 0.582 . . . . 73.510000000000005 111.779 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 67.73 65.56 0.38 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.026 0.53 . . . . 72.510000000000005 112.429 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 123' ' ' PRO . 50.8 mm -104.62 111.67 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 74.109999999999999 111.115 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -93.53 -23.13 18.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.234 -0.439 . . . . 71.019999999999996 111.683 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.496 ' OE1' ' HA3' ' A' ' 92' ' ' GLY . 6.0 tp-100 -161.48 -65.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.021 0.438 . . . . 64.129999999999995 111.291 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.7 p -104.04 125.67 33.82 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.208 0.448 . . . . 73.409999999999997 112.208 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HA ' HD12 ' A' ' 119' ' ' ILE . 52.2 Cg_exo -55.93 150.23 47.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.545 2.163 . . . . 74.450000000000003 112.456 170.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.8 p -118.93 -176.12 3.05 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 -174.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.63 -48.41 19.86 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.104 -0.498 . . . . 64.349999999999994 112.049 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.96 -25.94 65.6 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.036 -0.529 . . . . 75.430000000000007 111.974 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 123' ' ' PRO . 59.2 m -63.87 -36.99 85.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.83 0.348 . . . . 63.310000000000002 110.856 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.39 -47.1 74.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.979 0.419 . . . . 75.340000000000003 110.937 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.72 -41.47 95.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.224 -0.443 . . . . 64.519999999999996 111.072 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.37 -54.43 47.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.466 -0.334 . . . . 74.519999999999996 110.238 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 20' ' ' ILE . 74.4 m -50.03 -51.58 40.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 111.785 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.537 ' HG3' ' HA3' ' A' ' 23' ' ' GLY . 46.1 tt0 -67.17 -55.02 15.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.381 -0.372 . . . . 73.129999999999995 111.792 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.49 -54.86 42.29 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.942 0.349 . . . . 52.229999999999997 111.942 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.6 76.47 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.4 -0.364 . . . . 54.340000000000003 111.85 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.15 -46.85 93.67 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 63.509999999999998 113.274 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 94.7 m -63.34 -51.2 66.92 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.88 0.371 . . . . 63.340000000000003 111.815 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.06 -42.63 98.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.133 0.492 . . . . 64.25 111.068 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 84' ' ' ALA . 53.7 tp -64.76 -41.24 96.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.053 0.454 . . . . 73.439999999999998 110.757 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.24 -42.72 98.82 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.183 -0.462 . . . . 52.210000000000001 112.68 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.15 -39.18 85.44 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.955 0.407 . . . . 74.140000000000001 110.926 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -59.89 -49.5 77.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.46 -0.336 . . . . 72.420000000000002 111.12 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.38 -47.91 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 112.133 0.419 . . . . 71.239999999999995 112.133 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -71.83 -41.5 68.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.106 0.409 . . . . 64.439999999999998 112.106 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -64.08 -33.16 75.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 111.559 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.6 -26.86 14.7 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.109 -0.496 . . . . 70.239999999999995 111.286 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -97.69 -63.68 1.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.339 -0.391 . . . . 75.219999999999999 112.013 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 147' ' ' LEU . 4.8 tt . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 111.861 0.319 . . . . 64.239999999999995 111.861 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.59 -0.152 . . . . 73.450000000000003 110.59 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 46.8 mm 74.55 96.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 121.31 0.576 . . . . 63.32 110.589 -172.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -81.99 123.24 5.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.056 -0.52 . . . . 54.229999999999997 113.735 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.7 t -95.36 106.4 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 O-C-N 122.608 -0.348 . . . . 65.400000000000006 111.115 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.613 ' HB3' HD23 ' A' ' 36' ' ' LEU . 93.1 m-85 -90.96 105.96 18.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.925 0.393 . . . . 71.129999999999995 111.614 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 35.9 p90 -146.75 -178.59 6.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.434 -0.348 . . . . 72.420000000000002 110.945 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.566 HG13 ' HB3' ' A' ' 10' ' ' TYR . 2.8 p -134.55 104.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.089 0.471 . . . . 75.329999999999998 111.086 176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -52.48 -25.34 9.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.215 0.82 . . . . 73.319999999999993 113.215 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -74.08 -32.42 63.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.763 0.316 . . . . 54.409999999999997 111.644 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.566 ' HB3' HG13 ' A' ' 7' ' ' VAL . 61.0 t80 -104.31 137.41 42.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.07 0.462 . . . . 74.129999999999995 112.226 -173.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.12 -161.79 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.98 0.752 . . . . 63.009999999999998 114.98 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.63 7.56 17.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.772 0.429 . . . . 73.5 111.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 84.8 p -30.75 -65.65 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.279 1.214 . . . . 55.509999999999998 114.279 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.46 -35.04 79.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.085 0.402 . . . . 72.409999999999997 112.085 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -60.21 -40.29 89.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.092 0.472 . . . . 70.430000000000007 110.747 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.44 -37.18 68.64 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 71.439999999999998 110.764 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.92 -31.64 67.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.206 -0.452 . . . . 51.329999999999998 111.352 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -52.21 -43.02 64.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.251 -0.431 . . . . 64.299999999999997 110.997 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . . . -67.76 -47.29 69.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.972 -0.558 . . . . 61.409999999999997 111.609 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.74 -55.4 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 62.119999999999997 111.386 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.03 -46.73 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.212 -0.449 . . . . 75.239999999999995 111.207 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.17 -50.22 74.88 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.414 -0.357 . . . . 71.040000000000006 111.864 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.17 -48.77 84.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.819 -0.705 . . . . 74.310000000000002 113.305 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 30' ' ' GLY . 1.8 mp -72.11 -32.3 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 122.521 -0.399 . . . . 74.340000000000003 112.013 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -72.0 -30.2 64.99 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.679 -0.638 . . . . 63.210000000000001 110.628 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HB3' ' NZ ' ' A' ' 26' ' ' LYS . 4.6 mmmp? -64.99 -24.11 67.42 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.137 0.494 . . . . 74.430000000000007 110.692 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.449 HG21 ' HG2' ' A' ' 140' ' ' GLN . 60.3 m -79.07 -40.44 31.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.219 0.533 . . . . 74.239999999999995 110.474 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.57 21.63 7.47 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.892 -0.595 . . . . 73.140000000000001 113.492 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.44 -77.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 122.402 -0.47 . . . . 72.0 111.995 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 114.67 115.48 3.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.306 -0.473 . . . . 72.25 113.133 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' SER . 29.7 m -90.59 157.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.187 0.518 . . . . 65.329999999999998 112.247 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' CG ' ' H2 ' ' A' ' 1' ' ' SER . 9.4 m-20 -96.28 130.62 43.33 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 110.926 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.41 120.19 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.142 -0.348 . . . . 71.329999999999998 111.759 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.79 104.15 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.672 0.273 . . . . 60.229999999999997 111.717 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 11.4 m-20 -77.05 103.23 6.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.811 0.339 . . . . 74.400000000000006 111.049 173.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.613 HD23 ' HB3' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -67.96 78.81 0.22 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.968 0.89 . . . . 72.109999999999999 111.864 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.1 -25.62 0.23 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.404 -0.816 . . . . 75.239999999999995 112.397 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.97 157.87 34.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.778 0.323 . . . . 43.200000000000003 111.364 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 70.28 2.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.207 0.527 . . . . 72.420000000000002 111.976 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.63 147.65 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 75.430000000000007 111.527 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.4 166.8 10.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.98 0.419 . . . . 74.340000000000003 111.259 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD13 HD12 ' A' ' 45' ' ' LEU . 3.9 mm? -56.22 -24.4 41.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.451 -0.341 . . . . 74.299999999999997 111.201 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.74 -49.6 77.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.218 -0.446 . . . . 65.0 111.033 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.82 -46.41 71.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.879 0.371 . . . . 74.120000000000005 111.168 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 42' ' ' LEU . 93.7 mt -57.53 -46.82 83.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.191 -0.459 . . . . 74.239999999999995 111.767 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.4 -44.92 96.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.698 0.285 . . . . 74.349999999999994 111.586 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 9.5 tp10 -64.57 -42.52 95.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.167 0.508 . . . . 70.209999999999994 110.83 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.73 -42.06 71.1 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.969 -0.56 . . . . 74.540000000000006 111.485 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 45' ' ' LEU . 67.2 t -56.1 -37.61 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.979 0.418 . . . . 74.049999999999997 111.43 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.11 -21.32 79.89 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.964 -0.636 . . . . 54.119999999999997 112.993 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 12.5 mmt180 -100.74 5.3 43.59 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.57 -0.371 . . . . 71.310000000000002 111.821 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.1 p -70.83 4.58 2.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.324 0.861 . . . . 75.409999999999997 113.324 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.5 p -58.96 -36.39 74.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 52.520000000000003 110.927 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -154.95 138.82 6.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.624 -0.716 . . . . 14.01 112.047 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.0 169.76 17.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.256 0.528 . . . . 75.340000000000003 112.196 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 88' ' ' PHE . 7.3 p -131.46 136.24 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.767 0.318 . . . . 74.230000000000004 111.388 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.7 mp -112.69 133.16 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.936 0.398 . . . . 60.0 112.062 -175.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.93 -124.45 5.41 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.263 -0.494 . . . . 50.310000000000002 112.686 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.442 ' SD ' ' HA3' ' A' ' 91' ' ' GLY . 54.9 ttm -155.07 154.7 32.83 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.429 -0.454 . . . . 72.239999999999995 110.892 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.546 ' HB3' HD13 ' A' ' 36' ' ' LEU . 67.7 p -114.19 156.95 43.52 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 120.607 0.242 . . . . 72.150000000000006 111.38 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.43 152.14 78.78 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.951 1.767 . . . . 74.230000000000004 111.826 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.34 -41.08 8.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.422 0.897 . . . . 73.129999999999995 113.422 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.48 -48.34 56.21 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.155 0.428 . . . . 72.209999999999994 112.155 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -14.49 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.027 0.38 . . . . 75.129999999999995 112.027 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -54.22 -32.18 55.2 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.225 0.454 . . . . 73.040000000000006 112.225 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.19 -33.21 70.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 75.430000000000007 111.252 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -67.84 -42.13 81.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.176 -0.465 . . . . 63.530000000000001 111.296 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.5 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.814 0.34 . . . . 51.509999999999998 110.855 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -51.62 -45.4 63.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.208 -0.451 . . . . 71.150000000000006 111.545 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.01 -49.47 16.43 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.047 -0.596 . . . . 64.409999999999997 113.184 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.83 76.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.005 0.372 . . . . 54.530000000000001 112.005 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 tt -48.39 -49.73 33.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.21 0.604 . . . . 74.299999999999997 111.387 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -60.13 -40.09 88.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.105 0.409 . . . . 71.400000000000006 112.105 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.2 m -74.33 -36.87 63.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.876 0.37 . . . . 72.230000000000004 111.395 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 79' ' ' VAL . 74.7 mt -71.63 -67.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.469 -0.332 . . . . 74.200000000000003 111.397 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.482 ' HA ' HG22 ' A' ' 79' ' ' VAL . 68.4 mt -61.65 -22.15 65.03 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.452 0.538 . . . . 75.400000000000006 112.452 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.45 -22.68 64.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.727 -0.749 . . . . 44.299999999999997 113.259 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -101.03 -26.2 13.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.458 0.54 . . . . 71.230000000000004 112.458 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 75' ' ' ILE . 33.7 m -70.51 179.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.381 0.61 . . . . 72.409999999999997 112.417 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.61 161.34 25.97 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.092 -0.504 . . . . 74.099999999999994 111.691 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -46.97 -42.89 18.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 112.814 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -145.92 133.03 20.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.089 0.471 . . . . 71.209999999999994 111.39 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -133.54 177.18 7.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.073 -0.512 . . . . 73.099999999999994 111.806 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.632 ' HB1' HD11 ' A' ' 138' ' ' LEU . . . -102.74 112.18 24.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.845 0.355 . . . . 62.350000000000001 111.24 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.75 169.69 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.91 0.386 . . . . 72.239999999999995 111.967 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.12 169.29 32.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.37 -0.443 . . . . 71.040000000000006 112.749 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.482 HG21 ' HB3' ' A' ' 116' ' ' ALA . 43.9 mm -100.42 146.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 74.129999999999995 111.895 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.543 ' HB2' HG22 ' A' ' 56' ' ' VAL . 17.8 t80 -135.28 109.58 8.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.501 -0.318 . . . . 60.32 110.749 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -64.62 93.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.557 0.577 . . . . 62.329999999999998 112.557 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 t -160.58 77.79 0.61 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.258 0.551 . . . . 73.329999999999998 111.819 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.442 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . 171.31 121.51 0.59 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.091 -0.576 . . . . 35.329999999999998 113.193 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.87 51.09 4.27 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.128 -0.558 . . . . 62.240000000000002 113.407 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.32 56.76 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.281 -0.485 . . . . 62.140000000000001 113.313 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.6 -154.89 0.38 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.67 0.388 . . . . 71.049999999999997 111.404 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 23.3 t70 69.66 154.93 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.321 0.648 . . . . 53.329999999999998 112.593 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 8.3 mm-40 -103.42 -56.33 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.095 -0.502 . . . . 72.140000000000001 112.31 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 88.4 Cg_endo -80.04 16.96 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.122 1.881 . . . . 72.109999999999999 113.759 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.3 tt -48.0 -56.39 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.705 1.002 . . . . 62.219999999999999 113.705 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.689 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.5 m-20 -61.17 -54.07 57.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.972 -0.455 . . . . 70.510000000000005 111.953 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 51.8 Cg_exo -54.66 -42.2 70.56 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.905 1.737 . . . . 74.340000000000003 112.654 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.61 -59.52 4.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.984 0.421 . . . . 74.409999999999997 111.342 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.51 -35.4 79.26 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.02 0.438 . . . . 44.210000000000001 111.511 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -62.71 -46.28 88.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.394 -0.366 . . . . 73.140000000000001 111.784 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 100' ' ' PRO . 53.2 mtpt -61.08 -45.15 95.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.499 0.19 . . . . 74.129999999999995 111.356 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.439 ' HA ' HD13 ' A' ' 110' ' ' LEU . 2.3 m-85 -58.59 -40.96 84.66 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 110.991 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.76 -49.66 74.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.715 -0.675 . . . . 74.439999999999998 111.9 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -81.29 -46.85 14.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.864 0.69 . . . . 73.030000000000001 112.864 -174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.5 -15.18 57.14 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.238 0.458 . . . . 54.149999999999999 112.238 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.61 4.98 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 114.398 0.519 . . . . 73.420000000000002 114.398 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 105' ' ' PHE . 7.5 mp -88.88 -175.33 4.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.095 0.448 . . . . 44.329999999999998 110.995 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 154.16 26.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.258 0.552 . . . . 61.140000000000001 111.982 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -100.98 -51.94 3.41 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.069 -0.514 . . . . 75.040000000000006 111.757 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.59 42.87 13.44 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.093 0.473 . . . . 72.540000000000006 111.563 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.5 t80 68.23 93.71 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.468 -0.787 . . . . 70.549999999999997 111.706 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.31 96.5 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.432 2.088 . . . . 70.030000000000001 112.276 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HB3' HG21 ' A' ' 87' ' ' ILE . . . -56.57 156.14 6.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.524 0.564 . . . . 71.040000000000006 112.524 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.667 HD13 ' N ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -77.13 139.42 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 110.402 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.667 ' N ' HD13 ' A' ' 117' ' ' ILE . 82.2 mtt180 -56.74 120.72 8.32 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.133 0.492 . . . . 73.319999999999993 111.659 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.8 mp -70.15 138.15 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.302 0.572 . . . . 71.109999999999999 112.172 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -65.86 -70.94 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.912 -0.586 . . . . 74.230000000000004 110.723 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -155.1 -58.98 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.172 0.511 . . . . 72.420000000000002 110.413 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.3 p -94.69 136.87 22.7 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.123 -0.489 . . . . 51.329999999999998 111.933 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.46 -165.21 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.962 2.442 . . . . 72.129999999999995 112.8 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 55.0 p -133.08 171.89 13.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.939 0.4 . . . . 60.310000000000002 111.542 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.81 -33.41 56.0 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.155 0.503 . . . . 63.43 111.569 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.76 -10.77 30.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.533 0.568 . . . . 71.5 112.533 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.5 m -63.56 -33.11 74.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.012 0.434 . . . . 62.130000000000003 111.13 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.552 ' HA ' ' HG ' ' A' ' 131' ' ' CYS . 82.9 m-85 -65.16 -41.67 94.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.301 0.572 . . . . 74.439999999999998 110.514 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.17 -49.71 76.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 73.510000000000005 111.099 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.17 -58.13 9.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.106 -0.497 . . . . 75.219999999999999 111.218 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.552 ' HG ' ' HA ' ' A' ' 128' ' ' TYR . 27.8 p -58.15 -47.09 84.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.671 0.619 . . . . 75.310000000000002 112.671 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.58 -54.75 27.15 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.154 0.427 . . . . 71.530000000000001 112.154 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.33 -48.6 72.47 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.117 0.414 . . . . 34.310000000000002 112.117 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.31 -42.84 92.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 111.312 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.49 97.48 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.317 -0.468 . . . . 75.299999999999997 112.774 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.475 HG23 ' NE2' ' A' ' 140' ' ' GLN . 46.6 m -62.05 -44.17 97.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.999 0.428 . . . . 63.310000000000002 111.096 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.92 -61.07 2.13 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.441 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.632 HD11 ' HB1' ' A' ' 84' ' ' ALA . 46.9 tp -63.34 -37.86 88.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.83 0.348 . . . . 74.299999999999997 111.722 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -51.14 45.46 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.114 -0.565 . . . . 74.099999999999994 113.165 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.475 ' NE2' HG23 ' A' ' 136' ' ' THR . 80.7 mt-30 -73.01 -7.84 53.04 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.353 -0.498 . . . . 74.420000000000002 111.983 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.471 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 62.6 t90 -55.26 -32.3 62.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.137 0.494 . . . . 73.209999999999994 110.191 170.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.62 -47.07 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 111.95 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 140' ' ' GLN . 11.3 t -73.66 -32.06 63.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.143 -0.348 . . . . 55.210000000000001 111.49 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -70.74 -41.83 71.29 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.86 0.362 . . . . 62.149999999999999 111.438 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.53 -61.05 1.76 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.532 0.567 . . . . 51.43 112.532 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -75.08 -55.08 6.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.902 0.382 . . . . 64.450000000000003 111.838 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 147' ' ' LEU . 10.1 tt . . . . . 0 CA--C 1.542 0.665 0 CA-C-O 120.922 0.392 . . . . 71.349999999999994 110.994 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 45.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.143 -0.317 . . . . 55.119999999999997 110.143 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 54' ' ' GLY . 47.2 mm 59.64 91.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.184 0.516 . . . . 71.519999999999996 111.53 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 104.64 2.3 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.833 -0.698 . . . . 65.439999999999998 112.84 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 m -87.3 107.79 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.427 0.632 . . . . 44.420000000000002 110.881 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.758 ' HB3' HD23 ' A' ' 36' ' ' LEU . 55.3 m-85 -104.22 118.37 36.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.897 -0.592 . . . . 60.130000000000003 111.206 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -152.16 176.51 11.49 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.202 0.445 . . . . 72.5 112.202 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' SER . 48.4 t -109.08 104.04 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 116.089 -0.505 . . . . 74.140000000000001 110.28 172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 62.1 p -59.67 -56.74 18.08 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.415 0.895 . . . . 74.099999999999994 113.415 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.23 -43.26 92.35 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.087 0.773 . . . . 65.0 113.087 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -77.26 121.02 23.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.14 0.495 . . . . 63.130000000000003 112.266 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.28 -162.61 6.17 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.844 -0.616 . . . . 44.509999999999998 114.408 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -81.9 7.77 12.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.925 0.343 . . . . 55.409999999999997 111.925 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 20.0 m -44.22 -43.97 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.578 0.955 . . . . 75.450000000000003 113.578 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.688 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 19.6 p-10 -73.57 -36.71 65.62 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.922 -0.486 . . . . 60.299999999999997 111.358 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mmt-85 -61.22 -40.62 94.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.519 0.676 . . . . 74.109999999999999 109.713 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.665 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . 79.7 mt -66.67 -41.68 87.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 73.439999999999998 110.838 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.74 83.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 75.109999999999999 111.136 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.48 -27.56 65.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.801 0.334 . . . . 72.329999999999998 110.994 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 22' ' ' ASN . . . -64.27 -37.64 88.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.089 0.471 . . . . 72.5 110.362 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.57 HG23 ' HA3' ' A' ' 135' ' ' GLY . 63.1 mt -63.1 -53.1 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.278 0.561 . . . . 74.510000000000005 110.301 171.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.14 -33.45 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.751 -0.659 . . . . 75.5 111.283 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 39.2 t30 -53.65 -60.14 3.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.356 -0.384 . . . . 53.439999999999998 111.187 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.17 97.93 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.12 -0.562 . . . . 71.549999999999997 113.06 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 29' ' ' VAL . 55.4 mt -60.75 -50.6 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.235 0.457 . . . . 73.120000000000005 112.235 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -67.97 -38.22 82.47 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.165 -0.335 . . . . 75.329999999999998 111.298 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.8 -32.89 69.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.091 0.472 . . . . 73.019999999999996 111.078 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.605 HG21 ' HG2' ' A' ' 140' ' ' GLN . 88.6 m -79.4 -35.27 40.92 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.175 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.91 32.25 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.365 -0.445 . . . . 75.519999999999996 113.279 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HB ' HG23 ' A' ' 24' ' ' ILE . 29.5 t -108.91 133.95 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 122.462 -0.434 . . . . 74.209999999999994 111.417 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.09 112.64 3.64 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.111 -0.566 . . . . 70.409999999999997 112.534 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 24' ' ' ILE . 7.7 p -99.22 140.85 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 112.48 0.548 . . . . 64.239999999999995 112.48 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -96.48 109.38 21.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.027 0.441 . . . . 71.319999999999993 110.695 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.07 116.91 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 111.872 0.323 . . . . 74.129999999999995 111.872 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.41 119.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.017 0.437 . . . . 54.420000000000002 111.942 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.67 105.27 16.1 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.934 0.397 . . . . 74.219999999999999 111.255 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 5' ' ' PHE . 2.9 pp -77.38 -10.02 59.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.843 0.354 . . . . 73.109999999999999 111.43 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.58 -12.26 66.67 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.206 -0.521 . . . . 34.530000000000001 113.14 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.18 -48.23 0.06 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.867 0.365 . . . . 73.409999999999997 111.77 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.613 0.597 . . . . 74.409999999999997 112.613 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.0 m -117.96 45.79 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.323 0.583 . . . . 73.129999999999995 110.957 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.35 149.39 48.46 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.463 0.542 . . . . 70.420000000000002 112.463 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.411 ' H ' HD22 ' A' ' 42' ' ' LEU . 3.3 mm? -58.55 -35.12 71.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 112.175 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -62.94 -40.17 96.86 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.883 0.373 . . . . 62.350000000000001 110.723 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LEU . 17.6 tp10 -70.41 -29.7 66.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.3 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 74' ' ' THR . 3.3 tm? -60.9 -46.96 88.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.146 0.498 . . . . 64.310000000000002 109.815 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.32 -40.0 94.88 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.39 0.614 . . . . 73.400000000000006 110.721 172.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.728 ' HG3' HH11 ' A' ' 51' ' ' ARG . 20.5 tp10 -79.83 -10.63 59.8 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.642 -0.708 . . . . 74.25 111.332 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 51' ' ' ARG . 53.3 tp -59.22 -28.67 66.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.92 0.488 . . . . 71.040000000000006 111.696 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.403 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 35.8 t -58.9 -23.95 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.988 0.423 . . . . 74.129999999999995 111.351 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.15 -34.95 25.19 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.926 -0.654 . . . . 61.439999999999998 112.151 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.728 HH11 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -68.83 -38.28 79.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.839 0.352 . . . . 72.230000000000004 111.273 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 p -67.12 -2.84 6.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.868 0.692 . . . . 63.439999999999998 112.868 -174.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -62.88 -22.21 66.55 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.134 0.492 . . . . 61.310000000000002 110.892 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 2' ' ' ILE . . . -153.58 137.43 5.77 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.99 -0.844 . . . . 70.120000000000005 110.99 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HB2' HG12 ' A' ' 85' ' ' VAL . 95.4 mt -116.58 116.54 27.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.583 0.691 . . . . 64.310000000000002 112.434 -173.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.02 105.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 74.129999999999995 110.266 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -101.93 119.61 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.846 0.355 . . . . 64.409999999999997 111.273 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 59' ' ' MET . . . -80.91 -12.04 83.14 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.028 -0.606 . . . . 54.210000000000001 113.84 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 49.6 ttp 71.3 149.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.301 0.572 . . . . 61.450000000000003 111.723 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 60.0 m -151.22 140.77 13.99 Favored Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 122.182 -0.324 . . . . 75.310000000000002 111.132 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.91 161.68 28.46 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.514 2.143 . . . . 73.450000000000003 112.978 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.38 -39.7 7.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.53 0.567 . . . . 71.340000000000003 112.53 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.68 64.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.092 0.405 . . . . 54.509999999999998 112.092 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 19.6 m -79.86 -19.27 48.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.443 -0.344 . . . . 73.329999999999998 111.893 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.712 ' HB1' HE22 ' A' ' 69' ' ' GLN . . . -64.88 -11.93 43.14 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.601 0.593 . . . . 52.229999999999997 112.601 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.94 -49.67 68.17 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.884 0.373 . . . . 52.420000000000002 111.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.7 p -65.59 -43.49 89.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.979 0.418 . . . . 35.329999999999998 111.197 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -53.85 -56.08 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.018 -0.537 . . . . 61.43 111.618 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.712 HE22 ' HB1' ' A' ' 65' ' ' ALA . 2.1 mp0 -60.33 -21.65 62.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.18 0.437 . . . . 74.319999999999993 112.18 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.23 -48.3 80.64 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.033 -0.603 . . . . 75.239999999999995 112.661 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -89.67 -19.34 24.97 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.869 0.366 . . . . 71.530000000000001 111.855 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tt -49.74 -34.71 19.86 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.904 0.481 . . . . 72.109999999999999 111.891 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m -47.7 -37.45 13.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.096 -0.502 . . . . 73.150000000000006 112.234 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.645 HG21 HD11 ' A' ' 45' ' ' LEU . 45.5 m -99.47 -35.79 9.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 111.759 0.281 . . . . 61.539999999999999 111.759 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 71' ' ' ALA . 68.3 mt -47.86 -44.4 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.491 0.552 . . . . 64.420000000000002 112.491 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.8 -35.76 64.21 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 71.239999999999995 111.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.06 -29.39 28.5 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.123 -0.561 . . . . 65.420000000000002 113.111 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -69.6 -30.01 67.66 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.025 0.38 . . . . 72.219999999999999 112.025 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.21 164.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.275 0.472 . . . . 51.210000000000001 112.275 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.99 148.33 22.44 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.233 -0.44 . . . . 70.340000000000003 110.28 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.19 -62.12 1.91 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.931 0.715 . . . . 74.209999999999994 112.931 -173.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 53.2 mttm -100.49 114.45 28.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.343 0.592 . . . . 75.439999999999998 111.799 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.666 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -163.8 -174.53 3.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.883 -0.599 . . . . 73.019999999999996 110.274 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.666 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -110.38 132.57 54.07 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.034 -0.416 . . . . 75.450000000000003 111.336 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.589 HG12 ' HB2' ' A' ' 55' ' ' LEU . 29.8 m -119.72 134.64 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.415 0.626 . . . . 72.310000000000002 112.43 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 127.72 8.42 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.84 -0.618 . . . . 73.219999999999999 112.334 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -129.02 145.86 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.687 -0.302 . . . . 74.510000000000005 110.917 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -146.81 135.31 21.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.997 0.427 . . . . 75.230000000000004 110.903 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.508 ' HB3' HG22 ' A' ' 117' ' ' ILE . 18.5 pt-20 -78.69 98.47 6.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 112.43 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -115.76 119.28 35.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.149 0.5 . . . . 72.140000000000001 111.756 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.26 -75.36 0.5 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.34 -0.457 . . . . 61.039999999999999 114.115 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.3 -72.98 1.85 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.077 -0.582 . . . . 41.329999999999998 112.263 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.9 -84.65 0.38 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.218 -0.515 . . . . 73.230000000000004 113.678 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.85 128.54 2.04 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.758 0.313 . . . . 75.099999999999994 111.827 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -150.38 158.03 43.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.334 -0.394 . . . . 64.319999999999993 111.024 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.653 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mt-10 -101.29 -59.47 0.1 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.709 0.633 . . . . 73.319999999999993 112.709 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 66.2 Cg_endo -81.79 44.94 1.83 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.366 2.044 . . . . 71.450000000000003 113.649 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.58 -39.92 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.213 0.449 . . . . 74.209999999999994 112.213 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.624 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 26.0 m-20 -68.15 -52.25 23.41 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 122.102 -0.374 . . . . 53.32 111.342 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 72.8 Cg_exo -51.41 -35.94 56.5 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.127 1.884 . . . . 63.119999999999997 112.613 172.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.86 -58.26 9.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.41 -0.359 . . . . 72.430000000000007 111.003 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.39 -34.11 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.169 0.509 . . . . 71.209999999999994 111.207 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -60.13 -40.51 90.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.806 -0.633 . . . . 74.120000000000005 111.675 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -60.46 -22.25 63.27 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.09 0.404 . . . . 63.420000000000002 112.09 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -91.15 -70.96 0.66 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.122 0.487 . . . . 74.150000000000006 111.996 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -71.46 -35.15 70.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.287 0.847 . . . . 64.219999999999999 113.287 -169.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.52 -24.97 63.81 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.965 0.412 . . . . 62.229999999999997 111.305 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.82 -55.4 3.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.97 0.414 . . . . 73.510000000000005 110.948 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HG2' ' A' ' 82' ' ' LYS . . . 159.09 -5.05 0.11 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.853 -0.689 . . . . 75.209999999999994 113.759 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 81.0 mt -77.59 99.44 5.75 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.52 -0.4 . . . . 73.019999999999996 111.236 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -74.88 129.51 37.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.124 0.488 . . . . 72.530000000000001 111.423 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -80.87 110.59 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.179 -0.464 . . . . 75.040000000000006 111.682 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.67 66.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.225 0.536 . . . . 45.25 111.692 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -118.39 90.34 38.48 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.459 -0.571 . . . . 75.019999999999996 109.459 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.91 33.22 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.126 2.551 . . . . 63.439999999999998 114.753 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 122.84 4.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.364 0.505 . . . . 53.539999999999999 112.364 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.74 123.48 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.296 -0.411 . . . . 65.120000000000005 110.516 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -149.22 28.44 0.82 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.392 0.516 . . . . 72.230000000000004 112.392 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mm -68.8 142.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.067 0.461 . . . . 74.319999999999993 111.332 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -75.16 -51.15 14.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 71.140000000000001 111.577 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -166.29 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.12 0.486 . . . . 71.340000000000003 111.201 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.8 p -114.3 130.37 24.04 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 111.862 0.319 . . . . 71.209999999999994 111.862 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.24 155.8 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.666 2.244 . . . . 53.140000000000001 112.641 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -105.84 170.07 8.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.08 0.467 . . . . 72.219999999999999 111.642 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.37 -24.73 60.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.184 -0.462 . . . . 65.430000000000007 111.547 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -84.39 -24.19 29.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.801 0.334 . . . . 71.239999999999995 111.557 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -55.56 -32.17 62.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.052 0.453 . . . . 75.349999999999994 111.253 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 71.0 m-85 -56.48 -45.77 80.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 111.182 175.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -57.53 -46.24 84.09 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.345 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.34 -47.11 72.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.143 0.496 . . . . 53.399999999999999 111.005 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 16' ' ' LEU . 67.7 m -58.04 -48.42 80.13 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.72 -0.673 . . . . 75.239999999999995 111.343 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 52.4 mt-10 -58.54 -49.5 77.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.405 . . . . 64.540000000000006 111.604 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.71 -32.7 71.43 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.476 0.547 . . . . 74.010000000000005 112.476 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.67 -60.49 2.35 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.193 0.442 . . . . 70.430000000000007 112.193 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.57 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -65.34 -43.16 95.52 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.141 -0.552 . . . . 73.510000000000005 113.995 -174.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 73.2 m -60.92 -38.78 86.96 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.448 -0.442 . . . . 74.099999999999994 112.127 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.62 -49.89 73.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.935 0.398 . . . . 73.040000000000006 110.973 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.06 -40.26 92.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.324 -0.398 . . . . 75.420000000000002 110.987 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.491 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -59.32 -45.71 95.01 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.104 -0.57 . . . . 62.420000000000002 112.771 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.605 ' HG2' HG21 ' A' ' 27' ' ' THR . 52.4 mt-30 -64.29 -38.97 92.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.037 0.446 . . . . 75.400000000000006 111.254 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -65.49 -58.0 6.88 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 111.87 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 83.9 t -57.11 -50.88 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.379 0.511 . . . . 64.319999999999993 112.379 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.519 HG21 HG22 ' A' ' 29' ' ' VAL . 15.2 t -62.69 -36.86 84.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 34.350000000000001 112.034 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -81.87 -23.26 36.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.737 0.303 . . . . 73.120000000000005 111.414 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.91 -47.97 15.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.024 0.44 . . . . 75.129999999999995 110.518 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -79.61 6.72 9.86 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.46 -0.336 . . . . 72.219999999999999 111.829 177.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.623 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 122.926 0.491 . . . . 62.020000000000003 111.739 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.6 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.634 0.254 . . . . 54.25 111.496 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.683 HD11 ' HA2' ' A' ' 139' ' ' GLY . 46.0 mm 58.8 95.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.155 0.503 . . . . 74.030000000000001 112.181 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.67 96.09 1.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.915 -0.659 . . . . 50.229999999999997 112.473 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.33 114.09 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.655 0.74 . . . . 72.140000000000001 112.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.64 105.05 17.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.753 -0.658 . . . . 72.239999999999995 110.78 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HE1' ' HB ' ' A' ' 33' ' ' VAL . 24.7 p90 -116.21 179.99 3.83 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.897 0.38 . . . . 75.409999999999997 111.455 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.14 113.79 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.242 0.544 . . . . 71.439999999999998 111.408 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 24.5 m -75.57 -25.02 56.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.195 0.522 . . . . 64.519999999999996 111.556 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -71.78 -16.37 62.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.751 -0.659 . . . . 75.239999999999995 111.978 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 70.8 t80 -125.69 106.24 9.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.979 0.419 . . . . 64.430000000000007 112.056 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.65 -162.4 5.44 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.583 0.593 . . . . 55.25 114.583 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -80.41 7.63 9.32 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.456 0.539 . . . . 74.549999999999997 112.456 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.6 m -44.69 -35.92 2.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.843 0.683 . . . . 74.230000000000004 112.843 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 11.7 p-10 -65.67 -43.19 90.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 70.140000000000001 111.328 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -71.09 -38.94 72.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.014 0.435 . . . . 71.049999999999997 110.618 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.92 -43.73 91.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 64.400000000000006 110.968 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.13 75.62 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 111.221 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.23 -34.06 77.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.309 -0.405 . . . . 74.219999999999999 111.144 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.97 92.88 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.042 0.448 . . . . 71.129999999999995 110.736 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.417 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.7 mt -63.4 -48.49 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.171 0.51 . . . . 70.150000000000006 110.347 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 31' ' ' VAL . 74.6 mt -56.96 -33.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.938 -0.574 . . . . 54.25 111.573 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -58.67 -43.54 89.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.961 0.41 . . . . 70.140000000000001 111.045 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.51 -37.28 62.34 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.05 -0.595 . . . . 73.439999999999998 112.875 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.433 HD12 HG13 ' A' ' 2' ' ' ILE . 46.5 mm -64.47 -45.21 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.044 0.45 . . . . 74.219999999999999 111.305 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 p -61.83 -42.49 99.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.842 0.353 . . . . 51.340000000000003 111.034 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -57.84 -36.79 72.78 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.827 0.346 . . . . 73.230000000000004 111.439 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.0 m -78.15 -8.6 58.49 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.225 0.536 . . . . 73.519999999999996 111.401 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.19 42.71 23.11 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.163 -0.541 . . . . 40.140000000000001 113.092 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.9 t -127.76 143.94 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 122.595 -0.356 . . . . 72.430000000000007 111.506 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.93 152.25 36.51 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.116 -0.564 . . . . 74.200000000000003 112.732 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 21' ' ' ILE . 22.4 t -112.87 147.39 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.465 0.543 . . . . 75.219999999999999 112.465 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -111.26 103.41 11.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.556 0.343 . . . . 73.549999999999997 110.387 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 30.5 m -100.91 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.851 0.685 . . . . 52.43 112.851 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -139.88 127.3 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 116.125 -0.489 . . . . 62.210000000000001 110.931 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -94.22 111.01 22.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.915 0.388 . . . . 74.530000000000001 110.969 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -82.57 11.79 5.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.314 0.487 . . . . 71.150000000000006 112.314 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.39 -9.08 58.18 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.453 -0.403 . . . . 64.319999999999993 112.369 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.41 179.29 5.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.999 0.428 . . . . 45.109999999999999 111.468 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 93.09 0.22 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 51.240000000000002 111.416 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.99 149.75 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.277 0.561 . . . . 73.120000000000005 112.214 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -147.95 170.58 17.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.959 -0.564 . . . . 75.409999999999997 111.176 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.0 mm? -65.18 -22.48 66.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.394 -0.366 . . . . 65.409999999999997 111.686 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -62.45 -42.25 99.33 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.632 0.253 . . . . 63.240000000000002 111.361 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.2 -45.19 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.986 0.422 . . . . 55.43 110.813 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 45' ' ' LEU . 5.7 tt -55.79 -38.67 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.074 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -61.39 -21.92 64.51 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.375 0.509 . . . . 73.340000000000003 112.375 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -58.69 -19.7 41.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.991 0.425 . . . . 72.209999999999994 111.355 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -53.18 -34.97 59.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.238 -0.437 . . . . 65.409999999999997 111.436 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.96 -44.11 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.942 0.401 . . . . 74.329999999999998 111.599 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.99 -23.14 50.47 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.984 -0.627 . . . . 51.240000000000002 113.812 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 -1.86 40.69 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.187 -0.596 . . . . 75.230000000000004 111.557 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 53' ' ' THR . 27.9 p -36.79 -58.76 0.73 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.172 1.545 . . . . 54.32 115.172 -170.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 71.6 p -61.09 -20.54 62.74 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.701 1.0 . . . . 75.420000000000002 113.701 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.34 136.18 4.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.19 -1.005 . . . . 30.329999999999998 113.838 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 57' ' ' ILE . 0.7 OUTLIER -171.08 -179.48 2.74 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.064 0.546 . . . . 54.219999999999999 111.258 -178.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.53 131.07 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.409 . . . . 61.439999999999998 111.46 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.514 HD11 HD13 ' A' ' 55' ' ' LEU . 3.3 mp -117.05 137.01 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.991 0.424 . . . . 72.120000000000005 111.983 -176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.88 140.26 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.481 -0.648 . . . . 74.209999999999994 111.481 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.488 ' SD ' ' CE2' ' A' ' 10' ' ' TYR . 4.2 ppp? -67.49 146.95 53.46 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 117.652 0.726 . . . . 53.409999999999997 111.897 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 95.1 p -99.38 144.56 28.49 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 112.758 0.651 . . . . 61.240000000000002 112.758 -172.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 90.3 Cg_endo -75.39 -176.3 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.807 2.338 . . . . 74.400000000000006 112.526 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.94 -55.16 25.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.813 0.672 . . . . 44.229999999999997 112.813 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.73 73.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.232 0.456 . . . . 75.019999999999996 112.232 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 62.2 m -65.08 -50.07 67.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.681 -0.236 . . . . 71.150000000000006 111.506 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.64 -49.67 67.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.007 0.432 . . . . 64.230000000000004 111.644 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.45 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.188 0.44 . . . . 72.040000000000006 112.188 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -95.65 -29.56 14.24 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.846 0.313 . . . . 73.329999999999998 111.846 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.11 -13.44 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.021 0.378 . . . . 50.329999999999998 112.021 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.49 -40.8 5.87 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.2 0.815 . . . . 71.239999999999995 113.2 -175.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.05 -52.3 28.86 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.858 -0.687 . . . . 64.140000000000001 112.614 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.18 -28.25 66.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.734 0.302 . . . . 73.409999999999997 111.767 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.25 -46.13 86.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.82 0.343 . . . . 74.140000000000001 110.899 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -58.04 -45.06 87.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.09 0.471 . . . . 72.040000000000006 110.431 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.3 m -55.97 -47.7 77.17 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.853 -0.612 . . . . 75.099999999999994 111.479 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.488 ' O ' HG13 ' A' ' 79' ' ' VAL . 77.4 mt -61.06 -55.73 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.34 -0.391 . . . . 65.430000000000007 111.204 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.8 -30.92 58.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.228 0.455 . . . . 75.510000000000005 112.228 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.24 -21.24 55.41 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.061 -0.59 . . . . 63.200000000000003 113.656 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 m -100.18 -6.44 26.15 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.088 0.773 . . . . 65.25 113.088 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -75.86 172.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.46 0.541 . . . . 75.200000000000003 112.46 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -99.68 178.32 4.88 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.528 . . . . 70.439999999999998 110.585 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -87.49 -18.05 30.74 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.871 0.693 . . . . 64.040000000000006 112.871 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -148.96 44.98 1.0 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.192 1.182 . . . . 73.510000000000005 114.192 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.418 ' NE2' HD22 ' A' ' 110' ' ' LEU . 5.9 pm0 -94.38 166.78 11.9 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.393 -0.817 . . . . 71.430000000000007 111.425 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.75 115.46 27.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 111.843 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.92 114.76 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.572 0.701 . . . . 72.420000000000002 112.031 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.47 145.36 25.16 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.06 -0.591 . . . . 64.299999999999997 112.416 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -152.83 140.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.071 0.435 . . . . 75.049999999999997 111.192 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -155.85 110.84 2.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.217 0.532 . . . . 74.239999999999995 110.72 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.99 131.31 35.95 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.4 -0.364 . . . . 73.420000000000002 111.506 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 HG21 ' A' ' 127' ' ' THR . 12.2 t -170.89 179.91 3.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.402 -0.363 . . . . 72.349999999999994 111.161 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.31 -17.56 18.08 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.287 -0.483 . . . . 44.439999999999998 113.92 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.82 -119.25 0.75 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.398 -0.43 . . . . 35.229999999999997 112.336 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.55 74.03 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.424 -0.893 . . . . 60.109999999999999 114.155 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -97.89 109.98 22.64 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.609 -0.348 . . . . 71.340000000000003 110.654 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.696 ' HB2' ' HB ' ' A' ' 98' ' ' ILE . 16.2 p-10 -137.98 95.02 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.654 0.74 . . . . 64.329999999999998 112.454 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 39.1 mt-10 -103.76 -48.78 0.15 Allowed Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.189 -0.46 . . . . 75.439999999999998 112.051 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.531 ' O ' HD13 ' A' ' 101' ' ' LEU . 54.8 Cg_endo -91.52 27.46 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.231 1.954 . . . . 71.409999999999997 112.647 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 95' ' ' ASP . 7.1 tt -59.93 -51.49 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.988 0.736 . . . . 74.519999999999996 112.988 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 12.0 m-20 -62.74 -49.46 82.38 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.403 0.519 . . . . 71.519999999999996 112.403 -175.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 74.7 Cg_exo -51.45 -50.3 14.39 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.102 1.868 . . . . 74.409999999999997 112.973 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.5 mp -63.05 -47.7 81.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.87 0.322 . . . . 63.340000000000003 111.87 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 105' ' ' PHE . 62.1 mt -58.77 -38.79 79.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.008 0.432 . . . . 70.209999999999994 111.044 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -58.17 -42.16 85.41 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.282 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 100' ' ' PRO . 11.3 mmpt? -55.98 -49.51 73.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 74.150000000000006 111.215 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.409 ' HD2' ' HA ' ' A' ' 102' ' ' LEU . 38.9 m-85 -56.0 -47.49 77.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.233 0.457 . . . . 72.129999999999995 112.233 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -79.61 -35.53 39.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.679 0.622 . . . . 65.019999999999996 112.679 -175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.59 -44.94 63.56 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.07 -0.394 . . . . 72.329999999999998 111.873 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.51 -41.39 63.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.835 0.35 . . . . 63.229999999999997 111.34 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.36 43.43 2.54 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.013 -0.613 . . . . 62.409999999999997 112.612 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.418 HD22 ' NE2' ' A' ' 83' ' ' GLN . 59.3 mt -83.86 136.21 34.2 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.869 0.366 . . . . 61.0 111.553 -176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 74.0 m -71.68 93.41 1.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.856 0.36 . . . . 65.209999999999994 110.841 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.0 p -88.15 128.91 35.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.286 -0.416 . . . . 54.219999999999999 111.328 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.75 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.777 0.288 . . . . 52.43 111.777 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -164.89 94.44 0.91 Allowed Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.523 0.202 . . . . 70.200000000000003 111.408 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 115.67 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.309 2.006 . . . . 64.049999999999997 111.706 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.0 35.9 3.91 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.067 0.766 . . . . 64.239999999999995 113.067 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 117' ' ' ILE . 13.7 tt -61.09 82.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.293 1.044 . . . . 62.399999999999999 111.427 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -163.63 25.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.011 -0.995 . . . . 70.319999999999993 109.744 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.3 mm -88.59 137.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.795 -0.639 . . . . 72.299999999999997 111.954 -172.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -52.04 -51.8 55.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.689 -0.687 . . . . 72.239999999999995 112.35 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 179.98 -72.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.274 0.559 . . . . 62.43 110.958 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p -82.56 146.85 54.43 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.024 -0.535 . . . . 64.25 111.96 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.48 106.0 1.86 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.401 2.067 . . . . 61.439999999999998 112.903 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 52.3 p -85.79 -178.58 6.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.276 -0.42 . . . . 64.299999999999997 111.23 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -49.57 -35.61 21.11 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.165 0.431 . . . . 43.509999999999998 112.165 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -55.9 -42.74 76.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 73.239999999999995 111.319 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.43 HG21 HG21 ' A' ' 90' ' ' THR . 46.5 m -63.8 -40.72 97.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.997 0.427 . . . . 73.540000000000006 111.025 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -61.68 -48.84 78.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.222 -0.445 . . . . 72.5 111.619 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -53.54 -42.06 67.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.885 0.328 . . . . 62.119999999999997 111.885 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.02 -47.47 85.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.869 0.366 . . . . 63.119999999999997 111.056 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.1 m -66.46 -46.4 76.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.188 -0.46 . . . . 65.340000000000003 111.797 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.51 -48.81 77.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.233 -0.439 . . . . 62.310000000000002 111.898 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -78.26 -51.11 10.65 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.545 0.572 . . . . 71.540000000000006 112.545 -172.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.66 -36.07 71.39 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.34 0.496 . . . . 75.319999999999993 112.34 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.96 -45.01 62.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.406 -0.426 . . . . 73.120000000000005 113.399 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 88.5 m -67.8 -55.05 14.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.93 0.344 . . . . 73.430000000000007 111.93 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.82 -54.05 43.85 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.875 0.369 . . . . 53.25 111.635 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.8 -40.23 83.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.653 -0.249 . . . . 74.319999999999993 111.539 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.683 ' HA2' HD11 ' A' ' 2' ' ' ILE . . . -55.93 -47.72 77.69 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.259 -0.496 . . . . 60.32 113.2 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.96 -14.87 62.37 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.186 0.439 . . . . 75.230000000000004 112.186 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -90.62 -53.77 4.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.84 0.352 . . . . 73.530000000000001 110.972 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.9 t -54.43 -40.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 112.16 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 139' ' ' GLY . 6.8 t -69.64 -43.87 71.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.697 0.284 . . . . 64.340000000000003 111.575 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -63.81 -38.99 93.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.144 0.497 . . . . 74.420000000000002 111.011 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.37 -44.95 72.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.605 -0.725 . . . . 73.400000000000006 112.192 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -92.75 -21.97 19.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.308 -0.405 . . . . 65.120000000000005 111.865 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 120.71 0.29 . . . . 74.239999999999995 110.937 179.324 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 28.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 119.999 -0.048 . . . . 75.540000000000006 110.888 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 3' ' ' GLY . 47.8 mm 67.8 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.182 0.515 . . . . 51.009999999999998 111.892 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 2' ' ' ILE . . . -123.58 101.08 0.68 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.204 -0.522 . . . . 24.309999999999999 113.077 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 57.4 t -86.23 99.66 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 122.322 -0.516 . . . . 72.5 110.975 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.698 ' HB3' HD23 ' A' ' 36' ' ' LEU . 82.1 m-85 -90.25 126.74 35.94 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.282 0.475 . . . . 73.349999999999994 112.282 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 6.7 p90 -143.96 163.29 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.272 -0.422 . . . . 72.409999999999997 110.945 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.518 ' HB ' HD11 ' A' ' 36' ' ' LEU . 3.9 p -129.02 105.41 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.452 0.644 . . . . 74.439999999999998 112.487 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -61.5 -28.14 69.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.077 0.465 . . . . 63.549999999999997 111.445 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.05 -22.59 62.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.795 0.665 . . . . 70.409999999999997 112.795 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 2.3 t80 -129.06 92.15 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.895 0.702 . . . . 71.239999999999995 112.895 -173.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 -158.58 7.67 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 115.746 1.058 . . . . 41.530000000000001 115.746 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -59.34 7.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.528 1.307 . . . . 74.230000000000004 114.528 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -47.16 -35.79 7.78 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.561 0.619 . . . . 74.519999999999996 112.298 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.89 -39.69 79.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.974 0.416 . . . . 74.409999999999997 110.784 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -58.34 -45.65 87.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.192 0.52 . . . . 60.219999999999999 110.508 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 20' ' ' ILE . 79.6 mt -59.49 -51.33 70.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.894 -0.594 . . . . 72.409999999999997 111.644 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . . . -55.49 -43.24 75.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.106 0.479 . . . . 54.509999999999998 111.479 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 21' ' ' ILE . 34.7 tt0 -66.29 -34.49 78.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.078 0.466 . . . . 73.239999999999995 110.845 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.17 -31.61 72.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.175 -0.466 . . . . 52.340000000000003 111.29 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.515 HG23 ' HA3' ' A' ' 135' ' ' GLY . 71.5 mt -67.91 -57.46 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.152 0.501 . . . . 71.230000000000004 111.005 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 18' ' ' GLN . 14.0 tt -63.2 -25.17 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.088 -0.506 . . . . 75.420000000000002 111.736 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -54.56 -46.8 73.74 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.778 0.323 . . . . 54.32 111.744 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.19 -37.35 42.77 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.019 -0.61 . . . . 74.239999999999995 112.922 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -62.94 -42.73 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.994 0.426 . . . . 64.439999999999998 111.585 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.439 HG23 HG12 ' A' ' 21' ' ' ILE . 44.6 p -66.64 -39.87 88.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.574 -0.285 . . . . 71.230000000000004 111.574 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -58.54 -41.6 85.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.272 0.558 . . . . 74.510000000000005 109.888 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -64.0 -31.74 73.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.843 -0.617 . . . . 74.120000000000005 110.806 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 39.59 3.41 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.126 -0.488 . . . . 53.439999999999998 113.633 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.08 132.14 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.915 0.388 . . . . 73.549999999999997 111.444 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.33 96.54 2.18 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.314 -0.47 . . . . 74.299999999999997 113.708 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.3 m -102.86 142.48 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.911 0.386 . . . . 71.120000000000005 111.797 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -95.75 144.65 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.974 0.416 . . . . 75.319999999999993 111.78 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 32.6 m -101.18 151.72 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.913 0.387 . . . . 75.230000000000004 111.512 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -137.16 114.18 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.012 0.434 . . . . 75.019999999999996 111.984 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.69 92.6 3.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.732 0.301 . . . . 74.530000000000001 110.374 171.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -65.81 -23.81 66.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.274 0.472 . . . . 71.400000000000006 112.274 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -98.08 24.51 31.48 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.12 -0.562 . . . . 41.039999999999999 112.943 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.88 -178.14 3.35 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.038 0.447 . . . . 50.119999999999997 111.837 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.45 44.9 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.307 0.484 . . . . 65.209999999999994 112.307 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.62 128.33 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.115 0.483 . . . . 75.409999999999997 111.765 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.61 166.85 11.31 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.341 -0.391 . . . . 71.450000000000003 111.263 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.75 -25.55 55.25 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.419 -0.355 . . . . 75.099999999999994 111.824 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -59.38 -49.75 76.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.624 0.25 . . . . 71.540000000000006 110.831 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.23 -39.1 75.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.037 0.446 . . . . 71.310000000000002 111.049 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -35.18 71.5 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.031 0.443 . . . . 71.530000000000001 110.626 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -58.3 -29.89 66.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.558 -0.292 . . . . 73.420000000000002 111.673 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -60.37 -29.19 68.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.033 0.444 . . . . 61.420000000000002 110.961 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.2 -21.28 66.11 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.358 -0.383 . . . . 72.310000000000002 111.699 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.15 -55.13 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.893 0.378 . . . . 62.240000000000002 111.243 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.61 -18.43 77.2 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.923 -0.656 . . . . 63.109999999999999 112.76 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -100.63 5.99 43.98 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.209 0.448 . . . . 73.120000000000005 112.209 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -64.92 -9.47 21.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.026 0.38 . . . . 61.25 112.026 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.4 p -58.44 -18.92 32.27 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.136 0.493 . . . . 70.340000000000003 111.355 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.68 137.23 3.65 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 112.59 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -148.59 133.52 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 64.109999999999999 110.628 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 4' ' ' VAL . 5.6 p -112.58 117.74 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 50.549999999999997 111.443 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -116.49 110.38 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 110.653 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.56 41.55 3.06 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.043 -0.599 . . . . 72.530000000000001 113.396 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 88' ' ' PHE . 92.1 mmm 61.84 173.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.381 0.61 . . . . 72.439999999999998 112.425 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -158.84 154.25 22.31 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.305 -0.407 . . . . 54.409999999999997 111.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 60.3 Cg_endo -70.69 157.9 57.27 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.462 2.108 . . . . 64.329999999999998 111.915 173.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.71 62.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.591 0.589 . . . . 73.129999999999995 112.591 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.26 68.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.548 0.573 . . . . 72.230000000000004 112.548 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.2 m -89.07 -49.77 6.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.91 0.386 . . . . 73.239999999999995 111.567 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.45 -23.26 65.73 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.368 -0.378 . . . . 65.409999999999997 111.549 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.8 -34.53 59.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.779 0.324 . . . . 73.120000000000005 111.403 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 t -65.18 -45.15 86.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.236 0.541 . . . . 74.099999999999994 110.455 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.401 HD11 HD22 ' A' ' 36' ' ' LEU . 71.5 mt -59.95 -40.55 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.002 -0.544 . . . . 61.329999999999998 110.617 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.92 -34.8 78.22 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.818 -0.628 . . . . 71.109999999999999 111.028 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.38 -42.26 56.95 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.211 -0.518 . . . . 73.209999999999994 112.93 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.85 6.82 33.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.041 0.385 . . . . 55.219999999999999 112.041 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.1 tp -39.58 -61.1 0.86 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.295 0.85 . . . . 72.049999999999997 113.295 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.9 m -57.23 -40.02 76.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.172 0.434 . . . . 54.149999999999999 112.172 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.06 -45.01 94.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.937 0.399 . . . . 74.329999999999998 110.926 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.45 -37.49 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.058 0.456 . . . . 75.239999999999995 111.255 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.16 -15.2 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.289 -0.414 . . . . 62.020000000000003 111.157 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 -39.28 5.75 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.403 -0.427 . . . . 42.100000000000001 112.664 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.6 p -67.56 -40.12 84.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.878 0.325 . . . . 54.130000000000003 111.878 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -69.44 169.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.041 0.448 . . . . 71.540000000000006 111.803 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -133.06 -176.15 4.02 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.288 -0.258 . . . . 62.219999999999999 110.704 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 43.1 tt0 -47.27 -65.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.486 0.55 . . . . 64.040000000000006 112.486 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -152.49 130.03 11.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.256 0.551 . . . . 75.129999999999995 112.036 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.78 -79.47 0.18 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.005 -0.543 . . . . 73.140000000000001 110.896 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.558 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -170.21 117.78 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.902 0.334 . . . . 62.549999999999997 111.902 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 85' ' ' VAL . 15.9 m -124.62 99.56 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.648 0.737 . . . . 61.520000000000003 111.529 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -74.84 77.88 1.09 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.125 -0.489 . . . . 65.349999999999994 113.147 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.5 mm -86.63 121.43 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.059 0.392 . . . . 74.120000000000005 112.059 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 p90 -153.76 -179.03 7.44 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.296 -0.411 . . . . 73.109999999999999 110.41 174.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.497 ' HB2' HG22 ' A' ' 117' ' ' ILE . 11.3 tp10 -106.43 144.25 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.779 0.659 . . . . 75.0 112.779 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -125.51 -23.76 4.03 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.413 -0.358 . . . . 72.299999999999997 111.905 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 119' ' ' ILE . . . -119.75 -98.52 1.75 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.604 -0.332 . . . . 44.119999999999997 113.097 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.95 42.91 0.48 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.532 -0.842 . . . . 63.439999999999998 114.037 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.33 55.1 22.86 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.353 -0.451 . . . . 55.240000000000002 113.459 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.24 -159.96 0.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.883 0.327 . . . . 73.140000000000001 111.883 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' HD2' ' A' ' 97' ' ' PRO . 32.4 t70 74.05 162.1 0.25 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.267 0.627 . . . . 51.109999999999999 112.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 40.1 mt-10 -103.26 -55.45 0.11 Allowed Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 64.450000000000003 112.744 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 91.8 Cg_endo -76.46 11.19 1.93 Allowed 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.337 2.025 . . . . 62.240000000000002 113.513 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.3 tt -44.64 -56.31 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.122 0.786 . . . . 63.210000000000001 113.122 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.697 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.6 m-20 -60.83 -54.89 50.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 112.327 0.492 . . . . 73.109999999999999 112.327 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.0 Cg_exo -54.0 -36.17 83.35 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.275 1.983 . . . . 55.119999999999997 113.093 176.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.19 -62.16 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.462 -0.335 . . . . 53.210000000000001 111.68 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.51 -41.02 88.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t -57.93 -37.31 73.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.826 0.346 . . . . 53.219999999999999 111.57 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -64.3 -45.85 86.17 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.734 0.302 . . . . 74.25 111.522 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -62.37 -29.13 70.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.994 0.426 . . . . 74.430000000000007 111.361 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -71.35 -37.4 71.68 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.944 0.402 . . . . 73.340000000000003 110.579 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.501 HD22 HD12 ' A' ' 108' ' ' LEU . 6.7 t30 -62.58 -46.34 88.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.348 -0.387 . . . . 73.340000000000003 111.528 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.501 HD12 HD22 ' A' ' 107' ' ' ASN . 9.5 mp -73.52 -41.77 62.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.785 0.326 . . . . 52.409999999999997 111.326 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 72.22 1.26 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.316 -0.468 . . . . 55.229999999999997 113.61 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 mp -102.29 164.41 11.7 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 72.349999999999994 111.112 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.558 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 29.4 m -66.2 95.36 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.72 0.295 . . . . 51.25 111.289 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.2 p -83.68 164.72 19.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.036 0.446 . . . . 75.209999999999994 111.785 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -94.72 -83.83 0.34 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.617 -0.265 . . . . 71.140000000000001 111.671 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 116' ' ' ALA . 34.3 t80 -162.38 89.29 1.38 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.948 0.404 . . . . 73.409999999999997 110.907 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.0 27.28 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.625 2.883 . . . . 72.25 114.199 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB3' ' CE2' ' A' ' 114' ' ' PHE . . . -87.69 94.65 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.827 -0.546 . . . . 41.329999999999998 110.991 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.497 HG22 ' HB2' ' A' ' 89' ' ' GLU . 31.2 pt -68.61 107.31 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.495 0.664 . . . . 64.209999999999994 112.674 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -103.34 -23.95 13.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.081 -0.509 . . . . 70.450000000000003 111.651 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.2 mp -90.42 145.73 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.556 -0.293 . . . . 70.420000000000002 110.605 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -120.23 5.68 10.75 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.426 0.528 . . . . 74.120000000000005 112.426 -178.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.504 ' H ' HG22 ' A' ' 119' ' ' ILE . 53.1 tt0 -178.76 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.795 0.331 . . . . 71.319999999999993 111.662 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.1 p -117.42 122.56 30.83 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 116.516 -0.311 . . . . 74.519999999999996 111.603 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 119' ' ' ILE . 32.8 Cg_endo -63.34 141.03 79.99 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.653 2.235 . . . . 74.340000000000003 112.863 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 62.1 p -93.68 173.87 7.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.331 0.586 . . . . 60.450000000000003 112.383 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -53.58 -28.73 33.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.644 -0.707 . . . . 71.430000000000007 112.509 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -66.86 -39.55 87.61 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.322 0.49 . . . . 63.149999999999999 112.322 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 71.9 p -54.62 -40.46 68.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.571 0.582 . . . . 70.329999999999998 112.571 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -55.27 -35.3 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.313 0.486 . . . . 70.420000000000002 112.313 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.42 -50.64 51.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.831 0.348 . . . . 74.230000000000004 111.098 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.406 ' N ' HD22 ' A' ' 130' ' ' LEU . 3.2 mm? -61.66 -33.9 74.77 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.931 0.396 . . . . 65.299999999999997 111.036 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -61.75 -45.89 91.99 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.288 -0.414 . . . . 74.109999999999999 111.227 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.22 -52.77 62.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.392 -0.367 . . . . 73.140000000000001 111.166 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.9 -50.18 73.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 111.93 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.13 73.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.872 0.323 . . . . 71.540000000000006 111.872 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.515 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -68.55 -42.17 81.93 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.016 -0.612 . . . . 63.329999999999998 113.643 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.1 m -70.61 -47.74 58.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.556 -0.379 . . . . 73.109999999999999 111.931 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -55.92 -47.63 77.15 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.152 0.501 . . . . 65.340000000000003 110.989 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 138' ' ' LEU . 2.5 tm? -70.08 -39.98 75.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.996 -0.547 . . . . 73.5 110.385 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.49 -40.72 78.78 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.577 -0.344 . . . . 24.25 112.803 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 136' ' ' THR . 96.7 mt-30 -62.35 -38.31 89.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.131 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -61.09 -45.16 95.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.797 0.332 . . . . 73.319999999999993 110.563 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.35 -53.28 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.346 -0.388 . . . . 43.25 111.791 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.0 t -68.32 -37.54 80.68 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.132 0.419 . . . . 71.430000000000007 112.132 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -71.56 -35.44 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.887 0.375 . . . . 74.439999999999998 111.438 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.18 -25.36 66.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 74.040000000000006 110.353 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 77.0 mtt180 -100.1 8.02 44.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.591 -0.731 . . . . 44.140000000000001 111.848 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 C-N-CA 125.777 1.631 . . . . 62.210000000000001 111.506 174.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 80.1 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.885 -0.043 . . . . 71.409999999999997 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.9 mp 60.27 110.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.173 0.511 . . . . 62.329999999999998 111.73 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.02 91.82 1.66 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.853 -0.689 . . . . 55.200000000000003 113.326 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 59.4 t -80.91 123.54 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.027 0.413 . . . . 63.43 111.392 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 84.0 m-85 -116.38 133.69 55.73 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.494 0.553 . . . . 63.229999999999997 112.494 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -149.27 -178.18 6.26 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 110.826 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.5 p -129.51 83.55 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.482 0.658 . . . . 50.219999999999999 111.799 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -53.77 -29.75 41.48 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.008 0.744 . . . . 72.430000000000007 113.008 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.81 -13.94 62.52 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.345 0.498 . . . . 63.32 112.345 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.89 135.35 41.55 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.497 0.925 . . . . 71.239999999999995 113.497 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.19 -162.1 4.97 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 116.394 1.318 . . . . 62.140000000000001 116.394 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.415 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 73.8 m-85 -76.03 8.57 3.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.383 0.882 . . . . 72.400000000000006 113.383 -174.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -49.04 -35.58 16.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.114 0.413 . . . . 64.209999999999994 112.114 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -66.43 -37.99 86.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 64.340000000000003 110.919 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -69.16 -39.27 78.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.869 -0.605 . . . . 75.430000000000007 110.735 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -41.37 94.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.149 -0.478 . . . . 52.350000000000001 110.626 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.98 92.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.071 -0.513 . . . . 62.219999999999999 110.858 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -57.48 -46.62 83.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.946 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 132' ' ' GLU . . . -56.57 -47.03 80.38 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.174 -0.466 . . . . 62.210000000000001 111.302 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.15 -51.45 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 111.042 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 25' ' ' THR . 75.4 mt -55.79 -57.74 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.204 -0.453 . . . . 50.119999999999997 111.191 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -58.81 -29.45 66.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.865 0.364 . . . . 75.349999999999994 111.705 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -38.82 34.43 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.102 -0.57 . . . . 43.530000000000001 113.484 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.15 -24.7 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.486 0.55 . . . . 73.299999999999997 112.486 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 21' ' ' ILE . 32.9 p -57.57 -29.3 64.32 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.061 -0.4 . . . . 75.109999999999999 111.777 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.728 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.5 mmpt? -64.63 -17.61 64.18 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.937 0.399 . . . . 54.229999999999997 111.941 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -88.23 -9.79 51.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.085 0.469 . . . . 62.119999999999997 110.825 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.98 37.53 74.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.528 -0.368 . . . . 62.119999999999997 113.363 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 143' ' ' THR . 61.8 t -128.84 141.55 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.56 -0.376 . . . . 55.439999999999998 111.564 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.95 4.64 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.46 -0.4 . . . . 43.130000000000003 113.092 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.2 m -94.86 148.45 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.109 0.48 . . . . 71.129999999999995 112.016 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.4 125.07 37.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.217 -0.447 . . . . 75.239999999999995 111.072 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 131.89 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.983 0.42 . . . . 72.329999999999998 111.793 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 62.2 t -141.43 147.21 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.6 0.36 . . . . 64.219999999999999 110.991 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 6.6 m-20 -82.72 118.06 23.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.125 0.417 . . . . 74.340000000000003 112.125 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 37' ' ' GLY . 1.6 pp -77.65 -25.41 49.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.963 0.411 . . . . 73.409999999999997 111.85 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.645 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -87.31 -13.13 66.35 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.072 -0.585 . . . . 75.540000000000006 113.233 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 166.58 20.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.434 0.635 . . . . 63.439999999999998 112.039 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.84 76.83 2.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.954 -0.566 . . . . 63.399999999999999 111.396 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.72 164.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.336 0.495 . . . . 65.230000000000004 112.336 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.54 -163.24 1.32 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.215 0.531 . . . . 53.130000000000003 111.943 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.5 mm? -62.25 -24.17 67.1 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.151 0.797 . . . . 64.409999999999997 113.151 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.87 -52.53 62.74 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.104 -0.372 . . . . 65.120000000000005 110.844 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.05 -42.51 99.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.886 0.374 . . . . 73.140000000000001 111.1 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -58.08 -58.28 9.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.127 -0.488 . . . . 50.530000000000001 110.999 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -64.49 -36.38 84.0 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.844 0.312 . . . . 74.150000000000006 111.844 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.68 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.902 0.382 . . . . 71.230000000000004 110.704 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.503 HD11 HD13 ' A' ' 55' ' ' LEU . 45.0 tp -59.53 -44.23 93.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.382 -0.372 . . . . 72.120000000000005 110.71 172.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' LEU . 57.4 t -56.92 -33.25 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.071 0.462 . . . . 63.049999999999997 110.91 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.46 -40.38 94.36 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.02 -0.609 . . . . 74.329999999999998 112.469 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -87.03 6.37 32.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.084 0.402 . . . . 70.299999999999997 112.084 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.4 p -45.35 -26.59 0.55 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.256 1.206 . . . . 64.129999999999995 114.256 -170.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -54.71 -32.51 59.72 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.14 -0.35 . . . . 75.209999999999994 111.569 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.661 ' HA3' HG21 ' A' ' 142' ' ' VAL . . . -160.8 137.64 5.07 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.071 -0.585 . . . . 73.109999999999999 113.375 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD13 HD11 ' A' ' 48' ' ' LEU . 2.0 pt? -145.2 157.56 44.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.076 0.465 . . . . 65.420000000000002 111.416 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 75.1 t -114.58 116.59 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.458 -0.337 . . . . 44.350000000000001 110.998 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -98.69 115.18 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.65 0.262 . . . . 65.340000000000003 111.077 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 90' ' ' THR . . . -79.6 -24.09 61.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.117 -0.563 . . . . 72.25 114.079 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 60' ' ' SER . 16.7 tmm? 68.62 153.92 0.1 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.987 0.423 . . . . 64.049999999999997 111.665 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.513 ' N ' ' SD ' ' A' ' 59' ' ' MET . 40.6 t -162.95 146.46 8.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.031 -0.418 . . . . 74.450000000000003 111.342 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.0 160.52 12.41 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.954 2.436 . . . . 75.239999999999995 113.546 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -41.43 -37.31 1.02 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.685 0.994 . . . . 64.519999999999996 113.685 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.3 -47.28 47.05 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.168 0.433 . . . . 72.099999999999994 112.168 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.44 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 66.6 m -98.4 -27.08 14.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.681 0.277 . . . . 63.420000000000002 111.409 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -55.69 -32.67 63.47 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.492 -0.322 . . . . 42.210000000000001 111.824 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.11 89.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.941 0.4 . . . . 72.129999999999995 111.128 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -62.49 -33.61 75.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.203 0.525 . . . . 75.109999999999999 111.01 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.526 HD11 HD13 ' A' ' 36' ' ' LEU . 57.8 mt -75.04 -40.08 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.969 -0.56 . . . . 54.329999999999998 111.203 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -53.01 -44.73 67.52 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.851 -0.613 . . . . 63.229999999999997 112.573 -172.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.75 -43.71 80.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.032 -0.604 . . . . 63.329999999999998 112.839 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -77.31 -34.77 55.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 110.949 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -56.46 -42.86 78.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.99 0.516 . . . . 65.239999999999995 111.267 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -53.06 -33.91 54.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.26 0.552 . . . . 73.409999999999997 111.105 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -82.89 -41.67 18.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.036 -0.529 . . . . 74.219999999999999 111.257 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 71' ' ' ALA . 78.6 mt -57.62 -43.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.027 0.38 . . . . 72.010000000000005 112.027 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HE2' ' A' ' 104' ' ' LYS . 67.5 mt -61.69 -19.85 62.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.288 0.477 . . . . 72.239999999999995 112.288 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.63 -15.63 65.49 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.026 -0.607 . . . . 71.310000000000002 112.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.9 m -98.41 -36.85 9.83 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.881 0.326 . . . . 64.349999999999994 111.881 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 75' ' ' ILE . 27.2 m -106.13 123.46 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.233 0.539 . . . . 73.349999999999994 112.096 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HA ' HD23 ' A' ' 108' ' ' LEU . 3.3 p-10 -160.9 -172.56 3.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.268 0.556 . . . . 72.439999999999998 111.806 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.7 -86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 64.129999999999995 113.519 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 16.9 ptmt -155.45 6.49 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.658 0.984 . . . . 74.230000000000004 113.658 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 3.1 pt20 -65.16 178.01 0.95 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.972 0.415 . . . . 64.329999999999998 112.051 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.89 124.53 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.439 0.903 . . . . 74.040000000000006 113.439 -168.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.12 102.53 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.648 0.737 . . . . 73.420000000000002 111.569 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.33 94.6 1.67 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.42 -0.419 . . . . 55.409999999999997 112.771 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.24 139.02 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 122.274 -0.545 . . . . 75.239999999999995 112.144 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -136.83 -179.38 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 110.249 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -112.86 134.4 54.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.363 0.875 . . . . 73.310000000000002 113.363 -173.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 58' ' ' GLY . 6.4 t -154.41 130.67 10.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.796 -0.638 . . . . 51.009999999999998 110.864 169.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 86.84 -59.21 4.57 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.077 -0.582 . . . . 72.340000000000003 113.551 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.78 -98.42 0.18 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.502 -0.38 . . . . 74.409999999999997 113.184 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.51 -128.01 26.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.248 -0.501 . . . . 72.209999999999994 113.882 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -123.09 136.0 54.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.403 -0.469 . . . . 75.099999999999994 111.888 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.51 145.52 3.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.735 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 5.7 mp0 -103.58 -44.32 0.18 Allowed Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 112.566 0.58 . . . . 74.400000000000006 112.566 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 87.7 Cg_exo -50.59 -13.75 0.9 Allowed 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.762 2.308 . . . . 70.439999999999998 114.128 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -51.78 -37.67 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.183 0.438 . . . . 65.209999999999994 112.183 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.735 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.2 m-20 -63.63 -56.38 26.51 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.004 0.372 . . . . 72.519999999999996 112.004 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.5 Cg_exo -55.04 -36.92 93.91 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.008 1.805 . . . . 53.340000000000003 112.64 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.98 -58.3 9.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.406 -0.361 . . . . 63.210000000000001 111.326 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 91.3 mt -57.96 -40.77 81.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.128 0.49 . . . . 54.299999999999997 111.068 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t -56.59 -45.12 81.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.846 -0.615 . . . . 71.510000000000005 111.581 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 53.7 tptt -55.46 -49.22 73.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.302 -0.408 . . . . 74.129999999999995 111.347 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.2 -35.5 81.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.489 -0.323 . . . . 71.200000000000003 111.869 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 102' ' ' LEU . 74.7 mmt-85 -69.0 -55.46 10.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 111.913 0.338 . . . . 75.530000000000001 111.913 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -61.08 -43.77 98.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.104 0.409 . . . . 65.25 112.104 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 80' ' ' ASN . 8.6 mp -73.97 -37.43 64.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.622 0.249 . . . . 73.150000000000006 111.29 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.09 53.12 35.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.318 -0.468 . . . . 72.510000000000005 114.035 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 110' ' ' LEU . 3.4 mp -77.18 173.42 11.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.474 -0.427 . . . . 72.329999999999998 111.024 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 94.1 m -65.87 93.47 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 74.540000000000006 110.142 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -101.37 132.73 46.78 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.301 0.482 . . . . 74.430000000000007 112.301 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.65 -64.16 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.155 0.428 . . . . 50.119999999999997 112.155 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -147.99 111.97 3.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 120.725 0.298 . . . . 51.420000000000002 110.305 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -89.14 6.57 4.51 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.858 2.372 . . . . 70.219999999999999 114.822 -171.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.71 144.61 45.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.038 0.385 . . . . 64.219999999999999 112.038 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.2 pt -94.16 157.19 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.947 0.721 . . . . 62.409999999999997 112.947 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 118' ' ' ARG . 9.7 mmt85 -152.52 -49.77 0.1 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.386 0.674 . . . . 73.540000000000006 111.645 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 119' ' ' ILE . 1.9 mp -72.7 112.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.232 0.539 . . . . 62.329999999999998 111.669 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -82.83 -22.86 34.0 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.187 -0.46 . . . . 61.539999999999999 111.418 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.6 tt0 -160.13 -67.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.165 0.507 . . . . 73.209999999999994 111.714 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.411 HG23 HE21 ' A' ' 121' ' ' GLN . 61.3 p -91.8 129.35 42.56 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.343 -0.389 . . . . 74.540000000000006 112.03 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 37.3 Cg_exo -61.84 152.69 73.02 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.801 2.334 . . . . 71.099999999999994 112.779 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.8 p -111.16 166.17 11.3 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.906 0.384 . . . . 74.209999999999994 111.85 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.52 -34.76 64.95 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.26 0.552 . . . . 73.049999999999997 111.197 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -73.47 -31.22 63.65 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.865 -0.607 . . . . 72.109999999999999 111.356 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.1 m -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.818 0.342 . . . . 63.140000000000001 111.42 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -57.35 -40.74 78.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.481 -0.327 . . . . 70.140000000000001 111.331 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.526 ' HB3' ' NZ ' ' A' ' 129' ' ' LYS . 8.4 mtpm? -60.89 -28.79 69.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.011 0.434 . . . . 65.430000000000007 111.616 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 91.7 mt -70.75 -48.14 55.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.043 0.449 . . . . 64.439999999999998 110.223 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.54 -33.26 72.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.05 -0.523 . . . . 72.230000000000004 111.364 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' A' ' 19' ' ' ALA . 45.9 mt-10 -83.4 -75.17 0.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.274 -0.421 . . . . 64.140000000000001 112.046 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.85 -53.68 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.555 0.576 . . . . 70.010000000000005 112.555 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -65.79 -40.36 91.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.863 0.363 . . . . 71.120000000000005 111.231 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.62 66.46 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 53.340000000000003 113.156 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.541 HG22 ' NE2' ' A' ' 140' ' ' GLN . 61.0 m -60.27 -50.12 74.89 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.702 -0.293 . . . . 64.200000000000003 111.631 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.83 -50.56 72.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.038 0.447 . . . . 72.109999999999999 111.311 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.23 -50.19 65.26 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.653 -0.703 . . . . 72.510000000000005 110.94 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 143' ' ' THR . . . -64.95 -43.53 95.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.219 -0.515 . . . . 23.440000000000001 113.186 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.541 ' NE2' HG22 ' A' ' 136' ' ' THR . 45.0 mt-30 -58.33 -51.37 70.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.216 0.45 . . . . 52.229999999999997 112.216 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -56.11 -52.85 62.82 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.977 0.418 . . . . 71.400000000000006 111.655 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.661 HG21 ' HA3' ' A' ' 54' ' ' GLY . 61.9 t -57.91 -51.68 67.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.027 -0.533 . . . . 54.409999999999997 112.4 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 29' ' ' VAL . 14.2 t -74.07 -37.34 64.25 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.934 0.346 . . . . 73.239999999999995 111.934 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -76.64 -13.36 60.06 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.144 -0.347 . . . . 74.400000000000006 111.625 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -67.57 -51.31 52.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.388 0.614 . . . . 74.310000000000002 110.074 167.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -62.54 -34.2 76.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.594 -0.73 . . . . 73.219999999999999 110.642 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 CA--C 1.545 0.783 0 CA-C-N 115.723 -0.671 . . . . 61.130000000000003 111.244 177.674 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.076 0.028 . . . . 75.530000000000001 111.076 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 2.4 mp 66.83 109.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 121.256 0.55 . . . . 73.239999999999995 111.241 -173.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.04 113.74 4.08 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.22 -0.514 . . . . 50.409999999999997 113.186 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.95 104.86 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.48 -0.423 . . . . 75.030000000000001 111.15 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.776 ' HB3' HD23 ' A' ' 36' ' ' LEU . 98.6 m-85 -96.29 111.63 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.099 0.476 . . . . 53.039999999999999 111.679 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -127.86 178.51 6.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 111.624 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 9' ' ' GLU . 17.3 t -134.46 114.61 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.335 -0.393 . . . . 71.310000000000002 110.637 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 m -74.45 -8.52 56.58 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.957 0.408 . . . . 71.049999999999997 111.79 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.563 ' H ' HG12 ' A' ' 7' ' ' VAL . 44.6 tt0 -96.25 -50.53 4.76 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.459 0.54 . . . . 73.239999999999995 112.459 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.419 ' H ' HG12 ' A' ' 7' ' ' VAL . 78.2 t80 -103.16 138.87 39.41 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.109 0.48 . . . . 74.349999999999994 112.239 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.87 -164.37 4.7 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.566 -0.743 . . . . 70.120000000000005 114.606 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.48 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 97.5 m-85 -100.37 7.8 44.06 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.889 0.329 . . . . 73.409999999999997 111.889 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.754 ' HB3' HG21 ' A' ' 90' ' ' THR . 89.8 p -41.41 -46.76 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.553 0.575 . . . . 71.099999999999994 112.553 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.66 -43.91 76.72 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.088 0.47 . . . . 75.340000000000003 111.748 175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.23 -35.45 73.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.151 0.501 . . . . 73.120000000000005 110.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.78 -38.68 83.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.95 -0.568 . . . . 62.450000000000003 110.818 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.3 75.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.871 -0.604 . . . . 71.310000000000002 111.069 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -58.92 -42.87 90.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.163 -0.471 . . . . 72.140000000000001 110.962 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . . . -65.3 -39.2 92.19 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.011 0.434 . . . . 73.129999999999995 111.137 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.98 -58.49 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.199 -0.455 . . . . 60.140000000000001 111.276 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 tt -59.1 -37.16 66.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.652 0.263 . . . . 63.350000000000001 110.938 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -53.66 -56.77 14.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 70.120000000000005 111.457 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.12 -45.23 88.53 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.116 -0.564 . . . . 31.309999999999999 113.926 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.3 mt -66.19 -45.98 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 112.424 0.527 . . . . 72.209999999999994 112.424 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.6 p -65.2 -42.71 93.28 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.909 -0.495 . . . . 63.539999999999999 110.821 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.42 -32.4 64.82 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.192 -0.458 . . . . 64.549999999999997 110.88 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 m -71.98 -33.15 67.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.375 -0.375 . . . . 62.43 110.993 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.45 5.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.106 -0.569 . . . . 44.240000000000002 114.165 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.1 t -112.49 130.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 122.2 -0.588 . . . . 72.209999999999994 111.979 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 121.49 6.14 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.462 -0.399 . . . . 62.240000000000002 112.927 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.9 m -99.41 164.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 112.667 0.618 . . . . 73.109999999999999 112.667 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.15 110.34 21.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.801 -0.636 . . . . 73.209999999999994 111.092 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.47 112.71 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.295 0.569 . . . . 71.540000000000006 112.077 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.46 129.22 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.283 -0.417 . . . . 74.409999999999997 111.47 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -94.58 116.62 28.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.005 -0.368 . . . . 70.349999999999994 110.005 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.4 pp -89.31 -7.48 55.29 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.113 0.412 . . . . 65.200000000000003 112.113 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.504 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -86.55 -26.71 31.94 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.12 -0.562 . . . . 51.149999999999999 112.506 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.31 162.79 18.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.107 0.48 . . . . 61.219999999999999 111.705 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.67 96.36 0.08 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.015 0.435 . . . . 64.230000000000004 111.648 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.11 150.02 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.286 0.565 . . . . 54.420000000000002 112.039 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -107.4 173.05 6.49 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.939 -0.573 . . . . 73.030000000000001 110.249 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.6 mm? -59.81 -20.57 57.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.323 -0.236 . . . . 74.510000000000005 111.114 176.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -61.98 -52.81 62.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.756 0.312 . . . . 61.399999999999999 111.506 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -40.79 84.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.868 0.366 . . . . 74.310000000000002 110.835 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 49' ' ' VAL . 1.8 tm? -65.09 -39.81 93.7 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.264 0.554 . . . . 72.209999999999994 109.964 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -59.42 -40.86 88.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.789 -0.641 . . . . 73.329999999999998 111.274 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.86 -36.09 75.24 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.51 -0.314 . . . . 72.010000000000005 111.053 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.58 -47.05 83.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.869 0.366 . . . . 64.120000000000005 110.224 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 45' ' ' LEU . 82.3 t -55.01 -37.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.08 0.467 . . . . 74.109999999999999 111.479 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.36 -53.13 14.23 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.274 -0.488 . . . . 73.439999999999998 113.131 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.19 6.1 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.52 0.563 . . . . 72.349999999999994 112.52 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -48.39 -24.92 1.39 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.848 1.055 . . . . 55.009999999999998 113.848 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.733 HG21 HH22 ' A' ' 146' ' ' ARG . 77.7 p -67.24 -25.86 66.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.587 0.588 . . . . 71.129999999999995 112.587 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.12 137.02 5.6 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.138 -0.553 . . . . 54.310000000000002 112.69 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -163.2 172.84 14.2 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.578 -0.366 . . . . 74.310000000000002 111.811 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.08 124.65 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.909 0.385 . . . . 74.030000000000001 111.144 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -117.2 145.32 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.966 0.413 . . . . 74.319999999999993 111.569 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.5 -89.74 0.39 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 73.540000000000006 112.583 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.488 ' HG3' HG22 ' A' ' 90' ' ' THR . 4.0 ppp? -172.48 158.47 4.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.557 0.343 . . . . 73.129999999999995 110.642 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -117.58 114.42 37.98 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 111.798 0.296 . . . . 61.109999999999999 111.798 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.66 160.32 28.15 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.368 2.045 . . . . 73.530000000000001 112.432 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.13 -31.45 19.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.522 0.564 . . . . 72.219999999999999 112.522 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.6 96.16 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.158 0.504 . . . . 74.129999999999995 111.681 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -90.11 -21.8 22.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 111.541 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.426 ' HA ' ' HB ' ' A' ' 68' ' ' ILE . . . -52.93 -24.56 9.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.2 0.815 . . . . 72.519999999999996 113.2 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.01 -56.04 7.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.408 0.522 . . . . 64.420000000000002 112.408 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -84.6 -33.63 23.31 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.822 0.344 . . . . 54.009999999999998 111.4 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 65' ' ' ALA . 50.7 mm -60.89 -53.21 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.288 0.477 . . . . 75.409999999999997 112.288 -176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.5 -38.65 69.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.848 0.356 . . . . 72.099999999999994 111.346 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.11 87.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.0 -0.619 . . . . 70.400000000000006 112.391 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.98 95.07 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.991 0.424 . . . . 52.140000000000001 111.495 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.79 -35.44 68.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.333 -0.394 . . . . 73.540000000000006 111.353 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.6 m -54.28 -27.02 32.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.998 0.428 . . . . 55.409999999999997 111.427 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.7 m -99.19 -49.53 4.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.312 -0.403 . . . . 72.340000000000003 111.284 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.1 mt -54.57 -48.59 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.818 0.673 . . . . 73.530000000000001 112.818 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.27 -36.68 68.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.031 0.382 . . . . 55.43 112.031 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.49 66.24 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.038 -0.601 . . . . 64.409999999999997 113.13 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -100.29 5.12 44.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.188 0.44 . . . . 50.200000000000003 112.188 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.82 162.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.01 0.433 . . . . 64.420000000000002 111.996 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -117.54 106.84 13.57 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.851 0.358 . . . . 73.140000000000001 111.456 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.613 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 38.3 tt0 50.14 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.978 0.732 . . . . 63.5 112.978 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.613 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 62.2 pttt -159.39 48.02 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.261 0.553 . . . . 73.510000000000005 110.972 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.44 172.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.065 0.765 . . . . 72.439999999999998 113.065 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.579 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -88.02 109.65 20.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 74.439999999999998 111.894 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG12 HD11 ' A' ' 55' ' ' LEU . 29.7 m -107.41 119.02 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.567 0.699 . . . . 60.240000000000002 111.788 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.06 159.85 21.43 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.997 -0.547 . . . . 42.229999999999997 112.399 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -144.39 131.36 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.398 -0.472 . . . . 74.430000000000007 111.961 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -140.05 93.44 2.64 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.65 0.738 . . . . 74.120000000000005 110.659 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.33 114.48 2.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.834 -0.621 . . . . 64.120000000000005 112.16 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.754 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.0 t -108.65 29.68 7.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 111.973 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . -178.53 -54.41 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.186 -1.007 . . . . 52.299999999999997 114.086 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.85 -14.35 58.8 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.496 -0.859 . . . . 54.539999999999999 113.2 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.05 67.48 3.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.226 -0.511 . . . . 71.120000000000005 112.499 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.48 -179.27 6.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.221 0.534 . . . . 61.0 112.15 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -75.93 133.65 40.44 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.124 -0.489 . . . . 71.540000000000006 110.818 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.7 mt-10 -54.46 -37.45 54.54 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 113.744 1.016 . . . . 71.430000000000007 113.744 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 38.0 Cg_endo -66.21 32.18 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.843 1.695 . . . . 65.430000000000007 113.94 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.423 ' H ' ' C ' ' A' ' 96' ' ' GLU . 7.6 tp -66.59 -44.1 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.118 -0.364 . . . . 74.400000000000006 111.975 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.452 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 9.6 m-20 -56.09 -47.0 99.7 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 112.429 0.529 . . . . 65.299999999999997 112.429 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 83.1 Cg_exo -45.77 -37.46 16.28 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.717 2.278 . . . . 54.109999999999999 113.436 170.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.5 -42.65 34.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.802 0.334 . . . . 73.239999999999995 110.927 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.35 -32.48 64.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.348 -0.387 . . . . 75.239999999999995 111.197 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -55.58 -46.92 77.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.264 0.554 . . . . 71.019999999999996 110.992 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.407 ' HA ' HD13 ' A' ' 108' ' ' LEU . 32.0 mmtp -66.36 -51.62 55.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.065 -0.516 . . . . 73.299999999999997 111.313 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.601 ' HD1' HD22 ' A' ' 110' ' ' LEU . 24.3 m-85 -59.58 -44.86 93.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.034 0.445 . . . . 73.349999999999994 112.119 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -77.46 -60.76 2.23 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.423 0.527 . . . . 65.109999999999999 112.423 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -62.41 -32.37 73.19 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.542 0.571 . . . . 71.510000000000005 112.542 -170.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 104' ' ' LYS . 9.0 mp -79.06 -20.37 49.02 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.347 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.61 44.62 6.79 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.28 -0.486 . . . . 54.43 114.166 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.601 HD22 ' HD1' ' A' ' 105' ' ' PHE . 8.7 mp -70.39 133.96 47.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.256 0.528 . . . . 74.129999999999995 111.361 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.579 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 36.7 m -60.8 94.02 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.947 0.403 . . . . 64.510000000000005 111.381 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -103.82 137.03 42.41 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.513 -0.312 . . . . 61.509999999999998 111.64 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' A' ' 138' ' ' LEU . . . -54.69 -64.15 0.93 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.408 -0.36 . . . . 65.409999999999997 111.942 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -162.79 98.49 1.08 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.894 0.378 . . . . 73.150000000000006 110.873 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -85.18 46.6 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.008 2.472 . . . . 74.200000000000003 113.887 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.17 37.75 0.95 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 62.530000000000001 112.024 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.9 pt -105.3 144.0 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 112.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -133.37 108.74 8.89 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.313 -0.403 . . . . 73.120000000000005 110.55 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.42 140.95 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 64.120000000000005 110.697 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.58 153.26 32.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.667 0.27 . . . . 63.340000000000003 111.224 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 21.8 tt0 -51.66 -33.67 34.67 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.682 0.623 . . . . 74.140000000000001 112.682 -171.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p -108.61 99.09 31.87 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 120.606 0.241 . . . . 74.120000000000005 111.078 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HD2' ' HD2' ' A' ' 12' ' ' TYR . 85.0 Cg_exo -46.78 128.86 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.492 2.794 . . . . 61.340000000000003 114.301 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.5 p -100.45 -178.1 3.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.068 -0.514 . . . . 64.230000000000004 111.043 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 7.0 mp0 -57.37 -27.22 62.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.977 0.418 . . . . 74.439999999999998 111.404 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -59.33 -41.41 89.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 64.319999999999993 110.851 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 m -63.43 -36.75 84.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.098 -0.501 . . . . 71.430000000000007 111.175 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -62.38 -36.35 82.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.135 0.493 . . . . 71.239999999999995 111.144 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -69.63 -38.99 77.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 110.889 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.29 -54.74 32.41 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.849 -0.614 . . . . 63.399999999999999 110.721 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 19' ' ' ALA . 31.0 p -62.27 -38.29 88.77 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.75 0.278 . . . . 72.120000000000005 111.75 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.63 -56.63 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.349 0.595 . . . . 70.439999999999998 111.475 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -64.18 -56.89 11.59 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.735 -0.666 . . . . 71.409999999999997 111.94 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.73 84.41 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.863 0.32 . . . . 63.109999999999999 111.863 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.41 -44.64 66.48 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.348 -0.453 . . . . 72.010000000000005 113.24 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.47 ' HA ' HG12 ' A' ' 24' ' ' ILE . 94.8 m -55.83 -41.19 73.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.815 0.34 . . . . 73.030000000000001 111.486 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.36 -45.26 94.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.315 -0.402 . . . . 73.040000000000006 111.739 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 113' ' ' ALA . 4.1 mm? -56.49 -42.12 77.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.942 0.401 . . . . 62.299999999999997 110.936 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.35 82.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.097 -0.573 . . . . 50.109999999999999 112.693 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.25 -46.98 87.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.006 0.431 . . . . 51.409999999999997 111.857 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -56.67 -50.83 70.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.113 -0.494 . . . . 72.420000000000002 111.5 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 2' ' ' ILE . 58.2 t -69.84 -44.61 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.324 0.491 . . . . 74.409999999999997 112.324 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.4 t -65.98 -28.45 68.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.978 0.418 . . . . 62.020000000000003 111.712 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.03 -56.63 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.756 0.313 . . . . 74.310000000000002 111.207 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.37 -29.72 69.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.004 0.43 . . . . 71.239999999999995 111.522 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.733 HH22 HG21 ' A' ' 53' ' ' THR . 0.6 OUTLIER -75.73 -30.76 59.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.2 -0.312 . . . . 74.120000000000005 111.764 175.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.21 0.529 . . . . 72.450000000000003 109.579 175.21 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.645 0.259 . . . . 75.129999999999995 111.384 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm 64.93 111.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 112.67 0.618 . . . . 74.150000000000006 112.67 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.58 103.42 1.43 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.114 -0.565 . . . . 71.150000000000006 112.578 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.18 93.84 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.889 0.376 . . . . 71.120000000000005 111.558 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.656 ' HD2' HD23 ' A' ' 36' ' ' LEU . 17.5 m-85 -89.09 117.0 27.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.718 0.294 . . . . 72.030000000000001 111.443 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -134.92 151.03 50.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.432 0.634 . . . . 72.519999999999996 112.416 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 10' ' ' TYR . 39.7 t -96.1 97.95 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.788 -0.642 . . . . 63.439999999999998 111.52 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.712 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 20.1 m -70.88 -27.21 63.64 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.234 0.457 . . . . 61.200000000000003 112.234 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 33.7 tt0 -70.5 -42.25 71.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.662 0.616 . . . . 74.329999999999998 112.662 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.57 ' H ' HG12 ' A' ' 7' ' ' VAL . 69.4 t80 -111.5 106.77 15.75 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.666 0.988 . . . . 72.140000000000001 113.666 -171.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.94 -160.49 5.41 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.829 1.092 . . . . 71.150000000000006 115.829 167.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.415 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 56.7 m-85 -63.11 -2.17 1.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.22 0.822 . . . . 72.549999999999997 113.22 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 m -54.11 -31.51 52.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.231 0.538 . . . . 72.109999999999999 111.345 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 25.1 t70 -65.87 -32.73 74.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.652 -0.704 . . . . 60.229999999999997 111.745 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -94.44 -23.73 17.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.442 0.534 . . . . 74.329999999999998 112.442 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 12' ' ' TYR . 92.7 mt -54.64 -39.92 68.47 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.231 0.538 . . . . 71.450000000000003 111.384 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.41 -23.0 62.67 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.07 -0.513 . . . . 74.120000000000005 112.141 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.76 -34.9 76.67 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.912 0.387 . . . . 62.409999999999997 110.945 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 132' ' ' GLU . . . -62.09 -40.77 96.96 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.492 . . . . 73.430000000000007 111.04 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.467 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.5 mt -62.76 -52.95 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.044 -0.525 . . . . 74.450000000000003 110.601 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.521 HG23 HG21 ' A' ' 31' ' ' VAL . 83.5 mt -52.85 -43.94 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.939 -0.573 . . . . 74.109999999999999 111.235 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -56.95 -48.77 77.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.108 -0.496 . . . . 64.209999999999994 111.323 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.46 99.57 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.013 -0.613 . . . . 70.040000000000006 113.091 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -65.55 -48.47 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 72.230000000000004 111.71 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -68.33 -34.94 77.02 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.788 0.328 . . . . 74.519999999999996 111.267 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.12 -31.81 73.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.458 0.647 . . . . 62.43 110.558 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.0 m -75.16 -14.44 60.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.848 -0.615 . . . . 75.0 111.15 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.42 26.65 11.73 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.363 -0.38 . . . . 71.430000000000007 113.779 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 143' ' ' THR . 42.0 t -118.88 142.31 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.555 -0.379 . . . . 60.520000000000003 111.603 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.68 140.7 24.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.009 -0.615 . . . . 40.399999999999999 112.859 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 21' ' ' ILE . 33.1 m -106.4 145.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.985 0.365 . . . . 71.439999999999998 111.985 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -107.09 110.55 22.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.912 0.387 . . . . 70.409999999999997 110.172 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.94 113.8 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.55 0.69 . . . . 75.310000000000002 112.788 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.96 93.42 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.197 0.523 . . . . 74.230000000000004 110.925 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -79.0 70.88 5.41 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.557 0.694 . . . . 64.030000000000001 111.743 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.656 HD23 ' HD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -64.79 -23.79 67.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.231 -0.441 . . . . 53.100000000000001 111.636 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.614 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -75.17 -0.36 61.02 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.239 -0.505 . . . . 55.219999999999999 112.889 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 17.13 12.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.917 0.389 . . . . 61.420000000000002 110.607 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.99 97.63 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.527 -0.761 . . . . 73.329999999999998 112.166 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 36' ' ' LEU . 24.7 m -83.47 156.13 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.775 0.321 . . . . 74.040000000000006 111.327 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.6 179.61 4.17 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 111.364 -174.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.708 HD13 HD12 ' A' ' 45' ' ' LEU . 3.8 mm? -60.67 -20.87 62.03 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.322 0.49 . . . . 75.450000000000003 112.322 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 1.4 mp0 -59.42 -29.88 68.07 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.117 0.414 . . . . 71.109999999999999 112.117 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -86.25 -43.83 12.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.806 0.336 . . . . 72.230000000000004 111.311 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.708 HD12 HD13 ' A' ' 42' ' ' LEU . 80.6 mt -54.09 -28.3 38.36 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.564 0.579 . . . . 53.439999999999998 112.564 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 20.3 ptt180 -61.34 -33.16 73.16 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.696 0.284 . . . . 62.229999999999997 111.231 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.25 3.18 46.18 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.04 0.385 . . . . 75.129999999999995 112.04 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 2.3 tm? -56.52 -34.48 67.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.998 0.428 . . . . 74.299999999999997 110.213 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.62 -23.46 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.222 0.534 . . . . 72.299999999999997 111.785 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.17 -40.89 5.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.394 -0.431 . . . . 52.450000000000003 112.535 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -76.1 -15.42 60.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.242 0.46 . . . . 74.140000000000001 112.242 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -69.37 -7.67 39.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.004 0.372 . . . . 63.009999999999998 112.004 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.0 p -70.54 -26.79 63.72 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.327 0.584 . . . . 73.420000000000002 111.033 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.57 135.56 3.57 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.85 -0.614 . . . . 73.420000000000002 111.8 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.462 HD21 HG12 ' A' ' 85' ' ' VAL . 2.1 pt? -168.14 169.17 11.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.011 0.405 . . . . 73.109999999999999 111.491 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 8.5 p -134.69 128.14 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.929 0.395 . . . . 63.420000000000002 111.454 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.7 mp -113.75 135.12 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 111.302 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.03 133.34 10.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.359 -0.448 . . . . 74.040000000000006 112.823 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.526 ' HE1' ' H ' ' A' ' 93' ' ' GLY . 44.1 ttp -65.91 110.5 2.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.638 -0.33 . . . . 64.540000000000006 111.717 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 7' ' ' VAL . 93.4 p -103.49 148.27 35.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 111.982 0.364 . . . . 75.109999999999999 111.982 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HA ' ' HB3' ' A' ' 94' ' ' ASP . 28.0 Cg_endo -60.73 159.67 27.74 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.87 2.38 . . . . 61.329999999999998 112.451 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.57 -40.53 52.46 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.868 0.692 . . . . 63.5 112.868 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.79 -53.03 54.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.196 0.443 . . . . 71.120000000000005 112.196 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.1 m -79.34 -32.23 43.26 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.073 0.463 . . . . 73.140000000000001 111.204 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -27.56 65.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.99 -0.55 . . . . 52.409999999999997 111.498 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.71 -29.66 62.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.211 0.449 . . . . 71.230000000000004 112.211 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -82.05 -17.45 46.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.052 0.453 . . . . 74.430000000000007 111.717 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.643 HG12 ' HB2' ' A' ' 36' ' ' LEU . 26.1 mt -100.59 -47.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 112.169 -175.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -45.32 -45.48 12.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.288 1.035 . . . . 71.319999999999993 113.435 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.78 -63.94 4.52 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.047 -0.597 . . . . 71.349999999999994 113.196 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 45' ' ' LEU . . . -62.44 -28.73 70.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.069 0.461 . . . . 63.399999999999999 112.165 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.14 -33.69 63.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.079 -0.509 . . . . 54.5 111.363 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 m -54.66 -39.24 67.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.125 -0.489 . . . . 65.409999999999997 111.563 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -73.66 -38.16 65.05 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.916 0.389 . . . . 64.329999999999998 111.293 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.41 -58.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.849 0.357 . . . . 73.319999999999993 111.85 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.494 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.1 mp -60.91 -12.47 11.25 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.564 0.579 . . . . 72.219999999999999 112.564 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.17 -30.33 7.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 60.020000000000003 112.793 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -79.21 -24.16 43.3 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 111.792 0.293 . . . . 74.409999999999997 111.792 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -64.36 155.57 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.042 0.449 . . . . 74.510000000000005 111.878 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -80.15 160.55 25.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 71.019999999999996 111.612 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HA ' HD23 ' A' ' 108' ' ' LEU . 35.9 tt0 -54.87 -36.64 65.31 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.098 0.475 . . . . 60.030000000000001 111.939 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -138.87 122.08 16.96 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.452 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -163.78 169.93 17.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.778 0.323 . . . . 74.340000000000003 110.983 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.45 93.85 9.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.173 0.511 . . . . 72.219999999999999 111.801 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 55' ' ' LEU . 35.4 m -107.94 148.69 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.137 -0.483 . . . . 63.549999999999997 111.121 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.03 146.24 17.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.327 -0.463 . . . . 74.319999999999993 113.123 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.692 ' H ' ' HB3' ' A' ' 113' ' ' ALA . 39.0 mm -140.93 132.62 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.817 0.447 . . . . 74.430000000000007 110.623 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -152.21 159.38 43.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.956 0.408 . . . . 72.319999999999993 111.258 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.82 138.85 39.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.035 0.445 . . . . 72.540000000000006 111.556 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 t -121.01 4.04 10.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.526 0.679 . . . . 73.530000000000001 110.656 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.45 -93.09 0.45 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.652 -0.704 . . . . 74.510000000000005 112.359 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.57 70.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.195 -0.526 . . . . 63.439999999999998 113.416 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.526 ' H ' ' HE1' ' A' ' 59' ' ' MET . . . 85.24 52.98 3.24 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.502 -0.38 . . . . 64.450000000000003 113.158 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.67 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 11.3 m-20 -96.1 176.97 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.324 0.49 . . . . 74.040000000000006 112.324 -175.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.6 t70 64.41 160.67 0.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.41 0.684 . . . . 54.530000000000001 112.082 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.71 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 41.8 mt-10 -102.01 -53.81 0.14 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 112.254 0.464 . . . . 70.219999999999999 112.254 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 8.2 Cg_exo -75.27 22.97 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.395 2.064 . . . . 74.340000000000003 112.991 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.7 -35.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.336 0.495 . . . . 64.109999999999999 112.336 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.683 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.1 m-20 -66.36 -54.16 26.56 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 122.168 -0.332 . . . . 75.230000000000004 111.768 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 73.5 Cg_exo -51.0 -45.8 34.45 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.435 2.09 . . . . 73.450000000000003 113.0 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 97' ' ' PRO . 8.5 mp -55.46 -58.12 9.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.46 -0.336 . . . . 73.030000000000001 111.299 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.58 -32.24 71.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.499 -0.319 . . . . 73.319999999999993 111.488 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 t -62.93 -37.62 87.75 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.893 0.377 . . . . 72.430000000000007 111.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HG2' ' HB3' ' A' ' 76' ' ' LEU . 27.8 tptp -64.34 -41.76 96.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.729 0.299 . . . . 75.439999999999998 111.018 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -68.15 -44.06 76.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.023 0.44 . . . . 72.310000000000002 110.847 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -64.68 -39.1 93.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.961 -0.563 . . . . 74.030000000000001 111.813 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -62.23 -49.92 73.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.905 0.383 . . . . 74.140000000000001 111.181 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 81' ' ' GLU . 8.2 mp -74.17 -24.22 59.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.098 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.22 43.55 9.53 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.182 -0.532 . . . . 62.25 112.502 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.85 156.63 32.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.19 0.519 . . . . 71.099999999999994 111.905 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.4 m -66.97 106.54 1.96 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.774 0.657 . . . . 65.019999999999996 112.774 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.0 p -84.04 95.04 8.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.742 0.306 . . . . 64.140000000000001 111.12 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.692 ' HB3' ' H ' ' A' ' 87' ' ' ILE . . . -53.71 -70.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.202 0.445 . . . . 73.430000000000007 112.202 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -125.49 90.01 51.45 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 120.853 0.358 . . . . 75.5 111.044 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.14 98.71 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.57 2.18 . . . . 70.319999999999993 112.803 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.08 159.44 20.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.103 0.477 . . . . 52.210000000000001 111.987 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -138.26 34.1 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.892 -0.594 . . . . 73.129999999999995 110.59 175.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.7 mtm180 -96.92 20.2 11.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.493 0.923 . . . . 74.409999999999997 113.493 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.2 mt -100.42 149.49 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.86 -0.422 . . . . 72.140000000000001 109.86 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.04 -65.99 0.58 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.048 -0.408 . . . . 63.109999999999999 111.518 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.681 HE21 ' HA ' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -177.3 -26.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.987 0.423 . . . . 64.430000000000007 111.453 -177.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p -89.82 117.81 68.43 Favored Pre-proline 0 N--CA 1.47 0.553 0 N-CA-C 111.851 0.315 . . . . 65.239999999999995 111.851 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.68 134.48 44.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.56 2.173 . . . . 75.450000000000003 111.864 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -100.49 168.49 9.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.712 0.768 . . . . 64.409999999999997 112.717 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.59 -29.94 68.31 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.36 -0.836 . . . . 74.140000000000001 111.053 174.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -73.01 -31.92 64.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.888 -0.596 . . . . 73.319999999999993 110.973 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -35.58 67.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.858 0.361 . . . . 52.140000000000001 111.059 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -55.71 -48.27 75.45 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.284 -0.416 . . . . 73.349999999999994 111.591 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 5.3 mptp? -67.19 -32.77 74.07 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.945 0.35 . . . . 72.530000000000001 111.945 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.93 -53.58 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.234 0.54 . . . . 75.129999999999995 110.466 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.43 -34.35 75.84 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.87 -0.604 . . . . 73.099999999999994 111.526 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.9 tt0 -59.15 -66.67 0.47 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.952 0.501 . . . . 73.430000000000007 112.173 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.95 -47.21 86.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.795 0.331 . . . . 72.349999999999994 111.589 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.817 0.342 . . . . 72.099999999999994 111.454 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -63.02 -37.23 94.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.321 -0.466 . . . . 73.420000000000002 113.362 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 99.2 m -63.0 -58.0 8.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.738 0.304 . . . . 75.430000000000007 111.212 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.15 -41.52 99.29 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.616 -0.266 . . . . 74.239999999999995 111.457 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.63 -43.46 93.81 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 110.18 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 143' ' ' THR . . . -60.1 -45.81 95.32 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.103 -0.57 . . . . 62.009999999999998 112.458 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 136' ' ' THR . 80.3 mt-30 -66.68 -29.22 69.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.216 0.532 . . . . 75.420000000000002 111.166 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -65.1 -54.64 26.9 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.968 -0.56 . . . . 70.120000000000005 110.541 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.27 -46.81 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 112.789 0.663 . . . . 72.209999999999994 112.789 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.6 HG23 ' HD3' ' A' ' 144' ' ' ARG . 4.7 t -53.46 -33.61 54.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.681 0.623 . . . . 70.420000000000002 112.681 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.6 ' HD3' HG23 ' A' ' 143' ' ' THR . 11.0 mpt_? -99.76 -19.06 16.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.94 0.348 . . . . 75.239999999999995 111.94 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.31 -62.17 1.96 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.03 0.381 . . . . 64.430000000000007 112.03 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -60.17 -16.73 35.47 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.242 -0.435 . . . . 72.140000000000001 112.004 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 143' ' ' THR . 3.9 mm? . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 112.003 0.371 . . . . 71.019999999999996 112.003 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 67.1 p . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.345 0.116 . . . . 53.020000000000003 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm 63.55 89.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.281 0.562 . . . . 61.43 111.638 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.29 100.5 1.66 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.946 -0.57 . . . . 61.350000000000001 112.729 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 100.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.856 0.36 . . . . 64.329999999999998 111.108 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 94.5 m-85 -98.55 120.96 39.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.082 -0.508 . . . . 73.209999999999994 111.711 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.47 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 13.7 p90 -143.91 -179.7 6.64 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.105 0.479 . . . . 74.439999999999998 112.141 -176.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.448 HG13 ' HA3' ' A' ' 37' ' ' GLY . 33.0 t -126.61 90.79 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.189 -0.46 . . . . 32.100000000000001 110.108 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.46 ' HG ' ' HE2' ' A' ' 6' ' ' TYR . 23.2 m -40.87 -54.26 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.318 1.229 . . . . 65.109999999999999 114.318 -170.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.65 -25.92 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.594 0.59 . . . . 74.349999999999994 112.594 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' HE2' ' HA3' ' A' ' 91' ' ' GLY . 91.0 t80 -79.57 101.84 8.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.984 0.364 . . . . 73.299999999999997 111.984 -174.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.43 -159.36 6.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.156 -0.545 . . . . 75.200000000000003 114.365 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.06 7.35 0.06 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.806 1.039 . . . . 74.230000000000004 113.806 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 6' ' ' TYR . 11.4 t -46.15 -56.23 5.95 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.037 0.755 . . . . 55.549999999999997 113.037 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -64.02 -31.44 72.63 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.01 0.433 . . . . 74.510000000000005 111.323 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.81 -35.66 77.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.22 0.533 . . . . 71.329999999999998 110.817 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.5 mt -69.36 -44.84 70.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 71.420000000000002 110.661 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.95 -43.99 73.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.115 0.484 . . . . 51.43 110.935 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -53.31 -42.43 66.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.626 -0.716 . . . . 61.210000000000001 111.897 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.42 43.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.403 0.52 . . . . 75.530000000000001 112.403 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 16' ' ' LEU . 69.2 mt -61.13 -53.17 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.933 0.396 . . . . 74.319999999999993 111.794 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -59.34 -29.36 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.778 0.323 . . . . 74.239999999999995 111.865 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.61 -54.76 43.19 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.786 0.327 . . . . 70.439999999999998 111.757 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.91 -48.59 84.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.264 -0.494 . . . . 35.130000000000003 113.349 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.6 mt -64.8 -38.1 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.963 0.411 . . . . 63.329999999999998 111.481 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.9 m -60.12 -44.97 94.5 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.176 -0.328 . . . . 73.239999999999995 110.847 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.24 -16.11 63.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.743 0.306 . . . . 71.120000000000005 111.624 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -77.51 -20.99 53.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.34 0.591 . . . . 64.450000000000003 110.319 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 27.09 9.12 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.013 -0.54 . . . . 71.010000000000005 113.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 t -120.1 142.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.984 0.392 . . . . 61.149999999999999 111.62 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.93 118.77 4.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.094 -0.574 . . . . 62.5 112.979 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 1' ' ' SER . 35.6 m -91.07 167.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.519 0.563 . . . . 71.099999999999994 112.519 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -121.46 108.56 13.79 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.087 0.47 . . . . 73.219999999999999 111.203 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.85 113.28 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.522 -0.308 . . . . 75.129999999999995 111.41 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 60.9 t -140.12 110.15 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 120.87 0.367 . . . . 74.510000000000005 111.334 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -84.64 106.58 16.3 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.519 0.676 . . . . 73.25 111.931 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.575 ' HA ' HG13 ' A' ' 40' ' ' VAL . 1.3 pp -70.26 -14.25 62.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.095 -0.378 . . . . 74.319999999999993 111.863 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -60.0 -32.06 74.38 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.351 -0.386 . . . . 61.420000000000002 113.64 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.15 11.04 17.33 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.511 -0.406 . . . . 53.32 111.792 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.38 106.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.187 0.518 . . . . 71.310000000000002 111.566 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 36' ' ' LEU . 35.3 m -85.21 151.24 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.083 0.468 . . . . 74.439999999999998 111.544 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.47 176.09 6.43 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.167 -0.47 . . . . 64.340000000000003 111.176 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.467 ' H ' HD22 ' A' ' 42' ' ' LEU . 3.2 mm? -56.98 -24.51 53.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.571 -0.286 . . . . 74.540000000000006 111.736 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -63.07 -56.97 12.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 72.420000000000002 111.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 mp0 -59.99 -43.06 95.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.061 0.457 . . . . 75.400000000000006 110.73 176.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.18 -47.33 78.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.935 -0.575 . . . . 72.230000000000004 110.675 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -65.69 -39.03 90.85 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.25 -0.432 . . . . 41.130000000000003 111.578 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.24 -33.91 76.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.931 0.396 . . . . 70.209999999999994 111.257 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.656 HD11 HD13 ' A' ' 55' ' ' LEU . 52.8 tp -55.54 -34.61 64.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.495 -0.321 . . . . 74.329999999999998 111.148 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.38 -41.57 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.103 0.478 . . . . 72.129999999999995 111.063 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.67 -16.87 80.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.15 -0.548 . . . . 41.450000000000003 113.088 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -100.38 5.73 44.4 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.617 -0.343 . . . . 73.319999999999993 111.494 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.8 p -59.28 -3.73 0.45 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.059 . . . . 75.329999999999998 113.858 -172.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -67.46 -35.33 78.98 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.03 -0.419 . . . . 65.310000000000002 111.275 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.6 138.0 5.13 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.214 -0.517 . . . . 74.129999999999995 113.045 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.656 HD13 HD11 ' A' ' 48' ' ' LEU . 1.9 pt? -158.72 146.42 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.621 -0.34 . . . . 75.310000000000002 111.26 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.418 HG12 ' HE1' ' A' ' 88' ' ' PHE . 48.8 t -117.98 118.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.362 0.265 . . . . 32.240000000000002 110.806 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -112.06 120.63 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.217 0.451 . . . . 61.240000000000002 112.217 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.86 99.17 2.54 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.412 -0.423 . . . . 74.099999999999994 112.795 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.458 ' O ' HG22 ' A' ' 90' ' ' THR . 14.0 tmm? -56.67 132.54 52.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.901 0.381 . . . . 71.420000000000002 111.558 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -134.99 147.31 62.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 110.921 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.32 168.07 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.644 2.896 . . . . 70.200000000000003 115.045 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -43.73 -41.33 4.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.577 0.955 . . . . 73.430000000000007 113.577 -173.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.79 -45.88 64.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.038 0.447 . . . . 73.230000000000004 111.739 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -87.32 -36.02 18.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.074 0.464 . . . . 52.520000000000003 111.094 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -61.0 -26.96 67.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.071 -0.513 . . . . 73.209999999999994 112.147 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.75 83.0 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.835 0.35 . . . . 71.420000000000002 111.534 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -65.28 -31.14 72.12 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.826 0.346 . . . . 71.230000000000004 111.34 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.51 -39.48 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.873 0.368 . . . . 73.219999999999999 111.27 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.9 -43.67 66.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.298 -0.41 . . . . 70.340000000000003 112.018 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.52 -31.33 51.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 121.042 -0.599 . . . . 53.299999999999997 113.512 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.0 22.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.281 0.475 . . . . 74.120000000000005 112.281 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.6 tp -54.73 -55.53 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 51.509999999999998 112.582 -173.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -56.79 -38.15 72.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.836 0.35 . . . . 73.310000000000002 111.809 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -65.47 -46.27 80.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.94 0.4 . . . . 72.400000000000006 111.198 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.63 -47.4 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.418 -0.355 . . . . 73.150000000000006 111.208 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.72 -29.72 69.53 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.884 0.373 . . . . 71.150000000000006 111.55 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.27 -19.59 76.55 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 74.340000000000003 112.917 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -90.64 -37.95 13.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.069 0.396 . . . . 71.340000000000003 112.069 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.11 143.26 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.153 0.501 . . . . 74.219999999999999 112.045 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.608 ' N ' HD22 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -161.32 176.3 11.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.238 -0.437 . . . . 73.549999999999997 111.509 -177.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 57.68 -94.69 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.898 0.479 . . . . 63.32 111.886 173.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -179.07 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.043 0.449 . . . . 62.5 111.836 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -56.79 175.62 0.12 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.376 0.608 . . . . 74.019999999999996 112.611 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.44 98.43 11.62 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.755 0.65 . . . . 73.120000000000005 112.755 -170.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.42 105.0 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.596 0.712 . . . . 62.119999999999997 112.061 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 78.86 1.95 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 122.021 -0.424 . . . . 63.310000000000002 113.032 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.61 122.53 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 111.969 0.359 . . . . 43.240000000000002 111.969 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HE1' HG12 ' A' ' 56' ' ' VAL . 6.5 p90 -153.82 164.37 38.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.256 -0.276 . . . . 73.310000000000002 110.256 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' HB2' HD12 ' A' ' 119' ' ' ILE . 1.9 mp0 -83.86 133.64 34.73 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.884 -0.51 . . . . 75.299999999999997 111.427 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 59' ' ' MET . 10.4 t -87.04 7.18 28.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.437 0.637 . . . . 53.219999999999999 110.333 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.427 ' HA3' ' HE2' ' A' ' 10' ' ' TYR . . . 172.2 -82.79 0.08 OUTLIER Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.505 -0.771 . . . . 65.030000000000001 112.04 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.72 124.86 2.88 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.909 -0.662 . . . . 74.200000000000003 113.374 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.46 -152.81 6.9 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.933 -0.651 . . . . 52.520000000000003 112.822 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.06 121.59 35.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.903 0.383 . . . . 72.239999999999995 111.677 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . 3.3 p-10 -147.02 171.87 14.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 64.420000000000002 110.891 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.619 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 mt-10 -102.97 -44.62 0.19 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.453 0.909 . . . . 74.439999999999998 113.453 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.619 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 36.6 Cg_endo -62.83 -12.1 27.45 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.246 1.964 . . . . 73.519999999999996 114.703 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 99' ' ' ASP . 7.3 tp -53.99 -51.63 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.986 0.736 . . . . 64.5 112.986 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.709 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 6.6 m-20 -61.71 -54.56 50.42 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.134 0.42 . . . . 45.409999999999997 112.134 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.5 Cg_exo -56.88 -35.87 98.62 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.233 1.955 . . . . 72.109999999999999 112.744 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -56.76 13.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.214 -0.448 . . . . 73.219999999999999 111.12 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.81 -45.03 86.7 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 73.109999999999999 111.23 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 27.3 t -55.74 -37.87 69.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.161 -0.472 . . . . 73.439999999999998 111.943 177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.591 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 1.8 tpmt? -68.24 -58.66 4.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.765 0.317 . . . . 71.099999999999994 111.039 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -58.47 -27.38 64.35 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.732 0.271 . . . . 73.319999999999993 111.732 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' SER . 18.9 ttp180 -52.06 -50.16 62.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.964 0.411 . . . . 55.100000000000001 111.596 173.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.85 -40.56 54.47 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.332 -0.394 . . . . 75.439999999999998 111.593 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.723 ' HB3' HD13 ' A' ' 110' ' ' LEU . 10.8 mp -59.46 -40.09 85.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.846 0.355 . . . . 73.340000000000003 111.904 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 32.07 36.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.211 -0.519 . . . . 42.409999999999997 113.807 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 108' ' ' LEU . 10.9 mp -88.92 165.6 14.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.041 0.448 . . . . 71.299999999999997 111.509 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.2 m -80.28 122.71 27.23 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.271 0.471 . . . . 63.119999999999997 112.271 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.4 p -103.49 112.26 25.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.273 -0.421 . . . . 73.400000000000006 110.599 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.17 -48.75 67.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.909 0.385 . . . . 44.32 111.244 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.411 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -126.05 144.54 49.14 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 116.007 -0.542 . . . . 73.099999999999994 110.233 172.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.11 4.85 2.1 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.88 2.387 . . . . 71.239999999999995 113.57 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 70.12 159.81 0.2 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.811 0.671 . . . . 71.129999999999995 112.811 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.3 pt 42.44 31.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.295 1.22 . . . . 64.340000000000003 114.295 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.07 -7.86 16.0 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 122.001 -0.437 . . . . 75.310000000000002 111.871 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 89' ' ' GLU . 67.9 mt -91.79 144.78 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 120.939 0.399 . . . . 72.010000000000005 111.189 173.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 19.2 pttp -87.5 53.56 2.84 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.737 0.643 . . . . 53.43 112.737 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 5.5 tp-100 74.17 -47.4 0.64 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.69 0.626 . . . . 74.219999999999999 112.69 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.1 p -96.22 116.8 66.38 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 111.986 0.365 . . . . 61.210000000000001 111.986 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.38 140.08 62.29 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.52 2.147 . . . . 51.229999999999997 111.857 172.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 p -111.37 179.04 4.14 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.332 0.587 . . . . 74.239999999999995 112.096 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 -31.33 59.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.906 -0.588 . . . . 65.230000000000004 111.462 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.35 -40.95 81.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 110.779 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -51.94 -35.19 45.03 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.226 -0.443 . . . . 74.400000000000006 111.292 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -56.16 -63.15 1.28 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.506 -0.316 . . . . 71.040000000000006 111.019 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -51.78 -46.03 64.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.801 0.334 . . . . 73.230000000000004 111.655 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.18 -59.8 4.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.489 -0.323 . . . . 71.420000000000002 111.679 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.2 p -60.5 -39.84 89.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.791 0.293 . . . . 65.219999999999999 111.791 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.94 -69.36 0.22 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.44 0.533 . . . . 73.430000000000007 112.44 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.82 -32.32 69.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.619 0.6 . . . . 73.340000000000003 112.619 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.47 65.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.75 0.31 . . . . 62.130000000000003 110.849 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.0 -38.17 95.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.369 -0.443 . . . . 21.32 112.545 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.646 HG22 HE21 ' A' ' 140' ' ' GLN . 93.9 m -62.09 -49.16 77.02 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.649 -0.324 . . . . 34.240000000000002 111.032 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.21 -38.4 86.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.322 0.582 . . . . 74.540000000000006 110.408 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -58.45 -43.72 88.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.687 -0.688 . . . . 64.310000000000002 110.131 175.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.0 -33.86 65.26 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.034 -0.53 . . . . 32.229999999999997 113.406 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.646 HE21 HG22 ' A' ' 136' ' ' THR . 79.5 mt-30 -57.8 -44.4 86.3 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.829 0.315 . . . . 73.510000000000005 111.552 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -55.82 -50.67 69.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.674 0.273 . . . . 73.209999999999994 110.797 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.62 -46.06 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.42 0.526 . . . . 73.150000000000006 112.42 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' HD23 ' A' ' 147' ' ' LEU . 13.0 t -74.36 -42.59 59.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.77 -0.372 . . . . 71.040000000000006 111.829 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -64.02 -40.84 97.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.088 0.47 . . . . 74.150000000000006 110.567 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.07 -46.74 84.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.335 -0.848 . . . . 42.229999999999997 110.178 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -61.54 -47.39 85.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.363 -0.835 . . . . 72.109999999999999 112.266 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 143' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.795 0.665 . . . . 74.319999999999993 112.795 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.231 0.086 . . . . 65.409999999999997 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mm 64.0 96.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 121.326 0.584 . . . . 61.140000000000001 112.19 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 108.76 2.98 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.114 -0.494 . . . . 41.350000000000001 113.42 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.02 106.58 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.832 0.349 . . . . 41.130000000000003 110.683 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.734 ' HB3' HD23 ' A' ' 36' ' ' LEU . 23.9 m-85 -111.97 117.03 31.59 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.86 0.362 . . . . 71.200000000000003 111.579 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -147.02 173.16 12.7 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.877 0.37 . . . . 71.420000000000002 111.72 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 10' ' ' TYR . 19.2 t -99.59 86.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.098 0.475 . . . . 71.340000000000003 110.821 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -51.07 -19.81 1.22 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.627 0.973 . . . . 53.530000000000001 113.627 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -95.15 -50.95 4.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.515 0.561 . . . . 74.219999999999999 112.515 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.539 ' H ' HG12 ' A' ' 7' ' ' VAL . 60.9 t80 -72.33 114.05 10.03 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.002 0.741 . . . . 74.439999999999998 113.002 -174.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.66 -159.46 5.56 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 115.049 0.779 . . . . 51.530000000000001 115.049 171.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -65.55 7.28 0.24 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.917 1.08 . . . . 73.109999999999999 113.917 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.465 ' HB2' HG21 ' A' ' 90' ' ' THR . 34.9 t -49.87 -36.04 25.58 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.455 0.571 . . . . 63.539999999999999 112.337 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.89 -40.75 75.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.123 0.487 . . . . 55.009999999999998 110.689 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -62.18 -42.26 99.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 71.519999999999996 110.854 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.0 mt -59.42 -49.28 78.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.164 0.507 . . . . 71.349999999999994 110.614 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.89 79.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.965 -0.561 . . . . 73.120000000000005 111.548 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.15 -38.25 82.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.724 0.297 . . . . 75.299999999999997 111.352 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.72 88.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.879 0.371 . . . . 72.129999999999995 111.418 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.404 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.4 mt -70.17 -54.38 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.192 0.52 . . . . 63.210000000000001 111.157 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.509 HG23 HG11 ' A' ' 31' ' ' VAL . 72.1 mt -56.96 -35.25 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.117 -0.492 . . . . 61.25 111.609 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -47.24 -51.7 18.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.132 0.491 . . . . 63.219999999999999 111.272 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.98 -49.97 50.22 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.927 -0.654 . . . . 73.329999999999998 113.058 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.63 -42.9 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.818 0.673 . . . . 70.439999999999998 112.818 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 21' ' ' ILE . 12.7 t -67.76 -35.3 78.45 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.062 0.393 . . . . 75.209999999999994 112.062 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -84.67 -31.65 24.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 73.329999999999998 111.828 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.7 m -65.14 -30.25 71.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.052 0.453 . . . . 52.0 110.823 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 42.24 4.23 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.195 -0.526 . . . . 55.030000000000001 114.029 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.29 -76.35 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.258 -0.554 . . . . 63.32 111.463 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.34 157.23 8.28 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.481 -0.39 . . . . 72.430000000000007 112.255 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 21' ' ' ILE . 18.2 m -140.66 122.99 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 117.483 0.641 . . . . 75.129999999999995 112.501 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -109.63 104.27 13.26 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.284 -0.416 . . . . 74.540000000000006 110.357 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.48 124.18 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.173 0.435 . . . . 61.240000000000002 112.173 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.92 123.65 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.146 0.498 . . . . 54.240000000000002 110.71 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.91 81.46 7.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.191 -0.459 . . . . 61.32 112.091 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.3 pp -66.67 -19.67 65.81 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.853 -0.529 . . . . 74.209999999999994 111.526 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 17.88 51.64 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.403 -0.427 . . . . 75.329999999999998 112.924 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.5 -153.19 0.5 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.739 0.416 . . . . 54.520000000000003 110.503 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.18 99.75 10.49 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 122.074 -0.391 . . . . 70.400000000000006 111.89 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.15 165.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.911 0.386 . . . . 71.030000000000001 111.723 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.52 -171.33 3.2 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.924 0.392 . . . . 73.150000000000006 110.811 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.1 tm? -58.9 -28.52 66.27 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.125 0.417 . . . . 74.230000000000004 112.125 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.5 mp0 -54.2 -48.44 71.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.968 0.413 . . . . 72.129999999999995 111.752 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.49 -41.5 80.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.215 0.531 . . . . 74.209999999999994 110.917 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -60.9 -39.09 88.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.937 -0.574 . . . . 61.310000000000002 110.643 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -56.86 -48.14 78.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.808 -0.633 . . . . 74.420000000000002 111.709 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.15 -28.15 65.12 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.621 0.23 . . . . 75.430000000000007 111.621 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 39.4 tp -57.51 -27.97 63.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.872 0.367 . . . . 74.319999999999993 111.589 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -61.17 -38.06 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.05 0.452 . . . . 62.240000000000002 111.389 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.79 -30.65 14.46 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.127 -0.558 . . . . 71.340000000000003 112.659 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 89.2 mtt180 -75.59 0.57 17.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.936 0.495 . . . . 74.349999999999994 112.029 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.27 6.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.272 0.842 . . . . 72.230000000000004 113.272 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -80.83 -28.94 36.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.264 0.468 . . . . 74.140000000000001 112.264 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.0 137.38 4.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.844 -0.693 . . . . 61.25 113.14 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -163.79 167.63 20.64 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.693 0.627 . . . . 71.209999999999994 112.693 -176.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.62 121.26 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.104 -0.498 . . . . 52.409999999999997 111.026 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -108.45 143.75 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.009 0.433 . . . . 73.400000000000006 111.67 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -131.08 2.6 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.203 -0.523 . . . . 41.030000000000001 112.61 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.472 ' HB2' ' H ' ' A' ' 90' ' ' THR . 13.7 tmm? -110.08 127.27 54.77 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.148 -0.619 . . . . 62.240000000000002 110.901 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.2 p -97.32 105.48 25.46 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.629 -0.259 . . . . 43.329999999999998 111.545 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 155.39 67.98 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.313 2.009 . . . . 73.120000000000005 112.234 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.0 -35.07 23.22 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.573 0.582 . . . . 73.450000000000003 112.573 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.1 74.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 112.064 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -89.94 -40.17 12.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.716 0.294 . . . . 73.430000000000007 110.91 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -49.99 -39.46 41.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.483 0.313 . . . . 40.229999999999997 111.789 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.01 72.65 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.16 0.43 . . . . 71.409999999999997 112.16 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.8 p -76.63 -31.88 57.66 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.138 0.494 . . . . 64.319999999999993 110.695 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -63.04 -29.51 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 111.381 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 29.0 mm-40 -52.56 -26.73 14.14 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.864 0.364 . . . . 71.430000000000007 111.856 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.44 -54.64 2.63 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.136 -0.554 . . . . 50.039999999999999 112.916 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -63.72 -30.13 71.27 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.75 0.648 . . . . 34.240000000000002 112.75 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.0 -47.59 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.529 0.332 . . . . 71.400000000000006 111.288 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -57.88 -48.44 79.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.901 0.381 . . . . 63.109999999999999 111.4 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.2 m -57.86 -44.64 86.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.204 -0.453 . . . . 52.310000000000002 111.271 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 79' ' ' VAL . 69.5 mt -63.01 -55.08 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 74.219999999999999 111.248 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.42 HD21 ' HD2' ' A' ' 104' ' ' LYS . 49.0 tp -55.17 -34.99 64.31 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.71 -0.677 . . . . 44.119999999999997 112.256 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.01 -21.18 71.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.954 -0.641 . . . . 54.32 113.57 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.9 m -98.77 -21.2 16.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.004 0.742 . . . . 60.049999999999997 113.004 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -62.93 163.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.844 0.683 . . . . 73.340000000000003 112.844 -178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -79.53 161.82 25.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.868 -0.605 . . . . 64.299999999999997 111.217 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.39 -44.24 65.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.804 0.442 . . . . 74.340000000000003 112.122 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -143.1 143.74 31.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.768 0.318 . . . . 75.230000000000004 111.155 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.457 ' H ' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -158.21 177.31 11.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.313 0.578 . . . . 71.340000000000003 112.112 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.642 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -93.58 112.14 23.96 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.811 -0.631 . . . . 74.140000000000001 110.937 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.418 HG12 HD11 ' A' ' 55' ' ' LEU . 31.6 m -114.33 128.74 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.359 0.6 . . . . 55.149999999999999 112.149 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.67 17.73 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.051 -0.522 . . . . 71.129999999999995 112.409 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 57' ' ' ILE . 6.7 tp -148.46 137.83 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.783 0.325 . . . . 74.439999999999998 111.275 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.83 114.55 7.67 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.241 0.543 . . . . 71.109999999999999 111.21 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' HD12 ' A' ' 119' ' ' ILE . 44.7 mt-10 -60.02 93.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.21 0.529 . . . . 62.520000000000003 111.901 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.472 ' H ' ' HB2' ' A' ' 59' ' ' MET . 24.9 m -74.73 77.41 2.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.119 0.485 . . . . 64.519999999999996 111.491 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.22 -169.15 47.5 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.073 -0.584 . . . . 74.319999999999993 113.53 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.07 77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.421 -0.419 . . . . 60.140000000000001 113.412 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.469 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . -89.12 -176.51 46.35 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.254 -0.498 . . . . 53.420000000000002 112.863 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -94.48 164.85 12.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.42 -0.459 . . . . 71.420000000000002 110.848 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.13 115.64 20.12 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.205 0.526 . . . . 72.430000000000007 112.368 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.659 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 63.7 mt-10 -103.39 -59.14 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 112.148 0.425 . . . . 72.140000000000001 112.148 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 39.0 Cg_endo -98.27 27.12 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.87 2.38 . . . . 73.140000000000001 113.715 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.54 -51.61 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.728 0.64 . . . . 73.109999999999999 112.728 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.415 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 6.1 m-20 -64.22 -56.58 22.72 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.611 0.597 . . . . 75.420000000000002 112.611 -176.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 25.6 Cg_endo -59.75 -41.63 53.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.064 1.842 . . . . 63.310000000000002 113.078 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.72 -59.58 3.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.883 0.373 . . . . 65.430000000000007 110.997 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.08 -34.54 78.27 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.058 0.392 . . . . 71.340000000000003 112.058 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -60.48 -50.05 75.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.04 0.448 . . . . 62.520000000000003 111.567 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD2' HD21 ' A' ' 76' ' ' LEU . 32.8 ttmt -65.02 -43.33 92.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.548 -0.296 . . . . 73.239999999999995 111.259 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.28 -40.82 87.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.825 0.345 . . . . 74.230000000000004 111.419 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -55.24 -41.84 72.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.953 0.406 . . . . 74.329999999999998 110.919 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -70.14 -29.84 66.86 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.591 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.3 mt -81.47 -22.26 38.19 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.33 -73.5 2.35 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.238 -0.506 . . . . 71.219999999999999 112.66 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 83' ' ' GLN . 61.1 mt 60.36 -179.21 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.614 0.721 . . . . 74.010000000000005 112.732 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.642 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 73.5 m -97.16 103.98 15.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.852 -0.613 . . . . 62.039999999999999 110.167 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -114.01 102.73 10.46 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.183 0.438 . . . . 62.409999999999997 112.183 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.74 84.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.544 0.572 . . . . 70.230000000000004 112.544 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -152.46 132.44 7.24 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.413 -0.179 . . . . 75.230000000000004 110.787 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.62 -69.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.525 2.15 . . . . 53.439999999999998 114.543 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 161.2 38.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.578 0.584 . . . . 64.319999999999993 112.578 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.796 HG12 ' H ' ' A' ' 118' ' ' ARG . 11.1 tt -123.64 -150.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.156 0.582 . . . . 73.310000000000002 109.74 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.796 ' H ' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -147.08 114.02 6.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.141 -0.974 . . . . 74.049999999999997 111.634 175.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' HA ' ' A' ' 123' ' ' PRO . 73.4 mt -139.06 139.2 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 115.948 -0.569 . . . . 71.510000000000005 110.597 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -81.52 -61.24 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.966 0.358 . . . . 74.299999999999997 111.966 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -141.64 -52.6 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.145 -0.347 . . . . 75.439999999999998 111.61 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.8 p -92.29 130.0 39.22 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 116.788 -0.187 . . . . 71.420000000000002 111.066 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.653 ' HA ' HD13 ' A' ' 119' ' ' ILE . 12.3 Cg_endo -55.15 127.22 25.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.404 2.07 . . . . 72.209999999999994 112.691 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.8 p -74.48 154.48 38.68 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.22 -0.445 . . . . 55.229999999999997 111.906 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.45 -25.63 68.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.038 0.447 . . . . 74.219999999999999 111.385 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -38.18 75.13 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 109.998 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.452 ' OG1' HD11 ' A' ' 119' ' ' ILE . 33.6 m -55.19 -38.38 68.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.901 -0.591 . . . . 63.350000000000001 111.879 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 87.1 m-85 -58.36 -60.33 3.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.994 0.426 . . . . 75.209999999999994 111.265 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -58.33 -29.82 66.22 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.085 -0.507 . . . . 63.219999999999999 111.694 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.28 -50.11 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.273 -0.421 . . . . 71.219999999999999 110.368 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 128' ' ' TYR . 30.5 p -69.24 -22.74 63.83 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.882 0.327 . . . . 53.530000000000001 111.882 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 53.0 mt-10 -60.11 -53.0 62.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.881 0.372 . . . . 64.239999999999995 111.057 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.13 -55.74 8.63 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.08 0.467 . . . . 64.450000000000003 111.022 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.24 -57.55 12.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.944 -0.571 . . . . 72.349999999999994 112.434 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -56.4 -47.27 84.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.461 -0.4 . . . . 51.439999999999998 113.75 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.4 m -64.87 -33.53 76.23 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.558 -0.378 . . . . 63.340000000000003 111.64 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -55.04 -36.5 65.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.197 0.443 . . . . 73.030000000000001 112.197 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.3 mm? -56.32 -45.66 80.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.18 0.514 . . . . 70.129999999999995 110.902 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.69 -38.86 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.079 -0.581 . . . . 64.25 112.796 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 136' ' ' THR . 17.5 mm-40 -57.61 -50.05 74.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.847 0.356 . . . . 71.400000000000006 111.642 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -54.48 -50.88 66.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 111.533 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.18 -51.92 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 112.234 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -69.46 -43.3 73.54 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.403 0.52 . . . . 61.119999999999997 112.403 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.34 -43.1 78.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.106 0.41 . . . . 70.400000000000006 112.106 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.77 -30.59 71.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 111.095 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -75.24 -21.56 58.51 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.988 -0.551 . . . . 75.430000000000007 111.801 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.256 0.465 . . . . 51.439999999999998 112.256 -177.167 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.1 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.421 0.153 . . . . 54.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.6 mm 59.46 102.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.195 0.521 . . . . 54.030000000000001 111.887 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.65 94.43 1.87 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.833 -0.698 . . . . 62.439999999999998 113.061 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 33' ' ' VAL . 47.9 t -88.0 104.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.056 0.428 . . . . 75.120000000000005 111.091 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HB3' HD23 ' A' ' 36' ' ' LEU . 97.7 m-85 -103.86 119.03 38.08 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.204 0.526 . . . . 61.539999999999999 111.408 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.584 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 45.1 p90 -136.6 -178.08 5.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.155 -0.475 . . . . 74.25 111.678 -175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.9 100.93 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.813 0.339 . . . . 74.439999999999998 110.585 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.575 ' HB3' ' HE2' ' A' ' 6' ' ' TYR . 53.4 p -63.86 -18.49 64.21 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.281 0.845 . . . . 74.430000000000007 113.281 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -89.16 -10.94 45.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.067 0.461 . . . . 74.150000000000006 111.534 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -115.45 119.11 35.13 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.251 -0.281 . . . . 63.130000000000003 111.082 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.61 -161.32 7.45 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.253 -0.498 . . . . 54.340000000000003 114.131 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -84.75 8.23 17.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.01 0.744 . . . . 71.519999999999996 113.01 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 42.8 m -32.19 -51.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.578 0.955 . . . . 52.409999999999997 113.578 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.5 -40.95 76.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.692 0.282 . . . . 74.040000000000006 111.724 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -60.3 -39.06 85.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.292 0.567 . . . . 74.109999999999999 110.544 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.59 -53.32 53.52 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.734 -0.666 . . . . 51.25 110.905 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -39.8 68.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.999 0.428 . . . . 50.420000000000002 111.379 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -55.71 -45.51 77.89 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.683 -0.689 . . . . 74.049999999999997 111.516 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.18 -43.84 69.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.094 -0.503 . . . . 71.510000000000005 111.424 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' HG12 ' A' ' 24' ' ' ILE . 82.0 mt -57.0 -56.82 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.209 -0.451 . . . . 54.229999999999997 111.664 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -56.98 -35.92 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.806 0.336 . . . . 63.240000000000002 111.354 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.76 -37.4 86.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.015 0.436 . . . . 73.109999999999999 111.206 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.0 24.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.26 -0.495 . . . . 72.129999999999995 113.775 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 31' ' ' VAL . 44.8 mm -75.98 -41.59 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 122.407 -0.466 . . . . 71.439999999999998 112.044 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.2 p -61.24 -30.17 70.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 74.329999999999998 111.344 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.41 -12.57 60.07 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 71.25 111.176 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -90.35 -36.75 14.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.129 -0.487 . . . . 54.219999999999999 111.016 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.64 22.82 2.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.304 -0.474 . . . . 61.009999999999998 113.748 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 24' ' ' ILE . 67.7 t -130.16 140.39 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 117.148 0.474 . . . . 53.229999999999997 111.069 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.44 113.34 4.65 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.089 -0.577 . . . . 52.219999999999999 112.846 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.635 HG13 HG21 ' A' ' 24' ' ' ILE . 20.5 m -94.15 140.33 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.129 0.49 . . . . 63.340000000000003 112.139 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 51' ' ' ARG . 23.4 m-20 -101.38 113.26 26.19 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.095 -0.502 . . . . 71.519999999999996 111.079 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.573 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 36.0 m -106.11 125.95 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 120.969 0.414 . . . . 71.420000000000002 111.418 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.81 150.69 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.458 0.303 . . . . 45.530000000000001 111.523 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 15.7 m-20 -84.54 120.52 26.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.796 0.295 . . . . 72.049999999999997 111.796 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.496 HD11 ' HE1' ' A' ' 59' ' ' MET . 4.2 pp -86.12 -16.21 38.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.155 0.503 . . . . 73.140000000000001 111.38 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.73 -10.77 78.55 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.208 -0.52 . . . . 65.040000000000006 112.489 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.44 -178.32 5.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.836 0.35 . . . . 75.420000000000002 111.275 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 96.02 3.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.998 0.428 . . . . 72.200000000000003 111.236 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -85.5 132.58 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.259 0.552 . . . . 71.219999999999999 111.56 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -108.64 170.42 8.04 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.375 -0.375 . . . . 74.439999999999998 110.94 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 45' ' ' LEU . 3.3 mm? -55.9 -24.55 38.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.073 0.463 . . . . 63.140000000000001 111.084 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -57.56 -60.26 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.877 -0.601 . . . . 73.0 110.983 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -65.58 -38.08 88.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.08 -0.509 . . . . 73.310000000000002 110.973 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.575 HD12 HD13 ' A' ' 42' ' ' LEU . 92.9 mt -59.3 -34.79 72.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.451 -0.34 . . . . 74.329999999999998 111.448 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.84 -33.84 60.07 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.224 -0.297 . . . . 75.120000000000005 111.017 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.14 -39.13 77.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.992 0.425 . . . . 73.400000000000006 110.281 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.646 HD21 HG23 ' A' ' 75' ' ' ILE . 67.7 tp -52.61 -46.5 67.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.98 -0.554 . . . . 73.540000000000006 110.852 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.86 -44.23 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.046 0.45 . . . . 73.340000000000003 111.009 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.43 -29.88 72.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.144 -0.551 . . . . 42.240000000000002 113.025 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -99.61 8.69 44.2 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.069 0.396 . . . . 73.030000000000001 112.069 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.05 -3.41 0.13 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.502 0.927 . . . . 73.310000000000002 113.502 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -84.58 -27.63 27.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.793 0.33 . . . . 71.409999999999997 111.793 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.55 138.32 5.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.469 -0.396 . . . . 44.329999999999998 112.843 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 pp -159.12 162.99 36.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.319 0.488 . . . . 75.439999999999998 112.319 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -131.05 128.76 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.422 -0.353 . . . . 73.420000000000002 111.387 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.5 mp -95.59 139.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.758 0.313 . . . . 74.430000000000007 110.909 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -116.13 0.46 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.211 -0.519 . . . . 55.030000000000001 113.79 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -82.68 175.9 9.77 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 112.842 0.682 . . . . 72.299999999999997 112.842 -177.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.447 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 87.7 p -144.52 34.51 0.16 Allowed Pre-proline 0 CA--C 1.555 1.165 0 N-CA-C 114.07 1.137 . . . . 73.329999999999998 114.07 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 87.7 Cg_endo -77.53 149.13 26.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.651 1.568 . . . . 73.530000000000001 112.434 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.41 61.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.439 0.533 . . . . 63.240000000000002 112.439 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.4 66.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.105 0.479 . . . . 51.119999999999997 112.102 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -78.36 -29.95 47.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.987 0.422 . . . . 75.230000000000004 111.215 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.61 -29.37 62.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.139 -0.482 . . . . 63.130000000000003 111.904 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.86 80.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.063 0.459 . . . . 74.549999999999997 111.246 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.8 t -73.73 -43.83 58.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.991 0.424 . . . . 61.32 110.958 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.3 -50.37 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.077 -0.51 . . . . 61.219999999999999 111.846 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.64 -43.57 98.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.034 0.383 . . . . 74.040000000000006 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.44 -41.36 72.11 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.037 -0.601 . . . . 70.340000000000003 112.765 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -81.45 -32.68 32.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.74 0.305 . . . . 44.130000000000003 111.382 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.15 -43.91 74.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.973 0.509 . . . . 72.519999999999996 111.33 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.6 m -55.86 -21.96 22.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.776 0.322 . . . . 52.420000000000002 111.849 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 m -97.61 -29.89 13.17 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.101 0.476 . . . . 64.420000000000002 110.863 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.646 HG23 HD21 ' A' ' 48' ' ' LEU . 69.4 mt -64.07 -39.17 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.033 0.383 . . . . 71.230000000000004 112.033 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -51.1 -49.2 61.18 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.438 0.533 . . . . 73.109999999999999 112.438 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.79 -8.01 87.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.044 -0.598 . . . . 52.329999999999998 113.234 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.2 m -94.04 -24.68 17.52 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.929 0.344 . . . . 73.239999999999995 111.929 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 m -87.01 164.18 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.178 0.513 . . . . 64.010000000000005 111.905 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.93 -156.2 0.52 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.159 -0.473 . . . . 52.509999999999998 111.444 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.11 -80.57 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.951 0.723 . . . . 52.229999999999997 112.951 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -117.57 98.6 6.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.594 0.712 . . . . 64.219999999999999 111.874 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.11 166.48 11.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.459 0.647 . . . . 74.109999999999999 112.564 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -102.77 110.81 22.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.531 -0.759 . . . . 62.149999999999999 109.298 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -121.03 154.03 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.814 0.816 . . . . 72.409999999999997 113.033 -168.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.72 169.97 14.32 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.249 -0.887 . . . . 42.0 112.684 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -153.76 126.63 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.383 0.273 . . . . 72.340000000000003 110.848 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -137.28 92.48 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.717 0.77 . . . . 72.310000000000002 111.99 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.58 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.5 tp10 -66.63 121.31 15.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.653 -0.703 . . . . 70.299999999999997 110.473 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.492 HG21 ' OG ' ' A' ' 13' ' ' SER . 8.0 t -101.53 15.78 27.79 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 64.109999999999999 111.843 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . -158.24 -64.54 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.811 -0.709 . . . . 72.030000000000001 113.631 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.06 47.66 2.02 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.304 -0.474 . . . . 70.329999999999998 111.967 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 61' ' ' PRO . . . -66.49 -63.81 3.7 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.171 0.428 . . . . 51.240000000000002 114.171 -174.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -152.66 -178.56 6.95 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.182 0.491 . . . . 73.239999999999995 111.244 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.3 23.82 1.81 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.675 0.39 . . . . 71.340000000000003 111.49 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 34.0 tt0 -50.81 -47.85 84.94 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.361 0.874 . . . . 63.119999999999997 113.361 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.481 ' O ' HD23 ' A' ' 101' ' ' LEU . 51.7 Cg_endo -87.98 38.5 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.313 2.009 . . . . 74.0 113.701 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.7 tt -66.59 -58.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 113.635 0.976 . . . . 71.129999999999995 113.635 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 98' ' ' ILE . 9.9 m-20 -57.9 -55.73 42.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.935 1.087 . . . . 73.150000000000006 113.935 -172.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 32.4 Cg_endo -61.65 -14.64 37.0 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.315 2.01 . . . . 74.040000000000006 114.742 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 97' ' ' PRO . 4.0 mm? -100.89 -62.03 1.29 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -50.62 -45.15 57.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.508 0.929 . . . . 72.349999999999994 113.508 -170.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.7 t -52.81 -37.68 60.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.488 0.551 . . . . 71.310000000000002 112.488 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 0.5 OUTLIER -66.61 -44.0 83.25 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.831 0.348 . . . . 71.5 111.449 -177.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -63.16 -35.97 82.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.924 0.393 . . . . 64.140000000000001 111.154 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -69.4 -43.79 72.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.144 -0.48 . . . . 74.319999999999993 110.999 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.32 -55.14 38.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.622 . . . . 73.340000000000003 111.792 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 mp -71.69 -26.19 62.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.758 0.313 . . . . 72.430000000000007 111.312 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.68 62.14 3.32 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.172 -0.537 . . . . 55.219999999999999 113.579 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.39 142.66 35.78 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.069 0.461 . . . . 64.540000000000006 111.313 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 35.3 m -70.91 97.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.261 -0.427 . . . . 72.5 110.941 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.3 p -86.73 121.66 29.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 112.152 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.31 -58.8 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.435 0.531 . . . . 73.430000000000007 112.435 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -140.92 84.89 12.81 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 120.996 0.427 . . . . 74.140000000000001 111.667 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.39 64.53 4.96 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.824 2.349 . . . . 63.310000000000002 112.989 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.91 42.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.143 0.423 . . . . 71.349999999999994 112.143 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.518 HG21 ' H ' ' A' ' 89' ' ' GLU . 1.7 pp -71.2 73.23 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.847 0.832 . . . . 74.400000000000006 112.892 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -79.46 50.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.929 -0.578 . . . . 73.439999999999998 112.415 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 89' ' ' GLU . 49.0 mm -76.35 147.82 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 120.932 0.396 . . . . 73.209999999999994 111.721 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.96 -61.86 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.113 0.412 . . . . 70.140000000000001 112.113 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.525 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 35.2 tt0 -151.28 -48.94 0.12 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.098 0.475 . . . . 41.020000000000003 111.604 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.0 p -129.35 131.75 23.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.412 -0.358 . . . . 53.240000000000002 111.289 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 90' ' ' THR . 37.6 Cg_endo -65.96 143.76 73.85 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.475 2.117 . . . . 72.219999999999999 112.226 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.8 p -100.73 -177.72 3.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.991 0.424 . . . . 70.209999999999994 111.592 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -59.89 -26.76 66.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.076 0.465 . . . . 61.439999999999998 111.258 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -76.38 -24.38 54.11 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.38 -0.373 . . . . 74.340000000000003 111.902 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.0 m -59.07 -35.26 73.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.936 0.398 . . . . 75.140000000000001 111.466 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.43 -48.43 80.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.024 0.44 . . . . 63.520000000000003 111.346 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -50.13 -50.11 49.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.653 -0.703 . . . . 75.25 112.54 -174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 130' ' ' LEU . 7.2 mp -63.05 -46.39 87.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 72.400000000000006 111.232 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 82.2 m -61.05 -40.05 92.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 111.773 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.18 -52.56 12.1 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.865 0.364 . . . . 71.340000000000003 111.614 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.61 -63.49 1.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.422 -0.354 . . . . 70.409999999999997 110.941 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.21 79.55 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.481 -0.327 . . . . 72.019999999999996 111.405 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.04 94.67 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.282 -0.485 . . . . 34.439999999999998 113.083 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 54.8 m -60.67 -48.61 81.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.827 0.346 . . . . 63.329999999999998 111.151 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.09 -39.64 86.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.904 0.383 . . . . 62.210000000000001 111.304 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.44 -44.5 97.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.023 0.439 . . . . 65.230000000000004 110.662 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.3 -38.72 96.25 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.265 -0.493 . . . . 64.439999999999998 112.75 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 86.3 mt-30 -61.89 -28.83 69.79 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.998 0.37 . . . . 61.420000000000002 111.998 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -50.63 -40.33 52.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.129 0.49 . . . . 70.010000000000005 110.717 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.97 -51.95 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.025 -0.534 . . . . 74.319999999999993 111.755 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.564 ' HA ' ' HB2' ' A' ' 146' ' ' ARG . 10.0 t -69.1 -25.2 64.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.901 0.334 . . . . 73.219999999999999 111.901 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 94.7 mtt180 -65.73 -41.11 92.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.742 0.306 . . . . 75.239999999999995 111.093 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.65 -27.94 31.01 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.432 . . . . 75.540000000000006 110.936 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.68 ' HE ' ' HA ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -59.83 -59.23 5.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.357 -0.383 . . . . 72.219999999999999 111.132 175.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.3 tp . . . . . 0 CA--C 1.542 0.66 0 CA-C-N 116.662 -0.244 . . . . 72.230000000000004 111.514 174.612 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.679 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 53.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.009 -0.043 . . . . 72.219999999999999 110.933 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 63.33 122.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 112.726 0.639 . . . . 74.430000000000007 112.726 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.48 105.11 3.24 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.473 -0.394 . . . . 73.299999999999997 112.663 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.2 t -88.39 107.92 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 122.55 -0.383 . . . . 64.400000000000006 110.982 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.633 ' HE2' ' HB2' ' A' ' 55' ' ' LEU . 83.3 m-85 -88.71 142.0 28.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.938 0.718 . . . . 72.109999999999999 112.938 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -146.58 179.74 7.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.775 -0.648 . . . . 74.030000000000001 110.844 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.606 HG13 ' HA3' ' A' ' 37' ' ' GLY . 86.0 t -130.64 103.7 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.748 0.309 . . . . 44.420000000000002 111.721 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.7 m -54.95 -36.41 65.29 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.087 0.403 . . . . 74.049999999999997 112.087 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.7 -54.81 36.95 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.385 0.513 . . . . 74.200000000000003 112.385 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.423 ' H ' HG12 ' A' ' 7' ' ' VAL . 73.9 t80 -138.94 -55.29 0.6 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.092 -0.503 . . . . 62.240000000000002 110.898 -174.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.581 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -30.04 97.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.365 0.906 . . . . 71.420000000000002 115.365 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -70.82 5.76 1.81 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.073 0.464 . . . . 75.409999999999997 111.488 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -52.89 -14.17 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.029 0.751 . . . . 73.420000000000002 113.029 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.33 -37.01 74.26 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.093 0.473 . . . . 63.439999999999998 110.916 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.561 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 1.5 mtm180 -65.15 -34.41 78.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.056 -0.52 . . . . 55.0 111.127 175.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' HG13 ' A' ' 20' ' ' ILE . 75.6 mt -66.79 -48.18 69.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.406 172.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.85 -41.73 71.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.126 -0.488 . . . . 70.129999999999995 112.116 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -63.0 -46.02 89.64 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.906 0.384 . . . . 62.130000000000003 111.321 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.08 93.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.064 0.459 . . . . 63.149999999999999 111.217 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 16' ' ' LEU . 79.1 mt -63.71 -55.19 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.681 . . . . 73.540000000000006 111.814 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.79 -39.69 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 122.312 -0.243 . . . . 74.349999999999994 111.61 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 25' ' ' THR . 46.1 t-20 -55.77 -59.82 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.842 0.354 . . . . 53.32 111.025 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -45.07 96.67 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 120.952 -0.642 . . . . 73.319999999999993 113.42 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 30' ' ' GLY . 33.6 mt -72.92 -30.22 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.115 0.783 . . . . 75.150000000000006 113.115 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 22' ' ' ASN . 14.5 t -69.66 -35.18 74.94 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.571 -0.705 . . . . 54.299999999999997 110.743 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -74.62 -43.01 57.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.933 0.397 . . . . 70.310000000000002 110.807 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.416 HG21 HE21 ' A' ' 140' ' ' GLN . 97.9 m -59.34 -34.09 71.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.128 -0.487 . . . . 63.009999999999998 111.377 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.48 59.13 0.68 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.036 -0.602 . . . . 61.119999999999997 114.101 175.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 24' ' ' ILE . 61.1 t -140.07 -53.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.844 0.354 . . . . 63.25 111.24 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 84.65 119.06 0.83 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.326 -0.464 . . . . 75.519999999999996 113.564 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 1' ' ' SER . 30.9 m -116.6 146.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.324 0.49 . . . . 52.100000000000001 112.324 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.28 129.97 55.5 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.289 -0.414 . . . . 75.430000000000007 111.169 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.16 137.15 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.182 0.515 . . . . 52.420000000000002 112.205 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 59.7 t -132.64 140.33 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.507 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 17.4 t70 -107.88 130.34 55.01 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.176 0.512 . . . . 61.020000000000003 111.711 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -116.75 11.32 14.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.288 -0.415 . . . . 71.329999999999998 112.078 178.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.606 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -96.17 -35.12 5.63 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.007 -0.616 . . . . 72.310000000000002 113.353 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.0 -38.22 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.984 0.421 . . . . 42.100000000000001 111.816 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . . . -75.54 12.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.499 0.555 . . . . 71.409999999999997 112.499 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.24 114.05 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.227 0.537 . . . . 65.299999999999997 111.969 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.12 170.43 21.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.886 -0.597 . . . . 71.299999999999997 110.628 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.17 -34.8 70.7 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.618 -0.264 . . . . 64.120000000000005 111.447 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.44 -63.11 1.39 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.643 0.258 . . . . 63.43 111.624 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.47 -48.97 65.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.196 0.522 . . . . 65.5 111.637 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.09 -43.67 98.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.154 -0.475 . . . . 75.120000000000005 111.975 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -71.65 -34.73 70.0 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.309 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HB3' HH11 ' A' ' 51' ' ' ARG . 34.5 mt-10 -71.99 -28.75 63.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.659 0.266 . . . . 63.340000000000003 111.141 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.56 -40.0 77.96 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.935 0.398 . . . . 73.099999999999994 110.615 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -36.03 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.22 -0.445 . . . . 64.400000000000006 111.014 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.33 -40.29 41.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.169 -0.539 . . . . 72.209999999999994 112.647 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 47' ' ' GLU . 7.2 mpt_? -81.61 6.23 15.71 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.102 0.408 . . . . 73.140000000000001 112.102 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.9 p -49.84 -15.54 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.633 0.975 . . . . 74.439999999999998 113.633 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -47.59 -31.63 4.66 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.338 0.496 . . . . 73.420000000000002 112.338 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -179.82 141.56 4.75 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.076 -0.511 . . . . 33.200000000000003 112.095 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.633 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . 1.4 pt? -144.72 134.48 23.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.369 0.584 . . . . 65.150000000000006 112.136 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG22 ' HE1' ' A' ' 88' ' ' PHE . 11.4 p -118.11 124.99 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.076 0.465 . . . . 71.25 111.077 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.51 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.5 mp -113.2 139.64 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.287 0.477 . . . . 61.200000000000003 112.287 -172.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.1 131.23 10.54 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.3 -0.409 . . . . 74.209999999999994 112.579 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.07 120.26 22.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.551 0.575 . . . . 71.319999999999993 112.551 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.668 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 88.4 p -111.75 171.14 4.57 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.153 0.581 . . . . 61.350000000000001 111.051 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.668 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 30.9 Cg_endo -63.18 168.08 11.51 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.289 1.992 . . . . 65.420000000000002 113.526 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.831 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -58.22 -21.62 48.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.076 0.769 . . . . 72.030000000000001 113.076 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.19 -61.0 2.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.785 0.326 . . . . 52.350000000000001 111.305 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 -33.01 36.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.625 -0.261 . . . . 71.25 111.701 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -54.81 -37.59 66.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.179 0.437 . . . . 72.340000000000003 112.179 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.51 75.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.315 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -68.86 -40.85 79.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.28 0.562 . . . . 72.420000000000002 110.691 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.39 -44.5 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.914 -0.585 . . . . 74.329999999999998 111.081 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -57.44 -40.17 77.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.507 -0.315 . . . . 74.109999999999999 111.357 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.11 -49.16 73.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.153 -0.546 . . . . 33.32 112.887 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.39 67.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.918 0.39 . . . . 75.329999999999998 111.92 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 72' ' ' LEU . 3.2 tm? -52.8 -32.12 42.29 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.228 -0.442 . . . . 61.039999999999999 111.175 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.4 m -46.8 -41.03 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.729 0.412 . . . . 63.420000000000002 111.752 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.1 m -87.68 -45.32 10.49 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.892 0.377 . . . . 74.510000000000005 111.157 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.39 -51.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 112.418 0.525 . . . . 74.040000000000006 112.418 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.4 tp -55.91 -33.95 65.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.823 0.344 . . . . 72.430000000000007 111.889 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.37 -17.44 55.28 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.944 -0.646 . . . . 70.140000000000001 113.244 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.0 p -87.75 -16.35 34.48 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.336 0.495 . . . . 72.439999999999998 112.336 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.57 153.94 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.22 0.533 . . . . 73.200000000000003 112.084 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -87.14 148.64 25.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.082 -0.508 . . . . 75.109999999999999 111.158 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.76 -36.31 64.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.939 0.4 . . . . 71.019999999999996 111.997 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -118.19 87.15 2.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.489 0.661 . . . . 62.039999999999999 110.837 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.482 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 18.2 tp60 -131.38 172.83 11.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.993 -0.549 . . . . 74.5 110.867 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.482 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -107.98 123.72 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 64.540000000000006 111.836 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 112' ' ' THR . 35.3 m -130.03 171.8 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.842 0.353 . . . . 62.109999999999999 111.12 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.445 ' HA3' HG23 ' A' ' 56' ' ' VAL . . . -142.4 144.4 14.03 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.097 -0.573 . . . . 64.439999999999998 112.826 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -125.06 126.66 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.588 -0.36 . . . . 73.519999999999996 111.829 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 54.6 p90 -148.94 168.14 23.88 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.101 0.477 . . . . 75.209999999999994 111.725 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.58 155.38 21.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.377 0.608 . . . . 73.340000000000003 111.984 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -134.5 2.26 3.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.999 0.428 . . . . 54.229999999999997 111.765 176.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.62 -164.96 29.66 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.242 -0.504 . . . . 74.120000000000005 112.778 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.09 -29.66 62.79 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.039 0.376 . . . . 60.43 114.039 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.33 126.15 1.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.341 -0.457 . . . . 64.439999999999998 112.98 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 27.2 t70 -160.2 109.37 1.74 Allowed 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.444 -0.445 . . . . 75.099999999999994 111.41 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -168.32 156.77 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.569 0.348 . . . . 60.43 110.846 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.725 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 4.6 mp0 -94.15 -61.12 0.18 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 112.19 0.441 . . . . 64.430000000000007 112.19 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 6.1 Cg_exo -80.03 16.29 1.52 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.567 2.178 . . . . 61.229999999999997 113.749 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.544 HG23 ' H ' ' A' ' 99' ' ' ASP . 5.6 tt -47.9 -59.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.86 0.689 . . . . 72.129999999999995 112.86 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.544 ' H ' HG23 ' A' ' 98' ' ' ILE . 6.8 m-20 -63.83 -50.98 68.02 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 111.983 0.364 . . . . 74.230000000000004 111.983 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 94.3 Cg_exo -47.24 -40.8 27.9 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.437 2.091 . . . . 74.340000000000003 113.704 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 97' ' ' PRO . 7.4 mp -63.8 -59.82 4.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.838 0.351 . . . . 74.129999999999995 111.266 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.7 mt -53.93 -35.82 62.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.081 0.467 . . . . 71.439999999999998 111.334 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.3 t -57.78 -46.04 85.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.826 -0.624 . . . . 74.510000000000005 111.432 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -71.07 -41.07 71.19 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.673 0.249 . . . . 72.349999999999994 111.673 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.32 -35.68 76.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.184 0.516 . . . . 75.430000000000007 111.113 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 106' ' ' ARG . 15.0 tpt180 -79.53 -31.37 42.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.008 0.432 . . . . 74.400000000000006 110.591 177.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -59.67 -38.32 81.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.033 -0.53 . . . . 72.319999999999993 110.534 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.72 -52.82 26.57 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.103 -0.499 . . . . 72.530000000000001 110.789 173.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.39 34.34 0.82 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.123 -0.561 . . . . 64.120000000000005 113.797 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 110' ' ' LEU . 7.1 mp -83.56 136.12 34.37 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.458 -0.436 . . . . 73.519999999999996 111.111 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.4 t -77.78 125.74 29.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.096 -0.335 . . . . 74.200000000000003 110.096 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 85' ' ' VAL . 59.3 p -97.38 -8.48 29.43 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.679 0.992 . . . . 60.420000000000002 113.679 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 50.24 78.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.538 0.569 . . . . 73.319999999999993 112.538 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 64.82 106.9 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 112.388 0.514 . . . . 72.230000000000004 112.388 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.63 74.14 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.08 1.853 . . . . 73.409999999999997 111.906 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . . . -73.76 114.45 12.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.79 0.663 . . . . 60.149999999999999 112.79 -173.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.2 tt -159.04 80.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.949 0.88 . . . . 64.140000000000001 110.6 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -146.81 90.58 1.93 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.772 -0.649 . . . . 73.099999999999994 111.773 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.45 149.34 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.397 0.618 . . . . 71.109999999999999 112.232 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -91.23 -25.2 19.62 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.715 -0.675 . . . . 61.240000000000002 110.886 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 178.71 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.439 -0.8 . . . . 73.340000000000003 109.962 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p -128.62 140.06 37.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.794 -0.639 . . . . 74.319999999999993 110.795 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.21 169.15 14.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.621 2.214 . . . . 55.409999999999997 114.012 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 125' ' ' GLU . 91.1 m -107.43 160.06 15.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.866 -0.606 . . . . 53.520000000000003 110.526 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 124' ' ' THR . 9.4 pt-20 -43.47 -35.53 1.67 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.634 0.975 . . . . 62.420000000000002 113.634 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -62.36 -23.25 66.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.327 0.492 . . . . 62.299999999999997 112.327 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.0 m -57.98 -39.74 78.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.231 0.538 . . . . 71.349999999999994 110.556 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.561 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 11.3 m-85 -60.44 -32.03 70.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.906 -0.588 . . . . 73.040000000000006 111.278 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.7 -36.52 76.03 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.44 -0.345 . . . . 72.5 111.136 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.28 -53.66 34.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 64.340000000000003 110.256 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.7 m -58.79 -32.7 69.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.006 0.431 . . . . 53.43 111.083 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.04 -56.03 26.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.783 -0.644 . . . . 71.439999999999998 112.019 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.43 -34.76 76.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.802 0.334 . . . . 74.200000000000003 111.74 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.56 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.592 -0.276 . . . . 62.310000000000002 111.718 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -54.19 -49.36 60.0 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.546 -0.359 . . . . 72.209999999999994 113.558 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 55.4 m -59.79 -40.93 89.97 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.849 0.357 . . . . 72.0 111.431 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.47 -42.95 99.57 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.923 0.392 . . . . 74.120000000000005 111.365 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.77 0.319 . . . . 75.120000000000005 110.979 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.28 93.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.832 -0.699 . . . . 63.329999999999998 112.509 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 136' ' ' THR . 83.8 mt-30 -67.93 -23.82 65.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.039 0.447 . . . . 74.340000000000003 111.398 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.56 -44.81 77.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.216 0.531 . . . . 74.129999999999995 110.755 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.6 -50.24 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.97 -0.559 . . . . 73.010000000000005 111.857 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 140' ' ' GLN . 8.9 t -61.36 -33.52 73.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.669 0.271 . . . . 75.019999999999996 111.728 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -56.88 -46.75 81.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.078 0.466 . . . . 63.329999999999998 110.972 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.61 -29.83 62.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.125 -0.488 . . . . 72.439999999999998 111.351 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -86.84 -34.22 19.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.237 -0.438 . . . . 63.409999999999997 112.172 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.4 tp . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 112.544 0.572 . . . . 72.329999999999998 112.544 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 65.6 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.497 0.189 . . . . 72.430000000000007 111.288 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 142' ' ' VAL . 48.9 mm 60.26 89.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.113 0.482 . . . . 74.349999999999994 111.862 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.63 90.11 1.61 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.963 -0.637 . . . . 72.329999999999998 112.278 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.0 p -82.06 120.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.481 0.658 . . . . 65.319999999999993 112.154 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -95.13 126.99 40.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.625 -0.716 . . . . 74.109999999999999 111.197 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 5.3 p90 -159.37 -178.91 7.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.831 0.348 . . . . 73.510000000000005 110.968 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.48 106.18 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.266 0.555 . . . . 62.420000000000002 111.761 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.9 m -70.34 -24.27 62.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.052 0.389 . . . . 71.109999999999999 112.052 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.99 -47.38 77.81 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.145 0.498 . . . . 73.129999999999995 111.43 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -102.71 22.3 13.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.586 0.708 . . . . 64.409999999999997 109.274 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -30.33 91.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 117.392 1.717 . . . . 62.310000000000002 117.392 -170.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -104.69 -34.13 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.79 . . . . 65.109999999999999 109.675 156.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 16.3 m -79.75 -12.98 59.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.033 -0.985 . . . . 75.430000000000007 112.901 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.36 -39.09 92.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.038 0.447 . . . . 53.409999999999997 111.069 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -70.85 -38.34 73.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.215 0.531 . . . . 74.140000000000001 110.806 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -61.63 -44.53 96.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.961 -0.563 . . . . 71.230000000000004 110.959 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.46 87.42 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.054 -0.521 . . . . 71.310000000000002 111.346 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.07 -42.78 86.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.376 -0.374 . . . . 53.009999999999998 111.232 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.42 89.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.459 . . . . 73.299999999999997 111.115 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.96 -51.24 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.073 -0.512 . . . . 73.040000000000006 110.989 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.48 ' HA ' HG21 ' A' ' 31' ' ' VAL . 76.3 mt -55.21 -43.06 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.264 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.41 -33.1 73.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.104 0.478 . . . . 73.540000000000006 111.603 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.02 23.4 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.34 -0.457 . . . . 75.519999999999996 113.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.33 -50.54 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.42 0.526 . . . . 60.409999999999997 112.42 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 81.5 p -63.5 -37.39 87.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.319 0.488 . . . . 71.230000000000004 112.319 -175.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.05 -24.0 67.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.048 0.452 . . . . 71.120000000000005 111.213 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 m -81.31 -7.69 59.61 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.169 0.509 . . . . 64.329999999999998 111.185 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.93 13.79 35.97 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.124 -0.56 . . . . 63.049999999999997 113.846 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' THR . 58.4 t -116.95 128.36 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.449 -0.442 . . . . 64.319999999999993 111.175 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.41 30.48 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.039 -0.601 . . . . 72.030000000000001 113.225 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 1' ' ' SER . 49.0 t -109.56 141.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.794 -0.239 . . . . 54.539999999999999 111.516 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.52 117.98 34.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.087 0.47 . . . . 64.120000000000005 111.305 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 34.3 m -95.18 135.24 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.95 0.405 . . . . 65.549999999999997 111.724 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.38 104.84 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.012 0.434 . . . . 54.439999999999998 111.592 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 2.7 m-20 -78.8 92.53 4.85 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.954 0.407 . . . . 51.210000000000001 111.392 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -68.21 -13.02 61.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.892 0.377 . . . . 73.109999999999999 111.862 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -84.51 -8.09 83.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.132 -0.556 . . . . 73.129999999999995 113.016 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.42 172.69 6.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.091 0.472 . . . . 50.229999999999997 111.8 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.32 82.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.076 0.465 . . . . 70.299999999999997 111.399 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.26 162.7 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 72.25 112.145 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.69 167.12 22.03 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.317 -0.401 . . . . 71.299999999999997 110.779 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.502 HD13 HD12 ' A' ' 45' ' ' LEU . 3.9 mm? -59.55 -25.54 64.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.321 -0.237 . . . . 72.209999999999994 111.441 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -55.96 -34.37 65.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.02 0.438 . . . . 62.030000000000001 110.98 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -84.38 -50.08 8.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.389 0.614 . . . . 42.25 110.63 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.502 HD12 HD13 ' A' ' 42' ' ' LEU . 89.8 mt -56.62 -31.6 64.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.835 -0.62 . . . . 74.120000000000005 112.391 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -63.32 -46.41 86.79 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.961 0.41 . . . . 75.209999999999994 110.866 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 60.3 tt0 -63.11 -34.79 78.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.002 0.429 . . . . 74.239999999999995 110.497 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 54.4 tp -52.19 -45.34 65.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.08 -0.509 . . . . 53.299999999999997 111.177 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.29 -38.3 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.108 0.48 . . . . 72.040000000000006 111.077 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.84 -29.97 66.54 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.126 -0.559 . . . . 24.120000000000001 112.961 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 3.5 mpt_? -89.13 5.25 45.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.981 0.363 . . . . 51.340000000000003 111.981 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -51.36 -27.85 10.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.888 0.699 . . . . 61.140000000000001 112.888 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.3 p -53.77 -38.6 64.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.122 0.415 . . . . 52.109999999999999 112.122 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.24 134.84 4.71 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.895 -0.669 . . . . 54.43 113.039 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HB2' HG12 ' A' ' 85' ' ' VAL . 80.7 mt -137.93 174.75 10.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.878 0.471 . . . . 74.140000000000001 110.712 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 48.5 t -139.76 111.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 110.325 -0.25 . . . . 74.109999999999999 110.325 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.642 HD13 ' HB ' ' A' ' 85' ' ' VAL . 1.7 mp -91.93 128.41 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.643 0.609 . . . . 72.329999999999998 112.643 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.35 139.86 11.3 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 115.636 -0.711 . . . . 63.509999999999998 112.142 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.453 ' SD ' HD12 ' A' ' 98' ' ' ILE . 72.7 mtm -82.8 161.5 21.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.037 0.446 . . . . 72.109999999999999 111.777 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -143.6 164.27 31.53 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.1 0.407 . . . . 55.539999999999999 112.1 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 53.0 Cg_exo -55.51 168.23 1.64 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.063 2.509 . . . . 61.32 113.804 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -50.76 47.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.24 0.83 . . . . 61.310000000000002 113.24 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.18 66.51 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.942 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.4 m -58.39 -49.35 77.55 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.058 0.456 . . . . 74.430000000000007 111.236 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.504 ' HA ' HD12 ' A' ' 68' ' ' ILE . . . -57.97 -35.39 71.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.245 -0.434 . . . . 71.439999999999998 112.0 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.16 96.54 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.019 0.437 . . . . 63.340000000000003 111.14 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -66.08 -42.15 89.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.384 -0.371 . . . . 62.130000000000003 111.096 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 36' ' ' LEU . 67.3 mt -54.8 -54.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.073 0.463 . . . . 71.409999999999997 111.113 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.9 -30.9 69.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.013 -0.539 . . . . 74.010000000000005 111.53 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.12 -41.59 98.38 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.239 -0.505 . . . . 62.32 113.379 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.53 43.37 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.238 0.458 . . . . 51.100000000000001 112.238 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.25 -35.89 65.46 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.597 0.591 . . . . 74.109999999999999 112.597 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -56.97 -20.07 21.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.713 0.634 . . . . 71.340000000000003 112.713 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -100.42 -10.83 20.75 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.102 0.477 . . . . 70.219999999999999 111.714 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.3 mt -92.58 -46.82 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.198 0.444 . . . . 55.5 112.198 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -50.85 -54.99 19.2 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.969 0.729 . . . . 75.239999999999995 112.969 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.06 5.49 1.95 Allowed Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.033 0.773 . . . . 60.219999999999999 115.033 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.9 m -92.47 -12.65 31.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.87 0.835 . . . . 52.43 112.247 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 110' ' ' LEU . 11.3 m -136.46 129.36 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.927 0.714 . . . . 63.420000000000002 112.927 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.575 ' H ' ' NE2' ' A' ' 83' ' ' GLN . 30.8 p-10 -162.02 -174.22 4.03 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.04 -0.527 . . . . 73.439999999999998 111.074 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 60.69 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.907 1.076 . . . . 54.210000000000001 113.907 170.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -141.02 -5.01 1.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.189 0.811 . . . . 45.450000000000003 113.189 -172.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.575 ' NE2' ' H ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -53.88 127.22 25.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.999 0.428 . . . . 63.450000000000003 111.273 -178.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.43 140.76 29.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.671 0.619 . . . . 63.32 112.671 -171.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.642 ' HB ' HD13 ' A' ' 57' ' ' ILE . 17.8 m -131.97 109.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.551 0.691 . . . . 74.510000000000005 111.71 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -69.81 146.98 44.24 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.97 -0.559 . . . . 65.129999999999995 112.566 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 115' ' ' PRO . 49.9 mm -125.54 121.89 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 122.67 -0.312 . . . . 64.150000000000006 111.1 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.593 ' HB2' ' SG ' ' A' ' 131' ' ' CYS . 34.7 p90 -120.04 126.48 50.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.419 . . . . 75.030000000000001 110.411 175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.44 133.28 50.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.103 0.478 . . . . 74.549999999999997 111.96 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -156.28 -22.6 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.097 -0.501 . . . . 63.450000000000003 111.419 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.41 -60.03 3.64 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.005 -0.617 . . . . 53.229999999999997 113.138 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.11 -76.64 1.32 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.208 -0.52 . . . . 62.329999999999998 113.55 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 173.65 -65.61 0.11 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.642 -0.789 . . . . 62.039999999999999 113.439 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.41 111.79 22.75 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.279 0.562 . . . . 62.450000000000003 110.446 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.09 15.07 14.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.695 0.628 . . . . 75.519999999999996 112.695 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.403 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 45.4 tt0 -91.04 -50.5 0.33 Allowed Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.35 0.87 . . . . 64.030000000000001 113.35 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 71.7 Cg_endo -70.97 -2.39 10.96 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.163 1.909 . . . . 62.310000000000002 113.61 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.453 HD12 ' SD ' ' A' ' 59' ' ' MET . 10.9 tt -72.04 -26.07 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.831 0.348 . . . . 71.239999999999995 111.785 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.94 -53.83 56.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 112.852 0.686 . . . . 61.43 112.852 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 -29.4 35.89 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.674 1.583 . . . . 72.349999999999994 112.461 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.89 -48.63 79.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.181 -0.463 . . . . 72.150000000000006 111.279 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.04 -23.33 65.36 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.423 0.527 . . . . 74.25 112.423 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.9 t -100.68 -71.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.096 0.776 . . . . 74.150000000000006 113.096 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.54 -41.49 69.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.557 0.947 . . . . 52.439999999999998 113.557 -166.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.415 ' HD2' HD22 ' A' ' 110' ' ' LEU . 66.8 m-85 -59.39 -26.51 65.19 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.058 0.392 . . . . 72.329999999999998 112.058 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 106' ' ' ARG . 50.0 mtm105 -70.7 -34.18 71.69 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.11 0.481 . . . . 75.439999999999998 110.749 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.7 -33.96 73.25 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.11 -0.495 . . . . 72.349999999999994 111.367 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.97 -34.68 78.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.868 0.366 . . . . 62.109999999999999 111.365 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.48 5.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.072 -0.585 . . . . 64.319999999999993 113.983 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 85' ' ' VAL . 8.7 mp -74.65 122.81 23.77 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.217 -0.578 . . . . 64.349999999999994 111.158 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 34.9 m -74.46 94.13 2.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.897 0.379 . . . . 55.530000000000001 110.717 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.3 p -76.86 149.1 36.16 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.283 0.564 . . . . 32.130000000000003 112.367 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.458 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -76.73 -66.98 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.131 -0.486 . . . . 61.530000000000001 111.208 174.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -170.18 88.92 0.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 120.875 0.369 . . . . 71.420000000000002 111.106 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HA ' HG21 ' A' ' 87' ' ' ILE . 85.7 Cg_endo -90.46 100.57 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.851 2.367 . . . . 72.129999999999995 113.284 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 110.7 5.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.57 -0.286 . . . . 71.329999999999998 111.225 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.67 94.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.61 0.719 . . . . 74.450000000000003 112.75 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -107.12 -14.49 14.91 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.987 -0.551 . . . . 72.540000000000006 111.987 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 122' ' ' THR . 9.3 tp -84.37 156.16 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.49 0.662 . . . . 72.129999999999995 112.536 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -92.91 -39.34 11.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.738 -0.665 . . . . 50.009999999999998 110.158 171.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 177.01 -59.0 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.644 0.777 . . . . 63.399999999999999 110.245 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.476 ' O ' HD11 ' A' ' 119' ' ' ILE . 82.3 p -80.5 118.72 73.74 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 116.447 -0.342 . . . . 74.439999999999998 111.385 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.56 146.62 68.27 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.476 2.117 . . . . 65.129999999999995 113.295 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.3 p -99.16 179.31 4.64 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.891 0.377 . . . . 73.329999999999998 111.592 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.18 -32.73 72.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.047 0.451 . . . . 65.329999999999998 111.14 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -57.42 -35.59 70.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 110.956 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.6 m -62.55 -39.03 92.31 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.496 -0.32 . . . . 71.239999999999995 111.491 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -60.17 -47.47 85.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.04 0.448 . . . . 65.230000000000004 111.04 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -65.96 -38.39 88.43 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.115 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.58 -52.63 64.83 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 72.200000000000003 110.53 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 88' ' ' PHE . 83.0 m -60.62 -41.08 94.11 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.886 0.374 . . . . 64.109999999999999 111.511 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -55.74 -45.02 78.08 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.204 0.526 . . . . 54.219999999999999 111.295 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.25 -41.66 40.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.004 -0.544 . . . . 74.219999999999999 111.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.8 80.25 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.051 0.389 . . . . 73.299999999999997 112.051 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.19 -47.29 91.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.021 -0.609 . . . . 53.310000000000002 112.918 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 94.1 m -60.46 -45.8 92.37 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.849 0.357 . . . . 75.409999999999997 111.403 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.62 -45.07 90.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.284 -0.416 . . . . 74.129999999999995 111.411 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.53 -42.93 91.44 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.815 0.34 . . . . 72.310000000000002 111.29 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.21 -36.27 61.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.261 -0.495 . . . . 72.430000000000007 112.869 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 136' ' ' THR . 77.5 mt-30 -57.86 -45.48 86.24 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 65.099999999999994 111.165 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -62.7 -49.28 75.73 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.409 -0.36 . . . . 74.299999999999997 111.192 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.423 HG21 HD11 ' A' ' 2' ' ' ILE . 63.7 t -53.73 -56.64 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.325 0.491 . . . . 62.310000000000002 112.325 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -65.13 -40.22 94.15 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.218 0.451 . . . . 71.099999999999994 112.218 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -75.01 -35.43 61.99 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.942 0.349 . . . . 72.319999999999993 111.942 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.08 -44.26 54.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 75.239999999999995 110.672 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -58.14 -42.36 85.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.085 -0.507 . . . . 64.120000000000005 111.206 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 CA--C 1.543 0.689 0 CA-C-N 116.091 -0.504 . . . . 72.099999999999994 110.228 176.85 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.548 0.203 . . . . 63.32 111.548 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 44.3 mm 55.82 93.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 112.688 0.625 . . . . 72.319999999999993 112.688 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.09 109.89 3.81 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.563 -0.827 . . . . 70.200000000000003 113.318 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.1 p -88.66 111.46 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.527 0.679 . . . . 51.020000000000003 111.747 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -89.31 96.66 10.81 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.757 -0.656 . . . . 74.019999999999996 111.117 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 25.6 p90 -122.04 -177.89 3.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.994 -0.548 . . . . 73.329999999999998 110.358 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.17 93.93 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.413 0.625 . . . . 71.230000000000004 111.893 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.427 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 18.2 m -57.13 -27.09 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.379 0.609 . . . . 60.020000000000003 110.955 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.28 -23.06 64.71 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.324 -0.853 . . . . 75.140000000000001 112.598 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -142.73 144.8 32.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.488 0.661 . . . . 74.019999999999996 112.662 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.39 -162.8 6.2 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.385 -0.825 . . . . 72.239999999999995 114.894 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 38.2 m-85 -94.24 6.59 48.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.105 0.409 . . . . 75.25 112.105 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 16' ' ' LEU . 60.4 p -51.13 -34.07 29.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.244 0.461 . . . . 72.439999999999998 112.244 -173.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 13.5 t70 -58.31 -56.28 24.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.016 0.436 . . . . 65.209999999999994 111.193 174.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 18.7 mmt180 -65.69 -27.84 68.64 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.528 -0.305 . . . . 74.409999999999997 111.516 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 13' ' ' SER . 90.3 mt -67.41 -43.41 81.32 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 52.020000000000003 110.382 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.02 85.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.112 -0.495 . . . . 73.200000000000003 110.805 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -57.63 -45.99 84.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.963 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.49 -43.65 89.09 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 62.530000000000001 111.27 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.551 HD13 HG11 ' A' ' 56' ' ' VAL . 67.1 mt -59.0 -57.71 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.93 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.55 -35.29 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 111.609 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -60.08 -53.47 57.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.713 0.292 . . . . 75.129999999999995 111.129 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.38 97.85 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.558 . . . . 74.040000000000006 112.933 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.685 HG23 ' HB ' ' A' ' 29' ' ' VAL . 36.7 mm -61.47 -47.23 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.916 0.388 . . . . 75.519999999999996 111.889 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 p -70.29 -31.73 69.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.741 0.305 . . . . 72.239999999999995 111.426 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.675 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -64.43 -42.17 96.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.854 0.359 . . . . 75.409999999999997 110.8 174.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -69.6 -51.73 32.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.335 -0.393 . . . . 72.239999999999995 111.134 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.82 53.95 0.13 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.443 -0.344 . . . . 70.129999999999995 113.162 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.685 ' HB ' HG23 ' A' ' 24' ' ' ILE . 46.2 t -139.7 157.82 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.419 0.288 . . . . 53.409999999999997 110.643 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.26 150.19 17.26 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 121.275 -0.488 . . . . 71.329999999999998 113.338 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 24' ' ' ILE . 97.1 t -131.07 145.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.625 0.602 . . . . 75.510000000000005 112.625 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 4' ' ' VAL . 29.0 m-20 -93.29 142.83 26.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.982 -0.554 . . . . 74.129999999999995 111.126 171.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -110.02 131.08 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.815 0.34 . . . . 70.200000000000003 111.873 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.17 131.44 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 120.702 0.287 . . . . 70.540000000000006 111.465 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.6 m-20 -95.67 105.42 17.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.679 0.276 . . . . 74.540000000000006 111.17 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.47 -14.29 62.8 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.928 0.394 . . . . 75.200000000000003 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.18 30.86 7.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.372 -0.442 . . . . 73.200000000000003 112.93 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.07 174.83 10.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.881 0.372 . . . . 74.040000000000006 111.508 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.04 93.85 0.3 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.518 0.562 . . . . 62.219999999999999 112.518 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.61 174.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.42 -0.355 . . . . 74.340000000000003 111.336 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -145.46 172.2 13.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.001 0.429 . . . . 53.439999999999998 111.386 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.2 tm? -54.48 -29.56 50.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.769 0.427 . . . . 71.420000000000002 110.735 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -52.82 -48.02 67.27 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 111.986 0.365 . . . . 74.299999999999997 111.986 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.93 -38.05 78.08 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.868 0.366 . . . . 62.100000000000001 111.146 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.9 -43.67 82.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.835 0.35 . . . . 43.32 110.79 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.59 -50.43 73.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.712 0.291 . . . . 73.230000000000004 111.33 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.92 -30.39 71.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.052 0.453 . . . . 70.120000000000005 110.901 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 53.2 tp -58.92 -29.84 67.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.558 -0.292 . . . . 63.329999999999998 111.587 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.74 -33.42 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.194 0.521 . . . . 74.420000000000002 110.519 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.05 -31.65 11.77 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.003 -0.544 . . . . 74.310000000000002 112.469 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.657 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 99.7 mtt180 -73.47 -10.78 60.08 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.516 -0.403 . . . . 73.5 111.974 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -60.99 -10.79 6.37 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.768 0.285 . . . . 74.209999999999994 111.768 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.535 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 67.9 p -71.5 -28.61 64.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.429 . . . . 73.219999999999999 111.586 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -173.11 137.35 4.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.221 -0.445 . . . . 74.200000000000003 112.642 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.576 ' HG ' HD11 ' A' ' 57' ' ' ILE . 1.6 pt? -157.62 148.61 21.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.154 0.502 . . . . 63.140000000000001 111.806 -177.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.551 HG11 HD13 ' A' ' 20' ' ' ILE . 59.8 t -116.6 113.27 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 122.838 0.455 . . . . 73.239999999999995 111.03 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.576 HD11 ' HG ' ' A' ' 55' ' ' LEU . 3.3 mp -116.42 146.33 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 122.07 -0.394 . . . . 75.150000000000006 111.887 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -134.93 3.56 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.178 -0.534 . . . . 73.430000000000007 112.921 173.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mmt -122.5 156.23 34.54 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.44 -0.447 . . . . 51.109999999999999 111.11 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.8 p -97.9 113.54 63.86 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.327 -0.397 . . . . 64.409999999999997 111.924 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.45 146.05 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.864 2.376 . . . . 73.329999999999998 112.773 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.54 -24.96 2.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.988 0.736 . . . . 54.039999999999999 112.988 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.8 74.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.13 0.418 . . . . 53.439999999999998 112.13 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.0 p -100.0 4.43 44.81 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.788 0.292 . . . . 62.130000000000003 111.788 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.84 -31.01 10.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.497 0.555 . . . . 62.020000000000003 112.497 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.9 72.21 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.089 0.471 . . . . 33.539999999999999 111.695 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.1 t -65.17 -45.43 84.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.078 0.466 . . . . 73.150000000000006 110.874 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 50.4 mm -54.6 -52.95 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.912 -0.585 . . . . 70.230000000000004 111.657 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.14 -38.85 89.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.919 0.34 . . . . 74.409999999999997 111.919 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.82 -40.38 98.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.177 -0.535 . . . . 71.310000000000002 113.207 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -85.32 -44.4 12.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.314 0.487 . . . . 75.230000000000004 112.314 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 72' ' ' LEU . 1.4 tm? -53.45 -42.99 67.71 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.592 0.357 . . . . 75.319999999999993 111.57 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -51.16 -34.28 30.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.814 0.34 . . . . 63.140000000000001 111.864 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.3 m -89.93 -39.74 12.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.214 0.53 . . . . 63.43 111.21 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.575 HG23 HD21 ' A' ' 48' ' ' LEU . 72.1 mt -54.58 -41.41 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 111.733 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.94 -33.21 62.02 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.296 -0.411 . . . . 52.219999999999999 111.834 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.19 -31.73 33.72 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.137 -0.554 . . . . 71.049999999999997 112.902 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.8 m -72.7 -39.44 67.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.121 0.415 . . . . 61.310000000000002 112.121 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.0 m -87.91 147.34 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.02 0.438 . . . . 73.109999999999999 111.568 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.619 ' N ' HD22 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -160.94 -179.02 7.2 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.136 0.421 . . . . 55.140000000000001 112.136 -178.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.715 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 9.4 tp10 72.2 -106.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.886 0.874 . . . . 70.310000000000002 112.71 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.715 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 19.2 ptpt -164.98 24.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.417 0.895 . . . . 50.350000000000001 113.417 -172.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HG2' ' HA ' ' A' ' 53' ' ' THR . 1.3 mp0 -62.08 167.85 3.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.754 0.65 . . . . 70.329999999999998 112.754 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.94 123.92 34.81 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.77 -0.65 . . . . 75.519999999999996 112.349 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.74 108.53 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.493 0.663 . . . . 75.219999999999999 111.025 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 81.43 0.33 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.089 -0.505 . . . . 63.299999999999997 112.774 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 49.5 mm -79.53 109.08 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 122.568 -0.372 . . . . 75.329999999999998 111.391 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.409 ' HD2' ' HG1' ' A' ' 90' ' ' THR . 40.1 p90 -105.27 111.63 24.44 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.354 0.597 . . . . 74.010000000000005 110.555 173.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.819 ' HB2' HD11 ' A' ' 119' ' ' ILE . 7.7 pt-20 -57.9 104.05 0.17 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.488 0.661 . . . . 64.25 112.703 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.409 ' HG1' ' HD2' ' A' ' 88' ' ' PHE . 90.6 m -142.34 112.78 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.131 -0.486 . . . . 53.420000000000002 111.534 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.52 -139.77 15.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.192 -0.528 . . . . 64.400000000000006 113.481 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.04 -102.44 2.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.066 -0.587 . . . . 75.430000000000007 113.359 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.22 -96.18 0.54 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.22 -0.514 . . . . 70.200000000000003 112.46 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -106.89 123.65 48.47 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.559 -0.377 . . . . 65.430000000000007 110.282 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.63 159.1 44.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 64.409999999999997 111.211 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.583 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 37.9 mt-10 -103.91 -55.93 0.1 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.922 0.712 . . . . 74.310000000000002 112.922 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.583 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 39.3 Cg_endo -64.7 -14.59 45.55 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.287 1.991 . . . . 71.439999999999998 114.014 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 99' ' ' ASP . 9.9 tt -49.12 -51.86 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 113.26 0.837 . . . . 74.319999999999993 113.26 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.71 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 4.5 m-20 -61.53 -55.44 42.68 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.189 0.44 . . . . 75.219999999999999 112.189 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.7 Cg_exo -56.25 -33.35 90.69 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.009 1.806 . . . . 52.409999999999997 112.705 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.64 -57.06 7.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.06 -0.518 . . . . 74.310000000000002 111.479 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.33 -37.79 67.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.988 0.423 . . . . 63.210000000000001 110.862 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 100' ' ' PRO . 6.3 t -49.99 -43.33 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.616 . . . . 72.430000000000007 111.727 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.702 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -64.55 -44.21 91.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.646 -0.252 . . . . 74.230000000000004 111.16 -177.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -60.68 -36.89 79.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.87 0.366 . . . . 72.120000000000005 111.223 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -66.85 -60.77 2.37 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.159 -0.473 . . . . 74.319999999999993 111.698 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -60.61 -39.31 87.68 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.302 0.482 . . . . 63.439999999999998 112.302 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.58 -24.43 49.76 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.205 -0.309 . . . . 63.009999999999998 111.569 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.65 52.59 33.27 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.155 -0.545 . . . . 62.100000000000001 113.04 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.32 159.9 20.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.97 0.414 . . . . 73.129999999999995 111.535 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 88.2 m -79.63 110.02 14.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 40.5 110.77 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -108.52 141.57 40.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.44 0.533 . . . . 72.420000000000002 112.44 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.31 -86.13 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.418 -0.355 . . . . 74.510000000000005 111.131 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -148.63 96.42 3.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 121.104 0.478 . . . . 72.010000000000005 111.507 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.31 13.47 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.854 2.369 . . . . 73.519999999999996 113.193 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.2 78.01 2.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.285 0.564 . . . . 74.129999999999995 111.441 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.405 HG13 HD13 ' A' ' 119' ' ' ILE . 8.8 tt -62.5 112.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 113.175 0.806 . . . . 73.129999999999995 113.175 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -140.44 49.87 1.71 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.132 0.492 . . . . 74.239999999999995 111.259 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 89' ' ' GLU . 3.3 mp -89.66 116.31 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 110.957 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.96 -41.81 75.28 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.842 0.353 . . . . 72.030000000000001 111.933 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -178.38 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.432 0.634 . . . . 72.340000000000003 109.997 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -127.06 142.52 43.99 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.862 -0.608 . . . . 55.119999999999997 110.679 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 35.7 Cg_endo -63.98 148.36 91.63 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.631 2.221 . . . . 63.32 113.097 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.6 p -90.26 -178.68 5.45 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.158 0.504 . . . . 63.310000000000002 112.057 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.23 -42.48 69.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.023 -0.535 . . . . 72.230000000000004 111.718 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -59.99 -39.95 87.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 112.042 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.8 m -51.78 -30.75 24.21 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.983 0.364 . . . . 74.200000000000003 111.983 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.416 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 69.9 m-85 -58.24 -41.01 83.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.717 0.294 . . . . 71.230000000000004 111.733 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 53.3 mttm -82.94 -26.73 31.12 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.978 0.362 . . . . 71.510000000000005 111.978 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 -41.73 91.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.769 0.319 . . . . 75.209999999999994 110.862 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 30.3 p -81.63 -37.15 28.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.629 0.252 . . . . 73.530000000000001 111.105 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.67 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.7 tt0 -51.62 -71.32 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.01 0.524 . . . . 74.5 112.283 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -67.07 -38.61 86.08 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.465 0.542 . . . . 65.219999999999999 112.465 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.31 -54.44 37.03 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.806 0.336 . . . . 71.400000000000006 111.337 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.28 -43.67 97.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.935 -0.65 . . . . 42.030000000000001 112.641 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.494 HG22 HE21 ' A' ' 140' ' ' GLN . 86.7 m -64.66 -42.97 95.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.79 0.293 . . . . 75.310000000000002 111.79 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.83 -44.69 92.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.867 0.365 . . . . 55.399999999999999 110.781 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.13 -39.01 84.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.949 0.404 . . . . 72.099999999999994 110.83 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.67 -43.01 98.13 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.093 -0.575 . . . . 72.209999999999994 112.309 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.494 HE21 HG22 ' A' ' 136' ' ' THR . 78.5 mt-30 -62.89 -34.91 78.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.661 0.267 . . . . 72.019999999999996 111.059 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -63.09 -42.54 99.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.921 0.391 . . . . 72.209999999999994 110.653 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.04 -49.93 77.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.973 0.416 . . . . 62.140000000000001 111.2 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 4.9 t -77.86 -11.44 59.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.576 -0.284 . . . . 74.329999999999998 111.609 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -72.64 -61.54 1.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.076 0.465 . . . . 71.530000000000001 110.577 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.93 -40.02 96.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.824 -0.625 . . . . 63.25 111.704 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -75.66 -38.88 58.43 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.927 0.343 . . . . 73.420000000000002 111.927 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 143' ' ' THR . 3.1 mm? . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.648 0.261 . . . . 72.200000000000003 111.248 177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.311 0.101 . . . . 54.310000000000002 111.244 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.759 HG13 ' HA2' ' A' ' 139' ' ' GLY . 45.4 mm 67.14 122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 71.239999999999995 112.561 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.92 109.22 3.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.132 -0.556 . . . . 55.100000000000001 112.703 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.23 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.634 -0.333 . . . . 65.310000000000002 111.57 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 97.1 m-85 -86.87 120.64 28.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.898 0.38 . . . . 74.439999999999998 111.233 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 1.3 p90 -150.32 -179.9 7.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.393 -0.367 . . . . 64.340000000000003 110.924 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.7 t -133.49 110.62 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.68 -0.236 . . . . 64.25 110.522 173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 40.8 t -51.95 -33.48 37.73 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.404 0.52 . . . . 71.209999999999994 112.404 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -85.18 -12.6 52.31 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.711 0.634 . . . . 73.420000000000002 112.711 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -98.62 90.85 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.778 -0.576 . . . . 73.200000000000003 112.121 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.88 -162.03 4.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 115.067 0.787 . . . . 45.329999999999998 115.067 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' PRO . 39.4 m-85 -68.15 1.6 2.71 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.813 0.672 . . . . 64.230000000000004 112.813 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -54.63 -33.61 60.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.428 0.632 . . . . 74.25 110.581 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 23.6 t70 -59.66 -37.24 78.21 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.294 -0.866 . . . . 53.240000000000002 111.878 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -85.26 -26.73 26.46 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.182 -0.463 . . . . 73.5 111.904 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -55.62 -46.25 77.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 44.43 111.474 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.28 -54.29 47.16 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.243 0.46 . . . . 74.510000000000005 112.243 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.464 ' HA ' HG22 ' A' ' 21' ' ' ILE . 35.0 tt0 -67.25 -36.37 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.557 -0.292 . . . . 72.400000000000006 111.578 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.74 86.74 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.784 0.326 . . . . 74.310000000000002 111.689 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.76 -55.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.784 0.326 . . . . 64.0 111.533 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 18' ' ' GLN . 13.4 tt -60.55 -30.05 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.626 0.25 . . . . 74.109999999999999 111.315 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -53.42 -35.3 60.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.213 0.53 . . . . 63.5 111.32 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.35 -33.92 6.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.156 -0.545 . . . . 75.219999999999999 113.437 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.81 -24.46 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.129 0.789 . . . . 72.109999999999999 113.129 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -53.6 -33.37 54.67 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.404 0.52 . . . . 72.200000000000003 112.404 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.82 -18.45 60.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.282 0.475 . . . . 74.439999999999998 112.282 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.0 m -84.28 -15.93 44.94 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.205 0.526 . . . . 64.329999999999998 111.308 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.85 2.99 57.16 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.385 -0.435 . . . . 54.030000000000001 112.928 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -98.67 104.57 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.046 0.45 . . . . 63.530000000000001 111.299 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.23 128.54 9.55 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.133 -0.556 . . . . 74.430000000000007 112.427 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.2 m -90.54 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.1 0.476 . . . . 71.430000000000007 111.911 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.2 104.83 16.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.034 0.445 . . . . 74.5 111.069 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 6' ' ' TYR . 35.8 m -83.2 139.53 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.121 0.486 . . . . 74.409999999999997 112.285 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.4 t -139.09 118.4 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.382 -0.372 . . . . 72.140000000000001 111.401 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.9 m-20 -76.32 91.65 3.26 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.344 -0.222 . . . . 62.450000000000003 111.067 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 36' ' ' LEU . 2.5 pt? -59.79 -20.69 58.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.887 0.375 . . . . 55.32 111.963 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 12.58 66.94 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.29 -0.481 . . . . 72.040000000000006 113.39 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -161.51 -65.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.921 0.391 . . . . 75.150000000000006 111.916 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.65 77.82 4.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.132 0.491 . . . . 64.120000000000005 112.127 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.6 126.08 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.128 0.49 . . . . 62.210000000000001 111.807 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -163.78 170.9 16.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.134 -0.485 . . . . 55.32 110.172 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.7 tm? -54.73 -37.28 65.7 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.598 0.237 . . . . 73.299999999999997 111.151 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -58.55 -57.31 13.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 75.319999999999993 111.404 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -61.28 -35.52 77.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.293 -0.412 . . . . 73.329999999999998 111.288 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 2.8 tm? -61.09 -42.07 97.83 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.02 0.438 . . . . 73.129999999999995 110.268 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -67.87 -43.29 79.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.875 0.369 . . . . 75.319999999999993 111.046 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 27.9 mt-10 -62.63 -25.74 68.27 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.749 0.278 . . . . 72.319999999999993 111.749 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 64.3 tp -57.44 -36.85 71.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 70.299999999999997 110.576 173.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.63 -35.93 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.085 0.469 . . . . 43.109999999999999 111.031 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.48 77.39 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.115 -0.564 . . . . 64.530000000000001 112.642 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.571 ' NH1' ' HB3' ' A' ' 47' ' ' GLU . 7.5 mpt_? -100.39 6.83 44.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.431 0.293 . . . . 74.329999999999998 111.581 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -54.4 -19.94 6.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.135 0.791 . . . . 72.209999999999994 113.135 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 p -70.92 -17.99 62.67 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.933 0.345 . . . . 52.509999999999998 111.933 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -169.68 137.76 4.68 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.886 -0.673 . . . . 51.439999999999998 113.744 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.87 143.17 20.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.063 0.459 . . . . 74.200000000000003 111.047 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.51 122.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 73.040000000000006 111.299 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -105.27 130.29 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.23 -0.441 . . . . 73.030000000000001 111.519 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.597 ' HA2' ' HB2' ' A' ' 88' ' ' PHE . . . -80.15 56.72 4.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.019 -0.61 . . . . 71.0 112.709 175.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 90' ' ' THR . 24.8 mmt 65.41 173.04 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.444 0.64 . . . . 74.329999999999998 111.943 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.8 m -141.24 90.29 9.2 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 116.396 -0.365 . . . . 73.0 110.657 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.45 156.33 26.78 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.617 2.211 . . . . 41.399999999999999 113.258 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.98 -55.19 2.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.335 0.865 . . . . 64.510000000000005 113.335 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.97 67.75 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.305 0.483 . . . . 61.039999999999999 112.305 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -72.03 -40.74 68.22 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.774 0.321 . . . . 64.040000000000006 111.296 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.19 34.89 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.822 0.675 . . . . 74.540000000000006 112.822 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -59.58 4.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 65.140000000000001 112.29 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 t -65.11 -36.6 84.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.118 0.485 . . . . 45.43 111.482 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.495 HG22 ' HG ' ' A' ' 72' ' ' LEU . 56.2 mt -59.75 -33.31 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.924 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -53.24 -35.54 60.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.873 0.368 . . . . 62.140000000000001 111.894 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.95 -22.19 70.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.917 -0.658 . . . . 42.200000000000003 113.354 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.08 -31.45 11.06 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.57 0.581 . . . . 74.340000000000003 112.57 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HG ' HG22 ' A' ' 68' ' ' ILE . 49.6 mt -49.94 -44.81 50.69 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.167 0.803 . . . . 71.049999999999997 113.167 -174.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 m -52.28 -35.67 50.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.953 0.353 . . . . 71.340000000000003 111.953 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -85.18 -45.26 12.19 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 71.420000000000002 111.286 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.24 -50.2 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.266 -0.424 . . . . 55.009999999999998 111.776 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.57 -22.87 62.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.766 0.317 . . . . 73.319999999999993 111.747 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.36 -15.28 41.6 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.253 -0.499 . . . . 55.030000000000001 112.983 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.8 m -89.29 -27.21 20.7 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.483 -0.422 . . . . 74.200000000000003 111.804 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.0 m -70.76 131.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.345 0.593 . . . . 63.149999999999999 112.073 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -82.74 170.49 15.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 71.519999999999996 110.786 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 44.2 tt0 -48.6 -35.05 12.74 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.75 0.648 . . . . 65.430000000000007 112.75 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -154.21 141.32 19.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.444 0.64 . . . . 73.120000000000005 112.423 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 -179.08 7.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.416 -0.811 . . . . 72.319999999999993 109.852 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -88.5 91.51 8.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.259 0.552 . . . . 73.439999999999998 111.691 -177.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.8 m -103.32 138.0 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.997 0.427 . . . . 74.209999999999994 111.198 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.57 164.63 25.67 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.985 -0.626 . . . . 52.310000000000002 113.177 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -135.44 145.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.72 0.408 . . . . 75.430000000000007 110.51 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.597 ' HB2' ' HA2' ' A' ' 58' ' ' GLY . 36.8 m-85 -99.21 129.18 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.708 0.29 . . . . 74.239999999999995 110.978 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 117' ' ' ILE . 35.1 mp0 -70.2 80.29 0.52 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.239 0.542 . . . . 72.299999999999997 111.315 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 59' ' ' MET . 9.0 t -146.66 179.03 7.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.27 -0.423 . . . . 75.239999999999995 111.366 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 75.22 -72.12 1.69 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.336 -0.459 . . . . 72.230000000000004 113.736 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.32 -116.25 0.73 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.198 -0.525 . . . . 71.530000000000001 112.978 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.53 36.29 0.51 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.023 -0.608 . . . . 44.32 112.899 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.91 109.88 21.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.669 0.271 . . . . 73.420000000000002 111.391 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.06 157.27 25.86 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.406 -0.361 . . . . 74.310000000000002 111.622 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 2.8 mp0 -103.49 -55.78 0.1 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.227 0.825 . . . . 53.130000000000003 113.227 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 3.8 Cg_exo -77.26 16.92 0.94 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.703 2.269 . . . . 63.219999999999999 114.332 -176.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 99' ' ' ASP . 9.0 tt -44.36 -62.3 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 114.231 1.197 . . . . 75.409999999999997 114.231 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.515 ' H ' HG23 ' A' ' 98' ' ' ILE . 39.7 m-20 -62.72 -50.29 78.56 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.211 0.819 . . . . 72.109999999999999 113.211 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 63.8 Cg_exo -53.67 -43.22 59.7 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.373 2.049 . . . . 54.240000000000002 113.344 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.2 -44.72 68.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.572 0.225 . . . . 72.530000000000001 111.425 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.555 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 60.5 mt -56.05 -44.95 79.34 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.746 0.308 . . . . 54.5 110.985 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.2 t -56.91 -40.93 77.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.951 0.405 . . . . 74.519999999999996 110.951 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -39.69 78.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.403 -0.362 . . . . 74.230000000000004 111.185 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.646 ' HD1' HD12 ' A' ' 110' ' ' LEU . 29.4 m-85 -61.39 -32.46 72.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.568 0.223 . . . . 75.120000000000005 111.316 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 102' ' ' LEU . 2.1 mpt_? -73.92 -40.68 62.96 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.807 0.337 . . . . 55.399999999999999 111.111 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.63 -43.29 80.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.021 0.439 . . . . 63.439999999999998 111.426 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.496 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 81.2 mt -89.72 -41.76 11.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.031 0.443 . . . . 75.540000000000006 111.911 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 57.39 1.38 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.933 -0.467 . . . . 73.099999999999994 111.933 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.646 HD12 ' HD1' ' A' ' 105' ' ' PHE . 83.5 mt -96.32 163.01 13.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 74.420000000000002 112.34 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.438 HG21 HD11 ' A' ' 138' ' ' LEU . 87.4 m -66.15 136.4 55.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.588 -0.733 . . . . 60.43 112.104 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -131.9 96.54 3.95 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.378 -0.374 . . . . 55.329999999999998 111.073 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.33 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.393 0.516 . . . . 61.450000000000003 112.393 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -150.43 89.65 4.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 121.166 0.507 . . . . 74.400000000000006 110.791 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.95 30.62 0.51 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.037 2.492 . . . . 64.409999999999997 114.378 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.19 101.63 0.74 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.94 0.348 . . . . 62.210000000000001 111.94 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 89' ' ' GLU . 14.2 tt -153.0 143.53 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.004 0.431 . . . . 64.010000000000005 111.608 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -79.14 94.01 5.29 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.207 0.527 . . . . 74.540000000000006 111.74 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.436 HG12 HG23 ' A' ' 117' ' ' ILE . 49.4 mm -105.2 116.49 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.187 -0.461 . . . . 62.109999999999999 110.482 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 45.8 tptt -80.29 50.46 1.26 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.01 0.433 . . . . 61.439999999999998 111.498 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.5 tt0 71.57 -60.45 0.52 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.461 0.704 . . . . 72.019999999999996 112.558 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -86.75 120.85 72.0 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 111.816 0.302 . . . . 60.219999999999999 111.816 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' A' ' 12' ' ' TYR . 71.5 Cg_exo -51.81 137.85 51.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.81 2.34 . . . . 72.299999999999997 113.085 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.9 p -93.83 168.01 11.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.883 0.373 . . . . 72.349999999999994 111.518 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.44 -32.74 71.66 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.219 0.533 . . . . 70.010000000000005 110.807 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -73.24 -31.63 64.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.013 -0.54 . . . . 74.409999999999997 111.02 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.8 m -52.51 -38.38 59.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.27 -0.423 . . . . 60.5 111.809 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -52.47 -41.9 63.75 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.688 0.28 . . . . 64.230000000000004 111.626 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -65.57 -46.36 79.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.977 0.362 . . . . 62.25 111.977 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.93 -51.61 60.9 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.523 -0.308 . . . . 75.310000000000002 111.091 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.9 -29.94 71.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.804 0.298 . . . . 65.109999999999999 111.804 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.46 -58.16 7.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.942 0.401 . . . . 53.549999999999997 110.369 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.19 -12.35 61.6 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.201 0.445 . . . . 73.010000000000005 112.201 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.59 -62.84 1.53 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.897 0.38 . . . . 44.030000000000001 110.863 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.08 -42.35 99.72 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 63.149999999999999 113.51 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -35.85 61.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.287 0.477 . . . . 75.209999999999994 112.287 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 141' ' ' TRP . 29.4 t70 -60.17 -51.64 68.73 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.976 0.417 . . . . 61.119999999999997 110.925 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 138' ' ' LEU . 2.6 mm? -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.915 0.388 . . . . 74.450000000000003 110.919 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.759 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -63.89 -55.06 26.73 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.321 -0.466 . . . . 62.399999999999999 112.746 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -74.61 -14.88 60.83 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.598 -0.354 . . . . 55.43 111.715 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 62.2 t90 -50.28 -38.33 40.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.18 0.514 . . . . 73.109999999999999 110.546 176.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 146' ' ' ARG . 58.8 t -54.88 -61.05 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.437 -0.802 . . . . 51.240000000000002 111.623 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -70.62 -25.1 62.88 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.466 0.543 . . . . 71.030000000000001 112.466 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -67.93 -38.09 82.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.132 -0.355 . . . . 73.140000000000001 111.44 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.5 -50.33 7.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 120.965 0.412 . . . . 70.129999999999995 111.274 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 11.9 mtp180 -69.93 -19.0 63.4 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.893 0.701 . . . . 74.409999999999997 112.893 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 52.5 tp . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 123.396 0.678 . . . . 74.540000000000006 112.266 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 43.0 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 111.227 0.084 . . . . 74.129999999999995 111.227 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm 67.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 121.17 0.509 . . . . 61.43 111.766 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.95 109.58 3.21 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.2 -0.524 . . . . 73.040000000000006 112.972 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 111.58 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.795 0.331 . . . . 54.25 110.971 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.453 ' HE2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 m-85 -97.29 139.46 33.22 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.408 0.521 . . . . 71.030000000000001 112.408 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 35' ' ' ASP . 44.1 p90 -142.29 162.91 34.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.751 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 9' ' ' GLU . 20.7 t -106.29 115.73 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 122.213 -0.305 . . . . 61.039999999999999 111.591 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 35' ' ' ASP . 15.1 m -60.12 -20.28 57.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.96 0.41 . . . . 74.010000000000005 111.786 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.54 ' H ' HG12 ' A' ' 7' ' ' VAL . 43.2 tt0 -70.13 -69.51 0.35 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.127 -0.488 . . . . 71.329999999999998 111.696 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -137.38 -35.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.943 0.349 . . . . 72.209999999999994 111.943 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -28.55 103.37 0.01 OUTLIER Glycine 0 N--CA 1.472 1.091 0 N-CA-C 115.328 0.891 . . . . 53.210000000000001 115.328 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.62 5.47 3.06 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.83 0.452 . . . . 75.209999999999994 112.208 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 m -57.7 -19.73 29.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.653 0.612 . . . . 42.439999999999998 112.653 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -61.73 -34.85 76.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.247 0.546 . . . . 45.340000000000003 111.067 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -69.47 -37.73 77.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.727 -0.669 . . . . 75.510000000000005 111.079 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.641 HD13 ' SG ' ' A' ' 131' ' ' CYS . 64.5 mt -70.3 -39.98 74.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.811 -0.632 . . . . 75.400000000000006 110.706 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.05 74.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.828 -0.624 . . . . 73.430000000000007 111.706 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -61.73 -41.02 97.09 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.122 0.487 . . . . 73.109999999999999 111.032 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.04 87.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.367 -0.379 . . . . 53.130000000000003 111.399 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.85 -56.81 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.043 -0.526 . . . . 74.129999999999995 111.621 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 25' ' ' THR . 12.8 tt -54.77 -41.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.443 0.164 . . . . 52.520000000000003 111.443 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -51.31 -50.49 59.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.721 0.408 . . . . 55.409999999999997 111.832 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.26 -39.07 32.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.066 -0.588 . . . . 72.140000000000001 113.508 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 30' ' ' GLY . 49.6 mm -67.44 -41.61 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 122.268 -0.548 . . . . 70.25 112.119 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 21' ' ' ILE . 13.3 t -72.1 -31.18 65.81 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.996 -0.44 . . . . 74.200000000000003 110.532 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -59.04 -42.84 91.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.043 0.449 . . . . 75.239999999999995 109.795 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.1 m -67.09 -27.47 67.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.856 -0.611 . . . . 75.430000000000007 111.218 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.17 22.52 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.23 -0.509 . . . . 71.430000000000007 113.509 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -95.67 -52.96 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.459 -0.436 . . . . 71.239999999999995 112.028 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.54 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 87.64 134.78 4.49 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 121.124 -0.56 . . . . 62.219999999999999 113.55 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.0 m -108.69 171.74 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.198 0.523 . . . . 53.130000000000003 112.318 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -127.89 107.28 9.73 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.955 -0.566 . . . . 74.120000000000005 110.078 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -92.3 125.92 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.415 0.626 . . . . 75.25 112.334 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.1 t -122.68 126.19 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 111.374 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 5.4 p-10 -94.66 88.06 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.644 0.735 . . . . 65.010000000000005 111.771 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 36' ' ' LEU . 1.2 pp -69.73 -3.6 16.07 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.729 -0.669 . . . . 75.420000000000002 112.288 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.48 1.37 85.87 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.021 -0.609 . . . . 63.530000000000001 112.504 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.05 177.47 4.85 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.964 0.411 . . . . 71.349999999999994 111.132 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.64 84.33 0.29 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.035 0.445 . . . . 65.310000000000002 111.993 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.33 163.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.107 -0.497 . . . . 62.240000000000002 111.472 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.51 172.7 17.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.862 0.363 . . . . 73.049999999999997 111.89 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.4 mm? -56.11 -31.28 63.14 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.779 0.659 . . . . 75.439999999999998 112.779 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -61.33 -34.23 74.92 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.263 0.554 . . . . 65.329999999999998 111.171 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.27 -48.93 12.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.775 -0.648 . . . . 71.129999999999995 110.69 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.44 HD23 HG12 ' A' ' 75' ' ' ILE . 3.3 tm? -53.53 -40.17 65.25 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.057 -0.52 . . . . 73.129999999999995 111.667 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -59.59 -53.02 62.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.098 0.475 . . . . 54.450000000000003 111.366 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.47 -39.04 93.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.133 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.428 HD11 ' HZ ' ' A' ' 5' ' ' PHE . 59.0 tp -55.53 -52.81 62.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.976 -0.556 . . . . 52.240000000000002 111.434 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 45' ' ' LEU . 87.7 t -60.21 -44.23 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.308 -0.406 . . . . 61.210000000000001 111.608 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.73 89.21 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.059 -0.591 . . . . 53.140000000000001 113.457 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.23 8.22 43.94 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.785 0.661 . . . . 72.299999999999997 112.785 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.4 p -55.28 -3.1 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.93 1.085 . . . . 73.230000000000004 113.93 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -44.74 -41.37 6.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.61 0.596 . . . . 73.209999999999994 112.61 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 84' ' ' ALA . . . -149.84 136.86 5.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.354 -0.451 . . . . 72.319999999999993 112.291 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.453 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 83.9 mt -139.27 141.35 37.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.908 0.354 . . . . 73.040000000000006 111.671 -175.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.48 118.12 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.147 0.499 . . . . 71.310000000000002 111.191 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.2 mp -106.81 131.81 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.922 0.391 . . . . 74.430000000000007 111.709 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.77 58.16 0.46 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.35 -0.453 . . . . 72.120000000000005 113.424 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 89' ' ' GLU . 84.2 mtp 67.0 -178.49 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.96 0.726 . . . . 70.019999999999996 112.96 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -141.79 88.84 9.3 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.514 -0.767 . . . . 71.450000000000003 110.649 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.07 143.0 85.23 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 122.931 2.421 . . . . 63.32 113.253 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.8 -64.51 0.39 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.83 1.048 . . . . 75.319999999999993 113.83 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.31 -53.75 53.57 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.209 0.448 . . . . 74.129999999999995 112.209 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 68' ' ' ILE . 39.0 t -64.79 -25.81 68.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.455 0.539 . . . . 71.340000000000003 112.455 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.81 69.47 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.017 0.377 . . . . 74.299999999999997 112.017 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.24 -53.47 50.31 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.909 0.385 . . . . 73.420000000000002 111.735 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 m -71.19 -32.66 69.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.906 0.335 . . . . 72.209999999999994 111.906 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 64' ' ' SER . 76.6 mt -64.9 -47.35 88.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.852 0.316 . . . . 73.209999999999994 111.852 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.92 -42.34 89.44 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.712 0.292 . . . . 61.409999999999997 111.72 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.14 70.51 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.226 -0.511 . . . . 65.120000000000005 113.038 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.42 -43.12 16.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.794 0.331 . . . . 74.310000000000002 111.514 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.6 tp -52.93 -41.08 64.12 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.801 0.44 . . . . 73.219999999999999 111.833 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 t -51.57 -37.47 49.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.123 0.487 . . . . 72.239999999999995 111.582 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.0 m -84.51 -40.79 17.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 111.356 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.44 HG12 HD23 ' A' ' 45' ' ' LEU . 72.4 mt -54.8 -46.76 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.01 -0.541 . . . . 61.5 111.889 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.99 -47.08 65.06 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.883 0.373 . . . . 74.209999999999994 111.937 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.07 -26.86 67.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.059 -0.591 . . . . 72.519999999999996 113.373 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -78.05 -40.66 38.01 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.493 0.553 . . . . 71.200000000000003 112.493 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.01 168.97 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.266 0.555 . . . . 74.319999999999993 112.261 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.54 158.4 25.81 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 110.557 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.17 -82.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.317 0.858 . . . . 71.040000000000006 113.317 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -94.5 101.0 12.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.705 0.632 . . . . 70.219999999999999 112.705 -173.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.01 -164.99 1.21 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.051 -0.522 . . . . 74.329999999999998 111.151 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -110.33 134.85 51.88 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.861 0.362 . . . . 61.340000000000003 110.771 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 112' ' ' THR . 29.6 m -132.55 170.96 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.422 0.629 . . . . 72.409999999999997 112.508 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 110.96 0.63 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.819 -0.628 . . . . 63.140000000000001 111.982 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -101.04 114.36 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.217 -0.578 . . . . 55.439999999999998 111.202 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 29.0 p90 -123.0 110.78 15.8 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 74.230000000000004 111.503 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 41.8 mt-10 -78.77 81.77 5.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.234 0.54 . . . . 64.010000000000005 111.366 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -79.76 -9.57 59.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.067 -0.515 . . . . 72.299999999999997 112.164 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.26 -70.67 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.24 -0.505 . . . . 70.430000000000007 113.073 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.58 21.75 77.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.169 -0.539 . . . . 74.409999999999997 113.15 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.86 -85.28 0.26 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.278 -0.487 . . . . 72.430000000000007 113.944 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -163.52 129.93 3.26 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.42 -0.459 . . . . 75.140000000000001 111.369 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -163.38 152.75 14.82 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.097 0.475 . . . . 73.230000000000004 111.89 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.464 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.6 mp0 -95.23 -43.96 0.27 Allowed Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.858 1.058 . . . . 74.329999999999998 113.858 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 74.2 Cg_endo -71.13 23.28 0.22 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.27 1.98 . . . . 53.329999999999998 114.928 -170.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 99' ' ' ASP . 10.8 tt -57.71 -53.43 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 112.648 0.61 . . . . 75.319999999999993 112.648 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.679 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.3 m-20 -61.89 -55.88 37.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.472 0.545 . . . . 64.200000000000003 112.472 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.8 Cg_exo -54.12 -44.98 44.48 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.333 2.022 . . . . 73.409999999999997 112.81 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -60.48 -54.48 45.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.305 -0.407 . . . . 53.140000000000001 111.269 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.31 -38.69 80.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.518 -0.31 . . . . 70.450000000000003 111.725 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 t -62.46 -37.66 86.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.808 0.337 . . . . 45.520000000000003 111.339 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HE3' HD11 ' A' ' 108' ' ' LEU . 59.6 tptt -58.41 -47.73 82.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.024 0.44 . . . . 75.519999999999996 111.051 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.67 -46.42 75.73 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.327 -0.397 . . . . 74.340000000000003 111.773 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -62.53 -52.68 62.48 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.42 0.526 . . . . 74.019999999999996 112.42 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.27 -35.53 80.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.698 0.629 . . . . 74.349999999999994 112.698 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 ' HE3' ' A' ' 104' ' ' LYS . 80.7 mt -78.23 -15.58 58.66 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.107 -0.371 . . . . 75.140000000000001 111.605 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.04 40.19 51.91 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.06 -0.59 . . . . 20.440000000000001 112.899 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.93 104.03 3.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.828 0.346 . . . . 51.100000000000001 110.707 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -64.71 123.8 20.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.142 0.496 . . . . 64.120000000000005 112.086 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 76.6 p -89.92 136.89 32.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.361 -0.381 . . . . 42.219999999999999 111.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 138' ' ' LEU . . . -56.78 -54.64 44.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.082 0.468 . . . . 74.140000000000001 111.295 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -150.34 131.12 7.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.369 -0.378 . . . . 70.239999999999995 110.284 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.54 103.53 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.412 2.074 . . . . 72.239999999999995 112.688 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . . . -80.45 -179.47 7.17 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 44.32 112.714 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.25 145.2 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.92 -0.582 . . . . 71.400000000000006 111.019 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -72.24 150.23 43.84 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.482 0.919 . . . . 74.200000000000003 113.482 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 123' ' ' PRO . 23.4 mm -106.8 167.14 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.115 -0.948 . . . . 71.519999999999996 110.757 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.481 ' N ' HG22 ' A' ' 119' ' ' ILE . 57.6 tptt -64.19 -66.11 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.843 0.354 . . . . 71.230000000000004 111.773 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -151.13 -55.73 0.15 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.257 0.551 . . . . 74.109999999999999 111.027 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -92.82 118.63 67.98 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.956 -0.565 . . . . 75.150000000000006 110.413 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 119' ' ' ILE . 32.1 Cg_endo -61.95 141.27 88.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.675 2.25 . . . . 64.349999999999994 113.389 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.4 p -76.16 156.08 34.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.877 -0.601 . . . . 75.120000000000005 111.428 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.76 -30.9 71.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 111.037 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -57.29 -22.69 43.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.3 -0.409 . . . . 71.230000000000004 111.093 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.9 m -65.6 -25.76 67.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.852 0.358 . . . . 72.439999999999998 111.068 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -67.47 -48.16 67.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.913 0.387 . . . . 73.319999999999993 110.395 172.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.68 -31.62 71.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.467 0.651 . . . . 74.329999999999998 110.692 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.02 -63.02 1.44 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.369 -0.832 . . . . 74.340000000000003 111.005 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.641 ' SG ' HD13 ' A' ' 16' ' ' LEU . 64.6 m -62.24 -26.21 68.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.387 -0.37 . . . . 42.119999999999997 111.936 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.02 -69.86 0.1 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.189 -0.46 . . . . 61.409999999999997 111.751 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.57 -16.67 44.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.185 0.439 . . . . 42.409999999999997 112.185 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.78 -53.62 44.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 110.716 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.52 95.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.14 -0.552 . . . . 70.510000000000005 112.444 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 59.4 m -60.85 -46.74 89.4 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.918 0.34 . . . . 71.439999999999998 111.918 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.82 -43.62 98.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.771 0.32 . . . . 74.150000000000006 111.278 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 44.2 tp -57.31 -45.05 84.59 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.263 0.554 . . . . 51.100000000000001 110.008 173.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 143' ' ' THR . . . -61.97 -35.5 91.48 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.807 -0.633 . . . . 70.510000000000005 112.785 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLN . . . . . 0.511 ' HA ' HG22 ' A' ' 143' ' ' THR . 24.6 mt-30 -65.19 -35.56 81.45 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.909 0.354 . . . . 70.319999999999993 111.352 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -62.38 -47.6 83.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.072 0.463 . . . . 74.109999999999999 110.391 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.24 -55.53 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.821 -0.627 . . . . 55.439999999999998 111.684 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 140' ' ' GLN . 8.8 t -63.27 -28.31 69.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.071 0.397 . . . . 63.450000000000003 112.071 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -68.42 -50.47 52.52 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.104 0.478 . . . . 51.210000000000001 111.164 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.89 -29.69 66.95 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.52 . . . . 75.230000000000004 111.669 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 146' ' ' ARG . 23.8 ttt180 -100.58 -31.72 11.12 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.995 1.109 . . . . 63.450000000000003 113.995 -172.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.1 tp . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 113.943 1.09 . . . . 70.450000000000003 113.943 -173.114 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 57.4 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 110.375 -0.232 . . . . 50.140000000000001 110.375 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.724 HD11 HG21 ' A' ' 142' ' ' VAL . 30.3 mm 69.96 103.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 110.971 -174.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -90.13 106.58 3.35 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 121.211 -0.518 . . . . 65.319999999999993 112.969 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.626 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -83.09 116.1 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.53 0.681 . . . . 75.040000000000006 111.705 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 36' ' ' LEU . 63.0 m-85 -89.98 113.25 24.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.715 -0.675 . . . . 74.439999999999998 110.467 176.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 36.8 p90 -137.84 -178.59 5.32 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.146 0.498 . . . . 73.299999999999997 112.01 -176.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 10' ' ' TYR . 23.8 t -126.87 111.94 27.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.145 -0.48 . . . . 72.0 111.004 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.88 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 46.6 t -61.9 -26.33 68.1 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.19 0.811 . . . . 52.049999999999997 113.19 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -95.38 -64.5 1.05 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.285 0.564 . . . . 65.349999999999994 112.42 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.442 ' H ' HG12 ' A' ' 7' ' ' VAL . 19.8 t80 -71.6 127.26 31.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.855 -0.611 . . . . 74.340000000000003 112.247 -171.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.91 -161.98 7.44 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 114.994 0.758 . . . . 12.539999999999999 114.994 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -87.35 7.22 29.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.04 0.385 . . . . 74.430000000000007 112.04 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.1 t -46.87 -40.85 14.74 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.115 0.783 . . . . 63.039999999999999 113.115 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.88 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 20.1 p-10 -67.38 -41.63 84.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.143 0.497 . . . . 65.349999999999994 111.526 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -68.19 -36.66 79.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.174 -0.466 . . . . 73.040000000000006 110.819 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.85 -44.79 96.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.313 0.578 . . . . 62.409999999999997 110.375 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 21' ' ' ILE . . . -60.0 -39.85 87.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.806 -0.634 . . . . 72.140000000000001 111.303 175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -58.96 -44.06 91.42 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.589 -0.278 . . . . 44.329999999999998 111.083 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.15 -43.17 82.23 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.006 0.432 . . . . 61.109999999999999 111.158 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 66.4 mt -66.41 -58.71 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.152 -0.476 . . . . 63.350000000000001 111.846 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.678 HG13 ' HB ' ' A' ' 31' ' ' VAL . 13.4 tt -60.02 -48.92 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 111.903 0.334 . . . . 74.120000000000005 111.903 -176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.405 ' N ' HG23 ' A' ' 21' ' ' ILE . 10.7 t30 -66.65 -39.26 88.14 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.542 0.201 . . . . 74.439999999999998 111.542 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.47 95.02 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.891 -0.671 . . . . 72.040000000000006 112.644 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.64 HG22 ' HB ' ' A' ' 29' ' ' VAL . 59.9 mt -83.04 -35.71 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 112.17 0.433 . . . . 61.399999999999999 112.17 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 21' ' ' ILE . 70.8 p -69.12 -39.58 78.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 122.006 -0.434 . . . . 41.229999999999997 111.054 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.35 -43.07 78.74 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.097 0.475 . . . . 73.299999999999997 110.094 174.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 85.3 m -63.0 -43.01 99.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 111.028 173.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.54 67.44 0.33 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.222 -0.513 . . . . 63.109999999999999 113.619 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.64 ' HB ' HG22 ' A' ' 24' ' ' ILE . 62.5 t -139.37 -68.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 122.525 -0.397 . . . . 70.120000000000005 111.71 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.93 113.14 2.94 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.28 -0.486 . . . . 73.140000000000001 112.814 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 21' ' ' ILE . 82.2 t -109.65 144.42 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 120.686 0.279 . . . . 55.219999999999999 111.698 -176.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.494 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 18.2 m-20 -93.38 147.47 22.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 64.450000000000003 110.986 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -116.73 132.28 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 112.431 0.53 . . . . 72.099999999999994 112.431 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 86.9 t -141.49 125.02 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 116.035 -0.529 . . . . 73.209999999999994 111.026 176.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.5 m-20 -85.73 99.77 11.55 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.007 -0.433 . . . . 62.030000000000001 111.935 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.529 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -69.78 -21.12 63.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.027 0.442 . . . . 51.32 111.675 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.418 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -114.64 23.63 11.86 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.651 -0.785 . . . . 62.340000000000003 113.805 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.87 -72.95 0.11 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.73 0.641 . . . . 73.200000000000003 112.73 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.01 23.47 1.22 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.184 0.809 . . . . 74.540000000000006 113.184 -172.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.0 m -57.84 96.6 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.645 0.736 . . . . 73.209999999999994 112.25 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -146.77 171.59 14.94 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.87 -0.605 . . . . 75.040000000000006 110.448 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -53.27 -36.25 60.95 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.306 0.242 . . . . 60.450000000000003 111.242 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -57.17 -36.27 70.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.034 0.383 . . . . 55.229999999999997 112.034 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -69.04 -46.28 68.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.394 0.616 . . . . 62.32 110.519 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 49' ' ' VAL . 82.2 mt -61.52 -36.81 81.61 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.768 -0.651 . . . . 73.349999999999994 111.309 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' NH2' ' HA ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -58.55 -46.97 85.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.289 -0.414 . . . . 62.32 110.288 177.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 7.7 tp10 -66.39 -37.95 86.41 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.951 0.405 . . . . 65.420000000000002 110.877 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD11 HD21 ' A' ' 55' ' ' LEU . 59.4 tp -57.63 -30.48 65.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.178 -0.464 . . . . 74.239999999999995 111.607 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 45' ' ' LEU . 63.7 t -63.25 -53.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.98 0.419 . . . . 64.25 111.478 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.17 -37.36 49.08 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.264 -0.493 . . . . 63.340000000000003 113.697 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -90.24 8.08 34.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.078 0.399 . . . . 73.010000000000005 112.078 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -51.31 -8.77 0.05 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 114.425 1.268 . . . . 62.310000000000002 114.425 -175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.9 p -65.09 -18.18 65.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.778 0.659 . . . . 74.310000000000002 112.778 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.664 ' HA3' HD13 ' A' ' 2' ' ' ILE . . . -160.85 137.84 5.17 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.587 -0.816 . . . . 42.299999999999997 113.973 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 48' ' ' LEU . 4.7 mp -128.76 159.22 36.36 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.866 0.466 . . . . 55.32 110.824 178.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 70.7 t -140.66 122.46 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 122.429 0.291 . . . . 74.239999999999995 110.824 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -122.22 130.87 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.886 0.374 . . . . 74.519999999999996 111.253 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.23 -128.0 3.22 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.993 -0.622 . . . . 73.420000000000002 112.908 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 59' ' ' MET . 0.0 OUTLIER -84.5 161.29 20.31 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.14 0.495 . . . . 64.450000000000003 111.515 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -113.03 90.62 16.23 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.525 -0.307 . . . . 70.109999999999999 111.505 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.36 137.64 16.95 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.971 2.448 . . . . 75.230000000000004 112.093 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.93 -48.28 51.93 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.414 0.524 . . . . 72.200000000000003 112.414 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.88 -42.62 65.46 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.311 0.485 . . . . 43.43 112.311 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.1 m -78.84 -33.85 45.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.745 0.307 . . . . 64.319999999999993 111.493 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -54.73 -33.81 61.63 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 72.25 111.927 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.64 -33.58 76.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.97 0.359 . . . . 63.039999999999999 111.97 177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.8 m -85.22 -12.59 52.24 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.033 0.383 . . . . 73.400000000000006 112.033 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mm -87.86 -23.33 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 112.177 0.436 . . . . 73.329999999999998 112.177 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -48.49 -48.15 38.2 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.769 0.655 . . . . 54.520000000000003 112.769 -174.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.7 -57.3 7.35 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.14 -0.553 . . . . 75.420000000000002 113.322 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -55.86 -35.91 66.97 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.417 0.525 . . . . 74.530000000000001 112.417 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.53 -41.68 66.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.612 0.365 . . . . 70.099999999999994 111.006 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.5 m -58.98 -47.21 85.97 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.781 0.324 . . . . 74.540000000000006 111.537 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.0 -39.09 93.7 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.839 0.352 . . . . 71.420000000000002 111.275 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.469 ' O ' HG22 ' A' ' 79' ' ' VAL . 65.3 mt -58.37 -47.06 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 116.358 -0.383 . . . . 64.140000000000001 111.335 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 82.4 mt -55.35 -28.18 52.16 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.481 -0.327 . . . . 70.239999999999995 111.875 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.68 -32.23 30.85 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.216 -0.516 . . . . 73.420000000000002 113.195 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 92.6 p -80.78 -58.68 2.99 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.855 0.317 . . . . 72.209999999999994 111.855 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 75' ' ' ILE . 29.8 m -68.79 145.12 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 121.338 0.59 . . . . 71.409999999999997 112.112 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -161.37 -168.76 2.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.021 -0.536 . . . . 72.329999999999998 111.429 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.743 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 10.5 tp10 64.08 -95.76 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.701 1.0 . . . . 75.109999999999999 113.701 167.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.743 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 9.2 ptpp? -169.43 30.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 120.95 0.405 . . . . 73.230000000000004 111.801 -174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.458 ' OE1' ' HB3' ' A' ' 81' ' ' GLU . 8.0 mp0 -61.33 176.35 0.47 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.578 0.704 . . . . 72.439999999999998 112.642 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.688 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.06 139.53 30.53 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.573 0.582 . . . . 75.030000000000001 112.573 -174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.99 96.15 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.679 0.752 . . . . 63.520000000000003 110.854 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.3 80.68 0.73 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 115.944 -0.571 . . . . 53.399999999999999 113.285 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.44 HD13 ' HB ' ' A' ' 57' ' ' ILE . 32.5 mm -82.78 113.85 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 122.725 -0.28 . . . . 64.549999999999997 110.576 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -124.16 133.07 53.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.368 0.604 . . . . 75.230000000000004 112.267 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 9.5 tp10 -76.23 137.86 40.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.76 -0.655 . . . . 62.420000000000002 111.335 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -156.11 -2.75 0.13 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.97 0.73 . . . . 71.319999999999993 112.97 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.81 109.86 0.39 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.692 -0.766 . . . . 73.129999999999995 113.13 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.24 79.67 0.52 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.527 -0.368 . . . . 53.520000000000003 113.22 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.82 78.39 0.06 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.379 -0.439 . . . . 31.010000000000002 112.53 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -98.47 -174.8 2.91 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.239 0.542 . . . . 70.109999999999999 111.966 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -118.67 138.08 52.86 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.919 -0.582 . . . . 62.140000000000001 109.959 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.545 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 32.8 mt-10 -45.34 -48.4 34.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 N-CA-C 114.601 1.334 . . . . 71.030000000000001 114.601 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 86.0 Cg_exo -50.46 -12.21 0.49 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 122.915 2.41 . . . . 45.450000000000003 115.092 179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.2 tp -63.89 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 121.903 -0.498 . . . . 45.350000000000001 111.854 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.514 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.1 m-20 -57.18 -51.18 83.61 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 112.577 0.584 . . . . 74.109999999999999 112.577 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 90.4 Cg_exo -47.78 -40.18 31.49 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.309 2.006 . . . . 74.140000000000001 112.893 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 97' ' ' PRO . 9.7 mp -71.99 -41.57 67.49 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.58 -0.282 . . . . 62.140000000000001 111.205 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 97.3 mt -58.64 -37.3 75.62 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.063 0.459 . . . . 55.530000000000001 111.056 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.4 t -58.08 -31.85 67.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.19 -0.459 . . . . 54.340000000000003 110.917 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -68.29 -50.12 55.81 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.798 0.333 . . . . 73.129999999999995 110.742 177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -58.91 -37.33 76.37 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.16 0.505 . . . . 75.530000000000001 110.777 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -64.74 -60.05 3.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.69 -0.687 . . . . 74.340000000000003 111.207 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.18 -56.08 24.79 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 112.529 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.17 -23.07 65.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 111.737 0.273 . . . . 73.219999999999999 111.737 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 67.4 61.24 5.23 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.291 -0.481 . . . . 72.409999999999997 113.558 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.5 mt -87.59 156.55 19.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 122.625 -0.338 . . . . 74.140000000000001 110.989 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 27.5 m -70.12 93.1 0.79 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 50.140000000000001 111.509 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.5 p -86.63 159.07 19.33 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.22 0.533 . . . . 45.340000000000003 112.319 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -99.04 -164.81 1.17 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 116.127 -0.488 . . . . 73.409999999999997 111.808 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -60.25 112.34 5.34 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.171 -0.468 . . . . 72.239999999999995 112.074 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -90.68 107.4 0.32 Allowed 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.014 2.476 . . . . 74.439999999999998 113.484 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.796 ' HB3' ' HB3' ' A' ' 89' ' ' GLU . . . -89.66 177.38 6.55 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.189 -0.319 . . . . 51.240000000000002 110.634 173.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 10.9 tt -132.58 102.52 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 112.665 0.617 . . . . 74.530000000000001 112.665 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 55.99 93.55 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.353 0.871 . . . . 71.310000000000002 113.353 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.589 HG12 ' HG3' ' A' ' 89' ' ' GLU . 46.4 mm -95.35 74.71 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.04 0.447 . . . . 64.200000000000003 110.39 173.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.8 tttp 51.46 -84.16 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 112.807 0.669 . . . . 60.43 112.807 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 179.09 -42.73 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.181 0.592 . . . . 42.119999999999997 110.674 -175.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.8 p -96.08 114.62 64.56 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 116.197 -0.456 . . . . 73.299999999999997 111.521 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.47 127.76 26.63 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.713 2.276 . . . . 50.100000000000001 113.133 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 33.9 p -107.89 177.09 4.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.569 -0.287 . . . . 73.430000000000007 111.608 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.56 -34.96 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.01 0.433 . . . . 71.310000000000002 111.586 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.422 ' O ' HD13 ' A' ' 130' ' ' LEU . 16.0 m120 -58.05 -41.19 82.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.974 0.416 . . . . 71.430000000000007 110.609 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.7 m -56.82 -44.48 82.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.251 -0.431 . . . . 71.140000000000001 111.377 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -58.85 -46.36 87.93 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.279 0.562 . . . . 73.340000000000003 111.04 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.94 -32.48 72.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.775 -0.648 . . . . 65.409999999999997 111.802 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 126' ' ' ASN . 10.9 mp -77.78 -42.25 34.59 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.303 -0.248 . . . . 73.349999999999994 111.418 174.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.9 m -58.66 -53.32 59.72 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.853 0.359 . . . . 75.109999999999999 111.566 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.1 -54.08 50.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.269 -0.423 . . . . 64.5 111.759 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.81 -54.86 36.44 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.221 -0.445 . . . . 54.439999999999998 111.843 -177.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.67 -40.5 97.27 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.71 0.29 . . . . 75.319999999999993 111.777 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.42 -49.55 76.04 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.08 -0.581 . . . . 72.420000000000002 112.789 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.8 m -61.2 -42.62 98.91 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 62.299999999999997 111.041 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.33 -42.15 95.06 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.026 -0.534 . . . . 51.439999999999998 111.182 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.479 HD11 ' HB1' ' A' ' 84' ' ' ALA . 52.5 tp -62.73 -44.28 96.62 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.125 0.488 . . . . 73.129999999999995 110.636 174.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.34 -34.57 75.11 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 116.018 -0.537 . . . . 62.32 112.781 176.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 136' ' ' THR . 55.5 mt-30 -64.78 -25.68 68.02 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.714 0.292 . . . . 74.239999999999995 111.711 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -72.82 -52.43 14.94 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.068 0.461 . . . . 74.349999999999994 110.166 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.724 HG21 HD11 ' A' ' 2' ' ' ILE . 60.9 t -57.2 -45.16 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.797 -0.638 . . . . 72.329999999999998 112.172 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.591 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 9.0 t -61.71 -51.78 66.99 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.997 0.369 . . . . 51.32 111.997 -177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' N ' HG23 ' A' ' 143' ' ' THR . 90.5 mtt-85 -64.26 -41.64 96.85 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.113 0.482 . . . . 72.540000000000006 111.13 -178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.15 -49.87 68.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.122 -0.49 . . . . 70.450000000000003 111.725 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.484 ' NE ' ' HA ' ' A' ' 146' ' ' ARG . 0.1 OUTLIER -82.7 -11.07 58.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.183 0.438 . . . . 72.140000000000001 112.183 -174.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 143' ' ' THR . 0.2 OUTLIER -88.44 11.15 17.75 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.157 0.503 . . . . 43.109999999999999 110.395 172.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.838 ' HB3' ' HB2' ' A' ' 151' ' ' HIS . 39.2 tt0 57.72 19.89 5.95 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.325 0.583 . . . . 71.430000000000007 112.455 174.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.6 t60 64.26 -76.43 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 112.675 0.62 . . . . 75.25 112.675 173.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -94.13 18.68 10.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.547 0.573 . . . . 74.420000000000002 112.547 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.838 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 56.1 t60 -74.9 -17.06 60.63 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.055 0.455 . . . . 63.130000000000003 111.195 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -125.66 109.83 13.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.31 -0.405 . . . . 63.450000000000003 111.134 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -65.21 143.46 57.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.85 0.357 . . . . 74.319999999999993 111.83 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.84 -0.6 . . . . 75.340000000000003 111.108 177.153 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 25.3 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.389 0.137 . . . . 65.430000000000007 111.357 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 2' ' ' ILE . 3.0 mp 58.7 97.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 121.214 0.531 . . . . 53.219999999999999 111.869 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.29 96.11 1.9 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.193 -0.527 . . . . 42.340000000000003 112.98 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -85.56 105.73 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 O-C-N 122.374 -0.486 . . . . 74.200000000000003 111.398 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -95.21 123.14 38.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.755 0.312 . . . . 75.439999999999998 111.276 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.18 175.0 9.95 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.956 0.407 . . . . 73.530000000000001 111.541 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 7' ' ' VAL . 5.9 p -121.62 95.99 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.629 0.728 . . . . 64.430000000000007 111.129 176.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -52.6 -34.64 51.76 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.595 -0.73 . . . . 75.239999999999995 112.788 -176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.13 -35.99 69.26 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.64 0.608 . . . . 44.420000000000002 112.64 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -109.05 146.57 33.76 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.243 0.46 . . . . 75.319999999999993 112.243 -170.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.19 -164.18 5.18 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 114.521 0.568 . . . . 73.219999999999999 114.521 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.607 ' HD2' ' HG2' ' A' ' 123' ' ' PRO . 57.4 m-85 -87.45 9.47 20.69 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.762 0.425 . . . . 64.420000000000002 111.778 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 m -29.98 -48.97 0.1 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.729 1.381 . . . . 72.340000000000003 114.729 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -61.86 -46.17 90.62 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.896 0.379 . . . . 75.519999999999996 111.644 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.35 -38.21 89.39 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.928 0.394 . . . . 75.510000000000005 110.858 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.597 HD11 ' HG3' ' A' ' 123' ' ' PRO . 85.8 mt -61.59 -42.59 99.07 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.062 0.458 . . . . 74.120000000000005 110.778 176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -58.6 -47.26 84.92 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.135 -0.484 . . . . 62.420000000000002 110.759 175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.8 -37.75 60.24 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.14 0.495 . . . . 54.420000000000002 111.095 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.84 -54.37 19.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.289 -0.414 . . . . 55.509999999999998 111.498 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.4 mt -56.72 -46.79 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 121.234 0.54 . . . . 74.010000000000005 111.909 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.512 HG12 HG21 ' A' ' 31' ' ' VAL . 74.5 mt -60.19 -27.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 115.899 -0.591 . . . . 74.239999999999995 112.19 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -54.01 -68.59 0.17 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.018 0.377 . . . . 62.340000000000003 112.018 -176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.16 -36.64 89.57 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.242 -0.504 . . . . 63.539999999999999 113.644 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.05 -47.51 84.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 122.526 -0.397 . . . . 73.400000000000006 111.796 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 46.0 p -67.43 -34.66 77.68 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.109 0.411 . . . . 64.519999999999996 112.109 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -68.09 -23.23 64.91 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.277 0.56 . . . . 75.109999999999999 110.689 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 152' ' ' HIS . 87.8 m -80.6 -12.98 59.43 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.225 0.536 . . . . 45.329999999999998 110.544 173.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.15 27.22 26.35 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 121.183 -0.532 . . . . 70.0 113.113 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 143' ' ' THR . 45.2 t -116.14 137.28 50.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 122.582 -0.364 . . . . 73.310000000000002 111.463 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 142.59 17.89 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 121.348 -0.453 . . . . 35.409999999999997 112.747 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG21 HG12 ' A' ' 21' ' ' ILE . 34.4 m -107.97 146.25 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 112.46 0.541 . . . . 72.219999999999999 112.46 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -108.16 92.7 4.17 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.336 -0.393 . . . . 73.510000000000005 110.654 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.62 122.63 43.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.759 0.314 . . . . 74.519999999999996 111.58 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -127.61 136.76 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.001 0.429 . . . . 73.209999999999994 111.537 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -87.1 123.75 32.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.925 0.393 . . . . 74.409999999999997 111.196 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.75 -13.46 48.22 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.173 0.434 . . . . 63.539999999999999 112.173 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.65 68.27 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.364 -0.446 . . . . 52.200000000000003 112.993 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.86 14.66 3.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.166 0.432 . . . . 45.100000000000001 112.166 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.07 118.04 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.333 0.587 . . . . 63.409999999999997 112.217 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.71 99.67 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.625 0.726 . . . . 62.009999999999998 112.199 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.59 158.15 27.93 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.592 -0.731 . . . . 72.109999999999999 111.724 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.637 HD13 HD12 ' A' ' 45' ' ' LEU . 3.4 mm? -60.37 -37.89 82.18 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.037 0.384 . . . . 72.329999999999998 112.037 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -66.88 -30.11 70.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 111.089 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -77.2 -32.88 56.3 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.093 0.473 . . . . 72.329999999999998 110.597 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.637 HD12 HD13 ' A' ' 42' ' ' LEU . 85.4 mt -64.75 -32.28 73.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.416 -0.356 . . . . 72.409999999999997 110.825 174.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -58.78 -47.66 83.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.022 0.439 . . . . 75.510000000000005 110.193 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 73.1 mm-40 -58.19 -39.83 79.97 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.245 -0.434 . . . . 72.209999999999994 111.094 175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 65.8 tp -56.38 -34.34 66.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.762 0.315 . . . . 70.030000000000001 111.336 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.07 -52.94 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 120.844 0.354 . . . . 72.340000000000003 111.21 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.93 -25.14 73.2 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 120.905 -0.664 . . . . 53.219999999999999 113.47 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -98.87 7.42 46.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.717 0.407 . . . . 74.510000000000005 111.806 178.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.0 p -62.59 5.69 0.11 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.629 0.974 . . . . 55.32 113.629 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 68.0 p -79.79 -36.88 36.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 122.112 -0.368 . . . . 75.420000000000002 111.876 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.8 137.71 5.33 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.92 -0.657 . . . . 74.400000000000006 113.239 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.69 164.17 39.15 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.865 0.364 . . . . 65.540000000000006 111.597 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 56.6 t -122.36 129.58 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.611 0.364 . . . . 72.409999999999997 110.664 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -117.75 136.2 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-O 121.288 0.566 . . . . 64.420000000000002 112.463 -173.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -103.91 125.55 8.45 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 116.071 -0.513 . . . . 44.130000000000003 112.476 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.467 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 55.5 ttm -56.87 101.86 0.07 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.353 0.596 . . . . 71.230000000000004 111.465 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 67.1 m -92.88 132.95 29.88 Favored Pre-proline 0 N--CA 1.47 0.539 0 CA-C-N 116.166 -0.47 . . . . 72.120000000000005 112.196 -174.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.79 169.04 12.23 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.51 2.14 . . . . 62.229999999999997 112.756 177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -43.96 -42.83 6.19 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.358 0.874 . . . . 75.010000000000005 113.358 -173.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.72 -62.84 1.42 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 111.983 0.364 . . . . 51.350000000000001 111.983 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 50.3 m -70.76 -22.22 62.42 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.009 0.433 . . . . 52.140000000000001 111.515 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.86 -23.5 65.15 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.246 -0.434 . . . . 61.219999999999999 111.435 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.31 99.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.94 0.4 . . . . 71.530000000000001 111.356 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.3 m -62.24 -44.05 97.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.231 0.538 . . . . 61.5 110.904 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.447 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 61.5 mt -64.32 -45.32 96.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.044 -0.525 . . . . 51.43 110.832 176.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -54.42 -48.97 71.04 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.912 -0.586 . . . . 75.129999999999995 111.47 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.24 -27.28 72.21 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.051 -0.595 . . . . 73.340000000000003 112.927 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.96 -21.33 29.62 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.365 0.506 . . . . 72.409999999999997 112.365 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 68' ' ' ILE . 70.6 mt -51.26 -38.07 50.65 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.369 0.507 . . . . 72.439999999999998 112.369 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.4 m -54.25 -31.6 53.96 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.089 0.471 . . . . 71.310000000000002 111.535 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 m -94.13 -39.87 10.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.147 0.499 . . . . 65.109999999999999 111.196 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.4 mt -62.0 -54.27 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.262 0.467 . . . . 54.229999999999997 112.262 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -57.43 -17.53 13.55 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.723 0.638 . . . . 63.340000000000003 112.723 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.15 -27.85 7.56 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.149 -0.548 . . . . 54.399999999999999 113.113 175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.7 m -84.76 -25.58 28.17 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.462 0.542 . . . . 74.120000000000005 112.462 -177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.3 m -66.66 158.99 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.329 0.585 . . . . 63.109999999999999 112.359 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 83' ' ' GLN . 27.9 t-20 -92.9 143.79 25.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.03 -0.532 . . . . 74.239999999999995 110.914 179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -44.89 -44.62 9.78 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.382 0.882 . . . . 74.140000000000001 113.382 -175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 24.2 pttm -135.62 41.56 2.72 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.055 0.455 . . . . 71.409999999999997 112.012 -176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.635 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 3.9 pt20 -61.44 167.89 3.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.076 -0.511 . . . . 74.420000000000002 112.255 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -96.12 116.88 29.67 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.272 -0.422 . . . . 64.219999999999999 111.64 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.5 m -114.34 118.98 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 121.432 0.634 . . . . 73.200000000000003 112.121 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -89.16 139.27 15.14 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.088 -0.505 . . . . 72.140000000000001 112.781 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.31 138.95 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 120.896 0.379 . . . . 73.049999999999997 111.751 -177.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -139.87 150.83 45.1 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.223 -0.444 . . . . 64.319999999999993 110.466 175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 89' ' ' GLU . 0.6 OUTLIER -76.3 91.57 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.554 0.692 . . . . 75.540000000000006 112.309 -174.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.481 ' N ' HG12 ' A' ' 119' ' ' ILE . 52.8 m -154.51 134.34 12.94 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.192 -0.458 . . . . 53.329999999999998 111.243 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 59' ' ' MET . . . 99.35 -133.03 11.14 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.189 -0.529 . . . . 64.120000000000005 113.132 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.46 -125.69 9.54 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.084 -0.579 . . . . 62.310000000000002 113.297 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.66 -104.1 1.09 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.082 -0.58 . . . . 31.210000000000001 112.89 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -95.65 109.58 21.82 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 122.658 -0.319 . . . . 74.049999999999997 110.392 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.26 155.95 39.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.932 0.396 . . . . 63.25 111.543 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.632 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 31.6 mt-10 -106.95 -63.94 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 N-CA-C 113.041 0.756 . . . . 75.099999999999994 113.041 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 32.5 Cg_endo -104.1 27.43 0.09 OUTLIER 'Trans proline' 0 CA--C 1.553 1.447 0 C-N-CA 123.203 2.602 . . . . 73.049999999999997 116.204 -167.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 99' ' ' ASP . 12.6 tt -53.26 -49.93 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 118.769 0.713 . . . . 63.140000000000001 112.842 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.61 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 16.7 m-20 -61.8 -51.59 74.8 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 112.491 0.552 . . . . 74.310000000000002 112.491 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.6 Cg_exo -48.99 -43.92 34.23 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.117 1.878 . . . . 73.120000000000005 113.063 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.7 mp -65.48 -48.43 72.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.678 0.251 . . . . 63.140000000000001 111.678 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 95.1 mt -53.4 -47.85 69.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.003 0.43 . . . . 52.530000000000001 111.24 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -64.01 -43.83 94.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.429 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -56.53 -62.54 1.66 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.339 -0.391 . . . . 64.409999999999997 111.313 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -58.73 -30.53 67.54 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 111.797 0.295 . . . . 75.319999999999993 111.797 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 106' ' ' ARG . 31.5 ttt180 -61.76 -49.87 74.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.966 0.412 . . . . 74.530000000000001 111.256 175.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -69.47 -8.07 43.6 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.721 0.637 . . . . 70.510000000000005 112.721 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 mp -98.43 -40.33 8.33 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.849 0.357 . . . . 74.239999999999995 110.628 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 86.96 52.54 3.08 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.202 -0.523 . . . . 54.32 113.873 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.695 ' HA ' ' HA ' ' A' ' 82' ' ' LYS . 6.5 mp -76.54 151.17 36.44 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.894 0.378 . . . . 74.349999999999994 111.47 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.408 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 80.2 m -68.36 87.41 0.3 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.377 0.608 . . . . 75.140000000000001 110.142 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 35.9 m -99.53 135.74 40.49 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.733 -0.667 . . . . 52.420000000000002 112.149 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.83 -64.17 0.94 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.854 0.359 . . . . 51.340000000000003 111.889 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -158.23 99.72 1.76 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 120.656 0.265 . . . . 51.310000000000002 111.31 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -90.52 17.37 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.083 2.522 . . . . 75.219999999999999 114.027 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.98 13.07 19.44 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.238 0.458 . . . . 61.219999999999999 112.238 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.2 tp -91.59 139.43 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.088 0.47 . . . . 73.420000000000002 111.545 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -128.41 127.51 42.71 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.368 -0.378 . . . . 65.019999999999996 110.375 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.4 mp -106.48 141.06 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.225 0.536 . . . . 64.420000000000002 111.734 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 121' ' ' GLN . 19.5 ptmt -78.63 -40.32 34.61 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.961 -0.563 . . . . 75.219999999999999 112.497 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.58 ' HG2' HG23 ' A' ' 122' ' ' THR . 65.1 tt0 -175.36 -70.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.102 0.477 . . . . 73.219999999999999 111.679 -175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.58 HG23 ' HG2' ' A' ' 121' ' ' GLN . 60.7 p -115.1 153.45 47.22 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.459 -0.337 . . . . 51.039999999999999 111.78 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.607 ' HG2' ' HD2' ' A' ' 12' ' ' TYR . 72.7 Cg_endo -75.37 -175.57 2.49 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.619 2.213 . . . . 75.099999999999994 113.185 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.0 p -111.53 175.54 5.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.92 0.39 . . . . 42.140000000000001 111.322 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.82 -25.33 62.81 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.17 0.51 . . . . 74.230000000000004 110.83 174.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -70.3 -28.33 65.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.046 0.451 . . . . 74.299999999999997 110.901 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.9 m -54.22 -35.33 62.3 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.084 -0.507 . . . . 70.120000000000005 111.931 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -58.03 -27.55 63.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.008 0.432 . . . . 63.25 111.687 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -85.65 -39.67 17.02 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.939 0.399 . . . . 75.209999999999994 110.447 177.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.23 -56.17 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.008 -0.542 . . . . 71.400000000000006 111.155 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.4 m -55.06 -38.04 67.53 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.014 0.376 . . . . 75.120000000000005 112.014 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -67.12 -46.44 74.16 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.226 0.536 . . . . 72.230000000000004 110.908 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -62.18 -52.93 61.82 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.981 -0.554 . . . . 61.200000000000003 111.522 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.05 99.58 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.245 -0.434 . . . . 61.520000000000003 111.566 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -55.81 -38.94 75.62 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 121.258 -0.496 . . . . 73.040000000000006 112.799 177.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.431 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 88.9 m -65.96 -44.67 84.29 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.731 0.301 . . . . 71.349999999999994 111.126 176.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.04 -50.79 72.22 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 120.987 0.422 . . . . 54.520000000000003 111.695 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.454 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.9 mm? -70.14 -43.26 71.29 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.865 0.364 . . . . 61.420000000000002 111.165 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -54.0 -47.83 65.02 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 116.132 -0.486 . . . . 50.240000000000002 113.566 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 90.5 mt-30 -59.79 -53.12 61.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.668 0.27 . . . . 64.140000000000001 111.35 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 77.4 t90 -51.62 -52.98 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.753 0.311 . . . . 71.510000000000005 111.426 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 138' ' ' LEU . 57.4 t -57.08 -43.0 80.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.52 0.563 . . . . 72.129999999999995 112.52 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.429 HG21 HG21 ' A' ' 29' ' ' VAL . 8.7 t -78.11 -49.92 13.0 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.152 0.797 . . . . 75.140000000000001 113.152 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.67 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 0.8 OUTLIER -84.88 -4.73 59.23 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.155 0.798 . . . . 73.400000000000006 113.155 -172.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.41 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 27.7 t70 -62.09 -18.39 60.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.189 0.44 . . . . 33.210000000000001 112.189 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.599 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 1.7 mpt_? -78.72 -27.57 44.93 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.662 0.615 . . . . 75.439999999999998 112.662 -176.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 147' ' ' LEU . 8.6 tt -173.9 -37.23 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.11 0.481 . . . . 62.420000000000002 109.919 -174.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 76.36 98.42 0.07 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.072 -0.967 . . . . 73.510000000000005 113.359 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.8 -5.83 47.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.115 -1.069 . . . . 74.530000000000001 108.115 160.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 5.1 t60 59.88 -81.38 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.277 -1.329 . . . . 75.310000000000002 112.263 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 51.25 81.96 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.21 0.818 . . . . 71.329999999999998 113.21 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.513 ' HB2' HG23 ' A' ' 27' ' ' THR . 50.8 t-80 -173.69 146.84 1.33 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.248 0.547 . . . . 64.030000000000001 111.784 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -134.63 156.08 49.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.621 -0.718 . . . . 74.129999999999995 110.038 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.9 m80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.855 -0.593 . . . . 73.439999999999998 111.344 173.486 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 111.853 0.316 . . . . 74.140000000000001 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.639 HG13 HG21 ' A' ' 24' ' ' ILE . 46.4 mm -69.77 97.33 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 111.992 0.367 . . . . 75.200000000000003 111.992 -176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.44 94.16 1.38 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.084 -0.579 . . . . 55.0 112.529 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.453 HG21 ' HB1' ' A' ' 17' ' ' ALA . 6.7 p -91.9 110.25 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.261 0.553 . . . . 71.0 112.11 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HB3' HD23 ' A' ' 36' ' ' LEU . 82.5 m-85 -95.07 99.09 11.14 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.97 -0.559 . . . . 65.430000000000007 110.955 178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 14' ' ' ASP . 26.6 p90 -130.13 -179.52 5.28 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.837 0.351 . . . . 73.109999999999999 111.52 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 10' ' ' TYR . 22.3 t -121.98 107.32 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.921 0.391 . . . . 74.230000000000004 111.842 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 74.1 m -78.23 -21.91 49.25 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.089 0.471 . . . . 74.409999999999997 111.354 175.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -78.24 -32.69 49.88 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.885 -0.598 . . . . 75.5 112.052 -175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.689 ' H ' HG12 ' A' ' 7' ' ' VAL . 69.1 t80 -129.13 133.03 47.45 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.92 0.711 . . . . 75.209999999999994 112.92 -170.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.5 -162.49 5.19 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 115.562 0.985 . . . . 64.209999999999994 115.562 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -81.19 2.12 29.11 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.64 0.607 . . . . 72.329999999999998 112.64 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.3 t -49.36 -37.56 25.17 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.102 0.477 . . . . 71.239999999999995 111.853 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 17.0 t0 -56.71 -60.18 3.93 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.864 -0.607 . . . . 44.43 111.255 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 15' ' ' ARG . 20.1 mmt180 -70.97 -28.58 64.56 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.28 0.474 . . . . 72.530000000000001 112.28 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.4 mt -58.11 -43.99 87.44 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.275 0.56 . . . . 75.219999999999999 110.501 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 4' ' ' VAL . . . -75.04 -44.27 48.81 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.753 -0.658 . . . . 73.239999999999995 111.43 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -53.77 -53.26 54.79 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.387 -0.37 . . . . 74.120000000000005 111.883 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.2 -25.21 61.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.31 0.485 . . . . 75.400000000000006 112.31 -178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG12 ' HA ' ' A' ' 132' ' ' GLU . 66.1 mt -87.55 -57.4 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 120.846 0.355 . . . . 75.340000000000003 111.442 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.468 ' HB ' HG11 ' A' ' 31' ' ' VAL . 2.7 pp -59.15 -27.17 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.7 0.286 . . . . 72.329999999999998 111.762 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.442 ' N ' HD12 ' A' ' 21' ' ' ILE . 27.3 t-20 -59.4 -48.88 79.95 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.515 -0.311 . . . . 62.409999999999997 110.619 174.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.36 -34.24 87.32 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.166 -0.54 . . . . 31.43 112.758 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.639 HG21 HG13 ' A' ' 2' ' ' ILE . 62.4 mt -62.69 -53.12 51.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 122.49 -0.418 . . . . 75.420000000000002 111.335 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.8 t -68.19 -31.15 70.48 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.909 0.385 . . . . 70.030000000000001 111.001 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -62.34 -34.52 76.8 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.057 0.456 . . . . 74.430000000000007 111.034 173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -71.35 -31.88 67.88 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.311 -0.404 . . . . 72.299999999999997 111.0 174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.81 5.42 4.89 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.165 -0.541 . . . . 55.219999999999999 114.17 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.649 HG22 ' HB ' ' A' ' 143' ' ' THR . 21.8 t -94.34 126.53 46.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 117.439 0.619 . . . . 71.209999999999994 111.698 -178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.95 122.6 22.19 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.444 -0.408 . . . . 73.530000000000001 113.689 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG11 ' HB ' ' A' ' 21' ' ' ILE . 61.3 t -104.07 143.56 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.118 0.485 . . . . 64.010000000000005 112.168 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -116.77 113.68 22.91 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.136 -0.484 . . . . 75.099999999999994 110.422 176.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.84 124.0 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.269 0.557 . . . . 63.450000000000003 112.11 -177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.5 t -128.04 108.03 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.85 0.357 . . . . 60.119999999999997 111.497 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.49 111.23 20.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.908 0.385 . . . . 41.450000000000003 111.188 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.445 ' HA ' HG13 ' A' ' 40' ' ' VAL . 4.4 pp -86.8 -8.96 56.87 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.424 -0.353 . . . . 64.209999999999994 111.1 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.463 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -59.72 -45.3 95.95 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.356 -0.449 . . . . 64.409999999999997 112.768 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.58 17.69 3.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.701 0.286 . . . . 62.409999999999997 111.446 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.16 147.22 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.198 0.599 . . . . 52.43 111.917 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 36' ' ' LEU . 27.1 m -117.43 151.87 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.337 . . . . 72.420000000000002 111.546 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -104.98 169.36 8.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.053 0.454 . . . . 72.209999999999994 111.064 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.7 mm? -58.81 -18.44 32.35 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.116 0.413 . . . . 74.420000000000002 112.116 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -57.6 -55.46 34.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.828 0.347 . . . . 73.140000000000001 110.775 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.94 -37.19 78.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.179 0.514 . . . . 63.020000000000003 110.837 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 3.0 tm? -61.32 -38.73 87.92 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.978 -0.555 . . . . 72.319999999999993 111.127 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -70.85 -40.32 72.41 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.961 -0.462 . . . . 70.329999999999998 110.925 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 18.1 mm-40 -58.41 -28.15 64.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.008 0.432 . . . . 71.519999999999996 111.323 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.611 HD11 HD13 ' A' ' 55' ' ' LEU . 57.7 tp -56.18 -31.11 63.12 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 116.189 -0.459 . . . . 71.030000000000001 111.448 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.97 -36.39 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.872 0.367 . . . . 65.239999999999995 111.328 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.55 -20.01 55.31 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.081 -0.581 . . . . 54.539999999999999 112.895 175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 7.4 mpt_? -94.38 5.11 52.79 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.579 -0.365 . . . . 60.140000000000001 111.934 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -63.56 -16.0 59.61 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.889 0.329 . . . . 75.420000000000002 111.889 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.1 p -66.15 -25.31 66.9 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.821 0.343 . . . . 72.219999999999999 111.643 177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.5 135.93 3.56 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.374 -0.441 . . . . 32.210000000000001 112.493 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.611 HD13 HD11 ' A' ' 48' ' ' LEU . 2.3 pt? -163.83 170.32 17.02 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.117 0.484 . . . . 70.5 111.662 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.5 p -148.76 124.33 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.133 0.492 . . . . 73.340000000000003 111.174 176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -95.8 135.4 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.13 -0.486 . . . . 71.239999999999995 110.96 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.5 -86.58 0.68 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.229 -0.51 . . . . 70.120000000000005 113.805 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.529 ' N ' ' SD ' ' A' ' 59' ' ' MET . 1.5 pmm? -151.92 167.96 26.7 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.3 -0.53 . . . . 73.129999999999995 111.855 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.3 p -144.18 49.13 0.99 Allowed Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 112.345 0.498 . . . . 72.010000000000005 112.345 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.13 157.57 61.1 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.414 2.076 . . . . 75.129999999999995 113.599 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.0 -50.48 2.54 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.523 0.934 . . . . 74.519999999999996 113.523 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.04 -46.51 65.09 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.601 0.593 . . . . 64.299999999999997 112.601 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.7 m -102.11 5.26 40.31 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.507 0.558 . . . . 64.120000000000005 112.507 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.86 -29.88 70.85 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.776 1.028 . . . . 53.329999999999998 113.776 -172.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -37.47 -70.53 0.09 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.905 1.076 . . . . 73.120000000000005 113.905 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 53.4 m -77.39 -37.77 51.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.823 0.344 . . . . 71.349999999999994 111.79 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 57.8 mt -58.45 -43.99 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 112.462 0.541 . . . . 63.329999999999998 112.462 -175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -61.03 -40.82 95.03 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.852 0.358 . . . . 71.219999999999999 111.413 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.88 -36.52 90.35 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.016 -0.611 . . . . 24.239999999999998 112.203 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.456 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -68.52 -51.14 46.33 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.826 -0.22 . . . . 74.040000000000006 111.119 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 75' ' ' ILE . 98.3 mt -53.79 -45.71 70.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.925 0.393 . . . . 64.230000000000004 111.678 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.6 m -56.75 -28.1 60.58 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.104 -0.498 . . . . 61.200000000000003 111.285 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.7 m -86.89 -40.19 15.1 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.259 -0.428 . . . . 75.439999999999998 111.136 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.503 HD12 HD23 ' A' ' 72' ' ' LEU . 73.7 mt -56.13 -40.6 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.394 -0.366 . . . . 73.340000000000003 111.679 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.2 mt -56.37 -26.67 53.66 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.51 -0.314 . . . . 62.140000000000001 111.651 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.9 31.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 121.189 -0.529 . . . . 32.439999999999998 113.463 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.44 ' OG ' ' HA ' ' A' ' 75' ' ' ILE . 89.4 p -87.8 -34.27 18.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.247 0.524 . . . . 74.140000000000001 111.882 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.97 135.13 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.974 0.416 . . . . 73.120000000000005 111.59 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 82' ' ' LYS . 24.7 t-20 -89.53 107.01 18.83 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.298 0.481 . . . . 62.329999999999998 112.298 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 36.84 -75.48 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 114.89 1.441 . . . . 73.5 114.89 167.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.1 96.51 5.13 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.216 0.531 . . . . 74.299999999999997 112.401 -174.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.719 ' H ' HD23 ' A' ' 110' ' ' LEU . 85.6 mm-40 -133.97 172.72 12.43 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.433 -0.349 . . . . 74.120000000000005 110.851 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.5 107.81 18.06 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.048 0.452 . . . . 35.409999999999997 111.282 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.491 HG12 HD21 ' A' ' 55' ' ' LEU . 24.4 m -109.67 119.4 58.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.565 0.698 . . . . 72.129999999999995 112.158 -176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.39 142.51 25.01 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.177 -0.535 . . . . 74.400000000000006 112.507 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.54 ' H ' ' HB3' ' A' ' 113' ' ' ALA . 7.1 tp -160.86 137.82 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 O-C-N 122.655 -0.32 . . . . 73.120000000000005 110.793 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -161.64 161.69 29.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.532 0.333 . . . . 63.450000000000003 110.753 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 1.3 pm0 -81.65 146.28 30.14 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.495 0.664 . . . . 61.32 112.095 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 93.3 m -140.1 100.61 3.96 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.157 -0.474 . . . . 71.150000000000006 111.126 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . 79.01 -170.81 54.91 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.081 -0.58 . . . . 31.0 113.309 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.23 79.26 0.41 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.127 -0.559 . . . . 72.519999999999996 112.708 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.05 159.34 53.5 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.427 -0.416 . . . . 51.539999999999999 113.856 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -162.69 108.03 1.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 109.436 -0.579 . . . . 74.200000000000003 109.436 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -135.18 151.52 50.73 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.987 0.422 . . . . 70.310000000000002 111.556 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.633 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 4.2 tm-20 -91.47 -58.05 0.24 Allowed Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 116.384 -0.371 . . . . 55.100000000000001 111.943 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 96' ' ' GLU . 85.0 Cg_endo -84.83 84.95 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.93 1.753 . . . . 74.25 113.224 -175.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.648 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.5 tp -92.08 -66.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 112.005 0.372 . . . . 72.209999999999994 112.005 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.648 ' H ' HG23 ' A' ' 98' ' ' ILE . 4.6 m-20 -59.19 -46.85 99.23 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 113.029 0.751 . . . . 52.229999999999997 113.029 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.1 Cg_exo -42.67 -38.4 6.4 Favored 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.935 2.423 . . . . 73.430000000000007 114.289 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.42 -49.38 10.03 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.686 0.279 . . . . 74.219999999999999 111.053 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 98' ' ' ILE . 86.1 mt -51.28 -44.06 61.73 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.421 0.526 . . . . 52.509999999999998 112.421 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.3 t -57.24 -42.28 81.15 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.699 0.285 . . . . 71.129999999999995 111.655 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -59.32 -46.84 87.48 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.89 0.376 . . . . 74.519999999999996 111.271 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 110' ' ' LEU . 78.0 m-85 -63.22 -52.21 63.15 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.123 0.487 . . . . 71.439999999999998 111.135 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -54.62 -45.02 73.62 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.571 -0.74 . . . . 71.25 112.415 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -74.28 -56.1 5.26 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.569 0.581 . . . . 73.299999999999997 112.569 -175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.37 -40.96 96.22 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.508 0.558 . . . . 64.340000000000003 112.508 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 119.2 17.54 4.88 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 120.968 -0.634 . . . . 70.129999999999995 112.774 -175.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.719 HD23 ' H ' ' A' ' 83' ' ' GLN . 59.7 mt -73.31 102.9 3.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.064 0.459 . . . . 72.439999999999998 110.384 177.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.9 m -63.58 102.74 0.46 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.109 -0.496 . . . . 74.420000000000002 111.971 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -85.7 132.24 34.18 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.92 -0.582 . . . . 74.310000000000002 111.171 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.54 ' HB3' ' H ' ' A' ' 87' ' ' ILE . . . -55.66 -76.69 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.773 0.286 . . . . 71.200000000000003 111.773 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -164.69 88.54 1.05 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.966 0.412 . . . . 53.539999999999999 111.253 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -84.06 112.03 1.69 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.649 2.233 . . . . 73.329999999999998 113.859 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.603 ' HB3' HH21 ' A' ' 118' ' ' ARG . . . -170.28 -173.17 1.42 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.581 -0.281 . . . . 33.200000000000003 111.209 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.6 pt -142.71 88.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.233 0.539 . . . . 74.150000000000006 111.525 176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.603 HH21 ' HB3' ' A' ' 116' ' ' ALA . 8.4 ptp180 -104.87 -18.63 14.15 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.759 0.314 . . . . 75.129999999999995 111.658 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.67 111.39 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.043 0.449 . . . . 71.450000000000003 110.806 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -58.97 -48.68 80.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.04 -0.527 . . . . 74.010000000000005 112.138 -177.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.48 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 8.7 tt0 -158.81 -49.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.083 0.468 . . . . 65.310000000000002 111.335 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -114.49 117.85 42.27 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.337 -0.392 . . . . 74.400000000000006 111.662 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.55 126.45 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.376 2.05 . . . . 63.100000000000001 112.423 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.4 p -78.14 172.29 13.77 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.571 0.224 . . . . 62.439999999999998 110.924 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -53.63 -30.8 44.56 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.751 0.278 . . . . 70.439999999999998 111.751 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -52.95 -32.37 45.58 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.161 0.505 . . . . 70.010000000000005 111.081 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 m -61.19 -48.49 81.32 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.054 -0.521 . . . . 73.109999999999999 110.908 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -58.81 -51.51 69.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.192 -0.458 . . . . 65.230000000000004 111.248 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -33.76 76.3 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.22 -0.445 . . . . 73.019999999999996 112.097 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.24 -60.04 2.5 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.043 0.449 . . . . 52.409999999999997 110.914 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.3 m -59.99 -27.86 67.21 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.262 -0.426 . . . . 73.340000000000003 112.084 -176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.456 ' HA ' HG12 ' A' ' 20' ' ' ILE . 40.0 tt0 -52.43 -50.96 61.53 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.404 -0.362 . . . . 72.519999999999996 111.896 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.8 -46.89 85.89 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.735 0.303 . . . . 74.019999999999996 111.316 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -55.42 -48.94 73.65 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.914 0.388 . . . . 65.040000000000006 111.604 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.83 -38.72 94.62 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.097 -0.573 . . . . 70.0 113.108 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 99.7 m -63.35 -49.15 75.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.733 0.302 . . . . 72.25 111.186 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.12 -37.49 80.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.1 0.476 . . . . 72.439999999999998 110.751 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 142' ' ' VAL . 3.4 tm? -59.16 -51.59 69.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 74.230000000000004 110.237 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -57.97 -44.2 94.64 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.278 -0.487 . . . . 34.409999999999997 112.762 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.06 -30.84 71.26 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.230000000000004 111.331 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 88.5 t90 -71.65 -51.52 22.68 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.187 0.518 . . . . 74.310000000000002 110.833 176.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 138' ' ' LEU . 77.2 t -54.43 -46.88 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.279 -0.419 . . . . 62.329999999999998 112.005 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' ' 29' ' ' VAL . 7.4 t -62.41 -37.98 87.9 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.8 0.667 . . . . 71.510000000000005 112.8 -177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 141' ' ' TRP . 8.0 ptp180 -75.32 -41.38 56.92 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.076 -0.39 . . . . 71.219999999999999 111.54 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -89.19 -14.54 35.82 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.952 0.723 . . . . 72.530000000000001 112.952 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -65.77 -34.65 78.67 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.42 0.629 . . . . 64.219999999999999 109.673 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.5 tp -85.08 -78.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.433 -0.803 . . . . 74.299999999999997 109.818 171.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.756 ' HA ' ' HB3' ' A' ' 151' ' ' HIS . 33.1 tt0 -178.02 104.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.273 0.558 . . . . 72.329999999999998 112.231 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -114.83 -64.7 1.28 Allowed 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.254 -0.647 . . . . 75.299999999999997 109.254 169.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -120.4 25.8 9.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.979 -1.119 . . . . 75.329999999999998 107.979 168.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.756 ' HB3' ' HA ' ' A' ' 148' ' ' GLU . 20.8 t-80 -86.16 77.16 9.64 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.286 -1.325 . . . . 73.040000000000006 112.364 -170.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -88.57 78.3 7.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.422 0.63 . . . . 72.109999999999999 109.9 171.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 173.95 167.02 0.2 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.232 -0.895 . . . . 74.5 109.222 -173.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 . . . . . 0 C--O 1.256 1.429 0 CA-C-O 118.145 -0.931 . . . . 75.209999999999994 110.212 171.525 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.281 0.086 . . . . 64.099999999999994 110.779 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.7 mm 63.49 96.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-O 121.246 0.545 . . . . 75.010000000000005 110.919 -174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -80.55 108.86 2.86 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.723 -0.751 . . . . 72.129999999999995 112.622 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 4' ' ' VAL . 7.2 p -88.17 105.02 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.732 0.777 . . . . 52.240000000000002 111.203 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.56 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 88.1 m-85 -99.57 98.27 9.17 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.633 -0.712 . . . . 75.519999999999996 111.107 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.53 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 9.5 p90 -119.06 157.93 26.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.453 0.644 . . . . 64.420000000000002 112.349 -176.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.619 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 43.6 t -104.66 101.29 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.822 -0.626 . . . . 71.340000000000003 112.066 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.0 m -63.26 -23.83 67.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.438 0.637 . . . . 62.109999999999999 111.341 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -78.22 -20.59 51.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.783 -0.644 . . . . 64.329999999999998 112.407 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -137.24 132.67 34.14 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.11 0.782 . . . . 60.219999999999999 113.11 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' HA3' HG21 ' A' ' 90' ' ' THR . . . 56.36 -163.62 5.71 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 115.336 0.894 . . . . 74.329999999999998 115.336 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.84 7.52 10.29 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.502 0.556 . . . . 75.120000000000005 112.502 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.53 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 53.3 m -35.64 -47.88 0.5 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.987 1.106 . . . . 50.020000000000003 113.987 -172.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -54.66 -52.37 62.55 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.149 0.499 . . . . 64.299999999999997 111.687 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -77.3 -25.33 51.19 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 111.931 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 96.8 mt -66.39 -48.14 71.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.356 0.598 . . . . 72.040000000000006 110.087 172.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 21' ' ' ILE . . . -64.79 -43.71 92.3 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.635 -0.711 . . . . 70.120000000000005 111.268 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -51.26 -40.19 58.32 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.09 -0.504 . . . . 75.400000000000006 111.484 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.89 89.91 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.95 0.405 . . . . 71.319999999999993 111.343 176.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 63.5 mt -61.9 -52.34 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.123 0.487 . . . . 72.420000000000002 111.351 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 31' ' ' VAL . 65.3 mt -55.08 -49.51 71.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.738 -0.665 . . . . 60.420000000000002 111.544 -178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.77 -36.41 69.78 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.341 -0.39 . . . . 43.210000000000001 111.82 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.26 -46.46 42.18 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.088 -0.577 . . . . 52.009999999999998 113.258 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -65.68 -43.97 93.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.811 0.338 . . . . 74.530000000000001 111.572 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.8 p -63.53 -38.37 90.87 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.973 0.416 . . . . 71.340000000000003 111.164 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -64.8 -21.12 66.71 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.304 0.573 . . . . 75.219999999999999 111.285 176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.7 m -85.43 -17.84 35.4 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.156 -0.475 . . . . 72.140000000000001 111.438 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.26 16.71 10.82 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.302 -0.475 . . . . 54.030000000000001 113.848 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.8 t -122.14 138.39 52.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 117.212 0.506 . . . . 71.140000000000001 111.443 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.19 139.24 19.57 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 121.116 -0.564 . . . . 71.219999999999999 112.932 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 21' ' ' ILE . 29.8 t -105.79 141.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.84 0.352 . . . . 75.5 111.582 -176.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' HB2' ' HA2' ' A' ' 3' ' ' GLY . 22.6 m-20 -93.49 106.49 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.113 0.483 . . . . 71.200000000000003 111.134 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.8 m -87.6 109.02 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 121.349 0.595 . . . . 62.43 112.224 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.9 t -118.49 112.5 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.054 0.454 . . . . 64.109999999999999 111.404 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.48 76.46 8.23 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.385 -0.371 . . . . 71.319999999999993 111.234 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 37' ' ' GLY . 2.0 pp -70.31 -23.83 62.92 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.912 -0.493 . . . . 73.109999999999999 111.319 177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 7' ' ' VAL . . . -87.94 47.79 3.59 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 121.289 -0.481 . . . . 55.049999999999997 112.291 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.97 -65.95 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.942 0.497 . . . . 54.520000000000003 110.516 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -170.16 130.1 0.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.254 -0.43 . . . . 75.219999999999999 111.397 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.33 150.7 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 111.641 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -144.82 165.49 27.94 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.458 -0.337 . . . . 71.299999999999997 111.238 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.5 mm? -59.56 -26.27 65.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.147 0.425 . . . . 64.519999999999996 112.147 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -56.41 -50.52 71.4 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.994 0.426 . . . . 72.030000000000001 111.917 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -83.3 -33.92 25.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.567 -0.288 . . . . 71.049999999999997 111.274 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 89.1 mt -60.37 -29.45 68.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.627 0.251 . . . . 61.229999999999997 111.613 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.13 -39.02 89.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.181 0.515 . . . . 74.109999999999999 110.802 174.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -71.01 -25.72 62.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.326 -0.397 . . . . 61.520000000000003 111.912 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.0 tp -53.22 -28.91 29.43 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.907 0.384 . . . . 62.219999999999999 111.255 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.37 -49.67 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 116.312 -0.404 . . . . 72.209999999999994 111.865 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.68 -20.42 63.81 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.094 -0.574 . . . . 61.119999999999997 114.309 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -100.71 5.7 43.77 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 122.244 -0.563 . . . . 73.340000000000003 111.43 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.5 p -64.72 -7.38 10.6 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.648 0.981 . . . . 71.540000000000006 113.648 -172.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.1 p -60.58 -42.93 97.67 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.139 0.422 . . . . 75.430000000000007 112.139 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.26 135.35 6.59 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.989 -0.624 . . . . 33.119999999999997 112.34 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.2 mp -133.3 152.38 51.93 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 74.400000000000006 111.287 -176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -130.36 92.48 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.452 -0.34 . . . . 73.409999999999997 110.175 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.3 mp -99.92 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.178 0.513 . . . . 63.420000000000002 111.786 -174.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.82 151.73 17.87 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.33 -0.462 . . . . 43.210000000000001 112.714 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.499 ' SD ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -53.09 142.01 21.28 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.361 0.6 . . . . 71.140000000000001 112.559 176.793 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 95' ' ' ASP . 92.5 p -132.82 124.15 18.59 Favored Pre-proline 0 N--CA 1.47 0.539 0 N-CA-C 112.405 0.521 . . . . 60.030000000000001 112.405 -173.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.19 166.14 28.28 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.27 1.98 . . . . 72.409999999999997 112.149 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -29.36 -62.8 0.12 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.152 1.538 . . . . 74.230000000000004 115.152 -170.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.35 -38.14 70.97 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.399 0.518 . . . . 73.219999999999999 112.399 -175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.8 m -84.14 -39.67 19.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.329 -0.396 . . . . 43.229999999999997 111.215 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.72 68.6 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.864 0.364 . . . . 74.209999999999994 111.315 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.11 -36.66 70.92 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 50.119999999999997 111.298 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.2 m -63.47 -48.34 78.07 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.148 0.499 . . . . 74.030000000000001 110.748 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 61.7 mt -63.79 -52.47 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 116.099 -0.501 . . . . 75.549999999999997 111.611 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.84 -26.7 67.78 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.396 -0.366 . . . . 75.209999999999994 111.373 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.93 -42.25 38.3 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.027 -0.606 . . . . 73.230000000000004 112.159 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.18 5.78 18.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.927 0.343 . . . . 53.140000000000001 111.927 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -46.0 -48.4 16.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.115 0.566 . . . . 62.200000000000003 111.457 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 49.3 m -53.72 -37.48 63.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.135 -0.484 . . . . 73.140000000000001 111.939 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -77.72 -44.51 27.62 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.344 -0.389 . . . . 74.310000000000002 111.357 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -55.16 -58.86 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 112.173 0.434 . . . . 71.239999999999995 112.173 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.15 -23.68 67.55 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.061 0.393 . . . . 64.239999999999995 112.061 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -82.31 -25.04 52.83 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.026 -0.606 . . . . 65.510000000000005 112.99 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 m -85.52 -38.0 19.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.146 0.424 . . . . 64.430000000000007 112.146 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.27 125.06 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.253 0.549 . . . . 70.319999999999993 111.89 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -128.63 158.3 38.91 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.261 0.553 . . . . 74.530000000000001 112.122 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.659 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 44.1 tt0 62.37 -85.64 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.502 0.927 . . . . 74.010000000000005 113.502 168.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.659 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 65.2 pttt -165.04 23.51 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.394 -0.191 . . . . 74.409999999999997 111.48 -173.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.518 HE21 ' H ' ' A' ' 82' ' ' LYS . 14.7 mm-40 -50.79 158.33 0.68 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.137 0.791 . . . . 63.240000000000002 113.137 -169.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.15 117.64 28.28 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.617 0.599 . . . . 62.119999999999997 112.617 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.14 112.29 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 121.532 0.682 . . . . 54.43 111.894 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -100.12 145.05 17.16 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.111 -0.495 . . . . 34.530000000000001 112.102 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 42.7 mm -129.12 139.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 117.12 0.46 . . . . 73.319999999999993 111.519 -177.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -128.41 150.75 49.99 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 74.200000000000003 110.694 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 36.2 tt0 -127.91 150.91 49.67 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.002 0.371 . . . . 71.349999999999994 112.002 -174.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.499 HG22 ' SD ' ' A' ' 59' ' ' MET . 11.4 t -136.05 10.83 3.32 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.755 0.312 . . . . 73.319999999999993 111.481 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.504 ' H ' ' HG2' ' A' ' 89' ' ' GLU . . . -130.24 -85.75 0.39 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 121.456 -0.402 . . . . 62.140000000000001 112.985 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.1 -12.35 5.55 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.999 -0.62 . . . . 44.509999999999998 114.071 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.66 44.51 0.75 Allowed Glycine 0 N--CA 1.463 0.448 0 C-N-CA 121.153 -0.546 . . . . 64.430000000000007 112.059 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.53 -173.27 3.44 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.599 0.36 . . . . 74.420000000000002 111.596 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 60' ' ' SER . 19.9 t70 74.09 116.99 0.05 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.578 0.751 . . . . 71.409999999999997 111.938 -178.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -79.21 -47.47 1.6 Allowed Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 113.523 0.935 . . . . 72.200000000000003 113.523 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.05 9.54 2.37 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.181 1.921 . . . . 73.450000000000003 114.705 -174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.9 tt -46.82 -64.28 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.393 0.886 . . . . 72.310000000000002 113.393 -178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.641 ' H ' HG23 ' A' ' 98' ' ' ILE . 13.5 m-20 -67.92 -49.43 37.0 Favored Pre-proline 0 CA--C 1.545 0.757 0 O-C-N 121.715 -0.616 . . . . 51.109999999999999 112.593 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 79.8 Cg_exo -44.76 -39.52 13.76 Favored 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 122.444 2.096 . . . . 71.310000000000002 113.651 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.5 mt -77.18 -62.37 1.68 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.752 0.279 . . . . 71.519999999999996 111.752 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.2 mt -56.96 -47.85 79.74 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.415 0.524 . . . . 54.240000000000002 112.415 -175.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.7 t -59.37 -32.32 70.02 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.951 0.405 . . . . 43.130000000000003 111.557 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -78.89 -42.58 26.87 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.406 -0.361 . . . . 72.030000000000001 111.374 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -60.04 -29.01 68.23 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 111.908 0.336 . . . . 72.030000000000001 111.908 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -55.86 -36.28 67.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.011 0.374 . . . . 74.310000000000002 112.011 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.42 -21.63 61.23 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.944 0.402 . . . . 71.310000000000002 111.829 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 108' ' ' LEU . 6.8 mp -92.95 -68.77 0.78 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.914 0.388 . . . . 74.129999999999995 110.73 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 117.16 67.16 0.37 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.218 -0.515 . . . . 71.239999999999995 113.519 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 110' ' ' LEU . 6.4 mp -95.58 144.61 25.89 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 122.686 -0.303 . . . . 71.530000000000001 110.775 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 89.6 m -65.59 109.55 2.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.028 0.442 . . . . 64.409999999999997 111.524 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.5 m -86.44 135.01 33.65 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.279 -0.418 . . . . 62.299999999999997 111.313 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.78 -92.62 0.05 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.453 0.538 . . . . 70.140000000000001 112.453 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -144.71 91.77 6.05 Favored Pre-proline 0 N--CA 1.477 0.905 0 O-C-N 122.323 -0.236 . . . . 74.299999999999997 111.539 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -96.22 9.27 1.53 Allowed 'Trans proline' 0 CA--C 1.547 1.142 0 C-N-CA 122.979 2.453 . . . . 73.299999999999997 113.884 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.72 32.66 0.96 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.263 0.838 . . . . 74.209999999999994 113.263 -172.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.4 ' C ' ' HD3' ' A' ' 118' ' ' ARG . 13.1 tt -146.39 134.49 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.815 -0.553 . . . . 71.530000000000001 112.248 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER -129.96 155.16 46.54 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.076 0.465 . . . . 65.030000000000001 111.17 175.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 121' ' ' GLN . 2.1 mp -95.57 150.13 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 CA-C-N 116.2 -0.454 . . . . 54.130000000000003 111.308 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -62.89 -44.91 94.82 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.097 0.475 . . . . 74.450000000000003 111.93 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.504 ' H ' HG22 ' A' ' 119' ' ' ILE . 58.1 tt0 -178.36 -63.8 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.832 -0.622 . . . . 74.420000000000002 109.656 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p -119.52 115.0 34.17 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.802 -0.635 . . . . 72.129999999999995 110.559 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.461 ' HB2' ' OG1' ' A' ' 127' ' ' THR . 96.0 Cg_endo -77.43 -170.78 1.0 Allowed 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.819 2.346 . . . . 73.219999999999999 113.564 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 69.1 p -131.22 -169.08 2.11 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.121 0.486 . . . . 72.109999999999999 111.723 -177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 5.0 mp0 -59.06 -26.44 64.61 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.214 -0.448 . . . . 70.420000000000002 111.939 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -58.52 -35.87 72.94 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.282 -0.417 . . . . 74.439999999999998 111.685 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.461 ' OG1' ' HB2' ' A' ' 123' ' ' PRO . 30.6 m -60.3 -39.72 87.95 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.015 0.436 . . . . 62.299999999999997 111.389 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -59.97 -50.81 72.3 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.177 0.513 . . . . 71.349999999999994 110.895 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -62.6 -36.21 82.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.766 -0.652 . . . . 75.010000000000005 111.289 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.2 tt -61.48 -44.93 96.23 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.037 -0.529 . . . . 74.129999999999995 110.264 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 89.2 m -59.19 -42.57 91.16 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.134 -0.485 . . . . 55.509999999999998 111.502 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -58.68 -49.33 77.93 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.055 0.455 . . . . 62.030000000000001 111.226 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -58.77 -49.41 77.74 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.142 -0.481 . . . . 75.510000000000005 111.385 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.99 -51.92 67.2 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.092 -0.504 . . . . 44.130000000000003 112.006 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.89 -43.06 98.39 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.168 -0.539 . . . . 71.430000000000007 113.145 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 96.3 m -60.31 -44.91 95.0 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.665 0.269 . . . . 74.120000000000005 111.627 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.77 -48.62 80.96 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.879 0.371 . . . . 65.409999999999997 110.973 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.31 -43.15 92.66 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.337 -0.392 . . . . 60.310000000000002 111.048 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 143' ' ' THR . . . -58.7 -42.42 96.32 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.112 -0.566 . . . . 43.450000000000003 112.918 176.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -62.3 -35.12 78.06 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.672 0.272 . . . . 72.0 111.321 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.5 t90 -65.92 -47.51 74.49 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.849 0.357 . . . . 72.120000000000005 111.343 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.0 t -58.89 -53.07 52.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 111.937 0.347 . . . . 42.420000000000002 111.937 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 139' ' ' GLY . 2.9 t -62.06 -34.82 76.97 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-O 121.042 0.449 . . . . 64.430000000000007 111.248 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.522 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 43.6 ttm180 -63.97 -37.67 88.25 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.197 -0.456 . . . . 73.239999999999995 111.476 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.69 ' HA ' ' HA ' ' A' ' 149' ' ' HIS . 16.8 t70 -80.04 -44.9 19.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.858 0.361 . . . . 74.230000000000004 111.787 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -76.61 -7.84 56.04 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 113.318 0.859 . . . . 54.140000000000001 113.318 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt -93.29 -48.72 6.3 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.492 -0.558 . . . . 73.439999999999998 109.492 170.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -136.68 -74.9 0.43 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.185 -0.462 . . . . 61.0 110.712 173.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 75.3 t60 174.96 -48.88 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.659 0.784 . . . . 74.030000000000001 110.097 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.3 t60 -121.77 -6.85 9.08 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.368 -0.378 . . . . 71.340000000000003 111.655 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -123.74 149.04 46.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.759 0.314 . . . . 71.209999999999994 111.77 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.522 ' HB3' ' HA ' ' A' ' 144' ' ' ARG . 3.7 p80 -156.78 85.1 0.96 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.44 0.638 . . . . 72.5 110.632 169.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -67.68 -70.49 0.25 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.259 -0.428 . . . . 62.219999999999999 111.447 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 . . . . . 0 C--O 1.254 1.341 0 CA-C-O 119.253 -0.404 . . . . 55.140000000000001 111.731 -179.694 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 75.5 m . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 111.25 0.093 . . . . 65.299999999999997 111.25 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 48.1 mm 62.65 108.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.183 0.516 . . . . 62.229999999999997 111.898 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.68 117.01 4.34 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.914 -0.66 . . . . 65.019999999999996 113.04 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -92.54 115.85 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.411 0.624 . . . . 63.340000000000003 111.979 178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 3.1 m-85 -94.69 112.77 24.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.854 -0.612 . . . . 71.120000000000005 111.21 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -135.02 148.92 50.07 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.179 0.514 . . . . 75.349999999999994 112.225 -178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.615 HG22 HD11 ' A' ' 36' ' ' LEU . 15.1 t -112.86 95.43 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 115.956 -0.565 . . . . 72.340000000000003 111.096 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.4 m -56.14 -16.16 4.76 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.033 0.444 . . . . 62.240000000000002 112.038 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -90.27 -25.13 20.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.535 0.569 . . . . 72.420000000000002 112.535 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -128.18 123.76 35.1 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.479 0.918 . . . . 74.129999999999995 113.479 -170.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.69 -163.61 4.86 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 115.626 1.01 . . . . 51.0 115.626 171.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.403 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 93.7 m-85 -75.03 -0.86 20.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.044 0.757 . . . . 55.149999999999999 113.044 -174.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.3 p -59.28 -31.02 68.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.225 0.536 . . . . 73.239999999999995 110.351 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.84 -37.97 72.02 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.467 -0.788 . . . . 74.010000000000005 111.266 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 15' ' ' ARG . 5.1 mmp_? -85.85 -38.41 18.14 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.33 -0.395 . . . . 73.430000000000007 111.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.9 mt -50.45 -47.25 56.95 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.529 -0.305 . . . . 71.019999999999996 111.792 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.45 65.99 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.104 0.409 . . . . 53.340000000000003 112.104 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.93 -32.58 73.91 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.435 -0.348 . . . . 72.439999999999998 111.568 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.46 -41.96 31.2 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.824 0.345 . . . . 73.209999999999994 111.279 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 16' ' ' LEU . 71.9 mt -59.47 -56.06 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.884 0.373 . . . . 75.409999999999997 111.885 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.3 tt -58.61 -30.61 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.979 0.419 . . . . 71.120000000000005 111.81 -177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -72.82 -53.1 12.38 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.037 0.446 . . . . 72.530000000000001 111.182 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.537 ' HA3' ' HG3' ' A' ' 132' ' ' GLU . . . -63.58 -44.74 96.08 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.188 -0.46 . . . . 73.439999999999998 114.082 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.89 -52.05 48.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.381 0.511 . . . . 72.140000000000001 112.381 -175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -59.46 -34.49 72.59 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.031 0.443 . . . . 51.140000000000001 112.01 -176.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -84.53 5.76 26.35 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.502 0.556 . . . . 75.099999999999994 112.502 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.491 ' HA ' ' HE2' ' A' ' 153' ' ' HIS . 32.4 m -126.25 -47.78 1.6 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.789 0.328 . . . . 73.409999999999997 111.702 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.85 -89.32 0.75 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 120.997 -0.62 . . . . 64.310000000000002 113.585 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.86 172.31 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 112.164 0.431 . . . . 64.099999999999994 112.164 -175.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -72.03 157.61 53.05 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.397 -0.43 . . . . 61.32 113.652 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 1' ' ' SER . 38.8 t -108.73 148.35 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.527 0.331 . . . . 73.319999999999993 111.867 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -105.45 128.27 53.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.821 0.343 . . . . 43.409999999999997 110.858 173.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.68 138.9 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.538 0.569 . . . . 64.040000000000006 112.538 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.53 96.98 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 121.145 0.497 . . . . 74.109999999999999 111.277 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.64 86.83 6.33 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.314 -0.403 . . . . 75.329999999999998 110.955 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 7' ' ' VAL . 3.5 pp -91.29 -23.87 20.01 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.331 0.493 . . . . 70.120000000000005 112.331 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -78.99 47.99 3.23 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.027 -0.606 . . . . 61.039999999999999 113.303 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -171.91 -167.27 0.48 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.76 0.424 . . . . 74.430000000000007 110.691 -176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.58 104.28 5.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.854 0.359 . . . . 62.200000000000003 111.028 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.74 175.1 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.503 -0.317 . . . . 71.519999999999996 111.601 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -140.48 160.49 39.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.307 0.575 . . . . 71.340000000000003 112.331 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.5 tm? -55.16 -35.51 64.84 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.805 -0.634 . . . . 60.420000000000002 111.989 -177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.3 mt-30 -50.78 -43.38 58.55 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.083 0.468 . . . . 74.319999999999993 111.457 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.15 -24.36 64.07 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.001 -0.545 . . . . 53.210000000000001 111.445 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.99 -51.17 34.6 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.338 -0.392 . . . . 74.150000000000006 110.815 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -61.65 -32.64 72.8 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.83 0.347 . . . . 73.140000000000001 111.034 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 71.4 mm-40 -60.62 -48.87 79.86 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.034 0.445 . . . . 63.509999999999998 110.641 173.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.02 -39.35 71.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.887 -0.597 . . . . 64.230000000000004 111.812 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.9 t -56.8 -35.09 45.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.157 0.503 . . . . 72.109999999999999 111.186 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -85.36 -10.81 76.66 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.225 -0.512 . . . . 52.329999999999998 113.163 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -101.45 4.58 41.43 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 122.396 -0.473 . . . . 52.130000000000003 111.569 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.2 p -69.58 1.76 3.8 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.565 0.95 . . . . 74.230000000000004 113.565 -172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 60.5 p -64.15 -42.09 96.9 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.208 0.527 . . . . 62.100000000000001 110.838 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.59 136.59 5.35 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-N 115.803 -0.635 . . . . 51.439999999999998 112.32 175.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -160.81 148.41 15.75 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 122.496 -0.414 . . . . 74.329999999999998 111.657 -177.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -112.26 125.31 69.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.98 0.419 . . . . 71.519999999999996 110.974 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' ILE . 47.5 mt -128.92 136.27 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.064 0.459 . . . . 74.200000000000003 112.191 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.69 -163.88 34.13 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.146 -0.549 . . . . 62.43 112.401 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.6 mtm -98.17 135.26 40.08 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.018 -0.695 . . . . 72.349999999999994 110.648 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.9 p -79.62 150.8 73.57 Favored Pre-proline 0 N--CA 1.468 0.455 0 N-CA-C 112.199 0.444 . . . . 62.43 112.199 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 64' ' ' SER . 16.5 Cg_endo -90.85 157.59 4.07 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.831 2.354 . . . . 65.530000000000001 111.78 169.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.97 -31.58 29.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.174 0.435 . . . . 70.329999999999998 112.174 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.84 -33.02 73.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.975 0.361 . . . . 54.329999999999998 111.975 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.536 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 38.9 m -95.76 -13.21 24.31 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.685 0.278 . . . . 71.439999999999998 111.679 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.73 -42.4 35.1 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.86 0.689 . . . . 74.030000000000001 112.86 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.96 -47.08 78.28 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.99 0.424 . . . . 62.530000000000001 111.853 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.3 m -67.13 -45.82 75.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.147 0.498 . . . . 64.439999999999998 111.401 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.2 -46.96 91.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.981 -0.554 . . . . 75.129999999999995 112.155 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -57.82 -35.56 71.03 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.821 0.343 . . . . 75.450000000000003 111.895 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.83 -43.38 28.17 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.062 -0.59 . . . . 73.310000000000002 113.072 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.35 -26.07 51.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.225 0.454 . . . . 60.340000000000003 112.225 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.444 HD22 HD11 ' A' ' 101' ' ' LEU . 52.1 tp -52.8 -37.38 59.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.066 0.395 . . . . 64.150000000000006 112.066 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.8 t -59.12 -43.97 91.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.944 0.402 . . . . 63.109999999999999 111.324 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 86.9 m -68.63 -36.1 78.17 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.171 0.51 . . . . 72.349999999999994 111.004 177.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 79' ' ' VAL . 67.7 mt -61.96 -59.26 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.266 -0.425 . . . . 71.510000000000005 111.009 176.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.57 -30.16 65.03 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.251 0.463 . . . . 62.539999999999999 112.251 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.15 -24.04 67.21 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.127 -0.559 . . . . 65.310000000000002 113.439 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.1 p -97.97 -48.36 5.18 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.304 0.483 . . . . 74.129999999999995 112.304 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.8 m -77.88 85.99 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-O 122.033 0.92 . . . . 75.239999999999995 111.687 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.24 -178.12 4.83 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.862 -0.608 . . . . 73.230000000000004 112.144 -178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 65.74 -77.27 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.249 0.62 . . . . 45.399999999999999 111.981 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -168.35 29.33 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.9 0.704 . . . . 71.340000000000003 112.9 175.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -62.58 160.99 12.83 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.095 0.474 . . . . 75.329999999999998 111.647 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 138' ' ' LEU . . . -89.19 95.62 10.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.012 0.745 . . . . 72.109999999999999 113.012 -170.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 85' ' ' VAL . 18.4 m -102.67 92.95 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.76 0.791 . . . . 63.340000000000003 111.551 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.55 72.72 2.5 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 116.029 -0.532 . . . . 75.310000000000002 113.367 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 12.0 tt -96.54 133.67 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 O-C-N 122.639 -0.33 . . . . 73.409999999999997 111.035 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' CZ ' ' SG ' ' A' ' 131' ' ' CYS . 8.0 p90 -146.79 173.42 12.4 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.152 0.501 . . . . 75.420000000000002 112.206 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.05 96.61 0.15 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.239 0.542 . . . . 70.239999999999995 112.323 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 91.2 m -131.43 94.02 3.46 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.262 -0.426 . . . . 60.200000000000003 110.512 173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 138.65 168.63 11.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 121.355 -0.45 . . . . 31.420000000000002 112.629 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.496 ' HA3' ' OE1' ' A' ' 121' ' ' GLN . . . -114.52 -135.12 5.9 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.852 -0.689 . . . . 64.349999999999994 114.022 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.92 77.06 1.8 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.319 -0.467 . . . . 41.409999999999997 113.125 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.3 -179.86 7.25 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 122.631 -0.335 . . . . 72.340000000000003 110.734 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.3 t70 70.89 154.82 0.14 Allowed 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.868 0.692 . . . . 54.130000000000003 112.868 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.1 mt-10 -104.63 -57.36 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 112.755 0.65 . . . . 71.349999999999994 112.755 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 57.4 Cg_endo -68.51 -1.98 8.4 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.322 2.014 . . . . 65.230000000000004 113.996 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.8 tp -50.99 -45.1 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 N-CA-C 112.734 0.642 . . . . 73.400000000000006 112.734 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.704 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 5.5 m-20 -58.21 -55.74 42.33 Favored Pre-proline 0 CA--C 1.552 1.038 0 N-CA-C 111.997 0.369 . . . . 52.409999999999997 111.997 -178.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.704 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 82.6 Cg_exo -50.24 -48.99 17.64 Favored 'Trans proline' 0 C--N 1.362 1.26 0 C-N-CA 122.328 2.019 . . . . 74.310000000000002 113.358 173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' PRO . 11.2 mp -56.74 -51.98 66.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.06 0.393 . . . . 54.409999999999997 112.06 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 92.6 mt -53.44 -52.03 60.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.797 0.332 . . . . 73.109999999999999 111.67 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t -66.93 -34.46 77.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.776 0.322 . . . . 74.319999999999993 111.581 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.573 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 1.4 tpmt? -59.86 -60.85 3.17 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.841 0.353 . . . . 54.329999999999998 111.305 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -63.58 -30.85 71.91 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.533 -0.303 . . . . 64.420000000000002 111.55 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 102' ' ' LEU . 0.7 OUTLIER -59.5 -45.83 90.56 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.868 0.366 . . . . 64.120000000000005 110.378 176.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.52 -47.95 62.11 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.208 -0.451 . . . . 72.549999999999997 110.666 178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.9 mt -56.74 -48.7 77.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.866 0.365 . . . . 75.430000000000007 111.52 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 59.53 71.83 0.71 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 114.654 0.622 . . . . 35.240000000000002 114.654 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 110' ' ' LEU . 6.0 mp -90.93 -177.31 4.91 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.415 -0.461 . . . . 64.340000000000003 110.415 173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.2 m -63.83 101.89 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.123 0.416 . . . . 74.349999999999994 112.123 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.4 p -105.64 137.39 43.57 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.065 0.459 . . . . 70.140000000000001 111.565 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.41 -58.01 3.01 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.886 0.375 . . . . 50.240000000000002 111.796 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -167.78 89.83 0.69 Allowed Pre-proline 0 CA--C 1.543 0.686 0 CA-C-O 120.735 0.302 . . . . 74.230000000000004 110.453 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -83.01 -33.56 0.4 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.62 2.214 . . . . 73.409999999999997 114.368 -175.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.49 118.03 28.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.27 0.47 . . . . 62.32 112.27 -173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.507 HG23 HG12 ' A' ' 119' ' ' ILE . 12.6 tt -137.78 7.84 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 121.322 0.582 . . . . 73.510000000000005 111.779 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.6 mtt180 67.73 65.56 0.38 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.026 0.53 . . . . 72.510000000000005 112.429 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 123' ' ' PRO . 50.8 mm -104.62 111.67 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.136 0.493 . . . . 74.109999999999999 111.115 177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -93.53 -23.13 18.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.234 -0.439 . . . . 71.019999999999996 111.683 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.496 ' OE1' ' HA3' ' A' ' 92' ' ' GLY . 6.0 tp-100 -161.48 -65.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.021 0.438 . . . . 64.129999999999995 111.291 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.7 p -104.04 125.67 33.82 Favored Pre-proline 0 N--CA 1.472 0.674 0 N-CA-C 112.208 0.448 . . . . 73.409999999999997 112.208 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HA ' HD12 ' A' ' 119' ' ' ILE . 52.2 Cg_exo -55.93 150.23 47.63 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.545 2.163 . . . . 74.450000000000003 112.456 170.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 54.8 p -118.93 -176.12 3.05 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.19 0.441 . . . . 73.109999999999999 112.19 -174.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -46.63 -48.41 19.86 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.104 -0.498 . . . . 64.349999999999994 112.049 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -59.96 -25.94 65.6 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.036 -0.529 . . . . 75.430000000000007 111.974 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 123' ' ' PRO . 59.2 m -63.87 -36.99 85.73 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.83 0.348 . . . . 63.310000000000002 110.856 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -66.39 -47.1 74.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.979 0.419 . . . . 75.340000000000003 110.937 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.72 -41.47 95.35 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.224 -0.443 . . . . 64.519999999999996 111.072 177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.3 tt -58.37 -54.43 47.06 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.466 -0.334 . . . . 74.519999999999996 110.238 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.408 ' HB3' HG12 ' A' ' 20' ' ' ILE . 74.4 m -50.03 -51.58 40.99 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.208 -0.451 . . . . 72.319999999999993 111.785 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.537 ' HG3' ' HA3' ' A' ' 23' ' ' GLY . 46.1 tt0 -67.17 -55.02 15.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.381 -0.372 . . . . 73.129999999999995 111.792 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.49 -54.86 42.29 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.942 0.349 . . . . 52.229999999999997 111.942 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.23 -49.6 76.47 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.4 -0.364 . . . . 54.340000000000003 111.85 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.15 -46.85 93.67 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 63.509999999999998 113.274 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 94.7 m -63.34 -51.2 66.92 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.88 0.371 . . . . 63.340000000000003 111.815 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.06 -42.63 98.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.133 0.492 . . . . 64.25 111.068 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 84' ' ' ALA . 53.7 tp -64.76 -41.24 96.04 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.053 0.454 . . . . 73.439999999999998 110.757 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -60.24 -42.72 98.82 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 116.183 -0.462 . . . . 52.210000000000001 112.68 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -60.15 -39.18 85.44 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.955 0.407 . . . . 74.140000000000001 110.926 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 59.2 t90 -59.89 -49.5 77.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.46 -0.336 . . . . 72.420000000000002 111.12 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.38 -47.91 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 112.133 0.419 . . . . 71.239999999999995 112.133 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -71.83 -41.5 68.08 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.106 0.409 . . . . 64.439999999999998 112.106 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.64 ' HA ' ' HG3' ' A' ' 148' ' ' GLU . 61.2 ttt180 -64.08 -33.16 75.12 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 111.559 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -52.6 -26.86 14.7 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.109 -0.496 . . . . 70.239999999999995 111.286 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -97.69 -63.68 1.11 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.339 -0.391 . . . . 75.219999999999999 112.013 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 147' ' ' LEU . 4.8 tt -175.64 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 111.861 0.319 . . . . 64.239999999999995 111.861 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.64 ' HG3' ' HA ' ' A' ' 144' ' ' ARG . 46.1 mt-10 74.87 146.95 0.09 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.397 0.679 . . . . 73.319999999999993 112.198 -175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -106.6 -18.11 14.05 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.165 0.507 . . . . 72.239999999999995 109.783 169.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -108.5 130.69 55.26 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.879 -0.601 . . . . 74.319999999999993 111.086 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -134.87 99.42 4.3 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.899 0.38 . . . . 64.200000000000003 110.367 171.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.6 m170 67.27 176.25 0.25 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.616 -0.72 . . . . 64.109999999999999 111.709 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 27' ' ' THR . 56.9 m80 -97.33 154.88 17.15 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.086 0.469 . . . . 75.450000000000003 112.041 -174.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.2 p80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.351 -0.833 . . . . 73.219999999999999 110.931 176.105 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 39.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.59 -0.152 . . . . 73.450000000000003 110.59 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 46.8 mm 74.55 96.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 121.31 0.576 . . . . 63.32 110.589 -172.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 32' ' ' ASP . . . -81.99 123.24 5.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.056 -0.52 . . . . 54.229999999999997 113.735 -176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.7 t -95.36 106.4 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 O-C-N 122.608 -0.348 . . . . 65.400000000000006 111.115 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.613 ' HB3' HD23 ' A' ' 36' ' ' LEU . 93.1 m-85 -90.96 105.96 18.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.925 0.393 . . . . 71.129999999999995 111.614 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 35.9 p90 -146.75 -178.59 6.26 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.434 -0.348 . . . . 72.420000000000002 110.945 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.566 HG13 ' HB3' ' A' ' 10' ' ' TYR . 2.8 p -134.55 104.64 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.089 0.471 . . . . 75.329999999999998 111.086 176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.8 m -52.48 -25.34 9.93 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.215 0.82 . . . . 73.319999999999993 113.215 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -74.08 -32.42 63.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.763 0.316 . . . . 54.409999999999997 111.644 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.566 ' HB3' HG13 ' A' ' 7' ' ' VAL . 61.0 t80 -104.31 137.41 42.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.07 0.462 . . . . 74.129999999999995 112.226 -173.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.12 -161.79 5.03 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 114.98 0.752 . . . . 63.009999999999998 114.98 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -83.63 7.56 17.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.772 0.429 . . . . 73.5 111.893 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 84.8 p -30.75 -65.65 0.12 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.279 1.214 . . . . 55.509999999999998 114.279 -174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.46 -35.04 79.7 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.085 0.402 . . . . 72.409999999999997 112.085 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -60.21 -40.29 89.59 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.092 0.472 . . . . 70.430000000000007 110.747 175.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 71.9 mt -72.44 -37.18 68.64 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 71.439999999999998 110.764 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.92 -31.64 67.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.206 -0.452 . . . . 51.329999999999998 111.352 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -52.21 -43.02 64.01 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.251 -0.431 . . . . 64.299999999999997 110.997 175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . . . -67.76 -47.29 69.65 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.972 -0.558 . . . . 61.409999999999997 111.609 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -56.74 -55.4 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.965 0.412 . . . . 62.119999999999997 111.386 178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 68.1 mt -54.03 -46.73 66.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.212 -0.449 . . . . 75.239999999999995 111.207 178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -59.17 -50.22 74.88 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.414 -0.357 . . . . 71.040000000000006 111.864 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.17 -48.77 84.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 120.819 -0.705 . . . . 74.310000000000002 113.305 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 30' ' ' GLY . 1.8 mp -72.11 -32.3 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 122.521 -0.399 . . . . 74.340000000000003 112.013 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.6 t -72.0 -30.2 64.99 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.679 -0.638 . . . . 63.210000000000001 110.628 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HB3' ' NZ ' ' A' ' 26' ' ' LYS . 4.6 mmmp? -64.99 -24.11 67.42 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.137 0.494 . . . . 74.430000000000007 110.692 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.449 HG21 ' HG2' ' A' ' 140' ' ' GLN . 60.3 m -79.07 -40.44 31.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.219 0.533 . . . . 74.239999999999995 110.474 173.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.57 21.63 7.47 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.892 -0.595 . . . . 73.140000000000001 113.492 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -99.44 -77.05 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 O-C-N 122.402 -0.47 . . . . 72.0 111.995 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 114.67 115.48 3.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.306 -0.473 . . . . 72.25 113.133 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' SER . 29.7 m -90.59 157.09 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.187 0.518 . . . . 65.329999999999998 112.247 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' CG ' ' H2 ' ' A' ' 1' ' ' SER . 9.4 m-20 -96.28 130.62 43.33 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.211 -0.449 . . . . 75.109999999999999 110.926 -179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.8 t -94.41 120.19 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.142 -0.348 . . . . 71.329999999999998 111.759 -178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.6 t -133.79 104.15 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 120.672 0.273 . . . . 60.229999999999997 111.717 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.608 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 11.4 m-20 -77.05 103.23 6.86 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.811 0.339 . . . . 74.400000000000006 111.049 173.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.613 HD23 ' HB3' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -67.96 78.81 0.22 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.968 0.89 . . . . 72.109999999999999 111.864 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.1 -25.62 0.23 Allowed Glycine 0 CA--C 1.524 0.652 0 CA-C-N 115.404 -0.816 . . . . 75.239999999999995 112.397 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.97 157.87 34.23 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.778 0.323 . . . . 43.200000000000003 111.364 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.7 70.28 2.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.207 0.527 . . . . 72.420000000000002 111.976 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.9 m -69.63 147.65 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.048 0.452 . . . . 75.430000000000007 111.527 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -101.4 166.8 10.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.98 0.419 . . . . 74.340000000000003 111.259 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD13 HD12 ' A' ' 45' ' ' LEU . 3.9 mm? -56.22 -24.4 41.87 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.451 -0.341 . . . . 74.299999999999997 111.201 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -58.74 -49.6 77.02 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.218 -0.446 . . . . 65.0 111.033 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -67.82 -46.41 71.95 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.879 0.371 . . . . 74.120000000000005 111.168 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 HD13 ' A' ' 42' ' ' LEU . 93.7 mt -57.53 -46.82 83.39 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.191 -0.459 . . . . 74.239999999999995 111.767 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -61.4 -44.92 96.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.698 0.285 . . . . 74.349999999999994 111.586 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 9.5 tp10 -64.57 -42.52 95.59 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.167 0.508 . . . . 70.209999999999994 110.83 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.2 tp -54.73 -42.06 71.1 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.969 -0.56 . . . . 74.540000000000006 111.485 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 45' ' ' LEU . 67.2 t -56.1 -37.61 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.979 0.418 . . . . 74.049999999999997 111.43 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -73.11 -21.32 79.89 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 120.964 -0.636 . . . . 54.119999999999997 112.993 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 47' ' ' GLU . 12.5 mmt180 -100.74 5.3 43.59 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.57 -0.371 . . . . 71.310000000000002 111.821 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.1 p -70.83 4.58 2.45 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.324 0.861 . . . . 75.409999999999997 113.324 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.5 p -58.96 -36.39 74.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.21 0.529 . . . . 52.520000000000003 110.927 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -154.95 138.82 6.31 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 115.624 -0.716 . . . . 14.01 112.047 177.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.3 pp -164.0 169.76 17.53 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.256 0.528 . . . . 75.340000000000003 112.196 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' A' ' 88' ' ' PHE . 7.3 p -131.46 136.24 57.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 120.767 0.318 . . . . 74.230000000000004 111.388 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.7 mp -112.69 133.16 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.936 0.398 . . . . 60.0 112.062 -175.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.93 -124.45 5.41 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.263 -0.494 . . . . 50.310000000000002 112.686 173.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.442 ' SD ' ' HA3' ' A' ' 91' ' ' GLY . 54.9 ttm -155.07 154.7 32.83 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.429 -0.454 . . . . 72.239999999999995 110.892 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.546 ' HB3' HD13 ' A' ' 36' ' ' LEU . 67.7 p -114.19 156.95 43.52 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-O 120.607 0.242 . . . . 72.150000000000006 111.38 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.43 152.14 78.78 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.951 1.767 . . . . 74.230000000000004 111.826 172.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.34 -41.08 8.54 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.422 0.897 . . . . 73.129999999999995 113.422 -173.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.48 -48.34 56.21 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.155 0.428 . . . . 72.209999999999994 112.155 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -14.49 63.06 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.027 0.38 . . . . 75.129999999999995 112.027 -177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -54.22 -32.18 55.2 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.225 0.454 . . . . 73.040000000000006 112.225 178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.19 -33.21 70.68 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.161 0.505 . . . . 75.430000000000007 111.252 177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -67.84 -42.13 81.89 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.176 -0.465 . . . . 63.530000000000001 111.296 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mt -63.5 -44.43 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.814 0.34 . . . . 51.509999999999998 110.855 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -51.62 -45.4 63.23 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.208 -0.451 . . . . 71.150000000000006 111.545 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.01 -49.47 16.43 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.047 -0.596 . . . . 64.409999999999997 113.184 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.83 76.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.005 0.372 . . . . 54.530000000000001 112.005 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 tt -48.39 -49.73 33.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.21 0.604 . . . . 74.299999999999997 111.387 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.0 m -60.13 -40.09 88.56 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.105 0.409 . . . . 71.400000000000006 112.105 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 89.2 m -74.33 -36.87 63.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.876 0.37 . . . . 72.230000000000004 111.395 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 79' ' ' VAL . 74.7 mt -71.63 -67.82 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.469 -0.332 . . . . 74.200000000000003 111.397 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.482 ' HA ' HG22 ' A' ' 79' ' ' VAL . 68.4 mt -61.65 -22.15 65.03 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.452 0.538 . . . . 75.400000000000006 112.452 -175.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.45 -22.68 64.32 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.727 -0.749 . . . . 44.299999999999997 113.259 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.3 m -101.03 -26.2 13.79 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.458 0.54 . . . . 71.230000000000004 112.458 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 75' ' ' ILE . 33.7 m -70.51 179.18 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.381 0.61 . . . . 72.409999999999997 112.417 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -79.61 161.34 25.97 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.092 -0.504 . . . . 74.099999999999994 111.691 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -46.97 -42.89 18.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.699 0.8 . . . . 62.409999999999997 112.814 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -145.92 133.03 20.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.089 0.471 . . . . 71.209999999999994 111.39 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -133.54 177.18 7.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.073 -0.512 . . . . 73.099999999999994 111.806 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.632 ' HB1' HD11 ' A' ' 138' ' ' LEU . . . -102.74 112.18 24.84 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.845 0.355 . . . . 62.350000000000001 111.24 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.7 m -113.75 169.69 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.91 0.386 . . . . 72.239999999999995 111.967 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -154.12 169.29 32.58 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.37 -0.443 . . . . 71.040000000000006 112.749 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.482 HG21 ' HB3' ' A' ' 116' ' ' ALA . 43.9 mm -100.42 146.87 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.817 0.342 . . . . 74.129999999999995 111.895 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.543 ' HB2' HG22 ' A' ' 56' ' ' VAL . 17.8 t80 -135.28 109.58 8.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.501 -0.318 . . . . 60.32 110.749 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 21.4 mp0 -64.62 93.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.557 0.577 . . . . 62.329999999999998 112.557 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.5 t -160.58 77.79 0.61 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.258 0.551 . . . . 73.329999999999998 111.819 174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.442 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . 171.31 121.51 0.59 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.091 -0.576 . . . . 35.329999999999998 113.193 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.87 51.09 4.27 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.128 -0.558 . . . . 62.240000000000002 113.407 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.69 34.32 56.76 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.281 -0.485 . . . . 62.140000000000001 113.313 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -91.6 -154.89 0.38 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.67 0.388 . . . . 71.049999999999997 111.404 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 23.3 t70 69.66 154.93 0.13 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.321 0.648 . . . . 53.329999999999998 112.593 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 8.3 mm-40 -103.42 -56.33 0.1 OUTLIER Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 116.095 -0.502 . . . . 72.140000000000001 112.31 -176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 88.4 Cg_endo -80.04 16.96 1.39 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.122 1.881 . . . . 72.109999999999999 113.759 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 ' H ' ' A' ' 99' ' ' ASP . 8.3 tt -48.0 -56.39 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 N-CA-C 113.705 1.002 . . . . 62.219999999999999 113.705 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.689 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 10.5 m-20 -61.17 -54.07 57.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 121.972 -0.455 . . . . 70.510000000000005 111.953 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.689 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 51.8 Cg_exo -54.66 -42.2 70.56 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.905 1.737 . . . . 74.340000000000003 112.654 175.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 68.8 tp -54.61 -59.52 4.59 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.984 0.421 . . . . 74.409999999999997 111.342 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.51 -35.4 79.26 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.02 0.438 . . . . 44.210000000000001 111.511 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -62.71 -46.28 88.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.394 -0.366 . . . . 73.140000000000001 111.784 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.509 ' HG3' ' O ' ' A' ' 100' ' ' PRO . 53.2 mtpt -61.08 -45.15 95.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.499 0.19 . . . . 74.129999999999995 111.356 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.439 ' HA ' HD13 ' A' ' 110' ' ' LEU . 2.3 m-85 -58.59 -40.96 84.66 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 110.991 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.76 -49.66 74.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.715 -0.675 . . . . 74.439999999999998 111.9 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -81.29 -46.85 14.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.864 0.69 . . . . 73.030000000000001 112.864 -174.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.3 mt -63.5 -15.18 57.14 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.238 0.458 . . . . 54.149999999999999 112.238 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.05 43.61 4.98 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 114.398 0.519 . . . . 73.420000000000002 114.398 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 105' ' ' PHE . 7.5 mp -88.88 -175.33 4.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.095 0.448 . . . . 44.329999999999998 110.995 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 24.2 p -81.79 154.16 26.09 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.258 0.552 . . . . 61.140000000000001 111.982 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 40.2 p -100.98 -51.94 3.41 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.069 -0.514 . . . . 75.040000000000006 111.757 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 60.59 42.87 13.44 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.093 0.473 . . . . 72.540000000000006 111.563 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.5 t80 68.23 93.71 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.468 -0.787 . . . . 70.549999999999997 111.706 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.31 96.5 0.15 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.432 2.088 . . . . 70.030000000000001 112.276 177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.482 ' HB3' HG21 ' A' ' 87' ' ' ILE . . . -56.57 156.14 6.56 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.524 0.564 . . . . 71.040000000000006 112.524 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.667 HD13 ' N ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -77.13 139.42 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.13 -0.486 . . . . 74.239999999999995 110.402 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.667 ' N ' HD13 ' A' ' 117' ' ' ILE . 82.2 mtt180 -56.74 120.72 8.32 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.133 0.492 . . . . 73.319999999999993 111.659 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.8 mp -70.15 138.15 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.302 0.572 . . . . 71.109999999999999 112.172 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -65.86 -70.94 0.21 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.912 -0.586 . . . . 74.230000000000004 110.723 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -155.1 -58.98 0.11 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.172 0.511 . . . . 72.420000000000002 110.413 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.3 p -94.69 136.87 22.7 Favored Pre-proline 0 N--CA 1.472 0.633 0 CA-C-N 116.123 -0.489 . . . . 51.329999999999998 111.933 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -85.46 -165.21 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.962 2.442 . . . . 72.129999999999995 112.8 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 55.0 p -133.08 171.89 13.38 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.939 0.4 . . . . 60.310000000000002 111.542 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -53.81 -33.41 56.0 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.155 0.503 . . . . 63.43 111.569 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -64.76 -10.77 30.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.533 0.568 . . . . 71.5 112.533 -176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.5 m -63.56 -33.11 74.88 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.012 0.434 . . . . 62.130000000000003 111.13 173.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.552 ' HA ' ' HG ' ' A' ' 131' ' ' CYS . 82.9 m-85 -65.16 -41.67 94.47 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.301 0.572 . . . . 74.439999999999998 110.514 172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -60.17 -49.71 76.54 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.803 -0.635 . . . . 73.510000000000005 111.099 174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.17 -58.13 9.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.106 -0.497 . . . . 75.219999999999999 111.218 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.552 ' HG ' ' HA ' ' A' ' 128' ' ' TYR . 27.8 p -58.15 -47.09 84.43 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.671 0.619 . . . . 75.310000000000002 112.671 -176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.58 -54.75 27.15 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.154 0.427 . . . . 71.530000000000001 112.154 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -65.33 -48.6 72.47 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.117 0.414 . . . . 34.310000000000002 112.117 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -65.31 -42.84 92.59 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 111.312 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.49 97.48 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.317 -0.468 . . . . 75.299999999999997 112.774 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.475 HG23 ' NE2' ' A' ' 140' ' ' GLN . 46.6 m -62.05 -44.17 97.26 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.999 0.428 . . . . 63.310000000000002 111.096 175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -66.92 -61.07 2.13 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.82 0.343 . . . . 73.439999999999998 111.441 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.632 HD11 ' HB1' ' A' ' 84' ' ' ALA . 46.9 tp -63.34 -37.86 88.89 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.83 0.348 . . . . 74.299999999999997 111.722 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -66.37 -51.14 45.46 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.114 -0.565 . . . . 74.099999999999994 113.165 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.475 ' NE2' HG23 ' A' ' 136' ' ' THR . 80.7 mt-30 -73.01 -7.84 53.04 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.353 -0.498 . . . . 74.420000000000002 111.983 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.471 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 62.6 t90 -55.26 -32.3 62.24 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.137 0.494 . . . . 73.209999999999994 110.191 170.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.8 t -58.62 -47.07 89.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 111.95 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 140' ' ' GLN . 11.3 t -73.66 -32.06 63.79 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 122.143 -0.348 . . . . 55.210000000000001 111.49 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -70.74 -41.83 71.29 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.86 0.362 . . . . 62.149999999999999 111.438 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -90.53 -61.05 1.76 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.532 0.567 . . . . 51.43 112.532 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -75.08 -55.08 6.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.902 0.382 . . . . 64.450000000000003 111.838 -173.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 147' ' ' LEU . 10.1 tt -68.56 -25.31 64.84 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.922 0.392 . . . . 71.349999999999994 110.994 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 64.68 49.63 2.25 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.499 0.666 . . . . 72.150000000000006 111.23 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.43 -21.35 50.64 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.68 -0.691 . . . . 70.099999999999994 111.61 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.7 t60 68.99 -69.36 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.343 0.657 . . . . 72.430000000000007 112.181 175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -74.75 115.31 14.19 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.853 0.316 . . . . 71.209999999999994 111.853 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -76.52 147.09 38.01 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.694 -0.23 . . . . 72.099999999999994 110.427 170.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -104.89 165.6 10.96 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.113 0.482 . . . . 74.319999999999993 111.979 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.5 m80 . . . . . 0 C--O 1.25 1.131 0 CA-C-N 115.913 -0.585 . . . . 72.519999999999996 110.087 171.592 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 45.2 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 110.143 -0.317 . . . . 55.119999999999997 110.143 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.673 HD13 ' HA3' ' A' ' 54' ' ' GLY . 47.2 mm 59.64 91.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.184 0.516 . . . . 71.519999999999996 111.53 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.5 104.64 2.3 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.833 -0.698 . . . . 65.439999999999998 112.84 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.3 m -87.3 107.79 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.427 0.632 . . . . 44.420000000000002 110.881 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.758 ' HB3' HD23 ' A' ' 36' ' ' LEU . 55.3 m-85 -104.22 118.37 36.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.897 -0.592 . . . . 60.130000000000003 111.206 -176.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -152.16 176.51 11.49 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.202 0.445 . . . . 72.5 112.202 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 13' ' ' SER . 48.4 t -109.08 104.04 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 116.089 -0.505 . . . . 74.140000000000001 110.28 172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 62.1 p -59.67 -56.74 18.08 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.415 0.895 . . . . 74.099999999999994 113.415 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.23 -43.26 92.35 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.087 0.773 . . . . 65.0 113.087 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -77.26 121.02 23.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.14 0.495 . . . . 63.130000000000003 112.266 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.28 -162.61 6.17 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-N 115.844 -0.616 . . . . 44.509999999999998 114.408 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -81.9 7.77 12.1 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 111.925 0.343 . . . . 55.409999999999997 111.925 -178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 20.0 m -44.22 -43.97 7.57 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.578 0.955 . . . . 75.450000000000003 113.578 -173.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.688 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 19.6 p-10 -73.57 -36.71 65.62 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.922 -0.486 . . . . 60.299999999999997 111.358 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mmt-85 -61.22 -40.62 94.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.519 0.676 . . . . 74.109999999999999 109.713 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.665 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . 79.7 mt -66.67 -41.68 87.75 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 73.439999999999998 110.838 176.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.74 83.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.96 0.41 . . . . 75.109999999999999 111.136 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -69.48 -27.56 65.32 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.801 0.334 . . . . 72.329999999999998 110.994 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 22' ' ' ASN . . . -64.27 -37.64 88.22 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.089 0.471 . . . . 72.5 110.362 171.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.57 HG23 ' HA3' ' A' ' 135' ' ' GLY . 63.1 mt -63.1 -53.1 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.278 0.561 . . . . 74.510000000000005 110.301 171.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.3 mt -55.14 -33.45 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 115.751 -0.659 . . . . 75.5 111.283 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 39.2 t30 -53.65 -60.14 3.7 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.356 -0.384 . . . . 53.439999999999998 111.187 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.03 -40.17 97.93 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.12 -0.562 . . . . 71.549999999999997 113.06 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 29' ' ' VAL . 55.4 mt -60.75 -50.6 79.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.235 0.457 . . . . 73.120000000000005 112.235 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.5 p -67.97 -38.22 82.47 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 122.165 -0.335 . . . . 75.329999999999998 111.298 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.8 -32.89 69.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.091 0.472 . . . . 73.019999999999996 111.078 174.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.605 HG21 ' HG2' ' A' ' 140' ' ' GLN . 88.6 m -79.4 -35.27 40.92 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.95 0.405 . . . . 74.109999999999999 111.175 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.91 32.25 3.37 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.365 -0.445 . . . . 75.519999999999996 113.279 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.692 ' HB ' HG23 ' A' ' 24' ' ' ILE . 29.5 t -108.91 133.95 52.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 O-C-N 122.462 -0.434 . . . . 74.209999999999994 111.417 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.09 112.64 3.64 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.111 -0.566 . . . . 70.409999999999997 112.534 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 24' ' ' ILE . 7.7 p -99.22 140.85 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 112.48 0.548 . . . . 64.239999999999995 112.48 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -96.48 109.38 21.96 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.027 0.441 . . . . 71.319999999999993 110.695 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.07 116.91 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 111.872 0.323 . . . . 74.129999999999995 111.872 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.7 t -131.41 119.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.017 0.437 . . . . 54.420000000000002 111.942 -179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.67 105.27 16.1 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.934 0.397 . . . . 74.219999999999999 111.255 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 5' ' ' PHE . 2.9 pp -77.38 -10.02 59.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.843 0.354 . . . . 73.109999999999999 111.43 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.58 -12.26 66.67 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.206 -0.521 . . . . 34.530000000000001 113.14 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.18 -48.23 0.06 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.867 0.365 . . . . 73.409999999999997 111.77 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.613 0.597 . . . . 74.409999999999997 112.613 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.0 m -117.96 45.79 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.323 0.583 . . . . 73.129999999999995 110.957 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.35 149.39 48.46 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.463 0.542 . . . . 70.420000000000002 112.463 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.411 ' H ' HD22 ' A' ' 42' ' ' LEU . 3.3 mm? -58.55 -35.12 71.85 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.135 -0.484 . . . . 73.329999999999998 112.175 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -62.94 -40.17 96.86 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.883 0.373 . . . . 62.350000000000001 110.723 176.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LEU . 17.6 tp10 -70.41 -29.7 66.38 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 110.3 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 74' ' ' THR . 3.3 tm? -60.9 -46.96 88.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.146 0.498 . . . . 64.310000000000002 109.815 172.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' C ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -62.32 -40.0 94.88 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.39 0.614 . . . . 73.400000000000006 110.721 172.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.728 ' HG3' HH11 ' A' ' 51' ' ' ARG . 20.5 tp10 -79.83 -10.63 59.8 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.642 -0.708 . . . . 74.25 111.332 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 51' ' ' ARG . 53.3 tp -59.22 -28.67 66.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.92 0.488 . . . . 71.040000000000006 111.696 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.403 ' HA ' ' SG ' ' A' ' 52' ' ' CYS . 35.8 t -58.9 -23.95 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.988 0.423 . . . . 74.129999999999995 111.351 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -81.15 -34.95 25.19 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.926 -0.654 . . . . 61.439999999999998 112.151 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.728 HH11 ' HG3' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -68.83 -38.28 79.75 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.839 0.352 . . . . 72.230000000000004 111.273 179.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 p -67.12 -2.84 6.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.868 0.692 . . . . 63.439999999999998 112.868 -174.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.8 p -62.88 -22.21 66.55 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.134 0.492 . . . . 61.310000000000002 110.892 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.673 ' HA3' HD13 ' A' ' 2' ' ' ILE . . . -153.58 137.43 5.77 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.99 -0.844 . . . . 70.120000000000005 110.99 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HB2' HG12 ' A' ' 85' ' ' VAL . 95.4 mt -116.58 116.54 27.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.583 0.691 . . . . 64.310000000000002 112.434 -173.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 67.2 t -124.02 105.37 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 74.129999999999995 110.266 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -101.93 119.61 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 120.846 0.355 . . . . 64.409999999999997 111.273 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 59' ' ' MET . . . -80.91 -12.04 83.14 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.028 -0.606 . . . . 54.210000000000001 113.84 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 49.6 ttp 71.3 149.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.301 0.572 . . . . 61.450000000000003 111.723 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.524 ' HB3' ' HB2' ' A' ' 64' ' ' SER . 60.0 m -151.22 140.77 13.99 Favored Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 122.182 -0.324 . . . . 75.310000000000002 111.132 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.91 161.68 28.46 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.514 2.143 . . . . 73.450000000000003 112.978 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -45.38 -39.7 7.18 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.53 0.567 . . . . 71.340000000000003 112.53 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.85 -52.68 64.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.092 0.405 . . . . 54.509999999999998 112.092 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 60' ' ' SER . 19.6 m -79.86 -19.27 48.69 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.443 -0.344 . . . . 73.329999999999998 111.893 -176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.712 ' HB1' HE22 ' A' ' 69' ' ' GLN . . . -64.88 -11.93 43.14 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.601 0.593 . . . . 52.229999999999997 112.601 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.94 -49.67 68.17 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.884 0.373 . . . . 52.420000000000002 111.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.7 p -65.59 -43.49 89.54 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.979 0.418 . . . . 35.329999999999998 111.197 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 59.3 mt -53.85 -56.08 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.018 -0.537 . . . . 61.43 111.618 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.712 HE22 ' HB1' ' A' ' 65' ' ' ALA . 2.1 mp0 -60.33 -21.65 62.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.18 0.437 . . . . 74.319999999999993 112.18 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.23 -48.3 80.64 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.033 -0.603 . . . . 75.239999999999995 112.661 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -89.67 -19.34 24.97 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.869 0.366 . . . . 71.530000000000001 111.855 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.2 tt -49.74 -34.71 19.86 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.904 0.481 . . . . 72.109999999999999 111.891 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m -47.7 -37.45 13.07 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.096 -0.502 . . . . 73.150000000000006 112.234 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.645 HG21 HD11 ' A' ' 45' ' ' LEU . 45.5 m -99.47 -35.79 9.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 111.759 0.281 . . . . 61.539999999999999 111.759 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 71' ' ' ALA . 68.3 mt -47.86 -44.4 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.491 0.552 . . . . 64.420000000000002 112.491 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.8 -35.76 64.21 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.955 0.407 . . . . 71.239999999999995 111.933 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.06 -29.39 28.5 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.123 -0.561 . . . . 65.420000000000002 113.111 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -69.6 -30.01 67.66 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.025 0.38 . . . . 72.219999999999999 112.025 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.1 m -91.21 164.83 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.275 0.472 . . . . 51.210000000000001 112.275 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -94.99 148.33 22.44 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.233 -0.44 . . . . 70.340000000000003 110.28 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.19 -62.12 1.91 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.931 0.715 . . . . 74.209999999999994 112.931 -173.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HG2' ' HA3' ' A' ' 109' ' ' GLY . 53.2 mttm -100.49 114.45 28.06 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.343 0.592 . . . . 75.439999999999998 111.799 -176.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.666 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -163.8 -174.53 3.69 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.883 -0.599 . . . . 73.019999999999996 110.274 -178.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.666 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -110.38 132.57 54.07 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 122.034 -0.416 . . . . 75.450000000000003 111.336 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.589 HG12 ' HB2' ' A' ' 55' ' ' LEU . 29.8 m -119.72 134.64 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.415 0.626 . . . . 72.310000000000002 112.43 -177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.8 127.72 8.42 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.84 -0.618 . . . . 73.219999999999999 112.334 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -129.02 145.86 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 122.687 -0.302 . . . . 74.510000000000005 110.917 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -146.81 135.31 21.96 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.997 0.427 . . . . 75.230000000000004 110.903 174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.508 ' HB3' HG22 ' A' ' 117' ' ' ILE . 18.5 pt-20 -78.69 98.47 6.23 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 112.43 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -115.76 119.28 35.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.149 0.5 . . . . 72.140000000000001 111.756 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.26 -75.36 0.5 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.34 -0.457 . . . . 61.039999999999999 114.115 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 76.3 -72.98 1.85 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.077 -0.582 . . . . 41.329999999999998 112.263 -175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.9 -84.65 0.38 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.218 -0.515 . . . . 73.230000000000004 113.678 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -165.85 128.54 2.04 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.758 0.313 . . . . 75.099999999999994 111.827 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -150.38 158.03 43.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.334 -0.394 . . . . 64.319999999999993 111.024 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.653 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mt-10 -101.29 -59.47 0.1 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.709 0.633 . . . . 73.319999999999993 112.709 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.653 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 66.2 Cg_endo -81.79 44.94 1.83 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.366 2.044 . . . . 71.450000000000003 113.649 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.58 -39.92 82.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.213 0.449 . . . . 74.209999999999994 112.213 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.624 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 26.0 m-20 -68.15 -52.25 23.41 Favored Pre-proline 0 CA--C 1.546 0.818 0 O-C-N 122.102 -0.374 . . . . 53.32 111.342 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.624 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 72.8 Cg_exo -51.41 -35.94 56.5 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.127 1.884 . . . . 63.119999999999997 112.613 172.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.0 tp -60.86 -58.26 9.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.41 -0.359 . . . . 72.430000000000007 111.003 176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -58.39 -34.11 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.169 0.509 . . . . 71.209999999999994 111.207 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 t -60.13 -40.51 90.03 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.806 -0.633 . . . . 74.120000000000005 111.675 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -60.46 -22.25 63.27 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.09 0.404 . . . . 63.420000000000002 112.09 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -91.15 -70.96 0.66 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.122 0.487 . . . . 74.150000000000006 111.996 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -71.46 -35.15 70.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.287 0.847 . . . . 64.219999999999999 113.287 -169.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.52 -24.97 63.81 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.965 0.412 . . . . 62.229999999999997 111.305 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 mp -86.82 -55.4 3.87 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.97 0.414 . . . . 73.510000000000005 110.948 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HG2' ' A' ' 82' ' ' LYS . . . 159.09 -5.05 0.11 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.853 -0.689 . . . . 75.209999999999994 113.759 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 83' ' ' GLN . 81.0 mt -77.59 99.44 5.75 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.52 -0.4 . . . . 73.019999999999996 111.236 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.7 t -74.88 129.51 37.79 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.124 0.488 . . . . 72.530000000000001 111.423 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 73.0 p -80.87 110.59 16.54 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.179 -0.464 . . . . 75.040000000000006 111.682 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.83 -37.67 66.43 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.225 0.536 . . . . 45.25 111.692 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -118.39 90.34 38.48 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.459 -0.571 . . . . 75.019999999999996 109.459 174.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.91 33.22 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.126 2.551 . . . . 63.439999999999998 114.753 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 122.84 4.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.364 0.505 . . . . 53.539999999999999 112.364 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -129.74 123.48 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 116.296 -0.411 . . . . 65.120000000000005 110.516 176.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -149.22 28.44 0.82 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 112.392 0.516 . . . . 72.230000000000004 112.392 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mm -68.8 142.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.067 0.461 . . . . 74.319999999999993 111.332 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.9 tttp -75.16 -51.15 14.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.111 -0.495 . . . . 71.140000000000001 111.577 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -166.29 -39.51 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.12 0.486 . . . . 71.340000000000003 111.201 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.8 p -114.3 130.37 24.04 Favored Pre-proline 0 N--CA 1.472 0.636 0 N-CA-C 111.862 0.319 . . . . 71.209999999999994 111.862 -178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.24 155.8 63.28 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.666 2.244 . . . . 53.140000000000001 112.641 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.1 p -105.84 170.07 8.12 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.08 0.467 . . . . 72.219999999999999 111.642 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.37 -24.73 60.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.184 -0.462 . . . . 65.430000000000007 111.547 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -84.39 -24.19 29.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.801 0.334 . . . . 71.239999999999995 111.557 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.0 m -55.56 -32.17 62.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.052 0.453 . . . . 75.349999999999994 111.253 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.417 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 71.0 m-85 -56.48 -45.77 80.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 111.182 175.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -57.53 -46.24 84.09 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.345 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.34 -47.11 72.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.143 0.496 . . . . 53.399999999999999 111.005 176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 16' ' ' LEU . 67.7 m -58.04 -48.42 80.13 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.72 -0.673 . . . . 75.239999999999995 111.343 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 52.4 mt-10 -58.54 -49.5 77.17 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.31 -0.405 . . . . 64.540000000000006 111.604 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.71 -32.7 71.43 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.476 0.547 . . . . 74.010000000000005 112.476 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -77.67 -60.49 2.35 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.193 0.442 . . . . 70.430000000000007 112.193 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.57 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -65.34 -43.16 95.52 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.141 -0.552 . . . . 73.510000000000005 113.995 -174.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 73.2 m -60.92 -38.78 86.96 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.448 -0.442 . . . . 74.099999999999994 112.127 -176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.62 -49.89 73.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.935 0.398 . . . . 73.040000000000006 110.973 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.06 -40.26 92.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.324 -0.398 . . . . 75.420000000000002 110.987 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.491 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -59.32 -45.71 95.01 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.104 -0.57 . . . . 62.420000000000002 112.771 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.605 ' HG2' HG21 ' A' ' 27' ' ' THR . 52.4 mt-30 -64.29 -38.97 92.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.037 0.446 . . . . 75.400000000000006 111.254 178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 41.1 t90 -65.49 -58.0 6.88 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 111.87 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 83.9 t -57.11 -50.88 75.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.379 0.511 . . . . 64.319999999999993 112.379 -176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.519 HG21 HG22 ' A' ' 29' ' ' VAL . 15.2 t -62.69 -36.86 84.27 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.034 0.383 . . . . 34.350000000000001 112.034 -177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -81.87 -23.26 36.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.737 0.303 . . . . 73.120000000000005 111.414 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.91 -47.97 15.48 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.024 0.44 . . . . 75.129999999999995 110.518 175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 142' ' ' VAL . 0.0 OUTLIER -79.61 6.72 9.86 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.46 -0.336 . . . . 72.219999999999999 111.829 177.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.623 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.9 OUTLIER -58.59 -9.84 1.9 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 122.926 0.491 . . . . 62.020000000000003 111.739 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -36.57 -47.99 0.67 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.169 0.588 . . . . 63.420000000000002 112.027 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -135.74 -52.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.345 -0.389 . . . . 63.140000000000001 110.576 173.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 62.57 104.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.026 0.441 . . . . 75.209999999999994 112.005 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 40.9 p-80 -106.74 173.56 6.27 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.9 0.381 . . . . 71.349999999999994 111.307 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -151.75 151.02 30.85 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.801 0.334 . . . . 73.530000000000001 111.739 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -150.0 -35.18 0.17 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.524 -0.307 . . . . 73.430000000000007 111.167 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.817 -0.611 . . . . 73.200000000000003 111.18 176.805 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.6 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 120.634 0.254 . . . . 54.25 111.496 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.683 HD11 ' HA2' ' A' ' 139' ' ' GLY . 46.0 mm 58.8 95.04 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.155 0.503 . . . . 74.030000000000001 112.181 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.67 96.09 1.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.915 -0.659 . . . . 50.229999999999997 112.473 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -96.33 114.09 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.655 0.74 . . . . 72.140000000000001 112.064 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -96.64 105.05 17.08 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.753 -0.658 . . . . 72.239999999999995 110.78 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.411 ' HE1' ' HB ' ' A' ' 33' ' ' VAL . 24.7 p90 -116.21 179.99 3.83 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.897 0.38 . . . . 75.409999999999997 111.455 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 p -152.14 113.79 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.242 0.544 . . . . 71.439999999999998 111.408 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.433 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 24.5 m -75.57 -25.02 56.72 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.195 0.522 . . . . 64.519999999999996 111.556 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -71.78 -16.37 62.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.751 -0.659 . . . . 75.239999999999995 111.978 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 70.8 t80 -125.69 106.24 9.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.979 0.419 . . . . 64.430000000000007 112.056 -173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.65 -162.4 5.44 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 114.583 0.593 . . . . 55.25 114.583 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -80.41 7.63 9.32 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.456 0.539 . . . . 74.549999999999997 112.456 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.6 m -44.69 -35.92 2.88 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.843 0.683 . . . . 74.230000000000004 112.843 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 8' ' ' SER . 11.7 p-10 -65.67 -43.19 90.07 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.968 0.413 . . . . 70.140000000000001 111.328 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -71.09 -38.94 72.39 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.014 0.435 . . . . 71.049999999999997 110.618 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt -58.92 -43.73 91.16 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.11 0.481 . . . . 64.400000000000006 110.968 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.13 75.62 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 111.221 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -64.23 -34.06 77.23 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.309 -0.405 . . . . 74.219999999999999 111.144 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.49 -39.97 92.88 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.042 0.448 . . . . 71.129999999999995 110.736 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.417 ' O ' HG12 ' A' ' 24' ' ' ILE . 63.7 mt -63.4 -48.49 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.171 0.51 . . . . 70.150000000000006 110.347 173.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.596 HG23 HG21 ' A' ' 31' ' ' VAL . 74.6 mt -56.96 -33.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 115.938 -0.574 . . . . 54.25 111.573 177.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -58.67 -43.54 89.95 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.961 0.41 . . . . 70.140000000000001 111.045 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.51 -37.28 62.34 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.05 -0.595 . . . . 73.439999999999998 112.875 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.433 HD12 HG13 ' A' ' 2' ' ' ILE . 46.5 mm -64.47 -45.21 96.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.044 0.45 . . . . 74.219999999999999 111.305 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 p -61.83 -42.49 99.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.842 0.353 . . . . 51.340000000000003 111.034 175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -57.84 -36.79 72.78 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.827 0.346 . . . . 73.230000000000004 111.439 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.0 m -78.15 -8.6 58.49 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.225 0.536 . . . . 73.519999999999996 111.401 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.19 42.71 23.11 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.163 -0.541 . . . . 40.140000000000001 113.092 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.9 t -127.76 143.94 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 O-C-N 122.595 -0.356 . . . . 72.430000000000007 111.506 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.93 152.25 36.51 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.116 -0.564 . . . . 74.200000000000003 112.732 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.596 HG21 HG23 ' A' ' 21' ' ' ILE . 22.4 t -112.87 147.39 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 112.465 0.543 . . . . 75.219999999999999 112.465 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -111.26 103.41 11.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.556 0.343 . . . . 73.549999999999997 110.387 171.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 30.5 m -100.91 136.29 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.851 0.685 . . . . 52.43 112.851 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.7 t -139.88 127.3 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 116.125 -0.489 . . . . 62.210000000000001 110.931 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -94.22 111.01 22.71 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.915 0.388 . . . . 74.530000000000001 110.969 177.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 pp -82.57 11.79 5.34 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.314 0.487 . . . . 71.150000000000006 112.314 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.39 -9.08 58.18 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.453 -0.403 . . . . 64.319999999999993 112.369 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.41 179.29 5.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.999 0.428 . . . . 45.109999999999999 111.468 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 93.09 0.22 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.0 0.429 . . . . 51.240000000000002 111.416 177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.99 149.75 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.277 0.561 . . . . 73.120000000000005 112.214 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -147.95 170.58 17.4 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.959 -0.564 . . . . 75.409999999999997 111.176 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.0 mm? -65.18 -22.48 66.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.394 -0.366 . . . . 65.409999999999997 111.686 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -62.45 -42.25 99.33 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.632 0.253 . . . . 63.240000000000002 111.361 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.2 -45.19 20.35 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.986 0.422 . . . . 55.43 110.813 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 45' ' ' LEU . 5.7 tt -55.79 -38.67 70.23 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.074 -179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -61.39 -21.92 64.51 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.375 0.509 . . . . 73.340000000000003 112.375 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -58.69 -19.7 41.95 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.991 0.425 . . . . 72.209999999999994 111.355 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.8 tp -53.18 -34.97 59.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.238 -0.437 . . . . 65.409999999999997 111.436 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.96 -44.11 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.942 0.401 . . . . 74.329999999999998 111.599 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.99 -23.14 50.47 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 120.984 -0.627 . . . . 51.240000000000002 113.812 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 -1.86 40.69 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.187 -0.596 . . . . 75.230000000000004 111.557 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 53' ' ' THR . 27.9 p -36.79 -58.76 0.73 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 115.172 1.545 . . . . 54.32 115.172 -170.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 52' ' ' CYS . 71.6 p -61.09 -20.54 62.74 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 113.701 1.0 . . . . 75.420000000000002 113.701 -170.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.34 136.18 4.11 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.19 -1.005 . . . . 30.329999999999998 113.838 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 57' ' ' ILE . 0.7 OUTLIER -171.08 -179.48 2.74 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.064 0.546 . . . . 54.219999999999999 111.258 -178.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 p -143.53 131.07 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.96 0.409 . . . . 61.439999999999998 111.46 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.514 HD11 HD13 ' A' ' 55' ' ' LEU . 3.3 mp -117.05 137.01 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.991 0.424 . . . . 72.120000000000005 111.983 -176.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.88 140.26 14.91 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.481 -0.648 . . . . 74.209999999999994 111.481 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.488 ' SD ' ' CE2' ' A' ' 10' ' ' TYR . 4.2 ppp? -67.49 146.95 53.46 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 117.652 0.726 . . . . 53.409999999999997 111.897 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 64' ' ' SER . 95.1 p -99.38 144.56 28.49 Favored Pre-proline 0 N--CA 1.471 0.591 0 N-CA-C 112.758 0.651 . . . . 61.240000000000002 112.758 -172.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 90.3 Cg_endo -75.39 -176.3 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.807 2.338 . . . . 74.400000000000006 112.526 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.94 -55.16 25.49 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.813 0.672 . . . . 44.229999999999997 112.813 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.13 -49.73 73.1 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.232 0.456 . . . . 75.019999999999996 112.232 -177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 60' ' ' SER . 62.2 m -65.08 -50.07 67.55 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.681 -0.236 . . . . 71.150000000000006 111.506 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.64 -49.67 67.39 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.007 0.432 . . . . 64.230000000000004 111.644 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.58 -18.45 64.89 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.188 0.44 . . . . 72.040000000000006 112.188 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -95.65 -29.56 14.24 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 111.846 0.313 . . . . 73.329999999999998 111.846 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.11 -13.44 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 112.021 0.378 . . . . 50.329999999999998 112.021 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -44.49 -40.8 5.87 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.2 0.815 . . . . 71.239999999999995 113.2 -175.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.05 -52.3 28.86 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.858 -0.687 . . . . 64.140000000000001 112.614 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.18 -28.25 66.44 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.734 0.302 . . . . 73.409999999999997 111.767 177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.5 tp -58.25 -46.13 86.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.82 0.343 . . . . 74.140000000000001 110.899 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.9 m -58.04 -45.06 87.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.09 0.471 . . . . 72.040000000000006 110.431 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.3 m -55.97 -47.7 77.17 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.853 -0.612 . . . . 75.099999999999994 111.479 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.488 ' O ' HG13 ' A' ' 79' ' ' VAL . 77.4 mt -61.06 -55.73 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 116.34 -0.391 . . . . 65.430000000000007 111.204 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.8 -30.92 58.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.228 0.455 . . . . 75.510000000000005 112.228 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.24 -21.24 55.41 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.061 -0.59 . . . . 63.200000000000003 113.656 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.6 m -100.18 -6.44 26.15 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.088 0.773 . . . . 65.25 113.088 -175.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -75.86 172.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 112.46 0.541 . . . . 75.200000000000003 112.46 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -99.68 178.32 4.88 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.037 -0.528 . . . . 70.439999999999998 110.585 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -87.49 -18.05 30.74 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.871 0.693 . . . . 64.040000000000006 112.871 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -148.96 44.98 1.0 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.192 1.182 . . . . 73.510000000000005 114.192 -173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' NE2' HD22 ' A' ' 110' ' ' LEU . 5.9 pm0 -94.38 166.78 11.9 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 121.393 -0.817 . . . . 71.430000000000007 111.425 175.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.75 115.46 27.12 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.963 0.411 . . . . 74.010000000000005 111.843 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.9 m -117.92 114.76 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.572 0.701 . . . . 72.420000000000002 112.031 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.47 145.36 25.16 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.06 -0.591 . . . . 64.299999999999997 112.416 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -152.83 140.37 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.071 0.435 . . . . 75.049999999999997 111.192 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -155.85 110.84 2.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.217 0.532 . . . . 74.239999999999995 110.72 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -89.99 131.31 35.95 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.4 -0.364 . . . . 73.420000000000002 111.506 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 HG21 ' A' ' 127' ' ' THR . 12.2 t -170.89 179.91 3.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.402 -0.363 . . . . 72.349999999999994 111.161 178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.31 -17.56 18.08 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.287 -0.483 . . . . 44.439999999999998 113.92 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.82 -119.25 0.75 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.398 -0.43 . . . . 35.229999999999997 112.336 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.55 74.03 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.424 -0.893 . . . . 60.109999999999999 114.155 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -97.89 109.98 22.64 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 122.609 -0.348 . . . . 71.340000000000003 110.654 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.696 ' HB2' ' HB ' ' A' ' 98' ' ' ILE . 16.2 p-10 -137.98 95.02 2.96 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.654 0.74 . . . . 64.329999999999998 112.454 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 39.1 mt-10 -103.76 -48.78 0.15 Allowed Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 116.189 -0.46 . . . . 75.439999999999998 112.051 172.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.531 ' O ' HD13 ' A' ' 101' ' ' LEU . 54.8 Cg_endo -91.52 27.46 0.41 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.231 1.954 . . . . 71.409999999999997 112.647 174.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.696 ' HB ' ' HB2' ' A' ' 95' ' ' ASP . 7.1 tt -59.93 -51.49 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.988 0.736 . . . . 74.519999999999996 112.988 -174.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.535 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 12.0 m-20 -62.74 -49.46 82.38 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 112.403 0.519 . . . . 71.519999999999996 112.403 -175.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.553 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 74.7 Cg_exo -51.45 -50.3 14.39 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.102 1.868 . . . . 74.409999999999997 112.973 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 97' ' ' PRO . 10.5 mp -63.05 -47.7 81.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.87 0.322 . . . . 63.340000000000003 111.87 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 105' ' ' PHE . 62.1 mt -58.77 -38.79 79.25 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.008 0.432 . . . . 70.209999999999994 111.044 176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -58.17 -42.16 85.41 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.282 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 100' ' ' PRO . 11.3 mmpt? -55.98 -49.51 73.39 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.854 0.359 . . . . 74.150000000000006 111.215 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.409 ' HD2' ' HA ' ' A' ' 102' ' ' LEU . 38.9 m-85 -56.0 -47.49 77.64 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.233 0.457 . . . . 72.129999999999995 112.233 -177.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -79.61 -35.53 39.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.679 0.622 . . . . 65.019999999999996 112.679 -175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -71.59 -44.94 63.56 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.07 -0.394 . . . . 72.329999999999998 111.873 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.9 mp -73.51 -41.39 63.12 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.835 0.35 . . . . 63.229999999999997 111.34 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.36 43.43 2.54 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.013 -0.613 . . . . 62.409999999999997 112.612 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.418 HD22 ' NE2' ' A' ' 83' ' ' GLN . 59.3 mt -83.86 136.21 34.2 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.869 0.366 . . . . 61.0 111.553 -176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 74.0 m -71.68 93.41 1.26 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.856 0.36 . . . . 65.209999999999994 110.841 178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.0 p -88.15 128.91 35.44 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.286 -0.416 . . . . 54.219999999999999 111.328 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.75 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 111.777 0.288 . . . . 52.43 111.777 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -164.89 94.44 0.91 Allowed Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 120.523 0.202 . . . . 70.200000000000003 111.408 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.9 115.67 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.309 2.006 . . . . 64.049999999999997 111.706 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -131.0 35.9 3.91 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.067 0.766 . . . . 64.239999999999995 113.067 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 117' ' ' ILE . 13.7 tt -61.09 82.03 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.293 1.044 . . . . 62.399999999999999 111.427 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -163.63 25.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.011 -0.995 . . . . 70.319999999999993 109.744 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.3 mm -88.59 137.28 21.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 115.795 -0.639 . . . . 72.299999999999997 111.954 -172.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -52.04 -51.8 55.14 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.689 -0.687 . . . . 72.239999999999995 112.35 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 179.98 -72.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.274 0.559 . . . . 62.43 110.958 -177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p -82.56 146.85 54.43 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.024 -0.535 . . . . 64.25 111.96 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.48 106.0 1.86 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.401 2.067 . . . . 61.439999999999998 112.903 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 52.3 p -85.79 -178.58 6.65 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.276 -0.42 . . . . 64.299999999999997 111.23 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -49.57 -35.61 21.11 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.165 0.431 . . . . 43.509999999999998 112.165 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -55.9 -42.74 76.46 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 73.239999999999995 111.319 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.43 HG21 HG21 ' A' ' 90' ' ' THR . 46.5 m -63.8 -40.72 97.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.997 0.427 . . . . 73.540000000000006 111.025 178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -61.68 -48.84 78.97 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.222 -0.445 . . . . 72.5 111.619 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -53.54 -42.06 67.06 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.885 0.328 . . . . 62.119999999999997 111.885 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 93.0 mt -59.02 -47.47 85.09 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.869 0.366 . . . . 63.119999999999997 111.056 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.1 m -66.46 -46.4 76.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.188 -0.46 . . . . 65.340000000000003 111.797 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.51 -48.81 77.9 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.233 -0.439 . . . . 62.310000000000002 111.898 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -78.26 -51.11 10.65 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.545 0.572 . . . . 71.540000000000006 112.545 -172.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.66 -36.07 71.39 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.34 0.496 . . . . 75.319999999999993 112.34 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -52.96 -45.01 62.12 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.406 -0.426 . . . . 73.120000000000005 113.399 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 88.5 m -67.8 -55.05 14.48 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.93 0.344 . . . . 73.430000000000007 111.93 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.82 -54.05 43.85 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.875 0.369 . . . . 53.25 111.635 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.8 -40.23 83.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.653 -0.249 . . . . 74.319999999999993 111.539 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.683 ' HA2' HD11 ' A' ' 2' ' ' ILE . . . -55.93 -47.72 77.69 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.259 -0.496 . . . . 60.32 113.2 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -65.96 -14.87 62.37 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.186 0.439 . . . . 75.230000000000004 112.186 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -90.62 -53.77 4.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.84 0.352 . . . . 73.530000000000001 110.972 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 62.9 t -54.43 -40.81 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 116.183 -0.462 . . . . 64.120000000000005 112.16 -177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 139' ' ' GLY . 6.8 t -69.64 -43.87 71.75 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.697 0.284 . . . . 64.340000000000003 111.575 177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -63.81 -38.99 93.16 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.144 0.497 . . . . 74.420000000000002 111.011 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.37 -44.95 72.67 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.605 -0.725 . . . . 73.400000000000006 112.192 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -92.75 -21.97 19.64 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.308 -0.405 . . . . 65.120000000000005 111.865 -175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.27 -35.33 80.68 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.71 0.29 . . . . 74.239999999999995 110.937 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -50.08 -72.52 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.062 0.764 . . . . 74.439999999999998 113.062 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -108.77 -37.74 5.8 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.517 0.562 . . . . 74.129999999999995 112.517 -171.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -62.71 -37.92 88.42 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.872 0.323 . . . . 74.230000000000004 111.872 -175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.9 m80 51.93 66.22 1.27 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.229 0.455 . . . . 73.109999999999999 112.229 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 52.25 -92.24 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.387 0.514 . . . . 72.239999999999995 112.387 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 67.6 m80 48.98 -166.18 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.501 0.667 . . . . 62.539999999999999 112.725 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.4 m170 . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.528 -0.76 . . . . 60.229999999999997 110.634 169.816 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 28.5 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 119.999 -0.048 . . . . 75.540000000000006 110.888 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 3' ' ' GLY . 47.8 mm 67.8 159.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.182 0.515 . . . . 51.009999999999998 111.892 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' N ' HG22 ' A' ' 2' ' ' ILE . . . -123.58 101.08 0.68 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 121.204 -0.522 . . . . 24.309999999999999 113.077 176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 33' ' ' VAL . 57.4 t -86.23 99.66 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 122.322 -0.516 . . . . 72.5 110.975 176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.698 ' HB3' HD23 ' A' ' 36' ' ' LEU . 82.1 m-85 -90.25 126.74 35.94 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.282 0.475 . . . . 73.349999999999994 112.282 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 6.7 p90 -143.96 163.29 33.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.272 -0.422 . . . . 72.409999999999997 110.945 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.518 ' HB ' HD11 ' A' ' 36' ' ' LEU . 3.9 p -129.02 105.41 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.452 0.644 . . . . 74.439999999999998 112.487 -175.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.7 m -61.5 -28.14 69.09 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.077 0.465 . . . . 63.549999999999997 111.445 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.05 -22.59 62.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.795 0.665 . . . . 70.409999999999997 112.795 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.574 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 2.3 t80 -129.06 92.15 3.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.895 0.702 . . . . 71.239999999999995 112.895 -173.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.62 -158.58 7.67 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 115.746 1.058 . . . . 41.530000000000001 115.746 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -59.34 7.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.528 1.307 . . . . 74.230000000000004 114.528 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 t -47.16 -35.79 7.78 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.561 0.619 . . . . 74.519999999999996 112.298 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -68.89 -39.69 79.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.974 0.416 . . . . 74.409999999999997 110.784 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -58.34 -45.65 87.73 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.192 0.52 . . . . 60.219999999999999 110.508 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' HG13 ' A' ' 20' ' ' ILE . 79.6 mt -59.49 -51.33 70.35 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.894 -0.594 . . . . 72.409999999999997 111.644 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 6' ' ' TYR . . . -55.49 -43.24 75.43 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.106 0.479 . . . . 54.509999999999998 111.479 177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.462 ' HA ' HG22 ' A' ' 21' ' ' ILE . 34.7 tt0 -66.29 -34.49 78.11 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.078 0.466 . . . . 73.239999999999995 110.845 177.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.17 -31.61 72.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.175 -0.466 . . . . 52.340000000000003 111.29 176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.515 HG23 ' HA3' ' A' ' 135' ' ' GLY . 71.5 mt -67.91 -57.46 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.152 0.501 . . . . 71.230000000000004 111.005 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.462 HG22 ' HA ' ' A' ' 18' ' ' GLN . 14.0 tt -63.2 -25.17 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.088 -0.506 . . . . 75.420000000000002 111.736 -177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -54.56 -46.8 73.74 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.778 0.323 . . . . 54.32 111.744 177.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -75.19 -37.35 42.77 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 121.019 -0.61 . . . . 74.239999999999995 112.922 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.7 mt -62.94 -42.73 97.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 120.994 0.426 . . . . 64.439999999999998 111.585 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.439 HG23 HG12 ' A' ' 21' ' ' ILE . 44.6 p -66.64 -39.87 88.45 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.574 -0.285 . . . . 71.230000000000004 111.574 177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -58.54 -41.6 85.92 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.272 0.558 . . . . 74.510000000000005 109.888 175.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 89.3 m -64.0 -31.74 73.03 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.843 -0.617 . . . . 74.120000000000005 110.806 174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.47 39.59 3.41 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 116.126 -0.488 . . . . 53.439999999999998 113.633 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.08 132.14 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.915 0.388 . . . . 73.549999999999997 111.444 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.33 96.54 2.18 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.314 -0.47 . . . . 74.299999999999997 113.708 -177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.3 m -102.86 142.48 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.911 0.386 . . . . 71.120000000000005 111.797 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -95.75 144.65 25.96 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.974 0.416 . . . . 75.319999999999993 111.78 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 32.6 m -101.18 151.72 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.913 0.387 . . . . 75.230000000000004 111.512 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -137.16 114.18 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.012 0.434 . . . . 75.019999999999996 111.984 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.69 92.6 3.55 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 120.732 0.301 . . . . 74.530000000000001 110.374 171.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.1 pp -65.81 -23.81 66.77 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.274 0.472 . . . . 71.400000000000006 112.274 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -98.08 24.51 31.48 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.12 -0.562 . . . . 41.039999999999999 112.943 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.88 -178.14 3.35 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.038 0.447 . . . . 50.119999999999997 111.837 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.45 44.9 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.307 0.484 . . . . 65.209999999999994 112.307 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.9 m -71.62 128.33 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.115 0.483 . . . . 75.409999999999997 111.765 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.61 166.85 11.31 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.341 -0.391 . . . . 71.450000000000003 111.263 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.75 -25.55 55.25 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.419 -0.355 . . . . 75.099999999999994 111.824 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -59.38 -49.75 76.59 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.624 0.25 . . . . 71.540000000000006 110.831 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.23 -39.1 75.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.037 0.446 . . . . 71.310000000000002 111.049 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -35.18 71.5 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.031 0.443 . . . . 71.530000000000001 110.626 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -58.3 -29.89 66.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.558 -0.292 . . . . 73.420000000000002 111.673 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -60.37 -29.19 68.77 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.033 0.444 . . . . 61.420000000000002 110.961 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.2 -21.28 66.11 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.358 -0.383 . . . . 72.310000000000002 111.699 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.15 -55.13 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 120.893 0.378 . . . . 62.240000000000002 111.243 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.61 -18.43 77.2 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 120.923 -0.656 . . . . 63.109999999999999 112.76 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -100.63 5.99 43.98 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.209 0.448 . . . . 73.120000000000005 112.209 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.8 p -64.92 -9.47 21.47 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.026 0.38 . . . . 61.25 112.026 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.4 p -58.44 -18.92 32.27 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.136 0.493 . . . . 70.340000000000003 111.355 176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -175.68 137.23 3.65 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 116.121 -0.491 . . . . 64.239999999999995 112.59 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 ' N ' ' A' ' 55' ' ' LEU . 1.7 pt? -148.59 133.52 18.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 64.109999999999999 110.628 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.405 ' CG1' ' HA ' ' A' ' 4' ' ' VAL . 5.6 p -112.58 117.74 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 50.549999999999997 111.443 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -116.49 110.38 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 110.653 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.56 41.55 3.06 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.043 -0.599 . . . . 72.530000000000001 113.396 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 88' ' ' PHE . 92.1 mmm 61.84 173.1 0.12 Allowed 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.381 0.61 . . . . 72.439999999999998 112.425 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.6 m -158.84 154.25 22.31 Favored Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 116.305 -0.407 . . . . 54.409999999999997 111.602 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.574 ' HG3' ' HB2' ' A' ' 10' ' ' TYR . 60.3 Cg_endo -70.69 157.9 57.27 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.462 2.108 . . . . 64.329999999999998 111.915 173.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.51 -48.71 62.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.591 0.589 . . . . 73.129999999999995 112.591 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.59 -30.26 68.54 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.548 0.573 . . . . 72.230000000000004 112.548 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.2 m -89.07 -49.77 6.56 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.91 0.386 . . . . 73.239999999999995 111.567 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.45 -23.26 65.73 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.368 -0.378 . . . . 65.409999999999997 111.549 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.8 -34.53 59.42 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.779 0.324 . . . . 73.120000000000005 111.403 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 t -65.18 -45.15 86.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.236 0.541 . . . . 74.099999999999994 110.455 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.401 HD11 HD22 ' A' ' 36' ' ' LEU . 71.5 mt -59.95 -40.55 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.002 -0.544 . . . . 61.329999999999998 110.617 174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -62.92 -34.8 78.22 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.818 -0.628 . . . . 71.109999999999999 111.028 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.38 -42.26 56.95 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.211 -0.518 . . . . 73.209999999999994 112.93 176.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.85 6.82 33.55 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.041 0.385 . . . . 55.219999999999999 112.041 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.1 tp -39.58 -61.1 0.86 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.295 0.85 . . . . 72.049999999999997 113.295 -176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.9 m -57.23 -40.02 76.69 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.172 0.434 . . . . 54.149999999999999 112.172 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 97.6 m -63.06 -45.01 94.24 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.937 0.399 . . . . 74.329999999999998 110.926 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.45 -37.49 79.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.058 0.456 . . . . 75.239999999999995 111.255 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.16 -15.2 63.57 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.289 -0.414 . . . . 62.020000000000003 111.157 175.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.2 -39.28 5.75 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.403 -0.427 . . . . 42.100000000000001 112.664 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.6 p -67.56 -40.12 84.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.878 0.325 . . . . 54.130000000000003 111.878 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 m -69.44 169.97 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.041 0.448 . . . . 71.540000000000006 111.803 178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -133.06 -176.15 4.02 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 122.288 -0.258 . . . . 62.219999999999999 110.704 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 82' ' ' LYS . 43.1 tt0 -47.27 -65.72 0.52 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.486 0.55 . . . . 64.040000000000006 112.486 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -152.49 130.03 11.47 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.256 0.551 . . . . 75.129999999999995 112.036 176.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -144.78 -79.47 0.18 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.005 -0.543 . . . . 73.140000000000001 110.896 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.558 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -170.21 117.78 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.902 0.334 . . . . 62.549999999999997 111.902 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 85' ' ' VAL . 15.9 m -124.62 99.56 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.648 0.737 . . . . 61.520000000000003 111.529 177.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -74.84 77.88 1.09 Allowed Glycine 0 CA--C 1.526 0.742 0 CA-C-N 116.125 -0.489 . . . . 65.349999999999994 113.147 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.5 mm -86.63 121.43 37.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.059 0.392 . . . . 74.120000000000005 112.059 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' O ' ' HG2' ' A' ' 59' ' ' MET . 38.5 p90 -153.76 -179.03 7.44 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.296 -0.411 . . . . 73.109999999999999 110.41 174.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.497 ' HB2' HG22 ' A' ' 117' ' ' ILE . 11.3 tp10 -106.43 144.25 33.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.779 0.659 . . . . 75.0 112.779 -174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -125.51 -23.76 4.03 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.413 -0.358 . . . . 72.299999999999997 111.905 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 119' ' ' ILE . . . -119.75 -98.52 1.75 Allowed Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.604 -0.332 . . . . 44.119999999999997 113.097 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -158.95 42.91 0.48 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.532 -0.842 . . . . 63.439999999999998 114.037 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 65.33 55.1 22.86 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.353 -0.451 . . . . 55.240000000000002 113.459 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -89.24 -159.96 0.63 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 111.883 0.327 . . . . 73.140000000000001 111.883 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' OD1' ' HD2' ' A' ' 97' ' ' PRO . 32.4 t70 74.05 162.1 0.25 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.267 0.627 . . . . 51.109999999999999 112.484 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 40.1 mt-10 -103.26 -55.45 0.11 Allowed Pre-proline 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 64.450000000000003 112.744 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 91.8 Cg_endo -76.46 11.19 1.93 Allowed 'Trans proline' 0 C--N 1.364 1.379 0 C-N-CA 122.337 2.025 . . . . 62.240000000000002 113.513 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.454 HG23 ' H ' ' A' ' 99' ' ' ASP . 4.3 tt -44.64 -56.31 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 N-CA-C 113.122 0.786 . . . . 63.210000000000001 113.122 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.697 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.6 m-20 -60.83 -54.89 50.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 112.327 0.492 . . . . 73.109999999999999 112.327 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.697 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 66.0 Cg_exo -54.0 -36.17 83.35 Favored 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 122.275 1.983 . . . . 55.119999999999997 113.093 176.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.19 -62.16 1.49 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.462 -0.335 . . . . 53.210000000000001 111.68 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.51 -41.02 88.94 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.16 0.43 . . . . 73.0 112.16 -177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.3 t -57.93 -37.31 73.86 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.826 0.346 . . . . 53.219999999999999 111.57 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -64.3 -45.85 86.17 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.734 0.302 . . . . 74.25 111.522 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -62.37 -29.13 70.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.994 0.426 . . . . 74.430000000000007 111.361 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -71.35 -37.4 71.68 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.944 0.402 . . . . 73.340000000000003 110.579 171.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.501 HD22 HD12 ' A' ' 108' ' ' LEU . 6.7 t30 -62.58 -46.34 88.75 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.348 -0.387 . . . . 73.340000000000003 111.528 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.501 HD12 HD22 ' A' ' 107' ' ' ASN . 9.5 mp -73.52 -41.77 62.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.785 0.326 . . . . 52.409999999999997 111.326 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.48 72.22 1.26 Allowed Glycine 0 CA--C 1.528 0.881 0 C-N-CA 121.316 -0.468 . . . . 55.229999999999997 113.61 176.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 82' ' ' LYS . 5.3 mp -102.29 164.41 11.7 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.959 0.409 . . . . 72.349999999999994 111.112 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.558 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 29.4 m -66.2 95.36 0.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.72 0.295 . . . . 51.25 111.289 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 77.2 p -83.68 164.72 19.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.036 0.446 . . . . 75.209999999999994 111.785 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -94.72 -83.83 0.34 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.617 -0.265 . . . . 71.140000000000001 111.671 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 116' ' ' ALA . 34.3 t80 -162.38 89.29 1.38 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 120.948 0.404 . . . . 73.409999999999997 110.907 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -83.0 27.28 0.61 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.625 2.883 . . . . 72.25 114.199 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.428 ' HB3' ' CE2' ' A' ' 114' ' ' PHE . . . -87.69 94.65 9.8 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.827 -0.546 . . . . 41.329999999999998 110.991 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.497 HG22 ' HB2' ' A' ' 89' ' ' GLU . 31.2 pt -68.61 107.31 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.495 0.664 . . . . 64.209999999999994 112.674 -176.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -103.34 -23.95 13.54 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.081 -0.509 . . . . 70.450000000000003 111.651 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.2 mp -90.42 145.73 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 116.556 -0.293 . . . . 70.420000000000002 110.605 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.558 ' HD3' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -120.23 5.68 10.75 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.426 0.528 . . . . 74.120000000000005 112.426 -178.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.504 ' H ' HG22 ' A' ' 119' ' ' ILE . 53.1 tt0 -178.76 -58.74 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.795 0.331 . . . . 71.319999999999993 111.662 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.1 p -117.42 122.56 30.83 Favored Pre-proline 0 N--CA 1.473 0.705 0 CA-C-N 116.516 -0.311 . . . . 74.519999999999996 111.603 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 119' ' ' ILE . 32.8 Cg_endo -63.34 141.03 79.99 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.653 2.235 . . . . 74.340000000000003 112.863 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 62.1 p -93.68 173.87 7.47 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.331 0.586 . . . . 60.450000000000003 112.383 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -53.58 -28.73 33.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.644 -0.707 . . . . 71.430000000000007 112.509 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -66.86 -39.55 87.61 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.322 0.49 . . . . 63.149999999999999 112.322 -176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 71.9 p -54.62 -40.46 68.94 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.571 0.582 . . . . 70.329999999999998 112.571 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -55.27 -35.3 64.86 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.313 0.486 . . . . 70.420000000000002 112.313 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.42 -50.64 51.3 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.831 0.348 . . . . 74.230000000000004 111.098 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.406 ' N ' HD22 ' A' ' 130' ' ' LEU . 3.2 mm? -61.66 -33.9 74.77 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.931 0.396 . . . . 65.299999999999997 111.036 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -61.75 -45.89 91.99 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.288 -0.414 . . . . 74.109999999999999 111.227 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.22 -52.77 62.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.392 -0.367 . . . . 73.140000000000001 111.166 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.9 -50.18 73.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 111.93 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.13 73.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 111.872 0.323 . . . . 71.540000000000006 111.872 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.515 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -68.55 -42.17 81.93 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.016 -0.612 . . . . 63.329999999999998 113.643 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.404 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 89.1 m -70.61 -47.74 58.63 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.556 -0.379 . . . . 73.109999999999999 111.931 -177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -55.92 -47.63 77.15 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.152 0.501 . . . . 65.340000000000003 110.989 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 138' ' ' LEU . 2.5 tm? -70.08 -39.98 75.26 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.996 -0.547 . . . . 73.5 110.385 177.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.49 -40.72 78.78 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.577 -0.344 . . . . 24.25 112.803 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 136' ' ' THR . 96.7 mt-30 -62.35 -38.31 89.04 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.799 0.333 . . . . 64.239999999999995 111.131 175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 78.8 t90 -61.09 -45.16 95.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.797 0.332 . . . . 73.319999999999993 110.563 176.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -57.35 -53.28 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.346 -0.388 . . . . 43.25 111.791 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.0 t -68.32 -37.54 80.68 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.132 0.419 . . . . 71.430000000000007 112.132 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.792 ' HA ' ' HB2' ' A' ' 148' ' ' GLU . 21.5 ttt180 -71.56 -35.44 70.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.887 0.375 . . . . 74.439999999999998 111.438 -177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.18 -25.36 66.97 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.538 0.685 . . . . 74.040000000000006 110.353 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 147' ' ' LEU . 77.0 mtt180 -100.1 8.02 44.22 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.591 -0.731 . . . . 44.140000000000001 111.848 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 1.0 OUTLIER 117.12 -43.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.777 1.631 . . . . 62.210000000000001 111.506 174.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.792 ' HB2' ' HA ' ' A' ' 144' ' ' ARG . 38.4 tt0 72.08 -62.06 0.47 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.042 0.537 . . . . 65.109999999999999 112.369 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.6 t60 71.52 -75.71 0.07 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.905 0.482 . . . . 73.329999999999998 110.513 -177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -144.39 105.58 4.22 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.828 0.346 . . . . 62.350000000000001 111.597 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -145.82 114.0 6.61 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.229 0.538 . . . . 73.150000000000006 112.154 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -128.67 149.74 50.54 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.096 -0.502 . . . . 63.109999999999999 110.668 175.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -95.92 -11.36 26.76 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.477 0.547 . . . . 74.409999999999997 112.477 -175.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 19.2 t60 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.464 -0.779 . . . . 72.219999999999999 111.219 179.764 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 80.1 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.885 -0.043 . . . . 71.409999999999997 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 2' ' ' ILE . 2.9 mp 60.27 110.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 121.173 0.511 . . . . 62.329999999999998 111.73 -175.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.02 91.82 1.66 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 120.853 -0.689 . . . . 55.200000000000003 113.326 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.66 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 59.4 t -80.91 123.54 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.027 0.413 . . . . 63.43 111.392 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 84.0 m-85 -116.38 133.69 55.73 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.494 0.553 . . . . 63.229999999999997 112.494 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.499 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -149.27 -178.18 6.26 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 110.826 179.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.5 p -129.51 83.55 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 121.482 0.658 . . . . 50.219999999999999 111.799 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -53.77 -29.75 41.48 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.008 0.744 . . . . 72.430000000000007 113.008 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.81 -13.94 62.52 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 112.345 0.498 . . . . 63.32 112.345 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -134.89 135.35 41.55 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.497 0.925 . . . . 71.239999999999995 113.497 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.19 -162.1 4.97 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 116.394 1.318 . . . . 62.140000000000001 116.394 167.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.415 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 73.8 m-85 -76.03 8.57 3.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.383 0.882 . . . . 72.400000000000006 113.383 -174.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 88.8 p -49.04 -35.58 16.02 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.114 0.413 . . . . 64.209999999999994 112.114 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -66.43 -37.99 86.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.319 0.58 . . . . 64.340000000000003 110.919 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 -69.16 -39.27 78.87 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.869 -0.605 . . . . 75.430000000000007 110.735 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -41.37 94.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.149 -0.478 . . . . 52.350000000000001 110.626 174.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.29 -42.98 92.54 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.071 -0.513 . . . . 62.219999999999999 110.858 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -57.48 -46.62 83.48 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.946 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 132' ' ' GLU . . . -56.57 -47.03 80.38 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.174 -0.466 . . . . 62.210000000000001 111.302 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.3 mt -55.15 -51.45 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 111.042 176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 25' ' ' THR . 75.4 mt -55.79 -57.74 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 116.204 -0.453 . . . . 50.119999999999997 111.191 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -58.81 -29.45 66.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.865 0.364 . . . . 75.349999999999994 111.705 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.01 -38.82 34.43 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.102 -0.57 . . . . 43.530000000000001 113.484 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.15 -24.7 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.486 0.55 . . . . 73.299999999999997 112.486 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 21' ' ' ILE . 32.9 p -57.57 -29.3 64.32 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.061 -0.4 . . . . 75.109999999999999 111.777 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.728 ' HE2' ' HA ' ' A' ' 26' ' ' LYS . 10.5 mmpt? -64.63 -17.61 64.18 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.937 0.399 . . . . 54.229999999999997 111.941 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.2 m -88.23 -9.79 51.84 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.085 0.469 . . . . 62.119999999999997 110.825 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.98 37.53 74.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.528 -0.368 . . . . 62.119999999999997 113.363 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 143' ' ' THR . 61.8 t -128.84 141.55 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.56 -0.376 . . . . 55.439999999999998 111.564 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.97 113.95 4.64 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.46 -0.4 . . . . 43.130000000000003 113.092 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 1' ' ' SER . 27.2 m -94.86 148.45 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.109 0.48 . . . . 71.129999999999995 112.016 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -93.4 125.07 37.81 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.217 -0.447 . . . . 75.239999999999995 111.072 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.66 131.89 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 120.983 0.42 . . . . 72.329999999999998 111.793 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 62.2 t -141.43 147.21 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 122.6 0.36 . . . . 64.219999999999999 110.991 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 6.6 m-20 -82.72 118.06 23.09 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.125 0.417 . . . . 74.340000000000003 112.125 177.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 37' ' ' GLY . 1.6 pp -77.65 -25.41 49.65 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.963 0.411 . . . . 73.409999999999997 111.85 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.645 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -87.31 -13.13 66.35 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.072 -0.585 . . . . 75.540000000000006 113.233 -178.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.48 166.58 20.2 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.434 0.635 . . . . 63.439999999999998 112.039 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.84 76.83 2.12 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.954 -0.566 . . . . 63.399999999999999 111.396 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.7 m -82.72 164.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.336 0.495 . . . . 65.230000000000004 112.336 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -132.54 -163.24 1.32 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.215 0.531 . . . . 53.130000000000003 111.943 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.416 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.5 mm? -62.25 -24.17 67.1 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.151 0.797 . . . . 64.409999999999997 113.151 -173.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -62.87 -52.53 62.74 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.104 -0.372 . . . . 65.120000000000005 110.844 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -62.05 -42.51 99.26 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.886 0.374 . . . . 73.140000000000001 111.1 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 49' ' ' VAL . 3.0 tm? -58.08 -58.28 9.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.127 -0.488 . . . . 50.530000000000001 110.999 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -64.49 -36.38 84.0 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.844 0.312 . . . . 74.150000000000006 111.844 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -63.68 -38.14 90.0 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.902 0.382 . . . . 71.230000000000004 110.704 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.503 HD11 HD13 ' A' ' 55' ' ' LEU . 45.0 tp -59.53 -44.23 93.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.382 -0.372 . . . . 72.120000000000005 110.71 172.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 45' ' ' LEU . 57.4 t -56.92 -33.25 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.071 0.462 . . . . 63.049999999999997 110.91 176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -66.46 -40.38 94.36 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.02 -0.609 . . . . 74.329999999999998 112.469 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -87.03 6.37 32.79 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.084 0.402 . . . . 70.299999999999997 112.084 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.4 p -45.35 -26.59 0.55 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.256 1.206 . . . . 64.129999999999995 114.256 -170.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 32.3 m -54.71 -32.51 59.72 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.14 -0.35 . . . . 75.209999999999994 111.569 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.661 ' HA3' HG21 ' A' ' 142' ' ' VAL . . . -160.8 137.64 5.07 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.071 -0.585 . . . . 73.109999999999999 113.375 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD13 HD11 ' A' ' 48' ' ' LEU . 2.0 pt? -145.2 157.56 44.04 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.076 0.465 . . . . 65.420000000000002 111.416 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.66 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 75.1 t -114.58 116.59 53.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.458 -0.337 . . . . 44.350000000000001 110.998 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -98.69 115.18 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.65 0.262 . . . . 65.340000000000003 111.077 -176.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 90' ' ' THR . . . -79.6 -24.09 61.22 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 121.117 -0.563 . . . . 72.25 114.079 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 60' ' ' SER . 16.7 tmm? 68.62 153.92 0.1 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 120.987 0.423 . . . . 64.049999999999997 111.665 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.513 ' N ' ' SD ' ' A' ' 59' ' ' MET . 40.6 t -162.95 146.46 8.65 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.031 -0.418 . . . . 74.450000000000003 111.342 -177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.0 160.52 12.41 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.954 2.436 . . . . 75.239999999999995 113.546 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -41.43 -37.31 1.02 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.685 0.994 . . . . 64.519999999999996 113.685 -177.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -49.3 -47.28 47.05 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.168 0.433 . . . . 72.099999999999994 112.168 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.44 ' HB2' ' OG ' ' A' ' 60' ' ' SER . 66.6 m -98.4 -27.08 14.25 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.681 0.277 . . . . 63.420000000000002 111.409 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -55.69 -32.67 63.47 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.492 -0.322 . . . . 42.210000000000001 111.824 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.11 89.13 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.941 0.4 . . . . 72.129999999999995 111.128 174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -62.49 -33.61 75.21 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.203 0.525 . . . . 75.109999999999999 111.01 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.526 HD11 HD13 ' A' ' 36' ' ' LEU . 57.8 mt -75.04 -40.08 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.969 -0.56 . . . . 54.329999999999998 111.203 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -53.01 -44.73 67.52 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.851 -0.613 . . . . 63.229999999999997 112.573 -172.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.75 -43.71 80.34 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 121.032 -0.604 . . . . 63.329999999999998 112.839 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -77.31 -34.77 55.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 74.400000000000006 110.949 176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 tt -56.46 -42.86 78.89 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 122.99 0.516 . . . . 65.239999999999995 111.267 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 t -53.06 -33.91 54.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.26 0.552 . . . . 73.409999999999997 111.105 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 98.5 m -82.89 -41.67 18.66 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.036 -0.529 . . . . 74.219999999999999 111.257 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 71' ' ' ALA . 78.6 mt -57.62 -43.36 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 112.027 0.38 . . . . 72.010000000000005 112.027 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' HB3' ' HE2' ' A' ' 104' ' ' LYS . 67.5 mt -61.69 -19.85 62.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.288 0.477 . . . . 72.239999999999995 112.288 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.63 -15.63 65.49 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.026 -0.607 . . . . 71.310000000000002 112.569 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.9 m -98.41 -36.85 9.83 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.881 0.326 . . . . 64.349999999999994 111.881 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 75' ' ' ILE . 27.2 m -106.13 123.46 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.233 0.539 . . . . 73.349999999999994 112.096 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HA ' HD23 ' A' ' 108' ' ' LEU . 3.3 p-10 -160.9 -172.56 3.53 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.268 0.556 . . . . 72.439999999999998 111.806 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 69.7 -86.72 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.519 0.933 . . . . 64.129999999999995 113.519 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 110' ' ' LEU . 16.9 ptmt -155.45 6.49 0.23 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.658 0.984 . . . . 74.230000000000004 113.658 -170.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.459 ' O ' ' HB3' ' A' ' 110' ' ' LEU . 3.1 pt20 -65.16 178.01 0.95 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.972 0.415 . . . . 64.329999999999998 112.051 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.89 124.53 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 113.439 0.903 . . . . 74.040000000000006 113.439 -168.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.12 102.53 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-O 121.648 0.737 . . . . 73.420000000000002 111.569 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.33 94.6 1.67 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.42 -0.419 . . . . 55.409999999999997 112.771 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 tt -99.24 139.02 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 O-C-N 122.274 -0.545 . . . . 75.239999999999995 112.144 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -136.83 -179.38 5.66 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.221 -0.445 . . . . 71.310000000000002 110.249 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -112.86 134.4 54.39 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.363 0.875 . . . . 73.310000000000002 113.363 -173.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 58' ' ' GLY . 6.4 t -154.41 130.67 10.4 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.796 -0.638 . . . . 51.009999999999998 110.864 169.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 86.84 -59.21 4.57 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.077 -0.582 . . . . 72.340000000000003 113.551 179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.78 -98.42 0.18 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 121.502 -0.38 . . . . 74.409999999999997 113.184 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 67.51 -128.01 26.73 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 121.248 -0.501 . . . . 72.209999999999994 113.882 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -123.09 136.0 54.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.403 -0.469 . . . . 75.099999999999994 111.888 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.51 145.52 3.89 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.173 -0.467 . . . . 64.219999999999999 110.735 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.428 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 5.7 mp0 -103.58 -44.32 0.18 Allowed Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 112.566 0.58 . . . . 74.400000000000006 112.566 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 87.7 Cg_exo -50.59 -13.75 0.9 Allowed 'Trans proline' 0 C--N 1.364 1.383 0 C-N-CA 122.762 2.308 . . . . 70.439999999999998 114.128 174.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -51.78 -37.67 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.183 0.438 . . . . 65.209999999999994 112.183 175.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.735 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 8.2 m-20 -63.63 -56.38 26.51 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 112.004 0.372 . . . . 72.519999999999996 112.004 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.5 Cg_exo -55.04 -36.92 93.91 Favored 'Trans proline' 0 C--N 1.363 1.315 0 C-N-CA 122.008 1.805 . . . . 53.340000000000003 112.64 171.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.98 -58.3 9.15 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.406 -0.361 . . . . 63.210000000000001 111.326 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 106' ' ' ARG . 91.3 mt -57.96 -40.77 81.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.128 0.49 . . . . 54.299999999999997 111.068 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t -56.59 -45.12 81.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.846 -0.615 . . . . 71.510000000000005 111.581 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.52 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 53.7 tptt -55.46 -49.22 73.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.302 -0.408 . . . . 74.129999999999995 111.347 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.2 -35.5 81.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.489 -0.323 . . . . 71.200000000000003 111.869 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 102' ' ' LEU . 74.7 mmt-85 -69.0 -55.46 10.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 111.913 0.338 . . . . 75.530000000000001 111.913 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -61.08 -43.77 98.38 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.104 0.409 . . . . 65.25 112.104 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 80' ' ' ASN . 8.6 mp -73.97 -37.43 64.49 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.622 0.249 . . . . 73.150000000000006 111.29 178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 65.09 53.12 35.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.318 -0.468 . . . . 72.510000000000005 114.035 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 110' ' ' LEU . 3.4 mp -77.18 173.42 11.88 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 122.474 -0.427 . . . . 72.329999999999998 111.024 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 94.1 m -65.87 93.47 0.19 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.079 0.466 . . . . 74.540000000000006 110.142 175.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -101.37 132.73 46.78 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.301 0.482 . . . . 74.430000000000007 112.301 -171.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -62.65 -64.16 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.155 0.428 . . . . 50.119999999999997 112.155 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -147.99 111.97 3.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 120.725 0.298 . . . . 51.420000000000002 110.305 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -89.14 6.57 4.51 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.858 2.372 . . . . 70.219999999999999 114.822 -171.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.71 144.61 45.1 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.038 0.385 . . . . 64.219999999999999 112.038 -176.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.2 pt -94.16 157.19 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.947 0.721 . . . . 62.409999999999997 112.947 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 118' ' ' ARG . 9.7 mmt85 -152.52 -49.77 0.1 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.386 0.674 . . . . 73.540000000000006 111.645 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 119' ' ' ILE . 1.9 mp -72.7 112.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.232 0.539 . . . . 62.329999999999998 111.669 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -82.83 -22.86 34.0 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.187 -0.46 . . . . 61.539999999999999 111.418 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.6 tt0 -160.13 -67.29 0.07 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.165 0.507 . . . . 73.209999999999994 111.714 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.411 HG23 HE21 ' A' ' 121' ' ' GLN . 61.3 p -91.8 129.35 42.56 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 116.343 -0.389 . . . . 74.540000000000006 112.03 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.415 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 37.3 Cg_exo -61.84 152.69 73.02 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.801 2.334 . . . . 71.099999999999994 112.779 176.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.8 p -111.16 166.17 11.3 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.906 0.384 . . . . 74.209999999999994 111.85 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -55.52 -34.76 64.95 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.26 0.552 . . . . 73.049999999999997 111.197 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -73.47 -31.22 63.65 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.865 -0.607 . . . . 72.109999999999999 111.356 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 60.1 m -55.79 -38.58 70.11 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.818 0.342 . . . . 63.140000000000001 111.42 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -57.35 -40.74 78.69 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.481 -0.327 . . . . 70.140000000000001 111.331 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.526 ' HB3' ' NZ ' ' A' ' 129' ' ' LYS . 8.4 mtpm? -60.89 -28.79 69.15 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.011 0.434 . . . . 65.430000000000007 111.616 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 91.7 mt -70.75 -48.14 55.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.043 0.449 . . . . 64.439999999999998 110.223 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 81.3 m -60.54 -33.26 72.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.05 -0.523 . . . . 72.230000000000004 111.364 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.429 ' HG3' ' HB1' ' A' ' 19' ' ' ALA . 45.9 mt-10 -83.4 -75.17 0.33 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.274 -0.421 . . . . 64.140000000000001 112.046 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.85 -53.68 52.47 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.555 0.576 . . . . 70.010000000000005 112.555 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -65.79 -40.36 91.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.863 0.363 . . . . 71.120000000000005 111.231 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.07 -25.62 66.46 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.187 -0.53 . . . . 53.340000000000003 113.156 176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.541 HG22 ' NE2' ' A' ' 140' ' ' GLN . 61.0 m -60.27 -50.12 74.89 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.702 -0.293 . . . . 64.200000000000003 111.631 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -56.83 -50.56 72.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.038 0.447 . . . . 72.109999999999999 111.311 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.23 -50.19 65.26 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.653 -0.703 . . . . 72.510000000000005 110.94 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 143' ' ' THR . . . -64.95 -43.53 95.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.219 -0.515 . . . . 23.440000000000001 113.186 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.541 ' NE2' HG22 ' A' ' 136' ' ' THR . 45.0 mt-30 -58.33 -51.37 70.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.216 0.45 . . . . 52.229999999999997 112.216 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 47.4 t90 -56.11 -52.85 62.82 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.977 0.418 . . . . 71.400000000000006 111.655 -176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.661 HG21 ' HA3' ' A' ' 54' ' ' GLY . 61.9 t -57.91 -51.68 67.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.027 -0.533 . . . . 54.409999999999997 112.4 -177.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 29' ' ' VAL . 14.2 t -74.07 -37.34 64.25 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.934 0.346 . . . . 73.239999999999995 111.934 -176.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -76.64 -13.36 60.06 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 122.144 -0.347 . . . . 74.400000000000006 111.625 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 149' ' ' HIS . 14.2 t70 -67.57 -51.31 52.14 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.388 0.614 . . . . 74.310000000000002 110.074 167.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -62.54 -34.2 76.45 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.594 -0.73 . . . . 73.219999999999999 110.642 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.18 -37.93 44.63 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.723 -0.671 . . . . 61.130000000000003 111.244 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 3.4 tm-20 -148.4 -80.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 116.477 -0.329 . . . . 65.0 110.715 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 145' ' ' ASP . 11.7 t-80 175.88 -63.15 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.98 -0.748 . . . . 71.109999999999999 108.98 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.6 t60 63.46 149.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 114.036 1.124 . . . . 70.25 114.036 169.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -99.32 177.34 5.23 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.095 -0.502 . . . . 62.439999999999998 111.349 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -74.86 140.13 43.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.103 0.477 . . . . 65.450000000000003 111.526 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -63.25 -42.73 99.21 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.033 0.753 . . . . 71.219999999999999 113.033 -175.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.331 -0.842 . . . . 73.140000000000001 111.018 -172.225 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 13.5 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 111.076 0.028 . . . . 75.530000000000001 111.076 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 2.4 mp 66.83 109.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 121.256 0.55 . . . . 73.239999999999995 111.241 -173.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.04 113.74 4.08 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.22 -0.514 . . . . 50.409999999999997 113.186 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -89.95 104.86 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 O-C-N 122.48 -0.423 . . . . 75.030000000000001 111.15 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.776 ' HB3' HD23 ' A' ' 36' ' ' LEU . 98.6 m-85 -96.29 111.63 23.64 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.099 0.476 . . . . 53.039999999999999 111.679 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -127.86 178.51 6.11 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 111.624 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 9' ' ' GLU . 17.3 t -134.46 114.61 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 116.335 -0.393 . . . . 71.310000000000002 110.637 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.7 m -74.45 -8.52 56.58 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.957 0.408 . . . . 71.049999999999997 111.79 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.563 ' H ' HG12 ' A' ' 7' ' ' VAL . 44.6 tt0 -96.25 -50.53 4.76 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.459 0.54 . . . . 73.239999999999995 112.459 -177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' H ' HG12 ' A' ' 7' ' ' VAL . 78.2 t80 -103.16 138.87 39.41 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.109 0.48 . . . . 74.349999999999994 112.239 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.87 -164.37 4.7 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.566 -0.743 . . . . 70.120000000000005 114.606 176.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.48 ' HD2' ' HD2' ' A' ' 123' ' ' PRO . 97.5 m-85 -100.37 7.8 44.06 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.889 0.329 . . . . 73.409999999999997 111.889 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.754 ' HB3' HG21 ' A' ' 90' ' ' THR . 89.8 p -41.41 -46.76 3.47 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.553 0.575 . . . . 71.099999999999994 112.553 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.66 -43.91 76.72 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.088 0.47 . . . . 75.340000000000003 111.748 175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.23 -35.45 73.86 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.151 0.501 . . . . 73.120000000000005 110.882 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 68.8 mt -67.78 -38.68 83.69 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.95 -0.568 . . . . 62.450000000000003 110.818 177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.26 -36.3 75.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.871 -0.604 . . . . 71.310000000000002 111.069 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -58.92 -42.87 90.7 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.163 -0.471 . . . . 72.140000000000001 110.962 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' HB3' ' SG ' ' A' ' 131' ' ' CYS . . . -65.3 -39.2 92.19 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.011 0.434 . . . . 73.129999999999995 111.137 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.98 -58.49 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.199 -0.455 . . . . 60.140000000000001 111.276 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 12.8 tt -59.1 -37.16 66.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.652 0.263 . . . . 63.350000000000001 110.938 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -53.66 -56.77 14.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.402 -0.363 . . . . 70.120000000000005 111.457 176.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.12 -45.23 88.53 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.116 -0.564 . . . . 31.309999999999999 113.926 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.3 mt -66.19 -45.98 88.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 112.424 0.527 . . . . 72.209999999999994 112.424 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 81.6 p -65.2 -42.71 93.28 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.909 -0.495 . . . . 63.539999999999999 110.821 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -56.42 -32.4 64.82 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.192 -0.458 . . . . 64.549999999999997 110.88 173.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 m -71.98 -33.15 67.92 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.375 -0.375 . . . . 62.43 110.993 174.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.54 4.45 5.31 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.106 -0.569 . . . . 44.240000000000002 114.165 177.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.1 t -112.49 130.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 O-C-N 122.2 -0.588 . . . . 72.209999999999994 111.979 -177.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.64 121.49 6.14 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.462 -0.399 . . . . 62.240000000000002 112.927 178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.9 m -99.41 164.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 112.667 0.618 . . . . 73.109999999999999 112.667 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -109.15 110.34 21.55 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.801 -0.636 . . . . 73.209999999999994 111.092 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.9 m -82.47 112.71 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.295 0.569 . . . . 71.540000000000006 112.077 -177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.46 129.22 74.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.283 -0.417 . . . . 74.409999999999997 111.47 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -94.58 116.62 28.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 110.005 -0.368 . . . . 70.349999999999994 110.005 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.4 pp -89.31 -7.48 55.29 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.113 0.412 . . . . 65.200000000000003 112.113 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.504 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -86.55 -26.71 31.94 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.12 -0.562 . . . . 51.149999999999999 112.506 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.31 162.79 18.06 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.107 0.48 . . . . 61.219999999999999 111.705 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.67 96.36 0.08 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.015 0.435 . . . . 64.230000000000004 111.648 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.11 150.02 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.286 0.565 . . . . 54.420000000000002 112.039 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -107.4 173.05 6.49 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.939 -0.573 . . . . 73.030000000000001 110.249 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.6 mm? -59.81 -20.57 57.66 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.323 -0.236 . . . . 74.510000000000005 111.114 176.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -61.98 -52.81 62.48 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.756 0.312 . . . . 61.399999999999999 111.506 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.61 -40.79 84.26 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.868 0.366 . . . . 74.310000000000002 110.835 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 49' ' ' VAL . 1.8 tm? -65.09 -39.81 93.7 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.264 0.554 . . . . 72.209999999999994 109.964 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.7 ttt180 -59.42 -40.86 88.09 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.789 -0.641 . . . . 73.329999999999998 111.274 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -69.86 -36.09 75.24 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.51 -0.314 . . . . 72.010000000000005 111.053 175.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 tt -57.58 -47.05 83.17 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.869 0.366 . . . . 64.120000000000005 110.224 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 45' ' ' LEU . 82.3 t -55.01 -37.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.08 0.467 . . . . 74.109999999999999 111.479 177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -70.36 -53.13 14.23 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.274 -0.488 . . . . 73.439999999999998 113.131 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.19 6.1 14.95 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.52 0.563 . . . . 72.349999999999994 112.52 -178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -48.39 -24.92 1.39 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.848 1.055 . . . . 55.009999999999998 113.848 -174.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.733 HG21 HH22 ' A' ' 146' ' ' ARG . 77.7 p -67.24 -25.86 66.3 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.587 0.588 . . . . 71.129999999999995 112.587 -178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -153.12 137.02 5.6 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 121.138 -0.553 . . . . 54.310000000000002 112.69 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD11 HG12 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -163.2 172.84 14.2 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.578 -0.366 . . . . 74.310000000000002 111.811 -178.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.08 124.65 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 120.909 0.385 . . . . 74.030000000000001 111.144 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -117.2 145.32 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 120.966 0.413 . . . . 74.319999999999993 111.569 -176.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.5 -89.74 0.39 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.032 -0.604 . . . . 73.540000000000006 112.583 172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.488 ' HG3' HG22 ' A' ' 90' ' ' THR . 4.0 ppp? -172.48 158.47 4.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.557 0.343 . . . . 73.129999999999995 110.642 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.4 p -117.58 114.42 37.98 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 111.798 0.296 . . . . 61.109999999999999 111.798 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.66 160.32 28.15 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.368 2.045 . . . . 73.530000000000001 112.432 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.13 -31.45 19.61 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.522 0.564 . . . . 72.219999999999999 112.522 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.37 -42.6 96.16 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.158 0.504 . . . . 74.129999999999995 111.681 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.0 t -90.11 -21.8 22.09 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.249 -0.432 . . . . 74.530000000000001 111.541 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.426 ' HA ' ' HB ' ' A' ' 68' ' ' ILE . . . -52.93 -24.56 9.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.2 0.815 . . . . 72.519999999999996 113.2 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.01 -56.04 7.14 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.408 0.522 . . . . 64.420000000000002 112.408 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m -84.6 -33.63 23.31 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.822 0.344 . . . . 54.009999999999998 111.4 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 65' ' ' ALA . 50.7 mm -60.89 -53.21 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.288 0.477 . . . . 75.409999999999997 112.288 -176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -55.5 -38.65 69.46 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.848 0.356 . . . . 72.099999999999994 111.346 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.11 87.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.0 -0.619 . . . . 70.400000000000006 112.391 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.98 95.07 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.991 0.424 . . . . 52.140000000000001 111.495 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.79 -35.44 68.7 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.333 -0.394 . . . . 73.540000000000006 111.353 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.6 m -54.28 -27.02 32.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.998 0.428 . . . . 55.409999999999997 111.427 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 90.7 m -99.19 -49.53 4.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.312 -0.403 . . . . 72.340000000000003 111.284 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.1 mt -54.57 -48.59 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 112.818 0.673 . . . . 73.530000000000001 112.818 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.4 mt -56.27 -36.68 68.86 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.031 0.382 . . . . 55.43 112.031 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.49 66.24 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.038 -0.601 . . . . 64.409999999999997 113.13 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -100.29 5.12 44.51 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.188 0.44 . . . . 50.200000000000003 112.188 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.82 162.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 CA-C-O 121.01 0.433 . . . . 64.420000000000002 111.996 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -117.54 106.84 13.57 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.851 0.358 . . . . 73.140000000000001 111.456 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.613 ' HG2' ' HG2' ' A' ' 82' ' ' LYS . 38.3 tt0 50.14 -86.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 112.978 0.732 . . . . 63.5 112.978 175.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.613 ' HG2' ' HG2' ' A' ' 81' ' ' GLU . 62.2 pttt -159.39 48.02 0.3 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.261 0.553 . . . . 73.510000000000005 110.972 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.44 172.97 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.065 0.765 . . . . 72.439999999999998 113.065 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.579 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -88.02 109.65 20.0 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.237 0.541 . . . . 74.439999999999998 111.894 -174.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG12 HD11 ' A' ' 55' ' ' LEU . 29.7 m -107.41 119.02 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.567 0.699 . . . . 60.240000000000002 111.788 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -97.06 159.85 21.43 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.997 -0.547 . . . . 42.229999999999997 112.399 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.9 tp -144.39 131.36 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 122.398 -0.472 . . . . 74.430000000000007 111.961 -176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -140.05 93.44 2.64 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.65 0.738 . . . . 74.120000000000005 110.659 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -60.33 114.48 2.94 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.834 -0.621 . . . . 64.120000000000005 112.16 -175.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.754 HG21 ' HB3' ' A' ' 13' ' ' SER . 10.0 t -108.65 29.68 7.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.856 -0.611 . . . . 72.120000000000005 111.973 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . -178.53 -54.41 0.07 OUTLIER Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.186 -1.007 . . . . 52.299999999999997 114.086 -178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.85 -14.35 58.8 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.496 -0.859 . . . . 54.539999999999999 113.2 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.05 67.48 3.14 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.226 -0.511 . . . . 71.120000000000005 112.499 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -88.48 -179.27 6.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.221 0.534 . . . . 61.0 112.15 -177.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -75.93 133.65 40.44 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.124 -0.489 . . . . 71.540000000000006 110.818 175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 35.7 mt-10 -54.46 -37.45 54.54 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 113.744 1.016 . . . . 71.430000000000007 113.744 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 38.0 Cg_endo -66.21 32.18 0.11 Allowed 'Trans proline' 0 CA--C 1.552 1.421 0 C-N-CA 121.843 1.695 . . . . 65.430000000000007 113.94 173.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.423 ' H ' ' C ' ' A' ' 96' ' ' GLU . 7.6 tp -66.59 -44.1 90.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 O-C-N 122.118 -0.364 . . . . 74.400000000000006 111.975 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.452 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 9.6 m-20 -56.09 -47.0 99.7 Favored Pre-proline 0 CA--C 1.553 1.081 0 N-CA-C 112.429 0.529 . . . . 65.299999999999997 112.429 -178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 83.1 Cg_exo -45.77 -37.46 16.28 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.717 2.278 . . . . 54.109999999999999 113.436 170.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.5 -42.65 34.92 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.802 0.334 . . . . 73.239999999999995 110.927 176.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -56.35 -32.48 64.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.348 -0.387 . . . . 75.239999999999995 111.197 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.4 t -55.58 -46.92 77.16 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.264 0.554 . . . . 71.019999999999996 110.992 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.407 ' HA ' HD13 ' A' ' 108' ' ' LEU . 32.0 mmtp -66.36 -51.62 55.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.065 -0.516 . . . . 73.299999999999997 111.313 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.601 ' HD1' HD22 ' A' ' 110' ' ' LEU . 24.3 m-85 -59.58 -44.86 93.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.034 0.445 . . . . 73.349999999999994 112.119 -178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 50.6 ttp180 -77.46 -60.76 2.23 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.423 0.527 . . . . 65.109999999999999 112.423 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.0 m-20 -62.41 -32.37 73.19 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.542 0.571 . . . . 71.510000000000005 112.542 -170.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 104' ' ' LYS . 9.0 mp -79.06 -20.37 49.02 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.347 175.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.61 44.62 6.79 Favored Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.28 -0.486 . . . . 54.43 114.166 175.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.601 HD22 ' HD1' ' A' ' 105' ' ' PHE . 8.7 mp -70.39 133.96 47.4 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 117.256 0.528 . . . . 74.129999999999995 111.361 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.579 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 36.7 m -60.8 94.02 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.947 0.403 . . . . 64.510000000000005 111.381 -178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.0 m -103.82 137.03 42.41 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.513 -0.312 . . . . 61.509999999999998 111.64 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' A' ' 138' ' ' LEU . . . -54.69 -64.15 0.93 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.408 -0.36 . . . . 65.409999999999997 111.942 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -162.79 98.49 1.08 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.894 0.378 . . . . 73.150000000000006 110.873 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -85.18 46.6 1.85 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.008 2.472 . . . . 74.200000000000003 113.887 -175.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -147.17 37.75 0.95 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 62.530000000000001 112.024 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.9 pt -105.3 144.0 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 112.089 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -133.37 108.74 8.89 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.313 -0.403 . . . . 73.120000000000005 110.55 170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 mm -104.42 140.95 21.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.316 -0.402 . . . . 64.120000000000005 110.697 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.58 153.26 32.58 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.667 0.27 . . . . 63.340000000000003 111.224 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 21.8 tt0 -51.66 -33.67 34.67 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.682 0.623 . . . . 74.140000000000001 112.682 -171.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p -108.61 99.09 31.87 Favored Pre-proline 0 N--CA 1.473 0.684 0 CA-C-O 120.606 0.241 . . . . 74.120000000000005 111.078 172.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.48 ' HD2' ' HD2' ' A' ' 12' ' ' TYR . 85.0 Cg_exo -46.78 128.86 13.77 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.492 2.794 . . . . 61.340000000000003 114.301 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 80.5 p -100.45 -178.1 3.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.068 -0.514 . . . . 64.230000000000004 111.043 178.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 125' ' ' GLU . 7.0 mp0 -57.37 -27.22 62.09 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.977 0.418 . . . . 74.439999999999998 111.404 -178.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -59.33 -41.41 89.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.15 0.5 . . . . 64.319999999999993 110.851 175.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.9 m -63.43 -36.75 84.76 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.098 -0.501 . . . . 71.430000000000007 111.175 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -62.38 -36.35 82.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.135 0.493 . . . . 71.239999999999995 111.144 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -69.63 -38.99 77.4 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.105 -0.498 . . . . 74.329999999999998 110.889 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 6.5 tt -63.29 -54.74 32.41 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.849 -0.614 . . . . 63.399999999999999 110.721 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 19' ' ' ALA . 31.0 p -62.27 -38.29 88.77 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.75 0.278 . . . . 72.120000000000005 111.75 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.63 -56.63 19.71 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.349 0.595 . . . . 70.439999999999998 111.475 175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -64.18 -56.89 11.59 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.735 -0.666 . . . . 71.409999999999997 111.94 -177.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -47.73 84.41 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 111.863 0.32 . . . . 63.109999999999999 111.863 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.41 -44.64 66.48 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.348 -0.453 . . . . 72.010000000000005 113.24 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.47 ' HA ' HG12 ' A' ' 24' ' ' ILE . 94.8 m -55.83 -41.19 73.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.815 0.34 . . . . 73.030000000000001 111.486 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.36 -45.26 94.13 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.315 -0.402 . . . . 73.040000000000006 111.739 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 113' ' ' ALA . 4.1 mm? -56.49 -42.12 77.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.942 0.401 . . . . 62.299999999999997 110.936 176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -62.59 -48.35 82.35 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.097 -0.573 . . . . 50.109999999999999 112.693 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -59.25 -46.98 87.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.006 0.431 . . . . 51.409999999999997 111.857 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -56.67 -50.83 70.93 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.113 -0.494 . . . . 72.420000000000002 111.5 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 2' ' ' ILE . 58.2 t -69.84 -44.61 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.324 0.491 . . . . 74.409999999999997 112.324 -177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.4 t -65.98 -28.45 68.9 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.978 0.418 . . . . 62.020000000000003 111.712 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -63.03 -56.63 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.756 0.313 . . . . 74.310000000000002 111.207 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -60.37 -29.72 69.1 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.004 0.43 . . . . 71.239999999999995 111.522 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.733 HH22 HG21 ' A' ' 53' ' ' THR . 0.6 OUTLIER -75.73 -30.76 59.34 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.2 -0.312 . . . . 74.120000000000005 111.764 175.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -65.58 -44.09 87.75 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.21 0.529 . . . . 72.450000000000003 109.579 175.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.65 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 17.7 mm-40 -69.37 -41.05 77.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.179 -0.464 . . . . 73.510000000000005 110.414 175.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 74.27 -57.96 0.6 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.035 0.934 . . . . 63.109999999999999 112.859 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -111.65 28.72 8.48 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.25 -0.281 . . . . 71.409999999999997 111.231 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 51.6 m80 57.84 84.99 0.09 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.404 0.621 . . . . 72.340000000000003 110.841 -173.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.65 ' H ' ' HB3' ' A' ' 148' ' ' GLU . 86.4 t60 -76.77 115.71 16.79 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.681 -0.69 . . . . 71.239999999999995 111.405 -174.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -86.66 -178.21 6.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.125 -0.489 . . . . 64.329999999999998 111.189 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.489 -0.767 . . . . 74.010000000000005 111.199 179.532 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.1 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.645 0.259 . . . . 75.129999999999995 111.384 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.1 mm 64.93 111.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 112.67 0.618 . . . . 74.150000000000006 112.67 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.58 103.42 1.43 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.114 -0.565 . . . . 71.150000000000006 112.578 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 45.2 t -89.18 93.84 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.889 0.376 . . . . 71.120000000000005 111.558 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.656 ' HD2' HD23 ' A' ' 36' ' ' LEU . 17.5 m-85 -89.09 117.0 27.78 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.718 0.294 . . . . 72.030000000000001 111.443 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -134.92 151.03 50.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.432 0.634 . . . . 72.519999999999996 112.416 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.57 HG12 ' H ' ' A' ' 10' ' ' TYR . 39.7 t -96.1 97.95 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.788 -0.642 . . . . 63.439999999999998 111.52 -177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.712 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 20.1 m -70.88 -27.21 63.64 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.234 0.457 . . . . 61.200000000000003 112.234 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 33.7 tt0 -70.5 -42.25 71.59 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 112.662 0.616 . . . . 74.329999999999998 112.662 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.57 ' H ' HG12 ' A' ' 7' ' ' VAL . 69.4 t80 -111.5 106.77 15.75 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 113.666 0.988 . . . . 72.140000000000001 113.666 -171.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.94 -160.49 5.41 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 115.829 1.092 . . . . 71.150000000000006 115.829 167.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.415 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 56.7 m-85 -63.11 -2.17 1.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.22 0.822 . . . . 72.549999999999997 113.22 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.3 m -54.11 -31.51 52.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.231 0.538 . . . . 72.109999999999999 111.345 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.712 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 25.1 t70 -65.87 -32.73 74.4 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.652 -0.704 . . . . 60.229999999999997 111.745 176.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -94.44 -23.73 17.62 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.442 0.534 . . . . 74.329999999999998 112.442 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 12' ' ' TYR . 92.7 mt -54.64 -39.92 68.47 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.231 0.538 . . . . 71.450000000000003 111.384 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.41 -23.0 62.67 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.07 -0.513 . . . . 74.120000000000005 112.141 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.76 -34.9 76.67 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.912 0.387 . . . . 62.409999999999997 110.945 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 132' ' ' GLU . . . -62.09 -40.77 96.96 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.132 0.492 . . . . 73.430000000000007 111.04 174.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.467 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.5 mt -62.76 -52.95 53.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.044 -0.525 . . . . 74.450000000000003 110.601 175.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.521 HG23 HG21 ' A' ' 31' ' ' VAL . 83.5 mt -52.85 -43.94 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.939 -0.573 . . . . 74.109999999999999 111.235 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -56.95 -48.77 77.54 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.108 -0.496 . . . . 64.209999999999994 111.323 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.07 -42.46 99.57 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.013 -0.613 . . . . 70.040000000000006 113.091 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -65.55 -48.47 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.852 0.358 . . . . 72.230000000000004 111.71 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -68.33 -34.94 77.02 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.788 0.328 . . . . 74.519999999999996 111.267 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -63.12 -31.81 73.04 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.458 0.647 . . . . 62.43 110.558 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.0 m -75.16 -14.44 60.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.848 -0.615 . . . . 75.0 111.15 173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.42 26.65 11.73 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 116.363 -0.38 . . . . 71.430000000000007 113.779 176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.47 HG21 ' HB ' ' A' ' 143' ' ' THR . 42.0 t -118.88 142.31 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 O-C-N 122.555 -0.379 . . . . 60.520000000000003 111.603 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.68 140.7 24.58 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.009 -0.615 . . . . 40.399999999999999 112.859 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 21' ' ' ILE . 33.1 m -106.4 145.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 111.985 0.365 . . . . 71.439999999999998 111.985 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -107.09 110.55 22.69 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.912 0.387 . . . . 70.409999999999997 110.172 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.94 113.8 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.55 0.69 . . . . 75.310000000000002 112.788 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.4 t -101.96 93.42 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.197 0.523 . . . . 74.230000000000004 110.925 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -79.0 70.88 5.41 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.557 0.694 . . . . 64.030000000000001 111.743 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.656 HD23 ' HD2' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -64.79 -23.79 67.35 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.231 -0.441 . . . . 53.100000000000001 111.636 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.614 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -75.17 -0.36 61.02 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.239 -0.505 . . . . 55.219999999999999 112.889 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 17.13 12.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.917 0.389 . . . . 61.420000000000002 110.607 174.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 65.99 97.63 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.527 -0.761 . . . . 73.329999999999998 112.166 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.463 HG13 ' HA ' ' A' ' 36' ' ' LEU . 24.7 m -83.47 156.13 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-O 120.775 0.321 . . . . 74.040000000000006 111.327 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -119.6 179.61 4.17 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.085 0.469 . . . . 74.120000000000005 111.364 -174.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.708 HD13 HD12 ' A' ' 45' ' ' LEU . 3.8 mm? -60.67 -20.87 62.03 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.322 0.49 . . . . 75.450000000000003 112.322 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 1.4 mp0 -59.42 -29.88 68.07 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.117 0.414 . . . . 71.109999999999999 112.117 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -86.25 -43.83 12.64 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.806 0.336 . . . . 72.230000000000004 111.311 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.708 HD12 HD13 ' A' ' 42' ' ' LEU . 80.6 mt -54.09 -28.3 38.36 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.564 0.579 . . . . 53.439999999999998 112.564 -177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 20.3 ptt180 -61.34 -33.16 73.16 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.696 0.284 . . . . 62.229999999999997 111.231 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -99.25 3.18 46.18 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.04 0.385 . . . . 75.129999999999995 112.04 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB2' ' HA ' ' A' ' 45' ' ' LEU . 2.3 tm? -56.52 -34.48 67.06 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.998 0.428 . . . . 74.299999999999997 110.213 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -57.62 -23.46 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.222 0.534 . . . . 72.299999999999997 111.785 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.17 -40.89 5.99 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.394 -0.431 . . . . 52.450000000000003 112.535 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -76.1 -15.42 60.1 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.242 0.46 . . . . 74.140000000000001 112.242 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -69.37 -7.67 39.6 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.004 0.372 . . . . 63.009999999999998 112.004 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.0 p -70.54 -26.79 63.72 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.327 0.584 . . . . 73.420000000000002 111.033 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.57 135.56 3.57 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.85 -0.614 . . . . 73.420000000000002 111.8 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.462 HD21 HG12 ' A' ' 85' ' ' VAL . 2.1 pt? -168.14 169.17 11.22 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.011 0.405 . . . . 73.109999999999999 111.491 -174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' PHE . 8.5 p -134.69 128.14 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.929 0.395 . . . . 63.420000000000002 111.454 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.7 mp -113.75 135.12 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 111.302 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.03 133.34 10.94 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.359 -0.448 . . . . 74.040000000000006 112.823 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.526 ' HE1' ' H ' ' A' ' 93' ' ' GLY . 44.1 ttp -65.91 110.5 2.9 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.638 -0.33 . . . . 64.540000000000006 111.717 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 7' ' ' VAL . 93.4 p -103.49 148.27 35.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 111.982 0.364 . . . . 75.109999999999999 111.982 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.67 ' HA ' ' HB3' ' A' ' 94' ' ' ASP . 28.0 Cg_endo -60.73 159.67 27.74 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.87 2.38 . . . . 61.329999999999998 112.451 175.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.57 -40.53 52.46 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.868 0.692 . . . . 63.5 112.868 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.79 -53.03 54.11 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.196 0.443 . . . . 71.120000000000005 112.196 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.1 m -79.34 -32.23 43.26 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.073 0.463 . . . . 73.140000000000001 111.204 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.22 -27.56 65.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.99 -0.55 . . . . 52.409999999999997 111.498 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.71 -29.66 62.68 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.211 0.449 . . . . 71.230000000000004 112.211 177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -82.05 -17.45 46.63 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.052 0.453 . . . . 74.430000000000007 111.717 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.643 HG12 ' HB2' ' A' ' 36' ' ' LEU . 26.1 mt -100.59 -47.78 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 112.169 -175.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -45.32 -45.48 12.29 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.288 1.035 . . . . 71.319999999999993 113.435 -168.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.78 -63.94 4.52 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.047 -0.597 . . . . 71.349999999999994 113.196 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 45' ' ' LEU . . . -62.44 -28.73 70.01 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.069 0.461 . . . . 63.399999999999999 112.165 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -55.14 -33.69 63.13 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.079 -0.509 . . . . 54.5 111.363 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.0 m -54.66 -39.24 67.85 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.125 -0.489 . . . . 65.409999999999997 111.563 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 91.9 m -73.66 -38.16 65.05 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.916 0.389 . . . . 64.329999999999998 111.293 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.0 mt -60.41 -58.26 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.849 0.357 . . . . 73.319999999999993 111.85 -178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.494 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.1 mp -60.91 -12.47 11.25 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.564 0.579 . . . . 72.219999999999999 112.564 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -97.17 -30.33 7.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.218 -0.515 . . . . 60.020000000000003 112.793 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -79.21 -24.16 43.3 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 111.792 0.293 . . . . 74.409999999999997 111.792 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -64.36 155.57 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.042 0.449 . . . . 74.510000000000005 111.878 177.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -80.15 160.55 25.65 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.873 0.368 . . . . 71.019999999999996 111.612 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HA ' HD23 ' A' ' 108' ' ' LEU . 35.9 tt0 -54.87 -36.64 65.31 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.098 0.475 . . . . 60.030000000000001 111.939 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -138.87 122.08 16.96 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.452 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -163.78 169.93 17.64 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.778 0.323 . . . . 74.340000000000003 110.983 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.45 93.85 9.66 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.173 0.511 . . . . 72.219999999999999 111.801 -178.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 55' ' ' LEU . 35.4 m -107.94 148.69 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.137 -0.483 . . . . 63.549999999999997 111.121 178.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.03 146.24 17.14 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.327 -0.463 . . . . 74.319999999999993 113.123 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.692 ' H ' ' HB3' ' A' ' 113' ' ' ALA . 39.0 mm -140.93 132.62 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 122.817 0.447 . . . . 74.430000000000007 110.623 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -152.21 159.38 43.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.956 0.408 . . . . 72.319999999999993 111.258 174.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -103.82 138.85 39.83 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.035 0.445 . . . . 72.540000000000006 111.556 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 t -121.01 4.04 10.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.526 0.679 . . . . 73.530000000000001 110.656 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -134.45 -93.09 0.45 Allowed Glycine 0 CA--C 1.525 0.715 0 CA-C-N 115.652 -0.704 . . . . 74.510000000000005 112.359 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 157.57 70.29 0.01 OUTLIER Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.195 -0.526 . . . . 63.439999999999998 113.416 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.526 ' H ' ' HE1' ' A' ' 59' ' ' MET . . . 85.24 52.98 3.24 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.502 -0.38 . . . . 64.450000000000003 113.158 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.67 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 11.3 m-20 -96.1 176.97 5.89 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.324 0.49 . . . . 74.040000000000006 112.324 -175.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.6 t70 64.41 160.67 0.11 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.41 0.684 . . . . 54.530000000000001 112.082 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.71 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 41.8 mt-10 -102.01 -53.81 0.14 Allowed Pre-proline 0 CA--C 1.547 0.83 0 N-CA-C 112.254 0.464 . . . . 70.219999999999999 112.254 -176.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 8.2 Cg_exo -75.27 22.97 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 122.395 2.064 . . . . 74.340000000000003 112.991 175.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.3 tt -52.7 -35.79 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.336 0.495 . . . . 64.109999999999999 112.336 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.683 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.1 m-20 -66.36 -54.16 26.56 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 122.168 -0.332 . . . . 75.230000000000004 111.768 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 73.5 Cg_exo -51.0 -45.8 34.45 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.435 2.09 . . . . 73.450000000000003 113.0 171.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 97' ' ' PRO . 8.5 mp -55.46 -58.12 9.09 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.46 -0.336 . . . . 73.030000000000001 111.299 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.58 -32.24 71.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.499 -0.319 . . . . 73.319999999999993 111.488 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 t -62.93 -37.62 87.75 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.893 0.377 . . . . 72.430000000000007 111.104 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HG2' ' HB3' ' A' ' 76' ' ' LEU . 27.8 tptp -64.34 -41.76 96.61 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.729 0.299 . . . . 75.439999999999998 111.018 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -68.15 -44.06 76.84 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.023 0.44 . . . . 72.310000000000002 110.847 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -64.68 -39.1 93.09 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.961 -0.563 . . . . 74.030000000000001 111.813 -178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -62.23 -49.92 73.82 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.905 0.383 . . . . 74.140000000000001 111.181 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 81' ' ' GLU . 8.2 mp -74.17 -24.22 59.36 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.098 176.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.22 43.55 9.53 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.182 -0.532 . . . . 62.25 112.502 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.2 mt -76.85 156.63 32.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.19 0.519 . . . . 71.099999999999994 111.905 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.4 m -66.97 106.54 1.96 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.774 0.657 . . . . 65.019999999999996 112.774 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.0 p -84.04 95.04 8.45 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.742 0.306 . . . . 64.140000000000001 111.12 175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.692 ' HB3' ' H ' ' A' ' 87' ' ' ILE . . . -53.71 -70.73 0.09 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.202 0.445 . . . . 73.430000000000007 112.202 -179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -125.49 90.01 51.45 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 120.853 0.358 . . . . 75.5 111.044 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -87.14 98.71 0.48 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.57 2.18 . . . . 70.319999999999993 112.803 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.08 159.44 20.49 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.103 0.477 . . . . 52.210000000000001 111.987 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -138.26 34.1 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.892 -0.594 . . . . 73.129999999999995 110.59 175.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 118' ' ' ARG . 44.7 mtm180 -96.92 20.2 11.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.493 0.923 . . . . 74.409999999999997 113.493 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 60.2 mt -100.42 149.49 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 109.86 -0.422 . . . . 72.140000000000001 109.86 167.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -59.04 -65.99 0.58 Allowed 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.048 -0.408 . . . . 63.109999999999999 111.518 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.681 HE21 ' HA ' ' A' ' 121' ' ' GLN . 0.0 OUTLIER -177.3 -26.85 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.987 0.423 . . . . 64.430000000000007 111.453 -177.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p -89.82 117.81 68.43 Favored Pre-proline 0 N--CA 1.47 0.553 0 N-CA-C 111.851 0.315 . . . . 65.239999999999995 111.851 178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.68 134.48 44.26 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.56 2.173 . . . . 75.450000000000003 111.864 175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.3 p -100.49 168.49 9.7 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.712 0.768 . . . . 64.409999999999997 112.717 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.59 -29.94 68.31 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.36 -0.836 . . . . 74.140000000000001 111.053 174.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -73.01 -31.92 64.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.888 -0.596 . . . . 73.319999999999993 110.973 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.5 m -56.13 -35.58 67.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.858 0.361 . . . . 52.140000000000001 111.059 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -55.71 -48.27 75.45 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.284 -0.416 . . . . 73.349999999999994 111.591 175.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 5.3 mptp? -67.19 -32.77 74.07 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.945 0.35 . . . . 72.530000000000001 111.945 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.93 -53.58 56.36 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.234 0.54 . . . . 75.129999999999995 110.466 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.43 -34.35 75.84 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.87 -0.604 . . . . 73.099999999999994 111.526 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.9 tt0 -59.15 -66.67 0.47 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.952 0.501 . . . . 73.430000000000007 112.173 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.95 -47.21 86.75 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.795 0.331 . . . . 72.349999999999994 111.589 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.84 -50.75 72.8 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.817 0.342 . . . . 72.099999999999994 111.454 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.467 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -63.02 -37.23 94.62 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.321 -0.466 . . . . 73.420000000000002 113.362 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.489 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 99.2 m -63.0 -58.0 8.81 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.738 0.304 . . . . 75.430000000000007 111.212 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -63.15 -41.52 99.29 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.616 -0.266 . . . . 74.239999999999995 111.457 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.63 -43.46 93.81 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 110.18 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.428 ' O ' HG22 ' A' ' 143' ' ' THR . . . -60.1 -45.81 95.32 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.103 -0.57 . . . . 62.009999999999998 112.458 175.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 136' ' ' THR . 80.3 mt-30 -66.68 -29.22 69.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.216 0.532 . . . . 75.420000000000002 111.166 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 76.2 t90 -65.1 -54.64 26.9 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.968 -0.56 . . . . 70.120000000000005 110.541 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.27 -46.81 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 112.789 0.663 . . . . 72.209999999999994 112.789 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.6 HG23 ' HD3' ' A' ' 144' ' ' ARG . 4.7 t -53.46 -33.61 54.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.681 0.623 . . . . 70.420000000000002 112.681 -176.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.6 ' HD3' HG23 ' A' ' 143' ' ' THR . 11.0 mpt_? -99.76 -19.06 16.91 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.94 0.348 . . . . 75.239999999999995 111.94 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.71 ' HA ' ' HB2' ' A' ' 149' ' ' HIS . 30.3 t70 -57.31 -62.17 1.96 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.03 0.381 . . . . 64.430000000000007 112.03 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -60.17 -16.73 35.47 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.242 -0.435 . . . . 72.140000000000001 112.004 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 143' ' ' THR . 3.9 mm? -89.78 -49.25 6.74 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.003 0.371 . . . . 71.019999999999996 112.003 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -170.21 -39.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 111.867 0.321 . . . . 65.430000000000007 111.867 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 145' ' ' ASP . 42.5 t-80 73.68 51.48 0.12 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.636 0.976 . . . . 74.430000000000007 113.636 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -113.97 132.89 55.8 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.805 -0.559 . . . . 71.219999999999999 112.034 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.8 m170 62.11 -84.18 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.396 0.887 . . . . 72.340000000000003 113.396 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.457 ' O ' ' CG ' ' A' ' 152' ' ' HIS . 0.9 OUTLIER 56.4 96.84 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.649 0.738 . . . . 74.439999999999998 109.642 -166.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 154' ' ' HIS . 85.7 t60 68.19 130.46 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.371 -0.831 . . . . 72.019999999999996 110.998 -168.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' A' ' 153' ' ' HIS . 57.6 t60 . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.204 -0.903 . . . . 64.019999999999996 111.749 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 67.1 p . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.345 0.116 . . . . 53.020000000000003 110.764 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.7 mm 63.55 89.87 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.281 0.562 . . . . 61.43 111.638 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.29 100.5 1.66 Allowed Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.946 -0.57 . . . . 61.350000000000001 112.729 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 100.4 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.856 0.36 . . . . 64.329999999999998 111.108 178.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 94.5 m-85 -98.55 120.96 39.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.082 -0.508 . . . . 73.209999999999994 111.711 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' HB2' ' OG ' ' A' ' 13' ' ' SER . 13.7 p90 -143.91 -179.7 6.64 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.105 0.479 . . . . 74.439999999999998 112.141 -176.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.448 HG13 ' HA3' ' A' ' 37' ' ' GLY . 33.0 t -126.61 90.79 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.189 -0.46 . . . . 32.100000000000001 110.108 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.46 ' HG ' ' HE2' ' A' ' 6' ' ' TYR . 23.2 m -40.87 -54.26 2.73 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.318 1.229 . . . . 65.109999999999999 114.318 -170.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.65 -25.92 61.45 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.594 0.59 . . . . 74.349999999999994 112.594 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' HE2' ' HA3' ' A' ' 91' ' ' GLY . 91.0 t80 -79.57 101.84 8.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.984 0.364 . . . . 73.299999999999997 111.984 -174.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 55.43 -159.36 6.78 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.156 -0.545 . . . . 75.200000000000003 114.365 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -62.06 7.35 0.06 Allowed 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.806 1.039 . . . . 74.230000000000004 113.806 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.47 ' OG ' ' HB2' ' A' ' 6' ' ' TYR . 11.4 t -46.15 -56.23 5.95 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.037 0.755 . . . . 55.549999999999997 113.037 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 p-10 -64.02 -31.44 72.63 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.01 0.433 . . . . 74.510000000000005 111.323 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.4 mmt180 -68.81 -35.66 77.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.22 0.533 . . . . 71.329999999999998 110.817 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' O ' HG13 ' A' ' 20' ' ' ILE . 94.5 mt -69.36 -44.84 70.75 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.081 -0.509 . . . . 71.420000000000002 110.661 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.95 -43.99 73.91 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.115 0.484 . . . . 51.43 110.935 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -53.31 -42.43 66.66 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.626 -0.716 . . . . 61.210000000000001 111.897 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.45 -42.42 43.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.403 0.52 . . . . 75.530000000000001 112.403 -177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 16' ' ' LEU . 69.2 mt -61.13 -53.17 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 120.933 0.396 . . . . 74.319999999999993 111.794 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 30.9 pt -59.34 -29.36 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.778 0.323 . . . . 74.239999999999995 111.865 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -57.61 -54.76 43.19 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.786 0.327 . . . . 70.439999999999998 111.757 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.91 -48.59 84.88 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.264 -0.494 . . . . 35.130000000000003 113.349 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 136' ' ' THR . 50.6 mt -64.8 -38.1 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.963 0.411 . . . . 63.329999999999998 111.481 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 66.9 m -60.12 -44.97 94.5 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.176 -0.328 . . . . 73.239999999999995 110.847 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -70.24 -16.11 63.0 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.743 0.306 . . . . 71.120000000000005 111.624 177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 94.7 m -77.51 -20.99 53.42 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.34 0.591 . . . . 64.450000000000003 110.319 170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 27.09 9.12 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.013 -0.54 . . . . 71.010000000000005 113.709 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.8 t -120.1 142.65 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.984 0.392 . . . . 61.149999999999999 111.62 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -84.93 118.77 4.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 121.094 -0.574 . . . . 62.5 112.979 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 1' ' ' SER . 35.6 m -91.07 167.24 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.519 0.563 . . . . 71.099999999999994 112.519 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -121.46 108.56 13.79 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.087 0.47 . . . . 73.219999999999999 111.203 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.9 t -88.85 113.28 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.522 -0.308 . . . . 75.129999999999995 111.41 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 60.9 t -140.12 110.15 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 120.87 0.367 . . . . 74.510000000000005 111.334 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -84.64 106.58 16.3 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.519 0.676 . . . . 73.25 111.931 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.575 ' HA ' HG13 ' A' ' 40' ' ' VAL . 1.3 pp -70.26 -14.25 62.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.095 -0.378 . . . . 74.319999999999993 111.863 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -60.0 -32.06 74.38 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-N 116.351 -0.386 . . . . 61.420000000000002 113.64 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.15 11.04 17.33 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.511 -0.406 . . . . 53.32 111.792 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 67.38 106.7 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.187 0.518 . . . . 71.310000000000002 111.566 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.575 HG13 ' HA ' ' A' ' 36' ' ' LEU . 35.3 m -85.21 151.24 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.083 0.468 . . . . 74.439999999999998 111.544 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -94.47 176.09 6.43 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.167 -0.47 . . . . 64.340000000000003 111.176 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.467 ' H ' HD22 ' A' ' 42' ' ' LEU . 3.2 mm? -56.98 -24.51 53.88 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.571 -0.286 . . . . 74.540000000000006 111.736 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -63.07 -56.97 12.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 72.420000000000002 111.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . 2.5 mp0 -59.99 -43.06 95.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.061 0.457 . . . . 75.400000000000006 110.73 176.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 tt -56.18 -47.33 78.5 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.935 -0.575 . . . . 72.230000000000004 110.675 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -65.69 -39.03 90.85 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.25 -0.432 . . . . 41.130000000000003 111.578 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -67.24 -33.91 76.32 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.931 0.396 . . . . 70.209999999999994 111.257 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.656 HD11 HD13 ' A' ' 55' ' ' LEU . 52.8 tp -55.54 -34.61 64.86 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.495 -0.321 . . . . 74.329999999999998 111.148 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -55.38 -41.57 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.103 0.478 . . . . 72.129999999999995 111.063 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -76.67 -16.87 80.39 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 121.15 -0.548 . . . . 41.450000000000003 113.088 177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 35.3 mmt-85 -100.38 5.73 44.4 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.617 -0.343 . . . . 73.319999999999993 111.494 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.8 p -59.28 -3.73 0.45 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.858 1.059 . . . . 75.329999999999998 113.858 -172.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -67.46 -35.33 78.98 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.03 -0.419 . . . . 65.310000000000002 111.275 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.6 138.0 5.13 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.214 -0.517 . . . . 74.129999999999995 113.045 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.656 HD13 HD11 ' A' ' 48' ' ' LEU . 1.9 pt? -158.72 146.42 17.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 122.621 -0.34 . . . . 75.310000000000002 111.26 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.418 HG12 ' HE1' ' A' ' 88' ' ' PHE . 48.8 t -117.98 118.81 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 122.362 0.265 . . . . 32.240000000000002 110.806 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.53 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.6 mp -112.06 120.63 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.217 0.451 . . . . 61.240000000000002 112.217 -173.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.86 99.17 2.54 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.412 -0.423 . . . . 74.099999999999994 112.795 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.458 ' O ' HG22 ' A' ' 90' ' ' THR . 14.0 tmm? -56.67 132.54 52.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.901 0.381 . . . . 71.420000000000002 111.558 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.0 t -134.99 147.31 62.21 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 110.921 -176.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -48.32 168.07 0.1 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 123.644 2.896 . . . . 70.200000000000003 115.045 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 95' ' ' ASP . . . -43.73 -41.33 4.8 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.577 0.955 . . . . 73.430000000000007 113.577 -173.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.79 -45.88 64.01 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.038 0.447 . . . . 73.230000000000004 111.739 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.1 m -87.32 -36.02 18.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.074 0.464 . . . . 52.520000000000003 111.094 178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -61.0 -26.96 67.96 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.071 -0.513 . . . . 73.209999999999994 112.147 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.35 -46.75 83.0 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.835 0.35 . . . . 71.420000000000002 111.534 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -65.28 -31.14 72.12 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.826 0.346 . . . . 71.230000000000004 111.34 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.51 -39.48 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 120.873 0.368 . . . . 73.219999999999999 111.27 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.9 -43.67 66.36 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.298 -0.41 . . . . 70.340000000000003 112.018 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.52 -31.33 51.89 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 121.042 -0.599 . . . . 53.299999999999997 113.512 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.0 22.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.281 0.475 . . . . 74.120000000000005 112.281 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 45.6 tp -54.73 -55.53 28.92 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.582 0.586 . . . . 51.509999999999998 112.582 -173.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -56.79 -38.15 72.12 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.836 0.35 . . . . 73.310000000000002 111.809 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.7 m -65.47 -46.27 80.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.94 0.4 . . . . 72.400000000000006 111.198 177.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 75.6 mt -62.63 -47.4 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.418 -0.355 . . . . 73.150000000000006 111.208 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.9 mt -60.72 -29.72 69.53 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.884 0.373 . . . . 71.150000000000006 111.55 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.27 -19.59 76.55 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.075 -0.583 . . . . 74.340000000000003 112.917 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.1 m -90.64 -37.95 13.43 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.069 0.396 . . . . 71.340000000000003 112.069 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.11 143.26 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.153 0.501 . . . . 74.219999999999999 112.045 -178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.608 ' N ' HD22 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -161.32 176.3 11.33 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.238 -0.437 . . . . 73.549999999999997 111.509 -177.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 82' ' ' LYS . 0.5 OUTLIER 57.68 -94.69 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.898 0.479 . . . . 63.32 111.886 173.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' H ' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -179.07 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.043 0.449 . . . . 62.5 111.836 177.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -56.79 175.62 0.12 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.376 0.608 . . . . 74.019999999999996 112.611 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.44 98.43 11.62 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.755 0.65 . . . . 73.120000000000005 112.755 -170.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.3 m -108.42 105.0 17.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-O 121.596 0.712 . . . . 62.119999999999997 112.061 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.15 78.86 1.95 Allowed Glycine 0 CA--C 1.526 0.765 0 O-C-N 122.021 -0.424 . . . . 63.310000000000002 113.032 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.5 mm -81.61 122.53 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 111.969 0.359 . . . . 43.240000000000002 111.969 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HE1' HG12 ' A' ' 56' ' ' VAL . 6.5 p90 -153.82 164.37 38.47 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.256 -0.276 . . . . 73.310000000000002 110.256 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' HB2' HD12 ' A' ' 119' ' ' ILE . 1.9 mp0 -83.86 133.64 34.73 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.884 -0.51 . . . . 75.299999999999997 111.427 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 59' ' ' MET . 10.4 t -87.04 7.18 28.88 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.437 0.637 . . . . 53.219999999999999 110.333 171.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.427 ' HA3' ' HE2' ' A' ' 10' ' ' TYR . . . 172.2 -82.79 0.08 OUTLIER Glycine 0 CA--C 1.53 1.029 0 CA-C-N 115.505 -0.771 . . . . 65.030000000000001 112.04 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.72 124.86 2.88 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.909 -0.662 . . . . 74.200000000000003 113.374 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -162.46 -152.81 6.9 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 120.933 -0.651 . . . . 52.520000000000003 112.822 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -94.06 121.59 35.71 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.903 0.383 . . . . 72.239999999999995 111.677 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 62' ' ' ALA . 3.3 p-10 -147.02 171.87 14.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 64.420000000000002 110.891 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.619 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 43.0 mt-10 -102.97 -44.62 0.19 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.453 0.909 . . . . 74.439999999999998 113.453 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.619 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 36.6 Cg_endo -62.83 -12.1 27.45 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.246 1.964 . . . . 73.519999999999996 114.703 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 99' ' ' ASP . 7.3 tp -53.99 -51.63 44.04 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.986 0.736 . . . . 64.5 112.986 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.709 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 6.6 m-20 -61.71 -54.56 50.42 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.134 0.42 . . . . 45.409999999999997 112.134 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.709 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.5 Cg_exo -56.88 -35.87 98.62 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.233 1.955 . . . . 72.109999999999999 112.744 176.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -56.76 13.62 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.214 -0.448 . . . . 73.219999999999999 111.12 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.6 mt -57.81 -45.03 86.7 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.236 -0.438 . . . . 73.109999999999999 111.23 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 27.3 t -55.74 -37.87 69.05 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.161 -0.472 . . . . 73.439999999999998 111.943 177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.591 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 1.8 tpmt? -68.24 -58.66 4.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.765 0.317 . . . . 71.099999999999994 111.039 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -58.47 -27.38 64.35 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.732 0.271 . . . . 73.319999999999993 111.732 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' SER . 18.9 ttp180 -52.06 -50.16 62.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.964 0.411 . . . . 55.100000000000001 111.596 173.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -75.85 -40.56 54.47 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.332 -0.394 . . . . 75.439999999999998 111.593 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.723 ' HB3' HD13 ' A' ' 110' ' ' LEU . 10.8 mp -59.46 -40.09 85.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.846 0.355 . . . . 73.340000000000003 111.904 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 80.28 32.07 36.12 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.211 -0.519 . . . . 42.409999999999997 113.807 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 108' ' ' LEU . 10.9 mp -88.92 165.6 14.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.041 0.448 . . . . 71.299999999999997 111.509 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.2 m -80.28 122.71 27.23 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.271 0.471 . . . . 63.119999999999997 112.271 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.4 p -103.49 112.26 25.08 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.273 -0.421 . . . . 73.400000000000006 110.599 173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.17 -48.75 67.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.909 0.385 . . . . 44.32 111.244 179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.411 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -126.05 144.54 49.14 Favored Pre-proline 0 CA--C 1.539 0.519 0 CA-C-N 116.007 -0.542 . . . . 73.099999999999994 110.233 172.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.11 4.85 2.1 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.88 2.387 . . . . 71.239999999999995 113.57 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 70.12 159.81 0.2 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.811 0.671 . . . . 71.129999999999995 112.811 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.3 pt 42.44 31.24 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 114.295 1.22 . . . . 64.340000000000003 114.295 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.07 -7.86 16.0 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 122.001 -0.437 . . . . 75.310000000000002 111.871 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 89' ' ' GLU . 67.9 mt -91.79 144.78 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 120.939 0.399 . . . . 72.010000000000005 111.189 173.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.485 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 19.2 pttp -87.5 53.56 2.84 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.737 0.643 . . . . 53.43 112.737 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 120' ' ' LYS . 5.5 tp-100 74.17 -47.4 0.64 Allowed 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 112.69 0.626 . . . . 74.219999999999999 112.69 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.1 p -96.22 116.8 66.38 Favored Pre-proline 0 N--CA 1.47 0.529 0 N-CA-C 111.986 0.365 . . . . 61.210000000000001 111.986 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.38 140.08 62.29 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.52 2.147 . . . . 51.229999999999997 111.857 172.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.6 p -111.37 179.04 4.14 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.332 0.587 . . . . 74.239999999999995 112.096 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 -31.33 59.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.906 -0.588 . . . . 65.230000000000004 111.462 174.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -68.35 -40.95 81.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 110.779 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -51.94 -35.19 45.03 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.226 -0.443 . . . . 74.400000000000006 111.292 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -56.16 -63.15 1.28 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.506 -0.316 . . . . 71.040000000000006 111.019 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -51.78 -46.03 64.02 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.801 0.334 . . . . 73.230000000000004 111.655 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.18 -59.8 4.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.489 -0.323 . . . . 71.420000000000002 111.679 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.2 p -60.5 -39.84 89.21 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.791 0.293 . . . . 65.219999999999999 111.791 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.94 -69.36 0.22 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.44 0.533 . . . . 73.430000000000007 112.44 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.82 -32.32 69.34 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.619 0.6 . . . . 73.340000000000003 112.619 -171.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.72 -43.47 65.82 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.75 0.31 . . . . 62.130000000000003 110.849 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.0 -38.17 95.14 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.369 -0.443 . . . . 21.32 112.545 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.646 HG22 HE21 ' A' ' 140' ' ' GLN . 93.9 m -62.09 -49.16 77.02 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.649 -0.324 . . . . 34.240000000000002 111.032 176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -61.21 -38.4 86.46 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 121.322 0.582 . . . . 74.540000000000006 110.408 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -58.45 -43.72 88.92 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.687 -0.688 . . . . 64.310000000000002 110.131 175.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -71.0 -33.86 65.26 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 116.034 -0.53 . . . . 32.229999999999997 113.406 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.646 HE21 HG22 ' A' ' 136' ' ' THR . 79.5 mt-30 -57.8 -44.4 86.3 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.829 0.315 . . . . 73.510000000000005 111.552 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -55.82 -50.67 69.91 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.674 0.273 . . . . 73.209999999999994 110.797 177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.62 -46.06 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.42 0.526 . . . . 73.150000000000006 112.42 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.448 ' O ' HD23 ' A' ' 147' ' ' LEU . 13.0 t -74.36 -42.59 59.08 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.77 -0.372 . . . . 71.040000000000006 111.829 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.1 ttt-85 -64.02 -40.84 97.25 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.088 0.47 . . . . 74.150000000000006 110.567 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.07 -46.74 84.94 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.335 -0.848 . . . . 42.229999999999997 110.178 175.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -61.54 -47.39 85.77 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.363 -0.835 . . . . 72.109999999999999 112.266 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 143' ' ' THR . 4.3 mm? -62.99 -46.4 87.87 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.795 0.665 . . . . 74.319999999999993 112.795 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.26 -17.4 37.07 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.997 -0.44 . . . . 61.420000000000002 111.977 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 73.69 -37.24 0.37 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.487 0.715 . . . . 75.409999999999997 112.171 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -82.17 135.02 35.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 110.047 -0.353 . . . . 70.120000000000005 110.047 173.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -73.04 -31.12 64.24 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.209 0.818 . . . . 72.129999999999995 113.209 -171.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 61.47 175.53 0.12 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.519 0.676 . . . . 73.5 112.67 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -174.16 108.12 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.577 -0.738 . . . . 74.319999999999993 110.782 171.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 71.2 m80 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.565 -0.731 . . . . 73.439999999999998 111.157 178.191 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 111.231 0.086 . . . . 65.409999999999997 111.231 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.3 mm 64.0 96.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 121.326 0.584 . . . . 61.140000000000001 112.19 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.46 108.76 2.98 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 116.114 -0.494 . . . . 41.350000000000001 113.42 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.7 t -87.02 106.58 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.832 0.349 . . . . 41.130000000000003 110.683 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.734 ' HB3' HD23 ' A' ' 36' ' ' LEU . 23.9 m-85 -111.97 117.03 31.59 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.86 0.362 . . . . 71.200000000000003 111.579 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -147.02 173.16 12.7 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.877 0.37 . . . . 71.420000000000002 111.72 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.539 HG12 ' H ' ' A' ' 10' ' ' TYR . 19.2 t -99.59 86.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.098 0.475 . . . . 71.340000000000003 110.821 179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -51.07 -19.81 1.22 Allowed 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.627 0.973 . . . . 53.530000000000001 113.627 -174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -95.15 -50.95 4.84 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.515 0.561 . . . . 74.219999999999999 112.515 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' H ' HG12 ' A' ' 7' ' ' VAL . 60.9 t80 -72.33 114.05 10.03 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.002 0.741 . . . . 74.439999999999998 113.002 -174.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.66 -159.46 5.56 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 115.049 0.779 . . . . 51.530000000000001 115.049 171.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -65.55 7.28 0.24 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 113.917 1.08 . . . . 73.109999999999999 113.917 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.465 ' HB2' HG21 ' A' ' 90' ' ' THR . 34.9 t -49.87 -36.04 25.58 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.455 0.571 . . . . 63.539999999999999 112.337 -176.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -69.89 -40.75 75.46 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.123 0.487 . . . . 55.009999999999998 110.689 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -62.18 -42.26 99.11 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.907 -0.588 . . . . 71.519999999999996 110.854 177.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 95.0 mt -59.42 -49.28 78.43 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.164 0.507 . . . . 71.349999999999994 110.614 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.31 -43.89 79.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.965 -0.561 . . . . 73.120000000000005 111.548 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -60.15 -38.25 82.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.724 0.297 . . . . 75.299999999999997 111.352 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.72 88.2 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.879 0.371 . . . . 72.129999999999995 111.418 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.404 HG23 ' HA3' ' A' ' 135' ' ' GLY . 66.4 mt -70.17 -54.38 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.192 0.52 . . . . 63.210000000000001 111.157 176.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.509 HG23 HG11 ' A' ' 31' ' ' VAL . 72.1 mt -56.96 -35.25 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.117 -0.492 . . . . 61.25 111.609 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -47.24 -51.7 18.04 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.132 0.491 . . . . 63.219999999999999 111.272 177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -66.98 -49.97 50.22 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.927 -0.654 . . . . 73.329999999999998 113.058 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -62.63 -42.9 97.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.818 0.673 . . . . 70.439999999999998 112.818 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 21' ' ' ILE . 12.7 t -67.76 -35.3 78.45 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.062 0.393 . . . . 75.209999999999994 112.062 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -84.67 -31.65 24.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.828 0.307 . . . . 73.329999999999998 111.828 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.7 m -65.14 -30.25 71.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.052 0.453 . . . . 52.0 110.823 173.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.64 42.24 4.23 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.195 -0.526 . . . . 55.030000000000001 114.029 175.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.29 -76.35 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 122.258 -0.554 . . . . 63.32 111.463 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.34 157.23 8.28 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 121.481 -0.39 . . . . 72.430000000000007 112.255 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 21' ' ' ILE . 18.2 m -140.66 122.99 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 117.483 0.641 . . . . 75.129999999999995 112.501 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -109.63 104.27 13.26 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.284 -0.416 . . . . 74.540000000000006 110.357 172.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.48 124.18 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 112.173 0.435 . . . . 61.240000000000002 112.173 -175.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.92 123.65 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.146 0.498 . . . . 54.240000000000002 110.71 175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.91 81.46 7.16 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.191 -0.459 . . . . 61.32 112.091 -175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 5' ' ' PHE . 4.3 pp -66.67 -19.67 65.81 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.853 -0.529 . . . . 74.209999999999994 111.526 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.29 17.88 51.64 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.403 -0.427 . . . . 75.329999999999998 112.924 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.5 -153.19 0.5 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.739 0.416 . . . . 54.520000000000003 110.503 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.18 99.75 10.49 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 122.074 -0.391 . . . . 70.400000000000006 111.89 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.15 165.72 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 CA-C-O 120.911 0.386 . . . . 71.030000000000001 111.723 177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.52 -171.33 3.2 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.924 0.392 . . . . 73.150000000000006 110.811 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.1 tm? -58.9 -28.52 66.27 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.125 0.417 . . . . 74.230000000000004 112.125 -177.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.414 ' NE2' ' H ' ' A' ' 43' ' ' GLN . 1.5 mp0 -54.2 -48.44 71.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.968 0.413 . . . . 72.129999999999995 111.752 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -68.49 -41.5 80.01 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.215 0.531 . . . . 74.209999999999994 110.917 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 45' ' ' LEU . 0.9 OUTLIER -60.9 -39.09 88.01 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.937 -0.574 . . . . 61.310000000000002 110.643 179.415 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -56.86 -48.14 78.8 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.808 -0.633 . . . . 74.420000000000002 111.709 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -70.15 -28.15 65.12 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 111.621 0.23 . . . . 75.430000000000007 111.621 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 39.4 tp -57.51 -27.97 63.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.872 0.367 . . . . 74.319999999999993 111.589 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.5 t -61.17 -38.06 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.05 0.452 . . . . 62.240000000000002 111.389 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -88.79 -30.65 14.46 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.127 -0.558 . . . . 71.340000000000003 112.659 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.415 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 89.2 mtt180 -75.59 0.57 17.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.936 0.495 . . . . 74.349999999999994 112.029 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.8 p -67.27 6.1 0.63 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.272 0.842 . . . . 72.230000000000004 113.272 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -80.83 -28.94 36.02 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.264 0.468 . . . . 74.140000000000001 112.264 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.0 137.38 4.72 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.844 -0.693 . . . . 61.25 113.14 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.418 HD11 HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -163.79 167.63 20.64 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.693 0.627 . . . . 71.209999999999994 112.693 -176.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.6 p -146.62 121.26 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.104 -0.498 . . . . 52.409999999999997 111.026 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.4 mp -108.45 143.75 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.009 0.433 . . . . 73.400000000000006 111.67 -176.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -131.08 2.6 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 121.203 -0.523 . . . . 41.030000000000001 112.61 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.472 ' HB2' ' H ' ' A' ' 90' ' ' THR . 13.7 tmm? -110.08 127.27 54.77 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.148 -0.619 . . . . 62.240000000000002 110.901 177.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.2 p -97.32 105.48 25.46 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.629 -0.259 . . . . 43.329999999999998 111.545 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.18 155.39 67.98 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.313 2.009 . . . . 73.120000000000005 112.234 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.0 -35.07 23.22 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.573 0.582 . . . . 73.450000000000003 112.573 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.52 -42.1 74.07 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.0 0.428 . . . . 74.409999999999997 112.064 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 91.9 p -89.94 -40.17 12.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.716 0.294 . . . . 73.430000000000007 110.91 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' O ' ' HG2' ' A' ' 69' ' ' GLN . . . -49.99 -39.46 41.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.483 0.313 . . . . 40.229999999999997 111.789 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.29 -46.01 72.65 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.16 0.43 . . . . 71.409999999999997 112.16 177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 77.8 p -76.63 -31.88 57.66 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.138 0.494 . . . . 64.319999999999993 110.695 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 81.3 mt -63.04 -29.51 47.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 111.381 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 65' ' ' ALA . 29.0 mm-40 -52.56 -26.73 14.14 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.864 0.364 . . . . 71.430000000000007 111.856 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.44 -54.64 2.63 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.136 -0.554 . . . . 50.039999999999999 112.916 176.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -63.72 -30.13 71.27 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.75 0.648 . . . . 34.240000000000002 112.75 -176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -52.0 -47.59 64.86 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.529 0.332 . . . . 71.400000000000006 111.288 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.5 m -57.88 -48.44 79.84 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.901 0.381 . . . . 63.109999999999999 111.4 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 62.2 m -57.86 -44.64 86.73 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.204 -0.453 . . . . 52.310000000000002 111.271 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.486 ' O ' HG13 ' A' ' 79' ' ' VAL . 69.5 mt -63.01 -55.08 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.152 0.501 . . . . 74.219999999999999 111.248 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.42 HD21 ' HD2' ' A' ' 104' ' ' LYS . 49.0 tp -55.17 -34.99 64.31 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.71 -0.677 . . . . 44.119999999999997 112.256 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -78.01 -21.18 71.57 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 120.954 -0.641 . . . . 54.32 113.57 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.9 m -98.77 -21.2 16.49 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.004 0.742 . . . . 60.049999999999997 113.004 -174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 75' ' ' ILE . 31.1 m -62.93 163.98 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.844 0.683 . . . . 73.340000000000003 112.844 -178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -79.53 161.82 25.77 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.868 -0.605 . . . . 64.299999999999997 111.217 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -52.39 -44.24 65.2 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.804 0.442 . . . . 74.340000000000003 112.122 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -143.1 143.74 31.95 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.768 0.318 . . . . 75.230000000000004 111.155 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.457 ' H ' HD22 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -158.21 177.31 11.42 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.313 0.578 . . . . 71.340000000000003 112.112 -179.754 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.642 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -93.58 112.14 23.96 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.811 -0.631 . . . . 74.140000000000001 110.937 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.418 HG12 HD11 ' A' ' 55' ' ' LEU . 31.6 m -114.33 128.74 71.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.359 0.6 . . . . 55.149999999999999 112.149 -176.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -117.03 152.67 17.73 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-N 116.051 -0.522 . . . . 71.129999999999995 112.409 176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 57' ' ' ILE . 6.7 tp -148.46 137.83 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.783 0.325 . . . . 74.439999999999998 111.275 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.83 114.55 7.67 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.241 0.543 . . . . 71.109999999999999 111.21 174.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' O ' HD12 ' A' ' 119' ' ' ILE . 44.7 mt-10 -60.02 93.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.21 0.529 . . . . 62.520000000000003 111.901 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.472 ' H ' ' HB2' ' A' ' 59' ' ' MET . 24.9 m -74.73 77.41 2.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.119 0.485 . . . . 64.519999999999996 111.491 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.22 -169.15 47.5 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.073 -0.584 . . . . 74.319999999999993 113.53 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.07 77.5 0.39 Allowed Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.421 -0.419 . . . . 60.140000000000001 113.412 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' HA3' ' SD ' ' A' ' 59' ' ' MET . . . -89.12 -176.51 46.35 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.254 -0.498 . . . . 53.420000000000002 112.863 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -94.48 164.85 12.82 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.42 -0.459 . . . . 71.420000000000002 110.848 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -126.13 115.64 20.12 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.205 0.526 . . . . 72.430000000000007 112.368 -175.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.659 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 63.7 mt-10 -103.39 -59.14 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.92 0 N-CA-C 112.148 0.425 . . . . 72.140000000000001 112.148 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.659 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 39.0 Cg_endo -98.27 27.12 0.18 Allowed 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 122.87 2.38 . . . . 73.140000000000001 113.715 -175.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.54 -51.61 70.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.728 0.64 . . . . 73.109999999999999 112.728 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' N ' ' HD2' ' A' ' 100' ' ' PRO . 6.1 m-20 -64.22 -56.58 22.72 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 112.611 0.597 . . . . 75.420000000000002 112.611 -176.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 25.6 Cg_endo -59.75 -41.63 53.43 Favored 'Trans proline' 0 C--N 1.36 1.178 0 C-N-CA 122.064 1.842 . . . . 63.310000000000002 113.078 -177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.7 tt -65.72 -59.58 3.77 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.883 0.373 . . . . 65.430000000000007 110.997 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.9 mt -64.08 -34.54 78.27 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.058 0.392 . . . . 71.340000000000003 112.058 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.7 t -60.48 -50.05 75.13 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.04 0.448 . . . . 62.520000000000003 111.567 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.42 ' HD2' HD21 ' A' ' 76' ' ' LEU . 32.8 ttmt -65.02 -43.33 92.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.548 -0.296 . . . . 73.239999999999995 111.259 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.28 -40.82 87.31 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.825 0.345 . . . . 74.230000000000004 111.419 175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -55.24 -41.84 72.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.953 0.406 . . . . 74.329999999999998 110.919 175.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -70.14 -29.84 66.86 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.107 -0.497 . . . . 74.340000000000003 111.591 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.3 mt -81.47 -22.26 38.19 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.087 0.403 . . . . 73.209999999999994 112.087 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.33 -73.5 2.35 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.238 -0.506 . . . . 71.219999999999999 112.66 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.457 HD22 ' H ' ' A' ' 83' ' ' GLN . 61.1 mt 60.36 -179.21 0.1 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.614 0.721 . . . . 74.010000000000005 112.732 175.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.642 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 73.5 m -97.16 103.98 15.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.852 -0.613 . . . . 62.039999999999999 110.167 174.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 68.8 p -114.01 102.73 10.46 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.183 0.438 . . . . 62.409999999999997 112.183 -173.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -59.15 -47.74 84.19 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.544 0.572 . . . . 70.230000000000004 112.544 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -152.46 132.44 7.24 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.413 -0.179 . . . . 75.230000000000004 110.787 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.62 -69.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 122.525 2.15 . . . . 53.439999999999998 114.543 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -158.05 161.2 38.02 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.578 0.584 . . . . 64.319999999999993 112.578 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.796 HG12 ' H ' ' A' ' 118' ' ' ARG . 11.1 tt -123.64 -150.46 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.156 0.582 . . . . 73.310000000000002 109.74 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.796 ' H ' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -147.08 114.02 6.13 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.141 -0.974 . . . . 74.049999999999997 111.634 175.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' HA ' ' A' ' 123' ' ' PRO . 73.4 mt -139.06 139.2 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 115.948 -0.569 . . . . 71.510000000000005 110.597 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -81.52 -61.24 1.99 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.966 0.358 . . . . 74.299999999999997 111.966 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -141.64 -52.6 0.44 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.145 -0.347 . . . . 75.439999999999998 111.61 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 80.8 p -92.29 130.0 39.22 Favored Pre-proline 0 N--CA 1.471 0.625 0 CA-C-N 116.788 -0.187 . . . . 71.420000000000002 111.066 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.653 ' HA ' HD13 ' A' ' 119' ' ' ILE . 12.3 Cg_endo -55.15 127.22 25.38 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.404 2.07 . . . . 72.209999999999994 112.691 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 71.8 p -74.48 154.48 38.68 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.22 -0.445 . . . . 55.229999999999997 111.906 -178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.45 -25.63 68.09 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.038 0.447 . . . . 74.219999999999999 111.385 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -38.18 75.13 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.131 -0.486 . . . . 73.420000000000002 109.998 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.452 ' OG1' HD11 ' A' ' 119' ' ' ILE . 33.6 m -55.19 -38.38 68.3 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.901 -0.591 . . . . 63.350000000000001 111.879 -178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.445 ' O ' ' HG3' ' A' ' 132' ' ' GLU . 87.1 m-85 -58.36 -60.33 3.95 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.994 0.426 . . . . 75.209999999999994 111.265 177.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -58.33 -29.82 66.22 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.085 -0.507 . . . . 63.219999999999999 111.694 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.28 -50.11 42.83 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.273 -0.421 . . . . 71.219999999999999 110.368 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' A' ' 128' ' ' TYR . 30.5 p -69.24 -22.74 63.83 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 111.882 0.327 . . . . 53.530000000000001 111.882 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 128' ' ' TYR . 53.0 mt-10 -60.11 -53.0 62.96 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.881 0.372 . . . . 64.239999999999995 111.057 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.13 -55.74 8.63 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.08 0.467 . . . . 64.450000000000003 111.022 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.24 -57.55 12.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.944 -0.571 . . . . 72.349999999999994 112.434 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.404 ' HA3' HG23 ' A' ' 20' ' ' ILE . . . -56.4 -47.27 84.28 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 121.461 -0.4 . . . . 51.439999999999998 113.75 -176.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 140' ' ' GLN . 44.4 m -64.87 -33.53 76.23 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 122.558 -0.378 . . . . 63.340000000000003 111.64 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -55.04 -36.5 65.61 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.197 0.443 . . . . 73.030000000000001 112.197 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 84' ' ' ALA . 3.3 mm? -56.32 -45.66 80.23 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.18 0.514 . . . . 70.129999999999995 110.902 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -68.69 -38.86 86.33 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 121.079 -0.581 . . . . 64.25 112.796 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 136' ' ' THR . 17.5 mm-40 -57.61 -50.05 74.42 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.847 0.356 . . . . 71.400000000000006 111.642 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 60.2 t90 -54.48 -50.88 66.71 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 111.533 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.18 -51.92 66.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 112.234 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -69.46 -43.3 73.54 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.403 0.52 . . . . 61.119999999999997 112.403 -174.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -68.34 -43.1 78.23 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.106 0.41 . . . . 70.400000000000006 112.106 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -63.77 -30.59 71.67 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 73.340000000000003 111.095 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -75.24 -21.56 58.51 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.988 -0.551 . . . . 75.430000000000007 111.801 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 148' ' ' GLU . 92.7 mt -113.69 -56.36 2.41 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.256 0.465 . . . . 51.439999999999998 112.256 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 147' ' ' LEU . 43.4 mm-40 71.25 107.49 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.442 0.697 . . . . 75.049999999999997 112.479 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -143.75 -62.71 0.39 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.07 -0.514 . . . . 70.230000000000004 111.412 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -134.1 118.01 17.24 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.679 0.622 . . . . 63.520000000000003 112.679 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -97.28 144.52 26.99 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.296 -0.631 . . . . 64.040000000000006 109.296 166.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 64.21 99.95 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.606 -0.516 . . . . 74.120000000000005 109.606 -168.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -127.27 179.05 5.65 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.574 0.583 . . . . 54.130000000000003 112.574 -167.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.567 -0.73 . . . . 73.25 110.835 173.271 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.1 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.421 0.153 . . . . 54.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.6 mm 59.46 102.2 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-O 121.195 0.521 . . . . 54.030000000000001 111.887 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.65 94.43 1.87 Allowed Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.833 -0.698 . . . . 62.439999999999998 113.061 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.543 ' HB ' HG12 ' A' ' 33' ' ' VAL . 47.9 t -88.0 104.75 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.056 0.428 . . . . 75.120000000000005 111.091 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.459 ' HB3' HD23 ' A' ' 36' ' ' LEU . 97.7 m-85 -103.86 119.03 38.08 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.204 0.526 . . . . 61.539999999999999 111.408 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.584 ' HB2' ' HB3' ' A' ' 13' ' ' SER . 45.1 p90 -136.6 -178.08 5.02 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.155 -0.475 . . . . 74.25 111.678 -175.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.9 100.93 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.813 0.339 . . . . 74.439999999999998 110.585 173.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.575 ' HB3' ' HE2' ' A' ' 6' ' ' TYR . 53.4 p -63.86 -18.49 64.21 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.281 0.845 . . . . 74.430000000000007 113.281 -175.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -89.16 -10.94 45.29 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.067 0.461 . . . . 74.150000000000006 111.534 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -115.45 119.11 35.13 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 122.251 -0.281 . . . . 63.130000000000003 111.082 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.61 -161.32 7.45 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 121.253 -0.498 . . . . 54.340000000000003 114.131 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -84.75 8.23 17.85 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.01 0.744 . . . . 71.519999999999996 113.01 -174.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.584 ' HB3' ' HB2' ' A' ' 6' ' ' TYR . 42.8 m -32.19 -51.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.578 0.955 . . . . 52.409999999999997 113.578 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.5 -40.95 76.7 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.692 0.282 . . . . 74.040000000000006 111.724 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -60.3 -39.06 85.6 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.292 0.567 . . . . 74.109999999999999 110.544 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -63.59 -53.32 53.52 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.734 -0.666 . . . . 51.25 110.905 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.56 -39.8 68.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.999 0.428 . . . . 50.420000000000002 111.379 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -55.71 -45.51 77.89 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.683 -0.689 . . . . 74.049999999999997 111.516 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.18 -43.84 69.94 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.094 -0.503 . . . . 71.510000000000005 111.424 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' O ' HG12 ' A' ' 24' ' ' ILE . 82.0 mt -57.0 -56.82 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.209 -0.451 . . . . 54.229999999999997 111.664 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.1 tt -56.98 -35.92 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 120.806 0.336 . . . . 63.240000000000002 111.354 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -62.76 -37.4 86.47 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.015 0.436 . . . . 73.109999999999999 111.206 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.23 -33.0 24.31 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 121.26 -0.495 . . . . 72.129999999999995 113.775 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 31' ' ' VAL . 44.8 mm -75.98 -41.59 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 122.407 -0.466 . . . . 71.439999999999998 112.044 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.2 p -61.24 -30.17 70.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 74.329999999999998 111.344 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -76.41 -12.57 60.07 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.373 0.606 . . . . 71.25 111.176 176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.9 m -90.35 -36.75 14.46 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.129 -0.487 . . . . 54.219999999999999 111.016 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.64 22.82 2.69 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 121.304 -0.474 . . . . 61.009999999999998 113.748 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 24' ' ' ILE . 67.7 t -130.16 140.39 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 117.148 0.474 . . . . 53.229999999999997 111.069 177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.44 113.34 4.65 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.089 -0.577 . . . . 52.219999999999999 112.846 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.635 HG13 HG21 ' A' ' 24' ' ' ILE . 20.5 m -94.15 140.33 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-O 121.129 0.49 . . . . 63.340000000000003 112.139 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 51' ' ' ARG . 23.4 m-20 -101.38 113.26 26.19 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.095 -0.502 . . . . 71.519999999999996 111.079 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.573 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 36.0 m -106.11 125.95 61.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 120.969 0.414 . . . . 71.420000000000002 111.418 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.2 t -138.81 150.69 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 122.458 0.303 . . . . 45.530000000000001 111.523 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 15.7 m-20 -84.54 120.52 26.43 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.796 0.295 . . . . 72.049999999999997 111.796 176.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.496 HD11 ' HE1' ' A' ' 59' ' ' MET . 4.2 pp -86.12 -16.21 38.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.155 0.503 . . . . 73.140000000000001 111.38 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.73 -10.77 78.55 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.208 -0.52 . . . . 65.040000000000006 112.489 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.44 -178.32 5.84 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.836 0.35 . . . . 75.420000000000002 111.275 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.21 96.02 3.23 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.998 0.428 . . . . 72.200000000000003 111.236 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.6 m -85.5 132.58 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 121.259 0.552 . . . . 71.219999999999999 111.56 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -108.64 170.42 8.04 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.375 -0.375 . . . . 74.439999999999998 110.94 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 45' ' ' LEU . 3.3 mm? -55.9 -24.55 38.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.073 0.463 . . . . 63.140000000000001 111.084 177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -57.56 -60.26 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.877 -0.601 . . . . 73.0 110.983 173.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -65.58 -38.08 88.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.08 -0.509 . . . . 73.310000000000002 110.973 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.575 HD12 HD13 ' A' ' 42' ' ' LEU . 92.9 mt -59.3 -34.79 72.72 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.451 -0.34 . . . . 74.329999999999998 111.448 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -75.84 -33.84 60.07 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 122.224 -0.297 . . . . 75.120000000000005 111.017 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -58.14 -39.13 77.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.992 0.425 . . . . 73.400000000000006 110.281 174.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.646 HD21 HG23 ' A' ' 75' ' ' ILE . 67.7 tp -52.61 -46.5 67.02 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.98 -0.554 . . . . 73.540000000000006 110.852 173.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.6 t -58.86 -44.23 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.046 0.45 . . . . 73.340000000000003 111.009 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.43 -29.88 72.8 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 121.144 -0.551 . . . . 42.240000000000002 113.025 176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -99.61 8.69 44.2 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.069 0.396 . . . . 73.030000000000001 112.069 178.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -57.05 -3.41 0.13 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.502 0.927 . . . . 73.310000000000002 113.502 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.7 p -84.58 -27.63 27.12 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.793 0.33 . . . . 71.409999999999997 111.793 176.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.55 138.32 5.25 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 121.469 -0.396 . . . . 44.329999999999998 112.843 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 pp -159.12 162.99 36.54 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.319 0.488 . . . . 75.439999999999998 112.319 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.2 t -131.05 128.76 62.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.422 -0.353 . . . . 73.420000000000002 111.387 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.5 mp -95.59 139.06 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.758 0.313 . . . . 74.430000000000007 110.909 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.03 -116.13 0.46 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.211 -0.519 . . . . 55.030000000000001 113.79 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.664 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -82.68 175.9 9.77 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 112.842 0.682 . . . . 72.299999999999997 112.842 -177.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.447 ' N ' ' CD ' ' A' ' 61' ' ' PRO . 87.7 p -144.52 34.51 0.16 Allowed Pre-proline 0 CA--C 1.555 1.165 0 N-CA-C 114.07 1.137 . . . . 73.329999999999998 114.07 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 59' ' ' MET . 87.7 Cg_endo -77.53 149.13 26.88 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.651 1.568 . . . . 73.530000000000001 112.434 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -51.15 -45.41 61.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.439 0.533 . . . . 63.240000000000002 112.439 -176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.4 66.36 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.105 0.479 . . . . 51.119999999999997 112.102 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 t -78.36 -29.95 47.74 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.987 0.422 . . . . 75.230000000000004 111.215 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.61 -29.37 62.07 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.139 -0.482 . . . . 63.130000000000003 111.904 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.65 -43.86 80.73 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.063 0.459 . . . . 74.549999999999997 111.246 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.8 t -73.73 -43.83 58.03 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.991 0.424 . . . . 61.32 110.958 177.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.9 mt -58.3 -50.37 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.077 -0.51 . . . . 61.219999999999999 111.846 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.64 -43.57 98.61 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.034 0.383 . . . . 74.040000000000006 112.034 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -54.44 -41.36 72.11 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.037 -0.601 . . . . 70.340000000000003 112.765 177.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -81.45 -32.68 32.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.74 0.305 . . . . 44.130000000000003 111.382 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -55.15 -43.91 74.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.973 0.509 . . . . 72.519999999999996 111.33 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 62.6 m -55.86 -21.96 22.76 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.776 0.322 . . . . 52.420000000000002 111.849 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.9 m -97.61 -29.89 13.17 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.101 0.476 . . . . 64.420000000000002 110.863 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.646 HG23 HD21 ' A' ' 48' ' ' LEU . 69.4 mt -64.07 -39.17 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.033 0.383 . . . . 71.230000000000004 112.033 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.6 mt -51.1 -49.2 61.18 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.438 0.533 . . . . 73.109999999999999 112.438 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.79 -8.01 87.95 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.044 -0.598 . . . . 52.329999999999998 113.234 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 63.2 m -94.04 -24.68 17.52 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 111.929 0.344 . . . . 73.239999999999995 111.929 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.4 m -87.01 164.18 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.178 0.513 . . . . 64.010000000000005 111.905 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -96.93 -156.2 0.52 Allowed 'General case' 0 CA--C 1.551 1.009 0 CA-C-N 116.159 -0.473 . . . . 52.509999999999998 111.444 -176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.11 -80.57 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.951 0.723 . . . . 52.229999999999997 112.951 -172.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -117.57 98.6 6.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.594 0.712 . . . . 64.219999999999999 111.874 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -100.11 166.48 11.0 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.459 0.647 . . . . 74.109999999999999 112.564 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -102.77 110.81 22.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.531 -0.759 . . . . 62.149999999999999 109.298 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.1 m -121.03 154.03 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.814 0.816 . . . . 72.409999999999997 113.033 -168.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.72 169.97 14.32 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.249 -0.887 . . . . 42.0 112.684 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 tp -153.76 126.63 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.383 0.273 . . . . 72.340000000000003 110.848 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -137.28 92.48 2.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.717 0.77 . . . . 72.310000000000002 111.99 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.58 ' O ' HG13 ' A' ' 119' ' ' ILE . 11.5 tp10 -66.63 121.31 15.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.653 -0.703 . . . . 70.299999999999997 110.473 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.492 HG21 ' OG ' ' A' ' 13' ' ' SER . 8.0 t -101.53 15.78 27.79 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.083 0.468 . . . . 64.109999999999999 111.843 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 121' ' ' GLN . . . -158.24 -64.54 0.01 OUTLIER Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.811 -0.709 . . . . 72.030000000000001 113.631 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.06 47.66 2.02 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.304 -0.474 . . . . 70.329999999999998 111.967 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 61' ' ' PRO . . . -66.49 -63.81 3.7 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 114.171 0.428 . . . . 51.240000000000002 114.171 -174.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -152.66 -178.56 6.95 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.182 0.491 . . . . 73.239999999999995 111.244 -175.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.3 23.82 1.81 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.675 0.39 . . . . 71.340000000000003 111.49 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB3' ' HD3' ' A' ' 97' ' ' PRO . 34.0 tt0 -50.81 -47.85 84.94 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 113.361 0.874 . . . . 63.119999999999997 113.361 -177.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.481 ' O ' HD23 ' A' ' 101' ' ' LEU . 51.7 Cg_endo -87.98 38.5 0.49 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.313 2.009 . . . . 74.0 113.701 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 99' ' ' ASP . 8.7 tt -66.59 -58.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 N-CA-C 113.635 0.976 . . . . 71.129999999999995 113.635 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.45 ' N ' HG23 ' A' ' 98' ' ' ILE . 9.9 m-20 -57.9 -55.73 42.06 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.935 1.087 . . . . 73.150000000000006 113.935 -172.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 99' ' ' ASP . 32.4 Cg_endo -61.65 -14.64 37.0 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 122.315 2.01 . . . . 74.040000000000006 114.742 -170.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 97' ' ' PRO . 4.0 mm? -100.89 -62.03 1.29 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -50.62 -45.15 57.49 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.508 0.929 . . . . 72.349999999999994 113.508 -170.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.7 t -52.81 -37.68 60.24 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.488 0.551 . . . . 71.310000000000002 112.488 -177.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 0.5 OUTLIER -66.61 -44.0 83.25 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.831 0.348 . . . . 71.5 111.449 -177.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -63.16 -35.97 82.06 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.924 0.393 . . . . 64.140000000000001 111.154 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -69.4 -43.79 72.72 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.144 -0.48 . . . . 74.319999999999993 110.999 176.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -59.32 -55.14 38.52 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.833 -0.622 . . . . 73.340000000000003 111.792 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.6 mp -71.69 -26.19 62.41 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.758 0.313 . . . . 72.430000000000007 111.312 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.68 62.14 3.32 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.172 -0.537 . . . . 55.219999999999999 113.579 177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.39 142.66 35.78 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.069 0.461 . . . . 64.540000000000006 111.313 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 35.3 m -70.91 97.61 1.45 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.261 -0.427 . . . . 72.5 110.941 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 33.3 p -86.73 121.66 29.55 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 112.152 -177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -63.31 -58.8 5.95 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.435 0.531 . . . . 73.430000000000007 112.435 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -140.92 84.89 12.81 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-O 120.996 0.427 . . . . 74.140000000000001 111.667 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -86.39 64.53 4.96 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.824 2.349 . . . . 63.310000000000002 112.989 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -164.91 42.91 0.08 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.143 0.423 . . . . 71.349999999999994 112.143 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.518 HG21 ' H ' ' A' ' 89' ' ' GLU . 1.7 pp -71.2 73.23 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 121.847 0.832 . . . . 74.400000000000006 112.892 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -79.46 50.7 1.14 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.929 -0.578 . . . . 73.439999999999998 112.415 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 89' ' ' GLU . 49.0 mm -76.35 147.82 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 120.932 0.396 . . . . 73.209999999999994 111.721 -177.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.96 -61.86 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.113 0.412 . . . . 70.140000000000001 112.113 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.525 ' O ' ' HA2' ' A' ' 91' ' ' GLY . 35.2 tt0 -151.28 -48.94 0.12 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.098 0.475 . . . . 41.020000000000003 111.604 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.0 p -129.35 131.75 23.84 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 116.412 -0.358 . . . . 53.240000000000002 111.289 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 90' ' ' THR . 37.6 Cg_endo -65.96 143.76 73.85 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.475 2.117 . . . . 72.219999999999999 112.226 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 30.8 p -100.73 -177.72 3.56 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.991 0.424 . . . . 70.209999999999994 111.592 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -59.89 -26.76 66.14 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.076 0.465 . . . . 61.439999999999998 111.258 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -76.38 -24.38 54.11 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.38 -0.373 . . . . 74.340000000000003 111.902 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.0 m -59.07 -35.26 73.07 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.936 0.398 . . . . 75.140000000000001 111.466 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -58.43 -48.43 80.72 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.024 0.44 . . . . 63.520000000000003 111.346 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -50.13 -50.11 49.73 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.653 -0.703 . . . . 75.25 112.54 -174.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 130' ' ' LEU . 7.2 mp -63.05 -46.39 87.74 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.86 0.362 . . . . 72.400000000000006 111.232 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 82.2 m -61.05 -40.05 92.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.236 -0.438 . . . . 71.409999999999997 111.773 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.18 -52.56 12.1 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.865 0.364 . . . . 71.340000000000003 111.614 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.61 -63.49 1.28 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.422 -0.354 . . . . 70.409999999999997 110.941 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.17 -35.21 79.55 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.481 -0.327 . . . . 72.019999999999996 111.405 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.84 -38.04 94.67 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.282 -0.485 . . . . 34.439999999999998 113.083 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 54.8 m -60.67 -48.61 81.02 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.827 0.346 . . . . 63.329999999999998 111.151 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -67.09 -39.64 86.81 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 120.904 0.383 . . . . 62.210000000000001 111.304 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.7 tp -61.44 -44.5 97.0 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.023 0.439 . . . . 65.230000000000004 110.662 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.3 -38.72 96.25 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.265 -0.493 . . . . 64.439999999999998 112.75 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.489 ' O ' ' HG3' ' A' ' 144' ' ' ARG . 86.3 mt-30 -61.89 -28.83 69.79 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.998 0.37 . . . . 61.420000000000002 111.998 178.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 83.2 t90 -50.63 -40.33 52.74 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.129 0.49 . . . . 70.010000000000005 110.717 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.97 -51.95 66.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.025 -0.534 . . . . 74.319999999999993 111.755 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.564 ' HA ' ' HB2' ' A' ' 146' ' ' ARG . 10.0 t -69.1 -25.2 64.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.901 0.334 . . . . 73.219999999999999 111.901 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 140' ' ' GLN . 94.7 mtt180 -65.73 -41.11 92.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.742 0.306 . . . . 75.239999999999995 111.093 176.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -82.65 -27.94 31.01 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.006 0.432 . . . . 75.540000000000006 110.936 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.68 ' HE ' ' HA ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -59.83 -59.23 5.76 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.357 -0.383 . . . . 72.219999999999999 111.132 175.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.3 tp -175.57 -95.84 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.662 -0.244 . . . . 72.230000000000004 111.514 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -150.75 109.74 3.9 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.878 0.37 . . . . 72.019999999999996 111.409 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -159.54 22.36 0.18 Allowed 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 121.522 0.677 . . . . 63.520000000000003 109.984 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -90.65 55.58 3.02 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.573 0.583 . . . . 74.310000000000002 112.573 -174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -87.07 -32.91 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.867 -0.52 . . . . 73.25 110.882 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -66.58 97.06 0.41 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.348 -0.387 . . . . 74.319999999999993 111.898 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -87.02 76.98 9.27 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 122.345 -0.222 . . . . 64.109999999999999 111.458 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.9 m80 . . . . . 0 C--O 1.251 1.171 0 N-CA-C 112.223 0.453 . . . . 63.399999999999999 112.223 -177.53 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.679 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 53.6 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.009 -0.043 . . . . 72.219999999999999 110.933 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 63.33 122.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 112.726 0.639 . . . . 74.430000000000007 112.726 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -94.48 105.11 3.24 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.473 -0.394 . . . . 73.299999999999997 112.663 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.2 t -88.39 107.92 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 O-C-N 122.55 -0.383 . . . . 64.400000000000006 110.982 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.633 ' HE2' ' HB2' ' A' ' 55' ' ' LEU . 83.3 m-85 -88.71 142.0 28.05 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.938 0.718 . . . . 72.109999999999999 112.938 -176.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -146.58 179.74 7.34 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.775 -0.648 . . . . 74.030000000000001 110.844 174.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.606 HG13 ' HA3' ' A' ' 37' ' ' GLY . 86.0 t -130.64 103.7 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 120.748 0.309 . . . . 44.420000000000002 111.721 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.7 m -54.95 -36.41 65.29 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.087 0.403 . . . . 74.049999999999997 112.087 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -54.7 -54.81 36.95 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.385 0.513 . . . . 74.200000000000003 112.385 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.423 ' H ' HG12 ' A' ' 7' ' ' VAL . 73.9 t80 -138.94 -55.29 0.6 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.092 -0.503 . . . . 62.240000000000002 110.898 -174.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.581 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -30.04 97.03 0.01 OUTLIER Glycine 0 CA--C 1.531 1.074 0 N-CA-C 115.365 0.906 . . . . 71.420000000000002 115.365 177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -70.82 5.76 1.81 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.073 0.464 . . . . 75.409999999999997 111.488 177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 m -52.89 -14.17 0.53 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.029 0.751 . . . . 73.420000000000002 113.029 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.33 -37.01 74.26 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.093 0.473 . . . . 63.439999999999998 110.916 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.561 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 1.5 mtm180 -65.15 -34.41 78.32 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.056 -0.52 . . . . 55.0 111.127 175.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' HG13 ' A' ' 20' ' ' ILE . 75.6 mt -66.79 -48.18 69.8 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.202 -0.454 . . . . 64.140000000000001 110.406 172.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.85 -41.73 71.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.126 -0.488 . . . . 70.129999999999995 112.116 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -63.0 -46.02 89.64 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.906 0.384 . . . . 62.130000000000003 111.321 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.08 93.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.064 0.459 . . . . 63.149999999999999 111.217 176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 16' ' ' LEU . 79.1 mt -63.71 -55.19 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 115.701 -0.681 . . . . 73.540000000000006 111.814 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.6 tt -60.79 -39.69 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 O-C-N 122.312 -0.243 . . . . 74.349999999999994 111.61 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 25' ' ' THR . 46.1 t-20 -55.77 -59.82 4.32 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.842 0.354 . . . . 53.32 111.025 178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.42 -45.07 96.67 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 120.952 -0.642 . . . . 73.319999999999993 113.42 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 30' ' ' GLY . 33.6 mt -72.92 -30.22 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.115 0.783 . . . . 75.150000000000006 113.115 -174.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 22' ' ' ASN . 14.5 t -69.66 -35.18 74.94 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.571 -0.705 . . . . 54.299999999999997 110.743 177.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -74.62 -43.01 57.53 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.933 0.397 . . . . 70.310000000000002 110.807 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.416 HG21 HE21 ' A' ' 140' ' ' GLN . 97.9 m -59.34 -34.09 71.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.128 -0.487 . . . . 63.009999999999998 111.377 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' HA3' ' CD2' ' A' ' 150' ' ' HIS . . . 104.48 59.13 0.68 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.036 -0.602 . . . . 61.119999999999997 114.101 175.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 24' ' ' ILE . 61.1 t -140.07 -53.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.844 0.354 . . . . 63.25 111.24 176.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 84.65 119.06 0.83 Allowed Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.326 -0.464 . . . . 75.519999999999996 113.564 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.679 ' HA ' ' O ' ' A' ' 1' ' ' SER . 30.9 m -116.6 146.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 112.324 0.49 . . . . 52.100000000000001 112.324 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -109.28 129.97 55.5 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.289 -0.414 . . . . 75.430000000000007 111.169 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.9 m -90.16 137.15 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.182 0.515 . . . . 52.420000000000002 112.205 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 5' ' ' PHE . 59.7 t -132.64 140.33 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.507 179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 17.4 t70 -107.88 130.34 55.01 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.176 0.512 . . . . 61.020000000000003 111.711 -178.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD21 HG23 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -116.75 11.32 14.53 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.288 -0.415 . . . . 71.329999999999998 112.078 178.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.606 ' HA3' HG13 ' A' ' 7' ' ' VAL . . . -96.17 -35.12 5.63 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 121.007 -0.616 . . . . 72.310000000000002 113.353 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.0 -38.22 0.31 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.984 0.421 . . . . 42.100000000000001 111.816 -178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . . . -75.54 12.44 1.01 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.499 0.555 . . . . 71.409999999999997 112.499 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 m -54.24 114.05 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.227 0.537 . . . . 65.299999999999997 111.969 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -160.12 170.43 21.25 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.886 -0.597 . . . . 71.299999999999997 110.628 -178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.17 -34.8 70.7 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.618 -0.264 . . . . 64.120000000000005 111.447 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -58.44 -63.11 1.39 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.643 0.258 . . . . 63.43 111.624 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -52.47 -48.97 65.56 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.196 0.522 . . . . 65.5 111.637 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.09 -43.67 98.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.154 -0.475 . . . . 75.120000000000005 111.975 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -71.65 -34.73 70.0 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.309 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HB3' HH11 ' A' ' 51' ' ' ARG . 34.5 mt-10 -71.99 -28.75 63.61 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.659 0.266 . . . . 63.340000000000003 111.141 175.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.56 -40.0 77.96 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.935 0.398 . . . . 73.099999999999994 110.615 173.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.39 -36.03 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.22 -0.445 . . . . 64.400000000000006 111.014 175.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -74.33 -40.29 41.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.169 -0.539 . . . . 72.209999999999994 112.647 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 47' ' ' GLU . 7.2 mpt_? -81.61 6.23 15.71 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.102 0.408 . . . . 73.140000000000001 112.102 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.9 p -49.84 -15.54 0.19 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.633 0.975 . . . . 74.439999999999998 113.633 -175.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 62.3 p -47.59 -31.63 4.66 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.338 0.496 . . . . 73.420000000000002 112.338 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -179.82 141.56 4.75 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 116.076 -0.511 . . . . 33.200000000000003 112.095 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.633 ' HB2' ' HE2' ' A' ' 5' ' ' PHE . 1.4 pt? -144.72 134.48 23.6 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 117.369 0.584 . . . . 65.150000000000006 112.136 -177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG22 ' HE1' ' A' ' 88' ' ' PHE . 11.4 p -118.11 124.99 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.076 0.465 . . . . 71.25 111.077 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.51 ' HA ' ' HB2' ' A' ' 5' ' ' PHE . 3.5 mp -113.2 139.64 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 N-CA-C 112.287 0.477 . . . . 61.200000000000003 112.287 -172.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.1 131.23 10.54 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 116.3 -0.409 . . . . 74.209999999999994 112.579 174.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 56.3 ttp -78.07 120.26 22.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.551 0.575 . . . . 71.319999999999993 112.551 -175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.668 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 88.4 p -111.75 171.14 4.57 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.153 0.581 . . . . 61.350000000000001 111.051 178.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.668 ' HD2' ' HB2' ' A' ' 60' ' ' SER . 30.9 Cg_endo -63.18 168.08 11.51 Favored 'Trans proline' 0 CA--C 1.548 1.197 0 C-N-CA 122.289 1.992 . . . . 65.420000000000002 113.526 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.831 ' HA ' ' HB3' ' A' ' 65' ' ' ALA . . . -58.22 -21.62 48.75 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.076 0.769 . . . . 72.030000000000001 113.076 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -51.19 -61.0 2.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.785 0.326 . . . . 52.350000000000001 111.305 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.5 m -80.59 -33.01 36.33 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.625 -0.261 . . . . 71.25 111.701 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.831 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . . . -54.81 -37.59 66.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.179 0.437 . . . . 72.340000000000003 112.179 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.2 -39.51 75.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.073 0.463 . . . . 75.319999999999993 111.315 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.3 t -68.86 -40.85 79.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.28 0.562 . . . . 72.420000000000002 110.691 176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.39 -44.5 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.914 -0.585 . . . . 74.329999999999998 111.081 177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -57.44 -40.17 77.85 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.507 -0.315 . . . . 74.109999999999999 111.357 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.11 -49.16 73.87 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.153 -0.546 . . . . 33.32 112.887 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.39 67.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.918 0.39 . . . . 75.329999999999998 111.92 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 72' ' ' LEU . 3.2 tm? -52.8 -32.12 42.29 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.228 -0.442 . . . . 61.039999999999999 111.175 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.4 m -46.8 -41.03 14.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.729 0.412 . . . . 63.420000000000002 111.752 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 55.1 m -87.68 -45.32 10.49 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.892 0.377 . . . . 74.510000000000005 111.157 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 70.5 mt -51.39 -51.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 112.418 0.525 . . . . 74.040000000000006 112.418 -176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 49.4 tp -55.91 -33.95 65.12 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.823 0.344 . . . . 72.430000000000007 111.889 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.37 -17.44 55.28 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.944 -0.646 . . . . 70.140000000000001 113.244 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.0 p -87.75 -16.35 34.48 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.336 0.495 . . . . 72.439999999999998 112.336 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.4 m -84.57 153.94 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-O 121.22 0.533 . . . . 73.200000000000003 112.084 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -87.14 148.64 25.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.082 -0.508 . . . . 75.109999999999999 111.158 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.76 -36.31 64.7 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.939 0.4 . . . . 71.019999999999996 111.997 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -118.19 87.15 2.66 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.489 0.661 . . . . 62.039999999999999 110.837 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.482 ' HG3' ' H ' ' A' ' 84' ' ' ALA . 18.2 tp60 -131.38 172.83 11.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.993 -0.549 . . . . 74.5 110.867 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.482 ' H ' ' HG3' ' A' ' 83' ' ' GLN . . . -107.98 123.72 49.07 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 64.540000000000006 111.836 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' A' ' 112' ' ' THR . 35.3 m -130.03 171.8 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 120.842 0.353 . . . . 62.109999999999999 111.12 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' HA3' HG23 ' A' ' 56' ' ' VAL . . . -142.4 144.4 14.03 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.097 -0.573 . . . . 64.439999999999998 112.826 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.8 mm -125.06 126.66 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.588 -0.36 . . . . 73.519999999999996 111.829 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.67 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 54.6 p90 -148.94 168.14 23.88 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.101 0.477 . . . . 75.209999999999994 111.725 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.58 155.38 21.49 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.377 0.608 . . . . 73.340000000000003 111.984 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 t -134.5 2.26 3.21 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 120.999 0.428 . . . . 54.229999999999997 111.765 176.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -173.62 -164.96 29.66 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.242 -0.504 . . . . 74.120000000000005 112.778 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.09 -29.66 62.79 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.039 0.376 . . . . 60.43 114.039 -178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.33 126.15 1.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.341 -0.457 . . . . 64.439999999999998 112.98 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 27.2 t70 -160.2 109.37 1.74 Allowed 'General case' 0 CA--C 1.543 0.673 0 O-C-N 122.444 -0.445 . . . . 75.099999999999994 111.41 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -168.32 156.77 8.67 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.569 0.348 . . . . 60.43 110.846 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.725 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 4.6 mp0 -94.15 -61.12 0.18 Allowed Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 112.19 0.441 . . . . 64.430000000000007 112.19 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 6.1 Cg_exo -80.03 16.29 1.52 Allowed 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 122.567 2.178 . . . . 61.229999999999997 113.749 -176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.544 HG23 ' H ' ' A' ' 99' ' ' ASP . 5.6 tt -47.9 -59.37 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 112.86 0.689 . . . . 72.129999999999995 112.86 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.544 ' H ' HG23 ' A' ' 98' ' ' ILE . 6.8 m-20 -63.83 -50.98 68.02 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 111.983 0.364 . . . . 74.230000000000004 111.983 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 94.3 Cg_exo -47.24 -40.8 27.9 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.437 2.091 . . . . 74.340000000000003 113.704 174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 97' ' ' PRO . 7.4 mp -63.8 -59.82 4.07 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.838 0.351 . . . . 74.129999999999995 111.266 176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 92.7 mt -53.93 -35.82 62.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.081 0.467 . . . . 71.439999999999998 111.334 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.3 t -57.78 -46.04 85.14 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.826 -0.624 . . . . 74.510000000000005 111.432 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -71.07 -41.07 71.19 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.673 0.249 . . . . 72.349999999999994 111.673 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -60.32 -35.68 76.17 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.184 0.516 . . . . 75.430000000000007 111.113 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 106' ' ' ARG . 15.0 tpt180 -79.53 -31.37 42.07 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.008 0.432 . . . . 74.400000000000006 110.591 177.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -59.67 -38.32 81.18 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.033 -0.53 . . . . 72.319999999999993 110.534 172.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.72 -52.82 26.57 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.103 -0.499 . . . . 72.530000000000001 110.789 173.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 122.39 34.34 0.82 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.123 -0.561 . . . . 64.120000000000005 113.797 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 110' ' ' LEU . 7.1 mp -83.56 136.12 34.37 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.458 -0.436 . . . . 73.519999999999996 111.111 177.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.4 t -77.78 125.74 29.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.096 -0.335 . . . . 74.200000000000003 110.096 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.643 ' HA ' HG23 ' A' ' 85' ' ' VAL . 59.3 p -97.38 -8.48 29.43 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.679 0.992 . . . . 60.420000000000002 113.679 -168.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . 50.24 78.82 0.09 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.538 0.569 . . . . 73.319999999999993 112.538 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 64.82 106.9 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 112.388 0.514 . . . . 72.230000000000004 112.388 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.63 74.14 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.08 1.853 . . . . 73.409999999999997 111.906 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . . . -73.76 114.45 12.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.79 0.663 . . . . 60.149999999999999 112.79 -173.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 11.2 tt -159.04 80.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.949 0.88 . . . . 64.140000000000001 110.6 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -146.81 90.58 1.93 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.772 -0.649 . . . . 73.099999999999994 111.773 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.3 pp -149.45 149.34 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.397 0.618 . . . . 71.109999999999999 112.232 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -91.23 -25.2 19.62 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.715 -0.675 . . . . 61.240000000000002 110.886 174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 178.71 -52.34 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.439 -0.8 . . . . 73.340000000000003 109.962 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.4 p -128.62 140.06 37.38 Favored Pre-proline 0 N--CA 1.472 0.674 0 CA-C-N 115.794 -0.639 . . . . 74.319999999999993 110.795 176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.21 169.15 14.56 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.621 2.214 . . . . 55.409999999999997 114.012 -177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 125' ' ' GLU . 91.1 m -107.43 160.06 15.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.866 -0.606 . . . . 53.520000000000003 110.526 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.42 ' N ' HG22 ' A' ' 124' ' ' THR . 9.4 pt-20 -43.47 -35.53 1.67 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.634 0.975 . . . . 62.420000000000002 113.634 -177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -62.36 -23.25 66.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.327 0.492 . . . . 62.299999999999997 112.327 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 91.0 m -57.98 -39.74 78.92 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.231 0.538 . . . . 71.349999999999994 110.556 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.561 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 11.3 m-85 -60.44 -32.03 70.99 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.906 -0.588 . . . . 73.040000000000006 111.278 176.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -69.7 -36.52 76.03 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.44 -0.345 . . . . 72.5 111.136 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.28 -53.66 34.08 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.923 0.392 . . . . 64.340000000000003 110.256 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.7 m -58.79 -32.7 69.56 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.006 0.431 . . . . 53.43 111.083 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.04 -56.03 26.69 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.783 -0.644 . . . . 71.439999999999998 112.019 177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.43 -34.76 76.55 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.802 0.334 . . . . 74.200000000000003 111.74 -178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.06 -59.56 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.592 -0.276 . . . . 62.310000000000002 111.718 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -54.19 -49.36 60.0 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.546 -0.359 . . . . 72.209999999999994 113.558 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.488 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 55.4 m -59.79 -40.93 89.97 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.849 0.357 . . . . 72.0 111.431 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.47 -42.95 99.57 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.923 0.392 . . . . 74.120000000000005 111.365 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.66 -38.97 87.93 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.77 0.319 . . . . 75.120000000000005 110.979 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -58.31 -46.28 93.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.832 -0.699 . . . . 63.329999999999998 112.509 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 136' ' ' THR . 83.8 mt-30 -67.93 -23.82 65.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.039 0.447 . . . . 74.340000000000003 111.398 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -67.56 -44.81 77.36 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.216 0.531 . . . . 74.129999999999995 110.755 174.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.6 -50.24 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.97 -0.559 . . . . 73.010000000000005 111.857 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 140' ' ' GLN . 8.9 t -61.36 -33.52 73.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.669 0.271 . . . . 75.019999999999996 111.728 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 -56.88 -46.75 81.65 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.078 0.466 . . . . 63.329999999999998 110.972 174.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -56.61 -29.83 62.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.125 -0.488 . . . . 72.439999999999998 111.351 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? -86.84 -34.22 19.56 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.237 -0.438 . . . . 63.409999999999997 112.172 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.4 tp -151.39 -86.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.544 0.572 . . . . 72.329999999999998 112.544 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.23 -70.64 0.36 Allowed 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.391 0.615 . . . . 75.439999999999998 111.375 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 150' ' ' HIS . 6.2 t60 -157.82 -51.2 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.863 -0.608 . . . . 71.099999999999994 110.074 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 149' ' ' HIS . 44.8 t-80 175.85 84.64 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.748 -0.66 . . . . 62.119999999999997 109.847 175.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -72.73 83.42 1.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.166 0.508 . . . . 72.129999999999995 112.166 -173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -159.05 158.36 32.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.548 0.739 . . . . 63.350000000000001 110.107 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.16 149.09 38.5 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.182 0.515 . . . . 72.109999999999999 112.218 -175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 . . . . . 0 C--O 1.254 1.332 0 CA-C-O 118.577 -0.725 . . . . 63.210000000000001 109.705 169.704 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 65.6 m . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.497 0.189 . . . . 72.430000000000007 111.288 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 142' ' ' VAL . 48.9 mm 60.26 89.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.113 0.482 . . . . 74.349999999999994 111.862 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.63 90.11 1.61 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.963 -0.637 . . . . 72.329999999999998 112.278 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.539 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.0 p -82.06 120.12 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.481 0.658 . . . . 65.319999999999993 112.154 -177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -95.13 126.99 40.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.625 -0.716 . . . . 74.109999999999999 111.197 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 5.3 p90 -159.37 -178.91 7.49 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.831 0.348 . . . . 73.510000000000005 110.968 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -134.48 106.18 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.266 0.555 . . . . 62.420000000000002 111.761 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.9 m -70.34 -24.27 62.96 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.052 0.389 . . . . 71.109999999999999 112.052 177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -55.99 -47.38 77.81 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.145 0.498 . . . . 73.129999999999995 111.43 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -102.71 22.3 13.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.586 0.708 . . . . 64.409999999999997 109.274 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -30.33 91.89 0.01 OUTLIER Glycine 0 CA--C 1.527 0.788 0 N-CA-C 117.392 1.717 . . . . 62.310000000000002 117.392 -170.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -104.69 -34.13 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.79 . . . . 65.109999999999999 109.675 156.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.408 ' HB2' ' HB2' ' A' ' 6' ' ' TYR . 16.3 m -79.75 -12.98 59.76 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.033 -0.985 . . . . 75.430000000000007 112.901 -174.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -62.36 -39.09 92.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.038 0.447 . . . . 53.409999999999997 111.069 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -70.85 -38.34 73.17 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.215 0.531 . . . . 74.140000000000001 110.806 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.8 mt -61.63 -44.53 96.82 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.961 -0.563 . . . . 71.230000000000004 110.959 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.62 -37.46 87.42 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.054 -0.521 . . . . 71.310000000000002 111.346 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -58.07 -42.78 86.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.376 -0.374 . . . . 53.009999999999998 111.232 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.68 -43.42 89.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.065 0.459 . . . . 73.299999999999997 111.115 177.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.96 -51.24 74.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.073 -0.512 . . . . 73.040000000000006 110.989 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.48 ' HA ' HG21 ' A' ' 31' ' ' VAL . 76.3 mt -55.21 -43.06 69.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.264 178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -61.41 -33.1 73.14 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.104 0.478 . . . . 73.540000000000006 111.603 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.45 -32.02 23.4 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.34 -0.457 . . . . 75.519999999999996 113.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 51.3 mm -85.33 -50.54 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 112.42 0.526 . . . . 60.409999999999997 112.42 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 81.5 p -63.5 -37.39 87.1 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.319 0.488 . . . . 71.230000000000004 112.319 -175.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -65.05 -24.0 67.35 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 121.048 0.452 . . . . 71.120000000000005 111.213 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.3 m -81.31 -7.69 59.61 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.169 0.509 . . . . 64.329999999999998 111.185 176.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.93 13.79 35.97 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 121.124 -0.56 . . . . 63.049999999999997 113.846 177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' THR . 58.4 t -116.95 128.36 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.449 -0.442 . . . . 64.319999999999993 111.175 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.41 30.48 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.039 -0.601 . . . . 72.030000000000001 113.225 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 1' ' ' SER . 49.0 t -109.56 141.33 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 122.794 -0.239 . . . . 54.539999999999999 111.516 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -111.52 117.98 34.48 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.087 0.47 . . . . 64.120000000000005 111.305 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' HB ' ' HE1' ' A' ' 6' ' ' TYR . 34.3 m -95.18 135.24 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.95 0.405 . . . . 65.549999999999997 111.724 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.2 t -133.38 104.84 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.012 0.434 . . . . 54.439999999999998 111.592 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 2.7 m-20 -78.8 92.53 4.85 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.954 0.407 . . . . 51.210000000000001 111.392 175.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -68.21 -13.02 61.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.892 0.377 . . . . 73.109999999999999 111.862 178.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' N ' HD12 ' A' ' 36' ' ' LEU . . . -84.51 -8.09 83.65 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.132 -0.556 . . . . 73.129999999999995 113.016 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.42 172.69 6.73 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.091 0.472 . . . . 50.229999999999997 111.8 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.32 82.93 1.05 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.076 0.465 . . . . 70.299999999999997 111.399 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.26 162.7 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.186 0.517 . . . . 72.25 112.145 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -136.69 167.12 22.03 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.317 -0.401 . . . . 71.299999999999997 110.779 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.502 HD13 HD12 ' A' ' 45' ' ' LEU . 3.9 mm? -59.55 -25.54 64.62 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.321 -0.237 . . . . 72.209999999999994 111.441 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -55.96 -34.37 65.63 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.02 0.438 . . . . 62.030000000000001 110.98 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -84.38 -50.08 8.12 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.389 0.614 . . . . 42.25 110.63 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.502 HD12 HD13 ' A' ' 42' ' ' LEU . 89.8 mt -56.62 -31.6 64.48 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.835 -0.62 . . . . 74.120000000000005 112.391 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -63.32 -46.41 86.79 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.961 0.41 . . . . 75.209999999999994 110.866 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.481 ' O ' ' HD3' ' A' ' 51' ' ' ARG . 60.3 tt0 -63.11 -34.79 78.37 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.002 0.429 . . . . 74.239999999999995 110.497 178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 54.4 tp -52.19 -45.34 65.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.08 -0.509 . . . . 53.299999999999997 111.177 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.29 -38.3 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.108 0.48 . . . . 72.040000000000006 111.077 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -71.84 -29.97 66.54 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.126 -0.559 . . . . 24.120000000000001 112.961 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 47' ' ' GLU . 3.5 mpt_? -89.13 5.25 45.46 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.981 0.363 . . . . 51.340000000000003 111.981 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -51.36 -27.85 10.89 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.888 0.699 . . . . 61.140000000000001 112.888 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.3 p -53.77 -38.6 64.63 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.122 0.415 . . . . 52.109999999999999 112.122 -178.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.24 134.84 4.71 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.895 -0.669 . . . . 54.43 113.039 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HB2' HG12 ' A' ' 85' ' ' VAL . 80.7 mt -137.93 174.75 10.24 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.878 0.471 . . . . 74.140000000000001 110.712 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' VAL . 48.5 t -139.76 111.68 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 110.325 -0.25 . . . . 74.109999999999999 110.325 175.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.642 HD13 ' HB ' ' A' ' 85' ' ' VAL . 1.7 mp -91.93 128.41 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 112.643 0.609 . . . . 72.329999999999998 112.643 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.35 139.86 11.3 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 115.636 -0.711 . . . . 63.509999999999998 112.142 173.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.453 ' SD ' HD12 ' A' ' 98' ' ' ILE . 72.7 mtm -82.8 161.5 21.98 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.037 0.446 . . . . 72.109999999999999 111.777 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 80.7 p -143.6 164.27 31.53 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.1 0.407 . . . . 55.539999999999999 112.1 -174.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.587 ' HA ' ' HA3' ' A' ' 93' ' ' GLY . 53.0 Cg_exo -55.51 168.23 1.64 Allowed 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 123.063 2.509 . . . . 61.32 113.804 177.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -50.76 47.7 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.24 0.83 . . . . 61.310000000000002 113.24 -175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.74 -52.18 66.51 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.942 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.4 m -58.39 -49.35 77.55 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.058 0.456 . . . . 74.430000000000007 111.236 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.504 ' HA ' HD12 ' A' ' 68' ' ' ILE . . . -57.97 -35.39 71.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.245 -0.434 . . . . 71.439999999999998 112.0 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.31 -41.16 96.54 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.019 0.437 . . . . 63.340000000000003 111.14 176.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.6 m -66.08 -42.15 89.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.384 -0.371 . . . . 62.130000000000003 111.096 176.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.623 HD11 HD13 ' A' ' 36' ' ' LEU . 67.3 mt -54.8 -54.53 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.073 0.463 . . . . 71.409999999999997 111.113 176.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -59.9 -30.9 69.34 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.013 -0.539 . . . . 74.010000000000005 111.53 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.12 -41.59 98.38 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.239 -0.505 . . . . 62.32 113.379 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.63 4.53 43.37 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.238 0.458 . . . . 51.100000000000001 112.238 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.25 -35.89 65.46 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.597 0.591 . . . . 74.109999999999999 112.597 -175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.7 m -56.97 -20.07 21.67 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.713 0.634 . . . . 71.340000000000003 112.713 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -100.42 -10.83 20.75 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.102 0.477 . . . . 70.219999999999999 111.714 178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 60.3 mt -92.58 -46.82 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 N-CA-C 112.198 0.444 . . . . 55.5 112.198 -177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.8 mt -50.85 -54.99 19.2 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.969 0.729 . . . . 75.239999999999995 112.969 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.06 5.49 1.95 Allowed Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.033 0.773 . . . . 60.219999999999999 115.033 -175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.9 m -92.47 -12.65 31.46 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.87 0.835 . . . . 52.43 112.247 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 110' ' ' LEU . 11.3 m -136.46 129.36 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.927 0.714 . . . . 63.420000000000002 112.927 -175.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.575 ' H ' ' NE2' ' A' ' 83' ' ' GLN . 30.8 p-10 -162.02 -174.22 4.03 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.04 -0.527 . . . . 73.439999999999998 111.074 176.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 60.69 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.907 1.076 . . . . 54.210000000000001 113.907 170.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -141.02 -5.01 1.14 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.189 0.811 . . . . 45.450000000000003 113.189 -172.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.575 ' NE2' ' H ' ' A' ' 80' ' ' ASN . 1.0 OUTLIER -53.88 127.22 25.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.999 0.428 . . . . 63.450000000000003 111.273 -178.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.489 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -89.43 140.76 29.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.671 0.619 . . . . 63.32 112.671 -171.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.642 ' HB ' HD13 ' A' ' 57' ' ' ILE . 17.8 m -131.97 109.69 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.551 0.691 . . . . 74.510000000000005 111.71 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' HA2' ' HB2' ' A' ' 113' ' ' ALA . . . -69.81 146.98 44.24 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.97 -0.559 . . . . 65.129999999999995 112.566 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.43 HG21 ' HA ' ' A' ' 115' ' ' PRO . 49.9 mm -125.54 121.89 61.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 O-C-N 122.67 -0.312 . . . . 64.150000000000006 111.1 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.593 ' HB2' ' SG ' ' A' ' 131' ' ' CYS . 34.7 p90 -120.04 126.48 50.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.981 0.419 . . . . 75.030000000000001 110.411 175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.44 133.28 50.12 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.103 0.478 . . . . 74.549999999999997 111.96 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 73.0 m -156.28 -22.6 0.1 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.097 -0.501 . . . . 63.450000000000003 111.419 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.41 -60.03 3.64 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.005 -0.617 . . . . 53.229999999999997 113.138 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.11 -76.64 1.32 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.208 -0.52 . . . . 62.329999999999998 113.55 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 61' ' ' PRO . . . 173.65 -65.61 0.11 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.642 -0.789 . . . . 62.039999999999999 113.439 -178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -89.41 111.79 22.75 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.279 0.562 . . . . 62.450000000000003 110.446 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -92.09 15.07 14.2 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.695 0.628 . . . . 75.519999999999996 112.695 -172.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.403 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 45.4 tt0 -91.04 -50.5 0.33 Allowed Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 113.35 0.87 . . . . 64.030000000000001 113.35 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 71.7 Cg_endo -70.97 -2.39 10.96 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.163 1.909 . . . . 62.310000000000002 113.61 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.453 HD12 ' SD ' ' A' ' 59' ' ' MET . 10.9 tt -72.04 -26.07 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 120.831 0.348 . . . . 71.239999999999995 111.785 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.94 -53.83 56.81 Favored Pre-proline 0 CA--C 1.553 1.076 0 N-CA-C 112.852 0.686 . . . . 61.43 112.852 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.72 -29.4 35.89 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.674 1.583 . . . . 72.349999999999994 112.461 176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.89 -48.63 79.63 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.181 -0.463 . . . . 72.150000000000006 111.279 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.6 mt -61.04 -23.33 65.36 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.423 0.527 . . . . 74.25 112.423 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.9 t -100.68 -71.62 0.7 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.096 0.776 . . . . 74.150000000000006 113.096 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -54.54 -41.49 69.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.557 0.947 . . . . 52.439999999999998 113.557 -166.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.415 ' HD2' HD22 ' A' ' 110' ' ' LEU . 66.8 m-85 -59.39 -26.51 65.19 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.058 0.392 . . . . 72.329999999999998 112.058 -177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 106' ' ' ARG . 50.0 mtm105 -70.7 -34.18 71.69 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.11 0.481 . . . . 75.439999999999998 110.749 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.7 -33.96 73.25 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.11 -0.495 . . . . 72.349999999999994 111.367 177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.97 -34.68 78.28 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.868 0.366 . . . . 62.109999999999999 111.365 176.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 111.01 25.48 5.07 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.072 -0.585 . . . . 64.319999999999993 113.983 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 85' ' ' VAL . 8.7 mp -74.65 122.81 23.77 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.217 -0.578 . . . . 64.349999999999994 111.158 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 34.9 m -74.46 94.13 2.55 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.897 0.379 . . . . 55.530000000000001 110.717 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 65.3 p -76.86 149.1 36.16 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.283 0.564 . . . . 32.130000000000003 112.367 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.458 ' HB2' ' HA2' ' A' ' 86' ' ' GLY . . . -76.73 -66.98 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.131 -0.486 . . . . 61.530000000000001 111.208 174.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -170.18 88.92 0.53 Allowed Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 120.875 0.369 . . . . 71.420000000000002 111.106 177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.43 ' HA ' HG21 ' A' ' 87' ' ' ILE . 85.7 Cg_endo -90.46 100.57 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.851 2.367 . . . . 72.129999999999995 113.284 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -144.02 110.7 5.61 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.57 -0.286 . . . . 71.329999999999998 111.225 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 1.2 pp -63.67 94.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.61 0.719 . . . . 74.450000000000003 112.75 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 25.6 mmm-85 -107.12 -14.49 14.91 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.987 -0.551 . . . . 72.540000000000006 111.987 178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.476 HD11 ' O ' ' A' ' 122' ' ' THR . 9.3 tp -84.37 156.16 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.49 0.662 . . . . 72.129999999999995 112.536 -175.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.772 ' HD2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -92.91 -39.34 11.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.738 -0.665 . . . . 50.009999999999998 110.158 171.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 177.01 -59.0 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.644 0.777 . . . . 63.399999999999999 110.245 174.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.476 ' O ' HD11 ' A' ' 119' ' ' ILE . 82.3 p -80.5 118.72 73.74 Favored Pre-proline 0 N--CA 1.472 0.646 0 CA-C-N 116.447 -0.342 . . . . 74.439999999999998 111.385 177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.56 146.62 68.27 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.476 2.117 . . . . 65.129999999999995 113.295 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.3 p -99.16 179.31 4.64 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.891 0.377 . . . . 73.329999999999998 111.592 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.18 -32.73 72.47 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.047 0.451 . . . . 65.329999999999998 111.14 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -57.42 -35.59 70.27 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 110.956 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.6 m -62.55 -39.03 92.31 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.496 -0.32 . . . . 71.239999999999995 111.491 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -60.17 -47.47 85.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.04 0.448 . . . . 65.230000000000004 111.04 177.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -65.96 -38.39 88.43 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.147 -0.479 . . . . 63.43 111.115 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tt -58.58 -52.63 64.83 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.291 -0.413 . . . . 72.200000000000003 110.53 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 88' ' ' PHE . 83.0 m -60.62 -41.08 94.11 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.886 0.374 . . . . 64.109999999999999 111.511 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -55.74 -45.02 78.08 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.204 0.526 . . . . 54.219999999999999 111.295 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -77.25 -41.66 40.21 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.004 -0.544 . . . . 74.219999999999999 111.96 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.44 -48.8 80.25 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.051 0.389 . . . . 73.299999999999997 112.051 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.19 -47.29 91.8 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.021 -0.609 . . . . 53.310000000000002 112.918 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.424 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 94.1 m -60.46 -45.8 92.37 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.849 0.357 . . . . 75.409999999999997 111.403 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -58.62 -45.07 90.02 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.284 -0.416 . . . . 74.129999999999995 111.411 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.3 tp -65.53 -42.93 91.44 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.815 0.34 . . . . 72.310000000000002 111.29 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -55.21 -36.27 61.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 121.261 -0.495 . . . . 72.430000000000007 112.869 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 136' ' ' THR . 77.5 mt-30 -57.86 -45.48 86.24 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 65.099999999999994 111.165 175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -62.7 -49.28 75.73 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.409 -0.36 . . . . 74.299999999999997 111.192 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.423 HG21 HD11 ' A' ' 2' ' ' ILE . 63.7 t -53.73 -56.64 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 112.325 0.491 . . . . 62.310000000000002 112.325 -176.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -65.13 -40.22 94.15 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.218 0.451 . . . . 71.099999999999994 112.218 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -75.01 -35.43 61.99 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.942 0.349 . . . . 72.319999999999993 111.942 -174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -74.08 -44.26 54.73 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.074 0.464 . . . . 75.239999999999995 110.672 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -58.14 -42.36 85.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.085 -0.507 . . . . 64.120000000000005 111.206 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -77.74 -60.13 2.5 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.091 -0.504 . . . . 72.099999999999994 110.228 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.55 91.33 0.07 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.448 0.699 . . . . 71.340000000000003 111.581 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -112.62 9.77 19.4 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.519 0.676 . . . . 73.040000000000006 110.808 178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -169.82 107.9 0.38 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.638 -0.71 . . . . 64.219999999999999 109.747 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -69.36 -66.82 0.53 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.395 -0.366 . . . . 75.310000000000002 111.88 -172.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 60.73 -178.51 0.1 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.282 0.475 . . . . 72.400000000000006 112.282 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 78.1 t60 69.73 -59.18 0.51 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.294 0.638 . . . . 72.430000000000007 111.617 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 . . . . . 0 C--O 1.253 1.284 0 CA-C-O 118.913 -0.565 . . . . 61.109999999999999 111.081 175.357 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 111.548 0.203 . . . . 63.32 111.548 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 44.3 mm 55.82 93.55 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 112.688 0.625 . . . . 72.319999999999993 112.688 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.09 109.89 3.81 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.563 -0.827 . . . . 70.200000000000003 113.318 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 32' ' ' ASP . 7.1 p -88.66 111.46 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.527 0.679 . . . . 51.020000000000003 111.747 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -89.31 96.66 10.81 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.757 -0.656 . . . . 74.019999999999996 111.117 177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.512 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 25.6 p90 -122.04 -177.89 3.71 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.994 -0.548 . . . . 73.329999999999998 110.358 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.17 93.93 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.413 0.625 . . . . 71.230000000000004 111.893 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.427 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 18.2 m -57.13 -27.09 61.52 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.379 0.609 . . . . 60.020000000000003 110.955 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.28 -23.06 64.71 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.324 -0.853 . . . . 75.140000000000001 112.598 -176.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -142.73 144.8 32.81 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.488 0.661 . . . . 74.019999999999996 112.662 -174.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.39 -162.8 6.2 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.385 -0.825 . . . . 72.239999999999995 114.894 178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.409 ' HB2' ' HG2' ' A' ' 123' ' ' PRO . 38.2 m-85 -94.24 6.59 48.17 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.105 0.409 . . . . 75.25 112.105 -175.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 16' ' ' LEU . 60.4 p -51.13 -34.07 29.36 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.244 0.461 . . . . 72.439999999999998 112.244 -173.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 13.5 t70 -58.31 -56.28 24.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.016 0.436 . . . . 65.209999999999994 111.193 174.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' HB3' ' HE2' ' A' ' 128' ' ' TYR . 18.7 mmt180 -65.69 -27.84 68.64 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.528 -0.305 . . . . 74.409999999999997 111.516 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 13' ' ' SER . 90.3 mt -67.41 -43.41 81.32 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.047 0.451 . . . . 52.020000000000003 110.382 173.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.02 85.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.112 -0.495 . . . . 73.200000000000003 110.805 175.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -57.63 -45.99 84.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.963 174.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.49 -43.65 89.09 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.967 0.413 . . . . 62.530000000000001 111.27 176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.551 HD13 HG11 ' A' ' 56' ' ' VAL . 67.1 mt -59.0 -57.71 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.93 175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.55 -35.29 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.118 -0.492 . . . . 73.239999999999995 111.609 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -60.08 -53.47 57.42 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.713 0.292 . . . . 75.129999999999995 111.129 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.38 97.85 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 121.129 -0.558 . . . . 74.040000000000006 112.933 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.685 HG23 ' HB ' ' A' ' 29' ' ' VAL . 36.7 mm -61.47 -47.23 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.916 0.388 . . . . 75.519999999999996 111.889 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 p -70.29 -31.73 69.19 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.741 0.305 . . . . 72.239999999999995 111.426 178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.675 ' HA ' ' HE3' ' A' ' 26' ' ' LYS . 0.3 OUTLIER -64.43 -42.17 96.18 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.854 0.359 . . . . 75.409999999999997 110.8 174.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.0 m -69.6 -51.73 32.55 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.335 -0.393 . . . . 72.239999999999995 111.134 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.82 53.95 0.13 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.443 -0.344 . . . . 70.129999999999995 113.162 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.685 ' HB ' HG23 ' A' ' 24' ' ' ILE . 46.2 t -139.7 157.82 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 122.419 0.288 . . . . 53.409999999999997 110.643 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.26 150.19 17.26 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 121.275 -0.488 . . . . 71.329999999999998 113.338 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 HG21 ' A' ' 24' ' ' ILE . 97.1 t -131.07 145.4 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 112.625 0.602 . . . . 75.510000000000005 112.625 -176.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.531 ' O ' HG12 ' A' ' 4' ' ' VAL . 29.0 m-20 -93.29 142.83 26.88 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.982 -0.554 . . . . 74.129999999999995 111.126 171.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -110.02 131.08 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 120.815 0.34 . . . . 70.200000000000003 111.873 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -138.17 131.44 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 120.702 0.287 . . . . 70.540000000000006 111.465 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 8.6 m-20 -95.67 105.42 17.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.679 0.276 . . . . 74.540000000000006 111.17 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.47 -14.29 62.8 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 120.928 0.394 . . . . 75.200000000000003 111.87 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -111.18 30.86 7.63 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.372 -0.442 . . . . 73.200000000000003 112.93 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.07 174.83 10.23 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.881 0.372 . . . . 74.040000000000006 111.508 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.04 93.85 0.3 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.518 0.562 . . . . 62.219999999999999 112.518 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -89.61 174.92 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.42 -0.355 . . . . 74.340000000000003 111.336 174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -145.46 172.2 13.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.001 0.429 . . . . 53.439999999999998 111.386 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 42' ' ' LEU . 3.2 tm? -54.48 -29.56 50.42 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.769 0.427 . . . . 71.420000000000002 110.735 177.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -52.82 -48.02 67.27 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 111.986 0.365 . . . . 74.299999999999997 111.986 178.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -58.93 -38.05 78.08 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.868 0.366 . . . . 62.100000000000001 111.146 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.9 -43.67 82.78 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 120.835 0.35 . . . . 43.32 110.79 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.9 ttt85 -58.59 -50.43 73.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.712 0.291 . . . . 73.230000000000004 111.33 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -63.92 -30.39 71.48 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.052 0.453 . . . . 70.120000000000005 110.901 176.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 51' ' ' ARG . 53.2 tp -58.92 -29.84 67.38 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.558 -0.292 . . . . 63.329999999999998 111.587 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.74 -33.42 40.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 121.194 0.521 . . . . 74.420000000000002 110.519 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -89.05 -31.65 11.77 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 116.003 -0.544 . . . . 74.310000000000002 112.469 173.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.657 ' HB2' ' HA ' ' A' ' 48' ' ' LEU . 99.7 mtt180 -73.47 -10.78 60.08 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 122.516 -0.403 . . . . 73.5 111.974 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.9 p -60.99 -10.79 6.37 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 111.768 0.285 . . . . 74.209999999999994 111.768 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.535 ' HA ' ' HG2' ' A' ' 83' ' ' GLN . 67.9 p -71.5 -28.61 64.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.002 0.429 . . . . 73.219999999999999 111.586 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -173.11 137.35 4.11 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 116.221 -0.445 . . . . 74.200000000000003 112.642 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.576 ' HG ' HD11 ' A' ' 57' ' ' ILE . 1.6 pt? -157.62 148.61 21.33 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.154 0.502 . . . . 63.140000000000001 111.806 -177.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.551 HG11 HD13 ' A' ' 20' ' ' ILE . 59.8 t -116.6 113.27 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 122.838 0.455 . . . . 73.239999999999995 111.03 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.576 HD11 ' HG ' ' A' ' 55' ' ' LEU . 3.3 mp -116.42 146.33 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 O-C-N 122.07 -0.394 . . . . 75.150000000000006 111.887 -174.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.73 -134.93 3.56 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 121.178 -0.534 . . . . 73.430000000000007 112.921 173.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.8 mmt -122.5 156.23 34.54 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 122.44 -0.447 . . . . 51.109999999999999 111.11 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.8 p -97.9 113.54 63.86 Favored Pre-proline 0 N--CA 1.47 0.527 0 CA-C-N 116.327 -0.397 . . . . 64.409999999999997 111.924 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.45 146.05 1.77 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.864 2.376 . . . . 73.329999999999998 112.773 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.54 -24.96 2.37 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.988 0.736 . . . . 54.039999999999999 112.988 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.94 -49.8 74.68 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.13 0.418 . . . . 53.439999999999998 112.13 177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 87.0 p -100.0 4.43 44.81 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.788 0.292 . . . . 62.130000000000003 111.788 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.84 -31.01 10.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.497 0.555 . . . . 62.020000000000003 112.497 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.9 72.21 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.089 0.471 . . . . 33.539999999999999 111.695 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.1 t -65.17 -45.43 84.92 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.078 0.466 . . . . 73.150000000000006 110.874 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 72' ' ' LEU . 50.4 mm -54.6 -52.95 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 115.912 -0.585 . . . . 70.230000000000004 111.657 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -66.14 -38.85 89.15 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 111.919 0.34 . . . . 74.409999999999997 111.919 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -60.82 -40.38 98.13 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.177 -0.535 . . . . 71.310000000000002 113.207 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 75' ' ' ILE . . . -85.32 -44.4 12.87 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.314 0.487 . . . . 75.230000000000004 112.314 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 72' ' ' LEU . 1.4 tm? -53.45 -42.99 67.71 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.592 0.357 . . . . 75.319999999999993 111.57 -174.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 m -51.16 -34.28 30.67 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.814 0.34 . . . . 63.140000000000001 111.864 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.3 m -89.93 -39.74 12.82 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.214 0.53 . . . . 63.43 111.21 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.575 HG23 HD21 ' A' ' 48' ' ' LEU . 72.1 mt -54.58 -41.41 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.163 -0.471 . . . . 74.040000000000006 111.733 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.94 -33.21 62.02 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.296 -0.411 . . . . 52.219999999999999 111.834 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.19 -31.73 33.72 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.137 -0.554 . . . . 71.049999999999997 112.902 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.8 m -72.7 -39.44 67.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.121 0.415 . . . . 61.310000000000002 112.121 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 75' ' ' ILE . 34.0 m -87.91 147.34 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.02 0.438 . . . . 73.109999999999999 111.568 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.619 ' N ' HD22 ' A' ' 80' ' ' ASN . 0.0 OUTLIER -160.94 -179.02 7.2 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.136 0.421 . . . . 55.140000000000001 112.136 -178.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.715 ' HG3' ' HG2' ' A' ' 82' ' ' LYS . 9.4 tp10 72.2 -106.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.886 0.874 . . . . 70.310000000000002 112.71 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.715 ' HG2' ' HG3' ' A' ' 81' ' ' GLU . 19.2 ptpt -164.98 24.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.417 0.895 . . . . 50.350000000000001 113.417 -172.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HG2' ' HA ' ' A' ' 53' ' ' THR . 1.3 mp0 -62.08 167.85 3.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.754 0.65 . . . . 70.329999999999998 112.754 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.578 ' HA ' ' HB ' ' A' ' 111' ' ' THR . . . -90.94 123.92 34.81 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.77 -0.65 . . . . 75.519999999999996 112.349 -175.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.0 m -100.74 108.53 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.493 0.663 . . . . 75.219999999999999 111.025 175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.91 81.43 0.33 Allowed Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.089 -0.505 . . . . 63.299999999999997 112.774 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.502 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 49.5 mm -79.53 109.08 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 O-C-N 122.568 -0.372 . . . . 75.329999999999998 111.391 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' HD2' ' HG1' ' A' ' 90' ' ' THR . 40.1 p90 -105.27 111.63 24.44 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.354 0.597 . . . . 74.010000000000005 110.555 173.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.819 ' HB2' HD11 ' A' ' 119' ' ' ILE . 7.7 pt-20 -57.9 104.05 0.17 Allowed 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.488 0.661 . . . . 64.25 112.703 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.409 ' HG1' ' HD2' ' A' ' 88' ' ' PHE . 90.6 m -142.34 112.78 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.131 -0.486 . . . . 53.420000000000002 111.534 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.52 -139.77 15.31 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.192 -0.528 . . . . 64.400000000000006 113.481 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.04 -102.44 2.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.066 -0.587 . . . . 75.430000000000007 113.359 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.22 -96.18 0.54 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.22 -0.514 . . . . 70.200000000000003 112.46 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -106.89 123.65 48.47 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.559 -0.377 . . . . 65.430000000000007 110.282 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -150.63 159.1 44.74 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 64.409999999999997 111.211 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.583 ' H ' ' HD2' ' A' ' 97' ' ' PRO . 37.9 mt-10 -103.91 -55.93 0.1 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.922 0.712 . . . . 74.310000000000002 112.922 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.583 ' HD2' ' H ' ' A' ' 96' ' ' GLU . 39.3 Cg_endo -64.7 -14.59 45.55 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.287 1.991 . . . . 71.439999999999998 114.014 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG23 ' N ' ' A' ' 99' ' ' ASP . 9.9 tt -49.12 -51.86 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 N-CA-C 113.26 0.837 . . . . 74.319999999999993 113.26 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.71 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 4.5 m-20 -61.53 -55.44 42.68 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.189 0.44 . . . . 75.219999999999999 112.189 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.71 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 50.7 Cg_exo -56.25 -33.35 90.69 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.009 1.806 . . . . 52.409999999999997 112.705 174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.8 tp -66.64 -57.06 7.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.06 -0.518 . . . . 74.310000000000002 111.479 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.33 -37.79 67.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.988 0.423 . . . . 63.210000000000001 110.862 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 100' ' ' PRO . 6.3 t -49.99 -43.33 50.42 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.844 -0.616 . . . . 72.430000000000007 111.727 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.702 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -64.55 -44.21 91.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.646 -0.252 . . . . 74.230000000000004 111.16 -177.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -60.68 -36.89 79.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.87 0.366 . . . . 72.120000000000005 111.223 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -66.85 -60.77 2.37 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.159 -0.473 . . . . 74.319999999999993 111.698 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -60.61 -39.31 87.68 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.302 0.482 . . . . 63.439999999999998 112.302 -177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.58 -24.43 49.76 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 122.205 -0.309 . . . . 63.009999999999998 111.569 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 66.65 52.59 33.27 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.155 -0.545 . . . . 62.100000000000001 113.04 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 89.3 mt -84.32 159.9 20.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.97 0.414 . . . . 73.129999999999995 111.535 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' A' ' 84' ' ' ALA . 88.2 m -79.63 110.02 14.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 40.5 110.77 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.8 p -108.52 141.57 40.21 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.44 0.533 . . . . 72.420000000000002 112.44 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.31 -86.13 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.418 -0.355 . . . . 74.510000000000005 111.131 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -148.63 96.42 3.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-O 121.104 0.478 . . . . 72.010000000000005 111.507 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.31 13.47 2.55 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.854 2.369 . . . . 73.519999999999996 113.193 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.2 78.01 2.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.285 0.564 . . . . 74.129999999999995 111.441 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.405 HG13 HD13 ' A' ' 119' ' ' ILE . 8.8 tt -62.5 112.64 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 113.175 0.806 . . . . 73.129999999999995 113.175 -175.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -140.44 49.87 1.71 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.132 0.492 . . . . 74.239999999999995 111.259 173.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 89' ' ' GLU . 3.3 mp -89.66 116.31 30.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.793 0.33 . . . . 64.420000000000002 110.957 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -55.96 -41.81 75.28 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.842 0.353 . . . . 72.030000000000001 111.933 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -178.38 -50.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.432 0.634 . . . . 72.340000000000003 109.997 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -127.06 142.52 43.99 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.862 -0.608 . . . . 55.119999999999997 110.679 175.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 12' ' ' TYR . 35.7 Cg_endo -63.98 148.36 91.63 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.631 2.221 . . . . 63.32 113.097 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 43.6 p -90.26 -178.68 5.45 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.158 0.504 . . . . 63.310000000000002 112.057 -177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -54.23 -42.48 69.89 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.023 -0.535 . . . . 72.230000000000004 111.718 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -59.99 -39.95 87.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 112.042 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 56.8 m -51.78 -30.75 24.21 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.983 0.364 . . . . 74.200000000000003 111.983 -176.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.416 ' HE2' ' HB3' ' A' ' 15' ' ' ARG . 69.9 m-85 -58.24 -41.01 83.2 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.717 0.294 . . . . 71.230000000000004 111.733 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 132' ' ' GLU . 53.3 mttm -82.94 -26.73 31.12 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.978 0.362 . . . . 71.510000000000005 111.978 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.68 -41.73 91.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.769 0.319 . . . . 75.209999999999994 110.862 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 30.3 p -81.63 -37.15 28.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.629 0.252 . . . . 73.530000000000001 111.105 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.67 ' HB3' ' HA ' ' A' ' 129' ' ' LYS . 37.7 tt0 -51.62 -71.32 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.01 0.524 . . . . 74.5 112.283 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -67.07 -38.61 86.08 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.465 0.542 . . . . 65.219999999999999 112.465 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.31 -54.44 37.03 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.806 0.336 . . . . 71.400000000000006 111.337 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.28 -43.67 97.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 120.935 -0.65 . . . . 42.030000000000001 112.641 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.494 HG22 HE21 ' A' ' 140' ' ' GLN . 86.7 m -64.66 -42.97 95.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.79 0.293 . . . . 75.310000000000002 111.79 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -63.83 -44.69 92.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.867 0.365 . . . . 55.399999999999999 110.781 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.13 -39.01 84.79 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.949 0.404 . . . . 72.099999999999994 110.83 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -59.67 -43.01 98.13 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.093 -0.575 . . . . 72.209999999999994 112.309 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.494 HE21 HG22 ' A' ' 136' ' ' THR . 78.5 mt-30 -62.89 -34.91 78.4 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.661 0.267 . . . . 72.019999999999996 111.059 175.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -63.09 -42.54 99.64 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.921 0.391 . . . . 72.209999999999994 110.653 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.04 -49.93 77.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 120.973 0.416 . . . . 62.140000000000001 111.2 176.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 149' ' ' HIS . 4.9 t -77.86 -11.44 59.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 116.576 -0.284 . . . . 74.329999999999998 111.609 177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -72.64 -61.54 1.77 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.076 0.465 . . . . 71.530000000000001 110.577 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.93 -40.02 96.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.824 -0.625 . . . . 63.25 111.704 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -75.66 -38.88 58.43 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.927 0.343 . . . . 73.420000000000002 111.927 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.525 ' O ' ' HG3' ' A' ' 148' ' ' GLU . 3.1 mm? -113.0 -89.0 0.53 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.648 0.261 . . . . 72.200000000000003 111.248 177.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 13.3 mt-10 -156.84 -59.71 0.09 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.233 0.613 . . . . 73.349999999999994 110.239 -176.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.484 ' O ' HG23 ' A' ' 143' ' ' THR . 17.7 t-80 -153.1 -48.15 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.056 -0.52 . . . . 73.319999999999993 110.479 169.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -177.49 93.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.245 -0.434 . . . . 73.310000000000002 111.286 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 77.5 t60 66.76 151.41 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.319 0.581 . . . . 75.310000000000002 112.344 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -75.4 134.65 40.88 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.318 0.58 . . . . 73.109999999999999 112.395 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -155.44 -101.59 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.727 -0.669 . . . . 75.530000000000001 110.054 174.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 20.7 p80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 119.311 -0.376 . . . . 73.310000000000002 110.611 164.837 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 58.0 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.311 0.101 . . . . 54.310000000000002 111.244 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.759 HG13 ' HA2' ' A' ' 139' ' ' GLY . 45.4 mm 67.14 122.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.561 0.578 . . . . 71.239999999999995 112.561 176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -87.92 109.22 3.48 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.132 -0.556 . . . . 55.100000000000001 112.703 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.7 t -92.23 102.4 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.634 -0.333 . . . . 65.310000000000002 111.57 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 57' ' ' ILE . 97.1 m-85 -86.87 120.64 28.36 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.898 0.38 . . . . 74.439999999999998 111.233 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 1.3 p90 -150.32 -179.9 7.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.393 -0.367 . . . . 64.340000000000003 110.924 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 65.7 t -133.49 110.62 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 116.68 -0.236 . . . . 64.25 110.522 173.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 14' ' ' ASP . 40.8 t -51.95 -33.48 37.73 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.404 0.52 . . . . 71.209999999999994 112.404 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -85.18 -12.6 52.31 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 112.711 0.634 . . . . 73.420000000000002 112.711 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -98.62 90.85 4.87 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.778 -0.576 . . . . 73.200000000000003 112.121 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 54.88 -162.03 4.61 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 115.067 0.787 . . . . 45.329999999999998 115.067 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 123' ' ' PRO . 39.4 m-85 -68.15 1.6 2.71 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.813 0.672 . . . . 64.230000000000004 112.813 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.3 m -54.63 -33.61 60.83 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.428 0.632 . . . . 74.25 110.581 175.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 8' ' ' SER . 23.6 t70 -59.66 -37.24 78.21 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.294 -0.866 . . . . 53.240000000000002 111.878 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -85.26 -26.73 26.46 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.182 -0.463 . . . . 73.5 111.904 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 99.4 mt -55.62 -46.25 77.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.847 0.356 . . . . 44.43 111.474 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.28 -54.29 47.16 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.243 0.46 . . . . 74.510000000000005 112.243 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.464 ' HA ' HG22 ' A' ' 21' ' ' ILE . 35.0 tt0 -67.25 -36.37 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.557 -0.292 . . . . 72.400000000000006 111.578 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.18 -42.74 86.74 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.784 0.326 . . . . 74.310000000000002 111.689 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.76 -55.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.784 0.326 . . . . 64.0 111.533 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 18' ' ' GLN . 13.4 tt -60.55 -30.05 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.626 0.25 . . . . 74.109999999999999 111.315 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -53.42 -35.3 60.28 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.213 0.53 . . . . 63.5 111.32 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.35 -33.92 6.96 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.156 -0.545 . . . . 75.219999999999999 113.437 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.81 -24.46 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 113.129 0.789 . . . . 72.109999999999999 113.129 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 t -53.6 -33.37 54.67 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.404 0.52 . . . . 72.200000000000003 112.404 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -61.82 -18.45 60.03 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.282 0.475 . . . . 74.439999999999998 112.282 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.0 m -84.28 -15.93 44.94 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.205 0.526 . . . . 64.329999999999998 111.308 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.85 2.99 57.16 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.385 -0.435 . . . . 54.030000000000001 112.928 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.9 t -98.67 104.57 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.046 0.45 . . . . 63.530000000000001 111.299 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.23 128.54 9.55 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.133 -0.556 . . . . 74.430000000000007 112.427 177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.2 m -90.54 137.32 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.1 0.476 . . . . 71.430000000000007 111.911 -178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -94.2 104.83 16.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.034 0.445 . . . . 74.5 111.069 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 ' HB ' ' CE1' ' A' ' 6' ' ' TYR . 35.8 m -83.2 139.53 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.121 0.486 . . . . 74.409999999999997 112.285 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.4 t -139.09 118.4 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.382 -0.372 . . . . 72.140000000000001 111.401 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 6' ' ' TYR . 4.9 m-20 -76.32 91.65 3.26 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.344 -0.222 . . . . 62.450000000000003 111.067 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 36' ' ' LEU . 2.5 pt? -59.79 -20.69 58.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.887 0.375 . . . . 55.32 111.963 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 12.58 66.94 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.29 -0.481 . . . . 72.040000000000006 113.39 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -161.51 -65.63 0.06 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.921 0.391 . . . . 75.150000000000006 111.916 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.65 77.82 4.16 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.132 0.491 . . . . 64.120000000000005 112.127 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -136.6 126.08 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.128 0.49 . . . . 62.210000000000001 111.807 178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -163.78 170.9 16.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.134 -0.485 . . . . 55.32 110.172 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 42' ' ' LEU . 2.7 tm? -54.73 -37.28 65.7 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.598 0.237 . . . . 73.299999999999997 111.151 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -58.55 -57.31 13.52 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.012 0.434 . . . . 75.319999999999993 111.404 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -61.28 -35.52 77.52 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.293 -0.412 . . . . 73.329999999999998 111.288 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 2.8 tm? -61.09 -42.07 97.83 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.02 0.438 . . . . 73.129999999999995 110.268 177.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -67.87 -43.29 79.73 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.875 0.369 . . . . 75.319999999999993 111.046 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.571 ' HB3' ' NH1' ' A' ' 51' ' ' ARG . 27.9 mt-10 -62.63 -25.74 68.27 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 111.749 0.278 . . . . 72.319999999999993 111.749 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 64.3 tp -57.44 -36.85 71.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 70.299999999999997 110.576 173.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.63 -35.93 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.085 0.469 . . . . 43.109999999999999 111.031 176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.48 77.39 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.115 -0.564 . . . . 64.530000000000001 112.642 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.571 ' NH1' ' HB3' ' A' ' 47' ' ' GLU . 7.5 mpt_? -100.39 6.83 44.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.431 0.293 . . . . 74.329999999999998 111.581 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -54.4 -19.94 6.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.135 0.791 . . . . 72.209999999999994 113.135 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.2 p -70.92 -17.99 62.67 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 111.933 0.345 . . . . 52.509999999999998 111.933 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 2' ' ' ILE . . . -169.68 137.76 4.68 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.886 -0.673 . . . . 51.439999999999998 113.744 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 55' ' ' LEU . 2.0 pt? -154.87 143.17 20.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.063 0.459 . . . . 74.200000000000003 111.047 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.51 122.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.245 0.545 . . . . 73.040000000000006 111.299 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -105.27 130.29 56.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.23 -0.441 . . . . 73.030000000000001 111.519 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.597 ' HA2' ' HB2' ' A' ' 88' ' ' PHE . . . -80.15 56.72 4.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.019 -0.61 . . . . 71.0 112.709 175.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 90' ' ' THR . 24.8 mmt 65.41 173.04 0.22 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.444 0.64 . . . . 74.329999999999998 111.943 -176.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.8 m -141.24 90.29 9.2 Favored Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 116.396 -0.365 . . . . 73.0 110.657 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -57.45 156.33 26.78 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.617 2.211 . . . . 41.399999999999999 113.258 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -40.98 -55.19 2.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.335 0.865 . . . . 64.510000000000005 113.335 -178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.44 -25.97 67.75 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.305 0.483 . . . . 61.039999999999999 112.305 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.4 t -72.03 -40.74 68.22 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.774 0.321 . . . . 64.040000000000006 111.296 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.19 34.89 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.822 0.675 . . . . 74.540000000000006 112.822 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -59.58 4.24 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.29 0.478 . . . . 65.140000000000001 112.29 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.1 t -65.11 -36.6 84.78 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.118 0.485 . . . . 45.43 111.482 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.495 HG22 ' HG ' ' A' ' 72' ' ' LEU . 56.2 mt -59.75 -33.31 51.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.924 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -53.24 -35.54 60.09 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 120.873 0.368 . . . . 62.140000000000001 111.894 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.95 -22.19 70.22 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.917 -0.658 . . . . 42.200000000000003 113.354 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.08 -31.45 11.06 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 112.57 0.581 . . . . 74.340000000000003 112.57 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' HG ' HG22 ' A' ' 68' ' ' ILE . 49.6 mt -49.94 -44.81 50.69 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.167 0.803 . . . . 71.049999999999997 113.167 -174.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.9 m -52.28 -35.67 50.79 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 111.953 0.353 . . . . 71.340000000000003 111.953 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 45.3 m -85.18 -45.26 12.19 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.026 0.441 . . . . 71.420000000000002 111.286 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.24 -50.2 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 116.266 -0.424 . . . . 55.009999999999998 111.776 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.57 -22.87 62.35 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.766 0.317 . . . . 73.319999999999993 111.747 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.36 -15.28 41.6 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.253 -0.499 . . . . 55.030000000000001 112.983 176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 75.8 m -89.29 -27.21 20.7 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.483 -0.422 . . . . 74.200000000000003 111.804 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.0 m -70.76 131.66 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-O 121.345 0.593 . . . . 63.149999999999999 112.073 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -82.74 170.49 15.01 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 71.519999999999996 110.786 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 44.2 tt0 -48.6 -35.05 12.74 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.75 0.648 . . . . 65.430000000000007 112.75 -177.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -154.21 141.32 19.4 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.444 0.64 . . . . 73.120000000000005 112.423 176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.82 -179.08 7.86 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.416 -0.811 . . . . 72.319999999999993 109.852 173.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' HB1' HD12 ' A' ' 138' ' ' LEU . . . -88.5 91.51 8.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.259 0.552 . . . . 73.439999999999998 111.691 -177.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.8 m -103.32 138.0 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 120.997 0.427 . . . . 74.209999999999994 111.198 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -138.57 164.63 25.67 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.985 -0.626 . . . . 52.310000000000002 113.177 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -135.44 145.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 122.72 0.408 . . . . 75.430000000000007 110.51 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.597 ' HB2' ' HA2' ' A' ' 58' ' ' GLY . 36.8 m-85 -99.21 129.18 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 120.708 0.29 . . . . 74.239999999999995 110.978 174.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' HB3' HG21 ' A' ' 117' ' ' ILE . 35.1 mp0 -70.2 80.29 0.52 Allowed 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.239 0.542 . . . . 72.299999999999997 111.315 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 59' ' ' MET . 9.0 t -146.66 179.03 7.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.27 -0.423 . . . . 75.239999999999995 111.366 -178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 121' ' ' GLN . . . 75.22 -72.12 1.69 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.336 -0.459 . . . . 72.230000000000004 113.736 178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.32 -116.25 0.73 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.198 -0.525 . . . . 71.530000000000001 112.978 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.53 36.29 0.51 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.023 -0.608 . . . . 44.32 112.899 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -106.91 109.88 21.89 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.669 0.271 . . . . 73.420000000000002 111.391 -177.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -161.06 157.27 25.86 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.406 -0.361 . . . . 74.310000000000002 111.622 -175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 97' ' ' PRO . 2.8 mp0 -103.49 -55.78 0.1 Allowed Pre-proline 0 CA--C 1.551 1.019 0 N-CA-C 113.227 0.825 . . . . 53.130000000000003 113.227 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 96' ' ' GLU . 3.8 Cg_exo -77.26 16.92 0.94 Allowed 'Trans proline' 0 CA--C 1.549 1.227 0 C-N-CA 122.703 2.269 . . . . 63.219999999999999 114.332 -176.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.515 HG23 ' H ' ' A' ' 99' ' ' ASP . 9.0 tt -44.36 -62.3 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 N-CA-C 114.231 1.197 . . . . 75.409999999999997 114.231 -177.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.515 ' H ' HG23 ' A' ' 98' ' ' ILE . 39.7 m-20 -62.72 -50.29 78.56 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 113.211 0.819 . . . . 72.109999999999999 113.211 -172.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 63.8 Cg_exo -53.67 -43.22 59.7 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.373 2.049 . . . . 54.240000000000002 113.344 177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.0 mp -70.2 -44.72 68.09 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.572 0.225 . . . . 72.530000000000001 111.425 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.555 ' O ' ' HD3' ' A' ' 106' ' ' ARG . 60.5 mt -56.05 -44.95 79.34 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.746 0.308 . . . . 54.5 110.985 176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.2 t -56.91 -40.93 77.22 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.951 0.405 . . . . 74.519999999999996 110.951 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -39.69 78.71 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.403 -0.362 . . . . 74.230000000000004 111.185 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.646 ' HD1' HD12 ' A' ' 110' ' ' LEU . 29.4 m-85 -61.39 -32.46 72.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.568 0.223 . . . . 75.120000000000005 111.316 177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.555 ' HD3' ' O ' ' A' ' 102' ' ' LEU . 2.1 mpt_? -73.92 -40.68 62.96 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.807 0.337 . . . . 55.399999999999999 111.111 175.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -56.63 -43.29 80.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.021 0.439 . . . . 63.439999999999998 111.426 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.496 ' HB3' ' O ' ' A' ' 81' ' ' GLU . 81.2 mt -89.72 -41.76 11.72 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.031 0.443 . . . . 75.540000000000006 111.911 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 93.24 57.39 1.38 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.933 -0.467 . . . . 73.099999999999994 111.933 -174.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.646 HD12 ' HD1' ' A' ' 105' ' ' PHE . 83.5 mt -96.32 163.01 13.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.346 0.593 . . . . 74.420000000000002 112.34 -174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.438 HG21 HD11 ' A' ' 138' ' ' LEU . 87.4 m -66.15 136.4 55.88 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.588 -0.733 . . . . 60.43 112.104 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 22.5 p -131.9 96.54 3.95 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.378 -0.374 . . . . 55.329999999999998 111.073 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.33 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.393 0.516 . . . . 61.450000000000003 112.393 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -150.43 89.65 4.45 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 121.166 0.507 . . . . 74.400000000000006 110.791 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.95 30.62 0.51 Allowed 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.037 2.492 . . . . 64.409999999999997 114.378 -172.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -165.19 101.63 0.74 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 111.94 0.348 . . . . 62.210000000000001 111.94 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.437 HG21 ' HB3' ' A' ' 89' ' ' GLU . 14.2 tt -153.0 143.53 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.004 0.431 . . . . 64.010000000000005 111.608 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -79.14 94.01 5.29 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.207 0.527 . . . . 74.540000000000006 111.74 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.436 HG12 HG23 ' A' ' 117' ' ' ILE . 49.4 mm -105.2 116.49 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.187 -0.461 . . . . 62.109999999999999 110.482 175.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' A' ' 121' ' ' GLN . 45.8 tptt -80.29 50.46 1.26 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.01 0.433 . . . . 61.439999999999998 111.498 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 91' ' ' GLY . 28.5 tt0 71.57 -60.45 0.52 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.461 0.704 . . . . 72.019999999999996 112.558 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.9 p -86.75 120.85 72.0 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 111.816 0.302 . . . . 60.219999999999999 111.816 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' A' ' 12' ' ' TYR . 71.5 Cg_exo -51.81 137.85 51.25 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.81 2.34 . . . . 72.299999999999997 113.085 177.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.9 p -93.83 168.01 11.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.883 0.373 . . . . 72.349999999999994 111.518 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.44 -32.74 71.66 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.219 0.533 . . . . 70.010000000000005 110.807 173.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -73.24 -31.63 64.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.013 -0.54 . . . . 74.409999999999997 111.02 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 72.8 m -52.51 -38.38 59.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.27 -0.423 . . . . 60.5 111.809 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -52.47 -41.9 63.75 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.688 0.28 . . . . 64.230000000000004 111.626 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -65.57 -46.36 79.75 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 111.977 0.362 . . . . 62.25 111.977 -178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.93 -51.61 60.9 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.523 -0.308 . . . . 75.310000000000002 111.091 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.9 -29.94 71.07 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.804 0.298 . . . . 65.109999999999999 111.804 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.46 -58.16 7.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.942 0.401 . . . . 53.549999999999997 110.369 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -69.19 -12.35 61.6 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.201 0.445 . . . . 73.010000000000005 112.201 -178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.59 -62.84 1.53 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.897 0.38 . . . . 44.030000000000001 110.863 172.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -62.08 -42.35 99.72 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.384 -0.436 . . . . 63.149999999999999 113.51 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -35.85 61.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.287 0.477 . . . . 75.209999999999994 112.287 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 141' ' ' TRP . 29.4 t70 -60.17 -51.64 68.73 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.976 0.417 . . . . 61.119999999999997 110.925 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.466 HD22 ' H ' ' A' ' 138' ' ' LEU . 2.6 mm? -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.915 0.388 . . . . 74.450000000000003 110.919 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.759 ' HA2' HG13 ' A' ' 2' ' ' ILE . . . -63.89 -55.06 26.73 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.321 -0.466 . . . . 62.399999999999999 112.746 177.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -74.61 -14.88 60.83 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 122.598 -0.354 . . . . 55.43 111.715 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.408 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 62.2 t90 -50.28 -38.33 40.66 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.18 0.514 . . . . 73.109999999999999 110.546 176.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.411 HG13 ' HD3' ' A' ' 146' ' ' ARG . 58.8 t -54.88 -61.05 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.437 -0.802 . . . . 51.240000000000002 111.623 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.7 t -70.62 -25.1 62.88 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.466 0.543 . . . . 71.030000000000001 112.466 -177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -67.93 -38.09 82.45 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.132 -0.355 . . . . 73.140000000000001 111.44 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.5 -50.33 7.35 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 120.965 0.412 . . . . 70.129999999999995 111.274 176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 11.9 mtp180 -69.93 -19.0 63.4 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.893 0.701 . . . . 74.409999999999997 112.893 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 52.5 tp 77.88 -49.59 0.5 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.396 0.678 . . . . 74.540000000000006 112.266 179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 55.92 17.93 2.8 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 120.996 0.427 . . . . 61.549999999999997 112.054 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.7 t60 57.04 21.27 6.16 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.989 -0.55 . . . . 71.230000000000004 111.71 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.3 m80 60.37 91.05 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.206 0.526 . . . . 71.519999999999996 111.064 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -82.97 66.04 8.39 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.599 0.592 . . . . 73.329999999999998 112.599 -170.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.8 m80 62.12 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.339 0.866 . . . . 70.200000000000003 113.339 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 67.25 96.31 0.06 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.927 0.491 . . . . 75.420000000000002 112.167 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 83.6 t60 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.743 -0.646 . . . . 73.329999999999998 111.58 178.161 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.676 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 43.0 m . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 111.227 0.084 . . . . 74.129999999999995 111.227 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.9 mm 67.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-O 121.17 0.509 . . . . 61.43 111.766 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.95 109.58 3.21 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 121.2 -0.524 . . . . 73.040000000000006 112.972 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.65 111.58 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.795 0.331 . . . . 54.25 110.971 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.453 ' HE2' ' HB3' ' A' ' 55' ' ' LEU . 60.5 m-85 -97.29 139.46 33.22 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.408 0.521 . . . . 71.030000000000001 112.408 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 35' ' ' ASP . 44.1 p90 -142.29 162.91 34.26 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.751 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 9' ' ' GLU . 20.7 t -106.29 115.73 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 122.213 -0.305 . . . . 61.039999999999999 111.591 -175.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.406 ' OG ' ' HB2' ' A' ' 35' ' ' ASP . 15.1 m -60.12 -20.28 57.57 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.96 0.41 . . . . 74.010000000000005 111.786 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.54 ' H ' HG12 ' A' ' 7' ' ' VAL . 43.2 tt0 -70.13 -69.51 0.35 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.127 -0.488 . . . . 71.329999999999998 111.696 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -137.38 -35.16 0.68 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.943 0.349 . . . . 72.209999999999994 111.943 178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' HA3' ' HB ' ' A' ' 7' ' ' VAL . . . -28.55 103.37 0.01 OUTLIER Glycine 0 N--CA 1.472 1.091 0 N-CA-C 115.328 0.891 . . . . 53.210000000000001 115.328 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.62 5.47 3.06 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.83 0.452 . . . . 75.209999999999994 112.208 -176.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.6 m -57.7 -19.73 29.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.653 0.612 . . . . 42.439999999999998 112.653 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -61.73 -34.85 76.54 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.247 0.546 . . . . 45.340000000000003 111.067 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -69.47 -37.73 77.42 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.727 -0.669 . . . . 75.510000000000005 111.079 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.641 HD13 ' SG ' ' A' ' 131' ' ' CYS . 64.5 mt -70.3 -39.98 74.52 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.811 -0.632 . . . . 75.400000000000006 110.706 176.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.05 74.82 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.828 -0.624 . . . . 73.430000000000007 111.706 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -61.73 -41.02 97.09 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.122 0.487 . . . . 73.109999999999999 111.032 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.04 87.78 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.367 -0.379 . . . . 53.130000000000003 111.399 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 72.7 mt -62.85 -56.81 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.043 -0.526 . . . . 74.129999999999995 111.621 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.528 ' O ' HG22 ' A' ' 25' ' ' THR . 12.8 tt -54.77 -41.57 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 111.443 0.164 . . . . 52.520000000000003 111.443 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -51.31 -50.49 59.27 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.721 0.408 . . . . 55.409999999999997 111.832 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -76.26 -39.07 32.45 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.066 -0.588 . . . . 72.140000000000001 113.508 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 30' ' ' GLY . 49.6 mm -67.44 -41.61 86.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 O-C-N 122.268 -0.548 . . . . 70.25 112.119 -178.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 21' ' ' ILE . 13.3 t -72.1 -31.18 65.81 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.996 -0.44 . . . . 74.200000000000003 110.532 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -59.04 -42.84 91.2 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.043 0.449 . . . . 75.239999999999995 109.795 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 97.1 m -67.09 -27.47 67.38 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.856 -0.611 . . . . 75.430000000000007 111.218 174.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.17 22.52 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.23 -0.509 . . . . 71.430000000000007 113.509 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -95.67 -52.96 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 122.459 -0.436 . . . . 71.239999999999995 112.028 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.54 ' H ' HG22 ' A' ' 24' ' ' ILE . . . 87.64 134.78 4.49 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 121.124 -0.56 . . . . 62.219999999999999 113.55 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' ' O ' ' A' ' 1' ' ' SER . 34.0 m -108.69 171.74 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.198 0.523 . . . . 53.130000000000003 112.318 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -127.89 107.28 9.73 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.955 -0.566 . . . . 74.120000000000005 110.078 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.4 m -92.3 125.92 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 121.415 0.626 . . . . 75.25 112.334 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 88.1 t -122.68 126.19 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 120.99 0.424 . . . . 73.340000000000003 111.374 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.534 ' HB3' ' CZ ' ' A' ' 6' ' ' TYR . 5.4 p-10 -94.66 88.06 5.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.644 0.735 . . . . 65.010000000000005 111.771 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 36' ' ' LEU . 1.2 pp -69.73 -3.6 16.07 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.729 -0.669 . . . . 75.420000000000002 112.288 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -81.48 1.37 85.87 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.021 -0.609 . . . . 63.530000000000001 112.504 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.05 177.47 4.85 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.964 0.411 . . . . 71.349999999999994 111.132 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.64 84.33 0.29 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.035 0.445 . . . . 65.310000000000002 111.993 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.33 163.2 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.107 -0.497 . . . . 62.240000000000002 111.472 176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -159.51 172.7 17.39 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.862 0.363 . . . . 73.049999999999997 111.89 -175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 42' ' ' LEU . 3.4 mm? -56.11 -31.28 63.14 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.779 0.659 . . . . 75.439999999999998 112.779 -175.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -61.33 -34.23 74.92 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.263 0.554 . . . . 65.329999999999998 111.171 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.27 -48.93 12.29 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.775 -0.648 . . . . 71.129999999999995 110.69 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.44 HD23 HG12 ' A' ' 75' ' ' ILE . 3.3 tm? -53.53 -40.17 65.25 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.057 -0.52 . . . . 73.129999999999995 111.667 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -59.59 -53.02 62.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.098 0.475 . . . . 54.450000000000003 111.366 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -63.47 -39.04 93.4 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.133 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.428 HD11 ' HZ ' ' A' ' 5' ' ' PHE . 59.0 tp -55.53 -52.81 62.45 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.976 -0.556 . . . . 52.240000000000002 111.434 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 45' ' ' LEU . 87.7 t -60.21 -44.23 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.308 -0.406 . . . . 61.210000000000001 111.608 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.73 89.21 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.059 -0.591 . . . . 53.140000000000001 113.457 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.23 8.22 43.94 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.785 0.661 . . . . 72.299999999999997 112.785 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.4 p -55.28 -3.1 0.05 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.93 1.085 . . . . 73.230000000000004 113.93 -175.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -44.74 -41.37 6.79 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.61 0.596 . . . . 73.209999999999994 112.61 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 84' ' ' ALA . . . -149.84 136.86 5.9 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.354 -0.451 . . . . 72.319999999999993 112.291 176.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.453 ' HB3' ' HE2' ' A' ' 5' ' ' PHE . 83.9 mt -139.27 141.35 37.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.908 0.354 . . . . 73.040000000000006 111.671 -175.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.48 118.12 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.147 0.499 . . . . 71.310000000000002 111.191 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.515 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.2 mp -106.81 131.81 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 120.922 0.391 . . . . 74.430000000000007 111.709 -173.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.77 58.16 0.46 Allowed Glycine 0 CA--C 1.531 1.079 0 C-N-CA 121.35 -0.453 . . . . 72.120000000000005 113.424 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 89' ' ' GLU . 84.2 mtp 67.0 -178.49 0.21 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 112.96 0.726 . . . . 70.019999999999996 112.96 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.1 p -141.79 88.84 9.3 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.514 -0.767 . . . . 71.450000000000003 110.649 174.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.07 143.0 85.23 Favored 'Trans proline' 0 N--CA 1.48 0.727 0 C-N-CA 122.931 2.421 . . . . 63.32 113.253 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -37.8 -64.51 0.39 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.83 1.048 . . . . 75.319999999999993 113.83 -175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -56.31 -53.75 53.57 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.209 0.448 . . . . 74.129999999999995 112.209 -177.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' HG13 ' A' ' 68' ' ' ILE . 39.0 t -64.79 -25.81 68.08 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.455 0.539 . . . . 71.340000000000003 112.455 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.81 69.47 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.017 0.377 . . . . 74.299999999999997 112.017 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.24 -53.47 50.31 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.909 0.385 . . . . 73.420000000000002 111.735 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 69.8 m -71.19 -32.66 69.14 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.906 0.335 . . . . 72.209999999999994 111.906 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 64' ' ' SER . 76.6 mt -64.9 -47.35 88.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 111.852 0.316 . . . . 73.209999999999994 111.852 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -58.92 -42.34 89.44 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.712 0.292 . . . . 61.409999999999997 111.72 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -55.62 -38.14 70.51 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.226 -0.511 . . . . 65.120000000000005 113.038 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.42 -43.12 16.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.794 0.331 . . . . 74.310000000000002 111.514 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.6 tp -52.93 -41.08 64.12 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.801 0.44 . . . . 73.219999999999999 111.833 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.9 t -51.57 -37.47 49.84 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.123 0.487 . . . . 72.239999999999995 111.582 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.0 m -84.51 -40.79 17.22 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 111.356 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.44 HG12 HD23 ' A' ' 45' ' ' LEU . 72.4 mt -54.8 -46.76 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 116.01 -0.541 . . . . 61.5 111.889 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.99 -47.08 65.06 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.883 0.373 . . . . 74.209999999999994 111.937 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.07 -26.86 67.62 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 121.059 -0.591 . . . . 72.519999999999996 113.373 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -78.05 -40.66 38.01 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.493 0.553 . . . . 71.200000000000003 112.493 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.2 m -76.01 168.97 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.266 0.555 . . . . 74.319999999999993 112.261 -177.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -80.54 158.4 25.81 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 110.557 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.17 -82.3 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 113.317 0.858 . . . . 71.040000000000006 113.317 -171.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -94.5 101.0 12.88 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.705 0.632 . . . . 70.219999999999999 112.705 -173.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.01 -164.99 1.21 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.051 -0.522 . . . . 74.329999999999998 111.151 176.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -110.33 134.85 51.88 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.861 0.362 . . . . 61.340000000000003 110.771 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 112' ' ' THR . 29.6 m -132.55 170.96 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.422 0.629 . . . . 72.409999999999997 112.508 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 110.96 0.63 Allowed Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.819 -0.628 . . . . 63.140000000000001 111.982 175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -101.04 114.36 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 122.217 -0.578 . . . . 55.439999999999998 111.202 -177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.464 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 29.0 p90 -123.0 110.78 15.8 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.29 0.567 . . . . 74.230000000000004 111.503 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 59' ' ' MET . 41.8 mt-10 -78.77 81.77 5.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.234 0.54 . . . . 64.010000000000005 111.366 179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -79.76 -9.57 59.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.067 -0.515 . . . . 72.299999999999997 112.164 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.26 -70.67 0.79 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.24 -0.505 . . . . 70.430000000000007 113.073 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.58 21.75 77.76 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.169 -0.539 . . . . 74.409999999999997 113.15 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.86 -85.28 0.26 Allowed Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.278 -0.487 . . . . 72.430000000000007 113.944 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -163.52 129.93 3.26 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 122.42 -0.459 . . . . 75.140000000000001 111.369 -176.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -163.38 152.75 14.82 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.097 0.475 . . . . 73.230000000000004 111.89 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.464 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 2.6 mp0 -95.23 -43.96 0.27 Allowed Pre-proline 0 CA--C 1.554 1.129 0 N-CA-C 113.858 1.058 . . . . 74.329999999999998 113.858 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 96' ' ' GLU . 74.2 Cg_endo -71.13 23.28 0.22 Allowed 'Trans proline' 0 C--N 1.361 1.188 0 C-N-CA 122.27 1.98 . . . . 53.329999999999998 114.928 -170.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.414 HG23 ' N ' ' A' ' 99' ' ' ASP . 10.8 tt -57.71 -53.43 44.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 N-CA-C 112.648 0.61 . . . . 75.319999999999993 112.648 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.679 ' HB2' ' HD3' ' A' ' 100' ' ' PRO . 14.3 m-20 -61.89 -55.88 37.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 112.472 0.545 . . . . 64.200000000000003 112.472 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.679 ' HD3' ' HB2' ' A' ' 99' ' ' ASP . 52.8 Cg_exo -54.12 -44.98 44.48 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.333 2.022 . . . . 73.409999999999997 112.81 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 42.9 tp -60.48 -54.48 45.07 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.305 -0.407 . . . . 53.140000000000001 111.269 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.31 -38.69 80.91 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.518 -0.31 . . . . 70.450000000000003 111.725 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.6 t -62.46 -37.66 86.79 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.808 0.337 . . . . 45.520000000000003 111.339 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HE3' HD11 ' A' ' 108' ' ' LEU . 59.6 tptt -58.41 -47.73 82.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.024 0.44 . . . . 75.519999999999996 111.051 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -66.67 -46.42 75.73 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.327 -0.397 . . . . 74.340000000000003 111.773 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -62.53 -52.68 62.48 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.42 0.526 . . . . 74.019999999999996 112.42 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -63.27 -35.53 80.64 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.698 0.629 . . . . 74.349999999999994 112.698 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 ' HE3' ' A' ' 104' ' ' LYS . 80.7 mt -78.23 -15.58 58.66 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 122.107 -0.371 . . . . 75.140000000000001 111.605 177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 73.04 40.19 51.91 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 121.06 -0.59 . . . . 20.440000000000001 112.899 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 79.9 mt -72.93 104.03 3.93 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.828 0.346 . . . . 51.100000000000001 110.707 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.9 t -64.71 123.8 20.27 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.142 0.496 . . . . 64.120000000000005 112.086 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 76.6 p -89.92 136.89 32.77 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.361 -0.381 . . . . 42.219999999999999 111.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 138' ' ' LEU . . . -56.78 -54.64 44.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.082 0.468 . . . . 74.140000000000001 111.295 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -150.34 131.12 7.16 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.369 -0.378 . . . . 70.239999999999995 110.284 176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.54 103.53 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.412 2.074 . . . . 72.239999999999995 112.688 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 88' ' ' PHE . . . -80.45 -179.47 7.17 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.714 0.635 . . . . 44.32 112.714 -177.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 12.9 tt -131.25 145.2 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.92 -0.582 . . . . 71.400000000000006 111.019 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -72.24 150.23 43.84 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.482 0.919 . . . . 74.200000000000003 113.482 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 123' ' ' PRO . 23.4 mm -106.8 167.14 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.115 -0.948 . . . . 71.519999999999996 110.757 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.481 ' N ' HG22 ' A' ' 119' ' ' ILE . 57.6 tptt -64.19 -66.11 0.59 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.843 0.354 . . . . 71.230000000000004 111.773 176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -151.13 -55.73 0.15 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.257 0.551 . . . . 74.109999999999999 111.027 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -92.82 118.63 67.98 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.956 -0.565 . . . . 75.150000000000006 110.413 177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 119' ' ' ILE . 32.1 Cg_endo -61.95 141.27 88.87 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.675 2.25 . . . . 64.349999999999994 113.389 -176.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 81.4 p -76.16 156.08 34.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.877 -0.601 . . . . 75.120000000000005 111.428 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -64.76 -30.9 71.92 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.165 0.507 . . . . 74.340000000000003 111.037 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -57.29 -22.69 43.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.3 -0.409 . . . . 71.230000000000004 111.093 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 33.9 m -65.6 -25.76 67.54 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.852 0.358 . . . . 72.439999999999998 111.068 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -67.47 -48.16 67.97 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.913 0.387 . . . . 73.319999999999993 110.395 172.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -61.68 -31.62 71.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.467 0.651 . . . . 74.329999999999998 110.692 176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 57.5 tp -61.02 -63.02 1.44 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.369 -0.832 . . . . 74.340000000000003 111.005 172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.641 ' SG ' HD13 ' A' ' 16' ' ' LEU . 64.6 m -62.24 -26.21 68.25 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.387 -0.37 . . . . 42.119999999999997 111.936 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.02 -69.86 0.1 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.189 -0.46 . . . . 61.409999999999997 111.751 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -83.57 -16.67 44.51 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.185 0.439 . . . . 42.409999999999997 112.185 -178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.78 -53.62 44.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.812 0.339 . . . . 74.430000000000007 110.716 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.52 95.45 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.14 -0.552 . . . . 70.510000000000005 112.444 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 140' ' ' GLN . 59.4 m -60.85 -46.74 89.4 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 111.918 0.34 . . . . 71.439999999999998 111.918 178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -62.82 -43.62 98.31 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.771 0.32 . . . . 74.150000000000006 111.278 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 113' ' ' ALA . 44.2 tp -57.31 -45.05 84.59 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.263 0.554 . . . . 51.100000000000001 110.008 173.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 143' ' ' THR . . . -61.97 -35.5 91.48 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.807 -0.633 . . . . 70.510000000000005 112.785 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLN . . . . . 0.511 ' HA ' HG22 ' A' ' 143' ' ' THR . 24.6 mt-30 -65.19 -35.56 81.45 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.909 0.354 . . . . 70.319999999999993 111.352 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -62.38 -47.6 83.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.072 0.463 . . . . 74.109999999999999 110.391 175.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 59.7 t -62.24 -55.53 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.821 -0.627 . . . . 55.439999999999998 111.684 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 140' ' ' GLN . 8.8 t -63.27 -28.31 69.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.071 0.397 . . . . 63.450000000000003 112.071 -178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.509 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 37.7 ttt180 -68.42 -50.47 52.52 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.104 0.478 . . . . 51.210000000000001 111.164 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.89 -29.69 66.95 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 116.057 -0.52 . . . . 75.230000000000004 111.669 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 146' ' ' ARG . 23.8 ttt180 -100.58 -31.72 11.12 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.995 1.109 . . . . 63.450000000000003 113.995 -172.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.1 tp -151.54 -94.47 0.06 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 113.943 1.09 . . . . 70.450000000000003 113.943 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' CG ' ' HA ' ' A' ' 144' ' ' ARG . 7.4 mm-40 58.46 97.17 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.093 0.557 . . . . 71.239999999999995 112.32 -168.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -115.93 -43.09 3.01 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 122.212 -0.305 . . . . 73.140000000000001 111.583 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.97 31.81 0.4 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.898 0.38 . . . . 73.219999999999999 111.624 176.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.425 ' HE1' ' HG2' ' A' ' 140' ' ' GLN . 39.2 t-80 -85.1 134.09 34.2 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.344 -0.389 . . . . 73.049999999999997 111.314 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -138.57 141.91 39.24 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.13 0.49 . . . . 71.329999999999998 112.051 -176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -115.6 122.47 45.72 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.883 0.473 . . . . 65.150000000000006 110.391 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 119.248 -0.406 . . . . 73.430000000000007 111.642 178.212 . . . . . . . . 0 0 . 1 stop_ save_